Citrus Sinensis ID: 011287

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------49
Protein Sequence
MLAMEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDDVHDSSWNPSHIGDISAKINDGNGGASSSEGSITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRASQWKKAIEALQNP
Secondary Structure (PSIPRED)
cccccccccccccccccccccccccccccccccccccccccccccccEEEEEEEEccccEEEEEEEcccccEEEEEEccHHHHHHHHHHHHHHHHHHHHHHcccccEEcEEEEEcccccEEEEEEEccccccHHHHHHccccccccHHHHHHHHHHHHHHHHcccccccccccccccccccccEEEEcccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHccccccccccHHHHHHHHHHccccccccccHHHHHHHHHHHccccccccccccccHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHcccccccEEEEEEEcccEEEEcccccEEEEEEEccccccccEEEccccccEEEEccccEEEEEcccccHHHHHHHHHHHccc
Secondary Structure Prediction (SSPRO)
cccHcccccccccccccccccccccccccccccccccccccccHHHEEEEEEEEEEccEEEEEEEEccccEEEEEEEEEHHHHHHcccHHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEEcccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEcccHccEEEccccccccccccccccHHHccHHHHccccEccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHccccccccccHHHHHHHHHHccccccccccccccccHHHHccHHHccccHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHccccccHcccccccEEEccccccccccHHHHHHHHHHcccccEEEEcHHHHHHcccccccccccccccccccccEEEEEccccEEEEEccccHHHHHHHHHHHHccc
Coil and Loop (DISEMBL)
mlamekdfdsklriegnnnsstncptvqrsksfafrapqehfsiqdfelgkiygvgsyskvvrakkidtgTVYALKIMDKKFITKENKTAYVKLERIVLdqldhpgvvrlFFTFQDTFSLYMALesceggelfdqitskghlsedeARFYTAEVVDALEYIHSmglihrdikpenllltadghikiadfgsvkpmqdsritvlpnaasddkactfvgtaayvppevlnsspatfgndlwALGCTLyqmlsgtspfkdtsEWLIFQRIIArdirfpnyfSDAARDLIDRLldvdpsgrpgagpggyavlkmhpffkgidwknirgqtppklasepmvqsgegddvhdsswnpshigdisakindgnggasssegsITRLAsidsfdskwqqfldpgeSVLMISMVKKLQKLTSKKVQLIltnkpkliyvdpsklvvkgniiwsdnsndlsiqvsspshfkivtpkkvlSFEDAKQRASQWKKAIEALQNP
Flexible Loop (DISEMBL)
MLAMEKDFDSKlriegnnnsstncptVQRSKSFAFRAPQEHfsiqdfelgkiYGVGsyskvvrakkidtgtvyalkimdkkfitkenKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDDVHDSSWNPSHIGDISAKINDGNGGASSSEGSITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKvqliltnkpkliyvdpsKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRASQWKKAIEALQNP
Low Complexity Region (SEG)
MLAMEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSdaardlidrlldvdPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDDVHDSSWNPSHIGDISAKINDGNGGASSSEGSITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRASQWKKAIEALQNP
Disordered region (IsUnstruct)
**********************************FRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDP*****AGPGGYAVLKMHPFFKGIDWKNIR*********************************************************IDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV****HFKIVTP**************************
Disordered Region (DISOPRED)
**********************************************FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS*********SDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDDVH*****************************************************************TSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSND*SI*VSSPSHFKIVTPKKVLSFEDAKQRASQWKKAIEALQ**
Disordered Region (DISEMBL)
********DSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP*****************DSSWNPSHIGDISAKINDG*********SITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFE*******************
Disordered Region (DISPRO)
****************************************HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDDVHDSSWNPSHIGDISA*****************R******FDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRASQWKKAIEALQN*
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MLAMEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDDVHDSSWNPSHIGDISAKINDGNGGASSSEGSITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRASQWKKAIEALQNP
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	489	2.2.26 [Sep-21-2011]
Q4V3C8	486	3-phosphoinositide-depend	yes	no	0.991	0.997	0.840	0.0
Q9XF67	491	3-phosphoinositide-depend	no	no	0.991	0.987	0.825	0.0
Q9Z2A0	559	3-phosphoinositide-depend	yes	no	0.879	0.769	0.385	4e-85
O55173	559	3-phosphoinositide-depend	yes	no	0.879	0.769	0.383	7e-85
O15530	556	3-phosphoinositide-depend	yes	no	0.879	0.773	0.383	1e-84
Q6A1A2	396	Putative 3-phosphoinositi	no	no	0.607	0.75	0.469	2e-74
Q54PK9	908	3-phosphoinositide-depend	yes	no	0.574	0.309	0.416	5e-62
Q12701	592	Serine/threonine-protein	yes	no	0.572	0.472	0.424	2e-59
P34102	910	Protein kinase 3 OS=Dicty	no	no	0.576	0.309	0.390	5e-59
Q12236	1081	Serine/threonine-protein	yes	no	0.576	0.260	0.398	3e-58

>sp|Q4V3C8|PDPK2_ARATH 3-phosphoinositide-dependent protein kinase 2 OS=Arabidopsis thaliana GN=PDPK2 PE=1 SV=1

 Score =  844 bits (2181), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 410/488 (84%), Positives = 441/488 (90%), Gaps = 3/488 (0%)

Query: 1   MLAMEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSK 60
           ML M+K+FDSKL ++GN  SS+N  T+ RSKSFAF+APQE+F+  DFELGKIYGVGSYSK
Sbjct: 1   MLTMDKEFDSKLTLQGN--SSSNGETISRSKSFAFKAPQENFTYHDFELGKIYGVGSYSK 58

Query: 61  VVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL 120
           VVRAKK D GTVYALKIMDKKFITKENKTAYVKLERIVLDQL+HPG+V+LFFTFQDT SL
Sbjct: 59  VVRAKKKDNGTVYALKIMDKKFITKENKTAYVKLERIVLDQLEHPGIVKLFFTFQDTQSL 118

Query: 121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA 180
           YMALESCEGGELFDQIT KG LSEDEARFY+AEVVDALEYIH+MGLIHRDIKPENLLLT 
Sbjct: 119 YMALESCEGGELFDQITRKGRLSEDEARFYSAEVVDALEYIHNMGLIHRDIKPENLLLTL 178

Query: 181 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 240
           DGHIKIADFGSVKPMQDS+ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA
Sbjct: 179 DGHIKIADFGSVKPMQDSQITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 238

Query: 241 LGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGA 300
           LGCTLYQMLSGTSPFKD SEWLIFQRIIARDI+FPN+FS+AARDLIDRLLD DPS RPGA
Sbjct: 239 LGCTLYQMLSGTSPFKDASEWLIFQRIIARDIKFPNHFSEAARDLIDRLLDTDPSRRPGA 298

Query: 301 GPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDDVHDSSWNPSHIGDISAK 360
           G  GY  LK HPFFKG+DWKN+R QTPPKLA +P  QS    +   S WNP+H+GD S  
Sbjct: 299 GSEGYDSLKRHPFFKGVDWKNLRSQTPPKLAPDPASQSA-SPERDGSPWNPTHVGDTSVL 357

Query: 361 INDGNGGASSSEGSITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQLILT 420
            NDG+ G S S GSITRLASIDSFDS+WQQFL+PGESVLMIS VKKLQK+TSKKVQLILT
Sbjct: 358 QNDGHNGLSESSGSITRLASIDSFDSRWQQFLEPGESVLMISAVKKLQKITSKKVQLILT 417

Query: 421 NKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRASQWK 480
           NKP+LIYVDPSKLVVKGNIIWSDNSNDL++QVSSPSHFKI TPKKVLSFEDAKQRA QWK
Sbjct: 418 NKPRLIYVDPSKLVVKGNIIWSDNSNDLNVQVSSPSHFKICTPKKVLSFEDAKQRALQWK 477

Query: 481 KAIEALQN 488
           KAIE LQN
Sbjct: 478 KAIETLQN 485

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9XF67|PDPK1_ARATH 3-phosphoinositide-dependent protein kinase 1 OS=Arabidopsis thaliana GN=PDPK1 PE=1 SV=1

 Score =  837 bits (2161), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 407/493 (82%), Positives = 441/493 (89%), Gaps = 8/493 (1%)

Query: 1   MLAMEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSK 60
           MLAMEK+FDSKL ++GN   S+N   V RSKSF+F+APQE+F+  DFE GKIYGVGSYSK
Sbjct: 1   MLAMEKEFDSKLVLQGN---SSNGANVSRSKSFSFKAPQENFTSHDFEFGKIYGVGSYSK 57

Query: 61  VVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL 120
           VVRAKK +TGTVYALKIMDKKFITKENKTAYVKLERIVLDQL+HPG+++L+FTFQDT SL
Sbjct: 58  VVRAKKKETGTVYALKIMDKKFITKENKTAYVKLERIVLDQLEHPGIIKLYFTFQDTSSL 117

Query: 121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA 180
           YMALESCEGGELFDQIT KG LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT+
Sbjct: 118 YMALESCEGGELFDQITRKGRLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTS 177

Query: 181 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 240
           DGHIKIADFGSVKPMQDS+ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA
Sbjct: 178 DGHIKIADFGSVKPMQDSQITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 237

Query: 241 LGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGA 300
           LGCTLYQMLSGTSPFKD SEWLIFQRIIARDI+FPN+FS+AARDLIDRLLD +PS RPGA
Sbjct: 238 LGCTLYQMLSGTSPFKDASEWLIFQRIIARDIKFPNHFSEAARDLIDRLLDTEPSRRPGA 297

Query: 301 GPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSG--EGDDVHDSSWNPSHIGDIS 358
           G  GY  LK HPFF G+DWKN+R QTPPKLA +P  Q+   E DD H S WN +HIGD  
Sbjct: 298 GSEGYVALKRHPFFNGVDWKNLRSQTPPKLAPDPASQTASPERDDTHGSPWNLTHIGDSL 357

Query: 359 AKINDGNGG---ASSSEGSITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKV 415
           A  N+G+     +S S GSITRLASIDSFDS+WQQFL+PGESVLMIS VKKLQK+TSKKV
Sbjct: 358 ATQNEGHSAPPTSSESSGSITRLASIDSFDSRWQQFLEPGESVLMISAVKKLQKITSKKV 417

Query: 416 QLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQR 475
           QLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDL++ V+SPSHFKI TPKKVLSFEDAKQR
Sbjct: 418 QLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLNVVVTSPSHFKICTPKKVLSFEDAKQR 477

Query: 476 ASQWKKAIEALQN 488
           AS WKKAIE LQN
Sbjct: 478 ASVWKKAIETLQN 490

May couple lipid signals to the activation-loop phosphorylation of several protein kinases of the so-called AGC kinase family. Interacts via its pleckstrin homology domain with phosphatidic acid, PtdIns3P and PtdIns(3,4)P2 and to a lesser extent with PtdIns(4,5)P2 and PtdIns4P. May play a general role in signaling processes controlling the pathogen/stress response, polar auxin transport and development. Transphosphorylates the AGC protein kinases OXI1/AGC2-1, PK1/S6K1, PK19/S6K2 and PID resulting in their activation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9Z2A0|PDPK1_MOUSE 3-phosphoinositide-dependent protein kinase 1 OS=Mus musculus GN=Pdpk1 PE=1 SV=2

 Score =  315 bits (808), Expect = 4e-85,   Method: Compositional matrix adjust.
 Identities = 183/475 (38%), Positives = 257/475 (54%), Gaps = 45/475 (9%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 83  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 142

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 143 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 202

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A +FVGTA YV P
Sbjct: 203 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANSFVGTAQYVSP 254

Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F   ARD
Sbjct: 255 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYHFPEKFFPKARD 314

Query: 285 LIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDD 343
           L+++LL +D + R G     GY  LK HPFF+ I W+N+  QTPPKL +     S + +D
Sbjct: 315 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFETITWENLHQQTPPKLTAYLPAMSEDDED 374

Query: 344 VHDSSWN--------------------------PSHIG-DISAKINDGNGGASS-----S 371
            + +  N                          P   G +I   I+D +  +       S
Sbjct: 375 CYGNYDNLLSQFGFMQVSSSSSSHSLSTVETSLPQRSGSNIEQYIHDLDTNSFELDLQFS 434

Query: 372 EGSITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPS 431
           E     L    +  + W QF++    +L +  V K + L +++ QL+LT  P L YVDP 
Sbjct: 435 EDEKRLLLEKQAGGNPWHQFVE-NNLILKMGPVDKRKGLFARRRQLLLTEGPHLYYVDPV 493

Query: 432 KLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRASQWKKAIEAL 486
             V+KG I W   S +L  +  +   F + TP +     D    A +W + I+ +
Sbjct: 494 NKVLKGEIPW---SQELRPEAKNFKTFFVHTPNRTYYLMDPSGNAHKWCRKIQEV 545

Serine/threonine kinase which acts as a master kinase, phosphorylating and activating a subgroup of the AGC family of protein kinases. Its targets include: protein kinase B (PKB/AKT1, PKB/AKT2, PKB/AKT3), p70 ribosomal protein S6 kinase (RPS6KB1), p90 ribosomal protein S6 kinase (RPS6KA1, RPS6KA2 and RPS6KA3), cyclic AMP-dependent protein kinase (PRKACA), protein kinase C (PRKCD and PRKCZ), serum and glucocorticoid-inducible kinase (SGK1, SGK2 and SGK3), p21-activated kinase-1 (PAK1), protein kinase PKN (PKN1 and PKN2). Plays a central role in the transduction of signals from insulin by providing the activating phosphorylation to PKB/AKT1, thus propagating the signal to downstream targets controlling cell proliferation and survival, as well as glucose and amino acid uptake and storage. Negatively regulates the TGF-beta-induced signaling by: modulating the association of SMAD3 and SMAD7 with TGF-beta receptor, phosphorylating SMAD2, SMAD3, SMAD4 and SMAD7, preventing the nuclear translocation of SMAD3 and SMAD4 and the translocation of SMAD7 from the nucleus to the cytoplasm in response to TGF-beta. Activates PPARG transcriptional activity and promotes adipocyte differentiation. Activates the NF-kappa-B pathway via phosphorylation of IKKB. The tyrosine phosphorylated form is crucial for the regulation of focal adhesions by angiotensin II. Controls proliferation, survival, and growth of developing pancreatic cells. Participates in the regulation of Ca(2+) entry and Ca(2+)-activated K(+) channels of mast cells. Essential for the motility of vascular endothelial cells (ECs) and is involved in the regulation of their chemotaxis. Plays a critical role in cardiac homeostasis by serving as a dual effector for cell survival and beta-adrenergic response. Plays an important role during thymocyte development by regulating the expression of key nutrient receptors on the surface of pre-T cells and mediating Notch-induced cell growth and proliferative responses. Provides negative feedback inhibition to toll-like receptor-mediated NF-kappa-B activation in macrophages.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O55173|PDPK1_RAT 3-phosphoinositide-dependent protein kinase 1 OS=Rattus norvegicus GN=Pdpk1 PE=1 SV=2

 Score =  315 bits (806), Expect = 7e-85,   Method: Compositional matrix adjust.
 Identities = 182/475 (38%), Positives = 256/475 (53%), Gaps = 45/475 (9%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 83  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 142

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 143 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 202

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A +FVGTA YV P
Sbjct: 203 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPDSKQARANSFVGTAQYVSP 254

Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F   ARD
Sbjct: 255 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 314

Query: 285 LIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDD 343
           L+++LL +D + R G     GY  LK HPFF+ I W+N+  QTPPKL +     S + +D
Sbjct: 315 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESITWENLHQQTPPKLTAYLPAMSEDDED 374

Query: 344 VH---------------------------DSSWNPSHIGDISAKINDGNGGASS-----S 371
            +                           D+S       +I   I+D +  +       S
Sbjct: 375 CYGNYDNLLSQFGCMQVSSSSSSHSLSAVDASLPQRSGSNIEQYIHDLDTNSFELDLQFS 434

Query: 372 EGSITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPS 431
           E     L    +  + W QF++    +L +  V K + L +++ QL+LT  P L YVDP 
Sbjct: 435 EDEKRLLLEKQAGGNPWHQFVE-NNLILKMGPVDKRKGLFARRRQLLLTEGPHLYYVDPV 493

Query: 432 KLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRASQWKKAIEAL 486
             V+KG I W   S +L  +  +   F + TP +     D    A +W + I+ +
Sbjct: 494 NKVLKGEIPW---SQELRPEAKNFKTFFVHTPNRTYYLMDPSGNAHKWCRKIQEV 545

Serine/threonine kinase which acts as a master kinase, phosphorylating and activating a subgroup of the AGC family of protein kinases. Its targets include: protein kinase B (PKB/AKT1, PKB/AKT2, PKB/AKT3), p70 ribosomal protein S6 kinase (RPS6KB1), p90 ribosomal protein S6 kinase (RPS6KA1, RPS6KA2 and RPS6KA3), cyclic AMP-dependent protein kinase (PRKACA), protein kinase C (PRKCD and PRKCZ), serum and glucocorticoid-inducible kinase (SGK1, SGK2 and SGK3), p21-activated kinase-1 (PAK1), protein kinase PKN (PKN1 and PKN2). Plays a central role in the transduction of signals from insulin by providing the activating phosphorylation to PKB/AKT1, thus propagating the signal to downstream targets controlling cell proliferation and survival, as well as glucose and amino acid uptake and storage. Negatively regulates the TGF-beta-induced signaling by: modulating the association of SMAD3 and SMAD7 with TGF-beta receptor, phosphorylating SMAD2, SMAD3, SMAD4 and SMAD7, preventing the nuclear translocation of SMAD3 and SMAD4 and the translocation of SMAD7 from the nucleus to the cytoplasm in response to TGF-beta. Activates PPARG transcriptional activity and promotes adipocyte differentiation. Activates the NF-kappa-B pathway via phosphorylation of IKKB. The tyrosine phosphorylated form is crucial for the regulation of focal adhesions by angiotensin II. Controls proliferation, survival, and growth of developing pancreatic cells. Participates in the regulation of Ca(2+) entry and Ca(2+)-activated K(+) channels of mast cells. Essential for the motility of vascular endothelial cells (ECs) and is involved in the regulation of their chemotaxis. Plays a critical role in cardiac homeostasis by serving as a dual effector for cell survival and beta-adrenergic response. Plays an important role during thymocyte development by regulating the expression of key nutrient receptors on the surface of pre-T cells and mediating Notch-induced cell growth and proliferative responses. Provides negative feedback inhibition to toll-like receptor-mediated NF-kappa-B activation in macrophages.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O15530|PDPK1_HUMAN 3-phosphoinositide-dependent protein kinase 1 OS=Homo sapiens GN=PDPK1 PE=1 SV=1

 Score =  314 bits (804), Expect = 1e-84,   Method: Compositional matrix adjust.
 Identities = 182/475 (38%), Positives = 257/475 (54%), Gaps = 45/475 (9%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 80  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 139

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 140 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 199

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A +FVGTA YV P
Sbjct: 200 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANSFVGTAQYVSP 251

Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F   ARD
Sbjct: 252 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 311

Query: 285 LIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDD 343
           L+++LL +D + R G     GY  LK HPFF+ + W+N+  QTPPKL +     S + +D
Sbjct: 312 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLTAYLPAMSEDDED 371

Query: 344 VHDSSWN--------------------------PSHIG-DISAKINDGNGGASS-----S 371
            + +  N                          P   G +I   I+D +  +       S
Sbjct: 372 CYGNYDNLLSQFGCMQVSSSSSSHSLSASDTGLPQRSGSNIEQYIHDLDSNSFELDLQFS 431

Query: 372 EGSITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPS 431
           E     L    +  + W QF++    +L +  V K + L +++ QL+LT  P L YVDP 
Sbjct: 432 EDEKRLLLEKQAGGNPWHQFVE-NNLILKMGPVDKRKGLFARRRQLLLTEGPHLYYVDPV 490

Query: 432 KLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRASQWKKAIEAL 486
             V+KG I W   S +L  +  +   F + TP +     D    A +W + I+ +
Sbjct: 491 NKVLKGEIPW---SQELRPEAKNFKTFFVHTPNRTYYLMDPSGNAHKWCRKIQEV 542

Serine/threonine kinase which acts as a master kinase, phosphorylating and activating a subgroup of the AGC family of protein kinases. Its targets include: protein kinase B (PKB/AKT1, PKB/AKT2, PKB/AKT3), p70 ribosomal protein S6 kinase (RPS6KB1), p90 ribosomal protein S6 kinase (RPS6KA1, RPS6KA2 and RPS6KA3), cyclic AMP-dependent protein kinase (PRKACA), protein kinase C (PRKCD and PRKCZ), serum and glucocorticoid-inducible kinase (SGK1, SGK2 and SGK3), p21-activated kinase-1 (PAK1), protein kinase PKN (PKN1 and PKN2). Plays a central role in the transduction of signals from insulin by providing the activating phosphorylation to PKB/AKT1, thus propagating the signal to downstream targets controlling cell proliferation and survival, as well as glucose and amino acid uptake and storage. Negatively regulates the TGF-beta-induced signaling by: modulating the association of SMAD3 and SMAD7 with TGF-beta receptor, phosphorylating SMAD2, SMAD3, SMAD4 and SMAD7, preventing the nuclear translocation of SMAD3 and SMAD4 and the translocation of SMAD7 from the nucleus to the cytoplasm in response to TGF-beta. Activates PPARG transcriptional activity and promotes adipocyte differentiation. Activates the NF-kappa-B pathway via phosphorylation of IKKB. The tyrosine phosphorylated form is crucial for the regulation of focal adhesions by angiotensin II. Controls proliferation, survival, and growth of developing pancreatic cells. Participates in the regulation of Ca(2+) entry and Ca(2+)-activated K(+) channels of mast cells. Essential for the motility of vascular endothelial cells (ECs) and is involved in the regulation of their chemotaxis. Plays a critical role in cardiac homeostasis by serving as a dual effector for cell survival and beta-adrenergic response. Plays an important role during thymocyte development by regulating the expression of key nutrient receptors on the surface of pre-T cells and mediating Notch-induced cell growth and proliferative responses. Provides negative feedback inhibition to toll-like receptor-mediated NF-kappa-B activation in macrophages. Isoform 3 is catalytically inactive.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6A1A2|PDPK2_HUMAN Putative 3-phosphoinositide-dependent protein kinase 2 OS=Homo sapiens GN=PDPK2 PE=5 SV=1

 Score =  280 bits (715), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 144/307 (46%), Positives = 193/307 (62%), Gaps = 10/307 (3%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 53  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 112

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 113 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 172

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D +I+I DFG+ K        VL   +   +A +FVGTA YV P
Sbjct: 173 GIIHRDLKPENILLNEDMYIQITDFGTAK--------VLSPESKQARANSFVGTAQYVSP 224

Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F   ARD
Sbjct: 225 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 284

Query: 285 LIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL-ASEPMVQSGEGD 342
           L+++LL +D + R G     GY  LK HPFF+ + W+N+  QTPPKL A  P +   + D
Sbjct: 285 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLTAYLPAMSEDDED 344

Query: 343 DVHDSSW 349
              + SW
Sbjct: 345 CYGNVSW 351

Phosphorylates and activates not only PKB/AKT, but also PKA, PKC-zeta, RPS6KA1 and RPS6KB1. May play a general role in signaling processes and in development.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54PK9|PDPKB_DICDI 3-phosphoinositide-dependent protein kinase B OS=Dictyostelium discoideum GN=pdkB PE=3 SV=1

 Score =  239 bits (609), Expect = 5e-62,   Method: Compositional matrix adjust.
 Identities = 123/295 (41%), Positives = 174/295 (58%), Gaps = 14/295 (4%)

Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S  DF+  +  G G+Y KV    + +T  ++A KI++KK I KE K  YV  E+ +LD L
Sbjct: 267 SRSDFDFIRTIGKGAYGKVKLVIEKETQLIFASKILNKKLIIKEKKAKYVNTEKTILDSL 326

Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           D+P +V+LF+TFQD  +LY  LE C  G+L   +   G  S D  RFY AE++ ALEY+H
Sbjct: 327 DNPNIVKLFYTFQDENNLYFILEYCPNGDLLGALKKAGCFSIDVVRFYAAEILIALEYLH 386

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
             G+ HRD+KPEN+LL  + H+K++DFGS K +       + +     ++ +F GTA YV
Sbjct: 387 GKGIAHRDLKPENILLGKNQHLKLSDFGSAKQLS------IGSHHKGSRSGSFCGTAEYV 440

Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAA 282
            PE+L    A    D+W+ GC LYQ++SG  PFK  +E+  F  I  R+  +P+ F    
Sbjct: 441 CPELLTEKSAGVEADIWSYGCLLYQLVSGKLPFKGFNEYQTFLLITKREFSYPDNFDKCC 500

Query: 283 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI-DWKNIRGQTPPKLASEPMV 336
            +LID+LLD+DP  RP       + +K H FF  I DW +I  QTPP +  E MV
Sbjct: 501 MNLIDQLLDLDPYKRPTI-----SEIKNHEFFSSIQDWSSIPSQTPPPI--EQMV 548

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q12701|KSG1_SCHPO Serine/threonine-protein kinase ksg1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=ksg1 PE=1 SV=2

 Score =  230 bits (587), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 123/290 (42%), Positives = 168/290 (57%), Gaps = 10/290 (3%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           + DF+ G+I G GSYS V+ A +  T   YA+K++DK+ I KE K  YV +E+  L  L 
Sbjct: 96  VSDFKFGEILGEGSYSTVLTATENSTKREYAIKVLDKRHIIKEKKEKYVNIEKEALCILS 155

Query: 104 -HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HPG ++LF+TFQD  +LY  L     GEL D I   G  +E  A++Y A +VD+++Y+H
Sbjct: 156 KHPGFIKLFYTFQDAHNLYFVLSLARNGELLDYINKLGRFNEICAQYYAALIVDSIDYMH 215

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDK----ACTFVGT 218
             G+IHRD+KPEN+LL  +   KI DFGS K +  S  +   +    DK    + +FVGT
Sbjct: 216 GRGVIHRDLKPENILLDDNMRTKITDFGSAKILNSSHGSHEEDTHHADKPQAHSRSFVGT 275

Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
           A YV PEVL+   A   +D+WA GC L+QML+G  PF   +E+L FQ I+      P   
Sbjct: 276 ARYVSPEVLSDKIAGTASDIWAFGCILFQMLAGKPPFVAGNEYLTFQSILHLSYEIPPDI 335

Query: 279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 328
           SD A DLI +LL +DP  R          +  HPFF GI + N   + PP
Sbjct: 336 SDVASDLIKKLLVLDPKDRLTVDE-----IHQHPFFNGIKFDNTLWELPP 380

Involved in the control of cell cycle arrest via a phosphoinositide signaling pathway.

Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P34102|PK3_DICDI Protein kinase 3 OS=Dictyostelium discoideum GN=pkgC PE=3 SV=2

 Score =  229 bits (583), Expect = 5e-59,   Method: Compositional matrix adjust.
 Identities = 114/292 (39%), Positives = 179/292 (61%), Gaps = 10/292 (3%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
            +I DFEL K+ GVGS+ +V   ++ DTG  YA+K+++KK + K+ + A+   E++VL  
Sbjct: 493 LTIDDFELLKVLGVGSFGRVYLVRRKDTGKFYAMKVLNKKDMLKKKQIAHTNTEKMVLST 552

Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           +DHP +VRL F FQ+   L+M ++   GGELF  +   G   E+ A+FY AEV+ +L Y+
Sbjct: 553 MDHPFIVRLHFAFQNEDFLFMCMDYVPGGELFHHLQKAGKFPEELAKFYIAEVICSLHYL 612

Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL---PNAASDDKACTFVGT 218
           HS  +I+RDIKPEN+LL  +GHIK+ DFG    +  S IT +    N      A TF GT
Sbjct: 613 HSNNIIYRDIKPENILLDEEGHIKLTDFG----LSKSGITSVVGSKNGGEGGFATTFCGT 668

Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+ PE++  +      D W++G  L++ML+G SPF  ++   +++ +I  ++R P + 
Sbjct: 669 PEYLAPEIITGAGHGKAADWWSVGILLFEMLTGRSPFLASNRNDMYKSMIQGNLRMPMFL 728

Query: 279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ--TPP 328
           S  A+DL+++LL  DP+ R G+   G+  +  HPFF+ I W+ +  +  TPP
Sbjct: 729 SSDAQDLLEKLLVPDPNKRLGST-QGFEEISSHPFFELIPWRMLESKMITPP 779

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q12236|PKH2_YEAST Serine/threonine-protein kinase PKH2 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=PKH2 PE=1 SV=1

 Score =  226 bits (576), Expect = 3e-58,   Method: Compositional matrix adjust.
 Identities = 116/291 (39%), Positives = 179/291 (61%), Gaps = 9/291 (3%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           I+DF+ G + G G+YS V+ A  IDT   YA K+++K+++ ++ K  YV +E+  L +L+
Sbjct: 176 IKDFKFGSVIGDGAYSTVMLATSIDTKKRYAAKVLNKEYLIRQKKVKYVSIEKTALQKLN 235

Query: 104 H-PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           + P VVRLF TFQD  SLY  LE    G+    +   G L E  AR+Y A+++DA++Y+H
Sbjct: 236 NSPSVVRLFSTFQDESSLYFLLEYAPNGDFLSLMKKYGSLDETCARYYAAQIIDAIDYLH 295

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV-LPNAASDDKACTFVGTAAY 221
           S G+IHRDIKPEN+LL  +  IK+ DFG+ K +  +  +V  P      ++ +FVGTA Y
Sbjct: 296 SNGIIHRDIKPENILLDGEMKIKLTDFGTAKLLNPTNNSVSKPEYDLSTRSKSFVGTAEY 355

Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDA 281
           V PE+LN S   +  D+WA GC L+QM++G  PFK T+E+L FQ+++     F   F   
Sbjct: 356 VSPELLNDSFTDYRCDIWAFGCILFQMIAGKPPFKATNEYLTFQKVMKVQYAFTPGFPLI 415

Query: 282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN--IRGQTPPKL 330
            RDL+ ++L  +   R        + +K H FFK +++K+  +  +TPP++
Sbjct: 416 IRDLVKKILVKNLDRR-----LTISQIKEHHFFKDLNFKDGSVWSKTPPEI 461

Serine/threonine-protein kinase which is part sphingolipid-mediated signaling pathway that is required for the internalization step of endocytosis by regulating eisosome assembly and organization, and modulating the organization of the plasma membrane. Phosphorylates and activates PKC1. Activates YPK1 and YPK2, 2 components of signaling cascade required for maintenance of cell wall integrity. Required for stress-induced P-body assembly and regulates global mRNA decay at the deadenylation step.

Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	489
255586617	506	3-phosphoinositide-dependent protein kin	0.997	0.964	0.857	0.0
297829596	486	hypothetical protein ARALYDRAFT_897238 [	0.991	0.997	0.844	0.0
350539745	494	3-phosphoinositide-dependent protein kin	0.979	0.969	0.856	0.0
225449645	502	PREDICTED: 3-phosphoinositide-dependent	0.985	0.960	0.833	0.0
224109900	496	predicted protein [Populus trichocarpa]	0.997	0.983	0.846	0.0
30681369	486	3-phosphoinositide-dependent protein kin	0.991	0.997	0.840	0.0
110743925	486	3-phosphoinositide-dependent protein kin	0.991	0.997	0.840	0.0
356535531	491	PREDICTED: 3-phosphoinositide-dependent	0.997	0.993	0.855	0.0
12322773	483	putative 3-phosphoinositide-dependent pr	0.985	0.997	0.841	0.0
296090372	468	unnamed protein product [Vitis vinifera]	0.938	0.980	0.879	0.0

>gi|255586617|ref|XP_002533941.1| 3-phosphoinositide-dependent protein kinase-1, putative [Ricinus communis] gi|223526096|gb|EEF28448.1| 3-phosphoinositide-dependent protein kinase-1, putative [Ricinus communis]

 Score =  874 bits (2257), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 433/505 (85%), Positives = 459/505 (90%), Gaps = 17/505 (3%)

Query: 1   MLAMEKDFDSKLRIEGNNNSSTN--------------CPTVQRSKSFAFRAPQEHFSIQD 46
           MLAMEKDFDSKLRI+ +NNSS++                 VQRSKSFAFRAPQE+FSIQD
Sbjct: 1   MLAMEKDFDSKLRIQSSNNSSSSSSISSNHNNNNNNNIGNVQRSKSFAFRAPQENFSIQD 60

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           FELGKIYGVGSYSKVVRAKK DTG VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG
Sbjct: 61  FELGKIYGVGSYSKVVRAKKKDTGMVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 120

Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           +VRLFFTFQD+FSLYMALESCEGGELFDQIT KG LSEDEARFY AEVVDALEYIH MGL
Sbjct: 121 IVRLFFTFQDSFSLYMALESCEGGELFDQITRKGRLSEDEARFYAAEVVDALEYIHGMGL 180

Query: 167 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 226
           IHRDIKPENLLLTADGHIK+ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV
Sbjct: 181 IHRDIKPENLLLTADGHIKVADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 240

Query: 227 LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLI 286
           LNSSPATFGNDLWALGCTLYQMLSGTSPFKD SEWLIFQRIIARDIRFPNYFS+ ARD+I
Sbjct: 241 LNSSPATFGNDLWALGCTLYQMLSGTSPFKDASEWLIFQRIIARDIRFPNYFSEEARDII 300

Query: 287 DRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDDVHD 346
           DRLLD+DPS RPGAGP GYA LK+HPFFKGI+WKN+R +TPPKLA E M QSG+G+   D
Sbjct: 301 DRLLDIDPSRRPGAGPEGYAALKIHPFFKGINWKNLREETPPKLALEAMTQSGDGELDPD 360

Query: 347 SSWNPSHIGDISAKINDGNGGASSS---EGSITRLASIDSFDSKWQQFLDPGESVLMISM 403
           ++WNP+HIGD SA+ NDG GG SS+    GSITRLASIDSFDSKWQQFLDPGESVLMISM
Sbjct: 361 ATWNPTHIGDGSARQNDGTGGPSSTAEASGSITRLASIDSFDSKWQQFLDPGESVLMISM 420

Query: 404 VKKLQKLTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTP 463
           VKKLQKLTSKKVQLILTNKPKLIYVDPSKL+VKGNIIWSDNSNDLS+QVSSPSHFKI TP
Sbjct: 421 VKKLQKLTSKKVQLILTNKPKLIYVDPSKLLVKGNIIWSDNSNDLSVQVSSPSHFKIFTP 480

Query: 464 KKVLSFEDAKQRASQWKKAIEALQN 488
           KKV+SFEDAKQRA QWKKAIE+LQN
Sbjct: 481 KKVMSFEDAKQRAWQWKKAIESLQN 505

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297829596|ref|XP_002882680.1| hypothetical protein ARALYDRAFT_897238 [Arabidopsis lyrata subsp. lyrata] gi|297328520|gb|EFH58939.1| hypothetical protein ARALYDRAFT_897238 [Arabidopsis lyrata subsp. lyrata]

 Score =  851 bits (2198), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 412/488 (84%), Positives = 443/488 (90%), Gaps = 3/488 (0%)

Query: 1   MLAMEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSK 60
           ML MEK+FDSKL ++GN  SS+N  T+ RSKSFAF+APQE+F+  DFELGKIYGVGSYSK
Sbjct: 1   MLTMEKEFDSKLSLQGN--SSSNGATISRSKSFAFKAPQENFTYHDFELGKIYGVGSYSK 58

Query: 61  VVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL 120
           VVRAKK D GTVYALKIMDKKFITKENKTAYVKLERIVLDQL+HPG+V+LFFTFQDT SL
Sbjct: 59  VVRAKKKDNGTVYALKIMDKKFITKENKTAYVKLERIVLDQLEHPGIVKLFFTFQDTQSL 118

Query: 121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA 180
           YMALESCEGGELFDQIT KG LSEDEARFY+AEVVDALEYIH+MGLIHRDIKPENLLLT+
Sbjct: 119 YMALESCEGGELFDQITRKGRLSEDEARFYSAEVVDALEYIHNMGLIHRDIKPENLLLTS 178

Query: 181 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 240
           DGHIKIADFGSVKPMQDS+ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA
Sbjct: 179 DGHIKIADFGSVKPMQDSQITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 238

Query: 241 LGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGA 300
           LGCTLYQMLSGTSPFKD SEWLIFQRIIARDI+FPN+FS+AARDLIDRLLD DPS RPGA
Sbjct: 239 LGCTLYQMLSGTSPFKDASEWLIFQRIIARDIKFPNHFSEAARDLIDRLLDTDPSRRPGA 298

Query: 301 GPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDDVHDSSWNPSHIGDISAK 360
           G  GYA LK HPFFKG+DWKN+R QTPPKLA +P  QS    +   S WNP+H+GD S  
Sbjct: 299 GSEGYASLKRHPFFKGVDWKNLRSQTPPKLAPDPASQSA-SPERDGSPWNPTHVGDTSVL 357

Query: 361 INDGNGGASSSEGSITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQLILT 420
            NDG+ G S S GSITRLASIDSFDS+WQQFL+PGESVLMIS VKKLQK+TSKKVQLILT
Sbjct: 358 QNDGHNGLSESSGSITRLASIDSFDSRWQQFLEPGESVLMISAVKKLQKITSKKVQLILT 417

Query: 421 NKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRASQWK 480
           NKP+LIYVDPSKLVVKGNIIWSDNSNDL++QVSSPSHFKI TPKKVLSFEDAKQRA QWK
Sbjct: 418 NKPRLIYVDPSKLVVKGNIIWSDNSNDLNVQVSSPSHFKICTPKKVLSFEDAKQRALQWK 477

Query: 481 KAIEALQN 488
           KAIE LQN
Sbjct: 478 KAIETLQN 485

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|350539745|ref|NP_001234519.1| 3-phosphoinositide-dependent protein kinase-1 [Solanum lycopersicum] gi|57168305|gb|AAW38936.1| 3-phosphoinositide-dependent protein kinase-1 [Solanum lycopersicum]

 Score =  850 bits (2196), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 419/489 (85%), Positives = 443/489 (90%), Gaps = 10/489 (2%)

Query: 4   MEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVR 63
           ME++FD+KL+I+ NN+++T     QRSKSFAFRAPQE+F+IQDFELGKIYGVGSYSKVVR
Sbjct: 11  MEQEFDAKLKIQ-NNSANT-----QRSKSFAFRAPQENFTIQDFELGKIYGVGSYSKVVR 64

Query: 64  AKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA 123
           AKK DT  VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA
Sbjct: 65  AKKKDTANVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA 124

Query: 124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH 183
           LESCEGGELFDQIT KG LSEDEARFY AEVVDALEYIHSMGLIHRDIKPENLLLT+DGH
Sbjct: 125 LESCEGGELFDQITRKGRLSEDEARFYAAEVVDALEYIHSMGLIHRDIKPENLLLTSDGH 184

Query: 184 IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGC 243
           IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGC
Sbjct: 185 IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGC 244

Query: 244 TLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPG 303
           TLYQMLSGTSPFKD SEWLIFQRIIARDIRFPNYFS+ ARD+ID+LLDVDPS RPGAGP 
Sbjct: 245 TLYQMLSGTSPFKDASEWLIFQRIIARDIRFPNYFSNEARDIIDQLLDVDPSRRPGAGPD 304

Query: 304 GYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGD-DVHDSSWNPSHIGDISAKIN 362
           GYA LK HPFF GIDW+N+R QTPP+LA EP   S     D  D SWNPSHIGD S + N
Sbjct: 305 GYASLKNHPFFSGIDWENLRLQTPPRLAMEPKAPSTHSSGDEQDPSWNPSHIGDGSVRPN 364

Query: 363 DGNGGASS---SEGSITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQLIL 419
           DGNG A+S   +  SITRLASIDSFDSKW+QFLDPGESVLMISMVKKLQKLTSKKVQLIL
Sbjct: 365 DGNGAAASVSEAGNSITRLASIDSFDSKWKQFLDPGESVLMISMVKKLQKLTSKKVQLIL 424

Query: 420 TNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRASQW 479
           TNKPKLIYVDPSKLV+KGNIIWSDN NDLSIQV+SPS FKI TPKKV+SFEDAK RA QW
Sbjct: 425 TNKPKLIYVDPSKLVIKGNIIWSDNPNDLSIQVTSPSQFKICTPKKVMSFEDAKNRAQQW 484

Query: 480 KKAIEALQN 488
           KKAIEALQN
Sbjct: 485 KKAIEALQN 493

Source: Solanum lycopersicum

Species: Solanum lycopersicum

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225449645|ref|XP_002262670.1| PREDICTED: 3-phosphoinositide-dependent protein kinase 1-like [Vitis vinifera]

 Score =  850 bits (2195), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 420/504 (83%), Positives = 445/504 (88%), Gaps = 22/504 (4%)

Query: 4   MEKDFDSKLRIEGNNNSSTNCPT----------------VQRSKSFAFRAPQEHFSIQDF 47
           MEKDFDSKLRI+ N+++                      VQRSKSFAFRAPQE+F+IQDF
Sbjct: 1   MEKDFDSKLRIQSNSSNGGTAGGGGGGGGGGGGGGGAGAVQRSKSFAFRAPQENFTIQDF 60

Query: 48  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV 107
           ELGKIYGVGSYSKVVRA+K DTG VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG+
Sbjct: 61  ELGKIYGVGSYSKVVRARKKDTGIVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGI 120

Query: 108 VRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLI 167
           VRLFFTFQDTFSLYMALESCEGGELFDQIT KG LSE+EARFY AEVVDALEYIHS+GLI
Sbjct: 121 VRLFFTFQDTFSLYMALESCEGGELFDQITRKGRLSENEARFYAAEVVDALEYIHSLGLI 180

Query: 168 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 227
           HRDIKPENLLLTADGHIKIADFGSVKPMQDS ITVLPNAASDDKACTFVGTAAYVPPEVL
Sbjct: 181 HRDIKPENLLLTADGHIKIADFGSVKPMQDSLITVLPNAASDDKACTFVGTAAYVPPEVL 240

Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLID 287
           NSSPATFGNDLWALGCTLYQMLSGTSPFKD SEWLIFQRIIARDIRFPNYFSD ARDLID
Sbjct: 241 NSSPATFGNDLWALGCTLYQMLSGTSPFKDASEWLIFQRIIARDIRFPNYFSDEARDLID 300

Query: 288 RLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDDVHDS 347
           RLLD +PS RPGAG  GYA LKMHPFF G+DWKN+R QTPPKLA E    S EGDD  D 
Sbjct: 301 RLLDTEPSRRPGAGRDGYASLKMHPFFNGVDWKNLRSQTPPKLAME--AHSSEGDDGQD- 357

Query: 348 SWNPSHIGDISAKINDGNGGASSSE---GSITRLASIDSFDSKWQQFLDPGESVLMISMV 404
           SWNP+HIGD SA+ NDGN GA+SS    GS+TRLASIDSFDSKWQQFL+ GESVLMISMV
Sbjct: 358 SWNPAHIGDGSARQNDGNSGATSSSEAPGSVTRLASIDSFDSKWQQFLEQGESVLMISMV 417

Query: 405 KKLQKLTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPK 464
           KK+QKLT+KKVQLILTNKPKLIYVDP+KL+VKGNIIWSDN NDLSIQV+SPSHFKI TPK
Sbjct: 418 KKIQKLTNKKVQLILTNKPKLIYVDPAKLMVKGNIIWSDNPNDLSIQVTSPSHFKICTPK 477

Query: 465 KVLSFEDAKQRASQWKKAIEALQN 488
           KV+SFED+KQRA QWKKAIE LQN
Sbjct: 478 KVMSFEDSKQRAWQWKKAIEGLQN 501

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224109900|ref|XP_002315349.1| predicted protein [Populus trichocarpa] gi|222864389|gb|EEF01520.1| predicted protein [Populus trichocarpa]

 Score =  847 bits (2188), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 419/495 (84%), Positives = 445/495 (89%), Gaps = 7/495 (1%)

Query: 1   MLAMEKDFDSKLRIEGNNN----SSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVG 56
           ML ME++FDSKLRI+  ++    S+ N  +VQRSKSFAFRAPQE+F+I DFELGKIYGVG
Sbjct: 1   MLEMEREFDSKLRIQSGDHPSSSSNNNNGSVQRSKSFAFRAPQENFTIHDFELGKIYGVG 60

Query: 57  SYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD 116
           SYSKVVRAKK DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG+VRLFFTFQD
Sbjct: 61  SYSKVVRAKKKDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGIVRLFFTFQD 120

Query: 117 TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENL 176
            +SLYMALESCEGGELFDQIT KG LSEDEA FY AEVVDALEYIHSMGLIHRDIKPENL
Sbjct: 121 NYSLYMALESCEGGELFDQITRKGRLSEDEACFYAAEVVDALEYIHSMGLIHRDIKPENL 180

Query: 177 LLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGN 236
           LLTA+GHIKIADFGSVKPMQDS ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGN
Sbjct: 181 LLTAEGHIKIADFGSVKPMQDSCITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGN 240

Query: 237 DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSG 296
           DLWALGCTLYQMLSGTSPFKD SEWLIFQRIIARDIRFP+YFS  ARDLID LLD+DPS 
Sbjct: 241 DLWALGCTLYQMLSGTSPFKDASEWLIFQRIIARDIRFPDYFSGEARDLIDHLLDIDPSR 300

Query: 297 RPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDDVHDSSWNPSHIGD 356
           RPGAG GGYA LK HPFF+G+DWKN+RG+TPPKL SEPMVQSG+ D    S +NP+  GD
Sbjct: 301 RPGAGRGGYAELKNHPFFEGVDWKNLRGETPPKLVSEPMVQSGDSDHDSGSPYNPTRAGD 360

Query: 357 ISAKINDGNGGASSSE---GSITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSK 413
            S   NDGN G SSS      ITRLASIDSFDSKWQQFLDPGESVLMI+MVKKLQKLTSK
Sbjct: 361 SSLTQNDGNAGVSSSAEATAHITRLASIDSFDSKWQQFLDPGESVLMIAMVKKLQKLTSK 420

Query: 414 KVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAK 473
           KVQLILTNKPKLIYVDPSKLVVKGNIIWSDNS+DLS+QV+SPSHFKI TPKKV SFEDAK
Sbjct: 421 KVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSDDLSVQVTSPSHFKICTPKKVRSFEDAK 480

Query: 474 QRASQWKKAIEALQN 488
           QRA QWKKAIE+LQN
Sbjct: 481 QRAWQWKKAIESLQN 495

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|30681369|ref|NP_187665.2| 3-phosphoinositide-dependent protein kinase [Arabidopsis thaliana] gi|75316154|sp|Q4V3C8.1|PDPK2_ARATH RecName: Full=3-phosphoinositide-dependent protein kinase 2; Short=AtPDK2 gi|66792634|gb|AAY56419.1| At3g10540 [Arabidopsis thaliana] gi|95147296|gb|ABF57283.1| At3g10540 [Arabidopsis thaliana] gi|332641402|gb|AEE74923.1| 3-phosphoinositide-dependent protein kinase [Arabidopsis thaliana]

 Score =  844 bits (2181), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 410/488 (84%), Positives = 441/488 (90%), Gaps = 3/488 (0%)

Query: 1   MLAMEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSK 60
           ML M+K+FDSKL ++GN  SS+N  T+ RSKSFAF+APQE+F+  DFELGKIYGVGSYSK
Sbjct: 1   MLTMDKEFDSKLTLQGN--SSSNGETISRSKSFAFKAPQENFTYHDFELGKIYGVGSYSK 58

Query: 61  VVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL 120
           VVRAKK D GTVYALKIMDKKFITKENKTAYVKLERIVLDQL+HPG+V+LFFTFQDT SL
Sbjct: 59  VVRAKKKDNGTVYALKIMDKKFITKENKTAYVKLERIVLDQLEHPGIVKLFFTFQDTQSL 118

Query: 121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA 180
           YMALESCEGGELFDQIT KG LSEDEARFY+AEVVDALEYIH+MGLIHRDIKPENLLLT 
Sbjct: 119 YMALESCEGGELFDQITRKGRLSEDEARFYSAEVVDALEYIHNMGLIHRDIKPENLLLTL 178

Query: 181 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 240
           DGHIKIADFGSVKPMQDS+ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA
Sbjct: 179 DGHIKIADFGSVKPMQDSQITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 238

Query: 241 LGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGA 300
           LGCTLYQMLSGTSPFKD SEWLIFQRIIARDI+FPN+FS+AARDLIDRLLD DPS RPGA
Sbjct: 239 LGCTLYQMLSGTSPFKDASEWLIFQRIIARDIKFPNHFSEAARDLIDRLLDTDPSRRPGA 298

Query: 301 GPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDDVHDSSWNPSHIGDISAK 360
           G  GY  LK HPFFKG+DWKN+R QTPPKLA +P  QS    +   S WNP+H+GD S  
Sbjct: 299 GSEGYDSLKRHPFFKGVDWKNLRSQTPPKLAPDPASQSA-SPERDGSPWNPTHVGDTSVL 357

Query: 361 INDGNGGASSSEGSITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQLILT 420
            NDG+ G S S GSITRLASIDSFDS+WQQFL+PGESVLMIS VKKLQK+TSKKVQLILT
Sbjct: 358 QNDGHNGLSESSGSITRLASIDSFDSRWQQFLEPGESVLMISAVKKLQKITSKKVQLILT 417

Query: 421 NKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRASQWK 480
           NKP+LIYVDPSKLVVKGNIIWSDNSNDL++QVSSPSHFKI TPKKVLSFEDAKQRA QWK
Sbjct: 418 NKPRLIYVDPSKLVVKGNIIWSDNSNDLNVQVSSPSHFKICTPKKVLSFEDAKQRALQWK 477

Query: 481 KAIEALQN 488
           KAIE LQN
Sbjct: 478 KAIETLQN 485

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|110743925|dbj|BAE99796.1| 3-phosphoinositide-dependent protein kinase-1 like [Arabidopsis thaliana]

 Score =  844 bits (2180), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 410/488 (84%), Positives = 440/488 (90%), Gaps = 3/488 (0%)

Query: 1   MLAMEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSK 60
           ML M+K+FDSKL ++GN  SS+N  T+ RSKSFAF+APQE+F+  DFELGKIYGVGSYSK
Sbjct: 1   MLTMDKEFDSKLTLQGN--SSSNGETISRSKSFAFKAPQENFTYHDFELGKIYGVGSYSK 58

Query: 61  VVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL 120
           VVRAKK D GTVYALKIMDKKFITKENKTAYVKLERIVLDQL+HPG+V+LFFTFQDT SL
Sbjct: 59  VVRAKKKDNGTVYALKIMDKKFITKENKTAYVKLERIVLDQLEHPGIVKLFFTFQDTQSL 118

Query: 121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA 180
           YMALESCEGGELFDQIT KG LSEDEARFY+AEVVDALEYIH+MGLIHRDIKPENLLLT 
Sbjct: 119 YMALESCEGGELFDQITRKGRLSEDEARFYSAEVVDALEYIHNMGLIHRDIKPENLLLTL 178

Query: 181 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 240
           DGHIKIADFGSVKPMQDS+ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA
Sbjct: 179 DGHIKIADFGSVKPMQDSQITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 238

Query: 241 LGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGA 300
           LGCTLYQMLSGTSPFKD SEWLIFQRIIARDI FPN+FS+AARDLIDRLLD DPS RPGA
Sbjct: 239 LGCTLYQMLSGTSPFKDASEWLIFQRIIARDIEFPNHFSEAARDLIDRLLDTDPSRRPGA 298

Query: 301 GPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDDVHDSSWNPSHIGDISAK 360
           G  GY  LK HPFFKG+DWKN+R QTPPKLA +P  QS    +   S WNP+H+GD S  
Sbjct: 299 GSEGYDSLKRHPFFKGVDWKNLRSQTPPKLAPDPASQSA-SPERDGSPWNPTHVGDTSVL 357

Query: 361 INDGNGGASSSEGSITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQLILT 420
            NDG+ G S S GSITRLASIDSFDS+WQQFL+PGESVLMIS VKKLQK+TSKKVQLILT
Sbjct: 358 QNDGHNGLSESSGSITRLASIDSFDSRWQQFLEPGESVLMISAVKKLQKITSKKVQLILT 417

Query: 421 NKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRASQWK 480
           NKP+LIYVDPSKLVVKGNIIWSDNSNDL++QVSSPSHFKI TPKKVLSFEDAKQRA QWK
Sbjct: 418 NKPRLIYVDPSKLVVKGNIIWSDNSNDLNVQVSSPSHFKICTPKKVLSFEDAKQRALQWK 477

Query: 481 KAIEALQN 488
           KAIE LQN
Sbjct: 478 KAIETLQN 485

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356535531|ref|XP_003536298.1| PREDICTED: 3-phosphoinositide-dependent protein kinase 2-like [Glycine max]

 Score =  841 bits (2172), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 419/490 (85%), Positives = 451/490 (92%), Gaps = 2/490 (0%)

Query: 1   MLAMEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSK 60
           ML MEKDFDSKL+I+GN++SS     VQRSKSFAFRAPQE+++IQDFELGKIYGVGSYSK
Sbjct: 1   MLEMEKDFDSKLKIQGNSSSSNGAGNVQRSKSFAFRAPQENYTIQDFELGKIYGVGSYSK 60

Query: 61  VVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL 120
           VVRAKK DTG VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG+VRL+FTFQD+FSL
Sbjct: 61  VVRAKKKDTGIVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGIVRLYFTFQDSFSL 120

Query: 121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA 180
           YMALESCEGGELFDQIT KG LSE+EARFY AEV+DALEYIH++G+IHRDIKPENLLLTA
Sbjct: 121 YMALESCEGGELFDQITRKGRLSENEARFYAAEVIDALEYIHNLGVIHRDIKPENLLLTA 180

Query: 181 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 240
           +GHIKIADFGSVKPMQDS+ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA
Sbjct: 181 EGHIKIADFGSVKPMQDSQITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 240

Query: 241 LGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGA 300
           LGCTLYQMLSGTSPFKD SEWLIFQRIIAR++RFP+YFSD ARDLIDRLLD+DPS RPGA
Sbjct: 241 LGCTLYQMLSGTSPFKDASEWLIFQRIIARELRFPDYFSDEARDLIDRLLDLDPSRRPGA 300

Query: 301 GPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDDVHDSSWNPSHIGDISAK 360
           GP GYA+LK HPFFKG+DW N+R Q PPKLA EP  QS   DDVHDSSW+PSHIGD SA 
Sbjct: 301 GPDGYAILKSHPFFKGVDWDNLRAQIPPKLAPEPGTQSPASDDVHDSSWSPSHIGDGSAA 360

Query: 361 INDGNGGASSSEGS--ITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQLI 418
                 GA+SSEG+  ITRLASIDSFDSKWQQFL+PGESVLMISMVKKLQKLTSKKVQLI
Sbjct: 361 SVRQPDGATSSEGTGHITRLASIDSFDSKWQQFLEPGESVLMISMVKKLQKLTSKKVQLI 420

Query: 419 LTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRASQ 478
           LTNKPKLIYVDPSKL+VKGNIIWSDN NDLSIQV+SPS+FKI TPKKV+SFEDAKQRA Q
Sbjct: 421 LTNKPKLIYVDPSKLIVKGNIIWSDNPNDLSIQVASPSNFKICTPKKVMSFEDAKQRAWQ 480

Query: 479 WKKAIEALQN 488
           WKKAIE LQN
Sbjct: 481 WKKAIEGLQN 490

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|12322773|gb|AAG51370.1|AC011560_2 putative 3-phosphoinositide-dependent protein kinase-1; 57432-54928 [Arabidopsis thaliana] gi|8567784|gb|AAF76356.1| 3-phosphoinositide-dependent protein kinase-1, putative [Arabidopsis thaliana]

 Score =  840 bits (2170), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 408/485 (84%), Positives = 439/485 (90%), Gaps = 3/485 (0%)

Query: 4   MEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVR 63
           M+K+FDSKL ++GN  SS+N  T+ RSKSFAF+APQE+F+  DFELGKIYGVGSYSKVVR
Sbjct: 1   MDKEFDSKLTLQGN--SSSNGETISRSKSFAFKAPQENFTYHDFELGKIYGVGSYSKVVR 58

Query: 64  AKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA 123
           AKK D GTVYALKIMDKKFITKENKTAYVKLERIVLDQL+HPG+V+LFFTFQDT SLYMA
Sbjct: 59  AKKKDNGTVYALKIMDKKFITKENKTAYVKLERIVLDQLEHPGIVKLFFTFQDTQSLYMA 118

Query: 124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH 183
           LESCEGGELFDQIT KG LSEDEARFY+AEVVDALEYIH+MGLIHRDIKPENLLLT DGH
Sbjct: 119 LESCEGGELFDQITRKGRLSEDEARFYSAEVVDALEYIHNMGLIHRDIKPENLLLTLDGH 178

Query: 184 IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGC 243
           IKIADFGSVKPMQDS+ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGC
Sbjct: 179 IKIADFGSVKPMQDSQITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGC 238

Query: 244 TLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPG 303
           TLYQMLSGTSPFKD SEWLIFQRIIARDI+FPN+FS+AARDLIDRLLD DPS RPGAG  
Sbjct: 239 TLYQMLSGTSPFKDASEWLIFQRIIARDIKFPNHFSEAARDLIDRLLDTDPSRRPGAGSE 298

Query: 304 GYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDDVHDSSWNPSHIGDISAKIND 363
           GY  LK HPFFKG+DWKN+R QTPPKLA +P  QS    +   S WNP+H+GD S   ND
Sbjct: 299 GYDSLKRHPFFKGVDWKNLRSQTPPKLAPDPASQSA-SPERDGSPWNPTHVGDTSVLQND 357

Query: 364 GNGGASSSEGSITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQLILTNKP 423
           G+ G S S GSITRLASIDSFDS+WQQFL+PGESVLMIS VKKLQK+TSKKVQLILTNKP
Sbjct: 358 GHNGLSESSGSITRLASIDSFDSRWQQFLEPGESVLMISAVKKLQKITSKKVQLILTNKP 417

Query: 424 KLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRASQWKKAI 483
           +LIYVDPSKLVVKGNIIWSDNSNDL++QVSSPSHFKI TPKKVLSFEDAKQRA QWKKAI
Sbjct: 418 RLIYVDPSKLVVKGNIIWSDNSNDLNVQVSSPSHFKICTPKKVLSFEDAKQRALQWKKAI 477

Query: 484 EALQN 488
           E LQN
Sbjct: 478 ETLQN 482

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296090372|emb|CBI40191.3| unnamed protein product [Vitis vinifera]

 Score =  838 bits (2166), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 407/463 (87%), Positives = 428/463 (92%), Gaps = 4/463 (0%)

Query: 29  RSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK 88
           RSKSFAFRAPQE+F+IQDFELGKIYGVGSYSKVVRA+K DTG VYALKIMDKKFITKENK
Sbjct: 6   RSKSFAFRAPQENFTIQDFELGKIYGVGSYSKVVRARKKDTGIVYALKIMDKKFITKENK 65

Query: 89  TAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEAR 148
           TAYVKLERIVLDQLDHPG+VRLFFTFQDTFSLYMALESCEGGELFDQIT KG LSE+EAR
Sbjct: 66  TAYVKLERIVLDQLDHPGIVRLFFTFQDTFSLYMALESCEGGELFDQITRKGRLSENEAR 125

Query: 149 FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 208
           FY AEVVDALEYIHS+GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS ITVLPNAAS
Sbjct: 126 FYAAEVVDALEYIHSLGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSLITVLPNAAS 185

Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII 268
           DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD SEWLIFQRII
Sbjct: 186 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDASEWLIFQRII 245

Query: 269 ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 328
           ARDIRFPNYFSD ARDLIDRLLD +PS RPGAG  GYA LKMHPFF G+DWKN+R QTPP
Sbjct: 246 ARDIRFPNYFSDEARDLIDRLLDTEPSRRPGAGRDGYASLKMHPFFNGVDWKNLRSQTPP 305

Query: 329 KLASEPMVQSGEGDDVHDSSWNPSHIGDISAKINDGNGGASSSE---GSITRLASIDSFD 385
           KLA E M  S EGDD  D SWNP+HIGD SA+ NDGN GA+SS    GS+TRLASIDSFD
Sbjct: 306 KLAMEAMAHSSEGDDGQD-SWNPAHIGDGSARQNDGNSGATSSSEAPGSVTRLASIDSFD 364

Query: 386 SKWQQFLDPGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNS 445
           SKWQQFL+ GESVLMISMVKK+QKLT+KKVQLILTNKPKLIYVDP+KL+VKGNIIWSDN 
Sbjct: 365 SKWQQFLEQGESVLMISMVKKIQKLTNKKVQLILTNKPKLIYVDPAKLMVKGNIIWSDNP 424

Query: 446 NDLSIQVSSPSHFKIVTPKKVLSFEDAKQRASQWKKAIEALQN 488
           NDLSIQV+SPSHFKI TPKKV+SFED+KQRA QWKKAIE LQN
Sbjct: 425 NDLSIQVTSPSHFKICTPKKVMSFEDSKQRAWQWKKAIEGLQN 467

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	489
TAIR|locus:2075740	486	AT3G10540 [Arabidopsis thalian	0.991	0.997	0.815	7.8e-213
TAIR|locus:2184357	491	PDK1 "3'-phosphoinositide-depe	0.991	0.987	0.803	2.1e-210
UNIPROTKB|F1Q2Y3	558	PDPK1 "Uncharacterized protein	0.668	0.586	0.421	1.5e-77
MGI|MGI:1338068	559	Pdpk1 "3-phosphoinositide depe	0.660	0.577	0.426	5.9e-76
UNIPROTKB|Q5F3U4	556	PDPK1 "Uncharacterized protein	0.744	0.654	0.398	7.5e-76
UNIPROTKB|E9PER6	529	PDPK1 "3-phosphoinositide-depe	0.654	0.604	0.424	9.6e-76
UNIPROTKB|O15530	556	PDPK1 "3-phosphoinositide-depe	0.654	0.575	0.424	9.6e-76
RGD|620307	559	Pdpk1 "3-phosphoinositide depe	0.660	0.577	0.423	9.6e-76
UNIPROTKB|O55173	559	Pdpk1 "3-phosphoinositide-depe	0.660	0.577	0.423	9.6e-76
ZFIN|ZDB-GENE-061013-109	536	pdpk1a "3-phosphoinositide dep	0.619	0.565	0.444	1.6e-75

TAIR|locus:2075740 AT3G10540 [Arabidopsis thaliana (taxid:3702)]

 Score = 2057 (729.2 bits), Expect = 7.8e-213, P = 7.8e-213
 Identities = 398/488 (81%), Positives = 428/488 (87%)

Query:     1 MLAMEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSK 60
             ML M+K+FDSKL ++GN  SS+N  T+ RSKSFAF+APQE+F+  DFELGKIYGVGSYSK
Sbjct:     1 MLTMDKEFDSKLTLQGN--SSSNGETISRSKSFAFKAPQENFTYHDFELGKIYGVGSYSK 58

Query:    61 VVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL 120
             VVRAKK D GTVYALKIMDKKFITKENKTAYVKLERIVLDQL+HPG+V+LFFTFQDT SL
Sbjct:    59 VVRAKKKDNGTVYALKIMDKKFITKENKTAYVKLERIVLDQLEHPGIVKLFFTFQDTQSL 118

Query:   121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA 180
             YMALESCEGGELFDQIT KG LSEDEARFY+AEVVDALEYIH+MGLIHRDIKPENLLLT 
Sbjct:   119 YMALESCEGGELFDQITRKGRLSEDEARFYSAEVVDALEYIHNMGLIHRDIKPENLLLTL 178

Query:   181 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 240
             DGHIKIADFGSVKPMQDS+ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA
Sbjct:   179 DGHIKIADFGSVKPMQDSQITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 238

Query:   241 LGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXXXXXXXXXXXPSGRPGA 300
             LGCTLYQMLSGTSPFKD SEWLIFQRIIARDI+FPN+FS              PS RPGA
Sbjct:   239 LGCTLYQMLSGTSPFKDASEWLIFQRIIARDIKFPNHFSEAARDLIDRLLDTDPSRRPGA 298

Query:   301 GPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDDVHDSSWNPSHIGDISAK 360
             G  GY  LK HPFFKG+DWKN+R QTPPKLA +P  QS   +    S WNP+H+GD S  
Sbjct:   299 GSEGYDSLKRHPFFKGVDWKNLRSQTPPKLAPDPASQSASPER-DGSPWNPTHVGDTSVL 357

Query:   361 INDGNGGASSSEGSITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQLILT 420
              NDG+ G S S GSITRLASIDSFDS+WQQFL+PGESVLMIS VKKLQK+TSKKVQLILT
Sbjct:   358 QNDGHNGLSESSGSITRLASIDSFDSRWQQFLEPGESVLMISAVKKLQKITSKKVQLILT 417

Query:   421 NKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRASQWK 480
             NKP+LIYVDPSKLVVKGNIIWSDNSNDL++QVSSPSHFKI TPKKVLSFEDAKQRA QWK
Sbjct:   418 NKPRLIYVDPSKLVVKGNIIWSDNSNDLNVQVSSPSHFKICTPKKVLSFEDAKQRALQWK 477

Query:   481 KAIEALQN 488
             KAIE LQN
Sbjct:   478 KAIETLQN 485

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005886 "plasma membrane" evidence=IDA

GO:0009827 "plant-type cell wall modification" evidence=RCA

GO:0009860 "pollen tube growth" evidence=RCA

TAIR|locus:2184357 PDK1 "3'-phosphoinositide-dependent protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 2034 (721.1 bits), Expect = 2.1e-210, P = 2.1e-210
 Identities = 396/493 (80%), Positives = 429/493 (87%)

Query:     1 MLAMEKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSK 60
             MLAMEK+FDSKL ++GN+++  N   V RSKSF+F+APQE+F+  DFE GKIYGVGSYSK
Sbjct:     1 MLAMEKEFDSKLVLQGNSSNGAN---VSRSKSFSFKAPQENFTSHDFEFGKIYGVGSYSK 57

Query:    61 VVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL 120
             VVRAKK +TGTVYALKIMDKKFITKENKTAYVKLERIVLDQL+HPG+++L+FTFQDT SL
Sbjct:    58 VVRAKKKETGTVYALKIMDKKFITKENKTAYVKLERIVLDQLEHPGIIKLYFTFQDTSSL 117

Query:   121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA 180
             YMALESCEGGELFDQIT KG LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT+
Sbjct:   118 YMALESCEGGELFDQITRKGRLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTS 177

Query:   181 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 240
             DGHIKIADFGSVKPMQDS+ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA
Sbjct:   178 DGHIKIADFGSVKPMQDSQITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA 237

Query:   241 LGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXXXXXXXXXXXPSGRPGA 300
             LGCTLYQMLSGTSPFKD SEWLIFQRIIARDI+FPN+FS              PS RPGA
Sbjct:   238 LGCTLYQMLSGTSPFKDASEWLIFQRIIARDIKFPNHFSEAARDLIDRLLDTEPSRRPGA 297

Query:   301 GPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQ--SGEGDDVHDSSWNPSHIGDIS 358
             G  GY  LK HPFF G+DWKN+R QTPPKLA +P  Q  S E DD H S WN +HIGD  
Sbjct:   298 GSEGYVALKRHPFFNGVDWKNLRSQTPPKLAPDPASQTASPERDDTHGSPWNLTHIGDSL 357

Query:   359 AKINDGNGG---ASSSEGSITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKV 415
             A  N+G+     +S S GSITRLASIDSFDS+WQQFL+PGESVLMIS VKKLQK+TSKKV
Sbjct:   358 ATQNEGHSAPPTSSESSGSITRLASIDSFDSRWQQFLEPGESVLMISAVKKLQKITSKKV 417

Query:   416 QLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQR 475
             QLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDL++ V+SPSHFKI TPKKVLSFEDAKQR
Sbjct:   418 QLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLNVVVTSPSHFKICTPKKVLSFEDAKQR 477

Query:   476 ASQWKKAIEALQN 488
             AS WKKAIE LQN
Sbjct:   478 ASVWKKAIETLQN 490

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004676 "3-phosphoinositide-dependent protein kinase activity" evidence=IGI

GO:0035091 "phosphatidylinositol binding" evidence=IDA

GO:0070300 "phosphatidic acid binding" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0045860 "positive regulation of protein kinase activity" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

UNIPROTKB|F1Q2Y3 PDPK1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 669 (240.6 bits), Expect = 1.5e-77, Sum P(2) = 1.5e-77
 Identities = 142/337 (42%), Positives = 198/337 (58%)

Query:    45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
             +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct:    82 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 141

Query:   105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
             P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct:   142 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEMVSALEYLHGK 201

Query:   165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A +FVGTA YV P
Sbjct:   202 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANSFVGTAQYVSP 253

Query:   225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
             E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct:   254 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 313

Query:   285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDD 343
                       + R G    GGY+ L+ HPFF+ I W+N++ QTPPKL +     S + +D
Sbjct:   314 LVEKLLVLDATKRLGCEEMGGYSPLRAHPFFESITWENLQHQTPPKLTAYLPAMSEDDED 373

Query:   344 VHDSSWNP-SHIGDISAKINDGNGGASSSEGSITRLA 379
              + +  N  S  G +    +  +   S+S+  + ++A
Sbjct:   374 CYGNYDNLLSQFGCMQVSSSSSSHSLSASDAGLPQMA 410

GO:0090004 "positive regulation of establishment of protein localization to plasma membrane" evidence=IEA

GO:0043304 "regulation of mast cell degranulation" evidence=IEA

GO:0043122 "regulation of I-kappaB kinase/NF-kappaB cascade" evidence=IEA

GO:0035556 "intracellular signal transduction" evidence=IEA

GO:0034122 "negative regulation of toll-like receptor signaling pathway" evidence=IEA

GO:0032869 "cellular response to insulin stimulus" evidence=IEA

GO:0032148 "activation of protein kinase B activity" evidence=IEA

GO:0030512 "negative regulation of transforming growth factor beta receptor signaling pathway" evidence=IEA

GO:0018107 "peptidyl-threonine phosphorylation" evidence=IEA

GO:0016023 "cytoplasmic membrane-bounded vesicle" evidence=IEA

GO:0010667 "negative regulation of cardiac muscle cell apoptotic process" evidence=IEA

GO:0010594 "regulation of endothelial cell migration" evidence=IEA

GO:0006972 "hyperosmotic response" evidence=IEA

GO:0006469 "negative regulation of protein kinase activity" evidence=IEA

GO:0004676 "3-phosphoinositide-dependent protein kinase activity" evidence=IEA

GO:0003323 "type B pancreatic cell development" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

MGI|MGI:1338068 Pdpk1 "3-phosphoinositide dependent protein kinase 1" [Mus musculus (taxid:10090)]

 Score = 657 (236.3 bits), Expect = 5.9e-76, Sum P(2) = 5.9e-76
 Identities = 142/333 (42%), Positives = 192/333 (57%)

Query:    45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
             +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct:    83 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 142

Query:   105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
             P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct:   143 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 202

Query:   165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A +FVGTA YV P
Sbjct:   203 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANSFVGTAQYVSP 254

Query:   225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
             E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct:   255 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYHFPEKFFPKARD 314

Query:   285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDD 343
                       + R G     GY  LK HPFF+ I W+N+  QTPPKL +     S + +D
Sbjct:   315 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFETITWENLHQQTPPKLTAYLPAMSEDDED 374

Query:   344 VHDSSWNP-SHIGDISAKINDGNGGASSSEGSI 375
              + +  N  S  G +    +  +   S+ E S+
Sbjct:   375 CYGNYDNLLSQFGFMQVSSSSSSHSLSTVETSL 407

GO:0000166 "nucleotide binding" evidence=IEA

GO:0003323 "type B pancreatic cell development" evidence=IMP

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISO

GO:0004676 "3-phosphoinositide-dependent protein kinase activity" evidence=ISO;IDA

GO:0005158 "insulin receptor binding" evidence=ISO

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISO;IDA

GO:0005829 "cytosol" evidence=ISO

GO:0005886 "plasma membrane" evidence=ISO

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=ISO;IDA

GO:0006469 "negative regulation of protein kinase activity" evidence=ISO

GO:0006972 "hyperosmotic response" evidence=IDA

GO:0007165 "signal transduction" evidence=TAS

GO:0010594 "regulation of endothelial cell migration" evidence=IMP

GO:0010667 "negative regulation of cardiac muscle cell apoptotic process" evidence=IMP

GO:0016020 "membrane" evidence=IEA

GO:0016023 "cytoplasmic membrane-bounded vesicle" evidence=IDA

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0018107 "peptidyl-threonine phosphorylation" evidence=ISO

GO:0019901 "protein kinase binding" evidence=ISO

GO:0030054 "cell junction" evidence=IEA

GO:0030512 "negative regulation of transforming growth factor beta receptor signaling pathway" evidence=ISO

GO:0032148 "activation of protein kinase B activity" evidence=ISO

GO:0032869 "cellular response to insulin stimulus" evidence=ISO

GO:0034122 "negative regulation of toll-like receptor signaling pathway" evidence=IMP

GO:0042981 "regulation of apoptotic process" evidence=ISO

GO:0043122 "regulation of I-kappaB kinase/NF-kappaB cascade" evidence=ISO

GO:0043304 "regulation of mast cell degranulation" evidence=IMP

GO:0048041 "focal adhesion assembly" evidence=ISO

GO:0090004 "positive regulation of establishment of protein localization to plasma membrane" evidence=ISO

UNIPROTKB|Q5F3U4 PDPK1 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 656 (236.0 bits), Expect = 7.5e-76, Sum P(2) = 7.5e-76
 Identities = 154/386 (39%), Positives = 212/386 (54%)

Query:    15 EGNNNSSTNCPTVQRSKSF----AFRAPQEHFSI-QDFELGKIYGVGSYSKVVRAKKIDT 69
             +G+N  ST   +   S S       + PQ       DF+ GKI G GS+S VV A+++ +
Sbjct:    48 QGSNMESTAAESRSSSNSLPQHTGQQPPQPRKKRPDDFKFGKILGEGSFSTVVLARELTS 107

Query:    70 GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG 129
                YA+KI++K+ I KENK  YV  ER V+ +LDHP  V+L+FTFQD   LY  L   + 
Sbjct:   108 SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 167

Query:   130 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADF 189
             GEL   I   G   E   RFYTAE+V ALEY+H  G+IHRD+KPEN+LL  D HI+I DF
Sbjct:   168 GELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDF 227

Query:   190 GSVKPMQ-DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQM 248
             G+ K +  DSR           +A +FVGTA YV PE+L    A   +DLWALGC +YQ+
Sbjct:   228 GTAKVLSADSR---------QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 278

Query:   249 LSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXXXXXXXXXXXPSGRPGAGP-GGYAV 307
             ++G  PF+  +E+LIFQ+II  +  FP  F                + R G    GGY  
Sbjct:   279 VAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAKDLVEKLLVLDATKRLGCEEMGGYGP 338

Query:   308 LKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDDVHDSSWNP-SHIGDISAKINDGNG 366
             LK HPFF+ I W+N+  QTPPKL +     S + +D + +  N  S  G +       +G
Sbjct:   339 LKAHPFFESIVWENLHLQTPPKLTAYLPAMSEDDEDCYGNYDNLLSQFGCMQV-----SG 393

Query:   367 GASSSEGSITRLASIDSFDSKWQQFL 392
              ASS   S+   ++  +     +Q++
Sbjct:   394 SASSHSLSVPETSTPQTSGGNIEQYI 419

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|E9PER6 PDPK1 "3-phosphoinositide-dependent protein kinase 1" [Homo sapiens (taxid:9606)]

 Score = 655 (235.6 bits), Expect = 9.6e-76, Sum P(2) = 9.6e-76
 Identities = 140/330 (42%), Positives = 191/330 (57%)

Query:    45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
             +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct:    53 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 112

Query:   105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
             P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct:   113 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 172

Query:   165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A +FVGTA YV P
Sbjct:   173 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANSFVGTAQYVSP 224

Query:   225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
             E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct:   225 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 284

Query:   285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDD 343
                       + R G     GY  LK HPFF+ + W+N+  QTPPKL +     S + +D
Sbjct:   285 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLTAYLPAMSEDDED 344

Query:   344 VHDSSWNP-SHIGDISAKINDGNGGASSSE 372
              + +  N  S  G +    +  +   S+S+
Sbjct:   345 CYGNYDNLLSQFGCMQVSSSSSSHSLSASD 374

GO:0005524 "ATP binding" evidence=IEA

GO:0003323 "type B pancreatic cell development" evidence=IEA

GO:0004676 "3-phosphoinositide-dependent protein kinase activity" evidence=IEA

GO:0005158 "insulin receptor binding" evidence=IEA

GO:0005829 "cytosol" evidence=IEA

GO:0005886 "plasma membrane" evidence=IEA

GO:0006972 "hyperosmotic response" evidence=IEA

GO:0010594 "regulation of endothelial cell migration" evidence=IEA

GO:0010667 "negative regulation of cardiac muscle cell apoptotic process" evidence=IEA

GO:0016023 "cytoplasmic membrane-bounded vesicle" evidence=IEA

GO:0019901 "protein kinase binding" evidence=IEA

GO:0034122 "negative regulation of toll-like receptor signaling pathway" evidence=IEA

GO:0043304 "regulation of mast cell degranulation" evidence=IEA

GO:0048041 "focal adhesion assembly" evidence=IEA

UNIPROTKB|O15530 PDPK1 "3-phosphoinositide-dependent protein kinase 1" [Homo sapiens (taxid:9606)]

 Score = 655 (235.6 bits), Expect = 9.6e-76, Sum P(2) = 9.6e-76
 Identities = 140/330 (42%), Positives = 191/330 (57%)

Query:    45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
             +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct:    80 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 139

Query:   105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
             P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct:   140 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 199

Query:   165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A +FVGTA YV P
Sbjct:   200 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANSFVGTAQYVSP 251

Query:   225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
             E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct:   252 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 311

Query:   285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDD 343
                       + R G     GY  LK HPFF+ + W+N+  QTPPKL +     S + +D
Sbjct:   312 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLTAYLPAMSEDDED 371

Query:   344 VHDSSWNP-SHIGDISAKINDGNGGASSSE 372
              + +  N  S  G +    +  +   S+S+
Sbjct:   372 CYGNYDNLLSQFGCMQVSSSSSSHSLSASD 401

GO:0005524 "ATP binding" evidence=IEA

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0003323 "type B pancreatic cell development" evidence=IEA

GO:0005158 "insulin receptor binding" evidence=IEA

GO:0006972 "hyperosmotic response" evidence=IEA

GO:0010594 "regulation of endothelial cell migration" evidence=IEA

GO:0010667 "negative regulation of cardiac muscle cell apoptotic process" evidence=IEA

GO:0016023 "cytoplasmic membrane-bounded vesicle" evidence=IEA

GO:0019901 "protein kinase binding" evidence=IEA

GO:0034122 "negative regulation of toll-like receptor signaling pathway" evidence=IEA

GO:0043304 "regulation of mast cell degranulation" evidence=IEA

GO:0048041 "focal adhesion assembly" evidence=IEA

GO:0005925 "focal adhesion" evidence=IEA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA;TAS

GO:0005515 "protein binding" evidence=IPI

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=TAS

GO:0030512 "negative regulation of transforming growth factor beta receptor signaling pathway" evidence=IDA

GO:0043122 "regulation of I-kappaB kinase/NF-kappaB cascade" evidence=IMP

GO:0042981 "regulation of apoptotic process" evidence=IMP

GO:0030036 "actin cytoskeleton organization" evidence=TAS

GO:0035556 "intracellular signal transduction" evidence=IDA

GO:0005654 "nucleoplasm" evidence=TAS

GO:0005829 "cytosol" evidence=TAS

GO:0007173 "epidermal growth factor receptor signaling pathway" evidence=TAS

GO:0007268 "synaptic transmission" evidence=TAS

GO:0007596 "blood coagulation" evidence=TAS

GO:0008286 "insulin receptor signaling pathway" evidence=TAS

GO:0008543 "fibroblast growth factor receptor signaling pathway" evidence=TAS

GO:0016301 "kinase activity" evidence=EXP

GO:0030168 "platelet activation" evidence=TAS

GO:0031295 "T cell costimulation" evidence=TAS

GO:0048011 "neurotrophin TRK receptor signaling pathway" evidence=TAS

GO:0048015 "phosphatidylinositol-mediated signaling" evidence=TAS

GO:0050852 "T cell receptor signaling pathway" evidence=TAS

GO:0032869 "cellular response to insulin stimulus" evidence=IMP

GO:0090004 "positive regulation of establishment of protein localization to plasma membrane" evidence=IMP

GO:0018107 "peptidyl-threonine phosphorylation" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0004676 "3-phosphoinositide-dependent protein kinase activity" evidence=IDA

GO:0032148 "activation of protein kinase B activity" evidence=IDA

GO:0006469 "negative regulation of protein kinase activity" evidence=IDA

RGD|620307 Pdpk1 "3-phosphoinositide dependent protein kinase-1" [Rattus norvegicus (taxid:10116)]

 Score = 655 (235.6 bits), Expect = 9.6e-76, Sum P(2) = 9.6e-76
 Identities = 141/333 (42%), Positives = 192/333 (57%)

Query:    45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
             +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct:    83 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 142

Query:   105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
             P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct:   143 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 202

Query:   165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A +FVGTA YV P
Sbjct:   203 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPDSKQARANSFVGTAQYVSP 254

Query:   225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
             E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct:   255 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 314

Query:   285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDD 343
                       + R G     GY  LK HPFF+ I W+N+  QTPPKL +     S + +D
Sbjct:   315 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESITWENLHQQTPPKLTAYLPAMSEDDED 374

Query:   344 VHDSSWNP-SHIGDISAKINDGNGGASSSEGSI 375
              + +  N  S  G +    +  +   S+ + S+
Sbjct:   375 CYGNYDNLLSQFGCMQVSSSSSSHSLSAVDASL 407

GO:0003323 "type B pancreatic cell development" evidence=IEA;ISO

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISO

GO:0004676 "3-phosphoinositide-dependent protein kinase activity" evidence=ISO;IDA;TAS

GO:0005158 "insulin receptor binding" evidence=IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISO

GO:0005829 "cytosol" evidence=IDA

GO:0005886 "plasma membrane" evidence=ISO;IDA;TAS

GO:0005925 "focal adhesion" evidence=IEA

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=ISO

GO:0006469 "negative regulation of protein kinase activity" evidence=IEA;ISO

GO:0006972 "hyperosmotic response" evidence=IEA;ISO

GO:0010594 "regulation of endothelial cell migration" evidence=IEA;ISO

GO:0010667 "negative regulation of cardiac muscle cell apoptotic process" evidence=IEA;ISO

GO:0016023 "cytoplasmic membrane-bounded vesicle" evidence=IEA;ISO

GO:0016301 "kinase activity" evidence=ISO

GO:0018107 "peptidyl-threonine phosphorylation" evidence=IEA;ISO

GO:0019901 "protein kinase binding" evidence=IDA

GO:0030512 "negative regulation of transforming growth factor beta receptor signaling pathway" evidence=IEA;ISO

GO:0032148 "activation of protein kinase B activity" evidence=IEA;ISO

GO:0032869 "cellular response to insulin stimulus" evidence=IEA;ISO

GO:0034122 "negative regulation of toll-like receptor signaling pathway" evidence=IEA;ISO

GO:0035556 "intracellular signal transduction" evidence=IEA;ISO

GO:0042981 "regulation of apoptotic process" evidence=ISO

GO:0043122 "regulation of I-kappaB kinase/NF-kappaB cascade" evidence=IEA;ISO

GO:0043304 "regulation of mast cell degranulation" evidence=IEA;ISO

GO:0048041 "focal adhesion assembly" evidence=IMP

GO:0090004 "positive regulation of establishment of protein localization to plasma membrane" evidence=IEA;ISO

UNIPROTKB|O55173 Pdpk1 "3-phosphoinositide-dependent protein kinase 1" [Rattus norvegicus (taxid:10116)]

 Score = 655 (235.6 bits), Expect = 9.6e-76, Sum P(2) = 9.6e-76
 Identities = 141/333 (42%), Positives = 192/333 (57%)

Query:    45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
             +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct:    83 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 142

Query:   105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
             P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct:   143 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 202

Query:   165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A +FVGTA YV P
Sbjct:   203 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPDSKQARANSFVGTAQYVSP 254

Query:   225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
             E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct:   255 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 314

Query:   285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDD 343
                       + R G     GY  LK HPFF+ I W+N+  QTPPKL +     S + +D
Sbjct:   315 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESITWENLHQQTPPKLTAYLPAMSEDDED 374

Query:   344 VHDSSWNP-SHIGDISAKINDGNGGASSSEGSI 375
              + +  N  S  G +    +  +   S+ + S+
Sbjct:   375 CYGNYDNLLSQFGCMQVSSSSSSHSLSAVDASL 407

GO:0005524 "ATP binding" evidence=IEA

ZFIN|ZDB-GENE-061013-109 pdpk1a "3-phosphoinositide dependent protein kinase-1a" [Danio rerio (taxid:7955)]

 Score = 655 (235.6 bits), Expect = 1.6e-75, Sum P(2) = 1.6e-75
 Identities = 140/315 (44%), Positives = 188/315 (59%)

Query:    30 SKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT 89
             S + A + PQ  F  +DF  GKI G GS+S VV AK++ TG  YA+KI++K  I KENK 
Sbjct:    61 SSTPALKPPQS-FKKEDFSFGKILGEGSFSTVVLAKELATGKEYAMKILEKNHIRKENKA 119

Query:    90 AYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF 149
              YV  E+ +L  +DHP  V+LFFTFQD+  LY AL   + GEL   I   G   E   RF
Sbjct:   120 HYVIREKDILSCIDHPFFVKLFFTFQDSQKLYFALSYAKNGELLRYIRKIGSFDETCTRF 179

Query:   150 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 209
             YTAE+V ALEY+H++G+IHRD+KPEN+LL  D HI+I DFG+ K +           ++ 
Sbjct:   180 YTAEIVCALEYLHTVGIIHRDLKPENILLCEDMHIQITDFGTAKQLSSD--------SAQ 231

Query:   210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA 269
              +A +FVGTA YV PE+L    A   +DLWA+GC +YQ+++G  PF+  +E+LIFQ+II 
Sbjct:   232 TRANSFVGTAQYVSPELLTEKSACKSSDLWAMGCIIYQLVAGLPPFRAGNEYLIFQKIIK 291

Query:   270 RDIRFPNYFSXXXXXXXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPP 328
              +  FP  F               P  R G    GG+  LK H FF+ + W+N+  QTPP
Sbjct:   292 LEYEFPEKFFPKAKDLVQRLLSLDPRKRLGCEEMGGFGPLKGHMFFETVSWENLPLQTPP 351

Query:   329 KLASEPMVQSGEGDD 343
             KL   P + +   DD
Sbjct:   352 KLT--PYLPAMAEDD 364

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0000166 "nucleotide binding" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9XF67	PDPK1_ARATH	2, ., 7, ., 1, 1, ., 1	0.8255	0.9918	0.9877	no	no
Q4V3C8	PDPK2_ARATH	2, ., 7, ., 1, 1, ., 1	0.8401	0.9918	0.9979	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.994
3rd Layer	2.7.11	0.998

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	489
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-132
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-105
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	7e-99
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-95
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-86
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-84
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-83
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-79
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	6e-77
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	6e-74
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-72
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	7e-69
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-68
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-67
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-66
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-66
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-65
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-64
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-64
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	6e-64
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	7e-64
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-63
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-62
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-62
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	6e-61
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	7e-61
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-59
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-59
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	8e-59
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-58
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-57
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	8e-57
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	9e-57
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-56
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-56
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-56
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	9e-56
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-55
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-55
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-55
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-54
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-54
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	5e-54
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-53
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	7e-53
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	7e-53
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-52
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	9e-52
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-51
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-51
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-51
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	6e-51
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-50
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-50
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	6e-50
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	8e-50
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	9e-50
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-49
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-49
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-49
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	7e-49
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-48
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-47
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-47
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-46
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-46
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-46
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-45
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-45
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	7e-45
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	8e-45
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	9e-44
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-43
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-41
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-41
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-39
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-39
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-39
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-38
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-38
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	9e-38
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	6e-37
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-36
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-36
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-36
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-36
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	4e-36
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-36
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-36
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	6e-35
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	8e-35
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-34
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-34
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	5e-34
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	7e-34
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	9e-34
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-33
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-32
cd01262	107	cd01262, PH_PDK1, 3-Phosphoinositide dependent pro	1e-32
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-32
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-32
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-31
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-31
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-30
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-30
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-30
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-29
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	6e-29
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	9e-29
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-28
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-28
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-28
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-28
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	5e-28
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-28
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-28
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	6e-28
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-27
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-27
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-27
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	5e-27
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	6e-27
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-26
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-26
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-26
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-26
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-26
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-26
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	7e-26
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	7e-26
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-25
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-25
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-25
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-25
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-25
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-25
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-25
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	9e-25
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-24
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-24
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	4e-24
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-23
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-23
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-23
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-23
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-23
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	5e-23
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-22
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-22
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-22
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	9e-22
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-21
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-21
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-21
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-21
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-21
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	7e-21
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-20
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-20
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-20
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-20
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-20
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	5e-20
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	9e-20
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-19
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-19
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-19
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-19
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	8e-19
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	9e-19
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	9e-19
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-18
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-18
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-18
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-18
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-18
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-18
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	7e-18
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	9e-18
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-17
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-17
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-17
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-17
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-17
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-17
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-17
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-17
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-17
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-17
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-17
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-16
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-16
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-16
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-16
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-16
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	6e-16
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	6e-16
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-15
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-15
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-15
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-15
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-15
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-15
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	8e-15
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	8e-15
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-14
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	4e-14
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-13
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-13
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-13
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-13
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-13
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	9e-13
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-12
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-12
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-12
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-12
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-12
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	7e-12
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	7e-12
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	7e-12
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	8e-12
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-11
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-11
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-11
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	5e-11
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	8e-11
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	9e-11
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-10
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-10
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-10
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	7e-10
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	7e-10
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-09
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-09
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-09
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-09
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-09
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	4e-09
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-09
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-09
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-09
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-09
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	6e-09
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	9e-09
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-08
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-08
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-08
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-08
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-08
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-08
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-08
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-08
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-08
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-08
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	3e-08
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-08
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-08
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	7e-08
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	8e-08
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-07
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-07
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-07
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-07
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-07
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-07
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-07
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-07
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-07
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-07
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-07
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	5e-07
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	5e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	6e-07
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	6e-07
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	7e-07
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	7e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-06
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	3e-06
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-06
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-06
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	5e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	5e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	7e-06
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	7e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	7e-06
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-05
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-05
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-05
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-05
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-05
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-05
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	6e-05
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	8e-05
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-04
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-04
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	3e-04
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	4e-04
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	4e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-04
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	7e-04
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	0.001
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	0.001

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  384 bits (988), Expect = e-132
 Identities = 134/281 (47%), Positives = 179/281 (63%), Gaps = 12/281 (4%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD- 103
            DF+ GKI G GS+S VV AK+ +T   YA+KI+DK+ + KE K  YVK+E+ VL +L+ 
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HPG+++L++TFQD  +LY  LE    GEL   I   G L E   RFY AE++ ALEY+HS
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPM----------QDSRITVLPNAASDDKAC 213
            G+IHRD+KPEN+LL  D HIKI DFG+ K +           D+         +  +  
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180

Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR 273
           +FVGTA YV PE+LN  PA   +DLWALGC +YQML+G  PF+ ++E+L FQ+I+  +  
Sbjct: 181 SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYS 240

Query: 274 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 314
           FP  F   A+DLI++LL +DP  R G    GY  LK HPFF
Sbjct: 241 FPPNFPPDAKDLIEKLLVLDPQDRLGVNE-GYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  313 bits (804), Expect = e-105
 Identities = 113/261 (43%), Positives = 158/261 (60%), Gaps = 12/261 (4%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS+ KV+  +K DTG +YA+K++ KK I K  +  +   ER +L +++HP +V+L + 
Sbjct: 2   GKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYA 61

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           FQ    LY+ LE   GGELF  ++ +G  SE+ ARFY AE+V ALEY+HS+G+I+RD+KP
Sbjct: 62  FQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKP 121

Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
           EN+LL ADGHIK+ DFG  K            ++   +  TF GT  Y+ PEVL      
Sbjct: 122 ENILLDADGHIKLTDFGLAK----------ELSSEGSRTNTFCGTPEYLAPEVLLGKGYG 171

Query: 234 FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVD 293
              D W+LG  LY+ML+G  PF       I+++I+   +RFP + S  ARDLI  LL  D
Sbjct: 172 KAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKD 231

Query: 294 PSGRPGAGPGGYAVLKMHPFF 314
           P+ R G+G      +K HPFF
Sbjct: 232 PTKRLGSGG--AEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  299 bits (767), Expect = 7e-99
 Identities = 114/278 (41%), Positives = 162/278 (58%), Gaps = 13/278 (4%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
            DFE  K  G GS+ +V+  +   +G  YALKI+ K  I K  +  +V  E+ +L  + H
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P +V L+ +FQD  +LY+ +E   GGELF  +   G   E  ARFY A+VV ALEY+HS+
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL 120

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
            +++RD+KPENLLL +DG+IKI DFG  K     R+          +  T  GT  Y+ P
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFAK-----RV--------KGRTYTLCGTPEYLAP 167

Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD 284
           E++ S       D WALG  +Y+ML+G  PF D +   I+++I+   +RFP++FS  A+D
Sbjct: 168 EIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKD 227

Query: 285 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 322
           LI  LL VD + R G    G   +K HP+F GIDW  +
Sbjct: 228 LIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIAL 265

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  288 bits (739), Expect = 2e-95
 Identities = 110/272 (40%), Positives = 155/272 (56%), Gaps = 22/272 (8%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           +E+ +  G GS+ KV  A+   TG + A+K++ KK I K+ +      E  +L +L HP 
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILR--EIKILKKLKHPN 58

Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           +VRL+  F+D   LY+ +E CEGG+LFD +  +G LSEDEARFY  +++ ALEY+HS G+
Sbjct: 59  IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118

Query: 167 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 226
           +HRD+KPEN+LL  DGH+K+ADFG  + +              +K  TFVGT  Y+ PEV
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDP-----------GEKLTTFVGTPEYMAPEV 167

Query: 227 LNSSPATFGNDLWALGCTLYQMLSGTSPFK-DTSEWLIFQRIIARDIRFPNY---FSDAA 282
           L         D+W+LG  LY++L+G  PF  D     +F++I      FP      S  A
Sbjct: 168 LLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEA 227

Query: 283 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 314
           +DLI +LL  DP  R  A          HPFF
Sbjct: 228 KDLIRKLLVKDPEKRLTAEE-----ALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  264 bits (677), Expect = 7e-86
 Identities = 113/266 (42%), Positives = 157/266 (59%), Gaps = 6/266 (2%)

Query: 56  GSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ 115
           G+Y +V  AKK  TG +YA+K++ K  + ++N+   V  ER +L Q   P VV+L+++FQ
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63

Query: 116 DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPEN 175
              +LY+ +E   GG+L   + + G L ED AR Y AE+V ALEY+HS G+IHRD+KP+N
Sbjct: 64  GKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDN 123

Query: 176 LLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFG 235
           +L+ ++GH+K+ DFG  K     R   L +   +DK    VGT  Y+ PEV+     +  
Sbjct: 124 ILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK--RIVGTPDYIAPEVILGQGHSKT 181

Query: 236 NDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF--SDAARDLIDRLLDVD 293
            D W+LGC LY+ L G  PF   +   IFQ I+   I +P     SD A DLI +LL  D
Sbjct: 182 VDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPD 241

Query: 294 PSGRPGAGPGGYAVLKMHPFFKGIDW 319
           P  R GA       +K HPFFKGIDW
Sbjct: 242 PEKRLGA--KSIEEIKNHPFFKGIDW 265

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  263 bits (674), Expect = 3e-84
 Identities = 132/349 (37%), Positives = 186/349 (53%), Gaps = 37/349 (10%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           DFE+ K+ G G++ +V   +  DTG VYA+K++ K  + K N+ A+V+ ER +L   D P
Sbjct: 2   DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSP 61

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 165
            +V+L+++FQD   LY+ +E   GG+L + +  K    E+ ARFY AE+V AL+ +H +G
Sbjct: 62  WIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG 121

Query: 166 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDS---------RITVL----PNAASDDK- 211
            IHRDIKP+N+L+ ADGHIK+ADFG  K M  +            +L          D  
Sbjct: 122 FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHK 181

Query: 212 -----ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQR 266
                A + VGT  Y+ PEVL  +P     D W+LG  LY+ML G  PF   +    + +
Sbjct: 182 QRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNK 241

Query: 267 IIA--RDIRFPNY--FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 322
           II     +RFP     S  A DLI RLL  DP  R G+    +  +K HPFFKGIDW+N+
Sbjct: 242 IINWKESLRFPPDPPVSPEAIDLICRLL-CDPEDRLGS----FEEIKSHPFFKGIDWENL 296

Query: 323 RGQTPPKLASEPMVQSGEGD-----DVHDSSWNPSHIGDISAKINDGNG 366
           R   PP +   P + S   D     D  D      ++   S K+N G  
Sbjct: 297 RETKPPFV---PEL-SSPLDTSNFDDFEDDKDLSDYLSQNSKKLNKGKQ 341

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  260 bits (667), Expect = 1e-83
 Identities = 118/309 (38%), Positives = 172/309 (55%), Gaps = 24/309 (7%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           + F+  K+ G G   +V   +   TG ++ALK++DKK + K NK   V  E+ +L  LDH
Sbjct: 1   KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVVDALEYIH 162
           P +  L+ +FQ    L + ++ C GGELF   Q      LSE+ ARFY AEV+ ALEY+H
Sbjct: 61  PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADF-----GSVKP-------------MQDSRITVLP 204
            +G+++RD+KPEN+LL   GHI ++DF       V+P                + I    
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSET 180

Query: 205 NAASDD-KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLI 263
            +     ++ +FVGT  Y+ PEV++        D W LG  LY+ML GT+PFK ++    
Sbjct: 181 FSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240

Query: 264 FQRIIARDIRFPNY--FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN 321
           F  I+ +++ FP     S +ARDLI +LL  DPS R G+   G A +K HPFF+G++W  
Sbjct: 241 FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSK-RGAAEIKQHPFFRGVNWAL 299

Query: 322 IRGQTPPKL 330
           IR  TPP +
Sbjct: 300 IRHTTPPII 308

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  247 bits (632), Expect = 4e-79
 Identities = 102/270 (37%), Positives = 154/270 (57%), Gaps = 15/270 (5%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           GVG + +V   K       +ALK + K+ I +  +  ++  E+ +L++ +HP +V+L+ T
Sbjct: 2   GVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRT 61

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           F+D   +YM +E C GGEL+  +  +G   E  ARFY A VV A EY+H+ G+I+RD+KP
Sbjct: 62  FKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKP 121

Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
           ENLLL ++G++K+ DFG  K ++  +           K  TF GT  YV PE++ +    
Sbjct: 122 ENLLLDSNGYVKLVDFGFAKKLKSGQ-----------KTWTFCGTPEYVAPEIILNKGYD 170

Query: 234 FGNDLWALGCTLYQMLSGTSPFK--DTSEWLIFQRIIARD--IRFPNYFSDAARDLIDRL 289
           F  D W+LG  LY++L+G  PF   D     I+  I+  +  + FPNY   AA+DLI +L
Sbjct: 171 FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQL 230

Query: 290 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDW 319
           L  +P  R G   GG   +K H +F G DW
Sbjct: 231 LRRNPEERLGNLKGGIKDIKKHKWFNGFDW 260

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  241 bits (617), Expect = 6e-77
 Identities = 106/276 (38%), Positives = 153/276 (55%), Gaps = 24/276 (8%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           +EL +  G GS+  V +AK   TG + A+KI+ K+   K  K    + E  +L +L HP 
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSE-KSKKDQTARREIRILRRLSHPN 59

Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           +VRL   F+D   LY+ +E CEGG+LFD ++  G LSEDEA+    +++  LEY+HS G+
Sbjct: 60  IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119

Query: 167 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 226
           IHRD+KPEN+LL  +G +KIADFG  K +            S     TFVGT  Y+ PEV
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKL----------LKSSSSLTTFVGTPWYMAPEV 169

Query: 227 LN-SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW---LIFQRIIARDIRFPNYF---- 278
           L   +      D+W+LG  LY++L+G  PF   +      + +RI+   + F        
Sbjct: 170 LLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSG 229

Query: 279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 314
           S+ A+DLI + L+ DPS RP A       +  HP+F
Sbjct: 230 SEEAKDLIKKCLNKDPSKRPTA-----EEILQHPWF 260

Length = 260

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  236 bits (603), Expect = 6e-74
 Identities = 114/299 (38%), Positives = 166/299 (55%), Gaps = 15/299 (5%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           + DFE+G+  G GS+ +V  AK   TG  YA+K + K+ I K  +  +V  E+ +L +L 
Sbjct: 17  LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +V +  +FQD   +Y  LE   GGELF  +   G    D A+FY AE+V A EY+HS
Sbjct: 77  HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS 136

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
             +I+RD+KPENLLL   GH+K+ DFG  K     ++         D+  T  GT  Y+ 
Sbjct: 137 KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVP--------DRTFTLCGTPEYLA 183

Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAAR 283
           PEV+ S       D W +G  LY+ ++G  PF D + + I+++I+A  ++FPN+F   AR
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRAR 243

Query: 284 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGD 342
           DL+  LL  D + R G   GG A +K HP+F G +W  +  +  P  A  P+     GD
Sbjct: 244 DLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYP--APIPVRVKSPGD 300

Length = 329

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  230 bits (588), Expect = 3e-72
 Identities = 110/300 (36%), Positives = 164/300 (54%), Gaps = 19/300 (6%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
            D E  K  G G++ +V   +   +   YALK+M    + +  +  +V  E+ VL ++ H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P ++RLF+T  D   LYM +E   GGELF  + + G  S     FY +E+V ALEY+HS 
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
            +++RD+KPEN+LL  +GHIK+ DFG  K ++             D+  T  GT  Y+ P
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAKKLR-------------DRTWTLCGTPEYLAP 167

Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD 284
           EV+ S       D WALG  +Y+ML G  PF D + + I+++I+A  + FP +    A+D
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKD 227

Query: 285 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPPKLASEPMVQSGEGD 342
           LI +LL VD + R G    G   +K H +FK +DW ++  R   PP +   P V S +GD
Sbjct: 228 LIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPPIV---PKV-SHDGD 283

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  224 bits (572), Expect = 7e-69
 Identities = 116/317 (36%), Positives = 174/317 (54%), Gaps = 39/317 (12%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           DFE  K+ G G++ +V   +K DTG +YA+K + K  + ++ + A+V+ ER +L + D+P
Sbjct: 2   DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNP 61

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 165
            VV+L+++FQD   LY+ +E   GG++   +  K   +E+E RFY AE + A++ IH +G
Sbjct: 62  WVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG 121

Query: 166 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT--------VLPNAASD-------- 209
            IHRDIKP+NLLL A GHIK++DFG    ++ S  T         LP+   D        
Sbjct: 122 YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSS 181

Query: 210 -DKACTF-----------VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF-- 255
             KA T+           VGT  Y+ PEV   +      D W+LG  +Y+ML G  PF  
Sbjct: 182 KRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCS 241

Query: 256 KDTSEWLIFQRII--ARDIRFPN--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH 311
            +  E   +++II     ++FP+    S  A+DLI RL   +   R G    G   +K H
Sbjct: 242 DNPQE--TYRKIINWKETLQFPDEVPLSPEAKDLIKRLC-CEAERRLGN--NGVNEIKSH 296

Query: 312 PFFKGIDWKNIRGQTPP 328
           PFFKG+DW++IR +  P
Sbjct: 297 PFFKGVDWEHIRERPAP 313

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  220 bits (563), Expect = 2e-68
 Identities = 109/294 (37%), Positives = 167/294 (56%), Gaps = 22/294 (7%)

Query: 46  DFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTA-YVKLERIVLDQ 101
           +FEL ++ G G+Y KV   +K+   D G +YA+K++ K  I ++ KTA + + ER VL+ 
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 102 LDH-PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
           +   P +V L + FQ    L++ L+   GGELF  +  + H +E E R Y AE+V AL++
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120

Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           +H +G+I+RDIK EN+LL ++GH+ + DFG  K            A  +++A +F GT  
Sbjct: 121 LHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL---------AEEEERAYSFCGTIE 171

Query: 221 YVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPF----KDTSEWLIFQRIIARDIRF 274
           Y+ PEV+           D W+LG   +++L+G SPF    +  S+  I +RI+     F
Sbjct: 172 YMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPF 231

Query: 275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 328
           P   S  ARD I +LL+ DP  R GA   G   +K HPFF+GIDW ++  +  P
Sbjct: 232 PKTMSAEARDFIQKLLEKDPKKRLGA--NGADEIKNHPFFQGIDWDDLAAKRIP 283

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  217 bits (554), Expect = 1e-67
 Identities = 104/269 (38%), Positives = 150/269 (55%), Gaps = 21/269 (7%)

Query: 56  GSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER-IVLDQLDHPGVVRLFFTF 114
           G++  V  AKK  TG  +A+K++ K  +  +N+   VK ER I++ Q + P V +L+++F
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66

Query: 115 QDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPE 174
           Q    LY+ +E   GG+    I + G L ED A+ Y AEVV  +E +H  G+IHRDIKPE
Sbjct: 67  QSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPE 126

Query: 175 NLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATF 234
           NLL+   GH+K+ DFG       SR  +            FVGT  Y+ PE +       
Sbjct: 127 NLLIDQTGHLKLTDFGL------SRNGLENK--------KFVGTPDYLAPETILGVGDDK 172

Query: 235 GNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----NYFSDAARDLIDRLL 290
            +D W+LGC +++ L G  PF   +   +F  I++R I +P     + S  A DLI+RLL
Sbjct: 173 MSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLL 232

Query: 291 DVDPSGRPGAGPGGYAVLKMHPFFKGIDW 319
            +DP+ R GA   GY  +K HPFFK I+W
Sbjct: 233 CMDPAKRLGA--NGYQEIKSHPFFKSINW 259

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  216 bits (551), Expect = 3e-66
 Identities = 100/270 (37%), Positives = 146/270 (54%), Gaps = 11/270 (4%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVR 109
           K+ G GS+ KV+ A+   T  +YA+K++ K  I +++       E+ VL     HP + +
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 110 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 169
           L   FQ    L+  +E   GG+L   I   G   E  ARFY AE+V  L+++H  G+I+R
Sbjct: 61  LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120

Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 229
           D+K +N+LL ++GHIKIADFG  K                    TF GT  Y+ PE+L+ 
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMCKE----------GILGGVTTSTFCGTPDYIAPEILSY 170

Query: 230 SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL 289
            P     D WALG  LY+ML+G SPF+   E  +FQ I+  ++R+P + S  A+ ++   
Sbjct: 171 QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSF 230

Query: 290 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDW 319
           L  +P  R G  P G   +K HPFF+ IDW
Sbjct: 231 LTKNPEKRLGCLPTGEQDIKGHPFFREIDW 260

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  216 bits (551), Expect = 3e-66
 Identities = 116/305 (38%), Positives = 172/305 (56%), Gaps = 23/305 (7%)

Query: 51  KIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENK-TAYVKLERIVLDQLDHPG 106
           K+ G G Y KV + +K+   DTG ++A+K++ K  I +  K TA+ K ER +L+ + HP 
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           +V L + FQ    LY+ LE   GGELF  +  +G   ED A FY +E+  ALE++H  G+
Sbjct: 62  IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121

Query: 167 IHRDIKPENLLLTADGHIKIADFGSVK-PMQDSRITVLPNAASDDKACTFVGTAAYVPPE 225
           I+RD+KPEN+LL A GH+K+ DFG  K  + +  +T            TF GT  Y+ PE
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT-----------HTFCGTIEYMAPE 170

Query: 226 VLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDL 285
           +L  S      D W+LG  +Y ML+G  PF   +      +I+   +  P Y +  ARDL
Sbjct: 171 ILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDL 230

Query: 286 IDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI---RGQTPPKLASEPMVQSGEGD 342
           + +LL  +PS R GAGPG  A ++ HPFF+ ++W ++   + + P K    P++QS E  
Sbjct: 231 LKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFK----PLLQSEEDV 286

Query: 343 DVHDS 347
              DS
Sbjct: 287 SQFDS 291

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  213 bits (544), Expect = 3e-65
 Identities = 117/293 (39%), Positives = 155/293 (52%), Gaps = 30/293 (10%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           DF++    G G Y +V  AKK DTG + ALK M K  + K N+  +V  ER +L      
Sbjct: 2   DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 165
            +V+L + FQD   LY+A+E   GG+    + + G LSED ARFY AE+ +A++ +H +G
Sbjct: 62  WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121

Query: 166 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 225
            IHRD+KPEN L+ A GHIK+ DFG  K                  A + VG+  Y+ PE
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSK-------------GIVTYANSVVGSPDYMAPE 168

Query: 226 VLNSSPATFGNDLWALGCTLYQMLSGTSPF-----KDTSEWL-----IFQRIIARDIRFP 275
           VL      F  D W+LGC LY+ L G  PF      +T E L       QR +  D RF 
Sbjct: 169 VLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRF- 227

Query: 276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 328
              SD A DLI +L++ DPS R     G    +K HPFFK +DW  +R   PP
Sbjct: 228 -NLSDEAWDLITKLIN-DPSRR----FGSLEDIKNHPFFKEVDWNELRELKPP 274

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  211 bits (538), Expect = 2e-64
 Identities = 106/283 (37%), Positives = 152/283 (53%), Gaps = 18/283 (6%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL-DQLDHPGVVR 109
           K+ G GS+ KV+ AK    G  YA+K++ KK I K+ +  ++  ER VL   + HP +V 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 110 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 169
           L ++FQ    LY  L+   GGELF  +  +    E  ARFY AE+  AL Y+HS+ +I+R
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120

Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 229
           D+KPEN+LL + GH+ + DFG  K                    TF GT  Y+ PEVL  
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK----------EGIEHSKTTSTFCGTPEYLAPEVLRK 170

Query: 230 SPATFGNDLWALGCTLYQMLSGTSPF--KDTSEWLIFQRIIARDIRFPNYFSDAARDLID 287
            P     D W LG  LY+ML G  PF  +DT+E  ++  I+ + +R     S +AR L++
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE--MYDNILNKPLRLKPNISVSARHLLE 228

Query: 288 RLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
            LL  D + R GA    +  +K H FF  I+W ++  +  TPP
Sbjct: 229 GLLQKDRTKRLGAK-DDFLEIKNHVFFSSINWDDLVNKKITPP 270

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  208 bits (532), Expect = 3e-64
 Identities = 94/271 (34%), Positives = 148/271 (54%), Gaps = 17/271 (6%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           FEL ++ G G++ KV   +K DT  ++A+K M+K+   ++     V  ER +L +L+HP 
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           +V L+++FQD  ++Y+ ++   GG+L   ++ K   SE++ +F+  E+V ALEY+HS G+
Sbjct: 62  LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121

Query: 167 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 226
           IHRDIKP+N+LL   GH+ I DF     +    +T            +  GT  Y+ PEV
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT-----------STSGTPGYMAPEV 170

Query: 227 LNSSPATFGNDLWALGCTLYQMLSGTSPFK---DTSEWLIFQRIIARDIRFPNYFSDAAR 283
           L     +   D W+LG T Y+ L G  P++    T    I  +    D+ +P  +S  A 
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAI 230

Query: 284 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 314
           D I++LL+ DP  R G        LK HP+F
Sbjct: 231 DAINKLLERDPQKRLGDNL---KDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  209 bits (533), Expect = 6e-64
 Identities = 111/277 (40%), Positives = 154/277 (55%), Gaps = 14/277 (5%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS+ KV++ +K DT  +YALK + K  I   ++  +   ER VL Q++ P +V L F+
Sbjct: 2   GKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFS 61

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           FQ    LY+ L    GGELF  +  +G      ARFYTAE++ ALE +H   +I+RD+KP
Sbjct: 62  FQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKP 121

Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
           EN+LL   GHI + DFG  K           N   DDK  TF GT  Y+ PE+L     T
Sbjct: 122 ENILLDYQGHIALCDFGLCK----------LNMKDDDKTNTFCGTPEYLAPELLLGHGYT 171

Query: 234 FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVD 293
              D W LG  LY+ML+G  PF D +   ++++I+   +RFP+ F   A+DL+  LL  D
Sbjct: 172 KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRD 231

Query: 294 PSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
           P+ R G    G   +K HPFF  + WK +  +G  PP
Sbjct: 232 PTRRLGY--NGAQEIKNHPFFSQLSWKKLLMKGIQPP 266

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  209 bits (534), Expect = 7e-64
 Identities = 105/289 (36%), Positives = 153/289 (52%), Gaps = 13/289 (4%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           K+ G G++ KV+  ++  TG  YA+KI+ K+ I  +++ A+   E  VL    HP +  L
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60

Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 170
            ++FQ    L   +E   GGELF  ++ +   SED ARFY AE+V AL Y+HS  +++RD
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120

Query: 171 IKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 230
           +K ENL+L  DGHIKI DFG  K             +      TF GT  Y+ PEVL  +
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCK----------EGISDGATMKTFCGTPEYLAPEVLEDN 170

Query: 231 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLL 290
                 D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP   S  A+ L+  LL
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLL 230

Query: 291 DVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI-RGQTPPKLASEPMVQS 338
             DP  R G GP     +  H FF  I+W+++ + +  P    +P V S
Sbjct: 231 KKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPF--KPQVTS 277

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  206 bits (527), Expect = 2e-63
 Identities = 75/258 (29%), Positives = 140/258 (54%), Gaps = 16/258 (6%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
            +E+ K  G GS+ KV   ++   G +Y LK +D   ++++ +   +  E  +L +L+HP
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN-EVKILKKLNHP 59

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----GHLSEDEARFYTAEVVDALEYI 161
            +++ + +F++   L + +E  +GG+L  +I  +        E++   +  ++  AL+Y+
Sbjct: 60  NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119

Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           HS  ++HRDIKP+N+ LT++G +K+ DFG  K +            + D A T VGT  Y
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS----------TVDLAKTVVGTPYY 169

Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR-FPNYFSD 280
           + PE+  + P  + +D+W+LGC LY++ +   PF+  +   +  +I+       P+ +S 
Sbjct: 170 LSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSS 229

Query: 281 AARDLIDRLLDVDPSGRP 298
             R+L+  LL  DP  RP
Sbjct: 230 ELRNLVSSLLQKDPEERP 247

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  203 bits (520), Expect = 1e-62
 Identities = 83/275 (30%), Positives = 136/275 (49%), Gaps = 21/275 (7%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           ++  G++ G GS+  V  A   DTG + A+K ++    ++E   A  + E  +L  L HP
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALER-EIRILSSLQHP 59

Query: 106 GVVRLFFTFQDTF--SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            +VR + + +D    +L + LE   GG L   +   G L E   R YT ++++ L Y+HS
Sbjct: 60  NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
            G++HRDIK  N+L+ +DG +K+ADFG  K + D                +  GT  ++ 
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTG--------SVRGTPYWMA 171

Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE--WLIFQRIIARDI--RFPNYFS 279
           PEV+         D+W+LGCT+ +M +G  P+ +       ++ +I +       P + S
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALY-KIGSSGEPPEIPEHLS 230

Query: 280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 314
           + A+D + + L  DP  RP A       L  HPF 
Sbjct: 231 EEAKDFLRKCLRRDPKKRPTA-----DELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  206 bits (525), Expect = 2e-62
 Identities = 107/304 (35%), Positives = 177/304 (58%), Gaps = 26/304 (8%)

Query: 46  DFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTA-YVKLERIVLDQ 101
           +FEL K+ G G+Y KV   +K+   DTG +YA+K++ K  + ++ KT  + + ER VL+ 
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 102 L-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
           +   P +V L + FQ    L++ L+   GGE+F  +  + + SEDE RFY+ E++ ALE+
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120

Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           +H +G+++RDIK EN+LL ++GH+ + DFG  K                ++  +F GT  
Sbjct: 121 LHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE---------KERTYSFCGTIE 171

Query: 221 YVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPF----KDTSEWLIFQRIIARDIRF 274
           Y+ PE++       G   D W+LG  ++++L+G SPF    +  ++  + +RI+  D  F
Sbjct: 172 YMAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPF 230

Query: 275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI---RGQTP--PK 329
           P++    A+DL+ +LL  DP  R GAGP G + +K HPFFKG+DW+ +   +   P  P 
Sbjct: 231 PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPS 290

Query: 330 LASE 333
           + +E
Sbjct: 291 IRNE 294

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  201 bits (514), Expect = 6e-61
 Identities = 107/284 (37%), Positives = 164/284 (57%), Gaps = 19/284 (6%)

Query: 51  KIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV 107
           K+ G GS+ KV   +KI   D G +YA+K++ KK   K       K+ER +L +++HP +
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVL-KKATLKVRDRVRTKMERDILAEVNHPFI 60

Query: 108 VRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLI 167
           V+L + FQ    LY+ L+   GG+LF +++ +   +E++ +FY AE+  AL+++HS+G+I
Sbjct: 61  VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 120

Query: 168 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 227
           +RD+KPEN+LL  +GHIK+ DFG  K   D           + KA +F GT  Y+ PEV+
Sbjct: 121 YRDLKPENILLDEEGHIKLTDFGLSKESID----------HEKKAYSFCGTVEYMAPEVV 170

Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPF--KDTSEWLIFQRIIARDIRFPNYFSDAARDL 285
           N    T   D W+ G  +++ML+G+ PF  KD  E +    I+   +  P + S  A+ L
Sbjct: 171 NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM--TMILKAKLGMPQFLSPEAQSL 228

Query: 286 IDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW-KNIRGQTPP 328
           +  L   +P+ R GAGP G   +K HPFF  IDW K  R +  P
Sbjct: 229 LRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKP 272

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  203 bits (518), Expect = 7e-61
 Identities = 107/318 (33%), Positives = 156/318 (49%), Gaps = 40/318 (12%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           F   K  G+G++ +V   +K+DT  +YA+K + K  +   N+ A+VK ER +L + D+  
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62

Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           VV+L+++FQD  +LY  ++   GG++   +   G   ED ARFY AE+  A+E +H MG 
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122

Query: 167 IHRDIKPENLLLTADGHIKIADFG----------------SVKPMQDS------------ 198
           IHRDIKP+N+L+  DGHIK+ DFG                     QDS            
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 199 -RITVLPNAASDD----KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTS 253
            R+  L            A + VGT  Y+ PEVL  +  T   D W++G  LY+ML G  
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242

Query: 254 PFKDTSEWLIFQRII--ARDIRFPNY--FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLK 309
           PF   +      ++I     +  P+    S  A DLI RL       R   G  G   +K
Sbjct: 243 PFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDR--LGKNGADEIK 299

Query: 310 MHPFFKGIDWKNIRGQTP 327
            HPFFKGID+ ++  +  
Sbjct: 300 AHPFFKGIDFASLIRRQK 317

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  197 bits (503), Expect = 2e-59
 Identities = 104/280 (37%), Positives = 150/280 (53%), Gaps = 12/280 (4%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           K+ G G++ KV+  ++  TG  YA+KI+ K+ I  +++ A+   E  VL    HP +  L
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 170
            + FQ    L   +E   GGELF  ++ +   +E+ ARFY AE+V ALEY+HS  +++RD
Sbjct: 61  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120

Query: 171 IKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 230
           IK ENL+L  DGHIKI DFG  K       T+           TF GT  Y+ PEVL  +
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCKEGISDGATMK----------TFCGTPEYLAPEVLEDN 170

Query: 231 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLL 290
                 D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP   S  A+ L+  LL
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 230

Query: 291 DVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
             DP  R G GP     +  H FF  I+W+++  +   PP
Sbjct: 231 KKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPP 270

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  198 bits (505), Expect = 5e-59
 Identities = 116/332 (34%), Positives = 173/332 (52%), Gaps = 47/332 (14%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF   K+ G G++ +V   +K DTG +YA+K + K  + K+++ A+VK ER VL + D 
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P VV L+++FQD   LY+ +E   GG+L   +      SED  RFY AE V A+E +H +
Sbjct: 61  PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120

Query: 165 GLIHRDIKPENLLLTADGHIKIADFG---------------------SVKPMQDSRITVL 203
           G IHRDIKP+N+L+   GHIK++DFG                     S K   D+R +V 
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180

Query: 204 PNA-----ASDDKACTF-----------VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQ 247
            ++     +S D+  T+           VGT  Y+ PE+          D W+LG  +++
Sbjct: 181 VDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240

Query: 248 MLSGTSPFKDTSEWLIFQRIIA--RDIRFPN--YFSDAARDLIDRLLDVDPSGRPGAGPG 303
            L G  PF   +    +++II     + FP+  + S  A DLI RL+  +   R   G G
Sbjct: 241 CLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLI-TNAENR--LGRG 297

Query: 304 GYAVLKMHPFFKGIDWKNIRG-QTP--PKLAS 332
           G   +K HPFF+G+DW  IR  + P  P+L S
Sbjct: 298 GAHEIKSHPFFRGVDWDTIRQIRAPFIPQLKS 329

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  196 bits (500), Expect = 8e-59
 Identities = 103/295 (34%), Positives = 152/295 (51%), Gaps = 26/295 (8%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF++  + G G + +V   ++  TG +YA+K+M K  +  +   ++ + ER +L   + 
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHS 163
           P + +L + FQD  +LY+ +E   GG+L   +   +    ED A+FY AE+V A+  +H 
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           MG +HRDIKPEN+L+   GHIK+ADFGS   +  +   V             VGT  Y+ 
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARL-TANKMVNSKLP--------VGTPDYIA 171

Query: 224 PEVLNS----SPATFG--NDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA--RDIRFP 275
           PEVL +       T+G   D W+LG   Y+M+ G SPF + +    +  I+   R ++FP
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFP 231

Query: 276 N--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 328
                S    DLI  LL      R      GY  L  HPFF  IDW NIR   PP
Sbjct: 232 EDPKVSSDFLDLIQSLL-CGQKERL-----GYEGLCCHPFFSKIDWNNIRNSLPP 280

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  194 bits (495), Expect = 2e-58
 Identities = 101/294 (34%), Positives = 165/294 (56%), Gaps = 20/294 (6%)

Query: 46  DFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTA-YVKLERIVLDQ 101
           +FEL K+ G G+Y KV   +K+   D+G +YA+K++ K  I ++ KT  + + ER VL+ 
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 102 LDH-PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
           +   P +V L + FQ    L++ L+   GGELF  ++ +    E E + Y+ E+V ALE+
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120

Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           +H +G+I+RDIK EN+LL ++GH+ + DFG  K                ++A +F GT  
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH---------EDEVERAYSFCGTIE 171

Query: 221 YVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPF----KDTSEWLIFQRIIARDIRF 274
           Y+ P+++           D W++G  +Y++L+G SPF    +  S+  I +RI+  +  +
Sbjct: 172 YMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 231

Query: 275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 328
           P   S  A+D+I RLL  DP  R G GP     +K HPFF+ I+W ++  +  P
Sbjct: 232 PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAKKVP 285

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score =  193 bits (493), Expect = 1e-57
 Identities = 115/296 (38%), Positives = 165/296 (55%), Gaps = 25/296 (8%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
            DFE+ K+ G G++ +V   K  +TG VYA+KI++K  + K  +TA  + ER VL   D 
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHS 163
             +  L + FQD  +LY+ ++   GG+L   ++     L ED ARFY AE+V A++ +H 
Sbjct: 61  RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGS-VKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           +G +HRDIKP+N+LL  +GHI++ADFGS ++ + D   TV  N A        VGT  Y+
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG--TVQSNVA--------VGTPDYI 170

Query: 223 PPEVLNSSPATFGN-----DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--IRFP 275
            PE+L +     G      D W+LG  +Y+ML G +PF   S    + +I+      +FP
Sbjct: 171 SPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFP 230

Query: 276 NY---FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 328
                 S+ A+DLI RL+   P  R   G  G    K HPFF+GIDW NIR  T P
Sbjct: 231 PDVTDVSEEAKDLIRRLI-CSPETR--LGRNGLQDFKDHPFFEGIDWDNIRNSTAP 283

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  191 bits (487), Expect = 8e-57
 Identities = 117/330 (35%), Positives = 174/330 (52%), Gaps = 28/330 (8%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ---LDHPGVVRL 110
           G G++ +V + +K DT  +YA+K++ KK I  + + A+   ER +L +    + P +V L
Sbjct: 2   GKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGL 61

Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 170
            F+FQ    LY+  +   GGELF  +  +G  SED A+FY AE+V ALE++H   +++RD
Sbjct: 62  KFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRD 121

Query: 171 IKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNS 229
           +KPEN+LL A GHI + DFG  K           N   +    TF GT  Y+ PEV L+ 
Sbjct: 122 LKPENILLDATGHIALCDFGLSK----------ANLTDNKTTNTFCGTTEYLAPEVLLDE 171

Query: 230 SPATFGNDLWALGCTLYQMLSGTSPF--KDTSEWLIFQRIIARDIRFP-NYFSDAARDLI 286
              T   D W+LG  +++M  G SPF  +DT +  +++ I    +RFP N  SD  R  +
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ--MYRNIAFGKVRFPKNVLSDEGRQFV 229

Query: 287 DRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ--TPPKLASEPMVQSGEGDDV 344
             LL+ +P  R GA       LK HPFF  IDW  +  +  TPP    +P+V S E    
Sbjct: 230 KGLLNRNPQHRLGAHRDAVE-LKEHPFFADIDWDLLSKKQITPP---FKPIVDSDEDVSN 285

Query: 345 HDSSWNPSHIGDISAKIND---GNGGASSS 371
            D  +  S + +      +   G  GA+S+
Sbjct: 286 FDPEFTNSSLLNAGIVPWEDVPGLPGANST 315

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  190 bits (485), Expect = 9e-57
 Identities = 107/291 (36%), Positives = 156/291 (53%), Gaps = 20/291 (6%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD-QLDHPGVVR 109
           K+ G GS+ KV+ A+   T   +A+K + K  + +++      +ER VL    +HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 110 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 169
           LF TFQ    L+  +E   GG+L   I S G   E  ARFY AE++  L+++H  G+I+R
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120

Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 229
           D+K +N+LL  DGHIKIADFG  K           N   + KA TF GT  Y+ PE+L  
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCK----------ENMNGEGKASTFCGTPDYIAPEILKG 170

Query: 230 SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL 289
                  D W+ G  LY+ML G SPF    E  +F  I+     FP + S  A+D + +L
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKL 230

Query: 290 LDVDPSGRPG-AGPGGYAVLKMHPFFKGIDWKNI-RGQTPPKLASEPMVQS 338
            + DP+ R G  G      ++ HPFF+GIDW+ + + + PP    +P V+S
Sbjct: 231 FERDPTKRLGVDGD-----IRQHPFFRGIDWERLEKREIPPPF--KPKVKS 274

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  190 bits (484), Expect = 2e-56
 Identities = 103/311 (33%), Positives = 163/311 (52%), Gaps = 28/311 (9%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVR 109
           ++ G GSY+KV+  +   T  +YA+K++ K+ +  +    +V+ E+ V +   +HP +V 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60

Query: 110 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 169
           L   FQ    L+  +E   GG+L   +  +  L E+ ARFY+AE+  AL ++H  G+I+R
Sbjct: 61  LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120

Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 229
           D+K +N+LL A+GHIK+ D+G  K                D   TF GT  Y+ PE+L  
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCK----------EGIRPGDTTSTFCGTPNYIAPEILRG 170

Query: 230 SPATFGNDLWALGCTLYQMLSGTSPF----------KDTSEWLIFQRIIARDIRFPNYFS 279
               F  D WALG  +++M++G SPF          ++T ++L FQ I+ + IR P   S
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYL-FQVILEKQIRIPRSLS 229

Query: 280 DAARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNI--RGQTPPKLASEPMV 336
             A  ++   L+ DP  R G  P  G+  +K HPFF+ IDW  +  +   PP    +P +
Sbjct: 230 VKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPP---YKPNI 286

Query: 337 QSGEGDDVHDS 347
           +S    D  D 
Sbjct: 287 ESDRDLDNFDP 297

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  190 bits (484), Expect = 2e-56
 Identities = 101/286 (35%), Positives = 145/286 (50%), Gaps = 13/286 (4%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           DF    + G GS+ KV+ A++  T  +YA+KI+ K  I +++      +E+ VL     P
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60

Query: 106 G-VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
             + +L   FQ    LY  +E   GG+L   I   G   E  A FY AE+   L ++HS 
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+I+RD+K +N++L A+GHIKIADFG  K           N        TF GT  Y+ P
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCKE----------NIFGGKTTRTFCGTPDYIAP 170

Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD 284
           E++   P     D WA G  LY+ML+G  PF    E  +FQ I+  ++ +P   S  A  
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVS 230

Query: 285 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
           +   LL   P+ R G GP G   ++ H FF+ IDW+ +  R   PP
Sbjct: 231 ICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQPP 276

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  190 bits (483), Expect = 2e-56
 Identities = 106/281 (37%), Positives = 151/281 (53%), Gaps = 13/281 (4%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           K+ G G++ KV+  K+  TG  YA+KI+ K+ I  +++ A+   E  VL    HP +  L
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60

Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS-MGLIHR 169
            ++FQ    L   +E   GGELF  ++ +   SED ARFY AE+V AL+Y+HS   +++R
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120

Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 229
           D+K ENL+L  DGHIKI DFG  K       T+           TF GT  Y+ PEVL  
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK----------TFCGTPEYLAPEVLED 170

Query: 230 SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL 289
           +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP   S  A+ L+  L
Sbjct: 171 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGL 230

Query: 290 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
           L  DP  R G GP     +  H FF GI W+++  +   PP
Sbjct: 231 LKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPP 271

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  184 bits (470), Expect = 9e-56
 Identities = 83/250 (33%), Positives = 124/250 (49%), Gaps = 46/250 (18%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G +  V  A+   TG   A+KI+ K+  +   +    ++E  +L +L+HP +V+L+  
Sbjct: 2   GEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIE--ILKKLNHPNIVKLYGV 59

Query: 114 FQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIK 172
           F+D   LY+ +E CEGG L D +    G LSEDE      ++++ LEY+HS G+IHRD+K
Sbjct: 60  FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLK 119

Query: 173 PENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL-NSS 230
           PEN+LL +D G +K+ADFG  K +                  T VGT AY+ PEVL    
Sbjct: 120 PENILLDSDNGKVKLADFGLSKLLTS----------DKSLLKTIVGTPAYMAPEVLLGKG 169

Query: 231 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLL 290
             +  +D+W+LG  LY++                                  +DLI ++L
Sbjct: 170 YYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKML 198

Query: 291 DVDPSGRPGA 300
             DP  RP A
Sbjct: 199 QKDPEKRPSA 208

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  188 bits (479), Expect = 1e-55
 Identities = 103/280 (36%), Positives = 155/280 (55%), Gaps = 12/280 (4%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           K+ G G++ KV+  ++  +G  YA+KI+ K+ I  +++ A+   E  VL    HP +  L
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 170
            ++FQ    L   +E   GGELF  ++ +   SED  RFY AE+V AL+Y+HS  +++RD
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120

Query: 171 IKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 230
           +K ENL+L  DGHIKI DFG  K         + +AA+     TF GT  Y+ PEVL  +
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEG-------ITDAATMK---TFCGTPEYLAPEVLEDN 170

Query: 231 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLL 290
                 D W LG  +Y+M+ G  PF +     +F+ I+  DI+FP   S  A+ L+  LL
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLL 230

Query: 291 DVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
             DP+ R G GP     +  H FF G++W+++  +   PP
Sbjct: 231 IKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPP 270

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  187 bits (478), Expect = 2e-55
 Identities = 96/287 (33%), Positives = 144/287 (50%), Gaps = 16/287 (5%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD--- 103
           F    + G G + KV+ A+   TG +YA+K + K  I   ++   +  E+ + +  +   
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +V LF  FQ    +   +E   GG+L   I      SE  A FY A VV  L+Y+H 
Sbjct: 61  HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHE 119

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
             +++RD+K +NLLL  +G +KIADFG  K                D+  TF GT  ++ 
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFGLCKE----------GMGFGDRTSTFCGTPEFLA 169

Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAAR 283
           PEVL  +  T   D W LG  +Y+ML G SPF    E  +F  I+  ++R+P + S  A 
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAI 229

Query: 284 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
            ++ RLL  +P  R G+G      +K  PFF+ I+W ++  R   PP
Sbjct: 230 SIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKPP 276

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  187 bits (475), Expect = 3e-55
 Identities = 103/281 (36%), Positives = 151/281 (53%), Gaps = 14/281 (4%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER-IVLDQLDHPGVVR 109
           K+ G GS+ KV+ AK+   G+ YA+K++ KK I K+ +  ++  ER ++L  L HP +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 110 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 169
           L ++FQ    LY  L+   GGELF  +  +    E  ARFY AEV  A+ Y+HS+ +I+R
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120

Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 229
           D+KPEN+LL + GH+ + DFG  K               ++   TF GT  Y+ PEVL  
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK----------EGVEPEETTSTFCGTPEYLAPEVLRK 170

Query: 230 SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL 289
            P     D W LG  LY+ML G  PF       ++  I+ + ++ P   + AA DL+  L
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGL 230

Query: 290 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ--TPP 328
           L  D   R GA    +  +K H FF  I+W ++  +  TPP
Sbjct: 231 LHKDQRRRLGA-KADFLEIKNHVFFSPINWDDLYHKRITPP 270

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  183 bits (467), Expect = 2e-54
 Identities = 87/283 (30%), Positives = 143/283 (50%), Gaps = 19/283 (6%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G + +V   +   TG +YA K +DKK + K         E+ +L+++    +V L + 
Sbjct: 2   GKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYA 61

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSMGLIHRDI 171
           F+    L + +    GG+L   I + G     E  A FY A+++  LE++H   +++RD+
Sbjct: 62  FETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDL 121

Query: 172 KPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP 231
           KPEN+LL   G+++I+D G    ++  +           K     GT  Y+ PEVL    
Sbjct: 122 KPENVLLDDHGNVRISDLGLAVELKGGK-----------KIKGRAGTPGYMAPEVLQGEV 170

Query: 232 ATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQRIIARDIRFPNYFSDAARDLID 287
             F  D +ALGCTLY+M++G SPF+   E +    + +R +   + +P+ FS  A+DL +
Sbjct: 171 YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCE 230

Query: 288 RLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ--TPP 328
            LL  DP  R G   G    ++ HP FK ++W+ +      PP
Sbjct: 231 ALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLEPP 273

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  184 bits (469), Expect = 2e-54
 Identities = 102/308 (33%), Positives = 164/308 (53%), Gaps = 21/308 (6%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD-QLDHPGVVR 109
           ++ G GS+ KV+ A+  ++G +YA+K++ K  I +++       E+ +L    +HP + +
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 110 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 169
           L+  FQ    L+  +E   GG+L   I       E  ARFY AE+  AL ++H  G+I+R
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120

Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 229
           D+K +N+LL  +GH K+ADFG  K    +  T            TF GT  Y+ PE+L  
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT----------TSTFCGTPDYIAPEILQE 170

Query: 230 SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL 289
                  D WA+G  LY+ML G +PF+  +E  +F+ I+  ++ +P + S  A D++   
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAF 230

Query: 290 LDVDPSGRPGA-GPGGYAVLKMHPFFKGIDWK--NIRGQTPPKLASEPMVQSGEGDDVHD 346
           +  +P+ R G+   GG   +  HPFFK +DW+  N R   PP     P ++S E  DV  
Sbjct: 231 MTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPP---FRPRIKSRE--DV-- 283

Query: 347 SSWNPSHI 354
           S+++P  I
Sbjct: 284 SNFDPDFI 291

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  183 bits (466), Expect = 5e-54
 Identities = 112/300 (37%), Positives = 159/300 (53%), Gaps = 15/300 (5%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           DFE  K+   G+Y  V   +  +T   +A+K ++K+ +   N+   V +ER +L   ++P
Sbjct: 2   DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENP 61

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 165
            VV +F +F+    L M +E  EGG+    + + G L  D AR Y AE V ALEY+H+ G
Sbjct: 62  FVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG 121

Query: 166 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV-----GTAA 220
           ++HRD+KP+NLL+T+ GHIK+ DFG  K    S  T L     +     F+     GT  
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181

Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF-KDTSEWLIFQRIIARDIRFP---N 276
           Y+ PEV+         D WA+G  LY+ L G  PF  DT E L F ++I+ DI +P    
Sbjct: 182 YIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL-FGQVISDDIEWPEGDE 240

Query: 277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTP---PKLASE 333
                A+DLI RLL  +P  R G   GG   +K H FF G+DW  +  Q     P+L SE
Sbjct: 241 ALPADAQDLISRLLRQNPLERLGT--GGAFEVKQHRFFLGLDWNGLLRQKAEFIPQLESE 298

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  183 bits (465), Expect = 3e-53
 Identities = 107/297 (36%), Positives = 156/297 (52%), Gaps = 25/297 (8%)

Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
             +DF++ K+ G G++ +V   +   +  VYA+K++ K  + K + +A+   ER ++   
Sbjct: 41  KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA 100

Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           +   +V+L + FQD   LYM +E   GG+L + + S   + E  ARFYTAEVV AL+ IH
Sbjct: 101 NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEVVLALDAIH 159

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           SMG IHRD+KP+N+LL   GH+K+ADFG+   M  + +     A         VGT  Y+
Sbjct: 160 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA---------VGTPDYI 210

Query: 223 PPEVLNSSPAT--FGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRII--ARDIRFP- 275
            PEVL S      +G   D W++G  LY+ML G +PF   S    + +I+     + FP 
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPD 270

Query: 276 -NYFSDAARDLIDRLLDVDPSGRPGA-GPGGYAVLKMHPFFKGIDWK--NIRGQTPP 328
               S  A+DLI   L    + R    G  G   +K HPFFK   W   NIR    P
Sbjct: 271 DIEISKQAKDLICAFL----TDREVRLGRNGVDEIKSHPFFKNDQWTFDNIRETVAP 323

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  180 bits (459), Expect = 7e-53
 Identities = 100/281 (35%), Positives = 153/281 (54%), Gaps = 14/281 (4%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER-IVLDQLDHPGVVR 109
           K+ G GS+ KV+ A+       YA+K++ KK I K+ +  ++  ER ++L  + HP +V 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 110 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 169
           L F+FQ    LY  L+   GGELF  +  +    E  ARFY AE+  AL Y+HS+ +++R
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120

Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 229
           D+KPEN+LL + GHI + DFG  K        +  N  +     TF GT  Y+ PEVL+ 
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCKE------NIEHNGTTS----TFCGTPEYLAPEVLHK 170

Query: 230 SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL 289
            P     D W LG  LY+ML G  PF   +   ++  I+ + ++     +++AR L++ L
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGL 230

Query: 290 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ--TPP 328
           L  D + R GA    +  +K H FF  I+W ++  +  TPP
Sbjct: 231 LQKDRTKRLGA-KDDFMEIKNHIFFSPINWDDLINKKITPP 270

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  180 bits (459), Expect = 7e-53
 Identities = 98/283 (34%), Positives = 145/283 (51%), Gaps = 15/283 (5%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE-RIVLDQLDHPGVVR 109
           K+ G GS+ KV+ A+   T  VYA+K++ K  I +++       E RI+     HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 110 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 169
           L   FQ    L+  +E   GG+L  QI       E  +RFY AEV  AL ++H  G+I+R
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120

Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 229
           D+K +N+LL A+GH K+ADFG  K              +     TF GT  Y+ PE+L  
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCK----------EGILNGVTTTTFCGTPDYIAPEILQE 170

Query: 230 SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL 289
                  D WALG  +Y+M++G  PF+  +E  +F+ I+  D+ +P + S  A  ++   
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAF 230

Query: 290 LDVDPSGRPGAGP--GGYAVLKMHPFFKGIDWKNI--RGQTPP 328
           +  +P+ R G     GG   +K HPFFK IDW  +  R   PP
Sbjct: 231 MTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPP 273

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  180 bits (459), Expect = 2e-52
 Identities = 108/307 (35%), Positives = 167/307 (54%), Gaps = 32/307 (10%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           DFE  K+ G G++ +V   +K DTG +YA+KI+ K  + ++ + A+++ ER +L + D  
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 165
            VV++F++FQD  +LY+ +E   GG++   +  K  LSE+  +FY AE V A++ IH +G
Sbjct: 62  WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG 121

Query: 166 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT--------------VLPNAASDDK 211
            IHRDIKP+NLLL A GH+K++DFG    ++ +  T                 N  S  K
Sbjct: 122 FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRK 181

Query: 212 ACTF-----------VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           A T+           VGT  Y+ PEV   +      D W+LG  +Y+ML G  PF   + 
Sbjct: 182 AETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241

Query: 261 WLIFQRII--ARDIRFPNY--FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 316
              +++++     + FP     S+ A+DLI R    D   R G+   G   +K HPFF+G
Sbjct: 242 QETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGS--NGVEEIKSHPFFEG 298

Query: 317 IDWKNIR 323
           +DW +IR
Sbjct: 299 VDWGHIR 305

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score =  178 bits (452), Expect = 9e-52
 Identities = 109/296 (36%), Positives = 161/296 (54%), Gaps = 25/296 (8%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
            DFE+ K+ G G++ +V   K   T  +YA+KI++K  + K  +TA  + ER VL   D 
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHS 163
             +  L + FQD   LY+ ++   GG+L   ++  +  L ED ARFY AE+V A+  IH 
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGS-VKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           +  +HRDIKP+N+LL  +GHI++ADFGS +K  QD  +          ++   VGT  Y+
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV----------QSSVAVGTPDYI 170

Query: 223 PPEVLNSSPATFGN-----DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR--FP 275
            PE+L +     G      D W+LG  +Y+ML G +PF   S    + +I+  + R  FP
Sbjct: 171 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFP 230

Query: 276 NYFSDA---ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 328
           ++ +D    A+DLI RL+    S     G  G    K H FF+GIDW+NIR    P
Sbjct: 231 SHITDVSEEAKDLIQRLI---CSRERRLGQNGIEDFKKHAFFEGIDWENIRNLEAP 283

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  177 bits (449), Expect = 2e-51
 Identities = 98/282 (34%), Positives = 152/282 (53%), Gaps = 17/282 (6%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER-IVLDQLDHPGVVR 109
           K+ G GS+ KV+ AK+   G  YA+K++ KK +    +  ++  ER ++L  + HP +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 110 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 169
           L ++FQ T  LY  L+   GGELF  +  +    E  ARFY AE+  AL Y+HS+ +++R
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120

Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 229
           D+KPEN+LL + GH+ + DFG  K             A  D   TF GT  Y+ PEV+  
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK----------EGIAQSDTTTTFCGTPEYLAPEVIRK 170

Query: 230 SPATFGNDLWALGCTLYQMLSGTSPF--KDTSEWLIFQRIIARDIRFPNYFSDAARDLID 287
            P     D W LG  LY+ML G  PF  +D +E  ++  I+ + +      S  A  +++
Sbjct: 171 QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE--MYDNILHKPLVLRPGASLTAWSILE 228

Query: 288 RLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI-RGQTPP 328
            LL+ D   R GA    +  ++ HPFF+ + W ++ + + PP
Sbjct: 229 ELLEKDRQRRLGA-KEDFLEIQEHPFFESLSWTDLEQKKIPP 269

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  176 bits (448), Expect = 3e-51
 Identities = 107/312 (34%), Positives = 167/312 (53%), Gaps = 28/312 (8%)

Query: 51  KIYGVGSYSKV--VRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGV 107
           ++ G GSY+KV  VR KK D   +YA+K++ K+ +  +    +V+ E+ V +Q   +P +
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQ--IYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFL 58

Query: 108 VRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLI 167
           V L   FQ T  L++ +E   GG+L   +  +  L E+ ARFY AE+  AL ++H  G+I
Sbjct: 59  VGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGII 118

Query: 168 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 227
           +RD+K +N+LL ADGHIK+ D+G  K                D   TF GT  Y+ PE+L
Sbjct: 119 YRDLKLDNVLLDADGHIKLTDYGMCK----------EGLGPGDTTSTFCGTPNYIAPEIL 168

Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFK--------DTSEWLIFQRIIARDIRFPNYFS 279
                 F  D WALG  +++M++G SPF         +T ++L FQ I+ + IR P + S
Sbjct: 169 RGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYL-FQVILEKPIRIPRFLS 227

Query: 280 DAARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNI-RGQTPPKLASEPMVQ 337
             A  ++   L+ DP  R G  P  G++ +K H FF+ IDW  + + Q  P    +P + 
Sbjct: 228 VKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPPF--KPQIT 285

Query: 338 SGEGDDVHDSSW 349
              G +  D+ +
Sbjct: 286 DDYGLENFDTQF 297

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  173 bits (442), Expect = 5e-51
 Identities = 86/274 (31%), Positives = 140/274 (51%), Gaps = 27/274 (9%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
            FE+ +  G G + +V +A+   TG   A+K++  K  +KE K   +  E  +L +  HP
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVI--KLESKEKKEKIIN-EIQILKKCKHP 57

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 164
            +V+ + ++     L++ +E C GG L D + S    L+E +  +   E++  LEY+HS 
Sbjct: 58  NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRDIK  N+LLT+DG +K+ DFG    + D++              T VGT  ++ P
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN-----------TMVGTPYWMAP 166

Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIARD----IRFPNYFS 279
           EV+N  P  +  D+W+LG T  ++  G  P+ +      +F   IA +    +R P  +S
Sbjct: 167 EVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF--KIATNGPPGLRNPEKWS 224

Query: 280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 313
           D  +D + + L  +P  RP A       L  HPF
Sbjct: 225 DEFKDFLKKCLQKNPEKRPTA-----EQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  175 bits (445), Expect = 6e-51
 Identities = 97/281 (34%), Positives = 150/281 (53%), Gaps = 17/281 (6%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD-QLDHPGVVR 109
           K+ G GS+ KV+ A+    G  +A+K + K  +  ++      +E+ VL    ++P +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 110 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 169
           L+ TFQ    L+  +E   GG+L   I  KG      A FY AE+V  L+++HS G+I+R
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120

Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 229
           D+K +N++L  DGHIKIADFG  K           N   D++A TF GT  Y+ PE+L  
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCK----------ENVFGDNRASTFCGTPDYIAPEILQG 170

Query: 230 SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL 289
              TF  D W+ G  LY+ML G SPF    E  +F+ I      +P + +  ++D++++L
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKL 230

Query: 290 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT--PP 328
            + DP+ R G        ++ HPFFK I+W  +  +   PP
Sbjct: 231 FERDPTRRLGV----VGNIRGHPFFKTINWTALEKRELDPP 267

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  175 bits (444), Expect = 1e-50
 Identities = 103/318 (32%), Positives = 167/318 (52%), Gaps = 28/318 (8%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVR 109
           ++ G GSY+KV+  +   T  +YA+K++ K+ +  +    +V+ E+ V +Q  +HP +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 110 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 169
           L   FQ    L+  +E   GG+L   +  +  L E+ ARFY+AE+  AL Y+H  G+I+R
Sbjct: 61  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120

Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 229
           D+K +N+LL ++GHIK+ D+G  K                D   TF GT  Y+ PE+L  
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCK----------EGLRPGDTTSTFCGTPNYIAPEILRG 170

Query: 230 SPATFGNDLWALGCTLYQMLSGTSPF----------KDTSEWLIFQRIIARDIRFPNYFS 279
               F  D WALG  +++M++G SPF          ++T ++L FQ I+ + IR P   S
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL-FQVILEKQIRIPRSLS 229

Query: 280 DAARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQ--TPPKLASEPMV 336
             A  ++   L+ DP  R G  P  G+A ++ HPFF+ +DW  +  +   PP    +P +
Sbjct: 230 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPP---FKPNI 286

Query: 337 QSGEGDDVHDSSWNPSHI 354
               G D  D+ +    +
Sbjct: 287 SGEFGLDNFDAQFTNEPV 304

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  174 bits (441), Expect = 3e-50
 Identities = 101/287 (35%), Positives = 147/287 (51%), Gaps = 15/287 (5%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           DF    + G GS+ KV+ A++  T  +YA+KI+ K  + +++      +E+ VL   D P
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 106 G-VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
             + +L   FQ    LY  +E   GG+L   I   G   E +A FY AE+   L ++H  
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKP-MQDSRITVLPNAASDDKACTFVGTAAYVP 223
           G+I+RD+K +N++L ++GHIKIADFG  K  M D   T            TF GT  Y+ 
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR-----------TFCGTPDYIA 169

Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAAR 283
           PE++   P     D WA G  LY+ML+G  PF    E  +FQ I+  ++ +P   S  A 
Sbjct: 170 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAV 229

Query: 284 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
            +   L+   PS R G GP G   ++ H FF+ IDW  +  R   PP
Sbjct: 230 SICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENREIQPP 276

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  172 bits (438), Expect = 6e-50
 Identities = 100/291 (34%), Positives = 149/291 (51%), Gaps = 20/291 (6%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD-QLDHPGVVR 109
           K+ G GS+ KV  A+   T   +A+K + K  +  ++      +E+ VL    +HP +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 110 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 169
           L+ TFQ   +L+  +E   GG+L   I S        A FY AE++  L+++HS G+++R
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120

Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 229
           D+K +N+LL  DGHIKIADFG  K           N   D K CTF GT  Y+ PE+L  
Sbjct: 121 DLKLDNILLDTDGHIKIADFGMCK----------ENMLGDAKTCTFCGTPDYIAPEILLG 170

Query: 230 SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL 289
                  D W+ G  LY+ML G SPF    E  +FQ I   +  +P + +  A+D++ +L
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKL 230

Query: 290 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPPKLASEPMVQS 338
              +P  R G        ++ HPFF+ IDW  +  R   PP    +P V+S
Sbjct: 231 FVREPERRLGVK----GDIRQHPFFREIDWSALEEREIEPP---FKPKVKS 274

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  174 bits (441), Expect = 8e-50
 Identities = 109/368 (29%), Positives = 161/368 (43%), Gaps = 28/368 (7%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
            + + +  G GS+ +V  A+        ALK++ KK  +K  +      E  +L  L+HP
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 106 G-VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH---LSEDEARFYTAEVVDALEYI 161
             +V+L+  FQD  SLY+ +E  +GG L D +   G    LSE EA F  A+++ ALEY+
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 162 HSMGLIHRDIKPENLLLTADGH-IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           HS G+IHRDIKPEN+LL  DG  +K+ DFG  K + D   T    A       T VGT  
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPA----LPSTSVGTPG 173

Query: 221 YVPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII--------- 268
           Y+ PEVL   + + A+  +D+W+LG TLY++L+G  PF+         + +         
Sbjct: 174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233

Query: 269 ----ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG 324
                     P   S AA DL+ +LL  DP  R  +       L  H   K  D  ++  
Sbjct: 234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLK 293

Query: 325 QTPPKLASEPMVQSGEGDDVHDSSWNPSHIGDISAKINDGNGGASSSEGSITRLASIDSF 384
                     +  S E      +S   S         N     A +   S    +S    
Sbjct: 294 PDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSLLL 353

Query: 385 DSKWQQFL 392
            +   +  
Sbjct: 354 STASSKRS 361

Length = 384

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  171 bits (435), Expect = 9e-50
 Identities = 95/296 (32%), Positives = 150/296 (50%), Gaps = 20/296 (6%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           F   ++ G G + +V   +   TG +YA K ++KK I K    A    E+ +L++++   
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEAR--FYTAEVVDALEYIHSM 164
           VV L + ++   +L + L    GG+L   I + G+   DE R  FY AE+   LE +H  
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121

Query: 165 GLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
            +++RD+KPEN+LL   GHI+I+D G +V+  +   I               VGT  Y+ 
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIR------------GRVGTVGYMA 169

Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQRIIARDIRFPNYFS 279
           PEV+ +   TF  D W LGC +Y+M+ G SPF+   E +    + +R+      +   FS
Sbjct: 170 PEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFS 229

Query: 280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR-GQTPPKLASEP 334
           +AAR +  +LL  DP  R G    G   +K HPFF+  ++K +  G   P    +P
Sbjct: 230 EAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPFCPDP 285

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score =  174 bits (442), Expect = 1e-49
 Identities = 114/324 (35%), Positives = 163/324 (50%), Gaps = 45/324 (13%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           F   K  G+G++ +V  A+K+DT  +YA+K + KK +   N+ A+VK ER +L + D+  
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           VVRL+++FQD  +LY  ++   GG++   +   G   ED ARFY AE+  A+E +H MG 
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122

Query: 167 IHRDIKPENLLLTADGHIKIADFGSVK----------------PMQDS------------ 198
           IHRDIKP+N+L+  DGHIK+ DFG                     QDS            
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 199 -----RITVLP-NAASDDKAC---TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQML 249
                R+  L   AA   + C   + VGT  Y+ PEVL  +  T   D W++G  LY+ML
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 250 SGTSPFKDTSEWLIFQRII----ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGY 305
            G  PF   +      ++I    +  I      S  A DLI +L    P  R   G  G 
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCR-GPEDR--LGKNGA 299

Query: 306 AVLKMHPFFKGIDW-KNIRGQTPP 328
             +K HPFFK ID+  ++R Q+ P
Sbjct: 300 DEIKAHPFFKTIDFSSDLRQQSAP 323

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score =  172 bits (437), Expect = 2e-49
 Identities = 107/296 (36%), Positives = 162/296 (54%), Gaps = 25/296 (8%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DFE+ K+ G G++ +V   K  +   V+A+KI++K  + K  +TA  + ER VL   D+
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHS 163
             +  L + FQD  +LY+ ++   GG+L   ++  +  L ED ARFY AE+V A++ +H 
Sbjct: 61  QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGS-VKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           +  +HRDIKP+N+L+  +GHI++ADFGS +K M+D  +          ++   VGT  Y+
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV----------QSSVAVGTPDYI 170

Query: 223 PPEVLNSSPATFGN-----DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR--FP 275
            PE+L +     G      D W+LG  +Y+ML G +PF   S    + +I+    R  FP
Sbjct: 171 SPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 230

Query: 276 NYFSDA---ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 328
              +D    A+DLI RL+    S     G  G    K HPFF GIDW NIR    P
Sbjct: 231 AQVTDVSEDAKDLIRRLI---CSREHRLGQNGIEDFKQHPFFTGIDWDNIRNCEAP 283

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score =  172 bits (437), Expect = 3e-49
 Identities = 106/308 (34%), Positives = 168/308 (54%), Gaps = 32/308 (10%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DFE  K+ G G++ +V   +K DTG VYA+KI+ K  + ++ +  +++ ER +L + D 
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
             VV++F++FQD  +LY+ +E   GG++   +  K  L+E+E +FY AE V A++ IH +
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT--------VLP------NAASDD 210
           G IHRDIKP+NLLL + GH+K++DFG    ++ +  T         LP      N  S  
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180

Query: 211 KACTF-----------VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 259
           KA T+           VGT  Y+ PEV   +      D W+LG  +Y+ML G  PF   +
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240

Query: 260 EWLIFQRII--ARDIRFPNY--FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
               +++++     + FP     S+ A+DLI R            G  G   +K +PFF+
Sbjct: 241 PQETYKKVMNWKETLIFPPEVPISEKAKDLILRFC---CEWEHRIGAPGVEEIKTNPFFE 297

Query: 316 GIDWKNIR 323
           G+DW++IR
Sbjct: 298 GVDWEHIR 305

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  170 bits (431), Expect = 7e-49
 Identities = 99/279 (35%), Positives = 146/279 (52%), Gaps = 13/279 (4%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           DF    + G GS+ KV+ A++  T  +YA+KI+ K  + +++      +E+ VL     P
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60

Query: 106 G-VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
             + +L   FQ    LY  +E   GG+L  QI   G   E  A FY AE+   L ++HS 
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKP-MQDSRITVLPNAASDDKACTFVGTAAYVP 223
           G+I+RD+K +N++L ++GHIKIADFG  K  M D   T            TF GT  Y+ 
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK-----------TFCGTPDYIA 169

Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAAR 283
           PE++   P     D WA G  LY+ML+G +PF+   E  +FQ I+  ++ +P   S  A 
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAV 229

Query: 284 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 322
            +   L+   P  R G GP G   +K H FF+ IDW+ +
Sbjct: 230 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL 268

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score =  171 bits (434), Expect = 1e-48
 Identities = 114/358 (31%), Positives = 169/358 (47%), Gaps = 62/358 (17%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           K  G+G++ +V  A K+DT  +YA+K + KK +   N+ A+VK ER +L + D+  VV+L
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66

Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 170
           +++FQD  +LY  ++   GG++   +       E  ARFY AE+  A+E +H MG IHRD
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126

Query: 171 IKPENLLLTADGHIKIADFG-----------------------SVKPMQ----------- 196
           IKP+N+L+  DGHIK+ DFG                       S++P             
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186

Query: 197 DSRITVLPNAASDDKAC---TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTS 253
           D   T+   A    + C   + VGT  Y+ PEVL     T   D W++G  L++ML G  
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQP 246

Query: 254 PFKDTSEWLIFQRII--ARDIRFPNY--FSDAARDLIDRLL--DVDPSGRPGAGPGGYAV 307
           PF   +      ++I     +  P     S  A DLI +L     +  GR GA       
Sbjct: 247 PFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADD----- 301

Query: 308 LKMHPFFKGIDWK-NIRGQTPPKLA--SEPM---------VQSGEGDDVHDSS--WNP 351
           +K HPFF  +D+  +IR Q  P +   S PM          +S   D   DS+  W+ 
Sbjct: 302 IKAHPFFSEVDFSSDIRTQPAPYVPKISHPMDTSNFDPVEEESPWNDASGDSTRTWDT 359

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  164 bits (418), Expect = 1e-47
 Identities = 84/270 (31%), Positives = 135/270 (50%), Gaps = 17/270 (6%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           +++LG + G G++  V +   ++TG   A+K +  + I +E   + +  E  +L  L HP
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKS-IMQEIDLLKNLKHP 59

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 165
            +V+   + + + SLY+ LE  E G L   I   G   E     Y  +V+  L Y+H  G
Sbjct: 60  NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119

Query: 166 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 225
           +IHRDIK  N+L T DG +K+ADFG    + D                + VGT  ++ PE
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLND----------VSKDDASVVGTPYWMAPE 169

Query: 226 VLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-IRFPNYFSDAARD 284
           V+  S A+  +D+W+LGCT+ ++L+G  P+ D +      RI+  D    P   S   +D
Sbjct: 170 VIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKD 229

Query: 285 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 314
            + +    DP+ RP A      +LK HP+ 
Sbjct: 230 FLMQCFQKDPNLRPTAK----QLLK-HPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  167 bits (423), Expect = 4e-47
 Identities = 109/294 (37%), Positives = 158/294 (53%), Gaps = 23/294 (7%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +D+E+ K+ G G++ +V   +   T  VYA+K++ K  + K + +A+   ER ++   + 
Sbjct: 43  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P VV+LF+ FQD   LYM +E   GG+L + + S   + E  ARFYTAEVV AL+ IHSM
Sbjct: 103 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSM 161

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G IHRD+KP+N+LL   GH+K+ADFG+   M    +          +  T VGT  Y+ P
Sbjct: 162 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV---------RCDTAVGTPDYISP 212

Query: 225 EVLNSS--PATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRII--ARDIRFP--N 276
           EVL S      +G   D W++G  LY+ML G +PF   S    + +I+     + FP  N
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN 272

Query: 277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID--WKNIRGQTPP 328
             S  A++LI   L  D   R   G  G   +K H FFK     W+ +R    P
Sbjct: 273 DISKEAKNLICAFL-TDREVR--LGRNGVEEIKRHLFFKNDQWAWETLRDTVAP 323

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  164 bits (417), Expect = 1e-46
 Identities = 94/279 (33%), Positives = 144/279 (51%), Gaps = 14/279 (5%)

Query: 45  QDFELGKIYGVGSYSKVVRAK-KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +DF   +  G GS+ +V+ A  K +     A+K  +K  I K+ +  +V  ER +L+ ++
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP  V L+ +F+D   LY+ LE   GGE F  +        D   FY A++V   EY+ S
Sbjct: 90  HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS 149

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + +++RD+KPENLLL  DG IK+ DFG  K +             D +  T  GT  Y+ 
Sbjct: 150 LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-------------DTRTYTLCGTPEYIA 196

Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAAR 283
           PE+L +       D W LG  +Y++L G  PF      LI+Q+I+   I FP +  +  +
Sbjct: 197 PEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCK 256

Query: 284 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 322
            L+ +LL  D + R G    G   +K HP+F  IDW ++
Sbjct: 257 HLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSL 295

Length = 340

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  165 bits (419), Expect = 1e-46
 Identities = 114/315 (36%), Positives = 172/315 (54%), Gaps = 28/315 (8%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +D+++ K+ G G++ +V   +   +  VYA+K++ K  + K + +A+   ER ++   + 
Sbjct: 43  EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P VV+LF  FQD   LYM +E   GG+L + + S   + E  A+FYTAEVV AL+ IHSM
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSM 161

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           GLIHRD+KP+N+LL   GH+K+ADFG+   M ++ +          +  T VGT  Y+ P
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV---------RCDTAVGTPDYISP 212

Query: 225 EVLNSS--PATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRII--ARDIRFPN-- 276
           EVL S      +G   D W++G  L++ML G +PF   S    + +I+     + FP   
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDV 272

Query: 277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG--IDWKNIR---GQTPPKLA 331
             S  A++LI   L  D   R   G  G   +K HPFFK    +W NIR       P+L+
Sbjct: 273 EISKHAKNLICAFL-TDREVR--LGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELS 329

Query: 332 SEPMVQSGEGDDVHD 346
           S+  + S   DD+ D
Sbjct: 330 SD--IDSSNFDDIED 342

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score =  161 bits (409), Expect = 4e-46
 Identities = 98/287 (34%), Positives = 147/287 (51%), Gaps = 20/287 (6%)

Query: 52  IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL---DHPGVV 108
           I G G + +V   +K DTG +YA+K +DKK I  +        ERI+L  +   D P +V
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 109 RLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            + + F     L   L+   GG+L   ++  G  SE E RFY AE++  LE++H+  +++
Sbjct: 61  CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120

Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN 228
           RD+KP N+LL   GH++I+D G            L    S  K    VGT  Y+ PEVL 
Sbjct: 121 RDLKPANILLDEHGHVRISDLG------------LACDFSKKKPHASVGTHGYMAPEVLQ 168

Query: 229 SSPATFGN-DLWALGCTLYQMLSGTSPF---KDTSEWLIFQRIIARDIRFPNYFSDAARD 284
              A   + D ++LGC L+++L G SPF   K   +  I +  +   +  P+ FS   R 
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 228

Query: 285 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT-PPKL 330
           L++ LL  D + R G    G   +K HPFF+ +DW+ +  Q  PP L
Sbjct: 229 LLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPPPL 275

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score =  160 bits (405), Expect = 2e-45
 Identities = 100/292 (34%), Positives = 146/292 (50%), Gaps = 23/292 (7%)

Query: 52  IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL---DHPGVV 108
           I G G + +V   +K DTG +YA+K +DKK I  +        ERI+L  +   D P +V
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 109 RLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            + + F     L   L+   GG+L   ++  G  SE E RFY  E++  LE++H+  +++
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120

Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN 228
           RD+KP N+LL   GH++I+D G            L    S  K    VGT  Y+ PEVL 
Sbjct: 121 RDLKPANILLDEHGHVRISDLG------------LACDFSKKKPHASVGTHGYMAPEVLQ 168

Query: 229 SSPATFGNDLW-ALGCTLYQMLSGTSPF-----KDTSEWLIFQRIIARDIRFPNYFSDAA 282
              A   +  W +LGC L+++L G SPF     KD  E  I +  +  ++  P+ FS   
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRMTLTVNVELPDSFSPEL 226

Query: 283 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEP 334
           + L++ LL  D S R G    G   +K H FFKGIDW+ +  Q  P     P
Sbjct: 227 KSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQKYPPPLIPP 278

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  158 bits (402), Expect = 4e-45
 Identities = 90/280 (32%), Positives = 128/280 (45%), Gaps = 25/280 (8%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE-RIVLDQLDH 104
           D E  K+ G GS   V + +   TG +YALK +       E     +  E + +    + 
Sbjct: 2   DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKI--HVDGDEEFRKQLLRELKTLRSC-ES 58

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P VV+ +  F     + + LE  +GG L D +   G + E    +   +++  L+Y+H+ 
Sbjct: 59  PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTK 118

Query: 165 -GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
             +IHRDIKP NLL+ + G +KIADFG  K        VL N  + D+  TFVGT  Y+ 
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISK--------VLEN--TLDQCNTFVGTVTYMS 168

Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD---TSEWLIFQRIIARDIRF--PNYF 278
           PE +     ++  D+W+LG TL +   G  PF      S + + Q I            F
Sbjct: 169 PERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEF 228

Query: 279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID 318
           S   RD I   L  DP  RP A     A L  HPF K  D
Sbjct: 229 SPEFRDFISACLQKDPKKRPSA-----AELLQHPFIKKAD 263

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  157 bits (400), Expect = 7e-45
 Identities = 85/276 (30%), Positives = 135/276 (48%), Gaps = 25/276 (9%)

Query: 48  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL---ERIVLDQLDH 104
           + G   G G++ KV  A  +DTG + A+K +      ++N    +K    E  VL+ L H
Sbjct: 3   QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIR----IQDNDPKTIKEIADEMKVLELLKH 58

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P +V+ +        +Y+ +E C GG L + +     L E   R YT ++++ L Y+HS 
Sbjct: 59  PNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH 118

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G++HRDIKP N+ L  +G IK+ DFG    ++++  T+     S        GT AY+ P
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS------LAGTPAYMAP 172

Query: 225 EVLNSSPAT--FGN-DLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIARD---IRFPNY 277
           EV+            D+W+LGC + +M +G  P+ +  +E+ I   + A     I     
Sbjct: 173 EVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQ 232

Query: 278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 313
            S   +D +DR L+ DP  RP A     + L  HPF
Sbjct: 233 LSPEGKDFLDRCLESDPKKRPTA-----SELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score =  158 bits (400), Expect = 8e-45
 Identities = 93/296 (31%), Positives = 152/296 (51%), Gaps = 20/296 (6%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           F   ++ G G + +V   +   TG +YA K ++KK I K    +    E+ +L++++   
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSM 164
           VV L + ++   +L + L    GG+L   I + G+    E+ A FY AE++  LE +H  
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121

Query: 165 GLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
             ++RD+KPEN+LL   GHI+I+D G +VK         +P     +     VGT  Y+ 
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLAVK---------IPEG---ESIRGRVGTVGYMA 169

Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQRIIARDIRFPNYFS 279
           PEVLN+   T   D W LGC +Y+M+ G SPF+   E +    + +R++  +  +   FS
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFS 229

Query: 280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR-GQTPPKLASEP 334
           + A+ +   LL  DP  R G    G   +K HPFF+ +++K +  G   P    +P
Sbjct: 230 EEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVPDP 285

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score =  155 bits (393), Expect = 9e-44
 Identities = 91/287 (31%), Positives = 146/287 (50%), Gaps = 21/287 (7%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           ++ G G + +V   +   TG +YA K ++KK I K    A    E+ +L++++   VV L
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65

Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEAR--FYTAEVVDALEYIHSMGLIH 168
            + ++   +L + L    GG+L   I + G+   DE R  FY AE+   LE +    +++
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125

Query: 169 RDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 227
           RD+KPEN+LL   GHI+I+D G +V+  +   +               VGT  Y+ PEV+
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLAVQIPEGETVR------------GRVGTVGYMAPEVI 173

Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQRIIARDIRFPNYFSDAAR 283
           N+   TF  D W LGC +Y+M+ G SPF+   E +    + +R+      +   FS+ A+
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAK 233

Query: 284 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT--PP 328
            +   LL  +P  R G    G A +K HP FK I++K +      PP
Sbjct: 234 SICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPP 280

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score =  153 bits (388), Expect = 5e-43
 Identities = 95/296 (32%), Positives = 150/296 (50%), Gaps = 20/296 (6%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           F   ++ G G + +V   +   TG +YA K ++KK I K    +    E+ +L++++   
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEAR--FYTAEVVDALEYIHSM 164
           VV L + ++   +L + L    GG+L   I   G    +E R  FY AE+   LE +H  
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121

Query: 165 GLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
            +++RD+KPEN+LL   GHI+I+D G +V   +   I               VGT  Y+ 
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK------------GRVGTVGYMA 169

Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI--IARDIR--FPNYFS 279
           PEV+ +   TF  D WALGC LY+M++G SPF+   + +  + +  + ++++  +   FS
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFS 229

Query: 280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR-GQTPPKLASEP 334
             AR L   LL  DP  R G   GG   +K HP FK I++K +  G   P    +P
Sbjct: 230 PDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPFKPDP 285

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score =  149 bits (378), Expect = 1e-41
 Identities = 84/283 (29%), Positives = 142/283 (50%), Gaps = 18/283 (6%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G + +V   +   TG +YA K ++KK + K        +E+ +L ++    +V L + 
Sbjct: 2   GKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYA 61

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGH----LSEDEARFYTAEVVDALEYIHSMGLIHR 169
           FQ    L + +    GG+L   I +         E  A FYTA+++  LE++H   +I+R
Sbjct: 62  FQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYR 121

Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 229
           D+KPEN+LL  DG+++I+D G    ++D +           K   + GT  ++ PE+L  
Sbjct: 122 DLKPENVLLDNDGNVRISDLGLAVELKDGQ----------SKTKGYAGTPGFMAPELLQG 171

Query: 230 SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQRIIARDIRFPNYFSDAARDL 285
               F  D +ALG TLY+M++   PF+   E +    + QRI+   + +P+ FS A++  
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSF 231

Query: 286 IDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 328
            + LL  DP  R G   G    L+ HP F+ ++W+ +     P
Sbjct: 232 CEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLP 274

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  148 bits (375), Expect = 3e-41
 Identities = 76/269 (28%), Positives = 131/269 (48%), Gaps = 27/269 (10%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           D+E+ +  G GS+  V + ++   G +   K +D   +T++ K   V  E  +L +L HP
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVS-EVNILRELKHP 59

Query: 106 GVVRLFFTFQDTFS--LYMALESCEGGELFDQIT----SKGHLSEDEARFYTAEVVDALE 159
            +VR +    D  +  LY+ +E CEGG+L   I      + ++ E+       +++ AL 
Sbjct: 60  NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119

Query: 160 YIH-----SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
             H        ++HRD+KP N+ L A+ ++K+ DFG  K +                A T
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS----------SFAKT 169

Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI---IARD 271
           +VGT  Y+ PE LN       +D+W+LGC +Y++ + + PF   ++  +  +I     R 
Sbjct: 170 YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRR 229

Query: 272 IRFPNYFSDAARDLIDRLLDVDPSGRPGA 300
           I  P  +S    ++I  +L+VDP  RP  
Sbjct: 230 I--PYRYSSELNEVIKSMLNVDPDKRPST 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  142 bits (360), Expect = 3e-39
 Identities = 83/269 (30%), Positives = 130/269 (48%), Gaps = 21/269 (7%)

Query: 50  GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV--LDQLDHPGV 107
           G++ G GS+  V     +D G  +A+K +      +  + A  +LE+ +  L +L HP +
Sbjct: 5   GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64

Query: 108 VRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLI 167
           V+   T ++  +LY+ LE   GG L   +   G   E   R YT +++  LEY+H    +
Sbjct: 65  VQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTV 124

Query: 168 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 227
           HRDIK  N+L+  +G +K+ADFG  K     ++     A S      F G+  ++ PEV+
Sbjct: 125 HRDIKGANILVDTNGVVKLADFGMAK-----QVVEFSFAKS------FKGSPYWMAPEVI 173

Query: 228 NSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI--RFPNYFSDAARD 284
                     D+W+LGCT+ +M +G  P+          +I         P++ SD A+D
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKD 233

Query: 285 LIDRLLDVDPSGRPGAGPGGYAVLKMHPF 313
            I + L  DPS RP A     A L  HPF
Sbjct: 234 FILKCLQRDPSLRPTA-----AELLEHPF 257

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  142 bits (361), Expect = 4e-39
 Identities = 84/287 (29%), Positives = 138/287 (48%), Gaps = 38/287 (13%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P+E +  ++ E  KI G G+  +V +A    TG   A+K M    + K+NK   +  E +
Sbjct: 17  PRELY--KNLE--KI-GEGASGEVYKATDRATGKEVAIKKMR---LRKQNKELIIN-EIL 67

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT-SKGHLSEDEARFYTAEVVD 156
           ++    HP +V  + ++     L++ +E  +GG L D IT +   ++E +  +   EV+ 
Sbjct: 68  IMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQ 127

Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG---SVKPMQDSRITVLPNAASDDKAC 213
            LEY+HS  +IHRDIK +N+LL+ DG +K+ADFG    +   +  R +V           
Sbjct: 128 GLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV----------- 176

Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP-FKDTSEWLIFQRIIAR-- 270
             VGT  ++ PEV+         D+W+LG    +M  G  P  ++     +F   I    
Sbjct: 177 --VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFL--ITTKG 232

Query: 271 --DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
              ++ P  +S   +D +++ L  DP  RP A       L  HPF K
Sbjct: 233 IPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSA-----EELLQHPFLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  141 bits (357), Expect = 6e-39
 Identities = 72/259 (27%), Positives = 123/259 (47%), Gaps = 18/259 (6%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           DF++ K  G GSY  V + K++     YALK +D   ++++ +   V   RI L  ++HP
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRI-LASVNHP 59

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQIT----SKGHLSEDEARFYTAEVVDALEYI 161
            ++     F D   L + +E    G+L   I+     +  + E E      +++  L+ +
Sbjct: 60  NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119

Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H   ++HRD+K  N+LL A+  +KI D G  K                + A T +GT  Y
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISK------------VLKKNMAKTQIGTPHY 167

Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII-ARDIRFPNYFSD 280
           + PEV    P ++ +D+W+LGC LY+M +   PF+  S   +  ++   +    P  +S 
Sbjct: 168 MAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQ 227

Query: 281 AARDLIDRLLDVDPSGRPG 299
             ++ I  +L V P  RP 
Sbjct: 228 DLQNFIRSMLQVKPKLRPN 246

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  140 bits (355), Expect = 3e-38
 Identities = 84/273 (30%), Positives = 127/273 (46%), Gaps = 20/273 (7%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           + F L +  G GS+ +V +A    T  V A+K++D +    E++   ++ E   L Q   
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE--EAEDEIEDIQQEIQFLSQCRS 58

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P + + + +F     L++ +E C GG   D +   G L E    F   EV+  LEY+H  
Sbjct: 59  PYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP-GKLDETYIAFILREVLLGLEYLHEE 117

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G IHRDIK  N+LL+ +G +K+ADFG    +  +            K  TFVGT  ++ P
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS----------KRNTFVGTPFWMAP 167

Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF--PNYFSDAA 282
           EV+  S      D+W+LG T  ++  G  P  D     +   I   +      N FS   
Sbjct: 168 EVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPF 227

Query: 283 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
           +D +   L+ DP  RP A      +LK H F K
Sbjct: 228 KDFVSLCLNKDPKERPSA----KELLK-HKFIK 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  139 bits (353), Expect = 4e-38
 Identities = 86/279 (30%), Positives = 131/279 (46%), Gaps = 29/279 (10%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +D+EL +  G G+Y  V +A+ I TG + A+K++    +   +    ++ E  +L +  H
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK---LEPGDDFEIIQQEISMLKECRH 59

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVVDALEYIH 162
           P +V  F ++     L++ +E C GG L D  Q+T +G LSE +  +   E +  L Y+H
Sbjct: 60  PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLH 118

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
             G IHRDIK  N+LLT DG +K+ADFG       +++T     A+  K  +F+GT  ++
Sbjct: 119 ETGKIHRDIKGANILLTEDGDVKLADFGV-----SAQLT-----ATIAKRKSFIGTPYWM 168

Query: 223 PPEVLN---SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP---- 275
            PEV             D+WALG T  ++     P  D         I   +   P    
Sbjct: 169 APEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKD 228

Query: 276 -NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 313
              +S    D I + L  DP  RP A       L  HPF
Sbjct: 229 KEKWSPVFHDFIKKCLTKDPKKRPTA-----TKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  138 bits (349), Expect = 9e-38
 Identities = 78/259 (30%), Positives = 122/259 (47%), Gaps = 16/259 (6%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           DFE+    G GS+  V +  +     VYA+K +D   + +  +   +   R VL +LD  
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEAR-VLAKLDSS 59

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITS--KGHLSEDEA-RFYTAEVVDALEYIH 162
            ++R + +F D   L + +E  E G+L   +       L ED+  RF+  +++  L ++H
Sbjct: 60  YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI-QILLGLAHLH 118

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S  ++HRDIK  NL L A  ++KI D G  K + D+  T   N        T VGT  Y+
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--TNFAN--------TIVGTPYYL 168

Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII-ARDIRFPNYFSDA 281
            PE+    P    +D+WALG  LY+  +G  PF   ++  +  +II          +S  
Sbjct: 169 SPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQ 228

Query: 282 ARDLIDRLLDVDPSGRPGA 300
              LID+ L  D   RP  
Sbjct: 229 LAQLIDQCLTKDYRQRPDT 247

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  136 bits (345), Expect = 6e-37
 Identities = 85/292 (29%), Positives = 125/292 (42%), Gaps = 49/292 (16%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDK-------KFITKENKTAYVKLERIV 98
           D+EL ++ GVG+ + V  A  +      A+K +D          + KE +          
Sbjct: 2   DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQA--------- 52

Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK---GHLSEDEARFYTAEVV 155
           + Q +HP VV+ + +F     L++ +    GG L D + S    G L E        EV+
Sbjct: 53  MSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVL 112

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS----VKPMQDSRITVLPNAASDDK 211
             LEY+HS G IHRDIK  N+LL  DG +KIADFG           +R            
Sbjct: 113 KGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR----------KV 162

Query: 212 ACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR 270
             TFVGT  ++ PEV+       F  D+W+ G T  ++ +G +P+       +    +  
Sbjct: 163 RKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN 222

Query: 271 DIRFPNY--------FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 314
           D   P+         +S + R +I   L  DPS RP A       L  H FF
Sbjct: 223 D--PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTA-----EELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  135 bits (342), Expect = 2e-36
 Identities = 81/271 (29%), Positives = 136/271 (50%), Gaps = 29/271 (10%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G++ KV +A+  +TG   A KI+    I  E +     +E  +L +  HP +V L+  
Sbjct: 14  GDGAFGKVYKAQHKETGLFAAAKIIQ---IESEEELEDFMVEIDILSECKHPNIVGLYEA 70

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSMGLIHRDIK 172
           +     L++ +E C+GG L   +      L+E + R+   ++++AL ++HS  +IHRD+K
Sbjct: 71  YFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLK 130

Query: 173 PENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN--- 228
             N+LLT DG +K+ADFG S K           N ++  K  TF+GT  ++ PEV+    
Sbjct: 131 AGNILLTLDGDVKLADFGVSAK-----------NKSTLQKRDTFIGTPYWMAPEVVACET 179

Query: 229 --SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRFPNYFSDAAR 283
              +P  +  D+W+LG TL ++     P  + +   +  +I+  +   +  P+ +S +  
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFN 239

Query: 284 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 314
           D +   L  DP  RP A     A L  HPF 
Sbjct: 240 DFLKSCLVKDPDDRPTA-----AELLKHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score =  135 bits (341), Expect = 2e-36
 Identities = 80/283 (28%), Positives = 151/283 (53%), Gaps = 20/283 (7%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G + +V   +  +TG +YA K +DKK + K++      LE+ +L++++ P +V L + 
Sbjct: 2   GKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYA 61

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEAR--FYTAEVVDALEYIHSMGLIHRDI 171
           F+    L + +    GG+L   I + G    +  R   Y+A++   + ++HSM +++RD+
Sbjct: 62  FESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDM 121

Query: 172 KPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP 231
           KPEN+LL   G+ +++D G    ++D +           +A    GT  Y+ PE+L   P
Sbjct: 122 KPENVLLDDQGNCRLSDLGLAVELKDGKTIT-------QRA----GTNGYMAPEILKEEP 170

Query: 232 ATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQRIIARDIRFPNY-FSDAARDLI 286
            ++  D +A+GC++Y+M++G +PFKD  E +    + +R +  +++F +  F++ ++D+ 
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDIC 230

Query: 287 DRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR-GQTPP 328
              L   P  R G+        K H FFK I++  +  G  PP
Sbjct: 231 RLFLAKKPEDRLGSREKNDDPRK-HEFFKTINFPRLEAGLIPP 272

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  134 bits (339), Expect = 2e-36
 Identities = 79/261 (30%), Positives = 139/261 (53%), Gaps = 21/261 (8%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLD 103
            + + ++ G GS+ + +  + +++   YA+K   + K     E+     + E ++L ++ 
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDS----RKEAVLLAKMK 56

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT-SKGHL-SEDEARFYTAEVVDALEYI 161
           HP +V    +F+    LY+ +E C+GG+L  +I   +G L  ED    +  ++   +++I
Sbjct: 57  HPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHI 116

Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H   ++HRDIK +N+ LT +G +K+ DFGS      +R+   P A     ACT+VGT  Y
Sbjct: 117 HEKRVLHRDIKSKNIFLTQNGKVKLGDFGS------ARLLTSPGAY----ACTYVGTPYY 166

Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW--LIFQRIIARDIRFPNYFS 279
           VPPE+  + P    +D+W+LGC LY++ +   PF+  S W  LI +         P+++S
Sbjct: 167 VPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS-WKNLILKVCQGSYKPLPSHYS 225

Query: 280 DAARDLIDRLLDVDPSGRPGA 300
              R LI ++   +P  RP A
Sbjct: 226 YELRSLIKQMFKRNPRSRPSA 246

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  135 bits (342), Expect = 3e-36
 Identities = 87/308 (28%), Positives = 136/308 (44%), Gaps = 65/308 (21%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV-LDQL-DH 104
           +++ K  G G++  V  A+  +TG + A+K M KKF + E     + L  +  L +L +H
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEE---CMNLREVKSLRKLNEH 57

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITS--KGHLSEDEARFYTAEVVDALEYIH 162
           P +V+L   F++   LY   E  EG  L+  +        SE   R    +++  L +IH
Sbjct: 58  PNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR-ITVLPNAASDDKACTFVGTAAY 221
             G  HRD+KPENLL++    +KIADFG  + ++     T             +V T  Y
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT------------DYVSTRWY 164

Query: 222 VPPEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRI----- 267
             PE+L      SSP     D+WALGC + ++ +    F  +SE    + I   +     
Sbjct: 165 RAPEILLRSTSYSSP----VDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTK 220

Query: 268 --------IARD--IRFPNY--------FSDAARDLID---RLLDVDPSGRPGAGPGGYA 306
                   +A     RFP +          +A+ + ID    +L  DP  RP A      
Sbjct: 221 QDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTAS----Q 276

Query: 307 VLKMHPFF 314
            L+ HP+F
Sbjct: 277 ALQ-HPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  134 bits (340), Expect = 4e-36
 Identities = 86/301 (28%), Positives = 142/301 (47%), Gaps = 56/301 (18%)

Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGV 107
           LGKI G G+Y  V +A+   TG + A+K +  +F ++   KTA  +++  +L +L+HP +
Sbjct: 4   LGKI-GEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIK--LLKELNHPNI 60

Query: 108 VRLFFTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 165
           ++L   F+    LY+  E  +    +L      +  L E   + Y  +++  L + HS G
Sbjct: 61  IKLLDVFRHKGDLYLVFEFMDTDLYKLIK--DRQRGLPESLIKSYLYQLLQGLAFCHSHG 118

Query: 166 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT-FVGTAAYVPP 224
           ++HRD+KPENLL+  +G +K+ADFG  +           +  S  +  T +V T  Y  P
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLAR-----------SFGSPVRPYTHYVVTRWYRAP 167

Query: 225 EVL-NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRI------------ 267
           E+L      +   D+W++GC   ++LS    F   SE    + IF+ +            
Sbjct: 168 ELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFT 227

Query: 268 -IARD--IRFPNY--------FSDA---ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 313
            +AR+    FP          F +A   A DL+ ++L  DP  R  A       L  HP+
Sbjct: 228 SLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITA----EQALA-HPY 282

Query: 314 F 314
           F
Sbjct: 283 F 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  135 bits (341), Expect = 4e-36
 Identities = 85/303 (28%), Positives = 126/303 (41%), Gaps = 57/303 (18%)

Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL---ERIVLDQLDHP 105
           LG + G G+Y  V++ +   TG + A+K    KF   E+     K    E  VL QL H 
Sbjct: 6   LGVV-GEGAYGVVLKCRNKATGEIVAIK----KFKESEDDEDVKKTALREVKVLRQLRHE 60

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 165
            +V L   F+    LY+  E  E   L     S G L  D  R Y  +++ A+ Y HS  
Sbjct: 61  NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN 120

Query: 166 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT-FVGTAAYVPP 224
           +IHRDIKPEN+L++  G +K+ DFG  + ++          A      T +V T  Y  P
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALR----------ARPASPLTDYVATRWYRAP 170

Query: 225 EVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQ-------------- 265
           E+L          D+WA+GC + ++L G   F   S+    +LI +              
Sbjct: 171 ELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS 230

Query: 266 --------------RIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH 311
                         +  + + R+P   S  A D +   L +DP  R          L  H
Sbjct: 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTC-----DELLQH 285

Query: 312 PFF 314
           P+F
Sbjct: 286 PYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  134 bits (340), Expect = 4e-36
 Identities = 83/301 (27%), Positives = 133/301 (44%), Gaps = 57/301 (18%)

Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN---KTAYVKLERI-VLDQLDH 104
           L K+ G G+Y  V +A+   TG + ALK +  +   +E     TA   L  I +L +L H
Sbjct: 4   LEKL-GEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTA---LREISLLKELKH 57

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIHS 163
           P +V+L         LY+  E C+  +L   +    G LS +  +    +++  L Y HS
Sbjct: 58  PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS 116

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
             ++HRD+KP+N+L+  DG +K+ADFG       +R   +P      +    V T  Y  
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADFGL------ARAFGIPLRTYTHE----VVTLWYRA 166

Query: 224 PEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQ------------- 265
           PE+L  S   +   D+W++GC   +M++G   F   SE    + IFQ             
Sbjct: 167 PEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV 226

Query: 266 -RIIARDIRFPNY-----------FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 313
            ++      FP +                 DL+ ++L  +P+ R  A       LK HP+
Sbjct: 227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISA----KEALK-HPY 281

Query: 314 F 314
           F
Sbjct: 282 F 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  131 bits (331), Expect = 6e-35
 Identities = 84/279 (30%), Positives = 136/279 (48%), Gaps = 50/279 (17%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALK------IMDKKFITKENKTAYVKLERI 97
           + +F++ K  G G +S V +A  +  G V ALK      +MD K   +++    + L   
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAK--ARQDCLKEIDL--- 55

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF-------Y 150
            L QLDHP V++   +F +   L + LE  + G+L   I    H  + +          Y
Sbjct: 56  -LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIK---HFKKQKRLIPERTIWKY 111

Query: 151 TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG-----SVKPMQDSRITVLPN 205
             ++  ALE++HS  ++HRDIKP N+ +TA G +K+ D G     S K            
Sbjct: 112 FVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--------- 162

Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL--I 263
                 A + VGT  Y+ PE ++ +   F +D+W+LGC LY+M +  SPF      L  +
Sbjct: 163 ------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL 216

Query: 264 FQRIIARDIRFP----NYFSDAARDLIDRLLDVDPSGRP 298
            ++I   D  +P    +++S+  RDL+ R ++ DP  RP
Sbjct: 217 CKKIEKCD--YPPLPADHYSEELRDLVSRCINPDPEKRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  131 bits (331), Expect = 8e-35
 Identities = 82/303 (27%), Positives = 130/303 (42%), Gaps = 74/303 (24%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY-------VKLERIVL 99
           +E     G G+Y +V +A+   TG + ALK    K   +  K  +       +KL    L
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALK----KIRMENEKEGFPITAIREIKL----L 52

Query: 100 DQLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQ---ITSKG-HLSEDEARFYTAE 153
            +L HP +VRL    T +   S+YM  E  +     D    + S     +E + + Y  +
Sbjct: 53  QKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD----HDLTGLLDSPEVKFTESQIKCYMKQ 108

Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           +++ L+Y+HS G++HRDIK  N+L+  DG +K+ADFG  +P          N        
Sbjct: 109 LLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNR------- 161

Query: 214 TFVGTAAYVPPEVL----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW----LIFQ 265
             V T  Y PPE+L       P     D+W++GC L ++  G   F+ ++E      IF+
Sbjct: 162 --VITLWYRPPELLLGATRYGPEV---DMWSVGCILAELFLGKPIFQGSTELEQLEKIFE 216

Query: 266 ----------------------------RIIARDIRFPNYFSDAARDLIDRLLDVDPSGR 297
                                       +   R+  F +    +A DL+D+LL +DP  R
Sbjct: 217 LCGSPTDENWPGVSKLPWFENLKPKKPYKRRLRE-FFKHLIDPSALDLLDKLLTLDPKKR 275

Query: 298 PGA 300
             A
Sbjct: 276 ISA 278

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  129 bits (327), Expect = 2e-34
 Identities = 80/275 (29%), Positives = 129/275 (46%), Gaps = 26/275 (9%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           + F++ +  G GSY  V +A   +TG V A+K++    + ++ +   +  E  +L Q D 
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP---VEEDLQE--IIKEISILKQCDS 57

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVVDALEYIH 162
           P +V+ + ++     L++ +E C  G + D  +IT+K  L+E+E      + +  LEY+H
Sbjct: 58  PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLH 116

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S   IHRDIK  N+LL  +G  K+ADFG    + D+            K  T +GT  ++
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM----------AKRNTVIGTPFWM 166

Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFS 279
            PEV+         D+W+LG T  +M  G  P+ D         I  +    +  P  +S
Sbjct: 167 APEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWS 226

Query: 280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 314
               D + + L  DP  RP A       L  HPF 
Sbjct: 227 PEFNDFVKKCLVKDPEERPSA-----IQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  129 bits (326), Expect = 4e-34
 Identities = 76/252 (30%), Positives = 126/252 (50%), Gaps = 19/252 (7%)

Query: 52  IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH---PGVV 108
           + G G+Y  V R K + TG V ALKI++    T ++  + ++ E  +L QL     P + 
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIIN--LDTPDDDVSDIQREVALLSQLRQSQPPNIT 65

Query: 109 RLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
           + + ++     L++ +E  EGG +   +   G ++E        EV+ AL+YIH +G+IH
Sbjct: 66  KYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIH 124

Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN 228
           RDIK  N+L+T  G++K+ DFG    +  +            K  TFVGT  ++ PEV+ 
Sbjct: 125 RDIKAANILVTNTGNVKLCDFGVAALLNQNS----------SKRSTFVGTPYWMAPEVIT 174

Query: 229 SSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII-ARDIRFP-NYFSDAARDL 285
                    D+W+LG T+Y+M +G  P+ D   +     I  ++  R   N +S   R+ 
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREF 234

Query: 286 IDRLLDVDPSGR 297
           +   LD +P  R
Sbjct: 235 VAACLDEEPKER 246

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  128 bits (323), Expect = 5e-34
 Identities = 82/257 (31%), Positives = 133/257 (51%), Gaps = 17/257 (6%)

Query: 47  FELGKIYGVGSYSKVVRAK-KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           +E+ K  G GS+ K+  AK K D+      +I   K   KE + +  K E I+L ++ HP
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEAS--KKEVILLAKMKHP 59

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQIT-SKGHL-SEDEARFYTAEVVDALEYIHS 163
            +V  F +FQ+   L++ +E C+GG+L  +I   +G L SED+   +  ++   L++IH 
Sbjct: 60  NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119

Query: 164 MGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
             ++HRDIK +N+ L+ +G + K+ DFG  + + DS           + A T VGT  Y+
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM----------ELAYTCVGTPYYL 169

Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS-EWLIFQRIIARDIRFPNYFSDA 281
            PE+  + P     D+W+LGC LY++ +   PF+  +   L+ +            FS  
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRD 229

Query: 282 ARDLIDRLLDVDPSGRP 298
            R LI +L  V P  RP
Sbjct: 230 LRSLISQLFKVSPRDRP 246

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  128 bits (323), Expect = 7e-34
 Identities = 75/273 (27%), Positives = 134/273 (49%), Gaps = 16/273 (5%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV--LDQLD 103
           ++  GK+ G G++ +V     +DTG   A+K +     + E K     LE  +  L  L 
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           H  +V+ +   +D  +L + +E   GG + DQ+ + G L+E   R YT ++++ +EY+HS
Sbjct: 63  HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHS 122

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
             ++HRDIK  N+L  + G++K+ DFG+ K +Q          +S     +  GT  ++ 
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC-------SSGTGMKSVTGTPYWMS 175

Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI--RFPNYFSDA 281
           PEV++        D+W++GCT+ +ML+   P+ +        +I  +    + P++ S  
Sbjct: 176 PEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPD 235

Query: 282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 314
           AR+ + R    +   RP A       L  H F 
Sbjct: 236 ARNFLRRTFVENAKKRPSA-----EELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  127 bits (321), Expect = 9e-34
 Identities = 67/209 (32%), Positives = 102/209 (48%), Gaps = 13/209 (6%)

Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 152
           E ++L  L HP ++  +  F D  +L + +E   GG L+D+I         E+   +Y  
Sbjct: 49  EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLF 108

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++V A+ YIH  G++HRDIK  N+ LT  G IK+ DFG  K +                A
Sbjct: 109 QIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM----------A 158

Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD- 271
            T VGT  Y+ PE+       F +D+WALGC LY++L+    F  T+   +  +I+  + 
Sbjct: 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNY 218

Query: 272 IRFPNYFSDAARDLIDRLLDVDPSGRPGA 300
               + +S     L+  LL  DP  RP A
Sbjct: 219 TPVVSVYSSELISLVHSLLQQDPEKRPTA 247

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  126 bits (319), Expect = 2e-33
 Identities = 79/258 (30%), Positives = 138/258 (53%), Gaps = 25/258 (9%)

Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALK-IMDKKFITKENKTAYVKLERIVLDQLDHPGV 107
           + KI G GS+ K +  K  + G  Y +K I   K   KE + +  + E  VL  + HP +
Sbjct: 5   VKKI-GEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREES--RKEVAVLSNMKHPNI 61

Query: 108 VRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHL-SEDEARFYTAEVVDALEYIHSMG 165
           V+   +F++  +LY+ ++ CEGG+L+ +I + +G L  ED+   +  ++  AL+++H   
Sbjct: 62  VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK 121

Query: 166 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 225
           ++HRDIK +N+ LT DG IK+ DFG  +        VL +     + C  +GT  Y+ PE
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIAR--------VLNSTVELARTC--IGTPYYLSPE 171

Query: 226 VLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR-----FPNYFSD 280
           +  + P    +D+WALGC LY+M +    F+  +     + ++ + IR       +++S 
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN----MKNLVLKIIRGSYPPVSSHYSY 227

Query: 281 AARDLIDRLLDVDPSGRP 298
             R+L+ +L   +P  RP
Sbjct: 228 DLRNLVSQLFKRNPRDRP 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  125 bits (315), Expect = 1e-32
 Identities = 79/267 (29%), Positives = 132/267 (49%), Gaps = 26/267 (9%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS   V  A    TG   A+K MD   + K+ +   +  E +++    HP +V ++ +
Sbjct: 28  GEGSTGIVCIATDKSTGRQVAVKKMD---LRKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +     L++ +E  EGG L D I +   ++E++       V+ AL ++H+ G+IHRDIK 
Sbjct: 85  YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKS 143

Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
           +++LLT+DG +K++DFG    +       +P   S       VGT  ++ PEV++  P  
Sbjct: 144 DSILLTSDGRVKLSDFGFCAQVSKE----VPRRKS------LVGTPYWMAPEVISRLPYG 193

Query: 234 FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----IRFPNYFSDAARDLIDR 288
              D+W+LG  + +M+ G  P+ +       +RI  RD     ++  +  S   R  +DR
Sbjct: 194 TEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI--RDNLPPKLKNLHKVSPRLRSFLDR 251

Query: 289 LLDVDPSGRPGAGPGGYAVLKMHPFFK 315
           +L  DP+ R  A     A L  HPF  
Sbjct: 252 MLVRDPAQRATA-----AELLNHPFLA 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|241293 cd01262, PH_PDK1, 3-Phosphoinositide dependent protein kinase 1 (PDK1) pleckstrin homology (PH) domain

 Score =  119 bits (301), Expect = 1e-32
 Identities = 43/106 (40%), Positives = 58/106 (54%), Gaps = 3/106 (2%)

Query: 382 DSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPSKLVVKGNIIW 441
                 W  FL  GE +L + +V K + L +KK QLILT+ P+L YVDP K+V+KG I W
Sbjct: 1   QQQSENWWHFLVNGELILKMGLVDKRKGLFAKKRQLILTDGPRLYYVDPVKMVLKGEIPW 60

Query: 442 SDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRASQWKKAIEALQ 487
           S     L  +V +   F I TP +    ED +  A +W KAIE + 
Sbjct: 61  SPE---LRPEVKNFKTFFIHTPNRTYYLEDPEGNAKKWCKAIEEVL 103

PDK1 plays an important role in insulin and growth factor signalling cascades. It phosphorylates and activates many AGC (cAMP-dependent, cGMP-dependent, protein kinase C (PKC)) family of protein kinases members, including protein kinase B (PKB, also known as Akt), p70 ribosomal S6-kinase (S6K), serum and glucocorticoid responsive kinase (SGK), p90 ribosomal S6 kinase (RSK), and PKC. PDK1 contains an N-terminal serine/threonine kinase domain followed by a PH domain. Following binding of the PH domain to PtdIns(3,4,5)P3 and PtdIns(3,4)P2, PDK1 activates these enzymes by phosphorylating a Ser/Thr residue in their activation loop. PH domains have diverse functions, but in general are involved in targeting proteins to the appropriate cellular location or in the interaction with a binding partner. They share little sequence conservation, but all have a common fold, which is electrostatically polarized. Less than 10% of PH domains bind phosphoinositide phosphates (PIPs) with high affinity and specificity. PH domains are distinguished from other PIP-binding domains by their specific high-affinity binding to PIPs with two vicinal phosphate groups: PtdIns(3,4)P2, PtdIns(4,5)P2 or PtdIns(3,4,5)P3 which results in targeting some PH domain proteins to the plasma membrane. A few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains. PH domains are found in cellular signaling proteins such as serine/threonine kinase, tyrosine kinases, regulators of G-proteins, endocytotic GTPases, adaptors, as well as cytoskeletal associated molecules and in lipid associated enzymes. Length = 107

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  124 bits (313), Expect = 1e-32
 Identities = 72/277 (25%), Positives = 132/277 (47%), Gaps = 24/277 (8%)

Query: 50  GKIYGVGSYSKVVRAKKIDTGTVYALK-IMDKKFITKENKTAY--VKLERIVLDQLDHPG 106
           G+  G G++S   +A+ + TGT+ A+K +   +  + E +     ++ E  ++ +L+HP 
Sbjct: 5   GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64

Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           ++R+     +     + +E   GG +   ++  G   E     YT +++  L Y+H   +
Sbjct: 65  IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124

Query: 167 IHRDIKPENLLLTADGH-IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 225
           IHRD+K  NLL+ + G  ++IADFG+   +  ++ T      + +     +GT A++ PE
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARL-AAKGT-----GAGEFQGQLLGTIAFMAPE 178

Query: 226 VLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRIIARDI---RFPNYF 278
           VL         D+W++GC + +M +   P+          LIF+  IA        P + 
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK--IASATTAPSIPEHL 236

Query: 279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
           S   RD+  R L++ P  RP +       L  HP F+
Sbjct: 237 SPGLRDVTLRCLELQPEDRPPS-----RELLKHPVFR 268

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  123 bits (312), Expect = 2e-32
 Identities = 78/284 (27%), Positives = 130/284 (45%), Gaps = 30/284 (10%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
            D E     G G+   V +     TG + A+K +  +      K    +L+  +L + + 
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELD--ILHKCNS 58

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTAEVVDALEYIH 162
           P +V  +  F +   + + +E  +GG L D+I    +G + E         V+  L Y+H
Sbjct: 59  PYIVGFYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLH 117

Query: 163 S-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
               +IHRD+KP N+L+ + G IK+ DFG    + +S             A TFVGT++Y
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS------------LAKTFVGTSSY 165

Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK--DTSEWLIF---QRIIARDI-RFP 275
           + PE +  +  +  +D+W+LG +L ++ +G  P+   +     IF   Q I+     R P
Sbjct: 166 MAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLP 225

Query: 276 N-YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID 318
           +  FS   +D ++  L  DP  RP      Y  L  HPF K  +
Sbjct: 226 SGKFSPDFQDFVNLCLIKDPRERP-----SYKELLEHPFIKKYE 264

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  123 bits (309), Expect = 1e-31
 Identities = 87/276 (31%), Positives = 143/276 (51%), Gaps = 33/276 (11%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G++ KV +AK  +TG + A K+++ K  ++E    Y+ +E  +L   +HP +V+L   
Sbjct: 21  GDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYM-VEIEILATCNHPYIVKLLGA 77

Query: 114 FQDTFSLYMALESCEGGELFDQIT---SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 170
           F     L++ +E C GG + D I     +G L+E + +    ++++AL+Y+HSM +IHRD
Sbjct: 78  FYWDGKLWIMIEFCPGGAV-DAIMLELDRG-LTEPQIQVICRQMLEALQYLHSMKIIHRD 135

Query: 171 IKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV--- 226
           +K  N+LLT DG IK+ADFG S K           N  +  +  +F+GT  ++ PEV   
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVSAK-----------NVKTLQRRDSFIGTPYWMAPEVVMC 184

Query: 227 --LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRFPNYFSDA 281
             +  +P  +  D+W+LG TL +M     P  + +   +  +I   +   +  P+ +S  
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSME 244

Query: 282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI 317
            RD +   LD  P  RP A     A L  HPF   +
Sbjct: 245 FRDFLKTALDKHPETRPSA-----AQLLEHPFVSSV 275

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  121 bits (306), Expect = 2e-31
 Identities = 87/302 (28%), Positives = 128/302 (42%), Gaps = 55/302 (18%)

Query: 48  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-VLDQLDHPG 106
            LG+I G G++  V +AK  +TG   ALK +  +    E       L  I  L    HP 
Sbjct: 4   ILGRI-GEGAHGIVFKAKDRETGETVALKKVALR--RLEGGIPNQALREIKALQACQHPY 60

Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSMG 165
           VV+L   F       + +E     +L + +  +   L E + + Y   ++  + Y+H+ G
Sbjct: 61  VVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG 119

Query: 166 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 225
           ++HRD+KP NLL++ADG +KIADFG  +         L +          V T  Y  PE
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLF-SEEEPRLYSHQ--------VATRWYRAPE 170

Query: 226 VLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQ--RII-------------- 268
           +L  +     G DLWA+GC   ++L+G+  F   ++  I Q   +               
Sbjct: 171 LLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND--IEQLAIVFRTLGTPNEETWPGL 228

Query: 269 -----ARDIRFPN--------YFSDA---ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHP 312
                   I FP          F DA   A DL+  LL  DPS R  A     A    HP
Sbjct: 229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSA-----AEALRHP 283

Query: 313 FF 314
           +F
Sbjct: 284 YF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  119 bits (301), Expect = 1e-30
 Identities = 85/293 (29%), Positives = 134/293 (45%), Gaps = 50/293 (17%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE-RIVLDQLDH 104
            FEL ++ G G+Y KV +A+   TG + A+KIMD   I ++ +   +K E  I+    +H
Sbjct: 7   IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD---IIEDEEEE-IKEEYNILRKYSNH 62

Query: 105 PGVVRLFFTFQDTF----------SLYMALESCEGGELFDQI----TSKGHLSEDEARFY 150
           P +     TF   F           L++ +E C GG + D +         L E+   + 
Sbjct: 63  PNIA----TFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYI 118

Query: 151 TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDD 210
             E +  L Y+H   +IHRDIK +N+LLT +  +K+ DFG V    DS +          
Sbjct: 119 LRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFG-VSAQLDSTLG--------- 168

Query: 211 KACTFVGTAAYVPPEVL--NSSP-ATFGN--DLWALGCTLYQMLSGTSPFKDTSEW-LIF 264
           +  TF+GT  ++ PEV+  +  P A++    D+W+LG T  ++  G  P  D      +F
Sbjct: 169 RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF 228

Query: 265 QRIIARD----IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 313
           +  I R+    ++ P  +S    D I   L  +   RP         L  HPF
Sbjct: 229 K--IPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEE-----LLEHPF 274

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  118 bits (297), Expect = 3e-30
 Identities = 79/281 (28%), Positives = 134/281 (47%), Gaps = 32/281 (11%)

Query: 50  GKIYGVGSYSKVVRAKKIDTGTVYALK-------IMDKKFITKENKTAYVKLERIVLDQL 102
           G++ G G+Y +V  A  + TG + A+K       I  +    +++    ++ E   L  L
Sbjct: 6   GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65

Query: 103 DHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
           DH  +V+   F T ++  S++  LE   GG +   + + G   E   RF+T +V++ L Y
Sbjct: 66  DHLNIVQYLGFETTEEYLSIF--LEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAY 123

Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           +HS G++HRD+K +NLL+ ADG  KI+DFG  K   D           +D+  +  G+  
Sbjct: 124 LHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD--------IYDNDQNMSMQGSVF 175

Query: 221 YVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP--- 275
           ++ PEV++S    +    D+W+LGC + +M +G  P+ D        ++  +    P   
Sbjct: 176 WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPP 235

Query: 276 ---NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 313
                 S  A D ++    ++P  RP A       L  HPF
Sbjct: 236 DVSMNLSPVALDFLNACFTINPDNRPTA-----RELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  118 bits (299), Expect = 3e-30
 Identities = 77/308 (25%), Positives = 128/308 (41%), Gaps = 61/308 (19%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV----LDQL 102
           +E     G G+Y  V +A+ ++TG   ALK +  +    E       L  I     L+  
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKV--RVPLSEEGIPLSTLREIALLKQLESF 58

Query: 103 DHPGVVRLF--FTFQDT---FSLYMALESCEG--GELFDQITSKGHLSEDEARFYTAEVV 155
           +HP +VRL        T     L +  E  +        +    G L  +  +    +++
Sbjct: 59  EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-LPPETIKDLMRQLL 117

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ-DSRITVLPNAASDDKACT 214
             ++++HS  ++HRD+KP+N+L+T+DG +KIADFG  +    +  +T            +
Sbjct: 118 RGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALT------------S 165

Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW----LIFQRI--- 267
            V T  Y  PEVL  S      D+W++GC   ++      F+ TSE      IF  I   
Sbjct: 166 VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLP 225

Query: 268 ----------IARDIRFPNYF-----------SDAARDLIDRLLDVDPSGRPGAGPGGYA 306
                     + R   FP+Y             +   DL+ ++L  +P  R  A    + 
Sbjct: 226 SEEEWPRNVSLPRS-SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISA----FE 280

Query: 307 VLKMHPFF 314
            L+ HP+F
Sbjct: 281 ALQ-HPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  114 bits (287), Expect = 4e-29
 Identities = 75/257 (29%), Positives = 133/257 (51%), Gaps = 25/257 (9%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           ++ G GSY +V   +    G  Y +K ++ +  ++  + A  + E  +L QL HP +V  
Sbjct: 6   RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKA-AEQEAQLLSQLKHPNIV-- 62

Query: 111 FFTFQDTFS-----LYMALESCEGGELFDQIT-SKGHL-SEDEARFYTAEVVDALEYIHS 163
              +++++      LY+ +  CEGG+L+ ++   KG L  E++   +  ++  AL+Y+H 
Sbjct: 63  --AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE 120

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
             ++HRD+K +N+ LT    IK+ D G  +        VL N    D A T +GT  Y+ 
Sbjct: 121 KHILHRDLKTQNVFLTRTNIIKVGDLGIAR--------VLEN--QCDMASTLIGTPYYMS 170

Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPF--KDTSEWLIFQRIIARDIRFPNYFSDA 281
           PE+ ++ P  + +D+WALGC +Y+M +    F  KD +  L+++ I  +    P  +S  
Sbjct: 171 PELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS-LVYRIIEGKLPPMPKDYSPE 229

Query: 282 ARDLIDRLLDVDPSGRP 298
             +LI  +L   P  RP
Sbjct: 230 LGELIATMLSKRPEKRP 246

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  114 bits (287), Expect = 6e-29
 Identities = 75/259 (28%), Positives = 131/259 (50%), Gaps = 22/259 (8%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           +E  ++ G G++  V   ++     +  +K +  + +TK+ + A  + E  VL  L HP 
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLA-AQNECQVLKLLSHPN 60

Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSM 164
           ++  +  F +  +L + +E   GG L + I  + +  L ED    +  +++ AL ++H+ 
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120

Query: 165 GLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
            ++HRD+K +N+LL  D H   +KI DFG  K +           +S  KA T VGT  Y
Sbjct: 121 LILHRDLKTQNILL--DKHKMVVKIGDFGISKIL-----------SSKSKAYTVVGTPCY 167

Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP--NYFS 279
           + PE+    P    +D+WALGC LY++ S    F+  +   +  +I+      P  + +S
Sbjct: 168 ISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIM-SGTFAPISDRYS 226

Query: 280 DAARDLIDRLLDVDPSGRP 298
              R LI  +L++DPS RP
Sbjct: 227 PDLRQLILSMLNLDPSKRP 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  114 bits (286), Expect = 9e-29
 Identities = 81/271 (29%), Positives = 137/271 (50%), Gaps = 34/271 (12%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALK------IMDKKFITKENKTAYVKLERI 97
           + +F + K  G G +S+V RA  +  G   ALK      +MD K   + +    + L   
Sbjct: 1   LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAK--ARADCIKEIDL--- 55

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI----TSKGHLSEDEARFYTAE 153
            L QL+HP V++ + +F +   L + LE  + G+L   I      K  + E     Y  +
Sbjct: 56  -LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQ 114

Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           +  ALE++HS  ++HRDIKP N+ +TA G +K+ D G +     S+ T          A 
Sbjct: 115 LCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLG-LGRFFSSKTTA---------AH 164

Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF--KDTSEWLIFQRIIARD 271
           + VGT  Y+ PE ++ +   F +D+W+LGC LY+M +  SPF     + + + ++I   D
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD 224

Query: 272 IRFP----NYFSDAARDLIDRLLDVDPSGRP 298
             +P    +++S+  R L++  ++ DP  RP
Sbjct: 225 --YPPLPSDHYSEELRQLVNMCINPDPEKRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  113 bits (285), Expect = 1e-28
 Identities = 86/286 (30%), Positives = 135/286 (47%), Gaps = 31/286 (10%)

Query: 36  RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE 95
           R PQE     DFEL +  G G+Y  V +A+ ++TG + A+K++    +      A V+ E
Sbjct: 5   RNPQE-----DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQE 56

Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
            I++    H  +V  F ++     L++ +E C GG L D     G LSE +  + + E +
Sbjct: 57  IIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL 116

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
             L Y+HS G +HRDIK  N+LLT +GH+K+ADFG       ++IT     A+  K  +F
Sbjct: 117 QGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGV-----SAQIT-----ATIAKRKSF 166

Query: 216 VGTAAYVPPEVLNSSPATFGN---DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI 272
           +GT  ++ PEV         N   D+WA+G T  ++     P  D         +   + 
Sbjct: 167 IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNF 226

Query: 273 RFPNY-----FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 313
           + P       +S++    +   L  +P  RP A       L  HPF
Sbjct: 227 QPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEK-----LLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  113 bits (283), Expect = 2e-28
 Identities = 75/273 (27%), Positives = 133/273 (48%), Gaps = 20/273 (7%)

Query: 50  GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL------ERIVLDQLD 103
           G + G GS+  V       +G + A+K ++   ++  +K     +      E  +L +L 
Sbjct: 5   GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           H  +V+   +  D   L + LE   GG +   + + G   E   R +  +++  L Y+H+
Sbjct: 65  HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
            G+IHRDIK  N+L+   G IKI+DFG  K ++ +      +  ++    +  G+  ++ 
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN----SLSTKTNGARPSLQGSVFWMA 180

Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQRIIARDIR--FPNYFSD 280
           PEV+  +  T   D+W+LGC + +ML+G  PF D ++   IF+  I  +     P+  S 
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK--IGENASPEIPSNISS 238

Query: 281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 313
            A D +++  ++D + RP A     A L  HPF
Sbjct: 239 EAIDFLEKTFEIDHNKRPTA-----AELLKHPF 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  114 bits (288), Expect = 3e-28
 Identities = 84/299 (28%), Positives = 129/299 (43%), Gaps = 59/299 (19%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER--IVLDQL 102
           + +E+ +  G G+Y  V +A    T  V ALK   K F    N T   +  R  + L +L
Sbjct: 7   RKYEILQKLGKGAYGIVWKAIDRRTKEVVALK---KIFDAFRNATDAQRTFREIMFLQEL 63

Query: 103 -DHPGVVRLFFTF-----QDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEV 154
            DHP +V+L         +D   +Y+  E  E     D   +     L +   R+   ++
Sbjct: 64  GDHPNIVKLLNVIKAENDKD---IYLVFEYMET----DLHAVIRANILEDVHKRYIMYQL 116

Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           + AL+YIHS  +IHRD+KP N+LL +D  +K+ADFG  + + +          +D     
Sbjct: 117 LKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD----- 171

Query: 215 FVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSE------------- 260
           +V T  Y  PE+L  S   T G D+W++GC L +ML G   F  TS              
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGP 231

Query: 261 --------------WLIFQRIIARDIR-----FPNYFSDAARDLIDRLLDVDPSGRPGA 300
                           +   + +R  +      P   SD A DL+ +LL  +P+ R  A
Sbjct: 232 PSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKA-SDDALDLLKKLLVFNPNKRLTA 289

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  113 bits (283), Expect = 4e-28
 Identities = 79/266 (29%), Positives = 135/266 (50%), Gaps = 26/266 (9%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS   V  A++  +G   A+K+MD   + K+ +   +  E +++    H  VV ++ +
Sbjct: 30  GEGSTGIVCIAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHQNVVEMYKS 86

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +     L++ +E  +GG L D I S+  L+E++       V+ AL Y+HS G+IHRDIK 
Sbjct: 87  YLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKS 145

Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
           +++LLT DG +K++DFG    +       +P      K  + VGT  ++ PEV++ +P  
Sbjct: 146 DSILLTLDGRVKLSDFGFCAQISKD----VP------KRKSLVGTPYWMAPEVISRTPYG 195

Query: 234 FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----IRFPNYFSDAARDLIDR 288
              D+W+LG  + +M+ G  P+   S     +R+  RD     ++  +  S   RD ++R
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--RDSPPPKLKNAHKISPVLRDFLER 253

Query: 289 LLDVDPSGRPGAGPGGYAVLKMHPFF 314
           +L  +P  R  A       L  HPF 
Sbjct: 254 MLTREPQERATAQE-----LLDHPFL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  112 bits (281), Expect = 5e-28
 Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 18/209 (8%)

Query: 97  IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS----KGHLSEDEARFYTA 152
           I+ +QL HP +VR + TF +   LY+ ++  EG  L +   S    K   +E+       
Sbjct: 61  IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120

Query: 153 EVVDALEYIH-SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDK 211
           ++V AL Y+H    ++HRD+ P N++L  D  + I DFG  K  Q       P +    K
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ-------PES----K 169

Query: 212 ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII--A 269
             + VGT  Y  PE++ + P     D+WA GC LYQM +   PF  T+   +  +I+   
Sbjct: 170 LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV 229

Query: 270 RDIRFPNYFSDAARDLIDRLLDVDPSGRP 298
            +      +S+   D+I   L  D   RP
Sbjct: 230 YEPLPEGMYSEDVTDVITSCLTPDAEARP 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  112 bits (280), Expect = 5e-28
 Identities = 76/272 (27%), Positives = 140/272 (51%), Gaps = 23/272 (8%)

Query: 50  GKIYGVGSYSKVVRAKKIDTGTVYALKIM--DKKFITKENKTAYVKLERIVLDQLDHPGV 107
           GK+ G G++ +V     +DTG   A K +  D +      + + ++ E  +L  L H  +
Sbjct: 7   GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66

Query: 108 VRLFFTFQD----TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           V+ +   +D    T +++M  E   GG + DQ+ + G L+E   R YT ++++ + Y+HS
Sbjct: 67  VQYYGCLRDRAEKTLTIFM--EYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS 124

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
             ++HRDIK  N+L  + G++K+ DFG+ K     R+  +  + +  ++ T  GT  ++ 
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASK-----RLQTICMSGTGIRSVT--GTPYWMS 177

Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--DIRFPNYFSDA 281
           PEV++        D+W+LGCT+ +ML+   P+ +        +I  +  + + P++ S+ 
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEH 237

Query: 282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 313
           ARD +  +  V+   RP A       L  HPF
Sbjct: 238 ARDFLGCIF-VEARHRPSAEE-----LLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  112 bits (280), Expect = 6e-28
 Identities = 76/263 (28%), Positives = 137/263 (52%), Gaps = 18/263 (6%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIM--DKKFITKENKTAYVKLERIVLDQLD 103
           ++ LGK+ G G++ +V      DTG   A+K +  D +      +   ++ E  +L  L 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 104 HPGVVRLFFTFQD----TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 159
           H  +V+ +   +D    T S++M  E   GG + DQ+ S G L+E+  R YT ++++ + 
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFM--EHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVS 120

Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           Y+HS  ++HRDIK  N+L  + G++K+ DFG+ K     R+  +  + +  K+ T  GT 
Sbjct: 121 YLHSNMIVHRDIKGANILRDSVGNVKLGDFGASK-----RLQTICLSGTGMKSVT--GTP 173

Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--DIRFPNY 277
            ++ PEV++        D+W++GCT+ +ML+   P+ +        +I  +  +   P +
Sbjct: 174 YWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPH 233

Query: 278 FSDAARDLIDRLLDVDPSGRPGA 300
            SD  RD + R+  V+   RP A
Sbjct: 234 VSDHCRDFLKRIF-VEAKLRPSA 255

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  112 bits (280), Expect = 6e-28
 Identities = 80/264 (30%), Positives = 127/264 (48%), Gaps = 19/264 (7%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P+E F+    +L +I G GS+ +V +     T  V A+KI+D +    E++   ++ E  
Sbjct: 2   PEELFT----KLERI-GKGSFGEVYKGIDNRTKEVVAIKIIDLE--EAEDEIEDIQQEIT 54

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           VL Q D P + R + ++     L++ +E   GG   D +   G L E        E++  
Sbjct: 55  VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKG 113

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           L+Y+HS   IHRDIK  N+LL+  G +K+ADFG    + D++I          K  TFVG
Sbjct: 114 LDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI----------KRNTFVG 163

Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-IRFPN 276
           T  ++ PEV+  S   F  D+W+LG T  ++  G  P  D     +   I          
Sbjct: 164 TPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEG 223

Query: 277 YFSDAARDLIDRLLDVDPSGRPGA 300
            +S   ++ ++  L+ DP  RP A
Sbjct: 224 QYSKPFKEFVEACLNKDPRFRPTA 247

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score =  110 bits (276), Expect = 1e-27
 Identities = 73/245 (29%), Positives = 121/245 (49%), Gaps = 22/245 (8%)

Query: 75  LKIMDKK----FITKE-NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG 129
           L +MD +    FI K   K++    ER+ +     P +V L        S+++ L+  EG
Sbjct: 10  LLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEG 69

Query: 130 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADF 189
           G+L+  I+   ++ E+  + + AE+V AL+ +H  G++ RD+ P N+LL   GHI++  F
Sbjct: 70  GKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYF 129

Query: 190 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQML 249
                ++DS          D +A   +    Y  PEV   S  T   D W+LG  L+++L
Sbjct: 130 SRWSEVEDS---------CDGEAVENM----YCAPEVGGISEETEACDWWSLGAILFELL 176

Query: 250 SGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLK 309
           +G +  +     +        +I  P + S+ AR L+ +LL  +P+ R GAG  G   +K
Sbjct: 177 TGKTLVECHPSGI--NTHTTLNI--PEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIK 232

Query: 310 MHPFF 314
            HPFF
Sbjct: 233 SHPFF 237

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score =  113 bits (285), Expect = 3e-27
 Identities = 85/270 (31%), Positives = 129/270 (47%), Gaps = 23/270 (8%)

Query: 36  RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFI--TKENKTAYVK 93
             P+EH  +    L  + G    +    A +   G+    K++  KF+    E + AY +
Sbjct: 62  NNPREHMYV----LTTLVGRNPTTAAFVATR---GSDPKEKVV-AKFVMLNDERQAAYAR 113

Query: 94  LERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS--KGHL--SEDEARF 149
            E   L   DH G+V+ F  F+    L + +E   GG+L  QI    K HL   E E   
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173

Query: 150 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 209
              ++V AL+ +HS  ++HRD+K  N+ L   G IK+ DFG  K   DS         S 
Sbjct: 174 LFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS--------VSL 225

Query: 210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII- 268
           D A +F GT  Y+ PE+      +   D+W+LG  LY++L+   PFK  S+  I Q+++ 
Sbjct: 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY 285

Query: 269 ARDIRFPNYFSDAARDLIDRLLDVDPSGRP 298
            +   FP   S   + L+D LL  +P+ RP
Sbjct: 286 GKYDPFPCPVSSGMKALLDPLLSKNPALRP 315

Length = 478

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score =  115 bits (289), Expect = 3e-27
 Identities = 51/148 (34%), Positives = 89/148 (60%)

Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           SI++F + K    G++ KV   +K +   +YA+K++ K  +  +N    V+ ER  L   
Sbjct: 2   SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS 61

Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
             P +V L+++ Q   ++Y+ +E   GG++   +   G+  E+ A  Y +EV  AL+Y+H
Sbjct: 62  KSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH 121

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFG 190
             G+IHRD+KP+N+L++ +GHIK+ DFG
Sbjct: 122 RHGIIHRDLKPDNMLISNEGHIKLTDFG 149

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  109 bits (275), Expect = 5e-27
 Identities = 88/302 (29%), Positives = 136/302 (45%), Gaps = 59/302 (19%)

Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGV 107
           LGKI G G++S+V++A+   TG  YA+K M K F + E        E   L +L  HP +
Sbjct: 4   LGKI-GEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR--EIQALRRLSPHPNI 60

Query: 108 VRLFFTFQD--TFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSM 164
           +RL     D  T  L +  E  +   L++ I   K  L E   + Y  +++ +L+++H  
Sbjct: 61  LRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+ HRDIKPEN+L+  D  +K+ADFGS + +  S+    P          ++ T  Y  P
Sbjct: 120 GIFHRDIKPENILIKDD-ILKLADFGSCRGI-YSK---PPYTE-------YISTRWYRAP 167

Query: 225 E-VLNSSPATFGNDLWALGCTLYQMLS------GT--------------SPFKDTSEWLI 263
           E +L         D+WA+GC  +++LS      GT              +P  D      
Sbjct: 168 ECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTP--DAEVLKK 225

Query: 264 FQRIIARDIRFPN-----------YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHP 312
           F++    +  FP+             S    DL+ +LL  DP  R  A       L+ HP
Sbjct: 226 FRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITA----KQALR-HP 280

Query: 313 FF 314
           +F
Sbjct: 281 YF 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  109 bits (273), Expect = 6e-27
 Identities = 81/274 (29%), Positives = 135/274 (49%), Gaps = 34/274 (12%)

Query: 44  IQDFELGKIYGVGSYSKVVRA------KKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           + +F++ K  G G +S+V RA      K +    V   ++MD K   +++    + L   
Sbjct: 1   LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAK--ARQDCVKEIDL--- 55

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT----SKGHLSEDEARFYTAE 153
            L QL+HP V++   +F +   L + LE  + G+L   I      K  + E     Y  +
Sbjct: 56  -LKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQ 114

Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           +  A+E++HS  ++HRDIKP N+ +TA G +K+ D G +     S+ T          A 
Sbjct: 115 LCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLG-LGRFFSSKTTA---------AH 164

Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL--IFQRIIARD 271
           + VGT  Y+ PE ++ +   F +D+W+LGC LY+M +  SPF      L  + Q+I   D
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD 224

Query: 272 IRFP----NYFSDAARDLIDRLLDVDPSGRPGAG 301
             +P     ++S+  R+L+   +  DP  RP  G
Sbjct: 225 --YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIG 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  108 bits (271), Expect = 1e-26
 Identities = 82/268 (30%), Positives = 130/268 (48%), Gaps = 27/268 (10%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P+E F+    +L +I G GS+ +V +     T  V A+KI+D +    E++   ++ E  
Sbjct: 2   PEELFT----KLERI-GKGSFGEVFKGIDNRTQQVVAIKIIDLE--EAEDEIEDIQQEIT 54

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           VL Q D P V + + ++     L++ +E   GG   D + + G   E +      E++  
Sbjct: 55  VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKG 113

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           L+Y+HS   IHRDIK  N+LL+  G +K+ADFG    + D++I          K  TFVG
Sbjct: 114 LDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI----------KRNTFVG 163

Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP-- 275
           T  ++ PEV+  S      D+W+LG T  ++  G  P  D        R++    +    
Sbjct: 164 TPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP----MRVLFLIPKNNPP 219

Query: 276 ---NYFSDAARDLIDRLLDVDPSGRPGA 300
                FS   ++ ID  L+ DPS RP A
Sbjct: 220 TLTGEFSKPFKEFIDACLNKDPSFRPTA 247

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  109 bits (275), Expect = 1e-26
 Identities = 81/323 (25%), Positives = 131/323 (40%), Gaps = 81/323 (25%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALK--------IMDKKFITKENKTAYVKLERIV 98
           +EL K  G G+Y  V  A    TG   A+K        ++D K I +E     +KL    
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILRE-----IKL---- 52

Query: 99  LDQLDHPGVVRLFFTF----QDTFS-LYMALESCEGGELFDQ-----ITSKGHLSEDEAR 148
           L  L H  ++ L         + F+ +Y+  E      L +      I S   L++D  +
Sbjct: 53  LRHLRHENIIGLLDILRPPSPEDFNDVYIVTE------LMETDLHKVIKSPQPLTDDHIQ 106

Query: 149 FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 208
           ++  +++  L+Y+HS  +IHRD+KP N+L+ ++  +KI DFG       +R         
Sbjct: 107 YFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGL------ARGVDPDEDEK 160

Query: 209 DDKACT-FVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW----L 262
                T +V T  Y  PE+ L+SS  T   D+W++GC   ++L+    F          L
Sbjct: 161 GFL--TEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNL 218

Query: 263 IF-----------QRII---------------ARDI--RFPNYFSDAARDLIDRLLDVDP 294
           I            + I                 + +   FP   S  A DL++++L  DP
Sbjct: 219 IVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGA-SPEAIDLLEKMLVFDP 277

Query: 295 SGRPGAGPGGYAVLKMHPFFKGI 317
             R  A       L  HP+   +
Sbjct: 278 KKRITAD----EALA-HPYLAQL 295

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  107 bits (270), Expect = 3e-26
 Identities = 82/292 (28%), Positives = 134/292 (45%), Gaps = 48/292 (16%)

Query: 48  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL---ERIVLDQLDH 104
           EL ++ G G+   V + +  +TG ++ALK      IT +      K    E  +      
Sbjct: 5   ELSRL-GEGAGGSVTKCRLKNTGMIFALKT-----ITTDPNPDLQKQILRELEINKSCKS 58

Query: 105 PGVVRLFFTFQD--TFSLYMALESCEGGEL---FDQITSKGHLSEDEARFYTAE-VVDAL 158
           P +V+ +  F D  + S+ +A+E CEGG L   + ++  +G    ++     AE V+  L
Sbjct: 59  PYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGL 118

Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
            Y+HS  +IHRDIKP N+LLT  G +K+ DFG            +     +  A TF GT
Sbjct: 119 SYLHSRKIIHRDIKPSNILLTRKGQVKLCDFG------------VSGELVNSLAGTFTGT 166

Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF-KDTSEWLIFQRIIARDIRFPN- 276
           + Y+ PE +   P +  +D+W+LG TL ++     PF  +    L    +++  +  PN 
Sbjct: 167 SFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNP 226

Query: 277 ----------YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM--HPFFKG 316
                      +S+  +D I + L+ DP+ RP           M  HP+ K 
Sbjct: 227 ELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPW-------DMLEHPWIKA 271

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  106 bits (267), Expect = 3e-26
 Identities = 74/257 (28%), Positives = 123/257 (47%), Gaps = 22/257 (8%)

Query: 54  GVGSYSKV--VRAKKIDTGTVYALKIMDKKFI--TKENKTAYVKLERIVLDQLDHPGVVR 109
           G GS+  V  V+ KK        LK++ +  +     N+T     E  +L +LDHP +V+
Sbjct: 9   GKGSFGTVYLVKDKKAVAEE--RLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66

Query: 110 LFFTFQDTFSLYMALESCEGGELFDQITSKGH----LSEDEARFYTAEVVDALEYIHSMG 165
              +F +  +  +  E CEG +L  ++    H    LSE++   +  +++  + Y+H   
Sbjct: 67  FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR 126

Query: 166 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 225
           ++HRD+K +N+ L  +  +KI DFG       SR+ +     S D A TF GT  Y+ PE
Sbjct: 127 ILHRDLKAKNIFLK-NNLLKIGDFGV------SRLLM----GSCDLATTFTGTPYYMSPE 175

Query: 226 VLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-RFPNYFSDAARD 284
            L        +D+W+LGC LY+M      F+  +   +  RI+       P  +S     
Sbjct: 176 ALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNS 235

Query: 285 LIDRLLDVDPSGRPGAG 301
           ++  +L+ DPS RP A 
Sbjct: 236 IMQSMLNKDPSLRPSAA 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  107 bits (269), Expect = 4e-26
 Identities = 89/304 (29%), Positives = 133/304 (43%), Gaps = 61/304 (20%)

Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL---ERIVLDQLDHP 105
           LG + G GSY  V++ K  +TG + A+K    KF+  E+     K+   E  +L QL H 
Sbjct: 6   LGLV-GEGSYGMVMKCKHKETGQIVAIK----KFLESEDDKMVKKIAMREIRMLKQLRHE 60

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 165
            +V L   F+    LY+  E  +   L D       L E   R Y  +++  +E+ HS  
Sbjct: 61  NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN 120

Query: 166 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT-FVGTAAYVPP 224
           +IHRDIKPEN+L++  G +K+ DFG  + +           A+  +  T +V T  Y  P
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTL-----------AAPGEVYTDYVATRWYRAP 169

Query: 225 EVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSE------------------WLIF 264
           E+L      +G   D+WA+GC + +ML+G   F   S+                    IF
Sbjct: 170 ELLVGDT-KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF 228

Query: 265 QR--------------IIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM 310
           Q+              I   + RFP   S    DL  + L +DP  RP +     + L  
Sbjct: 229 QKNPLFAGMRLPEVKEIEPLEKRFPK-LSGLVLDLAKQCLRIDPDDRPSS-----SQLLH 282

Query: 311 HPFF 314
           H FF
Sbjct: 283 HEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  106 bits (265), Expect = 7e-26
 Identities = 78/261 (29%), Positives = 130/261 (49%), Gaps = 28/261 (10%)

Query: 52  IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL-DQLDHPGVVRL 110
           + G G+Y  V  A+ + T     ++I  K+   ++++      E I L   L H  +V+ 
Sbjct: 15  VLGKGTYGIVYAARDLST----QVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQY 70

Query: 111 F--FTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEA--RFYTAEVVDALEYIHSMG 165
               +    F ++M  E   GG L   + SK G L ++E    FYT ++++ L+Y+H   
Sbjct: 71  LGSDSENGFFKIFM--EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ 128

Query: 166 LIHRDIKPENLLL-TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           ++HRDIK +N+L+ T  G +KI+DFG+ K +          A  +    TF GT  Y+ P
Sbjct: 129 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL----------AGINPCTETFTGTLQYMAP 178

Query: 225 EVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSE--WLIFQRIIARD-IRFPNYFS 279
           EV++  P  +G   D+W+LGCT+ +M +G  PF +  E    +F+  + +     P   S
Sbjct: 179 EVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLS 238

Query: 280 DAARDLIDRLLDVDPSGRPGA 300
             A++ I R  + DP  R  A
Sbjct: 239 AEAKNFILRCFEPDPDKRASA 259

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  106 bits (266), Expect = 7e-26
 Identities = 85/297 (28%), Positives = 146/297 (49%), Gaps = 36/297 (12%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P+E + I    +G++ G G++ KV +A+  +TG + A K++D K  ++E    Y+ +E  
Sbjct: 3   PEEFWEI----IGEL-GDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYM-VEID 54

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVV 155
           +L   DHP +V+L   F    +L++ +E C GG + D +  +    L+E + R    + +
Sbjct: 55  ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTL 113

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACT 214
           +AL Y+H   +IHRD+K  N+L T DG IK+ADFG S K           N  +  +  +
Sbjct: 114 EALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAK-----------NTRTIQRRDS 162

Query: 215 FVGTAAYVPPEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA 269
           F+GT  ++ PEV+        P  +  D+W+LG TL +M     P  + +   +  +I  
Sbjct: 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAK 222

Query: 270 RD---IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR 323
            +   +  P+ +S   +D + + L+ +   R          L  HPF      K IR
Sbjct: 223 SEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTT-----TQLLQHPFVTVNSNKPIR 274

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  106 bits (266), Expect = 7e-26
 Identities = 76/268 (28%), Positives = 123/268 (45%), Gaps = 28/268 (10%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G+   V  A  + TG   A+K M+   + ++ K   +  E +V+ +  HP +V    +
Sbjct: 28  GQGASGTVYTAIDVATGQEVAIKQMN---LQQQPKKELIINEILVMRENKHPNIVNYLDS 84

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +     L++ +E   GG L D +T +  + E +      E + ALE++HS  +IHRDIK 
Sbjct: 85  YLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKS 143

Query: 174 ENLLLTADGHIKIADFG---SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 230
           +N+LL  DG +K+ DFG    + P Q  R              T VGT  ++ PEV+   
Sbjct: 144 DNILLGMDGSVKLTDFGFCAQITPEQSKR-------------STMVGTPYWMAPEVVTRK 190

Query: 231 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFSDAARDLID 287
                 D+W+LG    +M+ G  P+ + +       I      +++ P   S   RD ++
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 250

Query: 288 RLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
           R L++D   R  A       L  HPF K
Sbjct: 251 RCLEMDVEKRGSAKE-----LLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  106 bits (265), Expect = 1e-25
 Identities = 76/282 (26%), Positives = 129/282 (45%), Gaps = 37/282 (13%)

Query: 48  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV 107
           ELGK    G+Y  V +     TG   A+K  + +    E+K   + +E  +L +   P +
Sbjct: 8   ELGK----GNYGSVYKVLHRPTGVTMAMK--EIRLELDESKFNQIIMELDILHKAVSPYI 61

Query: 108 VRLFFTFQDTFSLYMALESCEGG---ELFDQITSKGHLSEDEARFYTAEVVDALEYI-HS 163
           V  +  F    ++YM +E  + G   +L+    +   + ED  R  T  VV  L+++   
Sbjct: 62  VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
             +IHRD+KP N+L+  +G +K+ DFG    +  S             A T +G  +Y+ 
Sbjct: 122 HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL------------AKTNIGCQSYMA 169

Query: 224 PEVLNSSPA------TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA----RDIR 273
           PE + S         T  +D+W+LG ++ +M  G  P+   +   IF ++ A        
Sbjct: 170 PERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPT 229

Query: 274 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
            P+ +SD A+D + + L+  P+ RP      YA L  HP+  
Sbjct: 230 LPSGYSDDAQDFVAKCLNKIPNRRP-----TYAQLLEHPWLV 266

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  106 bits (265), Expect = 1e-25
 Identities = 80/267 (29%), Positives = 132/267 (49%), Gaps = 26/267 (9%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS   V  A +  TG   A+K MD   + K+ +   +  E +++    H  VV ++ +
Sbjct: 31  GEGSTGIVCIATEKHTGKQVAVKKMD---LRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +     L++ +E  EGG L D I +   ++E++       V+ AL Y+H+ G+IHRDIK 
Sbjct: 88  YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKS 146

Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
           +++LLT+DG IK++DFG    +       +P      K  + VGT  ++ PEV++  P  
Sbjct: 147 DSILLTSDGRIKLSDFGFCAQVSKE----VP------KRKSLVGTPYWMAPEVISRLPYG 196

Query: 234 FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----IRFPNYFSDAARDLIDR 288
              D+W+LG  + +M+ G  P+ +       +RI  RD     ++  +  S   R  +D 
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI--RDNLPPRVKDSHKVSSVLRGFLDL 254

Query: 289 LLDVDPSGRPGAGPGGYAVLKMHPFFK 315
           +L  +PS R  A       L  HPF K
Sbjct: 255 MLVREPSQRATA-----QELLQHPFLK 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  105 bits (262), Expect = 2e-25
 Identities = 79/264 (29%), Positives = 129/264 (48%), Gaps = 19/264 (7%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P+E F+    +L KI G GS+ +V +     T  V A+KI+D +    E++   ++ E  
Sbjct: 2   PEELFT----KLEKI-GKGSFGEVFKGIDNRTQKVVAIKIIDLE--EAEDEIEDIQQEIT 54

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           VL Q D P V + + ++     L++ +E   GG   D +   G L E +      E++  
Sbjct: 55  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKG 113

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           L+Y+HS   IHRDIK  N+LL+  G +K+ADFG    + D++I          K  TFVG
Sbjct: 114 LDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI----------KRNTFVG 163

Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-IRFPN 276
           T  ++ PEV+  S      D+W+LG T  ++  G  P  +     +   I   +      
Sbjct: 164 TPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEG 223

Query: 277 YFSDAARDLIDRLLDVDPSGRPGA 300
            +S   ++ ++  L+ +PS RP A
Sbjct: 224 NYSKPLKEFVEACLNKEPSFRPTA 247

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  105 bits (264), Expect = 2e-25
 Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 40/290 (13%)

Query: 42  FSIQDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 100
             + D E LG+I G G+  +V + +   TG V A+K M +    +ENK   + L+ +VL 
Sbjct: 12  ADLNDLENLGEI-GSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLD-VVLK 69

Query: 101 QLDHPGVVRLFFTFQDTFSLYMALE---SCEGGELFDQIT--SKGHLSEDEARFYTAEVV 155
             D P +V+ +  F     +++ +E   +C      D++    +G + ED     T  +V
Sbjct: 70  SHDCPYIVKCYGYFITDSDVFICMELMSTC-----LDKLLKRIQGPIPEDILGKMTVAIV 124

Query: 156 DALEYI-HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
            AL Y+    G+IHRD+KP N+LL A G++K+ DFG    + DS+      A +    C 
Sbjct: 125 KALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK------AKTRSAGC- 177

Query: 215 FVGTAAYVPPEVLNSSPATFGN-----DLWALGCTLYQMLSGTSPFKD-TSEWLIFQRII 268
               AAY+ PE +   P          D+W+LG +L ++ +G  P+K+  +E+ +  +I+
Sbjct: 178 ----AAYMAPERI-DPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL 232

Query: 269 ARDIRFPNY---FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
             +         FS      +D  L  D   RP      Y  L  HPF +
Sbjct: 233 QEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRP-----KYRELLQHPFIR 277

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  104 bits (261), Expect = 2e-25
 Identities = 70/225 (31%), Positives = 113/225 (50%), Gaps = 21/225 (9%)

Query: 36  RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE 95
           R PQ      D+EL +  G G+Y  V +A+ + TG + A+KI+    +   +  + ++ E
Sbjct: 5   RNPQ-----HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIK---LEPGDDFSLIQQE 56

Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
             ++ +  H  +V  F ++     L++ +E C GG L D     G LSE +  +   E +
Sbjct: 57  IFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL 116

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
             L Y+HS G +HRDIK  N+LLT +G +K+ADFG       ++IT     A+  K  +F
Sbjct: 117 QGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVA-----AKIT-----ATIAKRKSF 166

Query: 216 VGTAAYVPPEVLNSSPATFGN---DLWALGCTLYQMLSGTSPFKD 257
           +GT  ++ PEV         N   D+WA+G T  ++     P  D
Sbjct: 167 IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFD 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  104 bits (260), Expect = 3e-25
 Identities = 77/276 (27%), Positives = 138/276 (50%), Gaps = 23/276 (8%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIM----DKKFITKENKTAYVKLERIVLDQ 101
           ++ LGK+ G G++ +V      DTG   A+K +    D +  +KE      +++  +L  
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQ--LLKN 60

Query: 102 LDHPGVVRLFFTFQD--TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 159
           L H  +V+ +   +D     L + +E   GG + DQ+ + G L+E+  R YT +++  + 
Sbjct: 61  LRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVS 120

Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           Y+HS  ++HRDIK  N+L  + G++K+ DFG+ K     RI  +  + +  K+ T  GT 
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGASK-----RIQTICMSGTGIKSVT--GTP 173

Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI--RFPNY 277
            ++ PEV++        D+W++ CT+ +ML+   P+ +        +I  +      P+ 
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDG 233

Query: 278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 313
            SDA RD + ++  V+   RP         L  HPF
Sbjct: 234 VSDACRDFLKQIF-VEEKRRP-----TAEFLLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score =  104 bits (261), Expect = 4e-25
 Identities = 67/268 (25%), Positives = 113/268 (42%), Gaps = 36/268 (13%)

Query: 56  GSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTF 114
           G + KV   K   T  ++  KI+  K         +  +E +V   + D+P  ++L+++ 
Sbjct: 27  GKFGKVSVLKHKPTQKLFVQKIIKAK--------NFNAIEPMVHQLMKDNPNFIKLYYSV 78

Query: 115 Q--DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIK 172
                  L M  +  + G+LFD +  +G LSE E +    ++V+AL  +H   +IH DIK
Sbjct: 79  TTLKGHVLIM--DYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIK 136

Query: 173 PENLLLT-ADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP 231
            EN+L   A   I + D+G  K +                   + GT  Y  PE +    
Sbjct: 137 LENVLYDRAKDRIYLCDYGLCKII--------------GTPSCYDGTLDYFSPEKIKGHN 182

Query: 232 ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLI----FQRIIARDIRFPNYFSDAARDLID 287
                D WA+G   Y++L+G  PFK+  +  +      +   + + F    S  A D + 
Sbjct: 183 YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQ 242

Query: 288 RLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
            +L  + + R       Y  +  HPF K
Sbjct: 243 SMLKYNINYRLTN----YNEIIKHPFLK 266

Length = 267

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  102 bits (257), Expect = 9e-25
 Identities = 60/271 (22%), Positives = 111/271 (40%), Gaps = 44/271 (16%)

Query: 48  ELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKENKTAYVKL----ERIVL 99
            LGK  G G++ +V + K            A+K +      KE+ +         E  ++
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL------KEDASEQQIEEFLREARIM 55

Query: 100 DQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDA 157
            +LDHP VV+L     ++   LY+ +E  EGG+L   +  ++  LS  +   +  ++   
Sbjct: 56  RKLDHPNVVKLLGVCTEEE-PLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARG 114

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFG--------SVKPMQDSRITVLPNAASD 209
           +EY+ S   IHRD+   N L+  +  +KI+DFG             +  ++ +       
Sbjct: 115 MEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPI------- 167

Query: 210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII 268
                      ++ PE L     T  +D+W+ G  L+++ + G  P+   S   + + + 
Sbjct: 168 ----------RWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLK 217

Query: 269 ARD-IRFPNYFSDAARDLIDRLLDVDPSGRP 298
               +  P        DL+ +    DP  RP
Sbjct: 218 NGYRLPQPPNCPPELYDLMLQCWAEDPEDRP 248

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  102 bits (257), Expect = 2e-24
 Identities = 85/312 (27%), Positives = 131/312 (41%), Gaps = 61/312 (19%)

Query: 43  SIQDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALKI--MDKKFITKENKTAYVKLERIVL 99
           S+ +FE L +I G G+Y  V RA+   +G + ALK   MD +   ++        E  +L
Sbjct: 5   SVTEFEKLNRI-GEGTYGIVYRARDTTSGEIVALKKVRMDNE---RDGIPISSLREITLL 60

Query: 100 DQLDHPGVVRL--FFTFQDTFSLYMALESCEG--GELFDQITSKGHLSEDEARFYTAEVV 155
             L HP +V L      +   S+++ +E CE     L D + +    SE + +    +++
Sbjct: 61  LNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLL 118

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
             L+Y+H   +IHRD+K  NLLLT  G +KIADFG  +        + P           
Sbjct: 119 RGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPK---------- 168

Query: 216 VGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE-------------- 260
           V T  Y  PE+L   +  T   D+WA+GC L ++L+        SE              
Sbjct: 169 VVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTP 228

Query: 261 ----WLIF------QRIIARD-------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPG 303
               W  F       +             +FP + S+A   L++ LL  DP  R  A   
Sbjct: 229 NESIWPGFSDLPLVGKFTLPKQPYNNLKHKFP-WLSEAGLRLLNFLLMYDPKKRATAE-- 285

Query: 304 GYAVLKMHPFFK 315
               L+   +FK
Sbjct: 286 --EALE-SSYFK 294

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  102 bits (255), Expect = 3e-24
 Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 27/211 (12%)

Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL---ERIVLDQLDHP 105
           L KI G GSY  V + +  +TG + A+K    KF+  E+     K+   E  +L QL HP
Sbjct: 6   LSKI-GEGSYGVVFKCRNRETGQIVAIK----KFVESEDDPVIKKIALREIRMLKQLKHP 60

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 165
            +V L   F+    L++  E C+   L +   +   + E   +    + + A+ + H   
Sbjct: 61  NLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN 120

Query: 166 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 225
            IHRD+KPEN+L+T  G IK+ DFG       +RI   P     D    +V T  Y  PE
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGF------ARILTGPGDDYTD----YVATRWYRAPE 170

Query: 226 VL-----NSSPATFGNDLWALGCTLYQMLSG 251
           +L        P     D+WA+GC   ++L+G
Sbjct: 171 LLVGDTQYGPPV----DVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  100 bits (252), Expect = 4e-24
 Identities = 55/268 (20%), Positives = 110/268 (41%), Gaps = 37/268 (13%)

Query: 48  ELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
            LGK  G G++ +V +              A+K + K+  +++    +++ E  ++ +LD
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDASEQQIEEFLR-EARIMRKLD 59

Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEY 160
           HP +V+L     ++   L + +E   GG+L D +       LS  +   +  ++   +EY
Sbjct: 60  HPNIVKLLGVCTEEE-PLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118

Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFG--------SVKPMQDSRITVLPNAASDDKA 212
           + S   IHRD+   N L+  +  +KI+DFG            ++  ++ +          
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPI---------- 168

Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD 271
                   ++ PE L     T  +D+W+ G  L+++ + G  P+   S   + + +    
Sbjct: 169 -------RWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGY 221

Query: 272 IR-FPNYFSDAARDLIDRLLDVDPSGRP 298
               P         L+ +    DP  RP
Sbjct: 222 RLPKPPNCPPELYKLMLQCWAEDPEDRP 249

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  100 bits (250), Expect = 1e-23
 Identities = 84/293 (28%), Positives = 135/293 (46%), Gaps = 34/293 (11%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G+   V  A  + TG   A+K ++   + K+ K   +  E +V+ +L +P +V    +
Sbjct: 28  GQGASGTVFTAIDVATGQEVAIKQIN---LQKQPKKELIINEILVMKELKNPNIVNFLDS 84

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTA--EVVDALEYIHSMGLIHRDI 171
           F     L++ +E   GG L D +T       DEA+      E + ALE++H+  +IHRDI
Sbjct: 85  FLVGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDI 141

Query: 172 KPENLLLTADGHIKIADFG---SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN 228
           K +N+LL  DG +K+ DFG    + P Q  R              T VGT  ++ PEV+ 
Sbjct: 142 KSDNVLLGMDGSVKLTDFGFCAQITPEQSKR-------------STMVGTPYWMAPEVVT 188

Query: 229 SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFSDAARDL 285
                   D+W+LG    +M+ G  P+ + +       I      +++ P   S   RD 
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDF 248

Query: 286 IDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQS 338
           ++R L++D   R     G    L  HPF K    K +   TP  LA++  ++S
Sbjct: 249 LNRCLEMDVEKR-----GSAKELLQHPFLKLA--KPLSSLTPLILAAKEAMKS 294

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 99.3 bits (247), Expect = 3e-23
 Identities = 68/228 (29%), Positives = 116/228 (50%), Gaps = 34/228 (14%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           FEL ++ G G+Y +V + + + TG + A+K+MD      E++   +KLE  +L +  H  
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSHH- 72

Query: 107 VVRLFFTFQDTF----------SLYMALESCEGGELFDQI-TSKGH-LSEDEARFYTAEV 154
             R   T+   F           L++ +E C  G + D +  +KG+ L ED   +   E+
Sbjct: 73  --RNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREI 130

Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           +  L ++H+  +IHRDIK +N+LLT +  +K+ DFG V    D  +          +  T
Sbjct: 131 LRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFG-VSAQLDRTV---------GRRNT 180

Query: 215 FVGTAAYVPPEVL--NSSPAT---FGNDLWALGCTLYQMLSGTSPFKD 257
           F+GT  ++ PEV+  + +P     + +D+W+LG T  +M  G  P  D
Sbjct: 181 FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD 228

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  100 bits (250), Expect = 3e-23
 Identities = 88/305 (28%), Positives = 134/305 (43%), Gaps = 69/305 (22%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF- 111
           G G+Y +V  A    TG   A+K + + F +  + K  Y +L   +L  +DH  V+ L  
Sbjct: 24  GSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELR--LLKHMDHENVIGLLD 81

Query: 112 -FT-------FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            FT       FQD   L   L    G +L + I     LS+D  +F   +++  L+YIHS
Sbjct: 82  VFTPASSLEDFQD-VYLVTHLM---GADL-NNIVKCQKLSDDHIQFLVYQILRGLKYIHS 136

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
            G+IHRD+KP N+ +  D  +KI DFG       +R T       DD+   +V T  Y  
Sbjct: 137 AGIIHRDLKPSNIAVNEDCELKILDFGL------ARHT-------DDEMTGYVATRWYRA 183

Query: 224 PEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDT----------------SEWLIFQR 266
           PE+ LN        D+W++GC + ++L+G + F  +                 E L+ Q+
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL-QK 242

Query: 267 IIARDIR-------------FPNYFSDA---ARDLIDRLLDVDPSGRPGAGPGGYAVLKM 310
           I +   R             F   FS A   A DL++++L +DP  R  A          
Sbjct: 243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEA-----LA 297

Query: 311 HPFFK 315
           HP+  
Sbjct: 298 HPYLA 302

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score =  101 bits (254), Expect = 4e-23
 Identities = 73/266 (27%), Positives = 129/266 (48%), Gaps = 22/266 (8%)

Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           + ++ G G+   V+ AK++  G  +A+K++D + +++ +K    + E   L   D   +V
Sbjct: 36  ISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNR-AQAEVCCLLNCDFFSIV 94

Query: 109 RLF--FTFQD------TFSLYMALESCEGGELFDQITSKGHLS----EDEARFYTAEVVD 156
           +    F  +D         + + L+    G+L  +I S+   +    E EA     +V+ 
Sbjct: 95  KCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLL 154

Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           A+ ++HS  +IHRDIK  N+LL ++G +K+ DFG  K        +     SDD   TF 
Sbjct: 155 AVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK--------MYAATVSDDVGRTFC 206

Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA-RDIRFP 275
           GT  YV PE+    P +   D+++LG  LY++L+   PF   +   +  + +A R    P
Sbjct: 207 GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLP 266

Query: 276 NYFSDAARDLIDRLLDVDPSGRPGAG 301
              S   ++++  LL  DP  RP + 
Sbjct: 267 PSISPEMQEIVTALLSSDPKRRPSSS 292

Length = 496

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 99.0 bits (246), Expect = 4e-23
 Identities = 75/268 (27%), Positives = 122/268 (45%), Gaps = 28/268 (10%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G+   V  A  I TG   A+K M+   + ++ K   +  E +V+ +  +P +V    +
Sbjct: 28  GQGASGTVYTAIDIATGQEVAIKQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDS 84

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +     L++ +E   GG L D +T    + E +      E + AL+++HS  +IHRDIK 
Sbjct: 85  YLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALDFLHSNQVIHRDIKS 143

Query: 174 ENLLLTADGHIKIADFG---SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 230
           +N+LL  DG +K+ DFG    + P Q  R              T VGT  ++ PEV+   
Sbjct: 144 DNILLGMDGSVKLTDFGFCAQITPEQSKR-------------STMVGTPYWMAPEVVTRK 190

Query: 231 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFSDAARDLID 287
                 D+W+LG    +M+ G  P+ + +       I      +++ P   S   RD ++
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLN 250

Query: 288 RLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
           R L++D   R     G    L  HPF K
Sbjct: 251 RCLEMDVDRR-----GSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 98.6 bits (245), Expect = 5e-23
 Identities = 76/266 (28%), Positives = 130/266 (48%), Gaps = 26/266 (9%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS   V  A    +G + A+K MD   + K+ +   +  E +++    H  VV ++ +
Sbjct: 29  GEGSTGIVCIATVKSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +     L++ +E  EGG L D I +   ++E++       V+ AL  +H+ G+IHRDIK 
Sbjct: 86  YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKS 144

Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
           +++LLT DG +K++DFG    +       +P   S       VGT  ++ PE+++  P  
Sbjct: 145 DSILLTHDGRVKLSDFGFCAQVSKE----VPRRKS------LVGTPYWMAPELISRLPYG 194

Query: 234 FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----IRFPNYFSDAARDLIDR 288
              D+W+LG  + +M+ G  P+ +       + I  RD     ++  +  S + +  +DR
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI--RDNLPPKLKNLHKVSPSLKGFLDR 252

Query: 289 LLDVDPSGRPGAGPGGYAVLKMHPFF 314
           LL  DP+ R  A     A L  HPF 
Sbjct: 253 LLVRDPAQRATA-----AELLKHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 96.1 bits (239), Expect = 2e-22
 Identities = 74/260 (28%), Positives = 124/260 (47%), Gaps = 17/260 (6%)

Query: 50  GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTA----YVKLERIV--LDQLD 103
           G++ G G+Y  V      + G + A+K ++   +   N  A    Y KL+  V  L  L 
Sbjct: 5   GEVLGKGAYGTVY-CGLTNQGQLIAVKQVE---LDTSNVLAAEKEYEKLQEEVDLLKSLK 60

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           H  +V+   T  D  ++ + +E   GG +   +   G L E     YT +++D + Y+H+
Sbjct: 61  HVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN 120

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
             ++HRDIK  N++L  +G IK+ DFG  + +      V  +    +   +  GT  ++ 
Sbjct: 121 NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL----AWVGLHGTHSNMLKSMHGTPYWMA 176

Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQRIIARDI--RFPNYFSD 280
           PEV+N S     +D+W++GCT+++M +G  P         +F     R +  R P+ FS 
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSA 236

Query: 281 AARDLIDRLLDVDPSGRPGA 300
           AA D +   L  D   RP A
Sbjct: 237 AAIDFVTSCLTRDQHERPSA 256

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 96.7 bits (241), Expect = 4e-22
 Identities = 79/298 (26%), Positives = 122/298 (40%), Gaps = 63/298 (21%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDT--GTVYALK----IMDKKFITKENKTAYVKLERIVLD 100
           +EL K  G G+Y  V  A+  +T      A+K    +  KK + K        L  + L 
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKR------ALRELKLL 55

Query: 101 QL--DHPGVVRLF---FTFQDTFS---LYMALESCEGGELFDQITSKGHLSEDEARFYTA 152
           +    H  +  L+     F   F+   LY  L   +   L   I S   L++   + +  
Sbjct: 56  RHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEAD---LHQIIRSGQPLTDAHFQSFIY 112

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           +++  L+YIHS  ++HRD+KP NLL+ AD  +KI DFG  +           N   +   
Sbjct: 113 QILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS-------ENPGENAGF 165

Query: 213 CT-FVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFK--DTSEWL------ 262
            T +V T  Y  PE+ L+    T   D+W++GC L ++L     FK  D  + L      
Sbjct: 166 MTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQV 225

Query: 263 -------IFQRI-------------IARDIRFPNYFSDA---ARDLIDRLLDVDPSGR 297
                     RI                   F + F +A   A DL+++LL  DP+ R
Sbjct: 226 LGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKR 283

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 95.6 bits (238), Expect = 4e-22
 Identities = 82/296 (27%), Positives = 137/296 (46%), Gaps = 40/296 (13%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL---ERIVLDQ 101
           +D E     G G+   V + K I TGTV     M KK +    K++  K    E  ++ +
Sbjct: 5   EDLETISDLGAGNGGSVSKVKHIPTGTV-----MAKKVVHIGAKSSVRKQILRELQIMHE 59

Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEY 160
              P +V  +  F +  ++ M +E  + G L D+I  K G +  +        VV+ L Y
Sbjct: 60  CRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTY 118

Query: 161 IHSM-GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           ++++  ++HRDIKP N+L+ + G IK+ DFG            L N+ +D    TFVGT+
Sbjct: 119 LYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGE--------LINSIAD----TFVGTS 166

Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL-----------IFQRII 268
            Y+ PE +     T  +D+W+LG ++ ++  G  PF  ++              + Q+I+
Sbjct: 167 TYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV 226

Query: 269 ARDI-RFP-NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 322
                R P + F +  RD +D  L  DP+ RP        +  M PF + +   N+
Sbjct: 227 QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQ----QLCAMPPFIQALRASNV 278

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 95.2 bits (236), Expect = 9e-22
 Identities = 74/268 (27%), Positives = 121/268 (45%), Gaps = 28/268 (10%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G+   V  A  + TG   A++ M+   + ++ K   +  E +V+ +  +P +V    +
Sbjct: 29  GQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +     L++ +E   GG L D +T    + E +      E + ALE++HS  +IHRDIK 
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIHRDIKS 144

Query: 174 ENLLLTADGHIKIADFG---SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 230
           +N+LL  DG +K+ DFG    + P Q  R              T VGT  ++ PEV+   
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITPEQSKR-------------STMVGTPYWMAPEVVTRK 191

Query: 231 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFSDAARDLID 287
                 D+W+LG    +M+ G  P+ + +       I      +++ P   S   RD ++
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251

Query: 288 RLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
           R LD+D   R     G    L  H F K
Sbjct: 252 RCLDMDVEKR-----GSAKELLQHQFLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 95.8 bits (239), Expect = 1e-21
 Identities = 63/191 (32%), Positives = 88/191 (46%), Gaps = 41/191 (21%)

Query: 141 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 200
           HLS D  +++  +++  L+YIHS  ++HRD+KP NLLL  +  +KI DFG       +RI
Sbjct: 102 HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGL------ARI 155

Query: 201 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF--KD 257
              P          +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F  KD
Sbjct: 156 AD-PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD 214

Query: 258 TSE--WLIFQ-----------RII---ARD-IR-------------FPNYFSDAARDLID 287
                 LI              II   AR+ I+             FPN     A DL+D
Sbjct: 215 YLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNA-DPKALDLLD 273

Query: 288 RLLDVDPSGRP 298
           ++L  +P  R 
Sbjct: 274 KMLTFNPHKRI 284

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 95.1 bits (237), Expect = 1e-21
 Identities = 81/317 (25%), Positives = 128/317 (40%), Gaps = 65/317 (20%)

Query: 47  FELGKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-VL 99
           F++G  Y      G G+Y  V  A    +G   A+K +   F       A   L  + +L
Sbjct: 1   FDVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVP--TLAKRTLRELKIL 58

Query: 100 DQLDHPGVVRL---FFTFQDTF-SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
               H  ++ +          F  +Y+ ++  E  +L   I S   L+E+  R++  +++
Sbjct: 59  RHFKHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLL 117

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
             L+YIHS  +IHRD+KP NLL+  D  ++I DFG  + +          ++S  +   F
Sbjct: 118 RGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGL----------SSSPTEHKYF 167

Query: 216 ----VGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTS--PFKDTSEWL------ 262
               V T  Y  PE+L S P  T   D+W++GC   +ML      P K+    L      
Sbjct: 168 MTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSV 227

Query: 263 -------IFQRIIARDIR-----FPN--------YFSDA---ARDLIDRLLDVDPSGRPG 299
                  +  RI +  +R      P          F  A   A DL+ ++L  DP  R  
Sbjct: 228 LGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERIT 287

Query: 300 AGPGGYAVLKMHPFFKG 316
                 A+   HPF   
Sbjct: 288 VEQ---ALQ--HPFLAQ 299

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 94.5 bits (235), Expect = 1e-21
 Identities = 82/310 (26%), Positives = 121/310 (39%), Gaps = 80/310 (25%)

Query: 39  QEHFSIQDFELGKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYV 92
            E FS  D E  K++      G GS+  V  A+ + T  V A+K M     +   K +  
Sbjct: 5   AELFSKDDPE--KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKM-----SYSGKQSNE 57

Query: 93  KLERIV-----LDQLDHPGVVRLFFTFQDTFSLYMALESCEG--GELFDQITSKGHLSED 145
           K + I+     L QL HP  +     +    + ++ +E C G   ++ +    K  L E 
Sbjct: 58  KWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEV 115

Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
           E        +  L Y+HS   IHRDIK  N+LLT  G +K+ADFGS              
Sbjct: 116 EIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGS-------------- 161

Query: 206 AASDDKACTFVGTAAYVPPEV---LNSSPATFGNDLWALGCT------------------ 244
           A+    A +FVGT  ++ PEV   ++        D+W+LG T                  
Sbjct: 162 ASLVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 221

Query: 245 -LYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPG 303
            LY +    SP   +++W                 SD  R+ +D  L   P  RP +   
Sbjct: 222 ALYHIAQNDSPTLSSNDW-----------------SDYFRNFVDSCLQKIPQDRPSS--- 261

Query: 304 GYAVLKMHPF 313
               L  H F
Sbjct: 262 --EELLKHRF 269

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 93.6 bits (232), Expect = 2e-21
 Identities = 71/228 (31%), Positives = 117/228 (51%), Gaps = 34/228 (14%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           FEL ++ G G+Y +V + + + TG + A+K+MD   +T + +   +K E  +L +  H  
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEE-IKQEINMLKKYSHH- 62

Query: 107 VVRLFFTFQDTF----------SLYMALESCEGGELFDQI-TSKGH-LSEDEARFYTAEV 154
             R   T+   F           L++ +E C  G + D I  +KG+ L E+   +   E+
Sbjct: 63  --RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 120

Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           +  L ++H   +IHRDIK +N+LLT +  +K+ DFG V    D  +          +  T
Sbjct: 121 LRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG-VSAQLDRTV---------GRRNT 170

Query: 215 FVGTAAYVPPEVL--NSSP-AT--FGNDLWALGCTLYQMLSGTSPFKD 257
           F+GT  ++ PEV+  + +P AT  F +DLW+LG T  +M  G  P  D
Sbjct: 171 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 218

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 96.1 bits (239), Expect = 5e-21
 Identities = 46/116 (39%), Positives = 65/116 (56%), Gaps = 8/116 (6%)

Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP 275
           +GT  Y+ PE+L   P     D WALG  L++ L+G  PF D +   +FQ I+ RDI +P
Sbjct: 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600

Query: 276 N---YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 328
                 S  A++ I+ LL +DP+ R G        LK HP F G+DW+N++ QT P
Sbjct: 601 EGEEKLSVNAQNAIEILLTMDPTKRAGLKE-----LKQHPLFHGVDWENLQNQTMP 651

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 92.3 bits (230), Expect = 7e-21
 Identities = 85/320 (26%), Positives = 131/320 (40%), Gaps = 77/320 (24%)

Query: 43  SIQDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKK---F-ITKENKTAYVKLE 95
           S+ ++E L +I   G+Y  V RA+   TG + ALK   M+K+   F IT         L 
Sbjct: 3   SVDEYEKLNRIEE-GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITS--------LR 53

Query: 96  RI-VLDQLDHPGVVRL----FFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARF 149
            I +L +L HP +V +      +  D   +YM +E  E  +L   + T K    + E + 
Sbjct: 54  EINILLKLQHPNIVTVKEVVVGSNLD--KIYMVMEYVEH-DLKSLMETMKQPFLQSEVKC 110

Query: 150 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 209
              +++  + ++H   ++HRD+K  NLLL   G +KI DFG  +                
Sbjct: 111 LMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQL---- 166

Query: 210 DKACTFVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSE------- 260
                 V T  Y  PE+L  +   +    D+W++GC   ++L+    F   SE       
Sbjct: 167 ------VVTLWYRAPELLLGAK-EYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKI 219

Query: 261 -----------WLIFQRIIA--------------RDIRFPNYF-SDAARDLIDRLLDVDP 294
                      W  F  +                R  +FP    SD   DL++RLL  DP
Sbjct: 220 FKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRK-KFPALSLSDNGFDLLNRLLTYDP 278

Query: 295 SGRPGAGPGGYAVLKMHPFF 314
           + R  A       LK HP+F
Sbjct: 279 AKRISA----EDALK-HPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 91.9 bits (229), Expect = 1e-20
 Identities = 89/307 (28%), Positives = 136/307 (44%), Gaps = 60/307 (19%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIM--DKKFITKE--NKTAYVKLERI-VLDQ 101
           +E GK  G G+Y+ V +A+  +TG + A+K +   ++   K+  N TA   L  I +L +
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTA---LREIKLLQE 58

Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEY 160
           L HP ++ L   F    ++ +  E  E  +L   I  K   L+  + + Y    +  LEY
Sbjct: 59  LKHPNIIGLLDVFGHKSNINLVFEFMET-DLEKVIKDKSIVLTPADIKSYMLMTLRGLEY 117

Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           +HS  ++HRD+KP NLL+ +DG +K+ADFG       +R    PN     K    V T  
Sbjct: 118 LHSNWILHRDLKPNNLLIASDGVLKLADFGL------ARSFGSPN----RKMTHQVVTRW 167

Query: 221 YVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF------------------------ 255
           Y  PE+L  +     G D+W++GC   ++L    PF                        
Sbjct: 168 YRAPELLFGARHYGVGVDMWSVGCIFAELLLRV-PFLPGDSDIDQLGKIFEALGTPTEEN 226

Query: 256 -------KDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVL 308
                   D  E+  F     + I FP   SD A DL+ RLL ++P+ R  A        
Sbjct: 227 WPGVTSLPDYVEFKPFPPTPLKQI-FPAA-SDDALDLLQRLLTLNPNKRITA-----RQA 279

Query: 309 KMHPFFK 315
             HP+F 
Sbjct: 280 LEHPYFS 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 92.0 bits (229), Expect = 1e-20
 Identities = 82/326 (25%), Positives = 132/326 (40%), Gaps = 74/326 (22%)

Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK-----TAYVKLERI 97
            ++D+E+    G G++ +V +A++I TG V ALK    K +    K     TA   L  I
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALK----KILMHNEKDGFPITA---LREI 58

Query: 98  -VLDQLDHPGVVRLFFTFQD-------------TFSLYMALESCEGGELFDQITSKGHLS 143
            +L +L HP VV L     +               + YM  +    G L +       L+
Sbjct: 59  KILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLS--GLLENP---SVKLT 113

Query: 144 EDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV- 202
           E + + Y  ++++ + Y+H   ++HRDIK  N+L+   G +KIADFG  +P         
Sbjct: 114 ESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPK 173

Query: 203 LPNAASDDKACTFVGTAAYVPPEVL----NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
                   K    V T  Y PPE+L      + A    D+W +GC   +M +     +  
Sbjct: 174 GGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAV---DIWGIGCVFAEMFTRRPILQGK 230

Query: 259 SEW----LIFQRI-IARDIRFPNY-----------FSDAAR--------------DLIDR 288
           S+     LIF+      +  +P +           F++  R              DL+ +
Sbjct: 231 SDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSK 290

Query: 289 LLDVDPSGRPGAGPGGYAVLKMHPFF 314
           LL +DP  R  A          HP+F
Sbjct: 291 LLSLDPYKRLTASDA-----LEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 90.7 bits (226), Expect = 1e-20
 Identities = 69/269 (25%), Positives = 118/269 (43%), Gaps = 44/269 (16%)

Query: 54  GVGSYSKVVRAK---KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           G G++ +V + K   K    T  A+K + K+  ++E +  ++K E  V+ +L HP VVRL
Sbjct: 4   GEGAFGEVYKGKLKGKDGKTTEVAVKTL-KEDASEEERKDFLK-EARVMKKLGHPNVVRL 61

Query: 111 F-FTFQDTFSLYMALESCEGGEL---------FDQITSKGHLSEDEARFYTAEVVDALEY 160
                ++   LY+ LE  EGG+L               K  LS  +   +  ++   +EY
Sbjct: 62  LGVCTEEE-PLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           + S   +HRD+   N L+  D  +KI+DFG    +  SR     +   DD      G   
Sbjct: 121 LASKKFVHRDLAARNCLVGEDLVVKISDFG----L--SR-----DVYDDDYYRKKTGGKL 169

Query: 221 YV---PPEVLNS---SPATFGNDLWALGCTLYQMLS-GTSPF--KDTSEWLIFQRIIA-- 269
            +    PE L     +  +   D+W+ G  L+++ + G +P+      E  + + +    
Sbjct: 170 PIRWMAPESLKDGIFTSKS---DVWSFGVLLWEIFTLGATPYPGLSNEE--VLEYLRKGY 224

Query: 270 RDIRFPNYFSDAARDLIDRLLDVDPSGRP 298
           R +  P Y  D   +L+     +DP  RP
Sbjct: 225 R-LPKPEYCPDELYELMLSCWQLDPEDRP 252

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 92.2 bits (229), Expect = 2e-20
 Identities = 84/313 (26%), Positives = 139/313 (44%), Gaps = 49/313 (15%)

Query: 18  NNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKI 77
            +SS++  +   +   A  A +   S+ + E     G G+   V +     TG +YALK+
Sbjct: 50  PSSSSSSSSSSSASGSAPSAAK---SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKV 106

Query: 78  MD-------KKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG 130
           +        ++ I +E +         +L  ++HP VV+    F     + + LE  +GG
Sbjct: 107 IYGNHEDTVRRQICREIE---------ILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG 157

Query: 131 ELFD-QITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADF 189
            L    I  +  L+ D AR    +++  + Y+H   ++HRDIKP NLL+ +  ++KIADF
Sbjct: 158 SLEGTHIADEQFLA-DVAR----QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADF 212

Query: 190 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT-----FGNDLWALGCT 244
           G       SRI     A + D   + VGT AY+ PE +N+         +  D+W+LG +
Sbjct: 213 GV------SRIL----AQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVS 262

Query: 245 LYQMLSGTSPFK--DTSEW--LIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGA 300
           + +   G  PF      +W  L+    +++    P   S   R  I   L  +P+ R  A
Sbjct: 263 ILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSA 322

Query: 301 GPGGYAVLKMHPF 313
                  L  HPF
Sbjct: 323 -----MQLLQHPF 330

Length = 353

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 89.9 bits (223), Expect = 5e-20
 Identities = 77/297 (25%), Positives = 127/297 (42%), Gaps = 57/297 (19%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-VLDQLDHPGVVRLFF 112
           G G+Y  V +A+   TG V ALK +  +  T+        +  I +L +L+HP +V+L  
Sbjct: 9   GEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66

Query: 113 TFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDI 171
                  LY+  E   +  + F   +    +     + Y  +++  L + HS  ++HRD+
Sbjct: 67  VIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 126

Query: 172 KPENLLLTADGHIKIADFGSVK----PMQDSRITVLPNAASDDKACTFVGTAAYVPPEV- 226
           KP+NLL+  +G IK+ADFG  +    P++     V+              T  Y  PE+ 
Sbjct: 127 KPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--------------TLWYRAPEIL 172

Query: 227 LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRIIARD-------IRFP 275
           L     +   D+W+LGC   +M++  + F   SE    + IF+ +   D          P
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP 232

Query: 276 NY------------------FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 314
           +Y                    +  RDL+ ++L  DP+ R  A     A L  HPFF
Sbjct: 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAK----AALA-HPFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 89.7 bits (222), Expect = 5e-20
 Identities = 58/216 (26%), Positives = 105/216 (48%), Gaps = 14/216 (6%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           FE+  + G G+Y  V++ +  +T  + A+K        +E K   ++ E  +L  L    
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR-ELKMLRTLKQEN 61

Query: 107 VVRLFFTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           +V L   F+    LY+  E  E    EL +++ +   +  ++ R Y  +++ A+ + H  
Sbjct: 62  IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNG--VPPEKVRSYIYQLIKAIHWCHKN 119

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
            ++HRDIKPENLL++ +  +K+ DFG  + + +          S+     +V T  Y  P
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSE---------GSNANYTEYVATRWYRSP 170

Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           E+L  +P     D+W++GC L ++  G   F   SE
Sbjct: 171 ELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESE 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 89.8 bits (223), Expect = 9e-20
 Identities = 84/324 (25%), Positives = 139/324 (42%), Gaps = 82/324 (25%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALK--------IMDKKFITKENKTAYVKLERIV 98
           +++ ++ G GSY  V  A    TG   A+K        + D   I +E     +KL R+ 
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILRE-----IKLLRL- 55

Query: 99  LDQLDHPGVVRLFF--------TFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFY 150
              L HP +V +           F+D + ++  +ES    +L   I +   L+ +  +F+
Sbjct: 56  ---LRHPDIVEIKHIMLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPEHHQFF 108

Query: 151 TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM-QDSRITVLPNAASD 209
             +++ AL+YIH+  + HRD+KP+N+L  AD  +KI DFG  +    D+   +     +D
Sbjct: 109 LYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF---WTD 165

Query: 210 DKACTFVGTAAYVPPEVLNS-----SPATFGNDLWALGCTLYQMLSGTS--PFKD----- 257
                +V T  Y  PE+  S     +PA    D+W++GC   ++L+G    P K+     
Sbjct: 166 -----YVATRWYRAPELCGSFFSKYTPAI---DIWSIGCIFAEVLTGKPLFPGKNVVHQL 217

Query: 258 --------TSEWLIFQRI-------------IARDIRFPNYFSDA---ARDLIDRLLDVD 293
                   T       R+               + + F   F +A   A  L++RLL  D
Sbjct: 218 DLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFD 277

Query: 294 PSGRPGAGPGGYAVLKMHPFFKGI 317
           P  RP A           P+FKG+
Sbjct: 278 PKDRPTA-----EEALADPYFKGL 296

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 87.9 bits (219), Expect = 1e-19
 Identities = 63/269 (23%), Positives = 113/269 (42%), Gaps = 37/269 (13%)

Query: 47  FELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
            ELGK  G G++ +V +         T T  A+K + K+  ++E +  +++ E  ++ +L
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASEEEREEFLE-EASIMKKL 58

Query: 103 DHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALE 159
            HP +VRL    T  +   LY+  E   GG+L D +      L+  +      ++   +E
Sbjct: 59  SHPNIVRLLGVCTQGE--PLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGME 116

Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFG---SVKPMQDSRITVLPNAASDDKACTFV 216
           Y+ S   +HRD+   N L+T +  +KI+DFG    +      R                 
Sbjct: 117 YLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYR----------------K 160

Query: 217 GTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR 270
                +P     PE L     T  +D+W+ G  L+++ + G  P+   S   + + +   
Sbjct: 161 RGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDG 220

Query: 271 D-IRFPNYFSDAARDLIDRLLDVDPSGRP 298
             +  P    D   +L+ +    DP  RP
Sbjct: 221 YRLPRPENCPDELYELMLQCWAYDPEDRP 249

Length = 258

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 91.8 bits (228), Expect = 2e-19
 Identities = 72/293 (24%), Positives = 124/293 (42%), Gaps = 37/293 (12%)

Query: 68  DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ--DTFSLYMALE 125
            TG   A+K++      +E++ A  + E  +  +L HP +V L  + +      L+   E
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFE 59

Query: 126 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG--- 182
              G  L + + + G L   E      +V+DAL   H+ G++HRD+KP+N++++  G   
Sbjct: 60  YVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRP 119

Query: 183 HIKIADFGSVKPMQDSRITVLPNAASDD-----KACTFVGTAAYVPPEVLNSSPATFGND 237
           H K+ DFG          T+LP     D     +    +GT  Y  PE L   P T  +D
Sbjct: 120 HAKVLDFGIG--------TLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSD 171

Query: 238 LWALGCTLYQMLSGTSPFKDTS-EWLIFQRIIARDIRFPNYFSDAARDLIDRLLDV---D 293
           L+A G    + L+G    +  S   +++Q++   D+  P +   A   L   L      D
Sbjct: 172 LYAWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWI--AGHPLGQVLRKALNKD 229

Query: 294 PSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTP------PKLASEPMVQSGE 340
           P  R  + P       +   F+ ++   + G          +  + P+V SG 
Sbjct: 230 PRQRAASAP------ALAERFRALELCALVGILRMGEGAGREAIAAPLVASGT 276

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 88.6 bits (220), Expect = 2e-19
 Identities = 81/302 (26%), Positives = 125/302 (41%), Gaps = 67/302 (22%)

Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           L KI G G++ +V +A+   T  + ALK  +M+ +   KE        E  +L  L H  
Sbjct: 17  LAKI-GQGTFGEVFKARHKKTKQIVALKKVLMENE---KEGFPITALREIKILQLLKHEN 72

Query: 107 VVRL----------FFTFQDTFSLYMALESCEG--GELFDQITSKGHLSEDEARFYTAEV 154
           VV L          +  ++ +F  Y+  E CE     L      K  LSE +       +
Sbjct: 73  VVNLIEICRTKATPYNRYKGSF--YLVFEFCEHDLAGLLSNKNVKFTLSEIKK--VMKML 128

Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           ++ L YIH   ++HRD+K  N+L+T DG +K+ADFG       +R   L   +  ++   
Sbjct: 129 LNGLYYIHRNKILHRDMKAANILITKDGILKLADFGL------ARAFSLSKNSKPNRYTN 182

Query: 215 FVGTAAYVPPEVL----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI--- 267
            V T  Y PPE+L    +  P     D+W  GC + +M + +   +  +E      I   
Sbjct: 183 RVVTLWYRPPELLLGERDYGPPI---DMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQL 239

Query: 268 ---IARDI-------------------------RFPNYFSDA-ARDLIDRLLDVDPSGRP 298
              I  ++                         R   Y  D  A DLID+LL +DP+ R 
Sbjct: 240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRI 299

Query: 299 GA 300
            A
Sbjct: 300 DA 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 87.9 bits (218), Expect = 3e-19
 Identities = 83/308 (26%), Positives = 131/308 (42%), Gaps = 69/308 (22%)

Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK----TAYVKLERIV 98
            +  F++    G G+Y +V +A+  DTG + ALK   K  +  E +    TA  +++  +
Sbjct: 5   CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALK---KVRLDNEKEGFPITAIREIK--I 59

Query: 99  LDQLDHPGVVRLFFTF----------QDTFSLYMALESCEGGELFDQITSK-GHLSEDEA 147
           L QL+H  +V L              +D  + Y+  E  +  +L   + S   H SED  
Sbjct: 60  LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHI 118

Query: 148 RFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA 207
           + +  ++++ L Y H    +HRDIK  N+LL   G IK+ADFG  +         L N+ 
Sbjct: 119 KSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR---------LYNSE 169

Query: 208 SDDKACTFVGTAAYVPPEVL----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLI 263
                   V T  Y PPE+L       PA    D+W+ GC L ++ +    F+   E   
Sbjct: 170 ESRPYTNKVITLWYRPPELLLGEERYGPAI---DVWSCGCILGELFTKKPIFQANQELAQ 226

Query: 264 FQRIIAR------------DIRFPNY----------------FS---DAARDLIDRLLDV 292
            + +I+R             I+ P +                FS     A DL+D +L +
Sbjct: 227 LE-LISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTL 285

Query: 293 DPSGRPGA 300
           DPS R  A
Sbjct: 286 DPSKRCTA 293

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 87.3 bits (216), Expect = 8e-19
 Identities = 70/214 (32%), Positives = 102/214 (47%), Gaps = 31/214 (14%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE-NKTAYVKLERIVLDQLDHPGVVRLF- 111
           G G+Y  V  A    TG   A+K + + F ++   K AY +L   +L  + H  V+ L  
Sbjct: 24  GSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELR--LLKHMKHENVIGLLD 81

Query: 112 -FT-------FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            FT       F D F L M     + G+L         LSED  +F   +++  L+YIH+
Sbjct: 82  VFTPDLSLDRFHD-FYLVMPFMGTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHA 136

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
            G+IHRD+KP NL +  D  +KI DFG  +              +D +   +V T  Y  
Sbjct: 137 AGIIHRDLKPGNLAVNEDCELKILDFGLAR-------------QTDSEMTGYVVTRWYRA 183

Query: 224 PEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFK 256
           PEV LN    T   D+W++GC + +ML+G   FK
Sbjct: 184 PEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK 217

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 87.0 bits (216), Expect = 9e-19
 Identities = 83/294 (28%), Positives = 123/294 (41%), Gaps = 75/294 (25%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT-AYVKLERI-VLDQLDHPGVVRL- 110
           G G+Y  V  AK  +T    A+K +   F   +N+  A   L  I +L  LDH  V+ + 
Sbjct: 14  GRGAYGIVCSAKNSETNEKVAIKKIANAF---DNRIDAKRTLREIKLLRHLDHENVIAIK 70

Query: 111 -------FFTFQDTFSLYMALESCEGGELFDQ-----ITSKGHLSEDEARFYTAEVVDAL 158
                     F D + +Y         EL D      I S   LS+D  +++  +++  L
Sbjct: 71  DIMPPPHREAFNDVYIVY---------ELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGL 121

Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           +YIHS  ++HRD+KP NLLL A+  +KI DFG  +            +   D    +V T
Sbjct: 122 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR----------TTSEKGDFMTEYVVT 171

Query: 219 AAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF--KDTSEWLIFQRIIAR----- 270
             Y  PE+ LN S  T   D+W++GC   ++L     F  KD    L   ++I       
Sbjct: 172 RWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQL---KLITELLGSP 228

Query: 271 ---DIRF-------------PNY--------FSDA---ARDLIDRLLDVDPSGR 297
              D+ F             P          F  A   A DL++++L  DPS R
Sbjct: 229 SEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKR 282

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 85.9 bits (213), Expect = 9e-19
 Identities = 78/303 (25%), Positives = 129/303 (42%), Gaps = 58/303 (19%)

Query: 48  ELGKIYGVGSYSKVVRAKKIDTGTVYALK---IMDKKFITKENKTAYVKLERIVLDQLDH 104
           +L KI G G+Y  V +AK  +T  + ALK   + D      E   +    E  +L +L H
Sbjct: 4   KLEKI-GEGTYGTVFKAKNRETHEIVALKRVRLDDDD----EGVPSSALREICLLKELKH 58

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
             +VRL+        L +  E C+    + FD  +  G +  +  + +  +++  L + H
Sbjct: 59  KNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFD--SCNGDIDPEIVKSFMFQLLKGLAFCH 116

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S  ++HRD+KP+NLL+  +G +K+ADFG  +      I V   +A        V T  Y 
Sbjct: 117 SHNVLHRDLKPQNLLINKNGELKLADFGLARAFG---IPVRCYSAE-------VVTLWYR 166

Query: 223 PPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF---KDTSEWL--IFQRI--------- 267
           PP+VL  +   +   D+W+ GC   ++ +   P     D  + L  IF+ +         
Sbjct: 167 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWP 226

Query: 268 ----IARDIRFPNY------------FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH 311
               +     +P Y             +   RDL+  LL  +P  R  A       L+ H
Sbjct: 227 GVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAE----EALQ-H 281

Query: 312 PFF 314
           P+F
Sbjct: 282 PYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 85.8 bits (212), Expect = 1e-18
 Identities = 74/272 (27%), Positives = 122/272 (44%), Gaps = 36/272 (13%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHP 105
           +E+ +  G G+Y KV +      G+  A+KI+D      E     ++ E  +L  L DHP
Sbjct: 20  WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEE----IEAEYNILKALSDHP 75

Query: 106 GVVRLFFTF-----QDTFSLYMALESCEGGELFDQITSKGHLSEDE------ARFYTAEV 154
            VV+ +  +     ++   L++ LE C GG + D +  KG L   E        +   E 
Sbjct: 76  NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV--KGFLKRGERMEEPIIAYILHEA 133

Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           +  L+++H    IHRD+K  N+LLT +G +K+ DFG    +  +R+          +  T
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL----------RRNT 183

Query: 215 FVGTAAYVPPEVLNSSP---ATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA 269
            VGT  ++ PEV+       +T+    D+W+LG T  ++  G  P  D        +I  
Sbjct: 184 SVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR 243

Query: 270 R---DIRFPNYFSDAARDLIDRLLDVDPSGRP 298
                +  P  +S+   D I + L  D   RP
Sbjct: 244 NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRP 275

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 66/216 (30%), Positives = 102/216 (47%), Gaps = 27/216 (12%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQL 102
           DFE     G G+   V +     +G      IM +K I  E K A    +  E  VL + 
Sbjct: 2   DFEKLGELGAGNGGVVTKVLHRPSGL-----IMARKLIHLEIKPAIRNQIIRELKVLHEC 56

Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYI 161
           + P +V  +  F     + + +E  +GG L DQ+  K G + E+     +  V+  L Y+
Sbjct: 57  NSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPENILGKISIAVLRGLTYL 115

Query: 162 ---HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
              H   ++HRD+KP N+L+ + G IK+ DFG    + DS             A +FVGT
Sbjct: 116 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM------------ANSFVGT 161

Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 254
            +Y+ PE L  +  T  +D+W+LG +L +M  G  P
Sbjct: 162 RSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 85.7 bits (212), Expect = 3e-18
 Identities = 68/214 (31%), Positives = 103/214 (48%), Gaps = 32/214 (14%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE-NKTAYVKLERIVLDQLDHPGVVRLF- 111
           G G+Y  V  A    TG   A+K + + F ++   K AY +L   +L  + H  V+ L  
Sbjct: 24  GSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYREL--TLLKHMQHENVIGLLD 81

Query: 112 -FT-------FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            FT       FQD F L M     +  ++         LSED+ ++   +++  L+YIHS
Sbjct: 82  VFTSAVSGDEFQD-FYLVMPYMQTDLQKIMGH-----PLSEDKVQYLVYQMLCGLKYIHS 135

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
            G+IHRD+KP NL +  D  +KI DFG  +              +D +   +V T  Y  
Sbjct: 136 AGIIHRDLKPGNLAVNEDCELKILDFGLAR-------------HADAEMTGYVVTRWYRA 182

Query: 224 PEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFK 256
           PEV LN        D+W++GC + +ML+G + FK
Sbjct: 183 PEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK 216

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 84.5 bits (209), Expect = 3e-18
 Identities = 71/281 (25%), Positives = 119/281 (42%), Gaps = 48/281 (17%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL-DQLDHPGVVRLFF 112
           G G+Y+ V + +   TG + ALK +    +  E  T    +  I L  +L H  +VRL  
Sbjct: 9   GEGTYATVYKGRNRTTGEIVALKEIH---LDAEEGTPSTAIREISLMKELKHENIVRLHD 65

Query: 113 TFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 170
                  L +  E  +    +  D    +G L  +  + +T +++  + + H   ++HRD
Sbjct: 66  VIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRD 125

Query: 171 IKPENLLLTADGHIKIADFGSVKPMQDSRITVLP-NAASDDKACTFVGTAAYVPPEVL-N 228
           +KP+NLL+   G +K+ADFG       +R   +P N  S++     V T  Y  P+VL  
Sbjct: 126 LKPQNLLINKRGELKLADFGL------ARAFGIPVNTFSNE-----VVTLWYRAPDVLLG 174

Query: 229 SSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIF-------QRIIARDIRFPNY 277
           S   +   D+W++GC + +M++G   F  T+       IF       +       + P Y
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234

Query: 278 FSDAAR------------------DLIDRLLDVDPSGRPGA 300
                R                  DL+ RLL ++P  R  A
Sbjct: 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISA 275

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 85.1 bits (210), Expect = 4e-18
 Identities = 84/295 (28%), Positives = 130/295 (44%), Gaps = 40/295 (13%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQL 102
           DFE     G G+   V +     +G      IM +K I  E K A    +  E  VL + 
Sbjct: 6   DFEKISELGAGNGGVVFKVSHKPSGL-----IMARKLIHLEIKPAIRNQIIRELQVLHEC 60

Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYI 161
           + P +V  +  F     + + +E  +GG L DQ+  K G + E      +  V+  L Y+
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYL 119

Query: 162 HSM-GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
                ++HRD+KP N+L+ + G IK+ DFG    + DS             A +FVGT +
Sbjct: 120 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS------------MANSFVGTRS 167

Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF--KDTSEW-LIFQRIIARDIRFPNY 277
           Y+ PE L  +  +  +D+W++G +L +M  G  P    D  E  L+F   +  D      
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGD------ 221

Query: 278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLAS 332
              A  +   R     P GRP +  G  +   M   F+ +D+  I  + PPKL S
Sbjct: 222 --PAESETSPR---PRPPGRPLSSYGPDSRPPM-AIFELLDY--IVNEPPPKLPS 268

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 84.3 bits (209), Expect = 5e-18
 Identities = 77/315 (24%), Positives = 125/315 (39%), Gaps = 63/315 (20%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
              +GK +       + + K   T T+ A+K   K  +   +K     L  E I   QL 
Sbjct: 3   LTLIGKCFEDLMIVHLAKHKP--TNTLVAVK---KINLDSCSKEDLKLLQQEIITSRQLQ 57

Query: 104 HPGVVRLFFTFQDTFSLY-----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
           HP ++    +F     LY     MA  SCE  +L      +G L E    F   +V++AL
Sbjct: 58  HPNILPYVTSFIVDSELYVVSPLMAYGSCE--DLLKTHFPEG-LPELAIAFILKDVLNAL 114

Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM--QDSRITVLPNAASDDKACTFV 216
           +YIHS G IHR +K  ++LL+ DG + ++       M     R  V+      D   + V
Sbjct: 115 DYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV-----HDFPKSSV 169

Query: 217 GTAAYVPPEVL--NSSPATFGNDLWALGCTLYQMLSGTSPFKDT-SEWLIFQRI------ 267
               ++ PEVL  N       +D++++G T  ++ +G  PFKD  +  ++ +++      
Sbjct: 170 KNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPC 229

Query: 268 ---------------------------IARDIRFPNYFSDAARDLIDRLLDVDPSGRPGA 300
                                       + D  +   FS+     ++  L  DP  RP A
Sbjct: 230 LLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSA 289

Query: 301 GPGGYAVLKMHPFFK 315
                + L  H FFK
Sbjct: 290 -----SQLLNHSFFK 299

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 86.7 bits (215), Expect = 7e-18
 Identities = 76/285 (26%), Positives = 126/285 (44%), Gaps = 40/285 (14%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN-KTAYVKLERIVLDQL 102
           +Q +++ ++ G G   +V  A         ALK + +        K  +++  +I  D L
Sbjct: 1   MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAAD-L 59

Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEG---GELFDQITSKGHLSEDEAR----------F 149
            HPG+V ++    D   +Y  +   EG     L   +  K  LS++ A           F
Sbjct: 60  IHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119

Query: 150 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 209
           +   +   +EY+HS G++HRD+KP+N+LL   G + I D+G+    +     +L     +
Sbjct: 120 HK--ICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177

Query: 210 DKAC--------TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF--KDTS 259
              C          VGT  Y+ PE L   PA+   D++ALG  LYQML+ + P+  K   
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237

Query: 260 EWLIFQRIIA-------RDIRFPNYFSDAARDLIDRLLDVDPSGR 297
           +      I++       R+I  P + S  A     + L VDP+ R
Sbjct: 238 KISYRDVILSPIEVAPYREI--PPFLSQIAM----KALAVDPAER 276

Length = 932

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 83.5 bits (206), Expect = 9e-18
 Identities = 71/252 (28%), Positives = 103/252 (40%), Gaps = 19/252 (7%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS+  V  A    T  V A+K M         K   +  E   L QL HP  +     
Sbjct: 30  GHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGC 89

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +    + ++ +E C G         K  L E E    T   +  L Y+HS  +IHRDIK 
Sbjct: 90  YLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKA 149

Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV---LNSS 230
            N+LLT  G +K+ADFGS              A+    A +FVGT  ++ PEV   ++  
Sbjct: 150 GNILLTEPGQVKLADFGS--------------ASKSSPANSFVGTPYWMAPEVILAMDEG 195

Query: 231 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--IRFPNYFSDAARDLIDR 288
                 D+W+LG T  ++     P  + +       I   D      N ++D+ R  +D 
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDY 255

Query: 289 LLDVDPSGRPGA 300
            L   P  RP +
Sbjct: 256 CLQKIPQERPAS 267

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 82.9 bits (205), Expect = 1e-17
 Identities = 78/281 (27%), Positives = 131/281 (46%), Gaps = 36/281 (12%)

Query: 48  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV 107
           ELG+    G+Y  V + + + TGT+ A+K +     ++E K   + L+ I +  +D P  
Sbjct: 8   ELGR----GAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLD-ISMRSVDCPYT 62

Query: 108 VRLF---FTFQDTFSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHS 163
           V  +   F   D + + M +      + + ++  KG  + ED        +V ALEY+HS
Sbjct: 63  VTFYGALFREGDVW-ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121

Query: 164 -MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
            + +IHRD+KP N+L+  +G +K+ DFG    + DS        A    A    G   Y+
Sbjct: 122 KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS-------VAKTIDA----GCKPYM 170

Query: 223 PPEVLNSSPATFG----NDLWALGCTLYQMLSGTSPF---KDTSEWLIFQRIIARDIRFP 275
            PE +N      G    +D+W+LG T+ ++ +G  P+   K   + L  Q +     + P
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLK-QVVEEPSPQLP 229

Query: 276 N-YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
              FS   +D +++ L  +   RP      Y  L  HPFF+
Sbjct: 230 AEKFSPEFQDFVNKCLKKNYKERP-----NYPELLQHPFFE 265

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 82.8 bits (204), Expect = 1e-17
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 15/204 (7%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL-ERIVLDQLDHPGVVRLFF 112
           G GSY+ V + K    G + ALK++    + +E  T +  + E  +L  L H  +V L  
Sbjct: 14  GEGSYATVYKGKSKVNGKLVALKVIR---LQEEEGTPFTAIREASLLKGLKHANIVLLHD 70

Query: 113 TFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIK 172
                 +L +  E              G L  +  + +  +++  L YIH   ++HRD+K
Sbjct: 71  IIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLK 130

Query: 173 PENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSP 231
           P+NLL++  G +K+ADFG       +R   +P+    ++  T      Y PP+V L S+ 
Sbjct: 131 PQNLLISDTGELKLADFGL------ARAKSVPSHTYSNEVVTL----WYRPPDVLLGSTE 180

Query: 232 ATFGNDLWALGCTLYQMLSGTSPF 255
            +   D+W +GC   +M+ G + F
Sbjct: 181 YSTCLDMWGVGCIFVEMIQGVAAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 82.4 bits (204), Expect = 1e-17
 Identities = 82/304 (26%), Positives = 130/304 (42%), Gaps = 62/304 (20%)

Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI----VLDQLDH 104
           + KI G G+Y  V +A+   TG + ALK      I  E +   V    I    +L +L+H
Sbjct: 4   VEKI-GEGTYGVVYKARDKLTGEIVALKK-----IRLETEDEGVPSTAIREISLLKELNH 57

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF--YTAEVVDALEYIH 162
           P +VRL         LY+  E  +  +L   + S      D      Y  +++  + Y H
Sbjct: 58  PNIVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH 116

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF-VGTAAY 221
           S  ++HRD+KP+NLL+  +G +K+ADFG       +R   +P      +  T  V T  Y
Sbjct: 117 SHRVLHRDLKPQNLLIDREGALKLADFGL------ARAFGVPV-----RTYTHEVVTLWY 165

Query: 222 VPPEVLNSSP--ATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRIIARD---- 271
             PE+L  S   +T   D+W++GC   +M++    F   SE    + IF+ +   D    
Sbjct: 166 RAPEILLGSRQYST-PVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVW 224

Query: 272 ----------IRFPNY-----------FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM 310
                       FP +             +   DL+ ++L  DP+ R  A     A+   
Sbjct: 225 PGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISA---KAALQ-- 279

Query: 311 HPFF 314
           HP+F
Sbjct: 280 HPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 83.0 bits (205), Expect = 2e-17
 Identities = 75/286 (26%), Positives = 125/286 (43%), Gaps = 61/286 (21%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFF 112
           G+G++  V  A+   TG   A+K + K F T    K  Y +L+  +L  L H  ++ L  
Sbjct: 19  GMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK--LLKHLRHENIISL-- 74

Query: 113 TFQDTF-----SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLI 167
              D F      +Y   E   G +L   +TS+  L +   +++  +++  L+Y+HS G++
Sbjct: 75  --SDIFISPLEDIYFVTE-LLGTDLHRLLTSR-PLEKQFIQYFLYQILRGLKYVHSAGVV 130

Query: 168 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV- 226
           HRD+KP N+L+  +  +KI DFG  +  QD ++T             +V T  Y  PE+ 
Sbjct: 131 HRDLKPSNILINENCDLKICDFGLARI-QDPQMT------------GYVSTRYYRAPEIM 177

Query: 227 LNSSPATFGNDLWALGCTLYQMLSGTS--PFKD-------TSEWL------IFQRIIARD 271
           L         D+W+ GC   +ML G    P KD        ++ L      +   I + +
Sbjct: 178 LTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN 237

Query: 272 I-----------------RFPNYFSDAARDLIDRLLDVDPSGRPGA 300
                             +F N    +A DL++++L  DP  R  A
Sbjct: 238 TLRFVQSLPKREPVPFSEKFKN-ADPSAIDLLEKMLVFDPQKRISA 282

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 76/287 (26%), Positives = 121/287 (42%), Gaps = 37/287 (12%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHP 105
           +E+ +  G G+Y KV +      G++ A+KI+D      E     ++ E  +L  L +HP
Sbjct: 24  WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEE----IEAEYNILQSLPNHP 79

Query: 106 GVVRLFFTF--QDTFS---LYMALESCEGG---ELFDQITSKGH-LSEDEARFYTAEVVD 156
            VV+ +  F   D      L++ LE C GG   EL   +   G  L E    +     + 
Sbjct: 80  NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALL 139

Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
            L+++H+  +IHRD+K  N+LLT +G +K+ DFG    +  +R+          +  T V
Sbjct: 140 GLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL----------RRNTSV 189

Query: 217 GTAAYVPPEVLN-----SSPATFGNDLWALGCTLYQMLSGTSPFKD---TSEWLIFQRII 268
           GT  ++ PEV+              D+W+LG T  ++  G  P  D           R  
Sbjct: 190 GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP 249

Query: 269 ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
              +  P  +  +    I + L  D   RP         L  HPF K
Sbjct: 250 PPTLLHPEKWCRSFNHFISQCLIKDFEARPSV-----THLLEHPFIK 291

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 83.2 bits (205), Expect = 2e-17
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 26  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 83

Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 84  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 143

Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 144 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 190

Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 191 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 64/250 (25%), Positives = 101/250 (40%), Gaps = 19/250 (7%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS+  V  A+ +    V A+K M         K   +  E   L +L HP  ++    
Sbjct: 24  GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGC 83

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +    + ++ +E C G         K  L E E    T   +  L Y+HS  +IHRD+K 
Sbjct: 84  YLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKA 143

Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV---LNSS 230
            N+LL+  G +K+ DFGS   M                A  FVGT  ++ PEV   ++  
Sbjct: 144 GNILLSEPGLVKLGDFGSASIMA--------------PANXFVGTPYWMAPEVILAMDEG 189

Query: 231 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--IRFPNYFSDAARDLIDR 288
                 D+W+LG T  ++     P  + +       I   +       ++S+  R+ +D 
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249

Query: 289 LLDVDPSGRP 298
            L   P  RP
Sbjct: 250 CLQKIPQDRP 259

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 84.8 bits (209), Expect = 3e-17
 Identities = 82/303 (27%), Positives = 135/303 (44%), Gaps = 52/303 (17%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           + ++E+ K  G G + +V   K   T   +  K +  + + +  K+  V +E  V+ +L 
Sbjct: 12  LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLV-IEVNVMRELK 70

Query: 104 HPGVVRLFFTFQDTFS--LYMALESCEGGELFDQITSK----GHLSEDEARFYTAEVVDA 157
           H  +VR    F +  +  LY+ +E C+ G+L   I       G + E      T +++ A
Sbjct: 71  HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHA 130

Query: 158 LEYIHSMG-------LIHRDIKPENLLL-TADGHI----------------KIADFGSVK 193
           L Y H++        ++HRD+KP+N+ L T   HI                KI DFG  K
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190

Query: 194 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSG 251
                      N   +  A + VGT  Y  PE+L     ++ +  D+WALGC +Y++ SG
Sbjct: 191 -----------NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239

Query: 252 TSPFKDTSEWLIFQRIIARDIRFPNY----FSDAARDLIDRLLDVDPSGRPGAGPG-GYA 306
            +PF   +    F ++I+   R P+      S     LI  LL++    RP A    GY 
Sbjct: 240 KTPFHKANN---FSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQ 296

Query: 307 VLK 309
           ++K
Sbjct: 297 IIK 299

Length = 1021

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 81.5 bits (201), Expect = 3e-17
 Identities = 71/287 (24%), Positives = 120/287 (41%), Gaps = 32/287 (11%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           QD +  +I G G+   V +A  + T  + A+K++      +  K    +LE  +L + D 
Sbjct: 1   QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELE--ILYKCDS 58

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P ++  +  F     + +  E  +GG L         + E         VV  L Y+ S+
Sbjct: 59  PYIIGFYGAFFVENRISICTEFMDGGSL----DVYRKIPEHVLGRIAVAVVKGLTYLWSL 114

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
            ++HRD+KP N+L+   G +K+ DFG    + +S             A T+VGT AY+ P
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS------------IAKTYVGTNAYMAP 162

Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSP----FKDTSEWL---IFQRIIARDI-RFP- 275
           E ++       +D+W+LG +  ++  G  P     K+    +   + Q I+  D    P 
Sbjct: 163 ERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPV 222

Query: 276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 322
             FS+     I + +   P  RP         L  HPF    +  N 
Sbjct: 223 GQFSEKFVHFITQCMRKQPKERPAP-----ENLMDHPFIVQYNDGNA 264

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 81.6 bits (202), Expect = 4e-17
 Identities = 69/238 (28%), Positives = 101/238 (42%), Gaps = 55/238 (23%)

Query: 49  LGKIYGVGSYSKVVRA--KKIDTGTVYALKIMDKKFITKENKTAYVKL------ERIVLD 100
            G I G G+Y +V +A  K    G  YA+K    KF  K +K  Y  +      E  +L 
Sbjct: 5   EGCI-GRGTYGRVYKAKRKNGKDGKEYAIK----KF--KGDKEQYTGISQSACREIALLR 57

Query: 101 QLDHPGVVRL---FFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEV- 154
           +L H  VV L   F    D  S+Y+  +  E     D  QI  K H          + V 
Sbjct: 58  ELKHENVVSLVEVFLEHADK-SVYLLFDYAE----HDLWQII-KFHRQAKRVSIPPSMVK 111

Query: 155 ------VDALEYIHSMGLIHRDIKPENLLLTADGH----IKIADFGSVKPMQDSRITVLP 204
                 ++ + Y+HS  ++HRD+KP N+L+  +G     +KI D G       +R+   P
Sbjct: 112 SLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL------ARLFNAP 165

Query: 205 NA--ASDDKACTFVGTAAYVPPEVLNSS----PATFGNDLWALGCTLYQMLSGTSPFK 256
               A  D     V T  Y  PE+L  +     A    D+WA+GC   ++L+    FK
Sbjct: 166 LKPLADLDPV---VVTIWYRAPELLLGARHYTKAI---DIWAIGCIFAELLTLEPIFK 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 81.3 bits (200), Expect = 5e-17
 Identities = 69/250 (27%), Positives = 104/250 (41%), Gaps = 19/250 (7%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS+  V  A+ + T  V A+K M         K   +  E   L ++ HP  +     
Sbjct: 34  GHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGC 93

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +    + ++ +E C G         K  L E E    T   +  L Y+HS  +IHRDIK 
Sbjct: 94  YLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKA 153

Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV---LNSS 230
            N+LLT  G +K+ADFGS              A+    A +FVGT  ++ PEV   ++  
Sbjct: 154 GNILLTEPGQVKLADFGS--------------ASIASPANSFVGTPYWMAPEVILAMDEG 199

Query: 231 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--IRFPNYFSDAARDLIDR 288
                 D+W+LG T  ++     P  + +       I   +      N +SD  R+ +D 
Sbjct: 200 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDS 259

Query: 289 LLDVDPSGRP 298
            L   P  RP
Sbjct: 260 CLQKIPQDRP 269

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 79.8 bits (197), Expect = 1e-16
 Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 23/217 (10%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI----VLDQLDHPG 106
           KI G G+Y  V + +   TG + A+K      I  E++   V    I    +L +L HP 
Sbjct: 7   KI-GEGTYGVVYKGRNKKTGQIVAMKK-----IRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 107 VVRLFFTFQDTFSLYMALE--SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           +V L         LY+  E  S +  +  D +    ++  +  + Y  +++  + + HS 
Sbjct: 61  IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
            ++HRD+KP+NLL+   G IK+ADFG       +R   +P      +    V T  Y  P
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGL------ARAFGIPVRVYTHE----VVTLWYRAP 170

Query: 225 EVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           EVL  SP  +   D+W++G    +M +    F   SE
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSE 207

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 68/233 (29%), Positives = 105/233 (45%), Gaps = 48/233 (20%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL-ERIVLDQLDHPGVVRL-- 110
           G GSY+ V + +   TG + ALK +    +  E    +  + E  +L  L H  +V L  
Sbjct: 14  GEGSYATVYKGRSKLTGQLVALKEIR---LEHEEGAPFTAIREASLLKDLKHANIVTLHD 70

Query: 111 ----------FFTFQDT-FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 159
                      F + DT    YM  + C GG           LS    R +  +++  L 
Sbjct: 71  IIHTKKTLTLVFEYLDTDLKQYM--DDCGGG-----------LSMHNVRLFLFQLLRGLA 117

Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP-NAASDDKACTFVGT 218
           Y H   ++HRD+KP+NLL++  G +K+ADFG       +R   +P    S++     V T
Sbjct: 118 YCHQRRVLHRDLKPQNLLISERGELKLADFGL------ARAKSVPSKTYSNE-----VVT 166

Query: 219 AAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF---KDTSEWL--IFQ 265
             Y PP+VL  S+  +   D+W +GC  Y+M +G   F    D  + L  IF+
Sbjct: 167 LWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFR 219

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 16/210 (7%)

Query: 48  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV 107
           +L K+ G G+Y+ V + +   T  + ALK  + +   +E        E  +L  L H  +
Sbjct: 9   KLDKL-GEGTYATVFKGRSKLTENLVALK--EIRLEHEEGAPCTAIREVSLLKNLKHANI 65

Query: 108 VRLFFTFQDTFSLYMALESCEGGELFDQITSKGHL-SEDEARFYTAEVVDALEYIHSMGL 166
           V L         L +  E  +  +L   + + G+L S    + +  +++  L Y H   +
Sbjct: 66  VTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKI 124

Query: 167 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 226
           +HRD+KP+NLL+   G +K+ADFG       +R   +P     ++    V T  Y PP+V
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGL------ARAKSVPTKTYSNE----VVTLWYRPPDV 174

Query: 227 -LNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            L S+  +   D+W +GC LY+M +G   F
Sbjct: 175 LLGSTEYSTPIDMWGVGCILYEMATGRPMF 204

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 79.4 bits (196), Expect = 3e-16
 Identities = 65/295 (22%), Positives = 120/295 (40%), Gaps = 49/295 (16%)

Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMD----KKFITKENKTA------YVKLERI- 97
            G   G G+Y KV +A    TG + A+K +        +TK+ +        +  L  + 
Sbjct: 13  KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72

Query: 98  VLDQLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
           +++++ H  ++ L   +   D  +L M + +    +L   +  K  L+E + +    +++
Sbjct: 73  IMNEIKHENIMGLVDVYVEGDFINLVMDIMA---SDLKKVVDRKIRLTESQVKCILLQIL 129

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG----SVKPMQDSRITVLPNAASDDK 211
           + L  +H    +HRD+ P N+ + + G  KIADFG       P     ++        ++
Sbjct: 130 NGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189

Query: 212 ACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSE---------- 260
             + V T  Y  PE+L  +    F  D+W++GC   ++L+G   F   +E          
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFEL 249

Query: 261 --------W-------LIFQRIIARDIRFPNYF---SDAARDLIDRLLDVDPSGR 297
                   W       L  +    +       F   SD A DL+  LL ++P  R
Sbjct: 250 LGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLER 304

Length = 335

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 77.8 bits (192), Expect = 4e-16
 Identities = 51/204 (25%), Positives = 88/204 (43%), Gaps = 17/204 (8%)

Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTAEVVDALE 159
           LDH  ++RL+        L M  E    G L D++   + GH        Y  ++ + + 
Sbjct: 53  LDHENLIRLYGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMR 111

Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK--PMQDSRITVLPNAASDDKACTFVG 217
           Y+ S   IHRD+   N+LL +D  +KI DFG ++  P  +    +  +         F  
Sbjct: 112 YLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH-----LKVPF-- 164

Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF-- 274
             A+  PE L +   +  +D+W  G TL++M + G  P+   S   I ++I     R   
Sbjct: 165 --AWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLER 222

Query: 275 PNYFSDAARDLIDRLLDVDPSGRP 298
           P        +++ +    +P+ RP
Sbjct: 223 PEACPQDIYNVMLQCWAHNPADRP 246

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 78.6 bits (193), Expect = 6e-16
 Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 23/209 (11%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A         A+K + + F +    +  Y +L   +L  + H  V+ L  
Sbjct: 24  GSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELR--LLKHMKHENVIGLLD 81

Query: 113 TFQ-----DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLI 167
            F      + F+    + +  G +L + I     LS++  +F   +++  L+YIHS G+I
Sbjct: 82  VFTPATSIENFNEVYLVTNLMGADL-NNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGII 140

Query: 168 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV- 226
           HRD+KP N+ +  D  ++I DFG  +              +DD+   +V T  Y  PE+ 
Sbjct: 141 HRDLKPSNVAVNEDCELRILDFGLAR-------------QADDEMTGYVATRWYRAPEIM 187

Query: 227 LNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           LN        D+W++GC + ++L G + F
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLKGKALF 216

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 77.8 bits (192), Expect = 6e-16
 Identities = 78/297 (26%), Positives = 132/297 (44%), Gaps = 44/297 (14%)

Query: 48  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV 107
           +LG+I G G++  V +     +GT+ A+K +      KE K   + L+ ++    D P +
Sbjct: 8   DLGEI-GRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS-DCPYI 65

Query: 108 VRLF---FTFQDTFSLYMALESCEGGELFDQITS--KGHLSEDEARFYTAEVVDALEYI- 161
           V+ +   F   D + + M L      + +  +    K  + E+         V AL Y+ 
Sbjct: 66  VKFYGALFREGDCW-ICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK 124

Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
             + +IHRD+KP N+LL  +G+IK+ DFG    + DS       A + D  C       Y
Sbjct: 125 EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI------AKTRDAGCR-----PY 173

Query: 222 VPPEVLNSSPAT---FGNDLWALGCTLYQMLSGTSPFKDTSEWL-IFQR----------I 267
           + PE ++ S        +D+W+LG TLY++ +G  P+    +W  +F +          I
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY---PKWNSVFDQLTQVVKGDPPI 230

Query: 268 IARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG 324
           ++        FS +  + I+  L  D S RP      Y  L  HPF K  + +N+  
Sbjct: 231 LSNSEER--EFSPSFVNFINLCLIKDESKRP-----KYKELLEHPFIKDYEERNVDV 280

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 77.8 bits (191), Expect = 1e-15
 Identities = 80/294 (27%), Positives = 130/294 (44%), Gaps = 38/294 (12%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQ 101
            DFE     G G+   V + +   +G      IM +K I  E K A    +  E  VL +
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGL-----IMARKLIHLEIKPAIRNQIIRELQVLHE 59

Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
            + P +V  +  F     + + +E  +GG L   +     + E+     +  V+  L Y+
Sbjct: 60  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYL 119

Query: 162 HSM-GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
                ++HRD+KP N+L+ + G IK+ DFG    + DS             A +FVGT +
Sbjct: 120 REKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS------------MANSFVGTRS 167

Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF--KDTSEW-LIFQR-IIARDIRFPN 276
           Y+ PE L  +  +  +D+W++G +L ++  G  P    D  E   IF R ++  +   P+
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPH 227

Query: 277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKL 330
             S   R          P GRP +G G  +   M   F+ +D+  I  + PPKL
Sbjct: 228 SISPRPR----------PPGRPVSGHGMDSRPAM-AIFELLDY--IVNEPPPKL 268

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 59/219 (26%), Positives = 102/219 (46%), Gaps = 27/219 (12%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL----DQLDHPGVVR 109
           GVG+Y  V +A+   +G   ALK +  +  T E+      +  + L    +  DHP +VR
Sbjct: 9   GVGAYGTVYKARDPHSGHFVALKSV--RVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 110 LF------FTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           L        T ++T  + +  E  +       D++   G L  +  +    + +  L+++
Sbjct: 67  LMDVCATSRTDRET-KVTLVFEHVDQDLRTYLDKVPPPG-LPAETIKDLMRQFLRGLDFL 124

Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H+  ++HRD+KPEN+L+T+ G +K+ADFG  + +   ++ + P           V T  Y
Sbjct: 125 HANCIVHRDLKPENILVTSGGQVKLADFGLAR-IYSCQMALTP----------VVVTLWY 173

Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
             PEVL  S      D+W++GC   +M      F   SE
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE 212

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 75.8 bits (186), Expect = 3e-15
 Identities = 75/296 (25%), Positives = 116/296 (39%), Gaps = 53/296 (17%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GSY+ V +      G + ALK++  K  T+E        E  +L  L H  +V L   
Sbjct: 14  GEGSYATVYKGISRINGQLVALKVISMK--TEEGVPFTAIREASLLKGLKHANIVLLHDI 71

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
                +L    E          I   G L     R +  +++  L YIH   ++HRD+KP
Sbjct: 72  IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKP 131

Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPA 232
           +NLL++  G +K+ADFG       +R   +P+     +    V T  Y PP+VL  ++  
Sbjct: 132 QNLLISYLGELKLADFGL------ARAKSIPSQTYSSE----VVTLWYRPPDVLLGATDY 181

Query: 233 TFGNDLWALGCTLYQMLSGTSPFKDTSE--------WLIFQRIIARDI-----RFPNYFS 279
           +   D+W  GC   +ML G   F   S+        W +   +   D      + PNY  
Sbjct: 182 SSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLG-VPTEDTWPGVSKLPNYKP 240

Query: 280 D---------------------AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 314
           +                      A DL  ++L + P  R  A         +HP+F
Sbjct: 241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDA-----LLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 76.4 bits (188), Expect = 3e-15
 Identities = 86/359 (23%), Positives = 136/359 (37%), Gaps = 72/359 (20%)

Query: 47  FELGKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 100
           F+LG  Y      G GS   V  A   D     A+K   K  +T      +   E  ++ 
Sbjct: 1   FDLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVK---KIVLTDPQSVKHALREIKIIR 57

Query: 101 QLDHPGVVRLFFTF-------QDTFSLYMALES-CEGGELFD----QITSKGHLSEDEAR 148
           +LDH  +V+++           +       L S     E  +     +  +G LSE+ AR
Sbjct: 58  RLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHAR 117

Query: 149 FYTAEVVDALEYIHSMGLIHRDIKPENLLL-TADGHIKIADFGSVKPMQDSRITVLPNAA 207
            +  +++  L+YIHS  ++HRD+KP N+ + T D  +KI DFG       +RI V P+ +
Sbjct: 118 LFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGL------ARI-VDPHYS 170

Query: 208 SDDKACTFVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEW---- 261
                   + T  Y  P +L  SP  +    D+WA GC   +ML+G   F    E     
Sbjct: 171 HKGYLSEGLVTKWYRSPRLL-LSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ 229

Query: 262 LIF--------------QRIIARDIRFPNYF------------SDAARDLIDRLLDVDPS 295
           LI                 +I   +R                 +  A D ++++L  +P 
Sbjct: 230 LILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPM 289

Query: 296 GRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDDVHDSSWNPSHI 354
            R  A         MHP+     +     +  P  +  P     E DD+   +   S I
Sbjct: 290 DRLTAEEA-----LMHPYMS--CYSCPFDE--PV-SLHPFHIEDELDDILLMTEIHSII 338

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 74.7 bits (183), Expect = 4e-15
 Identities = 65/252 (25%), Positives = 110/252 (43%), Gaps = 15/252 (5%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G++ +V   +     T  A+K   ++ +  + K  +++  RI L Q  HP +VRL   
Sbjct: 4   GRGNFGEVFSGRLRADNTPVAVKSC-RETLPPDLKAKFLQEARI-LKQYSHPNIVRLIGV 61

Query: 114 FQDTFSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIK 172
                 +Y+ +E  +GG+    + ++G  L   E           +EY+ S   IHRD+ 
Sbjct: 62  CTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLA 121

Query: 173 PENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA 232
             N L+T    +KI+DFG  +  +D     +  +    K      TA    PE LN    
Sbjct: 122 ARNCLVTEKNVLKISDFGMSREEEDG----VYASTGGMKQIPVKWTA----PEALNYGRY 173

Query: 233 TFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSDAARDLIDRL 289
           +  +D+W+ G  L++  S G  P+ + S     +  I + +R   P    DA   L++R 
Sbjct: 174 SSESDVWSFGILLWEAFSLGAVPYANLSNQQT-REAIEQGVRLPCPELCPDAVYRLMERC 232

Query: 290 LDVDPSGRPGAG 301
            + DP  RP   
Sbjct: 233 WEYDPGQRPSFS 244

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 74.5 bits (183), Expect = 5e-15
 Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 14/208 (6%)

Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAE 153
           E  V+ +L HP +V+L+        LY+  E  E G L + +  + G LS+D       +
Sbjct: 49  EAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQD 108

Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           V + +EY+     IHRD+   N L+++ G +K++DFG  + + D   T    A    K  
Sbjct: 109 VCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWS 168

Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDI 272
                    PPEV N S  +  +D+W+ G  ++++ + G  PF+  S + +   +I+R  
Sbjct: 169 ---------PPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVV-EMISRGF 218

Query: 273 RF--PNYFSDAARDLIDRLLDVDPSGRP 298
           R   P   S    +++       P GRP
Sbjct: 219 RLYRPKLASMTVYEVMYSCWHEKPEGRP 246

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 74.8 bits (184), Expect = 8e-15
 Identities = 70/270 (25%), Positives = 119/270 (44%), Gaps = 25/270 (9%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           F   +   GK  G G++ KVV A      K D     A+K++     + E +    +L+ 
Sbjct: 32  FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELK- 90

Query: 97  IVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAE 153
            ++  L +H  +V L         + +  E C  G+L + +  K    L+ ++   ++ +
Sbjct: 91  -IMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQ 149

Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKP-MQDSRITVLPNAASDDK 211
           V   + ++ S   IHRD+   N+LLT  G I KI DFG  +  M DS   V  NA    K
Sbjct: 150 VAKGMAFLASKNCIHRDLAARNVLLT-HGKIVKICDFGLARDIMNDSNYVVKGNARLPVK 208

Query: 212 ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR 270
                    ++ PE + +   TF +D+W+ G  L+++ S G++P+        F ++I  
Sbjct: 209 ---------WMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE 259

Query: 271 DIRF--PNYFSDAARDLIDRLLDVDPSGRP 298
             R   P +      D++    D DP  RP
Sbjct: 260 GYRMAQPEHAPAEIYDIMKTCWDADPLKRP 289

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 74.7 bits (183), Expect = 8e-15
 Identities = 65/229 (28%), Positives = 109/229 (47%), Gaps = 28/229 (12%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVY-ALKIMDKKFITKENKTAYVKLERIV----L 99
           Q +E     G G+Y KV +A+ +  G  + ALK +  +  T E       +  +     L
Sbjct: 1   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV--RVQTGEEGMPLSTIREVAVLRHL 58

Query: 100 DQLDHPGVVRLF------FTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYT 151
           +  +HP VVRLF       T ++T  L +  E  +       D++   G +  +  +   
Sbjct: 59  ETFEHPNVVRLFDVCTVSRTDRET-KLTLVFEHVDQDLTTYLDKVPEPG-VPTETIKDMM 116

Query: 152 AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDK 211
            +++  L+++HS  ++HRD+KP+N+L+T+ G IK+ADFG       +RI     A +   
Sbjct: 117 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL------ARIYSFQMALT--- 167

Query: 212 ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
             + V T  Y  PEVL  S      DLW++GC   +M      F+ +S+
Sbjct: 168 --SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 214

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 74.8 bits (184), Expect = 1e-14
 Identities = 61/223 (27%), Positives = 98/223 (43%), Gaps = 39/223 (17%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN----KTAYVKLERI---- 97
           D E  +  G G++  V        G   ALK M   F   +N    K  + +L+ +    
Sbjct: 1   DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF---QNLVSCKRVFRELKMLCFFK 57

Query: 98  ---VLDQLD--HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTA 152
              VL  LD   P  +  F   ++ + +   ++S    +L   I S   LS D  + +  
Sbjct: 58  HDNVLSALDILQPPHIDPF---EEIYVVTELMQS----DLHKIIVSPQPLSSDHVKVFLY 110

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           +++  L+Y+HS G++HRDIKP NLL+ ++  +KI DFG            L      D++
Sbjct: 111 QILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFG------------LARVEEPDES 158

Query: 213 CTF---VGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSG 251
                 V T  Y  PE+L  S   T   D+W++GC   ++L  
Sbjct: 159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGR 201

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 72.7 bits (178), Expect = 4e-14
 Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 15/208 (7%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G+Y+ V + +   T  + ALK  + +   +E        E  +L  L H  +V L   
Sbjct: 15  GEGTYATVFKGRSKLTENLVALK--EIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSMGLIHRDIK 172
                SL +  E  +  +L   +   G+ +S    + +  +++  L Y H   ++HRD+K
Sbjct: 73  VHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLK 131

Query: 173 PENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSP 231
           P+NLL+   G +K+ADFG       +R   +P     ++    V T  Y PP+V L SS 
Sbjct: 132 PQNLLINERGELKLADFGL------ARAKSVPTKTYSNE----VVTLWYRPPDVLLGSSE 181

Query: 232 ATFGNDLWALGCTLYQMLSGTSPFKDTS 259
            +   D+W +GC  ++M SG   F  ++
Sbjct: 182 YSTQIDMWGVGCIFFEMASGRPLFPGST 209

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 72.0 bits (176), Expect = 1e-13
 Identities = 68/297 (22%), Positives = 129/297 (43%), Gaps = 73/297 (24%)

Query: 55  VGSYSKVVRAKKIDT--GTVYALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF 111
           +GS ++ +     DT  G   A+K + + F  + + K AY +L  ++L  ++H  ++ L 
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYREL--VLLKCVNHKNIISLL 86

Query: 112 --FTFQDTFS----LYMALESCEGGELFD-QITSKGHLSEDEAR--FYTAEVVDALEYIH 162
             FT Q +      +Y+ +E      L D  +    H+  D  R  +   +++  ++++H
Sbjct: 87  NVFTPQKSLEEFQDVYLVME------LMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH 140

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S G+IHRD+KP N+++ +D  +KI DFG  +            A ++     +V T  Y 
Sbjct: 141 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TACTNFMMTPYVVTRYYR 189

Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT---SEW-----------LIFQRII 268
            PEV+         D+W++GC + +++ G+  F+ T    +W             F   +
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249

Query: 269 ARDIR-----------------FPNYF-----------SDAARDLIDRLLDVDPSGR 297
              +R                 FP++            +  ARDL+ ++L +DP  R
Sbjct: 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKR 306

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 70.2 bits (172), Expect = 1e-13
 Identities = 65/255 (25%), Positives = 106/255 (41%), Gaps = 28/255 (10%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G++  V +   +   T  A+K   +  +  + K  +++   I L Q DHP +V+L   
Sbjct: 4   GKGNFGDVYKGV-LKGNTEVAVKTC-RSTLPPDLKRKFLQEAEI-LKQYDHPNIVKLIGV 60

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE----VVDA---LEYIHSMGL 166
                 +Y+ +E   GG L         L + + R    +     +DA   +EY+ S   
Sbjct: 61  CVQKQPIYIVMELVPGGSLLT------FLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNC 114

Query: 167 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 226
           IHRD+   N L+  +  +KI+DFG  +  +    TV    +   K      TA    PE 
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV----SDGLKQIPIKWTA----PEA 166

Query: 227 LNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSDAAR 283
           LN    T  +D+W+ G  L++  S G +P+   S     +R I    R   P    +   
Sbjct: 167 LNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER-IESGYRMPAPQLCPEEIY 225

Query: 284 DLIDRLLDVDPSGRP 298
            L+ +    DP  RP
Sbjct: 226 RLMLQCWAYDPENRP 240

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 17/205 (8%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G+Y+ V + +   T  + ALK  + +   +E        E  +L  L H  +V L   
Sbjct: 15  GEGTYATVYKGRSKLTDNLVALK--EIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 114 FQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDI 171
                SL +  E  +    +  D   +  ++     + +  +++  L Y H   ++HRD+
Sbjct: 73  IHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHN--VKLFLFQLLRGLNYCHRRKVLHRDL 130

Query: 172 KPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSS 230
           KP+NLL+   G +K+ADFG       +R   +P     ++    V T  Y PP++ L S+
Sbjct: 131 KPQNLLINERGELKLADFGL------ARAKSIPTKTYSNE----VVTLWYRPPDILLGST 180

Query: 231 PATFGNDLWALGCTLYQMLSGTSPF 255
             +   D+W +GC  Y+M +G   F
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGRPLF 205

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 75/301 (24%), Positives = 128/301 (42%), Gaps = 72/301 (23%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQL 102
           + ++LG I G GS+  V  A  IDT    A+K  + D +         Y   E +++  L
Sbjct: 66  KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ---------YKNRELLIMKNL 116

Query: 103 DHPGVVRLF-FTFQDTF-----SLYMALESCEGGELFDQITSK--GHLSEDE-------A 147
           +H  ++ L  + + + F     ++++ +      E   Q   K   H + +         
Sbjct: 117 NHINIIFLKDYYYTECFKKNEKNIFLNVVM----EFIPQTVHKYMKHYARNNHALPLFLV 172

Query: 148 RFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVKPMQDSRITVLPNA 206
           + Y+ ++  AL YIHS  + HRD+KP+NLL+  + H +K+ DFGS K           N 
Sbjct: 173 KLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK-----------NL 221

Query: 207 ASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQ 265
            +  ++ +++ +  Y  PE+ L ++  T   DLW+LGC + +M+ G   F   S      
Sbjct: 222 LAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLV 281

Query: 266 RIIA-----------------RDIRFPNYFS------------DAARDLIDRLLDVDPSG 296
           RII                   DI+FP+               D A + I + L  +P  
Sbjct: 282 RIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLK 341

Query: 297 R 297
           R
Sbjct: 342 R 342

Length = 440

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 69.8 bits (171), Expect = 2e-13
 Identities = 63/265 (23%), Positives = 113/265 (42%), Gaps = 28/265 (10%)

Query: 45  QDFELGKIYGVGSYSKV---VRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
           +D  LG+  G G +  V   V     +     A+K   K   +   +  +++ E  ++ Q
Sbjct: 6   EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTC-KNCTSPSVREKFLQ-EAYIMRQ 63

Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSKGHLSEDEARFYTAEVVDALE 159
            DHP +V+L     +   +++ +E    GEL  + Q  +K  L       Y+ ++  AL 
Sbjct: 64  FDHPHIVKLIGVITEN-PVWIVMELAPLGELRSYLQ-VNKYSLDLASLILYSYQLSTALA 121

Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           Y+ S   +HRDI   N+L+++   +K+ DFG  + ++D          S  KA       
Sbjct: 122 YLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE---------SYYKASKGKLPI 172

Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-----DIR 273
            ++ PE +N    T  +D+W  G  ++++L  G  PF    + +    +I R      + 
Sbjct: 173 KWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPF----QGVKNNDVIGRIENGERLP 228

Query: 274 FPNYFSDAARDLIDRLLDVDPSGRP 298
            P         L+ +    DPS RP
Sbjct: 229 MPPNCPPTLYSLMTKCWAYDPSKRP 253

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 67.9 bits (166), Expect = 9e-13
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 40/224 (17%)

Query: 46  DFELGKIYGVGSYSKVVRAK---KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           +    K  G G +  V   K   KID     A+K++ +  +++++     K    V+ +L
Sbjct: 5   ELTFLKELGSGQFGVVHLGKWRGKIDV----AIKMIREGAMSEDDFIEEAK----VMMKL 56

Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTA-------EVV 155
            HP +V+L+        +++  E    G L +      +L E + +  T        +V 
Sbjct: 57  SHPNLVQLYGVCTKQRPIFIVTEYMANGCLLN------YLRERKGKLGTEWLLDMCSDVC 110

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           +A+EY+ S G IHRD+   N L+  D  +K++DFG       +R  +      DD+  + 
Sbjct: 111 EAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGL------ARYVL------DDQYTSS 158

Query: 216 VGT---AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
            GT     + PPEV + S  +  +D+W+ G  ++++ S G  P+
Sbjct: 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPY 202

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 81/316 (25%), Positives = 127/316 (40%), Gaps = 72/316 (22%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL--DH 104
           +E  +  G G+Y KV +A+  +TG + ALK    +    E       L  I L Q+  + 
Sbjct: 3   YEKLEKIGEGTYGKVYKARDKNTGKLVALK--KTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 105 PGVVRLF---FTFQDT--FSLYMALESCEGGELFDQITSKGH-----LSEDEARFYTAEV 154
             +VRL       +     SLY+  E  +  +L   + S G      L     + +  ++
Sbjct: 61  IYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119

Query: 155 VDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           +  + + H  G++HRD+KP+NLL+    G +KIAD G        R   +P      K+ 
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGL------GRAFSIPV-----KSY 168

Query: 214 TF-VGTAAYVPPEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE------- 260
           T  + T  Y  PEVL      S+P     D+W++GC   +M      F   SE       
Sbjct: 169 THEIVTLWYRAPEVLLGSTHYSTPV----DIWSVGCIFAEMSRKQPLFPGDSELQQLLHI 224

Query: 261 --------------------WLIFQRIIARDIR--FPNYFSDAARDLIDRLLDVDPSGRP 298
                               W  F +   +D+    P+  S    DL+ ++L  DP+ R 
Sbjct: 225 FKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPD-LSPEGLDLLQKMLRYDPAKRI 283

Query: 299 GAGPGGYAVLKMHPFF 314
            A     A L  HP+F
Sbjct: 284 SA----KAALT-HPYF 294

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 68.2 bits (167), Expect = 2e-12
 Identities = 73/305 (23%), Positives = 122/305 (40%), Gaps = 82/305 (26%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFI-TKENKTAYVKLERIVLDQLDHPGVVR 109
           K  G G+   V  A    TG   A+K + + F      K AY +L  +++  ++H  ++ 
Sbjct: 22  KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYREL--VLMKLVNHKNIIG 79

Query: 110 LF--FTFQDTFS----LYMALESCEGGELFD----QITSKGHLSEDEAR--FYTAEVVDA 157
           L   FT Q +      +Y+ +E      L D    Q+     +  D  R  +   +++  
Sbjct: 80  LLNVFTPQKSLEEFQDVYLVME------LMDANLCQVI---QMDLDHERMSYLLYQMLCG 130

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT-FV 216
           ++++HS G+IHRD+KP N+++ +D  +KI DFG            L   A      T +V
Sbjct: 131 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG------------LARTAGTSFMMTPYV 178

Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT---SEW------------ 261
            T  Y  PEV+         D+W++GC + +M+ GT  F  T    +W            
Sbjct: 179 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSD 238

Query: 262 ----------------------LIFQRIIARDIRFPNYFSDA-------ARDLIDRLLDV 292
                                   F+ +   D+ FP             ARDL+ ++L +
Sbjct: 239 EFMSRLQPTVRNYVENRPKYAGYSFEELFP-DVLFPPDSESHNKLKASQARDLLSKMLVI 297

Query: 293 DPSGR 297
           DP  R
Sbjct: 298 DPEKR 302

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 68.2 bits (166), Expect = 3e-12
 Identities = 38/105 (36%), Positives = 51/105 (48%), Gaps = 9/105 (8%)

Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
           + R    +++ A+EYIH   LIHRDIK EN+ L  DG I + DFG+  P +  R      
Sbjct: 268 QTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA---- 323

Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS 250
                    +VGT A   PE+L         D+W+ G  L  MLS
Sbjct: 324 -----FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 66.3 bits (162), Expect = 4e-12
 Identities = 53/226 (23%), Positives = 97/226 (42%), Gaps = 42/226 (18%)

Query: 43  SIQDFELGKIYGVGSYSKVV----RAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ER 96
           + ++ +LG   G G +  V+    R +K+      A+K +      K++ TA      E 
Sbjct: 4   NSKELKLGATIGKGEFGDVMLGDYRGQKV------AVKCL------KDDSTAAQAFLAEA 51

Query: 97  IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEV 154
            V+  L HP +V+L         LY+  E    G L D + S+G   ++  +   +  +V
Sbjct: 52  SVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDV 111

Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV----LPNAASDD 210
            + +EY+     +HRD+   N+L++ D   K++DFG  K   ++        LP      
Sbjct: 112 CEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK---EASQGQDSGKLP------ 162

Query: 211 KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                     +  PE L     +  +D+W+ G  L+++ S G  P+
Sbjct: 163 --------VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 65.7 bits (160), Expect = 4e-12
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 32/225 (14%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL-ERIVLD 100
            ++Q   LG+I G G +  V++ +   TG   A+K +      K + TA   L E  V+ 
Sbjct: 3   LNLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNI------KCDVTAQAFLEETAVMT 54

Query: 101 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF--YTAEVVDAL 158
           +L H  +VRL         LY+ +E    G L + + ++G       +   ++ +V + +
Sbjct: 55  KLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGM 113

Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFG--SVKPMQ-DSRITVLPNAASDDKACTF 215
           EY+ S  L+HRD+   N+L++ DG  K++DFG   V  M  D+  + LP           
Sbjct: 114 EYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDN--SKLP----------- 160

Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
                +  PE L     +  +D+W+ G  L+++ S G +P+   S
Sbjct: 161 ---VKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS 202

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 65.1 bits (159), Expect = 7e-12
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 26/214 (12%)

Query: 54  GVGSYSKVV----RAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVR 109
           G G++  VV      K      V A+K + ++ I    K  +++ E  V+ QLDHP +VR
Sbjct: 4   GHGNFGSVVKGVYLMKSGKEVEV-AVKTLKQEHI-AAGKKEFLR-EASVMAQLDHPCIVR 60

Query: 110 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 169
           L    +    L + +E    G L   +  +  +   + +    +V   + Y+ S   +HR
Sbjct: 61  LIGVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHR 119

Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----P 224
           D+   N+LL      KI+DFG  + +          A SD    T   TA   P     P
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRAL---------GAGSDYYRAT---TAGRWPLKWYAP 167

Query: 225 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKD 257
           E +N    +  +D+W+ G TL++  S G  P+ +
Sbjct: 168 ECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGE 201

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 65.5 bits (160), Expect = 7e-12
 Identities = 29/112 (25%), Positives = 55/112 (49%), Gaps = 17/112 (15%)

Query: 150 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 209
           +++++   ++Y+ S   IHRD+   N+L+ ++  +KI+DFG            L     +
Sbjct: 114 FSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFG------------LAKVLPE 161

Query: 210 DKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK 256
           DK   +V      P     PE L +S  +  +D+W+ G TLY++ +   P +
Sbjct: 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQ 213

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 65.4 bits (159), Expect = 7e-12
 Identities = 62/264 (23%), Positives = 115/264 (43%), Gaps = 29/264 (10%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL-ERIVLD 100
            ++++ +L +  G G +  V+       G   A+K +      K + TA   L E  V+ 
Sbjct: 3   LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCI------KNDATAQAFLAEASVMT 54

Query: 101 QLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDA 157
           QL H  +V+L     ++   LY+  E    G L D + S+G   L  D    ++ +V +A
Sbjct: 55  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 114

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV-LPNAASDDKACTFV 216
           +EY+ +   +HRD+   N+L++ D   K++DFG  K    ++ T  LP            
Sbjct: 115 MEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP------------ 162

Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRI-IARDIRF 274
               +  PE L     +  +D+W+ G  L+++ S G  P+       +  R+     +  
Sbjct: 163 --VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA 220

Query: 275 PNYFSDAARDLIDRLLDVDPSGRP 298
           P+       D++ +   +D + RP
Sbjct: 221 PDGCPPVVYDVMKQCWHLDAATRP 244

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 65.3 bits (159), Expect = 8e-12
 Identities = 45/164 (27%), Positives = 80/164 (48%), Gaps = 13/164 (7%)

Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGH-LSEDEARFYTA 152
           E  ++ QL HP +VRL+        +Y+  E  E G L D + T +G  L+ ++     A
Sbjct: 51  EANLMKQLQHPRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAA 109

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++ + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K 
Sbjct: 110 QIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIK- 168

Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 169 --------WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 44/168 (26%), Positives = 78/168 (46%), Gaps = 12/168 (7%)

Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTA 152
           E  ++  L H  +VRL+        +Y+  E    G L D + S   G +   +   ++A
Sbjct: 51  EANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA 110

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++ + + YI     IHRD++  N+L++     KIADFG  + ++D+  T    A    K 
Sbjct: 111 QIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK- 169

Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
                   +  PE +N    T  +D+W+ G  LY++++ G  P+   S
Sbjct: 170 --------WTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS 209

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 46/191 (24%), Positives = 94/191 (49%), Gaps = 21/191 (10%)

Query: 74  ALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELF 133
           A+K + +  +++E+       E  V+ +L HP +V+L+    +   + +  E  E G L 
Sbjct: 32  AIKTIREGAMSEED----FIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLS 87

Query: 134 DQI-TSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV 192
           D +   +G  S++       +V + + Y+ S  +IHRD+   N L+  +  +K++DFG  
Sbjct: 88  DYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGM- 146

Query: 193 KPMQDSRITVLPNAASDDKACTFVGT---AAYVPPEVLNSSPATFGNDLWALGCTLYQML 249
                +R  +      DD+  +  GT     +  PEV + S  +  +D+W+ G  ++++ 
Sbjct: 147 -----TRFVL------DDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVF 195

Query: 250 S-GTSPFKDTS 259
           S G +P+++ S
Sbjct: 196 SEGKTPYENRS 206

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 22/219 (10%)

Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 154
           E  +L  ++HP +++L  TF       + L   +  +L+  + +K +++  +       V
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERSV 191

Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           + A++Y+H   +IHRDIK EN+ +   G + + DFG+            P   + +K   
Sbjct: 192 LRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGA---------ACFPVDINANKYYG 242

Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF--KD------TSEWLIFQR 266
           + GT A   PE+L   P     D+W+ G  L++M +       KD       S+  I + 
Sbjct: 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQI-KL 301

Query: 267 IIARDIRFPNYFSDAARDLIDRL---LDVDPSGRPGAGP 302
           II R    PN F   A+  +D +   L    S +PG+ P
Sbjct: 302 IIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRP 340

Length = 391

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 63.0 bits (153), Expect = 5e-11
 Identities = 48/191 (25%), Positives = 88/191 (46%), Gaps = 12/191 (6%)

Query: 68  DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALE 125
            TG + A+K + K+   ++N + + K E  +L  L H  +V+     + Q    L + +E
Sbjct: 31  GTGEMVAVKTL-KRECGQQNTSGWKK-EINILKTLYHENIVKYKGCCSEQGGKGLQLIME 88

Query: 126 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIK 185
               G L D +  K  L+  +   +  ++ + + Y+HS   IHRD+   N+LL  D  +K
Sbjct: 89  YVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVK 147

Query: 186 IADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTL 245
           I DFG  K + +           D  +  F     +   E L  +  ++ +D+W+ G TL
Sbjct: 148 IGDFGLAKAVPEGHEYY--RVREDGDSPVF-----WYAVECLKENKFSYASDVWSFGVTL 200

Query: 246 YQMLSGTSPFK 256
           Y++L+     +
Sbjct: 201 YELLTHCDSKQ 211

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 62.2 bits (151), Expect = 8e-11
 Identities = 46/173 (26%), Positives = 77/173 (44%), Gaps = 29/173 (16%)

Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE- 153
           E  V+ +L H  +V+L+        +Y+  E    G L + +   G       RF  ++ 
Sbjct: 49  EAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGK------RFQPSQL 102

Query: 154 ------VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA 207
                 V + + Y+ S   IHRD+   N L+   G +K++DFG            L    
Sbjct: 103 LEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFG------------LSRYV 150

Query: 208 SDDKACTFVGTAAYV---PPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
            DD+  + VG+   V   PPEVL  S  +  +D+WA G  ++++ S G  P++
Sbjct: 151 LDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 63.0 bits (153), Expect = 9e-11
 Identities = 51/205 (24%), Positives = 84/205 (40%), Gaps = 22/205 (10%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           + + K    GS  +V  A K        LKI  K             +E ++L  ++HP 
Sbjct: 68  YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK---------GTTLIEAMLLQNVNHPS 118

Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMG 165
           V+R+  T        M L      +L+  +T +   L  D+A     ++++ L Y+H+  
Sbjct: 119 VIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR 177

Query: 166 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 225
           +IHRD+K EN+ +     + I D G+ +          P  A         GT     PE
Sbjct: 178 IIHRDVKTENIFINDVDQVCIGDLGAAQ---------FPVVAPAFLG--LAGTVETNAPE 226

Query: 226 VLNSSPATFGNDLWALGCTLYQMLS 250
           VL         D+W+ G  L++ML+
Sbjct: 227 VLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 62/259 (23%), Positives = 113/259 (43%), Gaps = 21/259 (8%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +  +L K  G G + +V  A   +  T  A+K M    ++ E   A++  E  V+  L H
Sbjct: 6   ESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVE---AFLA-EANVMKTLQH 60

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF--YTAEVVDALEYIH 162
             +V+L         +Y+  E    G L D + S     +   +   ++A++ + + +I 
Sbjct: 61  DKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 119

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
               IHRD++  N+L++A    KIADFG  + ++D+  T    A    K         + 
Sbjct: 120 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK---------WT 170

Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRFPNYFS-- 279
            PE +N    T  +D+W+ G  L ++++ G  P+   S   +  R + R  R P   +  
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI-RALERGYRMPRPENCP 229

Query: 280 DAARDLIDRLLDVDPSGRP 298
           +   +++ R     P  RP
Sbjct: 230 EELYNIMMRCWKNRPEERP 248

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 62.6 bits (152), Expect = 2e-10
 Identities = 39/160 (24%), Positives = 69/160 (43%), Gaps = 13/160 (8%)

Query: 98  VLDQLDHPGVVRLF--FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
           +L  + H  ++ L   + ++ T  + M    C+   LF  +   G L  ++A      ++
Sbjct: 139 ILKTISHRAIINLIHAYRWKSTVCMVMPKYKCD---LFTYVDRSGPLPLEQAITIQRRLL 195

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           +AL Y+H  G+IHRD+K EN+ L    +  + DFG+   +     T         +   +
Sbjct: 196 EALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT--------PQCYGW 247

Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            GT     PE+L   P     D+W+ G  L++M       
Sbjct: 248 SGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 62/252 (24%), Positives = 108/252 (42%), Gaps = 17/252 (6%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           ++ G G++ +V +    D   V A+K   K+ + +E K  ++   RI L Q DHP +V+L
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTPV-AVKTC-KEDLPQELKIKFLSEARI-LKQYDHPNIVKL 57

Query: 111 FFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 169
                    +Y+ +E   GG+    +   K  L   +   +  +    + Y+ S   IHR
Sbjct: 58  IGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHR 117

Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 229
           D+   N L+  +  +KI+DFG  +   D   +     +S  K      TA    PE LN 
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYS-----SSGLKQIPIKWTA----PEALNY 168

Query: 230 SPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSDAARDLI 286
              +  +D+W+ G  L++  S G  P+   +     ++ + +  R   P    D    ++
Sbjct: 169 GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQ-VEKGYRMSCPQKCPDDVYKVM 227

Query: 287 DRLLDVDPSGRP 298
            R  D  P  RP
Sbjct: 228 QRCWDYKPENRP 239

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 60.9 bits (147), Expect = 4e-10
 Identities = 62/273 (22%), Positives = 120/273 (43%), Gaps = 65/273 (23%)

Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q +      +Y+ +E 
Sbjct: 46  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL 103

Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 104 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 160

Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 161 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 209

Query: 247 QMLSGTS--PFKD-TSEW--LI---------FQRIIARDIR-------------FPNYFS 279
           +M+      P +D   +W  +I         F + +   +R             FP  F 
Sbjct: 210 EMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFP 269

Query: 280 DA---------------ARDLIDRLLDVDPSGR 297
           D+               ARDL+ ++L +DP+ R
Sbjct: 270 DSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 302

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 59.3 bits (144), Expect = 7e-10
 Identities = 40/171 (23%), Positives = 70/171 (40%), Gaps = 32/171 (18%)

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF-------- 149
           ++ +L H  +V+L+    +   +Y+  E    G L D       L   E +         
Sbjct: 54  IMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLD------FLKSGEGKKLRLPQLVD 107

Query: 150 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAAS 208
             A++ + + Y+ S   IHRD+   N+L+  +  + KIADFG            L     
Sbjct: 108 MAAQIAEGMAYLESRNYIHRDLAARNILV-GENLVCKIADFG------------LARLIE 154

Query: 209 DDKACTFVGTA---AYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           DD+     G      +  PE  N    T  +D+W+ G  L ++++ G  P+
Sbjct: 155 DDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPY 205

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 59.4 bits (144), Expect = 7e-10
 Identities = 56/234 (23%), Positives = 97/234 (41%), Gaps = 18/234 (7%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           ++F L +  G G + +V      +   V A+KI+  K      +  + K E   L +L H
Sbjct: 6   EEFTLERKLGSGYFGEVWEGLWKNRVRV-AIKIL--KSDDLLKQQDFQK-EVQALKRLRH 61

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF--YTAEVVDALEYIH 162
             ++ LF        +Y+  E  E G L   + S        A       +V + + Y+ 
Sbjct: 62  KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
               IHRD+   N+L+  D   K+ADFG  + +++          S DK   +  TA   
Sbjct: 122 EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL------SSDKKIPYKWTA--- 172

Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRFP 275
            PE  +    +  +D+W+ G  LY+M + G  P+   +   ++ + I    R P
Sbjct: 173 -PEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQ-ITAGYRMP 224

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 58.8 bits (142), Expect = 1e-09
 Identities = 47/188 (25%), Positives = 86/188 (45%), Gaps = 16/188 (8%)

Query: 68  DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALE 125
           +TG   A+K +  +  +  N  A +K E  +L  L H  +V+     T      + + +E
Sbjct: 31  NTGEQVAVKSLKPE--SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME 88

Query: 126 SCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI 184
               G L + +  +K  ++  +   Y  ++   ++Y+ S   +HRD+   N+L+ ++  +
Sbjct: 89  FLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQV 148

Query: 185 KIADFGSVKPMQDSR--ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALG 242
           KI DFG  K ++  +   TV      DD        A    PE L  S     +D+W+ G
Sbjct: 149 KIGDFGLTKAIETDKEYYTV-----KDDLDSPVFWYA----PECLIQSKFYIASDVWSFG 199

Query: 243 CTLYQMLS 250
            TLY++L+
Sbjct: 200 VTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 8/95 (8%)

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           +++ A++YIH  G+IHRDIK EN+L+     I + DFG+    + S  T      +    
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIA---- 323

Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQ 247
               GT     PEVL   P T   D+W+ G  +++
Sbjct: 324 ----GTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 47/192 (24%), Positives = 93/192 (48%), Gaps = 23/192 (11%)

Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q +      +Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110

Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167

Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216

Query: 247 QMLSGTSPFKDT 258
           +M+ G   F  T
Sbjct: 217 EMIKGGVLFPGT 228

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 52/267 (19%), Positives = 101/267 (37%), Gaps = 32/267 (11%)

Query: 51  KIYGVGSYSKVV--RAKKIDTGTVYALKIMDKKFITK--ENKTAYVKLERIVLDQLDHPG 106
              G G + +V   +AK I+      L ++ K       EN  +  + E  +  +L H  
Sbjct: 11  TTLGRGEFGEVFLAKAKGIEEEGGETL-VLVKALQKTKDENLQSEFRRELDMFRKLSHKN 69

Query: 107 VVRLFFTFQDTFSLYMALESCEGGEL--FDQITSKGHLSEDEARFYTAEVVD-------A 157
           VVRL    ++    YM LE  + G+L  F + T             T + V         
Sbjct: 70  VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           ++++ +   +HRD+   N L+++   +K++               L     + +      
Sbjct: 130 MDHLSNARFVHRDLAARNCLVSSQREVKVSLLS------------LSKDVYNSEYYKLRN 177

Query: 218 TAA---YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIR 273
                 ++ PE +     +  +D+W+ G  ++++ + G  PF   S+  +  R+ A  + 
Sbjct: 178 ALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLE 237

Query: 274 F--PNYFSDAARDLIDRLLDVDPSGRP 298
              P         L+ R   V+P  RP
Sbjct: 238 LPVPEGCPSRLYKLMTRCWAVNPKDRP 264

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 77/305 (25%), Positives = 132/305 (43%), Gaps = 66/305 (21%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK----TAYVKLERIVLDQLDHPGVVR 109
           G G+Y  V +A+   T    ALK   K  + +E++    TA  ++   +L ++ H  +VR
Sbjct: 11  GEGTYGVVYKARDRVTNETIALK---KIRLEQEDEGVPSTAIREIS--LLKEMQHGNIVR 65

Query: 110 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDE--ARFYTAEVVDALEYIHSMGLI 167
           L         LY+  E  +  +L   + S    +++    + Y  +++  + Y HS  ++
Sbjct: 66  LQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVL 124

Query: 168 HRDIKPENLLLT-ADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 226
           HRD+KP+NLL+      +K+ADFG       +R   +P      +    V T  Y  PE+
Sbjct: 125 HRDLKPQNLLIDRRTNALKLADFGL------ARAFGIPVRTFTHE----VVTLWYRAPEI 174

Query: 227 L-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRIIARD------ 271
           L      S+P     D+W++GC   +M++    F   SE    + IF+ +   +      
Sbjct: 175 LLGSRHYSTPV----DIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG 230

Query: 272 -IRFPNYFS------------------DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHP 312
               P+Y S                   A  DL+ ++L +DPS R  A     A L+ H 
Sbjct: 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITAR----AALE-HE 285

Query: 313 FFKGI 317
           +FK +
Sbjct: 286 YFKDL 290

Length = 294

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 58.5 bits (141), Expect = 4e-09
 Identities = 23/43 (53%), Positives = 32/43 (74%)

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM 195
           +V+  L  +H +G++HRDIKPENLL+T DG +KI DFG+   M
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDM 359

Length = 507

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 57.2 bits (138), Expect = 4e-09
 Identities = 52/232 (22%), Positives = 98/232 (42%), Gaps = 50/232 (21%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER-------IVLD 100
           K+ G G + +V   +         LK+  K+ I    K  K  Y + +R        ++ 
Sbjct: 10  KVIGAGEFGEVCSGR---------LKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMG 60

Query: 101 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL-- 158
           Q DHP ++ L      +  + +  E  E G L         L + + +F   ++V  L  
Sbjct: 61  QFDHPNIIHLEGVVTKSKPVMIVTEYMENGSL------DAFLRKHDGQFTVIQLVGMLRG 114

Query: 159 -----EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
                +Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA      
Sbjct: 115 IASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD-----PEAA------ 163

Query: 214 TFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
            +      +P     PE +     T  +D+W+ G  +++++S G  P+ + S
Sbjct: 164 -YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS 214

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 57.8 bits (139), Expect = 4e-09
 Identities = 68/258 (26%), Positives = 113/258 (43%), Gaps = 46/258 (17%)

Query: 54  GVGSYSKVVRAKKID--TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL- 110
           G G+Y  V +AK+ D      YALK ++   I+          E  +L +L HP V+ L 
Sbjct: 10  GRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMS-----ACREIALLRELKHPNVISLQ 64

Query: 111 --FFTFQDTFSLYMALESCEGGELFDQI----TSKGH-----LSEDEARFYTAEVVDALE 159
             F +  D   +++  +  E  +L+  I     SK +     L     +    +++D + 
Sbjct: 65  KVFLSHADR-KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122

Query: 160 YIHSMGLIHRDIKPENLLLTAD----GHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           Y+H+  ++HRD+KP N+L+  +    G +KIAD G  +        + P A  D    TF
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP---LKPLADLDPVVVTF 179

Query: 216 VGTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF 274
                Y  PE +L +   T   D+WA+GC   ++L+    F    E          DI+ 
Sbjct: 180 ----WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE----------DIKT 225

Query: 275 PNYFSDAARDLIDRLLDV 292
            N +     D +DR+ +V
Sbjct: 226 SNPYH---HDQLDRIFNV 240

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 57.8 bits (139), Expect = 4e-09
 Identities = 68/258 (26%), Positives = 113/258 (43%), Gaps = 46/258 (17%)

Query: 54  GVGSYSKVVRAKKIDTG--TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV--- 108
           G G+Y  V +AK+ D      YALK ++   I+          E  +L +L HP V+   
Sbjct: 10  GRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMS-----ACREIALLRELKHPNVIALQ 64

Query: 109 RLFFTFQDTFSLYMALESCEGGELFDQI----TSKGH-----LSEDEARFYTAEVVDALE 159
           ++F +  D   +++  +  E  +L+  I     SK +     L     +    +++D + 
Sbjct: 65  KVFLSHSDR-KVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122

Query: 160 YIHSMGLIHRDIKPENLLLTAD----GHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           Y+H+  ++HRD+KP N+L+  +    G +KIAD G  +        + P A  D    TF
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP---LKPLADLDPVVVTF 179

Query: 216 VGTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF 274
                Y  PE +L +   T   D+WA+GC   ++L+    F    E          DI+ 
Sbjct: 180 ----WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE----------DIKT 225

Query: 275 PNYFSDAARDLIDRLLDV 292
            N F     D +DR+  V
Sbjct: 226 SNPFH---HDQLDRIFSV 240

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 56.5 bits (136), Expect = 5e-09
 Identities = 50/201 (24%), Positives = 91/201 (45%), Gaps = 24/201 (11%)

Query: 62  VRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY 121
           +R K+ID   +  LK  ++K +  E        E  ++ QLD+P +VR+    +   +L 
Sbjct: 18  MRKKQIDVA-IKVLKNENEKSVRDEMMR-----EAEIMHQLDNPYIVRMIGVCEAE-ALM 70

Query: 122 MALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA 180
           + +E   GG L   ++ K   ++         +V   ++Y+     +HRD+   N+LL  
Sbjct: 71  LVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVN 130

Query: 181 DGHIKIADFGSVKPMQDSRITVLPNAASDD---KACTFVG-TAAYVPPEVLNSSPATFGN 236
             + KI+DFG  K +            +DD   KA +       +  PE +N    +  +
Sbjct: 131 QHYAKISDFGLSKAL-----------GADDSYYKARSAGKWPLKWYAPECINFRKFSSRS 179

Query: 237 DLWALGCTLYQMLS-GTSPFK 256
           D+W+ G T+++  S G  P+K
Sbjct: 180 DVWSYGITMWEAFSYGQKPYK 200

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 56.4 bits (136), Expect = 6e-09
 Identities = 42/164 (25%), Positives = 70/164 (42%), Gaps = 12/164 (7%)

Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDE-ARFYTA- 152
           E  V+ ++ HP +V+L          Y+  E    G L D +        +     Y A 
Sbjct: 52  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 111

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 112 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK- 170

Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 171 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 206

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 56.6 bits (136), Expect = 9e-09
 Identities = 54/233 (23%), Positives = 100/233 (42%), Gaps = 37/233 (15%)

Query: 45  QDFELGKIYGVGSYSKVVRAK-KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +D +   + G G++ +V+RA  K D   + A   M K+F ++ +   +     ++     
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEA---------------- 147
           HP ++ L    ++   LY+A+E    G L D +     L  D A                
Sbjct: 62  HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121

Query: 148 -RFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ---DSRITVL 203
            +F  ++V   ++Y+     IHRD+   N+L+  +   KIADFG  +  +      +  L
Sbjct: 122 LQF-ASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRL 180

Query: 204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           P                ++  E LN S  T  +D+W+ G  L++++S G +P+
Sbjct: 181 P--------------VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPY 219

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 56.1 bits (135), Expect = 1e-08
 Identities = 63/289 (21%), Positives = 121/289 (41%), Gaps = 51/289 (17%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTG-----TVYALKIMDKKFITKENKTAYVKL--ERIV 98
           +  LGK  G G + KVV+A           T  A+K++ +      + +    L  E  +
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN----ASSSELRDLLSEFNL 56

Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSK---GHLSEDEARFYTA- 152
           L Q++HP V++L+        L + +E  + G L  F + + K    +L  D  R  +  
Sbjct: 57  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYL 116

Query: 153 ------------------EVVDALEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVK 193
                             ++   ++Y+  M L+HRD+   N+L+ A+G   KI+DFG  +
Sbjct: 117 DNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV-AEGRKMKISDFGLSR 175

Query: 194 PM--QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS- 250
            +  +DS +       S  +         ++  E L     T  +D+W+ G  L+++++ 
Sbjct: 176 DVYEEDSYVK-----RSKGRI-----PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 225

Query: 251 GTSPFKDTSEWLIFQRI-IARDIRFPNYFSDAARDLIDRLLDVDPSGRP 298
           G +P+   +   +F  +     +  P   S+   +L+      +P  RP
Sbjct: 226 GGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRP 274

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 52/232 (22%), Positives = 101/232 (43%), Gaps = 37/232 (15%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVY--ALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           D +   + G G++ +V++A+    G     A+K M K++ +K++   +     ++     
Sbjct: 8   DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGH 66

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQI----------------TSKGHLSEDEA 147
           HP ++ L    +    LY+A+E    G L D +                ++   LS  + 
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 148 RFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ---DSRITVLP 204
             + A+V   ++Y+     IHRD+   N+L+  +   KIADFG  +  +      +  LP
Sbjct: 127 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 186

Query: 205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                           ++  E LN S  T  +D+W+ G  L++++S G +P+
Sbjct: 187 --------------VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 224

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 38/145 (26%), Positives = 63/145 (43%), Gaps = 26/145 (17%)

Query: 139 KGHLSEDEARF-------YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS 191
           + +L +   R        Y +++   +EY+ S   +HRD+   N+L+ ++  +KI DFG 
Sbjct: 95  RDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGL 154

Query: 192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLY 246
            K        VLP     DK    V      P     PE L  S  +  +D+W+ G  LY
Sbjct: 155 TK--------VLPQ----DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 202

Query: 247 QMLSGTSPFKDTSEWLIFQRIIARD 271
           ++ + +   K  S    F R++  D
Sbjct: 203 ELFTYSD--KSCSPPAEFMRMMGND 225

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 58/230 (25%), Positives = 102/230 (44%), Gaps = 36/230 (15%)

Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDK--KFITKENKTAYVKLERIVL- 99
           S Q F++  + G G++ KVV A         A+KI+    K+ T++ K     +E++   
Sbjct: 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKY-TRDAKIEIQFMEKVRQA 185

Query: 100 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGE-LFDQITSKGHLSEDEARFYTAEVVDAL 158
           D  D   ++++   FQ+  + +M +   + G  L D I   G  S         +   AL
Sbjct: 186 DPADRFPLMKIQRYFQNE-TGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVAL 244

Query: 159 EYIHS-MGLIHRDIKPENLLL-TADG---------------HIKIADFGSVKPMQDSRIT 201
           +Y H+ + L+H D+KPEN+L+ T+D                 ++I D G     + SR  
Sbjct: 245 DYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTA 304

Query: 202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSG 251
           +             V T  Y  PEV+      +  D+W++GC +Y++ +G
Sbjct: 305 I-------------VSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTG 341

Length = 467

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 55/246 (22%), Positives = 106/246 (43%), Gaps = 45/246 (18%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER-------IVLD 100
           ++ G G + +V R +         LK+  K+ I    K  K+ Y + +R        ++ 
Sbjct: 10  EVIGAGEFGEVCRGR---------LKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMG 60

Query: 101 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL-- 158
           Q DHP ++ L      +  + +  E  E G L         L +++ +F   ++V  L  
Sbjct: 61  QFDHPNIIHLEGVVTKSRPVMIITEFMENGAL------DSFLRQNDGQFTVIQLVGMLRG 114

Query: 159 -----EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
                +Y+  M  +HRD+   N+L+ ++   K++DFG  + ++D          SD    
Sbjct: 115 IAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD--------TSDPTYT 166

Query: 214 TFVGTAA---YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIA 269
           + +G      +  PE +     T  +D+W+ G  +++++S G  P+ D S   +    I 
Sbjct: 167 SSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIN-AIE 225

Query: 270 RDIRFP 275
           +D R P
Sbjct: 226 QDYRLP 231

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 55.1 bits (132), Expect = 2e-08
 Identities = 49/209 (23%), Positives = 89/209 (42%), Gaps = 16/209 (7%)

Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTA 152
           E  ++ +L H  +V L+    +   +Y+  E    G L D +      +L   +     A
Sbjct: 51  EAQIMKKLRHDKLVPLYAVVSEE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAA 109

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++ D + YI  M  IHRD++  N+L+  +   KIADFG  + ++D+  T    A    K 
Sbjct: 110 QIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIK- 168

Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD 271
                   +  PE       T  +D+W+ G  L ++++ G  P+       + ++ + R 
Sbjct: 169 --------WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQ-VERG 219

Query: 272 IRF--PNYFSDAARDLIDRLLDVDPSGRP 298
            R   P    ++  +L+      DP  RP
Sbjct: 220 YRMPCPQGCPESLHELMKLCWKKDPDERP 248

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 55.1 bits (132), Expect = 2e-08
 Identities = 52/226 (23%), Positives = 96/226 (42%), Gaps = 37/226 (16%)

Query: 52  IYGVGSYSKVVRAK-KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           + G G++ +V++A+ K D   + A     K++ +K++   +     ++     HP ++ L
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEA-----------------RFYTAE 153
               +    LY+A+E    G L D +     L  D A                  F  A+
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF-AAD 120

Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ---DSRITVLPNAASDD 210
           V   ++Y+     IHRD+   N+L+  +   KIADFG  +  +      +  LP      
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP------ 174

Query: 211 KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                     ++  E LN S  T  +D+W+ G  L++++S G +P+
Sbjct: 175 --------VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 212

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 52/215 (24%), Positives = 90/215 (41%), Gaps = 30/215 (13%)

Query: 54  GVGSYSKVVRA--KKIDTGTVYALKIMDKKFITKENKTAYVKLERI----VLDQLDHPGV 107
           G G++  V +   K   +    A+KI+       +N    +K E +    V+ QLD+P +
Sbjct: 4   GSGNFGTVKKGMYKMKKSEKTVAVKIL-----KNDNNDPALKDELLREANVMQQLDNPYI 58

Query: 108 VRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLI 167
           VR+     +  S  + +E  E G L   +    H++E        +V   ++Y+     +
Sbjct: 59  VRMI-GICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFV 117

Query: 168 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP---- 223
           HRD+   N+LL    + KI+DFG            L  A   D+      T    P    
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFG------------LSKALGADENYYKAKTHGKWPVKWY 165

Query: 224 -PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
            PE +N    +  +D+W+ G  +++  S G  P+K
Sbjct: 166 APECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYK 200

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 51/203 (25%), Positives = 84/203 (41%), Gaps = 43/203 (21%)

Query: 74  ALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELF 133
           A+KI+ +    K  +  ++K E  +L +L  P ++RL     D   L M  E  E G+L 
Sbjct: 50  AVKIL-RPDANKNARNDFLK-EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL- 106

Query: 134 DQITSKGHLSEDEAR--------------------FYTAEVVDALEYIHSMGLIHRDIKP 173
           +Q  S  HL + E                          ++   ++Y+ S+  +HRD+  
Sbjct: 107 NQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLAT 166

Query: 174 ENLLLTADGHIKIADFGSVKPMQDS---RI---TVLPNAASDDKACTFVGTAAYVPPEVL 227
            N L+  +  IKIADFG  + +      RI    VLP                ++  E +
Sbjct: 167 RNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLP--------------IRWMAWECI 212

Query: 228 NSSPATFGNDLWALGCTLYQMLS 250
                T  +D+WA G TL+++L 
Sbjct: 213 LMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 54/235 (22%), Positives = 89/235 (37%), Gaps = 48/235 (20%)

Query: 48  ELGKIYGVGSYSKV----VRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
            L +  G G++ +V     R +  D      + +        E   +   +E +++ + +
Sbjct: 9   TLLRALGHGAFGEVYEGLYRGRDGDA-VELQVAVKTLPESCSEQDESDFLMEALIMSKFN 67

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEAR-------------FY 150
           H  +VRL     +    ++ LE   GG+L      K  L E+  R             F 
Sbjct: 68  HQNIVRLIGVSFERLPRFILLELMAGGDL------KSFLRENRPRPERPSSLTMKDLLFC 121

Query: 151 TAEVVDALEYIHSMGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDS---RI---T 201
             +V    +Y+     IHRDI   N LLT  G     KIADFG  + +  +   R     
Sbjct: 122 ARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRA 181

Query: 202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           +LP                ++PPE       T   D+W+ G  L+++ S G  P+
Sbjct: 182 MLP--------------IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY 222

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 54.9 bits (132), Expect = 3e-08
 Identities = 50/195 (25%), Positives = 90/195 (46%), Gaps = 12/195 (6%)

Query: 69  TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCE 128
           TG    ++ ++ +  T E  T +++ E  V    +HP +V    TF     L++      
Sbjct: 24  TGEYVTVRRINLEACTNEMVT-FLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82

Query: 129 GGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            G   D I +     +SE    +    V+ AL+YIH MG +HR +K  ++L++ DG + +
Sbjct: 83  YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYL 142

Query: 187 ADFGSVKPM--QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFG--NDLWALG 242
           +   S   M     R+ V+      D     V    ++ PEVL  +   +   +D++++G
Sbjct: 143 SGLRSNLSMINHGQRLRVV-----HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVG 197

Query: 243 CTLYQMLSGTSPFKD 257
            T  ++ +G  PFKD
Sbjct: 198 ITACELANGHVPFKD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 54.4 bits (131), Expect = 3e-08
 Identities = 63/299 (21%), Positives = 106/299 (35%), Gaps = 65/299 (21%)

Query: 47  FELGKIYGVGSYSKVVRAK-KIDTGTV--YALKIMDKKFITKENKTAYVKLERIVLDQLD 103
            +LGKI G G +  V+  +   D G+    A+K M     T      ++  E   +   D
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLS-EAACMKDFD 59

Query: 104 HPGVVRL---------------------FFTFQD--TFSLYMALESCEGGELFDQITSKG 140
           HP V++L                     F    D  +F LY  L                
Sbjct: 60  HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLG-----------GLPE 108

Query: 141 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM----- 195
            L       +  ++   +EY+ +   IHRD+   N +L  D  + +ADFG  K +     
Sbjct: 109 KLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDY 168

Query: 196 -QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
            +  RI  +P                ++  E L     T  +D+WA G T++++ + G +
Sbjct: 169 YRQGRIAKMP--------------VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQT 214

Query: 254 PFKDTSEWLIFQRII-ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH 311
           P+       I+  +     ++ P    D   DL+      DP  RP      +  L+  
Sbjct: 215 PYPGVENHEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRP-----TFTKLREV 268

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 55.3 bits (133), Expect = 3e-08
 Identities = 51/184 (27%), Positives = 79/184 (42%), Gaps = 20/184 (10%)

Query: 126 SCEGGELFDQITSKGHLSEDEARF-------YTAEVVDALEYIHSMGLIHRDIKPENLLL 178
           S   G   DQ  +   L EDE          ++ +V   + ++ S   IHRD+   N+LL
Sbjct: 188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILL 247

Query: 179 TADGHIKIADFGSVKPMQ-DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGND 237
           T     KI DFG  + ++ DS   V  NA    K         ++ PE + +   TF +D
Sbjct: 248 THGRITKICDFGLARDIRNDSNYVVKGNARLPVK---------WMAPESIFNCVYTFESD 298

Query: 238 LWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSDAARDLIDRLLDVDP 294
           +W+ G  L+++ S G+SP+        F ++I    R   P        D++    D DP
Sbjct: 299 VWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADP 358

Query: 295 SGRP 298
             RP
Sbjct: 359 LKRP 362

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 53.8 bits (129), Expect = 4e-08
 Identities = 53/240 (22%), Positives = 98/240 (40%), Gaps = 50/240 (20%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLERI-------VLD 100
           K+ G G + +V R           LK+  +K +    K  K  Y + +R        ++ 
Sbjct: 11  KVIGAGEFGEVFRG---------ILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMG 61

Query: 101 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL-- 158
           Q  H  ++RL           +  E  E G L D+     +L + +  F + ++V  L  
Sbjct: 62  QFSHHNIIRLEGVVTKFKPAMIITEYMENGAL-DK-----YLRDHDGEFSSYQLVGMLRG 115

Query: 159 -----EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
                +Y+  M  +HRD+   N+L+ ++   K++DFG            L     DD   
Sbjct: 116 IAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFG------------LSRVLEDDPEG 163

Query: 214 TFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRI 267
           T+  +   +P     PE +     T  +D+W+ G  +++++S G  P+ D S   + + I
Sbjct: 164 TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI 223

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 54.3 bits (130), Expect = 5e-08
 Identities = 54/242 (22%), Positives = 99/242 (40%), Gaps = 33/242 (13%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAK-------KIDTGTVYALKIMDKKFITKENKTA 90
           P+  FS     LGK  G G + +VV A+       K       A+K++      K+    
Sbjct: 8   PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 67

Query: 91  YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------- 139
             ++E + +    H  ++ L         LY+ +E    G L + + ++           
Sbjct: 68  VSEMEMMKMIG-KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 126

Query: 140 GHLSEDEARFY-----TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
             + +++  F      T +V   +EY+ S   IHRD+   N+L+T +  +KIADFG  + 
Sbjct: 127 ARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 186

Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
           +         N     K         ++ PE L     T  +D+W+ G  ++++ + G S
Sbjct: 187 VN--------NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 238

Query: 254 PF 255
           P+
Sbjct: 239 PY 240

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 54.2 bits (130), Expect = 7e-08
 Identities = 43/175 (24%), Positives = 77/175 (44%), Gaps = 13/175 (7%)

Query: 128 EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIA 187
           E       I     LS  +   ++ +V + +E++ S   +HRD+   N+L+     +KI 
Sbjct: 222 ERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKIC 281

Query: 188 DFGSVKP-MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
           DFG  +  M+DS      N  S  K  TF+      P  + N+   T  +D+W+ G  L+
Sbjct: 282 DFGLARDIMRDS------NYIS--KGSTFLPLKWMAPESIFNNLYTTL-SDVWSFGILLW 332

Query: 247 QMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSDAARDLIDRLLDVDPSGRP 298
           ++ + G +P+ +      F   I R  R   P + SD   +++ +  +     RP
Sbjct: 333 EIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRP 387

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 53.3 bits (128), Expect = 8e-08
 Identities = 55/244 (22%), Positives = 95/244 (38%), Gaps = 45/244 (18%)

Query: 80  KKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK 139
           +K  T + K  ++K E  ++   +HP +V+L          Y+ +E  EGG+L   +   
Sbjct: 35  RKGATDQEKKEFLK-EAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDA 93

Query: 140 GHLSEDEARFYTA------------EVVDALEYIHSMGLIHRDIKPENLLLTADGH---- 183
                   RF               +V     Y+  M  IHRD+   N L++  G+    
Sbjct: 94  -----RVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADR 148

Query: 184 -IKIADFGSVKPMQDSRI------TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGN 236
            +KI DFG  + +  S         +LP                ++ PE L     T  +
Sbjct: 149 VVKIGDFGLARDIYKSDYYRKEGEGLLP--------------VRWMAPESLLDGKFTTQS 194

Query: 237 DLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRFPNYFSDAARDLIDRLLDVDP 294
           D+W+ G  ++++L+ G  P+   +   + Q + A   ++ P    D    L+      DP
Sbjct: 195 DVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDP 254

Query: 295 SGRP 298
           S RP
Sbjct: 255 SERP 258

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 54/259 (20%), Positives = 101/259 (38%), Gaps = 69/259 (26%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTG-----TVYALKIMDKKFITKENKTAYV 92
           P+         LGK  G G++ +VV+A+ +        +  A+K++      K++ T   
Sbjct: 5   PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML------KDDAT--- 55

Query: 93  KLERIVLDQL----------DHPGVVRLFFTFQDTFSLYMALESCEGGELFD-------- 134
             E+ + D +           H  ++ L         LY+ +E    G L D        
Sbjct: 56  --EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPP 113

Query: 135 --------QITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
                       +  L++ +   +  +V   +E++ S   IHRD+   N+L+T D  +KI
Sbjct: 114 GEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKI 173

Query: 187 ADFGSVKPMQ---------DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGND 237
           ADFG  + +          + R+ V                  ++ PE L     T  +D
Sbjct: 174 ADFGLARDIHHIDYYRKTTNGRLPV-----------------KWMAPEALFDRVYTHQSD 216

Query: 238 LWALGCTLYQMLS-GTSPF 255
           +W+ G  L+++ + G SP+
Sbjct: 217 VWSFGVLLWEIFTLGGSPY 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 56/242 (23%), Positives = 98/242 (40%), Gaps = 33/242 (13%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTA 90
           P+   S     LGK  G G + +VV A+ I       +     A+K++      K+    
Sbjct: 5   PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDL 64

Query: 91  YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG---------- 140
             ++E + +    H  ++ L         LY+ +E    G L + + ++           
Sbjct: 65  VSEMEMMKMIG-KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDT 123

Query: 141 -HLSEDEARFY-----TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
             L E++  F        +V   +EY+ S   IHRD+   N+L+T D  +KIADFG  + 
Sbjct: 124 CKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARD 183

Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
           +         N     K         ++ PE L     T  +D+W+ G  L+++ + G S
Sbjct: 184 VH--------NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGS 235

Query: 254 PF 255
           P+
Sbjct: 236 PY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 52.4 bits (125), Expect = 2e-07
 Identities = 46/213 (21%), Positives = 91/213 (42%), Gaps = 21/213 (9%)

Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLDHPGVV 108
           K+ G G++  V +   +  G    + +  K         A V+   E +++  +DHP +V
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 109 RLF-FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           RL       T  L   L     G L D +   K ++       +  ++   + Y+    L
Sbjct: 73  RLLGVCLSPTIQLVTQL--MPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL 130

Query: 167 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA---AYVP 223
           +HRD+   N+L+ +  H+KI DFG  + ++            D+K     G      ++ 
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLE-----------GDEKEYNADGGKMPIKWMA 179

Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
            E ++    T  +D+W+ G T++++++ G  P+
Sbjct: 180 LECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 212

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 46/223 (20%), Positives = 90/223 (40%), Gaps = 23/223 (10%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVL 99
               +    K+ G G +  V +   I  G    + +  K    +  +  + ++    + +
Sbjct: 4   LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAM 63

Query: 100 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDAL 158
             LDH  +VRL        SL +  +    G L D +   +  L       +  ++   +
Sbjct: 64  GSLDHAYIVRLLGICPGA-SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGM 122

Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
            Y+    ++HR++   N+LL +D  ++IADFG           +L     DDK   +  +
Sbjct: 123 YYLEEHRMVHRNLAARNILLKSDSIVQIADFGVAD--------LLY---PDDK--KYFYS 169

Query: 219 AAYVPPEVLNSSPATFG-----NDLWALGCTLYQMLS-GTSPF 255
               P + +      FG     +D+W+ G T+++M+S G  P+
Sbjct: 170 EHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPY 212

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 56/221 (25%), Positives = 95/221 (42%), Gaps = 34/221 (15%)

Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARF----YTAEVVD 156
           L+HP V++      ++    + LE C  G+L + + S +G +++   +        EV  
Sbjct: 52  LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVAS 111

Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV--KPMQDSRITVLPNAASDDKACT 214
            L ++H    IH D+   N  LTAD  +KI D+G    +  +D  IT       D  A  
Sbjct: 112 GLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT------KDCHAVP 165

Query: 215 FVGTAAYVPPEVLNS-------SPATFGNDLWALGCTLYQMLS-GTSPFKDTS-EWLIFQ 265
               A    PE++            T  +++W+LG T++++ +    P+ D S E ++ Q
Sbjct: 166 LRWLA----PELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQ 221

Query: 266 RIIARDIRFPNYFSDAARDLIDRLLDV------DPSGRPGA 300
            +  +DI+ P           DR  +V      DP  RP A
Sbjct: 222 VVREQDIKLPK--PQLDLKYSDRWYEVMQFCWLDPETRPTA 260

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 47/185 (25%), Positives = 79/185 (42%), Gaps = 37/185 (20%)

Query: 87  NKTA---YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLS 143
           NK A   ++K  +I + +L  P ++RL      +  L M  E  E G+L +Q  S+    
Sbjct: 59  NKNARNDFLKEIKI-MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL-NQFLSRHEPQ 116

Query: 144 EDEA------------RFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS 191
           E                F   ++   ++Y+ S+  +HRD+   N L+  +  IKIADFG 
Sbjct: 117 EAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGM 176

Query: 192 VKPMQDS---RI---TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTL 245
            + +      RI    VLP                ++  E +     T  +D+WA G TL
Sbjct: 177 SRNLYSGDYYRIQGRAVLP--------------IRWMSWESILLGKFTTASDVWAFGVTL 222

Query: 246 YQMLS 250
           +++L+
Sbjct: 223 WEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 57/245 (23%), Positives = 103/245 (42%), Gaps = 39/245 (15%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAK-------KIDTGTVYALKIMDKKFITKENKTA 90
           P+  F      LGK  G G + +VVRA+       + D     A+K++      K+    
Sbjct: 5   PKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADL 64

Query: 91  YVKLERI-VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK---------- 139
             ++E + ++ +  H  ++ L         LY+ +E    G L + + ++          
Sbjct: 65  ISEMELMKLIGK--HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFD 122

Query: 140 -GHLSEDEARFY-----TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK 193
              + E++  F        +V   +EY+ S   IHRD+   N+L+T D  +KIADFG  +
Sbjct: 123 ITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR 182

Query: 194 PMQDSRITVLPNAASDDKACTFVG--TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS- 250
            + D           D    T  G     ++ PE L     T  +D+W+ G  ++++ + 
Sbjct: 183 GVHD----------IDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTL 232

Query: 251 GTSPF 255
           G SP+
Sbjct: 233 GGSPY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 59/273 (21%), Positives = 110/273 (40%), Gaps = 39/273 (14%)

Query: 49  LGKIYGVGSYSKVVRAK--KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           LGK  G G +  V+  +  + D+    A+K M     T+     ++  E + + + DHP 
Sbjct: 3   LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLS-EAVCMKEFDHPN 61

Query: 107 VVRLF-FTFQDTFSL----------YMALESCEGGELFDQITSKG-HLSEDEARFYTAEV 154
           V+RL     Q   S           +M         L+ ++     +L       +  ++
Sbjct: 62  VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121

Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM------QDSRITVLPNAAS 208
              +EY+ S   IHRD+   N +L  + ++ +ADFG  K +      +  RI  +P    
Sbjct: 122 ASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP---- 177

Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK--DTSEWLIFQ 265
                       ++  E L     T  +D+W+ G T++++ + G +P+   + SE   + 
Sbjct: 178 ----------VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYL 227

Query: 266 RIIARDIRFPNYFSDAARDLIDRLLDVDPSGRP 298
           R   R ++ P    D    L+     ++P  RP
Sbjct: 228 RQGNR-LKQPPDCLDGLYSLMSSCWLLNPKDRP 259

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 44/186 (23%), Positives = 77/186 (41%), Gaps = 33/186 (17%)

Query: 83  ITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG---------ELF 133
           +TK  +  ++K E  ++ +L +P ++RL         L M  E  E G         E+ 
Sbjct: 56  VTKTARNDFLK-EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIE 114

Query: 134 DQITSKGHL---SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 190
              T   ++   S     +   ++   ++Y+ S+  +HRD+   N L+     IKIADFG
Sbjct: 115 STFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFG 174

Query: 191 SVKPMQDS---RI---TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCT 244
             + +      RI    VLP                ++  E +     T  +D+WA G T
Sbjct: 175 MSRNLYSGDYYRIQGRAVLP--------------IRWMAWESILLGKFTTASDVWAFGVT 220

Query: 245 LYQMLS 250
           L++M +
Sbjct: 221 LWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 48/191 (25%), Positives = 83/191 (43%), Gaps = 28/191 (14%)

Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF----- 149
           E  ++ +L H  +V+L+    +   +Y+  E    G L D       L + E R      
Sbjct: 51  EAQIMKKLRHDKLVQLYAVVSEE-PIYIVTEYMSKGSLLD------FLKDGEGRALKLPN 103

Query: 150 ---YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPN 205
                A+V   + YI  M  IHRD++  N+L+  DG + KIADFG  + ++D+  T    
Sbjct: 104 LVDMAAQVAAGMAYIERMNYIHRDLRSANILV-GDGLVCKIADFGLARLIEDNEYTARQG 162

Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIF 264
           A    K         +  PE       T  +D+W+ G  L ++++ G  P+   +   + 
Sbjct: 163 AKFPIK---------WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVL 213

Query: 265 QRIIARDIRFP 275
           ++ + R  R P
Sbjct: 214 EQ-VERGYRMP 223

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 50.8 bits (122), Expect = 4e-07
 Identities = 51/210 (24%), Positives = 87/210 (41%), Gaps = 34/210 (16%)

Query: 70  GTVY--ALKIMDKKFIT---KENKTAYVKLERI-------VLDQLDHPGVVRLFFTFQDT 117
           G V    LK+  KK I    K  K      +R+       ++ Q DHP ++RL      +
Sbjct: 18  GEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS 77

Query: 118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL-------EYIHSMGLIHRD 170
             + +  E  E G L         L E++ +F   ++V  L       +Y+  M  +HRD
Sbjct: 78  RPVMIITEYMENGSL------DKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRD 131

Query: 171 IKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 230
           +   N+L+ ++   K++DFG       SR      A    K         +  PE +   
Sbjct: 132 LAARNILVNSNLVCKVSDFGL------SRRLEDSEATYTTKGGKI--PIRWTAPEAIAYR 183

Query: 231 PATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
             T  +D+W+ G  +++++S G  P+ D S
Sbjct: 184 KFTSASDVWSFGIVMWEVMSYGERPYWDMS 213

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 50.8 bits (121), Expect = 5e-07
 Identities = 47/205 (22%), Positives = 91/205 (44%), Gaps = 18/205 (8%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G + +V       T  V A+K +    ++ E   A+++ E  V+ +L H  +V+L+  
Sbjct: 15  GQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPE---AFLQ-EAQVMKKLRHEKLVQLYAV 69

Query: 114 FQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDI 171
             +   +Y+  E    G L D +  +   +L   +     A++   + Y+  M  +HRD+
Sbjct: 70  VSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 128

Query: 172 KPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP 231
           +  N+L+  +   K+ADFG  + ++D+  T    A    K         +  PE      
Sbjct: 129 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK---------WTAPEAALYGR 179

Query: 232 ATFGNDLWALGCTLYQMLS-GTSPF 255
            T  +D+W+ G  L ++ + G  P+
Sbjct: 180 FTIKSDVWSFGILLTELTTKGRVPY 204

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 50.8 bits (121), Expect = 5e-07
 Identities = 53/252 (21%), Positives = 99/252 (39%), Gaps = 39/252 (15%)

Query: 41  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI--V 98
           H   +D  L +  G G++ KV  A+  +        ++  K +      A    +R   +
Sbjct: 1   HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 60

Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELF----------------DQITSKGHL 142
           L  L H  +V+ +    D   L M  E  + G+L                     +KG L
Sbjct: 61  LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 120

Query: 143 SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS---R 199
              +     +++   + Y+ S   +HRD+   N L+ A+  +KI DFG  + +  +   R
Sbjct: 121 GLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR 180

Query: 200 I---TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           +   T+LP                ++PPE +     T  +D+W+ G  L+++ + G  P+
Sbjct: 181 VGGHTMLP--------------IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 226

Query: 256 KDTSEWLIFQRI 267
              S   + + I
Sbjct: 227 FQLSNTEVIECI 238

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 50.7 bits (121), Expect = 6e-07
 Identities = 58/281 (20%), Positives = 113/281 (40%), Gaps = 50/281 (17%)

Query: 47  FELGKIYGVGSYSKVVRAK-KIDTGTV--YALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           F LG++ G G +  V  A+ K + G+    A+K++     +  +   +++ E   + + D
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLR-EAACMKEFD 59

Query: 104 HPGVVRL---------------------FFTFQDTFSLYMALESCEGGELFDQITSKGHL 142
           HP V++L                     F    D  +  +   S  G E F        L
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLM--SRIGEEPFT-------L 110

Query: 143 SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV 202
                  +  ++   +EY+ S   IHRD+   N +L  +  + +ADFG  K +       
Sbjct: 111 PLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIY------ 164

Query: 203 LPNAASDD---KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDT 258
                S D   + C       ++  E L  +  T  +D+WA G T++++++ G +P+   
Sbjct: 165 -----SGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV 219

Query: 259 SEWLIFQRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRP 298
               I+  +I  + ++ P    +   +L+ +    +P  RP
Sbjct: 220 ENSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRP 260

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 50.8 bits (122), Expect = 6e-07
 Identities = 62/283 (21%), Positives = 110/283 (38%), Gaps = 53/283 (18%)

Query: 46  DFELGKIYGVGSYSKVVR--AKKIDTGTVY---ALKIMDKKFITKENKTAYVKLERIVLD 100
              L +  G GS+  V    AK +  G      A+K +++    +E    ++  E  V+ 
Sbjct: 7   KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER-IEFLN-EASVMK 64

Query: 101 QLDHPGVVRLF---FTFQDTFSL--YMALESCEGGELFDQITSKGHLSEDEA-------- 147
           + +   VVRL     T Q T  +   MA      G+L   +  +    E E         
Sbjct: 65  EFNCHHVVRLLGVVSTGQPTLVVMELMAK-----GDLKSYL--RSRRPEAENNPGLGPPT 117

Query: 148 --RFY--TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS---RI 200
             +F    AE+ D + Y+ +   +HRD+   N ++  D  +KI DFG  + + ++   R 
Sbjct: 118 LQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK 177

Query: 201 T---VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
               +LP                ++ PE L     T  +D+W+ G  L++M +    P++
Sbjct: 178 GGKGLLP--------------VRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQ 223

Query: 257 DTSEWLIFQRIIARDI-RFPNYFSDAARDLIDRLLDVDPSGRP 298
             S   + + +I       P    D   +L+      +P  RP
Sbjct: 224 GLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRP 266

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 50.5 bits (121), Expect = 7e-07
 Identities = 52/224 (23%), Positives = 92/224 (41%), Gaps = 31/224 (13%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLDH 104
            E  K+ G G++  V +   I  G    + +  K    + +  A  ++  E  V+  +DH
Sbjct: 9   LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68

Query: 105 PGVVRLF-FTFQDTFSL---YMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALE 159
           P VVRL          L    M L     G L D +   K ++       +  ++   + 
Sbjct: 69  PHVVRLLGICLSSQVQLITQLMPL-----GCLLDYVRNHKDNIGSQYLLNWCVQIAKGMS 123

Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           Y+    L+HRD+   N+L+    H+KI DFG  K        +L     D+K   +    
Sbjct: 124 YLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAK--------LLD---VDEK--EYHAEG 170

Query: 220 AYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKD 257
             VP      E +     T  +D+W+ G T++++++ G  P++ 
Sbjct: 171 GKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 50.4 bits (120), Expect = 7e-07
 Identities = 40/202 (19%), Positives = 81/202 (40%), Gaps = 38/202 (18%)

Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-----------------T 137
           E  ++ +L HP +V L         + M  E    G+L + +                 T
Sbjct: 57  EASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGT 116

Query: 138 SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD 197
            K  L   +      ++   +EY+ S   +H+D+   N+L+    H+KI+D G  + +  
Sbjct: 117 VKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYS 176

Query: 198 S---RI---TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS- 250
           +   R+   ++LP                ++PPE +     +  +D+W+ G  L+++ S 
Sbjct: 177 ADYYRVQPKSLLP--------------IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSF 222

Query: 251 GTSPFKDTSEWLIFQRIIARDI 272
           G  P+   S   + + +  R +
Sbjct: 223 GLQPYYGFSNQEVIEMVRKRQL 244

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 50.6 bits (121), Expect = 1e-06
 Identities = 44/160 (27%), Positives = 78/160 (48%), Gaps = 16/160 (10%)

Query: 144 EDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKP-MQDSRIT 201
           +D  RF +++V   ++++ S   IHRD+   N+LLT DG + KI DFG  +  M DS   
Sbjct: 212 DDLLRF-SSQVAQGMDFLASKNCIHRDVAARNVLLT-DGRVAKICDFGLARDIMNDSNYV 269

Query: 202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSE 260
           V  NA    K         ++ PE +     T  +D+W+ G  L+++ S G SP+     
Sbjct: 270 VKGNARLPVK---------WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV 320

Query: 261 WLIFQRIIARDIRF--PNYFSDAARDLIDRLLDVDPSGRP 298
              F +++ R  +   P++       ++    +++P+ RP
Sbjct: 321 NSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERP 360

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 35/164 (21%), Positives = 72/164 (43%), Gaps = 12/164 (7%)

Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTA 152
           E  ++ +L HP +++L+        +Y+  E  + G L +  Q  +   L   +     A
Sbjct: 51  EAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAA 110

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           +V   + Y+ +   IHRD+   N+L+  +   K+ADFG  + +++        A    K 
Sbjct: 111 QVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIK- 169

Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE    +  +  +D+W+ G  L ++++ G  P+
Sbjct: 170 --------WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPY 205

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 48.8 bits (116), Expect = 3e-06
 Identities = 50/222 (22%), Positives = 98/222 (44%), Gaps = 26/222 (11%)

Query: 48  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV 107
           E+G+  G  + + V  A+   TGT+  ++I D +  T+E+  A    E ++     HP +
Sbjct: 5   EIGR--GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQN-EVVLSHFFRHPNI 61

Query: 108 VRLFFTFQD-----TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           +  +  F         S +MA  S     L      +G +SE          +  L Y+H
Sbjct: 62  MTSWTVFTTGSWLWVISPFMAYGSAN--SLLKTYFPEG-MSEALIGNILFGALRGLNYLH 118

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGS----VKPMQDSRITV-LPNAASDDKACTFVG 217
             G IHR+IK  ++L++ DG + ++        V+  Q +++    P  ++         
Sbjct: 119 QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFST--------S 170

Query: 218 TAAYVPPEVLNSSPATFG--NDLWALGCTLYQMLSGTSPFKD 257
              ++ PE+L      +   +D++++G T  ++ +G  PF+D
Sbjct: 171 VLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 48.8 bits (116), Expect = 3e-06
 Identities = 52/222 (23%), Positives = 94/222 (42%), Gaps = 29/222 (13%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTG----TVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
           +F+  K+ G G++  V +   I  G       A+K + +    K NK   +  E  V+  
Sbjct: 8   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE--ILDEAYVMAS 65

Query: 102 LDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALE 159
           +D+P V RL       T  L   L     G L D +   K ++       +  ++   + 
Sbjct: 66  VDNPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 123

Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           Y+    L+HRD+   N+L+    H+KI DFG  K +            +D+K   +    
Sbjct: 124 YLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GADEKE--YHAEG 170

Query: 220 AYVPP-----EVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             VP      E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 171 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 212

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 48.2 bits (115), Expect = 4e-06
 Identities = 37/153 (24%), Positives = 66/153 (43%), Gaps = 18/153 (11%)

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           +V   +EY+ S   +HRD+   N +L     +K+ADFG  + + D     + N       
Sbjct: 106 QVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH------ 159

Query: 213 CTFVGTAAYVPP-----EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQR 266
                T A +P      E L +   T  +D+W+ G  L+++++ G  P+ D   + I   
Sbjct: 160 -----TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVY 214

Query: 267 II-ARDIRFPNYFSDAARDLIDRLLDVDPSGRP 298
           ++  R +  P Y  D   +++       P  RP
Sbjct: 215 LLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRP 247

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 48.0 bits (114), Expect = 4e-06
 Identities = 36/168 (21%), Positives = 69/168 (41%), Gaps = 13/168 (7%)

Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTA 152
           E + L Q DH  +VRL        ++ +  E    G L D    K  G L   +      
Sbjct: 56  EALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGAL-DSFLRKHEGQLVAGQLMGMLP 114

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
            +   ++Y+  MG +H+ +    +L+ +D   KI+ F     +Q+ +   +    S    
Sbjct: 115 GLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKS- 170

Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
                   +  PE +     +  +D+W+ G  +++++S G  P+ D S
Sbjct: 171 -----PVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS 213

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 48.5 bits (115), Expect = 5e-06
 Identities = 41/153 (26%), Positives = 72/153 (47%), Gaps = 13/153 (8%)

Query: 150 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP-MQDSRITVLPNAAS 208
           +T +V   +E++ S   +HRD+   N+LL     +KI DFG  +  M DS      N  S
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDS------NYVS 295

Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRI 267
             K  TF+    ++ PE +  +  T  +D+W+ G  L+++ S G +P+        F   
Sbjct: 296 --KGSTFL-PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK 352

Query: 268 IARDIRF--PNYFSDAARDLIDRLLDVDPSGRP 298
           I    R   P++ +    D++ +  + +P  RP
Sbjct: 353 IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRP 385

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 47.6 bits (113), Expect = 5e-06
 Identities = 38/195 (19%), Positives = 83/195 (42%), Gaps = 37/195 (18%)

Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTA--------- 152
           L HP +++      +     +  E CE G+L      K +LS+++     +         
Sbjct: 52  LQHPNILQCLGQCVEAIPYLLVFEYCELGDL------KSYLSQEQWHRRNSQLLLLQRMA 105

Query: 153 -EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP--MQDSRITVLPNAASD 209
            E+   + ++H    +H D+   N  LT+D  +K+ D+G + P   ++  I       ++
Sbjct: 106 CEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYG-IGPSRYKEDYIE------TE 158

Query: 210 DKACTFVGTAAYVPPEVLNS-------SPATFGNDLWALGCTLYQML-SGTSPFKDTSEW 261
           D  C       ++ PE++         +  T  +++WALG TL+++  +   P+   S+ 
Sbjct: 159 DDKCV---PLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR 215

Query: 262 LIFQRIIA-RDIRFP 275
            +   +I  + ++  
Sbjct: 216 EVLNHVIKDQQVKLF 230

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 47.7 bits (113), Expect = 7e-06
 Identities = 40/155 (25%), Positives = 70/155 (45%), Gaps = 17/155 (10%)

Query: 150 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 209
           Y+ +V   +E++ S   IHRD+   N+LL+ +  +KI DFG  + +        P+    
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD-----PDYVRK 238

Query: 210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII 268
             A        ++ PE +     T  +D+W+ G  L+++ S G SP+        F R +
Sbjct: 239 GDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 295

Query: 269 ARDIRF--PNYFSDAARDLIDRLLDV---DPSGRP 298
               R   P+Y +    ++   +LD    +PS RP
Sbjct: 296 KEGTRMRAPDYTTP---EMYQTMLDCWHGEPSQRP 327

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 47.7 bits (113), Expect = 7e-06
 Identities = 55/240 (22%), Positives = 97/240 (40%), Gaps = 51/240 (21%)

Query: 49  LGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
           LGK  G G + +VV A+ I       +  T  A+K++      K+      ++E + +  
Sbjct: 22  LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 81

Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-----------GHLSEDEARFY 150
             H  ++ L         LY+ +E    G L + + ++             + E++  F 
Sbjct: 82  -KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140

Query: 151 -----TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV---------KPMQ 196
                  +V   +EY+ S   IHRD+   N+L+T D  +KIADFG           K   
Sbjct: 141 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 200

Query: 197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           + R+ V                  ++ PE L     T  +D+W+ G  L+++ + G SP+
Sbjct: 201 NGRLPV-----------------KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 47.7 bits (113), Expect = 7e-06
 Identities = 40/155 (25%), Positives = 70/155 (45%), Gaps = 17/155 (10%)

Query: 150 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM-QDSRITVLPNAAS 208
           Y+ +V   +E++ S   IHRD+   N+LL+ +  +KI DFG  + + +D       +A  
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238

Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIF-QR 266
             K         ++ PE +     T  +D+W+ G  L+++ S G SP+        F QR
Sbjct: 239 PLK---------WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQR 289

Query: 267 IIARD---IRFPNYFSDAARDLIDRLLDVDPSGRP 298
           +  +D   +R P   +     ++      DP  RP
Sbjct: 290 L--KDGTRMRAPENATPEIYRIMLACWQGDPKERP 322

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 38/159 (23%), Positives = 63/159 (39%), Gaps = 31/159 (19%)

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGH-------IKIADFGSVKPMQDSRITVLPN 205
           ++  AL Y+    L+H ++  +N+L+   G        IK++D G         ITVL  
Sbjct: 109 QLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG-------IPITVLSR 161

Query: 206 AASDDKACTFVGTAAYVPPE---VLNSSPATFGNDLWALGCTLYQMLS-GTSPFK--DTS 259
               ++         ++ PE      +S      D W+ G TL ++ S G  P     +S
Sbjct: 162 EERVER-------IPWIAPECIRNGQASLTIAA-DKWSFGTTLLEICSNGEEPLSTLSSS 213

Query: 260 EWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRP 298
           E   F +      R P        +LI++    DP+ RP
Sbjct: 214 EKERFYQ---DQHRLPMPDCAELANLINQCWTYDPTKRP 249

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 50/243 (20%), Positives = 98/243 (40%), Gaps = 38/243 (15%)

Query: 41  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI--V 98
           H   +D  L    G G++ KV  A+  +        ++  K + + +++A    +R   +
Sbjct: 1   HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAEL 60

Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELF---------------DQITSKGHLS 143
           L  L H  +VR +    +   L M  E    G+L                 +  + G L+
Sbjct: 61  LTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLT 120

Query: 144 EDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS---RI 200
             +     +++   + Y+ S+  +HRD+   N L+     +KI DFG  + +  +   R+
Sbjct: 121 LGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 180

Query: 201 ---TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
              T+LP                ++PPE +     T  +D+W+ G  L+++ + G  P+ 
Sbjct: 181 GGRTMLP--------------IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWY 226

Query: 257 DTS 259
             S
Sbjct: 227 QLS 229

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 26/116 (22%), Positives = 50/116 (43%), Gaps = 29/116 (25%)

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS---- 208
           ++   + Y+H  G+IH+DI   N ++  +  +KI D                NA S    
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD----------------NALSRDLF 168

Query: 209 -DDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKD 257
             D  C  +G     P      E L +   +  +D+W+ G  L+++++ G +P+ +
Sbjct: 169 PMDYHC--LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE 222

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 40/185 (21%), Positives = 77/185 (41%), Gaps = 34/185 (18%)

Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG-------------H 141
           E  +L  L H  +V+ +    +   L M  E  + G+L   + + G              
Sbjct: 57  EAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE 116

Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS--- 198
           L++ +      ++   + Y+ S   +HRD+   N L+  +  +KI DFG  + +  +   
Sbjct: 117 LTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY 176

Query: 199 RI---TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSP 254
           R+   T+LP                ++PPE +     T  +D+W+LG  L+++ + G  P
Sbjct: 177 RVGGHTMLP--------------IRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Query: 255 FKDTS 259
           +   S
Sbjct: 223 WYQLS 227

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 51/260 (19%), Positives = 98/260 (37%), Gaps = 44/260 (16%)

Query: 41  HFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLE 95
              +      +  G G++ KV + +     +  + T  A+K + +    K  +    + E
Sbjct: 1   EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60

Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL----------------FDQITSK 139
             ++  L HP +V L           M  E    G+L                    T K
Sbjct: 61  --LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118

Query: 140 GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS- 198
             L   +      ++   +EY+ S   +HRD+   N L+     +KI+DFG  + +  + 
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSAD 178

Query: 199 --RI---TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GT 252
             R+   ++LP                ++PPE +     T  +D+W+ G  L+++ S G 
Sbjct: 179 YYRVQSKSLLP--------------VRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGL 224

Query: 253 SPFKDTSEWLIFQRIIARDI 272
            P+   S   + + I +R +
Sbjct: 225 QPYYGFSNQEVIEMIRSRQL 244

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 46.3 bits (110), Expect = 2e-05
 Identities = 51/245 (20%), Positives = 92/245 (37%), Gaps = 50/245 (20%)

Query: 41  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT-----KENKTAYVKL- 94
           H       L +  G G++ KV        G  Y L+  + K +      KE  +   +  
Sbjct: 1   HVQRDTIVLKRELGEGAFGKVFL------GECYHLEPENDKELVAVKTLKETASNDARKD 54

Query: 95  ---ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS------------- 138
              E  +L    H  +V+ +    +     M  E  E G+L   + S             
Sbjct: 55  FEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDS 114

Query: 139 -KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD 197
             G L+  +      ++   + Y+ S   +HRD+   N L+  D  +KI DFG  + +  
Sbjct: 115 PMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYT 174

Query: 198 S---RI---TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS- 250
           +   R+   T+LP                ++PPE +     T  +D+W+ G  L+++ + 
Sbjct: 175 TDYYRVGGHTMLP--------------IRWMPPESIMYRKFTTESDVWSFGVVLWEIFTY 220

Query: 251 GTSPF 255
           G  P+
Sbjct: 221 GKQPW 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 43.2 bits (102), Expect = 6e-05
 Identities = 31/113 (27%), Positives = 46/113 (40%), Gaps = 23/113 (20%)

Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT 201
           L+E+E     A  +  L  +     +HR  K  N+LLT DG +K+   GSV         
Sbjct: 14  LNEEEI---WAVCLQCLGALRE---LHRQAKSGNILLTWDGLLKL--DGSV--------A 57

Query: 202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 254
                 S            ++ PEV+     T   D+++LG TLY+ L    P
Sbjct: 58  FKTPEQSR-------PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELP 103

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 44.2 bits (104), Expect = 8e-05
 Identities = 48/217 (22%), Positives = 89/217 (41%), Gaps = 29/217 (13%)

Query: 51  KIYGVGSYSKVVRAKKIDTG----TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           K+ G G++  V +   I  G       A+K++ +    K NK   +  E  V+  +  P 
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKE--ILDEAYVMAGVGSPY 70

Query: 107 VVRLF-FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIHSM 164
           V RL       T  L   L     G L D +  +K  +   +   +  ++   + Y+  +
Sbjct: 71  VCRLLGICLTSTVQLVTQLMPY--GCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV 128

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
            L+HRD+   N+L+ +  H+KI DFG  + +             D     +      VP 
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLL-------------DIDETEYHADGGKVPI 175

Query: 225 -----EVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                E +     T  +D+W+ G T++++++ G  P+
Sbjct: 176 KWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPY 212

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 60/283 (21%), Positives = 109/283 (38%), Gaps = 53/283 (18%)

Query: 54  GVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKL----ERIVLDQLDH 104
           G G++ +V +A+       +  T+ A+K++      KE  +A ++     E  ++ + DH
Sbjct: 14  GQGAFGRVFQARAPGLLPYEPFTMVAVKML------KEEASADMQADFQREAALMAEFDH 67

Query: 105 PGVVRLF------------FTFQDTFSLYMALESC----------EGGELFDQITSKGHL 142
           P +V+L             F +     L   L                       +   L
Sbjct: 68  PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL 127

Query: 143 SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV 202
           S  E      +V   + Y+     +HRD+   N L+  +  +KIADFG  + +  +    
Sbjct: 128 SCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY- 186

Query: 203 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSP-FKDTSE 260
               AS++ A        ++PPE +  +  T  +D+WA G  L+++ S G  P +    E
Sbjct: 187 ---KASENDAIPI----RWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239

Query: 261 WLIFQRIIARD---IRFPNYFSDAARDLIDRLLDVDPSGRPGA 300
            +I+     RD   +  P+       +L+       PS RP  
Sbjct: 240 EVIYY---VRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSF 279

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 30/149 (20%), Positives = 65/149 (43%), Gaps = 10/149 (6%)

Query: 152 AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDK 211
            E+ D + Y+++   +HRD+   N ++  D  +KI DFG  + + ++            K
Sbjct: 126 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY--------RK 177

Query: 212 ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR 270
               +    ++ PE L     T  +D+W+ G  L+++ +    P++  S   + + ++  
Sbjct: 178 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG 237

Query: 271 D-IRFPNYFSDAARDLIDRLLDVDPSGRP 298
             +  P+   D   +L+      +P  RP
Sbjct: 238 GLLDKPDNCPDMLFELMRMCWQYNPKMRP 266

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 44.1 bits (104), Expect = 1e-04
 Identities = 49/201 (24%), Positives = 83/201 (41%), Gaps = 28/201 (13%)

Query: 61  VVRAKKIDTGTVYALKIM--DKKFITKE-NKTAYVKLERIV-LDQLDHPGVVRLFFTFQD 116
           + R KK   G  Y  K +    +F+ KE N    +    I  + +L HP +V+L    + 
Sbjct: 698 ISRGKK---GASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRS 754

Query: 117 TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH---SMGLIHRDIKP 173
               Y+  E  EG  L + + +   LS +  R     +  AL ++H   S  ++  ++ P
Sbjct: 755 EKGAYLIHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSP 811

Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
           E ++      I   D       +      LP     D  C    ++AYV PE   +   T
Sbjct: 812 EKII------IDGKD-------EPHLRLSLPGLLCTDTKCFI--SSAYVAPETRETKDIT 856

Query: 234 FGNDLWALGCTLYQMLSGTSP 254
             +D++  G  L ++L+G SP
Sbjct: 857 EKSDIYGFGLILIELLTGKSP 877

Length = 968

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 26/110 (23%), Positives = 51/110 (46%), Gaps = 9/110 (8%)

Query: 151 TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDD 210
            AE+ D + Y+++   +HRD+   N ++  D  +KI DFG  + + ++            
Sbjct: 125 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY--------R 176

Query: 211 KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
           K    +    ++ PE L     T  +D+W+ G  L+++ S    P++  S
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 226

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 42.6 bits (100), Expect = 3e-04
 Identities = 16/42 (38%), Positives = 25/42 (59%)

Query: 151 TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV 192
             +++  LEYIH  G+ H DIKPEN+++  +    I D+G  
Sbjct: 132 MKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIA 173

Length = 294

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 41.8 bits (98), Expect = 4e-04
 Identities = 42/158 (26%), Positives = 69/158 (43%), Gaps = 37/158 (23%)

Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGH--------IKIADFGSVKPMQDSRITVLPNAAS 208
           AL ++   GL H ++  +N+LL  +          IK++D G         ITVLP    
Sbjct: 112 ALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG-------ISITVLPKEIL 164

Query: 209 DDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSG-TSPFK--DTSEWLIF 264
            ++         +VPPE + N    +   D W+ G TL+++ SG   P    D+ + L F
Sbjct: 165 LER-------IPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF 217

Query: 265 ----QRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRP 298
                ++ A     P +   A   LI++ +D +P  RP
Sbjct: 218 YEDRHQLPA-----PKWTELAN--LINQCMDYEPDFRP 248

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 41.8 bits (98), Expect = 4e-04
 Identities = 33/136 (24%), Positives = 62/136 (45%), Gaps = 34/136 (25%)

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG--SVKPMQDSRITVLPNAASDD 210
           E+   L ++H    IH D+   N LLTAD  +KI D+G    K  +D  +T       D 
Sbjct: 108 EIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT------PDQ 161

Query: 211 KACTFVGTAAYVP-----PEVLNS-------SPATFGNDLWALGCTLYQMLS-GTSPFKD 257
                     +VP     PE+++           T  +++W+LG T++++   G+ P++ 
Sbjct: 162 L---------WVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH 212

Query: 258 TSEWLIFQRIIARDIR 273
            S+    ++++   +R
Sbjct: 213 LSD----EQVLTYTVR 224

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 42.9 bits (101), Expect = 4e-04
 Identities = 16/40 (40%), Positives = 29/40 (72%), Gaps = 1/40 (2%)

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLT-ADGHIKIADFGS 191
           +++ AL+ +HS G++HRD+KP+N++ +   G  KI D G+
Sbjct: 263 QILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGA 302

Length = 566

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 42.1 bits (99), Expect = 5e-04
 Identities = 46/197 (23%), Positives = 80/197 (40%), Gaps = 34/197 (17%)

Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           F +  SL    E  EG EL+ +  +   L       Y+ +V   +E++ S   IHRD+  
Sbjct: 147 FIEDKSLSDVEEDEEGDELYKEPLTLEDLIS-----YSFQVARGMEFLASRKCIHRDLAA 201

Query: 174 ENLLLTADGHIKIADFGSVKPMQ---------DSRITVLPNAASDDKACTFVGTAAYVPP 224
            N+LL+ +  +KI DFG  + +          D+R+ +                  ++ P
Sbjct: 202 RNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL-----------------KWMAP 244

Query: 225 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSDA 281
           E +     T  +D+W+ G  L+++ S G SP+        F R +    R   P Y +  
Sbjct: 245 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPE 304

Query: 282 ARDLIDRLLDVDPSGRP 298
              ++      +P  RP
Sbjct: 305 IYSIMLDCWHNNPEDRP 321

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 41.2 bits (96), Expect = 7e-04
 Identities = 39/203 (19%), Positives = 78/203 (38%), Gaps = 37/203 (18%)

Query: 93  KLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELF----------------DQI 136
           K E ++  +L HP +V L         L M    C   +L                 D  
Sbjct: 56  KHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDK 115

Query: 137 TSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ 196
           T K  L   +      ++   +E++ S  ++H+D+   N+L+    ++KI+D G  + + 
Sbjct: 116 TVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175

Query: 197 DSRI------TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS 250
            +        ++LP                ++ PE +     +  +D+W+ G  L+++ S
Sbjct: 176 AADYYKLMGNSLLP--------------IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Query: 251 -GTSPFKDTSEWLIFQRIIARDI 272
            G  P+   S   + + I  R +
Sbjct: 222 YGLQPYCGYSNQDVIEMIRNRQV 244

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 40.8 bits (96), Expect = 0.001
 Identities = 29/107 (27%), Positives = 46/107 (42%), Gaps = 15/107 (14%)

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYT------ 151
           +L +L  P + RL         L M +E  E G+L +Q   K H++E             
Sbjct: 72  ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL-NQFLQK-HVAETSGLACNSKSLSF 129

Query: 152 -------AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS 191
                   ++   + Y+ S+  +HRD+   N L+  +  IKIADFG 
Sbjct: 130 STLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGM 176

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 39.9 bits (93), Expect = 0.001
 Identities = 50/212 (23%), Positives = 86/212 (40%), Gaps = 27/212 (12%)

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTA-EVVD 156
           ++ Q+ H  +V L+          M  E  E G L   +  K  +     +F  A ++  
Sbjct: 57  MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLAS 116

Query: 157 ALEYIHSMGLIHRDIKPENLLLTADG-------HIKIADFGSVKPMQDSRITVLPNAASD 209
           AL Y+    L+H ++  +N+LL  +G        IK++D G         ITVL      
Sbjct: 117 ALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG-------IPITVLSRQECV 169

Query: 210 DKACTFVGTAAYVPPE-VLNSSPATFGNDLWALGCTLYQM-LSGTSPFKDTSEWLI-FQR 266
           ++         ++ PE V +S   +   D W+ G TL+++  +G  P KD +  L   +R
Sbjct: 170 ER-------IPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT--LAEKER 220

Query: 267 IIARDIRFPNYFSDAARDLIDRLLDVDPSGRP 298
                            DL+   ++ DP+ RP
Sbjct: 221 FYEGQCMLVTPSCKELADLMTHCMNYDPNQRP 252

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	489
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
PF14593	104	PH_3: PH domain; PDB: 1W1H_D 1W1D_A 1W1G_A 2VKI_A.	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd01262	89	PH_PDK1 3-Phosphoinositide dependent protein kinas	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG3653	534	consensus Transforming growth factor beta/activin	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.97
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.96
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.94
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.92
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.9
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.89
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.88
PRK12274	218	serine/threonine protein kinase; Provisional	99.88
PRK10345	210	hypothetical protein; Provisional	99.86
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.85
smart00090	237	RIO RIO-like kinase.	99.84
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.84
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.81
PRK14879	211	serine/threonine protein kinase; Provisional	99.81
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.79
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.77
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.77
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.76
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.75
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.7
cd01251	103	PH_centaurin_alpha Centaurin alpha Pleckstrin homo	99.67
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.66
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.64
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.62
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.61
cd01264	101	PH_melted Melted pleckstrin homology (PH) domain.	99.61
cd01233	100	Unc104 Unc-104 pleckstrin homology (PH) domain. Un	99.57
KOG1243	690	consensus Protein kinase [General function predict	99.55
cd01265	95	PH_PARIS-1 PARIS-1 pleckstrin homology (PH) domain	99.52
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.52
cd01238	106	PH_Tec Tec pleckstrin homology (PH) domain. Tec pl	99.5
cd01257	101	PH_IRS Insulin receptor substrate (IRS) pleckstrin	99.49
cd01247	91	PH_GPBP Goodpasture antigen binding protein (GPBP)	99.49
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.48
cd01236	104	PH_outspread Outspread Pleckstrin homology (PH) do	99.47
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.47
cd01235	101	PH_SETbf Set binding factor Pleckstrin Homology (P	99.44
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.43
cd01266	108	PH_Gab Gab (Grb2-associated binder) pleckstrin hom	99.43
cd01260	96	PH_CNK Connector enhancer of KSR (Kinase suppresso	99.42
cd01241	102	PH_Akt Akt pleckstrin homology (PH) domain. Akt pl	99.39
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.37
cd01244	98	PH_RasGAP_CG9209 RAS_GTPase activating protein (GA	99.36
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.33
cd01252	125	PH_cytohesin Cytohesin Pleckstrin homology (PH) do	99.29
cd01245	98	PH_RasGAP_CG5898 RAS GTPase-activating protein (GA	99.26
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.25
cd01246	91	PH_oxysterol_bp Oxysterol binding protein (OSBP) P	99.19
cd01254	121	PH_PLD Phospholipase D (PLD) pleckstrin homology (	99.19
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.19
KOG3087	229	consensus Serine/threonine protein kinase [General	99.17
cd01250	94	PH_centaurin Centaurin Pleckstrin homology (PH) do	99.07
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.06
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.03
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.99
PF15409	89	PH_8: Pleckstrin homology domain	98.98
PF00169	104	PH: PH domain; InterPro: IPR001849 The pleckstrin	98.92
cd01219	101	PH_FGD FGD (faciogenital dysplasia protein) plecks	98.9
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.85
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.84
KOG0930	395	consensus Guanine nucleotide exchange factor Cytoh	98.82
COG4248	637	Uncharacterized protein with protein kinase and he	98.75
cd01263	122	PH_anillin Anillin Pleckstrin homology (PH) domain	98.66
PRK09902	216	hypothetical protein; Provisional	98.66
cd01220	99	PH_CDEP Chondrocyte-derived ezrin-like domain cont	98.64
PF15413	112	PH_11: Pleckstrin homology domain; PDB: 3MDB_D 3FE	98.64
cd01237	106	Unc112 Unc-112 pleckstrin homology (PH) domain. Un	98.64
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.62
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.55
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.54
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.49
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.47
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.42
KOG1090	1732	consensus Predicted dual-specificity phosphatase [	98.38
smart00233	102	PH Pleckstrin homology domain. Domain commonly fou	98.36
PF01636	239	APH: Phosphotransferase enzyme family This family	98.34
cd01253	104	PH_beta_spectrin Beta-spectrin pleckstrin homology	98.33
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.22
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.15
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.13
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.1
cd01218	104	PH_phafin2 Phafin2 Pleckstrin Homology (PH) domain	98.08
cd00821	96	PH Pleckstrin homology (PH) domain. Pleckstrin hom	98.08
cd01256	110	PH_dynamin Dynamin pleckstrin homology (PH) domain	98.07
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	98.04

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-105  Score=799.11  Aligned_cols=439  Identities=48%  Similarity=0.779  Sum_probs=386.5

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCC
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTF  118 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  118 (489)
                      ++++..||.|++.||+|+|++|++|++++++++||||++.|+++.++.++.++.+|+++|.+| +||+|++||.+|+|+.
T Consensus        68 ~kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~  147 (604)
T KOG0592|consen   68 EKKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE  147 (604)
T ss_pred             ccCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc
Confidence            388999999999999999999999999999999999999999999999999999999999999 8999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      .+|||+||+++|+|+++|++.|.|++.++++|++||+.||+|||++|||||||||||||||.|||++|+|||.|+.+.+.
T Consensus       148 sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~  227 (604)
T KOG0592|consen  148 SLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS  227 (604)
T ss_pred             ceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999775


Q ss_pred             ccccc---CCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCC
Q 011287          199 RITVL---PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP  275 (489)
Q Consensus       199 ~~~~~---~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p  275 (489)
                      .....   .......+..+||||+.|++||+|.+...++.+||||||||||||++|.+||++.+++.+|++|+..++.||
T Consensus       228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp  307 (604)
T KOG0592|consen  228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP  307 (604)
T ss_pred             hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC
Confidence            43311   111122334689999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCCCCCCCCCCCccCCCCCCCCCCCCCCCCCCC
Q 011287          276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDDVHDSSWNPSHIG  355 (489)
Q Consensus       276 ~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (489)
                      +++++.++|||+++|..||++|+|+     .+|++||||.+++|++++.++||++.++.+..+...++.....|.....+
T Consensus       308 ~~fp~~a~dLv~KLLv~dp~~Rlt~-----~qIk~HpFF~~Vdw~nlw~~~PP~l~py~p~~~~s~e~~s~~~~~~~~~~  382 (604)
T KOG0592|consen  308 EGFPEDARDLIKKLLVRDPSDRLTS-----QQIKAHPFFEGVDWENLWQQTPPKLQPYKPATSISPEYYSAYTPLEPGLD  382 (604)
T ss_pred             CCCCHHHHHHHHHHHccCccccccH-----HHHhhCcccccCChhhhhhcCCCcccCCCCcccCCcccCcccccccCCcc
Confidence            9999999999999999999999999     88999999999999999999999999998877665554433322111111


Q ss_pred             C-------------------------ccccccCCCCCCCCCCCcccccccc--cccCcccccccCCCceEEEEEeeehhh
Q 011287          356 D-------------------------ISAKINDGNGGASSSEGSITRLASI--DSFDSKWQQFLDPGESVLMISMVKKLQ  408 (489)
Q Consensus       356 ~-------------------------~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~g~~~k~~  408 (489)
                      .                         ..++...+++.++.......|+.++  ++.++.||+|++ |++|+++|.|.|++
T Consensus       383 ~~~~~~~~~~~S~s~~~psn~~~~~~~~~~~~~~~~~~s~~~~~~~R~q~le~~~~~~~w~~f~~-~~~i~k~~~l~k~~  461 (604)
T KOG0592|consen  383 ERALFQVPSSASQSSALPSNVTHNGDKVAQPVAPSASSSESKNDTARLQSLESQSKDNPWHQFLE-GSLILKEGALEKRQ  461 (604)
T ss_pred             ccccccccccccccccCCCcccccccchhhccccccccccCcchhhhhhhccccccCccHHHhhh-hhhHHhHHHHHhhh
Confidence            1                         0011001111111111122334333  447889999998 99999999999999


Q ss_pred             hhhccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEEcCCCcEEEEcCCceEEEEcCCccHHHHHHHHHHhc
Q 011287          409 KLTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRASQWKKAIEALQ  487 (489)
Q Consensus       409 g~~~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~~~~~f~i~~p~r~y~~~d~~~~~~~W~~~i~~~~  487 (489)
                      |+|.|||+|+||++||++|+||.++++||||||+++   +.++.+++++|+|+||+|+|++.|+++.|..||++|+++.
T Consensus       462 ~lf~rkr~lllTn~~rll~~~~~~~~lk~eip~~~~---~~~e~~n~~~~~i~TP~k~~~l~d~~~~as~w~~ai~~~~  537 (604)
T KOG0592|consen  462 GLFARKRMLLLTNGPRLLYVDPQNLVLKGEIPWSPD---LRVELKNSSTFFIHTPNKVYYLEDPEQRASVWCKAIETVR  537 (604)
T ss_pred             hhhhceeEEEecCCCeEEEEecccceeccccccCcc---cceeeccCcceEEECCccceeccCcccchhHHHHhhhhhh
Confidence            999999999999999999999999999999999996   9999999999999999999999999999999999999874

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-68  Score=515.22  Aligned_cols=284  Identities=42%  Similarity=0.758  Sum_probs=263.4

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCE
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  119 (489)
                      +...++||+++++||+|+||+||.++.++|++.||+|+++|..+.+......+..|+.+|..++||+||+++..||+...
T Consensus        20 ~~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~k   99 (357)
T KOG0598|consen   20 EMVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEK   99 (357)
T ss_pred             ccCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCe
Confidence            35778999999999999999999999999999999999999999999899999999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcc
Q 011287          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      +|+|+||+.||+|+.+|++++.|+|..+++|+++|+.||.|||++|||||||||||||+|.+||++|+|||+++....  
T Consensus       100 LylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~--  177 (357)
T KOG0598|consen  100 LYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK--  177 (357)
T ss_pred             EEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc--
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999985422  


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCC-CCCCC
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR-FPNYF  278 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~-~p~~~  278 (489)
                              ......++|||+.|||||++.+.+|+.++|+||||+++|+|++|.+||.+.+...++++|..+... .|..+
T Consensus       178 --------~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~l  249 (357)
T KOG0598|consen  178 --------DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYL  249 (357)
T ss_pred             --------CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccC
Confidence                    235667899999999999999999999999999999999999999999999999999999999954 45559


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC-CCCCCCCCCC
Q 011287          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG-QTPPKLASEP  334 (489)
Q Consensus       279 ~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~-~~~p~~~~~~  334 (489)
                      +.++++||+++|..||++|++ ...+.+++++||||.+++|+.+.. ...|++.|..
T Consensus       250 s~~ardll~~LL~rdp~~RLg-~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~  305 (357)
T KOG0598|consen  250 SEEARDLLKKLLKRDPRQRLG-GPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNV  305 (357)
T ss_pred             CHHHHHHHHHHhccCHHHhcC-CCCChHHhhcCcccccCCHHHHHhcCCCCCeecCC
Confidence            999999999999999999998 345789999999999999999865 4556555443

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3e-67  Score=493.19  Aligned_cols=273  Identities=42%  Similarity=0.763  Sum_probs=263.6

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCE
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  119 (489)
                      ...+++||++++.||.|+||.|.+++++.+|..||+|++++..+.+....+.+.+|+.+|+.+.||++++++++|.|...
T Consensus        39 ~~~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~  118 (355)
T KOG0616|consen   39 NPYSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSN  118 (355)
T ss_pred             CCcchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCe
Confidence            34899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcc
Q 011287          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      +|+||||.+||+|+.++++.++|++..+++|++||+.||+|||+++|++|||||||||||.+|++||+|||+|+...   
T Consensus       119 lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~---  195 (355)
T KOG0616|consen  119 LYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS---  195 (355)
T ss_pred             EEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec---
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999753   


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS  279 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~  279 (489)
                                .+..+.||||.|+|||++..++|+.++|+|||||++|||++|.+||.+.++..++++|+.+++.||..++
T Consensus       196 ----------~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs  265 (355)
T KOG0616|consen  196 ----------GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFS  265 (355)
T ss_pred             ----------CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccC
Confidence                      3466889999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC
Q 011287          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  325 (489)
Q Consensus       280 ~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~  325 (489)
                      ++++|||.++|+.|-.+|.+.-..|..+|++||||++++|..+..+
T Consensus       266 ~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r  311 (355)
T KOG0616|consen  266 SDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQR  311 (355)
T ss_pred             HHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhc
Confidence            9999999999999999999887778999999999999999998664

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=4.9e-65  Score=511.87  Aligned_cols=294  Identities=41%  Similarity=0.722  Sum_probs=264.9

Q ss_pred             cccccCCCCCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEE
Q 011287           32 SFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLF  111 (489)
Q Consensus        32 s~~~~~~~~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~  111 (489)
                      +..++..+.+++.+||+++++||+|+||.||+|+.+.||..||+|+++|....+.+.+..+..|+.+|...++|+||+||
T Consensus       128 te~lR~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLy  207 (550)
T KOG0605|consen  128 TEYLRLRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLY  207 (550)
T ss_pred             HHHHHhccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEE
Confidence            34566777789999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             EEEEcCCEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccC
Q 011287          112 FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS  191 (489)
Q Consensus       112 ~~~~~~~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~  191 (489)
                      ..|+|..++|+||||++|||+..+|.+.+.|++..+++|+++++.|++.||++|+|||||||+|+|||.+||+||+|||+
T Consensus       208 YsFQD~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGL  287 (550)
T KOG0605|consen  208 YSFQDKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGL  287 (550)
T ss_pred             EEecCCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccc---------------cCCCC----------------------CCCCccceecCCcCCChhhhcCCCCCC
Q 011287          192 VKPMQDSRITV---------------LPNAA----------------------SDDKACTFVGTAAYVPPEVLNSSPATF  234 (489)
Q Consensus       192 a~~~~~~~~~~---------------~~~~~----------------------~~~~~~~~~gt~~Y~aPE~l~~~~~~~  234 (489)
                      +.-+.......               .+...                      ......+.+|||.|+|||++.+..|+.
T Consensus       288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~  367 (550)
T KOG0605|consen  288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGK  367 (550)
T ss_pred             cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCc
Confidence            86543211000               00000                      011235689999999999999999999


Q ss_pred             CCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC--CCCCC--CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          235 GNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--IRFPN--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       235 ~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~--~~~p~--~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      .+|+||||||+||||.|.+||.+.++.+++++|....  +.||.  .++++++|||.+||+ ||++|+++  .|++||+.
T Consensus       368 ~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~--~G~~EIK~  444 (550)
T KOG0605|consen  368 ECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGS--KGAEEIKK  444 (550)
T ss_pred             cccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCc--ccHHHHhc
Confidence            9999999999999999999999999999999999865  67776  478999999999999 99999995  58999999


Q ss_pred             CCCCCCCCcccccCCCCC
Q 011287          311 HPFFKGIDWKNIRGQTPP  328 (489)
Q Consensus       311 hpff~~i~~~~~~~~~~p  328 (489)
                      ||||++++|+.++...||
T Consensus       445 HPfF~~v~W~~l~~~~ap  462 (550)
T KOG0605|consen  445 HPFFKGVDWDHLREMPAP  462 (550)
T ss_pred             CCccccCCcchhhcCCCC
Confidence            999999999999976644

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-63  Score=507.97  Aligned_cols=284  Identities=36%  Similarity=0.650  Sum_probs=266.1

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCC
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTF  118 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~  118 (489)
                      .++++++|.++++||+|+||+|++|..+.+++.||||+++|..+...+.++.+..|+.|+.... ||+++.|++.|+.+.
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~  442 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE  442 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence            3889999999999999999999999999999999999999999999999999999999998885 999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      ++|+||||+.||++ .++++.+.|++..+++|+++++.||.|||++||||||||.+|||+|.+||+||+|||+++...  
T Consensus       443 ~l~fvmey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m--  519 (694)
T KOG0694|consen  443 HLFFVMEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM--  519 (694)
T ss_pred             eEEEEEEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC--
Confidence            99999999999994 445556789999999999999999999999999999999999999999999999999998532  


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF  278 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~  278 (489)
                              ....++++|||||.|+|||+|.+..|+.++|+|||||+|||||.|..||.+.++.+++..|+..++.+|..+
T Consensus       520 --------~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~l  591 (694)
T KOG0694|consen  520 --------GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFL  591 (694)
T ss_pred             --------CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcc
Confidence                    345688899999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC-CCCCCCCCCC
Q 011287          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG-QTPPKLASEP  334 (489)
Q Consensus       279 ~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~-~~~p~~~~~~  334 (489)
                      +.++.++++++|.+||++|+++.+.+..+|+.||||+.|+|+.|.. +..|++.|..
T Consensus       592 s~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i  648 (694)
T KOG0694|consen  592 SKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTI  648 (694)
T ss_pred             cHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCccc
Confidence            9999999999999999999999998999999999999999999865 4566555543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-60  Score=486.87  Aligned_cols=260  Identities=35%  Similarity=0.695  Sum_probs=249.9

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      .+|..++.||+|||+.||.+++.++|..||+|++.|..+.+....+.+.+|+++.+.|+|||||++|.+|+|.+++|+|+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            56999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccC
Q 011287          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (489)
Q Consensus       125 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~  204 (489)
                      |+|..++|..++++.+.++|.++++|+.||+.||.|||+++|+|||||..|+|++++++|||+|||+|..+..+      
T Consensus        98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~------  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD------  171 (592)
T ss_pred             EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCc------
Confidence            99999999999999999999999999999999999999999999999999999999999999999999987543      


Q ss_pred             CCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHH
Q 011287          205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD  284 (489)
Q Consensus       205 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  284 (489)
                          .++..++||||.|.|||++....++..+||||+|||+|.||.|+|||+..+-.+++.+|...++.+|..++.+|++
T Consensus       172 ----~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~d  247 (592)
T KOG0575|consen  172 ----GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKD  247 (592)
T ss_pred             ----ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHH
Confidence                3677899999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCCCCCCCCCCCHHHHhcCCCC-CCCCc
Q 011287          285 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFF-KGIDW  319 (489)
Q Consensus       285 Li~~~L~~dP~~R~t~~~~~~~~l~~hpff-~~i~~  319 (489)
                      ||.+||++||.+||++     .+++.|+|| ++.--
T Consensus       248 LI~~lL~~~P~~Rpsl-----~~vL~h~Ff~~g~~p  278 (592)
T KOG0575|consen  248 LIRKLLRPNPSERPSL-----DEVLDHPFFKSGFTP  278 (592)
T ss_pred             HHHHHhcCCcccCCCH-----HHHhcCHhhhCCCcC
Confidence            9999999999999999     899999999 55443

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.1e-61  Score=467.81  Aligned_cols=293  Identities=36%  Similarity=0.625  Sum_probs=264.6

Q ss_pred             CCCCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 011287           38 PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (489)
Q Consensus        38 ~~~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  117 (489)
                      +...+.+++|++++.||.|.-|+||+|+.+.++..+|+|+|+|..+...++...+..|.+||+.++||++..||..|+.+
T Consensus        70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~  149 (459)
T KOG0610|consen   70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD  149 (459)
T ss_pred             CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence            44678889999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCcccc
Q 011287          118 FSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~  195 (489)
                      ...|+|||||+||+|..+++++  +.|+++.+++|+++++.||+|||-.|||+||||||||||.++|||.|+||.++...
T Consensus       150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRC  229 (459)
T ss_pred             ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence            9999999999999999999876  56999999999999999999999999999999999999999999999999987654


Q ss_pred             CCcccc-----------------------------c-c----------------CCCCCCCCccceecCCcCCChhhhcC
Q 011287          196 QDSRIT-----------------------------V-L----------------PNAASDDKACTFVGTAAYVPPEVLNS  229 (489)
Q Consensus       196 ~~~~~~-----------------------------~-~----------------~~~~~~~~~~~~~gt~~Y~aPE~l~~  229 (489)
                      .....-                             . .                ..+....+.++||||-+|+|||++.+
T Consensus       230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G  309 (459)
T KOG0610|consen  230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG  309 (459)
T ss_pred             CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence            211000                             0 0                00223456778999999999999999


Q ss_pred             CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCHHHHHHHHHhhccCCCCCCCCCCCCHHH
Q 011287          230 SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAV  307 (489)
Q Consensus       230 ~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~  307 (489)
                      ...+.++|+|+||+.+||||.|..||.|.+..+++.+|+...+.||.  .++.+++|||+++|.+||++|++.. .|.++
T Consensus       310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~-rGA~e  388 (459)
T KOG0610|consen  310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSK-RGAAE  388 (459)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccc-cchHH
Confidence            99999999999999999999999999999999999999999999997  4689999999999999999999964 46799


Q ss_pred             HhcCCCCCCCCcccccCCCCCCCC
Q 011287          308 LKMHPFFKGIDWKNIRGQTPPKLA  331 (489)
Q Consensus       308 l~~hpff~~i~~~~~~~~~~p~~~  331 (489)
                      |++||||+|++|.-++...||.++
T Consensus       389 IK~HpFF~gVnWaLir~~~PP~iP  412 (459)
T KOG0610|consen  389 IKRHPFFEGVNWALIRCARPPEIP  412 (459)
T ss_pred             hhcCccccCCChhheeccCCCcCC
Confidence            999999999999977777777653

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-60  Score=464.33  Aligned_cols=261  Identities=38%  Similarity=0.577  Sum_probs=236.0

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccc----hhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK----ENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  118 (489)
                      ..+-|.+.+.||.|+||.|-+|.++.||+.||||++.+.....    ......+.+|+++|++|+|||||+++++|....
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            4577999999999999999999999999999999999877665    335566889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCC---CCEEEeeccCcccc
Q 011287          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD---GHIKIADFGSVKPM  195 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~---g~ikL~DFG~a~~~  195 (489)
                      ..|+||||++||+|++.+-.++.+.+...+.+++|++.||.|||++||+||||||+|||++.+   ..+||+|||+|+..
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~  329 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS  329 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence            999999999999999999999999999999999999999999999999999999999999877   68999999999976


Q ss_pred             CCccccccCCCCCCCCccceecCCcCCChhhhcCCC---CCCCCcchhhhHHHHHHhhCCCCCCCCCHHH-HHHHHHhcC
Q 011287          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP---ATFGNDLWALGCTLYQMLSGTSPFKDTSEWL-IFQRIIARD  271 (489)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~---~~~~sDiwSLG~ilyelltG~~PF~~~~~~~-~~~~i~~~~  271 (489)
                      ..           .....++|||+.|+|||++....   +..++|+|||||+||-+|+|.+||.+..... ..+.|..+.
T Consensus       330 g~-----------~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~  398 (475)
T KOG0615|consen  330 GE-----------GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGR  398 (475)
T ss_pred             cc-----------ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCc
Confidence            43           34567999999999999998765   3457899999999999999999998766555 778899998


Q ss_pred             CCCC----CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 011287          272 IRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (489)
Q Consensus       272 ~~~p----~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~  319 (489)
                      +.|-    ..++.++.+||.+||..||++||++     +++++||||+.++.
T Consensus       399 y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~-----~eaL~hpW~~~~~~  445 (475)
T KOG0615|consen  399 YAFGPLQWDRISEEALDLINWMLVVDPENRPSA-----DEALNHPWFKDAPC  445 (475)
T ss_pred             ccccChhhhhhhHHHHHHHHHhhEeCcccCcCH-----HHHhcChhhhcccc
Confidence            8764    3589999999999999999999999     89999999997653

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-60  Score=448.12  Aligned_cols=290  Identities=36%  Similarity=0.644  Sum_probs=271.7

Q ss_pred             cCCCCCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 011287           36 RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  115 (489)
Q Consensus        36 ~~~~~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  115 (489)
                      .....+.+++||.++++||+|.||.|.+++.+.+|+.||||+++|..+.....+.....|-.+|+..+||++..|...|+
T Consensus       159 ~~~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQ  238 (516)
T KOG0690|consen  159 AKRKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQ  238 (516)
T ss_pred             ccccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhc
Confidence            34456779999999999999999999999999999999999999999998888888899999999999999999999999


Q ss_pred             cCCEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCcccc
Q 011287          116 DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (489)
Q Consensus       116 ~~~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~  195 (489)
                      ..+.+++||||+.||+|+-++.+...|++..+++|.++|+.||.|||+++||+||||.+|+|+|.|||+||+|||+++.-
T Consensus       239 t~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~  318 (516)
T KOG0690|consen  239 TQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE  318 (516)
T ss_pred             cCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc
Confidence            99999999999999999999999989999999999999999999999999999999999999999999999999999842


Q ss_pred             CCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCC
Q 011287          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP  275 (489)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p  275 (489)
                      -          .......+|||||.|+|||+|.+..|+.++|+|.+||++|||++|++||...+...++..|+..++.||
T Consensus       319 I----------~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFP  388 (516)
T KOG0690|consen  319 I----------KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFP  388 (516)
T ss_pred             c----------cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCC
Confidence            2          224567799999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccc-cCCCCCCCCCCCc
Q 011287          276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI-RGQTPPKLASEPM  335 (489)
Q Consensus       276 ~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~-~~~~~p~~~~~~~  335 (489)
                      ..++++++.|+..+|.+||.+|++.+..+..++..|+||.+++|+.. ++..+|++.|...
T Consensus       389 r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVt  449 (516)
T KOG0690|consen  389 RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVT  449 (516)
T ss_pred             ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcc
Confidence            99999999999999999999999999888999999999999999986 4566777766543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4e-56  Score=431.43  Aligned_cols=260  Identities=30%  Similarity=0.505  Sum_probs=239.2

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-  118 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-  118 (489)
                      ..++.+|.+.++.||+|+.|+||+|+++.|++.+|+|++.-  ...+....++.+|+++++.++|||||++|+.|.++. 
T Consensus        74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~--~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~  151 (364)
T KOG0581|consen   74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL--NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE  151 (364)
T ss_pred             cccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc--cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc
Confidence            34667799999999999999999999999999999999933  345667788999999999999999999999999998 


Q ss_pred             EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeeccCCCCeeeCCCCCEEEeeccCccccCC
Q 011287          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~-~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~  197 (489)
                      .++++||||+||+|.+++.+.|+++|.....++.+++.||.|||. ++||||||||+||||+..|.|||||||.++.+.+
T Consensus       152 ~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn  231 (364)
T KOG0581|consen  152 EISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN  231 (364)
T ss_pred             eEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence            499999999999999999998999999999999999999999995 8999999999999999999999999999987653


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCC-----CHHHHHHHHHh-cC
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT-----SEWLIFQRIIA-RD  271 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~-----~~~~~~~~i~~-~~  271 (489)
                                  ...++|+||..|||||.+.+..|+.++||||||+.+.|+++|+.||...     +..+++..|+. ..
T Consensus       232 ------------S~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~pp  299 (364)
T KOG0581|consen  232 ------------SIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPP  299 (364)
T ss_pred             ------------hhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCC
Confidence                        2567999999999999999999999999999999999999999999875     67788889988 45


Q ss_pred             CCCCCC-CCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 011287          272 IRFPNY-FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (489)
Q Consensus       272 ~~~p~~-~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~  318 (489)
                      +.+|.. +|+++++||..||++||.+|+++     .++++|||++...
T Consensus       300 P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~-----~qLl~Hpfi~~~~  342 (364)
T KOG0581|consen  300 PRLPEGEFSPEFRSFVSCCLRKDPSERPSA-----KQLLQHPFIKKFE  342 (364)
T ss_pred             CCCCcccCCHHHHHHHHHHhcCCcccCCCH-----HHHhcCHHHhhcc
Confidence            678887 99999999999999999999999     8999999998643

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-54  Score=442.27  Aligned_cols=261  Identities=39%  Similarity=0.705  Sum_probs=241.1

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccch--hHHHHHHHHHHHHHhCC-CCCccEEEEEEEcC
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE--NKTAYVKLERIVLDQLD-HPGVVRLFFTFQDT  117 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~--~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~  117 (489)
                      ......|.+++.||+|+||.|++|++..+|..||+|++++......  .....+.+|+.+++++. ||||+++++++...
T Consensus        13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~   92 (370)
T KOG0583|consen   13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP   92 (370)
T ss_pred             ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence            3557899999999999999999999999999999998887643322  35567779999999998 99999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCC-CCEEEeeccCccccC
Q 011287          118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQ  196 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~-g~ikL~DFG~a~~~~  196 (489)
                      ..+|+|||||.||+|++++.+.+++.|..++.++.||+.||+|||++||+||||||||||++.+ +++||+|||++....
T Consensus        93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~  172 (370)
T KOG0583|consen   93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP  172 (370)
T ss_pred             CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence            9999999999999999999999999999999999999999999999999999999999999999 999999999998753


Q ss_pred             CccccccCCCCCCCCccceecCCcCCChhhhcCCC-CC-CCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCC
Q 011287          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP-AT-FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF  274 (489)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~-~~-~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~  274 (489)
                                .......++|||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...+...++.+|..+.+.+
T Consensus       173 ----------~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~  242 (370)
T KOG0583|consen  173 ----------GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKI  242 (370)
T ss_pred             ----------CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccC
Confidence                      1234566899999999999999877 74 88999999999999999999999999999999999999999


Q ss_pred             CCCC-CHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          275 PNYF-SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       275 p~~~-~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      |..+ ++++++||++||+.||.+|+++     .++++||||+.
T Consensus       243 p~~~~S~~~~~Li~~mL~~~P~~R~t~-----~~i~~h~w~~~  280 (370)
T KOG0583|consen  243 PSYLLSPEARSLIEKMLVPDPSTRITL-----LEILEHPWFQK  280 (370)
T ss_pred             CCCcCCHHHHHHHHHHcCCCcccCCCH-----HHHhhChhhcc
Confidence            9999 9999999999999999999998     88999999985

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-55  Score=433.01  Aligned_cols=287  Identities=32%  Similarity=0.592  Sum_probs=263.1

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCE
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  119 (489)
                      .+++.+.|..-++||+|+||.||-++.+.||+.||+|.++|+.+.+........+|..+|.+++.++||.+-..|+..+.
T Consensus       180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~  259 (591)
T KOG0986|consen  180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA  259 (591)
T ss_pred             hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence            56789999999999999999999999999999999999999988888888888899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCC
Q 011287          120 LYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~  197 (489)
                      +++||..|+||||.-+|.+.|  .|++..+++|+++|+.||++||+.+||+|||||+|||+|+.||++|+|+|+|..+..
T Consensus       260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            999999999999999998876  699999999999999999999999999999999999999999999999999997654


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCH----HHHHHHHHhcCCC
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRIIARDIR  273 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~----~~~~~~i~~~~~~  273 (489)
                      .           ......+||.+|||||++.+..|+...|+|||||+||+|+.|+.||+...+    .++-++++.....
T Consensus       340 g-----------~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~e  408 (591)
T KOG0986|consen  340 G-----------KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEE  408 (591)
T ss_pred             C-----------CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhh
Confidence            3           233355999999999999999999999999999999999999999987554    3566778888889


Q ss_pred             CCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC-CCCCCCCCCCccC
Q 011287          274 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG-QTPPKLASEPMVQ  337 (489)
Q Consensus       274 ~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~-~~~p~~~~~~~~~  337 (489)
                      +|+.+|+++++|++.+|.+||++|++....+.+++++||||++++|..+.. ..+|++.|.+...
T Consensus       409 y~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~aV  473 (591)
T KOG0986|consen  409 YSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGAV  473 (591)
T ss_pred             cccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCcccc
Confidence            999999999999999999999999999988999999999999999999865 4567677666543

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-55  Score=427.09  Aligned_cols=284  Identities=35%  Similarity=0.631  Sum_probs=265.0

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCC
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTF  118 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~  118 (489)
                      ..+...||.++.+||+|+||.|.+|..+.|.+.||||+++|..+...+..+-...|..+|.... -|++++|+..|+.-+
T Consensus       344 d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD  423 (683)
T KOG0696|consen  344 DRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD  423 (683)
T ss_pred             cceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence            3567889999999999999999999999999999999999999998888888888999998874 679999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      .+|+||||+.||+|..+|++-|+|-|..+.+|+++|+-||-|||++||++||||..|||++.+||+||+|||+++.-   
T Consensus       424 RLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn---  500 (683)
T KOG0696|consen  424 RLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN---  500 (683)
T ss_pred             heeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccc---
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999842   


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF  278 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~  278 (489)
                             ........+|||||.|+|||++...+|+.++|+||+||+||||+.|++||.+.++.++++.|...+..+|..+
T Consensus       501 -------i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKsl  573 (683)
T KOG0696|consen  501 -------IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSL  573 (683)
T ss_pred             -------ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccc
Confidence                   2334567799999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC-CCCCCCCCC
Q 011287          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG-QTPPKLASE  333 (489)
Q Consensus       279 ~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~-~~~p~~~~~  333 (489)
                      |.++.+++..+|.+.|.+|++++..+-.++..||||+.|||+.+.. +.+|++.|-
T Consensus       574 SkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk  629 (683)
T KOG0696|consen  574 SKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPK  629 (683)
T ss_pred             cHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCc
Confidence            9999999999999999999999988889999999999999999855 455555543

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.7e-53  Score=428.11  Aligned_cols=274  Identities=40%  Similarity=0.741  Sum_probs=252.1

Q ss_pred             CCCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 011287           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (489)
Q Consensus        39 ~~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  118 (489)
                      ...+.+++|++.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+..
T Consensus        12 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   91 (329)
T PTZ00263         12 TSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN   91 (329)
T ss_pred             cCCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC
Confidence            34567899999999999999999999999999999999998765555555667888999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      .+|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.... 
T Consensus        92 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~-  170 (329)
T PTZ00263         92 RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-  170 (329)
T ss_pred             EEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC-
Confidence            9999999999999999999888999999999999999999999999999999999999999999999999999975432 


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF  278 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~  278 (489)
                                  ...+.+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+....+.+|..+
T Consensus       171 ------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~  238 (329)
T PTZ00263        171 ------------RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWF  238 (329)
T ss_pred             ------------CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCC
Confidence                        12346899999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC
Q 011287          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  325 (489)
Q Consensus       279 ~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~  325 (489)
                      +..+++||.+||+.||.+|+++...+++++++||||.+.+|+.+...
T Consensus       239 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~~~~  285 (329)
T PTZ00263        239 DGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYAR  285 (329)
T ss_pred             CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHHHHhC
Confidence            99999999999999999999977677899999999999999987543

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-54  Score=420.45  Aligned_cols=257  Identities=33%  Similarity=0.581  Sum_probs=233.2

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lyl  122 (489)
                      ...+|.+.+.||+|+||+||+|+++.++..||||.+.+..+. ...++.+..|+.+|+.++|||||++++.+.+.+++|+
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~-~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l   86 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLN-KKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL   86 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccC-HHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence            468999999999999999999999999999999999887653 3456678889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCC------CCEEEeeccCccccC
Q 011287          123 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD------GHIKIADFGSVKPMQ  196 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~------g~ikL~DFG~a~~~~  196 (489)
                      |||||.||||.++|++.+.+++..++.++.||+.||++||+++||||||||+||||+.+      -.+||+|||+|+.+.
T Consensus        87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~  166 (429)
T KOG0595|consen   87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ  166 (429)
T ss_pred             EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence            99999999999999999999999999999999999999999999999999999999875      358999999999876


Q ss_pred             CccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCC---
Q 011287          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR---  273 (489)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~---  273 (489)
                      +.           ....+.||++.|||||++....|+.|+|+||+|+|+|||++|++||...+..+.+..+..+...   
T Consensus       167 ~~-----------~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~  235 (429)
T KOG0595|consen  167 PG-----------SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPV  235 (429)
T ss_pred             ch-----------hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCc
Confidence            43           3456889999999999999999999999999999999999999999999999999888766533   


Q ss_pred             CCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          274 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       274 ~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      +|..+++...+|+..+|+.+|..|.+.     .+-..|+|...
T Consensus       236 ~~~~~s~~~~~Ll~~ll~~~~~~~~~~-----~~~~~~~~l~~  273 (429)
T KOG0595|consen  236 LPAELSNPLRELLISLLQRNPKDRISF-----EDFFDHPFLAA  273 (429)
T ss_pred             hhhhccCchhhhhhHHHhcCccccCch-----HHhhhhhhccc
Confidence            445688888999999999999999876     67778887754

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-54  Score=441.39  Aligned_cols=265  Identities=34%  Similarity=0.595  Sum_probs=246.4

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lyl  122 (489)
                      ...-|++++.||.|+.|.|-+|++..||+..|||++.+.....+.....+.+|+.+|+.+.||||++||+++.+...+|+
T Consensus        10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl   89 (786)
T KOG0588|consen   10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL   89 (786)
T ss_pred             cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence            45678999999999999999999999999999999988765555667789999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccc
Q 011287          123 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~  202 (489)
                      |+||++||.|++++.+.|++++.++..++.||+.|+.|||..+|+||||||||+||+..++|||+|||.|..-.+     
T Consensus        90 vlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~-----  164 (786)
T KOG0588|consen   90 VLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP-----  164 (786)
T ss_pred             EEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccC-----
Confidence            999999999999999999999999999999999999999999999999999999999999999999999975432     


Q ss_pred             cCCCCCCCCccceecCCcCCChhhhcCCCC-CCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHH
Q 011287          203 LPNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDA  281 (489)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~-~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~  281 (489)
                            +....+.||++.|.|||++.+.+| +.++||||.|||||.||+|++||.+.|-..++.++..+.+..|..++++
T Consensus       165 ------gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~e  238 (786)
T KOG0588|consen  165 ------GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSE  238 (786)
T ss_pred             ------CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHH
Confidence                  234457899999999999999987 6889999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCccccc
Q 011287          282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR  323 (489)
Q Consensus       282 ~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~  323 (489)
                      +++||++||..||++|+|.     ++|++|||+.+..-....
T Consensus       239 aQdLLr~ml~VDp~~RiT~-----~eI~kHP~l~g~~~~~~~  275 (786)
T KOG0588|consen  239 AQDLLRRMLDVDPSTRITT-----EEILKHPFLSGYTSLPSS  275 (786)
T ss_pred             HHHHHHHHhccCccccccH-----HHHhhCchhhcCCCCChh
Confidence            9999999999999999998     899999999987654444

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-55  Score=470.99  Aligned_cols=278  Identities=40%  Similarity=0.679  Sum_probs=255.7

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~l  120 (489)
                      ++..+||+|+++||+|+||.|.+++.+.|++.||+|++.|-...+......+..|+.+|...+.+-|++|+..|+|+.++
T Consensus        71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L  150 (1317)
T KOG0612|consen   71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL  150 (1317)
T ss_pred             hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence            56789999999999999999999999999999999999997777777888899999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      |+||||++||||..++.+.+++++..++||+++|+.||.-||+.|+|||||||+|||||..|||||+|||.+-.+.... 
T Consensus       151 YlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG-  229 (1317)
T KOG0612|consen  151 YLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG-  229 (1317)
T ss_pred             EEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCC-
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999988775432 


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhc----C-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc--CCC
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLN----S-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--DIR  273 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~----~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~--~~~  273 (489)
                              .-.....||||.|.|||+|.    + +.|+..+|+|||||++|||+.|..||.+.+-.+++.+|+.-  .+.
T Consensus       230 --------~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~  301 (1317)
T KOG0612|consen  230 --------TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLS  301 (1317)
T ss_pred             --------cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcC
Confidence                    33445679999999999994    3 45899999999999999999999999999999999999875  788


Q ss_pred             CC--CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCCCCCCC
Q 011287          274 FP--NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKL  330 (489)
Q Consensus       274 ~p--~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~~~p~~  330 (489)
                      ||  ..+|.++++||.++|+ +|+.|++-  .|+.++++||||.|++|++++...||..
T Consensus       302 FP~~~~VSeeakdLI~~ll~-~~e~RLgr--ngiedik~HpFF~g~~W~~iR~~~pP~v  357 (1317)
T KOG0612|consen  302 FPDETDVSEEAKDLIEALLC-DREVRLGR--NGIEDIKNHPFFEGIDWDNIRESVPPVV  357 (1317)
T ss_pred             CCcccccCHHHHHHHHHHhc-Chhhhccc--ccHHHHHhCccccCCChhhhhhcCCCCC
Confidence            99  4689999999999994 79999975  5789999999999999999998877754

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-54  Score=396.84  Aligned_cols=262  Identities=34%  Similarity=0.572  Sum_probs=249.2

Q ss_pred             CCCCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 011287           38 PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (489)
Q Consensus        38 ~~~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  117 (489)
                      ....++++||++++.||+|-||.||+|+.++++-.||+|++.|+.+...+...++.+|+++.+.|+||||+++|++|.|.
T Consensus        15 ~~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~   94 (281)
T KOG0580|consen   15 ATKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS   94 (281)
T ss_pred             cccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc
Confidence            34678999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCcccc
Q 011287          118 FSLYMALESCEGGELFDQIT--SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~--~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~  195 (489)
                      ..+|+++||+.+|+|+..+.  +..+|++..+..|+.|++.||.|||..+|+||||||+|+|++.+|.+|++|||-+..-
T Consensus        95 ~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~  174 (281)
T KOG0580|consen   95 KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHA  174 (281)
T ss_pred             ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence            99999999999999999999  6678999999999999999999999999999999999999999999999999988642


Q ss_pred             CCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCC
Q 011287          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP  275 (489)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p  275 (489)
                      .            ..+..+.|||..|.+||+..+..++..+|+|++|++.||++.|.+||...+..+++++|.+.++.+|
T Consensus       175 p------------~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p  242 (281)
T KOG0580|consen  175 P------------SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP  242 (281)
T ss_pred             C------------CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC
Confidence            2            3466789999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       276 ~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      ..++.+++|||.+||..+|.+|+..     .+++.|||...
T Consensus       243 ~~is~~a~dlI~~ll~~~p~~r~~l-----~~v~~hpwI~a  278 (281)
T KOG0580|consen  243 STISGGAADLISRLLVKNPIERLAL-----TEVMDHPWIVA  278 (281)
T ss_pred             cccChhHHHHHHHHhccCccccccH-----HHHhhhHHHHh
Confidence            9999999999999999999999988     88999999753

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-52  Score=415.28  Aligned_cols=267  Identities=38%  Similarity=0.665  Sum_probs=244.9

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      ++|++.+.||+|+||.||+|++..+|+.||+|++.............+.+|+.+++.++||||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            58999999999999999999999999999999997654444445567888999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccC
Q 011287          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (489)
Q Consensus       125 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~  204 (489)
                      ||+++|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....       
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~-------  153 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-------  153 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-------
Confidence            9999999999999888999999999999999999999999999999999999999999999999999875432       


Q ss_pred             CCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHH
Q 011287          205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD  284 (489)
Q Consensus       205 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  284 (489)
                            .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....++.+......+|..+++.+++
T Consensus       154 ------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  227 (291)
T cd05612         154 ------RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKD  227 (291)
T ss_pred             ------CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHH
Confidence                  12245799999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 011287          285 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (489)
Q Consensus       285 Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~  324 (489)
                      ||++||+.||.+|++.....+.+++.||||..++|..+..
T Consensus       228 li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~  267 (291)
T cd05612         228 LIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQ  267 (291)
T ss_pred             HHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHHHHhc
Confidence            9999999999999986555679999999999999987654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=6.5e-54  Score=403.94  Aligned_cols=258  Identities=28%  Similarity=0.486  Sum_probs=223.8

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      ++.|+.+.++|+|+||+||+|++++||+.||||.+.-.. ..........+|+.+|+.|+|||+|.|+++|.....+++|
T Consensus         1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV   79 (396)
T KOG0593|consen    1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV   79 (396)
T ss_pred             CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence            468999999999999999999999999999999985442 2223345567899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccc
Q 011287          124 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~  202 (489)
                      +|||+. ++++-+.+. ..++++.++.|++|++.|+.|||++++||||||||||||+.+|.+||||||+|+.+..+    
T Consensus        80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p----  154 (396)
T KOG0593|consen   80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP----  154 (396)
T ss_pred             eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCC----
Confidence            999987 666777665 45999999999999999999999999999999999999999999999999999987532    


Q ss_pred             cCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc-----------
Q 011287          203 LPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-----------  270 (489)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~-----------  270 (489)
                            ......+|.|.+|+|||++.+ .+|+..+||||+||++.||++|.+.|.+.++.+++..|...           
T Consensus       155 ------gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~i  228 (396)
T KOG0593|consen  155 ------GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSI  228 (396)
T ss_pred             ------cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHH
Confidence                  234557899999999999977 67999999999999999999999999999998887666541           


Q ss_pred             --------CCCCC------------CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 011287          271 --------DIRFP------------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (489)
Q Consensus       271 --------~~~~p------------~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~  318 (489)
                              .+.+|            +.++..+.||+++||..||.+|+++     ++++.||||.++-
T Consensus       229 F~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc-----~qll~H~yFd~~~  291 (396)
T KOG0593|consen  229 FSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSC-----EQLLHHPYFDGFI  291 (396)
T ss_pred             hccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccH-----HHHhcChHHHHHH
Confidence                    11222            1257789999999999999999999     8899999997543

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=9e-52  Score=416.89  Aligned_cols=264  Identities=38%  Similarity=0.661  Sum_probs=240.0

Q ss_pred             eEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEeccCCC
Q 011287           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG  130 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~~~gg  130 (489)
                      +.||+|+||.||+|++..+|+.||+|++.+...........+.+|..+++.++||||+++++.|.+...+|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            47999999999999999999999999998765544555566778999999999999999999999999999999999999


Q ss_pred             ChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCCC
Q 011287          131 ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDD  210 (489)
Q Consensus       131 ~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~  210 (489)
                      +|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....          ..
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~----------~~  150 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD----------GA  150 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC----------CC
Confidence            99999998889999999999999999999999999999999999999999999999999998743211          12


Q ss_pred             CccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 011287          211 KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLL  290 (489)
Q Consensus       211 ~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~~L  290 (489)
                      ....++||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+......+|..+++++.+||.+||
T Consensus       151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L  230 (323)
T cd05571         151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLL  230 (323)
T ss_pred             cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHc
Confidence            23467899999999999999999999999999999999999999999998888889998899999999999999999999


Q ss_pred             ccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 011287          291 DVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (489)
Q Consensus       291 ~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~  324 (489)
                      +.||++||+.......++++||||.+++|..+..
T Consensus       231 ~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~~~  264 (323)
T cd05571         231 KKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQ  264 (323)
T ss_pred             cCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHh
Confidence            9999999976555669999999999999998764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=7.4e-52  Score=420.65  Aligned_cols=273  Identities=34%  Similarity=0.614  Sum_probs=247.8

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCC-cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTG-TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg-~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  118 (489)
                      ..+..++|++.+.||+|+||.||+|++..++ ..||+|++.+...........+.+|+.+++.++||||+++++++.+..
T Consensus        25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~  104 (340)
T PTZ00426         25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES  104 (340)
T ss_pred             CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence            3467889999999999999999999976654 789999998765555556667888999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      .+|+||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.+.. 
T Consensus       105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~-  183 (340)
T PTZ00426        105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-  183 (340)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC-
Confidence            9999999999999999999888999999999999999999999999999999999999999999999999999976432 


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF  278 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~  278 (489)
                                  ...+.+||+.|+|||++.+..++.++|+|||||++|+|++|.+||.+.+...+++.+......+|..+
T Consensus       184 ------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~  251 (340)
T PTZ00426        184 ------------RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFL  251 (340)
T ss_pred             ------------CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Confidence                        12356899999999999998899999999999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC
Q 011287          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  325 (489)
Q Consensus       279 ~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~  325 (489)
                      ++.+++||++||+.||.+|++....+++++++||||.+++|..+...
T Consensus       252 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~  298 (340)
T PTZ00426        252 DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHK  298 (340)
T ss_pred             CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhC
Confidence            99999999999999999998655556799999999999999876543

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-54  Score=404.04  Aligned_cols=250  Identities=31%  Similarity=0.543  Sum_probs=225.3

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEE-EEEcCC
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFF-TFQDTF  118 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~-~~~~~~  118 (489)
                      ...++.+|++++.||+|+||+||+|+...+|..+|.|.+.-..+. ....+.+..|+.+|+.|+|||||++|+ .|.++.
T Consensus        14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md-~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~   92 (375)
T KOG0591|consen   14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMD-AKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN   92 (375)
T ss_pred             CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhcc-HHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence            567789999999999999999999999999999999999855444 445566777999999999999999998 555444


Q ss_pred             E-EEEEEeccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh--CC--cEeeccCCCCeeeCCCCCEEEeec
Q 011287          119 S-LYMALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHS--MG--LIHRDIKPENLLLTADGHIKIADF  189 (489)
Q Consensus       119 ~-lylV~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~aL~~LH~--~g--IiHrDLKpeNILl~~~g~ikL~DF  189 (489)
                      . +++|||||.+|||...|+.    ...++|..++.++.|++.||.+||.  ..  |+||||||.||+|+.+|.+||+||
T Consensus        93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf  172 (375)
T KOG0591|consen   93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF  172 (375)
T ss_pred             hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence            4 9999999999999998864    3469999999999999999999999  44  999999999999999999999999


Q ss_pred             cCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHh
Q 011287          190 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA  269 (489)
Q Consensus       190 G~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~  269 (489)
                      |+++.+...          ..-+.++||||.|||||.+.+.+|+.++|||||||++|||+.-++||.+.+-....++|.+
T Consensus       173 GL~r~l~s~----------~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~q  242 (375)
T KOG0591|consen  173 GLGRFLSSK----------TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQ  242 (375)
T ss_pred             hhHhHhcch----------hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHc
Confidence            999987543          2345689999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCC-CC-CCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          270 RDIR-FP-NYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       270 ~~~~-~p-~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      ++++ +| +.+|.++..||..|++.||..||+.
T Consensus       243 gd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  243 GDYPPLPDEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             CCCCCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence            9886 77 6789999999999999999999985

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-53  Score=423.20  Aligned_cols=257  Identities=33%  Similarity=0.516  Sum_probs=228.8

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCC-
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTF-  118 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~-  118 (489)
                      ...+++|.+++.||.|+||.||+|+.+.+|..||||.|++++...++  ..-.||+..|++|+ |||||+|++++.+.+ 
T Consensus         6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee--~~nLREvksL~kln~hpniikL~Evi~d~~~   83 (538)
T KOG0661|consen    6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE--CMNLREVKSLRKLNPHPNIIKLKEVIRDNDR   83 (538)
T ss_pred             hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH--HHHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence            34578999999999999999999999999999999999887665443  34457999999998 999999999999988 


Q ss_pred             EEEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCC
Q 011287          119 SLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~  197 (489)
                      .+|||||||+. +|.++++.+ ..|++..++.|++||+.||+|+|.+|++|||+||||||+..+..+||+|||+|+....
T Consensus        84 ~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S  162 (538)
T KOG0661|consen   84 ILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS  162 (538)
T ss_pred             eEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc
Confidence            99999999976 999999865 4699999999999999999999999999999999999999888999999999997653


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhc-CCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHh-------
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLN-SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA-------  269 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~-~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~-------  269 (489)
                                 ......+|.|.+|+|||+|. ...|+.+.||||+|||++|+++-++.|.|.++.+++.+|+.       
T Consensus       163 -----------kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~  231 (538)
T KOG0661|consen  163 -----------KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDK  231 (538)
T ss_pred             -----------CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCcc
Confidence                       33455789999999999975 55699999999999999999999999999999999888875       


Q ss_pred             ------------cCCCCCC-----------CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          270 ------------RDIRFPN-----------YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       270 ------------~~~~~p~-----------~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                                  .++.||.           ..+.++.+||.+||..||.+||||     +++++||||+.
T Consensus       232 ~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA-----~~al~~pffq~  296 (538)
T KOG0661|consen  232 DSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTA-----SQALQHPFFQV  296 (538)
T ss_pred             ccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccH-----HHHhcCccccc
Confidence                        2344442           368999999999999999999999     88999999974

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-54  Score=430.02  Aligned_cols=290  Identities=35%  Similarity=0.639  Sum_probs=269.9

Q ss_pred             ccccCCCCCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEE
Q 011287           33 FAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFF  112 (489)
Q Consensus        33 ~~~~~~~~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  112 (489)
                      ..+........+.+++++..||-|+||.|=+++.......+|+|+++|.++......+++..|+.+|..++.|+||+||-
T Consensus       408 ~~~~~e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYr  487 (732)
T KOG0614|consen  408 EDFAEEFAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYR  487 (732)
T ss_pred             HHHHhhhcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHH
Confidence            33444555677899999999999999999999987766679999999999999999999999999999999999999999


Q ss_pred             EEEcCCEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCc
Q 011287          113 TFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  192 (489)
Q Consensus       113 ~~~~~~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a  192 (489)
                      +|.|+.++|++||-|-||+|+..+...|.|++..+++|++++++|++|||++|||+|||||||.+++.+|-+||.|||+|
T Consensus       488 Tfrd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFA  567 (732)
T KOG0614|consen  488 TFRDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFA  567 (732)
T ss_pred             HhccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc--
Q 011287          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--  270 (489)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~--  270 (489)
                      +.+..           ..++.+|||||.|+|||++.++..+.++|.||||+++||||+|.+||.+.++..+++.|+++  
T Consensus       568 Kki~~-----------g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid  636 (732)
T KOG0614|consen  568 KKIGS-----------GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID  636 (732)
T ss_pred             HHhcc-----------CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh
Confidence            98754           45677999999999999999999999999999999999999999999999999999999986  


Q ss_pred             CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCCC-CCCCCCC
Q 011287          271 DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT-PPKLASE  333 (489)
Q Consensus       271 ~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~~-~p~~~~~  333 (489)
                      ...||..++..+.+||+++...+|.+|++...+|+.+|++|.||.++||+.++..+ ||++.++
T Consensus       637 ~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~  700 (732)
T KOG0614|consen  637 KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPS  700 (732)
T ss_pred             hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCcccc
Confidence            46799999999999999999999999999888999999999999999999998764 5555443

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.2e-51  Score=418.70  Aligned_cols=279  Identities=37%  Similarity=0.665  Sum_probs=238.7

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      ++|++++.||+|+||+||+|++..+++.||+|++.+...........+..|+.++..++||||+++++.+++...+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            58999999999999999999999999999999998765555556677888999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc-
Q 011287          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL-  203 (489)
Q Consensus       125 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~-  203 (489)
                      |||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.+........ 
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~  160 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY  160 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence            9999999999999888999999999999999999999999999999999999999999999999999986543211000 


Q ss_pred             -------CC-----------------CCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCC
Q 011287          204 -------PN-----------------AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS  259 (489)
Q Consensus       204 -------~~-----------------~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~  259 (489)
                             +.                 ..........+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~  240 (363)
T cd05628         161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET  240 (363)
T ss_pred             ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCC
Confidence                   00                 000111235689999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHhc--CCCCCC--CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCCC
Q 011287          260 EWLIFQRIIAR--DIRFPN--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT  326 (489)
Q Consensus       260 ~~~~~~~i~~~--~~~~p~--~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~~  326 (489)
                      ..+.+.++...  .+.+|+  .+++++++||.+|++ +|.+|++.  .+++++++||||++++|+.+....
T Consensus       241 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r--~~~~ei~~hp~f~~~~~~~~~~~~  308 (363)
T cd05628         241 PQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGA--PGVEEIKTNPFFEGVDWEHIRERP  308 (363)
T ss_pred             HHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCC--CCHHHHhCCCCCCCCCHHHHHhCC
Confidence            98888888763  455665  478999999999886 67766542  134999999999999999987543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=7.1e-51  Score=410.43  Aligned_cols=270  Identities=36%  Similarity=0.643  Sum_probs=243.9

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCC-CccEEEEEEEcCCEEEEEE
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP-GVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp-nIv~l~~~~~~~~~lylV~  124 (489)
                      +|++++.||+|+||.||+|++..+++.||+|++.+...........+..|..++..++|+ +|++++++|.+...+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            699999999999999999999999999999999876555555566677899999999764 6888999999999999999


Q ss_pred             eccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccC
Q 011287          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (489)
Q Consensus       125 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~  204 (489)
                      ||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||+++.....      
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~------  154 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG------  154 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC------
Confidence            99999999999998888999999999999999999999999999999999999999999999999998643211      


Q ss_pred             CCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHH
Q 011287          205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD  284 (489)
Q Consensus       205 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  284 (489)
                          .......+||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+....++.+......+|..+++++.+
T Consensus       155 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  230 (324)
T cd05587         155 ----GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVS  230 (324)
T ss_pred             ----CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence                1223456899999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC
Q 011287          285 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  325 (489)
Q Consensus       285 Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~  325 (489)
                      ||.+||..||.+|+++.....+++++||||++++|..+...
T Consensus       231 li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~~~~  271 (324)
T cd05587         231 ICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERR  271 (324)
T ss_pred             HHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhC
Confidence            99999999999999987667789999999999999887543

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=7.1e-51  Score=410.27  Aligned_cols=270  Identities=36%  Similarity=0.631  Sum_probs=244.5

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCEEEEEE
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      ||++++.||+|+||.||+|++..+++.||+|++.+..............|..++..+ +||+|+++++.+.+...+|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            699999999999999999999999999999999876554455555666788888777 5899999999999999999999


Q ss_pred             eccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccC
Q 011287          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (489)
Q Consensus       125 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~  204 (489)
                      ||+++|+|..++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+++.....      
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~------  154 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD------  154 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC------
Confidence            99999999999998888999999999999999999999999999999999999999999999999998743211      


Q ss_pred             CCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHH
Q 011287          205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD  284 (489)
Q Consensus       205 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  284 (489)
                          .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...+++.+......+|..++.++.+
T Consensus       155 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  230 (323)
T cd05616         155 ----GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVA  230 (323)
T ss_pred             ----CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHH
Confidence                1223356899999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC
Q 011287          285 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  325 (489)
Q Consensus       285 Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~  325 (489)
                      ||.+||+.||.+|+++...+..++++||||+.++|+.+...
T Consensus       231 li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~~  271 (323)
T cd05616         231 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERK  271 (323)
T ss_pred             HHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHHhC
Confidence            99999999999999987667799999999999999988654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=6.5e-51  Score=403.09  Aligned_cols=276  Identities=32%  Similarity=0.564  Sum_probs=238.6

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEe
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E  125 (489)
                      .|++.+.||+|+||.||+|.+..+|+.||+|.+.+...........+.+|+.+++.++|++|+++++++.+...+|+|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            48899999999999999999999999999999987655444444567789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          126 SCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       126 ~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      |+++|+|..++...  ..+++..+..++.|++.||+|||+.||+||||||+|||++.++.++|+|||++......     
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-----  155 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-----  155 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-----
Confidence            99999998887643  35899999999999999999999999999999999999999999999999998764321     


Q ss_pred             CCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHH----HHHHHHHhcCCCCCCCCC
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW----LIFQRIIARDIRFPNYFS  279 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~----~~~~~i~~~~~~~p~~~~  279 (489)
                            ......+||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+..    .....+......++..++
T Consensus       156 ------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s  229 (285)
T cd05631         156 ------ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFS  229 (285)
T ss_pred             ------CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCC
Confidence                  1123457999999999999999999999999999999999999999876542    333444455667888899


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC-CCCCCCC
Q 011287          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLAS  332 (489)
Q Consensus       280 ~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~-~~p~~~~  332 (489)
                      +++.+||++||+.||.+||++.+.+.+++++||||.+++|+.+... .+|++.|
T Consensus       230 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~  283 (285)
T cd05631         230 EDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPFCP  283 (285)
T ss_pred             HHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhCcCCcCCCC
Confidence            9999999999999999999987777899999999999999998764 3444443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-51  Score=417.06  Aligned_cols=281  Identities=39%  Similarity=0.693  Sum_probs=240.2

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      ++|++++.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++.|.+...+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            58999999999999999999999999999999998765444555667888999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccC
Q 011287          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (489)
Q Consensus       125 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~  204 (489)
                      |||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|+|||+++.+.........
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~  160 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY  160 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence            99999999999998888999999999999999999999999999999999999999999999999998765332110000


Q ss_pred             CC----------------------------CCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCC
Q 011287          205 NA----------------------------ASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK  256 (489)
Q Consensus       205 ~~----------------------------~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~  256 (489)
                      ..                            .......+.+||+.|+|||++....++.++|||||||++|+|++|.+||.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~  240 (364)
T cd05599         161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC  240 (364)
T ss_pred             ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCC
Confidence            00                            00001224589999999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHHHhcC--CCCCC--CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCCCCC
Q 011287          257 DTSEWLIFQRIIARD--IRFPN--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP  328 (489)
Q Consensus       257 ~~~~~~~~~~i~~~~--~~~p~--~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~~~p  328 (489)
                      +.+....+..+....  +.+|.  .+++++++||++||. +|.+|++.  .++++++.||||++++|+.+....+|
T Consensus       241 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~--~~~~~ll~h~~~~~~~~~~~~~~~~~  313 (364)
T cd05599         241 SDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGN--NGVNEIKSHPFFKGVDWEHIRERPAP  313 (364)
T ss_pred             CCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCC--CCHHHHhcCCCcCCCCHHHHhhcCCC
Confidence            999888888777543  34454  468999999999996 99999983  23499999999999999987655444

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.4e-52  Score=421.64  Aligned_cols=256  Identities=31%  Similarity=0.579  Sum_probs=239.9

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      +++|.+.+.||+|+||.||+|+.+.|.+.||||.+.|... .+.....+.+|+.+++.++|||||.++++|+....+++|
T Consensus         1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV   79 (808)
T KOG0597|consen    1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV   79 (808)
T ss_pred             CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence            5789999999999999999999999999999999988643 344567789999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      +|||.| +|+.++...+.++|+.++.++++++.||.|||+++|.|||+||.|||+..+|++|+||||+|+.+....    
T Consensus        80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t----  154 (808)
T KOG0597|consen   80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT----  154 (808)
T ss_pred             ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc----
Confidence            999987 999999999999999999999999999999999999999999999999999999999999999876432    


Q ss_pred             CCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHH
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAAR  283 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~~~  283 (489)
                            ....+.-|||.|||||++.+.+|+..+|+||||||+|||++|++||...+-......|.......|...+..+.
T Consensus       155 ------~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~  228 (808)
T KOG0597|consen  155 ------SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFV  228 (808)
T ss_pred             ------eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHH
Confidence                  33456789999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          284 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       284 ~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      .|++.+|.+||.+|++=     .+++.|||.++
T Consensus       229 nfl~gLL~kdP~~RltW-----~~Ll~HpF~k~  256 (808)
T KOG0597|consen  229 NFLQGLLIKDPAQRLTW-----TDLLGHPFWKG  256 (808)
T ss_pred             HHHHHHhhcChhhcccH-----HHHhcChHHhh
Confidence            99999999999999976     88999999875

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-51  Score=411.21  Aligned_cols=259  Identities=30%  Similarity=0.492  Sum_probs=228.9

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC--C
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT--F  118 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~  118 (489)
                      ....+.|+.++.||+|+||.||+|++..||+.||+|.+.... .++.......+|+.+|++|+||||++|.+...+.  .
T Consensus       113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~-~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~  191 (560)
T KOG0600|consen  113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDN-EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSG  191 (560)
T ss_pred             ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeeccc-CCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCc
Confidence            456778999999999999999999999999999999997663 3455666778899999999999999999988766  7


Q ss_pred             EEEEEEeccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCC
Q 011287          119 SLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~  197 (489)
                      .+|+|+|||+. ||..++...+ .|++.+++.|+.||+.||+|||++||+|||||.+|||||.+|.+||+|||+|+.+..
T Consensus       192 siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~  270 (560)
T KOG0600|consen  192 SIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP  270 (560)
T ss_pred             eEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence            89999999987 9999888743 699999999999999999999999999999999999999999999999999998765


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcCCC-CCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC-----
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----  271 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~-~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~-----  271 (489)
                      ..         .....+.|-|.+|+|||+|.+.. |+.++|+||+||||.||++|++.|.+.++.+++.+|.+.-     
T Consensus       271 ~~---------~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e  341 (560)
T KOG0600|consen  271 SG---------SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTE  341 (560)
T ss_pred             CC---------CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCCh
Confidence            43         22355779999999999998754 9999999999999999999999999999999999987620     


Q ss_pred             -----CCCC-------------------CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 011287          272 -----IRFP-------------------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (489)
Q Consensus       272 -----~~~p-------------------~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~  315 (489)
                           ..+|                   ..++..+.+|+..||..||.+|.||     .+++.|+||.
T Consensus       342 ~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA-----~~aL~seyF~  404 (560)
T KOG0600|consen  342 DYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTA-----SSALQSEYFT  404 (560)
T ss_pred             hccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccH-----HHHhcCcccc
Confidence                 1122                   2368999999999999999999999     8899999994

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.1e-50  Score=407.02  Aligned_cols=270  Identities=35%  Similarity=0.642  Sum_probs=244.0

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCEEEEEE
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~lylV~  124 (489)
                      +|++.+.||+|+||.||+|+++.+|+.||+|++.+..............|..++..+. |++|+++++.|.+...+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            6899999999999999999999999999999998765444555566777888888885 577889999999999999999


Q ss_pred             eccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccC
Q 011287          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (489)
Q Consensus       125 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~  204 (489)
                      ||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+++++|+|||+++.....      
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~------  154 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD------  154 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCC------
Confidence            99999999999998889999999999999999999999999999999999999999999999999998743221      


Q ss_pred             CCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHH
Q 011287          205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD  284 (489)
Q Consensus       205 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  284 (489)
                          .......+||+.|+|||++.+..++.++|+|||||++|+|++|++||.+.+.....+.+......+|..++.++.+
T Consensus       155 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  230 (323)
T cd05615         155 ----GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVS  230 (323)
T ss_pred             ----CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHH
Confidence                1123356799999999999998999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC
Q 011287          285 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  325 (489)
Q Consensus       285 Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~  325 (489)
                      |+.+||+.||.+|+++.+...+++++||||.+++|..+...
T Consensus       231 li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~  271 (323)
T cd05615         231 ICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENR  271 (323)
T ss_pred             HHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHhcC
Confidence            99999999999999988778899999999999999987654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.9e-50  Score=408.31  Aligned_cols=264  Identities=38%  Similarity=0.666  Sum_probs=239.2

Q ss_pred             eEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEeccCCC
Q 011287           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG  130 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~~~gg  130 (489)
                      +.||+|+||.||+|++..+|+.||+|++.+...........+.+|..+++.++||||+++++++.+...+|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            47999999999999999999999999998765555555667788999999999999999999999999999999999999


Q ss_pred             ChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCCC
Q 011287          131 ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDD  210 (489)
Q Consensus       131 ~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~  210 (489)
                      +|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....          ..
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~----------~~  150 (328)
T cd05593          81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD----------AA  150 (328)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc----------cc
Confidence            99999988888999999999999999999999999999999999999999999999999998753211          11


Q ss_pred             CccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 011287          211 KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLL  290 (489)
Q Consensus       211 ~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~~L  290 (489)
                      .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......+|..+++++.+||++||
T Consensus       151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L  230 (328)
T cd05593         151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLL  230 (328)
T ss_pred             ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHc
Confidence            22356899999999999998999999999999999999999999999888888888888889999999999999999999


Q ss_pred             ccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 011287          291 DVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (489)
Q Consensus       291 ~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~  324 (489)
                      +.||++|++.....+.++++||||.+++|..+..
T Consensus       231 ~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~  264 (328)
T cd05593         231 IKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYD  264 (328)
T ss_pred             CCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHh
Confidence            9999999976555679999999999999988754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-50  Score=417.20  Aligned_cols=282  Identities=38%  Similarity=0.655  Sum_probs=238.2

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      ++|.+++.||+|+||.||+|++..+|+.||||++.+...........+.+|+.+++.++||||++++++|.+...+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            58999999999999999999999999999999997765445555677888999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccc--
Q 011287          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV--  202 (489)
Q Consensus       125 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~--  202 (489)
                      |||+||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.+|+++|+|||+++.+.......  
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  160 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY  160 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence            999999999999988889999999999999999999999999999999999999999999999999997442211000  


Q ss_pred             ---cCC--CC------------------------------CCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHH
Q 011287          203 ---LPN--AA------------------------------SDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQ  247 (489)
Q Consensus       203 ---~~~--~~------------------------------~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilye  247 (489)
                         ...  ..                              ......+.+||+.|+|||++.+..++.++|||||||++|+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e  240 (377)
T cd05629         161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE  240 (377)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence               000  00                              0000123679999999999999999999999999999999


Q ss_pred             HhhCCCCCCCCCHHHHHHHHHh--cCCCCCC--CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCccccc
Q 011287          248 MLSGTSPFKDTSEWLIFQRIIA--RDIRFPN--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR  323 (489)
Q Consensus       248 lltG~~PF~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~  323 (489)
                      |++|.+||.+.+....+..+..  ....+|.  .++.++++||.+||+ +|.+|++.  .+..+++.||||++++|+.+.
T Consensus       241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r--~~~~~~l~hp~~~~~~~~~~~  317 (377)
T cd05629         241 CLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGR--GGAHEIKSHPFFRGVDWDTIR  317 (377)
T ss_pred             hhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCC--CCHHHHhcCCCcCCCCHHHHc
Confidence            9999999999888888888775  3455665  478999999999997 88887632  134899999999999999987


Q ss_pred             CCCCCC
Q 011287          324 GQTPPK  329 (489)
Q Consensus       324 ~~~~p~  329 (489)
                      ...+|.
T Consensus       318 ~~~~~~  323 (377)
T cd05629         318 QIRAPF  323 (377)
T ss_pred             cCCCCc
Confidence            555443

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.6e-50  Score=404.79  Aligned_cols=264  Identities=34%  Similarity=0.657  Sum_probs=238.1

Q ss_pred             eEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCEEEEEEeccCC
Q 011287           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEG  129 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~lylV~E~~~g  129 (489)
                      +.||+|+||.||+|+++.+++.||+|++.+..............|..++..+ +||||++++++|.+...+|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            4799999999999999999999999999876554455556667788888776 799999999999999999999999999


Q ss_pred             CChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCC
Q 011287          130 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  209 (489)
Q Consensus       130 g~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~  209 (489)
                      |+|..++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++.....          .
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~----------~  150 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN----------G  150 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC----------C
Confidence            999999998889999999999999999999999999999999999999999999999999998753211          1


Q ss_pred             CCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 011287          210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL  289 (489)
Q Consensus       210 ~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~~  289 (489)
                      ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...++..+......+|..++.++++||++|
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  230 (320)
T cd05590         151 KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAF  230 (320)
T ss_pred             CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Confidence            22345689999999999999999999999999999999999999999999999999999998999999999999999999


Q ss_pred             hccCCCCCCCCCC-CCHHHHhcCCCCCCCCcccccC
Q 011287          290 LDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRG  324 (489)
Q Consensus       290 L~~dP~~R~t~~~-~~~~~l~~hpff~~i~~~~~~~  324 (489)
                      |+.||.+||++.+ .+.+++++||||.+++|+.+..
T Consensus       231 L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~~~  266 (320)
T cd05590         231 MTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNR  266 (320)
T ss_pred             cccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHHHh
Confidence            9999999999855 5679999999999999998754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.8e-50  Score=415.25  Aligned_cols=280  Identities=35%  Similarity=0.563  Sum_probs=236.0

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      ..|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+|+||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence            36999999999999999999999999999999998766555566677889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc-
Q 011287          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL-  203 (489)
Q Consensus       125 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~-  203 (489)
                      |||+||+|.+++.+.+.+++..++.+++||+.||+|||+.||+||||||+||||+.+|++||+|||+++.+........ 
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~  160 (381)
T cd05626          81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY  160 (381)
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence            9999999999999888899999999999999999999999999999999999999999999999999865421100000 


Q ss_pred             --------C----------------------------CCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHH
Q 011287          204 --------P----------------------------NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQ  247 (489)
Q Consensus       204 --------~----------------------------~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilye  247 (489)
                              .                            .........+++||+.|+|||++.+..++.++|||||||++|+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e  240 (381)
T cd05626         161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE  240 (381)
T ss_pred             cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence                    0                            0000112245789999999999999899999999999999999


Q ss_pred             HhhCCCCCCCCCHHHHHHHHHh--cCCCCCC--CCCHHHHHHHHHhhccCC--CCCCCCCCCCHHHHhcCCCCCCCCccc
Q 011287          248 MLSGTSPFKDTSEWLIFQRIIA--RDIRFPN--YFSDAARDLIDRLLDVDP--SGRPGAGPGGYAVLKMHPFFKGIDWKN  321 (489)
Q Consensus       248 lltG~~PF~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~Li~~~L~~dP--~~R~t~~~~~~~~l~~hpff~~i~~~~  321 (489)
                      |++|.+||...+.......+..  ....+|.  .+++++++||.+||+.++  ..|+++     +++++||||++++|..
T Consensus       241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~-----~~~l~hp~f~~~~~~~  315 (381)
T cd05626         241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGA-----DDIKAHPFFSEVDFSS  315 (381)
T ss_pred             HHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCH-----HHHhcCcccCCCChhH
Confidence            9999999999887777666664  3345554  579999999999776544  449988     8999999999999987


Q ss_pred             ccCCCCCC
Q 011287          322 IRGQTPPK  329 (489)
Q Consensus       322 ~~~~~~p~  329 (489)
                      .....+++
T Consensus       316 ~~~~~~~~  323 (381)
T cd05626         316 DIRTQPAP  323 (381)
T ss_pred             HhhcCCCC
Confidence            55444443

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-50  Score=404.11  Aligned_cols=260  Identities=41%  Similarity=0.696  Sum_probs=235.9

Q ss_pred             EeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEeccCCCCh
Q 011287           53 YGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL  132 (489)
Q Consensus        53 LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~~~gg~L  132 (489)
                      ||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            69999999999999999999999999876544455556677899999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCCCCc
Q 011287          133 FDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA  212 (489)
Q Consensus       133 ~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~  212 (489)
                      .+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||+++.....          ....
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~----------~~~~  150 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD----------DDKT  150 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC----------CCcc
Confidence            999998889999999999999999999999999999999999999999999999999998753221          1223


Q ss_pred             cceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhcc
Q 011287          213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDV  292 (489)
Q Consensus       213 ~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~~L~~  292 (489)
                      ...+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+....++.+......+|..+++++++||.+||+.
T Consensus       151 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  230 (312)
T cd05585         151 NTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSR  230 (312)
T ss_pred             ccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCC
Confidence            45689999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 011287          293 DPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (489)
Q Consensus       293 dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~  324 (489)
                      ||.+||+..  +..++++||||...+|..+..
T Consensus       231 dp~~R~~~~--~~~e~l~hp~~~~~~~~~~~~  260 (312)
T cd05585         231 DPTRRLGYN--GAQEIKNHPFFSQLSWKKLLM  260 (312)
T ss_pred             CHHHcCCCC--CHHHHHcCCCcCCCCHHHHHh
Confidence            999999863  358999999999999987643

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.6e-50  Score=413.93  Aligned_cols=278  Identities=38%  Similarity=0.680  Sum_probs=240.1

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      ++|++.+.||+|+||.||+|+++.+++.||+|++.+...........+..|+.++..++||+|+++++.|++...+|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            58999999999999999999999999999999998765555556677888999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc-
Q 011287          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL-  203 (489)
Q Consensus       125 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~-  203 (489)
                      |||+||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.+|+++|+|||++..+........ 
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~  160 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY  160 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence            9999999999999888899999999999999999999999999999999999999999999999999876532210000 


Q ss_pred             -------C-----------------CCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCC
Q 011287          204 -------P-----------------NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS  259 (489)
Q Consensus       204 -------~-----------------~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~  259 (489)
                             +                 .........+.+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~  240 (360)
T cd05627         161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET  240 (360)
T ss_pred             cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence                   0                 0000112235689999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHhc--CCCCCCC--CCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC
Q 011287          260 EWLIFQRIIAR--DIRFPNY--FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  325 (489)
Q Consensus       260 ~~~~~~~i~~~--~~~~p~~--~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~  325 (489)
                      ....+.++...  .+.+|..  +++++++||.+|+ .||.+|+++.  ++.++++||||++++|..+...
T Consensus       241 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~--~~~ei~~hp~f~~~~~~~~~~~  307 (360)
T cd05627         241 PQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSN--GVEEIKSHPFFEGVDWGHIRER  307 (360)
T ss_pred             HHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCC--CHHHHhcCCCCCCCCHHHHhcC
Confidence            88888888753  3455653  7899999999987 5999999863  5699999999999999998654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8.6e-50  Score=423.32  Aligned_cols=393  Identities=25%  Similarity=0.348  Sum_probs=287.0

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCC-CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~t-g~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lyl  122 (489)
                      ...|.+.+.||+|++|.||+|.+..+ +..||+|.+...   .......+.+|+.+|+.++||||++++++|.+...+|+
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l  142 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL  142 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence            44599999999999999999999877 788999976433   34445667889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          123 ALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      ||||++||+|.+++..    ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus       143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS  222 (478)
T ss_pred             EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence            9999999999987753    356999999999999999999999999999999999999999999999999999865432


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC-CCCCC
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-RFPNY  277 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~-~~p~~  277 (489)
                      .        ......+++||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...++..+..+.. .+|..
T Consensus       223 ~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  294 (478)
T PTZ00267        223 V--------SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCP  294 (478)
T ss_pred             c--------ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence            1        11223467899999999999999999999999999999999999999999988888888877655 46778


Q ss_pred             CCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc--ccccCCCCCCCCCCCccCCCCCCCCCCCCCCCCCCC
Q 011287          278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW--KNIRGQTPPKLASEPMVQSGEGDDVHDSSWNPSHIG  355 (489)
Q Consensus       278 ~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~--~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (489)
                      +++++.+||.+||+.||++||++     ++++.|+|++.+.-  ..+.... ..       .+..  +.          .
T Consensus       295 ~s~~~~~li~~~L~~dP~~Rps~-----~~~l~~~~~~~~~~~~~~~~~~~-~~-------~~~~--~~----------~  349 (478)
T PTZ00267        295 VSSGMKALLDPLLSKNPALRPTT-----QQLLHTEFLKYVANLFQDIVRHS-ET-------ISPH--DR----------E  349 (478)
T ss_pred             CCHHHHHHHHHHhccChhhCcCH-----HHHHhCHHHHHHHHHHHHHhhhh-hh-------cChh--hH----------H
Confidence            99999999999999999999998     88999999864321  1110000 00       0000  00          0


Q ss_pred             CccccccCCCCCCCCCCCcccccccccccCcccccccCCCceEEEEEeeehhhhhh-ccceeEEEecCCeEEE-ECCCC-
Q 011287          356 DISAKINDGNGGASSSEGSITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLT-SKKVQLILTNKPKLIY-VDPSK-  432 (489)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~g~~~k~~g~~-~k~r~~~lt~~p~l~y-~d~~~-  432 (489)
                      .............  ......+.      .     .  ....+.+.|++.|...-. ||+|+|.+.++..... ..... 
T Consensus       350 ~~~~~~~~~~~~~--~~~~~~~~------~-----~--v~sDv~~~G~l~k~~~~~~wk~ry~~l~~~~l~~~~~~~~~~  414 (478)
T PTZ00267        350 EILRQLQESGERA--PPPSSIRY------G-----V--VTSDVTHGGYLYKYSSDMRWKKRYFYIGNGQLRISLSENPEN  414 (478)
T ss_pred             HHHHHHhhccccC--CCCcceec------c-----e--ecCCcccceEEeccCCCcchhhheEEecCCceEEEecccccc
Confidence            0000000000000  00000000      0     0  012356789998877644 9999999987555543 32211 


Q ss_pred             -CeeeeeeeccCCCCceEE----EEcCCCcEEEEc--CCceEEEEcCCccHHHHHHHHHHhc
Q 011287          433 -LVVKGNIIWSDNSNDLSI----QVSSPSHFKIVT--PKKVLSFEDAKQRASQWKKAIEALQ  487 (489)
Q Consensus       433 -~~~kg~i~~~~~~~~~~~----~~~~~~~f~i~~--p~r~y~~~d~~~~~~~W~~~i~~~~  487 (489)
                       ......+.+.....+..+    ..+.++.|.|.|  -.|+|+..+.+.++++|+++|++++
T Consensus       415 ~~~~~~~~~l~~~~~v~pv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~W~~~~~~~~  476 (478)
T PTZ00267        415 DGVAPKSVNLETVNDVFPVPEVYSQKHPNQLVLWFNNGQKIIAYAKTAEDRDQWISKFQRAC  476 (478)
T ss_pred             CCCCCccccHHHhcccccccHHhcCCCCceEEEEecCCcEEEEecCChHHHHHHHHHHHHHh
Confidence             000011122111111222    335688999976  3477777788899999999999976

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=5.3e-50  Score=404.05  Aligned_cols=267  Identities=35%  Similarity=0.619  Sum_probs=239.7

Q ss_pred             eEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHH---HhCCCCCccEEEEEEEcCCEEEEE
Q 011287           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL---DQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        47 y~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il---~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      |++.+.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.++   +.++||||+++++++.+...+|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            78999999999999999999999999999999876544444556677777665   456899999999999999999999


Q ss_pred             EeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      |||++||+|..++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....     
T Consensus        81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~-----  154 (324)
T cd05589          81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-----  154 (324)
T ss_pred             EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC-----
Confidence            999999999988865 57999999999999999999999999999999999999999999999999998743211     


Q ss_pred             CCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHH
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAAR  283 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~~~  283 (489)
                           ......++||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+....+..+......+|..+++.+.
T Consensus       155 -----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~  229 (324)
T cd05589         155 -----GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAI  229 (324)
T ss_pred             -----CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Confidence                 123346789999999999999999999999999999999999999999999999999999988999999999999


Q ss_pred             HHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 011287          284 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (489)
Q Consensus       284 ~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~  324 (489)
                      +||.+||+.||.+||++.+..+.++++||||++++|..+..
T Consensus       230 ~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~~~~  270 (324)
T cd05589         230 SIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLA  270 (324)
T ss_pred             HHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHHHHh
Confidence            99999999999999998877889999999999999988654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.2e-50  Score=405.67  Aligned_cols=264  Identities=38%  Similarity=0.659  Sum_probs=239.0

Q ss_pred             eEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEeccCCC
Q 011287           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG  130 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~~~gg  130 (489)
                      +.||+|+||.||+|++..+|+.||+|++.+...........+.+|..+++.++||||+++++.|.+...+|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            47999999999999999999999999998765544455566778999999999999999999999999999999999999


Q ss_pred             ChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCCC
Q 011287          131 ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDD  210 (489)
Q Consensus       131 ~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~  210 (489)
                      +|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....          ..
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~----------~~  150 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD----------GA  150 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC----------CC
Confidence            99999988888999999999999999999999999999999999999999999999999998743211          11


Q ss_pred             CccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 011287          211 KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLL  290 (489)
Q Consensus       211 ~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~~L  290 (489)
                      .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+......+|..+++++.+||.+||
T Consensus       151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L  230 (323)
T cd05595         151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL  230 (323)
T ss_pred             ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHc
Confidence            22356799999999999999999999999999999999999999999998888888888889999999999999999999


Q ss_pred             ccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 011287          291 DVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (489)
Q Consensus       291 ~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~  324 (489)
                      +.||.+|++.......++++||||.+++|..+..
T Consensus       231 ~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~  264 (323)
T cd05595         231 KKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQ  264 (323)
T ss_pred             cCCHHHhCCCCCCCHHHHHcCCCcCCCCHHHHHh
Confidence            9999999977666779999999999999988654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=5.2e-50  Score=413.31  Aligned_cols=280  Identities=38%  Similarity=0.599  Sum_probs=236.8

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      .+|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.|.+...+|+||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence            36999999999999999999999999999999998765555566678889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccc--
Q 011287          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV--  202 (489)
Q Consensus       125 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~--  202 (489)
                      |||++|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++..+.......  
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~  160 (382)
T cd05625          81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (382)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence            999999999999988889999999999999999999999999999999999999999999999999986432110000  


Q ss_pred             c-----------------------------------CCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHH
Q 011287          203 L-----------------------------------PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQ  247 (489)
Q Consensus       203 ~-----------------------------------~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilye  247 (489)
                      .                                   ..........+.+||+.|+|||++.+..++.++|||||||++|+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~e  240 (382)
T cd05625         161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  240 (382)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHH
Confidence            0                                   00000111235689999999999999999999999999999999


Q ss_pred             HhhCCCCCCCCCHHHHHHHHHhc--CCCCC--CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCccccc
Q 011287          248 MLSGTSPFKDTSEWLIFQRIIAR--DIRFP--NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR  323 (489)
Q Consensus       248 lltG~~PF~~~~~~~~~~~i~~~--~~~~p--~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~  323 (489)
                      |++|++||.+.+..+...++...  ...+|  ..+++++.+||.+|+ .||.+|++.  .+..++++||||++++|....
T Consensus       241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~--~~~~ei~~hp~f~~~~~~~~~  317 (382)
T cd05625         241 MLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGK--NGADEIKAHPFFKTIDFSSDL  317 (382)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCC--CCHHHHhcCCCcCCcChHHHH
Confidence            99999999998888777777653  33444  357999999999986 599999984  245899999999999998754


Q ss_pred             CCCC
Q 011287          324 GQTP  327 (489)
Q Consensus       324 ~~~~  327 (489)
                      .+.+
T Consensus       318 ~~~~  321 (382)
T cd05625         318 RQQS  321 (382)
T ss_pred             hcCC
Confidence            4433

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=8e-50  Score=402.95  Aligned_cols=264  Identities=39%  Similarity=0.671  Sum_probs=237.9

Q ss_pred             eEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEeccCCC
Q 011287           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG  130 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~~~gg  130 (489)
                      +.||+|+||.||+|++..+|+.||+|++.+...........+..|..+++.++||||+++++.|.+...+|+||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            47999999999999999999999999998765555555566778999999999999999999999999999999999999


Q ss_pred             ChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCC
Q 011287          131 ELFDQITSKGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  209 (489)
Q Consensus       131 ~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~-~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~  209 (489)
                      +|..++.+.+.+++..++.++.||+.||.|||+ .||+||||||+|||++.+|.+||+|||+++.....          .
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~----------~  150 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD----------G  150 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC----------C
Confidence            999999888889999999999999999999997 79999999999999999999999999998743211          1


Q ss_pred             CCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 011287          210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL  289 (489)
Q Consensus       210 ~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~~  289 (489)
                      ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+......+|..+++++.+||++|
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~  230 (325)
T cd05594         151 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGL  230 (325)
T ss_pred             cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Confidence            12235679999999999999999999999999999999999999999999888888898889999999999999999999


Q ss_pred             hccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 011287          290 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (489)
Q Consensus       290 L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~  324 (489)
                      |+.||++|++.......++++||||.++.|.....
T Consensus       231 L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~  265 (325)
T cd05594         231 LKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYE  265 (325)
T ss_pred             hhcCHHHhCCCCCCCHHHHhcCCCcCCCCHHHHHh
Confidence            99999999976555669999999999999997654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-51  Score=417.94  Aligned_cols=296  Identities=36%  Similarity=0.586  Sum_probs=257.7

Q ss_pred             cccccCCCCCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEE
Q 011287           32 SFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLF  111 (489)
Q Consensus        32 s~~~~~~~~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~  111 (489)
                      |...+.-+.++...-|..++.||-|+||+|.+++..+|...||+|.+.|..+...+....++.|+.||...+.+-||+||
T Consensus       616 SnYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLy  695 (1034)
T KOG0608|consen  616 SNYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLY  695 (1034)
T ss_pred             hhHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEE
Confidence            33455666788888899999999999999999999999999999999999888889999999999999999999999999


Q ss_pred             EEEEcCCEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccC
Q 011287          112 FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS  191 (489)
Q Consensus       112 ~~~~~~~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~  191 (489)
                      ..|+|.+++||||+|++|||+..+|-+.|-|.|..+++|++++..|+++.|..|+|||||||.|||||.+|||||+|||+
T Consensus       696 ySFQDkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGL  775 (1034)
T KOG0608|consen  696 YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGL  775 (1034)
T ss_pred             EEeccCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCcc---------cc-----ccCCCC------------------CCCCccceecCCcCCChhhhcCCCCCCCCcch
Q 011287          192 VKPMQDSR---------IT-----VLPNAA------------------SDDKACTFVGTAAYVPPEVLNSSPATFGNDLW  239 (489)
Q Consensus       192 a~~~~~~~---------~~-----~~~~~~------------------~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiw  239 (489)
                      +.-+.-..         ..     ...+++                  ......+.+||+.|+|||+|....|+..+|+|
T Consensus       776 CTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdww  855 (1034)
T KOG0608|consen  776 CTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWW  855 (1034)
T ss_pred             cccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhh
Confidence            86542211         00     000001                  11234567999999999999999999999999


Q ss_pred             hhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc----CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 011287          240 ALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR----DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (489)
Q Consensus       240 SLG~ilyelltG~~PF~~~~~~~~~~~i~~~----~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~  315 (489)
                      |.|||||+|+.|++||.+.+..++..++.+-    .+.....+++++.+||.++. .+++.|++-.  +.++++.||||+
T Consensus       856 s~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkn--g~d~vKaHpfFk  932 (1034)
T KOG0608|consen  856 SVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKN--GADQVKAHPFFK  932 (1034)
T ss_pred             HhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhccc--chhhhhcCcccc
Confidence            9999999999999999998888777676542    23344579999999999976 5899999874  457899999999


Q ss_pred             CCCcccccCCCCCCC
Q 011287          316 GIDWKNIRGQTPPKL  330 (489)
Q Consensus       316 ~i~~~~~~~~~~p~~  330 (489)
                      +|||.+++++..|.+
T Consensus       933 gIDfsslRkq~ApYI  947 (1034)
T KOG0608|consen  933 GIDFSSLRKQRAPYI  947 (1034)
T ss_pred             ccchHhhhhccCCcC
Confidence            999999998877743

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-51  Score=404.16  Aligned_cols=269  Identities=39%  Similarity=0.645  Sum_probs=232.6

Q ss_pred             CCCCCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccch-----------hHHHHHHHHHHHHHhCCCC
Q 011287           37 APQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE-----------NKTAYVKLERIVLDQLDHP  105 (489)
Q Consensus        37 ~~~~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~-----------~~~~~~~~E~~il~~l~hp  105 (489)
                      .......++.|++++.||+|.||.|-+|++..+++.||||++.|....+.           .-.+.+.+|+.+|++|.||
T Consensus        89 ~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~  168 (576)
T KOG0585|consen   89 DDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHP  168 (576)
T ss_pred             CcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCc
Confidence            33456678999999999999999999999999999999999987654432           2245789999999999999


Q ss_pred             CccEEEEEEEcC--CEEEEEEeccCCCChHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCC
Q 011287          106 GVVRLFFTFQDT--FSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG  182 (489)
Q Consensus       106 nIv~l~~~~~~~--~~lylV~E~~~gg~L~~~l~~~~~-l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g  182 (489)
                      |||+|+++..|.  ..+|+|+|||..|.+...-.. +. +++.+++.|+..++.||+|||.+|||||||||+|+||+.+|
T Consensus       169 nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d-~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  169 NVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPD-KPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             CeeEEEEeecCcccCceEEEEEeccCCccccCCCC-cccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC
Confidence            999999999864  679999999999988553322 34 99999999999999999999999999999999999999999


Q ss_pred             CEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCC----CCCCCcchhhhHHHHHHhhCCCCCCCC
Q 011287          183 HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP----ATFGNDLWALGCTLYQMLSGTSPFKDT  258 (489)
Q Consensus       183 ~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~----~~~~sDiwSLG~ilyelltG~~PF~~~  258 (489)
                      ++||+|||.+.......     ....+......+|||.|+|||...+..    .+.+.|||||||+||.|+.|+.||-+.
T Consensus       248 ~VKIsDFGVs~~~~~~~-----~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~  322 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGS-----DEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD  322 (576)
T ss_pred             cEEeeccceeeecccCC-----ccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence            99999999988663321     111222333479999999999987632    467889999999999999999999999


Q ss_pred             CHHHHHHHHHhcCCCCCCC--CCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          259 SEWLIFQRIIARDIRFPNY--FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       259 ~~~~~~~~i~~~~~~~p~~--~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      ...+++.+|.+..+.||..  +.++++|||.+||++||++|++.     .+++.|||...
T Consensus       323 ~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l-----~~ik~Hpwvt~  377 (576)
T KOG0585|consen  323 FELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITL-----PDIKLHPWVTR  377 (576)
T ss_pred             hHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeeh-----hhheecceecc
Confidence            9999999999999999986  79999999999999999999998     88999999853

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-51  Score=390.47  Aligned_cols=284  Identities=36%  Similarity=0.690  Sum_probs=261.0

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCC
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTF  118 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  118 (489)
                      ..+.++||.++++||+|+|+.|.+++.++|.+.||+|+++|...........++.|..+.... +||++|.|+..|+.+.
T Consensus       245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes  324 (593)
T KOG0695|consen  245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES  324 (593)
T ss_pred             cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence            457889999999999999999999999999999999999999888888888999999998776 7999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      .+++|.||++||+|.-++++..+++|+.+++|.++|+.||.|||++|||+||||..|+|++..||+||+|+|.++.-   
T Consensus       325 rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~---  401 (593)
T KOG0695|consen  325 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG---  401 (593)
T ss_pred             eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcC---
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999998742   


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCC--------CCCHHHHHHHHHhc
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK--------DTSEWLIFQRIIAR  270 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~--------~~~~~~~~~~i~~~  270 (489)
                             .......++|||||.|.|||+|.+..|+..+|+|+|||+++||++|+.||.        ..++.-++|-|+..
T Consensus       402 -------l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek  474 (593)
T KOG0695|consen  402 -------LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK  474 (593)
T ss_pred             -------CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh
Confidence                   223567789999999999999999999999999999999999999999995        23456688999999


Q ss_pred             CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCC-CCHHHHhcCCCCCCCCcccccC-CCCCCCCCC
Q 011287          271 DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRG-QTPPKLASE  333 (489)
Q Consensus       271 ~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~-~~~~~l~~hpff~~i~~~~~~~-~~~p~~~~~  333 (489)
                      ...+|..++-.+..+++..|++||.+|+++.. .|+++++.|+||+.+||+.+.+ +..|++.|.
T Consensus       475 qiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p~  539 (593)
T KOG0695|consen  475 QIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQPQ  539 (593)
T ss_pred             cccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCCc
Confidence            99999999999999999999999999999875 7899999999999999999865 445555443

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=7.3e-50  Score=402.56  Aligned_cols=264  Identities=36%  Similarity=0.628  Sum_probs=237.5

Q ss_pred             eEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCEEEEEEeccCC
Q 011287           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEG  129 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~lylV~E~~~g  129 (489)
                      ++||+|+||.||+|++..+++.||+|++.+..............|..++..+ +||||++++++|.+...+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            4699999999999999999999999999876554555556667788888766 799999999999999999999999999


Q ss_pred             CChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCC
Q 011287          130 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  209 (489)
Q Consensus       130 g~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~  209 (489)
                      |+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|+++|+|||++......          .
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~----------~  150 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN----------G  150 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccC----------C
Confidence            999999998888999999999999999999999999999999999999999999999999998753221          1


Q ss_pred             CCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 011287          210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL  289 (489)
Q Consensus       210 ~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~~  289 (489)
                      ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....++.+......+|..++.++.+||.+|
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~  230 (321)
T cd05591         151 VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAF  230 (321)
T ss_pred             ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence            22335679999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hccCCCCCCCCCC--CCHHHHhcCCCCCCCCcccccC
Q 011287          290 LDVDPSGRPGAGP--GGYAVLKMHPFFKGIDWKNIRG  324 (489)
Q Consensus       290 L~~dP~~R~t~~~--~~~~~l~~hpff~~i~~~~~~~  324 (489)
                      |+.||++|+++..  ....++++||||.+++|..+..
T Consensus       231 L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~~~  267 (321)
T cd05591         231 MTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQ  267 (321)
T ss_pred             hccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHHHh
Confidence            9999999997654  2679999999999999998754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=9.4e-50  Score=410.44  Aligned_cols=277  Identities=37%  Similarity=0.614  Sum_probs=234.1

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      .+|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+|+.++||||+++++.|.+...+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            48999999999999999999999999999999997765444555677888999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccc--
Q 011287          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV--  202 (489)
Q Consensus       125 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~--  202 (489)
                      |||++|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+++++|+|||+|..+.......  
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~  160 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence            999999999999988889999999999999999999999999999999999999999999999999986432110000  


Q ss_pred             -----------cC-C-------------------CCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhC
Q 011287          203 -----------LP-N-------------------AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSG  251 (489)
Q Consensus       203 -----------~~-~-------------------~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG  251 (489)
                                 .. .                   .........++||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G  240 (376)
T cd05598         161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG  240 (376)
T ss_pred             ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC
Confidence                       00 0                   0000112356899999999999999999999999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHHhcC--CCCC--CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 011287          252 TSPFKDTSEWLIFQRIIARD--IRFP--NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (489)
Q Consensus       252 ~~PF~~~~~~~~~~~i~~~~--~~~p--~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~  324 (489)
                      +.||.+.+..+....+....  +.+|  ..+++++.+||.+|+ .+|.+|++..  ++.++++||||++++|..+..
T Consensus       241 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~--t~~ell~h~~~~~~~~~~~~~  314 (376)
T cd05598         241 QPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKN--GADEIKAHPFFKGIDFASLIR  314 (376)
T ss_pred             CCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCC--CHHHHhCCCCcCCCCHHHHhh
Confidence            99999988877776665432  3333  358999999999977 5999999431  338999999999999988753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-50  Score=408.17  Aligned_cols=278  Identities=44%  Similarity=0.753  Sum_probs=242.1

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      ++|.+++.||+|+||+||+|++..+|+.||||++.+...........+..|+.++..++||||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            48999999999999999999999999999999998765555456677888999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccC
Q 011287          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (489)
Q Consensus       125 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~  204 (489)
                      ||+++|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+.........
T Consensus        81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  160 (350)
T cd05573          81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY  160 (350)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence            99999999999998888999999999999999999999999999999999999999999999999999866443200000


Q ss_pred             -------------------CCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHH
Q 011287          205 -------------------NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQ  265 (489)
Q Consensus       205 -------------------~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~  265 (489)
                                         ...........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~  240 (350)
T cd05573         161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN  240 (350)
T ss_pred             ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHH
Confidence                               0000122345689999999999999999999999999999999999999999999888888


Q ss_pred             HHHh--cCCCCCCC--CCHHHHHHHHHhhccCCCCCCC-CCCCCHHHHhcCCCCCCCCcccccCCCCC
Q 011287          266 RIIA--RDIRFPNY--FSDAARDLIDRLLDVDPSGRPG-AGPGGYAVLKMHPFFKGIDWKNIRGQTPP  328 (489)
Q Consensus       266 ~i~~--~~~~~p~~--~~~~~~~Li~~~L~~dP~~R~t-~~~~~~~~l~~hpff~~i~~~~~~~~~~p  328 (489)
                      ++..  ....+|..  +++++.+||.+||. ||.+|++ +     +++++||||++++|.......+|
T Consensus       241 ~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~-----~~ll~hp~~~~~~~~~~~~~~~~  302 (350)
T cd05573         241 KIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSF-----EEIKSHPFFKGIDWENLRETKPP  302 (350)
T ss_pred             HHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCH-----HHHhcCCCcCCCCHHHHhhCCCC
Confidence            8877  55556654  59999999999997 9999999 7     89999999999999987744433

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=9.4e-50  Score=403.30  Aligned_cols=264  Identities=36%  Similarity=0.700  Sum_probs=234.0

Q ss_pred             eEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCEEEEEEeccCC
Q 011287           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEG  129 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~lylV~E~~~g  129 (489)
                      ++||+|+||.||+|++..+++.||+|++.+...........+..|..++..+ +||||++++++|.+...+|+|||||+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4799999999999999999999999999877655555666788899999888 799999999999999999999999999


Q ss_pred             CChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCC
Q 011287          130 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  209 (489)
Q Consensus       130 g~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~  209 (489)
                      |+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....          ..
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~----------~~  150 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR----------PG  150 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc----------CC
Confidence            99999998888999999999999999999999999999999999999999999999999999874211          11


Q ss_pred             CCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCC---------CHHHHHHHHHhcCCCCCCCCCH
Q 011287          210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT---------SEWLIFQRIIARDIRFPNYFSD  280 (489)
Q Consensus       210 ~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~---------~~~~~~~~i~~~~~~~p~~~~~  280 (489)
                      ......+||+.|+|||++.+..++.++|+|||||++|+|++|+.||...         ......+.+......+|..++.
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~  230 (329)
T cd05588         151 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSV  230 (329)
T ss_pred             CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCH
Confidence            2334578999999999999999999999999999999999999999631         2234566778888889999999


Q ss_pred             HHHHHHHHhhccCCCCCCCCCC-CCHHHHhcCCCCCCCCcccccC
Q 011287          281 AARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRG  324 (489)
Q Consensus       281 ~~~~Li~~~L~~dP~~R~t~~~-~~~~~l~~hpff~~i~~~~~~~  324 (489)
                      ++.+||.+||+.||.+|+++.. .+++++++||||..++|..+..
T Consensus       231 ~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~~  275 (329)
T cd05588         231 KASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQ  275 (329)
T ss_pred             HHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHh
Confidence            9999999999999999999743 4679999999999999988754

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-52  Score=384.75  Aligned_cols=256  Identities=33%  Similarity=0.593  Sum_probs=234.8

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      -+.|++-++||+|.|+.|+++.++.||+.||+|+++....... ..+.+.+|+.+-+.|+|||||+|++++......|+|
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            4679999999999999999999999999999999986655544 567799999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCC---CCEEEeeccCccccCCccc
Q 011287          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD---GHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~---g~ikL~DFG~a~~~~~~~~  200 (489)
                      +|+++|++|..-|-+.--++|..+-.++.||++||.|||.+||||||+||+|+++-..   .-+||+|||+|..+..   
T Consensus        89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~---  165 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND---  165 (355)
T ss_pred             EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCC---
Confidence            9999999998877766678999999999999999999999999999999999999643   3599999999987652   


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCC----
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN----  276 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~----  276 (489)
                              ......++|||.|||||++...+|+..+||||.|||||-||.|++||.+.+...+++.|.++.+.+|.    
T Consensus       166 --------g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~  237 (355)
T KOG0033|consen  166 --------GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWD  237 (355)
T ss_pred             --------ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccC
Confidence                    34456789999999999999999999999999999999999999999999999999999999998875    


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      .+++++++||++||..||.+|+|+     .|.++|||..+
T Consensus       238 ~is~~Ak~LvrrML~~dP~kRIta-----~EAL~HpWi~~  272 (355)
T KOG0033|consen  238 TVTPEAKSLIRRMLTVNPKKRITA-----DEALKHPWICN  272 (355)
T ss_pred             cCCHHHHHHHHHHhccChhhhccH-----HHHhCCchhcc
Confidence            589999999999999999999999     88999999975

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.3e-49  Score=399.22  Aligned_cols=263  Identities=38%  Similarity=0.677  Sum_probs=234.2

Q ss_pred             eEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHH-HHHhCCCCCccEEEEEEEcCCEEEEEEeccCC
Q 011287           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-VLDQLDHPGVVRLFFTFQDTFSLYMALESCEG  129 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~lylV~E~~~g  129 (489)
                      +.||+|+||+||+|++..+|+.||+|++.+...........+..|.. +++.++||||+++++.+.+...+|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            47999999999999999999999999998764443333444444554 56789999999999999999999999999999


Q ss_pred             CChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCC
Q 011287          130 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  209 (489)
Q Consensus       130 g~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~  209 (489)
                      |+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....          .
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~----------~  150 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH----------S  150 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC----------C
Confidence            999999998889999999999999999999999999999999999999999999999999998743211          1


Q ss_pred             CCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 011287          210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL  289 (489)
Q Consensus       210 ~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~~  289 (489)
                      ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+++..+......++..+++.+.+||++|
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  230 (323)
T cd05575         151 KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGL  230 (323)
T ss_pred             CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence            22335689999999999999999999999999999999999999999999999999999988888889999999999999


Q ss_pred             hccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 011287          290 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (489)
Q Consensus       290 L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~  324 (489)
                      |+.||.+||++.+ .+.++++||||..++|..+..
T Consensus       231 l~~~p~~R~~~~~-~~~~il~~~~~~~~~~~~~~~  264 (323)
T cd05575         231 LQKDRTKRLGAKD-DFLEIKNHVFFSSINWDDLVN  264 (323)
T ss_pred             hhcCHHhCCCCCC-CHHHHHcCCCcCCCCHHHHhh
Confidence            9999999999863 678999999999999988754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-49  Score=400.86  Aligned_cols=266  Identities=39%  Similarity=0.674  Sum_probs=237.1

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      ++|++++.||+|+||.||+|++..+++.||+|++.+...........+..|+.++..++||||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999998765554555667888999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccC
Q 011287          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (489)
Q Consensus       125 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~  204 (489)
                      ||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....       
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-------  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-------  153 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-------
Confidence            9999999999999888899999999999999999999999999999999999999999999999999875432       


Q ss_pred             CCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC--CCCCC------
Q 011287          205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--IRFPN------  276 (489)
Q Consensus       205 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~--~~~p~------  276 (489)
                            .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+....  ...|.      
T Consensus       154 ------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  227 (333)
T cd05600         154 ------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRF  227 (333)
T ss_pred             ------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCcccc
Confidence                  2235679999999999999999999999999999999999999999988888777765432  22222      


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCCCCC
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP  328 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~~~p  328 (489)
                      .+++++.+||.+||..+|.+||++     .++++||||.+++|..+....||
T Consensus       228 ~~s~~~~~li~~~l~~~~~rr~s~-----~~ll~h~~~~~~~~~~~~~~~~~  274 (333)
T cd05600         228 NLSDEAWDLITKLINDPSRRFGSL-----EDIKNHPFFKEVDWNELRELKPP  274 (333)
T ss_pred             ccCHHHHHHHHHHhhChhhhcCCH-----HHHHhCcccCCCCHHHHhhCCCC
Confidence            458999999999999999999998     89999999999999988744443

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.5e-49  Score=401.61  Aligned_cols=269  Identities=36%  Similarity=0.658  Sum_probs=236.2

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      ++|++.+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++.+.+...+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            47999999999999999999999999999999998765544555667888999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          125 ESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       125 E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      ||+++|+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++..+....    
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~----  156 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK----  156 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC----
Confidence            999999999999876 679999999999999999999999999999999999999999999999999998654321    


Q ss_pred             CCCCCCCCccceecCCcCCChhhhc------CCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC--CCCC
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLN------SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--IRFP  275 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~------~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~--~~~p  275 (489)
                           .......+||+.|+|||++.      ...++.++|||||||++|+|++|+.||...+....+.++....  ..+|
T Consensus       157 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  231 (330)
T cd05601         157 -----MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFP  231 (330)
T ss_pred             -----ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCC
Confidence                 11122347999999999986      4557889999999999999999999999988888888776532  3445


Q ss_pred             C--CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCCCCC
Q 011287          276 N--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP  328 (489)
Q Consensus       276 ~--~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~~~p  328 (489)
                      .  .+++++.+||++||+ ||.+||++     +++++||||..++|..+....||
T Consensus       232 ~~~~~~~~~~~li~~ll~-~p~~R~t~-----~~l~~h~~~~~~~~~~~~~~~~~  280 (330)
T cd05601         232 EDPKVSSDFLDLIQSLLC-GQKERLGY-----EGLCCHPFFSKIDWNNIRNSLPP  280 (330)
T ss_pred             CCCCCCHHHHHHHHHHcc-ChhhCCCH-----HHHhCCCCcCCCCHHHHhhCCCC
Confidence            4  579999999999998 99999998     89999999999999988764444

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.9e-49  Score=401.19  Aligned_cols=264  Identities=36%  Similarity=0.707  Sum_probs=233.0

Q ss_pred             eEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCEEEEEEeccCC
Q 011287           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEG  129 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~lylV~E~~~g  129 (489)
                      +.||+|+||.||+|++..+++.||+|++.+...........+.+|..++..+ +||||+++++++.+...+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4799999999999999999999999999877555555566777888888776 899999999999999999999999999


Q ss_pred             CChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCC
Q 011287          130 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  209 (489)
Q Consensus       130 g~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~  209 (489)
                      |+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.....          .
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~----------~  150 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP----------G  150 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC----------C
Confidence            999999988888999999999999999999999999999999999999999999999999998743211          1


Q ss_pred             CCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCC---------CCHHHHHHHHHhcCCCCCCCCCH
Q 011287          210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD---------TSEWLIFQRIIARDIRFPNYFSD  280 (489)
Q Consensus       210 ~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~---------~~~~~~~~~i~~~~~~~p~~~~~  280 (489)
                      .....++||+.|+|||++.+..++.++|+|||||++|+|++|+.||..         .......+.+......+|..++.
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~  230 (329)
T cd05618         151 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSV  230 (329)
T ss_pred             CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCH
Confidence            223456899999999999999999999999999999999999999952         22334566777888899999999


Q ss_pred             HHHHHHHHhhccCCCCCCCCCC-CCHHHHhcCCCCCCCCcccccC
Q 011287          281 AARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRG  324 (489)
Q Consensus       281 ~~~~Li~~~L~~dP~~R~t~~~-~~~~~l~~hpff~~i~~~~~~~  324 (489)
                      .+.+||++||+.||++||++.. .+++++++||||++++|+.+..
T Consensus       231 ~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~~  275 (329)
T cd05618         231 KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQ  275 (329)
T ss_pred             HHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHc
Confidence            9999999999999999999753 5689999999999999987654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.1e-49  Score=398.45  Aligned_cols=261  Identities=38%  Similarity=0.717  Sum_probs=232.6

Q ss_pred             eEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh-CCCCCccEEEEEEEcCCEEEEEEeccCC
Q 011287           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ-LDHPGVVRLFFTFQDTFSLYMALESCEG  129 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~~~~lylV~E~~~g  129 (489)
                      +.||+|+||.||+|++..+++.||+|++.+..............|..++.. .+||||+++++++.+...+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            479999999999999999999999999987654444445555667777765 4899999999999999999999999999


Q ss_pred             CChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCC
Q 011287          130 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  209 (489)
Q Consensus       130 g~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~  209 (489)
                      |+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....          .
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~----------~  150 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG----------E  150 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC----------C
Confidence            999999988889999999999999999999999999999999999999999999999999998754221          1


Q ss_pred             CCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 011287          210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL  289 (489)
Q Consensus       210 ~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~~  289 (489)
                      ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...++..+......+|..++.++.+||.+|
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~  230 (316)
T cd05592         151 GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKL  230 (316)
T ss_pred             CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence            23345689999999999999999999999999999999999999999999998988888888889999999999999999


Q ss_pred             hccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC
Q 011287          290 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  325 (489)
Q Consensus       290 L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~  325 (489)
                      |+.||++||++.    .+++.||||..++|..+...
T Consensus       231 l~~~P~~R~~~~----~~l~~h~~~~~~~~~~~~~~  262 (316)
T cd05592         231 FERDPTKRLGVD----GDIRQHPFFRGIDWERLEKR  262 (316)
T ss_pred             ccCCHHHcCCCh----HHHHcCcccCCCCHHHHHhC
Confidence            999999999873    57999999999999887544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.3e-49  Score=397.05  Aligned_cols=260  Identities=36%  Similarity=0.675  Sum_probs=231.7

Q ss_pred             eEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh-CCCCCccEEEEEEEcCCEEEEEEeccCC
Q 011287           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ-LDHPGVVRLFFTFQDTFSLYMALESCEG  129 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~~~~lylV~E~~~g  129 (489)
                      +.||+|+||.||+|+++.+|+.||+|++.+..............|..++.. ++||||++++++|.+...+|+||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            479999999999999999999999999987644333444556667777765 4899999999999999999999999999


Q ss_pred             CChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCC
Q 011287          130 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  209 (489)
Q Consensus       130 g~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~  209 (489)
                      |+|..++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++....          ..
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~----------~~  150 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF----------GD  150 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc----------CC
Confidence            99999999888899999999999999999999999999999999999999999999999999864221          11


Q ss_pred             CCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 011287          210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL  289 (489)
Q Consensus       210 ~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~~  289 (489)
                      ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+......+|..++.++++||++|
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  230 (316)
T cd05620         151 NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKL  230 (316)
T ss_pred             CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence            22345789999999999999999999999999999999999999999999988888888888889999999999999999


Q ss_pred             hccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 011287          290 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (489)
Q Consensus       290 L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~  324 (489)
                      |+.||++||++.    +++++||||.+++|..+..
T Consensus       231 l~~dP~~R~~~~----~~~~~h~~f~~~~~~~~~~  261 (316)
T cd05620         231 FERDPTRRLGVV----GNIRGHPFFKTINWTALEK  261 (316)
T ss_pred             ccCCHHHcCCCh----HHHHcCCCcCCCCHHHHHh
Confidence            999999999983    5799999999999987654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=5.5e-49  Score=395.75  Aligned_cols=264  Identities=38%  Similarity=0.682  Sum_probs=238.9

Q ss_pred             eEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCEEEEEEeccCC
Q 011287           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEG  129 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~lylV~E~~~g  129 (489)
                      +.||+|+||.||+|.+..+++.||+|++.+...........+.+|..+++.+ +||||+++++++.+...+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4799999999999999999999999999876555555556677788888887 799999999999999999999999999


Q ss_pred             CChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCC
Q 011287          130 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  209 (489)
Q Consensus       130 g~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~  209 (489)
                      |+|..++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.....          .
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~----------~  150 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG----------G  150 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcC----------C
Confidence            999999998889999999999999999999999999999999999999999999999999998642211          1


Q ss_pred             CCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 011287          210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL  289 (489)
Q Consensus       210 ~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~~  289 (489)
                      ......+||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+....+..+......+|..++.++.+||++|
T Consensus       151 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  230 (318)
T cd05570         151 VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSF  230 (318)
T ss_pred             CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHH
Confidence            22335689999999999999999999999999999999999999999999988889999888899999999999999999


Q ss_pred             hccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 011287          290 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (489)
Q Consensus       290 L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~  324 (489)
                      |+.||++||++.+....+++.||||..++|.....
T Consensus       231 l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~~~~~  265 (318)
T cd05570         231 LTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLER  265 (318)
T ss_pred             ccCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHh
Confidence            99999999999777789999999999999987654

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=4.8e-49  Score=397.79  Aligned_cols=265  Identities=36%  Similarity=0.705  Sum_probs=235.1

Q ss_pred             eEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCEEEEEEeccCC
Q 011287           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEG  129 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~lylV~E~~~g  129 (489)
                      +.||+|+||.||+|++..+++.||+|++.+...........+.+|..++.++ +||||++++++|.+...+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4799999999999999999999999999877555555667788899998888 699999999999999999999999999


Q ss_pred             CChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCC
Q 011287          130 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  209 (489)
Q Consensus       130 g~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~  209 (489)
                      |+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++.....          .
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~----------~  150 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP----------G  150 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC----------C
Confidence            999999988888999999999999999999999999999999999999999999999999998743211          1


Q ss_pred             CCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCC-------CCHHHHHHHHHhcCCCCCCCCCHHH
Q 011287          210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD-------TSEWLIFQRIIARDIRFPNYFSDAA  282 (489)
Q Consensus       210 ~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~-------~~~~~~~~~i~~~~~~~p~~~~~~~  282 (489)
                      ......+||+.|+|||++.+..++.++|+|||||++|+|++|..||..       ......++.+......+|..++..+
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~  230 (327)
T cd05617         151 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKA  230 (327)
T ss_pred             CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHH
Confidence            223457899999999999999999999999999999999999999953       2234566777777888999999999


Q ss_pred             HHHHHHhhccCCCCCCCCCC-CCHHHHhcCCCCCCCCcccccCC
Q 011287          283 RDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQ  325 (489)
Q Consensus       283 ~~Li~~~L~~dP~~R~t~~~-~~~~~l~~hpff~~i~~~~~~~~  325 (489)
                      .++|.+||+.||.+|+++.. .++.++++||||.+++|+.+...
T Consensus       231 ~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~~  274 (327)
T cd05617         231 SHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKK  274 (327)
T ss_pred             HHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHhC
Confidence            99999999999999999854 57899999999999999987654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=4.3e-49  Score=397.64  Aligned_cols=264  Identities=35%  Similarity=0.649  Sum_probs=234.4

Q ss_pred             eEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHH-HHHhCCCCCccEEEEEEEcCCEEEEEEeccCC
Q 011287           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-VLDQLDHPGVVRLFFTFQDTFSLYMALESCEG  129 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~lylV~E~~~g  129 (489)
                      +.||+|+||+||+|++..+|+.||+|++.+...........+..|.. +++.++||||+++++++.+...+|+||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999999999999999998764433334444555554 56779999999999999999999999999999


Q ss_pred             CChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCC
Q 011287          130 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  209 (489)
Q Consensus       130 g~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~  209 (489)
                      |+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.....          .
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~----------~  150 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ----------S  150 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC----------C
Confidence            999999998889999999999999999999999999999999999999999999999999998743211          1


Q ss_pred             CCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 011287          210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL  289 (489)
Q Consensus       210 ~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~~  289 (489)
                      ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..++++.+......++...+..+.++|++|
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~l  230 (325)
T cd05604         151 DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEEL  230 (325)
T ss_pred             CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHH
Confidence            22345689999999999999999999999999999999999999999999999999999888888888999999999999


Q ss_pred             hccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC
Q 011287          290 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  325 (489)
Q Consensus       290 L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~  325 (489)
                      |+.||.+||++.+ .+.+++.||||.+++|..+...
T Consensus       231 l~~~p~~R~~~~~-~~~~i~~h~~f~~~~~~~~~~~  265 (325)
T cd05604         231 LEKDRQRRLGAKE-DFLEIQEHPFFESLSWTDLEQK  265 (325)
T ss_pred             hccCHHhcCCCCC-CHHHHhcCCCcCCCCHHHHHhC
Confidence            9999999999864 5789999999999999887654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.5e-51  Score=395.22  Aligned_cols=257  Identities=32%  Similarity=0.542  Sum_probs=241.8

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~l  120 (489)
                      .....+|++.+.||+|.||.|-+|.+...|+.||||.+.|..+..++....+.+|+++|..|+||||+++|++|+..+.+
T Consensus        49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKI  128 (668)
T KOG0611|consen   49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKI  128 (668)
T ss_pred             cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence            33457999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      .+||||+.+|+|.+|+.+.+.++|.+++.++.||+.|+.|||.++++|||||.+|||+|+|+++||+|||++-.+...  
T Consensus       129 vivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~--  206 (668)
T KOG0611|consen  129 VIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK--  206 (668)
T ss_pred             EEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc--
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999776543  


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCC-CCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS  279 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~-~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~  279 (489)
                               ....+|||++.|.+||++++.+| ++.+|-||||++||-|+.|..||.+.+...+...|..+.+.=|.. |
T Consensus       207 ---------kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~-P  276 (668)
T KOG0611|consen  207 ---------KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPET-P  276 (668)
T ss_pred             ---------cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCC-C
Confidence                     34568999999999999999998 678999999999999999999999999999999999998877664 7


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       280 ~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                      .++.-||+.||-.||++|.|+     .++-.|-|.
T Consensus       277 SdA~gLIRwmLmVNP~RRATi-----eDiAsHWWv  306 (668)
T KOG0611|consen  277 SDASGLIRWMLMVNPERRATI-----EDIASHWWV  306 (668)
T ss_pred             chHHHHHHHHHhcCcccchhH-----HHHhhhhee
Confidence            789999999999999999988     889999886

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=8.6e-49  Score=394.66  Aligned_cols=263  Identities=38%  Similarity=0.670  Sum_probs=233.5

Q ss_pred             eEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHH-HHHhCCCCCccEEEEEEEcCCEEEEEEeccCC
Q 011287           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-VLDQLDHPGVVRLFFTFQDTFSLYMALESCEG  129 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~lylV~E~~~g  129 (489)
                      ++||+|+||.||+|++..+|+.||+|++.+...........+..|.. +++.++||||++++++|.+...+|+||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999999999999999998765444334444444544 67889999999999999999999999999999


Q ss_pred             CChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCC
Q 011287          130 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  209 (489)
Q Consensus       130 g~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~  209 (489)
                      |+|...+.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....          .
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~----------~  150 (321)
T cd05603          81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP----------E  150 (321)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC----------C
Confidence            999999988888999999999999999999999999999999999999999999999999998743211          1


Q ss_pred             CCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 011287          210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL  289 (489)
Q Consensus       210 ~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~~  289 (489)
                      ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+....+..+......+|...+.++.++|.+|
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  230 (321)
T cd05603         151 ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGL  230 (321)
T ss_pred             CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Confidence            22345689999999999999899999999999999999999999999999888899999888899999999999999999


Q ss_pred             hccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 011287          290 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (489)
Q Consensus       290 L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~  324 (489)
                      |+.||.+|+++.. .+.++++|+||..++|..+..
T Consensus       231 l~~~p~~R~~~~~-~~~~~~~~~~~~~~~~~~~~~  264 (321)
T cd05603         231 LHKDQRRRLGAKA-DFLEIKNHVFFSPINWDDLYH  264 (321)
T ss_pred             ccCCHhhcCCCCC-CHHHHhCCCCcCCCCHHHHhc
Confidence            9999999999753 477999999999999998754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=7e-49  Score=397.00  Aligned_cols=270  Identities=38%  Similarity=0.734  Sum_probs=234.7

Q ss_pred             CeEEeeEEeeeCceEEEEEEEc---CCCcEEEEEEeeccccc-chhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCEE
Q 011287           46 DFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFIT-KENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSL  120 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~---~tg~~vAiK~~~k~~~~-~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~l  120 (489)
                      +|++++.||+|+||.||+|++.   .+++.||+|++.+.... .......+..|+.+++.+ +||||++++++|.+...+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            6999999999999999999874   57899999999765332 233445677899999999 599999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      |+||||+++|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+.... 
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~-  159 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-  159 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC-
Confidence            9999999999999999888889999999999999999999999999999999999999999999999999987643221 


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCC----CHHHHHHHHHhcCCCCC
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDT----SEWLIFQRIIARDIRFP  275 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~----~~~~~~~~i~~~~~~~p  275 (489)
                              ......++||+.|+|||++.+. .++.++|||||||++|+|++|..||...    ........+......+|
T Consensus       160 --------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  231 (332)
T cd05614         160 --------KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP  231 (332)
T ss_pred             --------CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence                    1223456899999999999865 4788999999999999999999999643    34455566777788889


Q ss_pred             CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 011287          276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (489)
Q Consensus       276 ~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~  324 (489)
                      ..+++.+.+||.+||+.||++||++.....+++++||||++.+|..+..
T Consensus       232 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~  280 (332)
T cd05614         232 SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALAL  280 (332)
T ss_pred             CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHh
Confidence            9999999999999999999999988766779999999999999988754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-50  Score=395.43  Aligned_cols=259  Identities=33%  Similarity=0.583  Sum_probs=222.8

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC--EEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF--SLY  121 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--~ly  121 (489)
                      ..++..++.||+|+||.||++.+.++|..+|||.+....   ....+.+.+|+.+|++++|||||++++......  .++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~   92 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN   92 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc---chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence            567999999999999999999999999999999987652   122667889999999999999999999754444  699


Q ss_pred             EEEeccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCC-CCCEEEeeccCccccCCcc
Q 011287          122 MALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-DGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~-~g~ikL~DFG~a~~~~~~~  199 (489)
                      +.|||+++|+|.+++.+.+ .|++..++.|..||+.||+|||++||+||||||+||||+. +|.+||+|||+++......
T Consensus        93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            9999999999999999987 7999999999999999999999999999999999999999 7999999999998765311


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCC-CCHHHHHHHHHhcC--CCCC
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIARD--IRFP  275 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~-~~~~~~~~~i~~~~--~~~p  275 (489)
                             ........+.||+.|||||++..+ ....++|||||||++.||+||.+||.. .......-.|....  +.+|
T Consensus       173 -------~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip  245 (313)
T KOG0198|consen  173 -------TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIP  245 (313)
T ss_pred             -------ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCC
Confidence                   112334568999999999999863 344699999999999999999999987 34444444444333  6789


Q ss_pred             CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       276 ~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                      ..+++++++||.+||..||++||||     .++++|||....
T Consensus       246 ~~ls~~a~~Fl~~C~~~~p~~Rpta-----~eLL~hpf~~~~  282 (313)
T KOG0198|consen  246 DSLSDEAKDFLRKCFKRDPEKRPTA-----EELLEHPFLKQN  282 (313)
T ss_pred             cccCHHHHHHHHHHhhcCcccCcCH-----HHHhhChhhhcc
Confidence            9999999999999999999999999     899999999753

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9.4e-49  Score=394.91  Aligned_cols=265  Identities=40%  Similarity=0.736  Sum_probs=236.3

Q ss_pred             eeEEeeeCceEEEEEEEc---CCCcEEEEEEeecccccc-hhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEe
Q 011287           50 GKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (489)
Q Consensus        50 ~~~LG~G~~g~Vy~a~~~---~tg~~vAiK~~~k~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E  125 (489)
                      ++.||+|+||.||+|++.   .+++.||+|++.+..... ......+..|+.+++.++||||+++++.|.++..+|+|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            368999999999999874   578999999997654322 2334556789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCC
Q 011287          126 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  205 (489)
Q Consensus       126 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~  205 (489)
                      |+++|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....       
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-------  153 (323)
T cd05584          81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE-------  153 (323)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC-------
Confidence            9999999999998889999999999999999999999999999999999999999999999999998743221       


Q ss_pred             CCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 011287          206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDL  285 (489)
Q Consensus       206 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~L  285 (489)
                         .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......+|..+++++.+|
T Consensus       154 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  230 (323)
T cd05584         154 ---GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDL  230 (323)
T ss_pred             ---CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence               12223467999999999999988999999999999999999999999999998889999999999999999999999


Q ss_pred             HHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 011287          286 IDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (489)
Q Consensus       286 i~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~  324 (489)
                      |.+||+.||++||++......+++.||||...+|..+..
T Consensus       231 i~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~~~~  269 (323)
T cd05584         231 LKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLA  269 (323)
T ss_pred             HHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCHHHHhc
Confidence            999999999999976666779999999999999988754

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-49  Score=403.12  Aligned_cols=258  Identities=40%  Similarity=0.696  Sum_probs=239.4

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~ly  121 (489)
                      ....|++++.||+|.||.||.|+++.||+.||+|++.|...........+.+|+.+|+.+. |||||.++++|++...+|
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            3457999999999999999999999999999999999987776667788999999999998 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCC----CCEEEeeccCccccCC
Q 011287          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD----GHIKIADFGSVKPMQD  197 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~----g~ikL~DFG~a~~~~~  197 (489)
                      +|||+|.||+|++.|.+. .++|..+..++.|++.|+.|||+.||+||||||||+|+...    +.+|++|||+|.....
T Consensus       113 lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~  191 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP  191 (382)
T ss_pred             EEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence            999999999999999887 49999999999999999999999999999999999999643    5799999999997643


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCC-
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-  276 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~-  276 (489)
                                 .......+||+.|+|||++...+|+..+||||+|||+|.|++|.+||.+.++...+.+|..+.+.|+. 
T Consensus       192 -----------~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~  260 (382)
T KOG0032|consen  192 -----------GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSE  260 (382)
T ss_pred             -----------CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCC
Confidence                       34566889999999999999999999999999999999999999999999999999999999988864 


Q ss_pred             ---CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          277 ---YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       277 ---~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                         .++..+++||++||..||.+|+++     +++++|||+++.
T Consensus       261 ~w~~is~~akd~i~~ll~~dp~~R~ta-----~~~L~HpWi~~~  299 (382)
T KOG0032|consen  261 PWDDISESAKDFIRKLLEFDPRKRLTA-----AQALQHPWIKSI  299 (382)
T ss_pred             CccccCHHHHHHHHHhcccCcccCCCH-----HHHhcCccccCC
Confidence               479999999999999999999999     889999998764

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=5.1e-49  Score=397.11  Aligned_cols=264  Identities=36%  Similarity=0.674  Sum_probs=233.6

Q ss_pred             eEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHH-HHHHhCCCCCccEEEEEEEcCCEEEEEEeccCC
Q 011287           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER-IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG  129 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~-~il~~l~hpnIv~l~~~~~~~~~lylV~E~~~g  129 (489)
                      +.||+|+||+||+|++..+++.||+|++.+...........+..|. .+++.++||||+++++++.+...+|+||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            4799999999999999999999999999875443333333344444 457889999999999999999999999999999


Q ss_pred             CChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCC
Q 011287          130 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  209 (489)
Q Consensus       130 g~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~  209 (489)
                      |+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||+++.....          .
T Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~----------~  150 (325)
T cd05602          81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH----------N  150 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC----------C
Confidence            999999998888999999999999999999999999999999999999999999999999998753221          1


Q ss_pred             CCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 011287          210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL  289 (489)
Q Consensus       210 ~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~~  289 (489)
                      .....++||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+......++..+++.+.+||++|
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  230 (325)
T cd05602         151 GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGL  230 (325)
T ss_pred             CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHH
Confidence            22345689999999999999999999999999999999999999999999999999998888888889999999999999


Q ss_pred             hccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC
Q 011287          290 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  325 (489)
Q Consensus       290 L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~  325 (489)
                      |+.||.+|+++.+ .+.++++|+||..++|+.+...
T Consensus       231 l~~~p~~R~~~~~-~~~~i~~~~~~~~~~~~~~~~~  265 (325)
T cd05602         231 LQKDRTKRLGAKD-DFMEIKNHIFFSPINWDDLINK  265 (325)
T ss_pred             cccCHHHCCCCCC-CHHHHhcCcccCCCCHHHHHhC
Confidence            9999999999864 5789999999999999987543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.1e-49  Score=369.71  Aligned_cols=255  Identities=31%  Similarity=0.456  Sum_probs=223.5

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      ++|...+.||+|.||.||+|++.+||+.||||.++... .++.......+|+..|+.++|+||+.|.++|.....+.+|+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~-~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf   80 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGN-AKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF   80 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccc-cccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence            57899999999999999999999999999999997663 33344556778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          125 ESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       125 E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      ||++. +|...|+.. -.++...++.|+.+++.||+|||++.|+||||||+|+||+.+|.+||+|||+|+.+....    
T Consensus        81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~----  155 (318)
T KOG0659|consen   81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN----  155 (318)
T ss_pred             Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCC----
Confidence            99986 999988765 459999999999999999999999999999999999999999999999999999876543    


Q ss_pred             CCCCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC-----------
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----------  271 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~-----------  271 (489)
                            ......|-|.+|+|||+|.+. .|+..+|+||.|||+.||+.|.+.|.|.++.+++..|...-           
T Consensus       156 ------~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~  229 (318)
T KOG0659|consen  156 ------RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEM  229 (318)
T ss_pred             ------cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccc
Confidence                  222233899999999998765 59999999999999999999999999999999998887510           


Q ss_pred             --------CC-CC--------CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          272 --------IR-FP--------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       272 --------~~-~p--------~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                              +. +|        ...++++.||+.+||..||.+|+++     .++++|+||+.
T Consensus       230 ~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita-----~qaL~~~yf~~  286 (318)
T KOG0659|consen  230 TSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITA-----SQALKHPYFKS  286 (318)
T ss_pred             cccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccH-----HHHhcchhhhc
Confidence                    00 11        1247888999999999999999999     88999999985

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.1e-48  Score=393.32  Aligned_cols=260  Identities=36%  Similarity=0.658  Sum_probs=231.0

Q ss_pred             eEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh-CCCCCccEEEEEEEcCCEEEEEEeccCC
Q 011287           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ-LDHPGVVRLFFTFQDTFSLYMALESCEG  129 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~~~~lylV~E~~~g  129 (489)
                      +.||+|+||.||+|++..+++.||+|++.+..............|..++.. ++||||+++++++.+...+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            479999999999999999999999999987644333444555667777775 4899999999999999999999999999


Q ss_pred             CChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCC
Q 011287          130 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  209 (489)
Q Consensus       130 g~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~  209 (489)
                      |+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.....          .
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~----------~  150 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----------D  150 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC----------C
Confidence            999999988888999999999999999999999999999999999999999999999999998743211          1


Q ss_pred             CCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 011287          210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL  289 (489)
Q Consensus       210 ~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~~  289 (489)
                      ......+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+....++.+......+|..++.++++||.+|
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  230 (316)
T cd05619         151 AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKL  230 (316)
T ss_pred             CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHH
Confidence            22345689999999999999999999999999999999999999999999888888888877888889999999999999


Q ss_pred             hccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 011287          290 LDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (489)
Q Consensus       290 L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~  324 (489)
                      |+.||++||++.    .+++.||||+.++|..+..
T Consensus       231 l~~~P~~R~~~~----~~l~~h~~~~~~~~~~~~~  261 (316)
T cd05619         231 FVREPERRLGVK----GDIRQHPFFREIDWSALEE  261 (316)
T ss_pred             hccCHhhcCCCh----HHHHcCcccCCCCHHHHHh
Confidence            999999999983    4899999999999987754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4e-49  Score=419.26  Aligned_cols=265  Identities=28%  Similarity=0.456  Sum_probs=229.7

Q ss_pred             CCCCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 011287           38 PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (489)
Q Consensus        38 ~~~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  117 (489)
                      +......++|++.+.||+|+||+||+|++..+|+.||||++...... +.....+.+|+.++..++|+||++++..+...
T Consensus        25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~  103 (496)
T PTZ00283         25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK  103 (496)
T ss_pred             ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence            33445568999999999999999999999999999999999776443 33445677899999999999999998877533


Q ss_pred             C--------EEEEEEeccCCCChHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEE
Q 011287          118 F--------SLYMALESCEGGELFDQITSK----GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIK  185 (489)
Q Consensus       118 ~--------~lylV~E~~~gg~L~~~l~~~----~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ik  185 (489)
                      .        .+++||||+++|+|.+++...    ..+++..+..++.|++.||.|||+.||+||||||+|||++.++++|
T Consensus       104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vk  183 (496)
T PTZ00283        104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVK  183 (496)
T ss_pred             cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEE
Confidence            2        478999999999999988653    4699999999999999999999999999999999999999999999


Q ss_pred             EeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHH
Q 011287          186 IADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQ  265 (489)
Q Consensus       186 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~  265 (489)
                      |+|||+++.+....        ........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+.
T Consensus       184 L~DFGls~~~~~~~--------~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~  255 (496)
T PTZ00283        184 LGDFGFSKMYAATV--------SDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMH  255 (496)
T ss_pred             EEecccCeeccccc--------cccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            99999998654321        1122346789999999999999999999999999999999999999999998888888


Q ss_pred             HHHhcCC-CCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          266 RIIARDI-RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       266 ~i~~~~~-~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      ++..... .+|..+++++.+||.+||+.||.+||++     .++++|||++.
T Consensus       256 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~-----~ell~~p~~~~  302 (496)
T PTZ00283        256 KTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSS-----SKLLNMPICKL  302 (496)
T ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCH-----HHHHhCHHHHH
Confidence            8776554 4778899999999999999999999998     89999999875

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.3e-49  Score=395.64  Aligned_cols=264  Identities=37%  Similarity=0.720  Sum_probs=236.7

Q ss_pred             eeEEeeeCceEEEEEEE---cCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEec
Q 011287           50 GKIYGVGSYSKVVRAKK---IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALES  126 (489)
Q Consensus        50 ~~~LG~G~~g~Vy~a~~---~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~  126 (489)
                      ++.||+|+||.||++++   ..+|+.||+|++.+..... .......+|+.++++++||||++++++|.+...+|+||||
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF   79 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence            36799999999999987   3679999999997654322 2234466799999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCC
Q 011287          127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNA  206 (489)
Q Consensus       127 ~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~  206 (489)
                      +++|+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.....        
T Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--------  151 (318)
T cd05582          80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--------  151 (318)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC--------
Confidence            999999999988888999999999999999999999999999999999999999999999999998754321        


Q ss_pred             CCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 011287          207 ASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLI  286 (489)
Q Consensus       207 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li  286 (489)
                        .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......+|..+++.+.+||
T Consensus       152 --~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li  229 (318)
T cd05582         152 --EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLL  229 (318)
T ss_pred             --CCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence              122335689999999999999889999999999999999999999999999888888898888899999999999999


Q ss_pred             HHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 011287          287 DRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (489)
Q Consensus       287 ~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~  324 (489)
                      ++||+.||++||++.+..+.+++.||||..++|..+..
T Consensus       230 ~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~~~~  267 (318)
T cd05582         230 RALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYR  267 (318)
T ss_pred             HHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHHHHHh
Confidence            99999999999999877789999999999999988754

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=8.8e-49  Score=402.62  Aligned_cols=267  Identities=37%  Similarity=0.624  Sum_probs=234.5

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCE
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  119 (489)
                      ..+..++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~  117 (370)
T cd05596          38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY  117 (370)
T ss_pred             CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            35678899999999999999999999999999999999976544444455667789999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcc
Q 011287          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      +|+|||||+||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..+....
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~  196 (370)
T cd05596         118 LYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG  196 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence            9999999999999998876 469999999999999999999999999999999999999999999999999987653221


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCC----CCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC--CC
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSS----PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--IR  273 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~----~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~--~~  273 (489)
                               .......+||+.|+|||++.+.    .++.++|+|||||++|+|++|++||.+.+....+.+|....  +.
T Consensus       197 ---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  267 (370)
T cd05596         197 ---------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLT  267 (370)
T ss_pred             ---------cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCC
Confidence                     1122356899999999998653    37889999999999999999999999999888888887643  55


Q ss_pred             CCC--CCCHHHHHHHHHhhccCCCC--CCCCCCCCHHHHhcCCCCCCCCccc
Q 011287          274 FPN--YFSDAARDLIDRLLDVDPSG--RPGAGPGGYAVLKMHPFFKGIDWKN  321 (489)
Q Consensus       274 ~p~--~~~~~~~~Li~~~L~~dP~~--R~t~~~~~~~~l~~hpff~~i~~~~  321 (489)
                      +|.  .++.++++||.+||+.+|.+  |+++     +++++||||++.+|..
T Consensus       268 ~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~-----~ell~h~~~~~~~~~~  314 (370)
T cd05596         268 FPDDIEISKQAKDLICAFLTDREVRLGRNGV-----DEIKSHPFFKNDQWTF  314 (370)
T ss_pred             CCCcCCCCHHHHHHHHHHccChhhccCCCCH-----HHHhcCcccCCCChhh
Confidence            666  47999999999999999987  8888     8999999999988864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.7e-49  Score=378.46  Aligned_cols=259  Identities=27%  Similarity=0.388  Sum_probs=226.0

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEE--cCCE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ--DTFS  119 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~  119 (489)
                      .++++|+.+..|++|+||.||+|+++.|++.||+|.++-.. .++..--.-.+|+.+|.+++|||||.+-.+..  +-+.
T Consensus        73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~  151 (419)
T KOG0663|consen   73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK  151 (419)
T ss_pred             ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence            35778999999999999999999999999999999986543 33444445567999999999999999988775  3467


Q ss_pred             EEEEEeccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          120 LYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      +|+|||||+. ||..++...+ +|...+++.++.|++.||+|||.+.|+||||||+|+|++..|.+||+|||+|+.+..+
T Consensus       152 iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp  230 (419)
T KOG0663|consen  152 IYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP  230 (419)
T ss_pred             eeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence            9999999987 9999998875 8999999999999999999999999999999999999999999999999999987654


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCCC-CCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc-------
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-------  270 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~-~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~-------  270 (489)
                      .          ......+-|.+|+|||+|.+.. |+.+.|+||+|||+.||+++++.|.+.++.+++.+|...       
T Consensus       231 ~----------k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~  300 (419)
T KOG0663|consen  231 L----------KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEA  300 (419)
T ss_pred             c----------ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccc
Confidence            2          2344678999999999998755 999999999999999999999999999999999998761       


Q ss_pred             ------------CCCCC------------CC-CCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          271 ------------DIRFP------------NY-FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       271 ------------~~~~p------------~~-~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                                  ...|+            .. ++....+|+..+|..||.+|.||     .+.++|+||...
T Consensus       301 iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA-----~~~L~h~~F~e~  367 (419)
T KOG0663|consen  301 IWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITA-----EDGLKHEYFRET  367 (419)
T ss_pred             cCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccH-----HHhhcccccccC
Confidence                        12222            11 56899999999999999999999     789999999863

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-48  Score=391.27  Aligned_cols=270  Identities=40%  Similarity=0.685  Sum_probs=230.8

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      ++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.++..++||||++++++|.+...+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            58999999999999999999999999999999998654444555666788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          125 ESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       125 E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      ||++||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.+|+++|+|||++..+....    
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~----  156 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG----  156 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC----
Confidence            99999999999976 4579999999999999999999999999999999999999999999999999987553321    


Q ss_pred             CCCCCCCCccceecCCcCCChhhhcC-----CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC--CCCCC
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLNS-----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--IRFPN  276 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~~-----~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~--~~~p~  276 (489)
                           .......+||+.|+|||++..     ..++.++|||||||++|+|++|+.||.+.+..+.+..+....  ..+|.
T Consensus       157 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  231 (331)
T cd05597         157 -----TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPP  231 (331)
T ss_pred             -----CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCC
Confidence                 111223579999999999863     457889999999999999999999999988888888776543  33443


Q ss_pred             ---CCCHHHHHHHHHhhccCCCC--CCCCCCCCHHHHhcCCCCCCCCcccccCCCCC
Q 011287          277 ---YFSDAARDLIDRLLDVDPSG--RPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP  328 (489)
Q Consensus       277 ---~~~~~~~~Li~~~L~~dP~~--R~t~~~~~~~~l~~hpff~~i~~~~~~~~~~p  328 (489)
                         .+++++++||++||+.++++  |+++     .++++||||.+++|..+....+|
T Consensus       232 ~~~~~~~~~~~li~~ll~~~~~r~~r~~~-----~~~l~hp~~~~~~~~~~~~~~~~  283 (331)
T cd05597         232 DVTDVSEEAKDLIRRLICSPETRLGRNGL-----QDFKDHPFFEGIDWDNIRNSTAP  283 (331)
T ss_pred             ccCCCCHHHHHHHHHHccCcccccCCCCH-----HHHhcCCCCCCCCHHHHhhCCCC
Confidence               47999999999999864433  5555     89999999999999988765444

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=9.9e-49  Score=386.51  Aligned_cols=262  Identities=32%  Similarity=0.598  Sum_probs=228.2

Q ss_pred             EeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEeccCCCCh
Q 011287           53 YGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL  132 (489)
Q Consensus        53 LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~~~gg~L  132 (489)
                      ||+|+||+||+|.+..+|+.||+|.+.+...........+..|+.+++.++||||++++++|.....+|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            69999999999999999999999999766544444445667899999999999999999999999999999999999999


Q ss_pred             HHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCC
Q 011287          133 FDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS  208 (489)
Q Consensus       133 ~~~l~~----~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~  208 (489)
                      ..++..    ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..+....         
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~---------  151 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ---------  151 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC---------
Confidence            887743    3569999999999999999999999999999999999999999999999999987653321         


Q ss_pred             CCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCH----HHHHHHHHhcCCCCCCCCCHHHHH
Q 011287          209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRIIARDIRFPNYFSDAARD  284 (489)
Q Consensus       209 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~----~~~~~~i~~~~~~~p~~~~~~~~~  284 (489)
                       .......||+.|+|||++.+..++.++|+|||||++|+|++|+.||.....    ......+......+|..+++++.+
T Consensus       152 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (280)
T cd05608         152 -SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKS  230 (280)
T ss_pred             -ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHH
Confidence             122345799999999999999999999999999999999999999986543    334455556666778889999999


Q ss_pred             HHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 011287          285 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (489)
Q Consensus       285 Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~  324 (489)
                      |+.+||+.||++||+..+...+++++||||++++|+.+..
T Consensus       231 li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~  270 (280)
T cd05608         231 FCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEA  270 (280)
T ss_pred             HHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHHhh
Confidence            9999999999999988777789999999999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.6e-48  Score=400.64  Aligned_cols=266  Identities=38%  Similarity=0.637  Sum_probs=230.1

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~l  120 (489)
                      ....++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.|.++..+
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL  118 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            34568999999999999999999999999999999999875544455556678899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      |+|||||+||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|..+.... 
T Consensus       119 ~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~-  196 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG-  196 (370)
T ss_pred             EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC-
Confidence            9999999999999998764 69999999999999999999999999999999999999999999999999998653221 


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCC----CCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC--CCC
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSP----ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--IRF  274 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~----~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~--~~~  274 (489)
                              .....+.+||+.|+|||++.+..    ++.++|+|||||++|+|++|++||.+.+....+.+|....  +.+
T Consensus       197 --------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~  268 (370)
T cd05621         197 --------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNF  268 (370)
T ss_pred             --------ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCC
Confidence                    11224668999999999997543    7889999999999999999999999999888888887643  556


Q ss_pred             CC--CCCHHHHHHHHHhhccCCCC--CCCCCCCCHHHHhcCCCCCCCCccc
Q 011287          275 PN--YFSDAARDLIDRLLDVDPSG--RPGAGPGGYAVLKMHPFFKGIDWKN  321 (489)
Q Consensus       275 p~--~~~~~~~~Li~~~L~~dP~~--R~t~~~~~~~~l~~hpff~~i~~~~  321 (489)
                      |.  .++..+++||.+||+.++.+  |+++     .++++||||++.+|+.
T Consensus       269 p~~~~~s~~~~~li~~~L~~~~~r~~R~~~-----~e~l~hp~~~~~~~~~  314 (370)
T cd05621         269 PEDVEISKHAKNLICAFLTDREVRLGRNGV-----EEIKQHPFFKNDQWNW  314 (370)
T ss_pred             CCcccCCHHHHHHHHHHccCchhccCCCCH-----HHHhcCcccCCCCcCh
Confidence            65  46999999999999855443  6666     8999999999876653

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3e-48  Score=392.68  Aligned_cols=273  Identities=38%  Similarity=0.658  Sum_probs=233.2

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      ++|++.+.||+|+||.||+|++..+++.||+|++.+...........+..|..++..++|++|+++++.+.+...+|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            58999999999999999999999999999999997754444445566778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          125 ESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       125 E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      ||++||+|.+++.+ .+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.+....    
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~----  156 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG----  156 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC----
Confidence            99999999999987 4679999999999999999999999999999999999999999999999999997654321    


Q ss_pred             CCCCCCCCccceecCCcCCChhhhcC-----CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC--CCCCC
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLNS-----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--IRFPN  276 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~~-----~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~--~~~p~  276 (489)
                           .......+||+.|+|||++.+     ..++.++|+|||||++|+|++|+.||.+.+..+.+.++....  +.+|.
T Consensus       157 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~  231 (331)
T cd05624         157 -----TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPS  231 (331)
T ss_pred             -----ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCC
Confidence                 111224579999999999875     457889999999999999999999999988888888887643  34444


Q ss_pred             ---CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCCCCCC
Q 011287          277 ---YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPK  329 (489)
Q Consensus       277 ---~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~~~p~  329 (489)
                         .++.++++||.+||+.++ +|++.  .+++++++||||++++|+.+....+|.
T Consensus       232 ~~~~~~~~~~~li~~ll~~~~-~~~~~--~~~~~~~~h~~f~~~~~~~~~~~~~~~  284 (331)
T cd05624         232 HITDVSEEAKDLIQRLICSRE-RRLGQ--NGIEDFKKHAFFEGIDWENIRNLEAPY  284 (331)
T ss_pred             ccccCCHHHHHHHHHHccCch-hhcCC--CCHHHHhcCCCcCCCCHHHHhhCCCCc
Confidence               368999999999999655 44432  245999999999999999987655443

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.7e-48  Score=392.10  Aligned_cols=271  Identities=37%  Similarity=0.654  Sum_probs=232.6

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      ++|++.+.||+|+||.||+++++.+++.||+|++.+...........+..|+.++..++|++|+++++.+.+...+|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            58999999999999999999999999999999997654444455566788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          125 ESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       125 E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      ||+++|+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.+++++|+|||++..+....    
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~----  156 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG----  156 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCC----
Confidence            99999999999987 4679999999999999999999999999999999999999999999999999987543211    


Q ss_pred             CCCCCCCCccceecCCcCCChhhhc-----CCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC--CCCCC
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLN-----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--IRFPN  276 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~-----~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~--~~~p~  276 (489)
                           .......+||+.|+|||++.     ...++.++|||||||++|+|++|+.||.+.+....+.++....  ..+|.
T Consensus       157 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~  231 (332)
T cd05623         157 -----TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPA  231 (332)
T ss_pred             -----cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCC
Confidence                 11222457999999999986     3457889999999999999999999999999888888887654  33443


Q ss_pred             ---CCCHHHHHHHHHhhccCCCC--CCCCCCCCHHHHhcCCCCCCCCcccccCCCCCC
Q 011287          277 ---YFSDAARDLIDRLLDVDPSG--RPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPK  329 (489)
Q Consensus       277 ---~~~~~~~~Li~~~L~~dP~~--R~t~~~~~~~~l~~hpff~~i~~~~~~~~~~p~  329 (489)
                         .+++++++||++||+.++.+  |+++     +++++||||.+++|+.+....+|.
T Consensus       232 ~~~~~s~~~~~li~~ll~~~~~r~~r~~~-----~~~~~h~~f~~~~~~~~~~~~~~~  284 (332)
T cd05623         232 QVTDVSEDAKDLIRRLICSREHRLGQNGI-----EDFKQHPFFTGIDWDNIRNCEAPY  284 (332)
T ss_pred             ccccCCHHHHHHHHHHccChhhhcCCCCH-----HHHhCCCCcCCCCHHHHhhCCCCc
Confidence               57999999999999875544  3444     999999999999999987655443

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-48  Score=383.70  Aligned_cols=268  Identities=33%  Similarity=0.580  Sum_probs=233.4

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEe
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E  125 (489)
                      .|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+...+|+|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            48999999999999999999999999999999977654444445566789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          126 SCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       126 ~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      |+.+|+|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+||+++++++++|+|||++..+...     
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-----  155 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG-----  155 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC-----
Confidence            99999999888654  45999999999999999999999999999999999999999999999999998764321     


Q ss_pred             CCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHH----HHHHHHhcCCCCCCCCC
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQRIIARDIRFPNYFS  279 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~----~~~~i~~~~~~~p~~~~  279 (489)
                            ......+|++.|+|||++.+..++.++|+||+||++|+|++|+.||.+.+...    ....+......+|..++
T Consensus       156 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (285)
T cd05605         156 ------ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFS  229 (285)
T ss_pred             ------CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccC
Confidence                  11224579999999999998889999999999999999999999998866533    23334445566778899


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 011287          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (489)
Q Consensus       280 ~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~  324 (489)
                      +.+.+||.+||+.||.+||+..+.+++++++||||...+|+.+..
T Consensus       230 ~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~  274 (285)
T cd05605         230 EAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEA  274 (285)
T ss_pred             HHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhh
Confidence            999999999999999999977666679999999999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-48  Score=393.70  Aligned_cols=262  Identities=38%  Similarity=0.649  Sum_probs=229.0

Q ss_pred             EeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCccEEEEEEEcCCEEEEEEeccCC
Q 011287           53 YGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL---DHPGVVRLFFTFQDTFSLYMALESCEG  129 (489)
Q Consensus        53 LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~~~~lylV~E~~~g  129 (489)
                      ||+|+||+||+|++..+|+.||+|++.+..............|..++..+   +||||+++++.|.+...+|+||||+.+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            69999999999999999999999999775544444444455566766655   799999999999999999999999999


Q ss_pred             CChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCC
Q 011287          130 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  209 (489)
Q Consensus       130 g~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~  209 (489)
                      |+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......          .
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~----------~  150 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD----------N  150 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC----------C
Confidence            999999998889999999999999999999999999999999999999999999999999998753211          1


Q ss_pred             CCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCC-CCCHHHHHHHH
Q 011287          210 DKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-YFSDAARDLID  287 (489)
Q Consensus       210 ~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~-~~~~~~~~Li~  287 (489)
                      ......+||..|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.++.+......+|. .+++++.+||+
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~  230 (330)
T cd05586         151 KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVK  230 (330)
T ss_pred             CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHH
Confidence            223456899999999998764 4889999999999999999999999999988888888888888876 47999999999


Q ss_pred             HhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC
Q 011287          288 RLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  325 (489)
Q Consensus       288 ~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~  325 (489)
                      +||+.||.+||++.. .+.++++||||..++|+.+...
T Consensus       231 ~~L~~~P~~R~~~~~-~~~~ll~h~~~~~~~~~~~~~~  267 (330)
T cd05586         231 GLLNRNPQHRLGAHR-DAVELKEHPFFADIDWDLLSKK  267 (330)
T ss_pred             HHcCCCHHHCCCCCC-CHHHHhcCccccCCCHHHHHhC
Confidence            999999999997643 4689999999999999887543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-48  Score=382.09  Aligned_cols=266  Identities=32%  Similarity=0.497  Sum_probs=233.7

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~l  120 (489)
                      ....++|++..+||.|..++||+|+.+.++..||||+++.+.....  ...+.+|...|+.++||||+++++.|..+..+
T Consensus        22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L   99 (516)
T KOG0582|consen   22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL   99 (516)
T ss_pred             CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence            3457899999999999999999999999999999999987654433  67899999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          121 YMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      |+||.||.+|++.+++...  ..|+|..+..++.+++.||.|||++|-||||||+.||||+.+|.|||+|||.+..+-..
T Consensus       100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS  179 (516)
T ss_pred             EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence            9999999999999999865  34999999999999999999999999999999999999999999999999988766443


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhc--CCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLN--SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN  276 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~--~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~  276 (489)
                      ..      ....+..+++||+.|||||++.  ..+|+.|+||||||++..||.+|..||....+..++-.-+++.+..|.
T Consensus       180 G~------R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~  253 (516)
T KOG0582|consen  180 GD------RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL  253 (516)
T ss_pred             Cc------eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc
Confidence            21      1112227899999999999964  456999999999999999999999999999988877776776665332


Q ss_pred             ----------CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 011287          277 ----------YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (489)
Q Consensus       277 ----------~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~  319 (489)
                                .++..++.+|..||+.||.+||||     +++++|+||+...-
T Consensus       254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptA-----skLlkh~FFk~~k~  301 (516)
T KOG0582|consen  254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTA-----SKLLKHAFFKKAKS  301 (516)
T ss_pred             cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCH-----HHHhccHHHhhccc
Confidence                      367889999999999999999999     88999999986553

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=6.3e-48  Score=396.38  Aligned_cols=268  Identities=39%  Similarity=0.641  Sum_probs=230.3

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCE
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  119 (489)
                      ..+..++|++.+.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+...
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  117 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            34567899999999999999999999999999999999976554445555667889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcc
Q 011287          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      +|+|||||+||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++..+....
T Consensus       118 ~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~  196 (371)
T cd05622         118 LYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG  196 (371)
T ss_pred             EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC
Confidence            99999999999999998764 68999999999999999999999999999999999999999999999999998654321


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCCC----CCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC--CC
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSP----ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--IR  273 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~----~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~--~~  273 (489)
                               .......+||+.|+|||++.+..    ++.++|||||||++|+|++|.+||.+.+....+.+|....  ..
T Consensus       197 ---------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~  267 (371)
T cd05622         197 ---------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT  267 (371)
T ss_pred             ---------cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCccc
Confidence                     11223568999999999997543    7889999999999999999999999999988888887643  44


Q ss_pred             CCC--CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 011287          274 FPN--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (489)
Q Consensus       274 ~p~--~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~  320 (489)
                      +|.  .++..+++||.+||. +|.+|++.  .+++++++||||++.+|.
T Consensus       268 ~~~~~~~s~~~~~li~~~L~-~~~~r~~r--~~~~ei~~h~~~~~~~~~  313 (371)
T cd05622         268 FPDDNDISKEAKNLICAFLT-DREVRLGR--NGVEEIKRHLFFKNDQWA  313 (371)
T ss_pred             CCCcCCCCHHHHHHHHHHcC-ChhhhcCC--CCHHHHhcCcccCCCChh
Confidence            554  589999999999998 66665543  134999999999986553

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-49  Score=394.42  Aligned_cols=259  Identities=31%  Similarity=0.526  Sum_probs=238.0

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      .=|.+.+.||+|-|++|-+|++.=||..||||+++|..+.... ...+..|+..|+.++|||||+||++......+|+|+
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s-t~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS-TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh-hhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            4589999999999999999999999999999999998766544 455667999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeC-CCCCEEEeeccCccccCCccccc
Q 011287          125 ESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT-ADGHIKIADFGSVKPMQDSRITV  202 (489)
Q Consensus       125 E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~-~~g~ikL~DFG~a~~~~~~~~~~  202 (489)
                      |.=.+|+|++||.++ ..+.|+.++.|++||+.|+.|||+..+|||||||||+.+- .-|-+||+|||++-.+.+     
T Consensus        97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P-----  171 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP-----  171 (864)
T ss_pred             EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC-----
Confidence            999999999999876 4599999999999999999999999999999999998765 458999999999877643     


Q ss_pred             cCCCCCCCCccceecCCcCCChhhhcCCCCC-CCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHH
Q 011287          203 LPNAASDDKACTFVGTAAYVPPEVLNSSPAT-FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDA  281 (489)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~-~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~  281 (489)
                            .....++||+..|-|||+|.+..|+ +++||||||||||-|++|++||...++.+++-+|+.+.+..|..++.+
T Consensus       172 ------G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~e  245 (864)
T KOG4717|consen  172 ------GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKE  245 (864)
T ss_pred             ------cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHH
Confidence                  3456689999999999999998875 678999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 011287          282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (489)
Q Consensus       282 ~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~  320 (489)
                      ++|||..||+.||.+|.+.     ++|..|+|++++|..
T Consensus       246 CrdLI~sMLvRdPkkRAsl-----EeI~s~~Wlq~~D~~  279 (864)
T KOG4717|consen  246 CRDLIQSMLVRDPKKRASL-----EEIVSTSWLQAGDRG  279 (864)
T ss_pred             HHHHHHHHHhcCchhhccH-----HHHhccccccCCCCC
Confidence            9999999999999999887     899999999998853

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-49  Score=379.03  Aligned_cols=259  Identities=31%  Similarity=0.471  Sum_probs=221.9

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc-----CCE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD-----TFS  119 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----~~~  119 (489)
                      ..|..++.||+|+||.|+.|.++.||+.||||.+...+.. .-......+|+.+|+.++|+||+.+++++..     -..
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~-~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFEN-QIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhc-hHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            3455589999999999999999999999999998754333 3445567789999999999999999999975     356


Q ss_pred             EEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcc
Q 011287          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      +|+|+|+|+ -||...|+.+..+++..++++++||+.||.|+|+.||+||||||+|+|++.+..+||+|||+|+..... 
T Consensus       101 vYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~-  178 (359)
T KOG0660|consen  101 VYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF-  178 (359)
T ss_pred             eEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc-
Confidence            999999995 499999988777999999999999999999999999999999999999999999999999999976532 


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhc-CCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc--------
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLN-SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--------  270 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~-~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~--------  270 (489)
                             ........++.|.+|+|||++. ...|+.+.||||+|||+.||++|++.|.|.+...+++.|+..        
T Consensus       179 -------~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~  251 (359)
T KOG0660|consen  179 -------FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED  251 (359)
T ss_pred             -------CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence                   1123445789999999999974 566999999999999999999999999999888777776541        


Q ss_pred             ---------------CCCCC--------CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 011287          271 ---------------DIRFP--------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (489)
Q Consensus       271 ---------------~~~~p--------~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~  318 (489)
                                     ....|        +..++.+.||+++||..||.+|+|+     ++++.||||....
T Consensus       252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita-----~eAL~hPYl~~~h  317 (359)
T KOG0660|consen  252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITA-----EEALAHPYLAPYH  317 (359)
T ss_pred             HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCH-----HHHhcChhhhhhc
Confidence                           11111        2578999999999999999999999     8999999998643

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.2e-50  Score=373.11  Aligned_cols=258  Identities=33%  Similarity=0.549  Sum_probs=232.1

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeeccccc-----chhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcC
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT-----KENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDT  117 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~-----~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  117 (489)
                      .+.|.--+.||+|..++|..+.++.||+++|+|++......     .....+....|+.+|+++ .||+|+++.++|+..
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            45678888999999999999999999999999999743222     222345566799999988 799999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCC
Q 011287          118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~  197 (489)
                      ..+++|+|.|+.|+|++++...-.++|..++.++.|+++|++|||.++||||||||+|||++++++++|+|||+|+.+..
T Consensus        96 sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~  175 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP  175 (411)
T ss_pred             chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence            99999999999999999999988899999999999999999999999999999999999999999999999999997653


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhc------CCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLN------SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD  271 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~------~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~  271 (489)
                                 ..+....||||+|+|||.+.      ..+|+..+|+||+|||+|.||.|.+||--.....++..|..+.
T Consensus       176 -----------GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGk  244 (411)
T KOG0599|consen  176 -----------GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGK  244 (411)
T ss_pred             -----------chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcc
Confidence                       34556789999999999983      4458899999999999999999999999999999999999999


Q ss_pred             CCCCC----CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          272 IRFPN----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       272 ~~~p~----~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                      ++|..    +++.+++|||.+||+.||.+|+|+     ++.+.||||..+
T Consensus       245 yqF~speWadis~~~KdLIsrlLqVdp~~Rita-----ke~LaHpff~q~  289 (411)
T KOG0599|consen  245 YQFRSPEWADISATVKDLISRLLQVDPTKRITA-----KEALAHPFFIQI  289 (411)
T ss_pred             cccCCcchhhccccHHHHHHHHHeeCchhcccH-----HHHhcChHHHHH
Confidence            98853    589999999999999999999999     899999999754

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-49  Score=397.46  Aligned_cols=252  Identities=32%  Similarity=0.538  Sum_probs=231.0

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      ..|.....||+|+-|.||.|+...+++.||||.|...   .....+.+.+|+.+|+..+|+|||.+++.|...+.+|+||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~---~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM  349 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLR---KQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM  349 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEec---cCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence            4688999999999999999999999999999999876   3445577889999999999999999999999889999999


Q ss_pred             eccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccC
Q 011287          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (489)
Q Consensus       125 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~  204 (489)
                      ||++||+|.+.+... .++|.++..++.+++.||+|||.+||+|||||.+|||++.+|.+||+|||++..+...      
T Consensus       350 Eym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~------  422 (550)
T KOG0578|consen  350 EYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE------  422 (550)
T ss_pred             eecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccc------
Confidence            999999999988865 5999999999999999999999999999999999999999999999999999876543      


Q ss_pred             CCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc---CCCCCCCCCHH
Q 011287          205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFSDA  281 (489)
Q Consensus       205 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~---~~~~p~~~~~~  281 (489)
                          .....+.+||+.|||||++....|++++||||||+++.||+-|.+||-..++...+..|-..   .+..|+.+|++
T Consensus       423 ----~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~  498 (550)
T KOG0578|consen  423 ----QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPE  498 (550)
T ss_pred             ----cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHH
Confidence                23667889999999999999999999999999999999999999999988888777777553   45678899999


Q ss_pred             HHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 011287          282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (489)
Q Consensus       282 ~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~  315 (489)
                      ++||+.+||+.|+.+|++|     .+||.||||+
T Consensus       499 ~kdFL~~cL~~dv~~RasA-----~eLL~HpFl~  527 (550)
T KOG0578|consen  499 LKDFLDRCLVVDVEQRASA-----KELLEHPFLK  527 (550)
T ss_pred             HHHHHHHHhhcchhcCCCH-----HHHhcChhhh
Confidence            9999999999999999999     8999999995

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=8.3e-47  Score=374.35  Aligned_cols=267  Identities=42%  Similarity=0.731  Sum_probs=244.1

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++++++||||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            47999999999999999999999999999999998765555555677888999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccC
Q 011287          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (489)
Q Consensus       125 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~  204 (489)
                      ||+++++|.+++.+.+.+++..+..++.||+.||.|||+.||+||||+|.||+++.++.++|+|||++......      
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~------  154 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR------  154 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC------
Confidence            99999999999998889999999999999999999999999999999999999999999999999998765321      


Q ss_pred             CCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHH
Q 011287          205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD  284 (489)
Q Consensus       205 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  284 (489)
                             .....|++.|+|||.+.+...+.++|+||||+++|+|++|..||...+.....+.+......+|..++..+++
T Consensus       155 -------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  227 (290)
T cd05580         155 -------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKD  227 (290)
T ss_pred             -------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHH
Confidence                   2345789999999999888889999999999999999999999998888888888888888899999999999


Q ss_pred             HHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 011287          285 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (489)
Q Consensus       285 Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~  324 (489)
                      +|.+||+.||.+|++.....++++++||||+.++|..+..
T Consensus       228 li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~  267 (290)
T cd05580         228 LIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQ  267 (290)
T ss_pred             HHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHHHhh
Confidence            9999999999999976656779999999999999998754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.1e-47  Score=377.42  Aligned_cols=255  Identities=27%  Similarity=0.436  Sum_probs=216.1

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      ++|++.+.||+|+||.||+|+++.+++.||+|++...... ......+.+|+.+++.++||||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF   79 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence            4799999999999999999999999999999999765332 233456778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccC
Q 011287          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (489)
Q Consensus       125 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~  204 (489)
                      ||++++.+..+....+.+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.......     
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-----  154 (287)
T cd07848          80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-----  154 (287)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-----
Confidence            999987776555555679999999999999999999999999999999999999999999999999998653221     


Q ss_pred             CCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC-------------
Q 011287          205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-------------  271 (489)
Q Consensus       205 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~-------------  271 (489)
                          ........||+.|+|||++.+..++.++|+|||||++|+|++|++||.+.+.......+....             
T Consensus       155 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07848         155 ----NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS  230 (287)
T ss_pred             ----cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence                112234679999999999998889999999999999999999999999877655443332210             


Q ss_pred             ------CCCC-------------CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          272 ------IRFP-------------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       272 ------~~~p-------------~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                            ..+|             ..++.++.+||++||+.||++|||+     +++++||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~-----~~~l~hp~f  287 (287)
T cd07848         231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLT-----EQCLNHPAF  287 (287)
T ss_pred             cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCH-----HHHhcCCCC
Confidence                  1111             2368889999999999999999999     899999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=5.4e-47  Score=375.22  Aligned_cols=276  Identities=33%  Similarity=0.563  Sum_probs=232.6

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEe
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E  125 (489)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+..|+.+++.++|++|+++++.+.+...+|+|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            48899999999999999999999999999999977655444445566779999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          126 SCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       126 ~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      |+.|++|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......     
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~-----  155 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-----  155 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC-----
Confidence            99999999988654  35999999999999999999999999999999999999999999999999998754321     


Q ss_pred             CCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHH---HHHHHHH-hcCCCCCCCCC
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW---LIFQRII-ARDIRFPNYFS  279 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~---~~~~~i~-~~~~~~p~~~~  279 (489)
                            .......|+..|+|||++.+..++.++|+|||||++|+|++|++||......   .....+. .....++..++
T Consensus       156 ------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (285)
T cd05630         156 ------QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFS  229 (285)
T ss_pred             ------ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCC
Confidence                  1122447999999999999989999999999999999999999999875431   2222222 22335677899


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC-CCCCCCCC
Q 011287          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG-QTPPKLAS  332 (489)
Q Consensus       280 ~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~-~~~p~~~~  332 (489)
                      +++.+||++||+.||++|||+...++.++++||||..++|..+.. +.+|++.|
T Consensus       230 ~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~  283 (285)
T cd05630         230 PDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPFKP  283 (285)
T ss_pred             HHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHHHhcCCCCCCCCC
Confidence            999999999999999999997655679999999999999997654 34444443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4.4e-47  Score=378.88  Aligned_cols=258  Identities=26%  Similarity=0.430  Sum_probs=212.3

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      .++|++.+.||+|+||.||+|++..+++.||+|++.....  ........+|+.+++.++||||+++++++.+...+|+|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   81 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV   81 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence            5789999999999999999999999999999999875422  22234466799999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccc
Q 011287          124 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~  202 (489)
                      |||+. ++|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.......   
T Consensus        82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---  157 (303)
T cd07869          82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS---  157 (303)
T ss_pred             EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC---
Confidence            99996 5888877664 569999999999999999999999999999999999999999999999999987542211   


Q ss_pred             cCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHH-HHHHHHHhc--CC------
Q 011287          203 LPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQRIIAR--DI------  272 (489)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~-~~~~~i~~~--~~------  272 (489)
                             ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..+. .....+...  ..      
T Consensus       158 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (303)
T cd07869         158 -------HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWP  230 (303)
T ss_pred             -------ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhcc
Confidence                   12234578999999999865 45788999999999999999999999875442 222222110  00      


Q ss_pred             ---C------------CC---------CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 011287          273 ---R------------FP---------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (489)
Q Consensus       273 ---~------------~p---------~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~  319 (489)
                         .            .|         ..+++.+++||++||+.||++|||+     .++++||||+++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~-----~~~l~h~~f~~~~~  296 (303)
T cd07869         231 GVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSA-----QAALSHEYFSDLPP  296 (303)
T ss_pred             chhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCH-----HHHhcCcccccCCh
Confidence               0            01         0245789999999999999999999     89999999998754

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=4.8e-47  Score=375.99  Aligned_cols=254  Identities=25%  Similarity=0.408  Sum_probs=215.6

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lyl  122 (489)
                      .+++|++.+.||+|+||.||+|++..++..||+|++.....  ......+.+|+.+++.++||||+++++++.+....|+
T Consensus         3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   80 (288)
T cd07871           3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL   80 (288)
T ss_pred             ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence            46899999999999999999999999999999999865432  2223456679999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccc
Q 011287          123 ALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~  201 (489)
                      ||||+.+ +|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......  
T Consensus        81 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--  157 (288)
T cd07871          81 VFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--  157 (288)
T ss_pred             EEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--
Confidence            9999985 9999887654 48999999999999999999999999999999999999999999999999987543211  


Q ss_pred             ccCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC---------
Q 011287          202 VLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---------  271 (489)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~---------  271 (489)
                              .......|++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+....         
T Consensus       158 --------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  229 (288)
T cd07871         158 --------KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWP  229 (288)
T ss_pred             --------ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhh
Confidence                    12234578999999999865 558899999999999999999999999888766655543210         


Q ss_pred             ----------CCCC-----------CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          272 ----------IRFP-----------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       272 ----------~~~p-----------~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                                ..+|           ..+++++++||.+||+.||.+|||+     +++++||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~-----~~~l~hp~f  288 (288)
T cd07871         230 GITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISA-----EAALRHSYF  288 (288)
T ss_pred             ccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCH-----HHHhcCCCC
Confidence                      1111           2468899999999999999999999     899999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.4e-47  Score=371.52  Aligned_cols=258  Identities=29%  Similarity=0.471  Sum_probs=224.3

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC-ccEEEEEEEcCC----
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG-VVRLFFTFQDTF----  118 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~----  118 (489)
                      +..|+.++.||+|+||+||+|+++.+|+.||+|.+.-.... +.......+|+.+|+.|+|+| |++|++++.+..    
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~   88 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG   88 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence            67799999999999999999999999999999999765432 445566788999999999999 999999998877    


Q ss_pred             --EEEEEEeccCCCChHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCc
Q 011287          119 --SLYMALESCEGGELFDQITSKG----HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  192 (489)
Q Consensus       119 --~lylV~E~~~gg~L~~~l~~~~----~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a  192 (489)
                        .+|+|+||++. +|..++...+    .++...++.++.||+.||+|||++||+||||||+||||+++|.+||+|||+|
T Consensus        89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence              89999999976 9999998765    4788899999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccccCCCCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc-
Q 011287          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-  270 (489)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~-  270 (489)
                      +.+.-+.          .....-++|.+|+|||+|.+. .|+...||||+|||++||+++++.|.+.++.++..+|... 
T Consensus       168 ra~~ip~----------~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~l  237 (323)
T KOG0594|consen  168 RAFSIPM----------RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLL  237 (323)
T ss_pred             HHhcCCc----------ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHc
Confidence            9654321          224456899999999999876 6999999999999999999999999999999988888651 


Q ss_pred             -----------------CCCCCC------------CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 011287          271 -----------------DIRFPN------------YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (489)
Q Consensus       271 -----------------~~~~p~------------~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~  318 (489)
                                       ...||.            ..++++.+|+.+||+.+|.+|.+|     +.++.||||..+.
T Consensus       238 GtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa-----~~al~h~yf~~~~  309 (323)
T KOG0594|consen  238 GTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISA-----KGALTHPYFSELP  309 (323)
T ss_pred             CCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCH-----HHHhcChhhcccc
Confidence                             111221            124589999999999999999999     8899999998764

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=7.6e-47  Score=372.46  Aligned_cols=262  Identities=29%  Similarity=0.572  Sum_probs=222.4

Q ss_pred             EeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEeccCCCCh
Q 011287           53 YGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL  132 (489)
Q Consensus        53 LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~~~gg~L  132 (489)
                      ||+|+||.||+|+++.+|+.||+|.+.+..............|+++++.++||||+++++.|.+...+|+||||++|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            69999999999999999999999999765544444445566799999999999999999999999999999999999999


Q ss_pred             HHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCCC
Q 011287          133 FDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDD  210 (489)
Q Consensus       133 ~~~l~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~  210 (489)
                      .+++...+  .+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||++.......           
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-----------  149 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-----------  149 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-----------
Confidence            98886543  48999999999999999999999999999999999999999999999999987653221           


Q ss_pred             CccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCH----HHHHHHHHhcCCCCC-CCCCHHHHHH
Q 011287          211 KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRIIARDIRFP-NYFSDAARDL  285 (489)
Q Consensus       211 ~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~----~~~~~~i~~~~~~~p-~~~~~~~~~L  285 (489)
                      ......|+..|+|||++.+..++.++|+|||||++|+|++|+.||.....    ......+......++ ..+++++++|
T Consensus       150 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  229 (277)
T cd05607         150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDI  229 (277)
T ss_pred             eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHH
Confidence            11234689999999999988899999999999999999999999976533    334444444444443 4689999999


Q ss_pred             HHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCCC
Q 011287          286 IDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT  326 (489)
Q Consensus       286 i~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~~  326 (489)
                      |.+||+.||.+||++.+. ..+++.||||++++|..+....
T Consensus       230 i~~~L~~~P~~R~~~~~~-~~~~~~h~~f~~~~~~~~~~~~  269 (277)
T cd05607         230 CRLFLAKKPEDRLGSREK-NDDPRKHEFFKTINFPRLEAGL  269 (277)
T ss_pred             HHHHhccCHhhCCCCccc-hhhhhcChhhcCCCHHHHhcCc
Confidence            999999999999999652 4778899999999998887543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2e-46  Score=370.98  Aligned_cols=275  Identities=32%  Similarity=0.573  Sum_probs=236.3

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEe
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E  125 (489)
                      .|+..+.||+|+||+||+|.+..+++.||+|.+.+...........+.+|+.+++.++|+||+++++.|.+...+|+|||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            47899999999999999999999999999999987655545555567789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          126 SCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       126 ~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      |+.+++|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......     
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-----  155 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-----  155 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC-----
Confidence            99999999888654  36999999999999999999999999999999999999999999999999998754321     


Q ss_pred             CCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHH----HHHHhcCCCCCCCCC
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIF----QRIIARDIRFPNYFS  279 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~----~~i~~~~~~~p~~~~  279 (489)
                            .......|+..|+|||++.+..++.++|+|||||++|+|++|..||.+.......    ..+......++..++
T Consensus       156 ------~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (285)
T cd05632         156 ------ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFS  229 (285)
T ss_pred             ------CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCC
Confidence                  1122457999999999999888999999999999999999999999887664433    333444456677899


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC-CCCCCCC
Q 011287          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG-QTPPKLA  331 (489)
Q Consensus       280 ~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~-~~~p~~~  331 (489)
                      .++.+|+.+||+.||++||++.+.++.+++.|+||+.++|+.+.. +..|++.
T Consensus       230 ~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  282 (285)
T cd05632         230 EEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFV  282 (285)
T ss_pred             HHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHHhcCcCCCCCC
Confidence            999999999999999999998877789999999999999997643 3334433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-46  Score=375.29  Aligned_cols=285  Identities=41%  Similarity=0.692  Sum_probs=244.9

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+..|+.+++.++||||+++++.+.+....|+||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            47999999999999999999999999999999998775555455667888999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccc
Q 011287          125 ESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (489)
Q Consensus       125 E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~  202 (489)
                      ||+.+++|.+++.+.  ..+++..++.++.|++.||+|||+.|++||||||+||+++.++.++|+|||++..........
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence            999999999998764  569999999999999999999999999999999999999999999999999987653321100


Q ss_pred             cCC-------------------CCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHH
Q 011287          203 LPN-------------------AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLI  263 (489)
Q Consensus       203 ~~~-------------------~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~  263 (489)
                      ...                   .........++||..|+|||++.+..++.++|||||||++|+|++|..||.+.+....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~  240 (316)
T cd05574         161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET  240 (316)
T ss_pred             ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence            000                   0111233456899999999999998899999999999999999999999999988888


Q ss_pred             HHHHHhcCCCCCCC--CCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCCCCCCC
Q 011287          264 FQRIIARDIRFPNY--FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKL  330 (489)
Q Consensus       264 ~~~i~~~~~~~p~~--~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~~~p~~  330 (489)
                      +..+......+|..  ++.++.++|.+||+.||++||++.. +.+++++||||++++|..+....||..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~-~~~~ll~~~~~~~~~~~~~~~~~~~~~  308 (316)
T cd05574         241 FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKR-GAAEIKQHPFFRGVNWALIRHTTPPII  308 (316)
T ss_pred             HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchh-hHHHHHcCchhhcCChhhcccCCCCCC
Confidence            88888777777665  6999999999999999999999321 238999999999999999887666654

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.8e-46  Score=379.42  Aligned_cols=260  Identities=28%  Similarity=0.480  Sum_probs=213.5

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC-----CEE
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT-----FSL  120 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~l  120 (489)
                      +|++.+.||+|+||.||+|++..+|..||||.+...... ......+.+|+.+++.++||||+++++++...     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc-chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence            599999999999999999999999999999998653222 22334577899999999999999999988543     358


Q ss_pred             EEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      |+|||||. ++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...... 
T Consensus        80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-  157 (338)
T cd07859          80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT-  157 (338)
T ss_pred             EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccccccc-
Confidence            99999995 6999999888889999999999999999999999999999999999999999999999999997543221 


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcC--CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc--------
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNS--SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--------  270 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~--~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~--------  270 (489)
                            .........+||+.|+|||++.+  ..++.++|||||||++|+|++|++||.+.+.......+...        
T Consensus       158 ------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  231 (338)
T cd07859         158 ------PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET  231 (338)
T ss_pred             ------CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence                  01112235689999999999876  57899999999999999999999999887654433222110        


Q ss_pred             ------------------C--CCC---CCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 011287          271 ------------------D--IRF---PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (489)
Q Consensus       271 ------------------~--~~~---p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~  319 (489)
                                        .  ..+   -..+++++.+||.+||+.||++||++     +++++||||+++..
T Consensus       232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-----~e~l~hp~f~~~~~  298 (338)
T cd07859         232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTA-----EEALADPYFKGLAK  298 (338)
T ss_pred             HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCH-----HHHhcCchhhhcCc
Confidence                              0  000   02367889999999999999999998     89999999987653

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.6e-47  Score=369.19  Aligned_cols=251  Identities=32%  Similarity=0.549  Sum_probs=216.6

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC-----C
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT-----F  118 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~  118 (489)
                      .=.|.-.+++|.|+||.||.|...++++.||||..-.+.       .+-.+|.++|+.++|||||+|..+|...     -
T Consensus        23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~-------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~   95 (364)
T KOG0658|consen   23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK-------RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEV   95 (364)
T ss_pred             EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC-------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence            346999999999999999999999999999999875432       2455699999999999999998888532     2


Q ss_pred             EEEEEEeccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCC-CCEEEeeccCcc
Q 011287          119 SLYMALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVK  193 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~-g~ikL~DFG~a~  193 (489)
                      ++.+||||++. +|.++++.    +..++.-.++.|.+||+.||.|||+.||+||||||+|+|+|.+ |.+||||||+|+
T Consensus        96 ~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen   96 YLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             HHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence            46789999986 99998884    4679999999999999999999999999999999999999976 999999999999


Q ss_pred             ccCCccccccCCCCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc--
Q 011287          194 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--  270 (489)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~--  270 (489)
                      .+...           ....++..|..|+|||.+.+. .|+.+.||||.||++.||+-|++.|.|.+...++..|.+.  
T Consensus       175 ~L~~~-----------epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG  243 (364)
T KOG0658|consen  175 VLVKG-----------EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLG  243 (364)
T ss_pred             eeccC-----------CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhC
Confidence            87543           334688899999999998765 5999999999999999999999999999988888777651  


Q ss_pred             ---------------CCCCC------------CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 011287          271 ---------------DIRFP------------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (489)
Q Consensus       271 ---------------~~~~p------------~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~  318 (489)
                                     +..+|            ...++++.+|+.++|+.+|.+|.++     .+++.||||..+.
T Consensus       244 ~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~-----~~~l~h~fFdelr  313 (364)
T KOG0658|consen  244 TPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSA-----LEALAHPFFDELR  313 (364)
T ss_pred             CCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCH-----HHHhcchhhHHhh
Confidence                           12222            3468999999999999999999999     8899999998654

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.1e-47  Score=382.87  Aligned_cols=257  Identities=28%  Similarity=0.495  Sum_probs=236.4

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCE-EE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS-LY  121 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-ly  121 (489)
                      .+++|..++.+|+|+||.+++++++..++.|++|.+.-........ .....|..+++++.|||||.+++.|.+++. ++
T Consensus         2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r-~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~   80 (426)
T KOG0589|consen    2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPER-RSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC   80 (426)
T ss_pred             ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhh-HHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence            3689999999999999999999999999999999998765554433 366779999999999999999999998887 99


Q ss_pred             EEEeccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcc
Q 011287          122 MALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      +||+||+||+|.+.|.+.  ..|+++.+..|+.||+.||.|||+++|+|||||+.|||++.++.|+|+|||+|+.+....
T Consensus        81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            999999999999999865  359999999999999999999999999999999999999999999999999999886532


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC-CCCCCCC
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-IRFPNYF  278 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~-~~~p~~~  278 (489)
                                ....+.+||+.|++||++.+.+|+.++|||||||++|||++-+++|.+.+......+|.... ...|..+
T Consensus       161 ----------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~y  230 (426)
T KOG0589|consen  161 ----------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMY  230 (426)
T ss_pred             ----------hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccc
Confidence                      35678999999999999999999999999999999999999999999999999999999887 5688999


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 011287          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (489)
Q Consensus       279 ~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~  315 (489)
                      +.+++.||..||..+|..||++     .+++.+|...
T Consensus       231 s~el~~lv~~~l~~~P~~RPsa-----~~LL~~P~l~  262 (426)
T KOG0589|consen  231 SSELRSLVKSMLRKNPEHRPSA-----LELLRRPHLL  262 (426)
T ss_pred             cHHHHHHHHHHhhcCCccCCCH-----HHHhhChhhh
Confidence            9999999999999999999999     8899998775

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=6.8e-46  Score=378.66  Aligned_cols=259  Identities=27%  Similarity=0.437  Sum_probs=215.7

Q ss_pred             CCCCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 011287           38 PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (489)
Q Consensus        38 ~~~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  117 (489)
                      +......++|++++.||+|+||.||+|++..+|+.||||++....  .......+.+|+.+++.++|+||+++++++.+.
T Consensus        67 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  144 (353)
T PLN00034         67 PSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHN  144 (353)
T ss_pred             CCCCCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC
Confidence            334556789999999999999999999999999999999986542  233445678899999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCC
Q 011287          118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~  197 (489)
                      ..+|+||||+++|+|...    ...++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus       145 ~~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~  220 (353)
T PLN00034        145 GEIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ  220 (353)
T ss_pred             CeEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence            999999999999998652    3467888899999999999999999999999999999999999999999999886532


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcC-----CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHH---HHHHHH-H
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNS-----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEW---LIFQRI-I  268 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-----~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~---~~~~~i-~  268 (489)
                      ..          ......+||..|+|||++..     ...+.++|||||||++|+|++|+.||......   .....+ .
T Consensus       221 ~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~  290 (353)
T PLN00034        221 TM----------DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM  290 (353)
T ss_pred             cc----------ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhc
Confidence            21          12234579999999999843     23456899999999999999999999743322   122222 2


Q ss_pred             hcCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          269 ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       269 ~~~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                      ......+..++.++++||.+||+.||++||++     .++++||||.+-
T Consensus       291 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~-----~ell~hp~~~~~  334 (353)
T PLN00034        291 SQPPEAPATASREFRHFISCCLQREPAKRWSA-----MQLLQHPFILRA  334 (353)
T ss_pred             cCCCCCCCccCHHHHHHHHHHccCChhhCcCH-----HHHhcCcccccC
Confidence            23445667889999999999999999999998     899999999864

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.4e-45  Score=373.10  Aligned_cols=258  Identities=24%  Similarity=0.427  Sum_probs=220.9

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ly  121 (489)
                      +..++|++.+.||+|+||.||+|++..+|..||+|++....  .......+.+|+.+++.++||||+++++++.+...+|
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   79 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            45689999999999999999999999999999999987542  2334566888999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM-GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~-gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      +||||+++|+|.+++.+.+.+++..+..++.|++.||.|||+. +|+||||||+|||++.+++++|+|||++......  
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  157 (331)
T cd06649          80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (331)
T ss_pred             EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence            9999999999999999888899999999999999999999986 6999999999999999999999999998754321  


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHH------------
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII------------  268 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~------------  268 (489)
                                .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..++...+-            
T Consensus       158 ----------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (331)
T cd06649         158 ----------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPH  227 (331)
T ss_pred             ----------ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCcc
Confidence                      2234579999999999999899999999999999999999999998765544322111            


Q ss_pred             ----------------------------------hc-CCCCC-CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCC
Q 011287          269 ----------------------------------AR-DIRFP-NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHP  312 (489)
Q Consensus       269 ----------------------------------~~-~~~~p-~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hp  312 (489)
                                                        .. ....+ ..+++++++||.+||+.||++||++     .++++||
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~-----~ell~h~  302 (331)
T cd06649         228 SISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADL-----KMLMNHT  302 (331)
T ss_pred             ccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCH-----HHHhcCh
Confidence                                              00 01111 2468899999999999999999999     8999999


Q ss_pred             CCCCCC
Q 011287          313 FFKGID  318 (489)
Q Consensus       313 ff~~i~  318 (489)
                      ||+...
T Consensus       303 ~~~~~~  308 (331)
T cd06649         303 FIKRSE  308 (331)
T ss_pred             HHhhcc
Confidence            998644

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=8.6e-46  Score=388.63  Aligned_cols=254  Identities=28%  Similarity=0.448  Sum_probs=211.4

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC----
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT----  117 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~----  117 (489)
                      ....+|++++.||+|+||.||+|.+..+++.||||.+.+..       ....+|+.+|+.++||||++++++|...    
T Consensus        63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~  135 (440)
T PTZ00036         63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKK  135 (440)
T ss_pred             CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence            34568999999999999999999999999999999885431       2244699999999999999998877432    


Q ss_pred             ----CEEEEEEeccCCCChHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCC-CEEEee
Q 011287          118 ----FSLYMALESCEGGELFDQIT----SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-HIKIAD  188 (489)
Q Consensus       118 ----~~lylV~E~~~gg~L~~~l~----~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g-~ikL~D  188 (489)
                          ..+++||||+++ +|.+++.    ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus       136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~D  214 (440)
T PTZ00036        136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCD  214 (440)
T ss_pred             CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeec
Confidence                357899999985 7776664    345799999999999999999999999999999999999999765 699999


Q ss_pred             ccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHH
Q 011287          189 FGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI  267 (489)
Q Consensus       189 FG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i  267 (489)
                      ||+|+.+...           ......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+....+.++
T Consensus       215 FGla~~~~~~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i  283 (440)
T PTZ00036        215 FGSAKNLLAG-----------QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRI  283 (440)
T ss_pred             cccchhccCC-----------CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            9999865321           122356789999999998664 6899999999999999999999999998876666555


Q ss_pred             Hhc-----------------CC------------CCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 011287          268 IAR-----------------DI------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (489)
Q Consensus       268 ~~~-----------------~~------------~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~  318 (489)
                      ...                 ..            .+|...++++++||.+||+.||.+|||+     .++++||||..+.
T Consensus       284 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta-----~e~l~hp~f~~~~  358 (440)
T PTZ00036        284 IQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNP-----IEALADPFFDDLR  358 (440)
T ss_pred             HHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCH-----HHHhCChhHHhhh
Confidence            431                 11            1344578899999999999999999999     8999999998765


Q ss_pred             c
Q 011287          319 W  319 (489)
Q Consensus       319 ~  319 (489)
                      .
T Consensus       359 ~  359 (440)
T PTZ00036        359 D  359 (440)
T ss_pred             c
Confidence            4

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-46  Score=383.45  Aligned_cols=260  Identities=33%  Similarity=0.547  Sum_probs=243.1

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCE
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  119 (489)
                      .......|.+.+.||+|.|+.|.+|++..|+..||||+++|.......... +.+|+++|..|+|||||++|.++..+..
T Consensus        51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k-~~rev~imk~l~HPnIvkl~~v~~t~~~  129 (596)
T KOG0586|consen   51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQK-LGREVDIMKSLNHPNIVKLFSVIETEAT  129 (596)
T ss_pred             ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHH-HHHHHHHHHhcCCcceeeeeeeeeecce
Confidence            445678899999999999999999999999999999999998777665555 8889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcc
Q 011287          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      +|+||||+.+|++++++.+++.+.+..++.++.|++.|++|||+++|+|||||++||||+.++++||+|||++..+..  
T Consensus       130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~--  207 (596)
T KOG0586|consen  130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY--  207 (596)
T ss_pred             eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc--
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999987753  


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCCCC-CCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF  278 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~-~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~  278 (489)
                               .....++||++.|.|||++.+..| ++.+|+||||+++|.|+.|.+||.+.+-.+...+.+.+.+.+|-.+
T Consensus       208 ---------~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~m  278 (596)
T KOG0586|consen  208 ---------GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYM  278 (596)
T ss_pred             ---------cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeeccccee
Confidence                     234568999999999999998875 6889999999999999999999999999999899999999999999


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       279 ~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      +.++++||+++|.++|.+|+++     ++++.|.|...
T Consensus       279 s~dce~lLrk~lvl~Pskr~~~-----dqim~~~W~n~  311 (596)
T KOG0586|consen  279 SCDCEDLLRKFLVLNPSKRGPC-----DQIMKDRWRND  311 (596)
T ss_pred             echhHHHHHHhhccCccccCCH-----HHhhhhcccch
Confidence            9999999999999999999999     88999999863

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=5.9e-46  Score=383.23  Aligned_cols=250  Identities=30%  Similarity=0.507  Sum_probs=217.4

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-C-----CCccEEEEEEEcCCE
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-H-----PGVVRLFFTFQDTFS  119 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~-h-----pnIv~l~~~~~~~~~  119 (489)
                      +|++.++||+|+||+|.+|.+..|++.||||++++.    .....+...|+.+|..|+ |     -|||+++++|...++
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H  262 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH  262 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence            689999999999999999999999999999999764    334455667999999886 3     589999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCC--CEEEeeccCcccc
Q 011287          120 LYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG--HIKIADFGSVKPM  195 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g--~ikL~DFG~a~~~  195 (489)
                      +|+|+|.+.. +|.++|+.+.  .|+...++.++.||+.||.+||++||||+|||||||||.+-+  .|||+|||+|+..
T Consensus       263 lciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  263 LCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            9999999965 9999999863  489999999999999999999999999999999999997654  7999999999864


Q ss_pred             CCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc-----
Q 011287          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-----  270 (489)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~-----  270 (489)
                      .             ....+++.+..|+|||++.+.+|+.+.||||||||++||++|.+.|.|.++.+++..|..-     
T Consensus       342 ~-------------q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp  408 (586)
T KOG0667|consen  342 S-------------QRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPP  408 (586)
T ss_pred             C-------------CcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCC
Confidence            3             2334889999999999999999999999999999999999999999999999998888650     


Q ss_pred             ---------------C--------------------------------CCCCC-----------CCCHHHHHHHHHhhcc
Q 011287          271 ---------------D--------------------------------IRFPN-----------YFSDAARDLIDRLLDV  292 (489)
Q Consensus       271 ---------------~--------------------------------~~~p~-----------~~~~~~~~Li~~~L~~  292 (489)
                                     .                                ...|.           .-...+.|||.+||+.
T Consensus       409 ~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~  488 (586)
T KOG0667|consen  409 PKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEW  488 (586)
T ss_pred             HHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhcc
Confidence                           0                                00120           0124579999999999


Q ss_pred             CCCCCCCCCCCCHHHHhcCCCCCCCC
Q 011287          293 DPSGRPGAGPGGYAVLKMHPFFKGID  318 (489)
Q Consensus       293 dP~~R~t~~~~~~~~l~~hpff~~i~  318 (489)
                      ||.+|+|+     .++++||||.+..
T Consensus       489 dP~~R~tp-----~qal~Hpfl~~~~  509 (586)
T KOG0667|consen  489 DPAERITP-----AQALNHPFLTGTS  509 (586)
T ss_pred             CchhcCCH-----HHHhcCccccccc
Confidence            99999999     8899999998654

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-45  Score=380.89  Aligned_cols=252  Identities=23%  Similarity=0.336  Sum_probs=210.5

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ly  121 (489)
                      ....+|++++.||+|+||.||+|.+..+++.||+|....         ..+.+|+.+++.++||||++++++|......+
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~  159 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTC  159 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence            455789999999999999999999999999999996532         23567999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccc
Q 011287          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~  201 (489)
                      +|||++. ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+|+.....   
T Consensus       160 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~---  235 (391)
T PHA03212        160 LILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI---  235 (391)
T ss_pred             EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc---
Confidence            9999995 699999988888999999999999999999999999999999999999999999999999999753221   


Q ss_pred             ccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCC-------HHHHHHHHHhc----
Q 011287          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS-------EWLIFQRIIAR----  270 (489)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~-------~~~~~~~i~~~----  270 (489)
                            ........+||+.|+|||++.+..++.++|||||||++|+|++|..||....       ....+..+...    
T Consensus       236 ------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~  309 (391)
T PHA03212        236 ------NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTH  309 (391)
T ss_pred             ------cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCC
Confidence                  1122345689999999999999999999999999999999999998875421       11112222110    


Q ss_pred             ----------------------CCCCC---------CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          271 ----------------------DIRFP---------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       271 ----------------------~~~~p---------~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                                            ....|         ..++.++.+||.+||+.||++|||+     .++++||||..+
T Consensus       310 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta-----~elL~hp~f~~~  382 (391)
T PHA03212        310 PNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSA-----EALLDFAAFQDI  382 (391)
T ss_pred             hhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCH-----HHHhcChhhccC
Confidence                                  00001         1246789999999999999999999     899999999864

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=4.2e-45  Score=360.53  Aligned_cols=262  Identities=35%  Similarity=0.605  Sum_probs=219.3

Q ss_pred             EEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh---CCCCCccEEEEEEEcCCEEEEEEeccC
Q 011287           52 IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ---LDHPGVVRLFFTFQDTFSLYMALESCE  128 (489)
Q Consensus        52 ~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~---l~hpnIv~l~~~~~~~~~lylV~E~~~  128 (489)
                      .||+|+||.||+|.+..+++.||+|.+.+.............+|..+++.   .+||+|+.+++++...+..|+||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            48999999999999999999999999987655433333334445444443   479999999999999999999999999


Q ss_pred             CCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCC
Q 011287          129 GGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS  208 (489)
Q Consensus       129 gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~  208 (489)
                      +|+|.+++...+.+++..+..++.|++.||+|||+.||+||||||+|||++.++.++|+|||++......          
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----------  150 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----------  150 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----------
Confidence            9999999988888999999999999999999999999999999999999999999999999998654321          


Q ss_pred             CCCccceecCCcCCChhhhc-CCCCCCCCcchhhhHHHHHHhhCCCCCCCCC---HHHHHHHHHhcCCCCCCCCCHHHHH
Q 011287          209 DDKACTFVGTAAYVPPEVLN-SSPATFGNDLWALGCTLYQMLSGTSPFKDTS---EWLIFQRIIARDIRFPNYFSDAARD  284 (489)
Q Consensus       209 ~~~~~~~~gt~~Y~aPE~l~-~~~~~~~sDiwSLG~ilyelltG~~PF~~~~---~~~~~~~i~~~~~~~p~~~~~~~~~  284 (489)
                        ......||..|+|||.+. +..++.++|+|||||++|+|++|..||....   ..............+|+.+++++.+
T Consensus       151 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (279)
T cd05633         151 --KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKS  228 (279)
T ss_pred             --CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHH
Confidence              112346899999999986 4568899999999999999999999997532   2233333344556778889999999


Q ss_pred             HHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC
Q 011287          285 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  325 (489)
Q Consensus       285 Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~  325 (489)
                      +|.+||+.||++|++....+++++++||||++++|.....+
T Consensus       229 li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~  269 (279)
T cd05633         229 LLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQ  269 (279)
T ss_pred             HHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHHhcC
Confidence            99999999999999865556799999999999999886543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-47  Score=357.70  Aligned_cols=260  Identities=33%  Similarity=0.526  Sum_probs=226.5

Q ss_pred             eeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCEEEEEEeccC
Q 011287           50 GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCE  128 (489)
Q Consensus        50 ~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~lylV~E~~~  128 (489)
                      .+.||+|+|+.|--+....||.+||||+++|.   .......+.+|++++..+ .|+||++|+++|+++...|+|||-+.
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~  159 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR  159 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence            46899999999999999999999999999886   344567788999999888 59999999999999999999999999


Q ss_pred             CCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCC---EEEeeccCccccCCccccccCC
Q 011287          129 GGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPN  205 (489)
Q Consensus       129 gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~---ikL~DFG~a~~~~~~~~~~~~~  205 (489)
                      ||.|+.+|+++..|+|.++..+..+|+.||.|||.+||.||||||||||.....+   +|||||.+..-+..... ..  
T Consensus       160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~-~s--  236 (463)
T KOG0607|consen  160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND-CS--  236 (463)
T ss_pred             CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCC-CC--
Confidence            9999999999999999999999999999999999999999999999999977654   89999998764432211 11  


Q ss_pred             CCCCCCccceecCCcCCChhhhc-----CCCCCCCCcchhhhHHHHHHhhCCCCCCCCC---------------HHHHHH
Q 011287          206 AASDDKACTFVGTAAYVPPEVLN-----SSPATFGNDLWALGCTLYQMLSGTSPFKDTS---------------EWLIFQ  265 (489)
Q Consensus       206 ~~~~~~~~~~~gt~~Y~aPE~l~-----~~~~~~~sDiwSLG~ilyelltG~~PF~~~~---------------~~~~~~  265 (489)
                      -.......+.||++.|||||+..     ...|+.++|+||||||+|-||+|++||.+.-               ...+|.
T Consensus       237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe  316 (463)
T KOG0607|consen  237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE  316 (463)
T ss_pred             CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence            12234455789999999999873     3458999999999999999999999998632               255788


Q ss_pred             HHHhcCCCCCC----CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 011287          266 RIIARDIRFPN----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (489)
Q Consensus       266 ~i~~~~~~~p~----~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~  320 (489)
                      .|..+.++||+    .+|.+++|||..+|..|+..|+++     .++++|||++.+.-+
T Consensus       317 sIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa-----~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  317 SIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSA-----AQVLNHPWVQRCAPE  370 (463)
T ss_pred             HHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhh-----hhccCCccccccchh
Confidence            99999999997    489999999999999999999999     889999999987543

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-48  Score=379.00  Aligned_cols=256  Identities=31%  Similarity=0.493  Sum_probs=230.9

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      ..|...+.||+|+||.||+|.+..|++.||+|++....  .+...+.+..|+.+|..++++||.++|+.|-....++++|
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM   90 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM   90 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence            46788899999999999999999999999999997653  3455677889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccC
Q 011287          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (489)
Q Consensus       125 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~  204 (489)
                      |||.||++.+.++..+.++|..+..++.+++.||.|||..+.+|||||+.|||+..+|.+||+|||.+..+...      
T Consensus        91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~------  164 (467)
T KOG0201|consen   91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT------  164 (467)
T ss_pred             HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeech------
Confidence            99999999999998877899999999999999999999999999999999999999999999999999876543      


Q ss_pred             CCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCHHHH
Q 011287          205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-RFPNYFSDAAR  283 (489)
Q Consensus       205 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~-~~p~~~~~~~~  283 (489)
                          ..+..+|+||+.|||||++....|+.++||||||++.|||++|.+||....+...+..|.+..+ .+...+++.++
T Consensus       165 ----~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~k  240 (467)
T KOG0201|consen  165 ----VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFK  240 (467)
T ss_pred             ----hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHH
Confidence                2344799999999999999988999999999999999999999999999888665555555433 34557899999


Q ss_pred             HHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          284 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       284 ~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                      +||..||+.||+.||+|     .+|++|+|.+..
T Consensus       241 EFV~~CL~k~P~~RpsA-----~~LLKh~FIk~a  269 (467)
T KOG0201|consen  241 EFVEACLDKNPEFRPSA-----KELLKHKFIKRA  269 (467)
T ss_pred             HHHHHHhhcCcccCcCH-----HHHhhhHHHHhc
Confidence            99999999999999999     899999999863

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.6e-45  Score=387.12  Aligned_cols=251  Identities=25%  Similarity=0.402  Sum_probs=205.7

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC------CCCccEEEEEEEcC
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD------HPGVVRLFFTFQDT  117 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~------hpnIv~l~~~~~~~  117 (489)
                      .++|++++.||+|+||+||+|.+..+++.||||++.+..    ........|+.+++.+.      |+++++++++|...
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~  203 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE  203 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence            478999999999999999999999999999999986431    12233455666666654      45689999998764


Q ss_pred             -CEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeeccCCCCeeeCCCC-------------
Q 011287          118 -FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADG-------------  182 (489)
Q Consensus       118 -~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~-~gIiHrDLKpeNILl~~~g-------------  182 (489)
                       ..+|+|||++ |++|.+++.+.+.+++..++.++.||+.||+|||+ .||+||||||+|||++.++             
T Consensus       204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~  282 (467)
T PTZ00284        204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP  282 (467)
T ss_pred             CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence             5789999998 67999999888899999999999999999999998 5999999999999998765             


Q ss_pred             ---CEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCC
Q 011287          183 ---HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS  259 (489)
Q Consensus       183 ---~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~  259 (489)
                         .+||+|||.+....             .....++||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+
T Consensus       283 ~~~~vkl~DfG~~~~~~-------------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~  349 (467)
T PTZ00284        283 DPCRVRICDLGGCCDER-------------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD  349 (467)
T ss_pred             CCceEEECCCCccccCc-------------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence               49999999875321             12335789999999999999999999999999999999999999999887


Q ss_pred             HHHHHHHHHhcCCCCCC------------------------------------------CCCHHHHHHHHHhhccCCCCC
Q 011287          260 EWLIFQRIIARDIRFPN------------------------------------------YFSDAARDLIDRLLDVDPSGR  297 (489)
Q Consensus       260 ~~~~~~~i~~~~~~~p~------------------------------------------~~~~~~~~Li~~~L~~dP~~R  297 (489)
                      ..+.+..+......+|.                                          ..++.+.|||.+||+.||.+|
T Consensus       350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R  429 (467)
T PTZ00284        350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR  429 (467)
T ss_pred             hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence            76655444322111110                                          013567899999999999999


Q ss_pred             CCCCCCCHHHHhcCCCCCCC
Q 011287          298 PGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       298 ~t~~~~~~~~l~~hpff~~i  317 (489)
                      ||+     +++++||||...
T Consensus       430 ~ta-----~e~L~Hp~~~~~  444 (467)
T PTZ00284        430 LNA-----RQMTTHPYVLKY  444 (467)
T ss_pred             CCH-----HHHhcCcccccc
Confidence            999     899999999853

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=4e-45  Score=361.74  Aligned_cols=252  Identities=28%  Similarity=0.435  Sum_probs=210.1

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcC-CCcEEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCccEEEEEEE-----
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFITKENKTAYVKLERIVLDQL---DHPGVVRLFFTFQ-----  115 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~-tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~-----  115 (489)
                      ++|++.+.||+|+||.||+|++.. +|..||+|++........ ......+|..+++.+   +||||+++++++.     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~   79 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   79 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC-chHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence            479999999999999999999864 578899999875433222 223344577777665   6999999999885     


Q ss_pred             cCCEEEEEEeccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCcc
Q 011287          116 DTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK  193 (489)
Q Consensus       116 ~~~~lylV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~  193 (489)
                      ....+|+||||+. ++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T cd07862          80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  158 (290)
T ss_pred             CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence            3456899999997 5899988764  358999999999999999999999999999999999999999999999999997


Q ss_pred             ccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC-
Q 011287          194 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-  272 (489)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~-  272 (489)
                      .....           .......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+..... 
T Consensus       159 ~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~  227 (290)
T cd07862         159 IYSFQ-----------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL  227 (290)
T ss_pred             eccCC-----------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCC
Confidence            64322           123355799999999999988899999999999999999999999999988877777654210 


Q ss_pred             ----C----------------------CCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          273 ----R----------------------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       273 ----~----------------------~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                          .                      +...+++.+++||.+||+.||++||++     .++++||||
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~-----~~~l~hp~f  290 (290)
T cd07862         228 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA-----YSALSHPYF  290 (290)
T ss_pred             CChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCH-----HHHhcCCCC
Confidence                0                      112467889999999999999999999     899999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2e-45  Score=377.90  Aligned_cols=258  Identities=28%  Similarity=0.391  Sum_probs=218.6

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-----EE
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-----SL  120 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----~l  120 (489)
                      +|++++.||+|+||.||+|.+..+|+.||||.+.+... .......+.+|+.+++.++||||+++++++.+..     .+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ-NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc-chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence            68999999999999999999999999999999865422 2233456778999999999999999999998776     79


Q ss_pred             EEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      |+||||+. ++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus        80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~-  157 (372)
T cd07853          80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE-  157 (372)
T ss_pred             EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCc-
Confidence            99999997 5899988888889999999999999999999999999999999999999999999999999997643221 


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc---------
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---------  270 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~---------  270 (489)
                              .......++|+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+....+..|...         
T Consensus       158 --------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~  229 (372)
T cd07853         158 --------SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAM  229 (372)
T ss_pred             --------cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence                    1112234689999999999774 4789999999999999999999999988877665554321         


Q ss_pred             --------------C---------CCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 011287          271 --------------D---------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (489)
Q Consensus       271 --------------~---------~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~  319 (489)
                                    .         +.+....++++.+||.+||+.||++|||+     .++++||||.+..+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~-----~e~l~hp~~~~~~~  296 (372)
T cd07853         230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISA-----ADALAHPYLDEGRL  296 (372)
T ss_pred             HHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCH-----HHHhcCHhhCCCcc
Confidence                          1         12234468899999999999999999999     89999999998654

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.9e-44  Score=360.12  Aligned_cols=280  Identities=37%  Similarity=0.581  Sum_probs=237.4

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++.++||||+++++.+.+...+|+||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            47999999999999999999999999999999987664433444556778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccC
Q 011287          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (489)
Q Consensus       125 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~  204 (489)
                      ||++|++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++...........
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY  160 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence            99999999999988888999999999999999999999999999999999999999999999999998742211100000


Q ss_pred             -----CCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCC---
Q 011287          205 -----NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN---  276 (489)
Q Consensus       205 -----~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~---  276 (489)
                           ............|+..|+|||.+.+..++.++|+|||||++|+|++|..||.+.+..+.++.+.......|.   
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  240 (305)
T cd05609         161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDE  240 (305)
T ss_pred             ccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccc
Confidence                 000011112356888999999998888999999999999999999999999988888888887776555443   


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCCC
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT  326 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~~  326 (489)
                      .++.++.++|.+||+.||++||++.  +..++++||||.+.+|..+..+.
T Consensus       241 ~~~~~~~~li~~~l~~~P~~R~~~~--~~~~ll~~~~~~~~~~~~~~~~~  288 (305)
T cd05609         241 ALPADAQDLISRLLRQNPLERLGTG--GAFEVKQHRFFLGLDWNGLLRQK  288 (305)
T ss_pred             cCCHHHHHHHHHHhccChhhccCcc--CHHHHHhCccccCCCHHHHhhcC
Confidence            5789999999999999999999973  45899999999999999876443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=5.4e-45  Score=364.80  Aligned_cols=257  Identities=24%  Similarity=0.401  Sum_probs=215.8

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lyl  122 (489)
                      .+++|.+.+.||+|+||.||+|+++.+++.||+|.+......  .......+|+.++++++||||+++++++.+....|+
T Consensus         4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   81 (309)
T cd07872           4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL   81 (309)
T ss_pred             CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence            468999999999999999999999999999999998754322  223345679999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccc
Q 011287          123 ALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~  201 (489)
                      ||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  
T Consensus        82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--  158 (309)
T cd07872          82 VFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT--  158 (309)
T ss_pred             EEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc--
Confidence            9999975 888888765 458999999999999999999999999999999999999999999999999987543211  


Q ss_pred             ccCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc----------
Q 011287          202 VLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR----------  270 (489)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~----------  270 (489)
                              .......+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+...          
T Consensus       159 --------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  230 (309)
T cd07872         159 --------KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWP  230 (309)
T ss_pred             --------cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Confidence                    11224468999999999865 45788999999999999999999999988766554444321          


Q ss_pred             ---------CCCCC-----------CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          271 ---------DIRFP-----------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       271 ---------~~~~p-----------~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                               ...+|           ..+++++++||.+||+.||.+|||+     +++++||||+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-----~e~l~h~~~~~~  292 (309)
T cd07872         231 GISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISA-----EEAMKHAYFRSL  292 (309)
T ss_pred             hhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCH-----HHHhcChhhhhc
Confidence                     11112           2468899999999999999999999     899999999864

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-44  Score=352.68  Aligned_cols=258  Identities=28%  Similarity=0.489  Sum_probs=224.5

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccch--hHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE--NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lyl  122 (489)
                      ++|++.+.||+|++|.||.|.+..+++.||+|.+........  .....+.+|+.++++++||||+++++++.+...+|+
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            579999999999999999999999999999999875533222  234567889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccc
Q 011287          123 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~  202 (489)
                      |+||+++++|.+++.+.+.+++..++.++.|++.||.|||+.||+||||+|+||+++.++.++|+|||+++.......  
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~--  159 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS--  159 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccc--
Confidence            999999999999999888899999999999999999999999999999999999999999999999999876533210  


Q ss_pred             cCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc--CCCCCCCCCH
Q 011287          203 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--DIRFPNYFSD  280 (489)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~--~~~~p~~~~~  280 (489)
                           .........|+..|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+...  ...+|..++.
T Consensus       160 -----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (263)
T cd06625         160 -----SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSP  234 (263)
T ss_pred             -----ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCH
Confidence                 011113456889999999999988999999999999999999999999887666655554433  4557788999


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       281 ~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                      .+.+||.+||..+|.+||++     .++++||||
T Consensus       235 ~~~~li~~~l~~~p~~Rpt~-----~~ll~~~~~  263 (263)
T cd06625         235 DARNFLRRTFVENAKKRPSA-----EELLRHFFV  263 (263)
T ss_pred             HHHHHHHHHhhcCcccCCCH-----HHHhhCCCC
Confidence            99999999999999999998     899999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.1e-44  Score=370.62  Aligned_cols=254  Identities=23%  Similarity=0.425  Sum_probs=211.2

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC----
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF----  118 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----  118 (489)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++.+... .......+.+|+.+++.++||||++++++|....    
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            35899999999999999999999999999999999976532 2333455668999999999999999999986543    


Q ss_pred             --EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccC
Q 011287          119 --SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (489)
Q Consensus       119 --~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~  196 (489)
                        .+|+||||+.+ +|...+..  .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~  174 (359)
T cd07876          98 FQDVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC  174 (359)
T ss_pred             cceeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence              57999999976 67776653  58999999999999999999999999999999999999999999999999987532


Q ss_pred             CccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc------
Q 011287          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR------  270 (489)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~------  270 (489)
                      ..           .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+...      
T Consensus       175 ~~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  243 (359)
T cd07876         175 TN-----------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSA  243 (359)
T ss_pred             cC-----------ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcH
Confidence            21           1223457899999999999999999999999999999999999999987765443332211      


Q ss_pred             ----------------CCCC--------------------CCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          271 ----------------DIRF--------------------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       271 ----------------~~~~--------------------p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                                      ...+                    +...++++++||.+||+.||++|||+     .++++||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~-----~e~l~hp~~  318 (359)
T cd07876         244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISV-----DEALRHPYI  318 (359)
T ss_pred             HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCH-----HHHhcCchh
Confidence                            1111                    11246789999999999999999999     899999999


Q ss_pred             CC
Q 011287          315 KG  316 (489)
Q Consensus       315 ~~  316 (489)
                      ..
T Consensus       319 ~~  320 (359)
T cd07876         319 TV  320 (359)
T ss_pred             hh
Confidence            74

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=6.7e-45  Score=358.11  Aligned_cols=261  Identities=33%  Similarity=0.602  Sum_probs=226.9

Q ss_pred             EeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEeccCCCCh
Q 011287           53 YGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL  132 (489)
Q Consensus        53 LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~~~gg~L  132 (489)
                      ||+|+||+||+|.+..+|+.||+|++.+...........+..|..+++.++||||++++++|......|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999999999999999999876444444455566799999999999999999999999999999999999999


Q ss_pred             HHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCCC
Q 011287          133 FDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDD  210 (489)
Q Consensus       133 ~~~l~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~  210 (489)
                      .+++.+.+  .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||.+......           .
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-----------~  149 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-----------K  149 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC-----------C
Confidence            99998765  7999999999999999999999999999999999999999999999999998754321           1


Q ss_pred             CccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCH----HHHHHHHHhcCCCCCCCCCHHHHHHH
Q 011287          211 KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRIIARDIRFPNYFSDAARDLI  286 (489)
Q Consensus       211 ~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~----~~~~~~i~~~~~~~p~~~~~~~~~Li  286 (489)
                      ......++..|+|||++.+..++.++|+|||||++|+|++|+.||.....    ..+...+......+|..+++.+.++|
T Consensus       150 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  229 (277)
T cd05577         150 KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLC  229 (277)
T ss_pred             ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHH
Confidence            12234678899999999888899999999999999999999999987644    33334444556667788999999999


Q ss_pred             HHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 011287          287 DRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (489)
Q Consensus       287 ~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~  324 (489)
                      ++||+.||.+||+..+.+..++++||||..++|..+..
T Consensus       230 ~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~~~  267 (277)
T cd05577         230 EALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEA  267 (277)
T ss_pred             HHHccCChhHccCCCcccHHHHHhChhhhcCChhhhhc
Confidence            99999999999988777789999999999999987743

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.1e-44  Score=353.07  Aligned_cols=257  Identities=39%  Similarity=0.738  Sum_probs=231.0

Q ss_pred             EeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEeccCCCCh
Q 011287           53 YGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL  132 (489)
Q Consensus        53 LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~~~gg~L  132 (489)
                      ||.|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+...+|+||||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            69999999999999999999999999876555455567788899999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCCCCc
Q 011287          133 FDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA  212 (489)
Q Consensus       133 ~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~  212 (489)
                      .+++.+...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......           ..
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-----------~~  149 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-----------KT  149 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-----------cc
Confidence            9999988889999999999999999999999999999999999999999999999999988654321           22


Q ss_pred             cceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCC--HHHHHHHHH--hcCCCCCCCCCHHHHHHHHH
Q 011287          213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS--EWLIFQRII--ARDIRFPNYFSDAARDLIDR  288 (489)
Q Consensus       213 ~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~--~~~~~~~i~--~~~~~~p~~~~~~~~~Li~~  288 (489)
                      ....|+..|+|||.+.+..++.++|+|||||++|+|++|..||....  .....+.+.  .....+|...++++.++|.+
T Consensus       150 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  229 (262)
T cd05572         150 WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQ  229 (262)
T ss_pred             ccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHH
Confidence            34578999999999988889999999999999999999999998877  666777777  45677888889999999999


Q ss_pred             hhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 011287          289 LLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (489)
Q Consensus       289 ~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~  320 (489)
                      ||+.||++||+..+.+++++++||||++.+|+
T Consensus       230 ~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  261 (262)
T cd05572         230 LLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE  261 (262)
T ss_pred             HccCChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence            99999999999666677999999999999986

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.4e-44  Score=357.34  Aligned_cols=251  Identities=26%  Similarity=0.406  Sum_probs=208.7

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCccEEEEEEEc-----C
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL---DHPGVVRLFFTFQD-----T  117 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~-----~  117 (489)
                      +|++.+.||+|+||+||+|+++.+|+.||+|.+....... .......+|..+++.+   +||||+++++++.+     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            5899999999999999999999999999999987543222 2223344577766655   79999999998864     3


Q ss_pred             CEEEEEEeccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCcccc
Q 011287          118 FSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~  195 (489)
                      ..+++||||+.+ +|.+++.+.  ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus        80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~  158 (288)
T cd07863          80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY  158 (288)
T ss_pred             ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence            468999999985 898888764  34899999999999999999999999999999999999999999999999998765


Q ss_pred             CCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC----
Q 011287          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD----  271 (489)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~----  271 (489)
                      ...           .......||..|+|||++.+..++.++|||||||++|+|++|++||.+.+....+.++....    
T Consensus       159 ~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~  227 (288)
T cd07863         159 SCQ-----------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP  227 (288)
T ss_pred             cCc-----------ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCC
Confidence            321           11224578999999999998889999999999999999999999999888776666654310    


Q ss_pred             -------C----------------CCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          272 -------I----------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       272 -------~----------------~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                             .                .+.+.++.++.+||.+||+.||++||++     .+++.||||
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~~~l~hp~f  288 (288)
T cd07863         228 EDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISA-----FRALQHPFF  288 (288)
T ss_pred             hhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCH-----HHHhcCCCC
Confidence                   0                0112467889999999999999999999     899999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.6e-44  Score=354.54  Aligned_cols=264  Identities=34%  Similarity=0.588  Sum_probs=222.4

Q ss_pred             EEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHH---HHHhCCCCCccEEEEEEEcCCEEEEEEeccC
Q 011287           52 IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI---VLDQLDHPGVVRLFFTFQDTFSLYMALESCE  128 (489)
Q Consensus        52 ~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~---il~~l~hpnIv~l~~~~~~~~~lylV~E~~~  128 (489)
                      +||+|+||.||+|.+..+++.||+|.+.+..............|..   .++...||+|+++++.|.+...+|+||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999999999999999998765443332222333433   3444689999999999999999999999999


Q ss_pred             CCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCC
Q 011287          129 GGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS  208 (489)
Q Consensus       129 gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~  208 (489)
                      ||+|.+++.+.+.+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++..+...          
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----------  150 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----------  150 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----------
Confidence            9999999988888999999999999999999999999999999999999999999999999998754321          


Q ss_pred             CCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCC---CHHHHHHHHHhcCCCCCCCCCHHHHH
Q 011287          209 DDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDT---SEWLIFQRIIARDIRFPNYFSDAARD  284 (489)
Q Consensus       209 ~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~---~~~~~~~~i~~~~~~~p~~~~~~~~~  284 (489)
                        .....+|+..|+|||++.+. .++.++|+||+||++|+|++|+.||.+.   ........+......+|..++.++.+
T Consensus       151 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  228 (278)
T cd05606         151 --KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS  228 (278)
T ss_pred             --CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHH
Confidence              12245799999999999754 5889999999999999999999999876   44444445555667788889999999


Q ss_pred             HHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCCCC
Q 011287          285 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTP  327 (489)
Q Consensus       285 Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~~~  327 (489)
                      +|.+||..||.+||......+.++++||||++++|..+.....
T Consensus       229 li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~~~~~~  271 (278)
T cd05606         229 LLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKY  271 (278)
T ss_pred             HHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchHhhhccc
Confidence            9999999999999966545569999999999999998765543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.9e-44  Score=369.39  Aligned_cols=254  Identities=24%  Similarity=0.405  Sum_probs=213.4

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC-----
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT-----  117 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----  117 (489)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++.+.... ......+.+|+.+++.++||||+++++++...     
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccC-chhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            368999999999999999999999999999999999765322 23345566799999999999999999988643     


Q ss_pred             -CEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccC
Q 011287          118 -FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (489)
Q Consensus       118 -~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~  196 (489)
                       ..+|+||||+.+ +|...+..  .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       101 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  177 (364)
T cd07875         101 FQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  177 (364)
T ss_pred             cCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence             357999999975 78777764  48999999999999999999999999999999999999999999999999997543


Q ss_pred             CccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC----
Q 011287          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI----  272 (489)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~----  272 (489)
                      ..           .......||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+.+++....    
T Consensus       178 ~~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  246 (364)
T cd07875         178 TS-----------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP  246 (364)
T ss_pred             CC-----------CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence            21           122345789999999999999999999999999999999999999998887776665543100    


Q ss_pred             ------------------C--------------C------CCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          273 ------------------R--------------F------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       273 ------------------~--------------~------p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                                        .              +      +...+..+++||.+||+.||.+|||+     .++++||||
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~-----~e~L~hp~~  321 (364)
T cd07875         247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV-----DEALQHPYI  321 (364)
T ss_pred             HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCH-----HHHhcCccc
Confidence                              0              0      01135678999999999999999999     899999999


Q ss_pred             CC
Q 011287          315 KG  316 (489)
Q Consensus       315 ~~  316 (489)
                      ..
T Consensus       322 ~~  323 (364)
T cd07875         322 NV  323 (364)
T ss_pred             cc
Confidence            73

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.2e-44  Score=364.79  Aligned_cols=256  Identities=26%  Similarity=0.450  Sum_probs=218.2

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lyl  122 (489)
                      ..++|++.+.||+|+||.||+|++..++..+|+|++....  .......+.+|+.+++.++||||++++++|.+...+|+
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence            4589999999999999999999999999999999986542  23345567889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccc
Q 011287          123 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM-GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~-gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~  201 (489)
                      ||||+.+|+|.+++.+.+.+++..+..++.|++.||.|||+. +|+||||||+|||++.+|.+||+|||++..+...   
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---  157 (333)
T cd06650          81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  157 (333)
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---
Confidence            999999999999999888899999999999999999999985 7999999999999999999999999998754321   


Q ss_pred             ccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHH---------------
Q 011287          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQR---------------  266 (489)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~---------------  266 (489)
                               ......||..|+|||++.+..++.++|+|||||++|+|++|+.||...........               
T Consensus       158 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (333)
T cd06650         158 ---------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETS  228 (333)
T ss_pred             ---------ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccC
Confidence                     12345789999999999988899999999999999999999999986554332211               


Q ss_pred             -----------------------------HHhc-CCCCC-CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 011287          267 -----------------------------IIAR-DIRFP-NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (489)
Q Consensus       267 -----------------------------i~~~-~~~~p-~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~  315 (489)
                                                   +... ...++ ..++.++++||.+||+.||++||++     .+++.||||+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~-----~ell~h~~~~  303 (333)
T cd06650         229 PRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADL-----KQLMVHAFIK  303 (333)
T ss_pred             cccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCH-----HHHhhCHHHh
Confidence                                         1111 11122 1367899999999999999999998     8999999997


Q ss_pred             CC
Q 011287          316 GI  317 (489)
Q Consensus       316 ~i  317 (489)
                      ..
T Consensus       304 ~~  305 (333)
T cd06650         304 RS  305 (333)
T ss_pred             cC
Confidence            53

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.1e-44  Score=371.73  Aligned_cols=258  Identities=21%  Similarity=0.330  Sum_probs=215.1

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEc--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKI--DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~--~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ly  121 (489)
                      ..+|++++.||+|+||.||+|...  .++..||+|.+...        ....+|+.+|+.++||||++++++|.....+|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~  162 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVC  162 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence            457999999999999999999864  45788999987543        22457999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccc
Q 011287          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~  201 (489)
                      +|||++. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.+....  
T Consensus       163 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~--  239 (392)
T PHA03207        163 MVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP--  239 (392)
T ss_pred             EEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc--
Confidence            9999996 5899999877889999999999999999999999999999999999999999999999999997654321  


Q ss_pred             ccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCH---HHHHHHHHh----cC---
Q 011287          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE---WLIFQRIIA----RD---  271 (489)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~---~~~~~~i~~----~~---  271 (489)
                            .......++||+.|+|||++.+..++.++|||||||++|+|++|+.||.+...   ...+..+..    ..   
T Consensus       240 ------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~  313 (392)
T PHA03207        240 ------DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF  313 (392)
T ss_pred             ------ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcccc
Confidence                  11222356899999999999999999999999999999999999999976432   122222221    00   


Q ss_pred             ----------------------CCCC-----CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCccccc
Q 011287          272 ----------------------IRFP-----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR  323 (489)
Q Consensus       272 ----------------------~~~p-----~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~  323 (489)
                                            +..|     ..++.++.+||.+||..||++||++     .+++.||||....|+.++
T Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa-----~e~l~~p~f~~~~~~~~~  387 (392)
T PHA03207        314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSA-----QDILSLPLFTKEPINLLN  387 (392)
T ss_pred             CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCH-----HHHhhCchhhccchhhhc
Confidence                                  1111     1356789999999999999999999     899999999988887664

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.5e-44  Score=366.11  Aligned_cols=254  Identities=22%  Similarity=0.394  Sum_probs=211.6

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC-----
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT-----  117 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----  117 (489)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++.+.... ......+.+|+.+++.++||||++++++|...     
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccC-hHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            368999999999999999999999999999999998764322 23345566799999999999999999998643     


Q ss_pred             -CEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccC
Q 011287          118 -FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (489)
Q Consensus       118 -~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~  196 (489)
                       ..+|+||||+++ +|.+.+..  .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~  170 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence             357999999976 67777754  48999999999999999999999999999999999999999999999999997543


Q ss_pred             CccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC-----
Q 011287          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----  271 (489)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~-----  271 (489)
                      ..           .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+....     
T Consensus       171 ~~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (355)
T cd07874         171 TS-----------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP  239 (355)
T ss_pred             Cc-----------cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            21           12234679999999999999999999999999999999999999999877655443332210     


Q ss_pred             ----------------------CC---------------CCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          272 ----------------------IR---------------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       272 ----------------------~~---------------~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                                            ..               .+...+.++++||.+||+.||++|||+     .++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~-----~ell~hp~~  314 (355)
T cd07874         240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV-----DEALQHPYI  314 (355)
T ss_pred             HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCH-----HHHhcCcch
Confidence                                  00               112235678999999999999999999     899999999


Q ss_pred             CC
Q 011287          315 KG  316 (489)
Q Consensus       315 ~~  316 (489)
                      ..
T Consensus       315 ~~  316 (355)
T cd07874         315 NV  316 (355)
T ss_pred             hc
Confidence            74

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=4.9e-45  Score=354.04  Aligned_cols=252  Identities=38%  Similarity=0.675  Sum_probs=215.9

Q ss_pred             eEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEec
Q 011287           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALES  126 (489)
Q Consensus        47 y~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~  126 (489)
                      |++++.||+|+||+||+|++..+++.||+|++......... .....+|..++++++||||+++++++.+...+++||||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence            89999999999999999999999999999999876443333 22334599999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCC
Q 011287          127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNA  206 (489)
Q Consensus       127 ~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~  206 (489)
                      +.+++|.+++.+.+.+++..+..++.||+.||.+||++||+||||||+||+++.++.++|+|||.+..+..         
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~---------  150 (260)
T PF00069_consen   80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE---------  150 (260)
T ss_dssp             ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS---------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---------
Confidence            99999999999778899999999999999999999999999999999999999999999999999875411         


Q ss_pred             CCCCCccceecCCcCCChhhhc-CCCCCCCCcchhhhHHHHHHhhCCCCCCCCC---HHHHHHHHHhcCCCCC----CCC
Q 011287          207 ASDDKACTFVGTAAYVPPEVLN-SSPATFGNDLWALGCTLYQMLSGTSPFKDTS---EWLIFQRIIARDIRFP----NYF  278 (489)
Q Consensus       207 ~~~~~~~~~~gt~~Y~aPE~l~-~~~~~~~sDiwSLG~ilyelltG~~PF~~~~---~~~~~~~i~~~~~~~p----~~~  278 (489)
                       .........++..|+|||++. +..++.++|+||||+++|+|++|..||...+   ......+........+    ...
T Consensus       151 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (260)
T PF00069_consen  151 -NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREK  229 (260)
T ss_dssp             -TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTS
T ss_pred             -cccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchh
Confidence             122334567899999999998 7889999999999999999999999999873   3334444433222211    122


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       279 ~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                      +.++.++|.+||+.||++||++     .++++||||
T Consensus       230 ~~~l~~li~~~l~~~p~~R~~~-----~~l~~~~~~  260 (260)
T PF00069_consen  230 SEELRDLIKKMLSKDPEQRPSA-----EELLKHPWF  260 (260)
T ss_dssp             HHHHHHHHHHHSSSSGGGSTTH-----HHHHTSGGG
T ss_pred             HHHHHHHHHHHccCChhHCcCH-----HHHhcCCCC
Confidence            4899999999999999999998     999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2e-44  Score=364.41  Aligned_cols=251  Identities=29%  Similarity=0.476  Sum_probs=219.5

Q ss_pred             CCCCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcE-EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Q 011287           38 PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTV-YALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  116 (489)
Q Consensus        38 ~~~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~-vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  116 (489)
                      +.......+..+.+.||.|+||+||+|.+.  |.. ||+|++......... ...+.+|+.+|.+++|||||++++++.+
T Consensus        34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~  110 (362)
T KOG0192|consen   34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTS  110 (362)
T ss_pred             cceecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            444556678888889999999999999995  455 999999876544444 7789999999999999999999999998


Q ss_pred             CC-EEEEEEeccCCCChHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCC-cEeeccCCCCeeeCCCC-CEEEeeccC
Q 011287          117 TF-SLYMALESCEGGELFDQITS--KGHLSEDEARFYTAEVVDALEYIHSMG-LIHRDIKPENLLLTADG-HIKIADFGS  191 (489)
Q Consensus       117 ~~-~lylV~E~~~gg~L~~~l~~--~~~l~e~~~~~i~~qil~aL~~LH~~g-IiHrDLKpeNILl~~~g-~ikL~DFG~  191 (489)
                      .. .+.+||||+++|+|.+++.+  .+.++...+..++.||+.|++|||+++ ||||||||+|||++.++ ++||+|||+
T Consensus       111 ~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGl  190 (362)
T KOG0192|consen  111 PPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGL  190 (362)
T ss_pred             CCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcc
Confidence            87 79999999999999999988  578999999999999999999999999 99999999999999998 999999999


Q ss_pred             ccccCCccccccCCCCCCCCccceecCCcCCChhhhc--CCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHh
Q 011287          192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN--SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA  269 (489)
Q Consensus       192 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~--~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~  269 (489)
                      ++......          .......||..|||||++.  ...|+.++||||||+++|||+||+.||.+.........+..
T Consensus       191 sr~~~~~~----------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~  260 (362)
T KOG0192|consen  191 SREKVISK----------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVV  260 (362)
T ss_pred             ceeecccc----------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence            98654321          1222368999999999999  66899999999999999999999999999988666555543


Q ss_pred             --cCCCCCCCCCHHHHHHHHHhhccCCCCCCCCC
Q 011287          270 --RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAG  301 (489)
Q Consensus       270 --~~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~  301 (489)
                        ..+.+|..+++.+..|+.+|+..||.+||+..
T Consensus       261 ~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~  294 (362)
T KOG0192|consen  261 GGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFL  294 (362)
T ss_pred             cCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHH
Confidence              44667888999999999999999999999883

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-44  Score=349.21  Aligned_cols=254  Identities=40%  Similarity=0.701  Sum_probs=219.9

Q ss_pred             eEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHH-HhCCCCCccEEEEEEEcCCEEEEEEeccCC
Q 011287           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL-DQLDHPGVVRLFFTFQDTFSLYMALESCEG  129 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il-~~l~hpnIv~l~~~~~~~~~lylV~E~~~g  129 (489)
                      +.||.|+||.||+|.+..+|+.||+|++.+...........+..|..++ ...+||||+++++++.+...+|+||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5789999999999999999999999999765433333333344455444 455899999999999999999999999999


Q ss_pred             CChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCC
Q 011287          130 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  209 (489)
Q Consensus       130 g~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~  209 (489)
                      ++|.+++...+.+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++.....            
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------------  149 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------------  149 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------------
Confidence            99999999888899999999999999999999999999999999999999999999999999874321            


Q ss_pred             CCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCC----CCCCHHHHHH
Q 011287          210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----NYFSDAARDL  285 (489)
Q Consensus       210 ~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~L  285 (489)
                        .....|+..|+|||.+.+..++.++|+||||+++|+|++|.+||...+....+..+......++    ..+++.+.++
T Consensus       150 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (260)
T cd05611         150 --NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDL  227 (260)
T ss_pred             --cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHH
Confidence              2245688999999999888889999999999999999999999999888888777766554433    3578999999


Q ss_pred             HHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 011287          286 IDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (489)
Q Consensus       286 i~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~  320 (489)
                      |.+||+.||++||++.  ++++++.||||..++|+
T Consensus       228 i~~~l~~~p~~R~~~~--~~~~~l~~~~~~~~~~~  260 (260)
T cd05611         228 INRLLCMDPAKRLGAN--GYQEIKSHPFFKSINWD  260 (260)
T ss_pred             HHHHccCCHHHccCCC--cHHHHHcChHhhcCCCC
Confidence            9999999999999984  46899999999999995

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.9e-44  Score=352.45  Aligned_cols=269  Identities=49%  Similarity=0.873  Sum_probs=240.2

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~lylV  123 (489)
                      ++|++.+.||.|+||.||+|++..+|+.||+|++.+..+........+.+|..++++++ ||||+++++++.+...+|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            58999999999999999999999999999999998866666666677888999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      ||++++++|.+++.+.+.+++..+..++.|++.||.+||++|++|+||+|+||+++.+|+++|+|||++...........
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~  160 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES  160 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence            99999999999999988999999999999999999999999999999999999999999999999999987654331100


Q ss_pred             C----------CCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCC
Q 011287          204 P----------NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR  273 (489)
Q Consensus       204 ~----------~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~  273 (489)
                      .          ..........+.|+..|+|||++....++.++|+|||||+++++++|+.||...+....++.+......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~  240 (280)
T cd05581         161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYS  240 (280)
T ss_pred             CCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCC
Confidence            0          000113344668899999999998888999999999999999999999999999988888888888889


Q ss_pred             CCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          274 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       274 ~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                      +|..+++.+.+||++||+.||++||++.+ ++.++++||||
T Consensus       241 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~-~~~~ll~~~~~  280 (280)
T cd05581         241 FPPNFPPDAKDLIEKLLVLDPQDRLGVNE-GYDELKAHPFF  280 (280)
T ss_pred             CCCccCHHHHHHHHHHhcCCHhhCCCccc-CHHHHhcCCCC
Confidence            99999999999999999999999999965 67899999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.4e-44  Score=365.52  Aligned_cols=253  Identities=25%  Similarity=0.442  Sum_probs=211.3

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC------
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT------  117 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------  117 (489)
                      .++|++++.||+|+||.||+|.+..+++.||+|++.+.... ......+.+|+.+++.++||||++++++|...      
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS-LIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh-hHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            47899999999999999999999999999999998764322 22334466799999999999999999888643      


Q ss_pred             CEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCC
Q 011287          118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~  197 (489)
                      ...|++++++ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~  170 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD  170 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence            4579999998 6789877754 5799999999999999999999999999999999999999999999999999975432


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC-----
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----  271 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~-----  271 (489)
                                   ....++||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+....     
T Consensus       171 -------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  237 (343)
T cd07878         171 -------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP  237 (343)
T ss_pred             -------------CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence                         2235679999999999876 568899999999999999999999998877655554443210     


Q ss_pred             ------------------CCCC--------CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          272 ------------------IRFP--------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       272 ------------------~~~p--------~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                                        ...|        ...++.+.+||.+||+.||.+|||+     .++++||||...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~-----~ell~hp~~~~~  304 (343)
T cd07878         238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISA-----SEALAHPYFSQY  304 (343)
T ss_pred             HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCH-----HHHhcCcchhcc
Confidence                              0011        2356778999999999999999999     899999999864

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=8e-44  Score=354.83  Aligned_cols=258  Identities=23%  Similarity=0.406  Sum_probs=216.3

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lyl  122 (489)
                      .+++|++.+.||+|+||.||+|++..+++.||+|.+......  .....+.+|+.+++.++||||+++++++.+...+|+
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l   81 (301)
T cd07873           4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL   81 (301)
T ss_pred             cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence            478999999999999999999999999999999998654322  223346679999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccc
Q 011287          123 ALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~  201 (489)
                      ||||+. ++|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++.......  
T Consensus        82 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--  158 (301)
T cd07873          82 VFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--  158 (301)
T ss_pred             EEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--
Confidence            999997 4898888764 568999999999999999999999999999999999999999999999999987543211  


Q ss_pred             ccCCCCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc----------
Q 011287          202 VLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR----------  270 (489)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~----------  270 (489)
                              .......+++.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+....+...          
T Consensus       159 --------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  230 (301)
T cd07873         159 --------KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWP  230 (301)
T ss_pred             --------CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhch
Confidence                    112234678999999998654 4788999999999999999999999988766554443321          


Q ss_pred             ---------CCCCC-----------CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 011287          271 ---------DIRFP-----------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (489)
Q Consensus       271 ---------~~~~p-----------~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~  318 (489)
                               ...+|           ..+++.+++||.+||+.||.+|||+     +++++||||+.+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~-----~eil~h~~f~~~~  293 (301)
T cd07873         231 GILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISA-----EEAMKHPYFHCLG  293 (301)
T ss_pred             hhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCH-----HHHhcCccccccc
Confidence                     11112           2468899999999999999999998     8999999998654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-45  Score=345.64  Aligned_cols=251  Identities=32%  Similarity=0.523  Sum_probs=217.5

Q ss_pred             CCCCeEEe-eEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHH-hCCCCCccEEEEEEE----c
Q 011287           43 SIQDFELG-KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD-QLDHPGVVRLFFTFQ----D  116 (489)
Q Consensus        43 ~~~dy~~~-~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~-~l~hpnIv~l~~~~~----~  116 (489)
                      ..+||.+. .+||-|-.|.|..+.++.||+.||+|++.-.        ....+|+++.- .-.|||||+++++|+    .
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~  130 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQG  130 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence            45788765 5789999999999999999999999987422        23445766543 347999999998886    4


Q ss_pred             CCEEEEEEeccCCCChHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCC---CCEEEeeccC
Q 011287          117 TFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD---GHIKIADFGS  191 (489)
Q Consensus       117 ~~~lylV~E~~~gg~L~~~l~~~~~--l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~---g~ikL~DFG~  191 (489)
                      ..++.+|||.++||+|+..|+.+|.  |+|.++..++.||..|+.|||+.+|.||||||||+|...+   ..+||+|||+
T Consensus       131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccc
Confidence            5679999999999999999998876  9999999999999999999999999999999999999754   4799999999


Q ss_pred             ccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCH----HHHHHHH
Q 011287          192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRI  267 (489)
Q Consensus       192 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~----~~~~~~i  267 (489)
                      |+.-..           .....+.|-|+.|+|||++....|+..+|+||||||+|-||+|.+||....-    ..+..+|
T Consensus       211 AK~t~~-----------~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI  279 (400)
T KOG0604|consen  211 AKETQE-----------PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRI  279 (400)
T ss_pred             ccccCC-----------CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHh
Confidence            996432           2334567899999999999999999999999999999999999999976433    4577889


Q ss_pred             HhcCCCCCC----CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          268 IARDIRFPN----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       268 ~~~~~~~p~----~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                      ..+.+.||.    .+|.+++|+|++||..+|.+|+|+     .++++|||..+.
T Consensus       280 ~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI-----~~~m~hpwi~~~  328 (400)
T KOG0604|consen  280 RTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTI-----EEVMDHPWINQY  328 (400)
T ss_pred             hccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeH-----HHhhcCchhccc
Confidence            999999996    479999999999999999999999     889999999754

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.6e-43  Score=343.33  Aligned_cols=253  Identities=27%  Similarity=0.560  Sum_probs=220.3

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc-CCEEEEEE
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD-TFSLYMAL  124 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~lylV~  124 (489)
                      +|++.+.||+|++|.||+|+++.+++.||+|.+....... .....+.+|..+++.++|||++++++.+.. ...+|+||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASR-RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM   79 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence            5999999999999999999999999999999987543332 234457779999999999999999998864 45689999


Q ss_pred             eccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccc
Q 011287          125 ESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (489)
Q Consensus       125 E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~  202 (489)
                      ||+++++|.+++...  ..+++.++..++.|++.||.+||++|++||||||+||+++.++.++|+|||++..+....   
T Consensus        80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~---  156 (257)
T cd08223          80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC---  156 (257)
T ss_pred             cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC---
Confidence            999999999988763  458999999999999999999999999999999999999999999999999987653321   


Q ss_pred             cCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCHH
Q 011287          203 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-RFPNYFSDA  281 (489)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~-~~p~~~~~~  281 (489)
                             .......|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+..+.. ..|..++++
T Consensus       157 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (257)
T cd08223         157 -------DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPE  229 (257)
T ss_pred             -------CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHH
Confidence                   122355789999999999999899999999999999999999999998887776666666544 466778999


Q ss_pred             HHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       282 ~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                      +.+||.+||+.||++||++     .++++||||
T Consensus       230 ~~~li~~~l~~~p~~Rp~~-----~~~l~~~~~  257 (257)
T cd08223         230 LGELIATMLSKRPEKRPSV-----KSILRQPYI  257 (257)
T ss_pred             HHHHHHHHhccCcccCCCH-----HHHhcCCCC
Confidence            9999999999999999998     899999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.1e-43  Score=346.86  Aligned_cols=260  Identities=28%  Similarity=0.513  Sum_probs=224.1

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccch------hHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCE
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE------NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~------~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  119 (489)
                      +|.+++.||.|+||.||+|.+..+++.||+|.+........      .....+.+|+.+++.++||||+++++++.+...
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            47889999999999999999999999999999876543321      233567889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcc
Q 011287          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      .++||||+++++|.+++.+.+.+++..++.++.|++.||+|||++|++||||+|+||+++.++.++|+|||.++......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS  160 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence            99999999999999999988889999999999999999999999999999999999999999999999999998765321


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHh-cCCCCCCCC
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA-RDIRFPNYF  278 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~-~~~~~p~~~  278 (489)
                      ...    ........+.|+..|+|||.+.+..++.++|+|||||++|+|++|..||.+.+.......+.. ....+|..+
T Consensus       161 ~~~----~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd06628         161 LST----KTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNI  236 (267)
T ss_pred             ccC----CccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCccc
Confidence            110    001122345689999999999988899999999999999999999999998776555554443 344677889


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       279 ~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                      +..+.++|++||+.||.+||++     .++++||||
T Consensus       237 ~~~~~~li~~~l~~~p~~Rp~~-----~~il~~~~~  267 (267)
T cd06628         237 SSEAIDFLEKTFEIDHNKRPTA-----AELLKHPFL  267 (267)
T ss_pred             CHHHHHHHHHHccCCchhCcCH-----HHHhhCCCC
Confidence            9999999999999999999998     899999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=5.8e-44  Score=347.15  Aligned_cols=255  Identities=36%  Similarity=0.644  Sum_probs=227.2

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEe
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E  125 (489)
                      +|++.+.||.|+||.||+|++..+++.||+|++.+...........+.+|+.++++++||||+++++.+.+...+|+|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            58999999999999999999999999999999987655554566778889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCC
Q 011287          126 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  205 (489)
Q Consensus       126 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~  205 (489)
                      |+.|++|.+++.+.+.+++..+..++.||+.||.|||++|++|+||+|+||++++++.++|+|||.+.......      
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~------  154 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT------  154 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc------
Confidence            99999999999887789999999999999999999999999999999999999999999999999987653321      


Q ss_pred             CCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCC---HHHHHHHHHhcCCCCCCCCCHHH
Q 011287          206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS---EWLIFQRIIARDIRFPNYFSDAA  282 (489)
Q Consensus       206 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~---~~~~~~~i~~~~~~~p~~~~~~~  282 (489)
                           ......|+..|+|||.+....++.++|+|||||++|+|++|..||...+   ...+.+........+|..++.++
T Consensus       155 -----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (258)
T cd05578         155 -----LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEA  229 (258)
T ss_pred             -----cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHH
Confidence                 1224568889999999998889999999999999999999999998876   34444444446677888899999


Q ss_pred             HHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          283 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       283 ~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                      .++|.+||+.||.+||++.   ..++++||||
T Consensus       230 ~~~i~~~l~~~p~~R~~~~---~~~l~~~~~~  258 (258)
T cd05578         230 IDAINKLLERDPQKRLGDN---LKDLKNHPYF  258 (258)
T ss_pred             HHHHHHHccCChhHcCCcc---HHHHhcCCCC
Confidence            9999999999999999983   5789999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=8.6e-44  Score=352.93  Aligned_cols=261  Identities=31%  Similarity=0.525  Sum_probs=223.8

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      +.|++++.||.|+||.||+|++..+++.||+|++...   .......+.+|+.+++.++||||+++++.+......|+||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   88 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI   88 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence            5699999999999999999999999999999998654   3334566777999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          125 ESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       125 E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      ||+++++|..++.+ ...+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++......     
T Consensus        89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-----  163 (292)
T cd06644          89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-----  163 (292)
T ss_pred             ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc-----
Confidence            99999999887765 456899999999999999999999999999999999999999999999999988653221     


Q ss_pred             CCCCCCCCccceecCCcCCChhhhc-----CCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC---CCCC
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLN-----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRFP  275 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~-----~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~---~~~p  275 (489)
                           ........++..|+|||++.     ...++.++|+|||||++|+|++|.+||...+......++....   ...|
T Consensus       164 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  238 (292)
T cd06644         164 -----LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQP  238 (292)
T ss_pred             -----ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCC
Confidence                 11223557889999999984     3446788999999999999999999998877766655554432   2345


Q ss_pred             CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCccccc
Q 011287          276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR  323 (489)
Q Consensus       276 ~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~  323 (489)
                      ..++.++.++|.+||+.||++||++     .++++||||..++|....
T Consensus       239 ~~~~~~~~~li~~~l~~~p~~Rp~~-----~~il~~~~~~~~~~~~~~  281 (292)
T cd06644         239 SKWSMEFRDFLKTALDKHPETRPSA-----AQLLEHPFVSSVTSNRPL  281 (292)
T ss_pred             cccCHHHHHHHHHHhcCCcccCcCH-----HHHhcCccccccccchhH
Confidence            6788999999999999999999998     899999999999887643

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.1e-43  Score=345.04  Aligned_cols=263  Identities=42%  Similarity=0.720  Sum_probs=230.5

Q ss_pred             EeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEeccCCCCh
Q 011287           53 YGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL  132 (489)
Q Consensus        53 LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~~~gg~L  132 (489)
                      ||.|+||.||+|.+..+|+.||+|++.+...........+.+|..++++++||||+++++.+.+....|+||||+.+++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            68999999999999999999999999776554445667788899999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCCCCc
Q 011287          133 FDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA  212 (489)
Q Consensus       133 ~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~  212 (489)
                      .+++.+.+.+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++...........  .......
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~--~~~~~~~  158 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL--NDDEKED  158 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc--ccccccc
Confidence            99999888899999999999999999999999999999999999999999999999999875432211000  0001122


Q ss_pred             cceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCC--CHHHHHHHHHhh
Q 011287          213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF--SDAARDLIDRLL  290 (489)
Q Consensus       213 ~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~--~~~~~~Li~~~L  290 (489)
                      ....++..|+|||.+....++.++|+|||||++|+|++|..||........+..+......+|...  +..+.++|.+||
T Consensus       159 ~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  238 (265)
T cd05579         159 KRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLL  238 (265)
T ss_pred             cCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHh
Confidence            345788999999999888899999999999999999999999999998888888888777777766  999999999999


Q ss_pred             ccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 011287          291 DVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (489)
Q Consensus       291 ~~dP~~R~t~~~~~~~~l~~hpff~~i~~  319 (489)
                      +.+|.+||++.  .+.++++||||++++|
T Consensus       239 ~~~p~~Rpt~~--~~~~~l~~~~~~~~~~  265 (265)
T cd05579         239 VPDPEKRLGAK--SIEEIKNHPFFKGIDW  265 (265)
T ss_pred             cCCHhhcCCCc--cHHHHhcCccccCCCC
Confidence            99999999984  4688999999999998

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=6.1e-44  Score=361.65  Aligned_cols=249  Identities=24%  Similarity=0.394  Sum_probs=204.3

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEE-----cCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKK-----IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQ  115 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~-----~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~  115 (489)
                      +..++|++++.||+|+||.||+|.+     ..++..||+|++....  .......+.+|+.++..+ +||||+++++++.
T Consensus         4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (338)
T cd05102           4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACT   81 (338)
T ss_pred             cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence            4457999999999999999999985     2456789999986532  223345677899999999 8999999999887


Q ss_pred             cC-CEEEEEEeccCCCChHHHHHhC-------------------------------------------------------
Q 011287          116 DT-FSLYMALESCEGGELFDQITSK-------------------------------------------------------  139 (489)
Q Consensus       116 ~~-~~lylV~E~~~gg~L~~~l~~~-------------------------------------------------------  139 (489)
                      .. ..+|+|||||++|+|.+++...                                                       
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence            54 4689999999999999998753                                                       


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCCCCc
Q 011287          140 -------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA  212 (489)
Q Consensus       140 -------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~  212 (489)
                             ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......        ....
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~--------~~~~  233 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD--------YVRK  233 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcc--------hhcc
Confidence                   2377889999999999999999999999999999999999999999999999986532210        1112


Q ss_pred             cceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHH-HHHHhc-CCCCCCCCCHHHHHHHHHh
Q 011287          213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIF-QRIIAR-DIRFPNYFSDAARDLIDRL  289 (489)
Q Consensus       213 ~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~-~~i~~~-~~~~p~~~~~~~~~Li~~~  289 (489)
                      .+..++..|+|||++.+..++.++|||||||++|+|++ |..||.+......+ +.+... ....|...++++.+||.+|
T Consensus       234 ~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  313 (338)
T cd05102         234 GSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLAC  313 (338)
T ss_pred             cCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence            23456788999999999999999999999999999997 99999886543333 333332 3456778899999999999


Q ss_pred             hccCCCCCCCC
Q 011287          290 LDVDPSGRPGA  300 (489)
Q Consensus       290 L~~dP~~R~t~  300 (489)
                      |+.||.+||++
T Consensus       314 l~~dp~~RPs~  324 (338)
T cd05102         314 WQGDPKERPTF  324 (338)
T ss_pred             ccCChhhCcCH
Confidence            99999999998

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.2e-43  Score=353.18  Aligned_cols=253  Identities=28%  Similarity=0.468  Sum_probs=216.4

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      ++|++.+.||+|+||.||+|++..++..||+|.+....  .......+.+|+.+++.++||||+++++.|.+...+|+||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM   78 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence            47999999999999999999999999999999986542  2334556778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       125 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~-~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      ||+++++|.+++.+.+.+++..++.++.|++.||.|||+ .+++||||||+|||++.++.++|+|||++......     
T Consensus        79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-----  153 (308)
T cd06615          79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----  153 (308)
T ss_pred             eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-----
Confidence            999999999999988889999999999999999999997 69999999999999999999999999998654221     


Q ss_pred             CCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc-------------
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-------------  270 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~-------------  270 (489)
                             ....++|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...+.......+...             
T Consensus       154 -------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (308)
T cd06615         154 -------MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPV  226 (308)
T ss_pred             -------ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccc
Confidence                   123567899999999998888999999999999999999999999765543332222110             


Q ss_pred             ------------------------CCCCC-CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          271 ------------------------DIRFP-NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       271 ------------------------~~~~p-~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                                              ....| ..++.++++||.+||..||++||++     .++++||||.+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-----~~ll~~~~~~~  292 (308)
T cd06615         227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADL-----KELTKHPFIKR  292 (308)
T ss_pred             cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCH-----HHHhcChhhhh
Confidence                                    11112 1367889999999999999999998     89999999975

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=3.7e-43  Score=347.81  Aligned_cols=270  Identities=37%  Similarity=0.710  Sum_probs=231.1

Q ss_pred             CeEEeeEEeeeCceEEEEEEEc---CCCcEEEEEEeeccccc-chhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCEE
Q 011287           46 DFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFIT-KENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSL  120 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~---~tg~~vAiK~~~k~~~~-~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~l  120 (489)
                      +|++.+.||.|+||.||+|++.   .+|..||+|++...... .......+.+|+.+++.+ +|+||+++++.|+....+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            5899999999999999999985   47999999998764332 223345677899999999 699999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      |+||||+++++|.+++...+.+++..+..++.||+.||.|||+.|++||||+|+|||++.+++++|+|||++....... 
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-  159 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE-  159 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc-
Confidence            9999999999999999988889999999999999999999999999999999999999999999999999987653321 


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCC--CCCCCCcchhhhHHHHHHhhCCCCCCCCC----HHHHHHHHHhcCCCC
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSS--PATFGNDLWALGCTLYQMLSGTSPFKDTS----EWLIFQRIIARDIRF  274 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~--~~~~~sDiwSLG~ilyelltG~~PF~~~~----~~~~~~~i~~~~~~~  274 (489)
                              ........|+..|+|||.+...  .++.++|+|||||++|+|++|..||...+    ...+...+......+
T Consensus       160 --------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  231 (290)
T cd05613         160 --------VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY  231 (290)
T ss_pred             --------ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCC
Confidence                    1122356789999999998753  46788999999999999999999997432    344455555666778


Q ss_pred             CCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 011287          275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (489)
Q Consensus       275 p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~  324 (489)
                      |..+++.+.+|+++||+.||++||++......+++.||||..++|+.+..
T Consensus       232 ~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~  281 (290)
T cd05613         232 PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAA  281 (290)
T ss_pred             CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHHhh
Confidence            88899999999999999999999987766789999999999999988753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1e-43  Score=347.21  Aligned_cols=253  Identities=31%  Similarity=0.519  Sum_probs=215.4

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lyl  122 (489)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++....   ......+.+|..+++.++||||+++++.+.+...+|+
T Consensus         7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~l   83 (267)
T cd06645           7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWI   83 (267)
T ss_pred             cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Confidence            3468999999999999999999999999999999986542   2233456779999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccc
Q 011287          123 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~  202 (489)
                      ||||+++++|.+++...+.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..+....   
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~---  160 (267)
T cd06645          84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI---  160 (267)
T ss_pred             EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc---
Confidence            99999999999999888899999999999999999999999999999999999999999999999999987553211   


Q ss_pred             cCCCCCCCCccceecCCcCCChhhhc---CCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCC----
Q 011287          203 LPNAASDDKACTFVGTAAYVPPEVLN---SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----  275 (489)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~Y~aPE~l~---~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p----  275 (489)
                             .......|+..|+|||++.   ...++.++|+|||||++|+|++|..||...........+.......+    
T Consensus       161 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  233 (267)
T cd06645         161 -------AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKD  233 (267)
T ss_pred             -------cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccc
Confidence                   1223457899999999984   45588899999999999999999999976655443333333332222    


Q ss_pred             -CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCC
Q 011287          276 -NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF  313 (489)
Q Consensus       276 -~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpf  313 (489)
                       ..++..+.++|.+||+.||++||++     .++++|||
T Consensus       234 ~~~~~~~~~~li~~~l~~~P~~R~~~-----~~ll~~~~  267 (267)
T cd06645         234 KMKWSNSFHHFVKMALTKNPKKRPTA-----EKLLQHPF  267 (267)
T ss_pred             cCCCCHHHHHHHHHHccCCchhCcCH-----HHHhcCCC
Confidence             2467899999999999999999998     89999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=6.5e-43  Score=338.63  Aligned_cols=253  Identities=30%  Similarity=0.478  Sum_probs=223.7

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEe
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E  125 (489)
                      +|.+.+.||+|++|.||+|++..+++.|++|.+....... .....+.+|+.+++.++||||+++++.+.+....|+|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNR-REREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCH-HHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence            6899999999999999999999999999999987654433 344567789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          126 SCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       126 ~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++.+....    
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~----  155 (256)
T cd08529          80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT----  155 (256)
T ss_pred             eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc----
Confidence            99999999999764  568999999999999999999999999999999999999999999999999988654321    


Q ss_pred             CCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCHHH
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-RFPNYFSDAA  282 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~-~~p~~~~~~~  282 (489)
                            .......|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+.....+++..... .++..++..+
T Consensus       156 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (256)
T cd08529         156 ------NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQL  229 (256)
T ss_pred             ------chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHH
Confidence                  112345788999999999999999999999999999999999999999888777777766543 3555789999


Q ss_pred             HHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          283 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       283 ~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                      .++|++||+.+|++||++     .+++.|||.
T Consensus       230 ~~~i~~~l~~~p~~Rp~~-----~~ll~~~~~  256 (256)
T cd08529         230 AQLIDQCLTKDYRQRPDT-----FQLLRNPSL  256 (256)
T ss_pred             HHHHHHHccCCcccCcCH-----HHHhhCCCC
Confidence            999999999999999998     899999984

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-43  Score=347.91  Aligned_cols=257  Identities=30%  Similarity=0.534  Sum_probs=223.3

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      .++|++.+.||.|+||.||+|++..++..||+|++...   .......+..|+.+++.++||||+++++.+.+....|+|
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL   80 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence            36799999999999999999999989999999998643   334455677899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccc
Q 011287          124 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~  202 (489)
                      |||+++++|.+++.+. ..+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++......    
T Consensus        81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~----  156 (280)
T cd06611          81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST----  156 (280)
T ss_pred             eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc----
Confidence            9999999999998764 56999999999999999999999999999999999999999999999999988654321    


Q ss_pred             cCCCCCCCCccceecCCcCCChhhhc-----CCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC---CCC
Q 011287          203 LPNAASDDKACTFVGTAAYVPPEVLN-----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRF  274 (489)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~Y~aPE~l~-----~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~---~~~  274 (489)
                            ........|++.|+|||++.     ...++.++|+|||||++|+|++|++||.+.+......++....   +..
T Consensus       157 ------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  230 (280)
T cd06611         157 ------LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQ  230 (280)
T ss_pred             ------ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCC
Confidence                  12233567899999999985     3446788999999999999999999999888777666666543   334


Q ss_pred             CCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 011287          275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (489)
Q Consensus       275 p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~  318 (489)
                      |..++.++.++|.+||+.||.+||++     .++++||||....
T Consensus       231 ~~~~~~~~~~li~~~l~~~p~~Rps~-----~~il~~~~~~~~~  269 (280)
T cd06611         231 PSKWSSSFNDFLKSCLVKDPDDRPTA-----AELLKHPFVSDQS  269 (280)
T ss_pred             cccCCHHHHHHHHHHhccChhhCcCH-----HHHhcChhhcccc
Confidence            66789999999999999999999998     8999999998653

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.4e-43  Score=349.08  Aligned_cols=244  Identities=17%  Similarity=0.241  Sum_probs=212.5

Q ss_pred             CCCCCeEEe--eEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc---
Q 011287           42 FSIQDFELG--KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD---  116 (489)
Q Consensus        42 ~~~~dy~~~--~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---  116 (489)
                      +..+|++..  ..||+|++|.||+|..  +|+.||||++.+...........+.+|+.+|++++||||+++++++.+   
T Consensus        15 i~~~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~   92 (283)
T PHA02988         15 IESDDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD   92 (283)
T ss_pred             cCHHHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEeccc
Confidence            445556555  7899999999999998  789999999977644444445678899999999999999999999876   


Q ss_pred             -CCEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeeccCCCCeeeCCCCCEEEeeccCccc
Q 011287          117 -TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (489)
Q Consensus       117 -~~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~-~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~  194 (489)
                       ...+++||||+++|+|.+++.+.+.+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++.
T Consensus        93 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~  172 (283)
T PHA02988         93 DLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKI  172 (283)
T ss_pred             CCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhh
Confidence             45789999999999999999988889999999999999999999998 4999999999999999999999999999876


Q ss_pred             cCCccccccCCCCCCCCccceecCCcCCChhhhcC--CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc--
Q 011287          195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS--SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--  270 (489)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~--~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~--  270 (489)
                      +...             ....+|+..|+|||++.+  ..++.++|||||||++|+|++|..||.+.+..+++..+...  
T Consensus       173 ~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~  239 (283)
T PHA02988        173 LSSP-------------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNN  239 (283)
T ss_pred             hccc-------------cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC
Confidence            4321             123468899999999976  67899999999999999999999999999888888877654  


Q ss_pred             CCCCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          271 DIRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       271 ~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      .+.+|...++++++||.+||+.||++||++
T Consensus       240 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~  269 (283)
T PHA02988        240 SLKLPLDCPLEIKCIVEACTSHDSIKRPNI  269 (283)
T ss_pred             CCCCCCcCcHHHHHHHHHHhcCCcccCcCH
Confidence            345666789999999999999999999998

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=4.8e-43  Score=342.05  Aligned_cols=259  Identities=28%  Similarity=0.463  Sum_probs=220.0

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeeccccc---chhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEE
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lyl  122 (489)
                      +|.+++.||.|+||.||+|.+ .+|+.+|+|.+......   .......+.+|+.+++.++|+||+++++++.+....|+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            588999999999999999987 57899999998654221   22334568889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccc
Q 011287          123 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~  202 (489)
                      ||||+++++|.+++.+.+.+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++..........
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  159 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG  159 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence            99999999999999988889999999999999999999999999999999999999999999999999987653211110


Q ss_pred             cCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc---CCCCCCCCC
Q 011287          203 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFS  279 (489)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~---~~~~p~~~~  279 (489)
                          ..........|+..|+|||++.+..++.++|+|||||++|+|++|..||...+.......+...   ...+|..++
T Consensus       160 ----~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (265)
T cd06631         160 ----THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFS  235 (265)
T ss_pred             ----cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCC
Confidence                0011223457899999999999888999999999999999999999999877665544444332   245677899


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       280 ~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                      .++.++|++||+.+|++||++     .++++||||
T Consensus       236 ~~~~~~i~~~l~~~p~~Rp~~-----~~~l~~~~~  265 (265)
T cd06631         236 AAAIDFVTSCLTRDQHERPSA-----LQLLRHDFL  265 (265)
T ss_pred             HHHHHHHHHHhcCCcccCCCH-----HHHhcCCCC
Confidence            999999999999999999998     899999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.3e-43  Score=356.01  Aligned_cols=262  Identities=24%  Similarity=0.387  Sum_probs=211.7

Q ss_pred             EEeeEEeee--CceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEe
Q 011287           48 ELGKIYGVG--SYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (489)
Q Consensus        48 ~~~~~LG~G--~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E  125 (489)
                      +++++||+|  +|++||+++++.+|+.||+|.+..... .......+.+|+.+++.++||||++++++|.++...|+|||
T Consensus         1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   79 (327)
T cd08227           1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS   79 (327)
T ss_pred             ChhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe
Confidence            357889999  788999999999999999999876533 23445678889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          126 SCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       126 ~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      |+++|+|.+++...  +.+++..++.++.||+.||+|||++||+||||||+|||++.++.++++||+.+...........
T Consensus        80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~  159 (327)
T cd08227          80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR  159 (327)
T ss_pred             ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence            99999999999753  4599999999999999999999999999999999999999999999999987654322110000


Q ss_pred             CCCCCCCCccceecCCcCCChhhhcC--CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCC--------
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLNS--SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR--------  273 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~~--~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~--------  273 (489)
                         .........+++..|+|||++.+  ..++.++|||||||++|+|++|+.||..................        
T Consensus       160 ---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (327)
T cd08227         160 ---VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI  236 (327)
T ss_pred             ---ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence               00111123467888999999976  45889999999999999999999999876554433332221110        


Q ss_pred             --------------------------------------CCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 011287          274 --------------------------------------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (489)
Q Consensus       274 --------------------------------------~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~  315 (489)
                                                            +...+++++.+||.+||+.||++|||+     +++++||||+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~-----~ell~~p~f~  311 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSA-----STLLNHSFFK  311 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCH-----HHHhcChhhh
Confidence                                                  112356789999999999999999999     8999999998


Q ss_pred             CCC
Q 011287          316 GID  318 (489)
Q Consensus       316 ~i~  318 (489)
                      .+.
T Consensus       312 ~~~  314 (327)
T cd08227         312 QIK  314 (327)
T ss_pred             hcc
Confidence            654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=4.3e-43  Score=345.85  Aligned_cols=252  Identities=27%  Similarity=0.377  Sum_probs=210.2

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEe
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E  125 (489)
                      +|++.+.||+|++|.||+|++..++..||+|++..... .+.....+.+|+.+++.++||||+++++++.++..+|+|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence            69999999999999999999999999999999865422 22334567779999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccc
Q 011287          126 SCEGGELFDQITSK---GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (489)
Q Consensus       126 ~~~gg~L~~~l~~~---~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~  202 (489)
                      |++ ++|.+++...   +.+++..++.++.||+.||.|||++||+||||||+||+++.+|.++|+|||++.......   
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---  155 (285)
T cd07861          80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV---  155 (285)
T ss_pred             cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc---
Confidence            997 5888888653   469999999999999999999999999999999999999999999999999987543211   


Q ss_pred             cCCCCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC----------
Q 011287          203 LPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD----------  271 (489)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~----------  271 (489)
                             .......+++.|+|||++.+. .++.++|+|||||++|+|++|++||.+.+.......+....          
T Consensus       156 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (285)
T cd07861         156 -------RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPG  228 (285)
T ss_pred             -------ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhc
Confidence                   112234678899999998654 47889999999999999999999999876644333222100          


Q ss_pred             -------------------CCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          272 -------------------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       272 -------------------~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                                         ......+++++++||++||+.||++|||+     .++++||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~-----~~ll~~~~~  285 (285)
T cd07861         229 VTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISA-----KKALNHPYF  285 (285)
T ss_pred             chhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCH-----HHHhcCCCC
Confidence                               00123478999999999999999999998     899999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=9.2e-43  Score=340.29  Aligned_cols=259  Identities=29%  Similarity=0.499  Sum_probs=219.9

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeeccccc--chhHHHHHHHHHHHHHhCCCCCccEEEEEEEc--CCE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT--KENKTAYVKLERIVLDQLDHPGVVRLFFTFQD--TFS  119 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~  119 (489)
                      +.+|++.+.||+|+||.||.|.+..+|..||+|.+......  .......+.+|+.+++.++||||+++++.+.+  ...
T Consensus         1 ~~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   80 (265)
T cd06652           1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT   80 (265)
T ss_pred             CCcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence            36899999999999999999999999999999988643211  22345678889999999999999999999876  357


Q ss_pred             EEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcc
Q 011287          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      +|+||||+++++|.+++.+.+.+++..+..++.|++.||+|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~  160 (265)
T cd06652          81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC  160 (265)
T ss_pred             EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence            89999999999999999888889999999999999999999999999999999999999999999999999988653221


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc--CCCCCCC
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--DIRFPNY  277 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~--~~~~p~~  277 (489)
                      .       .........|+..|+|||++.+..++.++|+|||||++|+|++|+.||...........+...  ...+|..
T Consensus       161 ~-------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  233 (265)
T cd06652         161 L-------SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPH  233 (265)
T ss_pred             c-------cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchh
Confidence            0       011223456899999999998888999999999999999999999999887665555554432  3446677


Q ss_pred             CCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 011287          278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (489)
Q Consensus       278 ~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~  315 (489)
                      ++..+.++|++|+. +|++||++     ++++.|||+.
T Consensus       234 ~~~~~~~~i~~~l~-~p~~Rp~~-----~~il~~~~~~  265 (265)
T cd06652         234 VSDHCRDFLKRIFV-EAKLRPSA-----DELLRHTFVH  265 (265)
T ss_pred             hCHHHHHHHHHHhc-ChhhCCCH-----HHHhcCcccC
Confidence            88999999999995 99999998     8999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.8e-43  Score=353.32  Aligned_cols=247  Identities=27%  Similarity=0.400  Sum_probs=195.4

Q ss_pred             eeEEeeeCceEEEEEEEc--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc--CCEEEEEEe
Q 011287           50 GKIYGVGSYSKVVRAKKI--DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD--TFSLYMALE  125 (489)
Q Consensus        50 ~~~LG~G~~g~Vy~a~~~--~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~lylV~E  125 (489)
                      ++.||+|+||+||+|+++  .+++.||+|.+.....     ...+.+|+.+++.++||||++++++|.+  ...+|+|||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence            578999999999999975  4678999999865422     2345679999999999999999999854  467899999


Q ss_pred             ccCCCChHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeee----CCCCCEEEeeccCc
Q 011287          126 SCEGGELFDQITSK---------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL----TADGHIKIADFGSV  192 (489)
Q Consensus       126 ~~~gg~L~~~l~~~---------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl----~~~g~ikL~DFG~a  192 (489)
                      |+.+ +|.+++...         ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||++
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            9965 888887532         248999999999999999999999999999999999999    45679999999999


Q ss_pred             cccCCccccccCCCCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCCCHH---------H
Q 011287          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEW---------L  262 (489)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~~~~---------~  262 (489)
                      +.+....       .........+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+..+.         .
T Consensus       160 ~~~~~~~-------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~  232 (317)
T cd07868         160 RLFNSPL-------KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD  232 (317)
T ss_pred             eccCCCC-------ccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHH
Confidence            8654321       011223356899999999998764 5899999999999999999999999754321         1


Q ss_pred             HHHHHHhcC----------------------------CCC----------CCCCCHHHHHHHHHhhccCCCCCCCCCCCC
Q 011287          263 IFQRIIARD----------------------------IRF----------PNYFSDAARDLIDRLLDVDPSGRPGAGPGG  304 (489)
Q Consensus       263 ~~~~i~~~~----------------------------~~~----------p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~  304 (489)
                      .+..+....                            ...          ....+.++.+||.+||+.||.+|||+    
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~----  308 (317)
T cd07868         233 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS----  308 (317)
T ss_pred             HHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCH----
Confidence            122221100                            000          01135678999999999999999999    


Q ss_pred             HHHHhcCCCC
Q 011287          305 YAVLKMHPFF  314 (489)
Q Consensus       305 ~~~l~~hpff  314 (489)
                       +++++||||
T Consensus       309 -~e~l~hp~f  317 (317)
T cd07868         309 -EQAMQDPYF  317 (317)
T ss_pred             -HHHhcCCCC
Confidence             899999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=8e-43  Score=341.11  Aligned_cols=258  Identities=29%  Similarity=0.512  Sum_probs=218.8

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeeccccc--chhHHHHHHHHHHHHHhCCCCCccEEEEEEEc--CCEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT--KENKTAYVKLERIVLDQLDHPGVVRLFFTFQD--TFSL  120 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~l  120 (489)
                      .+|++.+.||+|+||.||+|.+..++..||+|.+......  .......+.+|+.+++.++||||+++++.+.+  ...+
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            5899999999999999999999999999999998754322  22344567889999999999999999998875  3678


Q ss_pred             EEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      |++|||+++++|.+++.+.+.+++..+..++.|++.||+|||++||+||||+|+||+++.++.++|+|||++..+.....
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM  161 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence            99999999999999998888899999999999999999999999999999999999999999999999999876532110


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc--CCCCCCCC
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--DIRFPNYF  278 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~--~~~~p~~~  278 (489)
                             .........++..|+|||.+.+..++.++|+|||||++|+|++|+.||...........+...  ...+|..+
T Consensus       162 -------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  234 (266)
T cd06651         162 -------SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHI  234 (266)
T ss_pred             -------cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhc
Confidence                   011112346889999999999888999999999999999999999999887665555444332  35567778


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 011287          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (489)
Q Consensus       279 ~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~  315 (489)
                      ++.++++| +||..+|++||++     +++++||||+
T Consensus       235 ~~~~~~li-~~~~~~p~~Rp~~-----~eil~hp~~~  265 (266)
T cd06651         235 SEHARDFL-GCIFVEARHRPSA-----EELLRHPFAQ  265 (266)
T ss_pred             CHHHHHHH-HHhcCChhhCcCH-----HHHhcCcccc
Confidence            99999999 5666899999998     8999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3.3e-43  Score=343.61  Aligned_cols=253  Identities=28%  Similarity=0.473  Sum_probs=214.5

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lyl  122 (489)
                      ..++|++++.||+|+||.||+|++..+++.||+|++....   ......+.+|+.+++.++||||+++++++.....+|+
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i   83 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI   83 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence            3578999999999999999999999999999999986542   2233457789999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccc
Q 011287          123 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~  202 (489)
                      ||||+++++|.+++.+.+.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++..+....   
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~---  160 (267)
T cd06646          84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI---  160 (267)
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc---
Confidence            99999999999999888889999999999999999999999999999999999999999999999999998653211   


Q ss_pred             cCCCCCCCCccceecCCcCCChhhhc---CCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCC-----
Q 011287          203 LPNAASDDKACTFVGTAAYVPPEVLN---SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF-----  274 (489)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~Y~aPE~l~---~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~-----  274 (489)
                             .......|+..|+|||.+.   ...++.++|+|||||++|+|++|..||...+.......+....+..     
T Consensus       161 -------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  233 (267)
T cd06646         161 -------AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKD  233 (267)
T ss_pred             -------cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCcc
Confidence                   1223457889999999984   3447789999999999999999999997665444333332222221     


Q ss_pred             CCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCC
Q 011287          275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF  313 (489)
Q Consensus       275 p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpf  313 (489)
                      +..++..+.+||++||+.||++||++     +++++|+|
T Consensus       234 ~~~~~~~~~~li~~~l~~~P~~Rp~~-----~~il~~l~  267 (267)
T cd06646         234 KTKWSSTFHNFVKISLTKNPKKRPTA-----ERLLTHLF  267 (267)
T ss_pred             ccccCHHHHHHHHHHhhCChhhCcCH-----HHHhcCCC
Confidence            23478999999999999999999998     88999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.2e-43  Score=343.40  Aligned_cols=259  Identities=26%  Similarity=0.481  Sum_probs=219.8

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccc---hhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEE
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK---ENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lyl  122 (489)
                      +|+.++.||+|+||.||+|.+..+++.||+|++.......   ......+.+|+.+++.++||||+++++++.+....++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            4889999999999999999999999999999987543221   2235678889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCC-CEEEeeccCccccCCcccc
Q 011287          123 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-HIKIADFGSVKPMQDSRIT  201 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g-~ikL~DFG~a~~~~~~~~~  201 (489)
                      ||||+++++|.+++.+.+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||.+..+......
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~  160 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG  160 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence            999999999999998888899999999999999999999999999999999999998876 5999999998876443110


Q ss_pred             ccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHH---H--hcCCCCCC
Q 011287          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI---I--ARDIRFPN  276 (489)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i---~--~~~~~~p~  276 (489)
                            .........|+..|+|||++.+..++.++|+|||||++|+|++|..||...........+   .  .....+|.
T Consensus       161 ------~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (268)
T cd06630         161 ------AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPE  234 (268)
T ss_pred             ------CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCch
Confidence                  011223457899999999998888999999999999999999999999754432222222   1  23355677


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~  315 (489)
                      .+++++.+++.+||+.||.+||++     .++++||||+
T Consensus       235 ~~~~~~~~~i~~~l~~~p~~R~~~-----~~ll~~~~~~  268 (268)
T cd06630         235 HLSPGLRDVTLRCLELQPEDRPPS-----RELLKHPVFR  268 (268)
T ss_pred             hhCHHHHHHHHHHcCCCcccCcCH-----HHHhcCcccC
Confidence            889999999999999999999999     8999999995

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3e-44  Score=381.28  Aligned_cols=252  Identities=30%  Similarity=0.511  Sum_probs=210.7

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccEEEEEE-E-----
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTF-Q-----  115 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~-~-----  115 (489)
                      .-.+++|.+.|.+|||+.||+|++...|..||+|.+-..   .+.....+.+|+.+|+.|. |+|||.+++.. .     
T Consensus        35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~  111 (738)
T KOG1989|consen   35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN  111 (738)
T ss_pred             CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence            445689999999999999999999988899999988543   6778889999999999995 99999999832 1     


Q ss_pred             c-CCEEEEEEeccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCC--cEeeccCCCCeeeCCCCCEEEeecc
Q 011287          116 D-TFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMG--LIHRDIKPENLLLTADGHIKIADFG  190 (489)
Q Consensus       116 ~-~~~lylV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~g--IiHrDLKpeNILl~~~g~ikL~DFG  190 (489)
                      . ...+++.||||.||.|.++++++  ..|+|.++..|++++++||.+||.++  |||||||-|||||+.+|++||||||
T Consensus       112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFG  191 (738)
T KOG1989|consen  112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFG  191 (738)
T ss_pred             CceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccc
Confidence            1 24588999999999999999854  56999999999999999999999998  9999999999999999999999999


Q ss_pred             CccccCCccccccCCCCCCCCccceecCCcCCChhhh---cCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHH
Q 011287          191 SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI  267 (489)
Q Consensus       191 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l---~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i  267 (489)
                      .|.......... .........-...-|+.|+|||++   .+.+.+.|+|||||||+||-|+....||+....    -.|
T Consensus       192 Satt~~~~~~~~-~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----laI  266 (738)
T KOG1989|consen  192 SATTKILSPTSA-QEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----LAI  266 (738)
T ss_pred             ccccccCCCccH-HHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----eeE
Confidence            987432211000 000000011123569999999997   577899999999999999999999999988754    367


Q ss_pred             HhcCCCCCC--CCCHHHHHHHHHhhccCCCCCCCCCC
Q 011287          268 IARDIRFPN--YFSDAARDLIDRLLDVDPSGRPGAGP  302 (489)
Q Consensus       268 ~~~~~~~p~--~~~~~~~~Li~~~L~~dP~~R~t~~~  302 (489)
                      +++.+.||+  .++..+++||+.||+.||++||++-+
T Consensus       267 lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Q  303 (738)
T KOG1989|consen  267 LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQ  303 (738)
T ss_pred             EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHH
Confidence            899999997  68999999999999999999999854

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=9e-43  Score=382.71  Aligned_cols=152  Identities=34%  Similarity=0.593  Sum_probs=142.3

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lyl  122 (489)
                      .+++|.+++.||+|+||.||+|.+..+++.||||++.+...........+..|+.+++.++||||++++.++.+...+|+
T Consensus         2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l   81 (669)
T cd05610           2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL   81 (669)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence            36899999999999999999999999999999999987655555566778889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccc
Q 011287          123 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~  194 (489)
                      ||||+.|++|.+++...+.+++..++.++.||+.||.|||.+||+||||||+||||+.+++++|+|||+++.
T Consensus        82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~  153 (669)
T cd05610          82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV  153 (669)
T ss_pred             EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence            999999999999998888899999999999999999999999999999999999999999999999999863

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=6.3e-43  Score=344.80  Aligned_cols=252  Identities=29%  Similarity=0.521  Sum_probs=217.9

Q ss_pred             eEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEec
Q 011287           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALES  126 (489)
Q Consensus        47 y~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~  126 (489)
                      |++.+.||.|+||.||+|++..++..+|+|.+...   .......+.+|+.+++.++||||+++++.+......|+||||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~   83 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   83 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence            68899999999999999999999999999998654   233445677799999999999999999999999999999999


Q ss_pred             cCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCC
Q 011287          127 CEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  205 (489)
Q Consensus       127 ~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~  205 (489)
                      +.+++|..++.+ .+.+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......       
T Consensus        84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~-------  156 (282)
T cd06643          84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-------  156 (282)
T ss_pred             cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc-------
Confidence            999999888765 467999999999999999999999999999999999999999999999999998754321       


Q ss_pred             CCCCCCccceecCCcCCChhhhc-----CCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC---CCCCCC
Q 011287          206 AASDDKACTFVGTAAYVPPEVLN-----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRFPNY  277 (489)
Q Consensus       206 ~~~~~~~~~~~gt~~Y~aPE~l~-----~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~---~~~p~~  277 (489)
                         ........|+..|+|||++.     +..++.++|+|||||++|+|++|.+||...+.......+....   ...|..
T Consensus       157 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd06643         157 ---IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSR  233 (282)
T ss_pred             ---ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccc
Confidence               11223457899999999984     3457789999999999999999999999888777666665432   335667


Q ss_pred             CCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       278 ~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      ++.++.+||.+||+.||.+||++     .++++||||..
T Consensus       234 ~~~~~~~li~~~l~~~p~~Rp~~-----~~il~~~~~~~  267 (282)
T cd06643         234 WSSEFKDFLKKCLEKNVDARWTT-----TQLLQHPFVTV  267 (282)
T ss_pred             cCHHHHHHHHHHccCChhhCcCH-----HHHhcCCCEec
Confidence            89999999999999999999998     89999999974

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.1e-42  Score=342.96  Aligned_cols=254  Identities=27%  Similarity=0.435  Sum_probs=213.9

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      ++|++.+.||+|+||.||+|+++.+|+.||+|++...... ......+.+|+.+++.++||||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   79 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF   79 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC-ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence            5799999999999999999999999999999998654322 223345677999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccC
Q 011287          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (489)
Q Consensus       125 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~  204 (489)
                      ||++++.|..++...+.+++..++.++.||+.||+|||+.|++||||||+||+++.++.++|+|||++.......     
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-----  154 (286)
T cd07847          80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG-----  154 (286)
T ss_pred             eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCc-----
Confidence            999998888877777789999999999999999999999999999999999999999999999999998654321     


Q ss_pred             CCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc-------------
Q 011287          205 NAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-------------  270 (489)
Q Consensus       205 ~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~-------------  270 (489)
                           .......++..|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+..+....+...             
T Consensus       155 -----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07847         155 -----DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFS  229 (286)
T ss_pred             -----ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcc
Confidence                 11224467889999999876 45788999999999999999999999987765544333210             


Q ss_pred             ------CCCCC------------CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          271 ------DIRFP------------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       271 ------~~~~p------------~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                            ....|            +.++..+.+||.+||+.||++||++     .+++.||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-----~eil~~~~f  286 (286)
T cd07847         230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSC-----EELLEHPYF  286 (286)
T ss_pred             cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCH-----HHHhcCCCC
Confidence                  00011            2467889999999999999999998     899999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.1e-42  Score=338.76  Aligned_cols=257  Identities=32%  Similarity=0.520  Sum_probs=222.0

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      ++|++++.||.|+||+||+|....++..+|+|++.......  ....+.+|+.+++.++|+||+++++.+.+....|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   78 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM   78 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence            58999999999999999999999999999999987654333  4567888999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccc
Q 011287          125 ESCEGGELFDQITSK---GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (489)
Q Consensus       125 E~~~gg~L~~~l~~~---~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~  201 (489)
                      |++++++|.+++...   +.+++..++.++.||+.||.|||++||+||||+|+||++++++.++|+|||++..+......
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR  158 (267)
T ss_pred             eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence            999999999999764   45899999999999999999999999999999999999999999999999998766543211


Q ss_pred             ccCCCCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC-CCC----
Q 011287          202 VLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-RFP----  275 (489)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~-~~p----  275 (489)
                            ........+|+..|+|||++... .++.++|+|||||++|+|++|..||...+....+.++..... .++    
T Consensus       159 ------~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (267)
T cd06610         159 ------TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGAD  232 (267)
T ss_pred             ------cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccc
Confidence                  01123456799999999999776 789999999999999999999999998877666666555432 122    


Q ss_pred             -CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          276 -NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       276 -~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                       ..+++++.++|.+||+.||++||++     .+++.||||
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rp~~-----~~ll~~p~~  267 (267)
T cd06610         233 YKKYSKSFRKMISLCLQKDPSKRPTA-----EELLKHKFF  267 (267)
T ss_pred             cccccHHHHHHHHHHcCCChhhCcCH-----HHHhhCCCC
Confidence             2568899999999999999999998     899999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.1e-42  Score=346.36  Aligned_cols=254  Identities=28%  Similarity=0.455  Sum_probs=219.6

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|.+.....   .....+.+|+.+++.+.||||+++++.|.+....|+|
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv   95 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence            3689999999999999999999999999999999876532   2345677899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      |||+++++|.+++.. +.+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.......    
T Consensus        96 ~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~----  170 (296)
T cd06654          96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ----  170 (296)
T ss_pred             ecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc----
Confidence            999999999998865 468999999999999999999999999999999999999999999999999987543221    


Q ss_pred             CCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc---CCCCCCCCCH
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFSD  280 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~---~~~~p~~~~~  280 (489)
                            .......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+.......+...   ....|..++.
T Consensus       171 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (296)
T cd06654         171 ------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA  244 (296)
T ss_pred             ------cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCH
Confidence                  1123457899999999999888999999999999999999999999887765443333322   2234567889


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       281 ~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      .+.+||.+||+.||++||++     .+++.||||..
T Consensus       245 ~l~~li~~~l~~~p~~Rpt~-----~eil~~~~~~~  275 (296)
T cd06654         245 IFRDFLNRCLDMDVEKRGSA-----KELLQHQFLKI  275 (296)
T ss_pred             HHHHHHHHHCcCCcccCcCH-----HHHhhChhhhc
Confidence            99999999999999999998     89999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=9.1e-43  Score=343.49  Aligned_cols=251  Identities=26%  Similarity=0.448  Sum_probs=212.7

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      ++|++.+.||+|+||.||+|++..+++.||+|++.+..  .......+.+|+.++++++||||+++++.+.+....++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT   78 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence            47999999999999999999999999999999987542  2233456778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccC
Q 011287          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (489)
Q Consensus       125 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~  204 (489)
                      ||+++++|..+    ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++..+...      
T Consensus        79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~------  148 (279)
T cd06619          79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS------  148 (279)
T ss_pred             ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc------
Confidence            99999998654    35899999999999999999999999999999999999999999999999998754321      


Q ss_pred             CCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCH-------HHHHHHHHhcC-CCC-C
Q 011287          205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE-------WLIFQRIIARD-IRF-P  275 (489)
Q Consensus       205 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~-------~~~~~~i~~~~-~~~-p  275 (489)
                            .....+||..|+|||++.+..++.++|+|||||++|+|++|..||.....       ....+.+.... ... .
T Consensus       149 ------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (279)
T cd06619         149 ------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPV  222 (279)
T ss_pred             ------cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCC
Confidence                  22345799999999999998899999999999999999999999965321       12233333222 222 2


Q ss_pred             CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 011287          276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (489)
Q Consensus       276 ~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~  318 (489)
                      ..+++++.+||.+||+.||++||++     ++++.||||...+
T Consensus       223 ~~~~~~~~~li~~~l~~~P~~Rp~~-----~eil~~~~~~~~~  260 (279)
T cd06619         223 GQFSEKFVHFITQCMRKQPKERPAP-----ENLMDHPFIVQYN  260 (279)
T ss_pred             CcCCHHHHHHHHHHhhCChhhCCCH-----HHHhcCccccccc
Confidence            3478899999999999999999988     8999999998654

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1e-42  Score=346.55  Aligned_cols=254  Identities=29%  Similarity=0.480  Sum_probs=221.7

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      .+|++++.||.|+||.||+|.+..+|+.||+|.+....   ......+.+|..+++.++||||+++++++.+...+|+|+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   95 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM   95 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence            57999999999999999999999999999999986542   233456778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccC
Q 011287          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (489)
Q Consensus       125 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~  204 (489)
                      ||+++++|..++.. ..+++.++..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.......     
T Consensus        96 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~-----  169 (296)
T cd06655          96 EYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ-----  169 (296)
T ss_pred             EecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccc-----
Confidence            99999999998875 469999999999999999999999999999999999999999999999999987643321     


Q ss_pred             CCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc---CCCCCCCCCHH
Q 011287          205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFSDA  281 (489)
Q Consensus       205 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~---~~~~p~~~~~~  281 (489)
                           .......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||.+.+.......+...   ....|..+++.
T Consensus       170 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (296)
T cd06655         170 -----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPI  244 (296)
T ss_pred             -----ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHH
Confidence                 1123457899999999999888999999999999999999999999988776655444433   23456678999


Q ss_pred             HHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       282 ~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                      +.+||++||..||++||++     .+++.||||+..
T Consensus       245 ~~~li~~~l~~dp~~Rpt~-----~~il~~~~~~~~  275 (296)
T cd06655         245 FRDFLNRCLEMDVEKRGSA-----KELLQHPFLKLA  275 (296)
T ss_pred             HHHHHHHHhhcChhhCCCH-----HHHhhChHhhhc
Confidence            9999999999999999998     899999999753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=9.1e-43  Score=344.70  Aligned_cols=269  Identities=39%  Similarity=0.723  Sum_probs=228.8

Q ss_pred             CeEEeeEEeeeCceEEEEEEEc---CCCcEEEEEEeeccccc-chhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCEE
Q 011287           46 DFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFIT-KENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSL  120 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~---~tg~~vAiK~~~k~~~~-~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~l  120 (489)
                      +|++.+.||+|+||.||+|++.   .++..||+|++.+.... .......+.+|..++.++ +||||+++++.+.....+
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            5899999999999999999864   46789999998764332 223345677899999999 699999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      |+||||+.+|+|.+++.+.+.+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++..+.... 
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  159 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE-  159 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc-
Confidence            9999999999999999887889999999999999999999999999999999999999999999999999987653221 


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCC--CCCCCcchhhhHHHHHHhhCCCCCCCCC----HHHHHHHHHhcCCCC
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSP--ATFGNDLWALGCTLYQMLSGTSPFKDTS----EWLIFQRIIARDIRF  274 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~--~~~~sDiwSLG~ilyelltG~~PF~~~~----~~~~~~~i~~~~~~~  274 (489)
                              ........|+..|+|||.+.+..  .+.++|+||||+++|+|++|..||...+    .....+.+.......
T Consensus       160 --------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd05583         160 --------EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPF  231 (288)
T ss_pred             --------ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCC
Confidence                    11223457899999999987655  7889999999999999999999996432    334445566666778


Q ss_pred             CCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC
Q 011287          275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  325 (489)
Q Consensus       275 p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~  325 (489)
                      |..++..+.++|.+||+.||++|||+.  ++.++++||||+.++|+.+...
T Consensus       232 ~~~~~~~l~~li~~~l~~~p~~R~t~~--~~~~~l~~~~~~~~~~~~~~~~  280 (288)
T cd05583         232 PKTMSAEARDFIQKLLEKDPKKRLGAN--GADEIKNHPFFQGIDWDDLAAK  280 (288)
T ss_pred             CcccCHHHHHHHHHHhcCCHhhccCcc--hHHHHhcCcccccCCHHHHhhh
Confidence            888999999999999999999999984  4688999999999999877543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-43  Score=343.04  Aligned_cols=256  Identities=32%  Similarity=0.511  Sum_probs=224.2

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      ++|++.+.||.|+||.||+|++..+++.||+|++....  .......+.+|+.+++.++||||+++++.+.+...+|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM   78 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence            47999999999999999999999999999999987553  1233455778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccC
Q 011287          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (489)
Q Consensus       125 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~  204 (489)
                      ||+++++|.+++... .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||+++.+....     
T Consensus        79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-----  152 (274)
T cd06609          79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-----  152 (274)
T ss_pred             EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc-----
Confidence            999999999999875 79999999999999999999999999999999999999999999999999998764321     


Q ss_pred             CCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC-CCCCCC-CCHHH
Q 011287          205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-IRFPNY-FSDAA  282 (489)
Q Consensus       205 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~-~~~p~~-~~~~~  282 (489)
                           .......|++.|+|||.+.+..++.++|+|||||++|+|++|.+||...+.......+.... ..++.. ++.++
T Consensus       153 -----~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (274)
T cd06609         153 -----SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPF  227 (274)
T ss_pred             -----cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHH
Confidence                 12234578899999999998889999999999999999999999998877766665555443 334444 88999


Q ss_pred             HHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 011287          283 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (489)
Q Consensus       283 ~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~  318 (489)
                      .++|.+||..||++||++     +++++||||.+..
T Consensus       228 ~~~l~~~l~~~p~~Rpt~-----~~il~~~~~~~~~  258 (274)
T cd06609         228 KDFVSLCLNKDPKERPSA-----KELLKHKFIKKAK  258 (274)
T ss_pred             HHHHHHHhhCChhhCcCH-----HHHhhChhhcCCC
Confidence            999999999999999998     8999999998654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.5e-43  Score=359.40  Aligned_cols=250  Identities=26%  Similarity=0.394  Sum_probs=203.8

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ly  121 (489)
                      ....+|++++.||+|+||.||+|++..++..||+|+..+..         ...|..+++.++||||+++++++.+....|
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  133 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITC  133 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeE
Confidence            44568999999999999999999999999999999854331         235889999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          122 MALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      +|||++. ++|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.....  
T Consensus       134 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--  210 (357)
T PHA03209        134 MVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--  210 (357)
T ss_pred             EEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence            9999996 588888865 456999999999999999999999999999999999999999999999999998743211  


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCC-CCCCCH---------HHHHHHHHhc
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP-FKDTSE---------WLIFQRIIAR  270 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~P-F~~~~~---------~~~~~~i~~~  270 (489)
                               .......||..|+|||++.+..++.++|||||||++|+|+++..| |.....         ...+..+...
T Consensus       211 ---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~  281 (357)
T PHA03209        211 ---------PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIIST  281 (357)
T ss_pred             ---------cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHH
Confidence                     122346799999999999999999999999999999999985444 443211         0111111110


Q ss_pred             ----CCCCC------------------------------CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          271 ----DIRFP------------------------------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       271 ----~~~~p------------------------------~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                          ...+|                              ..++.++.+||.+||+.||++|||+     .++++||||+.
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta-----~e~l~hp~f~~  356 (357)
T PHA03209        282 LKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSA-----EEILNYPMFAQ  356 (357)
T ss_pred             hccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCH-----HHHhcCchhcc
Confidence                11111                              1356778899999999999999999     89999999985


Q ss_pred             C
Q 011287          317 I  317 (489)
Q Consensus       317 i  317 (489)
                      +
T Consensus       357 ~  357 (357)
T PHA03209        357 L  357 (357)
T ss_pred             C
Confidence            3

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.3e-42  Score=343.97  Aligned_cols=266  Identities=22%  Similarity=0.326  Sum_probs=218.6

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKID-----TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~-----tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  117 (489)
                      ..++|++.+.||+|+||.||+|..+.     .+..||+|.+.....  ......+.+|..+++.++||||+++++++.+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVSKG   81 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            45789999999999999999997652     356899998864421  22233466799999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEe
Q 011287          118 FSLYMALESCEGGELFDQITSKG----------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIA  187 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~~----------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~  187 (489)
                      ...|+||||+.+|+|.+++.+.+          .++...+..++.||+.||.|||++||+||||||+||+++.++.++|+
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~  161 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG  161 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence            99999999999999999997532          34677889999999999999999999999999999999999999999


Q ss_pred             eccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHH
Q 011287          188 DFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQR  266 (489)
Q Consensus       188 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~  266 (489)
                      |||+++.......        ........++..|+|||.+.+..++.++|+|||||++|+|++ |.+||.+.+..+....
T Consensus       162 Dfg~~~~~~~~~~--------~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~  233 (288)
T cd05061         162 DFGMTRDIYETDY--------YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF  233 (288)
T ss_pred             cCCcccccccccc--------ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            9999875432211        011122345678999999998889999999999999999998 8999998887777776


Q ss_pred             HHhc-CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc--CCCCCCCCc
Q 011287          267 IIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM--HPFFKGIDW  319 (489)
Q Consensus       267 i~~~-~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~--hpff~~i~~  319 (489)
                      +... ...+|...++.+.+++.+||+.||++||++.+ -.+.+.+  ||+|.+++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~-ll~~l~~~~~~~~~~~~~  288 (288)
T cd05061         234 VMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLE-IVNLLKDDLHPSFPEVSF  288 (288)
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHH-HHHHHHhhcCCCCCCCCC
Confidence            6654 34567778999999999999999999999843 1122222  999999998

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-45  Score=369.23  Aligned_cols=257  Identities=31%  Similarity=0.521  Sum_probs=229.8

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEe
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E  125 (489)
                      -++|+..||.|+||.||+|.+++++-.-|.|++...   .+...+...-|+.+|..++||+||+|++.|-.++.++++.|
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE  109 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE  109 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence            368999999999999999999999999999999754   34455566669999999999999999999988899999999


Q ss_pred             ccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccC
Q 011287          126 SCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (489)
Q Consensus       126 ~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~  204 (489)
                      ||.||-+...+..- ..|++.+++.+++|++.||.|||+++|||||||..|||++.+|.|+|+|||.+.....       
T Consensus       110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-------  182 (1187)
T KOG0579|consen  110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-------  182 (1187)
T ss_pred             ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh-------
Confidence            99999988877664 4599999999999999999999999999999999999999999999999998764322       


Q ss_pred             CCCCCCCccceecCCcCCChhhh-----cCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCC---CCC
Q 011287          205 NAASDDKACTFVGTAAYVPPEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR---FPN  276 (489)
Q Consensus       205 ~~~~~~~~~~~~gt~~Y~aPE~l-----~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~---~p~  276 (489)
                         ...+..+|.|||.|||||+.     .+.+|+.++||||||++|.+|..+.+|....+....+-+|-+..++   -|.
T Consensus       183 ---t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS  259 (1187)
T KOG0579|consen  183 ---TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPS  259 (1187)
T ss_pred             ---HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcc
Confidence               23455689999999999986     5678999999999999999999999999999999999998876654   477


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~  320 (489)
                      .++..+.|++.+||.+||..||++     ++|++||||.+++-.
T Consensus       260 ~Ws~~F~DfLk~cL~Knp~~Rp~a-----aqll~Hpfv~~~~Sn  298 (1187)
T KOG0579|consen  260 HWSRSFSDFLKRCLVKNPRNRPPA-----AQLLKHPFVQNAPSN  298 (1187)
T ss_pred             hhhhHHHHHHHHHHhcCCccCCCH-----HHHhhCcccccCCcc
Confidence            899999999999999999999999     899999999977643

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.1e-42  Score=335.60  Aligned_cols=253  Identities=28%  Similarity=0.539  Sum_probs=223.2

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEe
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E  125 (489)
                      +|++.+.||+|+||.||++++..+|+.||+|.+....... .....+.+|+.+++.++||||+++++++.+....|+|||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence            5899999999999999999999999999999987643332 234567789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          126 SCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       126 ~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      |+.+++|.+++...  ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......    
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~----  155 (256)
T cd08218          80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV----  155 (256)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch----
Confidence            99999999998764  258999999999999999999999999999999999999999999999999987653321    


Q ss_pred             CCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCHHH
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-RFPNYFSDAA  282 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~-~~p~~~~~~~  282 (489)
                            .......|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+..+.. ..|..++.++
T Consensus       156 ------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (256)
T cd08218         156 ------ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDL  229 (256)
T ss_pred             ------hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHH
Confidence                  112245688999999999988899999999999999999999999998888877777766554 4677889999


Q ss_pred             HHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          283 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       283 ~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                      .++|.+||+.+|.+||++     .++++||||
T Consensus       230 ~~li~~~l~~~p~~Rp~~-----~~vl~~~~~  256 (256)
T cd08218         230 RNLVSQLFKRNPRDRPSV-----NSILEKNFI  256 (256)
T ss_pred             HHHHHHHhhCChhhCcCH-----HHHhhCcCC
Confidence            999999999999999998     899999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-42  Score=336.71  Aligned_cols=252  Identities=32%  Similarity=0.514  Sum_probs=219.3

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      .++|++.+.||.|+||.||+|.+..+++.+|+|++....   ......+.+|..+++.++||||+++++.+.+...+|++
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~   78 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV   78 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence            378999999999999999999999999999999997542   22456788899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccc
Q 011287          124 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~  202 (489)
                      |||+.+++|.+++... ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++.......   
T Consensus        79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~---  155 (262)
T cd06613          79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI---  155 (262)
T ss_pred             EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh---
Confidence            9999999999999876 789999999999999999999999999999999999999999999999999987643211   


Q ss_pred             cCCCCCCCCccceecCCcCCChhhhcCC---CCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCC-----C
Q 011287          203 LPNAASDDKACTFVGTAAYVPPEVLNSS---PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR-----F  274 (489)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~---~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~-----~  274 (489)
                             .......++..|+|||++...   .++.++|+|||||++|+|++|.+||.+.+.......+....+.     .
T Consensus       156 -------~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  228 (262)
T cd06613         156 -------AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKD  228 (262)
T ss_pred             -------hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccc
Confidence                   122345789999999999776   7889999999999999999999999988766655555444222     2


Q ss_pred             CCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCC
Q 011287          275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF  313 (489)
Q Consensus       275 p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpf  313 (489)
                      +..++.++.+||++||..||.+||++     .+++.|+|
T Consensus       229 ~~~~~~~~~~li~~~l~~~p~~Rpt~-----~~il~~~~  262 (262)
T cd06613         229 KEKWSPVFHDFIKKCLTKDPKKRPTA-----TKLLQHPF  262 (262)
T ss_pred             hhhhhHHHHHHHHHHcCCChhhCCCH-----HHHhcCCC
Confidence            34567889999999999999999998     89999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.1e-42  Score=383.59  Aligned_cols=262  Identities=28%  Similarity=0.467  Sum_probs=219.6

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc--CC
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD--TF  118 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~  118 (489)
                      ...+++|++++.||+|+||+||+|++..++..||+|++...... ......+..|+.+|+.|+|||||+++++|.+  ..
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~   87 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ   87 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence            34568999999999999999999999999999999999765433 3344567789999999999999999998854  45


Q ss_pred             EEEEEEeccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-------CcEeeccCCCCeeeCC-------
Q 011287          119 SLYMALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSM-------GLIHRDIKPENLLLTA-------  180 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~aL~~LH~~-------gIiHrDLKpeNILl~~-------  180 (489)
                      .+|+|||||.+|+|.++|..    .+.+++..++.|+.||+.||.|||+.       +|+||||||+||||+.       
T Consensus        88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence            79999999999999999875    25799999999999999999999985       4999999999999964       


Q ss_pred             ----------CCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcC--CCCCCCCcchhhhHHHHHH
Q 011287          181 ----------DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS--SPATFGNDLWALGCTLYQM  248 (489)
Q Consensus       181 ----------~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~--~~~~~~sDiwSLG~ilyel  248 (489)
                                .+.+||+|||++..+...           ......+||+.|+|||++.+  ..++.++||||||||||+|
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~-----------s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYEL  236 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIE-----------SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL  236 (1021)
T ss_pred             ccccccccCCCCceEEccCCcccccccc-----------ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHH
Confidence                      235899999999765322           12235579999999999864  4588999999999999999


Q ss_pred             hhCCCCCCCCCHHHHHHHHHhcCCCCC-CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 011287          249 LSGTSPFKDTSEWLIFQRIIARDIRFP-NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (489)
Q Consensus       249 ltG~~PF~~~~~~~~~~~i~~~~~~~p-~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~  319 (489)
                      ++|..||...+....+..++.....+| ...+.++.+||..||+.+|.+||++     .+++.||||..+..
T Consensus       237 LTGk~PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa-----~QlL~h~~ik~i~~  303 (1021)
T PTZ00266        237 CSGKTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSA-----LQCLGYQIIKNVGP  303 (1021)
T ss_pred             HHCCCCCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCH-----HHHhccHHHhhcCC
Confidence            999999987766555544444444444 4578999999999999999999998     88999999987653

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=4.3e-43  Score=345.87  Aligned_cols=252  Identities=27%  Similarity=0.434  Sum_probs=208.3

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEe
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E  125 (489)
                      +|++.+.||+|+||.||+|++..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.+...+|+|+|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence            58999999999999999999999999999999875432 22233456679999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccC
Q 011287          126 SCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (489)
Q Consensus       126 ~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~  204 (489)
                      |+.+ +|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||+++.+....     
T Consensus        80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-----  153 (284)
T cd07839          80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-----  153 (284)
T ss_pred             cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC-----
Confidence            9975 88887765 4679999999999999999999999999999999999999999999999999987543211     


Q ss_pred             CCCCCCCccceecCCcCCChhhhcCCC-CCCCCcchhhhHHHHHHhhCCCCC-CCCCHHHHHHHHHhcC-----------
Q 011287          205 NAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPF-KDTSEWLIFQRIIARD-----------  271 (489)
Q Consensus       205 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~-~~~~sDiwSLG~ilyelltG~~PF-~~~~~~~~~~~i~~~~-----------  271 (489)
                           .......++..|+|||++.+.. ++.++|+|||||++|+|++|..|| .+.+....+..+....           
T Consensus       154 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (284)
T cd07839         154 -----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGV  228 (284)
T ss_pred             -----CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHh
Confidence                 1122346789999999987644 788999999999999999988875 5555444444432210           


Q ss_pred             ------C------------CCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          272 ------I------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       272 ------~------------~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                            .            .....+++++++||++||+.||.+|||+     ++++.||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~-----~~il~h~~f  284 (284)
T cd07839         229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISA-----EEALQHPYF  284 (284)
T ss_pred             hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCH-----HHHhcCCCC
Confidence                  0            0112468899999999999999999998     899999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.5e-42  Score=333.28  Aligned_cols=253  Identities=28%  Similarity=0.532  Sum_probs=223.9

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEe
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E  125 (489)
                      +|++.+.||.|+||.||.+++..+++.+++|.+........ ....+.+|+.++++++|+||+++++++.+...++++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK-ERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchh-HHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence            59999999999999999999999999999999876544333 34456789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          126 SCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       126 ~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      |+++++|.+++.+.  ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++.......    
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~----  155 (256)
T cd08221          80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY----  155 (256)
T ss_pred             ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc----
Confidence            99999999999775  468999999999999999999999999999999999999999999999999987653322    


Q ss_pred             CCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCC-CCCCCCHHH
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR-FPNYFSDAA  282 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~-~p~~~~~~~  282 (489)
                            .......|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+....+..+.+. .+..++.++
T Consensus       156 ------~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (256)
T cd08221         156 ------SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSEL  229 (256)
T ss_pred             ------ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHH
Confidence                  1223457899999999998888899999999999999999999999998888888777765543 345689999


Q ss_pred             HHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          283 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       283 ~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                      .++|.+||+.||.+||++     .++++|||+
T Consensus       230 ~~~i~~~l~~~p~~R~s~-----~~ll~~~~l  256 (256)
T cd08221         230 ISLVHSLLQQDPEKRPTA-----DEVLDQPLL  256 (256)
T ss_pred             HHHHHHHcccCcccCCCH-----HHHhhCcCC
Confidence            999999999999999998     899999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=9.2e-43  Score=344.11  Aligned_cols=254  Identities=29%  Similarity=0.468  Sum_probs=216.5

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      ++|++++.||+|+||.||+|++..+|..||+|.+....  .......+.+|+.++++++||||+++++.+.....+|+||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM   78 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence            57999999999999999999999999999999886532  2333456778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh-CCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          125 ESCEGGELFDQITSK---GHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       125 E~~~gg~L~~~l~~~---~~l~e~~~~~i~~qil~aL~~LH~-~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      ||+++++|..++...   +.+++..++.++.||+.||.|||+ .||+||||||+||+++.++.++|+|||++..+...  
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  156 (286)
T cd06622          79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--  156 (286)
T ss_pred             eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence            999999999988763   379999999999999999999997 59999999999999999999999999998754321  


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCC------CCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHH---HHHhc-
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSP------ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQ---RIIAR-  270 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~------~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~---~i~~~-  270 (489)
                                ......|+..|+|||.+.+..      ++.++|+|||||++|+|++|..||........+.   .+... 
T Consensus       157 ----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  226 (286)
T cd06622         157 ----------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD  226 (286)
T ss_pred             ----------ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcC
Confidence                      122346888999999985543      4789999999999999999999997765544333   33332 


Q ss_pred             CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          271 DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       271 ~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                      ...+|..++.++.+||.+||+.+|++||++     .++++||||...
T Consensus       227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-----~~l~~~~~~~~~  268 (286)
T cd06622         227 PPTLPSGYSDDAQDFVAKCLNKIPNRRPTY-----AQLLEHPWLVKY  268 (286)
T ss_pred             CCCCCcccCHHHHHHHHHHcccCcccCCCH-----HHHhcChhhhhc
Confidence            345677799999999999999999999998     899999999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.1e-42  Score=346.39  Aligned_cols=254  Identities=29%  Similarity=0.468  Sum_probs=219.1

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      ..+|++++.||+|+||.||+|.+..+++.||+|.+....   ......+.+|..+++.++||||+++++.|......|+|
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   94 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   94 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc---cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence            378999999999999999999999999999999986542   22345677899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      |||+++++|.+++.+ ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++.......    
T Consensus        95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~----  169 (297)
T cd06656          95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ----  169 (297)
T ss_pred             ecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc----
Confidence            999999999999875 468999999999999999999999999999999999999999999999999987543321    


Q ss_pred             CCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc---CCCCCCCCCH
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFSD  280 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~---~~~~p~~~~~  280 (489)
                            .......|++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+.......+...   ....|..++.
T Consensus       170 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (297)
T cd06656         170 ------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSA  243 (297)
T ss_pred             ------cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCH
Confidence                  1123456889999999999988999999999999999999999999877654433222221   2235667889


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       281 ~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      .+++||.+||..||++||++     +++++||||+.
T Consensus       244 ~~~~li~~~l~~~p~~Rps~-----~~il~~~~~~~  274 (297)
T cd06656         244 VFRDFLNRCLEMDVDRRGSA-----KELLQHPFLKL  274 (297)
T ss_pred             HHHHHHHHHccCChhhCcCH-----HHHhcCchhcc
Confidence            99999999999999999998     89999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3.5e-42  Score=334.02  Aligned_cols=248  Identities=28%  Similarity=0.575  Sum_probs=217.2

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEe
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E  125 (489)
                      +|++.+.||+|+||.||++++..+++.||+|.+.....  ......+..|..+++.++||||+++++.+.+...+|+|||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME   78 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            68999999999999999999999999999999865422  2334567779999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          126 SCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       126 ~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      |+++|+|.+++...  ..+++..+..++.||+.||.|||++||+|+||||+||++++++.++|+|||.+..+....    
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~----  154 (255)
T cd08219          79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG----  154 (255)
T ss_pred             eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc----
Confidence            99999999988653  458999999999999999999999999999999999999999999999999987653321    


Q ss_pred             CCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCHHH
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-RFPNYFSDAA  282 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~-~~p~~~~~~~  282 (489)
                            .......|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+..... .+|..++..+
T Consensus       155 ------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (255)
T cd08219         155 ------AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYEL  228 (255)
T ss_pred             ------cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHH
Confidence                  122346789999999999988899999999999999999999999998887777777766544 3677789999


Q ss_pred             HHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          283 RDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       283 ~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      .+||.+||+.||++||++     .+++.
T Consensus       229 ~~li~~~l~~~P~~Rp~~-----~~il~  251 (255)
T cd08219         229 RSLIKQMFKRNPRSRPSA-----TTILS  251 (255)
T ss_pred             HHHHHHHHhCCcccCCCH-----HHHhh
Confidence            999999999999999998     66764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.9e-42  Score=344.00  Aligned_cols=258  Identities=30%  Similarity=0.426  Sum_probs=215.3

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC--CEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT--FSL  120 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~l  120 (489)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++....... .......+|+.+++.++|+||+++++++.+.  ..+
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI   83 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence            4689999999999999999999999999999999986543222 2223455699999999999999999999765  568


Q ss_pred             EEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcc
Q 011287          121 YMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      |+||||+.+ +|.+++... ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++..+....
T Consensus        84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~  162 (309)
T cd07845          84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA  162 (309)
T ss_pred             EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence            999999975 888888763 679999999999999999999999999999999999999999999999999998654321


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc--------
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--------  270 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~--------  270 (489)
                                .......+++.|+|||++.+ ..++.++|+|||||++|+|++|++||.+.+....+..+...        
T Consensus       163 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  232 (309)
T cd07845         163 ----------KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESI  232 (309)
T ss_pred             ----------CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence                      11122345788999999865 45789999999999999999999999998888777666541        


Q ss_pred             -----------CCCCC-----------CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          271 -----------DIRFP-----------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       271 -----------~~~~p-----------~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                                 .+.++           ..+++++.+||.+||+.||++||++     .+++.||||++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~-----~~il~h~~f~~~  296 (309)
T cd07845         233 WPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATA-----EEALESSYFKEK  296 (309)
T ss_pred             chhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCH-----HHHhcChhhccC
Confidence                       11111           1258899999999999999999998     899999999853

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.2e-42  Score=339.58  Aligned_cols=254  Identities=30%  Similarity=0.467  Sum_probs=215.9

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEe
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E  125 (489)
                      +|++.+.||+|+||.||+|++..+|..||+|++....... .....+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc-hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence            6899999999999999999999999999999997654322 334567789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccC
Q 011287          126 SCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (489)
Q Consensus       126 ~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~  204 (489)
                      |+ +++|.+++... ..+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||.+.......     
T Consensus        80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~-----  153 (286)
T cd07832          80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE-----  153 (286)
T ss_pred             cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC-----
Confidence            99 99999998653 569999999999999999999999999999999999999999999999999988654321     


Q ss_pred             CCCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC------------
Q 011287          205 NAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD------------  271 (489)
Q Consensus       205 ~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~------------  271 (489)
                          ........|+..|+|||++.+. .++.++|||||||++|+|++|.+||.+.+....+..+...-            
T Consensus       154 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07832         154 ----PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT  229 (286)
T ss_pred             ----CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhcc
Confidence                1112345789999999998654 46899999999999999999999998887766665544310            


Q ss_pred             -------CCCC-----------CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 011287          272 -------IRFP-----------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (489)
Q Consensus       272 -------~~~p-----------~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~  315 (489)
                             ..++           +..+.++.+||++||+.||++||++     +++++||||.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~-----~~~l~h~~~~  286 (286)
T cd07832         230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSA-----AEALRHPYFT  286 (286)
T ss_pred             CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCH-----HHHhhCcCcC
Confidence                   0111           2357899999999999999999999     8999999994

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.5e-42  Score=341.85  Aligned_cols=254  Identities=20%  Similarity=0.340  Sum_probs=217.3

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCC-----cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTG-----TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  116 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg-----~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  116 (489)
                      +..++|++.+.||+|+||.||+|.+...+     ..||+|.+....  .......+.+|+.+++.++||||+++++++.+
T Consensus         2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~   79 (283)
T cd05048           2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK   79 (283)
T ss_pred             CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence            45689999999999999999999986555     789999986442  23344567889999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCC
Q 011287          117 TFSLYMALESCEGGELFDQITSK----------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA  180 (489)
Q Consensus       117 ~~~lylV~E~~~gg~L~~~l~~~----------------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~  180 (489)
                      ....|++|||+++|+|.+++...                ..+++..+..++.|++.||.|||++|++||||||+||+++.
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~  159 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE  159 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence            99999999999999999999765                45788999999999999999999999999999999999999


Q ss_pred             CCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCC
Q 011287          181 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS  259 (489)
Q Consensus       181 ~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~  259 (489)
                      ++.++|+|||++........        ........+++.|+|||.+.+..++.++|+|||||++|+|++ |..||.+.+
T Consensus       160 ~~~~~L~dfg~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~  231 (283)
T cd05048         160 GLTVKISDFGLSRDIYSADY--------YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS  231 (283)
T ss_pred             CCcEEECCCcceeecccccc--------ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            99999999999875432210        111223467889999999988889999999999999999998 999999988


Q ss_pred             HHHHHHHHHhcC-CCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          260 EWLIFQRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       260 ~~~~~~~i~~~~-~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      ..+....+.... ...|..+++++.+|+.+||+.||.+||++     .++++
T Consensus       232 ~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~-----~~i~~  278 (283)
T cd05048         232 NQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRF-----KDIHT  278 (283)
T ss_pred             HHHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCH-----HHHHH
Confidence            888877776544 34577899999999999999999999998     66664

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.8e-42  Score=342.69  Aligned_cols=255  Identities=29%  Similarity=0.454  Sum_probs=215.9

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeeccccc--chhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT--KENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      +|++.+.||+|+||.||+|.+..+|+.||+|.+......  .......+..|+.+++.++|+||+++++++.+...+|+|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            589999999999999999999999999999999765433  122344566799999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccc
Q 011287          124 LESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~  202 (489)
                      |||+ +|+|.+++...+ .+++..+..++.||+.||.|||++||+||||+|+||+++.+|.++|+|||++.......   
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~---  156 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN---  156 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC---
Confidence            9999 889999998776 79999999999999999999999999999999999999999999999999998654321   


Q ss_pred             cCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC---------
Q 011287          203 LPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI---------  272 (489)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~---------  272 (489)
                             .......++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.+....+.++.....         
T Consensus       157 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (298)
T cd07841         157 -------RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG  229 (298)
T ss_pred             -------ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhh
Confidence                   11223356888999999854 4578899999999999999999999988887666655543100         


Q ss_pred             -------------------CCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          273 -------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       273 -------------------~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                                         ......+..+.+||.+||+.||++||++     .+++.||||++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~-----~e~l~~~~~~~  287 (298)
T cd07841         230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITA-----RQALEHPYFSN  287 (298)
T ss_pred             cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCH-----HHHhhCccccC
Confidence                               0112357889999999999999999998     89999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.9e-42  Score=336.61  Aligned_cols=248  Identities=17%  Similarity=0.310  Sum_probs=211.1

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEc---CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~---~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  118 (489)
                      +...+|++.+.||+|+||.||+|.++   ..+..||+|.+....  .......+.+|..+++.++||||+++++++....
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   79 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN   79 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence            34578999999999999999999875   456799999987542  2233456778999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCC
Q 011287          119 SLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~  197 (489)
                      .+|+||||+++|+|.+++.+. +.+++..++.++.||+.||+|||++|++||||||+|||++.++.++++|||.+.....
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            999999999999999999874 5799999999999999999999999999999999999999999999999998764322


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCC
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFP  275 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p  275 (489)
                      ...         .......++..|+|||.+.+..++.++|||||||++|++++ |..||.+.+.....+.+... ....|
T Consensus       160 ~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~  230 (266)
T cd05064         160 EAI---------YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAP  230 (266)
T ss_pred             cch---------hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCC
Confidence            110         11112345678999999999999999999999999999775 99999998888777776654 34567


Q ss_pred             CCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          276 NYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       276 ~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      ..++..+.+++.+||+.+|.+||++
T Consensus       231 ~~~~~~~~~li~~c~~~~p~~RP~~  255 (266)
T cd05064         231 RNCPNLLHQLMLDCWQKERGERPRF  255 (266)
T ss_pred             CCCCHHHHHHHHHHcCCCchhCCCH
Confidence            7889999999999999999999998

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=5.6e-42  Score=332.93  Aligned_cols=253  Identities=30%  Similarity=0.544  Sum_probs=221.4

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEE--cCCEEEEE
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ--DTFSLYMA  123 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~lylV  123 (489)
                      +|++.+.||.|+||.||+|.+..+|..||+|++...... ......+..|+.+++.++||||+++++.+.  ....+|++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence            689999999999999999999999999999998765443 334456778999999999999999999775  34678999


Q ss_pred             EeccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----hCCcEeeccCCCCeeeCCCCCEEEeeccCccc
Q 011287          124 LESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIH-----SMGLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~aL~~LH-----~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~  194 (489)
                      |||+++++|.+++..    .+.+++..+..++.||+.||.|||     +.+++|+||+|+||+++.++.++|+|||++..
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~  159 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI  159 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence            999999999999875    357999999999999999999999     89999999999999999999999999999986


Q ss_pred             cCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC-C
Q 011287          195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-R  273 (489)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~-~  273 (489)
                      .....          .......|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.....+.+..... .
T Consensus       160 ~~~~~----------~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  229 (265)
T cd08217         160 LGHDS----------SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRR  229 (265)
T ss_pred             ccCCc----------ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCC
Confidence            54321          112345789999999999988899999999999999999999999999887777777766544 4


Q ss_pred             CCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          274 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       274 ~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                      +|..++..+.+|+.+||+.+|++||++     .++++|||+
T Consensus       230 ~~~~~~~~~~~l~~~~l~~~p~~Rp~~-----~~il~~~~~  265 (265)
T cd08217         230 IPYRYSSELNEVIKSMLNVDPDKRPST-----EELLQLPLI  265 (265)
T ss_pred             CccccCHHHHHHHHHHccCCcccCCCH-----HHHhhCCCC
Confidence            677889999999999999999999998     899999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.7e-42  Score=337.82  Aligned_cols=251  Identities=29%  Similarity=0.491  Sum_probs=211.5

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcC------
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDT------  117 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~------  117 (489)
                      +.|++.+.||+|+||.||+|.+..+++.||+|++....    .....+..|+.+++++ +||||++++++|.+.      
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            56899999999999999999999999999999987542    2234567788899888 799999999998752      


Q ss_pred             CEEEEEEeccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCcccc
Q 011287          118 FSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~  195 (489)
                      ..+|+||||+.+++|.+++...  ..+++..+..++.|++.||.|||++||+||||||+||++++++.++|+|||++...
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~  161 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  161 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence            4689999999999999998864  46899999999999999999999999999999999999999999999999998754


Q ss_pred             CCccccccCCCCCCCCccceecCCcCCChhhhc-----CCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc
Q 011287          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLN-----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR  270 (489)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~-----~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~  270 (489)
                      ...          ........|+..|+|||++.     +..++.++|+|||||++|+|++|..||...........+...
T Consensus       162 ~~~----------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~  231 (272)
T cd06637         162 DRT----------VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN  231 (272)
T ss_pred             ccc----------cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC
Confidence            321          11233567999999999986     345788999999999999999999999876665554444332


Q ss_pred             CC--CCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          271 DI--RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       271 ~~--~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                      ..  ..+..++.++.+|+.+||+.||.+||++     .+++.||||
T Consensus       232 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~-----~~il~~~~~  272 (272)
T cd06637         232 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTT-----EQLMKHPFI  272 (272)
T ss_pred             CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCH-----HHHhhCCCC
Confidence            21  1234578999999999999999999998     899999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.7e-42  Score=338.34  Aligned_cols=246  Identities=27%  Similarity=0.471  Sum_probs=207.4

Q ss_pred             CCeEEeeEE--eeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCEEE
Q 011287           45 QDFELGKIY--GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        45 ~dy~~~~~L--G~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~ly  121 (489)
                      ++|++.+.+  |+|+||.||+++++.++..+|+|++.+.....        .|..+...+ +||||+++++.|.....+|
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~   85 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHV   85 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence            467777776  99999999999999999999999987543221        122222222 7999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCC-CEEEeeccCccccCCccc
Q 011287          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-HIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g-~ikL~DFG~a~~~~~~~~  200 (489)
                      +||||+++++|.+++...+.+++..++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++......  
T Consensus        86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--  163 (267)
T PHA03390         86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--  163 (267)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--
Confidence            9999999999999998888899999999999999999999999999999999999999998 9999999998754321  


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHH----HHHHHHhcCCCCCC
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQRIIARDIRFPN  276 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~----~~~~i~~~~~~~p~  276 (489)
                                  ....|+..|+|||++.+..++.++|+|||||++|+|++|..||.......    .+.........+++
T Consensus       164 ------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (267)
T PHA03390        164 ------------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIK  231 (267)
T ss_pred             ------------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCccc
Confidence                        23468899999999999889999999999999999999999998654322    12222244456667


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      .+++.+.+||.+||+.||.+||++    ++++++||||.+
T Consensus       232 ~~~~~~~~li~~~l~~~p~~R~~~----~~~~l~h~~~~~  267 (267)
T PHA03390        232 NVSKNANDFVQSMLKYNINYRLTN----YNEIIKHPFLKI  267 (267)
T ss_pred             ccCHHHHHHHHHHhccChhhCCch----HHHHhcCCcccC
Confidence            899999999999999999999964    388999999973

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.4e-42  Score=362.76  Aligned_cols=250  Identities=26%  Similarity=0.336  Sum_probs=206.2

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      ...|.+.+.||+|+||.||+|.+..+++.||||....         ....+|+.+|++++|||||++++++......|+|
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv  238 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV  238 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence            4579999999999999999999999999999996421         2245699999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccc
Q 011287          124 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~  202 (489)
                      ||++. ++|..++... +.+++..++.++.||+.||.|||++||+||||||+||||+.++.++|+|||+++.+....   
T Consensus       239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~---  314 (461)
T PHA03211        239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW---  314 (461)
T ss_pred             EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc---
Confidence            99995 6898888764 569999999999999999999999999999999999999999999999999998653321   


Q ss_pred             cCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCC--------CHHHHHHHHHhcCC--
Q 011287          203 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT--------SEWLIFQRIIARDI--  272 (489)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~--------~~~~~~~~i~~~~~--  272 (489)
                           ........+||..|+|||++.+..++.++|||||||++|+|++|..|+...        ....+.+.+.....  
T Consensus       315 -----~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~  389 (461)
T PHA03211        315 -----STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHV  389 (461)
T ss_pred             -----ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccc
Confidence                 111223467999999999999999999999999999999999987655322        12233333322111  


Q ss_pred             -CCCC-------------------------------CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          273 -RFPN-------------------------------YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       273 -~~p~-------------------------------~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                       .+|.                               .++.++.+||.+||+.||.+|||+     +++++||||+.
T Consensus       390 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa-----~elL~hp~f~~  460 (461)
T PHA03211        390 DEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSA-----AELLRLPLFQS  460 (461)
T ss_pred             ccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCH-----HHHhhCcccCC
Confidence             1111                               245689999999999999999999     89999999974

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.6e-42  Score=341.93  Aligned_cols=254  Identities=31%  Similarity=0.471  Sum_probs=215.1

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.+..... .....+.+|+.+++.++||||+++++++.+....|+||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   79 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF   79 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence            47999999999999999999999999999999987653332 33455778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccC
Q 011287          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (489)
Q Consensus       125 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~  204 (489)
                      ||+++++|..+....+.+++..+..++.||+.||.|||+.|++||||+|+||++++++.++|+|||++..+....     
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-----  154 (286)
T cd07846          80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-----  154 (286)
T ss_pred             ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-----
Confidence            999999888877766679999999999999999999999999999999999999999999999999987653321     


Q ss_pred             CCCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC------------
Q 011287          205 NAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD------------  271 (489)
Q Consensus       205 ~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~------------  271 (489)
                           .......++..|+|||++.+. .++.++|+|||||++|+|++|++||.+.+..+....+....            
T Consensus       155 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07846         155 -----EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQ  229 (286)
T ss_pred             -----cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhc
Confidence                 112245688999999998754 47788999999999999999999998777655444433210            


Q ss_pred             -------CCC------------CCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          272 -------IRF------------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       272 -------~~~------------p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                             ..+            ++.++..+.+|+.+||+.||++||++     .+++.||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~-----~~il~~~~~  286 (286)
T cd07846         230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSS-----SQLLHHEFF  286 (286)
T ss_pred             cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhH-----HHHhcCCCC
Confidence                   011            23568899999999999999999999     899999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=8.5e-42  Score=338.24  Aligned_cols=253  Identities=28%  Similarity=0.480  Sum_probs=213.7

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcC-----
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDT-----  117 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~-----  117 (489)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....    .....+..|..+++++ +|||++++++++...     
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~   96 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG   96 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence            588999999999999999999999999999999986532    2335567788899988 899999999998643     


Q ss_pred             CEEEEEEeccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCcc
Q 011287          118 FSLYMALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK  193 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~  193 (489)
                      ...|+||||+++++|.+++..    ...+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.
T Consensus        97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~  176 (291)
T cd06639          97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA  176 (291)
T ss_pred             CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence            468999999999999998763    3568999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCccccccCCCCCCCCccceecCCcCCChhhhcCCC-----CCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHH
Q 011287          194 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP-----ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII  268 (489)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~-----~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~  268 (489)
                      ......          .......|+..|+|||++....     ++.++|+|||||++|+|++|++||...+.......+.
T Consensus       177 ~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~  246 (291)
T cd06639         177 QLTSTR----------LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP  246 (291)
T ss_pred             hccccc----------ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHh
Confidence            654321          1122346889999999986432     6789999999999999999999998877655555554


Q ss_pred             hcC---CCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 011287          269 ARD---IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (489)
Q Consensus       269 ~~~---~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~  315 (489)
                      ...   ...|..++..+.+||.+||+.||++||++     .++++||||+
T Consensus       247 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~il~~~~~~  291 (291)
T cd06639         247 RNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSV-----THLLEHPFIK  291 (291)
T ss_pred             cCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCH-----HHHhcCcccC
Confidence            432   23355678899999999999999999998     8999999994

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=6.5e-42  Score=332.86  Aligned_cols=257  Identities=34%  Similarity=0.551  Sum_probs=225.1

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      ++|++.+.||+|++|.||+|++..+++.||+|++......  .....+.+|+.++.+++||||+++++++.....+|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL   78 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence            4799999999999999999999999999999998765322  34566788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       125 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~-~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||.+.......    
T Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~----  154 (264)
T cd06623          79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL----  154 (264)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC----
Confidence            999999999999988889999999999999999999999 999999999999999999999999999987653321    


Q ss_pred             CCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCC---CHHHHHHHHHhc-CCCCCCC-C
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT---SEWLIFQRIIAR-DIRFPNY-F  278 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~---~~~~~~~~i~~~-~~~~p~~-~  278 (489)
                            .......++..|+|||.+.+..++.++|+||||+++|+|++|..||...   ........+... ...++.. +
T Consensus       155 ------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (264)
T cd06623         155 ------DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEF  228 (264)
T ss_pred             ------CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccC
Confidence                  1123557899999999999988999999999999999999999999877   444555555543 3345556 8


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 011287          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (489)
Q Consensus       279 ~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~  318 (489)
                      +..+.++|.+||..+|++||++     .++++||||+.++
T Consensus       229 ~~~l~~li~~~l~~~p~~R~~~-----~~ll~~~~~~~~~  263 (264)
T cd06623         229 SPEFRDFISACLQKDPKKRPSA-----AELLQHPFIKKAD  263 (264)
T ss_pred             CHHHHHHHHHHccCChhhCCCH-----HHHHhCHHHHhcc
Confidence            9999999999999999999998     8999999998654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.8e-42  Score=335.23  Aligned_cols=256  Identities=30%  Similarity=0.531  Sum_probs=215.6

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccc-------hhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-------ENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~-------~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  118 (489)
                      .|.+.+.||.|+||.||+|.+..+|+.||+|.+.......       ....+.+..|..+++.++||||+++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            5889999999999999999999999999999886432111       112346778999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      .+|+||||+.+++|.+++.+.+.+++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+|||+++.....
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  161 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI  161 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence            99999999999999999998888999999999999999999999999999999999999999999999999998754321


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCCC--CCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc--CCCC
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSP--ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--DIRF  274 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~--~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~--~~~~  274 (489)
                      .        .........|+..|+|||.+....  ++.++|+||||+++|+|++|..||...........+...  ...+
T Consensus       162 ~--------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  233 (272)
T cd06629         162 Y--------DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPI  233 (272)
T ss_pred             c--------cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcC
Confidence            1        111223456889999999987654  789999999999999999999999876655444433322  2333


Q ss_pred             CC----CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          275 PN----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       275 p~----~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                      |.    .++.++.++|.+||..||++||++     +++++||||
T Consensus       234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~il~~~~~  272 (272)
T cd06629         234 PPDVSMNLSPVALDFLNACFTINPDNRPTA-----RELLQHPFI  272 (272)
T ss_pred             CccccccCCHHHHHHHHHHhcCChhhCCCH-----HHHhhCCCC
Confidence            33    458999999999999999999998     899999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-41  Score=332.27  Aligned_cols=257  Identities=28%  Similarity=0.497  Sum_probs=220.6

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeeccc--ccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC--CEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKF--ITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT--FSL  120 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~--~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~l  120 (489)
                      .+|++.+.||+|+||.||+|++..+++.||+|.+....  .........+.+|+.+++.++||||+++++.+.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            68999999999999999999999999999999875432  12233456788899999999999999999998764  568


Q ss_pred             EEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      ++||||+++++|.+++...+.+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||+++...... 
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-  160 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC-  160 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccc-
Confidence            9999999999999999887889999999999999999999999999999999999999999999999999998653211 


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc--CCCCCCCC
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--DIRFPNYF  278 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~--~~~~p~~~  278 (489)
                            ..........|+..|+|||.+.+..++.++|+|||||++|+|++|++||...........+...  ...+|..+
T Consensus       161 ------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~  234 (264)
T cd06653         161 ------MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGV  234 (264)
T ss_pred             ------ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCccc
Confidence                  0111223457899999999999888999999999999999999999999887766655555433  34578899


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       279 ~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                      ++++.++|++||+ +|.+||++     .+++.|||.
T Consensus       235 ~~~~~~~i~~~l~-~~~~r~~~-----~~~~~~~~~  264 (264)
T cd06653         235 SDACRDFLKQIFV-EEKRRPTA-----EFLLRHPFV  264 (264)
T ss_pred             CHHHHHHHHHHhc-CcccCccH-----HHHhcCCCC
Confidence            9999999999998 57999999     889999983

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.4e-42  Score=333.62  Aligned_cols=251  Identities=31%  Similarity=0.499  Sum_probs=218.5

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      .++|++.+.||.|+||.||+|++..+++.||+|.+....     ....+.+|+.+++.++||||+++++.+.+...+|++
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~   76 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV   76 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence            368999999999999999999999999999999986542     156788899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccc
Q 011287          124 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~  202 (489)
                      +||+.+++|.+++... ..+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.......   
T Consensus        77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~---  153 (256)
T cd06612          77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM---  153 (256)
T ss_pred             EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc---
Confidence            9999999999999753 568999999999999999999999999999999999999999999999999988654321   


Q ss_pred             cCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc---CCCCCCCCC
Q 011287          203 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFS  279 (489)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~---~~~~p~~~~  279 (489)
                             .......|+..|+|||++.+..++.++|+||||||+|+|++|+.||...+.......+...   ....+..++
T Consensus       154 -------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (256)
T cd06612         154 -------AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWS  226 (256)
T ss_pred             -------cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcC
Confidence                   1223456889999999999989999999999999999999999999887665444333222   233455678


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       280 ~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                      ..+.++|.+||+.||++||++     .+++.||||
T Consensus       227 ~~~~~~i~~~l~~~P~~Rps~-----~~il~~~~~  256 (256)
T cd06612         227 PEFNDFVKKCLVKDPEERPSA-----IQLLQHPFI  256 (256)
T ss_pred             HHHHHHHHHHHhcChhhCcCH-----HHHhcCCCC
Confidence            999999999999999999998     899999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=7.5e-42  Score=331.32  Aligned_cols=253  Identities=32%  Similarity=0.536  Sum_probs=220.1

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeeccccc--chhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT--KENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      +|+..+.||+|+||.||+|.+..++..||+|.+......  .......+.+|+.+++.++||||+++++++.+...+|+|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            478889999999999999999989999999998654321  123445678899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      +||+++++|.+++.+.+.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.......    
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~----  156 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS----  156 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc----
Confidence            9999999999999988889999999999999999999999999999999999999999999999999987653321    


Q ss_pred             CCCCCCCCccceecCCcCCChhhhcCCC-CCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHh--cCCCCCCCCCH
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA--RDIRFPNYFSD  280 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~-~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~--~~~~~p~~~~~  280 (489)
                             ......|+..|+|||.+.... ++.++|+|||||++|+|++|+.||...........+..  ....+|..+++
T Consensus       157 -------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (258)
T cd06632         157 -------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSD  229 (258)
T ss_pred             -------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCH
Confidence                   123456889999999997776 89999999999999999999999988776555544443  23456778899


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       281 ~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                      .+.+++.+||+.+|++||++     .+++.|||+
T Consensus       230 ~~~~li~~~l~~~p~~Rp~~-----~~~l~~~~~  258 (258)
T cd06632         230 EAKDFILKCLQRDPSLRPTA-----AELLEHPFV  258 (258)
T ss_pred             HHHHHHHHHhhcCcccCcCH-----HHHhcCCCC
Confidence            99999999999999999998     899999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.8e-42  Score=356.31  Aligned_cols=250  Identities=22%  Similarity=0.395  Sum_probs=207.0

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCC-----CcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDT-----GTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQ  115 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~t-----g~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~  115 (489)
                      +..++|++++.||+|+||.||+|++..+     +..||+|++....  .......+.+|+.+++.+ +||||+++++.+.
T Consensus        35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~  112 (374)
T cd05106          35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACT  112 (374)
T ss_pred             ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence            4567899999999999999999996544     4579999997543  223355677899999999 8999999999999


Q ss_pred             cCCEEEEEEeccCCCChHHHHHhC--------------------------------------------------------
Q 011287          116 DTFSLYMALESCEGGELFDQITSK--------------------------------------------------------  139 (489)
Q Consensus       116 ~~~~lylV~E~~~gg~L~~~l~~~--------------------------------------------------------  139 (489)
                      +...+|+|||||.+|+|.+++.+.                                                        
T Consensus       113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (374)
T cd05106         113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS  192 (374)
T ss_pred             CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence            999999999999999999988642                                                        


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCC
Q 011287          140 --------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  205 (489)
Q Consensus       140 --------------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~  205 (489)
                                    .++++..+..++.||+.||.|||++||+||||||+|||++.+++++|+|||+++.+.....     
T Consensus       193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~-----  267 (374)
T cd05106         193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN-----  267 (374)
T ss_pred             ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc-----
Confidence                          2478889999999999999999999999999999999999999999999999876532210     


Q ss_pred             CCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc--CCCCCCCCCHHH
Q 011287          206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR--DIRFPNYFSDAA  282 (489)
Q Consensus       206 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~--~~~~p~~~~~~~  282 (489)
                         .....+..++..|+|||++.+..++.++|||||||++|+|++ |+.||........+..+...  ....|...++++
T Consensus       268 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  344 (374)
T cd05106         268 ---YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEI  344 (374)
T ss_pred             ---eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHH
Confidence               011112335668999999998899999999999999999997 99999876554444444433  344566789999


Q ss_pred             HHHHHHhhccCCCCCCCCC
Q 011287          283 RDLIDRLLDVDPSGRPGAG  301 (489)
Q Consensus       283 ~~Li~~~L~~dP~~R~t~~  301 (489)
                      +++|.+||+.||.+||++.
T Consensus       345 ~~li~~cl~~dp~~RPs~~  363 (374)
T cd05106         345 YSIMKMCWNLEPTERPTFS  363 (374)
T ss_pred             HHHHHHHcCCChhhCcCHH
Confidence            9999999999999999983

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.1e-41  Score=329.98  Aligned_cols=252  Identities=28%  Similarity=0.500  Sum_probs=221.5

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEe
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E  125 (489)
                      +|++.+.||+|+||.||+|.+..+++.+|+|.+....... .....+.+|+.+++.++||||+++++.+.....+++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence            5899999999999999999999999999999998664433 335668889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCC-CEEEeeccCccccCCccccc
Q 011287          126 SCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-HIKIADFGSVKPMQDSRITV  202 (489)
Q Consensus       126 ~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g-~ikL~DFG~a~~~~~~~~~~  202 (489)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||++|++||||+|+||+++.++ .++|+|||.+......    
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~----  155 (256)
T cd08220          80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK----  155 (256)
T ss_pred             cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC----
Confidence            99999999999764  3489999999999999999999999999999999999998654 5799999998865432    


Q ss_pred             cCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC-CCCCCCCCHH
Q 011287          203 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-IRFPNYFSDA  281 (489)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~-~~~p~~~~~~  281 (489)
                             .......|+..|+|||.+.+..++.++|+|||||++|+|++|..||.+.+.......+.... ..+|..++.+
T Consensus       156 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (256)
T cd08220         156 -------SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPD  228 (256)
T ss_pred             -------ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHH
Confidence                   11224578999999999998889999999999999999999999999887777666665543 4567789999


Q ss_pred             HHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       282 ~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                      +.++|.+||..||++||++     .++++||||
T Consensus       229 l~~li~~~l~~~p~~Rpt~-----~~ll~~p~~  256 (256)
T cd08220         229 LRQLILSMLNLDPSKRPQL-----SQIMAQPIC  256 (256)
T ss_pred             HHHHHHHHccCChhhCCCH-----HHHhhCCCC
Confidence            9999999999999999999     899999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-42  Score=334.77  Aligned_cols=252  Identities=30%  Similarity=0.511  Sum_probs=213.6

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCC----
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTF----  118 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~----  118 (489)
                      .++|++.+.||.|++|.||+|.++.+++.||+|++....    .....+.+|+.+++++ +||||+++++.+.+..    
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            489999999999999999999999999999999987542    2335678899999998 7999999999997644    


Q ss_pred             --EEEEEEeccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCc
Q 011287          119 --SLYMALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  192 (489)
Q Consensus       119 --~lylV~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a  192 (489)
                        .+|+||||+++++|.+++..    .+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~  160 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS  160 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence              58999999999999998865    357999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCccccccCCCCCCCCccceecCCcCCChhhhcC-----CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHH
Q 011287          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI  267 (489)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-----~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i  267 (489)
                      .......          .......|+..|+|||++..     ..++.++|+|||||++|+|++|.+||...+.......+
T Consensus       161 ~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~  230 (275)
T cd06608         161 AQLDSTL----------GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKI  230 (275)
T ss_pred             eecccch----------hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHh
Confidence            7543221          12234578999999999853     34678899999999999999999999877666555555


Q ss_pred             HhcCC---CCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          268 IARDI---RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       268 ~~~~~---~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                      .....   ..+..++.++++||.+||..||++||++     .++++|||+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~-----~~ll~~~~~  275 (275)
T cd06608         231 PRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFM-----EELLEHPFI  275 (275)
T ss_pred             hccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCH-----HHHhcCCCC
Confidence            54322   2234478899999999999999999998     899999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.5e-43  Score=351.43  Aligned_cols=258  Identities=29%  Similarity=0.458  Sum_probs=211.2

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSL  120 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~l  120 (489)
                      ..-..|++++.||+||-+.||++...+ .+.||+|.+.-. ........-..+|+.+|.+| .|.+||+||++-..++.+
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~-~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l  435 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLL-EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL  435 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHh-hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence            344569999999999999999999855 455666544222 23445566788899999999 599999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcc
Q 011287          121 YMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~~~-l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      |+||||=+ .||...|++.+. .+...+++|..|++.|+.++|++||||.||||.|+|+- .|.+||+|||.|..+....
T Consensus       436 YmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DT  513 (677)
T KOG0596|consen  436 YMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDT  513 (677)
T ss_pred             EEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCccc
Confidence            99999865 499999988754 44469999999999999999999999999999999984 7899999999999876554


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCCC-----------CCCCCcchhhhHHHHHHhhCCCCCCCCC-HHHHHHHH
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSP-----------ATFGNDLWALGCTLYQMLSGTSPFKDTS-EWLIFQRI  267 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~-----------~~~~sDiwSLG~ilyelltG~~PF~~~~-~~~~~~~i  267 (489)
                      ..+        ...+.+||+.|||||.+....           .+.++||||||||||+|+.|++||.... .+.-+..|
T Consensus       514 TsI--------~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI  585 (677)
T KOG0596|consen  514 TSI--------VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAI  585 (677)
T ss_pred             cce--------eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhh
Confidence            222        233669999999999985332           4678999999999999999999997643 44455566


Q ss_pred             HhcC--CCCCCCCCHH-HHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          268 IARD--IRFPNYFSDA-ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       268 ~~~~--~~~p~~~~~~-~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      ...+  ++||..-+.. +.++++.||..||.+||++     .+||+|||...
T Consensus       586 ~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si-----~eLLqhpFl~~  632 (677)
T KOG0596|consen  586 TDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSI-----PELLQHPFLQI  632 (677)
T ss_pred             cCCCccccccCCCCchHHHHHHHHHHhcCcccCCCc-----HHHhcCccccc
Confidence            6553  4787765555 9999999999999999999     88999999975

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.7e-42  Score=339.80  Aligned_cols=256  Identities=29%  Similarity=0.459  Sum_probs=220.0

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ly  121 (489)
                      +..++|++++.||+|+||+||+|.+..+|+.||+|++....  .......+.+|+.+++.++||||+++++.+.+...+|
T Consensus         2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (284)
T cd06620           2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNIC   79 (284)
T ss_pred             ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEE
Confidence            35679999999999999999999999999999999986542  2334566788999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~-~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      +||||+++++|.+++.+.+.+++..++.++.+++.||.|||+ .|++||||+|+||+++.++.++|+|||++......  
T Consensus        80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--  157 (284)
T cd06620          80 MCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--  157 (284)
T ss_pred             EEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence            999999999999999888889999999999999999999997 69999999999999999999999999998654221  


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHH-----------HHHHHHHh
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-----------LIFQRIIA  269 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~-----------~~~~~i~~  269 (489)
                                .....+|+..|+|||++.+..++.++|+|||||++|+|++|..||......           .....+..
T Consensus       158 ----------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (284)
T cd06620         158 ----------IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ  227 (284)
T ss_pred             ----------ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh
Confidence                      122457899999999998888999999999999999999999999865542           23333333


Q ss_pred             cC-CCCCCC-CCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          270 RD-IRFPNY-FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       270 ~~-~~~p~~-~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      .. ..++.. ++.++.+||.+||+.||.+||++     .++++|+||..
T Consensus       228 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~-----~e~~~~~~~~~  271 (284)
T cd06620         228 EPPPRLPSSDFPEDLRDFVDACLLKDPTERPTP-----QQLCAMPPFIQ  271 (284)
T ss_pred             ccCCCCCchhcCHHHHHHHHHHhcCCcccCcCH-----HHHhcCccccc
Confidence            22 233333 78899999999999999999999     89999999953

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=7.3e-42  Score=341.21  Aligned_cols=249  Identities=21%  Similarity=0.308  Sum_probs=205.3

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcC----------------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCC
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKID----------------TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP  105 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~----------------tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp  105 (489)
                      +..++|++.+.||+|+||.||+|++..                ++..||+|++....  .......+.+|+.++++++||
T Consensus         2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~   79 (304)
T cd05096           2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDP   79 (304)
T ss_pred             CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCC
Confidence            346799999999999999999998643                34579999986542  233455678899999999999


Q ss_pred             CccEEEEEEEcCCEEEEEEeccCCCChHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 011287          106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG-------------------HLSEDEARFYTAEVVDALEYIHSMGL  166 (489)
Q Consensus       106 nIv~l~~~~~~~~~lylV~E~~~gg~L~~~l~~~~-------------------~l~e~~~~~i~~qil~aL~~LH~~gI  166 (489)
                      ||+++++++.+....|+||||+.+|+|.+++....                   .+++..+..++.||+.||.|||+.||
T Consensus        80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i  159 (304)
T cd05096          80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF  159 (304)
T ss_pred             CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence            99999999999999999999999999999986532                   36778899999999999999999999


Q ss_pred             EeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHH
Q 011287          167 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY  246 (489)
Q Consensus       167 iHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ily  246 (489)
                      +||||||+|||++.++.+||+|||+++.+.....        ........++..|+|||++....++.++|||||||++|
T Consensus       160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~  231 (304)
T cd05096         160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDY--------YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLW  231 (304)
T ss_pred             cccCcchhheEEcCCccEEECCCccceecccCce--------eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHH
Confidence            9999999999999999999999999976533211        01122345678899999998888999999999999999


Q ss_pred             HHhh--CCCCCCCCCHHHHHHHHHh--------cCCCCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          247 QMLS--GTSPFKDTSEWLIFQRIIA--------RDIRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       247 ellt--G~~PF~~~~~~~~~~~i~~--------~~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      +|++  +..||...+.......+..        .....|..++..+.+|+.+||+.||++||++
T Consensus       232 el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~  295 (304)
T cd05096         232 EILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSF  295 (304)
T ss_pred             HHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCH
Confidence            9986  6788988776655544321        1123456788999999999999999999998

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=8.4e-42  Score=348.42  Aligned_cols=253  Identities=25%  Similarity=0.430  Sum_probs=211.9

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC------
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT------  117 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------  117 (489)
                      .++|++.+.||+|+||.||+|++..+|+.||+|++.+.... ......+.+|+.++++++||||++++++|...      
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQN-VTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccC-hhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            57899999999999999999999999999999998654322 23334566799999999999999999988643      


Q ss_pred             CEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCC
Q 011287          118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~  197 (489)
                      ..+|+||||+.+ +|.+.+...  +++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++.....
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  170 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  170 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence            357999999965 888888754  99999999999999999999999999999999999999999999999999976532


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC------
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD------  271 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~------  271 (489)
                      ..           ......|++.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+....+.++....      
T Consensus       171 ~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  239 (353)
T cd07850         171 SF-----------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDE  239 (353)
T ss_pred             CC-----------CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            21           1234568899999999999999999999999999999999999999877655554443210      


Q ss_pred             ----------------C--------------CC-------CCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          272 ----------------I--------------RF-------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       272 ----------------~--------------~~-------p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                                      .              .+       +...+..+++||.+||+.||++||++     .+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~eiL~~~~~  314 (353)
T cd07850         240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISV-----DDALQHPYI  314 (353)
T ss_pred             HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCH-----HHHhcChhH
Confidence                            0              00       11246678999999999999999999     899999999


Q ss_pred             CC
Q 011287          315 KG  316 (489)
Q Consensus       315 ~~  316 (489)
                      +.
T Consensus       315 ~~  316 (353)
T cd07850         315 NV  316 (353)
T ss_pred             hh
Confidence            83

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.2e-41  Score=335.23  Aligned_cols=256  Identities=25%  Similarity=0.445  Sum_probs=208.8

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHH-HHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-VLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      ++|++.+.||+|+||.||+|+++.+|+.||+|.+.+...... ... +..|.. .++.++||||+++++++.+...+|+|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~-~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKR-LLMDLDISMRSVDCPYTVTFYGALFREGDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHH-HHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence            589999999999999999999999999999999876533222 223 333544 46777999999999999999999999


Q ss_pred             EeccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          124 LESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSM-GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~aL~~LH~~-gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      |||++ |+|.+++..    ...+++..+..++.||+.||.|||++ +++||||||+||+++.++.+||+|||++..+...
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            99997 588777754    24689999999999999999999997 9999999999999999999999999998765321


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcC----CCCCCCCcchhhhHHHHHHhhCCCCCCCC-CHHHHHHHHHh-cCC
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNS----SPATFGNDLWALGCTLYQMLSGTSPFKDT-SEWLIFQRIIA-RDI  272 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~----~~~~~~sDiwSLG~ilyelltG~~PF~~~-~~~~~~~~i~~-~~~  272 (489)
                                 .......|+..|+|||++.+    ..++.++|+|||||++|+|++|+.||... +..+....+.. ...
T Consensus       158 -----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  226 (283)
T cd06617         158 -----------VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSP  226 (283)
T ss_pred             -----------cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCC
Confidence                       11123568899999999865    45688999999999999999999999753 22333333333 233


Q ss_pred             CCC-CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 011287          273 RFP-NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (489)
Q Consensus       273 ~~p-~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~  319 (489)
                      .+| ..++.++.++|.+||..+|.+||++     .++++||||.....
T Consensus       227 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~-----~~il~~~~~~~~~~  269 (283)
T cd06617         227 QLPAEKFSPEFQDFVNKCLKKNYKERPNY-----PELLQHPFFELHLS  269 (283)
T ss_pred             CCCccccCHHHHHHHHHHccCChhhCcCH-----HHHhcCchhhhccc
Confidence            444 3578999999999999999999998     89999999987543

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=8.9e-42  Score=336.85  Aligned_cols=253  Identities=29%  Similarity=0.486  Sum_probs=211.6

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEE-----c
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQ-----D  116 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~-----~  116 (489)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++....    .....+.+|..+++.+ +||||+++++++.     +
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   91 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN   91 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence            4689999999999999999999999999999999876431    2234567799999998 7999999999873     4


Q ss_pred             CCEEEEEEeccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCc
Q 011287          117 TFSLYMALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  192 (489)
Q Consensus       117 ~~~lylV~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a  192 (489)
                      ....|+||||+++++|.+++..    ...+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~  171 (286)
T cd06638          92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS  171 (286)
T ss_pred             CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence            5679999999999999988753    356899999999999999999999999999999999999999999999999998


Q ss_pred             cccCCccccccCCCCCCCCccceecCCcCCChhhhcC-----CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHH
Q 011287          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI  267 (489)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-----~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i  267 (489)
                      ..+....          .......|++.|+|||++..     ..++.++|+|||||++|+|++|+.||...+.......+
T Consensus       172 ~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~  241 (286)
T cd06638         172 AQLTSTR----------LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI  241 (286)
T ss_pred             eecccCC----------CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhc
Confidence            7653321          12234468999999999853     44788999999999999999999999887665544433


Q ss_pred             Hhc---CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          268 IAR---DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       268 ~~~---~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                      ...   ....|..++..+.+||.+||+.||++||++     .++++|+||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~ell~~~~~  286 (286)
T cd06638         242 PRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTV-----SDLLQHVFI  286 (286)
T ss_pred             cccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCH-----HHHhhcccC
Confidence            322   222455678899999999999999999998     899999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-42  Score=337.26  Aligned_cols=255  Identities=31%  Similarity=0.477  Sum_probs=216.5

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+++.++|+||+++++.+.+....|+||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   79 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD-EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF   79 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccc-ccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence            4799999999999999999999999999999998654322 233456778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccC
Q 011287          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (489)
Q Consensus       125 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~  204 (489)
                      ||++++.+..+..+...+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++.......     
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~-----  154 (288)
T cd07833          80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARP-----  154 (288)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCc-----
Confidence            999987777666666779999999999999999999999999999999999999999999999999987654321     


Q ss_pred             CCCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc-------------
Q 011287          205 NAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-------------  270 (489)
Q Consensus       205 ~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~-------------  270 (489)
                          ......+.++..|+|||++.+. .++.++|+|||||++|+|++|++||.+.+.......+...             
T Consensus       155 ----~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T cd07833         155 ----ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS  230 (288)
T ss_pred             ----cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc
Confidence                1122346788999999999888 7899999999999999999999999877665443332210             


Q ss_pred             -------------------CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          271 -------------------DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       271 -------------------~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                                         ...+|..++.++.+||++||..||++||++     +++++||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~il~~~~f  288 (288)
T cd07833         231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTC-----DELLQHPYF  288 (288)
T ss_pred             cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccH-----HHHhcCCCC
Confidence                               001344468999999999999999999998     899999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-42  Score=329.78  Aligned_cols=250  Identities=45%  Similarity=0.805  Sum_probs=227.0

Q ss_pred             EeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEeccCCCCh
Q 011287           53 YGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL  132 (489)
Q Consensus        53 LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~~~gg~L  132 (489)
                      ||.|+||.||.|.+..+++.||+|++.+...........+..|+.+++.++||||+++++.+.+...+|+||||+.+++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            69999999999999989999999999887666666677788899999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCCCCc
Q 011287          133 FDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA  212 (489)
Q Consensus       133 ~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~  212 (489)
                      .+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......          ...
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~----------~~~  150 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG----------SRT  150 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC----------Ccc
Confidence            9999988889999999999999999999999999999999999999999999999999987653321          122


Q ss_pred             cceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhcc
Q 011287          213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDV  292 (489)
Q Consensus       213 ~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~~L~~  292 (489)
                      ....++..|+|||.+.+...+.++|+|||||++|+|++|..||...+.....+.+......+|..++..+.++|++||..
T Consensus       151 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~  230 (250)
T cd05123         151 NTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQK  230 (250)
T ss_pred             cCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcC
Confidence            34568899999999988888999999999999999999999999888877888888888889999999999999999999


Q ss_pred             CCCCCCCCCCCCHHHHhcCCCC
Q 011287          293 DPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       293 dP~~R~t~~~~~~~~l~~hpff  314 (489)
                      ||++||++..  ..++++||||
T Consensus       231 ~p~~R~~~~~--~~~l~~~~~f  250 (250)
T cd05123         231 DPTKRLGSGG--AEEIKAHPFF  250 (250)
T ss_pred             CHhhCCCccc--HHHHHhCCCC
Confidence            9999999854  5789999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3.8e-42  Score=344.78  Aligned_cols=248  Identities=27%  Similarity=0.400  Sum_probs=194.6

Q ss_pred             EeeEEeeeCceEEEEEEEcC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEE--cCCEEEEEE
Q 011287           49 LGKIYGVGSYSKVVRAKKID--TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ--DTFSLYMAL  124 (489)
Q Consensus        49 ~~~~LG~G~~g~Vy~a~~~~--tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~lylV~  124 (489)
                      .++.||+|+||.||+|+++.  ++..||+|.+.....     ...+.+|+.+++.++||||+++++++.  ....+|+||
T Consensus         5 ~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07867           5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLF   79 (317)
T ss_pred             eceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEE
Confidence            34689999999999999754  678999999865422     234667999999999999999999885  456789999


Q ss_pred             eccCCCChHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeee----CCCCCEEEeeccC
Q 011287          125 ESCEGGELFDQITSK---------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL----TADGHIKIADFGS  191 (489)
Q Consensus       125 E~~~gg~L~~~l~~~---------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl----~~~g~ikL~DFG~  191 (489)
                      ||+.+ +|.+++...         ..+++..++.++.||+.||.|||+.||+||||||+|||+    +.++.+||+|||+
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07867          80 DYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             eeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence            99975 888877532         248899999999999999999999999999999999999    5667999999999


Q ss_pred             ccccCCccccccCCCCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCCCHH---------
Q 011287          192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEW---------  261 (489)
Q Consensus       192 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~~~~---------  261 (489)
                      ++.......       ........+||+.|+|||++.+. .++.++|||||||++|+|++|.+||....+.         
T Consensus       159 a~~~~~~~~-------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~  231 (317)
T cd07867         159 ARLFNSPLK-------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHH  231 (317)
T ss_pred             eeccCCCcc-------cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccH
Confidence            986543221       11223356889999999998764 5789999999999999999999999754321         


Q ss_pred             HHHHHHHhc--------------CC------------------------CCCCCCCHHHHHHHHHhhccCCCCCCCCCCC
Q 011287          262 LIFQRIIAR--------------DI------------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPG  303 (489)
Q Consensus       262 ~~~~~i~~~--------------~~------------------------~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~  303 (489)
                      .....+...              ..                        ......+..+.+||.+||+.||.+|||+   
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~---  308 (317)
T cd07867         232 DQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITS---  308 (317)
T ss_pred             HHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCH---
Confidence            011111100              00                        0011235678899999999999999999   


Q ss_pred             CHHHHhcCCCC
Q 011287          304 GYAVLKMHPFF  314 (489)
Q Consensus       304 ~~~~l~~hpff  314 (489)
                        +++++||||
T Consensus       309 --~e~l~hp~f  317 (317)
T cd07867         309 --EQALQDPYF  317 (317)
T ss_pred             --HHHhcCCCC
Confidence              899999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.3e-41  Score=331.89  Aligned_cols=246  Identities=21%  Similarity=0.346  Sum_probs=213.7

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ly  121 (489)
                      +...+|.+.+.||+|+||.||+|.++.+++.||+|++....    .....+.+|+.+++.++||||+++++++.....++
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (263)
T cd05052           3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   78 (263)
T ss_pred             CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence            34578999999999999999999999999999999986542    22445777999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcc
Q 011287          122 MALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      +||||+++++|.+++...  ..+++..++.++.|++.||.|||++|++||||||+||++++++.+||+|||++.......
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~  158 (263)
T cd05052          79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  158 (263)
T ss_pred             EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence            999999999999998764  358999999999999999999999999999999999999999999999999998654322


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCCC
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNY  277 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~  277 (489)
                      ..         ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+....++.+... ...+|..
T Consensus       159 ~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  229 (263)
T cd05052         159 YT---------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEG  229 (263)
T ss_pred             ee---------ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Confidence            11         1112234567999999998899999999999999999998 99999988887777776653 4567788


Q ss_pred             CCHHHHHHHHHhhccCCCCCCCC
Q 011287          278 FSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       278 ~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      ++.++.++|.+||+.||++||++
T Consensus       230 ~~~~~~~li~~cl~~~p~~Rp~~  252 (263)
T cd05052         230 CPPKVYELMRACWQWNPSDRPSF  252 (263)
T ss_pred             CCHHHHHHHHHHccCCcccCCCH
Confidence            99999999999999999999998

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5e-42  Score=337.69  Aligned_cols=256  Identities=31%  Similarity=0.471  Sum_probs=222.1

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      ..|+..+.||.|+||.||+|.+..++..||+|++.....  ......+.+|+.+++.++||||+++++.+.+....|+||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            468899999999999999999999999999999875422  234566788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccC
Q 011287          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (489)
Q Consensus       125 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~  204 (489)
                      ||++||+|.+++.. +.+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.......     
T Consensus        82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-----  155 (277)
T cd06640          82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-----  155 (277)
T ss_pred             ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc-----
Confidence            99999999998875 579999999999999999999999999999999999999999999999999987653321     


Q ss_pred             CCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc-CCCCCCCCCHHHH
Q 011287          205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-DIRFPNYFSDAAR  283 (489)
Q Consensus       205 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~-~~~~p~~~~~~~~  283 (489)
                           .......++..|+|||++.+..++.++|+|||||++|+|++|.+||...+.......+... ...++..++..+.
T Consensus       156 -----~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (277)
T cd06640         156 -----IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFK  230 (277)
T ss_pred             -----cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHH
Confidence                 1123456888999999999888999999999999999999999999887766655544333 3345566889999


Q ss_pred             HHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 011287          284 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (489)
Q Consensus       284 ~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~  318 (489)
                      ++|.+||+.+|++||++     .+++.||||....
T Consensus       231 ~li~~~l~~~p~~Rp~~-----~~il~~~~~~~~~  260 (277)
T cd06640         231 EFIDACLNKDPSFRPTA-----KELLKHKFIVKNA  260 (277)
T ss_pred             HHHHHHcccCcccCcCH-----HHHHhChHhhhcc
Confidence            99999999999999998     8999999997654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.8e-42  Score=354.01  Aligned_cols=253  Identities=24%  Similarity=0.368  Sum_probs=207.5

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEE-----cCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEc
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKK-----IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQD  116 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~-----~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~  116 (489)
                      ..++|++++.||+|+||.||+|++     ..++..||+|++.....  ......+.+|+.+++.+ +||||+++++++.+
T Consensus        33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~  110 (375)
T cd05104          33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTV  110 (375)
T ss_pred             chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence            345899999999999999999974     45678999999864422  22345677899999999 89999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhCC--------------------------------------------------------
Q 011287          117 TFSLYMALESCEGGELFDQITSKG--------------------------------------------------------  140 (489)
Q Consensus       117 ~~~lylV~E~~~gg~L~~~l~~~~--------------------------------------------------------  140 (489)
                      ....|+|||||++|+|.+++....                                                        
T Consensus       111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  190 (375)
T cd05104         111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR  190 (375)
T ss_pred             CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence            999999999999999999986532                                                        


Q ss_pred             -------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccc
Q 011287          141 -------------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (489)
Q Consensus       141 -------------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~  201 (489)
                                         .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... 
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-  269 (375)
T cd05104         191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN-  269 (375)
T ss_pred             cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccc-
Confidence                               367888999999999999999999999999999999999999999999999986543210 


Q ss_pred             ccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhcC--CCCCCCC
Q 011287          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD--IRFPNYF  278 (489)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~~--~~~p~~~  278 (489)
                             ........++..|+|||++.+..++.++|||||||++|+|++ |..||........+.+.....  ...|...
T Consensus       270 -------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (375)
T cd05104         270 -------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECA  342 (375)
T ss_pred             -------ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCC
Confidence                   011122345678999999999999999999999999999998 999998765444333333332  3346667


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       279 ~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      +.++.+||.+||+.||++||++     .++++
T Consensus       343 ~~~l~~li~~cl~~dP~~RPs~-----~eil~  369 (375)
T cd05104         343 PSEMYDIMKSCWDADPLKRPTF-----KQIVQ  369 (375)
T ss_pred             CHHHHHHHHHHccCChhHCcCH-----HHHHH
Confidence            8999999999999999999998     55653

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.1e-41  Score=337.40  Aligned_cols=249  Identities=20%  Similarity=0.344  Sum_probs=213.4

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEc-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  116 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~-----~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  116 (489)
                      +..++|.+.+.||+|+||.||++...     .++..+|+|.+...   .......+.+|+.++++++||||+++++++.+
T Consensus         2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   78 (288)
T cd05093           2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVE   78 (288)
T ss_pred             CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            45689999999999999999999862     35677999988654   23345567889999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCC
Q 011287          117 TFSLYMALESCEGGELFDQITSKG-------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH  183 (489)
Q Consensus       117 ~~~lylV~E~~~gg~L~~~l~~~~-------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~  183 (489)
                      ...+|+||||+++++|.+++...+             .+++..+..++.||+.||+|||++|++||||||+||+++.++.
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~  158 (288)
T cd05093          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL  158 (288)
T ss_pred             CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence            999999999999999999997543             3899999999999999999999999999999999999999999


Q ss_pred             EEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHH
Q 011287          184 IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWL  262 (489)
Q Consensus       184 ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~  262 (489)
                      ++|+|||++........        ........++..|+|||++.+..++.++|+|||||++|+|++ |.+||...+...
T Consensus       159 ~kl~dfg~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~  230 (288)
T cd05093         159 VKIGDFGMSRDVYSTDY--------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE  230 (288)
T ss_pred             EEeccCCccccccCCce--------eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            99999999875532211        011123346788999999998889999999999999999998 999999888887


Q ss_pred             HHHHHHhcC-CCCCCCCCHHHHHHHHHhhccCCCCCCCCC
Q 011287          263 IFQRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGAG  301 (489)
Q Consensus       263 ~~~~i~~~~-~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~  301 (489)
                      ....+.... ...+..++.++.+|+.+||+.||.+||++.
T Consensus       231 ~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~  270 (288)
T cd05093         231 VIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIK  270 (288)
T ss_pred             HHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence            777777665 345667899999999999999999999983

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-41  Score=336.54  Aligned_cols=254  Identities=26%  Similarity=0.435  Sum_probs=207.5

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lyl  122 (489)
                      .+++|++.+.||+|++|.||+|+++.+++.||+|.+......  .......+|+.+++.++||||+++++++.+....|+
T Consensus         3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (291)
T cd07844           3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL   80 (291)
T ss_pred             CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence            368999999999999999999999999999999998754321  122345579999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccc
Q 011287          123 ALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~  201 (489)
                      ||||+.+ +|.+++.+. +.+++..++.++.|++.||.|||++||+||||||+||+++.+|.++|+|||++.......  
T Consensus        81 v~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~--  157 (291)
T cd07844          81 VFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS--  157 (291)
T ss_pred             EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC--
Confidence            9999985 999988764 468999999999999999999999999999999999999999999999999986432211  


Q ss_pred             ccCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCC-HHHHHHHHHhc---------
Q 011287          202 VLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTS-EWLIFQRIIAR---------  270 (489)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~-~~~~~~~i~~~---------  270 (489)
                              .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.. .......+...         
T Consensus       158 --------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (291)
T cd07844         158 --------KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETW  229 (291)
T ss_pred             --------ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhh
Confidence                    11122356889999999875 457889999999999999999999997765 22222222110         


Q ss_pred             ----------CCCC-----------CCCCC--HHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          271 ----------DIRF-----------PNYFS--DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       271 ----------~~~~-----------p~~~~--~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                                ...+           ...++  .++.++|.+||+.||++||++     .+++.||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~-----~e~l~~~~f  291 (291)
T cd07844         230 PGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISA-----AEAMKHPYF  291 (291)
T ss_pred             hhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCH-----HHHhcCCCC
Confidence                      0000           01234  888999999999999999998     899999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.1e-41  Score=335.87  Aligned_cols=252  Identities=29%  Similarity=0.503  Sum_probs=211.3

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEc------
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQD------  116 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~------  116 (489)
                      .+.|++.+.||.|+||.||+|++..+++.||+|++...    ......+..|+.+++++ +||||++++++|..      
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   90 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH   90 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence            47899999999999999999999999999999998654    22334577788888888 79999999999853      


Q ss_pred             CCEEEEEEeccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccc
Q 011287          117 TFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (489)
Q Consensus       117 ~~~lylV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~  194 (489)
                      ...+|++|||+.+|+|.+++...  ..+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++..
T Consensus        91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~  170 (282)
T cd06636          91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  170 (282)
T ss_pred             CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence            46789999999999999998763  4589999999999999999999999999999999999999999999999999875


Q ss_pred             cCCccccccCCCCCCCCccceecCCcCCChhhhc-----CCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHh
Q 011287          195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN-----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA  269 (489)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~-----~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~  269 (489)
                      ....          ........|+..|+|||++.     ...++.++|+|||||++|+|++|.+||...........+..
T Consensus       171 ~~~~----------~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  240 (282)
T cd06636         171 LDRT----------VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR  240 (282)
T ss_pred             hhcc----------ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhh
Confidence            4321          11223567999999999985     34578899999999999999999999987665544443333


Q ss_pred             cCC-C-CCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          270 RDI-R-FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       270 ~~~-~-~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                      ... . .+..++.++.+||++||+.||.+||++     .++++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~-----~ell~~~~~  282 (282)
T cd06636         241 NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPST-----EQLLKHPFI  282 (282)
T ss_pred             CCCCCCcccccCHHHHHHHHHHhCCChhhCcCH-----HHHhcCCCC
Confidence            221 1 223578999999999999999999998     899999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.8e-41  Score=328.71  Aligned_cols=257  Identities=32%  Similarity=0.598  Sum_probs=219.2

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEe
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E  125 (489)
                      +|++.+.||+|+||.||+|.+..+++.||+|++...... ......+..|+.+++.++|+||+++++.+.+...+++|+|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence            589999999999999999999999999999999766433 3456778889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCC
Q 011287          126 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  205 (489)
Q Consensus       126 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~  205 (489)
                      |+++++|.+++.+.+.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++..........   
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~---  156 (264)
T cd06626          80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM---  156 (264)
T ss_pred             cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc---
Confidence            99999999999987789999999999999999999999999999999999999999999999999988764432110   


Q ss_pred             CCCCCCccceecCCcCCChhhhcCCC---CCCCCcchhhhHHHHHHhhCCCCCCCCC-HHHHHHHHHh-cCCCCCCCC--
Q 011287          206 AASDDKACTFVGTAAYVPPEVLNSSP---ATFGNDLWALGCTLYQMLSGTSPFKDTS-EWLIFQRIIA-RDIRFPNYF--  278 (489)
Q Consensus       206 ~~~~~~~~~~~gt~~Y~aPE~l~~~~---~~~~sDiwSLG~ilyelltG~~PF~~~~-~~~~~~~i~~-~~~~~p~~~--  278 (489)
                         ........++..|+|||++.+..   ++.++|+|||||++|+|++|+.||.+.. .......+.. ....+|...  
T Consensus       157 ---~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (264)
T cd06626         157 ---GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQL  233 (264)
T ss_pred             ---cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCccccc
Confidence               01122356889999999998766   8899999999999999999999997653 3333323322 334556544  


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       279 ~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                      ++.+.+||.+||+.||.+||++     .+++.|||+
T Consensus       234 ~~~~~~li~~~l~~~p~~R~~~-----~~i~~~~~~  264 (264)
T cd06626         234 SPEGKDFLDRCLESDPKKRPTA-----SELLQHPFV  264 (264)
T ss_pred             CHHHHHHHHHHccCCcccCCCH-----HHHhcCCCC
Confidence            8999999999999999999998     899999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-43  Score=351.65  Aligned_cols=254  Identities=31%  Similarity=0.558  Sum_probs=224.7

Q ss_pred             eeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEeccCC
Q 011287           50 GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG  129 (489)
Q Consensus        50 ~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~~~g  129 (489)
                      .++||.|-||+||-|+++.||+.||||+++|......+ ...+.+|+.+|+.+.||+||.+-+.|+..+.+++|||-+.|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence            57899999999999999999999999999987655543 47788999999999999999999999999999999999975


Q ss_pred             CChHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCC---CCEEEeeccCccccCCccccccC
Q 011287          130 GELFDQITS--KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD---GHIKIADFGSVKPMQDSRITVLP  204 (489)
Q Consensus       130 g~L~~~l~~--~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~---g~ikL~DFG~a~~~~~~~~~~~~  204 (489)
                       |+++.|-.  .|++++...++++.||+.||.|||.+||+|+||||||||+...   -.+||||||+|+++.+..     
T Consensus       648 -DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-----  721 (888)
T KOG4236|consen  648 -DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-----  721 (888)
T ss_pred             -hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh-----
Confidence             77776643  4889999999999999999999999999999999999999765   369999999999876543     


Q ss_pred             CCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCC----CCH
Q 011287          205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY----FSD  280 (489)
Q Consensus       205 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~----~~~  280 (489)
                            -..+.+||+.|+|||+|..+.|...-|+||+|||+|.-|.|..||...  .++-..|.+..+.+|..    +++
T Consensus       722 ------FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~eis~  793 (888)
T KOG4236|consen  722 ------FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWSEISP  793 (888)
T ss_pred             ------hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchhhcCH
Confidence                  345789999999999999999999999999999999999999999664  34556677777888753    899


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC-ccccc
Q 011287          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID-WKNIR  323 (489)
Q Consensus       281 ~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~-~~~~~  323 (489)
                      ++.|||..+|+..-++|.+.     ...+.|||+++.. |-+|+
T Consensus       794 ~AidlIn~LLqVkm~kRysv-----dk~lsh~Wlq~yq~w~DLR  832 (888)
T KOG4236|consen  794 EAIDLINNLLQVKMRKRYSV-----DKSLSHPWLQDYQTWLDLR  832 (888)
T ss_pred             HHHHHHHHHHHHHHHHhcch-----HhhccchhhhcchHHHHHH
Confidence            99999999999999999988     7799999998754 66555

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=9e-42  Score=340.78  Aligned_cols=252  Identities=24%  Similarity=0.385  Sum_probs=210.8

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEE--EEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcC
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVY--ALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDT  117 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~v--AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  117 (489)
                      .+..++|++.+.||+|+||.||+|.++.++..+  |+|.+...  ........+.+|+.++.++ +||||+++++++.+.
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~   80 (303)
T cd05088           3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   80 (303)
T ss_pred             ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC
Confidence            456789999999999999999999998887654  66665432  2234455677899999999 899999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCC
Q 011287          118 FSLYMALESCEGGELFDQITSKG----------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD  181 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~~----------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~  181 (489)
                      ..+|+||||+++|+|.+++.+.+                .+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~  160 (303)
T cd05088          81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN  160 (303)
T ss_pred             CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence            99999999999999999997543                47899999999999999999999999999999999999999


Q ss_pred             CCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCH
Q 011287          182 GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSE  260 (489)
Q Consensus       182 g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~  260 (489)
                      +.++|+|||++......           .......++..|+|||.+.+..++.++|||||||++|+|++ |.+||.+.+.
T Consensus       161 ~~~kl~dfg~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  229 (303)
T cd05088         161 YVAKIADFGLSRGQEVY-----------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC  229 (303)
T ss_pred             CcEEeCccccCcccchh-----------hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh
Confidence            99999999998632110           01111234567999999988889999999999999999998 9999998887


Q ss_pred             HHHHHHHHhc-CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          261 WLIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       261 ~~~~~~i~~~-~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      .+.+..+... ....|..+++++.+||.+||+.+|++||++     .+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-----~~il~  275 (303)
T cd05088         230 AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSF-----AQILV  275 (303)
T ss_pred             HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCH-----HHHHH
Confidence            7777666544 234566788999999999999999999999     55554

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-41  Score=325.03  Aligned_cols=253  Identities=32%  Similarity=0.587  Sum_probs=224.4

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEe
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E  125 (489)
                      +|++.+.||+|++|.||+|++..+++.||+|.+...... ......+.+|++++++++|||++++++++.+....|+|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence            589999999999999999999999999999999876443 2345678889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCC
Q 011287          126 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  205 (489)
Q Consensus       126 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~  205 (489)
                      |+++++|.+++.+.+.+++..+..++.|++.||.+||++||+||||+|+||+++.++.++|+|||.+.......      
T Consensus        80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~------  153 (254)
T cd06627          80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS------  153 (254)
T ss_pred             cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCc------
Confidence            99999999999988889999999999999999999999999999999999999999999999999998654322      


Q ss_pred             CCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHH-hcCCCCCCCCCHHHHH
Q 011287          206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII-ARDIRFPNYFSDAARD  284 (489)
Q Consensus       206 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~-~~~~~~p~~~~~~~~~  284 (489)
                          .......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+. .....+|..++..+.+
T Consensus       154 ----~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (254)
T cd06627         154 ----KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKD  229 (254)
T ss_pred             ----ccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHH
Confidence                11234568899999999988888999999999999999999999998877655554443 4445677889999999


Q ss_pred             HHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          285 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       285 Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                      +|.+||..+|++||++     .+++.||||
T Consensus       230 ~i~~~l~~~p~~R~~~-----~~~l~~~~~  254 (254)
T cd06627         230 FLMQCFQKDPNLRPTA-----KQLLKHPWI  254 (254)
T ss_pred             HHHHHHhCChhhCcCH-----HHHhcCCCC
Confidence            9999999999999998     899999998

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=7.9e-42  Score=336.89  Aligned_cols=252  Identities=29%  Similarity=0.455  Sum_probs=210.9

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEe
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E  125 (489)
                      +|++.+.||.|++|.||+|++..+|+.||||.+...... ......+.+|+.++++++||||+++++++.+....|+|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc-cccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence            589999999999999999999999999999998654322 2233467779999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          126 SCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       126 ~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      |+. ++|..++...  +.+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++..+....    
T Consensus        80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~----  154 (284)
T cd07860          80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV----  154 (284)
T ss_pred             ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc----
Confidence            996 5898888653  568999999999999999999999999999999999999999999999999987553221    


Q ss_pred             CCCCCCCCccceecCCcCCChhhhcCCC-CCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC-----------
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----------  271 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~-~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~-----------  271 (489)
                            .......++..|+|||++.+.. ++.++|+|||||++|+|++|+.||.+.++.....++....           
T Consensus       155 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (284)
T cd07860         155 ------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV  228 (284)
T ss_pred             ------cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhh
Confidence                  1122335788999999887644 6888999999999999999999998877765544433210           


Q ss_pred             -------CCC-----------CCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          272 -------IRF-----------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       272 -------~~~-----------p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                             ..+           ...++++++++|.+||+.||++||++     +++++||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-----~~~l~~~~f  284 (284)
T cd07860         229 TSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISA-----KAALAHPFF  284 (284)
T ss_pred             hHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCH-----HHHhcCCCC
Confidence                   011           13468899999999999999999998     899999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.6e-41  Score=334.88  Aligned_cols=254  Identities=18%  Similarity=0.334  Sum_probs=214.0

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEc----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKI----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~----~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  117 (489)
                      +.+++|++.+.||+|+||.||+|.+.    .++..||+|.+....  .......+.+|..+++.++||||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   79 (283)
T cd05090           2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE   79 (283)
T ss_pred             CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence            45689999999999999999999863    456889999986432  233445678899999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCC
Q 011287          118 FSLYMALESCEGGELFDQITSK-----------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA  180 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~-----------------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~  180 (489)
                      ...|+||||+++++|.+++...                 ..+++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~  159 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE  159 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence            9999999999999999998532                 23788899999999999999999999999999999999999


Q ss_pred             CCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCC
Q 011287          181 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS  259 (489)
Q Consensus       181 ~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~  259 (489)
                      ++.++|+|||+++.......        ........++..|+|||.+.+..++.++|+|||||++|+|++ |.+||.+.+
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~  231 (283)
T cd05090         160 QLHVKISDLGLSREIYSADY--------YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS  231 (283)
T ss_pred             CCcEEeccccccccccCCcc--------eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence            99999999999986543211        111234456778999999988889999999999999999998 999998887


Q ss_pred             HHHHHHHHHhcC-CCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          260 EWLIFQRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       260 ~~~~~~~i~~~~-~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      ...+.+.+.... +..|..+++.+.+++.+||+.||.+||++     .++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~-----~~i~~  278 (283)
T cd05090         232 NQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRF-----KDIHT  278 (283)
T ss_pred             HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCH-----HHHHH
Confidence            766666655433 45677889999999999999999999998     55654

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=4.7e-42  Score=334.61  Aligned_cols=253  Identities=29%  Similarity=0.491  Sum_probs=219.5

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      ++|++.+.||.|+||.||+|.++.+++.||+|.+.....  ......+.+|+.+++.++||||+++++.+.+...+|+|+
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM   78 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence            478999999999999999999999999999999876532  234556778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh-CCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccc
Q 011287          125 ESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (489)
Q Consensus       125 E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~-~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~  202 (489)
                      ||+.+++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||.+.......   
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~---  155 (265)
T cd06605          79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL---  155 (265)
T ss_pred             EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH---
Confidence            999999999999876 789999999999999999999999 999999999999999999999999999987543211   


Q ss_pred             cCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCC-----CHHHHHHHHHhc-CCCCCC
Q 011287          203 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT-----SEWLIFQRIIAR-DIRFPN  276 (489)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~-----~~~~~~~~i~~~-~~~~p~  276 (489)
                               .....|+..|+|||.+.+..++.++|+|||||++|+|++|..||...     ......+.+... ...+|.
T Consensus       156 ---------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (265)
T cd06605         156 ---------AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPS  226 (265)
T ss_pred             ---------hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCCh
Confidence                     11267889999999999999999999999999999999999999764     233444444443 233444


Q ss_pred             C-CCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          277 Y-FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       277 ~-~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      . ++.+++++|.+||..||++||++     .+++.||||+.
T Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rpt~-----~~ll~~~~~~~  262 (265)
T cd06605         227 GKFSPDFQDFVNLCLIKDPRERPSY-----KELLEHPFIKK  262 (265)
T ss_pred             hhcCHHHHHHHHHHcCCCchhCcCH-----HHHhhCchhhc
Confidence            4 89999999999999999999998     89999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.4e-42  Score=366.03  Aligned_cols=264  Identities=25%  Similarity=0.367  Sum_probs=202.7

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCC-CcEEEEEE--------------eecccccchhHHHHHHHHHHHHHhCCCCCcc
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDT-GTVYALKI--------------MDKKFITKENKTAYVKLERIVLDQLDHPGVV  108 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~t-g~~vAiK~--------------~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv  108 (489)
                      .++|++++.||+|+||+||+|..+.. +..++.|.              +.+...........+.+|+.+|+.++||||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            46899999999999999999986543 22223221              1111111223345678899999999999999


Q ss_pred             EEEEEEEcCCEEEEEEeccCCCChHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCC
Q 011287          109 RLFFTFQDTFSLYMALESCEGGELFDQITSK-----GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH  183 (489)
Q Consensus       109 ~l~~~~~~~~~lylV~E~~~gg~L~~~l~~~-----~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~  183 (489)
                      ++++++.+....|+|++++. ++|.+++...     .......++.++.||+.||.|||++||+||||||+|||++.+|.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~  305 (501)
T PHA03210        227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK  305 (501)
T ss_pred             cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence            99999999999999999995 4788877543     23456788899999999999999999999999999999999999


Q ss_pred             EEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCC-CCCC--CH
Q 011287          184 IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP-FKDT--SE  260 (489)
Q Consensus       184 ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~P-F~~~--~~  260 (489)
                      +||+|||+++.+....         ......++||..|+|||++.+..++.++|||||||++|+|++|..+ |...  +.
T Consensus       306 vkL~DFGla~~~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~  376 (501)
T PHA03210        306 IVLGDFGTAMPFEKER---------EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP  376 (501)
T ss_pred             EEEEeCCCceecCccc---------ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH
Confidence            9999999998664321         1223356899999999999999999999999999999999998754 4322  22


Q ss_pred             HHHHHHHHhc----CCCCC----------------------------CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHH
Q 011287          261 WLIFQRIIAR----DIRFP----------------------------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVL  308 (489)
Q Consensus       261 ~~~~~~i~~~----~~~~p----------------------------~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l  308 (489)
                      ...+.++...    ...+|                            ..++.++.++|.+||+.||.+|||+     .++
T Consensus       377 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa-----~el  451 (501)
T PHA03210        377 GKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGA-----AEL  451 (501)
T ss_pred             HHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCH-----HHH
Confidence            2222222210    11111                            1256778899999999999999999     899


Q ss_pred             hcCCCCCCCCcccc
Q 011287          309 KMHPFFKGIDWKNI  322 (489)
Q Consensus       309 ~~hpff~~i~~~~~  322 (489)
                      +.||||.+...+.+
T Consensus       452 L~hp~f~~~~~~~~  465 (501)
T PHA03210        452 LALPLFSAEEEEEI  465 (501)
T ss_pred             hhChhhhcCCchHH
Confidence            99999988765543

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.1e-41  Score=337.77  Aligned_cols=255  Identities=28%  Similarity=0.429  Sum_probs=214.4

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC--CEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT--FSL  120 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~l  120 (489)
                      ..++|++.+.||.|+||.||+|++..+++.+|+|.+...... ......+.+|+.+++.++||||+++++++.+.  ..+
T Consensus         3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~   81 (293)
T cd07843           3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI   81 (293)
T ss_pred             chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence            357899999999999999999999999999999999755333 22334456799999999999999999998877  889


Q ss_pred             EEEEeccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcc
Q 011287          121 YMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      |+||||+.+ +|.+++.... .+++..++.++.||+.||+|||+.|++||||||+||+++.++.++|+|||++..+....
T Consensus        82 ~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          82 YMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             EEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            999999975 9999887653 59999999999999999999999999999999999999999999999999988654321


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCCC-CCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc--------
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--------  270 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~-~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~--------  270 (489)
                                .......+++.|+|||.+.+.. ++.++|+|||||++|+|++|.+||.+.+....+.++...        
T Consensus       161 ----------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  230 (293)
T cd07843         161 ----------KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKI  230 (293)
T ss_pred             ----------cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHH
Confidence                      1122346788999999987654 688999999999999999999999988776655554321        


Q ss_pred             -----------------------CCCCCCC-CCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          271 -----------------------DIRFPNY-FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       271 -----------------------~~~~p~~-~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                                             ...+|.. +++.+.+||++||+.||++||++     .+++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~-----~ell~~~~f  293 (293)
T cd07843         231 WPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISA-----EDALKHPYF  293 (293)
T ss_pred             HHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCH-----HHHhcCCCC
Confidence                                   1123333 68889999999999999999998     899999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.6e-41  Score=336.99  Aligned_cols=258  Identities=28%  Similarity=0.410  Sum_probs=208.2

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-----
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-----  118 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----  118 (489)
                      +++|++.+.||+|+||.||+|++..+++.||||.+...... ........+|+.++++++||||+++++++.+..     
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc-CCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            57899999999999999999999999999999998654322 222334557999999999999999999886543     


Q ss_pred             ---EEEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccc
Q 011287          119 ---SLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (489)
Q Consensus       119 ---~lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~  194 (489)
                         ..|+||||+.+ +|.+.+.+. ..+++.+++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..
T Consensus        90 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  168 (310)
T cd07865          90 YKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA  168 (310)
T ss_pred             CCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence               45999999975 888887765 3699999999999999999999999999999999999999999999999999986


Q ss_pred             cCCccccccCCCCCCCCccceecCCcCCChhhhcCCC-CCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC--
Q 011287          195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--  271 (489)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~-~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~--  271 (489)
                      +......      .........++..|+|||.+.+.. ++.++|+|||||++|+|++|++||.+.+.......+....  
T Consensus       169 ~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~  242 (310)
T cd07865         169 FSLSKNS------KPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS  242 (310)
T ss_pred             ccCCccc------CCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            5432211      011223456889999999986644 7889999999999999999999998877654433322210  


Q ss_pred             -----------------CCCCC-------------CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          272 -----------------IRFPN-------------YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       272 -----------------~~~p~-------------~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                                       ..+|.             ..+..+.+||.+||..||.+||++     +++++||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~-----~e~l~h~~f  310 (310)
T cd07865         243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDA-----DTALNHDFF  310 (310)
T ss_pred             CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCH-----HHHhcCCCC
Confidence                             01111             125678899999999999999999     899999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=3.8e-41  Score=333.26  Aligned_cols=253  Identities=30%  Similarity=0.484  Sum_probs=219.1

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEe
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E  125 (489)
                      +|...+.||+|++|.||+|.+..+++.+|+|++...   .......+.+|+.+++.++||||+++++++......|+|+|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e   96 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME   96 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence            566678999999999999999999999999988543   22334557789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCC
Q 011287          126 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  205 (489)
Q Consensus       126 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~  205 (489)
                      |+.+++|.+++.. +.+++..+..++.|++.||+|||++||+||||+|+||+++.++.++|+|||.+......       
T Consensus        97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~-------  168 (285)
T cd06648          97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE-------  168 (285)
T ss_pred             ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccC-------
Confidence            9999999999887 67999999999999999999999999999999999999999999999999987654321       


Q ss_pred             CCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCC---CCCCCCHHH
Q 011287          206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR---FPNYFSDAA  282 (489)
Q Consensus       206 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~---~p~~~~~~~  282 (489)
                         ........|+..|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+......   .+..++..+
T Consensus       169 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  245 (285)
T cd06648         169 ---VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRL  245 (285)
T ss_pred             ---CcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHH
Confidence               11223456899999999999888999999999999999999999999988877777666654322   233478999


Q ss_pred             HHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          283 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       283 ~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                      .+||++||+.||++||++     .++++||||+..
T Consensus       246 ~~li~~~l~~~p~~Rpt~-----~~il~~~~~~~~  275 (285)
T cd06648         246 RSFLDRMLVRDPAQRATA-----AELLNHPFLAKA  275 (285)
T ss_pred             HHHHHHHcccChhhCcCH-----HHHccCcccccC
Confidence            999999999999999998     899999999853

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.2e-41  Score=328.82  Aligned_cols=248  Identities=25%  Similarity=0.403  Sum_probs=212.1

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lyl  122 (489)
                      .+++|++.+.||+|+||.||+|+.+. +..+|+|.+.....    ....+.+|+.++++++||||+++++++.+...+|+
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   76 (256)
T cd05114           2 NPSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYI   76 (256)
T ss_pred             CHHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEE
Confidence            45789999999999999999998854 56899998865422    23456779999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccc
Q 011287          123 ALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~  201 (489)
                      ||||+++|+|.+++... +.+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||.++....... 
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-  155 (256)
T cd05114          77 VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-  155 (256)
T ss_pred             EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-
Confidence            99999999999998753 5689999999999999999999999999999999999999999999999999875432211 


Q ss_pred             ccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhcC-CCCCCCCC
Q 011287          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRFPNYFS  279 (489)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~~-~~~p~~~~  279 (489)
                              .......++..|+|||++.+..++.++|+|||||++|+|++ |++||...+.......+.... ...|...+
T Consensus       156 --------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~  227 (256)
T cd05114         156 --------TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLAS  227 (256)
T ss_pred             --------eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Confidence                    01112235568999999998889999999999999999999 999999998888888877653 34567788


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCCCCHHHHh
Q 011287          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLK  309 (489)
Q Consensus       280 ~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~  309 (489)
                      .++.+|+.+||+.||++||++     ++++
T Consensus       228 ~~~~~li~~c~~~~p~~Rps~-----~~l~  252 (256)
T cd05114         228 MTVYEVMYSCWHEKPEGRPTF-----AELL  252 (256)
T ss_pred             HHHHHHHHHHccCCcccCcCH-----HHHH
Confidence            999999999999999999998     5665

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.1e-41  Score=344.92  Aligned_cols=260  Identities=26%  Similarity=0.417  Sum_probs=214.5

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEE----cCCEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ----DTFSL  120 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~----~~~~l  120 (489)
                      ++|++.+.||+|+||.||+|+++.+|+.||+|++.+..... .....+.+|+.+++.++||||++++++|.    +...+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVP-TLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccc-cchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            68999999999999999999999999999999987653322 23455667999999999999999998886    34578


Q ss_pred             EEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      |+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.++|+|||++........
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  162 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT  162 (334)
T ss_pred             EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence            99999996 59999998878899999999999999999999999999999999999999999999999999876543221


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc---------
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---------  270 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~---------  270 (489)
                      .      ........+|+..|+|||++.+ ..++.++|+|||||++|+|++|++||.+.+.......+...         
T Consensus       163 ~------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         163 E------HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL  236 (334)
T ss_pred             C------CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence            1      1112234578999999999865 45889999999999999999999999887654433332210         


Q ss_pred             -----------------CCCC-----CCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          271 -----------------DIRF-----PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       271 -----------------~~~~-----p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                                       ....     ....+.++.++|.+||+.||++||++     ++++.||||.+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-----~~~l~~~~~~~~  300 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITV-----EQALQHPFLAQY  300 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCH-----HHHHhChhhhhc
Confidence                             0011     13468999999999999999999998     899999999854

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=6e-42  Score=340.37  Aligned_cols=253  Identities=30%  Similarity=0.492  Sum_probs=218.0

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      +.|.....||+|+||.||++.+..++..||||.+...   .......+.+|+.+++.++||||+++++.+......|+||
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~   98 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR---KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM   98 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc---hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence            4566678899999999999999999999999998653   2334556778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccC
Q 011287          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (489)
Q Consensus       125 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~  204 (489)
                      ||+++++|.+++.. +.+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++......      
T Consensus        99 e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~------  171 (292)
T cd06658          99 EFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE------  171 (292)
T ss_pred             eCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc------
Confidence            99999999998754 57999999999999999999999999999999999999999999999999998754321      


Q ss_pred             CCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc---CCCCCCCCCHH
Q 011287          205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFSDA  281 (489)
Q Consensus       205 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~---~~~~p~~~~~~  281 (489)
                          ........|+..|+|||++.+..++.++|+|||||++|+|++|..||...+....+..+...   ....+...+..
T Consensus       172 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (292)
T cd06658         172 ----VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSV  247 (292)
T ss_pred             ----cccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHH
Confidence                11223467899999999999888999999999999999999999999988776665554432   22223357889


Q ss_pred             HHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       282 ~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      +.++|.+||+.||++||++     +++++||||..
T Consensus       248 ~~~li~~~l~~~P~~Rpt~-----~~il~~~~~~~  277 (292)
T cd06658         248 LRGFLDLMLVREPSQRATA-----QELLQHPFLKL  277 (292)
T ss_pred             HHHHHHHHccCChhHCcCH-----HHHhhChhhhc
Confidence            9999999999999999998     89999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.4e-41  Score=332.84  Aligned_cols=253  Identities=30%  Similarity=0.481  Sum_probs=220.5

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEe
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E  125 (489)
                      -|++.+.||+|+||.||+|.+..++..||+|++.....  ......+.+|+.+++.++||||+++++.+.+....|+|||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   82 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME   82 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence            47889999999999999999999999999999865422  2334567789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCC
Q 011287          126 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  205 (489)
Q Consensus       126 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~  205 (489)
                      |+++++|.+++.. +.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++..+....      
T Consensus        83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~------  155 (277)
T cd06641          83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ------  155 (277)
T ss_pred             eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch------
Confidence            9999999998875 579999999999999999999999999999999999999999999999999987653321      


Q ss_pred             CCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc-CCCCCCCCCHHHHH
Q 011287          206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-DIRFPNYFSDAARD  284 (489)
Q Consensus       206 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~  284 (489)
                          .......|+..|+|||.+.+...+.++|+|||||++|+|++|..||...+.......+... ...++..++.++.+
T Consensus       156 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (277)
T cd06641         156 ----IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKE  231 (277)
T ss_pred             ----hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHH
Confidence                1123456889999999998888899999999999999999999999888776666665443 23456678999999


Q ss_pred             HHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          285 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       285 Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      +|.+||+.+|.+||++     .++++||||..
T Consensus       232 ~i~~~l~~~p~~Rp~~-----~~~l~~~~~~~  258 (277)
T cd06641         232 FVEACLNKEPSFRPTA-----KELLKHKFIVR  258 (277)
T ss_pred             HHHHHccCChhhCcCH-----HHHHhCHHHhh
Confidence            9999999999999988     89999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-42  Score=354.43  Aligned_cols=249  Identities=31%  Similarity=0.556  Sum_probs=218.2

Q ss_pred             eEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEeccCCC
Q 011287           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG  130 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~~~gg  130 (489)
                      -+||+|.||+||.|++..|....|||.+..+   .....+-+..|+.+.+.|+|.|||++++.+..++++-+.||.++||
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG  657 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG  657 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence            3799999999999999999999999988644   2334556778999999999999999999999999999999999999


Q ss_pred             ChHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCC-CCCEEEeeccCccccCCccccccCCC
Q 011287          131 ELFDQITSK-GHL--SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-DGHIKIADFGSVKPMQDSRITVLPNA  206 (489)
Q Consensus       131 ~L~~~l~~~-~~l--~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~-~g~ikL~DFG~a~~~~~~~~~~~~~~  206 (489)
                      +|.+++... |++  +|.++-+|..||++||.|||++.|||||||-.|+||+. .|.+||+|||.++.+..-        
T Consensus       658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--------  729 (1226)
T KOG4279|consen  658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--------  729 (1226)
T ss_pred             cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccC--------
Confidence            999999764 888  89999999999999999999999999999999999975 589999999999976432        


Q ss_pred             CCCCCccceecCCcCCChhhhcCCC--CCCCCcchhhhHHHHHHhhCCCCCCCCCH--HHHHHH-HHhcCCCCCCCCCHH
Q 011287          207 ASDDKACTFVGTAAYVPPEVLNSSP--ATFGNDLWALGCTLYQMLSGTSPFKDTSE--WLIFQR-IIARDIRFPNYFSDA  281 (489)
Q Consensus       207 ~~~~~~~~~~gt~~Y~aPE~l~~~~--~~~~sDiwSLG~ilyelltG~~PF~~~~~--~~~~~~-i~~~~~~~p~~~~~~  281 (489)
                        ..-..+|.||..|||||++..++  |+.++|||||||++.||.||++||.....  ..+|+- ..+..+++|..++.+
T Consensus       730 --nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsae  807 (1226)
T KOG4279|consen  730 --NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAE  807 (1226)
T ss_pred             --CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHH
Confidence              23455899999999999997654  89999999999999999999999975433  334443 345567889999999


Q ss_pred             HHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       282 ~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                      ++.+|.+|+.+||..||+|     .+++..||++.-
T Consensus       808 ak~FilrcFepd~~~R~sA-----~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  808 AKNFILRCFEPDPCDRPSA-----KDLLQDPFLQHN  838 (1226)
T ss_pred             HHHHHHHHcCCCcccCccH-----HHhccCcccccC
Confidence            9999999999999999999     889999999753

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.7e-41  Score=332.25  Aligned_cols=248  Identities=31%  Similarity=0.510  Sum_probs=206.4

Q ss_pred             eEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccEEEEEEEcC--CEEEEE
Q 011287           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDT--FSLYMA  123 (489)
Q Consensus        47 y~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~--~~lylV  123 (489)
                      |++.+.||+|+||.||+|.+..+++.||+|.+.+......  .....+|..+++++. ||||+++++++.+.  ..+|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~--~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE--QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch--hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            7889999999999999999999999999999876532222  223346888888885 99999999999987  889999


Q ss_pred             EeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccc
Q 011287          124 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~  202 (489)
                      |||+.+ +|.+.+... +.+++..+..++.||+.||+|||+.|++||||+|+||+++. +.++|+|||++..+....   
T Consensus        79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~---  153 (282)
T cd07831          79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP---  153 (282)
T ss_pred             EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC---
Confidence            999975 888888753 57899999999999999999999999999999999999999 999999999997653221   


Q ss_pred             cCCCCCCCCccceecCCcCCChhhhc-CCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc-----------
Q 011287          203 LPNAASDDKACTFVGTAAYVPPEVLN-SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-----------  270 (489)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~Y~aPE~l~-~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~-----------  270 (489)
                              ......++..|+|||.+. +..++.++|+|||||++|+|++|.+||.+.+..+.+..+...           
T Consensus       154 --------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (282)
T cd07831         154 --------PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKK  225 (282)
T ss_pred             --------CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence                    112346789999999764 455788999999999999999999999988876655544321           


Q ss_pred             -------CCCCC-----------CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          271 -------DIRFP-----------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       271 -------~~~~p-----------~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                             .+.+|           ..++.++.+||.+||+.||++||++     .++++||||
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~-----~~~l~~~~~  282 (282)
T cd07831         226 FRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITA-----KQALRHPYF  282 (282)
T ss_pred             hcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCH-----HHHhhCCCC
Confidence                   11222           2468999999999999999999998     899999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.8e-41  Score=333.57  Aligned_cols=253  Identities=28%  Similarity=0.414  Sum_probs=205.5

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||+|++.....  ......+.+|+.+++.++|+||+++++++.+....|+|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   81 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV   81 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence            3789999999999999999999999999999999865432  22223456799999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccc
Q 011287          124 LESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~  202 (489)
                      |||+. ++|.+.+.. .+.+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||+++......   
T Consensus        82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---  157 (291)
T cd07870          82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS---  157 (291)
T ss_pred             Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC---
Confidence            99996 577776654 3568899999999999999999999999999999999999999999999999987543211   


Q ss_pred             cCCCCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCCCHH-HHHHHHHhc----------
Q 011287          203 LPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQRIIAR----------  270 (489)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~~~~-~~~~~i~~~----------  270 (489)
                             .......+++.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+.. +.+..+...          
T Consensus       158 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (291)
T cd07870         158 -------QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWP  230 (291)
T ss_pred             -------CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhh
Confidence                   112344678999999998764 4788999999999999999999999865532 222222110          


Q ss_pred             ----CCC-----C----C---------CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          271 ----DIR-----F----P---------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       271 ----~~~-----~----p---------~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                          ...     +    +         ...+.++.+++.+||+.||++|||+     .+++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~-----~~~l~h~~~  291 (291)
T cd07870         231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISA-----QDALLHPYF  291 (291)
T ss_pred             hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCH-----HHHhcCCCC
Confidence                000     0    0         0125789999999999999999999     899999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.4e-41  Score=334.27  Aligned_cols=248  Identities=20%  Similarity=0.323  Sum_probs=212.5

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKID-----TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~-----tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  117 (489)
                      ..++|.+.+.||+|+||.||+|++..     ++..||+|++....  .......+.+|+.+++.++||||+++++++.+.
T Consensus         3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   80 (280)
T cd05049           3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEG   80 (280)
T ss_pred             ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence            45789999999999999999998753     46899999986542  222346778899999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCC
Q 011287          118 FSLYMALESCEGGELFDQITSKG--------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH  183 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~~--------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~  183 (489)
                      ...|+||||+++++|.+++...+              .+++..+..++.||+.||.|||++|++||||||+||+++.++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence            99999999999999999997643              3789999999999999999999999999999999999999999


Q ss_pred             EEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHH
Q 011287          184 IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWL  262 (489)
Q Consensus       184 ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~  262 (489)
                      ++|+|||++........        ........++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+...
T Consensus       161 ~kl~d~g~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~  232 (280)
T cd05049         161 VKIGDFGMSRDVYTTDY--------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE  232 (280)
T ss_pred             EEECCcccceecccCcc--------eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            99999999875432210        011123356788999999999999999999999999999998 999999888887


Q ss_pred             HHHHHHhcCC-CCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          263 IFQRIIARDI-RFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       263 ~~~~i~~~~~-~~p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      ....+..+.. ..|..++..+.+|+++||+.||++||++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~  271 (280)
T cd05049         233 VIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINI  271 (280)
T ss_pred             HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCH
Confidence            7777776554 3456789999999999999999999998

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3.9e-41  Score=333.78  Aligned_cols=254  Identities=27%  Similarity=0.396  Sum_probs=209.6

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCE----
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFS----  119 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~----  119 (489)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.+. ||||+++++++.....    
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~   79 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP   79 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence            479999999999999999999999999999999865432 2223345677999999995 6999999999987665    


Q ss_pred             -EEEEEeccCCCChHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCC-CCCEEEeeccCc
Q 011287          120 -LYMALESCEGGELFDQITSK-----GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-DGHIKIADFGSV  192 (489)
Q Consensus       120 -lylV~E~~~gg~L~~~l~~~-----~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~-~g~ikL~DFG~a  192 (489)
                       .|+||||+++ +|.+++...     ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.++|+|||.+
T Consensus        80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~  158 (295)
T cd07837          80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG  158 (295)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence             8999999986 898887653     35899999999999999999999999999999999999998 889999999998


Q ss_pred             cccCCccccccCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC
Q 011287          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD  271 (489)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~  271 (489)
                      ..+....          .......+++.|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.++.....++....
T Consensus       159 ~~~~~~~----------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~  228 (295)
T cd07837         159 RAFSIPV----------KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLL  228 (295)
T ss_pred             eecCCCc----------cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            7553221          11122357889999998865 457899999999999999999999999887766655543310


Q ss_pred             -----C------------CCC-----------CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 011287          272 -----I------------RFP-----------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (489)
Q Consensus       272 -----~------------~~p-----------~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~  315 (489)
                           .            .+|           +.++.++.+||.+||+.||.+||++     .+++.||||+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~-----~eil~~~~~~  295 (295)
T cd07837         229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISA-----KAALTHPYFD  295 (295)
T ss_pred             CCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCH-----HHHhcCCCcC
Confidence                 0            011           2478899999999999999999998     8999999995

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.3e-41  Score=335.65  Aligned_cols=258  Identities=26%  Similarity=0.373  Sum_probs=213.0

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      +++|++.+.||+|++|.||+|.+..+|+.||+|.+...... ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus         1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (294)
T PLN00009          1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV   79 (294)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence            47899999999999999999999999999999998654322 23335567799999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCC-CCCEEEeeccCccccCCccc
Q 011287          124 LESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-DGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~~~--l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~-~g~ikL~DFG~a~~~~~~~~  200 (489)
                      |||+. ++|.+++.....  +++..++.++.||+.||+|||++|++||||+|+||+++. ++.+||+|||++....... 
T Consensus        80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~-  157 (294)
T PLN00009         80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-  157 (294)
T ss_pred             Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc-
Confidence            99996 488888866433  588899999999999999999999999999999999985 4579999999987543211 


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC--------
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--------  271 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~--------  271 (489)
                               .......+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||...+......++....        
T Consensus       158 ---------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  228 (294)
T PLN00009        158 ---------RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETW  228 (294)
T ss_pred             ---------cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence                     11123467899999999866 457889999999999999999999999877766555443210        


Q ss_pred             -------------CC--------CCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 011287          272 -------------IR--------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (489)
Q Consensus       272 -------------~~--------~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~  318 (489)
                                   ..        ....+++++.++|.+||+.||++||++     .+++.||||.+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~-----~~~l~~~~~~~~~  291 (294)
T PLN00009        229 PGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITA-----RAALEHEYFKDLG  291 (294)
T ss_pred             cccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCH-----HHHhcCchHhHHh
Confidence                         00        123468899999999999999999998     8999999998654

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=6.1e-41  Score=327.96  Aligned_cols=253  Identities=29%  Similarity=0.504  Sum_probs=211.4

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      .+.+.....||+|+||.||+|++..++..||+|.+....   ......+.+|+.+++.++|+||+++++++.+....|+|
T Consensus         7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            344555578999999999999999999999999886542   23445678899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCC-CCCEEEeeccCccccCCcc
Q 011287          124 LESCEGGELFDQITSK-GHL--SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-DGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~-~~l--~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~-~g~ikL~DFG~a~~~~~~~  199 (489)
                      +||+++++|.+++... +.+  ++..+..++.||+.||.|||+.||+||||||+||+++. ++.++|+|||++.......
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~  163 (268)
T cd06624          84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN  163 (268)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence            9999999999999864 456  88999999999999999999999999999999999986 6799999999987553211


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCCC--CCCCCcchhhhHHHHHHhhCCCCCCCCCHH--HHHHH-HHhcCCCC
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSP--ATFGNDLWALGCTLYQMLSGTSPFKDTSEW--LIFQR-IIARDIRF  274 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~--~~~~sDiwSLG~ilyelltG~~PF~~~~~~--~~~~~-i~~~~~~~  274 (489)
                                .......|+..|+|||.+....  ++.++|+|||||++|+|++|++||......  ..+.. .......+
T Consensus       164 ----------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  233 (268)
T cd06624         164 ----------PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEI  233 (268)
T ss_pred             ----------CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCC
Confidence                      1122346889999999986543  788999999999999999999999764322  12221 22344567


Q ss_pred             CCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       275 p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                      |..+++++++|+.+||+.+|.+||++     .+++.||||
T Consensus       234 ~~~~~~~~~~li~~~l~~~p~~Rpt~-----~~ll~~~~~  268 (268)
T cd06624         234 PESLSAEAKNFILRCFEPDPDKRASA-----HDLLQDPFL  268 (268)
T ss_pred             CcccCHHHHHHHHHHcCCCchhCCCH-----HHHHhCCCC
Confidence            88899999999999999999999998     899999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=3.4e-41  Score=326.78  Aligned_cols=253  Identities=31%  Similarity=0.570  Sum_probs=218.9

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEe
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E  125 (489)
                      +|.+.+.||+|+||.||+|.+..+|..||+|.+....... .....+.+|+.+++.++|+||+++++.+.+....|+|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence            5899999999999999999999999999999987653322 234556789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCC-EEEeeccCccccCCccccc
Q 011287          126 SCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVKPMQDSRITV  202 (489)
Q Consensus       126 ~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~-ikL~DFG~a~~~~~~~~~~  202 (489)
                      |+++++|.+++.+..  .+++..+..++.|++.||.|||++|++|+||||+||++++++. ++|+|||.+.......   
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~---  156 (257)
T cd08225          80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM---  156 (257)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc---
Confidence            999999999987653  4799999999999999999999999999999999999998865 6999999987654321   


Q ss_pred             cCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCHH
Q 011287          203 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-RFPNYFSDA  281 (489)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~-~~p~~~~~~  281 (489)
                             .......|+..|+|||++.+..++.++|+|||||++|+|++|..||...+.......+..... .++..++.+
T Consensus       157 -------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (257)
T cd08225         157 -------ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRD  229 (257)
T ss_pred             -------ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHH
Confidence                   112234688999999999888899999999999999999999999998877666665554433 345678899


Q ss_pred             HHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       282 ~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                      +.++|.+||+.+|++||++     .++++||||
T Consensus       230 ~~~~i~~~l~~~p~~Rpt~-----~~ll~~~~~  257 (257)
T cd08225         230 LRSLISQLFKVSPRDRPSI-----TSILKRPFL  257 (257)
T ss_pred             HHHHHHHHhccChhhCcCH-----HHHhhCCCC
Confidence            9999999999999999998     899999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.2e-41  Score=328.52  Aligned_cols=252  Identities=29%  Similarity=0.483  Sum_probs=212.1

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      .++|++.+.||+|+||.||+|++..+++.||||.+.............+.+|+.+++.++||||+++++++.+....|+|
T Consensus         1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence            36899999999999999999999999999999988765444455556677899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcc
Q 011287          124 LESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      |||+++|+|.+++..    ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..+....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~  160 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence            999999999988753    3458999999999999999999999999999999999999999999999999987654321


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCC--HHHHHHHHHhcCC-CC-C
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS--EWLIFQRIIARDI-RF-P  275 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~--~~~~~~~i~~~~~-~~-p  275 (489)
                                .......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||....  .....+.+..... .. +
T Consensus       161 ----------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  230 (267)
T cd08228         161 ----------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPT  230 (267)
T ss_pred             ----------HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCCh
Confidence                      11224468899999999998889999999999999999999999996543  2344444443222 12 2


Q ss_pred             CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       276 ~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      ..++..+.++|.+||+.+|++||++     .++++
T Consensus       231 ~~~~~~~~~li~~cl~~~p~~Rp~~-----~~vl~  260 (267)
T cd08228         231 EHYSEKLRELVSMCIYPDPDQRPDI-----GYVHQ  260 (267)
T ss_pred             hhcCHHHHHHHHHHCCCCcccCcCH-----HHHHH
Confidence            3577899999999999999999998     66653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.7e-41  Score=338.01  Aligned_cols=254  Identities=29%  Similarity=0.486  Sum_probs=218.5

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      .-|.....||+|+||.||+|.+..+++.||+|++....   ......+.+|+.+++.++||||+++++.+......|+||
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~   97 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM   97 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc---cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence            45666778999999999999999999999999986542   223455778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccC
Q 011287          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (489)
Q Consensus       125 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~  204 (489)
                      ||+++++|..++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..+....     
T Consensus        98 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-----  171 (297)
T cd06659          98 EFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-----  171 (297)
T ss_pred             ecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-----
Confidence            99999999987765 569999999999999999999999999999999999999999999999999987543211     


Q ss_pred             CCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC---CCCCCCCHH
Q 011287          205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI---RFPNYFSDA  281 (489)
Q Consensus       205 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~---~~p~~~~~~  281 (489)
                           ......+|+..|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+.....   ..+..++..
T Consensus       172 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (297)
T cd06659         172 -----PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPV  246 (297)
T ss_pred             -----ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHH
Confidence                 122346789999999999988899999999999999999999999998877766665544322   234467899


Q ss_pred             HHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       282 ~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                      +.++|++||+.+|.+||++     .++++||||...
T Consensus       247 l~~~i~~~l~~~P~~Rps~-----~~ll~~~~~~~~  277 (297)
T cd06659         247 LRDFLERMLTREPQERATA-----QELLDHPFLLQT  277 (297)
T ss_pred             HHHHHHHHhcCCcccCcCH-----HHHhhChhhccC
Confidence            9999999999999999998     899999999753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.7e-41  Score=341.71  Aligned_cols=253  Identities=28%  Similarity=0.446  Sum_probs=213.0

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-----
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-----  118 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----  118 (489)
                      .++|++++.||+|+||.||+|.+..+|..||+|++.+... .......+.+|+.+++.++||||++++++|....     
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            4689999999999999999999999999999999865422 2333445778999999999999999999997653     


Q ss_pred             -EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCC
Q 011287          119 -SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (489)
Q Consensus       119 -~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~  197 (489)
                       ..|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~  170 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS  170 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence             458999999 6789888764 5799999999999999999999999999999999999999999999999999875432


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCC---
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR---  273 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~---  273 (489)
                                   ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|++||.+.+....+..+......   
T Consensus       171 -------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  237 (343)
T cd07880         171 -------------EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK  237 (343)
T ss_pred             -------------CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence                         1123467899999999876 45788999999999999999999999988766555554432111   


Q ss_pred             ----------------------------CCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          274 ----------------------------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       274 ----------------------------~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                                                  +...+++++.++|.+||+.||++||++     .+++.||||+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~-----~~~l~~~~~~~~  304 (343)
T cd07880         238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITA-----AEALAHPYFEEF  304 (343)
T ss_pred             HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCH-----HHHhcCccHhhh
Confidence                                        123578889999999999999999999     889999999865

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=3.7e-41  Score=331.91  Aligned_cols=251  Identities=26%  Similarity=0.425  Sum_probs=211.2

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEe
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E  125 (489)
                      +|++.+.||.|++|.||+|++..+|..||||++.....  ......+.+|+.+++.++||||+++++.+.+....|+|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE   78 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence            69999999999999999999999999999999876532  2233456679999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccc
Q 011287          126 SCEGGELFDQITSK---GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (489)
Q Consensus       126 ~~~gg~L~~~l~~~---~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~  202 (489)
                      |+.+ +|.+++...   ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++.......   
T Consensus        79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~---  154 (284)
T cd07836          79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV---  154 (284)
T ss_pred             cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc---
Confidence            9985 898888754   358999999999999999999999999999999999999999999999999987543211   


Q ss_pred             cCCCCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC----------
Q 011287          203 LPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD----------  271 (489)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~----------  271 (489)
                             ......+++..|+|||++.+. .++.++|+|||||++|+|++|++||.+.+..+.+.++....          
T Consensus       155 -------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (284)
T cd07836         155 -------NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPG  227 (284)
T ss_pred             -------cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHH
Confidence                   112234678899999998664 47889999999999999999999999887666555543210          


Q ss_pred             --------CC-----------CCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          272 --------IR-----------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       272 --------~~-----------~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                              ..           +.+..+..++++|.+||+.||.+||++     .++++||||
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~-----~~~l~~~~f  284 (284)
T cd07836         228 ISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISA-----HDALQHPWF  284 (284)
T ss_pred             HhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCH-----HHHhcCCCC
Confidence                    00           112457889999999999999999998     899999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-43  Score=352.65  Aligned_cols=251  Identities=29%  Similarity=0.401  Sum_probs=224.6

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEe
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E  125 (489)
                      -|.-++.||.|+||.||.|++..|...||||.|....-....+-..+..|+..|+.++|||+|.+-+.|-.+...|+|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            48889999999999999999999999999999987766666677778889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccC
Q 011287          126 SCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (489)
Q Consensus       126 ~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~  204 (489)
                      ||-| +-.+++.-. .++.+.++..|+.+.+.||.|||+++.||||||..|||+++.|.|||+|||+|..+         
T Consensus       107 YClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~---------  176 (948)
T KOG0577|consen  107 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIM---------  176 (948)
T ss_pred             HHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhc---------
Confidence            9965 766666543 57999999999999999999999999999999999999999999999999999864         


Q ss_pred             CCCCCCCccceecCCcCCChhhhc---CCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC-CCCC-CCCC
Q 011287          205 NAASDDKACTFVGTAAYVPPEVLN---SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-IRFP-NYFS  279 (489)
Q Consensus       205 ~~~~~~~~~~~~gt~~Y~aPE~l~---~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~-~~~p-~~~~  279 (489)
                           ...++|+|||.|||||++.   .+.|+-++||||||++..+|.-.+||+...|....+..|-.++ +.++ +.++
T Consensus       177 -----~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS  251 (948)
T KOG0577|consen  177 -----APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWS  251 (948)
T ss_pred             -----CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhH
Confidence                 3456999999999999984   5679999999999999999999999999998887777776654 3444 4589


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       280 ~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      ..++.||+.||++-|.+|||+     ++++.|+|...
T Consensus       252 ~~F~~Fvd~CLqKipqeRpts-----e~ll~H~fv~R  283 (948)
T KOG0577|consen  252 DYFRNFVDSCLQKIPQERPTS-----EELLKHRFVLR  283 (948)
T ss_pred             HHHHHHHHHHHhhCcccCCcH-----HHHhhcchhcc
Confidence            999999999999999999999     89999999864

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-41  Score=340.75  Aligned_cols=258  Identities=25%  Similarity=0.416  Sum_probs=209.1

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC-----C
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT-----F  118 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~  118 (489)
                      .++|++.+.||+|+||.||+|++..+|+.||+|++...  ........+.+|+.+++.++||||+++++++...     .
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   81 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN   81 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc--ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence            36899999999999999999999999999999998542  1223345566799999999999999999887644     3


Q ss_pred             EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      .+|+|+||+.+ +|.+++.. +.+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus        82 ~~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~  159 (336)
T cd07849          82 DVYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE  159 (336)
T ss_pred             eEEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence            58999999975 88887754 57999999999999999999999999999999999999999999999999998765332


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHh--------
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA--------  269 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~--------  269 (489)
                      ..       ........+||..|+|||.+.+ ..++.++|||||||++|+|++|++||.+.+.......+..        
T Consensus       160 ~~-------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~  232 (336)
T cd07849         160 HD-------HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQE  232 (336)
T ss_pred             cc-------ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence            11       0112234578999999998754 5688999999999999999999999987665433322211        


Q ss_pred             -------c-----------CCC-----CCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          270 -------R-----------DIR-----FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       270 -------~-----------~~~-----~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                             .           ...     ..+..++++.+||.+||+.||++||++     .++++||||+..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~-----~e~l~hp~~~~~  298 (336)
T cd07849         233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITV-----EEALAHPYLEQY  298 (336)
T ss_pred             HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCH-----HHHhcCcccccc
Confidence                   0           000     112457889999999999999999998     899999999854

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5e-41  Score=329.72  Aligned_cols=253  Identities=21%  Similarity=0.329  Sum_probs=214.5

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCC-----CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDT-----GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  116 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~t-----g~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  116 (489)
                      +..++|++.+.||+|+||.||+|.++..     +..||+|.+....  .......+.+|+.+++.++||||+++++++.+
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (277)
T cd05032           3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVST   80 (277)
T ss_pred             cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence            4568999999999999999999998644     4899999986542  22233456789999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEE
Q 011287          117 TFSLYMALESCEGGELFDQITSK----------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI  186 (489)
Q Consensus       117 ~~~lylV~E~~~gg~L~~~l~~~----------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL  186 (489)
                      ....|+||||+++|+|.+++...          +.+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|
T Consensus        81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence            99999999999999999998653          23678899999999999999999999999999999999999999999


Q ss_pred             eeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHH
Q 011287          187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQ  265 (489)
Q Consensus       187 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~  265 (489)
                      +|||+++.+.....        ........++..|+|||.+.+..++.++|+|||||++|+|++ |.+||.+.+.....+
T Consensus       161 ~dfg~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~  232 (277)
T cd05032         161 GDFGMTRDIYETDY--------YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLK  232 (277)
T ss_pred             CCcccchhhccCcc--------cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHH
Confidence            99999876543221        011223456789999999988889999999999999999998 999999888877776


Q ss_pred             HHHhc-CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHh
Q 011287          266 RIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLK  309 (489)
Q Consensus       266 ~i~~~-~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~  309 (489)
                      .+... ...+|..++.++.+||.+||+.+|++|||+     .+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~-----~~l~  272 (277)
T cd05032         233 FVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTF-----LEIV  272 (277)
T ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCH-----HHHH
Confidence            66644 345788889999999999999999999998     5565

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-42  Score=356.74  Aligned_cols=244  Identities=35%  Similarity=0.557  Sum_probs=213.4

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~ly  121 (489)
                      ..++|++...+|.|+||.|-.+.+..+++.+++|++.+..       ....+|..++... +||||+++++++.+...+|
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~  392 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY  392 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceee
Confidence            4688999999999999999999999999999999997761       1233355444444 7999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeee-CCCCCEEEeeccCccccCCccc
Q 011287          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL-TADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl-~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      +|||.+.|+.|.+.+.....+. .++..|+++|+.|+.|||++|||||||||+|||+ +..|+++|+|||.++.....  
T Consensus       393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--  469 (612)
T KOG0603|consen  393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--  469 (612)
T ss_pred             eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence            9999999999999998876666 8888999999999999999999999999999999 68999999999999865432  


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHH-HHHHHHHhcCCCCCCCCC
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQRIIARDIRFPNYFS  279 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~-~~~~~i~~~~~~~p~~~~  279 (489)
                                 ..+-+-|..|+|||++....|+.++||||||++||+||+|+.||...... ++..+|....+  ...+|
T Consensus       470 -----------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~--s~~vS  536 (612)
T KOG0603|consen  470 -----------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKF--SECVS  536 (612)
T ss_pred             -----------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCcc--ccccC
Confidence                       22446789999999999999999999999999999999999999876554 66666655433  38899


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       280 ~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                      .++++||++||+.||.+||++     .+++.||||
T Consensus       537 ~~AKdLl~~LL~~dP~~Rl~~-----~~i~~h~w~  566 (612)
T KOG0603|consen  537 DEAKDLLQQLLQVDPALRLGA-----DEIGAHPWF  566 (612)
T ss_pred             HHHHHHHHHhccCChhhCcCh-----hhhccCcch
Confidence            999999999999999999999     789999999

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1e-40  Score=322.14  Aligned_cols=255  Identities=32%  Similarity=0.564  Sum_probs=222.4

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC--CEEEEE
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT--FSLYMA  123 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~lylV  123 (489)
                      +|.+.+.||+|++|.||+|.+..+++.|++|++...... ......+.+|+.++++++||||+++++.+.+.  ..+|+|
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence            588999999999999999999999999999999765432 34566788899999999999999999999988  899999


Q ss_pred             EeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      +||+++++|.+++.+...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........  
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--  157 (260)
T cd06606          80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG--  157 (260)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc--
Confidence            999999999999998888999999999999999999999999999999999999999999999999998866443210  


Q ss_pred             CCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCC-HHHHHHHHH--hcCCCCCCCCCH
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS-EWLIFQRII--ARDIRFPNYFSD  280 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~-~~~~~~~i~--~~~~~~p~~~~~  280 (489)
                            .......++..|+|||.+.+...+.++|+|||||++|+|++|..||.... .......+.  .....+|..++.
T Consensus       158 ------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (260)
T cd06606         158 ------EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSE  231 (260)
T ss_pred             ------ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCH
Confidence                  01234578899999999998889999999999999999999999998776 333333333  244567788899


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       281 ~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                      .+.++|.+||+.||++||++     .+++.||||
T Consensus       232 ~l~~~i~~~l~~~p~~Rp~~-----~~ll~~~~~  260 (260)
T cd06606         232 EAKDFLRKCLRRDPKKRPTA-----DELLQHPFL  260 (260)
T ss_pred             HHHHHHHHhCcCChhhCCCH-----HHHhhCCCC
Confidence            99999999999999999998     899999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=9.9e-41  Score=322.55  Aligned_cols=253  Identities=31%  Similarity=0.603  Sum_probs=223.9

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEe
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E  125 (489)
                      +|.+.+.||.|+||.||+|.+..++..||+|++...... ......+..|+.+++.++|||++++++.+.+....++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence            689999999999999999999999999999999765433 2344557789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccc
Q 011287          126 SCEGGELFDQITSK----GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (489)
Q Consensus       126 ~~~gg~L~~~l~~~----~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~  201 (489)
                      |+++++|.+++.+.    ..+++..+..++.+++.||.|||++|++|+||+|+||+++.++.++|+|||.+.......  
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--  157 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--  157 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence            99999999999764    679999999999999999999999999999999999999999999999999987654321  


Q ss_pred             ccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC-CCCCCCCCH
Q 011287          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-IRFPNYFSD  280 (489)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~-~~~p~~~~~  280 (489)
                              .......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+.......+.... ..+|..++.
T Consensus       158 --------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (258)
T cd08215         158 --------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSS  229 (258)
T ss_pred             --------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCH
Confidence                    12234578999999999999889999999999999999999999998888777776665543 346668899


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       281 ~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                      .+.+++.+||..+|++||++     .++++||||
T Consensus       230 ~~~~~i~~~l~~~p~~Rp~~-----~~ll~~~~~  258 (258)
T cd08215         230 ELRNLVSSLLQKDPEERPSI-----AQILQSPFI  258 (258)
T ss_pred             HHHHHHHHHcCCChhhCcCH-----HHHhcCCCC
Confidence            99999999999999999999     899999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=5.1e-41  Score=369.03  Aligned_cols=258  Identities=26%  Similarity=0.344  Sum_probs=209.7

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      +++|++++.||+|+||.||+|++..+|+.||+|++.............+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus         1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence            47899999999999999999999999999999999765444444556678899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCc
Q 011287          124 LESCEGGELFDQITSK-----------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  192 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~-----------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a  192 (489)
                      |||++||+|.+++...           ..++...+..++.||+.||+|||++||+||||||+|||++.+|.++|+|||++
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA  160 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA  160 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence            9999999999988642           23556778889999999999999999999999999999999999999999999


Q ss_pred             cccCCccccccCC--------CCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHH
Q 011287          193 KPMQDSRITVLPN--------AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIF  264 (489)
Q Consensus       193 ~~~~~~~~~~~~~--------~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~  264 (489)
                      +............        ..........+||+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus       161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~  240 (932)
T PRK13184        161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS  240 (932)
T ss_pred             eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence            8763211000000        00011223468999999999999999999999999999999999999999876554332


Q ss_pred             HHH-HhcCCCC--CCCCCHHHHHHHHHhhccCCCCCCCCC
Q 011287          265 QRI-IARDIRF--PNYFSDAARDLIDRLLDVDPSGRPGAG  301 (489)
Q Consensus       265 ~~i-~~~~~~~--p~~~~~~~~~Li~~~L~~dP~~R~t~~  301 (489)
                      ... .......  ...+++.+.+++.+||+.||++|+++.
T Consensus       241 ~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~  280 (932)
T PRK13184        241 YRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSV  280 (932)
T ss_pred             hhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHH
Confidence            221 1111111  135789999999999999999999873

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.3e-41  Score=341.83  Aligned_cols=257  Identities=28%  Similarity=0.427  Sum_probs=213.0

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC-----C
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT-----F  118 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~  118 (489)
                      ..+|.+.+.||+|+||.||+|++..+++.||||.+......... ...+.+|+.+++.++||||+++++++...     .
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRID-AKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccch-hHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            35799999999999999999999999999999998764333322 34456799999999999999999888654     3


Q ss_pred             EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      .+|+|+||+. ++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.....
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  161 (337)
T cd07858          83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK  161 (337)
T ss_pred             cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence            5899999996 689999988888999999999999999999999999999999999999999999999999998765322


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc-------
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-------  270 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~-------  270 (489)
                      .          .......++..|+|||.+.. ..++.++|+|||||++|+|++|++||.+.+.......+...       
T Consensus       162 ~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  231 (337)
T cd07858         162 G----------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEE  231 (337)
T ss_pred             c----------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChH
Confidence            1          12234578899999998865 46889999999999999999999999876543333222110       


Q ss_pred             ---------------------CC---CCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          271 ---------------------DI---RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       271 ---------------------~~---~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                                           ..   ...+.+++++.+||++||+.||++||++     +++++||||..+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~-----~ell~h~~~~~~  297 (337)
T cd07858         232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITV-----EEALAHPYLASL  297 (337)
T ss_pred             HhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCH-----HHHHcCcchhhh
Confidence                                 00   0123578999999999999999999998     899999999865

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=6e-41  Score=335.22  Aligned_cols=252  Identities=30%  Similarity=0.410  Sum_probs=215.6

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      ..|++.+.||+|+||.||+|++..+|+.||+|++.............+.+|+.+++.++||||+++++++.+....|+||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            46999999999999999999999999999999987554444445566788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          125 ESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       125 E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      ||+.| +|.+.+.. .+.+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++.....      
T Consensus        95 e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~------  167 (307)
T cd06607          95 EYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP------  167 (307)
T ss_pred             HhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC------
Confidence            99975 77777654 45799999999999999999999999999999999999999999999999999865422      


Q ss_pred             CCCCCCCCccceecCCcCCChhhhc---CCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC-CCC-CCCC
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLN---SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-IRF-PNYF  278 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~---~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~-~~~-p~~~  278 (489)
                              ...+.|+..|+|||++.   ...++.++|||||||++|+|++|++||.+.+.......+.... ..+ +..+
T Consensus       168 --------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (307)
T cd06607         168 --------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDW  239 (307)
T ss_pred             --------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhh
Confidence                    12456888999999874   4568889999999999999999999998887766555544332 222 3357


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       279 ~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      +..++++|.+||+.||++||++     .+++.||||..
T Consensus       240 ~~~~~~li~~~l~~~p~~Rp~~-----~~il~~~~~~~  272 (307)
T cd06607         240 SDYFRNFVDSCLQKIPQDRPSS-----EELLKHRFVLR  272 (307)
T ss_pred             CHHHHHHHHHHhcCChhhCcCH-----HHHhcChhhcc
Confidence            8899999999999999999998     89999999974

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=4.2e-42  Score=338.00  Aligned_cols=256  Identities=30%  Similarity=0.481  Sum_probs=220.6

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      +.|+..+.||+|+||.||+|.+..++..||+|.+.....  ......+.+|+.+++.++||||+++++.+.+....|+||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence            457888999999999999999999999999999875422  234456888999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccC
Q 011287          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (489)
Q Consensus       125 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~  204 (489)
                      ||+++++|.+++.. +.+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++..+....     
T Consensus        82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-----  155 (277)
T cd06642          82 EYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-----  155 (277)
T ss_pred             EccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc-----
Confidence            99999999998865 579999999999999999999999999999999999999999999999999987654321     


Q ss_pred             CCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc-CCCCCCCCCHHHH
Q 011287          205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-DIRFPNYFSDAAR  283 (489)
Q Consensus       205 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~-~~~~p~~~~~~~~  283 (489)
                           .......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...........+... ...++..++.++.
T Consensus       156 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (277)
T cd06642         156 -----IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFK  230 (277)
T ss_pred             -----hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHH
Confidence                 1122356889999999999888999999999999999999999999877666555544333 2335556889999


Q ss_pred             HHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 011287          284 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (489)
Q Consensus       284 ~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~  318 (489)
                      ++|.+||+.+|++||++     .++++||||....
T Consensus       231 ~li~~~l~~~p~~Rp~~-----~~il~~~~~~~~~  260 (277)
T cd06642         231 EFVEACLNKDPRFRPTA-----KELLKHKFITRYT  260 (277)
T ss_pred             HHHHHHccCCcccCcCH-----HHHHHhHHHHHHh
Confidence            99999999999999998     8999999997644

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=6.1e-41  Score=326.45  Aligned_cols=245  Identities=22%  Similarity=0.344  Sum_probs=209.7

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ly  121 (489)
                      +..++|++++.||+|+||.||+|.+. ++..||+|.+....    .....+.+|+.+++.++||||+++++.+.+....|
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05072           3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY   77 (261)
T ss_pred             CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence            45689999999999999999999974 56789999876532    23456778999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcc
Q 011287          122 MALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      ++|||+++|+|.+++.+.  ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05072          78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE  157 (261)
T ss_pred             EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence            999999999999998753  568999999999999999999999999999999999999999999999999998654321


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCCC
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNY  277 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~  277 (489)
                      .         .......++..|+|||.+....++.++|+|||||++|+|++ |..||.+.+.......+... ....+..
T Consensus       158 ~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  228 (261)
T cd05072         158 Y---------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMEN  228 (261)
T ss_pred             e---------eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence            1         11112345678999999988889999999999999999998 99999988877776666543 2334456


Q ss_pred             CCHHHHHHHHHhhccCCCCCCCC
Q 011287          278 FSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       278 ~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      ++.++.+++.+||..+|++||++
T Consensus       229 ~~~~~~~li~~~l~~~p~~Rp~~  251 (261)
T cd05072         229 CPDELYDIMKTCWKEKAEERPTF  251 (261)
T ss_pred             CCHHHHHHHHHHccCCcccCcCH
Confidence            88999999999999999999998

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=4.4e-41  Score=325.78  Aligned_cols=240  Identities=25%  Similarity=0.416  Sum_probs=203.3

Q ss_pred             eEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEeccCCC
Q 011287           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG  130 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~~~gg  130 (489)
                      +.||+|+||.||+|++..+++.||+|.+....  .......+.+|..+++.++||||+++++++.+...+|+||||+.++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG   78 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence            46899999999999999999999999886432  2334456778999999999999999999999999999999999999


Q ss_pred             ChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCC
Q 011287          131 ELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  209 (489)
Q Consensus       131 ~L~~~l~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~  209 (489)
                      +|.+++.+.+ .+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.........        
T Consensus        79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--------  150 (252)
T cd05084          79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA--------  150 (252)
T ss_pred             cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCccccccccc--------
Confidence            9999997654 5899999999999999999999999999999999999999999999999998754321100        


Q ss_pred             CCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCCCCCHHHHHHHH
Q 011287          210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFSDAARDLID  287 (489)
Q Consensus       210 ~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~Li~  287 (489)
                      .......++..|+|||.+.+..++.++|+|||||++|+|++ |.+||...+.......+... ...+|..++..+.+|+.
T Consensus       151 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  230 (252)
T cd05084         151 STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLME  230 (252)
T ss_pred             ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHH
Confidence            00011123457999999998889999999999999999997 99999887776655555442 44567788999999999


Q ss_pred             HhhccCCCCCCCC
Q 011287          288 RLLDVDPSGRPGA  300 (489)
Q Consensus       288 ~~L~~dP~~R~t~  300 (489)
                      +||+.||++||++
T Consensus       231 ~~l~~~p~~Rps~  243 (252)
T cd05084         231 RCWEYDPGQRPSF  243 (252)
T ss_pred             HHcCCChhhCcCH
Confidence            9999999999998

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-41  Score=336.69  Aligned_cols=256  Identities=27%  Similarity=0.438  Sum_probs=207.8

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC--CEEE
Q 011287           46 DFELGKIYGVGSYSKVVRAKKID--TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT--FSLY  121 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~--tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~ly  121 (489)
                      +|++.+.||+|+||.||+|.+..  +++.||+|.+.+...........+.+|+.+++.++||||+++++++.+.  ..+|
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            58999999999999999999988  8999999999875333333445567799999999999999999999988  8899


Q ss_pred             EEEeccCCCChHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCC----CCCEEEeeccCc
Q 011287          122 MALESCEGGELFDQITSK-----GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA----DGHIKIADFGSV  192 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~~-----~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~----~g~ikL~DFG~a  192 (489)
                      +||||+++ +|.+.+...     ..+++..++.++.||+.||.|||+.||+||||||+||+++.    ++.+||+|||++
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            99999975 777766532     36899999999999999999999999999999999999999    899999999999


Q ss_pred             cccCCccccccCCCCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCCCHHH---------
Q 011287          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWL---------  262 (489)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~---------  262 (489)
                      ..+......       ........++..|+|||++.+. .++.++|+|||||++|+|++|++||.+.....         
T Consensus       160 ~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~  232 (316)
T cd07842         160 RLFNAPLKP-------LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRD  232 (316)
T ss_pred             cccCCCccc-------ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHH
Confidence            865433210       1122345789999999988664 57889999999999999999999998654321         


Q ss_pred             HHHHHHh--------------------------cCCCCC-----------CCCCHHHHHHHHHhhccCCCCCCCCCCCCH
Q 011287          263 IFQRIIA--------------------------RDIRFP-----------NYFSDAARDLIDRLLDVDPSGRPGAGPGGY  305 (489)
Q Consensus       263 ~~~~i~~--------------------------~~~~~p-----------~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~  305 (489)
                      .+..+..                          ....++           ...+.++.++|.+||+.||++|||+     
T Consensus       233 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~-----  307 (316)
T cd07842         233 QLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITA-----  307 (316)
T ss_pred             HHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCH-----
Confidence            1111100                          011111           1467789999999999999999998     


Q ss_pred             HHHhcCCCC
Q 011287          306 AVLKMHPFF  314 (489)
Q Consensus       306 ~~l~~hpff  314 (489)
                      .+++.||||
T Consensus       308 ~eil~~~~f  316 (316)
T cd07842         308 EEALEHPYF  316 (316)
T ss_pred             HHHhcCCCC
Confidence            899999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=8.8e-41  Score=326.48  Aligned_cols=253  Identities=19%  Similarity=0.308  Sum_probs=213.7

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDT---GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~t---g~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  119 (489)
                      ..++|++.+.||+|+||.||+|++..+   ...||+|++....  .......+..|..+++.++||||+++++.+.+...
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (266)
T cd05033           2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP   79 (266)
T ss_pred             ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence            467899999999999999999998654   4689999986542  22334556779999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          120 LYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      .|+||||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..+...
T Consensus        80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            99999999999999999764 57999999999999999999999999999999999999999999999999999876421


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCC
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPN  276 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~  276 (489)
                      ..        ........++..|+|||.+.+..++.++|+|||||++|+|++ |..||...........+... ....|.
T Consensus       160 ~~--------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  231 (266)
T cd05033         160 EA--------TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPM  231 (266)
T ss_pred             cc--------ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            10        001112234678999999998889999999999999999998 99999888777777666654 334566


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      ..+..+.+|+.+||+.+|++||++     .++++
T Consensus       232 ~~~~~l~~li~~cl~~~p~~Rp~~-----~ei~~  260 (266)
T cd05033         232 DCPSALYQLMLDCWQKDRNERPTF-----SQIVS  260 (266)
T ss_pred             CCCHHHHHHHHHHcCCCcccCcCH-----HHHHH
Confidence            789999999999999999999998     55654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-44  Score=337.93  Aligned_cols=255  Identities=29%  Similarity=0.446  Sum_probs=225.8

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      +-|.++..||+|+||.||+|.++++|+.+|||.+...     ...+.+..|+.++++++.|++|++|+.|.....+|+||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVM  107 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVM  107 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeeh
Confidence            4589999999999999999999999999999987543     34556777999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          125 ESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       125 E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      |||..|++.+.+.. +.++++.++..++...+.||+|||...-+|||||..|||++.+|+.||+|||.|..+.+.     
T Consensus       108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-----  182 (502)
T KOG0574|consen  108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-----  182 (502)
T ss_pred             hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhh-----
Confidence            99999999998875 467999999999999999999999999999999999999999999999999999866432     


Q ss_pred             CCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC---CCCCCCCCH
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRFPNYFSD  280 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~---~~~p~~~~~  280 (489)
                           ....++..||+.|||||++..-.|+.++||||||++..||.-|++||..-.+....-.|....   +.-|+.++.
T Consensus       183 -----MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~  257 (502)
T KOG0574|consen  183 -----MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSS  257 (502)
T ss_pred             -----HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhh
Confidence                 245678899999999999999999999999999999999999999998877765444444332   234667999


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 011287          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (489)
Q Consensus       281 ~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~  319 (489)
                      ++.|+|+.||.+.|++|-||     -++++|||.++..-
T Consensus       258 ~F~DFi~~CLiK~PE~R~TA-----~~L~~H~FiknA~g  291 (502)
T KOG0574|consen  258 EFNDFIRSCLIKKPEERKTA-----LRLCEHTFIKNAPG  291 (502)
T ss_pred             HHHHHHHHHhcCCHHHHHHH-----HHHhhhhhhcCCCc
Confidence            99999999999999999999     88999999986543

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=6.7e-41  Score=329.48  Aligned_cols=253  Identities=19%  Similarity=0.307  Sum_probs=210.8

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEc-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~-----~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  117 (489)
                      ..++|++.+.||+|+||.||+|.+.     .++..||+|++....  .......+.+|+.+++.++||||+++++++.+.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~   81 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   81 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            3568999999999999999999864     246789999985432  112234567799999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEe
Q 011287          118 FSLYMALESCEGGELFDQITSKG----------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIA  187 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~~----------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~  187 (489)
                      ...++||||+++|+|.+++.+..          .++...+..++.|++.||.|||+.|++||||||+||+++.++.++|+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~  161 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG  161 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence            99999999999999999987532          35778899999999999999999999999999999999999999999


Q ss_pred             eccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHH
Q 011287          188 DFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQR  266 (489)
Q Consensus       188 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~  266 (489)
                      |||++.........        .......++..|+|||++.+..++.++|+|||||++|+|++ |..||.+.+.......
T Consensus       162 dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~  233 (277)
T cd05062         162 DFGMTRDIYETDYY--------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF  233 (277)
T ss_pred             CCCCccccCCccee--------ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            99998755332110        01112345778999999998889999999999999999999 7999998888777766


Q ss_pred             HHhcC-CCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          267 IIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       267 i~~~~-~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      +.... ..+|...+..+.++|.+||+.||++||++     .++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~e~l~  273 (277)
T cd05062         234 VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF-----LEIIS  273 (277)
T ss_pred             HHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCH-----HHHHH
Confidence            65544 45677889999999999999999999998     66654

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=6.8e-41  Score=329.61  Aligned_cols=255  Identities=21%  Similarity=0.368  Sum_probs=213.8

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKID-----TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  116 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~-----tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  116 (489)
                      ...++|.+.+.||+|+||.||+|.+..     ++..||+|.+....  .......+.+|..+++.++|+||+++++++.+
T Consensus         3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   80 (277)
T cd05036           3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE   80 (277)
T ss_pred             CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence            345789999999999999999999987     78899999886432  22334557779999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCC---CEEE
Q 011287          117 TFSLYMALESCEGGELFDQITSKG-------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG---HIKI  186 (489)
Q Consensus       117 ~~~lylV~E~~~gg~L~~~l~~~~-------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g---~ikL  186 (489)
                      ....|+||||++|++|.+++.+.+       .+++..+..++.||+.||+|||++|++||||||+||+++.++   .+||
T Consensus        81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence            889999999999999999997653       489999999999999999999999999999999999998765   5999


Q ss_pred             eeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHH
Q 011287          187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQ  265 (489)
Q Consensus       187 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~  265 (489)
                      +|||+++.+......        .......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+......
T Consensus       161 ~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~  232 (277)
T cd05036         161 ADFGMARDIYRASYY--------RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME  232 (277)
T ss_pred             ccCccccccCCccce--------ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            999999865322110        01112234567999999998889999999999999999997 999999888777666


Q ss_pred             HHHhc-CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 011287          266 RIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (489)
Q Consensus       266 ~i~~~-~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~h  311 (489)
                      .+... ...+|..++..+.+++.+||+.||++||++     .++++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~-----~~vl~~  274 (277)
T cd05036         233 FVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNF-----ATILER  274 (277)
T ss_pred             HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCH-----HHHHHH
Confidence            55443 455678899999999999999999999998     777764

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.1e-41  Score=334.72  Aligned_cols=260  Identities=25%  Similarity=0.381  Sum_probs=212.0

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~ly  121 (489)
                      ..++|++.+.||+|+||.||++++..+++.||+|.+.+....  .....+..|+.++.++. ||||+++++++.++...+
T Consensus         2 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~   79 (288)
T cd06616           2 TAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCW   79 (288)
T ss_pred             cHHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEE
Confidence            356889999999999999999999999999999998764322  33455777999998885 999999999999999999


Q ss_pred             EEEeccCCCChHHHH---H--hCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeeccCCCCeeeCCCCCEEEeeccCcccc
Q 011287          122 MALESCEGGELFDQI---T--SKGHLSEDEARFYTAEVVDALEYIHSM-GLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (489)
Q Consensus       122 lV~E~~~gg~L~~~l---~--~~~~l~e~~~~~i~~qil~aL~~LH~~-gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~  195 (489)
                      ++|||+.+ +|.++.   .  ..+.+++..+..++.|++.||+|||+. ||+||||||+||+++.++.++|+|||++..+
T Consensus        80 ~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  158 (288)
T cd06616          80 ICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL  158 (288)
T ss_pred             EEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence            99999865 554432   2  236799999999999999999999975 9999999999999999999999999998754


Q ss_pred             CCccccccCCCCCCCCccceecCCcCCChhhhcCC---CCCCCCcchhhhHHHHHHhhCCCCCCCCCH-HHHHHHHHhcC
Q 011287          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS---PATFGNDLWALGCTLYQMLSGTSPFKDTSE-WLIFQRIIARD  271 (489)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~---~~~~~sDiwSLG~ilyelltG~~PF~~~~~-~~~~~~i~~~~  271 (489)
                      ....           ......|+..|+|||++.+.   .++.++|+|||||++|+|++|++||..... .+....+....
T Consensus       159 ~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~  227 (288)
T cd06616         159 VDSI-----------AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGD  227 (288)
T ss_pred             ccCC-----------ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCC
Confidence            3211           11233688999999999776   688999999999999999999999977542 22223333222


Q ss_pred             -CCC----CCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCccc
Q 011287          272 -IRF----PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  321 (489)
Q Consensus       272 -~~~----p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~  321 (489)
                       ..+    +..++.++.+||.+||+.||++||++     +++++||||+...|.+
T Consensus       228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~-----~~i~~~~~~~~~~~~~  277 (288)
T cd06616         228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKY-----KELLEHPFIKDYEERN  277 (288)
T ss_pred             CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCH-----HHHhcChhhhchhhcc
Confidence             122    23478999999999999999999998     8999999999876654

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=7.2e-41  Score=330.79  Aligned_cols=258  Identities=29%  Similarity=0.478  Sum_probs=223.6

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      .+.|++.+.||.|+||.||+|.+..++..||+|++.....    ....+..|+.+++.++|+||+++++.+......|+|
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   93 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV   93 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence            4669999999999999999999998999999999976432    345677899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccc
Q 011287          124 LESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~  202 (489)
                      +||+++++|.+++...+ .+++..+..++.|++.||.|||+.|++|+||+|+||+++.+++++|+|||++.......   
T Consensus        94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~---  170 (286)
T cd06614          94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK---  170 (286)
T ss_pred             EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch---
Confidence            99999999999999876 89999999999999999999999999999999999999999999999999986543221   


Q ss_pred             cCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC-C--CCCCCC
Q 011287          203 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-R--FPNYFS  279 (489)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~-~--~p~~~~  279 (489)
                             .......++..|+|||++.+..++.++|+|||||++|+|++|..||...+.......+..... .  .+..++
T Consensus       171 -------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (286)
T cd06614         171 -------SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWS  243 (286)
T ss_pred             -------hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCC
Confidence                   122344678899999999988899999999999999999999999998777665555544322 2  233478


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 011287          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (489)
Q Consensus       280 ~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~  320 (489)
                      ..++++|.+||+.+|.+||++     .+++.|+||....|.
T Consensus       244 ~~l~~li~~~l~~~p~~Rpt~-----~~il~~~~~~~~~~~  279 (286)
T cd06614         244 PEFKDFLNKCLVKDPEKRPSA-----EELLQHPFLKKACPK  279 (286)
T ss_pred             HHHHHHHHHHhccChhhCcCH-----HHHhhChHhhccCch
Confidence            999999999999999999998     899999999986554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.1e-41  Score=326.03  Aligned_cols=234  Identities=30%  Similarity=0.486  Sum_probs=201.0

Q ss_pred             eCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEeccCCCChHHH
Q 011287           56 GSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQ  135 (489)
Q Consensus        56 G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~~~gg~L~~~  135 (489)
                      |.||.||+|+++.+++.||+|.+.+..        ....|...+....||||+++++++.+....|+||||++||+|.++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   75 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH   75 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence            899999999999999999999986542        122344445556799999999999999999999999999999999


Q ss_pred             HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCCCCccce
Q 011287          136 ITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF  215 (489)
Q Consensus       136 l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~  215 (489)
                      +.+...+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||.+..+...             ....
T Consensus        76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-------------~~~~  142 (237)
T cd05576          76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-------------CDGE  142 (237)
T ss_pred             HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-------------cccC
Confidence            988878999999999999999999999999999999999999999999999999987654321             1223


Q ss_pred             ecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhccCCC
Q 011287          216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPS  295 (489)
Q Consensus       216 ~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~~L~~dP~  295 (489)
                      .++..|+|||.+.+..++.++|+||+||++|+|++|+.||........    ......+|..+++.+++||.+||+.||+
T Consensus       143 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~dp~  218 (237)
T cd05576         143 AVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN----THTTLNIPEWVSEEARSLLQQLLQFNPT  218 (237)
T ss_pred             CcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc----cccccCCcccCCHHHHHHHHHHccCCHH
Confidence            457789999999888899999999999999999999998865432110    1123457888999999999999999999


Q ss_pred             CCCCCCCCCHHHHhcCCCC
Q 011287          296 GRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       296 ~R~t~~~~~~~~l~~hpff  314 (489)
                      +||++++.+++++++||||
T Consensus       219 ~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         219 ERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             HhcCCCccchHHHHcCCCC
Confidence            9999988889999999998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=344.53  Aligned_cols=244  Identities=23%  Similarity=0.373  Sum_probs=213.6

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lyl  122 (489)
                      ..+.+.+++.||+|-||.|++|.... ...||+|.+....    ...+.+.+|+++|++|+|++||++++++..+..+||
T Consensus       204 ~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~----m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyI  278 (468)
T KOG0197|consen  204 PREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGS----MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYI  278 (468)
T ss_pred             cHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccc----cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEE
Confidence            34557889999999999999999943 4589999986542    233446689999999999999999999999889999


Q ss_pred             EEeccCCCChHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          123 ALESCEGGELFDQITS--KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~--~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      |||||+.|+|.++|+.  .+.+...+...+++|||+|++||+++++|||||-..||||++++.+||+|||+|+...++..
T Consensus       279 VtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y  358 (468)
T KOG0197|consen  279 VTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY  358 (468)
T ss_pred             EEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence            9999999999999997  45699999999999999999999999999999999999999999999999999996554433


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCCCC
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYF  278 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~  278 (489)
                      ....+         .--...|.|||.+....++.+|||||||++|+||+| |+.|+.+.+..+..+.+.++ .+.-|+.+
T Consensus       359 ~~~~~---------~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~C  429 (468)
T KOG0197|consen  359 TASEG---------GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGC  429 (468)
T ss_pred             eecCC---------CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCC
Confidence            22111         112456999999999999999999999999999999 99999999999999888776 45678899


Q ss_pred             CHHHHHHHHHhhccCCCCCCCC
Q 011287          279 SDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       279 ~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      |+++.+|+..|+..+|++|||.
T Consensus       430 P~~vY~lM~~CW~~~P~~RPtF  451 (468)
T KOG0197|consen  430 PDEVYELMKSCWHEDPEDRPTF  451 (468)
T ss_pred             CHHHHHHHHHHhhCCcccCCCH
Confidence            9999999999999999999997

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.5e-41  Score=334.95  Aligned_cols=255  Identities=29%  Similarity=0.471  Sum_probs=217.8

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      .++|++.+.||+|+||.||++.+..+++.||+|.+...   .......+.+|+.+++.++||||+++++++.+....|+|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv   94 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ---QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV   94 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc---cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence            37899999999999999999999999999999998643   223345677899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      +||+++++|.+++.+. .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.......    
T Consensus        95 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~----  169 (293)
T cd06647          95 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ----  169 (293)
T ss_pred             EecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc----
Confidence            9999999999998764 58999999999999999999999999999999999999999999999999887543221    


Q ss_pred             CCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHh-cC--CCCCCCCCH
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA-RD--IRFPNYFSD  280 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~-~~--~~~p~~~~~  280 (489)
                            .......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+.......+.. ..  ...+..++.
T Consensus       170 ------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (293)
T cd06647         170 ------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA  243 (293)
T ss_pred             ------cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCH
Confidence                  122345688999999999888899999999999999999999999988766544333322 22  223445788


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       281 ~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                      .++++|++||+.+|++||++     .+++.|+||+..
T Consensus       244 ~l~~li~~~l~~~p~~Rp~~-----~~il~h~~~~~~  275 (293)
T cd06647         244 IFRDFLNRCLEMDVEKRGSA-----KELLQHPFLKIA  275 (293)
T ss_pred             HHHHHHHHHccCChhhCcCH-----HHHhcCHHHhcC
Confidence            99999999999999999988     899999999854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=9.9e-41  Score=323.28  Aligned_cols=246  Identities=26%  Similarity=0.424  Sum_probs=214.9

Q ss_pred             eEEeeeCceEEEEEEEcCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEecc
Q 011287           51 KIYGVGSYSKVVRAKKIDT---GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESC  127 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~~t---g~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~~  127 (489)
                      +.||+|+||.||+|.+...   +..||+|++.......  ....+..|+.+++.++|+||+++++++.+...+++||||+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM   78 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence            4789999999999999866   9999999997653322  4567888999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          128 EGGELFDQITSK---------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       128 ~gg~L~~~l~~~---------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      ++++|.+++...         ..+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||.+......
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  158 (262)
T cd00192          79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD  158 (262)
T ss_pred             cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence            999999999875         77999999999999999999999999999999999999999999999999999866433


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCC
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPN  276 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~  276 (489)
                      ..        ........++..|+|||.+....++.++|+|||||++|+|++ |..||.........+.+... ....|.
T Consensus       159 ~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  230 (262)
T cd00192         159 DY--------YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPE  230 (262)
T ss_pred             cc--------cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence            21        112234567889999999988889999999999999999999 69999999888888777753 345678


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~h  311 (489)
                      .++.++.+++.+||+.||++||++     .++++|
T Consensus       231 ~~~~~~~~li~~~l~~~p~~Rps~-----~~l~~~  260 (262)
T cd00192         231 YCPDELYELMLSCWQLDPEDRPTF-----SELVER  260 (262)
T ss_pred             cCChHHHHHHHHHccCCcccCcCH-----HHHHHh
Confidence            889999999999999999999998     667653

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2e-40  Score=328.09  Aligned_cols=255  Identities=29%  Similarity=0.472  Sum_probs=212.5

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc--CCEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD--TFSLYM  122 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~lyl  122 (489)
                      ++|++.+.||.|++|.||+|.+..+++.||+|.+.....  ......+.+|+++++.++||||++++++|.+  ...+|+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   78 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI   78 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence            579999999999999999999999999999999875422  2344567789999999999999999998865  347899


Q ss_pred             EEeccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          123 ALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      ||||+++++|.+++..    ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS  158 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence            9999999999887653    356899999999999999999999999999999999999999999999999998754321


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCC-----CHHHHHHHHHhcC-C
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT-----SEWLIFQRIIARD-I  272 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~-----~~~~~~~~i~~~~-~  272 (489)
                                  ......++..|+|||.+.+..++.++|+|||||++|+|++|..||...     ...+....+.... .
T Consensus       159 ------------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  226 (287)
T cd06621         159 ------------LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNP  226 (287)
T ss_pred             ------------ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCch
Confidence                        112346788999999999889999999999999999999999999865     2233344433321 1


Q ss_pred             CCC------CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 011287          273 RFP------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (489)
Q Consensus       273 ~~p------~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~  318 (489)
                      .++      ..+++.+.+||.+||..||++|||+     .+++.||||....
T Consensus       227 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~-----~eil~~~~~~~~~  273 (287)
T cd06621         227 ELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTP-----WDMLEHPWIKAQM  273 (287)
T ss_pred             hhccCCCCCCchHHHHHHHHHHHcCCCcccCCCH-----HHHHhCccccccc
Confidence            122      1346789999999999999999998     8999999997543

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.4e-40  Score=334.29  Aligned_cols=252  Identities=29%  Similarity=0.411  Sum_probs=216.6

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      ..|...+.||+|+||.||+|++..++..||+|++.+...........+..|+.+++.++|||++++++++.+....|+||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            34889999999999999999999999999999997654444445566788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          125 ESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       125 E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      ||+.| +|.+.+.. ...+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++.....      
T Consensus       105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------  177 (317)
T cd06635         105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP------  177 (317)
T ss_pred             eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC------
Confidence            99975 78777754 45699999999999999999999999999999999999999999999999999864322      


Q ss_pred             CCCCCCCCccceecCCcCCChhhhc---CCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCC-C-CCCC
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLN---SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR-F-PNYF  278 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~---~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~-~-p~~~  278 (489)
                              .....|+..|+|||.+.   ...++.++|+|||||++|+|++|.+||...+.......+...... . +..+
T Consensus       178 --------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (317)
T cd06635         178 --------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW  249 (317)
T ss_pred             --------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccc
Confidence                    12346888999999974   456888999999999999999999999888777666666554332 2 3457


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       279 ~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      ++.+++||.+||+.+|.+||++     .++++|+|+..
T Consensus       250 ~~~l~~li~~~l~~~p~~Rpt~-----~~il~~~~~~~  282 (317)
T cd06635         250 SDYFRNFVDSCLQKIPQDRPTS-----EELLKHMFVLR  282 (317)
T ss_pred             cHHHHHHHHHHccCCcccCcCH-----HHHHhChhhhc
Confidence            8899999999999999999998     89999999953

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-42  Score=301.58  Aligned_cols=256  Identities=27%  Similarity=0.463  Sum_probs=219.0

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      +.|.-.+.||+|.||+||+|++++|++.||+|.+.... ..+.......+|+-+|+.++|.|||+++++...+..+-+|+
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrldd-ddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf   80 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccC-CCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence            45777889999999999999999999999999987653 23444556778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          125 ESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       125 E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      |||.. +|..+... +|.++.+.++.++.|++.+|.|+|++++.||||||.|+||+.+|.+||+|||+|+.+.-+-    
T Consensus        81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv----  155 (292)
T KOG0662|consen   81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV----  155 (292)
T ss_pred             HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce----
Confidence            99976 88888765 4789999999999999999999999999999999999999999999999999998765321    


Q ss_pred             CCCCCCCCccceecCCcCCChhhhcCCC-CCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhcC----------
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD----------  271 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~-~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~~----------  271 (489)
                            .-.+.-+-|.+|++|.++.+.. |+...|+||.|||+.|+.. |++.|.+.+-.+++.+|...-          
T Consensus       156 ------rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps  229 (292)
T KOG0662|consen  156 ------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPS  229 (292)
T ss_pred             ------EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCc
Confidence                  1112347799999999998765 8999999999999999986 899999999998888887521          


Q ss_pred             ----------CCCC---------CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          272 ----------IRFP---------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       272 ----------~~~p---------~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                                +.+|         +.++...+||++++|.-+|.+|++|     ++.++||||.+.
T Consensus       230 ~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisa-----eaalqhpyf~d~  289 (292)
T KOG0662|consen  230 MTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISA-----EAALQHPYFSDF  289 (292)
T ss_pred             cccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCH-----HHHhcCcccccc
Confidence                      1111         1245678999999999999999999     889999999864

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-41  Score=328.99  Aligned_cols=255  Identities=30%  Similarity=0.536  Sum_probs=216.1

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC---CCCccEEEEEEEcCCEEEE
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD---HPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~lyl  122 (489)
                      .|++.+.||+|+||.||+|.+..+++.||+|++....  .......+.+|+.+++.++   |||++++++++.+....|+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence            5888999999999999999999999999999987542  2233456778999999986   9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccc
Q 011287          123 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~  202 (489)
                      ||||+++++|.+++.. +.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++..+....   
T Consensus        80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~---  155 (277)
T cd06917          80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS---  155 (277)
T ss_pred             EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc---
Confidence            9999999999998876 479999999999999999999999999999999999999999999999999987654321   


Q ss_pred             cCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc-CCCCCC-CCC
Q 011287          203 LPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-DIRFPN-YFS  279 (489)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~-~~~~p~-~~~  279 (489)
                             .......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+.......+... ...++. .++
T Consensus       156 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (277)
T cd06917         156 -------SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYS  228 (277)
T ss_pred             -------cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCC
Confidence                   12234578999999999865 44788999999999999999999999887665544333322 123333 378


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 011287          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (489)
Q Consensus       280 ~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~  318 (489)
                      .++.+++.+||+.||++||++     .+++.|+||+...
T Consensus       229 ~~~~~~i~~~l~~~p~~R~~~-----~~il~~~~~~~~~  262 (277)
T cd06917         229 KLLREFVAACLDEEPKERLSA-----EELLKSKWIKAHS  262 (277)
T ss_pred             HHHHHHHHHHcCCCcccCcCH-----HHHhhChHhhccc
Confidence            899999999999999999998     8999999997643

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.1e-41  Score=325.49  Aligned_cols=248  Identities=22%  Similarity=0.368  Sum_probs=210.2

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      ..+|++.+.||+|+||.||+|++. ++..+|+|++.+....    ...+..|+.+++.++||||+++++++.+....|+|
T Consensus         3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05059           3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV   77 (256)
T ss_pred             hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence            468999999999999999999885 5678999998654322    23456699999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccc
Q 011287          124 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~  202 (489)
                      |||+++++|.+++... +.+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++.......  
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~--  155 (256)
T cd05059          78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY--  155 (256)
T ss_pred             EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc--
Confidence            9999999999999764 5689999999999999999999999999999999999999999999999999875432210  


Q ss_pred             cCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCCCCCH
Q 011287          203 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFSD  280 (489)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~~~  280 (489)
                             .......++..|+|||.+.+..++.++|+|||||++|+|++ |.+||...+..+....+... ....|...+.
T Consensus       156 -------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (256)
T cd05059         156 -------TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPT  228 (256)
T ss_pred             -------cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCH
Confidence                   00111123457999999998889999999999999999999 89999888777776666544 3456777899


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       281 ~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      ++.+++.+||..+|++||++     .++++
T Consensus       229 ~~~~li~~cl~~~p~~Rpt~-----~~~l~  253 (256)
T cd05059         229 EVYTIMYSCWHEKPEDRPAF-----KKLLS  253 (256)
T ss_pred             HHHHHHHHHhcCChhhCcCH-----HHHHH
Confidence            99999999999999999998     66654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=4.1e-41  Score=331.83  Aligned_cols=254  Identities=19%  Similarity=0.321  Sum_probs=215.9

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCC-----CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDT-----GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  116 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~t-----g~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  116 (489)
                      +.+.+|++.+.||+|+||.||+|.+..+     ++.||+|++....  .......+..|..++..++||||+++++++.+
T Consensus         2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~   79 (283)
T cd05091           2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK   79 (283)
T ss_pred             CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence            4567899999999999999999997543     5889999987542  22334567789999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCC
Q 011287          117 TFSLYMALESCEGGELFDQITSK----------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA  180 (489)
Q Consensus       117 ~~~lylV~E~~~gg~L~~~l~~~----------------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~  180 (489)
                      ...+++++||+.+++|.+++...                ..+++..+..++.|++.||.|||++||+||||||+||++++
T Consensus        80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~  159 (283)
T cd05091          80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD  159 (283)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence            99999999999999999998532                34788899999999999999999999999999999999999


Q ss_pred             CCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCC
Q 011287          181 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS  259 (489)
Q Consensus       181 ~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~  259 (489)
                      ++.+||+|||+++.+.....        ........+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.+
T Consensus       160 ~~~~kl~Dfg~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~  231 (283)
T cd05091         160 KLNVKISDLGLFREVYAADY--------YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS  231 (283)
T ss_pred             CCceEecccccccccccchh--------eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            99999999999886533211        111223456789999999988889999999999999999998 999999988


Q ss_pred             HHHHHHHHHhcCC-CCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          260 EWLIFQRIIARDI-RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       260 ~~~~~~~i~~~~~-~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      .......+..... .+|..++..+.+|+.+||+.+|.+||++     ++++.
T Consensus       232 ~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~-----~~i~~  278 (283)
T cd05091         232 NQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRF-----KDIHS  278 (283)
T ss_pred             HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCH-----HHHHH
Confidence            8888888777654 4578899999999999999999999998     66654

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.6e-40  Score=322.45  Aligned_cols=246  Identities=32%  Similarity=0.532  Sum_probs=210.4

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.+.............+.+|+.++++++|+||+++++.+.+....++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            68999999999999999999999999999999987654444445667888999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          125 ESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       125 E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      ||+++|+|..++..    ...+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++..+.... 
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~-  160 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-  160 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC-
Confidence            99999999998864    2458999999999999999999999999999999999999999999999999987553221 


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCC--HHHHHHHHHhcCC-CCCC-
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS--EWLIFQRIIARDI-RFPN-  276 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~--~~~~~~~i~~~~~-~~p~-  276 (489)
                               .......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||....  .......+..+.. ..|. 
T Consensus       161 ---------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (267)
T cd08224         161 ---------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPAD  231 (267)
T ss_pred             ---------cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChh
Confidence                     11234568899999999998889999999999999999999999996543  2233444443322 3444 


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCC
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      .++..+.++|.+||..+|++||++
T Consensus       232 ~~~~~~~~~i~~cl~~~p~~Rp~~  255 (267)
T cd08224         232 HYSEELRDLVSRCINPDPEKRPDI  255 (267)
T ss_pred             hcCHHHHHHHHHHcCCCcccCCCH
Confidence            688899999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.9e-41  Score=340.65  Aligned_cols=258  Identities=27%  Similarity=0.410  Sum_probs=219.7

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-----EE
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-----SL  120 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----~l  120 (489)
                      +|++.+.||.|++|.||+|++..+|+.||+|.+.+... .......+.+|+.+++.++||||+++++++.+..     .+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence            58999999999999999999999999999999876432 2334456778999999999999999999998775     79


Q ss_pred             EEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      |+||||+.+ +|.+++.+.+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++........
T Consensus        80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~  158 (330)
T cd07834          80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED  158 (330)
T ss_pred             EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence            999999974 8999998878899999999999999999999999999999999999999999999999999986544321


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCC------
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR------  273 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~------  273 (489)
                      .       ........++..|+|||++.+. .++.++|+|||||++|+|++|.+||.+.+..+.+..+......      
T Consensus       159 ~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  231 (330)
T cd07834         159 E-------KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDL  231 (330)
T ss_pred             c-------cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHh
Confidence            0       1122345789999999999887 7899999999999999999999999988877666655442110      


Q ss_pred             -------------------------CCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          274 -------------------------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       274 -------------------------~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                                               ....++.++.+||.+||+.||++||++     ++++.||||+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-----~~ll~~~~~~~~  295 (330)
T cd07834         232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITA-----DEALAHPYLAQL  295 (330)
T ss_pred             hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCH-----HHHHhCccHHhh
Confidence                                     112368899999999999999999998     899999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.2e-40  Score=330.28  Aligned_cols=250  Identities=20%  Similarity=0.329  Sum_probs=211.9

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEc-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  116 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~-----~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  116 (489)
                      +...+|.+.+.||+|+||.||+|++.     .++..+++|.+....   ......+.+|+.++++++||||+++++++.+
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   78 (291)
T cd05094           2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGD   78 (291)
T ss_pred             CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEcc
Confidence            45678999999999999999999863     346679999885432   2333557789999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCC
Q 011287          117 TFSLYMALESCEGGELFDQITSKG----------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA  180 (489)
Q Consensus       117 ~~~lylV~E~~~gg~L~~~l~~~~----------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~  180 (489)
                      ....++||||+++++|.+++...+                .+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~  158 (291)
T cd05094          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA  158 (291)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence            999999999999999999997643                3899999999999999999999999999999999999999


Q ss_pred             CCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCC
Q 011287          181 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS  259 (489)
Q Consensus       181 ~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~  259 (489)
                      ++.++|+|||++........        ........++..|+|||.+.+..++.++|||||||++|+|++ |..||...+
T Consensus       159 ~~~~~l~dfg~a~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  230 (291)
T cd05094         159 NLLVKIGDFGMSRDVYSTDY--------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS  230 (291)
T ss_pred             CCcEEECCCCcccccCCCce--------eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            99999999999975433211        111223457788999999999899999999999999999998 999998888


Q ss_pred             HHHHHHHHHhcCC-CCCCCCCHHHHHHHHHhhccCCCCCCCCCC
Q 011287          260 EWLIFQRIIARDI-RFPNYFSDAARDLIDRLLDVDPSGRPGAGP  302 (489)
Q Consensus       260 ~~~~~~~i~~~~~-~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~  302 (489)
                      .......+..... ..+..++..+.+|+.+||+.||++||++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~  274 (291)
T cd05094         231 NTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKE  274 (291)
T ss_pred             HHHHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHH
Confidence            8777776665543 355678999999999999999999999843

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1e-40  Score=328.98  Aligned_cols=248  Identities=21%  Similarity=0.332  Sum_probs=211.9

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEc-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  116 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~-----~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  116 (489)
                      +...+|.+.++||+|+||.||+|...     .++..+|+|.+...   .......+.+|+.+++.++||||+++++++.+
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   78 (280)
T cd05092           2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTE   78 (280)
T ss_pred             CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEec
Confidence            45678999999999999999999753     35778999987643   33445678889999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCC
Q 011287          117 TFSLYMALESCEGGELFDQITSKG---------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD  181 (489)
Q Consensus       117 ~~~lylV~E~~~gg~L~~~l~~~~---------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~  181 (489)
                      ....|+||||+.+|+|.+++...+               .+++..+..++.||+.||+|||++|++||||||+|||++++
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~  158 (280)
T cd05092          79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG  158 (280)
T ss_pred             CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC
Confidence            999999999999999999997653               48899999999999999999999999999999999999999


Q ss_pred             CCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCH
Q 011287          182 GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSE  260 (489)
Q Consensus       182 g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~  260 (489)
                      +.++|+|||++..+.....        ........++..|+|||.+.+..++.++|||||||++|+|++ |.+||...+.
T Consensus       159 ~~~kL~dfg~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  230 (280)
T cd05092         159 LVVKIGDFGMSRDIYSTDY--------YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN  230 (280)
T ss_pred             CCEEECCCCceeEcCCCce--------eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH
Confidence            9999999999875432211        011123345788999999999999999999999999999998 9999988887


Q ss_pred             HHHHHHHHhc-CCCCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          261 WLIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       261 ~~~~~~i~~~-~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      ......+... ....|..+++.+.+||.+||+.||.+||++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~  271 (280)
T cd05092         231 TEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVI  271 (280)
T ss_pred             HHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence            7777666554 345677889999999999999999999998

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=5e-41  Score=326.84  Aligned_cols=243  Identities=21%  Similarity=0.345  Sum_probs=212.0

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      ..+|++++.||.|+||.||+|++.. +..+|+|++....   ......+..|+.+++.++||||+++++++.+....|+|
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII   80 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence            4689999999999999999999987 8999999987652   22345577899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccc
Q 011287          124 LESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~  201 (489)
                      |||+++++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||.+........ 
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~-  159 (261)
T cd05148          81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY-  159 (261)
T ss_pred             EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc-
Confidence            9999999999999863  4689999999999999999999999999999999999999999999999999976533211 


Q ss_pred             ccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCCCCC
Q 011287          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFS  279 (489)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~~  279 (489)
                               ......++..|+|||.+.+..++.++|+|||||++|+|++ |+.||.+.+..+++..+... ....|...+
T Consensus       160 ---------~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (261)
T cd05148         160 ---------LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCP  230 (261)
T ss_pred             ---------cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCC
Confidence                     1112345678999999998889999999999999999998 89999988887777777654 345667889


Q ss_pred             HHHHHHHHHhhccCCCCCCCC
Q 011287          280 DAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       280 ~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      +++.++|.+||+.||.+||++
T Consensus       231 ~~~~~~i~~~l~~~p~~Rpt~  251 (261)
T cd05148         231 QEIYKIMLECWAAEPEDRPSF  251 (261)
T ss_pred             HHHHHHHHHHcCCCchhCcCH
Confidence            999999999999999999998

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=6.1e-41  Score=327.35  Aligned_cols=247  Identities=31%  Similarity=0.523  Sum_probs=210.1

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      +++|++.+.||+|+||.||+|++..+++.||||.+.+...........+.+|+.+++.++||||+++++.+.+....|++
T Consensus         1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08229           1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV   80 (267)
T ss_pred             CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence            36899999999999999999999999999999988765444444556777899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcc
Q 011287          124 LESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      |||+++++|.+++..    ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..+....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence            999999999998864    3468999999999999999999999999999999999999999999999999987653221


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCH--HHHHHHHHhcCC-CC-C
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE--WLIFQRIIARDI-RF-P  275 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~--~~~~~~i~~~~~-~~-p  275 (489)
                                .......|+..|+|||.+.+..++.++|+|||||++|+|++|..||.+...  ....+.+..... .. +
T Consensus       161 ----------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  230 (267)
T cd08229         161 ----------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPS  230 (267)
T ss_pred             ----------cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCc
Confidence                      112245789999999999998899999999999999999999999976543  233344443322 12 2


Q ss_pred             CCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          276 NYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       276 ~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      ..+++++++||.+||+.||++|||+
T Consensus       231 ~~~~~~~~~li~~~l~~~p~~Rpt~  255 (267)
T cd08229         231 DHYSEELRQLVNMCINPDPEKRPDI  255 (267)
T ss_pred             ccccHHHHHHHHHhcCCCcccCCCH
Confidence            4578999999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.1e-40  Score=338.71  Aligned_cols=256  Identities=27%  Similarity=0.391  Sum_probs=209.9

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC-------
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT-------  117 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-------  117 (489)
                      .+|.+.+.||.|+||.||+|.+..+|+.||+|.+....   ......+.+|+.+++.++||||+++++++...       
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~---~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED   81 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC---CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence            78999999999999999999999999999999986543   23445677899999999999999999776543       


Q ss_pred             -------CEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCC-CCCEEEeec
Q 011287          118 -------FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-DGHIKIADF  189 (489)
Q Consensus       118 -------~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~-~g~ikL~DF  189 (489)
                             ..+|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+||+++. ++.++|+||
T Consensus        82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df  159 (342)
T cd07854          82 VGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF  159 (342)
T ss_pred             cccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence                   36899999997 489888764 57999999999999999999999999999999999999974 557899999


Q ss_pred             cCccccCCccccccCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHH
Q 011287          190 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII  268 (489)
Q Consensus       190 G~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~  268 (489)
                      |.+..+......       .......+|+..|+|||++.. ..++.++|+|||||++|+|++|+.||.+.+.......+.
T Consensus       160 g~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~  232 (342)
T cd07854         160 GLARIVDPHYSH-------KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL  232 (342)
T ss_pred             ccceecCCcccc-------ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            998765322100       011122367889999998754 567889999999999999999999999887766555543


Q ss_pred             hcCC------------------------------CCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          269 ARDI------------------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       269 ~~~~------------------------------~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                      ....                              .+...++.++.+||.+||+.||.+||++     .+++.||||+.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~ell~h~~~~~~  306 (342)
T cd07854         233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTA-----EEALMHPYMSCY  306 (342)
T ss_pred             HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCH-----HHHhCCCccccc
Confidence            3110                              0123478899999999999999999998     899999999854

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-41  Score=329.48  Aligned_cols=251  Identities=28%  Similarity=0.432  Sum_probs=210.8

Q ss_pred             eEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEec
Q 011287           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALES  126 (489)
Q Consensus        47 y~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~  126 (489)
                      |++.+.||.|++|.||+|.+..+|..||+|++...... ......+.+|+.+++.++||||+++++++.+....|++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence            67899999999999999999999999999998765322 22334566799999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccC
Q 011287          127 CEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (489)
Q Consensus       127 ~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~  204 (489)
                      +. ++|.+++....  .+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++..+....     
T Consensus        80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-----  153 (283)
T cd07835          80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-----  153 (283)
T ss_pred             cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-----
Confidence            95 58999988765  69999999999999999999999999999999999999999999999999987543221     


Q ss_pred             CCCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC------------
Q 011287          205 NAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD------------  271 (489)
Q Consensus       205 ~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~------------  271 (489)
                           .......++..|+|||++.+. .++.++|+|||||++|+|++|.+||.+.+......++....            
T Consensus       154 -----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd07835         154 -----RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVT  228 (283)
T ss_pred             -----cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhh
Confidence                 111233568899999988664 47889999999999999999999998877655444433210            


Q ss_pred             -----------------CCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          272 -----------------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       272 -----------------~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                                       ......++..+.++|.+||+.||.+||++     .+++.||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-----~~il~~~~~  283 (283)
T cd07835         229 SLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISA-----KAALQHPYF  283 (283)
T ss_pred             hchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCH-----HHHhcCCCC
Confidence                             01123567899999999999999999998     899999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.5e-40  Score=323.46  Aligned_cols=240  Identities=22%  Similarity=0.332  Sum_probs=204.4

Q ss_pred             EEeeeCceEEEEEEE--cCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEeccCC
Q 011287           52 IYGVGSYSKVVRAKK--IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG  129 (489)
Q Consensus        52 ~LG~G~~g~Vy~a~~--~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~~~g  129 (489)
                      .||+|+||.||+|.+  ..++..+|+|++.... ........+.+|+.+++.++||||+++++++.+ ...++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence            689999999999965  4678999999986543 233445667889999999999999999998864 467899999999


Q ss_pred             CChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCC
Q 011287          130 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  209 (489)
Q Consensus       130 g~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~  209 (489)
                      |+|.+++.+.+.+++..+..++.|++.||+|||++||+||||||.||+++.++.++|+|||++..+.......       
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~-------  152 (257)
T cd05116          80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY-------  152 (257)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee-------
Confidence            9999999888889999999999999999999999999999999999999999999999999998654322100       


Q ss_pred             CCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhcC-CCCCCCCCHHHHHHHH
Q 011287          210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRFPNYFSDAARDLID  287 (489)
Q Consensus       210 ~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~Li~  287 (489)
                      .......++..|+|||.+....++.++|+|||||++|+|++ |..||.+.+...+...+.... ..+|..+++++.+||.
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~  232 (257)
T cd05116         153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMK  232 (257)
T ss_pred             eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence            00112234678999999988889999999999999999998 999999988887777776543 4677889999999999


Q ss_pred             HhhccCCCCCCCC
Q 011287          288 RLLDVDPSGRPGA  300 (489)
Q Consensus       288 ~~L~~dP~~R~t~  300 (489)
                      +||+.||++||++
T Consensus       233 ~~~~~~p~~Rp~~  245 (257)
T cd05116         233 LCWTYGVDERPGF  245 (257)
T ss_pred             HHhccCchhCcCH
Confidence            9999999999998

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.6e-40  Score=323.44  Aligned_cols=249  Identities=20%  Similarity=0.308  Sum_probs=211.6

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lyl  122 (489)
                      ..++|.+++.||+|+||.||+|+... +..+|+|.+.....    ....+.+|..+++.++||||+++++++.+...+|+
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   76 (256)
T cd05113           2 DPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYI   76 (256)
T ss_pred             ChHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEE
Confidence            45789999999999999999998754 55799998865432    23456779999999999999999999999889999


Q ss_pred             EEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccc
Q 011287          123 ALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~  201 (489)
                      ||||+.+|+|.+++... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||.++....... 
T Consensus        77 v~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-  155 (256)
T cd05113          77 VTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-  155 (256)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-
Confidence            99999999999999764 4689999999999999999999999999999999999999999999999999876533211 


Q ss_pred             ccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhcCC-CCCCCCC
Q 011287          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDI-RFPNYFS  279 (489)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~~~-~~p~~~~  279 (489)
                              .......++..|+|||.+.+..++.++|+|||||++|+|++ |..||...+.......+..... ..+...+
T Consensus       156 --------~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (256)
T cd05113         156 --------TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLAS  227 (256)
T ss_pred             --------eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCC
Confidence                    11112235678999999988889999999999999999998 9999998888777777766533 3466688


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       280 ~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      ..+.+++.+||+.||.+||++     .+++.
T Consensus       228 ~~~~~li~~cl~~~p~~Rp~~-----~~ll~  253 (256)
T cd05113         228 EKVYAIMYSCWHEKAEERPTF-----QQLLS  253 (256)
T ss_pred             HHHHHHHHHHcCCCcccCCCH-----HHHHH
Confidence            999999999999999999998     66664

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=4.6e-41  Score=341.04  Aligned_cols=252  Identities=24%  Similarity=0.370  Sum_probs=205.7

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEc-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEc-
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQD-  116 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~-----~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~-  116 (489)
                      .++|++++.||+|+||.||+|.+.     .+++.||+|++.....  ......+..|+.+++++ +||||+++++++.. 
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~   83 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--ASEYKALMTELKILIHIGHHLNVVNLLGACTKP   83 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC--HHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence            458999999999999999999753     3468999999864421  22344567799999999 89999999998764 


Q ss_pred             CCEEEEEEeccCCCChHHHHHhC---------------------------------------------------------
Q 011287          117 TFSLYMALESCEGGELFDQITSK---------------------------------------------------------  139 (489)
Q Consensus       117 ~~~lylV~E~~~gg~L~~~l~~~---------------------------------------------------------  139 (489)
                      ...+|++|||+++++|.+++...                                                         
T Consensus        84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence            46789999999999999988642                                                         


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCCCCccce
Q 011287          140 ----GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF  215 (489)
Q Consensus       140 ----~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~  215 (489)
                          ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+.....        .......
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~--------~~~~~~~  235 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD--------YVRKGDA  235 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcc--------hhhccCC
Confidence                2578999999999999999999999999999999999999999999999999986533211        1122234


Q ss_pred             ecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc--CCCCCCCCCHHHHHHHHHhhcc
Q 011287          216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR--DIRFPNYFSDAARDLIDRLLDV  292 (489)
Q Consensus       216 ~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~Li~~~L~~  292 (489)
                      .++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+.+......  ....|...++++.+++.+||+.
T Consensus       236 ~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~  315 (337)
T cd05054         236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHN  315 (337)
T ss_pred             CCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccC
Confidence            56778999999999999999999999999999998 99999875544444333332  3345677899999999999999


Q ss_pred             CCCCCCCCCCCCHHHHhc
Q 011287          293 DPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       293 dP~~R~t~~~~~~~~l~~  310 (489)
                      +|++||++     .++++
T Consensus       316 ~p~~RPs~-----~ell~  328 (337)
T cd05054         316 NPEDRPTF-----SELVE  328 (337)
T ss_pred             ChhhCcCH-----HHHHH
Confidence            99999998     55654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-40  Score=322.35  Aligned_cols=245  Identities=19%  Similarity=0.313  Sum_probs=209.0

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ly  121 (489)
                      +..++|++.+.||+|+||.||+|.+. +++.||+|.+.....    ....+.+|+.++++++||||+++++++.....+|
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05068           3 IDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY   77 (261)
T ss_pred             cchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence            34578999999999999999999975 457899999865432    2345677999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcc
Q 011287          122 MALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      +||||+.+++|.+++....  .+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++.+....
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05068          78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI  157 (261)
T ss_pred             eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence            9999999999999997654  69999999999999999999999999999999999999999999999999998764221


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCCC
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNY  277 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~  277 (489)
                      ..         ......++..|+|||.+.+..++.++|+|||||++|+|++ |+.||.+.+.......+... ....+..
T Consensus       158 ~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  228 (261)
T cd05068         158 YE---------AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPG  228 (261)
T ss_pred             cc---------ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCc
Confidence            00         0011123457999999998889999999999999999999 99999998877777666543 2345667


Q ss_pred             CCHHHHHHHHHhhccCCCCCCCC
Q 011287          278 FSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       278 ~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      .+..+.+++.+||+.||++||++
T Consensus       229 ~~~~~~~li~~~l~~~P~~Rp~~  251 (261)
T cd05068         229 CPKELYDIMLDCWKEDPDDRPTF  251 (261)
T ss_pred             CCHHHHHHHHHHhhcCcccCCCH
Confidence            89999999999999999999998

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.5e-40  Score=330.73  Aligned_cols=244  Identities=24%  Similarity=0.388  Sum_probs=206.2

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCc--EEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGT--VYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~--~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~ly  121 (489)
                      ++|++.+.||+|+||.||+|.+..++.  .+++|.+...  ........+.+|+.++.++ +||||+++++++.+...+|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            689999999999999999999987765  4688877532  2223345577899999999 7999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEE
Q 011287          122 MALESCEGGELFDQITSKG----------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIK  185 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~~~----------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ik  185 (489)
                      +||||+++|+|.+++.+..                .+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k  159 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK  159 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence            9999999999999997542                488999999999999999999999999999999999999999999


Q ss_pred             EeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHH
Q 011287          186 IADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIF  264 (489)
Q Consensus       186 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~  264 (489)
                      |+|||++......           ........+..|+|||++....++.++|||||||++|+|++ |..||.+.+.....
T Consensus       160 l~dfg~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~  228 (297)
T cd05089         160 IADFGLSRGEEVY-----------VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY  228 (297)
T ss_pred             ECCcCCCccccce-----------eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            9999998632211           00111123457999999998889999999999999999997 99999998888877


Q ss_pred             HHHHhc-CCCCCCCCCHHHHHHHHHhhccCCCCCCCCC
Q 011287          265 QRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAG  301 (489)
Q Consensus       265 ~~i~~~-~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~  301 (489)
                      .++... ....|..++.++.+||.+||+.||.+||++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~  266 (297)
T cd05089         229 EKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFA  266 (297)
T ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence            777654 3446677899999999999999999999993

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.4e-40  Score=334.09  Aligned_cols=254  Identities=19%  Similarity=0.310  Sum_probs=209.2

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcE----EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTV----YALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~----vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  117 (489)
                      +...+|++.+.||+|+||.||+|++..++..    ||+|++...  ........+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~   81 (316)
T cd05108           4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS   81 (316)
T ss_pred             cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence            4568999999999999999999998766654    899998643  2233445677899999999999999999988764


Q ss_pred             CEEEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccC
Q 011287          118 FSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~  196 (489)
                       ..++|+||+.+|+|.+++... ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.+.
T Consensus        82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence             578999999999999999874 468999999999999999999999999999999999999999999999999998764


Q ss_pred             CccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCC
Q 011287          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRF  274 (489)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~  274 (489)
                      .....        .......++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+..+.+... ....
T Consensus       161 ~~~~~--------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~  232 (316)
T cd05108         161 ADEKE--------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ  232 (316)
T ss_pred             CCCcc--------eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCC
Confidence            32210        01112234678999999999999999999999999999997 99999987766654433332 2344


Q ss_pred             CCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 011287          275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (489)
Q Consensus       275 p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~h  311 (489)
                      |..++.++.+++.+||..||++||++     .+++.+
T Consensus       233 ~~~~~~~~~~li~~cl~~~p~~Rps~-----~~l~~~  264 (316)
T cd05108         233 PPICTIDVYMIMVKCWMIDADSRPKF-----RELIIE  264 (316)
T ss_pred             CCCCCHHHHHHHHHHccCChhhCcCH-----HHHHHH
Confidence            56788999999999999999999998     555543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.4e-40  Score=329.97  Aligned_cols=249  Identities=21%  Similarity=0.296  Sum_probs=210.4

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCC----------------cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCC
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTG----------------TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP  105 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg----------------~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp  105 (489)
                      +..++|++++.||+|+||.||+|.+..++                ..||+|.+......  .....+.+|+.+++.++||
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~   79 (296)
T cd05051           2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--NAREDFLKEVKILSRLSDP   79 (296)
T ss_pred             CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhcCCC
Confidence            35679999999999999999999886644                56899998755322  3455678899999999999


Q ss_pred             CccEEEEEEEcCCEEEEEEeccCCCChHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCC
Q 011287          106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG-----------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPE  174 (489)
Q Consensus       106 nIv~l~~~~~~~~~lylV~E~~~gg~L~~~l~~~~-----------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpe  174 (489)
                      ||+++++++.+....++||||+.+++|.+++.+..           .+++..+..++.|++.||.|||++||+||||||+
T Consensus        80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~  159 (296)
T cd05051          80 NIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR  159 (296)
T ss_pred             CEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence            99999999999999999999999999999998765           6899999999999999999999999999999999


Q ss_pred             CeeeCCCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh--CC
Q 011287          175 NLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS--GT  252 (489)
Q Consensus       175 NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt--G~  252 (489)
                      ||+++.++.++|+|||++........        ........++..|+|||.+.+..++.++|||||||++|+|++  |.
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~  231 (296)
T cd05051         160 NCLVGKNYTIKIADFGMSRNLYSSDY--------YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE  231 (296)
T ss_pred             ceeecCCCceEEccccceeecccCcc--------eeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCC
Confidence            99999999999999999875433211        112224456789999999988889999999999999999998  78


Q ss_pred             CCCCCCCHHHHHHHHHhc--------CCCCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          253 SPFKDTSEWLIFQRIIAR--------DIRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       253 ~PF~~~~~~~~~~~i~~~--------~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      .||...+....+..+...        ....|..++.++.+||.+||+.||++||++
T Consensus       232 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~  287 (296)
T cd05051         232 QPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTF  287 (296)
T ss_pred             CCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCH
Confidence            899887776666655432        123455678999999999999999999998

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-40  Score=324.92  Aligned_cols=250  Identities=22%  Similarity=0.357  Sum_probs=208.4

Q ss_pred             eEEeeEEeeeCceEEEEEEEcC---CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCE----
Q 011287           47 FELGKIYGVGSYSKVVRAKKID---TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS----  119 (489)
Q Consensus        47 y~~~~~LG~G~~g~Vy~a~~~~---tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~----  119 (489)
                      |.+++.||+|+||.||.|....   ++..||+|.+...... ......+.+|+..++.++||||+++++++.....    
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence            6789999999999999999765   3488999998754322 3344567889999999999999999998765443    


Q ss_pred             --EEEEEeccCCCChHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccC
Q 011287          120 --LYMALESCEGGELFDQITSK------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS  191 (489)
Q Consensus       120 --lylV~E~~~gg~L~~~l~~~------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~  191 (489)
                        .++||||+++|+|..++...      ..+++..+..++.|++.||.|||+.|++||||||+||++++++.+||+|||+
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  159 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL  159 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence              79999999999999888542      3589999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc
Q 011287          192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR  270 (489)
Q Consensus       192 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~  270 (489)
                      ++.+......        .......++..|+|||.+.+..++.++|||||||++|+|++ |.+||.+.+..+.+..+...
T Consensus       160 ~~~~~~~~~~--------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~  231 (273)
T cd05035         160 SKKIYSGDYY--------RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG  231 (273)
T ss_pred             eeeccccccc--------cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            9865432211        11112234678999999988889999999999999999999 99999988887777776654


Q ss_pred             -CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          271 -DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       271 -~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                       ....|..++.++.+++.+||+.||++||++     .+++.
T Consensus       232 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-----~e~~~  267 (273)
T cd05035         232 NRLKQPEDCLDELYDLMYSCWRADPKDRPTF-----TKLRE  267 (273)
T ss_pred             CCCCCCcCCCHHHHHHHHHHcCCChhhCcCH-----HHHHH
Confidence             455778899999999999999999999998     55653

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.2e-40  Score=332.28  Aligned_cols=264  Identities=28%  Similarity=0.451  Sum_probs=211.5

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC------
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT------  117 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------  117 (489)
                      .++|++.+.||+|+||.||+|+++.+++.||+|.+...... ........+|+.+++.++||||+++++++.+.      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK-DGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCC-CCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence            68999999999999999999999999999999998654322 22223456799999999999999999887443      


Q ss_pred             --CEEEEEEeccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccc
Q 011287          118 --FSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (489)
Q Consensus       118 --~~lylV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~  194 (489)
                        ..+|+||||+.+ +|...+.. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++..
T Consensus        86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  164 (311)
T cd07866          86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP  164 (311)
T ss_pred             cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence              357999999975 77777765 35799999999999999999999999999999999999999999999999999986


Q ss_pred             cCCccccccCC-CCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC
Q 011287          195 MQDSRITVLPN-AASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI  272 (489)
Q Consensus       195 ~~~~~~~~~~~-~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~  272 (489)
                      ........... ...........|++.|+|||.+.+. .++.++|||||||++|+|++|++||.+.+.......+.....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~  244 (311)
T cd07866         165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG  244 (311)
T ss_pred             ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            54332111100 0011223455789999999988654 578999999999999999999999998887766555443110


Q ss_pred             -----------------------CCC-------CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          273 -----------------------RFP-------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       273 -----------------------~~p-------~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                                             ..|       ..+++.+.++|.+||+.||.+||++     .+++.||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~-----~ell~~~~f  311 (311)
T cd07866         245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTA-----SDALEHPYF  311 (311)
T ss_pred             CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCH-----HHHhcCCCC
Confidence                                   001       1245788999999999999999998     899999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=9.9e-41  Score=345.81  Aligned_cols=250  Identities=22%  Similarity=0.362  Sum_probs=206.8

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCC-----CcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccEEEEEEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDT-----GTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQ  115 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~t-----g~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~  115 (489)
                      +..++|++++.||+|+||.||+|++...     +..||||++....  .....+.+.+|+.+++++. ||||+++++++.
T Consensus        34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~  111 (400)
T cd05105          34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACT  111 (400)
T ss_pred             ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence            3467899999999999999999987433     4579999986542  2334456888999999996 999999999999


Q ss_pred             cCCEEEEEEeccCCCChHHHHHhC--------------------------------------------------------
Q 011287          116 DTFSLYMALESCEGGELFDQITSK--------------------------------------------------------  139 (489)
Q Consensus       116 ~~~~lylV~E~~~gg~L~~~l~~~--------------------------------------------------------  139 (489)
                      +...+|+|||||++|+|.+++.+.                                                        
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (400)
T cd05105         112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM  191 (400)
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence            999999999999999999988642                                                        


Q ss_pred             ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeC
Q 011287          140 ----------------------------------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT  179 (489)
Q Consensus       140 ----------------------------------------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~  179 (489)
                                                              ..+++..+..++.||+.||.|||+.||+||||||+|||++
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~  271 (400)
T cd05105         192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe
Confidence                                                    1377888899999999999999999999999999999999


Q ss_pred             CCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCC
Q 011287          180 ADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDT  258 (489)
Q Consensus       180 ~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~  258 (489)
                      .++.+||+|||+++.......        ........++..|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~  343 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSN--------YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM  343 (400)
T ss_pred             CCCEEEEEeCCcceecccccc--------ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence            999999999999986533211        112223457788999999999889999999999999999997 99999876


Q ss_pred             CHHHHHHHHHhc--CCCCCCCCCHHHHHHHHHhhccCCCCCCCCC
Q 011287          259 SEWLIFQRIIAR--DIRFPNYFSDAARDLIDRLLDVDPSGRPGAG  301 (489)
Q Consensus       259 ~~~~~~~~i~~~--~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~  301 (489)
                      .....+......  ....|..++.++.+++.+||+.||++||++.
T Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~  388 (400)
T cd05105         344 IVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFL  388 (400)
T ss_pred             chhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHH
Confidence            544433333333  3445677899999999999999999999983

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.3e-40  Score=325.88  Aligned_cols=245  Identities=21%  Similarity=0.362  Sum_probs=204.3

Q ss_pred             eEEeeEEeeeCceEEEEEEEcCCCc--EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC------C
Q 011287           47 FELGKIYGVGSYSKVVRAKKIDTGT--VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT------F  118 (489)
Q Consensus        47 y~~~~~LG~G~~g~Vy~a~~~~tg~--~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------~  118 (489)
                      |.+++.||+|+||.||+|++..++.  .||+|.+..... .......+..|..+++.++||||+++++.+...      .
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   79 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP   79 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence            4578999999999999999987775  699998876432 334456677899999999999999999876421      2


Q ss_pred             EEEEEEeccCCCChHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCc
Q 011287          119 SLYMALESCEGGELFDQITS------KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  192 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~------~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a  192 (489)
                      ..+++|||+.+|+|.+++..      ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++
T Consensus        80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence            47899999999999988742      134899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhcC
Q 011287          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD  271 (489)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~~  271 (489)
                      +.+......        .......+++.|+|||.+.+..++.++|+|||||++|+|++ |++||.+.........+....
T Consensus       160 ~~~~~~~~~--------~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~  231 (272)
T cd05075         160 KKIYNGDYY--------RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN  231 (272)
T ss_pred             cccCcccce--------ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence            875432210        01122346678999999999999999999999999999999 899999888877777766544


Q ss_pred             -CCCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          272 -IRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       272 -~~~p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                       ..++..++..+.++|.+||+.||.+||++
T Consensus       232 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  261 (272)
T cd05075         232 RLKQPPDCLDGLYSLMSSCWLLNPKDRPSF  261 (272)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCcccCcCH
Confidence             35667789999999999999999999998

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.8e-40  Score=331.84  Aligned_cols=249  Identities=24%  Similarity=0.369  Sum_probs=208.4

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKID-------TGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTF  114 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~-------tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~  114 (489)
                      ..++|.+++.||+|+||.||+|++..       ++..+|+|.+....  .+.....+.+|+.+++.+ +||||+++++++
T Consensus        16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (307)
T cd05098          16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGAC   93 (307)
T ss_pred             ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            34789999999999999999998643       33579999987542  233345577799999999 799999999999


Q ss_pred             EcCCEEEEEEeccCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeee
Q 011287          115 QDTFSLYMALESCEGGELFDQITSKG----------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL  178 (489)
Q Consensus       115 ~~~~~lylV~E~~~gg~L~~~l~~~~----------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl  178 (489)
                      .+...+|+||||+.+|+|.+++...+                .++...+..++.|++.||+|||++|++||||||+||++
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill  173 (307)
T cd05098          94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV  173 (307)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE
Confidence            99999999999999999999997642                47889999999999999999999999999999999999


Q ss_pred             CCCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCC
Q 011287          179 TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKD  257 (489)
Q Consensus       179 ~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~  257 (489)
                      +.++.++|+|||++.........        .......++..|+|||++.+..++.++|+|||||++|+|++ |..||.+
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~  245 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYY--------KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG  245 (307)
T ss_pred             cCCCcEEECCCcccccccccchh--------hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc
Confidence            99999999999998755321100        00111234568999999998889999999999999999998 9999988


Q ss_pred             CCHHHHHHHHHhcC-CCCCCCCCHHHHHHHHHhhccCCCCCCCCC
Q 011287          258 TSEWLIFQRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGAG  301 (489)
Q Consensus       258 ~~~~~~~~~i~~~~-~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~  301 (489)
                      .+....+..+.... ..+|..++.++.+||.+||..+|++||++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  290 (307)
T cd05098         246 VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK  290 (307)
T ss_pred             CCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHH
Confidence            87777766665543 356778899999999999999999999983

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.9e-40  Score=328.78  Aligned_cols=256  Identities=23%  Similarity=0.371  Sum_probs=214.5

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCC-----CcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEE
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDT-----GTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFT  113 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~t-----g~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  113 (489)
                      -.+..++|++.+.||+|+||.||+|.....     ...+|+|.+.....  ......+.+|+.+++++ +||||++++++
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   84 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGV   84 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            345678999999999999999999998644     37899999875422  22345577899999999 89999999999


Q ss_pred             EEcCCEEEEEEeccCCCChHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCee
Q 011287          114 FQDTFSLYMALESCEGGELFDQITSK----------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLL  177 (489)
Q Consensus       114 ~~~~~~lylV~E~~~gg~L~~~l~~~----------------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNIL  177 (489)
                      +.+...+|++|||+.+|+|..++...                +.+++..+..++.||+.||.|||+.||+||||||+|||
T Consensus        85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil  164 (293)
T cd05053          85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL  164 (293)
T ss_pred             EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence            99999999999999999999998642                45899999999999999999999999999999999999


Q ss_pred             eCCCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCC
Q 011287          178 LTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK  256 (489)
Q Consensus       178 l~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~  256 (489)
                      ++.++.++|+|||+++.+......        .......++..|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~  236 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYY--------RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP  236 (293)
T ss_pred             EcCCCeEEeCccccccccccccce--------eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCC
Confidence            999999999999999865432210        01111234567999999998899999999999999999997 999999


Q ss_pred             CCCHHHHHHHHHhcC-CCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          257 DTSEWLIFQRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       257 ~~~~~~~~~~i~~~~-~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      +.+..+.++.+.... ...|...+..+.+|+.+||..||++|||+     .++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~eil~  286 (293)
T cd05053         237 GIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTF-----KQLVE  286 (293)
T ss_pred             CCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCH-----HHHHH
Confidence            888777777665543 35667789999999999999999999999     56654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.8e-40  Score=331.29  Aligned_cols=251  Identities=23%  Similarity=0.388  Sum_probs=211.1

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEE-----cCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEE
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKK-----IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFT  113 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~-----~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  113 (489)
                      -++..++|.+.+.||+|+||.||+|.+     ..++..||+|++.+..  .......+.+|+.+++++ +||||+++++.
T Consensus        30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  107 (302)
T cd05055          30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGA  107 (302)
T ss_pred             ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence            457778999999999999999999986     3356789999986542  223345678899999999 79999999999


Q ss_pred             EEcCCEEEEEEeccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccC
Q 011287          114 FQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS  191 (489)
Q Consensus       114 ~~~~~~lylV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~  191 (489)
                      +.....+|+||||+.+|+|.+++....  .+++.++..++.|++.||.|||++||+|+||||+|||++.++.++|+|||+
T Consensus       108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~  187 (302)
T cd05055         108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL  187 (302)
T ss_pred             EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence            999999999999999999999997643  389999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc
Q 011287          192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR  270 (489)
Q Consensus       192 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~  270 (489)
                      ++.+......        .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+......+.+....
T Consensus       188 ~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~  259 (302)
T cd05055         188 ARDIMNDSNY--------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE  259 (302)
T ss_pred             cccccCCCce--------eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHc
Confidence            8765332100        01123346788999999999899999999999999999998 99999887766655555443


Q ss_pred             C--CCCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          271 D--IRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       271 ~--~~~p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      .  ...|...++++.+|+.+||+.+|++||++
T Consensus       260 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~  291 (302)
T cd05055         260 GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTF  291 (302)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCH
Confidence            3  23456789999999999999999999998

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=5.3e-40  Score=315.83  Aligned_cols=249  Identities=32%  Similarity=0.593  Sum_probs=216.6

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEe
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E  125 (489)
                      ||.+.+.||+|++|.||+|.+..+++.|++|++.....   .....+.+|..+++.++||||+++++.+......++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e   77 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME   77 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence            68999999999999999999998999999999976532   345677889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccC
Q 011287          126 SCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (489)
Q Consensus       126 ~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~  204 (489)
                      |+++++|.+++... ..+++..+..++.|++.||.+||++|++||||+|+||+++.++.++|+|||.+.......     
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-----  152 (253)
T cd05122          78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK-----  152 (253)
T ss_pred             cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccc-----
Confidence            99999999999876 679999999999999999999999999999999999999999999999999987654321     


Q ss_pred             CCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHh-cCCCCCCC--CCHH
Q 011287          205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA-RDIRFPNY--FSDA  281 (489)
Q Consensus       205 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~-~~~~~p~~--~~~~  281 (489)
                            ......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...+.......+.. ....++..  ++..
T Consensus       153 ------~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (253)
T cd05122         153 ------ARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDE  226 (253)
T ss_pred             ------cccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHH
Confidence                  03456789999999999988899999999999999999999999988755444333332 22233333  4899


Q ss_pred             HHHHHHHhhccCCCCCCCCCCCCHHHHhcCCC
Q 011287          282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF  313 (489)
Q Consensus       282 ~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpf  313 (489)
                      +.++|.+||+.||++||++     .+++.|||
T Consensus       227 ~~~~i~~~l~~~p~~R~t~-----~~~l~~~~  253 (253)
T cd05122         227 FKDFLKKCLQKNPEKRPTA-----EQLLKHPF  253 (253)
T ss_pred             HHHHHHHHccCChhhCCCH-----HHHhcCCC
Confidence            9999999999999999999     89999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.5e-40  Score=323.68  Aligned_cols=243  Identities=21%  Similarity=0.334  Sum_probs=207.3

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lyl  122 (489)
                      ..++|++.+.||+|+||.||+|.+. ++..+|+|.+......    ...+.+|+.++++++||||+++++++.+ ...|+
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~l   77 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYI   77 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEE
Confidence            4578999999999999999999875 5677999998764332    2457789999999999999999998854 56899


Q ss_pred             EEeccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          123 ALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      +|||+.+++|.+++...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..+.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05070          78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence            99999999999999763  3589999999999999999999999999999999999999999999999999976543211


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCCCC
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYF  278 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~  278 (489)
                               .......++..|+|||.+.+..++.++|+|||||++|+|++ |.+||.+.+.......+... ....|...
T Consensus       158 ---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  228 (260)
T cd05070         158 ---------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDC  228 (260)
T ss_pred             ---------ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcC
Confidence                     11112345668999999988889999999999999999999 99999988887777776654 44567778


Q ss_pred             CHHHHHHHHHhhccCCCCCCCC
Q 011287          279 SDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       279 ~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      +.++.+|+.+||+.||++|||+
T Consensus       229 ~~~~~~li~~~l~~~p~~Rpt~  250 (260)
T cd05070         229 PISLHELMLQCWKKDPEERPTF  250 (260)
T ss_pred             CHHHHHHHHHHcccCcccCcCH
Confidence            9999999999999999999998

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.4e-40  Score=324.77  Aligned_cols=253  Identities=18%  Similarity=0.304  Sum_probs=210.5

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGT----VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  116 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~----~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  116 (489)
                      .++.++|++.+.||+|+||+||+|++..+|+    .||+|++....  .......+.+|..+++.++||||+++++++..
T Consensus         3 ~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (279)
T cd05109           3 ILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT   80 (279)
T ss_pred             ccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence            3567899999999999999999999877776    48999986542  23334567789999999999999999998876


Q ss_pred             CCEEEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCcccc
Q 011287          117 TFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (489)
Q Consensus       117 ~~~lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~  195 (489)
                      . ..++++||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus        81 ~-~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          81 S-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             C-CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence            4 578999999999999999764 56999999999999999999999999999999999999999999999999999866


Q ss_pred             CCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCC
Q 011287          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIR  273 (489)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~  273 (489)
                      ......        .......++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+... ...
T Consensus       160 ~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~  231 (279)
T cd05109         160 DIDETE--------YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLP  231 (279)
T ss_pred             ccccce--------eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCC
Confidence            432211        00111234678999999998889999999999999999998 99999887766655555443 334


Q ss_pred             CCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHh
Q 011287          274 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLK  309 (489)
Q Consensus       274 ~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~  309 (489)
                      .+..++.++.++|.+||+.||++||++     .+++
T Consensus       232 ~~~~~~~~~~~li~~~l~~dp~~Rp~~-----~~l~  262 (279)
T cd05109         232 QPPICTIDVYMIMVKCWMIDSECRPRF-----RELV  262 (279)
T ss_pred             CCccCCHHHHHHHHHHcCCChhhCcCH-----HHHH
Confidence            566789999999999999999999999     5565

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.5e-40  Score=323.13  Aligned_cols=243  Identities=20%  Similarity=0.340  Sum_probs=205.9

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lyl  122 (489)
                      ..++|++.+.||+|+||.||+|++..+ ..||+|.+.+....    ...+.+|+.+++.++||||+++++.+.+ ...|+
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~l   77 (262)
T cd05071           4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI   77 (262)
T ss_pred             ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEE
Confidence            357899999999999999999998665 46999998764322    2456779999999999999999998754 56899


Q ss_pred             EEeccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          123 ALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      ||||+++|+|.+++.+.  ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||.+..+.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence            99999999999999763  3589999999999999999999999999999999999999999999999999976543221


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCCCC
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYF  278 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~  278 (489)
                               .......++..|+|||++.+..++.++|+|||||++|+|++ |.+||.+.........+... ....+..+
T Consensus       158 ---------~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  228 (262)
T cd05071         158 ---------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC  228 (262)
T ss_pred             ---------ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCcccc
Confidence                     11123346778999999988889999999999999999999 99999988877777666543 23445678


Q ss_pred             CHHHHHHHHHhhccCCCCCCCC
Q 011287          279 SDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       279 ~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      +..+.+||.+||+.||++||++
T Consensus       229 ~~~l~~li~~~l~~~p~~Rp~~  250 (262)
T cd05071         229 PESLHDLMCQCWRKEPEERPTF  250 (262)
T ss_pred             CHHHHHHHHHHccCCcccCCCH
Confidence            9999999999999999999998

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.7e-40  Score=321.21  Aligned_cols=239  Identities=23%  Similarity=0.416  Sum_probs=204.9

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEE-EcCCEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTF-QDTFSL  120 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-~~~~~l  120 (489)
                      +..++|++.+.||+|+||.||+|..  .|..||+|.+...     .....+.+|+.++++++|+|++++++++ .+...+
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (256)
T cd05082           3 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   75 (256)
T ss_pred             ccHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC-----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence            3567999999999999999999976  4788999998543     2234577899999999999999999865 456679


Q ss_pred             EEEEeccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          121 YMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      |+||||+++++|.+++.+.+  .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  155 (256)
T cd05082          76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  155 (256)
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence            99999999999999997653  3889999999999999999999999999999999999999999999999998754321


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCC
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPN  276 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~  276 (489)
                                   .....++..|+|||++.+..++.++|||||||++|+|++ |++||...+.......+... ....++
T Consensus       156 -------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  222 (256)
T cd05082         156 -------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD  222 (256)
T ss_pred             -------------CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Confidence                         112234568999999998889999999999999999997 99999988777776666544 334567


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCC
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      .+++.+.++|.+||+.||++||++
T Consensus       223 ~~~~~~~~li~~~l~~~p~~Rpt~  246 (256)
T cd05082         223 GCPPVVYDVMKQCWHLDAATRPSF  246 (256)
T ss_pred             CCCHHHHHHHHHHhcCChhhCcCH
Confidence            789999999999999999999998

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=5.7e-40  Score=329.37  Aligned_cols=251  Identities=30%  Similarity=0.410  Sum_probs=214.7

Q ss_pred             eEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEec
Q 011287           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALES  126 (489)
Q Consensus        47 y~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~  126 (489)
                      |...+.||+|+||.||+|++..+|..||+|++.............+..|+.+++.++|||++++++++.+....|+||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            77788899999999999999999999999999766544445556677899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCC
Q 011287          127 CEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  205 (489)
Q Consensus       127 ~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~  205 (489)
                      +. |+|.+.+.. ...+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++....         
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~---------  172 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---------  172 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC---------
Confidence            96 478777765 4568999999999999999999999999999999999999999999999999976321         


Q ss_pred             CCCCCCccceecCCcCCChhhhc---CCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCC--CCCCCCH
Q 011287          206 AASDDKACTFVGTAAYVPPEVLN---SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR--FPNYFSD  280 (489)
Q Consensus       206 ~~~~~~~~~~~gt~~Y~aPE~l~---~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~--~p~~~~~  280 (489)
                           ......|+..|+|||++.   ...++.++|+|||||++|+|++|.+||...+.......+......  ....++.
T Consensus       173 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (313)
T cd06633         173 -----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTD  247 (313)
T ss_pred             -----CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCH
Confidence                 122457899999999984   456788999999999999999999999887766655555443221  2245788


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       281 ~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                      .+++||.+||+.+|.+||++     .+++.||||+..
T Consensus       248 ~l~~li~~~l~~~P~~Rp~~-----~~~l~~~~~~~~  279 (313)
T cd06633         248 SFRGFVDYCLQKIPQERPAS-----AELLRHDFVRRD  279 (313)
T ss_pred             HHHHHHHHHccCChhhCcCH-----HHHhcCcccCCC
Confidence            89999999999999999998     899999999853

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.4e-40  Score=336.34  Aligned_cols=253  Identities=28%  Similarity=0.468  Sum_probs=209.6

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC------C
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT------F  118 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------~  118 (489)
                      ++|.+.+.||+|+||.||+|++..+|+.||+|++.+.... +.....+.+|+.+++.++||||++++++|...      .
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS-EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc-ccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            6899999999999999999999999999999998764322 22334567899999999999999999998754      3


Q ss_pred             EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      ..|+|+||+.+ +|..++.  ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++.... 
T Consensus        94 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~-  169 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA-  169 (342)
T ss_pred             eEEEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC-
Confidence            46999999964 7776653  3699999999999999999999999999999999999999999999999999875321 


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC------
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD------  271 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~------  271 (489)
                                  ......++..|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+....+..+....      
T Consensus       170 ------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (342)
T cd07879         170 ------------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPE  237 (342)
T ss_pred             ------------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence                        1224578899999999876 458889999999999999999999999877655544433210      


Q ss_pred             -----------------CCCC--------CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 011287          272 -----------------IRFP--------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (489)
Q Consensus       272 -----------------~~~p--------~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~  319 (489)
                                       ..++        +..++++.+||++||+.||++||++     .+++.||||+++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~-----~e~l~h~~f~~~~~  305 (342)
T cd07879         238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTA-----TEALEHPYFDSFRD  305 (342)
T ss_pred             HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCH-----HHHhcCcchhhccc
Confidence                             0111        2367889999999999999999998     89999999998653

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-40  Score=324.65  Aligned_cols=250  Identities=28%  Similarity=0.467  Sum_probs=209.6

Q ss_pred             eEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCccEEEEEEEcCCE----
Q 011287           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL---DHPGVVRLFFTFQDTFS----  119 (489)
Q Consensus        47 y~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~~~~----  119 (489)
                      |++.+.||+|+||.||+|+++.+++.||+|++..... .......+.+|+.+++.+   +||||+++++++.+...    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            7899999999999999999998999999999975433 222234455677777665   69999999999988776    


Q ss_pred             -EEEEEeccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccC
Q 011287          120 -LYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (489)
Q Consensus       120 -lylV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~  196 (489)
                       +|++|||+.+ +|.+++.+..  .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+.
T Consensus        80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~  158 (287)
T cd07838          80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS  158 (287)
T ss_pred             eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence             9999999975 8988887643  59999999999999999999999999999999999999999999999999987653


Q ss_pred             CccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC-----
Q 011287          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----  271 (489)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~-----  271 (489)
                      ...           ......++..|+|||++.+..++.++|+|||||++|+|++|.+||.+.+..+.+.++....     
T Consensus       159 ~~~-----------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (287)
T cd07838         159 FEM-----------ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSE  227 (287)
T ss_pred             CCc-----------ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCCh
Confidence            321           1123457889999999998889999999999999999999999999988877777665421     


Q ss_pred             CC-----------CC-----------CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          272 IR-----------FP-----------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       272 ~~-----------~p-----------~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                      ..           ++           ..+++.+.++|.+||+.||++||++     .+++.||||
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~-----~~il~~~~~  287 (287)
T cd07838         228 EEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISA-----FEALQHPYF  287 (287)
T ss_pred             HhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCH-----HHHhcCcCC
Confidence            00           01           1246788999999999999999998     899999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.7e-40  Score=336.42  Aligned_cols=252  Identities=26%  Similarity=0.423  Sum_probs=208.8

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC------
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT------  117 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------  117 (489)
                      .++|.+.+.||+|+||.||+|.+..+|+.||+|++.+.... ......+.+|+.++++++||||+++++++...      
T Consensus        16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (345)
T cd07877          16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   94 (345)
T ss_pred             cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-hHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence            48899999999999999999999999999999998764322 22334566799999999999999999988643      


Q ss_pred             CEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCC
Q 011287          118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~  197 (489)
                      ...|++++++ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.+|.++|+|||++.....
T Consensus        95 ~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~  172 (345)
T cd07877          95 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD  172 (345)
T ss_pred             ccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence            3478888887 6799887765 4699999999999999999999999999999999999999999999999999875321


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC----
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI----  272 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~----  272 (489)
                                   ......|+..|+|||.+.+ ..++.++|+|||||++|+|++|++||.+.+.......+.....    
T Consensus       173 -------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (345)
T cd07877         173 -------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA  239 (345)
T ss_pred             -------------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence                         1224578899999999866 5688899999999999999999999987766554444322110    


Q ss_pred             -------------------CC--------CCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          273 -------------------RF--------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       273 -------------------~~--------p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                                         ..        ....++++.+||.+||+.||.+||++     .+++.||||..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-----~e~l~h~~f~~  305 (345)
T cd07877         240 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA-----AQALAHAYFAQ  305 (345)
T ss_pred             HHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCH-----HHHhcChhhhh
Confidence                               11        11357889999999999999999998     89999999985

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3.7e-40  Score=322.47  Aligned_cols=249  Identities=20%  Similarity=0.332  Sum_probs=209.2

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGT---VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~---~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  119 (489)
                      ..++|++++.||+|+||.||+|+++.++.   .+|+|.+.....  ......+.+|..+++.++||||+++++++.+...
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (267)
T cd05066           2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP   79 (267)
T ss_pred             CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            35789999999999999999999875543   799999865432  2334567889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          120 LYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      .|+||||+++++|.+++.+. +.+++.++..++.|++.||.|||++|++||||||+|||++.++.++|+|||++..+...
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            99999999999999999875 46899999999999999999999999999999999999999999999999999865432


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCC
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPN  276 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~  276 (489)
                      ...       ........++..|+|||.+.+..++.++|+|||||++|++++ |..||...+..+....+... ....+.
T Consensus       160 ~~~-------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (267)
T cd05066         160 PEA-------AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPM  232 (267)
T ss_pred             cce-------eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCC
Confidence            100       001112233567999999998889999999999999999886 99999988877777666654 233445


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCC
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      .+++.+.+++.+||+.+|.+||++
T Consensus       233 ~~~~~~~~li~~~l~~~p~~Rp~~  256 (267)
T cd05066         233 DCPAALHQLMLDCWQKDRNERPKF  256 (267)
T ss_pred             CCCHHHHHHHHHHcccCchhCCCH
Confidence            678999999999999999999998

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-43  Score=380.22  Aligned_cols=258  Identities=32%  Similarity=0.574  Sum_probs=226.7

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEe
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E  125 (489)
                      +++-+-.||.|.||.||.|.+.+||...|+|-+.-.... ......+.+|..+|..++|||+|++|++-.+.+.+|+.||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence            567778899999999999999999999999988654333 4455678889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCC
Q 011287          126 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  205 (489)
Q Consensus       126 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~  205 (489)
                      ||+||+|.+.+...+..+|...+.|..|++.|+.|||+.|||||||||+||+++.+|-+|++|||+|..+.++..+.   
T Consensus      1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~--- 1391 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM--- 1391 (1509)
T ss_pred             HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcC---
Confidence            99999999999988889999999999999999999999999999999999999999999999999999887653221   


Q ss_pred             CCCCCCccceecCCcCCChhhhcC---CCCCCCCcchhhhHHHHHHhhCCCCCCC-CCHHHHHHHHHh-cCCCCCCCCCH
Q 011287          206 AASDDKACTFVGTAAYVPPEVLNS---SPATFGNDLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIA-RDIRFPNYFSD  280 (489)
Q Consensus       206 ~~~~~~~~~~~gt~~Y~aPE~l~~---~~~~~~sDiwSLG~ilyelltG~~PF~~-~~~~~~~~~i~~-~~~~~p~~~~~  280 (489)
                         .......+||+.|||||++.+   .+...++|||||||++.||+||+.||.. .++..++.+.-. ..+++|..+++
T Consensus      1392 ---~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~ 1468 (1509)
T KOG4645|consen 1392 ---PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSS 1468 (1509)
T ss_pred             ---CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhH
Confidence               233457799999999999965   4467899999999999999999999975 456666655544 45789999999


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 011287          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (489)
Q Consensus       281 ~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~  315 (489)
                      +.+|||++||+.||++|.++     .+|++|.|=+
T Consensus      1469 ~g~dFle~Cl~~dP~~Rw~~-----~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1469 EGRDFLEHCLEQDPKMRWTA-----SQLLEHAFGK 1498 (1509)
T ss_pred             hHHHHHHHHHhcCchhhhHH-----HHHHHhhccc
Confidence            99999999999999999988     7899999854

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=7.4e-41  Score=337.91  Aligned_cols=258  Identities=22%  Similarity=0.336  Sum_probs=205.9

Q ss_pred             eEEeee--CceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEeccC
Q 011287           51 KIYGVG--SYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCE  128 (489)
Q Consensus        51 ~~LG~G--~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~~~  128 (489)
                      ..||+|  +||+||+|++..+|+.||+|++....... .....+.+|+.+++.++||||++++++|......|+||||+.
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            356666  99999999999999999999987653332 344678889999999999999999999999999999999999


Q ss_pred             CCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCC
Q 011287          129 GGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNA  206 (489)
Q Consensus       129 gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~  206 (489)
                      +++|.+++.+.  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++++||+.+...........   
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~---  159 (328)
T cd08226          83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK---  159 (328)
T ss_pred             CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc---
Confidence            99999998864  3489999999999999999999999999999999999999999999999986543322110000   


Q ss_pred             CCCCCccceecCCcCCChhhhcCC--CCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCC-----------
Q 011287          207 ASDDKACTFVGTAAYVPPEVLNSS--PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR-----------  273 (489)
Q Consensus       207 ~~~~~~~~~~gt~~Y~aPE~l~~~--~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~-----------  273 (489)
                      ..........++..|+|||++.+.  .++.++|+|||||++|+|++|.+||.+.........+......           
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence            000011122456779999999764  4788999999999999999999999887655544443322111           


Q ss_pred             ------------------------------------CCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          274 ------------------------------------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       274 ------------------------------------~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                                                          .+..+++.+.+||++||+.||++|||+     .++++||||.++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta-----~e~l~~~~~~~~  314 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSA-----SSLLSHAFFKQV  314 (328)
T ss_pred             hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCH-----HHHhhCHHHHHH
Confidence                                                122356789999999999999999999     899999999754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=3.5e-40  Score=319.21  Aligned_cols=251  Identities=28%  Similarity=0.494  Sum_probs=220.7

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEe
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E  125 (489)
                      +|++.+.||+|+||.||+|++..+++.||+|.+........ ....+.+|..+++.++||||+++++++.+....|+|||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQK-EREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHH-HHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence            68999999999999999999999999999999976554433 34456679999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccc
Q 011287          126 SCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (489)
Q Consensus       126 ~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~  201 (489)
                      |+++++|.+++.+    ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......   
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---  156 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---  156 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence            9999999998876    356899999999999999999999999999999999999999999999999998765432   


Q ss_pred             ccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCH
Q 011287          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-RFPNYFSD  280 (489)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~-~~p~~~~~  280 (489)
                               ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+..... ..+..++.
T Consensus       157 ---------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (256)
T cd08530         157 ---------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQ  227 (256)
T ss_pred             ---------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCH
Confidence                     11234578899999999998899999999999999999999999999887776666655443 45667899


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       281 ~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                      +++++|.+||+.+|++||++     .++++||+.
T Consensus       228 ~~~~li~~~l~~~p~~Rp~~-----~~~l~~p~~  256 (256)
T cd08530         228 DLQNFIRSMLQVKPKLRPNC-----DKILASPAV  256 (256)
T ss_pred             HHHHHHHHHcCCCcccCCCH-----HHHhcCCCC
Confidence            99999999999999999998     899999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.4e-40  Score=334.94  Aligned_cols=267  Identities=24%  Similarity=0.365  Sum_probs=216.2

Q ss_pred             CCeE-EeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchh-----------HHHHHHHHHHHHHhCCCCCccEEEE
Q 011287           45 QDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN-----------KTAYVKLERIVLDQLDHPGVVRLFF  112 (489)
Q Consensus        45 ~dy~-~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~-----------~~~~~~~E~~il~~l~hpnIv~l~~  112 (489)
                      ++|. +.+.||.|+||+||+|.+..+++.||+|++.........           ....+.+|+.+++.++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4665 567899999999999999999999999998765333211           1123667999999999999999999


Q ss_pred             EEEcCCEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCc
Q 011287          113 TFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  192 (489)
Q Consensus       113 ~~~~~~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a  192 (489)
                      ++......|+||||+. |+|.+++.....+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||.+
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~  166 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA  166 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence            9999999999999997 599999988888999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccccCCC----CCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHH
Q 011287          193 KPMQDSRITVLPNA----ASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI  267 (489)
Q Consensus       193 ~~~~~~~~~~~~~~----~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i  267 (489)
                      ..+...........    ..........++..|+|||.+.+. .++.++|+|||||++|+|++|.+||.+.+....+..+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i  246 (335)
T PTZ00024        167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI  246 (335)
T ss_pred             eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            86653221100000    011122234678899999998764 4688999999999999999999999998887766655


Q ss_pred             HhcC-----CCC-----------------------CCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          268 IARD-----IRF-----------------------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       268 ~~~~-----~~~-----------------------p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                      ....     ..+                       ....+.++.++|.+||+.||++||++     ++++.||||++-
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~-----~~~l~~~~~~~~  319 (335)
T PTZ00024        247 FELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISA-----KEALKHEYFKSD  319 (335)
T ss_pred             HHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCH-----HHHhcCcccCCC
Confidence            4310     000                       12357889999999999999999998     899999999853

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.5e-40  Score=320.14  Aligned_cols=245  Identities=22%  Similarity=0.355  Sum_probs=211.0

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ly  121 (489)
                      +..++|++.+.||+|+||.||+|.+. .++.||+|.+.....    ....+.+|+.+++.++||||+++++++.+....|
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY   77 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence            45689999999999999999999975 468899999875432    2345778999999999999999999999989999


Q ss_pred             EEEeccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcc
Q 011287          122 MALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      +||||+++++|.+++....  .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..+....
T Consensus        78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            9999999999999997653  68999999999999999999999999999999999999999999999999988654321


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCCC
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNY  277 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~  277 (489)
                      .         .......++..|+|||.+.+..++.++|+|||||++|+|++ |+.||.+.+.....+.+... ....|..
T Consensus       158 ~---------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  228 (261)
T cd05034         158 Y---------TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPN  228 (261)
T ss_pred             h---------hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence            0         01112234568999999998889999999999999999998 99999998887777777654 3345667


Q ss_pred             CCHHHHHHHHHhhccCCCCCCCC
Q 011287          278 FSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       278 ~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      .+.++.+++.+||+.+|.+||++
T Consensus       229 ~~~~~~~~i~~~l~~~p~~Rp~~  251 (261)
T cd05034         229 CPEELYDLMLQCWDKDPEERPTF  251 (261)
T ss_pred             CCHHHHHHHHHHcccCcccCCCH
Confidence            89999999999999999999998

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-40  Score=319.63  Aligned_cols=240  Identities=21%  Similarity=0.347  Sum_probs=202.6

Q ss_pred             eEEeeeCceEEEEEEEcCCC---cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEecc
Q 011287           51 KIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESC  127 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~~tg---~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~~  127 (489)
                      +.||+|+||.||+|....++   ..||+|.+......  .....+..|+.+++.++||||+++++++.. ...++||||+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~   77 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELA   77 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeC
Confidence            47999999999999876554   79999998765433  334567779999999999999999998764 4689999999


Q ss_pred             CCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCC
Q 011287          128 EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA  207 (489)
Q Consensus       128 ~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~  207 (489)
                      ++|+|.+++.+.+.+++..+..++.|++.||+|||..|++||||||+|||++.++.++|+|||+++.+......      
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~------  151 (257)
T cd05060          78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY------  151 (257)
T ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcc------
Confidence            99999999998888999999999999999999999999999999999999999999999999998865432110      


Q ss_pred             CCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhcC-CCCCCCCCHHHHHH
Q 011287          208 SDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRFPNYFSDAARDL  285 (489)
Q Consensus       208 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~L  285 (489)
                       ........++..|+|||.+.+..++.++|+|||||++|+|++ |.+||...+.......+.... ...|..++..++++
T Consensus       152 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  230 (257)
T cd05060         152 -YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSI  230 (257)
T ss_pred             -cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHH
Confidence             000111124567999999998889999999999999999998 999999888777666665543 35677889999999


Q ss_pred             HHHhhccCCCCCCCC
Q 011287          286 IDRLLDVDPSGRPGA  300 (489)
Q Consensus       286 i~~~L~~dP~~R~t~  300 (489)
                      |.+||+.||++||++
T Consensus       231 i~~cl~~~p~~Rp~~  245 (257)
T cd05060         231 MLSCWKYRPEDRPTF  245 (257)
T ss_pred             HHHHhcCChhhCcCH
Confidence            999999999999998

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=4.5e-42  Score=324.72  Aligned_cols=260  Identities=28%  Similarity=0.414  Sum_probs=210.8

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCC----cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc-CC
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTG----TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD-TF  118 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg----~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~  118 (489)
                      +..|++++.||+|+||.||+|..+.++    +.||||.++.+.. ........-+|+.+++.++|||++.|..+|-. +.
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            467999999999999999999765553    3789999875522 22333445679999999999999999998876 78


Q ss_pred             EEEEEEeccCCCChHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCC----CCEEEeec
Q 011287          119 SLYMALESCEGGELFDQITSK-----GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD----GHIKIADF  189 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~-----~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~----g~ikL~DF  189 (489)
                      .+++++||++. ||++.|.-+     ..++...++.++.||+.|+.|||++=|+||||||.||||..+    |.|||+||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence            89999999987 999988643     358999999999999999999999999999999999999988    89999999


Q ss_pred             cCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCCCH--------
Q 011287          190 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSE--------  260 (489)
Q Consensus       190 G~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~~~--------  260 (489)
                      |+|+.+.+.-..       .-.....|-|.+|+|||+|.+. .|+.+.|+||+|||+.||++-.+.|.+..+        
T Consensus       181 GlaR~~~~plkp-------l~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pf  253 (438)
T KOG0666|consen  181 GLARLFNNPLKP-------LASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPF  253 (438)
T ss_pred             cHHHHhhccccc-------cccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCc
Confidence            999988654211       1122356889999999998775 599999999999999999999999986432        


Q ss_pred             -HHHHHHHHhcC-----------CCCCC--------------------------CCCHHHHHHHHHhhccCCCCCCCCCC
Q 011287          261 -WLIFQRIIARD-----------IRFPN--------------------------YFSDAARDLIDRLLDVDPSGRPGAGP  302 (489)
Q Consensus       261 -~~~~~~i~~~~-----------~~~p~--------------------------~~~~~~~~Li~~~L~~dP~~R~t~~~  302 (489)
                       ..++++|...-           ...|+                          .-++.+.+|+.+||..||.+|+|+  
T Consensus       254 q~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta--  331 (438)
T KOG0666|consen  254 QHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITA--  331 (438)
T ss_pred             hHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccH--
Confidence             34555565410           00111                          125569999999999999999999  


Q ss_pred             CCHHHHhcCCCCCCC
Q 011287          303 GGYAVLKMHPFFKGI  317 (489)
Q Consensus       303 ~~~~~l~~hpff~~i  317 (489)
                         ++.++|+||..-
T Consensus       332 ---~qAleh~yF~~d  343 (438)
T KOG0666|consen  332 ---EQALEHPYFTED  343 (438)
T ss_pred             ---HHHhcccccccC
Confidence               889999999853

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-40  Score=318.89  Aligned_cols=240  Identities=22%  Similarity=0.393  Sum_probs=209.2

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ly  121 (489)
                      +..++|++.+.||.|+||.||+|..  .|+.||+|.+.....    ....+.+|..+++.++|+||+++++++.+....|
T Consensus         3 ~~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   76 (256)
T cd05039           3 INSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY   76 (256)
T ss_pred             cChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence            3567999999999999999999987  489999999875522    3456777999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcc
Q 011287          122 MALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      +||||+++++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||.++......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~  156 (256)
T cd05039          77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ  156 (256)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence            9999999999999998765  69999999999999999999999999999999999999999999999999998653211


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCCC
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNY  277 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~  277 (489)
                                   ....++..|+|||.+....++.++|+|||||++|+|++ |..||...+.......+... ....|..
T Consensus       157 -------------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  223 (256)
T cd05039         157 -------------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEG  223 (256)
T ss_pred             -------------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccC
Confidence                         02234567999999988889999999999999999997 99999988877766655543 3456777


Q ss_pred             CCHHHHHHHHHhhccCCCCCCCC
Q 011287          278 FSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       278 ~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      +++++.++|.+||+.+|++||++
T Consensus       224 ~~~~~~~li~~~l~~~p~~Rp~~  246 (256)
T cd05039         224 CPPEVYKVMKDCWELDPAKRPTF  246 (256)
T ss_pred             CCHHHHHHHHHHhccChhhCcCH
Confidence            89999999999999999999998

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=6.3e-40  Score=329.04  Aligned_cols=250  Identities=24%  Similarity=0.382  Sum_probs=209.3

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKID-------TGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFT  113 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~-------tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  113 (489)
                      +..++|.+++.||+|+||.||+|++..       ....+|+|.+....  .......+..|+.+++.+ +||||++++++
T Consensus         9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (314)
T cd05099           9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGV   86 (314)
T ss_pred             ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence            445789999999999999999998632       35679999986542  223345577799999999 69999999999


Q ss_pred             EEcCCEEEEEEeccCCCChHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCee
Q 011287          114 FQDTFSLYMALESCEGGELFDQITSK----------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLL  177 (489)
Q Consensus       114 ~~~~~~lylV~E~~~gg~L~~~l~~~----------------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNIL  177 (489)
                      +.+...+|+||||+.+|+|.+++...                ..++...+..++.||+.||.|||++||+||||||+|||
T Consensus        87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil  166 (314)
T cd05099          87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVL  166 (314)
T ss_pred             EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEE
Confidence            99999999999999999999999753                24888999999999999999999999999999999999


Q ss_pred             eCCCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCC
Q 011287          178 LTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK  256 (489)
Q Consensus       178 l~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~  256 (489)
                      ++.++.+||+|||+++........        .......++..|+|||++.+..++.++|+|||||++|+|++ |..||.
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~  238 (314)
T cd05099         167 VTEDNVMKIADFGLARGVHDIDYY--------KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYP  238 (314)
T ss_pred             EcCCCcEEEccccccccccccccc--------cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCC
Confidence            999999999999999865432110        01111234567999999998889999999999999999999 999999


Q ss_pred             CCCHHHHHHHHHhcC-CCCCCCCCHHHHHHHHHhhccCCCCCCCCC
Q 011287          257 DTSEWLIFQRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGAG  301 (489)
Q Consensus       257 ~~~~~~~~~~i~~~~-~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~  301 (489)
                      +.+....+..+.... ..+|..++.++++||.+||..||++||++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~  284 (314)
T cd05099         239 GIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFK  284 (314)
T ss_pred             CCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHH
Confidence            888877777766543 356778899999999999999999999984

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-40  Score=324.45  Aligned_cols=252  Identities=31%  Similarity=0.497  Sum_probs=212.1

Q ss_pred             eEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC--CEEEEEE
Q 011287           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT--FSLYMAL  124 (489)
Q Consensus        47 y~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~lylV~  124 (489)
                      |++.+.||+|+||.||+|++..+|+.||+|++.... ........+.+|+.+++.++|||++++++++.+.  ..+|+||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence            789999999999999999999999999999998764 2333345567799999999999999999999988  8999999


Q ss_pred             eccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          125 ESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       125 E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      ||+++ +|.+++.+. ..+++..+..++.||+.||+|||+.|++|+||+|+||++++++.++|+|||.+........   
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~---  155 (287)
T cd07840          80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS---  155 (287)
T ss_pred             ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc---
Confidence            99975 899888765 5799999999999999999999999999999999999999999999999999886543221   


Q ss_pred             CCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC----------
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI----------  272 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~----------  272 (489)
                            .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+.....          
T Consensus       156 ------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07840         156 ------ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGV  229 (287)
T ss_pred             ------ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccc
Confidence                  11123356888999998765 4578999999999999999999999998887666555443100          


Q ss_pred             ---------------------CCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          273 ---------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       273 ---------------------~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                                           .+...+++++.++|++||+.||.+||++     .+++.||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~-----~~~l~~~~~  287 (287)
T cd07840         230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISA-----DQALQHEYF  287 (287)
T ss_pred             ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCH-----HHHhhCcCC
Confidence                                 0111138899999999999999999998     899999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=5.8e-40  Score=319.63  Aligned_cols=243  Identities=22%  Similarity=0.361  Sum_probs=206.5

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lyl  122 (489)
                      ..++|+++++||+|+||.||+|... +++.||+|.+.....    ....+.+|+.++++++||||+++++++.+ ...|+
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   77 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVTQ-EPIYI   77 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEcc-CCcEE
Confidence            4578999999999999999999864 578899999875432    23457789999999999999999998754 56899


Q ss_pred             EEeccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          123 ALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      +|||+.+++|.+++...  ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++........
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05067          78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY  157 (260)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence            99999999999998754  4689999999999999999999999999999999999999999999999999876542211


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCCCC
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYF  278 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~  278 (489)
                               .......++..|+|||++....++.++|+|||||++|+|++ |++||.+.+.....+.+... ....|...
T Consensus       158 ---------~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  228 (260)
T cd05067         158 ---------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNC  228 (260)
T ss_pred             ---------ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCC
Confidence                     11123345678999999998889999999999999999999 99999988877766665443 33556778


Q ss_pred             CHHHHHHHHHhhccCCCCCCCC
Q 011287          279 SDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       279 ~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      +.++.++|.+||+.+|++||++
T Consensus       229 ~~~~~~li~~~l~~~p~~Rp~~  250 (260)
T cd05067         229 PEELYELMRLCWKEKPEERPTF  250 (260)
T ss_pred             CHHHHHHHHHHccCChhhCCCH
Confidence            8999999999999999999998

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.7e-40  Score=328.63  Aligned_cols=251  Identities=29%  Similarity=0.473  Sum_probs=214.7

Q ss_pred             eEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEec
Q 011287           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALES  126 (489)
Q Consensus        47 y~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~  126 (489)
                      |.....||+|+||.||++....+|..||+|.+...   .......+.+|+.+++.++||||+++++.|...+..|+||||
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   98 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF   98 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence            44557899999999999999999999999987543   233455678899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCC
Q 011287          127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNA  206 (489)
Q Consensus       127 ~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~  206 (489)
                      +++++|.+++.. +.+++..++.++.|++.||+|||+.|++||||+|+||+++.+++++|+|||++.......       
T Consensus        99 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-------  170 (292)
T cd06657          99 LEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-------  170 (292)
T ss_pred             CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-------
Confidence            999999987754 578999999999999999999999999999999999999999999999999876543211       


Q ss_pred             CCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC---CCCCCCCCHHHH
Q 011287          207 ASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRFPNYFSDAAR  283 (489)
Q Consensus       207 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~---~~~p~~~~~~~~  283 (489)
                         .......|++.|+|||.+.+..++.++|+||+||++|+|++|.+||.+.........+....   ......+++.+.
T Consensus       171 ---~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  247 (292)
T cd06657         171 ---PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLK  247 (292)
T ss_pred             ---ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHH
Confidence               11234578999999999988888999999999999999999999999887766555543322   223345789999


Q ss_pred             HHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          284 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       284 ~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      +++.+||+.||.+||++     .+++.||||..
T Consensus       248 ~li~~~l~~~P~~R~~~-----~~ll~~~~~~~  275 (292)
T cd06657         248 GFLDRLLVRDPAQRATA-----AELLKHPFLAK  275 (292)
T ss_pred             HHHHHHHhCCcccCcCH-----HHHhcChHHhc
Confidence            99999999999999998     88999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-40  Score=336.60  Aligned_cols=252  Identities=28%  Similarity=0.466  Sum_probs=212.9

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCE----
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS----  119 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~----  119 (489)
                      .++|++.+.||+|+||.||+|++..+++.||+|++....... .....+.+|+.+++.++||||+++++++.....    
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSA-IHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchh-hHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            578999999999999999999999999999999986543222 233456679999999999999999988876554    


Q ss_pred             --EEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCC
Q 011287          120 --LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (489)
Q Consensus       120 --lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~  197 (489)
                        +|+|+||+ +++|.+++.. +.+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~  170 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD  170 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence              89999999 5699998876 5799999999999999999999999999999999999999999999999999875432


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC----
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI----  272 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~----  272 (489)
                      .             .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+....+..+.....    
T Consensus       171 ~-------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  237 (343)
T cd07851         171 E-------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE  237 (343)
T ss_pred             c-------------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Confidence            1             224468889999999865 4678899999999999999999999998877766665543210    


Q ss_pred             ---------------------------CCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          273 ---------------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       273 ---------------------------~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                                                 .....+++++.+||.+||+.||.+|||+     .++++||||..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~-----~ell~h~~~~~  303 (343)
T cd07851         238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITA-----AEALAHPYLAE  303 (343)
T ss_pred             HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCH-----HHHhcCCCccc
Confidence                                       0112358899999999999999999998     89999999985

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=4.7e-40  Score=327.14  Aligned_cols=256  Identities=29%  Similarity=0.431  Sum_probs=210.8

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC----
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF----  118 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----  118 (489)
                      ..++|++.+.||+|+||.||+|.++.+|+.||+|++...... ......+.+|+.+++.++||||+++++++.+..    
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            468999999999999999999999999999999998754322 223345667999999999999999999987654    


Q ss_pred             ------EEEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccC
Q 011287          119 ------SLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS  191 (489)
Q Consensus       119 ------~lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~  191 (489)
                            .+|+|+||+++ +|...+... ..+++..++.++.||+.||.|||+.||+||||||+||++++++.+||+|||+
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~  162 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL  162 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccc
Confidence                  79999999986 777777654 4699999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccccCCCCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc
Q 011287          192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR  270 (489)
Q Consensus       192 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~  270 (489)
                      +..+.....         .......++..|+|||.+.+. .++.++|||||||++|+|++|++||...+.......+...
T Consensus       163 ~~~~~~~~~---------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~  233 (302)
T cd07864         163 ARLYNSEES---------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRL  233 (302)
T ss_pred             cccccCCcc---------cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence            876543211         111223567889999988654 4788999999999999999999999887766555444331


Q ss_pred             ---CC---------------------------CCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          271 ---DI---------------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       271 ---~~---------------------------~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                         ..                           .....++..+.++|.+||+.||++||++     .+++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~-----~~il~~~~~  302 (302)
T cd07864         234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTA-----EEALNSPWL  302 (302)
T ss_pred             hCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCH-----HHHhcCCCC
Confidence               00                           0112468999999999999999999998     899999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1e-39  Score=319.50  Aligned_cols=251  Identities=20%  Similarity=0.333  Sum_probs=209.8

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGT---VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~---~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  119 (489)
                      ...+|++.+.||+|+||.||+|.++.+++   .||+|++.+..  .......+..|+.+++.++||||+++++++.+...
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   79 (269)
T cd05065           2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP   79 (269)
T ss_pred             ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc
Confidence            35789999999999999999999987665   69999986542  23345668889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          120 LYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      .++||||+++|+|.+++... +.+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence            99999999999999998764 56899999999999999999999999999999999999999999999999998765432


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCC
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPN  276 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~  276 (489)
                      ....     ..........+..|+|||.+.+..++.++|+|||||++|+|++ |..||...+.......+... ....|.
T Consensus       160 ~~~~-----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~  234 (269)
T cd05065         160 TSDP-----TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPM  234 (269)
T ss_pred             cccc-----ccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcc
Confidence            1100     0000001112457999999998889999999999999999886 99999988877777766543 234556


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCC
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      .++..+.+++.+||+.+|++||++
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rp~~  258 (269)
T cd05065         235 DCPTALHQLMLDCWQKDRNARPKF  258 (269)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCH
Confidence            789999999999999999999998

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=6.7e-40  Score=328.05  Aligned_cols=252  Identities=28%  Similarity=0.399  Sum_probs=214.0

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      ..|...+.||+|+||.||+|+++.++..+|+|.+.............+.+|+.+++.++|+|++++++++.+....|+||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            45888999999999999999999999999999987543334444456777999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          125 ESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       125 E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      ||+. |+|.+.+.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.....      
T Consensus        95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~------  167 (308)
T cd06634          95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------  167 (308)
T ss_pred             EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC------
Confidence            9997 588777654 45689999999999999999999999999999999999999999999999999875432      


Q ss_pred             CCCCCCCCccceecCCcCCChhhhc---CCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC-C-CCCCC
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLN---SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-R-FPNYF  278 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~---~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~-~-~p~~~  278 (489)
                              .....|+..|+|||.+.   ...++.++|||||||++|+|++|..||...+.......+..... . .+..+
T Consensus       168 --------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (308)
T cd06634         168 --------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW  239 (308)
T ss_pred             --------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccc
Confidence                    12456889999999974   34578899999999999999999999988766555544444332 2 23468


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       279 ~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      +..+.+||++||+.+|++||++     .++++||||..
T Consensus       240 ~~~~~~li~~cl~~~P~~Rp~~-----~~ll~~~~~~~  272 (308)
T cd06634         240 SEYFRNFVDSCLQKIPQDRPTS-----EVLLKHRFVLR  272 (308)
T ss_pred             cHHHHHHHHHHhhCCcccCCCH-----HHHhhCccccc
Confidence            8999999999999999999998     89999999975

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=6.9e-40  Score=321.51  Aligned_cols=252  Identities=21%  Similarity=0.330  Sum_probs=213.9

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKID-----TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~-----tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  117 (489)
                      ..++|++.+.||+|+||.||+|+.+.     +.+.||+|.+....  .......+.+|+.++++++||||+++++++.+.
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   80 (275)
T cd05046           3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA   80 (275)
T ss_pred             ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence            35789999999999999999999754     35679999886532  222456678899999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEee
Q 011287          118 FSLYMALESCEGGELFDQITSKG---------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIAD  188 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~~---------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~D  188 (489)
                      ...|+||||+++|+|.+++....         .+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~  160 (275)
T cd05046          81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL  160 (275)
T ss_pred             CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcc
Confidence            99999999999999999998765         699999999999999999999999999999999999999999999999


Q ss_pred             ccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHH
Q 011287          189 FGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRI  267 (489)
Q Consensus       189 FG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i  267 (489)
                      ||++.......         ........++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+
T Consensus       161 ~~~~~~~~~~~---------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~  231 (275)
T cd05046         161 LSLSKDVYNSE---------YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL  231 (275)
T ss_pred             cccccccCccc---------ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHH
Confidence            99987432211         112224467788999999988888999999999999999998 89999887777777776


Q ss_pred             HhcCCC--CCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          268 IARDIR--FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       268 ~~~~~~--~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      ......  .+..++..+.+++.+||+.||++||++     .+++.
T Consensus       232 ~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~-----~~~l~  271 (275)
T cd05046         232 QAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSF-----SELVS  271 (275)
T ss_pred             HcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCH-----HHHHH
Confidence            655443  456789999999999999999999998     56653

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.3e-39  Score=318.45  Aligned_cols=250  Identities=20%  Similarity=0.321  Sum_probs=209.3

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGT---VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~---~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  118 (489)
                      +..++|+..+.||+|+||.||+|+++.++.   .+|+|.+.....  ......+..|+.+++.++||||+++++++.+..
T Consensus         2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   79 (268)
T cd05063           2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT--EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK   79 (268)
T ss_pred             CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC--HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence            346789999999999999999999976665   799998865421  223455778999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCC
Q 011287          119 SLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~  197 (489)
                      ..|+||||+++++|.+++... +.+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          80 PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            999999999999999999764 6799999999999999999999999999999999999999999999999999876543


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCC
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFP  275 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p  275 (489)
                      ....       .........+..|+|||++....++.++|+|||||++|+|++ |..||...+.......+... ....+
T Consensus       160 ~~~~-------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~  232 (268)
T cd05063         160 DPEG-------TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAP  232 (268)
T ss_pred             cccc-------ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCC
Confidence            2100       000111123457999999988889999999999999999997 99999988887777777553 23344


Q ss_pred             CCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          276 NYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       276 ~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      ...+.++.+|+.+||+.||++||++
T Consensus       233 ~~~~~~~~~li~~c~~~~p~~Rp~~  257 (268)
T cd05063         233 MDCPSAVYQLMLQCWQQDRARRPRF  257 (268)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCcCH
Confidence            5678999999999999999999998

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.1e-39  Score=329.85  Aligned_cols=258  Identities=28%  Similarity=0.405  Sum_probs=209.8

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCC--CcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEE----cCC
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDT--GTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQ----DTF  118 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~t--g~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~----~~~  118 (489)
                      +|.+.+.||+|+||.||+|++..+  +..||+|.+..... .........+|+.+++++ +||||+++++.+.    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS-KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            589999999999999999999888  99999999865422 222344566799999998 5999999998653    224


Q ss_pred             EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      .+|++++|+. ++|.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.+++++|+|||+++.+...
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~  158 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN  158 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence            5889999986 599999988888999999999999999999999999999999999999999999999999999865432


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC------
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD------  271 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~------  271 (489)
                      ...      ........+||..|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.+....+..+....      
T Consensus       159 ~~~------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (332)
T cd07857         159 PGE------NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE  232 (332)
T ss_pred             ccc------ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            211      1112235689999999998765 568899999999999999999999998877555444333210      


Q ss_pred             ----------------------CCC---CCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          272 ----------------------IRF---PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       272 ----------------------~~~---p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                                            ..+   ....+..+.+||.+||+.||++||++     .+++.||||+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~-----~~ll~~~~~~~  297 (332)
T cd07857         233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISV-----EEALEHPYLAI  297 (332)
T ss_pred             HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCH-----HHHhcChhhhh
Confidence                                  011   12357899999999999999999998     88999999964

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1e-39  Score=318.14  Aligned_cols=242  Identities=21%  Similarity=0.345  Sum_probs=204.9

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      .++|++.+.||+|+||.||+|.+..+ ..+|+|.+.....    ....+.+|+.+++.++|||++++++++.+ ...|+|
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v   78 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIV   78 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEE
Confidence            46899999999999999999998654 4699998765422    23456779999999999999999988864 568999


Q ss_pred             EeccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccc
Q 011287          124 LESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~  201 (489)
                      |||+.+++|.+++...  ..+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|||++........ 
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-  157 (260)
T cd05069          79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-  157 (260)
T ss_pred             EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-
Confidence            9999999999999764  3489999999999999999999999999999999999999999999999999976533211 


Q ss_pred             ccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCCCCC
Q 011287          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFS  279 (489)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~~  279 (489)
                              .......++..|+|||.+.+..++.++|+|||||++|+|++ |.+||.+.+.......+... ...+|..++
T Consensus       158 --------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (260)
T cd05069         158 --------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCP  229 (260)
T ss_pred             --------cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccC
Confidence                    11112345678999999988889999999999999999999 99999998887777666554 334567789


Q ss_pred             HHHHHHHHHhhccCCCCCCCC
Q 011287          280 DAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       280 ~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      ..+.+++.+||..||++||++
T Consensus       230 ~~~~~li~~~l~~~p~~Rp~~  250 (260)
T cd05069         230 ESLHELMKLCWKKDPDERPTF  250 (260)
T ss_pred             HHHHHHHHHHccCCcccCcCH
Confidence            999999999999999999998

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=9.1e-40  Score=326.09  Aligned_cols=251  Identities=22%  Similarity=0.374  Sum_probs=211.2

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEc-------CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEE
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLF  111 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~-------~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~  111 (489)
                      -.+..++|.+++.||+|+||.||+|+..       ..+..||+|.+....  .......+.+|+.+++.+ +||||++++
T Consensus        10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~   87 (304)
T cd05101          10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL   87 (304)
T ss_pred             ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchhee
Confidence            3466789999999999999999999853       234579999986542  223345677899999999 899999999


Q ss_pred             EEEEcCCEEEEEEeccCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCC
Q 011287          112 FTFQDTFSLYMALESCEGGELFDQITSKG----------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPEN  175 (489)
Q Consensus       112 ~~~~~~~~lylV~E~~~gg~L~~~l~~~~----------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeN  175 (489)
                      +.+.+...+|+||||+.+|+|.+++.+..                .++...+..++.||+.||.|||++||+||||||+|
T Consensus        88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N  167 (304)
T cd05101          88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN  167 (304)
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence            99999999999999999999999997642                36788899999999999999999999999999999


Q ss_pred             eeeCCCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCC
Q 011287          176 LLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSP  254 (489)
Q Consensus       176 ILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~P  254 (489)
                      |+++.++.++|+|||+++.+.....        ........++..|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p  239 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDY--------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP  239 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccc--------cccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence            9999999999999999986543211        011122345678999999998889999999999999999998 8999


Q ss_pred             CCCCCHHHHHHHHHhcC-CCCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          255 FKDTSEWLIFQRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       255 F~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      |.+.+..++...+.... ...|..++.++.+||.+||..+|.+||++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~  286 (304)
T cd05101         240 YPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTF  286 (304)
T ss_pred             cccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCH
Confidence            99988888877765543 34567789999999999999999999998

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1e-39  Score=329.94  Aligned_cols=253  Identities=26%  Similarity=0.426  Sum_probs=209.1

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc-CCEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD-TFSLY  121 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~ly  121 (489)
                      ..++|++.+.||.|+||.||+|.+..+|+.||+|.+.+.... ......+..|+.+++.++||||++++++|.. ....|
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST-PVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            357899999999999999999999999999999998764322 2334556679999999999999999999875 56789


Q ss_pred             EEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccc
Q 011287          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~  201 (489)
                      +||||+ +++|..++.. +.+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||.+.....    
T Consensus        87 lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~----  160 (328)
T cd07856          87 FVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP----  160 (328)
T ss_pred             EEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC----
Confidence            999999 5688887764 4689999999999999999999999999999999999999999999999999874321    


Q ss_pred             ccCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHh-----------
Q 011287          202 VLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA-----------  269 (489)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~-----------  269 (489)
                               ......++..|+|||.+.+ ..++.++|+|||||++|+|++|++||.+.+....+..+.+           
T Consensus       161 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  231 (328)
T cd07856         161 ---------QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN  231 (328)
T ss_pred             ---------CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence                     1124567889999998765 5688999999999999999999999987665332221111           


Q ss_pred             ---------------cCCCC-----CCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          270 ---------------RDIRF-----PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       270 ---------------~~~~~-----p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                                     .....     .+.++.++.++|++||+.+|++||++     ++++.||||..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~-----~ell~~~~~~~  293 (328)
T cd07856         232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISA-----AEALAHPYLAP  293 (328)
T ss_pred             hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCH-----HHHhcCCcccc
Confidence                           00011     13467899999999999999999998     89999999974

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=6e-41  Score=312.25  Aligned_cols=259  Identities=27%  Similarity=0.444  Sum_probs=215.8

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCC
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTF  118 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  118 (489)
                      .+..+++.+++..||.|+.|+|++++.+.+|...|||.|.+.....  ....+.+...++... ++|+||+.|++|..+.
T Consensus        87 ~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nke--e~kRILmDldvv~~s~dcpyIV~c~GyFi~n~  164 (391)
T KOG0983|consen   87 YQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKE--ENKRILMDLDVVLKSHDCPYIVQCFGYFITNT  164 (391)
T ss_pred             cccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHH--HHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc
Confidence            3445667889999999999999999999999999999998764333  334566666666555 4899999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeeccCCCCeeeCCCCCEEEeeccCccccC
Q 011287          119 SLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~aL~~LH~-~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~  196 (489)
                      .+++.||.|.- .+..++.+ .++++|..+-.+...++.||.||-. +||+|||+||+|||+|+.|++||||||.+..+.
T Consensus       165 dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlv  243 (391)
T KOG0983|consen  165 DVFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV  243 (391)
T ss_pred             hHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceee
Confidence            99999999843 44455544 3679999999999999999999986 589999999999999999999999999998776


Q ss_pred             CccccccCCCCCCCCccceecCCcCCChhhhcCC---CCCCCCcchhhhHHHHHHhhCCCCCCCC-CHHHHHHHHHhcCC
Q 011287          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS---PATFGNDLWALGCTLYQMLSGTSPFKDT-SEWLIFQRIIARDI  272 (489)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~---~~~~~sDiwSLG~ilyelltG~~PF~~~-~~~~~~~~i~~~~~  272 (489)
                      ++.           ......|-+.|||||.+.-.   .|+..+||||||+.++||.||+.||.+. ++.+++-+|++..+
T Consensus       244 dSk-----------AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP  312 (391)
T KOG0983|consen  244 DSK-----------AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP  312 (391)
T ss_pred             ccc-----------ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC
Confidence            543           12234689999999999643   5889999999999999999999999884 56778888887654


Q ss_pred             C-CCC--CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          273 R-FPN--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       273 ~-~p~--~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                      . +|.  .+++.+++|+..||.+|+.+||..     .+|++|||....
T Consensus       313 P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y-----~~Ll~h~Fi~~y  355 (391)
T KOG0983|consen  313 PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKY-----NKLLEHPFIKRY  355 (391)
T ss_pred             CCCCcccCcCHHHHHHHHHHhhcCcccCcch-----HHHhcCcceeec
Confidence            3 332  489999999999999999999965     899999999753

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=9.6e-40  Score=323.06  Aligned_cols=248  Identities=21%  Similarity=0.341  Sum_probs=209.6

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEc-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~-----~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  117 (489)
                      ..++|++.+.||+|+||.||+|.+.     .++..||+|++.....  ......+.+|+.+++.++||||+++++++.+.
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~   80 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDHPNIVKLLGVCAVG   80 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC--HHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence            4579999999999999999999974     3678999999865422  23345577899999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCC
Q 011287          118 FSLYMALESCEGGELFDQITSKG----------------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPEN  175 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~~----------------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeN  175 (489)
                      ..+|+||||+.+|+|.+++....                      .+++..+..++.||+.||.|||++|++||||||+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n  160 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN  160 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence            99999999999999999997432                      37888899999999999999999999999999999


Q ss_pred             eeeCCCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCC
Q 011287          176 LLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSP  254 (489)
Q Consensus       176 ILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~P  254 (489)
                      |+++.++.++|+|||++..+.....        ........++..|+|||.+.+..++.++|+|||||++|+|++ |..|
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p  232 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADY--------YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP  232 (288)
T ss_pred             eEecCCCceEECccccceecccCcc--------ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999875432210        001112234567999999998889999999999999999997 8899


Q ss_pred             CCCCCHHHHHHHHHhcCC-CCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          255 FKDTSEWLIFQRIIARDI-RFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       255 F~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      |.+.+..+....+..... ..|..++.++.+||.+||+.||.+||++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~  279 (288)
T cd05050         233 YYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSF  279 (288)
T ss_pred             CCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCH
Confidence            988888777777765543 4567789999999999999999999998

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=4e-40  Score=329.82  Aligned_cols=258  Identities=26%  Similarity=0.380  Sum_probs=204.8

Q ss_pred             EEeee--CceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEeccCC
Q 011287           52 IYGVG--SYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG  129 (489)
Q Consensus        52 ~LG~G--~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~~~g  129 (489)
                      +||+|  ++|.||.++...+++.||+|++...... ......+..|+.+++.++||||++++++|.+....|++|||+++
T Consensus         5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCS-KEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY   83 (314)
T ss_pred             hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccc-hhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence            34443  5566777777779999999999765322 33456788899999999999999999999999999999999999


Q ss_pred             CChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCC
Q 011287          130 GELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA  207 (489)
Q Consensus       130 g~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~  207 (489)
                      |+|.+++.+.  ..+++..+..++.|++.||.|||++||+||||||+||+++.+|.++|+|||.+..+........   .
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~---~  160 (314)
T cd08216          84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR---V  160 (314)
T ss_pred             CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccc---c
Confidence            9999999864  4589999999999999999999999999999999999999999999999999876533221100   0


Q ss_pred             CCCCccceecCCcCCChhhhcCC--CCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC--------------
Q 011287          208 SDDKACTFVGTAAYVPPEVLNSS--PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--------------  271 (489)
Q Consensus       208 ~~~~~~~~~gt~~Y~aPE~l~~~--~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~--------------  271 (489)
                      .........++..|+|||++...  .++.++|+|||||++|+|++|..||..............+.              
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE  240 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence            11122345678899999999763  57889999999999999999999998765544322111110              


Q ss_pred             --------------------CCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 011287          272 --------------------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (489)
Q Consensus       272 --------------------~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~  318 (489)
                                          ...+..++.++.+|+.+||+.||++||++     .++++||||+.+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-----~~ll~~p~~~~~~  302 (314)
T cd08216         241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSA-----SQLLNHSFFKQCK  302 (314)
T ss_pred             CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCH-----HHHhcCchHhhhc
Confidence                                01112345789999999999999999999     8999999998653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=4.2e-40  Score=320.37  Aligned_cols=253  Identities=29%  Similarity=0.503  Sum_probs=215.7

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeeccccc--chhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT--KENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      +|.+.+.||+|+||.||+|++..++..+++|+++.....  .......+..|..+++.++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            589999999999999999999888888888887643321  222334566788999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcc
Q 011287          124 LESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      |||+++++|.+++..    ...+++..+..++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||++.......
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~  159 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC  159 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence            999999999988764    356999999999999999999999999999999999999974 679999999987653221


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc-CCCCCCCC
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-DIRFPNYF  278 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~-~~~~p~~~  278 (489)
                                .......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.+.+.......+... ...+|..+
T Consensus       160 ----------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (260)
T cd08222         160 ----------DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETY  229 (260)
T ss_pred             ----------ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchh
Confidence                      1223456888999999998888899999999999999999999999887777666666554 34466788


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       279 ~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                      +.++.++|.+||..||++||++     .+++.||||
T Consensus       230 ~~~~~~li~~~l~~~p~~Rp~~-----~~il~~~~~  260 (260)
T cd08222         230 SRQLNSIMQSMLNKDPSLRPSA-----AEILRNPFI  260 (260)
T ss_pred             cHHHHHHHHHHhcCChhhCcCH-----HHHhhCCCC
Confidence            9999999999999999999998     899999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-40  Score=322.77  Aligned_cols=251  Identities=29%  Similarity=0.493  Sum_probs=212.8

Q ss_pred             eEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEec
Q 011287           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALES  126 (489)
Q Consensus        47 y~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~  126 (489)
                      |++.+.||.|++|.||+|.+..+|+.+|+|.+...... ......+..|..++++++||||+++++++.+...+|+||||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence            67889999999999999999999999999998765332 23445677799999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCC
Q 011287          127 CEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  205 (489)
Q Consensus       127 ~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~  205 (489)
                      +++ +|.+++... +.+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||.+.......      
T Consensus        80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~------  152 (283)
T cd05118          80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV------  152 (283)
T ss_pred             cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc------
Confidence            975 888888764 679999999999999999999999999999999999999999999999999987654321      


Q ss_pred             CCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC-------------
Q 011287          206 AASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-------------  271 (489)
Q Consensus       206 ~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~-------------  271 (489)
                          .......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||.+.+..+.+.++....             
T Consensus       153 ----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd05118         153 ----RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS  228 (283)
T ss_pred             ----ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchh
Confidence                111234678899999999876 68999999999999999999999998888766555543210             


Q ss_pred             ------CCC-----------CCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          272 ------IRF-----------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       272 ------~~~-----------p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                            ..+           .+.++.++.++|.+||+.||.+||++     .++++||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~-----~~ll~~~~~  283 (283)
T cd05118         229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITA-----EQALAHPYF  283 (283)
T ss_pred             hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCH-----HHHhhCCCC
Confidence                  011           12367899999999999999999998     899999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-40  Score=322.21  Aligned_cols=251  Identities=29%  Similarity=0.490  Sum_probs=212.7

Q ss_pred             eEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEec
Q 011287           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALES  126 (489)
Q Consensus        47 y~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~  126 (489)
                      |++.+.||+|+||.||+|++..+++.||+|++.... ........+..|+.+++.++||||+++++++.+....|+||||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence            678899999999999999999999999999998654 2233345566799999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCC
Q 011287          127 CEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  205 (489)
Q Consensus       127 ~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~  205 (489)
                      +.+ +|.+++.+. ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||.+.......      
T Consensus        80 ~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~------  152 (282)
T cd07829          80 CDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL------  152 (282)
T ss_pred             cCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc------
Confidence            984 999999876 579999999999999999999999999999999999999999999999999987653321      


Q ss_pred             CCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc--------------
Q 011287          206 AASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--------------  270 (489)
Q Consensus       206 ~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~--------------  270 (489)
                          .......++..|+|||.+.+. .++.++|+|||||++|+|++|.+||.+.+....+.++...              
T Consensus       153 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07829         153 ----RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK  228 (282)
T ss_pred             ----cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcc
Confidence                112233567889999998776 7899999999999999999999999988766655544321              


Q ss_pred             ----CCCCC-----------CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          271 ----DIRFP-----------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       271 ----~~~~p-----------~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                          ...+|           +.++..+.++|++||+.||++||++     .++++||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~-----~~~l~~p~~  282 (282)
T cd07829         229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISA-----KEALKHPYF  282 (282)
T ss_pred             cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCH-----HHHhhCcCC
Confidence                01111           1247889999999999999999998     899999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=7.3e-40  Score=331.81  Aligned_cols=262  Identities=31%  Similarity=0.478  Sum_probs=214.6

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEc--CCE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQD--TFS  119 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~--~~~  119 (489)
                      ..++|++.+.||+|+||.||+|.+..+|..||+|.+.+...... ....+.+|+.+++.+ +||||+++++++..  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~-~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~   83 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNAT-DAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD   83 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcch-hhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence            45789999999999999999999999999999999865433322 234566799999999 99999999999864  346


Q ss_pred             EEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcc
Q 011287          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      .|+||||+.+ +|..++... .+++..++.++.||+.||.|||+.||+||||||+||+++.+|.++|+|||.+..+....
T Consensus        84 ~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~  161 (337)
T cd07852          84 IYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE  161 (337)
T ss_pred             EEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence            8999999974 999988765 78999999999999999999999999999999999999999999999999998654322


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC------
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI------  272 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~------  272 (489)
                      ...     .......++||..|+|||.+.+ ..++.++|+|||||++|+|++|++||.+........++.....      
T Consensus       162 ~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07852         162 ENP-----ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED  236 (337)
T ss_pred             ccc-----cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            110     1122335678999999998755 4578899999999999999999999988766554444322110      


Q ss_pred             -------------------------CCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          273 -------------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       273 -------------------------~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                                               .....++.++.+||.+||+.||++||++     .++++||||+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~-----~~il~~~~~~~~  301 (337)
T cd07852         237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTA-----EEALEHPYVAQF  301 (337)
T ss_pred             HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCH-----HHHhhChhhhhh
Confidence                                     0112368899999999999999999998     899999999875

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.7e-39  Score=320.26  Aligned_cols=248  Identities=19%  Similarity=0.314  Sum_probs=204.1

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcE----EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTV----YALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~----vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  117 (489)
                      +..++|++++.||+|+||+||+|.+..++..    +++|.+...  ........+..|..+++.++||||+++++++.. 
T Consensus         4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-   80 (279)
T cd05111           4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-   80 (279)
T ss_pred             CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-
Confidence            5678999999999999999999999888774    666665432  112233456667888899999999999998754 


Q ss_pred             CEEEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccC
Q 011287          118 FSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~  196 (489)
                      ...++++||+.+|+|.+++... +.+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||+++...
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            5678999999999999999764 579999999999999999999999999999999999999999999999999997653


Q ss_pred             CccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhcC-CCC
Q 011287          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRF  274 (489)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~~-~~~  274 (489)
                      ....        ........++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.......+.+..+. ...
T Consensus       161 ~~~~--------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~  232 (279)
T cd05111         161 PDDK--------KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQ  232 (279)
T ss_pred             CCCc--------ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC
Confidence            2210        111123456778999999998889999999999999999998 999999887766555554433 334


Q ss_pred             CCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          275 PNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       275 p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      |...+.++.+++.+|+..||++||++
T Consensus       233 ~~~~~~~~~~li~~c~~~~p~~Rps~  258 (279)
T cd05111         233 PQICTIDVYMVMVKCWMIDENVRPTF  258 (279)
T ss_pred             CCCCCHHHHHHHHHHcCCCcccCcCH
Confidence            55678899999999999999999999

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.8e-40  Score=324.45  Aligned_cols=248  Identities=20%  Similarity=0.300  Sum_probs=205.2

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCC--------------cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcc
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTG--------------TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV  108 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg--------------~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv  108 (489)
                      ..++|++.+.||+|+||.||+|++..++              ..||+|.+....  .......+.+|+.++++++||||+
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~   80 (295)
T cd05097           3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNII   80 (295)
T ss_pred             chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcC
Confidence            3579999999999999999999875432              358999986542  233455688899999999999999


Q ss_pred             EEEEEEEcCCEEEEEEeccCCCChHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCe
Q 011287          109 RLFFTFQDTFSLYMALESCEGGELFDQITSKG------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENL  176 (489)
Q Consensus       109 ~l~~~~~~~~~lylV~E~~~gg~L~~~l~~~~------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNI  176 (489)
                      ++++++......|+||||+.+++|.+++....            .+++..+..++.|++.||.|||++|++||||||+||
T Consensus        81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni  160 (295)
T cd05097          81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC  160 (295)
T ss_pred             eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence            99999999999999999999999999986532            368889999999999999999999999999999999


Q ss_pred             eeCCCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh--CCCC
Q 011287          177 LLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS--GTSP  254 (489)
Q Consensus       177 Ll~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt--G~~P  254 (489)
                      +++.++.+||+|||++..+.....        ........++..|+|||++.+..++.++|+|||||++|+|++  |..|
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p  232 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDY--------YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQP  232 (295)
T ss_pred             EEcCCCcEEecccccccccccCcc--------eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCC
Confidence            999999999999999875432210        111223355778999999998889999999999999999988  7789


Q ss_pred             CCCCCHHHHHHHHHh--------cCCCCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          255 FKDTSEWLIFQRIIA--------RDIRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       255 F~~~~~~~~~~~i~~--------~~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      |...+.......+..        .....+..+++.+.+||.+||+.||++||++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~  286 (295)
T cd05097         233 YSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTF  286 (295)
T ss_pred             CcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCH
Confidence            988777665554432        1123355678999999999999999999998

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2e-39  Score=314.59  Aligned_cols=248  Identities=22%  Similarity=0.368  Sum_probs=211.3

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      ..+|++.+.||+|+||.||+|.+. ++..+|+|.+......    ...+..|+.+++.++||||+++++++.+....|+|
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV   77 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence            568999999999999999999885 4778999988654332    23467799999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccc
Q 011287          124 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~  202 (489)
                      |||+.+++|.+++... +.+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||.+........  
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--  155 (256)
T cd05112          78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY--  155 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcc--
Confidence            9999999999998764 5689999999999999999999999999999999999999999999999999875432210  


Q ss_pred             cCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCCCCCH
Q 011287          203 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFSD  280 (489)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~~~  280 (489)
                             .......++..|+|||.+.+..++.++|+|||||++|+|++ |++||.........+.+... ....|...+.
T Consensus       156 -------~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (256)
T cd05112         156 -------TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQ  228 (256)
T ss_pred             -------cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCH
Confidence                   01112235678999999998889999999999999999998 99999988887777777654 3344667899


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       281 ~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      ++.+|+.+||+.+|++||++     .++++
T Consensus       229 ~~~~l~~~~l~~~p~~Rp~~-----~~~l~  253 (256)
T cd05112         229 SVYELMQHCWKERPEDRPSF-----SLLLH  253 (256)
T ss_pred             HHHHHHHHHcccChhhCCCH-----HHHHH
Confidence            99999999999999999998     56654

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.6e-39  Score=315.56  Aligned_cols=240  Identities=24%  Similarity=0.411  Sum_probs=204.9

Q ss_pred             eEEeeeCceEEEEEEEcC-CCc--EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEecc
Q 011287           51 KIYGVGSYSKVVRAKKID-TGT--VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESC  127 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~~-tg~--~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~~  127 (489)
                      +.||+|++|.||+|.+.. ++.  .||+|.+......  .....+.+|..++++++||||+++++.+.+ ...++||||+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~   77 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA   77 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence            468999999999999865 333  6999999776443  455678889999999999999999999988 8999999999


Q ss_pred             CCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCC
Q 011287          128 EGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  205 (489)
Q Consensus       128 ~gg~L~~~l~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~  205 (489)
                      ++++|.+++.+..  .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++..+......    
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~----  153 (257)
T cd05040          78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH----  153 (257)
T ss_pred             CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc----
Confidence            9999999998764  6899999999999999999999999999999999999999999999999999876432110    


Q ss_pred             CCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc--CCCCCCCCCHHH
Q 011287          206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR--DIRFPNYFSDAA  282 (489)
Q Consensus       206 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~--~~~~p~~~~~~~  282 (489)
                         ........++..|+|||.+.+..++.++|+|||||++|+|++ |..||...+..+....+...  ....|...+..+
T Consensus       154 ---~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (257)
T cd05040         154 ---YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDI  230 (257)
T ss_pred             ---eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHH
Confidence               011113457788999999999899999999999999999998 99999988888777766643  233556788999


Q ss_pred             HHHHHHhhccCCCCCCCC
Q 011287          283 RDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       283 ~~Li~~~L~~dP~~R~t~  300 (489)
                      .+++.+||+.+|++||++
T Consensus       231 ~~li~~~l~~~p~~Rps~  248 (257)
T cd05040         231 YNVMLQCWAHNPADRPTF  248 (257)
T ss_pred             HHHHHHHCCCCcccCCCH
Confidence            999999999999999998

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.4e-39  Score=329.33  Aligned_cols=259  Identities=23%  Similarity=0.365  Sum_probs=213.0

Q ss_pred             CCCCCCCCCeEEeeEEeeeCceEEEEEEEcCC-------CcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccE
Q 011287           38 PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDT-------GTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVR  109 (489)
Q Consensus        38 ~~~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~t-------g~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~  109 (489)
                      |.-.+...+|.+++.||+|+||.||+|++...       +..||+|++....  .......+.+|+.+++++ +||||++
T Consensus         5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~   82 (334)
T cd05100           5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIIN   82 (334)
T ss_pred             cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeee
Confidence            33344556899999999999999999986432       2478999886431  223345677899999999 7999999


Q ss_pred             EEEEEEcCCEEEEEEeccCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCC
Q 011287          110 LFFTFQDTFSLYMALESCEGGELFDQITSKG----------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP  173 (489)
Q Consensus       110 l~~~~~~~~~lylV~E~~~gg~L~~~l~~~~----------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKp  173 (489)
                      +++++.+...+|++|||+++|+|.+++.+..                .++...+..++.||+.||.|||++||+||||||
T Consensus        83 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp  162 (334)
T cd05100          83 LLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAA  162 (334)
T ss_pred             eeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccccc
Confidence            9999999999999999999999999997632                377888899999999999999999999999999


Q ss_pred             CCeeeCCCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CC
Q 011287          174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GT  252 (489)
Q Consensus       174 eNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~  252 (489)
                      +|||++.++.+||+|||+++........        .......++..|+|||++.+..++.++|||||||++|+|++ |.
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~  234 (334)
T cd05100         163 RNVLVTEDNVMKIADFGLARDVHNIDYY--------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGG  234 (334)
T ss_pred             ceEEEcCCCcEEECCcccceeccccccc--------ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCC
Confidence            9999999999999999998765432110        01112234567999999999999999999999999999998 89


Q ss_pred             CCCCCCCHHHHHHHHHhc-CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 011287          253 SPFKDTSEWLIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (489)
Q Consensus       253 ~PF~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~h  311 (489)
                      .||.+.+....+..+... ....|..++.++.+||.+||+.+|++||++     .+++++
T Consensus       235 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~-----~ell~~  289 (334)
T cd05100         235 SPYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTF-----KQLVED  289 (334)
T ss_pred             CCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCH-----HHHHHH
Confidence            999998887777776554 335667789999999999999999999998     566643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.5e-39  Score=322.12  Aligned_cols=246  Identities=22%  Similarity=0.365  Sum_probs=205.9

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEE
Q 011287           46 DFELGKIYGVGSYSKVVRAKKID-----TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~-----tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~l  120 (489)
                      +|++.+.||+|+||.||+|++..     ....+|+|.+.+...  ......+.+|+.+++.++||||+++++.+......
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL   78 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence            58899999999999999998753     336789998865422  22345677899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCe
Q 011287          121 YMALESCEGGELFDQITSK------------------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENL  176 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~------------------------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNI  176 (489)
                      |+||||+.+|+|.+++...                        ..+++..+..++.|++.||.|||++||+||||||+||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni  158 (290)
T cd05045          79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV  158 (290)
T ss_pred             EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence            9999999999999988642                        2478899999999999999999999999999999999


Q ss_pred             eeCCCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCC
Q 011287          177 LLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF  255 (489)
Q Consensus       177 Ll~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF  255 (489)
                      |+++++.++|+|||+++........        .......++..|+|||.+.+..++.++|||||||++|+|++ |..||
T Consensus       159 ll~~~~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~  230 (290)
T cd05045         159 LVAEGRKMKISDFGLSRDVYEEDSY--------VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY  230 (290)
T ss_pred             EEcCCCcEEeccccccccccCccch--------hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCC
Confidence            9999999999999998765332110        11122345678999999988889999999999999999998 99999


Q ss_pred             CCCCHHHHHHHHHhc-CCCCCCCCCHHHHHHHHHhhccCCCCCCCCC
Q 011287          256 KDTSEWLIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAG  301 (489)
Q Consensus       256 ~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~  301 (489)
                      .+.....+.+.+... ....|..++.++.+++.+||+.||++||++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~  277 (290)
T cd05045         231 PGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFA  277 (290)
T ss_pred             CCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence            988877766655432 3345677899999999999999999999983

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-39  Score=318.08  Aligned_cols=249  Identities=20%  Similarity=0.319  Sum_probs=211.7

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGT----VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~----~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  117 (489)
                      +...+|++++.||+|+||.||+|.++.+|.    .||+|.+.+...  ......+.+|+.+++.++||||+++++++.. 
T Consensus         4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-   80 (279)
T cd05057           4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-   80 (279)
T ss_pred             cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence            456899999999999999999999877665    589998865532  3344567789999999999999999999887 


Q ss_pred             CEEEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccC
Q 011287          118 FSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~  196 (489)
                      ...++||||+++|+|.+++... +.+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||.++...
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence            7899999999999999999874 569999999999999999999999999999999999999999999999999998654


Q ss_pred             CccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhcC-CCC
Q 011287          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRF  274 (489)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~~-~~~  274 (489)
                      ......        ......++..|+|||.+....++.++|+|||||++|++++ |..||.+....++.+.+.... ...
T Consensus       161 ~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~  232 (279)
T cd05057         161 VDEKEY--------HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQ  232 (279)
T ss_pred             Ccccce--------ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCC
Confidence            321110        0011123567999999988889999999999999999998 999999988877777776543 456


Q ss_pred             CCCCCHHHHHHHHHhhccCCCCCCCCC
Q 011287          275 PNYFSDAARDLIDRLLDVDPSGRPGAG  301 (489)
Q Consensus       275 p~~~~~~~~~Li~~~L~~dP~~R~t~~  301 (489)
                      |...+.++.+++.+||..||++||++.
T Consensus       233 ~~~~~~~~~~~~~~~l~~~p~~Rp~~~  259 (279)
T cd05057         233 PPICTIDVYMVLVKCWMIDAESRPTFK  259 (279)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCCCHH
Confidence            677889999999999999999999984

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=3.8e-39  Score=314.04  Aligned_cols=244  Identities=22%  Similarity=0.348  Sum_probs=206.3

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ly  121 (489)
                      +..++|++.+.||+|+||.||+|.+. .+..+|+|.+...    ......+.+|+.+++.++|+||+++++.+.+ ...|
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~   76 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY   76 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence            34689999999999999999999864 4567999988643    2234567779999999999999999999988 7789


Q ss_pred             EEEeccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcc
Q 011287          122 MALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      ++|||+++++|.+++.+.  ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||.+..+....
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            999999999999999764  457888999999999999999999999999999999999999999999999987654321


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCCC
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNY  277 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~  277 (489)
                      .         .......++..|+|||++....++.++|+|||||++|++++ |.+||.+.+.......+... ....+..
T Consensus       157 ~---------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  227 (260)
T cd05073         157 Y---------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPEN  227 (260)
T ss_pred             c---------ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCccc
Confidence            1         11112345678999999998889999999999999999998 99999988777766665543 2345567


Q ss_pred             CCHHHHHHHHHhhccCCCCCCCC
Q 011287          278 FSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       278 ~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      .+.++.+++.+||+.||++||++
T Consensus       228 ~~~~~~~~i~~~l~~~p~~Rp~~  250 (260)
T cd05073         228 CPEELYNIMMRCWKNRPEERPTF  250 (260)
T ss_pred             CCHHHHHHHHHHcccCcccCcCH
Confidence            89999999999999999999987

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.1e-39  Score=322.20  Aligned_cols=247  Identities=20%  Similarity=0.320  Sum_probs=203.2

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcC----------------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKID----------------TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV  107 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~----------------tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnI  107 (489)
                      .++|++.+.||+|+||.||+|.+..                ++..||+|++....  .......+.+|+.+++.++||||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i   81 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI   81 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence            4689999999999999999986532                34579999986542  23344567789999999999999


Q ss_pred             cEEEEEEEcCCEEEEEEeccCCCChHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCe
Q 011287          108 VRLFFTFQDTFSLYMALESCEGGELFDQITSKG-----------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENL  176 (489)
Q Consensus       108 v~l~~~~~~~~~lylV~E~~~gg~L~~~l~~~~-----------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNI  176 (489)
                      +++++++.+...+|+||||+.+|+|.+++....           .+++..+..++.||+.||+|||+.|++||||||+||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni  161 (296)
T cd05095          82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC  161 (296)
T ss_pred             ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence            999999999999999999999999999987643           367789999999999999999999999999999999


Q ss_pred             eeCCCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh--CCCC
Q 011287          177 LLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS--GTSP  254 (489)
Q Consensus       177 Ll~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt--G~~P  254 (489)
                      |++.++.++|+|||+++.+.....        ........++..|+|||......++.++|+|||||++|+|++  |..|
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~--------~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p  233 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDY--------YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQP  233 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcc--------eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCC
Confidence            999999999999999876532210        111223345678999999888889999999999999999998  7899


Q ss_pred             CCCCCHHHHHHHHHh--------cCCCCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          255 FKDTSEWLIFQRIIA--------RDIRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       255 F~~~~~~~~~~~i~~--------~~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      |...+..+.......        .....|..+++.+.+|+.+||+.||++||++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~  287 (296)
T cd05095         234 YSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSF  287 (296)
T ss_pred             ccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCH
Confidence            987766555443211        1223456688999999999999999999998

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-39  Score=312.86  Aligned_cols=244  Identities=23%  Similarity=0.359  Sum_probs=206.8

Q ss_pred             eEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEeccCCC
Q 011287           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG  130 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~~~gg  130 (489)
                      ++||.|+||.||+|.+.. ++.||+|.+......  .....+..|+.+++.++||||+++++++.+....|+||||+.++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   77 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG   77 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence            478999999999999987 999999998765332  34456778999999999999999999999999999999999999


Q ss_pred             ChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCC
Q 011287          131 ELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  209 (489)
Q Consensus       131 ~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~  209 (489)
                      +|.+++.+. ..+++..+..++.+++.||.|||++|++||||||+||+++.++.++|+|||++.........        
T Consensus        78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~--------  149 (251)
T cd05041          78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT--------  149 (251)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcce--------
Confidence            999999764 56899999999999999999999999999999999999999999999999998754321110        


Q ss_pred             CCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCCCCCHHHHHHHH
Q 011287          210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFSDAARDLID  287 (489)
Q Consensus       210 ~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~Li~  287 (489)
                      .......++..|+|||.+.+..++.++|+|||||++|+|++ |..||...........+... ....|..++.++.+++.
T Consensus       150 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  229 (251)
T cd05041         150 VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLML  229 (251)
T ss_pred             eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHH
Confidence            01112234567999999988889999999999999999999 89999888877766666543 34567788999999999


Q ss_pred             HhhccCCCCCCCCCCCCHHHHhc
Q 011287          288 RLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       288 ~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      +||+.+|.+||++     .++++
T Consensus       230 ~~l~~~p~~Rp~~-----~ell~  247 (251)
T cd05041         230 QCWAYDPENRPSF-----SEIYN  247 (251)
T ss_pred             HHhccChhhCcCH-----HHHHH
Confidence            9999999999998     56653

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.6e-39  Score=315.12  Aligned_cols=240  Identities=20%  Similarity=0.304  Sum_probs=199.8

Q ss_pred             EEeeeCceEEEEEEEc--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEeccCC
Q 011287           52 IYGVGSYSKVVRAKKI--DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG  129 (489)
Q Consensus        52 ~LG~G~~g~Vy~a~~~--~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~~~g  129 (489)
                      .||+|+||.||+|.+.  .++..||+|++....  .......+.+|+.+++.++||||++++++++. ...++||||+++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~   78 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG   78 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence            3899999999999875  456679999986542  23344568889999999999999999998864 478999999999


Q ss_pred             CChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCC
Q 011287          130 GELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS  208 (489)
Q Consensus       130 g~L~~~l~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~  208 (489)
                      ++|.+++.. .+.+++..+..++.||+.||.|||++|++||||||+|||++.++.++|+|||++..+.......      
T Consensus        79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~------  152 (257)
T cd05115          79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY------  152 (257)
T ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccce------
Confidence            999999875 4579999999999999999999999999999999999999999999999999987553321100      


Q ss_pred             CCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCCCCCHHHHHHH
Q 011287          209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFSDAARDLI  286 (489)
Q Consensus       209 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~Li  286 (489)
                       .......++..|+|||.+....++.++|+|||||++|+|++ |..||.+.........+..+ ...+|...++++.++|
T Consensus       153 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  231 (257)
T cd05115         153 -KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALM  231 (257)
T ss_pred             -eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Confidence             00111123568999999988889999999999999999996 99999988877766666553 3567788899999999


Q ss_pred             HHhhccCCCCCCCCC
Q 011287          287 DRLLDVDPSGRPGAG  301 (489)
Q Consensus       287 ~~~L~~dP~~R~t~~  301 (489)
                      .+||+.||++||+..
T Consensus       232 ~~c~~~~~~~Rp~~~  246 (257)
T cd05115         232 KDCWIYKWEDRPNFA  246 (257)
T ss_pred             HHHcCCChhhCcCHH
Confidence            999999999999983

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-41  Score=311.43  Aligned_cols=261  Identities=29%  Similarity=0.419  Sum_probs=208.2

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc----
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD----  116 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----  116 (489)
                      .++-++|.|.+.||+|||+-||+++...+++.||+|.+....   ....+...+|++..++++|||+++++++...    
T Consensus        17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D   93 (302)
T KOG2345|consen   17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD   93 (302)
T ss_pred             EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence            345679999999999999999999999999999999987653   4456678889999999999999999876543    


Q ss_pred             -CCEEEEEEeccCCCChHHHHHhC---C-CCCHHHHHHHHHHHHHHHHHHHhCC--cEeeccCCCCeeeCCCCCEEEeec
Q 011287          117 -TFSLYMALESCEGGELFDQITSK---G-HLSEDEARFYTAEVVDALEYIHSMG--LIHRDIKPENLLLTADGHIKIADF  189 (489)
Q Consensus       117 -~~~lylV~E~~~gg~L~~~l~~~---~-~l~e~~~~~i~~qil~aL~~LH~~g--IiHrDLKpeNILl~~~g~ikL~DF  189 (489)
                       ...+|++++|...|+|.+.+++.   | .++|.++..|+.+|+.||++||+..  .+||||||.|||+++.+.++|.||
T Consensus        94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~  173 (302)
T KOG2345|consen   94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL  173 (302)
T ss_pred             CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence             34599999999999999998764   3 6999999999999999999999998  999999999999999999999999


Q ss_pred             cCccccCCccccccCCCCCCCCccceecCCcCCChhhhc---CCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHH--HHH
Q 011287          190 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN---SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW--LIF  264 (489)
Q Consensus       190 G~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~---~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~--~~~  264 (489)
                      |++....-.-... ...........-..|..|+|||.+.   +...+.++|||||||++|.|+.|..||...-..  .+.
T Consensus       174 GS~~~a~i~i~~~-~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla  252 (302)
T KOG2345|consen  174 GSATQAPIQIEGS-RQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA  252 (302)
T ss_pred             cCccccceEeech-HHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence            9987542210000 0000000111224688999999985   445789999999999999999999999542110  011


Q ss_pred             HHHHhcCCCCCC--CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          265 QRIIARDIRFPN--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       265 ~~i~~~~~~~p~--~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      -.+....+.+|.  .+|..+.+||+.||+.||.+||++     .+++.
T Consensus       253 LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i-----~~ll~  295 (302)
T KOG2345|consen  253 LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTI-----PELLS  295 (302)
T ss_pred             EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCH-----HHHHH
Confidence            233455677775  489999999999999999999998     55654

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-41  Score=326.47  Aligned_cols=251  Identities=26%  Similarity=0.464  Sum_probs=210.0

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC--C----CccEEEEEEEcC
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH--P----GVVRLFFTFQDT  117 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~h--p----nIv~l~~~~~~~  117 (489)
                      ..+|.+++.+|+|.||.|..+.+.+++..||||+++.-    ....+....|+++|.++.+  |    -+|++.++|.-.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr  163 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR  163 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence            57899999999999999999999999999999998643    3344556679999999932  2    267788889999


Q ss_pred             CEEEEEEeccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCC---------------
Q 011287          118 FSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA---------------  180 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~---------------  180 (489)
                      +.+++|+|.+ |-++++++..++  +|+...++.+++||+.+++|||+++++|-||||||||+..               
T Consensus       164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~  242 (415)
T KOG0671|consen  164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF  242 (415)
T ss_pred             CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence            9999999999 559999998764  6999999999999999999999999999999999999832               


Q ss_pred             -----CCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCC
Q 011287          181 -----DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF  255 (489)
Q Consensus       181 -----~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF  255 (489)
                           +-+|+|+|||.|..-.             ...++.+.|..|+|||++.+-+++..+||||+||||+|+++|...|
T Consensus       243 ~r~~ks~~I~vIDFGsAtf~~-------------e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LF  309 (415)
T KOG0671|consen  243 IRPLKSTAIKVIDFGSATFDH-------------EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLF  309 (415)
T ss_pred             eccCCCcceEEEecCCcceec-------------cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceec
Confidence                 2368999999998532             3346789999999999999999999999999999999999999999


Q ss_pred             CCCCHHH---HHHHHHhc------------------CCCCCCC-------------------------CCHHHHHHHHHh
Q 011287          256 KDTSEWL---IFQRIIAR------------------DIRFPNY-------------------------FSDAARDLIDRL  289 (489)
Q Consensus       256 ~~~~~~~---~~~~i~~~------------------~~~~p~~-------------------------~~~~~~~Li~~~  289 (489)
                      ....+.+   ++++|+..                  .+..|+.                         -..++.|||++|
T Consensus       310 qtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~m  389 (415)
T KOG0671|consen  310 QTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRM  389 (415)
T ss_pred             ccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHH
Confidence            9877555   55666531                  1111211                         123478999999


Q ss_pred             hccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          290 LDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       290 L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                      |..||.+|+|+     .|++.||||+..
T Consensus       390 L~fDP~~RiTl-----~EAL~HpFF~~~  412 (415)
T KOG0671|consen  390 LEFDPARRITL-----REALSHPFFARL  412 (415)
T ss_pred             HccCccccccH-----HHHhcCHHhhcC
Confidence            99999999999     889999999864

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.7e-41  Score=341.87  Aligned_cols=251  Identities=22%  Similarity=0.403  Sum_probs=220.2

Q ss_pred             EEeeEEeeeCceEEEEEEEcCCCcEEEEEEeeccc-ccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCE--EEEEE
Q 011287           48 ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKF-ITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS--LYMAL  124 (489)
Q Consensus        48 ~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~-~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~--lylV~  124 (489)
                      ++..+||+|+|-+||+|.|..+|.+||.-.+.-.. ...+...+.+..|+.+|+.|+||||+++|+++.+...  +-+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            77889999999999999999999999966554332 2344556788899999999999999999999987655  88999


Q ss_pred             eccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeeccCCCCeeeCCC-CCEEEeeccCccccCCcccc
Q 011287          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG--LIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRIT  201 (489)
Q Consensus       125 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~g--IiHrDLKpeNILl~~~-g~ikL~DFG~a~~~~~~~~~  201 (489)
                      |.+..|+|..|+++.+.++...++.|+.||+.||.|||++.  |||||||.+||||+.+ |.|||+|+|+|..+...   
T Consensus       123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s---  199 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS---  199 (632)
T ss_pred             ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc---
Confidence            99999999999999999999999999999999999999995  9999999999999875 89999999999976532   


Q ss_pred             ccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCC-CCHHHHHHHHHhcCCC--CCCCC
Q 011287          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIARDIR--FPNYF  278 (489)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~-~~~~~~~~~i~~~~~~--~p~~~  278 (489)
                               .+.+.+|||.|||||++. ..|+..+||||||+.+.||+|+..||.. .+..++++++..+..+  |-..-
T Consensus       200 ---------~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~  269 (632)
T KOG0584|consen  200 ---------HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVK  269 (632)
T ss_pred             ---------ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccC
Confidence                     344679999999999997 7899999999999999999999999964 6778888888876432  33444


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       279 ~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                      .+++++||.+||.. .++||++     .+||+||||..-
T Consensus       270 dPevr~fIekCl~~-~~~R~sa-----~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  270 DPEVREFIEKCLAT-KSERLSA-----KELLKDPFFDED  302 (632)
T ss_pred             CHHHHHHHHHHhcC-chhccCH-----HHHhhChhhccc
Confidence            79999999999999 9999999     899999999753

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=3.1e-39  Score=321.01  Aligned_cols=260  Identities=27%  Similarity=0.453  Sum_probs=211.3

Q ss_pred             CCCCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEc
Q 011287           38 PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQD  116 (489)
Q Consensus        38 ~~~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~  116 (489)
                      ..-....++|++.+.||+|+||.||+|.+..+++.||+|.+.+....  .....+..|..++..+ .||||+++++++.+
T Consensus         8 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~   85 (296)
T cd06618           8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFIT   85 (296)
T ss_pred             eeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeec
Confidence            33456789999999999999999999999999999999999764322  2233444566656555 59999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeeccCCCCeeeCCCCCEEEeeccCccc
Q 011287          117 TFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (489)
Q Consensus       117 ~~~lylV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~aL~~LH~-~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~  194 (489)
                      ...+|+||||+.+ +|..++.. .+.+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.++|+|||++..
T Consensus        86 ~~~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~  164 (296)
T cd06618          86 DSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGR  164 (296)
T ss_pred             CCeEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchh
Confidence            9999999999964 77777665 4579999999999999999999997 5999999999999999999999999999876


Q ss_pred             cCCccccccCCCCCCCCccceecCCcCCChhhhcCCC----CCCCCcchhhhHHHHHHhhCCCCCCCCCH-HHHHHHHHh
Q 011287          195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP----ATFGNDLWALGCTLYQMLSGTSPFKDTSE-WLIFQRIIA  269 (489)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~----~~~~sDiwSLG~ilyelltG~~PF~~~~~-~~~~~~i~~  269 (489)
                      +....           ......++..|+|||.+.+..    ++.++|+|||||++|+|++|+.||..... .+....+..
T Consensus       165 ~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~  233 (296)
T cd06618         165 LVDSK-----------AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ  233 (296)
T ss_pred             ccCCC-----------cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhc
Confidence            53221           111235788999999987553    78899999999999999999999976432 344445544


Q ss_pred             cC-CCCCC--CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          270 RD-IRFPN--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       270 ~~-~~~p~--~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      .. ..++.  .++.++.+||.+||..||.+||++     .+++.||||..
T Consensus       234 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~-----~~il~~~~~~~  278 (296)
T cd06618         234 EEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKY-----RELLQHPFIRR  278 (296)
T ss_pred             CCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCH-----HHHhcChhhhc
Confidence            33 22332  478999999999999999999998     89999999974

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.8e-39  Score=315.58  Aligned_cols=246  Identities=24%  Similarity=0.405  Sum_probs=207.5

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDT---GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~t---g~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  119 (489)
                      ..++|.+.+.||+|+||.||+|.+..+   ...||+|.+....  .....+.+.+|+.+++.++||||+++++++.+. .
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~   80 (270)
T cd05056           4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-P   80 (270)
T ss_pred             chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-C
Confidence            457899999999999999999997654   4578999886542  133445678899999999999999999998764 5


Q ss_pred             EEEEEeccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          120 LYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      .|+||||+++|+|.+++.+.+ .+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||+++.....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence            789999999999999998753 5899999999999999999999999999999999999999999999999998765432


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCC
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPN  276 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~  276 (489)
                      ...         ......++..|+|||.+....++.++|+|||||++|+|++ |..||.+.+..+....+... ....|.
T Consensus       161 ~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  231 (270)
T cd05056         161 SYY---------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPP  231 (270)
T ss_pred             cce---------ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence            110         0112234568999999988889999999999999999986 99999988877766666554 345678


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCC
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      .++..+.++|.+||..+|++||++
T Consensus       232 ~~~~~~~~li~~~l~~~P~~Rpt~  255 (270)
T cd05056         232 NCPPTLYSLMTKCWAYDPSKRPRF  255 (270)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCH
Confidence            899999999999999999999998

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.2e-39  Score=337.59  Aligned_cols=254  Identities=21%  Similarity=0.354  Sum_probs=209.1

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEc-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccEEEEEEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQ  115 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~-----~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~  115 (489)
                      +..++|.+++.||+|+||.||+|++.     .+++.||+|++....  .......+..|+.+|.++. ||||+++++++.
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            44567999999999999999999963     356789999997542  2223345778999999997 999999999999


Q ss_pred             cCCEEEEEEeccCCCChHHHHHhCC-------------------------------------------------------
Q 011287          116 DTFSLYMALESCEGGELFDQITSKG-------------------------------------------------------  140 (489)
Q Consensus       116 ~~~~lylV~E~~~gg~L~~~l~~~~-------------------------------------------------------  140 (489)
                      ....+|+|||||.+|+|.+++.+.+                                                       
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            9999999999999999999986532                                                       


Q ss_pred             -------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCee
Q 011287          141 -------------------------------------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLL  177 (489)
Q Consensus       141 -------------------------------------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNIL  177 (489)
                                                                 .+++..+..++.||+.||+|||+.||+||||||+|||
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiL  271 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVL  271 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEE
Confidence                                                       2567778889999999999999999999999999999


Q ss_pred             eCCCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCC
Q 011287          178 LTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK  256 (489)
Q Consensus       178 l~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~  256 (489)
                      ++.++.++|+|||+++.+.....        ........++..|+|||.+.+..++.++|+|||||++|+|++ |..||.
T Consensus       272 l~~~~~~kL~DfGla~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~  343 (401)
T cd05107         272 ICEGKLVKICDFGLARDIMRDSN--------YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYP  343 (401)
T ss_pred             EeCCCEEEEEecCcceecccccc--------cccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCC
Confidence            99999999999999986432210        011223467889999999998889999999999999999998 899998


Q ss_pred             CCCHHHHHHHHHhc--CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          257 DTSEWLIFQRIIAR--DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       257 ~~~~~~~~~~i~~~--~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      .....+........  ....|..++.++.+|+.+||+.+|.+||++     ++|+.
T Consensus       344 ~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~-----~ell~  394 (401)
T cd05107         344 ELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDF-----SQLVH  394 (401)
T ss_pred             CCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCH-----HHHHH
Confidence            76555544443333  245677789999999999999999999998     55653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-39  Score=316.78  Aligned_cols=237  Identities=25%  Similarity=0.392  Sum_probs=198.9

Q ss_pred             eEEeeeCceEEEEEEEcCCCcE--EEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCEEEEEEecc
Q 011287           51 KIYGVGSYSKVVRAKKIDTGTV--YALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESC  127 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~~tg~~--vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~lylV~E~~  127 (489)
                      ++||+|+||.||+|++..++..  +|+|.+...  ........+.+|+.++.++ +||||+++++++.....+|+||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA   78 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence            3689999999999999888764  588877532  1223345677899999999 8999999999999999999999999


Q ss_pred             CCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccC
Q 011287          128 EGGELFDQITSKG----------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS  191 (489)
Q Consensus       128 ~gg~L~~~l~~~~----------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~  191 (489)
                      ++|+|.+++....                .+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||+
T Consensus        79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence            9999999997543                478999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc
Q 011287          192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR  270 (489)
Q Consensus       192 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~  270 (489)
                      +......           ........+..|+|||++....++.++|+|||||++|+|++ |..||.+.+....++.+...
T Consensus       159 ~~~~~~~-----------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~  227 (270)
T cd05047         159 SRGQEVY-----------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  227 (270)
T ss_pred             ccccchh-----------hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC
Confidence            8532110           00111233567999999988889999999999999999997 99999888877777766553


Q ss_pred             -CCCCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          271 -DIRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       271 -~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                       ....+..++.++.+|+.+||+.||.+||++
T Consensus       228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  258 (270)
T cd05047         228 YRLEKPLNCDDEVYDLMRQCWREKPYERPSF  258 (270)
T ss_pred             CCCCCCCcCCHHHHHHHHHHcccChhhCCCH
Confidence             334666788999999999999999999998

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.1e-39  Score=331.54  Aligned_cols=255  Identities=25%  Similarity=0.385  Sum_probs=205.0

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEE-----cCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKK-----IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQ  115 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~-----~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~  115 (489)
                      +..++|++++.||+|+||.||+|++     ..+++.||||++....  .......+.+|+.++.++ +||||+++++++.
T Consensus         4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (343)
T cd05103           4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT   81 (343)
T ss_pred             cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence            3457999999999999999999985     3568899999986542  223345677899999999 6899999998776


Q ss_pred             c-CCEEEEEEeccCCCChHHHHHhC-------------------------------------------------------
Q 011287          116 D-TFSLYMALESCEGGELFDQITSK-------------------------------------------------------  139 (489)
Q Consensus       116 ~-~~~lylV~E~~~gg~L~~~l~~~-------------------------------------------------------  139 (489)
                      . ...+|+|||||++|+|.+++...                                                       
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence            4 45689999999999999998653                                                       


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCC
Q 011287          140 ------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA  207 (489)
Q Consensus       140 ------------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~  207 (489)
                                  ..++...+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++........       
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~-------  234 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-------  234 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcc-------
Confidence                        1367788899999999999999999999999999999999999999999999876532210       


Q ss_pred             CCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHH-HHh-cCCCCCCCCCHHHHH
Q 011287          208 SDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQR-IIA-RDIRFPNYFSDAARD  284 (489)
Q Consensus       208 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~-i~~-~~~~~p~~~~~~~~~  284 (489)
                       ........++..|+|||.+.+..++.++|+|||||++|+|++ |..||........+.. +.. .....|...++++.+
T Consensus       235 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (343)
T cd05103         235 -YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQ  313 (343)
T ss_pred             -hhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHH
Confidence             011122345678999999998889999999999999999997 9999987543332222 222 234556678899999


Q ss_pred             HHHHhhccCCCCCCCCCCCCHHHHhcC
Q 011287          285 LIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (489)
Q Consensus       285 Li~~~L~~dP~~R~t~~~~~~~~l~~h  311 (489)
                      ++.+||+.||++||++     .++++|
T Consensus       314 ~~~~cl~~~p~~Rps~-----~eil~~  335 (343)
T cd05103         314 TMLDCWHGEPSQRPTF-----SELVEH  335 (343)
T ss_pred             HHHHHccCChhhCcCH-----HHHHHH
Confidence            9999999999999998     667654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=4.6e-39  Score=316.72  Aligned_cols=250  Identities=16%  Similarity=0.275  Sum_probs=208.8

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcC----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc-
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKID----TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD-  116 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~----tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-  116 (489)
                      ...++|++.+.||+|+||.||+|.+..    ++..||+|.+...  ........+.+|..+++.++||||+++++++.+ 
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~   80 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED   80 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            456899999999999999999999876    3688999988643  233445667889999999999999999997655 


Q ss_pred             CCEEEEEEeccCCCChHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEee
Q 011287          117 TFSLYMALESCEGGELFDQITSK--------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIAD  188 (489)
Q Consensus       117 ~~~lylV~E~~~gg~L~~~l~~~--------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~D  188 (489)
                      ....+++++|+.+|+|.+++...        ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence            57789999999999999998763        3589999999999999999999999999999999999999999999999


Q ss_pred             ccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHH
Q 011287          189 FGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRI  267 (489)
Q Consensus       189 FG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i  267 (489)
                      ||+++.+.......        ......++..|+|||++.+..++.++|||||||++|++++ |++||...+.......+
T Consensus       161 ~g~~~~~~~~~~~~--------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~  232 (280)
T cd05043         161 NALSRDLFPMDYHC--------LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYL  232 (280)
T ss_pred             CCCcccccCCceEE--------eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHH
Confidence            99998654332111        0112245678999999998889999999999999999999 99999988877766555


Q ss_pred             Hhc-CCCCCCCCCHHHHHHHHHhhccCCCCCCCCC
Q 011287          268 IAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAG  301 (489)
Q Consensus       268 ~~~-~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~  301 (489)
                      ... .+..+..+++++.+++.+||..||++||++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  267 (280)
T cd05043         233 KDGYRLAQPINCPDELFAVMACCWALDPEERPSFS  267 (280)
T ss_pred             HcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHH
Confidence            443 2234556789999999999999999999983

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=5e-39  Score=310.78  Aligned_cols=238  Identities=22%  Similarity=0.400  Sum_probs=201.6

Q ss_pred             eEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEeccCCC
Q 011287           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG  130 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~~~gg  130 (489)
                      ++||+|+||.||+|... ++..||+|++....  .......+.+|+.+++.++||||+++++++.+....++||||++++
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   77 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG   77 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence            47899999999999864 68899999986542  2223345778999999999999999999999999999999999999


Q ss_pred             ChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCC
Q 011287          131 ELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD  209 (489)
Q Consensus       131 ~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~  209 (489)
                      +|.+++... +.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++........         
T Consensus        78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~---------  148 (250)
T cd05085          78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY---------  148 (250)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccc---------
Confidence            999998754 4689999999999999999999999999999999999999999999999999865322110         


Q ss_pred             CCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCCCCCHHHHHHHH
Q 011287          210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFSDAARDLID  287 (489)
Q Consensus       210 ~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~Li~  287 (489)
                      .......++..|+|||++....++.++|+|||||++|+|++ |..||.+.+.......+... ...+|..++..+.+|+.
T Consensus       149 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  228 (250)
T cd05085         149 SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQ  228 (250)
T ss_pred             ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence            01112234567999999998889999999999999999998 99999988877766666554 34567778999999999


Q ss_pred             HhhccCCCCCCCC
Q 011287          288 RLLDVDPSGRPGA  300 (489)
Q Consensus       288 ~~L~~dP~~R~t~  300 (489)
                      +||+.+|++||++
T Consensus       229 ~~l~~~p~~Rp~~  241 (250)
T cd05085         229 RCWDYKPENRPKF  241 (250)
T ss_pred             HHcccCcccCCCH
Confidence            9999999999998

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.6e-39  Score=317.42  Aligned_cols=246  Identities=21%  Similarity=0.329  Sum_probs=197.4

Q ss_pred             CCe-EEeeEEeeeCceEEEEEE----EcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc--C
Q 011287           45 QDF-ELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD--T  117 (489)
Q Consensus        45 ~dy-~~~~~LG~G~~g~Vy~a~----~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~  117 (489)
                      ++| ++.+.||+|+||+||++.    ...++..||+|++.....  ......+.+|+.+++.++||||+++++++..  .
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG   80 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            345 999999999999998865    345788999999865421  2234557789999999999999999998765  3


Q ss_pred             CEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCC
Q 011287          118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~  197 (489)
                      ..+|+||||+++++|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++..+..
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence            4689999999999999999764 699999999999999999999999999999999999999999999999999986543


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHH--------------H
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL--------------I  263 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~--------------~  263 (489)
                      ....       ........++..|+|||.+.+..++.++|||||||++|+|++|..||.......              .
T Consensus       160 ~~~~-------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd05080         160 GHEY-------YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVR  232 (283)
T ss_pred             cchh-------hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhh
Confidence            2110       001112245667999999988889999999999999999999999986543210              0


Q ss_pred             HHHHHh--cCCCCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          264 FQRIIA--RDIRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       264 ~~~i~~--~~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      ......  .....|..++.++.+++.+||+.||++||++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~  271 (283)
T cd05080         233 LIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTF  271 (283)
T ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCH
Confidence            111111  1223466789999999999999999999998

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=4.3e-39  Score=311.66  Aligned_cols=248  Identities=24%  Similarity=0.386  Sum_probs=212.5

Q ss_pred             eEEeeEEeeeCceEEEEEEEcCCC----cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEE
Q 011287           47 FELGKIYGVGSYSKVVRAKKIDTG----TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        47 y~~~~~LG~G~~g~Vy~a~~~~tg----~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lyl  122 (489)
                      |++.+.||.|+||.||+|++..++    ..||+|++.....  ......+..|+.+++.++|+||+++++.+.+....|+
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence            467899999999999999998766    9999999865422  1145667889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          123 ALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~~~--l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      +|||+++++|.+++.....  +++..+..++.|++.||.+||+.|++||||||+||+++.++.++|+|||++........
T Consensus        79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence            9999999999999986544  99999999999999999999999999999999999999999999999999986544311


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhcC-CCCCCCC
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRFPNYF  278 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~~-~~~p~~~  278 (489)
                      ..         .....++..|+|||.+....++.++|+|||||++|+|++ |.+||...+.....+.+.... ...+..+
T Consensus       159 ~~---------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  229 (258)
T smart00219      159 YK---------KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENC  229 (258)
T ss_pred             cc---------cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcC
Confidence            10         001226789999999988889999999999999999998 899999888887777776543 3456678


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       279 ~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      +.++.+++.+||+.||++|||+     .++++
T Consensus       230 ~~~~~~~i~~~l~~~p~~Rpt~-----~~ll~  256 (258)
T smart00219      230 PPEIYKLMLQCWAEDPEDRPTF-----SELVE  256 (258)
T ss_pred             CHHHHHHHHHHCcCChhhCcCH-----HHHHh
Confidence            9999999999999999999998     66653

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.2e-40  Score=319.43  Aligned_cols=237  Identities=20%  Similarity=0.314  Sum_probs=197.4

Q ss_pred             eEEeeeCceEEEEEEEcCCCc-------EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           51 KIYGVGSYSKVVRAKKIDTGT-------VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~~tg~-------~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      +.||+|+||.||+|.+..++.       .||+|.+.+..   ......+..|..+++.++||||+++++++......++|
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv   77 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV   77 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence            468999999999999876554       48888875432   23345567789999999999999999999998999999


Q ss_pred             EeccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCC--------EEEeeccCccc
Q 011287          124 LESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH--------IKIADFGSVKP  194 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~--------ikL~DFG~a~~  194 (489)
                      |||+.+|+|..++...+ .+++..+..++.||+.||+|||++||+||||||+||+++.++.        ++++|||.+..
T Consensus        78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            99999999999997654 5899999999999999999999999999999999999988765        69999998764


Q ss_pred             cCCccccccCCCCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhC-CCCCCCCCHHHHHHHHHhcCC
Q 011287          195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSG-TSPFKDTSEWLIFQRIIARDI  272 (489)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG-~~PF~~~~~~~~~~~i~~~~~  272 (489)
                      ...              .....++..|+|||++.+. .++.++|+|||||++|+|++| .+||...+..... .+.....
T Consensus       158 ~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~  222 (258)
T cd05078         158 VLP--------------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-QFYEDRH  222 (258)
T ss_pred             cCC--------------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-HHHHccc
Confidence            322              1245688899999999764 578999999999999999998 5777665554433 3445566


Q ss_pred             CCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          273 RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       273 ~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      .+|...+.++.+||.+||+.||++||++     +++++
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~il~  255 (258)
T cd05078         223 QLPAPKWTELANLINQCMDYEPDFRPSF-----RAIIR  255 (258)
T ss_pred             cCCCCCcHHHHHHHHHHhccChhhCCCH-----HHHHH
Confidence            7888888999999999999999999998     66654

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.5e-40  Score=358.20  Aligned_cols=262  Identities=32%  Similarity=0.490  Sum_probs=207.6

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEE------------
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLF------------  111 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~------------  111 (489)
                      ..||+.+++||+||||.||+|+++-+|+.||||.+....  .......+.+|+.+|.+|+|||||++|            
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            578999999999999999999999999999999997664  444566788999999999999999998            


Q ss_pred             ------------------------------------------------EEEE----------------------------
Q 011287          112 ------------------------------------------------FTFQ----------------------------  115 (489)
Q Consensus       112 ------------------------------------------------~~~~----------------------------  115 (489)
                                                                      .++.                            
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                            0000                            


Q ss_pred             -----------------------cC--------CEEEEEEeccCCCChHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHh
Q 011287          116 -----------------------DT--------FSLYMALESCEGGELFDQITSKGHL-SEDEARFYTAEVVDALEYIHS  163 (489)
Q Consensus       116 -----------------------~~--------~~lylV~E~~~gg~L~~~l~~~~~l-~e~~~~~i~~qil~aL~~LH~  163 (489)
                                             .+        ..+|+-||||+.-.|.+++.++... ....++.+++||++||.|+|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~  715 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD  715 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence                                   01        3589999999986666666654333 488999999999999999999


Q ss_pred             CCcEeeccCCCCeeeCCCCCEEEeeccCccccCC----ccccccC----CCCCCCCccceecCCcCCChhhhcCCC---C
Q 011287          164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD----SRITVLP----NAASDDKACTFVGTAAYVPPEVLNSSP---A  232 (489)
Q Consensus       164 ~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~----~~~~~~~----~~~~~~~~~~~~gt~~Y~aPE~l~~~~---~  232 (489)
                      .|||||||||.|||++++++|||+|||+|+....    ......+    .........+.+||..|+|||++.+..   |
T Consensus       716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y  795 (1351)
T KOG1035|consen  716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY  795 (1351)
T ss_pred             CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence            9999999999999999999999999999987321    0000000    011223456789999999999997655   9


Q ss_pred             CCCCcchhhhHHHHHHhhCCCCCCCCCHH-HHHHHHHhcCCCCCCC----CCHHHHHHHHHhhccCCCCCCCCCCCCHHH
Q 011287          233 TFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQRIIARDIRFPNY----FSDAARDLIDRLLDVDPSGRPGAGPGGYAV  307 (489)
Q Consensus       233 ~~~sDiwSLG~ilyelltG~~PF~~~~~~-~~~~~i~~~~~~~p~~----~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~  307 (489)
                      +.|+|+||||+|+|||+.   ||...-+. .++..+..+.+++|..    --+.-..+|++||+.||++||||     .+
T Consensus       796 n~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA-----~e  867 (1351)
T KOG1035|consen  796 NSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTA-----TE  867 (1351)
T ss_pred             cchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCH-----HH
Confidence            999999999999999983   57654433 3455555555555532    24567889999999999999999     89


Q ss_pred             HhcCCCCC
Q 011287          308 LKMHPFFK  315 (489)
Q Consensus       308 l~~hpff~  315 (489)
                      ++++.||-
T Consensus       868 LL~s~llp  875 (1351)
T KOG1035|consen  868 LLNSELLP  875 (1351)
T ss_pred             HhhccCCC
Confidence            99999986

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-39  Score=318.05  Aligned_cols=249  Identities=32%  Similarity=0.511  Sum_probs=208.3

Q ss_pred             eEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCEEEEEEe
Q 011287           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLYMALE  125 (489)
Q Consensus        47 y~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~lylV~E  125 (489)
                      |.+.+.||+|++|.||+|+...+++.||||.+.+.....  ......+|...+++++ ||||+++++.+.+....|+|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW--EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch--hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            789999999999999999999999999999987653221  2223446888999998 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          126 SCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       126 ~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      |+ +|+|.+++....  .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+......     
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~-----  152 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR-----  152 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC-----
Confidence            99 779999888764  7899999999999999999999999999999999999999999999999998754321     


Q ss_pred             CCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC-----------
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----------  271 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~-----------  271 (489)
                            .......|+..|+|||++.. ..++.++|+|||||++++|++|++||...+....+.++...-           
T Consensus       153 ------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (283)
T cd07830         153 ------PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEG  226 (283)
T ss_pred             ------CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhH
Confidence                  11224568899999998854 457899999999999999999999998887766555443210           


Q ss_pred             --------CCC-----------CCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          272 --------IRF-----------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       272 --------~~~-----------p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                              ..+           ....+.++.+||++||+.||++||++     .+++.||||
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~-----~ei~~~~~~  283 (283)
T cd07830         227 YKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTA-----SQALQHPYF  283 (283)
T ss_pred             hhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCH-----HHHhhCCCC
Confidence                    000           11236889999999999999999998     899999998

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=4.9e-39  Score=312.01  Aligned_cols=237  Identities=24%  Similarity=0.417  Sum_probs=202.3

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lyl  122 (489)
                      ..++|++.+.||+|+||.||++..  +++.||+|.+...     .....+.+|+.+++.++||||+++++++... ..|+
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~-----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~   75 (254)
T cd05083           4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCD-----VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI   75 (254)
T ss_pred             cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCc-----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence            457899999999999999999864  7889999998543     1234577899999999999999999998765 4799


Q ss_pred             EEeccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          123 ALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      ||||+.+++|.+++...+  .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......  
T Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--  153 (254)
T cd05083          76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--  153 (254)
T ss_pred             EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence            999999999999997653  4899999999999999999999999999999999999999999999999998753211  


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCCCC
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYF  278 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~  278 (489)
                                 ......+..|+|||.+.+..++.++|+|||||++|+|++ |++||...+.......+... ....+..+
T Consensus       154 -----------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  222 (254)
T cd05083         154 -----------VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGC  222 (254)
T ss_pred             -----------CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcC
Confidence                       112234567999999988889999999999999999997 99999988877766665543 23345678


Q ss_pred             CHHHHHHHHHhhccCCCCCCCC
Q 011287          279 SDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       279 ~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      +..+.+++.+||+.+|.+||++
T Consensus       223 ~~~~~~li~~~l~~~p~~Rp~~  244 (254)
T cd05083         223 PADVYVLMTSCWETEPKKRPSF  244 (254)
T ss_pred             CHHHHHHHHHHcCCChhhCcCH
Confidence            9999999999999999999998

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=4.9e-39  Score=314.24  Aligned_cols=240  Identities=24%  Similarity=0.396  Sum_probs=202.0

Q ss_pred             eEEeeeCceEEEEEEEcCCC------cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           51 KIYGVGSYSKVVRAKKIDTG------TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~~tg------~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      +.||+|+||.||+|++...+      ..+|+|.+.+...  ......+.+|..+++.++||||+++++++.+....|+||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM   78 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence            46899999999999986544      7899998865421  223455777999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCC-----CEEEeeccCc
Q 011287          125 ESCEGGELFDQITSK-------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-----HIKIADFGSV  192 (489)
Q Consensus       125 E~~~gg~L~~~l~~~-------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g-----~ikL~DFG~a  192 (489)
                      ||+++++|.+++.+.       ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++     .++|+|||++
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            999999999999742       3478899999999999999999999999999999999999887     8999999998


Q ss_pred             cccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-
Q 011287          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-  270 (489)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-  270 (489)
                      +........        .......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+.......+... 
T Consensus       159 ~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~  230 (269)
T cd05044         159 RDIYKSDYY--------RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG  230 (269)
T ss_pred             ccccccccc--------ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC
Confidence            765332110        11123356788999999999899999999999999999998 99999988877776665543 


Q ss_pred             CCCCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          271 DIRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       271 ~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      .+..+..++..+.+||.+||+.+|.+||++
T Consensus       231 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~  260 (269)
T cd05044         231 RLQKPENCPDKIYQLMTNCWAQDPSERPTF  260 (269)
T ss_pred             ccCCcccchHHHHHHHHHHcCCCcccCCCH
Confidence            346677889999999999999999999998

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.2e-38  Score=314.32  Aligned_cols=247  Identities=20%  Similarity=0.335  Sum_probs=198.7

Q ss_pred             CCCeEEeeEEeeeCceEEEEEE----EcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEE--cC
Q 011287           44 IQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ--DT  117 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~----~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~  117 (489)
                      -++|++.+.||+|+||.||+|.    +..++..||+|.+...   .......+.+|+.+++.++||||+++++++.  +.
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   79 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence            3689999999999999999998    4457899999998654   2344566788999999999999999998764  34


Q ss_pred             CEEEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccC
Q 011287          118 FSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~  196 (489)
                      ..+|+||||+++|+|.+++.+. +.+++..+..++.|++.||.|||++||+||||||+||+++.+++++|+|||++..+.
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  159 (284)
T cd05081          80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP  159 (284)
T ss_pred             CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence            5689999999999999999764 468999999999999999999999999999999999999999999999999998654


Q ss_pred             CccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHH--------------
Q 011287          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL--------------  262 (489)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~--------------  262 (489)
                      ......       .......++..|+|||++.+..++.++|+|||||++|+|++|..|+.......              
T Consensus       160 ~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd05081         160 QDKEYY-------KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIV  232 (284)
T ss_pred             CCCcce-------eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccch
Confidence            321100       00011223456999999998889999999999999999999987765432211              


Q ss_pred             -HHHHHHhc--CCCCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          263 -IFQRIIAR--DIRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       263 -~~~~i~~~--~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                       .+..+...  .+..+..++.++.+||.+||+.+|++|||+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~  273 (284)
T cd05081         233 YHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSF  273 (284)
T ss_pred             HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence             01112222  223456788999999999999999999999

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3.1e-39  Score=315.28  Aligned_cols=247  Identities=30%  Similarity=0.502  Sum_probs=204.9

Q ss_pred             EEeeEEeeeCceEEEEEEEc----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           48 ELGKIYGVGSYSKVVRAKKI----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        48 ~~~~~LG~G~~g~Vy~a~~~----~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      .+.+.||.|+||.||+|...    ..+..|+||++...  ........+.+|...+++++||||+++++++.....+++|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv   79 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV   79 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence            57899999999999999997    45788999999442  2333466778899999999999999999999988889999


Q ss_pred             EeccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccc
Q 011287          124 LESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~  201 (489)
                      ||||++|+|.+++...  ..+++.....++.||+.||.|||+++++|+||+++||+++.++.+||+|||++........ 
T Consensus        80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~-  158 (259)
T PF07714_consen   80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK-  158 (259)
T ss_dssp             EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS-
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-
Confidence            9999999999999986  6799999999999999999999999999999999999999999999999999986522111 


Q ss_pred             ccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhcC-CCCCCCCC
Q 011287          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRFPNYFS  279 (489)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~~-~~~p~~~~  279 (489)
                             ........+...|+|||.+....++.++||||||+++|||++ |+.||...+...+...+.... ..+|..++
T Consensus       159 -------~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (259)
T PF07714_consen  159 -------YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCP  231 (259)
T ss_dssp             -------EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSB
T ss_pred             -------cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceeccchh
Confidence                   011223356778999999998889999999999999999999 789999998888887775543 34677899


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCCCCHHHHh
Q 011287          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLK  309 (489)
Q Consensus       280 ~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~  309 (489)
                      ..+.++|.+||..||.+||++     .+++
T Consensus       232 ~~~~~li~~C~~~~p~~RPs~-----~~i~  256 (259)
T PF07714_consen  232 KDIYSLIQQCWSHDPEKRPSF-----QEIL  256 (259)
T ss_dssp             HHHHHHHHHHT-SSGGGS--H-----HHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCH-----HHHH
Confidence            999999999999999999998     6664

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9.4e-39  Score=312.24  Aligned_cols=237  Identities=21%  Similarity=0.274  Sum_probs=193.7

Q ss_pred             eEEeeeCceEEEEEEEcC------------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 011287           51 KIYGVGSYSKVVRAKKID------------TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~~------------tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  118 (489)
                      +.||+|+||.||+|+...            ....+|+|++...   .......+.+|..+++.++||||+++++++.+..
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            468999999999998532            2346888987653   2333445677889999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCC-------EEEeecc
Q 011287          119 SLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-------IKIADFG  190 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~-------ikL~DFG  190 (489)
                      ..++||||+++|+|..++.+. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.       ++++|||
T Consensus        78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999999998888754 56999999999999999999999999999999999999987664       8999999


Q ss_pred             CccccCCccccccCCCCCCCCccceecCCcCCChhhhc-CCCCCCCCcchhhhHHHHHHh-hCCCCCCCCCHHHHHHHHH
Q 011287          191 SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN-SSPATFGNDLWALGCTLYQML-SGTSPFKDTSEWLIFQRII  268 (489)
Q Consensus       191 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~-~~~~~~~sDiwSLG~ilyell-tG~~PF~~~~~~~~~~~i~  268 (489)
                      ++.....              .....|+..|+|||.+. +..++.++|||||||++|+|+ +|..||......+. ....
T Consensus       158 ~~~~~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~  222 (262)
T cd05077         158 IPITVLS--------------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-ERFY  222 (262)
T ss_pred             CCccccC--------------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-HHHH
Confidence            9864421              12346788999999986 466899999999999999997 59999987654433 2333


Q ss_pred             hcCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          269 ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       269 ~~~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      ..........++++.+||.+||+.||++||+.     .+|+.
T Consensus       223 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~-----~~il~  259 (262)
T cd05077         223 EGQCMLVTPSCKELADLMTHCMNYDPNQRPFF-----RAIMR  259 (262)
T ss_pred             hcCccCCCCChHHHHHHHHHHcCCChhhCcCH-----HHHHH
Confidence            44444445567889999999999999999998     67764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9.8e-39  Score=315.40  Aligned_cols=252  Identities=20%  Similarity=0.314  Sum_probs=202.4

Q ss_pred             CCeEEeeEEeeeCceEEEEEEE----cCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC--C
Q 011287           45 QDFELGKIYGVGSYSKVVRAKK----IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT--F  118 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~----~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~  118 (489)
                      .-|++++.||+|+||.||+|+.    ..++..||+|.+....  .......+.+|+.+++.++||||+++++++.+.  .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence            3579999999999999999984    4578999999986442  233345688899999999999999999998875  6


Q ss_pred             EEEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCC
Q 011287          119 SLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~  197 (489)
                      ..|+||||++|++|.+++.+. ..+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++..+..
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            789999999999999999765 3589999999999999999999999999999999999999999999999999986543


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCH--------------HHH
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE--------------WLI  263 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~--------------~~~  263 (489)
                      ....       ........|+..|+|||++.+..++.++|||||||++|+|+++..|+.....              ...
T Consensus       162 ~~~~-------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd05079         162 DKEY-------YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTR  234 (284)
T ss_pred             Cccc-------eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHH
Confidence            2110       0111235677889999999888899999999999999999998776533211              011


Q ss_pred             HHHHHh--cCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          264 FQRIIA--RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       264 ~~~i~~--~~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      ......  .....+..++..+.+||.+||+.||.+||++     .++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~-----~~il~  278 (284)
T cd05079         235 LVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTF-----QNLIE  278 (284)
T ss_pred             HHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCH-----HHHHH
Confidence            111111  1233456789999999999999999999998     55653

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.5e-38  Score=317.40  Aligned_cols=248  Identities=18%  Similarity=0.341  Sum_probs=204.4

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGT----VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~----~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  117 (489)
                      +..++|+..+.||+|+||.||+|++..+|.    .||+|.+....  .......+.+|..+++.++||||+++++++...
T Consensus         4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~   81 (303)
T cd05110           4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP   81 (303)
T ss_pred             cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence            456899999999999999999999988776    46888875432  222334577899999999999999999988764


Q ss_pred             CEEEEEEeccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccC
Q 011287          118 FSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~  196 (489)
                       ..++++||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+.
T Consensus        82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence             4679999999999999988753 68999999999999999999999999999999999999999999999999998654


Q ss_pred             CccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCC
Q 011287          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRF  274 (489)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~  274 (489)
                      ....        ........++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.........+... .+..
T Consensus       161 ~~~~--------~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~  232 (303)
T cd05110         161 GDEK--------EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQ  232 (303)
T ss_pred             Cccc--------ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCC
Confidence            3211        011112345778999999998889999999999999999997 99999887665544443332 2334


Q ss_pred             CCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          275 PNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       275 p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      +...+..+.+++.+|+..||++||++
T Consensus       233 ~~~~~~~~~~li~~c~~~~p~~Rp~~  258 (303)
T cd05110         233 PPICTIDVYMVMVKCWMIDADSRPKF  258 (303)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCH
Confidence            55678999999999999999999998

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.9e-38  Score=308.79  Aligned_cols=242  Identities=21%  Similarity=0.354  Sum_probs=197.1

Q ss_pred             eEEeeeCceEEEEEEEcC---CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEE-cCCEEEEEEec
Q 011287           51 KIYGVGSYSKVVRAKKID---TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ-DTFSLYMALES  126 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~~---tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~lylV~E~  126 (489)
                      +.||+|+||.||+|.+..   .+..||+|.+...  ........+.+|..+++.++||||+++++++. .+...|+||||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   78 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY   78 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence            468999999999999754   3467999987532  22334556778999999999999999999765 45668999999


Q ss_pred             cCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCC
Q 011287          127 CEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  205 (489)
Q Consensus       127 ~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~  205 (489)
                      +.+|+|.+++.+. ..+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||+++.+.......   
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~---  155 (262)
T cd05058          79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS---  155 (262)
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCccee---
Confidence            9999999999764 457788889999999999999999999999999999999999999999999987653321100   


Q ss_pred             CCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhcC-CCCCCCCCHHHH
Q 011287          206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRFPNYFSDAAR  283 (489)
Q Consensus       206 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~~-~~~p~~~~~~~~  283 (489)
                         ........++..|+|||.+.+..++.++|||||||++|+|++ |.+||...+.......+.... ...|..+++.+.
T Consensus       156 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (262)
T cd05058         156 ---VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLY  232 (262)
T ss_pred             ---ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHH
Confidence               011122345778999999988889999999999999999999 678888877777666655443 345667899999


Q ss_pred             HHHHHhhccCCCCCCCC
Q 011287          284 DLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       284 ~Li~~~L~~dP~~R~t~  300 (489)
                      +++.+||..+|++||++
T Consensus       233 ~li~~cl~~~p~~Rp~~  249 (262)
T cd05058         233 EVMLSCWHPKPEMRPTF  249 (262)
T ss_pred             HHHHHHcCCChhhCCCH
Confidence            99999999999999998

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-40  Score=331.65  Aligned_cols=236  Identities=24%  Similarity=0.467  Sum_probs=206.9

Q ss_pred             EEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEecc
Q 011287           48 ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESC  127 (489)
Q Consensus        48 ~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~~  127 (489)
                      .-++-||.|+.|.||+|+.  .++.||||.++.          .-..++..|++|+||||+.+.+++.....+++|||||
T Consensus       127 sELeWlGSGaQGAVF~Grl--~netVAVKKV~e----------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfC  194 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRL--HNETVAVKKVRE----------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFC  194 (904)
T ss_pred             hhhhhhccCcccceeeeec--cCceehhHHHhh----------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeecc
Confidence            4466789999999999998  478999997631          1234788899999999999999999999999999999


Q ss_pred             CCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCC
Q 011287          128 EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA  207 (489)
Q Consensus       128 ~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~  207 (489)
                      ..|.|..+|+....++......|..+|+.|+.|||.++|||||||.-||||+.+..|||+|||.++.+...         
T Consensus       195 a~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---------  265 (904)
T KOG4721|consen  195 AQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---------  265 (904)
T ss_pred             ccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh---------
Confidence            99999999999999999999999999999999999999999999999999999999999999999876432         


Q ss_pred             CCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc--CCCCCCCCCHHHHHH
Q 011287          208 SDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--DIRFPNYFSDAARDL  285 (489)
Q Consensus       208 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~L  285 (489)
                        ...-+|+||..|||||++...+++.++|||||||+|+|||||..||...+...++.-+-.+  .+..|..+|+.++=|
T Consensus       266 --STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL  343 (904)
T KOG4721|consen  266 --STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLL  343 (904)
T ss_pred             --hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHH
Confidence              3445899999999999999999999999999999999999999999887665543322222  355678899999999


Q ss_pred             HHHhhccCCCCCCCCCCCCHHHHhcC
Q 011287          286 IDRLLDVDPSGRPGAGPGGYAVLKMH  311 (489)
Q Consensus       286 i~~~L~~dP~~R~t~~~~~~~~l~~h  311 (489)
                      |+.|++-.|..||+.     .+++.|
T Consensus       344 ~Kqcw~sKpRNRPSF-----rqil~H  364 (904)
T KOG4721|consen  344 LKQCWNSKPRNRPSF-----RQILLH  364 (904)
T ss_pred             HHHHHhcCCCCCccH-----HHHHHH
Confidence            999999999999987     556655

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=9.8e-39  Score=314.30  Aligned_cols=236  Identities=20%  Similarity=0.271  Sum_probs=193.5

Q ss_pred             EEeeeCceEEEEEEEcCC------------------------CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc
Q 011287           52 IYGVGSYSKVVRAKKIDT------------------------GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV  107 (489)
Q Consensus        52 ~LG~G~~g~Vy~a~~~~t------------------------g~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnI  107 (489)
                      .||+|+||.||+|....+                        ...||+|++....   ......+.+|..+++.++||||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni   78 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL   78 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence            689999999999985322                        2458899886542   2233456678889999999999


Q ss_pred             cEEEEEEEcCCEEEEEEeccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCC----
Q 011287          108 VRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG----  182 (489)
Q Consensus       108 v~l~~~~~~~~~lylV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g----  182 (489)
                      +++++++.+....|+||||+++|+|..++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++.++    
T Consensus        79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence            9999999999999999999999999998875 46799999999999999999999999999999999999998654    


Q ss_pred             ---CEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHH-hhCCCCCCC
Q 011287          183 ---HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQM-LSGTSPFKD  257 (489)
Q Consensus       183 ---~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyel-ltG~~PF~~  257 (489)
                         .++++|||++......              ....++..|+|||.+.+ ..++.++|+|||||++|+| ++|..||.+
T Consensus       159 ~~~~~kl~d~g~~~~~~~~--------------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~  224 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR--------------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE  224 (274)
T ss_pred             ccceeeecCCccccccccc--------------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccc
Confidence               3899999987643211              12357788999998865 5588999999999999998 479999988


Q ss_pred             CCHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          258 TSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       258 ~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      ....... ........+|...++.+.++|.+||+.+|++||++     .++++
T Consensus       225 ~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~-----~~il~  271 (274)
T cd05076         225 RTPSEKE-RFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSF-----RTILR  271 (274)
T ss_pred             cChHHHH-HHHHhccCCCCCCChHHHHHHHHHcccChhhCcCH-----HHHHH
Confidence            7655442 33444556677778899999999999999999988     66764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.1e-38  Score=309.02  Aligned_cols=239  Identities=22%  Similarity=0.360  Sum_probs=191.2

Q ss_pred             eEEeeeCceEEEEEEEcC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEeccC
Q 011287           51 KIYGVGSYSKVVRAKKID--TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCE  128 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~~--tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~~~  128 (489)
                      +.||+|+||.||+|....  ....+|+|.+....  .......+.+|+.+++.++||||+++++.+.+....|+||||++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP   78 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence            368999999999997533  44578888765432  23334556779999999999999999999999999999999999


Q ss_pred             CCChHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          129 GGELFDQITSKG-----HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       129 gg~L~~~l~~~~-----~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      +|+|.+++....     .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........  
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--  156 (269)
T cd05042          79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY--  156 (269)
T ss_pred             CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhe--
Confidence            999999997642     2467888999999999999999999999999999999999999999999998654322110  


Q ss_pred             CCCCCCCCccceecCCcCCChhhhcC-------CCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CC--
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLNS-------SPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DI--  272 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~~-------~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~--  272 (489)
                            .......++..|+|||++..       ..++.++|||||||++|+|++ |.+||....+.+....+... ..  
T Consensus       157 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~  230 (269)
T cd05042         157 ------ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKL  230 (269)
T ss_pred             ------eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccC
Confidence                  01123356778999999743       346789999999999999999 89999888776665554432 22  


Q ss_pred             ---CCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          273 ---RFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       273 ---~~p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                         ..+..++....+++..|+ .||++||++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~  260 (269)
T cd05042         231 PKPQLDLKYSDRWYEVMQFCW-LDPETRPTA  260 (269)
T ss_pred             CCCcccccCCHHHHHHHHHHh-cCcccccCH
Confidence               234467899999999998 599999998

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.2e-38  Score=310.27  Aligned_cols=245  Identities=21%  Similarity=0.372  Sum_probs=202.8

Q ss_pred             eEEeeEEeeeCceEEEEEEEc---CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-----
Q 011287           47 FELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-----  118 (489)
Q Consensus        47 y~~~~~LG~G~~g~Vy~a~~~---~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----  118 (489)
                      |.+.+.||+|+||.||+|...   .+++.||||++..... .......+.+|+.+++.++||||+++++++....     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence            678899999999999999864   3578999999965432 3334556778999999999999999999886432     


Q ss_pred             -EEEEEEeccCCCChHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccC
Q 011287          119 -SLYMALESCEGGELFDQITSK------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS  191 (489)
Q Consensus       119 -~lylV~E~~~gg~L~~~l~~~------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~  191 (489)
                       ..+++++|+.+|+|..++...      ..+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||+
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~  159 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL  159 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence             347899999999998877532      2478999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc
Q 011287          192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR  270 (489)
Q Consensus       192 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~  270 (489)
                      ++.......        ........+++.|++||.+....++.++|||||||++|+|++ |.+||.+.+....+..+...
T Consensus       160 ~~~~~~~~~--------~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  231 (273)
T cd05074         160 SKKIYSGDY--------YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG  231 (273)
T ss_pred             cccccCCcc--------eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC
Confidence            886533211        011123345678999999998889999999999999999999 99999988877776666544


Q ss_pred             -CCCCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          271 -DIRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       271 -~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                       ....+...+..+.+++.+||+.+|++||++
T Consensus       232 ~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~  262 (273)
T cd05074         232 NRLKQPPDCLEDVYELMCQCWSPEPKCRPSF  262 (273)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence             344566788999999999999999999998

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-39  Score=329.31  Aligned_cols=250  Identities=27%  Similarity=0.438  Sum_probs=215.8

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCc---E-EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGT---V-YALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~---~-vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  117 (489)
                      +..++-.+.+.||+|+||.||+|+.+..+.   . ||+|...............+..|+++|+.++|||||++|++..++
T Consensus       154 l~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~  233 (474)
T KOG0194|consen  154 LSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE  233 (474)
T ss_pred             EeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence            455677888999999999999999865422   3 899998764444455667788899999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccC
Q 011287          118 FSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~  196 (489)
                      ..+|+|||+|.||+|.+++++.+ .++..+...++.+.+.||+|||+++++||||-..|+|++.++.+||+|||+++.-.
T Consensus       234 ~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~  313 (474)
T KOG0194|consen  234 EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS  313 (474)
T ss_pred             CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence            99999999999999999999987 49999999999999999999999999999999999999999999999999987532


Q ss_pred             CccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhcCC--C
Q 011287          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDI--R  273 (489)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~~~--~  273 (489)
                      ....          ....---...|+|||.+....++.++||||+||++||+++ |..||.+.+..++.++|....+  .
T Consensus       314 ~~~~----------~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~  383 (474)
T KOG0194|consen  314 QYVM----------KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMP  383 (474)
T ss_pred             ceee----------ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCC
Confidence            1110          0001123467999999999999999999999999999999 8999999999999999966554  4


Q ss_pred             CCCCCCHHHHHHHHHhhccCCCCCCCCC
Q 011287          274 FPNYFSDAARDLIDRLLDVDPSGRPGAG  301 (489)
Q Consensus       274 ~p~~~~~~~~~Li~~~L~~dP~~R~t~~  301 (489)
                      +|...|.++..++.+|+..||++||++.
T Consensus       384 ~~~~~p~~~~~~~~~c~~~~p~~R~tm~  411 (474)
T KOG0194|consen  384 IPSKTPKELAKVMKQCWKKDPEDRPTMS  411 (474)
T ss_pred             CCCCCHHHHHHHHHHhccCChhhccCHH
Confidence            5677899999999999999999999984

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4.5e-38  Score=308.04  Aligned_cols=239  Identities=20%  Similarity=0.297  Sum_probs=191.1

Q ss_pred             eEEeeeCceEEEEEEEc--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEeccC
Q 011287           51 KIYGVGSYSKVVRAKKI--DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCE  128 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~--~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~~~  128 (489)
                      +.||+|+||.||+|...  .++..+|+|.+.....  ......+.+|+.+++.++||||+++++.+.+...+|+||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP   78 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence            46899999999999864  3567899998865432  2233457779999999999999999999999999999999999


Q ss_pred             CCChHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          129 GGELFDQITSKG-----HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       129 gg~L~~~l~~~~-----~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      +|+|.+++....     .+++..++.++.|++.||+|||+.|++||||||+||+++.+++++|+|||+++........  
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~--  156 (269)
T cd05087          79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY--  156 (269)
T ss_pred             CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCccee--
Confidence            999999987532     3577788899999999999999999999999999999999999999999998754322110  


Q ss_pred             CCCCCCCCccceecCCcCCChhhhcCC-------CCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHh-cCCCC
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLNSS-------PATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIA-RDIRF  274 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~-------~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~-~~~~~  274 (489)
                            .......|+..|+|||++.+.       .++.++|+|||||++|+|++ |+.||......+....... ....+
T Consensus       157 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~  230 (269)
T cd05087         157 ------VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKL  230 (269)
T ss_pred             ------ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCC
Confidence                  111234678899999998642       35789999999999999996 9999987766654433322 22222


Q ss_pred             -----CCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          275 -----PNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       275 -----p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                           +...++.+.+++++|+ .+|++||++
T Consensus       231 ~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~  260 (269)
T cd05087         231 PKPRLKLPLSDRWYEVMQFCW-LQPEQRPSA  260 (269)
T ss_pred             CCCccCCCCChHHHHHHHHHh-cCcccCCCH
Confidence                 2356889999999998 689999999

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=5.5e-38  Score=312.25  Aligned_cols=260  Identities=18%  Similarity=0.207  Sum_probs=196.0

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCC---CcEEEEEEeecccccc--hhH------HHHHHHHHHHHHhCCCCCcc
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDT---GTVYALKIMDKKFITK--ENK------TAYVKLERIVLDQLDHPGVV  108 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~t---g~~vAiK~~~k~~~~~--~~~------~~~~~~E~~il~~l~hpnIv  108 (489)
                      ....-++|++.+.||+|+||.||+|++..+   +..+|+|+........  +..      ......+...+..+.|++|+
T Consensus         7 ~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~   86 (294)
T PHA02882          7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP   86 (294)
T ss_pred             eccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence            344557899999999999999999999887   7778888654321110  100      00111233345567899999


Q ss_pred             EEEEEEEcCC----EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCE
Q 011287          109 RLFFTFQDTF----SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI  184 (489)
Q Consensus       109 ~l~~~~~~~~----~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~i  184 (489)
                      ++++......    ..|++++++.. ++.+.+.....+++..++.++.|++.||+|||+.||+||||||+|||++.++.+
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         87 KYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             cEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence            9998765432    45788888754 777777766668899999999999999999999999999999999999999999


Q ss_pred             EEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCH-H--
Q 011287          185 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE-W--  261 (489)
Q Consensus       185 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~-~--  261 (489)
                      +|+|||+|+.+........   ..........||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+. .  
T Consensus       166 ~l~DFGla~~~~~~~~~~~---~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~  242 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIE---YSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL  242 (294)
T ss_pred             EEEEcCCceeeccCCcccc---cccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence            9999999987643221110   011223345799999999999999999999999999999999999999987632 1  


Q ss_pred             ------HHHHHHHhcCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHh
Q 011287          262 ------LIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLK  309 (489)
Q Consensus       262 ------~~~~~i~~~~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~  309 (489)
                            +...++......+ ...++.+.++++.|+..+|++||+.     ++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~rp~~-----~~l~  290 (294)
T PHA02882        243 IHAAKCDFIKRLHEGKIKI-KNANKFIYDFIECVTKLSYEEKPDY-----DALI  290 (294)
T ss_pred             HHHhHHHHHHHhhhhhhcc-CCCCHHHHHHHHHHHhCCCCCCCCH-----HHHH
Confidence                  1223333333333 3468999999999999999999987     5665

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.1e-41  Score=309.46  Aligned_cols=259  Identities=29%  Similarity=0.431  Sum_probs=214.8

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEE--------
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ--------  115 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--------  115 (489)
                      ...|+-...||+|.||+||+|+.+.+|+.||+|++--. ..++..-....+|+.+|..|+|+|++.+++.+.        
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlme-neKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r   94 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLME-NEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR   94 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHh-ccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence            35678888999999999999999999999999865321 123444455667999999999999998876553        


Q ss_pred             cCCEEEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccc
Q 011287          116 DTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (489)
Q Consensus       116 ~~~~lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~  194 (489)
                      +...+|+||.+|+. +|..++... -+|+..+++.++.+++.||.|+|++.|+|||+||+|+||+.+|.+||+|||+|+.
T Consensus        95 ~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~  173 (376)
T KOG0669|consen   95 DRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARA  173 (376)
T ss_pred             ccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence            34558999999987 999988765 5799999999999999999999999999999999999999999999999999987


Q ss_pred             cCCccccccCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc---
Q 011287          195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---  270 (489)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~---  270 (489)
                      +.....      ....+....+-|.+|++||.+.+ ..|+++.|||+.|||+.+|++|.+-|.+.++..++..|...   
T Consensus       174 fs~~~n------~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs  247 (376)
T KOG0669|consen  174 FSTSKN------VVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGS  247 (376)
T ss_pred             eecccc------cCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhcc
Confidence            754432      12344567788999999999866 55999999999999999999999999999998877766431   


Q ss_pred             ----------------CC---CCCCC-------------CCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 011287          271 ----------------DI---RFPNY-------------FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (489)
Q Consensus       271 ----------------~~---~~p~~-------------~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~  315 (489)
                                      ..   ++|..             -++++.||+++||..||.+|+++     .++++|.||.
T Consensus       248 ~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~a-----d~alnh~~F~  319 (376)
T KOG0669|consen  248 ITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDA-----DQALNHDFFW  319 (376)
T ss_pred             CCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcch-----Hhhhchhhhh
Confidence                            01   12211             25689999999999999999999     7899999995

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.9e-38  Score=307.87  Aligned_cols=230  Identities=20%  Similarity=0.271  Sum_probs=191.3

Q ss_pred             eEEeeeCceEEEEEEEcCCC----------cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEE
Q 011287           51 KIYGVGSYSKVVRAKKIDTG----------TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~~tg----------~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~l  120 (489)
                      +.||+|+||.||+|.+..++          ..+++|++....    .....+.+|..+++.++||||+++++++.. ...
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence            46899999999999998777          357788765432    114667789999999999999999999888 778


Q ss_pred             EEEEeccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCC-------CEEEeeccCc
Q 011287          121 YMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-------HIKIADFGSV  192 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g-------~ikL~DFG~a  192 (489)
                      |+||||+.+|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++       .++|+|||++
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            99999999999999998765 799999999999999999999999999999999999999888       8999999998


Q ss_pred             cccCCccccccCCCCCCCCccceecCCcCCChhhhcCC--CCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHh
Q 011287          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS--PATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIA  269 (489)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~--~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~  269 (489)
                      .....              .....++..|+|||++.+.  .++.++|+|||||++|+|++ |..||...+......... 
T Consensus       156 ~~~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-  220 (259)
T cd05037         156 ITVLS--------------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-  220 (259)
T ss_pred             ccccc--------------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-
Confidence            75432              1234567789999999876  78999999999999999999 688887765433332222 


Q ss_pred             cCCCCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          270 RDIRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       270 ~~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      .....|......+.++|.+||..+|.+||++
T Consensus       221 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~  251 (259)
T cd05037         221 DQHRLPMPDCAELANLINQCWTYDPTKRPSF  251 (259)
T ss_pred             cCCCCCCCCchHHHHHHHHHhccChhhCCCH
Confidence            2333344445899999999999999999998

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.2e-38  Score=310.46  Aligned_cols=249  Identities=21%  Similarity=0.353  Sum_probs=203.7

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEc----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc--
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKI----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD--  116 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~----~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--  116 (489)
                      ...+|++.+.||+|+||.||+|+..    .++..||+|++......  .....+.+|+.+++.++||||+++++++.+  
T Consensus         2 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~   79 (284)
T cd05038           2 EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPG   79 (284)
T ss_pred             chhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCC
Confidence            3468999999999999999999964    35889999999765332  345678889999999999999999999887  


Q ss_pred             CCEEEEEEeccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCcccc
Q 011287          117 TFSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (489)
Q Consensus       117 ~~~lylV~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~  195 (489)
                      ....|+||||+++++|.+++.... .+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||.+...
T Consensus        80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence            567999999999999999998754 5999999999999999999999999999999999999999999999999999876


Q ss_pred             CCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHH-------------
Q 011287          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL-------------  262 (489)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~-------------  262 (489)
                      .......       .......++..|+|||.+.+..++.++|+|||||++|+|++|..||.......             
T Consensus       160 ~~~~~~~-------~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd05038         160 PEDKDYY-------YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIV  232 (284)
T ss_pred             ccCCcce-------eccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccH
Confidence            4321110       01112234567999999988889999999999999999999999987643221             


Q ss_pred             -HHHHHHhcC--CCCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          263 -IFQRIIARD--IRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       263 -~~~~i~~~~--~~~p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                       ....++...  ...|..++.++.+|+.+||+.+|++||++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~  273 (284)
T cd05038         233 TRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSF  273 (284)
T ss_pred             HHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCH
Confidence             112222222  23355678999999999999999999998

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=8.1e-38  Score=305.82  Aligned_cols=244  Identities=29%  Similarity=0.523  Sum_probs=205.8

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcC-CCcEEEEEEeecccc-------cchhHHHHHHHHHHHHHh-CCCCCccEEEEEEEc
Q 011287           46 DFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFI-------TKENKTAYVKLERIVLDQ-LDHPGVVRLFFTFQD  116 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~-tg~~vAiK~~~k~~~-------~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~  116 (489)
                      +|++.+.||+|+||.||+|++.. +++.+|+|.+.....       ........+..|..++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            58899999999999999999987 789999998864321       223334455668887764 799999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeeccCCCCeeeCCCCCEEEeeccC
Q 011287          117 TFSLYMALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGS  191 (489)
Q Consensus       117 ~~~lylV~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~aL~~LH~-~gIiHrDLKpeNILl~~~g~ikL~DFG~  191 (489)
                      ....|+||||+++++|.+++..    ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            9999999999999999988743    3469999999999999999999996 7899999999999999999999999999


Q ss_pred             ccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC
Q 011287          192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD  271 (489)
Q Consensus       192 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~  271 (489)
                      +.......           ......|+..|+|||.+.+..++.++|+|||||++|+|++|.+||...+.......+....
T Consensus       161 ~~~~~~~~-----------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~  229 (269)
T cd08528         161 AKQKQPES-----------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV  229 (269)
T ss_pred             eeeccccc-----------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhcc
Confidence            87643321           2234578999999999998889999999999999999999999998887776666665544


Q ss_pred             CC-CC-CCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          272 IR-FP-NYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       272 ~~-~p-~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      .. .+ ..+++.+.++|.+||+.||++||++
T Consensus       230 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~  260 (269)
T cd08528         230 YEPLPEGMYSEDVTDVITSCLTPDAEARPDI  260 (269)
T ss_pred             CCcCCcccCCHHHHHHHHHHCCCCCccCCCH
Confidence            33 22 2578999999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=319.49  Aligned_cols=265  Identities=31%  Similarity=0.471  Sum_probs=221.2

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccc----hhHHHHHHHHHHHHHhCCCCCccEEEEEEE-cC
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK----ENKTAYVKLERIVLDQLDHPGVVRLFFTFQ-DT  117 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~  117 (489)
                      ..++|-++.+||+|+|+.||+|.+....+.||+|+-......+    ++......+|..+.+.|+||.||++|++|. |.
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt  540 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT  540 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence            3578999999999999999999999999999999865433332    344556678999999999999999999996 67


Q ss_pred             CEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeeccCCCCeeeCC---CCCEEEeeccCc
Q 011287          118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG--LIHRDIKPENLLLTA---DGHIKIADFGSV  192 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~g--IiHrDLKpeNILl~~---~g~ikL~DFG~a  192 (489)
                      +..+-|+|||+|.+|.-|++.+..++|.+++.|+.||+.||.||....  |||-||||.|||+-.   -|.+||+|||++
T Consensus       541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS  620 (775)
T KOG1151|consen  541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS  620 (775)
T ss_pred             ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence            788999999999999999999999999999999999999999999874  999999999999954   378999999999


Q ss_pred             cccCCccccccCCCCCCCCccceecCCcCCChhhhcC----CCCCCCCcchhhhHHHHHHhhCCCCCCCCCH-HHHH--H
Q 011287          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS----SPATFGNDLWALGCTLYQMLSGTSPFKDTSE-WLIF--Q  265 (489)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~----~~~~~~sDiwSLG~ilyelltG~~PF~~~~~-~~~~--~  265 (489)
                      ++++.......   ......+.+.||-+|++||.+.-    ...+.++||||+|||+|+.+.|+-||..... ..++  .
T Consensus       621 KIMdddSy~~v---dGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN  697 (775)
T KOG1151|consen  621 KIMDDDSYNSV---DGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN  697 (775)
T ss_pred             hhccCCccCcc---cceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh
Confidence            99987653322   12345667899999999998742    2368899999999999999999999975422 2222  2


Q ss_pred             HHHh-cCCCCCC--CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 011287          266 RIIA-RDIRFPN--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (489)
Q Consensus       266 ~i~~-~~~~~p~--~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~  315 (489)
                      .|++ .+..||.  .++.++++||++||+..-+.|...     .+|-+||||.
T Consensus       698 TIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV-----~qLA~dpyll  745 (775)
T KOG1151|consen  698 TILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDV-----QQLACDPYLL  745 (775)
T ss_pred             chhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhH-----HHHccCcccc
Confidence            3433 4566774  689999999999999999999876     8899999996

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2e-37  Score=303.60  Aligned_cols=239  Identities=17%  Similarity=0.287  Sum_probs=191.0

Q ss_pred             eEEeeeCceEEEEEEEcCC--CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEeccC
Q 011287           51 KIYGVGSYSKVVRAKKIDT--GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCE  128 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~~t--g~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~~~  128 (489)
                      +.||+|+||.||+|.....  ...+++|.+....  .......+.+|..+++.++||||+++++.+.+....|+||||++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE   78 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence            3689999999999976432  3456677665432  22345667889999999999999999999999999999999999


Q ss_pred             CCChHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccC
Q 011287          129 GGELFDQITSK----GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (489)
Q Consensus       129 gg~L~~~l~~~----~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~  204 (489)
                      +|+|.+++.+.    ..+++..++.++.||+.||.|||+.|++||||||+|||++.+++++|+|||++........    
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~----  154 (268)
T cd05086          79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY----  154 (268)
T ss_pred             CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchh----
Confidence            99999999764    3467788899999999999999999999999999999999999999999999764221110    


Q ss_pred             CCCCCCCccceecCCcCCChhhhcC-------CCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhcC-----
Q 011287          205 NAASDDKACTFVGTAAYVPPEVLNS-------SPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-----  271 (489)
Q Consensus       205 ~~~~~~~~~~~~gt~~Y~aPE~l~~-------~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~~-----  271 (489)
                          .......+|+..|+|||++..       ..++.++|||||||++|+|++ |..||...++.+.+..+....     
T Consensus       155 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  230 (268)
T cd05086         155 ----IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLF  230 (268)
T ss_pred             ----hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccC
Confidence                111224578899999999853       235778999999999999996 688998888777666654432     


Q ss_pred             -CCCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          272 -IRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       272 -~~~p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                       ..++..+++.+.++++.|+ .+|.+||++
T Consensus       231 ~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~  259 (268)
T cd05086         231 KPQLELPYSERWYEVLQFCW-LSPEKRATA  259 (268)
T ss_pred             CCccCCCCcHHHHHHHHHHh-hCcccCCCH
Confidence             2344567899999999999 689999999

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=5.9e-39  Score=292.15  Aligned_cols=250  Identities=26%  Similarity=0.489  Sum_probs=209.5

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccEEEEEEEcC--CE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDT--FS  119 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~--~~  119 (489)
                      ..++|++.+.+|+|.|++||.|.+..+++.++||+++      .-+...+.+|+.+|+.|. ||||++|+++..|.  ..
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK------PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt  109 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK------PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT  109 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeec------hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence            4678999999999999999999999999999999984      345567899999999995 99999999999875  44


Q ss_pred             EEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCC-CCEEEeeccCccccCCc
Q 011287          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDS  198 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~-g~ikL~DFG~a~~~~~~  198 (489)
                      ..+|+||+++.+...+..   .|+.-.+++|+.|++.||.|||+.||+|||+||.|++||.. ..++|+|+|+|..+.+.
T Consensus       110 paLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             chhHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            689999999977655543   58999999999999999999999999999999999999965 57999999999987654


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCC-CCCCHHHHHHHHHhc------
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPF-KDTSEWLIFQRIIAR------  270 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF-~~~~~~~~~~~i~~~------  270 (489)
                      .           ..+-.+.+..|-.||+|-+ ..|+..-|+|||||++..|+..+-|| .|.+.++++-+|.+.      
T Consensus       187 ~-----------eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el  255 (338)
T KOG0668|consen  187 K-----------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDEL  255 (338)
T ss_pred             c-----------eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHH
Confidence            3           3345678889999999865 45889999999999999999987776 666666666555330      


Q ss_pred             -------CCCCC------------------------CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          271 -------DIRFP------------------------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       271 -------~~~~p------------------------~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                             ...++                        ...++++.||+.++|..|-.+||||     .|.+.||||..+
T Consensus       256 ~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTa-----kEam~HpyF~~~  328 (338)
T KOG0668|consen  256 YAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTA-----KEAMAHPYFAPV  328 (338)
T ss_pred             HHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccch-----HHHhcCchHHHH
Confidence                   01111                        1247999999999999999999999     889999999754

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.5e-37  Score=333.99  Aligned_cols=259  Identities=21%  Similarity=0.292  Sum_probs=185.3

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCC----CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEE--
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDT----GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT--  113 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~t----g~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~--  113 (489)
                      ..+..++|++.+.||+|+||.||+|++..+    +..||+|.+.....     .+....+  .++...+.++..+...  
T Consensus       127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~~~~~~~~~~~~~  199 (566)
T PLN03225        127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRACPNSCADFVYGFL  199 (566)
T ss_pred             CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhhchhhHHHHHHhhh
Confidence            456789999999999999999999999988    99999998754311     1111111  1122222222222211  


Q ss_pred             ----EEcCCEEEEEEeccCCCChHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCcEee
Q 011287          114 ----FQDTFSLYMALESCEGGELFDQITSKGH--------------------LSEDEARFYTAEVVDALEYIHSMGLIHR  169 (489)
Q Consensus       114 ----~~~~~~lylV~E~~~gg~L~~~l~~~~~--------------------l~e~~~~~i~~qil~aL~~LH~~gIiHr  169 (489)
                          ......+++||||+.+++|.+++.....                    ..+..+..++.||+.||.|||++||+||
T Consensus       200 ~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHR  279 (566)
T PLN03225        200 EPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHR  279 (566)
T ss_pred             cccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence                2455679999999999999998875421                    1234567899999999999999999999


Q ss_pred             ccCCCCeeeCC-CCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCC-----------------
Q 011287          170 DIKPENLLLTA-DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP-----------------  231 (489)
Q Consensus       170 DLKpeNILl~~-~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~-----------------  231 (489)
                      ||||+|||++. ++.+||+|||+|+.+....         ......++||+.|+|||.+....                 
T Consensus       280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~---------~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~  350 (566)
T PLN03225        280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGI---------NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPV  350 (566)
T ss_pred             cCCHHHEEEeCCCCcEEEEeCCCcccccccc---------ccCCcccccCCCccChHHhhccCCCCCCccccccccccch
Confidence            99999999986 5899999999998653321         12234678999999999764322                 


Q ss_pred             -----CCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHh-cCC---------------------CCCCCCCHHHHH
Q 011287          232 -----ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA-RDI---------------------RFPNYFSDAARD  284 (489)
Q Consensus       232 -----~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~-~~~---------------------~~p~~~~~~~~~  284 (489)
                           ++.++||||||||+|+|+++..|+.  +....+.+++. ...                     ...+..+..+.+
T Consensus       351 l~~~~~~~k~DVwSlGviL~el~~~~~~~~--~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~d  428 (566)
T PLN03225        351 LWQLNLPDRFDIYSAGLIFLQMAFPNLRSD--SNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWE  428 (566)
T ss_pred             hccccCCCCcccHHHHHHHHHHHhCcCCCc--hHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHH
Confidence                 3345699999999999999766543  33333322221 111                     111122345669


Q ss_pred             HHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCccc
Q 011287          285 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  321 (489)
Q Consensus       285 Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~  321 (489)
                      ||.+||+.||++|||+     .++++||||.+.++..
T Consensus       429 Li~~mL~~dP~kR~ta-----~e~L~Hpff~~~~~~~  460 (566)
T PLN03225        429 LLKSMMRFKGRQRISA-----KAALAHPYFDREGLLG  460 (566)
T ss_pred             HHHHHccCCcccCCCH-----HHHhCCcCcCCCCccc
Confidence            9999999999999999     8999999999887754

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-38  Score=323.17  Aligned_cols=245  Identities=22%  Similarity=0.367  Sum_probs=206.7

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lyl  122 (489)
                      ..+++.++..||+|+||+||+|++-   -.||||+++......+ ..+.+++|+.++++-+|.||+=+.+++..... .+
T Consensus       390 p~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI  464 (678)
T KOG0193|consen  390 PPEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI  464 (678)
T ss_pred             CHHHhhccceeccccccceeecccc---cceEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence            3456789999999999999999983   4799999988876666 77889999999999999999999999988766 99


Q ss_pred             EEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccc
Q 011287          123 ALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~  201 (489)
                      |+-+|+|-+|+.++.-. .+|....++.|+.||+.|+.|||.++|||||||..|||+.+++.|||+|||++..-..-   
T Consensus       465 iTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w---  541 (678)
T KOG0193|consen  465 ITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW---  541 (678)
T ss_pred             eehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeee---
Confidence            99999999999988643 56999999999999999999999999999999999999999999999999998753221   


Q ss_pred             ccCCCCCCCCccceecCCcCCChhhhc---CCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCC-----
Q 011287          202 VLPNAASDDKACTFVGTAAYVPPEVLN---SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR-----  273 (489)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~---~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~-----  273 (489)
                           ..........|...|||||+++   ..+|+..+|||||||++|||+||.+||...+...++-.+-.+...     
T Consensus       542 -----~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~  616 (678)
T KOG0193|consen  542 -----SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSK  616 (678)
T ss_pred             -----ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchh
Confidence                 1122233446788999999985   456899999999999999999999999977766655444444221     


Q ss_pred             CCCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          274 FPNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       274 ~p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      .-...+.++++|+..|+..++++||..
T Consensus       617 ~~s~~pk~mk~Ll~~C~~~~~~eRP~F  643 (678)
T KOG0193|consen  617 IRSNCPKAMKRLLSDCWKFDREERPLF  643 (678)
T ss_pred             hhccCHHHHHHHHHHHHhcCcccCccH
Confidence            123467899999999999999999987

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=7.6e-39  Score=319.85  Aligned_cols=252  Identities=27%  Similarity=0.479  Sum_probs=213.4

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC------CCCccEEEEEEEc
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD------HPGVVRLFFTFQD  116 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~------hpnIv~l~~~~~~  116 (489)
                      .-.+|.+....|+|-||+|..|.+..-|..||||++....+..    ..=..|+.+|++|+      --++++|+..|..
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~----KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h  505 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH----KTGLKELEILKKLNDADPEDKFHCLRLFRHFKH  505 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh----hhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence            3457999999999999999999999999999999998754332    23345899999994      3578999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCC-CCEEEeeccCc
Q 011287          117 TFSLYMALESCEGGELFDQITSKGH---LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSV  192 (489)
Q Consensus       117 ~~~lylV~E~~~gg~L~~~l~~~~~---l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~-g~ikL~DFG~a  192 (489)
                      .+++|+|+|-+. .+|.+++++.|.   |....++.|+.|+..||..|-.+||+|.||||.||||++. ..+||||||.|
T Consensus       506 knHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA  584 (752)
T KOG0670|consen  506 KNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSA  584 (752)
T ss_pred             cceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccc
Confidence            999999999985 499999998764   8999999999999999999999999999999999999976 46899999999


Q ss_pred             cccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC
Q 011287          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI  272 (489)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~  272 (489)
                      .....+.+            ..+.-+..|.|||++.+.+|+...|+||+||+||||+||+..|.|.+...++.-.+...-
T Consensus       585 ~~~~enei------------tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KG  652 (752)
T KOG0670|consen  585 SFASENEI------------TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKG  652 (752)
T ss_pred             cccccccc------------cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcC
Confidence            86654332            234556789999999999999999999999999999999999999988887765554333


Q ss_pred             CCCCC-----------------------------------------------------C-------CHHHHHHHHHhhcc
Q 011287          273 RFPNY-----------------------------------------------------F-------SDAARDLIDRLLDV  292 (489)
Q Consensus       273 ~~p~~-----------------------------------------------------~-------~~~~~~Li~~~L~~  292 (489)
                      .||..                                                     +       -..+++|+.+||.+
T Consensus       653 k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~L  732 (752)
T KOG0670|consen  653 KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLIL  732 (752)
T ss_pred             CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhcc
Confidence            33311                                                     1       23589999999999


Q ss_pred             CCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          293 DPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       293 dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      ||++|++.     .++|.||||.+
T Consensus       733 dP~KRit~-----nqAL~HpFi~~  751 (752)
T KOG0670|consen  733 DPEKRITV-----NQALKHPFITE  751 (752)
T ss_pred             ChhhcCCH-----HHHhcCCcccC
Confidence            99999998     88999999974

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-38  Score=327.33  Aligned_cols=242  Identities=30%  Similarity=0.497  Sum_probs=197.5

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC------
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF------  118 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~------  118 (489)
                      .-+..-+.||+|+||.||++++++||+.||||.+.+....  ...+...+|+++|++|+|||||+++++-++..      
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~--r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~   90 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSL--RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR   90 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhccc--chHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence            4567788999999999999999999999999999876422  23455667999999999999999998776543      


Q ss_pred             EEEEEEeccCCCChHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCC--CC--CEEEeeccC
Q 011287          119 SLYMALESCEGGELFDQITSK---GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA--DG--HIKIADFGS  191 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~---~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~--~g--~ikL~DFG~  191 (489)
                      .-.+|||||.||||+..+++-   ..|++.+...++..++.||.|||++||+||||||.||++-.  +|  ..||+|||+
T Consensus        91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            357999999999999999763   45999999999999999999999999999999999999843  34  479999999


Q ss_pred             ccccCCccccccCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCC----CHHHHHHH
Q 011287          192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDT----SEWLIFQR  266 (489)
Q Consensus       192 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~----~~~~~~~~  266 (489)
                      |+.+.+.           ....+++||..|++||++.. +.|+..+|+|||||++|++.||..||...    +.+++...
T Consensus       171 Arel~d~-----------s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~  239 (732)
T KOG4250|consen  171 ARELDDN-----------SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWH  239 (732)
T ss_pred             cccCCCC-----------CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhh
Confidence            9987543           35568999999999999985 88999999999999999999999999542    22334333


Q ss_pred             HHh---------------------cCCCCCCCCCHHH----HHHHHHhhccCCCCCCC
Q 011287          267 IIA---------------------RDIRFPNYFSDAA----RDLIDRLLDVDPSGRPG  299 (489)
Q Consensus       267 i~~---------------------~~~~~p~~~~~~~----~~Li~~~L~~dP~~R~t  299 (489)
                      +..                     ..+++|..+++.+    -..+..+|..+|++|.+
T Consensus       240 ~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~  297 (732)
T KOG4250|consen  240 IITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGH  297 (732)
T ss_pred             hhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCC
Confidence            332                     1234455555554    45677788899999984

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-37  Score=312.72  Aligned_cols=244  Identities=26%  Similarity=0.374  Sum_probs=195.4

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-EEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-SLYMA  123 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-~lylV  123 (489)
                      ++|.-...||+|+||.||+|.... |..||||.+.......   ...+.+|+.++.+++|||+|+|++++.+.. ..++|
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LV  150 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLV  150 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEE
Confidence            678888999999999999999855 4999999876543221   334888999999999999999999999988 59999


Q ss_pred             EeccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          124 LESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMG---LIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~aL~~LH~~g---IiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      +||+++|+|.+++....  .+++.....||.+++.||+|||...   ||||||||+|||+|++...||+|||+|+.....
T Consensus       151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~  230 (361)
T KOG1187|consen  151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG  230 (361)
T ss_pred             EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc
Confidence            99999999999998764  8999999999999999999999854   999999999999999999999999999654320


Q ss_pred             cccccCCCCCCCCccce-ecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCC---H---HHHHHHHH-hc
Q 011287          199 RITVLPNAASDDKACTF-VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS---E---WLIFQRII-AR  270 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~-~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~---~---~~~~~~i~-~~  270 (489)
                                .....+. .||..|++||.+..+..+.++||||||+++.||++|+.|.....   +   .+...... ..
T Consensus       231 ----------~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~  300 (361)
T KOG1187|consen  231 ----------DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG  300 (361)
T ss_pred             ----------ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc
Confidence                      1111122 79999999999999999999999999999999999998886432   1   11111111 11


Q ss_pred             ------CCCCC-CCCC--HH---HHHHHHHhhccCCCCCCCCCC
Q 011287          271 ------DIRFP-NYFS--DA---ARDLIDRLLDVDPSGRPGAGP  302 (489)
Q Consensus       271 ------~~~~p-~~~~--~~---~~~Li~~~L~~dP~~R~t~~~  302 (489)
                            +..+. ...+  ..   +..+..+|++.+|.+||++.+
T Consensus       301 ~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~  344 (361)
T KOG1187|consen  301 KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQ  344 (361)
T ss_pred             chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHH
Confidence                  12222 2233  22   557788999999999999843

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-37  Score=323.43  Aligned_cols=254  Identities=30%  Similarity=0.538  Sum_probs=223.3

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEE-----cC
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQ-----DT  117 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~-----~~  117 (489)
                      -+-|+|..+||.|.||.||+++++.+++..|+|++.-.    +...+.++.|.++|+.+ +|||++..|++|.     ..
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~----~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~   93 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT----EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG   93 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC----ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence            46799999999999999999999999999999998654    33445677788999887 6999999999885     35


Q ss_pred             CEEEEEEeccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCcccc
Q 011287          118 FSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~  195 (489)
                      +.+|||||||.||+.-+++++.  .++.|..+..|+.+++.||.|||.+.++|||||-.|||++.+|.|||+|||.+..+
T Consensus        94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl  173 (953)
T KOG0587|consen   94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  173 (953)
T ss_pred             CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence            6899999999999999998764  57999999999999999999999999999999999999999999999999998765


Q ss_pred             CCccccccCCCCCCCCccceecCCcCCChhhhcC-----CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc
Q 011287          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR  270 (489)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-----~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~  270 (489)
                      ..          ...+.++++||+.|||||++.-     ..|+..+|+||||++..||..|.+|+-...+...+-.|...
T Consensus       174 ds----------T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRN  243 (953)
T KOG0587|consen  174 DS----------TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN  243 (953)
T ss_pred             ec----------ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCC
Confidence            43          2467789999999999999853     34788899999999999999999999999888777676654


Q ss_pred             CC---CCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          271 DI---RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       271 ~~---~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      .+   .-|..++.++.++|..||.+|-.+||+.     .+++.|||...
T Consensus       244 PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~-----~~ll~hpFi~e  287 (953)
T KOG0587|consen  244 PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPST-----EELLKHPFITE  287 (953)
T ss_pred             CCccccchhhHHHHHHHHHHHHHhhccccCcch-----hhhccCCcccc
Confidence            33   2367799999999999999999999998     78999999973

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.4e-37  Score=327.36  Aligned_cols=252  Identities=23%  Similarity=0.389  Sum_probs=218.9

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEc-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEE
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTF  114 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~-----~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  114 (489)
                      ..+...+-++.+.||+|+||+||+|+-.     .....||||.++..  ...+....+++|+.++..++|||||+|++++
T Consensus       481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~--a~~~~~~dF~REaeLla~l~H~nIVrLlGVC  558 (774)
T KOG1026|consen  481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK--AENQARQDFRREAELLAELQHPNIVRLLGVC  558 (774)
T ss_pred             eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc--ccHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence            3456678899999999999999999863     23578999999754  2344678899999999999999999999999


Q ss_pred             EcCCEEEEEEeccCCCChHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCC
Q 011287          115 QDTFSLYMALESCEGGELFDQITSKG--------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA  180 (489)
Q Consensus       115 ~~~~~lylV~E~~~gg~L~~~l~~~~--------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~  180 (489)
                      ...+.+|+|+|||..|||.++|...+              +++..+...+|.||+.|++||-++.+|||||-..|.||.+
T Consensus       559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge  638 (774)
T KOG1026|consen  559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGE  638 (774)
T ss_pred             ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceecc
Confidence            99999999999999999999997542              2788899999999999999999999999999999999999


Q ss_pred             CCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCC
Q 011287          181 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS  259 (489)
Q Consensus       181 ~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~  259 (489)
                      +..|||+|||+++..-..+++.       .. ..-.-...|||||.+..+.++.+|||||+||+|+|+++ |+.||.+.+
T Consensus       639 ~l~VKIsDfGLsRdiYssDYYk-------~~-~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS  710 (774)
T KOG1026|consen  639 NLVVKISDFGLSRDIYSSDYYK-------VR-GNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS  710 (774)
T ss_pred             ceEEEecccccchhhhhhhhhc-------cc-CCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc
Confidence            9999999999998643322211       01 01123467999999999999999999999999999998 999999999


Q ss_pred             HHHHHHHHHhcC-CCCCCCCCHHHHHHHHHhhccCCCCCCCCC
Q 011287          260 EWLIFQRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGAG  301 (489)
Q Consensus       260 ~~~~~~~i~~~~-~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~  301 (489)
                      ..+.++.|.++. ++.|+..|.++.+|+..|++.+|.+||+..
T Consensus       711 n~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~  753 (774)
T KOG1026|consen  711 NQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFK  753 (774)
T ss_pred             hHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHH
Confidence            999999998876 467899999999999999999999999983

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-37  Score=295.08  Aligned_cols=253  Identities=26%  Similarity=0.447  Sum_probs=215.4

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC------
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT------  117 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------  117 (489)
                      ..+|.-++.+|.|.- .|..|-+.-+++.||+|.+...+.. ........+|..++..++|+||++++.+|.-.      
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n-~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~   93 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN-QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF   93 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc-CccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence            468999999999999 8999999999999999998776433 33345567899999999999999999999643      


Q ss_pred             CEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCC
Q 011287          118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~  197 (489)
                      ..+|+|||++.. +|...+..  .++-..+.++++|++.|+.|||+.||+||||||+||++..++.+||.|||+|+.-..
T Consensus        94 ~e~y~v~e~m~~-nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~  170 (369)
T KOG0665|consen   94 QEVYLVMELMDA-NLCQVILM--ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT  170 (369)
T ss_pred             HhHHHHHHhhhh-HHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCc
Confidence            458999999975 99888884  489999999999999999999999999999999999999999999999999985322


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc-------
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-------  270 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~-------  270 (489)
                                 .-....++.|..|+|||++.+..+...+||||+|||+.||++|...|.|.+...++.++...       
T Consensus       171 -----------~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~  239 (369)
T KOG0665|consen  171 -----------DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPS  239 (369)
T ss_pred             -----------ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHH
Confidence                       12455789999999999999999999999999999999999999999998887777666541       


Q ss_pred             --------------------CCC----CCCC-----------CCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 011287          271 --------------------DIR----FPNY-----------FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (489)
Q Consensus       271 --------------------~~~----~p~~-----------~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~  315 (489)
                                          ...    ||+.           -+..++||+.+||..||++|.++     ++++.||||+
T Consensus       240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv-----~daL~HPY~~  314 (369)
T KOG0665|consen  240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISV-----DDALRHPYIK  314 (369)
T ss_pred             HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccH-----HHHhcCCeee
Confidence                                011    2221           24568999999999999999998     8899999998


Q ss_pred             CCCc
Q 011287          316 GIDW  319 (489)
Q Consensus       316 ~i~~  319 (489)
                        -|
T Consensus       315 --vw  316 (369)
T KOG0665|consen  315 --VW  316 (369)
T ss_pred             --ee
Confidence              46

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=6.3e-36  Score=285.22  Aligned_cols=240  Identities=43%  Similarity=0.755  Sum_probs=209.1

Q ss_pred             CceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEeccCCCChHHHH
Q 011287           57 SYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI  136 (489)
Q Consensus        57 ~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~~~gg~L~~~l  136 (489)
                      +||.||+|.+..+|+.+|+|++........  ...+.+|+..+++++|+||+++++.+......++++||+.+++|.+++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~   78 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL   78 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence            689999999999999999999976533221  567888999999999999999999999989999999999999999999


Q ss_pred             HhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCCCCcccee
Q 011287          137 TSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV  216 (489)
Q Consensus       137 ~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~  216 (489)
                      .....++...+..++.+++.+|.+||+.|++|+||+|.||+++.++.++|+|||.+.......           ......
T Consensus        79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-----------~~~~~~  147 (244)
T smart00220       79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-----------LLTTFV  147 (244)
T ss_pred             HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-----------cccccc
Confidence            887669999999999999999999999999999999999999999999999999988654321           223456


Q ss_pred             cCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCC-CCHHHHHHHHHhcCCCCCCC---CCHHHHHHHHHhhcc
Q 011287          217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIARDIRFPNY---FSDAARDLIDRLLDV  292 (489)
Q Consensus       217 gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~-~~~~~~~~~i~~~~~~~p~~---~~~~~~~Li~~~L~~  292 (489)
                      ++..|+|||.+.+..++.++|+||||+++|+|++|..||.. .+.....+.+.......+..   ++.++.+++.+||..
T Consensus       148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  227 (244)
T smart00220      148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVK  227 (244)
T ss_pred             CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccC
Confidence            88899999999988889999999999999999999999988 55555555555555444433   889999999999999


Q ss_pred             CCCCCCCCCCCCHHHHhcCCCC
Q 011287          293 DPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       293 dP~~R~t~~~~~~~~l~~hpff  314 (489)
                      ||++||++     .++++||||
T Consensus       228 ~p~~Rp~~-----~~~~~~~~~  244 (244)
T smart00220      228 DPEKRLTA-----EEALQHPFF  244 (244)
T ss_pred             CchhccCH-----HHHhhCCCC
Confidence            99999998     899999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-36  Score=330.07  Aligned_cols=254  Identities=23%  Similarity=0.421  Sum_probs=218.6

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCc-----EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGT-----VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  116 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~-----~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  116 (489)
                      +....-.+++.||+|.||.||.|.......     .||||.+.+.  ..++....+.+|..+|+.++|||||+++++.-+
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~  766 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD  766 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence            456788999999999999999999865332     3888887653  456777888899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeec
Q 011287          117 TFSLYMALESCEGGELFDQITSK-------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADF  189 (489)
Q Consensus       117 ~~~lylV~E~~~gg~L~~~l~~~-------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DF  189 (489)
                      ....++++|||+||||..+|++.       ..++..+...++.+|+.|+.||+++++|||||...|+||+....+||+||
T Consensus       767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence            99999999999999999999876       24899999999999999999999999999999999999999999999999


Q ss_pred             cCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHH-H
Q 011287          190 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQR-I  267 (489)
Q Consensus       190 G~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~-i  267 (489)
                      |+|+.+-...++....        .-.-...|||||.+.+..++.++|||||||++||+++ |..||.+.+..+++.- .
T Consensus       847 GlArDiy~~~yyr~~~--------~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~  918 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHG--------EAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVL  918 (1025)
T ss_pred             chhHhhhhchheeccC--------ccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHH
Confidence            9999543333221111        0112347999999999999999999999999999999 9999999999888774 4


Q ss_pred             HhcCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          268 IARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       268 ~~~~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      ..+.+..|..+|..+.+|+..|+..+|++||+.     ..|++
T Consensus       919 ~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F-----~~i~~  956 (1025)
T KOG1095|consen  919 EGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSF-----RTIVE  956 (1025)
T ss_pred             hCCccCCCCCCChHHHHHHHHHccCChhhCccH-----HHHHh
Confidence            456788899999999999999999999999987     55654

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3e-35  Score=309.60  Aligned_cols=263  Identities=22%  Similarity=0.280  Sum_probs=191.5

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEc----------------CCCcEEEEEEeecccccc-----------hhHHHHH
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKI----------------DTGTVYALKIMDKKFITK-----------ENKTAYV   92 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~----------------~tg~~vAiK~~~k~~~~~-----------~~~~~~~   92 (489)
                      .+++.++|++.++||+|+||.||+|...                ..++.||||.+.......           ....+..
T Consensus       140 ~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~  219 (507)
T PLN03224        140 SRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETG  219 (507)
T ss_pred             CCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchh
Confidence            4578899999999999999999999752                345689999985431110           0011223


Q ss_pred             HHHHHHHHhCCCCCc-----cEEEEEEEc--------CCEEEEEEeccCCCChHHHHHhC--------------------
Q 011287           93 KLERIVLDQLDHPGV-----VRLFFTFQD--------TFSLYMALESCEGGELFDQITSK--------------------  139 (489)
Q Consensus        93 ~~E~~il~~l~hpnI-----v~l~~~~~~--------~~~lylV~E~~~gg~L~~~l~~~--------------------  139 (489)
                      ..|..++.+++|.++     ++++++|..        ....|+||||+++++|.+++...                    
T Consensus       220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~  299 (507)
T PLN03224        220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD  299 (507)
T ss_pred             HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence            346667777766554     556565542        35689999999999999988642                    


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCCCCccce
Q 011287          140 ----GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF  215 (489)
Q Consensus       140 ----~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~  215 (489)
                          ..+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++..+....         .......
T Consensus       300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~---------~~~~~~g  370 (507)
T PLN03224        300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI---------NFNPLYG  370 (507)
T ss_pred             hcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC---------ccCcccc
Confidence                123567888999999999999999999999999999999999999999999987543211         0111122


Q ss_pred             ecCCcCCChhhhcCCC--------------------C--CCCCcchhhhHHHHHHhhCCC-CCCCCCH-----------H
Q 011287          216 VGTAAYVPPEVLNSSP--------------------A--TFGNDLWALGCTLYQMLSGTS-PFKDTSE-----------W  261 (489)
Q Consensus       216 ~gt~~Y~aPE~l~~~~--------------------~--~~~sDiwSLG~ilyelltG~~-PF~~~~~-----------~  261 (489)
                      .+|+.|+|||++....                    +  ....|+||+|||+|+|++|.+ ||.+...           .
T Consensus       371 ~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~  450 (507)
T PLN03224        371 MLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDL  450 (507)
T ss_pred             CCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchH
Confidence            3578999999985432                    1  124699999999999999986 7754211           1


Q ss_pred             HHHHHHHhcCCCCC--CCCCHHHHHHHHHhhccCC---CCCCCCCCCCHHHHhcCCCCCC
Q 011287          262 LIFQRIIARDIRFP--NYFSDAARDLIDRLLDVDP---SGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       262 ~~~~~i~~~~~~~p--~~~~~~~~~Li~~~L~~dP---~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      ..+..+....+.++  +..++.++||+.+||..+|   .+|+|+     +++++||||..
T Consensus       451 ~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa-----~eaL~Hp~f~~  505 (507)
T PLN03224        451 NRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSV-----GQALSHRFFLP  505 (507)
T ss_pred             HHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCH-----HHHhCCCCcCC
Confidence            12222333344444  5678999999999999866   689999     89999999963

>PF14593 PH_3: PH domain; PDB: 1W1H_D 1W1D_A 1W1G_A 2VKI_A

Probab=100.00  E-value=2.7e-36  Score=247.84  Aligned_cols=100  Identities=49%  Similarity=0.814  Sum_probs=88.8

Q ss_pred             cccccccCCCceEEEEEeeehhhhhhccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEEcCCCcEEEEcCCc
Q 011287          386 SKWQQFLDPGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKK  465 (489)
Q Consensus       386 ~~~~~~~~~~~~i~~~g~~~k~~g~~~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~~~~~f~i~~p~r  465 (489)
                      |+||+|+++||+|+++|.|.|++|+|+|+|||||||+|||+|+||.+|++||||||++.   ++++.+++++|+|+||+|
T Consensus         1 ~~w~~fl~~ge~Il~~g~v~K~kgl~~kkR~liLTd~PrL~Yvdp~~~~~KGeI~~~~~---l~v~~k~~~~F~I~tp~R   77 (104)
T PF14593_consen    1 NKWHRFLNPGELILKQGYVKKRKGLFAKKRQLILTDGPRLFYVDPKKMVLKGEIPWSKE---LSVEVKSFKTFFIHTPKR   77 (104)
T ss_dssp             -TTGGGTT-T--EEEEEEEEEEETTEEEEEEEEEETTTEEEEEETTTTEEEEEE--STT----EEEECSSSEEEEEETTE
T ss_pred             CchHHhhcCCCeEEEEEEEEEeeceEEEEEEEEEccCCEEEEEECCCCeECcEEecCCc---eEEEEccCCEEEEECCCc
Confidence            57999999999999999999999999999999999999999999999999999999987   999999999999999999


Q ss_pred             eEEEEcCCccHHHHHHHHHHhcC
Q 011287          466 VLSFEDAKQRASQWKKAIEALQN  488 (489)
Q Consensus       466 ~y~~~d~~~~~~~W~~~i~~~~~  488 (489)
                      ||+|+|++++|.+||++|+++++
T Consensus        78 tY~l~d~~~~A~~W~~~I~~~~~  100 (104)
T PF14593_consen   78 TYYLEDPEGNAQQWVEAIEEVKK  100 (104)
T ss_dssp             EEEEE-TTS-HHHHHHHHHHHHH
T ss_pred             EEEEECCCCCHHHHHHHHHHHHH
Confidence            99999999999999999999863

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-37  Score=287.67  Aligned_cols=258  Identities=25%  Similarity=0.432  Sum_probs=210.3

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHH-HHhCCCCCccEEEEEEEcCC
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV-LDQLDHPGVVRLFFTFQDTF  118 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~i-l~~l~hpnIv~l~~~~~~~~  118 (489)
                      -.++.++.+-+..||.|+||+|++..++.+|+..|||.+....+  +..+..+..|.++ ++.-+.||||++|+....++
T Consensus        59 ~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG  136 (361)
T KOG1006|consen   59 HTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG  136 (361)
T ss_pred             cccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC
Confidence            45666777888999999999999999999999999999987655  3444556667775 45557999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeeccCCCCeeeCCCCCEEEeeccCc
Q 011287          119 SLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSV  192 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~-----~~~~l~e~~~~~i~~qil~aL~~LH~-~gIiHrDLKpeNILl~~~g~ikL~DFG~a  192 (489)
                      ..|+.||.|.- +|..+.+     +...++|+.+-.+....+.||+||-. .+|||||+||+|||++..|.+||||||.+
T Consensus       137 dcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIc  215 (361)
T KOG1006|consen  137 DCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGIC  215 (361)
T ss_pred             ceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccch
Confidence            99999999964 6654332     23569999999999999999999975 58999999999999999999999999998


Q ss_pred             cccCCccccccCCCCCCCCccceecCCcCCChhhhc--CCCCCCCCcchhhhHHHHHHhhCCCCCCCCCH-HHHHHHHHh
Q 011287          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN--SSPATFGNDLWALGCTLYQMLSGTSPFKDTSE-WLIFQRIIA  269 (489)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~--~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~-~~~~~~i~~  269 (489)
                      ..+.++--           ...-.|...|||||.+.  +..|+-++|+||||++|||+.||..|+++-+. .+++..+..
T Consensus       216 GqLv~SiA-----------kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~  284 (361)
T KOG1006|consen  216 GQLVDSIA-----------KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI  284 (361)
T ss_pred             HhHHHHHH-----------hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc
Confidence            76544321           11226888999999995  34589999999999999999999999998655 334444445


Q ss_pred             cCCC---CCCC---CCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          270 RDIR---FPNY---FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       270 ~~~~---~p~~---~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      ++++   ++..   ++..++.+|.-||.+|-+.||..     .+|+++||++-
T Consensus       285 gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky-----~~Lk~~~fyr~  332 (361)
T KOG1006|consen  285 GDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKY-----DDLKKFPFYRM  332 (361)
T ss_pred             CCCCeecCcccccccCHHHHHHHHHHhhcccccCcch-----hhhhcCchhhh
Confidence            5433   2332   78999999999999999999976     88999999974

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1e-36  Score=319.99  Aligned_cols=245  Identities=33%  Similarity=0.540  Sum_probs=203.4

Q ss_pred             eEEeeEEeeeCceE-EEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCEEEEEE
Q 011287           47 FELGKIYGVGSYSK-VVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        47 y~~~~~LG~G~~g~-Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      |.--+++|.|+-|+ ||+|..  .|++||||.+-      ........+|+..|+.. .|||||++|+.-++...+|+..
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll------~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal  582 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLL------EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL  582 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHh------hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence            44456779999985 899988  58999999873      34556788899999988 6999999999999999999999


Q ss_pred             eccCCCChHHHHHhCCC----CCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCC---CC--CEEEeeccCcccc
Q 011287          125 ESCEGGELFDQITSKGH----LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA---DG--HIKIADFGSVKPM  195 (489)
Q Consensus       125 E~~~gg~L~~~l~~~~~----l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~---~g--~ikL~DFG~a~~~  195 (489)
                      |.|.. +|.+++...+.    ......+....|++.||+|||+.+||||||||.||||+.   +|  .++|+|||+++.+
T Consensus       583 ELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  583 ELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             hHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            99976 99999987421    112456888999999999999999999999999999986   34  6899999999988


Q ss_pred             CCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhC-CCCCCCCCHHHHHHHHHhcCCCC
Q 011287          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSG-TSPFKDTSEWLIFQRIIARDIRF  274 (489)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG-~~PF~~~~~~~~~~~i~~~~~~~  274 (489)
                      .....       +-.+..+..||.+|+|||+|....-+.++||+||||++|+.++| ..||...-+  .-.+|+.+.+.+
T Consensus       662 ~~~~s-------S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~~~~~L  732 (903)
T KOG1027|consen  662 AGGKS-------SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILTGNYTL  732 (903)
T ss_pred             CCCcc-------hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH--hhhhhhcCccce
Confidence            76542       22345677899999999999998888899999999999999986 999977543  334677776654


Q ss_pred             CC---CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          275 PN---YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       275 p~---~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                      -.   .-..++.|||.+||.+||..||+|     .+++.||||
T Consensus       733 ~~L~~~~d~eA~dLI~~ml~~dP~~RPsa-----~~VL~HPlF  770 (903)
T KOG1027|consen  733 VHLEPLPDCEAKDLISRMLNPDPQLRPSA-----TDVLNHPLF  770 (903)
T ss_pred             eeeccCchHHHHHHHHHhcCCCcccCCCH-----HHHhCCCcc
Confidence            32   112289999999999999999999     889999999

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-37  Score=286.24  Aligned_cols=260  Identities=27%  Similarity=0.394  Sum_probs=216.9

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-----
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-----  118 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----  118 (489)
                      ..|.+-.+.||-|+||.||.+++..+|+.||+|.+..-+ ..-.....+.+|..+|...+|.|++..++..+...     
T Consensus        52 q~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFq  130 (449)
T KOG0664|consen   52 QQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQ  130 (449)
T ss_pred             cccCCCCCcccccceeEEEeccCCCCccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHH
Confidence            467788899999999999999999999999999886542 22334566788999999999999999988877543     


Q ss_pred             EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      .+|+++|.+.. +|...|.....++.+.++.+.+||+.||.|||+.||.||||||.|+|++.|..+||||||+|+..+..
T Consensus       131 EiYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d  209 (449)
T KOG0664|consen  131 ELYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR  209 (449)
T ss_pred             HHHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchh
Confidence            37889999964 89998888788999999999999999999999999999999999999999999999999999975432


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHh--------
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA--------  269 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~--------  269 (489)
                      .         ......-+-|-.|+|||++.+. .|+.+.||||+|||+.||+..+..|...++.+.++.|..        
T Consensus       210 ~---------~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~E  280 (449)
T KOG0664|consen  210 D---------RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQE  280 (449)
T ss_pred             h---------hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHH
Confidence            2         1122234678899999999875 499999999999999999999999999999888877754        


Q ss_pred             ---------------cC---CCC--------CCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 011287          270 ---------------RD---IRF--------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (489)
Q Consensus       270 ---------------~~---~~~--------p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~  319 (489)
                                     ..   +.+        |..-..++.+++.++|.+||++|.+.     ++.+.|+|......
T Consensus       281 aMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~-----~~A~~~~~~~e~R~  351 (449)
T KOG0664|consen  281 AMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISV-----EEALQHRYLEEGRL  351 (449)
T ss_pred             HHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccH-----hhhcccccccccce
Confidence                           11   111        22345778999999999999999987     78899999875443

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-35  Score=290.30  Aligned_cols=134  Identities=28%  Similarity=0.382  Sum_probs=115.3

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-----C---CCccEEEE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-----H---PGVVRLFF  112 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~-----h---pnIv~l~~  112 (489)
                      .+.-.+|.+.++||.|-|++||+|.|..+.+.||+|+.+..    +...+....|+.+|+++.     |   ..||+|++
T Consensus        74 ~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD  149 (590)
T KOG1290|consen   74 VFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLD  149 (590)
T ss_pred             cccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeec
Confidence            45557899999999999999999999999999999998654    334455666999998872     3   46999999


Q ss_pred             EEEc----CCEEEEEEeccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHh-CCcEeeccCCCCeeeC
Q 011287          113 TFQD----TFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLT  179 (489)
Q Consensus       113 ~~~~----~~~lylV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~-~gIiHrDLKpeNILl~  179 (489)
                      .|..    ..+++||+|++ |.+|+.+|.+.  ..++...++.|++||+.||.|||. +||||-||||||||+.
T Consensus       150 ~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  150 HFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             cceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence            9974    56899999999 66999999875  459999999999999999999996 5999999999999993

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=300.66  Aligned_cols=218  Identities=30%  Similarity=0.469  Sum_probs=191.9

Q ss_pred             cCCccccccCCCCCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccc-----hhHHHHHHHHHHHHHhC
Q 011287           28 QRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-----ENKTAYVKLERIVLDQL  102 (489)
Q Consensus        28 ~~~~s~~~~~~~~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~-----~~~~~~~~~E~~il~~l  102 (489)
                      ..+.....+.+.+.....+|..++.+|+|+||.|++|.++++..+|+||.+.|+.+..     ..+...+-.|+.+|..|
T Consensus       544 a~e~e~~~~~e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l  623 (772)
T KOG1152|consen  544 AVEPEGNIGCEKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATL  623 (772)
T ss_pred             ccCccccccceeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHh
Confidence            3344445556666677889999999999999999999999999999999998876553     33455677899999999


Q ss_pred             C---CCCccEEEEEEEcCCEEEEEEecc-CCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeee
Q 011287          103 D---HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL  178 (489)
Q Consensus       103 ~---hpnIv~l~~~~~~~~~lylV~E~~-~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl  178 (489)
                      +   |+||++++++|++.+++|++||-- +|.+|+++|..+..++|.+++.++.|++.|+++||+.||||||||-||+.+
T Consensus       624 ~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv  703 (772)
T KOG1152|consen  624 NKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV  703 (772)
T ss_pred             hhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEE
Confidence            7   999999999999999999999875 567999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCC-CCCCcchhhhHHHHHHhhCCCCCCC
Q 011287          179 TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKD  257 (489)
Q Consensus       179 ~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~-~~~sDiwSLG~ilyelltG~~PF~~  257 (489)
                      +.+|-+||+|||.|.....            .....|+||..|.|||+|.+..| +..-||||||++||.++....||..
T Consensus       704 d~~g~~klidfgsaa~~ks------------gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  704 DSNGFVKLIDFGSAAYTKS------------GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             ecCCeEEEeeccchhhhcC------------CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            9999999999999875432            34458999999999999999886 6778999999999999999888853

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-35  Score=299.66  Aligned_cols=269  Identities=22%  Similarity=0.372  Sum_probs=221.5

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcC----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEE
Q 011287           46 DFELGKIYGVGSYSKVVRAKKID----TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~----tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ly  121 (489)
                      +....+.||+|-||.||.|....    ..-.||||.+++....  +..+.+..|..+|+.++|||||+|++++.+. ..|
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~--d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~W  466 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP--DDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMW  466 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh--hhHHHHHHHHHHHHhCCCcchhheeeeeecc-cee
Confidence            34556789999999999998643    2446899999775322  3367788899999999999999999999875 699


Q ss_pred             EEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          122 MALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      +|||.++-|+|..+++.+ ..++......|++||+.||.|||+.++|||||-..|||+....-+||+|||+++.+.+...
T Consensus       467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y  546 (974)
T KOG4257|consen  467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY  546 (974)
T ss_pred             EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccch
Confidence            999999999999999876 5699999999999999999999999999999999999999999999999999998876543


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCCCC
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYF  278 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~  278 (489)
                      ...         +.---..-|||||-++-..++.++|||-|||.++|++. |.-||.+....+.+-.|.++ .++.|+.+
T Consensus       547 Yka---------S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nC  617 (974)
T KOG4257|consen  547 YKA---------SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNC  617 (974)
T ss_pred             hhc---------cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCC
Confidence            321         11112346999999999999999999999999999887 99999998888777777665 47789999


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCCC--CCH------------HHHhcCCCCCCCCcccccCCC
Q 011287          279 SDAARDLIDRLLDVDPSGRPGAGP--GGY------------AVLKMHPFFKGIDWKNIRGQT  326 (489)
Q Consensus       279 ~~~~~~Li~~~L~~dP~~R~t~~~--~~~------------~~l~~hpff~~i~~~~~~~~~  326 (489)
                      |+.+..|..+|+..||.+||...+  ..+            +++....+-....|++-....
T Consensus       618 Pp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~~~~Eq~r~~R~~a~~~~~~~~~~e  679 (974)
T KOG4257|consen  618 PPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKINSSEQLRRQRKVASMIWQNSDDIE  679 (974)
T ss_pred             ChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhhhhHHHHHhhhcccceeeccCCccC
Confidence            999999999999999999999854  122            233344455556676644443

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-34  Score=289.63  Aligned_cols=250  Identities=20%  Similarity=0.300  Sum_probs=210.6

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCE
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  119 (489)
                      +.+-.+...+.+.||+|-||+|.++.- ..+..||+|.++..  ........+..|+.+|.+|+||||++|++++..++.
T Consensus       533 ~EfPRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~--a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP  609 (807)
T KOG1094|consen  533 VEFPRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPD--ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP  609 (807)
T ss_pred             hhcchhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcc--cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc
Confidence            455567789999999999999999986 34799999998654  233345678889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCC
Q 011287          120 LYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~  197 (489)
                      +++|+||+++|+|.+++.++.  .+.......++.||+.|++||.+.++|||||.+.|+|++.++++||+|||.++.+-.
T Consensus       610 icmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys  689 (807)
T KOG1094|consen  610 LCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS  689 (807)
T ss_pred             hHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccccccc
Confidence            999999999999999999873  334556666999999999999999999999999999999999999999999985432


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHh--hCCCCCCCCCHHHHHHHHHh------
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQML--SGTSPFKDTSEWLIFQRIIA------  269 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyell--tG~~PF~~~~~~~~~~~i~~------  269 (489)
                      ...        -.....++-...|||||.+.-+.++.++|+|++|+++||++  +...||...++.+...+...      
T Consensus       690 g~y--------y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~  761 (807)
T KOG1094|consen  690 GDY--------YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQG  761 (807)
T ss_pred             CCc--------eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCC
Confidence            221        12233566778999999999999999999999999999975  58999999888777665543      


Q ss_pred             --cCCCCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          270 --RDIRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       270 --~~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                        .-+.-|..++..+.+|+-+|+..|-++||+.
T Consensus       762 ~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsF  794 (807)
T KOG1094|consen  762 RQVVLSRPPACPQGLYELMLRCWRRESEQRPSF  794 (807)
T ss_pred             cceeccCCCcCcHHHHHHHHHHhchhhhcCCCH
Confidence              1234577799999999999999999999987

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-34  Score=294.31  Aligned_cols=247  Identities=25%  Similarity=0.402  Sum_probs=213.8

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCC-C--cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDT-G--TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~t-g--~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~l  120 (489)
                      .++....++||+|+||.|+.|.+... |  -.||||.+.......  ....+.+|+.+|.+|+|||+++||++..+ ..+
T Consensus       109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~  185 (1039)
T KOG0199|consen  109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA  185 (1039)
T ss_pred             HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence            45678889999999999999999653 3  358999987653332  56778899999999999999999999998 678


Q ss_pred             EEEEeccCCCChHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          121 YMALESCEGGELFDQITS--KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~--~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      .+|||.|++|+|++.|.+  .+.|.......|+.||+.|+.||.++++|||||-..|+|+-....|||+|||+.+.+...
T Consensus       186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n  265 (1039)
T KOG0199|consen  186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN  265 (1039)
T ss_pred             hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence            999999999999999987  356999999999999999999999999999999999999998889999999999987654


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCC
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPN  276 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~  276 (489)
                      ......       ....--...|+|||.|+...++.++|+|++||+|+||++ |..||.+....+++++|-++ .+.-|+
T Consensus       266 ed~Yvm-------~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk  338 (1039)
T KOG0199|consen  266 EDMYVM-------APQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPK  338 (1039)
T ss_pred             CcceEe-------cCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCC
Confidence            322110       001112347999999999999999999999999999998 89999999999999998754 356788


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCC
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      .++.++.+++..|+..+|.+||+.
T Consensus       339 ~csedIY~imk~cWah~paDRptF  362 (1039)
T KOG0199|consen  339 YCSEDIYQIMKNCWAHNPADRPTF  362 (1039)
T ss_pred             CChHHHHHHHHHhccCCccccccH
Confidence            999999999999999999999997

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=6.5e-34  Score=326.47  Aligned_cols=230  Identities=20%  Similarity=0.302  Sum_probs=182.8

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEe
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E  125 (489)
                      .|....+||+|+||.||+|++..+|..||+|.+......       ...|+.++++++|||||++++++.+....|+|||
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E  763 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE  763 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence            456678999999999999999999999999988643211       1235778999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccc
Q 011287          126 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH---SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (489)
Q Consensus       126 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH---~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~  202 (489)
                      |+++|+|.+++..   +++..+..++.||+.||+|||   +.+|+||||||+||+++.++..++. ||.+....      
T Consensus       764 y~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~------  833 (968)
T PLN00113        764 YIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC------  833 (968)
T ss_pred             CCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc------
Confidence            9999999999963   899999999999999999999   6699999999999999998887775 66544221      


Q ss_pred             cCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCH----HHHHHHH-H---------
Q 011287          203 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRI-I---------  268 (489)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~----~~~~~~i-~---------  268 (489)
                              ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....    ...+.+. .         
T Consensus       834 --------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  905 (968)
T PLN00113        834 --------TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWI  905 (968)
T ss_pred             --------cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhhee
Confidence                    11133688999999999999999999999999999999999999954211    1111110 0         


Q ss_pred             hcC----CCCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          269 ARD----IRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       269 ~~~----~~~p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      ...    ...+.....++.+++.+|++.||++||++
T Consensus       906 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~  941 (968)
T PLN00113        906 DPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCA  941 (968)
T ss_pred             CccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCH
Confidence            000    01111122357789999999999999998

>cd01262 PH_PDK1 3-Phosphoinositide dependent protein kinase 1 (PDK1) pleckstrin homology (PH) domain

Probab=100.00  E-value=8.5e-34  Score=222.31  Aligned_cols=89  Identities=63%  Similarity=0.901  Sum_probs=85.1

Q ss_pred             EEEEEeeehhhhhhccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEEcCCCcEEEEcCCceEEEEcCCccHH
Q 011287          398 VLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRAS  477 (489)
Q Consensus       398 i~~~g~~~k~~g~~~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~~~~~f~i~~p~r~y~~~d~~~~~~  477 (489)
                      |+++|.|.|++|+|+|+|||||||+|||+|+||.+|++||||||+++  +++++.+|+++|+|+||+|||+|+|++++|+
T Consensus         1 Il~~g~v~Kr~glf~kkR~LiLTd~PrL~yvdp~~~~~KgeIp~s~~--~l~v~~~~~~~F~I~Tp~rty~leD~~~~a~   78 (89)
T cd01262           1 ILKIGAVKKRKGLFAKKRQLILTNGPRLIYVDPVKKVVKGEIPWSDV--ELRVEVKNSSHFFVHTPNKVYSFEDPKGRAS   78 (89)
T ss_pred             CceeeeeeehhccccceeeEEEecCceEEEEcCCcCeEEeEeccccc--ceEEEEecCccEEEECCCceEEEECCCCCHH
Confidence            68999999999999999999999999999999999999999999992  3999999999999999999999999999999


Q ss_pred             HHHHHHHHhcC
Q 011287          478 QWKKAIEALQN  488 (489)
Q Consensus       478 ~W~~~i~~~~~  488 (489)
                      +||++|+++.+
T Consensus        79 ~W~~~I~~~~~   89 (89)
T cd01262          79 QWKKAIEDLQK   89 (89)
T ss_pred             HHHHHHHHHhC
Confidence            99999999753

3-Phosphoinositide dependent protein kinase 1 (PDK1) pleckstrin homology (PH) domain. PDK1 contains an N-terminal serine/threonine kinase domain followed by a PH domain. Following binding of the PH domain to PtdIns(3,4,5)P3 and PtdIns(3,4)P2, PDK1 activates kinases such as Akt (PKB). PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains.

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-35  Score=301.68  Aligned_cols=260  Identities=36%  Similarity=0.677  Sum_probs=233.0

Q ss_pred             EEeeeCceEEEEEEE---cCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCEEEEEEecc
Q 011287           52 IYGVGSYSKVVRAKK---IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLYMALESC  127 (489)
Q Consensus        52 ~LG~G~~g~Vy~a~~---~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~lylV~E~~  127 (489)
                      ++|.|+||.|++++.   .+.|.-||+|+..+.......+. ....|+.++..++ ||++|+++..|+.+..+|+++++.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~   79 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL   79 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence            379999999998875   35689999999988766655555 5666899999987 999999999999999999999999


Q ss_pred             CCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCC
Q 011287          128 EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA  207 (489)
Q Consensus       128 ~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~  207 (489)
                      .||+|...+.+...+++...+++.++++.|++++|+.||+|||+|++||+++.+||+++.|||+++..-...        
T Consensus        80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~--------  151 (612)
T KOG0603|consen   80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK--------  151 (612)
T ss_pred             ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh--------
Confidence            999999999998899999999999999999999999999999999999999999999999999998654332        


Q ss_pred             CCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 011287          208 SDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLID  287 (489)
Q Consensus       208 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~  287 (489)
                            ..|||..|||||+++  +...++|+||+|++.|+|++|..||.+    ++...|+...+.+|..++..++++++
T Consensus       152 ------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~  219 (612)
T KOG0603|consen  152 ------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFR  219 (612)
T ss_pred             ------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHH
Confidence                  118999999999998  677889999999999999999999988    78889999999999999999999999


Q ss_pred             HhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCCC-CCCCCC
Q 011287          288 RLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT-PPKLAS  332 (489)
Q Consensus       288 ~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~~-~p~~~~  332 (489)
                      .++..+|.+|++++-.+..++++|+||..++|+.+..+. +|++.+
T Consensus       220 ~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp  265 (612)
T KOG0603|consen  220 QLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKP  265 (612)
T ss_pred             HHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCC
Confidence            999999999999987789999999999999999886654 444433

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=8.3e-34  Score=279.25  Aligned_cols=265  Identities=27%  Similarity=0.412  Sum_probs=208.3

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcC---CCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEc
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKID---TGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQD  116 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~---tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~  116 (489)
                      +.....|..+.+||+|+|++||+|.+..   .++.||+|.+...     .....+.+|.++|..+ .+.||+++.+.+..
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t-----s~p~ri~~El~~L~~~gG~~ni~~~~~~~rn  106 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT-----SSPSRILNELEMLYRLGGSDNIIKLNGCFRN  106 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc-----cCchHHHHHHHHHHHhccchhhhcchhhhcc
Confidence            3456789999999999999999999987   7899999987543     3445688999999998 58999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCC-CCCEEEeeccCcccc
Q 011287          117 TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-DGHIKIADFGSVKPM  195 (489)
Q Consensus       117 ~~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~-~g~ikL~DFG~a~~~  195 (489)
                      ++.+.+||||++..+..++...   ++...++.|++.++.||.++|.+|||||||||+|+|.+. .++-.|+|||+|...
T Consensus       107 nd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~  183 (418)
T KOG1167|consen  107 NDQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY  183 (418)
T ss_pred             CCeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHH
Confidence            9999999999999888777654   789999999999999999999999999999999999985 478999999999732


Q ss_pred             CCcc------c----cccC------------------------CCCCCCCccceecCCcCCChhhhcCCC-CCCCCcchh
Q 011287          196 QDSR------I----TVLP------------------------NAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWA  240 (489)
Q Consensus       196 ~~~~------~----~~~~------------------------~~~~~~~~~~~~gt~~Y~aPE~l~~~~-~~~~sDiwS  240 (489)
                      ....      .    ...+                        +...........||++|+|||++...+ .+.++||||
T Consensus       184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws  263 (418)
T KOG1167|consen  184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS  263 (418)
T ss_pred             HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence            2111      0    0000                        011122234578999999999997755 688999999


Q ss_pred             hhHHHHHHhhCCCCCCCCCH-HHHHHHHHh--------------cC---------------------C------------
Q 011287          241 LGCTLYQMLSGTSPFKDTSE-WLIFQRIIA--------------RD---------------------I------------  272 (489)
Q Consensus       241 LG~ilyelltG~~PF~~~~~-~~~~~~i~~--------------~~---------------------~------------  272 (489)
                      .|||+.-+++++.||-...+ ......|..              +.                     +            
T Consensus       264 ~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n  343 (418)
T KOG1167|consen  264 AGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPN  343 (418)
T ss_pred             ccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccc
Confidence            99999999999999864322 111100000              00                     0            


Q ss_pred             ----CCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 011287          273 ----RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (489)
Q Consensus       273 ----~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~  318 (489)
                          ..-+.++..+.||+++||..||.+|+||     ++.|+||||...+
T Consensus       344 ~~~~~~~d~~~~~~~dlLdk~le~np~kRitA-----EeALkHpFF~~~~  388 (418)
T KOG1167|consen  344 TEREIGSDVFPALLLDLLDKCLELNPQKRITA-----EDALKHPFFDEAD  388 (418)
T ss_pred             eeeccccccccHHHHHHHHHHccCChhhcccH-----HHHhcCcCCcchh
Confidence                0112356789999999999999999999     8899999998544

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-33  Score=283.68  Aligned_cols=244  Identities=21%  Similarity=0.345  Sum_probs=211.8

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      .|...-..||-|-||.||.+.+++..-.||||.++..    .-..+.+..|..+|+.++|||+|+|++++..+...|+|+
T Consensus       267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED----tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiT  342 (1157)
T KOG4278|consen  267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIIT  342 (1157)
T ss_pred             hheeeeeccCCCcccceeeeeeeccceeeehhhhhhc----chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEE
Confidence            3567778999999999999999999999999998543    234556777999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccc
Q 011287          125 ESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (489)
Q Consensus       125 E~~~gg~L~~~l~~~~~--l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~  202 (489)
                      |||..|+|++|+.+..+  ++.-...+++.||..|++||..+++|||||-..|.|+.++..+|++|||+++.+....++.
T Consensus       343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA  422 (1157)
T KOG4278|consen  343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA  422 (1157)
T ss_pred             ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceec
Confidence            99999999999987643  7777888899999999999999999999999999999999999999999999987654332


Q ss_pred             cCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCCCCCH
Q 011287          203 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFSD  280 (489)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~~~  280 (489)
                      -.+         .--...|.|||-|....++.++|||+|||+|+|+.| |-.||.+-+-.+.+..+.++ ...-|+++++
T Consensus       423 HAG---------AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPp  493 (1157)
T KOG4278|consen  423 HAG---------AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPP  493 (1157)
T ss_pred             ccC---------ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCH
Confidence            111         012456999999999999999999999999999998 99999998887777655443 3456899999


Q ss_pred             HHHHHHHHhhccCCCCCCCCC
Q 011287          281 AARDLIDRLLDVDPSGRPGAG  301 (489)
Q Consensus       281 ~~~~Li~~~L~~dP~~R~t~~  301 (489)
                      .+.+|++.|++..|+.||+..
T Consensus       494 kVYeLMraCW~WsPsDRPsFa  514 (1157)
T KOG4278|consen  494 KVYELMRACWNWSPSDRPSFA  514 (1157)
T ss_pred             HHHHHHHHHhcCCcccCccHH
Confidence            999999999999999999873

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-34  Score=296.69  Aligned_cols=255  Identities=30%  Similarity=0.485  Sum_probs=225.2

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      .+||+.+.++|.|+||.||+|+++.+++..|+|+++..   ......-+..|+.+++.++||||+.+++.+-....+++.
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe---p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic   90 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE---PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC   90 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeecc---CCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence            48999999999999999999999999999999999754   344556677899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      ||||.||+|.+.-.-.|++++.++.+.+++.+.+|.|||+.|-+|||||-.|||+++.|.+||+|||.+..+..      
T Consensus        91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita------  164 (829)
T KOG0576|consen   91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA------  164 (829)
T ss_pred             EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh------
Confidence            99999999999888889999999999999999999999999999999999999999999999999999865532      


Q ss_pred             CCCCCCCCccceecCCcCCChhhh---cCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCC-----
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP-----  275 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l---~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p-----  275 (489)
                          .-.+..+|.||+.|||||+.   ....|...+|+||+|+...|+---.+|.....+........+..+.-|     
T Consensus       165 ----ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk  240 (829)
T KOG0576|consen  165 ----TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDK  240 (829)
T ss_pred             ----hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCC
Confidence                23455689999999999986   456799999999999999999888888877777666656666655544     


Q ss_pred             CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       276 ~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      ..+++.+.+|++.+|-.+|.+||++     +.++.|||...
T Consensus       241 ~kws~~fh~fvK~altknpKkRpta-----eklL~h~fvs~  276 (829)
T KOG0576|consen  241 TKWSEFFHNFVKGALTKNPKKRPTA-----EKLLQHPFVSQ  276 (829)
T ss_pred             ccchHHHHHHHHHHhcCCCccCCCh-----hhheeceeecc
Confidence            3589999999999999999999999     67888999864

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-33  Score=294.31  Aligned_cols=254  Identities=20%  Similarity=0.336  Sum_probs=219.6

Q ss_pred             CCCCCCCCCCeEEeeEEeeeCceEEEEEEEcCCC---cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEE
Q 011287           37 APQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT  113 (489)
Q Consensus        37 ~~~~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg---~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  113 (489)
                      .....+....-.|.++||.|.||+||.|+.+..|   ..||||.++..  ..+.....+..|+.||-+.+||||++|.++
T Consensus       621 eFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G--ytekqrrdFL~EAsIMGQFdHPNIIrLEGV  698 (996)
T KOG0196|consen  621 EFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG--YTEKQRRDFLSEASIMGQFDHPNIIRLEGV  698 (996)
T ss_pred             HhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC--ccHHHHhhhhhhhhhcccCCCCcEEEEEEE
Confidence            3335667778899999999999999999998766   57999999655  345556778889999999999999999999


Q ss_pred             EEcCCEEEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCc
Q 011287          114 FQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  192 (489)
Q Consensus       114 ~~~~~~lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a  192 (489)
                      ......+.+|+|||++|+|..+|.++ |.|+..++..+++.|+.|+.||-+.|.|||||-..||||+.+-.+|++|||++
T Consensus       699 VTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLS  778 (996)
T KOG0196|consen  699 VTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLS  778 (996)
T ss_pred             EecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccce
Confidence            99999999999999999999999875 78999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccccCCCCCCCCccceec--CCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHh
Q 011287          193 KPMQDSRITVLPNAASDDKACTFVG--TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIA  269 (489)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~g--t~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~  269 (489)
                      +.+++...         ....+.-|  ...|.|||.+..+.++.++||||+|++++|.++ |..||-..+..+.+..|..
T Consensus       779 Rvledd~~---------~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~  849 (996)
T KOG0196|consen  779 RVLEDDPE---------AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQ  849 (996)
T ss_pred             eecccCCC---------ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHh
Confidence            98765431         11111112  357999999999999999999999999999776 9999999999998888766


Q ss_pred             c-CCCCCCCCCHHHHHHHHHhhccCCCCCCCCC
Q 011287          270 R-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAG  301 (489)
Q Consensus       270 ~-~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~  301 (489)
                      + .++-|-.+|..+.+|+..|+++|-.+||...
T Consensus       850 gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~  882 (996)
T KOG0196|consen  850 GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFA  882 (996)
T ss_pred             ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHH
Confidence            4 2334457899999999999999999999873

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-32  Score=247.40  Aligned_cols=213  Identities=26%  Similarity=0.441  Sum_probs=178.3

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~ly  121 (489)
                      ..++..-+..||+|+||.|-+.++..+|...|+|.+.....  .+.+..+.+|.++..+. .+|++|.+|+.+.++..++
T Consensus        44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn--~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw  121 (282)
T KOG0984|consen   44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN--SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW  121 (282)
T ss_pred             chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC--hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence            35677888999999999999999999999999999876543  34455667788876554 7999999999999999999


Q ss_pred             EEEeccCCCChHH----HHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeeccCCCCeeeCCCCCEEEeeccCccccC
Q 011287          122 MALESCEGGELFD----QITSKGHLSEDEARFYTAEVVDALEYIHSM-GLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (489)
Q Consensus       122 lV~E~~~gg~L~~----~l~~~~~l~e~~~~~i~~qil~aL~~LH~~-gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~  196 (489)
                      +.||.|.. +|..    .+.+.+.++|..+-.++..++.||+|||++ .++|||+||+||||+.+|++|+||||.+..+.
T Consensus       122 IcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~  200 (282)
T KOG0984|consen  122 ICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLV  200 (282)
T ss_pred             EeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence            99999965 6654    345567899999999999999999999976 89999999999999999999999999998765


Q ss_pred             CccccccCCCCCCCCccc-eecCCcCCChhhhc----CCCCCCCCcchhhhHHHHHHhhCCCCCCC-CCHHHHHHHHHhc
Q 011287          197 DSRITVLPNAASDDKACT-FVGTAAYVPPEVLN----SSPATFGNDLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIAR  270 (489)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~-~~gt~~Y~aPE~l~----~~~~~~~sDiwSLG~ilyelltG~~PF~~-~~~~~~~~~i~~~  270 (489)
                      ++-            +.+ -.|...|||||.+.    ...|+-++||||||+.+.||.+++.||.. .++.+++..+...
T Consensus       201 dSi------------Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee  268 (282)
T KOG0984|consen  201 DSI------------AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE  268 (282)
T ss_pred             hhh------------HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence            432            112 35778999999985    34689999999999999999999999975 4666676666554

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=1.5e-30  Score=246.04  Aligned_cols=216  Identities=39%  Similarity=0.672  Sum_probs=186.5

Q ss_pred             eEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEec
Q 011287           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALES  126 (489)
Q Consensus        47 y~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~  126 (489)
                      |.+.+.||.|++|.||+|.+..+++.+|+|.+......  .....+..|...++.++|+|++++++.+......++++|+
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   78 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY   78 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence            67889999999999999999988999999999765332  2456788899999999999999999999998999999999


Q ss_pred             cCCCChHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCC
Q 011287          127 CEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  205 (489)
Q Consensus       127 ~~gg~L~~~l~~~~~-l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~  205 (489)
                      +.+++|.+++..... +++..+..++.+++.+|.+||+.|++|+||+|.||+++.++.++|+|||.+..+....      
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~------  152 (225)
T smart00221       79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL------  152 (225)
T ss_pred             cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc------
Confidence            999999999988766 8999999999999999999999999999999999999999999999999988654321      


Q ss_pred             CCCCCCccceecCCcCCChhhh-cCCCCCCCCcchhhhHHHHHHhhCCCCCCC--CCHHHHHHHHHhcCCC
Q 011287          206 AASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPFKD--TSEWLIFQRIIARDIR  273 (489)
Q Consensus       206 ~~~~~~~~~~~gt~~Y~aPE~l-~~~~~~~~sDiwSLG~ilyelltG~~PF~~--~~~~~~~~~i~~~~~~  273 (489)
                         ........++..|++||++ ....++.++|+|+||+++|+|++|+.||..  .+...+.+.|..+...
T Consensus       153 ---~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  220 (225)
T smart00221      153 ---AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPL  220 (225)
T ss_pred             ---cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCcc
Confidence               0122356788899999999 666778899999999999999999999977  4444667777766533

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=1.8e-30  Score=241.08  Aligned_cols=212  Identities=39%  Similarity=0.664  Sum_probs=186.5

Q ss_pred             EeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEeccCCCCh
Q 011287           53 YGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL  132 (489)
Q Consensus        53 LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~~~gg~L  132 (489)
                      ||+|++|.||+++...+|+.+++|++.......  ....+.+|...++.+.|++|+++++++......++++|++.|++|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence            689999999999998889999999987543221  346688899999999999999999999999999999999999999


Q ss_pred             HHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCC-CCCEEEeeccCccccCCccccccCCCCCCC
Q 011287          133 FDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-DGHIKIADFGSVKPMQDSRITVLPNAASDD  210 (489)
Q Consensus       133 ~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~-~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~  210 (489)
                      .+++... ..++...+..++.+++.+|.+||+.|++|+||+|.||+++. +++++|+|||.+........          
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~----------  148 (215)
T cd00180          79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS----------  148 (215)
T ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc----------
Confidence            9999876 57999999999999999999999999999999999999999 89999999999876543210          


Q ss_pred             CccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 011287          211 KACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRL  289 (489)
Q Consensus       211 ~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~~  289 (489)
                      ......+...|++||.+... .++.++|+|+||+++++|                               ..+.+++.+|
T Consensus       149 ~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~  197 (215)
T cd00180         149 LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKM  197 (215)
T ss_pred             hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHH
Confidence            12345678899999999887 788999999999999999                               6789999999


Q ss_pred             hccCCCCCCCCCCCCHHHHhcCC
Q 011287          290 LDVDPSGRPGAGPGGYAVLKMHP  312 (489)
Q Consensus       290 L~~dP~~R~t~~~~~~~~l~~hp  312 (489)
                      ++.||++||++     +++++|+
T Consensus       198 l~~~p~~R~~~-----~~l~~~~  215 (215)
T cd00180         198 LQKDPEKRPSA-----KEILEHL  215 (215)
T ss_pred             hhCCcccCcCH-----HHHhhCC
Confidence            99999999998     7788764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=8.7e-32  Score=267.68  Aligned_cols=241  Identities=22%  Similarity=0.341  Sum_probs=191.6

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC--CCCCccEEEEEEEcCC---
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL--DHPGVVRLFFTFQDTF---  118 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l--~hpnIv~l~~~~~~~~---  118 (489)
                      ....++..+||+|.||.||+|+.  +++.||||++.      ....+....|+++.+..  .|+||+++++.-....   
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~  280 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFP------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR  280 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhc--cCceeEEEecC------HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence            55668899999999999999997  56999999984      44556677788887764  8999999988766444   


Q ss_pred             -EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------CcEeeccCCCCeeeCCCCCEEEee
Q 011287          119 -SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM---------GLIHRDIKPENLLLTADGHIKIAD  188 (489)
Q Consensus       119 -~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~---------gIiHrDLKpeNILl~~~g~ikL~D  188 (489)
                       .+++|++|.+.|+|.+++..+ .+++.....++..++.||+|||+.         .|+|||||..||||..|++.-|+|
T Consensus       281 ~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD  359 (534)
T KOG3653|consen  281 MEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD  359 (534)
T ss_pred             cceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence             789999999999999999986 699999999999999999999973         499999999999999999999999


Q ss_pred             ccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCC------CCCCcchhhhHHHHHHhhCCC---------
Q 011287          189 FGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA------TFGNDLWALGCTLYQMLSGTS---------  253 (489)
Q Consensus       189 FG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~------~~~sDiwSLG~ilyelltG~~---------  253 (489)
                      ||+|..+....        .......-+||..|||||+|.+...      -.+.||||+|.+++||++.-.         
T Consensus       360 FGLAl~~~p~~--------~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~  431 (534)
T KOG3653|consen  360 FGLALRLEPGK--------PQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPE  431 (534)
T ss_pred             cceeEEecCCC--------CCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCc
Confidence            99999876432        2223334799999999999976431      245799999999999998532         


Q ss_pred             ---CCCC-----CCHHHHHHHHH--hcCCCCCCCC-----CHHHHHHHHHhhccCCCCCCCCC
Q 011287          254 ---PFKD-----TSEWLIFQRII--ARDIRFPNYF-----SDAARDLIDRLLDVDPSGRPGAG  301 (489)
Q Consensus       254 ---PF~~-----~~~~~~~~~i~--~~~~~~p~~~-----~~~~~~Li~~~L~~dP~~R~t~~  301 (489)
                         ||..     .+-.++.....  +..+.+|+.+     ...+++.++.|++.||+-|+||+
T Consensus       432 Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~  494 (534)
T KOG3653|consen  432 YQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG  494 (534)
T ss_pred             ccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence               3321     11122222222  3456666543     45689999999999999999984

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-30  Score=281.96  Aligned_cols=244  Identities=25%  Similarity=0.454  Sum_probs=205.8

Q ss_pred             CeEEeeEEeeeCceEEEEEEEc---C----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcC
Q 011287           46 DFELGKIYGVGSYSKVVRAKKI---D----TGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDT  117 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~---~----tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  117 (489)
                      +..+.+.||+|.||.|++|.-.   .    ....||||.+......  .....+..|+.+|+.+ .||||+.+++.+...
T Consensus       297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t~~  374 (609)
T KOG0200|consen  297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACTQD  374 (609)
T ss_pred             hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence            4467789999999999999743   1    1567999998665433  5567788899999998 599999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCC
Q 011287          118 FSLYMALESCEGGELFDQITSKG----------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD  181 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~~----------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~  181 (489)
                      ..+++|+|||..|+|..++...+                .++......+++||+.|++||++.+++||||-..|||+..+
T Consensus       375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~  454 (609)
T KOG0200|consen  375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKN  454 (609)
T ss_pred             CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCC
Confidence            99999999999999999998765                38899999999999999999999999999999999999999


Q ss_pred             CCEEEeeccCccccCCccccccCCCCCCCCccceec--CCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCC
Q 011287          182 GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG--TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDT  258 (489)
Q Consensus       182 g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~g--t~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~  258 (489)
                      ..+||+|||+|+...........         .-.|  ...|||||.+....++.++||||+|++|||+++ |..|+.+.
T Consensus       455 ~~~kIaDFGlar~~~~~~~y~~~---------~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~  525 (609)
T KOG0200|consen  455 KVIKIADFGLARDHYNKDYYRTK---------SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI  525 (609)
T ss_pred             CEEEEccccceeccCCCCceEec---------CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence            99999999999865443222100         0112  234999999999999999999999999999998 89999985


Q ss_pred             C-HHHHHHHHHhcC-CCCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          259 S-EWLIFQRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       259 ~-~~~~~~~i~~~~-~~~p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      . ..+.++.+..+. ...|..+++++.++++.|++.+|++||+.
T Consensus       526 ~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F  569 (609)
T KOG0200|consen  526 PPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTF  569 (609)
T ss_pred             CcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCH
Confidence            5 555666665553 57899999999999999999999999988

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.3e-31  Score=246.26  Aligned_cols=236  Identities=22%  Similarity=0.376  Sum_probs=186.6

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEE-EEEcCCEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFF-TFQDTFSLY  121 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~-~~~~~~~ly  121 (489)
                      .+.|.|.+.||+|.||.+.+|.++.++..+++|.+.+..    -....+.+|...--.| .|.||+.-|+ .|+..+.+.
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv   98 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV   98 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence            356999999999999999999999999999999987753    2344566666543334 5899998876 577888899


Q ss_pred             EEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCC--CCCEEEeeccCccccCCcc
Q 011287          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA--DGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~--~g~ikL~DFG~a~~~~~~~  199 (489)
                      |++|||+.|+|.+.+...| +-|...+.++.|+++|++|||+.++||||||.+||||-.  ..++||||||..+..+..-
T Consensus        99 F~qE~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV  177 (378)
T KOG1345|consen   99 FVQEFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV  177 (378)
T ss_pred             EeeccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCcee
Confidence            9999999999999887754 899999999999999999999999999999999999943  3589999999987543211


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCC-----CCCCCCcchhhhHHHHHHhhCCCCCCCCC----HHHHHHHHH-h
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSS-----PATFGNDLWALGCTLYQMLSGTSPFKDTS----EWLIFQRII-A  269 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-----~~~~~sDiwSLG~ilyelltG~~PF~~~~----~~~~~~~i~-~  269 (489)
                                   ...--+..|.+||+....     ...+.+|+|.||+|+|.+|+|.+||....    .+--+.+.. .
T Consensus       178 -------------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~r  244 (378)
T KOG1345|consen  178 -------------KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKR  244 (378)
T ss_pred             -------------hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcc
Confidence                         111235679999987432     25778999999999999999999998532    222222222 2


Q ss_pred             cCCCCCC---CCCHHHHHHHHHhhccCCCCC
Q 011287          270 RDIRFPN---YFSDAARDLIDRLLDVDPSGR  297 (489)
Q Consensus       270 ~~~~~p~---~~~~~~~~Li~~~L~~dP~~R  297 (489)
                      .....|.   .+++.+..+.++-|..+|++|
T Consensus       245 k~~~~P~~F~~fs~~a~r~Fkk~lt~~~~dr  275 (378)
T KOG1345|consen  245 KNPALPKKFNPFSEKALRLFKKSLTPRFKDR  275 (378)
T ss_pred             cCccCchhhcccCHHHHHHHHHhcCCccccc
Confidence            3345554   478999999999999999999

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6e-30  Score=252.90  Aligned_cols=242  Identities=22%  Similarity=0.338  Sum_probs=188.2

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHH--hCCCCCccEEEEEEEcC----
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD--QLDHPGVVRLFFTFQDT----  117 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~--~l~hpnIv~l~~~~~~~----  117 (489)
                      ..+-.+.+.||+|.||+||+|+++  |..||||++...    ++  ..-.+|.++.+  .|+|+||+.++..=...    
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr----dE--~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~  281 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR----DE--RSWFRETEIYQTVMLRHENILGFIAADNKDNGSW  281 (513)
T ss_pred             hheeEEEEEecCccccceeecccc--CCceEEEEeccc----ch--hhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence            456799999999999999999994  899999999543    22  23344555554  46999999988654321    


Q ss_pred             CEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcEeeccCCCCeeeCCCCCEEEeec
Q 011287          118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM--------GLIHRDIKPENLLLTADGHIKIADF  189 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~--------gIiHrDLKpeNILl~~~g~ikL~DF  189 (489)
                      ..+|+|++|-+.|+|+++|++ ..++.+....++..++.||+|||..        .|.|||||..||||..+|.+-|+|+
T Consensus       282 TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL  360 (513)
T KOG2052|consen  282 TQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  360 (513)
T ss_pred             EEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence            358999999999999999998 5799999999999999999999963        3999999999999999999999999


Q ss_pred             cCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCC------CCCCcchhhhHHHHHHhhC----------CC
Q 011287          190 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA------TFGNDLWALGCTLYQMLSG----------TS  253 (489)
Q Consensus       190 G~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~------~~~sDiwSLG~ilyelltG----------~~  253 (489)
                      |+|.........      -+-..+..|||..|||||+|...-.      -..+||||||.+++|++..          ++
T Consensus       361 GLAv~h~~~t~~------idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~  434 (513)
T KOG2052|consen  361 GLAVRHDSDTDT------IDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQL  434 (513)
T ss_pred             eeeEEecccCCc------ccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcC
Confidence            999876544211      1233456799999999999965431      2458999999999999863          57


Q ss_pred             CCCC-----CCHHHHHHHHHh--cCCCCCCCCC-----HHHHHHHHHhhccCCCCCCCC
Q 011287          254 PFKD-----TSEWLIFQRIIA--RDIRFPNYFS-----DAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       254 PF~~-----~~~~~~~~~i~~--~~~~~p~~~~-----~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      ||.+     .+..++..-++.  ..+.+|+.+.     ..+..|++.|+..||.-|+||
T Consensus       435 Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltA  493 (513)
T KOG2052|consen  435 PYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTA  493 (513)
T ss_pred             CcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHH
Confidence            8854     333444443333  3455666543     235678999999999999998

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=4.1e-30  Score=268.84  Aligned_cols=246  Identities=19%  Similarity=0.323  Sum_probs=207.1

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCC----cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEE
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTG----TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg----~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ly  121 (489)
                      ..+-.++||.|+||+||+|.+.-.|    -+||||++.....  ......+.+|+.+|.+|+|||+++|+++..... +-
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~--~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q  773 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS--PKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ  773 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC--chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence            4567789999999999999986544    4678888765432  233456778999999999999999999998765 88


Q ss_pred             EEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          122 MALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      +|++|+++|.|.++++.+ +.+-......|.+||++|+.|||.++++||||-..|+||..-.++|++|||+|+.+.....
T Consensus       774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            999999999999999875 6799999999999999999999999999999999999999999999999999998765432


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCCCC
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYF  278 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~  278 (489)
                      .....        ..--.+.|||-|.+....|+.++||||+||+++|++| |..|+.+....++-..+..+ .+..|+..
T Consensus       854 ey~~~--------~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiC  925 (1177)
T KOG1025|consen  854 EYSAP--------GGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPIC  925 (1177)
T ss_pred             ccccc--------ccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCc
Confidence            22111        1112346888888899999999999999999999998 99999998887776555443 46788999


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCCC
Q 011287          279 SDAARDLIDRLLDVDPSGRPGAGP  302 (489)
Q Consensus       279 ~~~~~~Li~~~L~~dP~~R~t~~~  302 (489)
                      +-++..++.+|+-.|+..||++.+
T Consensus       926 tiDVy~~mvkCwmid~~~rp~fke  949 (1177)
T KOG1025|consen  926 TIDVYMVMVKCWMIDADSRPTFKE  949 (1177)
T ss_pred             cHHHHHHHHHHhccCcccCccHHH
Confidence            999999999999999999999854

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=1.6e-30  Score=292.02  Aligned_cols=205  Identities=20%  Similarity=0.242  Sum_probs=149.5

Q ss_pred             CCC-CCccEEEEEE-------EcCCEEEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccC
Q 011287          102 LDH-PGVVRLFFTF-------QDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIK  172 (489)
Q Consensus       102 l~h-pnIv~l~~~~-------~~~~~lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLK  172 (489)
                      +.| +||++++++|       .....++++||++ +++|.+++... ..+++..++.++.||+.||.|||++||+|||||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK  107 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR  107 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence            345 5777888877       2334678889988 55999999753 569999999999999999999999999999999


Q ss_pred             CCCeeeCCCCCEEEeeccCccccCCccc---cccC----------------------CCCCCCCccceecCCcCCChhhh
Q 011287          173 PENLLLTADGHIKIADFGSVKPMQDSRI---TVLP----------------------NAASDDKACTFVGTAAYVPPEVL  227 (489)
Q Consensus       173 peNILl~~~g~ikL~DFG~a~~~~~~~~---~~~~----------------------~~~~~~~~~~~~gt~~Y~aPE~l  227 (489)
                      |+||||+..|.+|++|||++........   ...+                      ...........+||+.|+|||++
T Consensus       108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~  187 (793)
T PLN00181        108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED  187 (793)
T ss_pred             chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence            9999997666665555555433211100   0000                      00000112235789999999999


Q ss_pred             cCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCC---CCCHHHHHHHHHhhccCCCCCCCCCCCC
Q 011287          228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN---YFSDAARDLIDRLLDVDPSGRPGAGPGG  304 (489)
Q Consensus       228 ~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~---~~~~~~~~Li~~~L~~dP~~R~t~~~~~  304 (489)
                      .+..++.++|||||||+||||++|.+||.....  .+..+....  +|.   .-.+.+.+++.+||++||.+||++    
T Consensus       188 ~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~--~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~----  259 (793)
T PLN00181        188 NGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRV--LPPQILLNWPKEASFCLWLLHPEPSCRPSM----  259 (793)
T ss_pred             ccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhh--cChhhhhcCHHHHHHHHHhCCCChhhCcCh----
Confidence            999999999999999999999999998864322  222222111  121   124567899999999999999999    


Q ss_pred             HHHHhcCCCCCC
Q 011287          305 YAVLKMHPFFKG  316 (489)
Q Consensus       305 ~~~l~~hpff~~  316 (489)
                       .++++||||..
T Consensus       260 -~eil~h~~~~~  270 (793)
T PLN00181        260 -SELLQSEFINE  270 (793)
T ss_pred             -HHHhhchhhhh
Confidence             89999999975

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.96  E-value=4.6e-30  Score=275.97  Aligned_cols=243  Identities=36%  Similarity=0.573  Sum_probs=197.3

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lyl  122 (489)
                      ...||..++.|..|+||.||+++++.+.+.+|+|+ +|..+.        .  ++++.....|++|              
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~li--------l--Rnilt~a~npfvv--------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLI--------L--RNILTFAGNPFVV--------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhcc-cccchh--------h--hccccccCCccee--------------
Confidence            35899999999999999999999999999999954 333111        1  1145555666666              


Q ss_pred             EEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccc
Q 011287          123 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~  202 (489)
                             ||-...++..|+++...        +.|++|||+.||+|||+||+|.+|+.-||+|++|||+++..-...-+.
T Consensus       136 -------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn  200 (1205)
T KOG0606|consen  136 -------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN  200 (1205)
T ss_pred             -------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence                   56666666667766544        889999999999999999999999999999999999987542221110


Q ss_pred             cC-----CCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 011287          203 LP-----NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY  277 (489)
Q Consensus       203 ~~-----~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~  277 (489)
                      ..     ....+......|||+.|.|||++....|+..+|+|++|+|+|+.+.|..||.+.+..+++...+.....+|+.
T Consensus       201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~  280 (1205)
T KOG0606|consen  201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE  280 (1205)
T ss_pred             hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc
Confidence            00     0111223345699999999999999999999999999999999999999999999999999999988888864


Q ss_pred             ---CCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCCCC
Q 011287          278 ---FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTP  327 (489)
Q Consensus       278 ---~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~~~  327 (489)
                         ++++++++|.++|+.+|..|.+..  +..++++|+||+.+||..|..|..
T Consensus       281 dea~p~Ea~dli~~LL~qnp~~Rlgt~--ga~evk~h~ff~~LDw~~llRqka  331 (1205)
T KOG0606|consen  281 DEALPPEAQDLIEQLLRQNPLCRLGTG--GALEVKQHGFFQLLDWKSLLRQKA  331 (1205)
T ss_pred             CcCCCHHHHHHHHHHHHhChHhhcccc--hhhhhhhccceeecccchhhhhhc
Confidence               789999999999999999999875  668999999999999997655443

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.95  E-value=1.3e-26  Score=228.06  Aligned_cols=257  Identities=38%  Similarity=0.598  Sum_probs=211.2

Q ss_pred             eEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCC-CccEEEEEEEcCCEEEEEEe
Q 011287           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP-GVVRLFFTFQDTFSLYMALE  125 (489)
Q Consensus        47 y~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp-nIv~l~~~~~~~~~lylV~E  125 (489)
                      |.+.+.||.|+||.||++.+.   ..+|+|.+.+...........+.+|..+++.+.|+ +|+++++.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            889999999999999999997   88999999877655544567788899999999988 79999999988888999999


Q ss_pred             ccCCCChHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCC-CEEEeeccCccccCCcccc
Q 011287          126 SCEGGELFDQITSKG---HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-HIKIADFGSVKPMQDSRIT  201 (489)
Q Consensus       126 ~~~gg~L~~~l~~~~---~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g-~ikL~DFG~a~~~~~~~~~  201 (489)
                      ++.++++.+++....   .+++..+..++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||.+..+......
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~  158 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST  158 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence            999999998777764   799999999999999999999999999999999999999988 7999999999855433211


Q ss_pred             ccCCCCCCCCccceecCCcCCChhhhcC---CCCCCCCcchhhhHHHHHHhhCCCCCCCCCH----HHHHHHHHhcCCC-
Q 011287          202 VLPNAASDDKACTFVGTAAYVPPEVLNS---SPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRIIARDIR-  273 (489)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~---~~~~~~sDiwSLG~ilyelltG~~PF~~~~~----~~~~~~i~~~~~~-  273 (489)
                      ...    .......+||..|+|||.+.+   ..+....|+||+|++++++++|..||.....    ......+...... 
T Consensus       159 ~~~----~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  234 (384)
T COG0515         159 SSI----PALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS  234 (384)
T ss_pred             ccc----cccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc
Confidence            000    013457799999999999987   5788899999999999999999999988763    4555555544433 


Q ss_pred             CCCCCC--------HHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 011287          274 FPNYFS--------DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (489)
Q Consensus       274 ~p~~~~--------~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~  315 (489)
                      +.....        ..+.+++.+++..+|..|.++     .....+++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~-----~~~~~~~~~~  279 (384)
T COG0515         235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSS-----SSDLSHDLLA  279 (384)
T ss_pred             cccccCccccchhhHHHHHHHHHHHhcCchhcCCH-----HHHhhchHhh
Confidence            222222        579999999999999999988     4555554443

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=5e-28  Score=221.72  Aligned_cols=158  Identities=25%  Similarity=0.267  Sum_probs=130.0

Q ss_pred             CChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCC
Q 011287          130 GELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS  208 (489)
Q Consensus       130 g~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~  208 (489)
                      |+|.+++... +.+++..++.++.||+.||.|||+.+      ||+|||++.++.+++  ||+++.....          
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----------   62 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----------   62 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----------
Confidence            6899999874 45999999999999999999999998      999999999999999  9998764321          


Q ss_pred             CCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHH-HHHHHHHhcCCCC-------CCCCCH
Q 011287          209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQRIIARDIRF-------PNYFSD  280 (489)
Q Consensus       209 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~-~~~~~i~~~~~~~-------p~~~~~  280 (489)
                           ...||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ..+..+.......       +..++.
T Consensus        63 -----~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  137 (176)
T smart00750       63 -----QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSA  137 (176)
T ss_pred             -----cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHh
Confidence                 125899999999999999999999999999999999999999765442 2333333322111       222344


Q ss_pred             --HHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 011287          281 --AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (489)
Q Consensus       281 --~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~  315 (489)
                        +++++|.+||+.||.+||++     .+++.|+|+.
T Consensus       138 ~~~~~~~i~~cl~~~p~~Rp~~-----~~ll~~~~~~  169 (176)
T smart00750      138 ARSFADFMRVCASRLPQRREAA-----NHYLAHCRAL  169 (176)
T ss_pred             hhhHHHHHHHHHhcccccccCH-----HHHHHHHHHH
Confidence              69999999999999999999     8899999874

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=4.8e-29  Score=267.94  Aligned_cols=261  Identities=26%  Similarity=0.418  Sum_probs=208.1

Q ss_pred             EEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecc---cccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           48 ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKK---FITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        48 ~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~---~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      ....++|.|++|.|+.+......+.++.|.+...   ..........+..|.-+-..+.|||++.....+++....+-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            6788999999999999998877777777765421   1222222223556777777889999988877777666666669


Q ss_pred             eccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccC
Q 011287          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (489)
Q Consensus       125 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~  204 (489)
                      |||++ ||+.++...+.++..++..++.|++.||.|||+.||.|||+||+|++++.+|.+||+|||.+..+.-..     
T Consensus       401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~-----  474 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW-----  474 (601)
T ss_pred             hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc-----
Confidence            99999 999999998899999999999999999999999999999999999999999999999999987664322     


Q ss_pred             CCCCCCCccceecCCcCCChhhhcCCCCCC-CCcchhhhHHHHHHhhCCCCCCCCCHHHHH--H-------HHHhcCCCC
Q 011287          205 NAASDDKACTFVGTAAYVPPEVLNSSPATF-GNDLWALGCTLYQMLSGTSPFKDTSEWLIF--Q-------RIIARDIRF  274 (489)
Q Consensus       205 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~-~sDiwSLG~ilyelltG~~PF~~~~~~~~~--~-------~i~~~~~~~  274 (489)
                       +........++|+..|+|||++.+..|++ ..||||.|+|++.|.+|+.||......+..  +       ++..+...+
T Consensus       475 -e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~  553 (601)
T KOG0590|consen  475 -EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRL  553 (601)
T ss_pred             -chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHH
Confidence             11123455789999999999999988865 579999999999999999999876544321  1       111111122


Q ss_pred             CCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 011287          275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (489)
Q Consensus       275 p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~  320 (489)
                      -..++...+.+|.+||+.||.+|.|+     ++|++.+||+.++--
T Consensus       554 ~~~lp~~~~~~~~~~l~~~P~~R~ti-----~~i~~d~W~~~i~~c  594 (601)
T KOG0590|consen  554 LSLLPRETRIIIYRMLQLDPTKRITI-----EQILNDEWIRSIECC  594 (601)
T ss_pred             HHhchhhHHHHHHHHccCChhheecH-----HHHhhChHhhhcceE
Confidence            23478899999999999999999999     899999999987643

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=1.1e-25  Score=227.00  Aligned_cols=249  Identities=22%  Similarity=0.295  Sum_probs=194.8

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCC-cEEEEEEeecccccchhHHHHHHHHHHHHHhCC----CCCccEEEEEE-EcCCE
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTG-TVYALKIMDKKFITKENKTAYVKLERIVLDQLD----HPGVVRLFFTF-QDTFS  119 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg-~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~----hpnIv~l~~~~-~~~~~  119 (489)
                      +|.+.+.||+|+||.||+|.+..++ ..+|+|+.........   ..+..|..++..+.    .+++..+++.+ .....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            8999999999999999999998774 6899998765422221   15677888888886    26899999999 57888


Q ss_pred             EEEEEeccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCC-----CCEEEeeccCc
Q 011287          120 LYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-----GHIKIADFGSV  192 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~-----g~ikL~DFG~a  192 (489)
                      -|+||+.+ |.+|.++....  +.|+..++..++.|++.||++||+.|++||||||+|+++...     ..+.|.|||+|
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99999998 67999988554  579999999999999999999999999999999999999865     36999999999


Q ss_pred             c--ccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHH---HHHHHH
Q 011287          193 K--PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW---LIFQRI  267 (489)
Q Consensus       193 ~--~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~---~~~~~i  267 (489)
                      +  .+.......  ..........+.||..|+|+.+..+...+.+.|+||++.++.+++.|.+||.+....   ..+...
T Consensus       175 r~~~~~~~~~~~--~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~  252 (322)
T KOG1164|consen  175 RRFKYVGDSGGN--LRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD  252 (322)
T ss_pred             ccccccCCCCcc--cccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence            8  432222110  000111134677999999999999999999999999999999999999999876532   222222


Q ss_pred             HhcCC-C-CCCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          268 IARDI-R-FPNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       268 ~~~~~-~-~p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      ..... . +....+.++.++...+-..+...+|..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy  287 (322)
T KOG1164|consen  253 PRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDY  287 (322)
T ss_pred             hhhhccccccCCChHHHHHHHHHhhccCCcCCCCH
Confidence            22211 1 344567788888888888899999876

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=1.8e-26  Score=233.74  Aligned_cols=189  Identities=20%  Similarity=0.199  Sum_probs=141.8

Q ss_pred             CCCCCCCCCeEEeeEEeeeCceEEEEEEEcC-CCcEEEEEEeecccc--cchhHHHHHHHHHHHHHhCCCCCccE-EEEE
Q 011287           38 PQEHFSIQDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFI--TKENKTAYVKLERIVLDQLDHPGVVR-LFFT  113 (489)
Q Consensus        38 ~~~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~-tg~~vAiK~~~k~~~--~~~~~~~~~~~E~~il~~l~hpnIv~-l~~~  113 (489)
                      .+.....++|.+.+.||+|+||+||+|+++. +++.||||++.....  ........+.+|+.+|+.++|+||++ ++..
T Consensus        11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~   90 (365)
T PRK09188         11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT   90 (365)
T ss_pred             cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc
Confidence            3455667899999999999999999999876 788889998753311  12334566889999999999999985 5432


Q ss_pred             EEcCCEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecc-CCCCeeeCCCCCEEEeeccCc
Q 011287          114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDI-KPENLLLTADGHIKIADFGSV  192 (489)
Q Consensus       114 ~~~~~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDL-KpeNILl~~~g~ikL~DFG~a  192 (489)
                          ...|+|||||+|++|.. +..   ..   ...++.|++.||.|||++||+|||| ||+|||++.++.++|+|||+|
T Consensus        91 ----~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA  159 (365)
T PRK09188         91 ----GKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLA  159 (365)
T ss_pred             ----CCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence                45899999999999963 221   11   1467899999999999999999999 999999999999999999999


Q ss_pred             cccCCccccccCCCCCCCCccceecCCcCCChhhhcCCC------CCCCCcch
Q 011287          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP------ATFGNDLW  239 (489)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~------~~~~sDiw  239 (489)
                      +.+.......  .........+.+++..|+|||.+....      .+..+|-|
T Consensus       160 ~~~~~~~~~~--~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        160 SVFRRRGALY--RIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             eecccCcchh--hhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            9775432110  000011223678999999999986433      23446666

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=2e-26  Score=211.88  Aligned_cols=252  Identities=19%  Similarity=0.281  Sum_probs=205.6

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC-CCccEEEEEEEcCC
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH-PGVVRLFFTFQDTF  118 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~  118 (489)
                      +-+....|.+++.||.|+||.+|+|....+|.+||||+-.+.     .....+..|..+.+.|++ .+|..+..++.+..
T Consensus        10 ~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-----a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~   84 (341)
T KOG1163|consen   10 ELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-----AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKD   84 (341)
T ss_pred             hheeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-----CCCcchhHHHHHHHHhccCCCCchhhhhccccc
Confidence            345678899999999999999999999999999999986433     233456778999998865 67888888888888


Q ss_pred             EEEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCC---CEEEeeccCccc
Q 011287          119 SLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG---HIKIADFGSVKP  194 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g---~ikL~DFG~a~~  194 (489)
                      .-.+||+.+ |.+|.++.+-. ..|+..++..++-|++.-++|+|.++++||||||+|+|..-+-   .+.|+|||+|+.
T Consensus        85 ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk  163 (341)
T KOG1163|consen   85 YNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK  163 (341)
T ss_pred             cceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhh
Confidence            889999999 66998887643 5699999999999999999999999999999999999997543   589999999998


Q ss_pred             cCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCC---HHHHHHHHHhcC
Q 011287          195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS---EWLIFQRIIARD  271 (489)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~---~~~~~~~i~~~~  271 (489)
                      +.+.....-   -.-.......||+.|.|--...+...+...|+-|+|.++..+..|.+||.+..   ..+-+.+|....
T Consensus       164 y~d~~t~~H---Ipyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK  240 (341)
T KOG1163|consen  164 YRDIRTRQH---IPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK  240 (341)
T ss_pred             hcccccccc---CccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh
Confidence            865432110   01123446789999999888888888889999999999999999999998754   445566777666


Q ss_pred             CCCC-----CCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          272 IRFP-----NYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       272 ~~~p-----~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      ...|     .++|.++.-.+..|-..--++-|.-
T Consensus       241 ~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy  274 (341)
T KOG1163|consen  241 MSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDY  274 (341)
T ss_pred             cCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence            5544     6789999999999988777777754

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.94  E-value=1.4e-26  Score=225.47  Aligned_cols=250  Identities=15%  Similarity=0.260  Sum_probs=205.1

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCC-----CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEE-
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDT-----GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ-  115 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~t-----g~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-  115 (489)
                      +...+++...++-+|.||.||.|.+++.     .+.|-+|.++..  ..+-....+..|.-.+..+.|||+.++.++.. 
T Consensus       281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie  358 (563)
T KOG1024|consen  281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE  358 (563)
T ss_pred             hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence            3456789999999999999999977643     244556655332  23344556677888888899999999988764 


Q ss_pred             cCCEEEEEEeccCCCChHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEe
Q 011287          116 DTFSLYMALESCEGGELFDQITSK--------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIA  187 (489)
Q Consensus       116 ~~~~lylV~E~~~gg~L~~~l~~~--------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~  187 (489)
                      +....+.++.+..-|+|..++...        ..++..+...++.|++.|++|||.+||||.||-..|.+|++.-.+||+
T Consensus       359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt  438 (563)
T KOG1024|consen  359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT  438 (563)
T ss_pred             ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence            556677888899889999999732        247788888999999999999999999999999999999999999999


Q ss_pred             eccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHH
Q 011287          188 DFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQR  266 (489)
Q Consensus       188 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~  266 (489)
                      |=.+++.+-+.++....+..        -....|||||.+....|+.++|+|||||+++||+| |+.|+..-++.++..-
T Consensus       439 DsaLSRDLFP~DYhcLGDnE--------nRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y  510 (563)
T KOG1024|consen  439 DSALSRDLFPGDYHCLGDNE--------NRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY  510 (563)
T ss_pred             cchhccccCcccccccCCCC--------CCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH
Confidence            99999877655444322111        12457999999999999999999999999999998 9999999999999887


Q ss_pred             HHhc-CCCCCCCCCHHHHHHHHHhhccCCCCCCCCC
Q 011287          267 IIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAG  301 (489)
Q Consensus       267 i~~~-~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~  301 (489)
                      +.++ .+..|-++|+++..++..|+..+|++||+..
T Consensus       511 lkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~  546 (563)
T KOG1024|consen  511 LKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFS  546 (563)
T ss_pred             HhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHH
Confidence            7765 3556889999999999999999999999983

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=2.3e-25  Score=213.36  Aligned_cols=247  Identities=21%  Similarity=0.322  Sum_probs=197.6

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~lylV  123 (489)
                      -.|.+++.||+|+||+++.|++.-++++||||.-..+     ...-++..|....+.| ..++|..+|.+.+...+-.+|
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV  102 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV  102 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence            4699999999999999999999999999999975433     2334566788888877 579999999998988888899


Q ss_pred             EeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCC-----CEEEeeccCccccCC
Q 011287          124 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-----HIKIADFGSVKPMQD  197 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g-----~ikL~DFG~a~~~~~  197 (489)
                      +|.+ |.+|.++..-. .+|+..++..+|.|++.-++++|++.+|+|||||+|+||...+     .|.++|||+|+.+.+
T Consensus       103 idLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  103 IDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             hhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence            9998 66888877655 3599999999999999999999999999999999999997543     589999999998876


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCC---CCHHHHHHHHHhcCCC-
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD---TSEWLIFQRIIARDIR-  273 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~---~~~~~~~~~i~~~~~~-  273 (489)
                      +....-   -.-....+..||+.|||--...+...+...|+-|||-++++.|.|.+||.+   .+..+-+++|-...-. 
T Consensus       182 p~TkqH---IPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T  258 (449)
T KOG1165|consen  182 PKTKQH---IPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST  258 (449)
T ss_pred             cccccc---CccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence            542110   011334577899999999999999999999999999999999999999976   5666777777553322 


Q ss_pred             ----CCCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          274 ----FPNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       274 ----~p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                          +..++|.++..-++-.-..+-.+-|..
T Consensus       259 ~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDY  289 (449)
T KOG1165|consen  259 PIEVLCEGFPEEFATYLRYVRRLDFFETPDY  289 (449)
T ss_pred             CHHHHHhcCHHHHHHHHHHHHhcCcccCCCH
Confidence                234567676666665555555555543

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2.4e-25  Score=217.55  Aligned_cols=268  Identities=25%  Similarity=0.413  Sum_probs=189.1

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCC-----------------------------------cEEEEEEeeccccc
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTG-----------------------------------TVYALKIMDKKFIT   84 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg-----------------------------------~~vAiK~~~k~~~~   84 (489)
                      .+++++||+|+..||+|+-+.||.|+....|                                   -+.|||.|-.-...
T Consensus       152 skFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~  231 (598)
T KOG4158|consen  152 SKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHD  231 (598)
T ss_pred             cccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccC
Confidence            6899999999999999999999999865432                                   13466655321111


Q ss_pred             c--hhHHHHHHHHH------------H--HHHh--------CCCCCccEEEEEEEc------------------------
Q 011287           85 K--ENKTAYVKLER------------I--VLDQ--------LDHPGVVRLFFTFQD------------------------  116 (489)
Q Consensus        85 ~--~~~~~~~~~E~------------~--il~~--------l~hpnIv~l~~~~~~------------------------  116 (489)
                      .  .......-+|.            .  ..+.        -.|||||+++..|.+                        
T Consensus       232 s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g  311 (598)
T KOG4158|consen  232 SGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSG  311 (598)
T ss_pred             CchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccc
Confidence            1  00111111111            0  0111        269999999877743                        


Q ss_pred             ---CCEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeC--CCC--CEEEeec
Q 011287          117 ---TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT--ADG--HIKIADF  189 (489)
Q Consensus       117 ---~~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~--~~g--~ikL~DF  189 (489)
                         ...+|+||...+. +|.+++-.+ ..+....+.+++|+++|+.|||++||.|||+|.+||||.  +|+  .+.|+||
T Consensus       312 ~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDF  389 (598)
T KOG4158|consen  312 AGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADF  389 (598)
T ss_pred             cCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccc
Confidence               3468999998876 999998764 578889999999999999999999999999999999985  333  5899999


Q ss_pred             cCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCC------CCCCCcchhhhHHHHHHhhCCCCCCCCCHHHH
Q 011287          190 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP------ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLI  263 (489)
Q Consensus       190 G~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~------~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~  263 (489)
                      |++-.-+........    ....-..-|...-||||+....+      .-.++|.|+.|.+.||+++...||.+..+...
T Consensus       390 GCcLAd~~hGlqlpy----~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L  465 (598)
T KOG4158|consen  390 GCCLADDNHGLQLPY----ESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL  465 (598)
T ss_pred             ceeeecccccccccc----ccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee
Confidence            998654332222111    11122345788899999986543      13579999999999999999999988555332


Q ss_pred             HHH-H-HhcCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 011287          264 FQR-I-IARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (489)
Q Consensus       264 ~~~-i-~~~~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~  315 (489)
                      --+ . ...-+.+|+.+++.+++||..+|+.||++|+++.-  .+.+++--.|.
T Consensus       466 ~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~i--AANvl~LsLw~  517 (598)
T KOG4158|consen  466 DTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNI--AANVLNLSLWR  517 (598)
T ss_pred             chhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccH--HHhHHHHHHhc
Confidence            111 1 12234578899999999999999999999999843  24455443333

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.91  E-value=3.6e-24  Score=208.54  Aligned_cols=234  Identities=27%  Similarity=0.408  Sum_probs=153.6

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC----------CCCccEEEEEEE
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD----------HPGVVRLFFTFQ  115 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~----------hpnIv~l~~~~~  115 (489)
                      ....++.||.|+++.||.+++.+||+++|+|++...........+.+++|......+.          |-.++-.++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            5688999999999999999999999999999987665445555666666665444432          212222222221


Q ss_pred             ---------cC---C-----EEEEEEeccCCCChHHHHH---hCCCC---CHHHH-HHHHHHHHHHHHHHHhCCcEeecc
Q 011287          116 ---------DT---F-----SLYMALESCEGGELFDQIT---SKGHL---SEDEA-RFYTAEVVDALEYIHSMGLIHRDI  171 (489)
Q Consensus       116 ---------~~---~-----~lylV~E~~~gg~L~~~l~---~~~~l---~e~~~-~~i~~qil~aL~~LH~~gIiHrDL  171 (489)
                               ..   .     +.+++|+-+. +||.+++.   .....   ....+ ..+..|++..+++||..|++|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence                     11   1     2367888885 48877654   22222   12233 344589999999999999999999


Q ss_pred             CCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCC--------CCCCCCcchhhhH
Q 011287          172 KPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS--------PATFGNDLWALGC  243 (489)
Q Consensus       172 KpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~--------~~~~~sDiwSLG~  243 (489)
                      +|+|++++.+|.++|+||+.+.......             .....+..|.+||.....        .++.+.|.|+||+
T Consensus       172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~-------------~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~  238 (288)
T PF14531_consen  172 KPENFLLDQDGGVFLGDFSSLVRAGTRY-------------RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGI  238 (288)
T ss_dssp             SGGGEEE-TTS-EEE--GGGEEETTEEE-------------EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHH
T ss_pred             ceeeEEEcCCCCEEEcChHHHeecCcee-------------eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHH
Confidence            9999999999999999999876543211             112345779999987442        3688889999999


Q ss_pred             HHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhccCCCCC
Q 011287          244 TLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGR  297 (489)
Q Consensus       244 ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~~L~~dP~~R  297 (489)
                      +||.|+||+.||..........    ..+.....+|..+++||+.||+.||.+|
T Consensus       239 ~ly~lWC~~lPf~~~~~~~~~~----~~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  239 TLYSLWCGRLPFGLSSPEADPE----WDFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHHSS-STCCCGGGSTSG----GGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHHccCCCCCCCcccccc----ccchhcCCcCHHHHHHHHHHccCCcccC
Confidence            9999999999998654321111    0333344789999999999999999988

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=4.8e-24  Score=198.49  Aligned_cols=142  Identities=20%  Similarity=0.228  Sum_probs=113.1

Q ss_pred             eeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchh-----------------------HHHHHHHHHHHHHhCCCCC
Q 011287           50 GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN-----------------------KTAYVKLERIVLDQLDHPG  106 (489)
Q Consensus        50 ~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~-----------------------~~~~~~~E~~il~~l~hpn  106 (489)
                      ...||+|+||.||+|.+. +|+.||||++.........                       .......|..++..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            468999999999999997 8999999999765322111                       0123456999999998777


Q ss_pred             ccEEEEEEEcCCEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCcEeeccCCCCeeeCCCCCEE
Q 011287          107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI-HSMGLIHRDIKPENLLLTADGHIK  185 (489)
Q Consensus       107 Iv~l~~~~~~~~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~L-H~~gIiHrDLKpeNILl~~~g~ik  185 (489)
                      +..........  .++||||++|+++...+.+.+.+++..+..++.|++.+|.+| |+.||+||||||+|||++ ++.++
T Consensus        81 v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~  157 (190)
T cd05147          81 IPCPEPILLKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY  157 (190)
T ss_pred             CCCCcEEEecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence            64433322222  389999999988776655567899999999999999999999 799999999999999998 57999


Q ss_pred             EeeccCcccc
Q 011287          186 IADFGSVKPM  195 (489)
Q Consensus       186 L~DFG~a~~~  195 (489)
                      |+|||+|...
T Consensus       158 LiDFG~a~~~  167 (190)
T cd05147         158 IIDVSQSVEH  167 (190)
T ss_pred             EEEccccccC
Confidence            9999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=1e-23  Score=199.54  Aligned_cols=176  Identities=20%  Similarity=0.233  Sum_probs=137.7

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHH------HHHHHHHHHhCCCCCccEEEEEE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY------VKLERIVLDQLDHPGVVRLFFTF  114 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~  114 (489)
                      .+.-.+|++.++||.|+||.||++..  ++..+|+|++.......+.....      ..+|+..+.++.||+|..+..++
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~  104 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY  104 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence            34567899999999999999999755  47789999997665554444333      57899999999999999998887


Q ss_pred             EcC--------CEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEE
Q 011287          115 QDT--------FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI  186 (489)
Q Consensus       115 ~~~--------~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL  186 (489)
                      .+.        ...++||||++|.+|.+..    .+++.    ...+++.+|..||+.|++|||+||+||+++.+| ++|
T Consensus       105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~l  175 (232)
T PRK10359        105 LLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRI  175 (232)
T ss_pred             eecccccccccCCeEEEEEEECCccHHHhh----hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEE
Confidence            643        3579999999999997763    23432    456999999999999999999999999999998 999


Q ss_pred             eeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHh
Q 011287          187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQML  249 (489)
Q Consensus       187 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyell  249 (489)
                      +|||.........            ..          ..++....+..++|+||||+++..+.
T Consensus       176 iDfg~~~~~~e~~------------a~----------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        176 IDLSGKRCTAQRK------------AK----------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EECCCcccccchh------------hH----------HHHHHHhHhcccccccceeEeehHHH
Confidence            9999876542211            00          11344555667899999999886654

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.90  E-value=3.6e-23  Score=192.75  Aligned_cols=144  Identities=21%  Similarity=0.201  Sum_probs=115.3

Q ss_pred             EeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccch-----------------------hHHHHHHHHHHHHHhCCCC
Q 011287           49 LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE-----------------------NKTAYVKLERIVLDQLDHP  105 (489)
Q Consensus        49 ~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~-----------------------~~~~~~~~E~~il~~l~hp  105 (489)
                      +.+.||+|++|+||+|++. +|+.||||++........                       .......+|...+.++.|+
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            3578999999999999987 899999999986532110                       0122346788999999999


Q ss_pred             CccEEEEEEEcCCEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeeccCCCCeeeCCCCCE
Q 011287          106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHI  184 (489)
Q Consensus       106 nIv~l~~~~~~~~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~-~gIiHrDLKpeNILl~~~g~i  184 (489)
                      +|.....+....  .|+||||++|+++.......+.+++..+..++.|++.+|.+||+ .||+||||||+|||++ ++.+
T Consensus        80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~  156 (190)
T cd05145          80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP  156 (190)
T ss_pred             CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence            875444333332  48999999988665443344678999999999999999999999 9999999999999998 8999


Q ss_pred             EEeeccCccccC
Q 011287          185 KIADFGSVKPMQ  196 (489)
Q Consensus       185 kL~DFG~a~~~~  196 (489)
                      +|+|||+|..+.
T Consensus       157 ~liDFG~a~~~~  168 (190)
T cd05145         157 YIIDVSQAVELD  168 (190)
T ss_pred             EEEEcccceecC
Confidence            999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.89  E-value=1.1e-23  Score=227.09  Aligned_cols=287  Identities=33%  Similarity=0.477  Sum_probs=240.8

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~l  120 (489)
                      .-+.++|.+.+-+-+|+++.++.+.-..+|...++|+..+.........+.+..+..++-...+|.++.....|.-...+
T Consensus       800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~  879 (1205)
T KOG0606|consen  800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL  879 (1205)
T ss_pred             cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence            35789999999999999999999999999999999987665444444445555566666556778888777777777889


Q ss_pred             EEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      ++|++|+.+++|...+...+..+++-++.++..++.++++||...+.|||++|.|+++..+|+.+++|||+......-..
T Consensus       880 ~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p  959 (1205)
T KOG0606|consen  880 PLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP  959 (1205)
T ss_pred             chhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccC
Confidence            99999999999999999999899999999999999999999999999999999999999999999999995543321100


Q ss_pred             cc-------------cC------C--CCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCC
Q 011287          201 TV-------------LP------N--AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS  259 (489)
Q Consensus       201 ~~-------------~~------~--~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~  259 (489)
                      ..             ..      .  ..........+||+.|.+||.+.+.....++|+|++|+++++.++|.+||.+..
T Consensus       960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen  960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred             cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence            00             00      0  001133556799999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHhcCCCCCC---CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCCCCCC
Q 011287          260 EWLIFQRIIARDIRFPN---YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPK  329 (489)
Q Consensus       260 ~~~~~~~i~~~~~~~p~---~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~~~p~  329 (489)
                      ...+++.|.......|.   ..+.++++++.++|..+|.+|.++.  +..++..|+||++++|+++..+..+.
T Consensus      1040 pq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~--~~~e~k~~~~~~~~~~~~l~~q~~~~ 1110 (1205)
T KOG0606|consen 1040 PQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK--GAAEVKGHPFFQDVDWENLALQKAEF 1110 (1205)
T ss_pred             hhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc--cccccccCCccCCCCccccccccCcc
Confidence            99999999999888775   4799999999999999999999984  44689999999999999998876544

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.88  E-value=1.5e-23  Score=226.26  Aligned_cols=234  Identities=24%  Similarity=0.396  Sum_probs=178.0

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeeccc--ccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKF--ITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~--~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      +|...+.||.+.|=.|.+|++.+ |. |+||++-+..  +.-....+.+. |+. ...++|||.+++..+.......|+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~-~ik-~~l~~~pn~lPfqk~~~t~kAAylv   99 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLE-EIK-FALMKAPNCLPFQKVLVTDKAAYLV   99 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHH-HHH-HHhhcCCcccchHHHHHhhHHHHHH
Confidence            79999999999999999999865 44 9999997653  22222233333 444 6667999999998887778889999


Q ss_pred             EeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      -+|... +|.+.+..+..+..-+.+.|+.||+.||..+|..||+|||||.|||||+.=.-+.|+||..-+..      ..
T Consensus       100 Rqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPt------YL  172 (1431)
T KOG1240|consen  100 RQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPT------YL  172 (1431)
T ss_pred             HHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCc------cC
Confidence            999976 99999998888999999999999999999999999999999999999999889999999876521      01


Q ss_pred             CCCCCCCCcccee----cCCcCCChhhhcCC----------C-CCCCCcchhhhHHHHHHhh-CCCCCCCC---------
Q 011287          204 PNAASDDKACTFV----GTAAYVPPEVLNSS----------P-ATFGNDLWALGCTLYQMLS-GTSPFKDT---------  258 (489)
Q Consensus       204 ~~~~~~~~~~~~~----gt~~Y~aPE~l~~~----------~-~~~~sDiwSLG~ilyellt-G~~PF~~~---------  258 (489)
                      +. .......-|-    .-..|.|||.+...          + .+++-||||+||+++||++ |++||.-.         
T Consensus       173 Pe-DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~  251 (1431)
T KOG1240|consen  173 PE-DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGN  251 (1431)
T ss_pred             CC-CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccC
Confidence            10 1111111222    23469999987431          1 4677899999999999988 79999521         


Q ss_pred             --CHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhccCCCCCCCCC
Q 011287          259 --SEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAG  301 (489)
Q Consensus       259 --~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~  301 (489)
                        +....+.+|          -+..++.||..|++.||++|++|+
T Consensus       252 ~~~~e~~Le~I----------ed~~~Rnlil~Mi~rdPs~RlSAe  286 (1431)
T KOG1240|consen  252 ADDPEQLLEKI----------EDVSLRNLILSMIQRDPSKRLSAE  286 (1431)
T ss_pred             ccCHHHHHHhC----------cCccHHHHHHHHHccCchhccCHH
Confidence              111111121          134789999999999999999993

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=5.4e-22  Score=184.27  Aligned_cols=201  Identities=14%  Similarity=0.152  Sum_probs=143.8

Q ss_pred             eEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchh-HHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCEEEEEE
Q 011287           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN-KTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        47 y~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~-~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~lylV~  124 (489)
                      +.+...|++|+||+||++..  .+.+++.+.+.-....... ....+.+|+.+|++|. |++|.+++++    ...|++|
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm   77 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR   77 (218)
T ss_pred             cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence            45778999999999998876  6788887776543221111 1235788999999995 5889999886    3479999


Q ss_pred             eccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecc-CCCCeeeCCCCCEEEeeccCccccCCccc--c
Q 011287          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDI-KPENLLLTADGHIKIADFGSVKPMQDSRI--T  201 (489)
Q Consensus       125 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDL-KpeNILl~~~g~ikL~DFG~a~~~~~~~~--~  201 (489)
                      ||+.|.+|...+..      . ...++.|++.+|.+||++||+|||| ||+|||++.+|+++|+|||+|........  .
T Consensus        78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r  150 (218)
T PRK12274         78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR  150 (218)
T ss_pred             eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence            99999888654321      1 1357889999999999999999999 79999999999999999999985443210  0


Q ss_pred             ccC-CCCCCCCccceecCCcCCChhhhcC--CCCCCCCcchhhhHHHHHHhhCCCCCCCCCH
Q 011287          202 VLP-NAASDDKACTFVGTAAYVPPEVLNS--SPATFGNDLWALGCTLYQMLSGTSPFKDTSE  260 (489)
Q Consensus       202 ~~~-~~~~~~~~~~~~gt~~Y~aPE~l~~--~~~~~~sDiwSLG~ilyelltG~~PF~~~~~  260 (489)
                      ... ..-..-...-...++.|++|+...-  ..--...++++.|+-+|.++|+..|+-+.++
T Consensus       151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence            000 0000000011236788888886532  2222567999999999999999999866543

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=6.1e-21  Score=179.74  Aligned_cols=136  Identities=16%  Similarity=0.175  Sum_probs=108.9

Q ss_pred             EEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-----CCCCccEEEEEEEcCC---E
Q 011287           48 ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-----DHPGVVRLFFTFQDTF---S  119 (489)
Q Consensus        48 ~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~l~~~~~~~~---~  119 (489)
                      .-.+.||+|+||.||.  +..++.. +||++....   ......+.+|+.+++.+     .||||+++|++++++.   .
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~   78 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY   78 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence            3457899999999995  7777666 699886542   22345688999999999     6799999999999874   4


Q ss_pred             EE-EEEec--cCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHhCCcEeeccCCCCeeeCCC----CCEEEeeccC
Q 011287          120 LY-MALES--CEGGELFDQITSKGHLSEDEARFYTAEVVDAL-EYIHSMGLIHRDIKPENLLLTAD----GHIKIADFGS  191 (489)
Q Consensus       120 ly-lV~E~--~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL-~~LH~~gIiHrDLKpeNILl~~~----g~ikL~DFG~  191 (489)
                      ++ +||||  +.+|+|.+++.+ +.+++.  ..++.|++.++ +|||+++|+||||||+|||++.+    +.++|+||+-
T Consensus        79 v~~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         79 VYDVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             EEEEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            44 78999  557999999976 457766  35678888887 99999999999999999999743    3799999544


Q ss_pred             c
Q 011287          192 V  192 (489)
Q Consensus       192 a  192 (489)
                      +
T Consensus       156 ~  156 (210)
T PRK10345        156 E  156 (210)
T ss_pred             C
Confidence            3

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=3.7e-21  Score=211.43  Aligned_cols=225  Identities=25%  Similarity=0.344  Sum_probs=173.4

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC---CCCccEEEEEEEcC
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD---HPGVVRLFFTFQDT  117 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~  117 (489)
                      .+....|.|-+.||+|+||.||.|.... |+.||+|+-.......-      ..-.+++.+|+   -+.|..+...+.-.
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEf------YI~~q~~~RLk~~~~~~~~~~~~a~~~~  766 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEF------YICLQVMERLKPQMLPSIMHISSAHVFQ  766 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceee------eehHHHHHhhchhhhcchHHHHHHHccC
Confidence            3456789999999999999999999977 99999998654433222      12334455554   23455555555555


Q ss_pred             CEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCC-------CCCEEEeecc
Q 011287          118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-------DGHIKIADFG  190 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~-------~g~ikL~DFG  190 (489)
                      +.-++|+||.+.|+|.++++..+.+++..+.+++.|++..|++||..||||+||||.|+||..       .--++|+|||
T Consensus       767 ~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG  846 (974)
T KOG1166|consen  767 NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFG  846 (974)
T ss_pred             CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecc
Confidence            667899999999999999998888999999999999999999999999999999999999953       2359999999


Q ss_pred             CccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc
Q 011287          191 SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR  270 (489)
Q Consensus       191 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~  270 (489)
                      .+..+..-        +...+....++|-.+-++|++.++++++.+|.|.|+.+++-||.|+.-          + ...+
T Consensus       847 ~siDm~lf--------p~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~----------q-~~~g  907 (974)
T KOG1166|consen  847 RSIDMKLF--------PDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM----------E-VKNG  907 (974)
T ss_pred             cceeeeEc--------CCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH----------H-hcCC
Confidence            98765332        123455677899999999999999999999999999999999998521          1 1111


Q ss_pred             -----CCCCCCCCCHH-HHHHHHHhhc
Q 011287          271 -----DIRFPNYFSDA-ARDLIDRLLD  291 (489)
Q Consensus       271 -----~~~~p~~~~~~-~~~Li~~~L~  291 (489)
                           ...+|..+..+ .-+++..+|+
T Consensus       908 ~~~~~~~~~~Ry~~~~~W~~~F~~lLN  934 (974)
T KOG1166|consen  908 SSWMVKTNFPRYWKRDMWNKFFDLLLN  934 (974)
T ss_pred             cceeccccchhhhhHHHHHHHHHHHhC
Confidence                 11244444444 4578888887

>smart00090 RIO RIO-like kinase

Probab=99.84  E-value=1.3e-20  Score=181.36  Aligned_cols=145  Identities=19%  Similarity=0.191  Sum_probs=116.0

Q ss_pred             CeEEeeEEeeeCceEEEEEE-EcCCCcEEEEEEeecccccc---------------------hhHHHHHHHHHHHHHhCC
Q 011287           46 DFELGKIYGVGSYSKVVRAK-KIDTGTVYALKIMDKKFITK---------------------ENKTAYVKLERIVLDQLD  103 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~-~~~tg~~vAiK~~~k~~~~~---------------------~~~~~~~~~E~~il~~l~  103 (489)
                      .|.+.+.||+|+||.||+|. +..+|+.||+|++.......                     ......+.+|..++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48899999999999999999 66789999999987542110                     001234567999999997


Q ss_pred             CCC--ccEEEEEEEcCCEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC-cEeeccCCCCeeeCC
Q 011287          104 HPG--VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG-LIHRDIKPENLLLTA  180 (489)
Q Consensus       104 hpn--Iv~l~~~~~~~~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~g-IiHrDLKpeNILl~~  180 (489)
                      +.+  +.+++..    ...|+||||+.|++|.........+....+..++.||+.+|.+||+.| |+||||||+||+++ 
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-  183 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-  183 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence            533  3444432    235899999999888776545556777788999999999999999999 99999999999999 


Q ss_pred             CCCEEEeeccCcccc
Q 011287          181 DGHIKIADFGSVKPM  195 (489)
Q Consensus       181 ~g~ikL~DFG~a~~~  195 (489)
                      ++.++|+|||.|...
T Consensus       184 ~~~i~LiDFg~a~~~  198 (237)
T smart00090      184 DGKVVIIDVSQSVEL  198 (237)
T ss_pred             CCCEEEEEChhhhcc
Confidence            889999999998754

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.84  E-value=7.5e-22  Score=200.48  Aligned_cols=170  Identities=29%  Similarity=0.436  Sum_probs=132.0

Q ss_pred             EEEEEEeccCCCChHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCcccc
Q 011287          119 SLYMALESCEGGELFDQITSKG---HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~~---~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~  195 (489)
                      ++|+.|++|+..+|.++|.+..   ..+......++.|+..|++|   +|.+|||+||.||+...+..+||.|||++...
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~  406 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ  406 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence            4789999999999999997543   36777889999999999999   99999999999999999999999999998765


Q ss_pred             CCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHH-HHHHHHHhcCCCC
Q 011287          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQRIIARDIRF  274 (489)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~-~~~~~i~~~~~~~  274 (489)
                      ....    ............+||..||+||.+.+..|+.++||||||+|+|||+.   +|....+. .++.-+..+  .+
T Consensus       407 ~~~~----~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~~er~~t~~d~r~g--~i  477 (516)
T KOG1033|consen  407 DKDE----TVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQFERIATLTDIRDG--II  477 (516)
T ss_pred             ccCC----cccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccHHHHHHhhhhhhcC--CC
Confidence            4432    11122335557799999999999999999999999999999999997   23222111 122222222  33


Q ss_pred             CCC---CCHHHHHHHHHhhccCCCCCCCC
Q 011287          275 PNY---FSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       275 p~~---~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      |+.   -.++-.+|+..||.+.|.+||++
T Consensus       478 p~~~~~d~p~e~~ll~~lls~~p~~RP~~  506 (516)
T KOG1033|consen  478 PPEFLQDYPEEYTLLQQLLSPSPEERPSA  506 (516)
T ss_pred             ChHHhhcCcHHHHHHHHhcCCCcccCchH
Confidence            321   13556799999999999999966

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.81  E-value=1.8e-21  Score=209.61  Aligned_cols=260  Identities=27%  Similarity=0.397  Sum_probs=210.1

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEc-CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKI-DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~-~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~ly  121 (489)
                      ...|.+.+.||+|+|+.|-++... .+...+|+|.+.... ........+..|..+-..+. |+|++.+++...+....+
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~   97 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL   97 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence            467888888999999999999884 455667777665443 22334445555777777776 999999999999999999


Q ss_pred             EEEeccCCCChHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-hCCcEeeccCCCCeeeCCCC-CEEEeeccCccccCC
Q 011287          122 MALESCEGGELFDQI-TSKG-HLSEDEARFYTAEVVDALEYIH-SMGLIHRDIKPENLLLTADG-HIKIADFGSVKPMQD  197 (489)
Q Consensus       122 lV~E~~~gg~L~~~l-~~~~-~l~e~~~~~i~~qil~aL~~LH-~~gIiHrDLKpeNILl~~~g-~ikL~DFG~a~~~~~  197 (489)
                      ++++|..|+++++.+ .... ..+...+..++.|+..++.|+| ..++.||||||+|.+++..+ .++++|||+|..+..
T Consensus        98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen   98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN  177 (601)
T ss_pred             cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence            999999999999998 5554 6889999999999999999999 99999999999999999999 999999999987655


Q ss_pred             ccccccCCCCCCCCccceec-CCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHH-H-HHhc---
Q 011287          198 SRITVLPNAASDDKACTFVG-TAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQ-R-IIAR---  270 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~g-t~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~-~-i~~~---  270 (489)
                      ..       .........+| ++.|+|||.+.+. ...+..|+||+|+++..+++|..|+.......... . +...   
T Consensus       178 ~~-------g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~  250 (601)
T KOG0590|consen  178 KN-------GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRF  250 (601)
T ss_pred             cC-------CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccccccc
Confidence            21       12334445678 9999999999885 45778899999999999999999997654433211 1 1111   


Q ss_pred             CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          271 DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       271 ~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      .......++..+.+++.++|..+|..|.+.     +++..+||+..
T Consensus       251 ~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~-----~~~~~d~~~~~  291 (601)
T KOG0590|consen  251 TQLPWNSISDQAHDLLHKILKENPSNRLSI-----EELKLDNWLSS  291 (601)
T ss_pred             ccCccccCChhhhhcccccccCCchhcccc-----ccccccccccc
Confidence            233446789999999999999999999998     77999999987

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=8.3e-19  Score=165.62  Aligned_cols=138  Identities=24%  Similarity=0.301  Sum_probs=115.0

Q ss_pred             eeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccc-----hhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           50 GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-----ENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        50 ~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~-----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      ++.||+|++|.||+|.+  +|..+++|+........     ......+.+|..++..+.|++|.....++.+....++||
T Consensus         1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~   78 (211)
T PRK14879          1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM   78 (211)
T ss_pred             CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence            36799999999999987  68889999865432211     112345677999999999999877776777777889999


Q ss_pred             eccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccc
Q 011287          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (489)
Q Consensus       125 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~  194 (489)
                      ||++|++|.+.+.....    ....++.+++.+|.+||+.|++|||++|.|||++ ++.++|+|||.+..
T Consensus        79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999998876432    7888999999999999999999999999999998 88999999999874

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.79  E-value=1.5e-19  Score=169.21  Aligned_cols=240  Identities=17%  Similarity=0.268  Sum_probs=192.0

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ly  121 (489)
                      +.+.+..+..+|.+.-.|+.|++++.  |..+++|++........ ....+..|.-.|+-..||||+.+++.+....++.
T Consensus       187 id~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~r-isrdfneefp~lrifshpnilpvlgacnsppnlv  263 (448)
T KOG0195|consen  187 IDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTAR-ISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV  263 (448)
T ss_pred             cchhhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhcchh-hcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence            34556677888899999999999995  55677888865543332 3345666888888889999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCC--cEeeccCCCCeeeCCCCCEEE--eeccCcccc
Q 011287          122 MALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSMG--LIHRDIKPENLLLTADGHIKI--ADFGSVKPM  195 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~~~~--l~e~~~~~i~~qil~aL~~LH~~g--IiHrDLKpeNILl~~~g~ikL--~DFG~a~~~  195 (489)
                      ++..|++-|+|+.++.....  .+..++..++..++.++.|||+..  |.---|....++||++.+.+|  +|--++...
T Consensus       264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe  343 (448)
T KOG0195|consen  264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE  343 (448)
T ss_pred             EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec
Confidence            99999999999999987644  688899999999999999999985  444468888999999876554  343332210


Q ss_pred             CCccccccCCCCCCCCccceecCCcCCChhhhcCCCC---CCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHh--c
Q 011287          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA---TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA--R  270 (489)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~---~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~--~  270 (489)
                                   .    ...-.+.|||||.|...+.   -.++|+|||.++++||.|...||...++.+.--+|--  .
T Consensus       344 -------------~----gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialegl  406 (448)
T KOG0195|consen  344 -------------V----GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGL  406 (448)
T ss_pred             -------------c----ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccc
Confidence                         0    1234688999999987764   3578999999999999999999999888876655543  3


Q ss_pred             CCCCCCCCCHHHHHHHHHhhccCCCCCCCCC
Q 011287          271 DIRFPNYFSDAARDLIDRLLDVDPSGRPGAG  301 (489)
Q Consensus       271 ~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~  301 (489)
                      ...+|++++.....|+.-|.+.||.+||...
T Consensus       407 rv~ippgis~hm~klm~icmnedpgkrpkfd  437 (448)
T KOG0195|consen  407 RVHIPPGISRHMNKLMNICMNEDPGKRPKFD  437 (448)
T ss_pred             cccCCCCccHHHHHHHHHHhcCCCCcCCCcc
Confidence            5678999999999999999999999999763

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.77  E-value=1.3e-18  Score=162.97  Aligned_cols=141  Identities=23%  Similarity=0.218  Sum_probs=110.1

Q ss_pred             eEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccch-------------------hHHHHHHHHHHHHHhCCCCC-
Q 011287           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE-------------------NKTAYVKLERIVLDQLDHPG-  106 (489)
Q Consensus        47 y~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~-------------------~~~~~~~~E~~il~~l~hpn-  106 (489)
                      |.+.+.||+|+||.||+|... +|+.||||++........                   ........|..++..+.|++ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            788899999999999999874 799999999765321000                   01123566888888887773 


Q ss_pred             -ccEEEEEEEcCCEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEE
Q 011287          107 -VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIK  185 (489)
Q Consensus       107 -Iv~l~~~~~~~~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ik  185 (489)
                       +..++.    ....++||||++|++|......      .....++.+++.++.++|+.||+||||||+||++++++.++
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~  165 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY  165 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence             444443    2346899999999988664321      45667889999999999999999999999999999999999


Q ss_pred             EeeccCccccCCc
Q 011287          186 IADFGSVKPMQDS  198 (489)
Q Consensus       186 L~DFG~a~~~~~~  198 (489)
                      |+|||.+......
T Consensus       166 liDfg~~~~~~~~  178 (198)
T cd05144         166 IIDWPQMVSTDHP  178 (198)
T ss_pred             EEECCccccCCCc
Confidence            9999999765443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.77  E-value=2.1e-18  Score=161.37  Aligned_cols=133  Identities=20%  Similarity=0.213  Sum_probs=107.2

Q ss_pred             EEeeeCceEEEEEEEcCCCcEEEEEEeecccccc-----hhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEec
Q 011287           52 IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-----ENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALES  126 (489)
Q Consensus        52 ~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~-----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~  126 (489)
                      .||+|+||.||+|..  +|..+++|+........     ......+.+|..+++.+.|+++.....++.+....++||||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            489999999999984  67899999865432111     12235567899999999888765444444556667999999


Q ss_pred             cCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccc
Q 011287          127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (489)
Q Consensus       127 ~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~  194 (489)
                      ++|++|.+.+.....       .++.+++.+|.+||+.|++|||++|.||+++ ++.++++|||++..
T Consensus        79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999988765321       7899999999999999999999999999999 88999999999874

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.76  E-value=2.8e-18  Score=158.81  Aligned_cols=141  Identities=20%  Similarity=0.270  Sum_probs=102.0

Q ss_pred             EeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHH---------------------HHHHHHHHHhCCCCC-
Q 011287           49 LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---------------------VKLERIVLDQLDHPG-  106 (489)
Q Consensus        49 ~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~---------------------~~~E~~il~~l~hpn-  106 (489)
                      +++.||+|+||+||+|.+. +|+.||||++.............                     ...|...+..+.+.+ 
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   79 (187)
T cd05119           1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV   79 (187)
T ss_pred             CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence            3578999999999999986 89999999987543222221111                     134566666664432 


Q ss_pred             -ccEEEEEEEcCCEEEEEEeccCCCChHH-HHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeeccCCCCeeeCCCCC
Q 011287          107 -VVRLFFTFQDTFSLYMALESCEGGELFD-QITSKGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGH  183 (489)
Q Consensus       107 -Iv~l~~~~~~~~~lylV~E~~~gg~L~~-~l~~~~~l~e~~~~~i~~qil~aL~~LH~-~gIiHrDLKpeNILl~~~g~  183 (489)
                       +.+++..    ...++||||++++.+.. .+... ... ..++.++.+++.++.++|. .||+||||||+||+++ ++.
T Consensus        80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~  152 (187)
T cd05119          80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK  152 (187)
T ss_pred             CCCceEec----CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence             4445543    23589999999954432 11111 111 6788999999999999999 9999999999999999 899


Q ss_pred             EEEeeccCccccCC
Q 011287          184 IKIADFGSVKPMQD  197 (489)
Q Consensus       184 ikL~DFG~a~~~~~  197 (489)
                      ++|+|||.+.....
T Consensus       153 ~~liDfg~a~~~~~  166 (187)
T cd05119         153 VYIIDVPQAVEIDH  166 (187)
T ss_pred             EEEEECcccccccC
Confidence            99999999975543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.75  E-value=1e-17  Score=180.29  Aligned_cols=139  Identities=19%  Similarity=0.238  Sum_probs=112.6

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeeccccc-----chhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT-----KENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~-----~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  119 (489)
                      ..|...+.||+|+||+||++...  +..+++|+.......     .......+.+|..+++.++|++++..+.+..+...
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             cccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            34567899999999999999874  344555543222111     11223557789999999999999988777777777


Q ss_pred             EEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccc
Q 011287          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~  194 (489)
                      .++||||++|++|.+++.        ....++.+++.+|.+||+.|++||||||+|||+ .++.++|+|||+++.
T Consensus       411 ~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             CEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            899999999999998875        356789999999999999999999999999999 678999999999874

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.70  E-value=2.2e-16  Score=152.22  Aligned_cols=138  Identities=20%  Similarity=0.251  Sum_probs=105.5

Q ss_pred             eeEEe-eeCceEEEEEEEcCCCcEEEEEEeecccc-----c-----chhHHHHHHHHHHHHHhCCCCCc--cEEEEEEEc
Q 011287           50 GKIYG-VGSYSKVVRAKKIDTGTVYALKIMDKKFI-----T-----KENKTAYVKLERIVLDQLDHPGV--VRLFFTFQD  116 (489)
Q Consensus        50 ~~~LG-~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~-----~-----~~~~~~~~~~E~~il~~l~hpnI--v~l~~~~~~  116 (489)
                      ...|| .|+.|+||.+..  .+..+++|.+....+     .     .......+.+|..++..|.|++|  +..+.+...
T Consensus        36 ~~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            34677 788888888876  378999998865321     1     11233557789999999988775  566665433


Q ss_pred             C-CE---EEEEEeccCC-CChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccC
Q 011287          117 T-FS---LYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS  191 (489)
Q Consensus       117 ~-~~---lylV~E~~~g-g~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~  191 (489)
                      . ..   .++|||+++| .+|.+++.. +.+++..    +.+|+.+|.+||++||+||||||+|||++.++.++|+|||.
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~  188 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR  188 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence            2 22   3599999997 688888765 4566654    56899999999999999999999999999999999999998


Q ss_pred             ccc
Q 011287          192 VKP  194 (489)
Q Consensus       192 a~~  194 (489)
                      +..
T Consensus       189 ~~~  191 (239)
T PRK01723        189 GEL  191 (239)
T ss_pred             ccc
Confidence            864

>cd01251 PH_centaurin_alpha Centaurin alpha Pleckstrin homology (PH) domain

Probab=99.67  E-value=1.2e-16  Score=133.40  Aligned_cols=89  Identities=18%  Similarity=0.330  Sum_probs=72.1

Q ss_pred             EEEeeehhhhh-h--ccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEE-------E-cCCCcEEEEcCCceEE
Q 011287          400 MISMVKKLQKL-T--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQ-------V-SSPSHFKIVTPKKVLS  468 (489)
Q Consensus       400 ~~g~~~k~~g~-~--~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~-------~-~~~~~f~i~~p~r~y~  468 (489)
                      |+|||.|++|. .  ||||||+|++.-..||.++.....+|+|+|+.......|.       . +....|.|+||+|||+
T Consensus         1 KeG~L~K~g~~~~k~wkkRwFvL~~~~L~Yyk~~~d~~~~G~I~L~~~~~~~~v~~~~~~~~~~~~~~~F~i~t~~Rty~   80 (103)
T cd01251           1 KEGFMEKTGPKHTEGFKKRWFTLDDRRLMYFKDPLDAFAKGEVFLGSQEDGYEVREGLPPGTQGNHWYGVTLVTPERKFL   80 (103)
T ss_pred             CceeEEecCCCCCCCceeEEEEEeCCEEEEECCCCCcCcCcEEEeeccccceeEeccCCccccccccceEEEEeCCeEEE
Confidence            58999999975 3  9999999998877789898888999999998653212231       1 2224899999999999


Q ss_pred             EE-cCCccHHHHHHHHHHhcC
Q 011287          469 FE-DAKQRASQWKKAIEALQN  488 (489)
Q Consensus       469 ~~-d~~~~~~~W~~~i~~~~~  488 (489)
                      |. +.+.++++|+++|+.|++
T Consensus        81 l~a~s~~e~~~Wi~ai~~v~~  101 (103)
T cd01251          81 FACETEQDRREWIAAFQNVLS  101 (103)
T ss_pred             EECCCHHHHHHHHHHHHHHhc
Confidence            99 566999999999999874

Centaurin alpha Pleckstrin homology (PH) domain. Centaurin alpha is a phophatidlyinositide binding protein consisting of an N-terminal ArfGAP domain and two PH domains. In response to growth factor activation, PI3K phosphorylates phosphatidylinositol 4,5-bisphosphate to phosphatidylinositol 3,4,5-trisphosphate. Centaurin alpha 1 is recruited to the plasma membrane following growth factor stimulation by specific binding of its PH domain to phosphatidylinositol 3,4,5-trisphosphate. Centaurin alpha 2 is constitutively bound to the plasma membrane since it binds phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol 3,4,5-trisphosphate with equal affinity. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specifici

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.66  E-value=5.2e-16  Score=136.89  Aligned_cols=132  Identities=23%  Similarity=0.232  Sum_probs=112.3

Q ss_pred             EeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC--CCccEEEEEEEcCCEEEEEEec
Q 011287           49 LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH--PGVVRLFFTFQDTFSLYMALES  126 (489)
Q Consensus        49 ~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~~~lylV~E~  126 (489)
                      +++.||.|.++.||++....  ..+++|.+.....     ...+..|..+++.+.|  .++.+++.++...+..|++|||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence            46789999999999999843  7899999865422     3457779999999976  5899999998888889999999


Q ss_pred             cCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CcEeeccCCCCeeeCCCCCEEEeeccCccc
Q 011287          127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM---GLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (489)
Q Consensus       127 ~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~---gIiHrDLKpeNILl~~~g~ikL~DFG~a~~  194 (489)
                      +.|+.+..+       +......++.+++.+|..||..   +++|+|++|+||++++++.++++|||.+..
T Consensus        75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            998877543       5567778899999999999985   799999999999999989999999999864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.64  E-value=1.5e-15  Score=157.36  Aligned_cols=196  Identities=21%  Similarity=0.343  Sum_probs=153.4

Q ss_pred             HHhCCCCCccEEEEEEEcCCEEEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCc-EeeccCCCCe
Q 011287           99 LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGL-IHRDIKPENL  176 (489)
Q Consensus        99 l~~l~hpnIv~l~~~~~~~~~lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gI-iHrDLKpeNI  176 (489)
                      |+.+.|.|+.++++...+....+.|.+||..|+|.+.+... -.++..-...++.+|+.||+|||.-.| .|+.+++.|.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            35678999999999999999999999999999999999873 357777778889999999999998765 9999999999


Q ss_pred             eeCCCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCC-------CCCCCcchhhhHHHHHHh
Q 011287          177 LLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP-------ATFGNDLWALGCTLYQML  249 (489)
Q Consensus       177 Ll~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~-------~~~~sDiwSLG~ilyell  249 (489)
                      +++....+||+|||+........        .........-...|.|||.+....       .+.+.|+||+|+|+||++
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~--------~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~  152 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETA--------EPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL  152 (484)
T ss_pred             eeeeeEEEEechhhhcccccccc--------cccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence            99999999999999987654300        000111112345689999997642       366789999999999999


Q ss_pred             hCCCCCCCC----CHHHHHHHHHh-cCCCC-CC-----CCCHHHHHHHHHhhccCCCCCCCCCC
Q 011287          250 SGTSPFKDT----SEWLIFQRIIA-RDIRF-PN-----YFSDAARDLIDRLLDVDPSGRPGAGP  302 (489)
Q Consensus       250 tG~~PF~~~----~~~~~~~~i~~-~~~~~-p~-----~~~~~~~~Li~~~L~~dP~~R~t~~~  302 (489)
                      +..-||...    ...++..++.. ....+ |.     .+++++..+++.|+..+|.+||++.+
T Consensus       153 ~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~  216 (484)
T KOG1023|consen  153 FRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQ  216 (484)
T ss_pred             hccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHH
Confidence            999999763    22345555555 22212 21     34568999999999999999999854

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.62  E-value=4e-16  Score=161.69  Aligned_cols=263  Identities=23%  Similarity=0.303  Sum_probs=203.5

Q ss_pred             CCCCCeEEeeEEee--eCceEEEEEEE--cCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEc
Q 011287           42 FSIQDFELGKIYGV--GSYSKVVRAKK--IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQD  116 (489)
Q Consensus        42 ~~~~dy~~~~~LG~--G~~g~Vy~a~~--~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~  116 (489)
                      +.-+.|.+.+.+|.  |.+|.||.++.  ..++..+|+|.-+...- .......-.+|....+.+ .|++.++.+..+..
T Consensus       111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s-~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~  189 (524)
T KOG0601|consen  111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFS-PPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG  189 (524)
T ss_pred             hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCC-CccccccccchhhcccccCccccccccCccccc
Confidence            33456889999999  99999999998  88999999997543322 112222233466555666 49999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHHHhCCcEeeccCCCCeeeCCC-CCEEEeecc
Q 011287          117 TFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVD----ALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFG  190 (489)
Q Consensus       117 ~~~lylV~E~~~gg~L~~~l~~~~~-l~e~~~~~i~~qil~----aL~~LH~~gIiHrDLKpeNILl~~~-g~ikL~DFG  190 (489)
                      .+.+|+-+|+|. .+|..+...... +++..++.++.+...    ||.++|+.+++|-|+||.||++..+ ...+++|||
T Consensus       190 ~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~  268 (524)
T KOG0601|consen  190 SGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFG  268 (524)
T ss_pred             CCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcc
Confidence            999999999996 588888876654 899999999999999    9999999999999999999999999 899999999


Q ss_pred             CccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCC--CHHHHHHHHH
Q 011287          191 SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT--SEWLIFQRII  268 (489)
Q Consensus       191 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~--~~~~~~~~i~  268 (489)
                      +...+.........     .......|...|++||.+.+ -++.+.|++|||-++.+..+|..++...  +.+..+..+.
T Consensus       269 ~v~~i~~~~~~~~~-----~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  269 LVSKISDGNFSSVF-----KVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             eeEEccCCccccce-----eeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            99887665422111     11112257788999999865 4677899999999999999988777654  3333333322


Q ss_pred             hcCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 011287          269 ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (489)
Q Consensus       269 ~~~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~  318 (489)
                       ...+|....+.++..++..|++.+|..|+++     +.+++|++.....
T Consensus       343 -ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~-----q~~~~l~~i~s~~  386 (524)
T KOG0601|consen  343 -IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTA-----QILTALNVIHSKL  386 (524)
T ss_pred             -CchhhhcCcchhhhhHHHHhcCcchhhhhHH-----HHHhccccccchh
Confidence             3344555667788889999999999999998     8899999987544

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.61  E-value=1.1e-16  Score=169.62  Aligned_cols=188  Identities=20%  Similarity=0.289  Sum_probs=121.1

Q ss_pred             cccccch-----hhHhhhhcCCCCCCCCCcccCCccccccCCCCCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEE
Q 011287            2 LAMEKDF-----DSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALK   76 (489)
Q Consensus         2 ~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK   76 (489)
                      ||.+.|+     .+.|+.-....++-+...+...-...++.|.+.. ..+|+. +.||.|++|+||.|+.+++|+.||||
T Consensus        73 LStR~DllP~~~~~eL~~Lqd~vpp~~~~~~~~~ie~elG~~~~~~-F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVK  150 (537)
T PRK04750         73 LSTRRDLFPPDIADELALLQDRVPPFDGALARAIIEKALGGPVEEW-FDDFDI-KPLASASIAQVHFARLKDNGREVVVK  150 (537)
T ss_pred             HHcCcccCCHHHHHHHHHHHcCCCCCCHHHHHHHHHHHhCCCHHHH-HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEE
Confidence            4555543     5666666665555544444433333444444332 567887 89999999999999999889999999


Q ss_pred             Eeecccccc-------------------------------hhHHHHHHHHHH------HHHhC----CCCCccEEEEEEE
Q 011287           77 IMDKKFITK-------------------------------ENKTAYVKLERI------VLDQL----DHPGVVRLFFTFQ  115 (489)
Q Consensus        77 ~~~k~~~~~-------------------------------~~~~~~~~~E~~------il~~l----~hpnIv~l~~~~~  115 (489)
                      +........                               .+....+.+|.+      .+.++    .+...+.+-.+|.
T Consensus       151 V~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~  230 (537)
T PRK04750        151 VLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYW  230 (537)
T ss_pred             EeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeec
Confidence            997541000                               011222333333      33333    2333344444443


Q ss_pred             c-CCEEEEEEeccCCCChHHH--HHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCC----CE
Q 011287          116 D-TFSLYMALESCEGGELFDQ--ITSKG----HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG----HI  184 (489)
Q Consensus       116 ~-~~~lylV~E~~~gg~L~~~--l~~~~----~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g----~i  184 (489)
                      + ....++||||+.|+.+.+.  +...+    .+.+..+..++.|++       ..|++|+|+||.||+++.+|    .+
T Consensus       231 d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i  303 (537)
T PRK04750        231 DYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RDGFFHADMHPGNIFVSYDPPENPRY  303 (537)
T ss_pred             ccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hCCeeeCCCChHHeEEecCCCCCCeE
Confidence            3 4557899999999999764  33433    244555555555554       58999999999999999988    99


Q ss_pred             EEeeccCccccCCc
Q 011287          185 KIADFGSVKPMQDS  198 (489)
Q Consensus       185 kL~DFG~a~~~~~~  198 (489)
                      +++|||++..+...
T Consensus       304 ~llDFGivg~l~~~  317 (537)
T PRK04750        304 IALDFGIVGSLNKE  317 (537)
T ss_pred             EEEecceEEECCHH
Confidence            99999999877543

>cd01264 PH_melted Melted pleckstrin homology (PH) domain

Probab=99.61  E-value=9.6e-16  Score=125.72  Aligned_cols=88  Identities=17%  Similarity=0.189  Sum_probs=69.2

Q ss_pred             EEEeeehhhh---hh--ccceeEEEecCCeEEEECCCCCee-eeeeeccCCCCceEEEEcC-----CCcEEEEcCCceEE
Q 011287          400 MISMVKKLQK---LT--SKKVQLILTNKPKLIYVDPSKLVV-KGNIIWSDNSNDLSIQVSS-----PSHFKIVTPKKVLS  468 (489)
Q Consensus       400 ~~g~~~k~~g---~~--~k~r~~~lt~~p~l~y~d~~~~~~-kg~i~~~~~~~~~~~~~~~-----~~~f~i~~p~r~y~  468 (489)
                      .+|+++|++|   ++  ||+|||+|+++-..||.+...... .|.|+|+.+.++..++...     .+.|.|.||+|||+
T Consensus         2 ~~G~l~k~~g~~r~~K~WkrRwF~L~~~~L~y~K~~~~~~~~~g~IdL~~~~sVk~~~~~~~~~~~~~~Fei~tp~rt~~   81 (101)
T cd01264           2 IEGQLKEKKGRWRFIKRWKTRYFTLSGAQLLFQKGKSKDDPDDCSIDLSKIRSVKAVAKKRRDRSLPKAFEIFTADKTYI   81 (101)
T ss_pred             cceEEeecCccceeeecceeEEEEEeCCEEEEEeccCccCCCCceEEcccceEEeeccccccccccCcEEEEEcCCceEE
Confidence            4799999999   55  999999999887778888754444 4999999983222222111     37999999999999


Q ss_pred             EE-cCCccHHHHHHHHHHhc
Q 011287          469 FE-DAKQRASQWKKAIEALQ  487 (489)
Q Consensus       469 ~~-d~~~~~~~W~~~i~~~~  487 (489)
                      |. |.+.++++|+++|+.++
T Consensus        82 l~A~se~e~e~WI~~i~~a~  101 (101)
T cd01264          82 LKAKDEKNAEEWLQCLNIAV  101 (101)
T ss_pred             EEeCCHHHHHHHHHHHHhhC
Confidence            99 67799999999998763

Melted pleckstrin homology (PH) domain. The melted protein has a C-terminal PH domain. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains. PH domains are found in cellular signaling proteins such as serine/threonine kinase, tyrosine kinsases, regulators of G-proteins, endocytotic GTPases, adaptors, as well as cytoskeletal associated molecules and in lipid associated enzymes.

>cd01233 Unc104 Unc-104 pleckstrin homology (PH) domain

Probab=99.57  E-value=5.1e-15  Score=122.93  Aligned_cols=86  Identities=16%  Similarity=0.219  Sum_probs=73.1

Q ss_pred             EEEEEeeehhhhhh--ccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEE--------cCCCcEEEEcCCceE
Q 011287          398 VLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV--------SSPSHFKIVTPKKVL  467 (489)
Q Consensus       398 i~~~g~~~k~~g~~--~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~--------~~~~~f~i~~p~r~y  467 (489)
                      |+|+|+|.|++|.+  ||||||+|.+.-..||.+......+|.|+|+.+    .++.        ++++.|.|.||+|||
T Consensus         2 v~k~G~L~Kkg~~~k~WkkRwfvL~~~~L~yyk~~~~~~~~~~I~L~~~----~v~~~~~~~~~~~~~~~F~I~t~~rt~   77 (100)
T cd01233           2 VSKKGYLNFPEETNSGWTRRFVVVRRPYLHIYRSDKDPVERGVINLSTA----RVEHSEDQAAMVKGPNTFAVCTKHRGY   77 (100)
T ss_pred             cceeEEEEeeCCCCCCcEEEEEEEECCEEEEEccCCCccEeeEEEeccc----EEEEccchhhhcCCCcEEEEECCCCEE
Confidence            68999999999866  999999999987778888887899999999954    3322        246799999999999


Q ss_pred             EEE-cCCccHHHHHHHHHHhc
Q 011287          468 SFE-DAKQRASQWKKAIEALQ  487 (489)
Q Consensus       468 ~~~-d~~~~~~~W~~~i~~~~  487 (489)
                      +|. +++.++++|+++|+..+
T Consensus        78 ~~~A~s~~e~~~Wi~ai~~~~   98 (100)
T cd01233          78 LFQALSDKEMIDWLYALNPLY   98 (100)
T ss_pred             EEEcCCHHHHHHHHHHhhhhh
Confidence            998 56689999999998765

Unc-104 pleckstrin homology (PH) domain. Unc-104 is a kinesin-like protein containing an N-terminal kinesin catalytic domain, followed by a forkhead associated domain with a C-terminal PH domain. These proteins are responsible for the transport of membrane vesicles along microtubules. The mechanism involves the binding of the PH domain to phosphatidiylinositol (4,5) P2-containing liposomes.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.55  E-value=7.4e-14  Score=146.26  Aligned_cols=229  Identities=17%  Similarity=0.283  Sum_probs=156.7

Q ss_pred             eeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEeccCCCChH
Q 011287           54 GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELF  133 (489)
Q Consensus        54 G~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~~~gg~L~  133 (489)
                      +-++.+..-.|..+.++.+|.|.+++...   ......+.+-..-|+.++||||+++++.+..+..+|+|+|.+.  .|.
T Consensus        21 ~~~~~a~~~~~t~k~~~~~vsVF~~~~~~---~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~   95 (690)
T KOG1243|consen   21 AFSSEALWPDGTRKADGGPVSVFVYKRSN---GEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLE   95 (690)
T ss_pred             cCCCcccccccceeccCCceEEEEEeCCC---chhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHH
Confidence            33444433356777889999999987652   2445667778888999999999999999999999999999995  577


Q ss_pred             HHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCCCCc
Q 011287          134 DQITSKGHLSEDEARFYTAEVVDALEYIH-SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA  212 (489)
Q Consensus       134 ~~l~~~~~l~e~~~~~i~~qil~aL~~LH-~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~  212 (489)
                      .++++.+   ...+..-+.||+.||.||| +.+++|++|.-..|+|+..|+.||++|.++........          ..
T Consensus        96 ~~lk~l~---~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~----------~~  162 (690)
T KOG1243|consen   96 TVLKELG---KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA----------PA  162 (690)
T ss_pred             HHHHHhH---HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc----------cc
Confidence            7777644   7788888999999999997 67899999999999999999999999998864432210          11


Q ss_pred             cceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhcc
Q 011287          213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDV  292 (489)
Q Consensus       213 ~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~~L~~  292 (489)
                      ....---.|..|+.+....  -..|.|-|||++++++.|  ++....+           ...+..++.....+-.+.+.-
T Consensus       163 ~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng--~~~~~~~-----------~~~~~~ipk~~~~~~~k~~~~  227 (690)
T KOG1243|consen  163 KSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG--SLLTKTD-----------LSNTGKIPKALIELYCKKLGA  227 (690)
T ss_pred             ccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc--ccCcchh-----------hhccCccchhHHHHHHHHhcc
Confidence            1112222466666554433  346999999999999999  3322221           122333444444444444445


Q ss_pred             CCCCCCCCCCCCHHHHh-cCCCCCC
Q 011287          293 DPSGRPGAGPGGYAVLK-MHPFFKG  316 (489)
Q Consensus       293 dP~~R~t~~~~~~~~l~-~hpff~~  316 (489)
                      .+..||..-. -+.+.+ -|.||++
T Consensus       228 ~~~~r~n~~~-~~~~~~~~~gff~n  251 (690)
T KOG1243|consen  228 TELKRPNKLR-FILECRLLGGFFRN  251 (690)
T ss_pred             ccccccchhh-HHHHHHhccccccc
Confidence            5556655221 122222 2666654

>cd01265 PH_PARIS-1 PARIS-1 pleckstrin homology (PH) domain

Probab=99.52  E-value=2.1e-14  Score=117.95  Aligned_cols=85  Identities=14%  Similarity=0.294  Sum_probs=67.0

Q ss_pred             EEeeehhhh--hh--ccceeEEEecC-CeE-EEECCCCCeeeeeeeccCCCCceEEEEc-CCCcEEEEcCCceEEEE-cC
Q 011287          401 ISMVKKLQK--LT--SKKVQLILTNK-PKL-IYVDPSKLVVKGNIIWSDNSNDLSIQVS-SPSHFKIVTPKKVLSFE-DA  472 (489)
Q Consensus       401 ~g~~~k~~g--~~--~k~r~~~lt~~-p~l-~y~d~~~~~~kg~i~~~~~~~~~~~~~~-~~~~f~i~~p~r~y~~~-d~  472 (489)
                      +|+|.|++|  .+  ||+|||||++. +.| ||.++.....+|.|+|..+.  +..... .+..|.|.||+|||+|. ++
T Consensus         2 ~GyL~K~g~~~~~K~WkkRWFvL~~~~~~L~Yyk~~~d~~p~G~I~L~~~~--~~~~~~~~~~~F~i~t~~r~y~l~A~s   79 (95)
T cd01265           2 CGYLHKIEGKGPLRGRRSRWFALDDRTCYLYYYKDSQDAKPLGRVDLSGAA--FTYDPREEKGRFEIHSNNEVIALKASS   79 (95)
T ss_pred             cccEEEecCCCCCcCceeEEEEEcCCCcEEEEECCCCcccccceEECCccE--EEcCCCCCCCEEEEEcCCcEEEEECCC
Confidence            599999876  33  99999999974 455 67777788999999999852  221222 25799999999999999 55


Q ss_pred             CccHHHHHHHHHHhc
Q 011287          473 KQRASQWKKAIEALQ  487 (489)
Q Consensus       473 ~~~~~~W~~~i~~~~  487 (489)
                      +.++++|+++|+..+
T Consensus        80 ~~e~~~Wi~al~~~~   94 (95)
T cd01265          80 DKQMNYWLQALQSKR   94 (95)
T ss_pred             HHHHHHHHHHHHhhc
Confidence            689999999999753

PARIS-1 pleckstrin homology (PH) domain. PARIS-1 contains a PH domain and a TBC-type GTPase catalytic domain. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains.

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.52  E-value=8.2e-14  Score=145.76  Aligned_cols=142  Identities=23%  Similarity=0.332  Sum_probs=97.6

Q ss_pred             eeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchh--------------------------------HHH------H
Q 011287           50 GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN--------------------------------KTA------Y   91 (489)
Q Consensus        50 ~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~--------------------------------~~~------~   91 (489)
                      .+.||.|++|+||+|+.+ +|+.||||+..... ...-                                ...      .
T Consensus       122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i-~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eld  199 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGI-EKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELD  199 (437)
T ss_pred             CcceeeeehhheEEEEec-CCCEEEEEeeCCCc-HHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHC
Confidence            367999999999999975 69999999985431 1000                                000      1


Q ss_pred             HHHHHHHHHhC----C-CCCccEEEEEE-EcCCEEEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHHh
Q 011287           92 VKLERIVLDQL----D-HPGVVRLFFTF-QDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVD-ALEYIHS  163 (489)
Q Consensus        92 ~~~E~~il~~l----~-hpnIv~l~~~~-~~~~~lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~-aL~~LH~  163 (489)
                      +.+|...+.++    . +++| .+-.++ ......++||||++|++|.+..... ...   ....++.+++. .+..+|.
T Consensus       200 f~~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~  275 (437)
T TIGR01982       200 LRREAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLR  275 (437)
T ss_pred             HHHHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHh
Confidence            23355444444    2 3433 322222 2234578999999999998876432 112   23345556655 4678999


Q ss_pred             CCcEeeccCCCCeeeCCCCCEEEeeccCccccCC
Q 011287          164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (489)
Q Consensus       164 ~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~  197 (489)
                      .|++|+|+||.||+++.+|.++|+|||++..+..
T Consensus       276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            9999999999999999999999999999987754

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd01238 PH_Tec Tec pleckstrin homology (PH) domain

Probab=99.50  E-value=4.7e-14  Score=118.32  Aligned_cols=85  Identities=19%  Similarity=0.217  Sum_probs=66.6

Q ss_pred             EEEEeeehhh-hh------hccceeEEEecCCeEEEECCCC--CeeeeeeeccCCCCceEEEE-----------cCCCcE
Q 011287          399 LMISMVKKLQ-KL------TSKKVQLILTNKPKLIYVDPSK--LVVKGNIIWSDNSNDLSIQV-----------SSPSHF  458 (489)
Q Consensus       399 ~~~g~~~k~~-g~------~~k~r~~~lt~~p~l~y~d~~~--~~~kg~i~~~~~~~~~~~~~-----------~~~~~f  458 (489)
                      |++|++.|++ |.      .||+|||+|++.-..||.++..  ...+|.|+|+.+   ..++.           .....|
T Consensus         1 ~k~g~l~Kr~~~~~~~~~~nwKkRwFvL~~~~L~Yyk~~~~~~~~~kG~I~L~~~---~~ve~~~~~~~~~~~~~~~~~F   77 (106)
T cd01238           1 ILESILVKRSQQKKKTSPLNYKERLFVLTKSKLSYYEGDFEKRGSKKGSIDLSKI---KCVETVKPEKNPPIPERFKYPF   77 (106)
T ss_pred             CcceeeeeeccCCCCCCCCCceeEEEEEcCCEEEEECCCcccccCcceeEECCcc---eEEEEecCCcCcccccccCccE
Confidence            5788998885 22      4999999998776667777653  479999999986   33332           124579


Q ss_pred             EEEcCCceEEEE-cCCccHHHHHHHHHHh
Q 011287          459 KIVTPKKVLSFE-DAKQRASQWKKAIEAL  486 (489)
Q Consensus       459 ~i~~p~r~y~~~-d~~~~~~~W~~~i~~~  486 (489)
                      .|+|++|||||. +.+.++++|+++|+.|
T Consensus        78 ~i~t~~r~~yl~A~s~~er~~WI~ai~~~  106 (106)
T cd01238          78 QVVHDEGTLYVFAPTEELRKRWIKALKQV  106 (106)
T ss_pred             EEEeCCCeEEEEcCCHHHHHHHHHHHHhC
Confidence            999999999998 5558999999999975

Tec pleckstrin homology (PH) domain. Proteins in the Tec family of cytoplasmic protein tyrosine kinases that includes Bruton's tyrosine kinase (BTK), BMX, IL2-inducible T-cell kinase (Itk) and Tec. These proteins generally have an N-terminal PH domain, followed by a Tek homology (TH) domain, a SH3 domain, a SH2 domain and a kinase domain. Tec PH domains tether these proteins to membranes following the activation of PI3K and its subsequent phosphorylation of phosphoinositides. The importance of PH domain membrane anchoring is confirmed by the discovery of a mutation of a critical arginine residue in the BTK PH domain, which causes X-linked agammaglobulinemia (XLA) in humans and a related disorder is mice. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few dis

>cd01257 PH_IRS Insulin receptor substrate (IRS) pleckstrin homology (PH) domain

Probab=99.49  E-value=9.1e-14  Score=114.72  Aligned_cols=87  Identities=16%  Similarity=0.175  Sum_probs=69.9

Q ss_pred             EEEEEeeehhhhhhccceeEEEecCC-----eEEEECCCC------CeeeeeeeccCCCCceEE-EEcCCCcEEEEcCCc
Q 011287          398 VLMISMVKKLQKLTSKKVQLILTNKP-----KLIYVDPSK------LVVKGNIIWSDNSNDLSI-QVSSPSHFKIVTPKK  465 (489)
Q Consensus       398 i~~~g~~~k~~g~~~k~r~~~lt~~p-----~l~y~d~~~------~~~kg~i~~~~~~~~~~~-~~~~~~~f~i~~p~r  465 (489)
                      |+++|||.|+  -.||||||||+..+     +|.|.+...      ...+|.|+|+.+.++... +.+....|.|.||.|
T Consensus         2 v~k~GyL~K~--K~~kkRwFVLr~~~~~~p~~Leyyk~ek~~~~~~~~p~~vI~L~~c~~v~~~~d~k~~~~f~i~t~dr   79 (101)
T cd01257           2 VRKSGYLRKQ--KSMHKRFFVLRAESSGGPARLEYYENEKKFLQKGSAPKRVIPLESCFNINKRADAKHRHLIALYTRDE   79 (101)
T ss_pred             ccEEEEEeEe--cCcEeEEEEEecCCCCCCceEEEECChhhccccCCCceEEEEccceEEEeeccccccCeEEEEEeCCc
Confidence            7899999998  57999999999863     786666643      578999999998332221 234457999999999


Q ss_pred             eEEEE-cCCccHHHHHHHHHHh
Q 011287          466 VLSFE-DAKQRASQWKKAIEAL  486 (489)
Q Consensus       466 ~y~~~-d~~~~~~~W~~~i~~~  486 (489)
                      +|+|. |.+.++++|+++|+++
T Consensus        80 ~f~l~aese~E~~~Wi~~i~~~  101 (101)
T cd01257          80 YFAVAAENEAEQDSWYQALLEL  101 (101)
T ss_pred             eEEEEeCCHHHHHHHHHHHhhC
Confidence            99999 6679999999999874

Insulin receptor substrate (IRS) pleckstrin homology (PH) domain. PH domains are only found in eukaryotes, and are often involved in targeting proteins to the plasma membrane via lipid binding. PH domains are found in cellular signaling proteins such as serine/threonine kinase, tyrosine kinsases, regulators of G-proteins, endocytotic GTPases, adaptors, a well as cytoskeletal associated molecules and in lipid associated enzymes. The IRS PH domain targets IRS molecules to the plasma membrane, usually in response to insulin stimulation.

>cd01247 PH_GPBP Goodpasture antigen binding protein (GPBP) Pleckstrin homology (PH) domain

Probab=99.49  E-value=7.2e-14  Score=113.65  Aligned_cols=83  Identities=12%  Similarity=0.183  Sum_probs=67.9

Q ss_pred             EEeeehhhhhh--ccceeEEEecCCeEEEECCCCC--eeeeeeeccCCCCceEEEEcCCCcEEEEcCC-ceEEEE-cCCc
Q 011287          401 ISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKL--VVKGNIIWSDNSNDLSIQVSSPSHFKIVTPK-KVLSFE-DAKQ  474 (489)
Q Consensus       401 ~g~~~k~~g~~--~k~r~~~lt~~p~l~y~d~~~~--~~kg~i~~~~~~~~~~~~~~~~~~f~i~~p~-r~y~~~-d~~~  474 (489)
                      .|||.|.++++  ||+|||||.++-..||.++...  ..+|.|+|+.+  .+.+....+..|.|.++. |||+|. +.+.
T Consensus         2 ~G~L~K~~~~~k~Wk~RwFvL~~g~L~Yyk~~~~~~~~~~G~I~L~~~--~i~~~~~~~~~F~i~~~~~r~~~L~A~s~~   79 (91)
T cd01247           2 NGVLSKWTNYINGWQDRYFVLKEGNLSYYKSEAEKSHGCRGSIFLKKA--IIAAHEFDENRFDISVNENVVWYLRAENSQ   79 (91)
T ss_pred             ceEEEEeccccCCCceEEEEEECCEEEEEecCccCcCCCcEEEECccc--EEEcCCCCCCEEEEEeCCCeEEEEEeCCHH
Confidence            69999999988  9999999998888899997653  36899999986  233333446789997655 999999 5668


Q ss_pred             cHHHHHHHHHH
Q 011287          475 RASQWKKAIEA  485 (489)
Q Consensus       475 ~~~~W~~~i~~  485 (489)
                      ++++|+++|+.
T Consensus        80 e~~~Wi~al~~   90 (91)
T cd01247          80 SRLLWMDSVVR   90 (91)
T ss_pred             HHHHHHHHHhh
Confidence            99999999985

Goodpasture antigen binding protein (GPBP) Pleckstrin homology (PH) domain. The GPBP protein is a kinase that phosphorylates an N-terminal region of the alpha 3 chain of type IV collagen , which is commonly known as the goodpasture antigen. It has has an N-terminal PH domain and a C-terminal START domain. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains. PH domains are found in cellular signaling proteins such as serine/threonine kinase, tyrosine kinsases, regulators of G-proteins, endocytotic GTPases, adaptors, as well as cyt

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.48  E-value=5.4e-13  Score=123.83  Aligned_cols=142  Identities=15%  Similarity=0.179  Sum_probs=104.0

Q ss_pred             eeEEeeeCceEEEEEEEcC------CCcEEEEEEeeccccc-------------------chhHHHHHH----HHHHHHH
Q 011287           50 GKIYGVGSYSKVVRAKKID------TGTVYALKIMDKKFIT-------------------KENKTAYVK----LERIVLD  100 (489)
Q Consensus        50 ~~~LG~G~~g~Vy~a~~~~------tg~~vAiK~~~k~~~~-------------------~~~~~~~~~----~E~~il~  100 (489)
                      ...||.|--+.||.|....      .+..+|||++......                   +......+.    .|...|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4578999999999998653      3589999998532110                   112233333    7999998


Q ss_pred             hCCC--CCccEEEEEEEcCCEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCcEeeccCCCCee
Q 011287          101 QLDH--PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI-HSMGLIHRDIKPENLL  177 (489)
Q Consensus       101 ~l~h--pnIv~l~~~~~~~~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~L-H~~gIiHrDLKpeNIL  177 (489)
                      ++..  -++.+++.+    ..-++||||+.+..+..-..+...+++..+..+..+++.+|..| |..||+|+||++.|||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL  157 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML  157 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            8843  345566654    35679999997754433222334566777788889999999998 8999999999999999


Q ss_pred             eCCCCCEEEeeccCccccC
Q 011287          178 LTADGHIKIADFGSVKPMQ  196 (489)
Q Consensus       178 l~~~g~ikL~DFG~a~~~~  196 (489)
                      ++ ++.+.|+|||.+....
T Consensus       158 ~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         158 WH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             EE-CCcEEEEECCCceeCC
Confidence            96 5789999999987554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd01236 PH_outspread Outspread Pleckstrin homology (PH) domain

Probab=99.47  E-value=7.6e-14  Score=115.61  Aligned_cols=86  Identities=16%  Similarity=0.210  Sum_probs=65.1

Q ss_pred             EEEeeehhhh-----------hhccceeEEEecCCeEEEE-CC-CCCeeeeeeeccCCCCceEEEE--cCCCcEEEEcCC
Q 011287          400 MISMVKKLQK-----------LTSKKVQLILTNKPKLIYV-DP-SKLVVKGNIIWSDNSNDLSIQV--SSPSHFKIVTPK  464 (489)
Q Consensus       400 ~~g~~~k~~g-----------~~~k~r~~~lt~~p~l~y~-d~-~~~~~kg~i~~~~~~~~~~~~~--~~~~~f~i~~p~  464 (489)
                      ++|||.|..+           ..||||||||++...|+|. |. .....+|+|+++.+..+...+.  .+...|.|.||+
T Consensus         1 ~~g~l~~~~~~~~~~~~~~~~K~WkrRWFvL~~~~~L~y~~d~~~~~~p~G~IdL~~~~~V~~~~~~~~~~~~f~I~tp~   80 (104)
T cd01236           1 YCGWLLVAPDGTDFDNPVHRSKRWQRRWFILYDHGLLTYALDEMPTTLPQGTIDMNQCTDVVDAEARTGQKFSICILTPD   80 (104)
T ss_pred             CcceeEEcCCCCcccccceeeccccceEEEEeCCCEEEEeeCCCCCcccceEEEccceEEEeecccccCCccEEEEECCC
Confidence            4678877654           1289999999998888774 43 3457899999998733222221  224689999999


Q ss_pred             ceEEEE-cCCccHHHHHHHHHH
Q 011287          465 KVLSFE-DAKQRASQWKKAIEA  485 (489)
Q Consensus       465 r~y~~~-d~~~~~~~W~~~i~~  485 (489)
                      |||+|. |.+.++++|+++|+.
T Consensus        81 R~f~l~Aete~E~~~Wi~~l~~  102 (104)
T cd01236          81 KEHFIKAETKEEISWWLNMLMV  102 (104)
T ss_pred             ceEEEEeCCHHHHHHHHHHHHh
Confidence            999999 667999999999986

Outspread Pleckstrin homology (PH) domain. Outspread contains two PH domains and a C-terminal coiled-coil region. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains. PH domains are found in cellular signaling proteins such as serine/threonine kinase, tyrosine kinsases, regulators of G-proteins, endocytotic GTPAses, adaptors, a well as cytoskeletal associated molecules and in lipid associated enzymes.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.47  E-value=3.4e-14  Score=147.40  Aligned_cols=251  Identities=25%  Similarity=0.310  Sum_probs=192.3

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEc-CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKI-DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFS  119 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~-~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  119 (489)
                      ....+|..+..||.|.|+.|+.+..+ .++..|++|...+......... +-..|..+...+ .|.++++.+..+.....
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di-~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDI-FSLGEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhh-cchhhhhHhhHhhcccccCCCCCCcccccc
Confidence            34578999999999999999998876 7899999998876544433333 333466666666 48899999888888888


Q ss_pred             EEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCC-CCEEEeeccCccccCCc
Q 011287          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDS  198 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~-g~ikL~DFG~a~~~~~~  198 (489)
                      .|+-.|||+++++...+.-.-.+++...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||++..+...
T Consensus       341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~  420 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS  420 (524)
T ss_pred             ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee
Confidence            89999999999887665444458999999999999999999999999999999999999886 78899999998643221


Q ss_pred             cccccCCCCCCCCccceecCCcCC--ChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 011287          199 RITVLPNAASDDKACTFVGTAAYV--PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN  276 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~--aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~  276 (489)
                                   ...+..+..+.  ++..+....+..++|++|||.-+++..+|.+.-...+.   ...|..+......
T Consensus       421 -------------~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~~~p~~~  484 (524)
T KOG0601|consen  421 -------------SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRSGDTPNLP  484 (524)
T ss_pred             -------------cccccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceeeecccccCCC
Confidence                         11223334444  45555666788999999999999999998765444333   2344555555555


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                      ....++..+.+.+..+|+..|+.+     .++..|.=|
T Consensus       485 ~~~~~~q~~~kv~~~~~~~~~~l~-----~~l~~~~~~  517 (524)
T KOG0601|consen  485 GLKLQLQVLLKVMINPDRKRRPSA-----VELSLHSEF  517 (524)
T ss_pred             chHHhhhhhhhhhcCCccccchhh-----hhhcccchh
Confidence            556899999999999999999988     556666544

>cd01235 PH_SETbf Set binding factor Pleckstrin Homology (PH) domain

Probab=99.44  E-value=3.2e-13  Score=112.34  Aligned_cols=84  Identities=24%  Similarity=0.304  Sum_probs=66.7

Q ss_pred             EEeeehhhhhh--ccceeEEEec-CCeE-EEECCCCCeeeeeeeccCCCCceEEEEc-----------CCCcEEEEcCCc
Q 011287          401 ISMVKKLQKLT--SKKVQLILTN-KPKL-IYVDPSKLVVKGNIIWSDNSNDLSIQVS-----------SPSHFKIVTPKK  465 (489)
Q Consensus       401 ~g~~~k~~g~~--~k~r~~~lt~-~p~l-~y~d~~~~~~kg~i~~~~~~~~~~~~~~-----------~~~~f~i~~p~r  465 (489)
                      +|+|.|+++..  ||+|||+|++ ...| ||.++.....+|.|+|+..   ..+...           ....|.|.|++|
T Consensus         2 ~G~L~K~g~~~k~WkkRwFvL~~~~~~L~Yy~~~~~~~~~g~I~L~~~---~~v~~~~~~~~~~~~~~~~~~f~i~t~~r   78 (101)
T cd01235           2 EGYLYKRGALLKGWKPRWFVLDPDKHQLRYYDDFEDTAEKGCIDLAEV---KSVNLAQPGMGAPKHTSRKGFFDLKTSKR   78 (101)
T ss_pred             eEEEEEcCCCCCCccceEEEEECCCCEEEEecCCCCCccceEEEccee---EEEeecCCCCCCCCCCCCceEEEEEeCCc
Confidence            79999999876  9999999996 4455 6666777899999999986   334321           123577789999


Q ss_pred             eEEEE-cCCccHHHHHHHHHHhc
Q 011287          466 VLSFE-DAKQRASQWKKAIEALQ  487 (489)
Q Consensus       466 ~y~~~-d~~~~~~~W~~~i~~~~  487 (489)
                      +|+|. +.+.++++|+++|+.++
T Consensus        79 ~~~~~a~s~~e~~~Wi~ai~~~i  101 (101)
T cd01235          79 TYNFLAENINEAQRWKEKIQQCI  101 (101)
T ss_pred             eEEEECCCHHHHHHHHHHHHhhC
Confidence            99997 66689999999999864

Set binding factor Pleckstrin Homology (PH) domain. Set binding factor is a myotubularin-related pseudo-phosphatase consisting of a Denn domain, a Gram domain, an inactive phosphatase domain, a SID motif and a C-terminal PH domain. Its PH domain is predicted to bind lipids based upon its ability to respond to phosphatidylinositol 3-kinase .

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.43  E-value=4.6e-13  Score=121.64  Aligned_cols=127  Identities=20%  Similarity=0.206  Sum_probs=95.7

Q ss_pred             eeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcc-EEEEEEEcCCEEEEEEeccC
Q 011287           50 GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV-RLFFTFQDTFSLYMALESCE  128 (489)
Q Consensus        50 ~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv-~l~~~~~~~~~lylV~E~~~  128 (489)
                      ++.|+.|.++.||+++..  +..|++|+......    .......|..+++.+.+.+++ +++....  ...++|||+++
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~   74 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE   74 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence            467899999999999874  78999998754321    112346688888888655544 4554433  23579999999


Q ss_pred             CCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----EeeccCCCCeeeCCCCCEEEeeccCcc
Q 011287          129 GGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL-----IHRDIKPENLLLTADGHIKIADFGSVK  193 (489)
Q Consensus       129 gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gI-----iHrDLKpeNILl~~~g~ikL~DFG~a~  193 (489)
                      |.++...        ......++.+++.+|..||..++     +|+|++|.||+++ ++.++++|||.+.
T Consensus        75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            9887543        11123457899999999999985     9999999999998 6789999999876

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd01266 PH_Gab Gab (Grb2-associated binder) pleckstrin homology (PH) domain

Probab=99.43  E-value=3.3e-13  Score=113.71  Aligned_cols=83  Identities=16%  Similarity=0.125  Sum_probs=67.0

Q ss_pred             EEeeehhhhh------hccceeEEEecCCe-------EEEECCCCCeeeeeeeccCCCCceEEEE-----cC-C---CcE
Q 011287          401 ISMVKKLQKL------TSKKVQLILTNKPK-------LIYVDPSKLVVKGNIIWSDNSNDLSIQV-----SS-P---SHF  458 (489)
Q Consensus       401 ~g~~~k~~g~------~~k~r~~~lt~~p~-------l~y~d~~~~~~kg~i~~~~~~~~~~~~~-----~~-~---~~f  458 (489)
                      +|||.|+++.      .||+|||+|++.-.       .||.|+...+.+|.|+|+.+   ..++.     .. .   ..|
T Consensus         2 eGwL~K~~~~~~~~~~~WkrRwFvL~~~~l~~~~~~L~Yyk~~~~~k~~g~I~L~~~---~~v~~~~~~~~~~~~~~~~f   78 (108)
T cd01266           2 EGWLKKSPPYKLLFRTKWVRRYFVLHCGDRERNLFALEYYKTSRKFKLEFVIDLESC---SQVDPGLLCTAGNCIFGYGF   78 (108)
T ss_pred             ceeeeeCCccccccccCcEEEEEEEeccccCCCcceEEEECCCCCCccceEEECCcc---EEEcccccccccCcccceEE
Confidence            6999999872      49999999998764       68888888899999999985   33322     11 1   249


Q ss_pred             EEEcCCceEEEE-cCCccHHHHHHHHHHh
Q 011287          459 KIVTPKKVLSFE-DAKQRASQWKKAIEAL  486 (489)
Q Consensus       459 ~i~~p~r~y~~~-d~~~~~~~W~~~i~~~  486 (489)
                      .|.||+|||+|. +.+.++++|+++|.++
T Consensus        79 ~i~t~~r~y~l~A~s~ee~~~Wi~~I~~~  107 (108)
T cd01266          79 DIETIVRDLYLVAKNEEEMTLWVNCICKL  107 (108)
T ss_pred             EEEeCCccEEEEECCHHHHHHHHHHHHhh
Confidence            999999999998 6668999999999875

Gab (Grb2-associated binder) pleckstrin homology (PH) domain. The Gab subfamily includes several Gab proteins, Drosophila DOS and C. elegans SOC-1. They are scaffolding adaptor proteins, which possess N-terminal PH domains and a C-terminus with proline-rich regions and multiple phosphorylation sites. Following activation of growth factor receptors, Gab proteins are tyrosine phosphorylated and activate PI3K, which generates 3-phosphoinositide lipids. By binding to these lipids via the PH domain, Gab proteins remain in proximity to the receptor, leading to further signaling. While not all Gab proteins depend on the PH domain for recruitment, it is required for Gab activity. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display str

>cd01260 PH_CNK Connector enhancer of KSR (Kinase suppressor of ras) (CNK) pleckstrin homology (PH) domain

Probab=99.42  E-value=2.3e-13  Score=112.23  Aligned_cols=86  Identities=19%  Similarity=0.204  Sum_probs=70.2

Q ss_pred             EEEeeehhhh--h----hccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEEcCCCcEEEEcCC-ceEEEE-c
Q 011287          400 MISMVKKLQK--L----TSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPK-KVLSFE-D  471 (489)
Q Consensus       400 ~~g~~~k~~g--~----~~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~~~~~f~i~~p~-r~y~~~-d  471 (489)
                      .+|||.|+++  -    .||+|||+|++.-.+||.++.....+|.|+|+...+....+.++...|.|.+|+ |+|+|. |
T Consensus         2 ~~GwL~kk~~~~g~~~k~WkkrwfvL~~~~L~yyk~~~~~~~~~~I~L~~~~v~~~~~~~k~~~F~I~~~~~~~~~f~a~   81 (96)
T cd01260           2 CDGWLWKRKKPGGFMGQKWARRWFVLKGTTLYWYRSKQDEKAEGLIFLSGFTIESAKEVKKKYAFKVCHPVYKSFYFAAE   81 (96)
T ss_pred             ceeEEEEecCCCCccccCceeEEEEEECCEEEEECCCCCCccceEEEccCCEEEEchhcCCceEEEECCCCCcEEEEEeC
Confidence            4799998753  2    599999999998888999998889999999998622222234566799999998 999998 6


Q ss_pred             CCccHHHHHHHHHH
Q 011287          472 AKQRASQWKKAIEA  485 (489)
Q Consensus       472 ~~~~~~~W~~~i~~  485 (489)
                      .+.++++|+++|..
T Consensus        82 s~~e~~~Wi~ai~~   95 (96)
T cd01260          82 TLDDLSQWVNHLIT   95 (96)
T ss_pred             CHHHHHHHHHHHHh
Confidence            66899999999975

Connector enhancer of KSR (Kinase suppressor of ras) (CNK) pleckstrin homology (PH) domain. CNK is believed to regulate the activity and the subcellular localization of RAS activated RAF. CNK is composed of N-terminal SAM and PDZ domains along with a central or C-terminal PH domain. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains. PH domains are found in cellular signaling proteins such as serine/threonine kinase, tyrosine kinsases, regulators of G-proteins, endocytotic GTPAses, adaptors, a well as cytoskelet

>cd01241 PH_Akt Akt pleckstrin homology (PH) domain

Probab=99.39  E-value=5.5e-13  Score=111.06  Aligned_cols=89  Identities=12%  Similarity=0.121  Sum_probs=66.9

Q ss_pred             EEEEEeeehhhhhh--ccceeEEEec-CCeEEEECCCCCeeeeeeeccCCCC----ceEEEEcCCCcEEEE------cCC
Q 011287          398 VLMISMVKKLQKLT--SKKVQLILTN-KPKLIYVDPSKLVVKGNIIWSDNSN----DLSIQVSSPSHFKIV------TPK  464 (489)
Q Consensus       398 i~~~g~~~k~~g~~--~k~r~~~lt~-~p~l~y~d~~~~~~kg~i~~~~~~~----~~~~~~~~~~~f~i~------~p~  464 (489)
                      |+|+||+.|+++.+  ||+|||+|++ +-.+||.|......+|.||++....    ...++......|.|.      ++.
T Consensus         1 v~k~G~L~K~g~~~~~Wk~R~f~L~~~~~l~~yk~~~~~~~~~~i~l~~~~v~~~~~~~~~~~~~~~F~i~~~~~~~~~~   80 (102)
T cd01241           1 VVKEGWLHKRGEYIKTWRPRYFLLKSDGSFIGYKEKPEDGDPFLPPLNNFSVAECQLMKTERPRPNTFIIRCLQWTTVIE   80 (102)
T ss_pred             CcEEEEEEeecCCCCCCeeEEEEEeCCCeEEEEecCCCccCccccccCCeEEeeeeeeeccCCCcceEEEEeccCCcccC
Confidence            57999999999977  9999999995 5556788865555568999887521    011122335689997      478


Q ss_pred             ceEEEEcCCccHHHHHHHHHHhc
Q 011287          465 KVLSFEDAKQRASQWKKAIEALQ  487 (489)
Q Consensus       465 r~y~~~d~~~~~~~W~~~i~~~~  487 (489)
                      |+|+ .|.+.++++|+++|+.|.
T Consensus        81 r~f~-a~s~ee~~eWi~ai~~v~  102 (102)
T cd01241          81 RTFH-VESPEEREEWIHAIQTVA  102 (102)
T ss_pred             EEEE-eCCHHHHHHHHHHHHhhC
Confidence            9987 477889999999999863

Akt pleckstrin homology (PH) domain. Akt (Protein Kinase B (PKB)) is a phosphatidylinositol 3'-kinase (PI3K)-dependent Ser/Thr kinase. The PH domain recruits Akt to the plasma membrane by binding to phosphoinositides (PtdIns-3,4-P2) and is required for activation. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.37  E-value=6.8e-14  Score=134.89  Aligned_cols=270  Identities=20%  Similarity=0.261  Sum_probs=171.7

Q ss_pred             ccccCCCCCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEee----cccccchhHHHHHHHHHHHHHhCCCCCcc
Q 011287           33 FAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMD----KKFITKENKTAYVKLERIVLDQLDHPGVV  108 (489)
Q Consensus        33 ~~~~~~~~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~----k~~~~~~~~~~~~~~E~~il~~l~hpnIv  108 (489)
                      +....|...+...+-+++..=|-| --.||++-+.+.|.+|..-.+.    |.....+.+.+.+   ..-|-.+.|.|||
T Consensus        55 Ileesp~~rw~krreqv~qrdvPg-id~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~v---FdnllqlvHsnlv  130 (458)
T KOG1266|consen   55 ILEESPCGRWGKRREQVGQRDVPG-IDDVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAV---FDNLLQLVHSNLV  130 (458)
T ss_pred             hhccCchhhhhhhhhhccCCCCCc-hHHHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHH---HHHHHHHHHHHHH
Confidence            333444444444444333322222 2247777777777776543322    1111122222222   2233445799999


Q ss_pred             EEEEEEEcC-----CEEEEEEeccCCCChHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC--cEeeccCCCCee
Q 011287          109 RLFFTFQDT-----FSLYMALESCEGGELFDQITSK----GHLSEDEARFYTAEVVDALEYIHSMG--LIHRDIKPENLL  177 (489)
Q Consensus       109 ~l~~~~~~~-----~~lylV~E~~~gg~L~~~l~~~----~~l~e~~~~~i~~qil~aL~~LH~~g--IiHrDLKpeNIL  177 (489)
                      +.+.++.+.     ..+.|+.||+..|+|..+|++.    ..+....-++|+-||+.||.|||+..  |+|+++...-|+
T Consensus       131 kfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tif  210 (458)
T KOG1266|consen  131 KFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIF  210 (458)
T ss_pred             HHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhhee
Confidence            999888654     4589999999999999999764    35889999999999999999999985  999999999999


Q ss_pred             eCCCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCC-C
Q 011287          178 LTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF-K  256 (489)
Q Consensus       178 l~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF-~  256 (489)
                      +..+|-+|+.--.... ....     ...........-.|-+.|.|||.=.....+.++|||++|....+|..|..-- .
T Consensus       211 iq~ngLIkig~~ap~s-~h~s-----~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tn  284 (458)
T KOG1266|consen  211 IQHNGLIKIGSVAPDS-THPS-----VNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTN  284 (458)
T ss_pred             ecCCceEEecccCccc-cchh-----hhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCC
Confidence            9999888874221110 0000     0000011111224567899999766666778899999999999998886542 2


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 011287          257 DTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (489)
Q Consensus       257 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~  320 (489)
                      +.+....-..|.+.-+.+.   ..--+++|.+||+..|+.||++     .+++-||..-++.-.
T Consensus       285 seS~~~~ee~ia~~i~~le---n~lqr~~i~kcl~~eP~~rp~a-----r~llfHpllfeVhsl  340 (458)
T KOG1266|consen  285 SESKVEVEENIANVIIGLE---NGLQRGSITKCLEGEPNGRPDA-----RLLLFHPLLFEVHSL  340 (458)
T ss_pred             Ccceeehhhhhhhheeecc---CccccCcCcccccCCCCCCcch-----hhhhcCceeeecchH
Confidence            3322222222222211111   1224678999999999999999     789999987665543

>cd01244 PH_RasGAP_CG9209 RAS_GTPase activating protein (GAP)_CG9209 pleckstrin homology (PH) domain

Probab=99.36  E-value=1.4e-12  Score=107.06  Aligned_cols=87  Identities=17%  Similarity=0.075  Sum_probs=64.4

Q ss_pred             EEEEeeehhhhhhccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEEc---CCCcEEEEcCCceEEEEc-CCc
Q 011287          399 LMISMVKKLQKLTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVS---SPSHFKIVTPKKVLSFED-AKQ  474 (489)
Q Consensus       399 ~~~g~~~k~~g~~~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~---~~~~f~i~~p~r~y~~~d-~~~  474 (489)
                      ++...-.++.+.-||+|||+||+.-..||.++. ...+|.|||+....+..+...   ..+.|.|+||.|||||.. .+.
T Consensus         8 ~kr~~~~~~~~~n~KkRwF~Lt~~~L~Y~k~~~-~~~~g~I~L~~i~~ve~v~~~~~~~~~~fqivt~~r~~yi~a~s~~   86 (98)
T cd01244           8 VDRSRLAWKKVLHFKKRYFQLTTTHLSWAKDVQ-CKKSALIKLAAIKGTEPLSDKSFVNVDIITIVCEDDTMQLQFEAPV   86 (98)
T ss_pred             EEcccCCCccCcCCceeEEEECCCEEEEECCCC-CceeeeEEccceEEEEEcCCcccCCCceEEEEeCCCeEEEECCCHH
Confidence            333333344445699999999977777777775 789999999986322222222   236899999999999995 458


Q ss_pred             cHHHHHHHHHHh
Q 011287          475 RASQWKKAIEAL  486 (489)
Q Consensus       475 ~~~~W~~~i~~~  486 (489)
                      ++++|+++|+++
T Consensus        87 E~~~Wi~al~k~   98 (98)
T cd01244          87 EATDWLNALEKQ   98 (98)
T ss_pred             HHHHHHHHHhcC
Confidence            999999999874

RAS_GTPase activating protein (GAP)_CG9209 pleckstrin homology (PH) domain. This protein consists of two C2 domains, followed by a RasGAP domain, a PH domain and a BTK domain. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains. PH domains are found in cellular signaling proteins such as serine/threonine kinase, tyrosine kinsases, regulators of G-proteins, endocytotic GTPAses, adaptors, as well as cytoskeletal associated molecules and in lipid associated enzymes.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.33  E-value=9.2e-13  Score=138.64  Aligned_cols=166  Identities=23%  Similarity=0.388  Sum_probs=125.1

Q ss_pred             HHHHHHHHHHHhC-CcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCC
Q 011287          152 AEVVDALEYIHSM-GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS  230 (489)
Q Consensus       152 ~qil~aL~~LH~~-gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~  230 (489)
                      .+.+.|+.|+|.. ++||++|.|++|.++.+|.+||+.|+++........ .....+.........-...|.|||++.+.
T Consensus       106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~-~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTE-YPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCc-cccccCCCCCChhhccCcccccchhhccc
Confidence            3444999999975 899999999999999999999999999876554322 11222333333344567789999999998


Q ss_pred             CCCCCCcchhhhHHHHHHh-hCCCCCCCCCHHHHHHHHH----hcCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCH
Q 011287          231 PATFGNDLWALGCTLYQML-SGTSPFKDTSEWLIFQRII----ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGY  305 (489)
Q Consensus       231 ~~~~~sDiwSLG~ilyell-tG~~PF~~~~~~~~~~~i~----~~~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~  305 (489)
                      ..+.++|++||||++|.+. .|+.-|.+.+....+..-.    .........+|+++++=+.++|..++.-||++     
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~-----  259 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTL-----  259 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcch-----
Confidence            8999999999999999999 6666666553322221111    12234557799999999999999999999977     


Q ss_pred             HHHhcCCCCCCCCccccc
Q 011287          306 AVLKMHPFFKGIDWKNIR  323 (489)
Q Consensus       306 ~~l~~hpff~~i~~~~~~  323 (489)
                      ..+...|||.+..-..|+
T Consensus       260 ~~l~~~~ff~D~~~~aLr  277 (700)
T KOG2137|consen  260 DLLLSIPFFSDPGLKALR  277 (700)
T ss_pred             hhhhcccccCCchhhhhh
Confidence            778999999876655544

>cd01252 PH_cytohesin Cytohesin Pleckstrin homology (PH) domain

Probab=99.29  E-value=5.3e-12  Score=109.29  Aligned_cols=87  Identities=18%  Similarity=0.215  Sum_probs=69.4

Q ss_pred             EEEeeehhhhhh--ccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEE--EcCCCcEEEEcCC-----------
Q 011287          400 MISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQ--VSSPSHFKIVTPK-----------  464 (489)
Q Consensus       400 ~~g~~~k~~g~~--~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~--~~~~~~f~i~~p~-----------  464 (489)
                      |+|||.|++|.+  ||+|||+|++.-..||.++.....+|.|+|+..  .+...  ...+..|.|.+|+           
T Consensus         2 k~G~L~K~~~~~~~WkkRwfvL~~~~L~yyk~~~~~~~~g~I~L~~~--~v~~~~~~~~~~~F~i~~~~~~~~i~~~~~~   79 (125)
T cd01252           2 REGWLLKQGGRVKTWKRRWFILTDNCLYYFEYTTDKEPRGIIPLENV--SIREVEDPSKPFCFELFSPSDKQQIKACKTE   79 (125)
T ss_pred             cEEEEEEeCCCCCCeEeEEEEEECCEEEEEcCCCCCCceEEEECCCc--EEEEcccCCCCeeEEEECCcccccccccccc
Confidence            679999999865  999999999987778888877889999999964  12222  1245679888765           


Q ss_pred             ----------ceEEEE-cCCccHHHHHHHHHHhcC
Q 011287          465 ----------KVLSFE-DAKQRASQWKKAIEALQN  488 (489)
Q Consensus       465 ----------r~y~~~-d~~~~~~~W~~~i~~~~~  488 (489)
                                ++|+|. +.+.++++|+++|+.++.
T Consensus        80 ~~~~~~~~~~~~~~~~A~s~~e~~~Wi~al~~~~~  114 (125)
T cd01252          80 SDGRVVEGNHSVYRISAANDEEMDEWIKSIKASIS  114 (125)
T ss_pred             ccccccccCceEEEEECCCHHHHHHHHHHHHHHHh
Confidence                      689898 556899999999998763

Cytohesin Pleckstrin homology (PH) domain. Cytohesin is an ARF-Guanine nucleotide Exchange Factor (GEF), which has a Sec7-type Arf-GEFdomain and a pleckstrin homology domain. It specifically binds phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4, 5)P3) via its PH domain and it acts as a PI 3-kinase effector mediating biological responses such as cell adhesion and membrane trafficking. PH domains are only found in eukaryotes. They share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains.

>cd01245 PH_RasGAP_CG5898 RAS GTPase-activating protein (GAP) CG5898 Pleckstrin homology (PH) domain

Probab=99.26  E-value=1.1e-11  Score=101.51  Aligned_cols=85  Identities=21%  Similarity=0.218  Sum_probs=66.8

Q ss_pred             EEEeeehhhhh-h--ccceeEEEec---CCeE-EEECCCCCeeeeeeeccCCCCceEEEE---cCCCcEEEEcCCc--eE
Q 011287          400 MISMVKKLQKL-T--SKKVQLILTN---KPKL-IYVDPSKLVVKGNIIWSDNSNDLSIQV---SSPSHFKIVTPKK--VL  467 (489)
Q Consensus       400 ~~g~~~k~~g~-~--~k~r~~~lt~---~p~l-~y~d~~~~~~kg~i~~~~~~~~~~~~~---~~~~~f~i~~p~r--~y  467 (489)
                      +.|++.|++|. +  ||+|||+|++   ..+| ||.++..++.+|.|+++.+ .+..+..   ..++.|.|.+|++  +|
T Consensus         1 ~~G~l~K~g~~~~K~wK~rwF~l~~~~s~~~l~yf~~~~~~~p~gli~l~~~-~V~~v~ds~~~r~~cFel~~~~~~~~y   79 (98)
T cd01245           1 KKGNLLKRTKSVTKLWKTLYFALILDGSRSHESLLSSPKKTKPIGLIDLSDA-YLYPVHDSLFGRPNCFQIVERALPTVY   79 (98)
T ss_pred             CCCccccCCCCcccccceeEEEEecCCCCceEEEEcCCCCCCccceeecccc-EEEEccccccCCCeEEEEecCCCCeEE
Confidence            35899999986 4  9999999985   4666 5555667899999999986 2222222   3358999999987  99


Q ss_pred             EEEcCCccHHHHHHHHHH
Q 011287          468 SFEDAKQRASQWKKAIEA  485 (489)
Q Consensus       468 ~~~d~~~~~~~W~~~i~~  485 (489)
                      ++.+.+.++++|+++|.+
T Consensus        80 ~~~a~~~er~~Wi~~l~~   97 (98)
T cd01245          80 YSCRSSEERDKWIESLQA   97 (98)
T ss_pred             EEeCCHHHHHHHHHHHhc
Confidence            999888999999999975

RAS GTPase-activating protein (GAP) CG5898 Pleckstrin homology (PH) domain. This protein has a domain architecture of SH2-SH3-SH2-PH-C2-Ras_GAP. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains. PH domains are found in cellular signaling proteins such as serine/threonine kinase, tyrosine kinsases, regulators of G-proteins, endocytotic GTPAses, adaptors, a well as cytoskeletal associated molecules and in lipid associated enzymes.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.25  E-value=4.6e-11  Score=107.78  Aligned_cols=134  Identities=19%  Similarity=0.190  Sum_probs=99.1

Q ss_pred             eEEeeeCceEEEEEEEcCCCcEEEEEEeeccccc-----chhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEe
Q 011287           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT-----KENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~-----~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E  125 (489)
                      ..+++|+-+.+|.+..  -|.++++|.=.++.-.     ..-......+|..++.++.--+|.-.+-++.|.....++||
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            4578999999999966  3455777753322222     22233456678889988866566555555667777889999


Q ss_pred             ccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccc
Q 011287          126 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (489)
Q Consensus       126 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~  194 (489)
                      |.+|-.|.+.+...   .    -.++..+=.-+.-||..||+|+||.++||++..+ .+.++|||++..
T Consensus        80 ~I~G~~lkd~l~~~---~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~i~~IDfGLg~~  140 (204)
T COG3642          80 YIEGELLKDALEEA---R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGEF  140 (204)
T ss_pred             EeCChhHHHHHHhc---c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-cEEEEECCcccc
Confidence            99998888888765   1    4456666667788999999999999999999755 499999999874

>cd01246 PH_oxysterol_bp Oxysterol binding protein (OSBP) Pleckstrin homology (PH) domain

Probab=99.19  E-value=5.1e-11  Score=96.75  Aligned_cols=85  Identities=22%  Similarity=0.281  Sum_probs=69.2

Q ss_pred             EEEeeehhhhhh--ccceeEEEecCCeEEEECCCCC--eeeeeeeccCCCCceEEEEcCCCcEEEEcCC-ceEEEE-cCC
Q 011287          400 MISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKL--VVKGNIIWSDNSNDLSIQVSSPSHFKIVTPK-KVLSFE-DAK  473 (489)
Q Consensus       400 ~~g~~~k~~g~~--~k~r~~~lt~~p~l~y~d~~~~--~~kg~i~~~~~~~~~~~~~~~~~~f~i~~p~-r~y~~~-d~~  473 (489)
                      .+|||.|+++..  |++|+|+|.++-.+||.++...  ...|.|+++.+  .+.........|.|.+++ |+|+|. +.+
T Consensus         1 ~~G~L~k~~~~~~~W~~r~~vl~~~~L~~~~~~~~~~~~~~~~i~l~~~--~~~~~~~~~~~F~i~~~~~~~~~~~a~s~   78 (91)
T cd01246           1 VEGWLLKWTNYLKGWQKRWFVLDNGLLSYYKNKSSMRGKPRGTILLSGA--VISEDDSDDKCFTIDTGGDKTLHLRANSE   78 (91)
T ss_pred             CeEEEEEecccCCCceeeEEEEECCEEEEEecCccCCCCceEEEEeceE--EEEECCCCCcEEEEEcCCCCEEEEECCCH
Confidence            379999988755  9999999998877788888766  88999999985  233333446899999987 999998 556


Q ss_pred             ccHHHHHHHHHHh
Q 011287          474 QRASQWKKAIEAL  486 (489)
Q Consensus       474 ~~~~~W~~~i~~~  486 (489)
                      .++.+|+.+|+.+
T Consensus        79 ~e~~~Wi~al~~a   91 (91)
T cd01246          79 EERQRWVDALELA   91 (91)
T ss_pred             HHHHHHHHHHHhC
Confidence            8999999999863

Oxysterol binding protein (OSBP) Pleckstrin homology (PH) domain. Oxysterol binding proteins are a multigene family that is conserved in yeast, flies, worms, mammals and plants. They all contain a C-terminal oxysterol binding domain, and most contain an N-terminal PH domain. OSBP PH domains bind to membrane phosphoinositides and thus likely play an important role in intracellular targeting. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains.

>cd01254 PH_PLD Phospholipase D (PLD) pleckstrin homology (PH) domain

Probab=99.19  E-value=5.3e-11  Score=102.22  Aligned_cols=72  Identities=18%  Similarity=0.272  Sum_probs=61.2

Q ss_pred             ccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEEcC----------------CCcEEEEcCCceEEEEcC-Cc
Q 011287          412 SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSS----------------PSHFKIVTPKKVLSFEDA-KQ  474 (489)
Q Consensus       412 ~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~~----------------~~~f~i~~p~r~y~~~d~-~~  474 (489)
                      |++|||+|.+.-.+||.||..+..+|+|.+...   ..++...                ...|.|.||+|||.|... +.
T Consensus        33 w~kRWFvlr~s~L~Y~~~~~~~~~~~vil~D~~---f~v~~~~~~~~~~~~~~~~~~~~~~~~~i~t~~R~~~l~a~s~~  109 (121)
T cd01254          33 WQKRWFIVKESFLAYMDDPSSAQILDVILFDVD---FKVNGGGKEDISLAVELKDITGLRHGLKITNSNRSLKLKCKSSR  109 (121)
T ss_pred             CcceeEEEeCCEEEEEcCCCCCceeeEEEEcCC---ccEEeCCcccccccccccccCCCceEEEEEcCCcEEEEEeCCHH
Confidence            899999999988889999999999999999876   4555322                247999999999999955 58


Q ss_pred             cHHHHHHHHHHh
Q 011287          475 RASQWKKAIEAL  486 (489)
Q Consensus       475 ~~~~W~~~i~~~  486 (489)
                      ++++|+++|+++
T Consensus       110 ~~~~Wi~~i~~a  121 (121)
T cd01254         110 KLKQWMASIEDA  121 (121)
T ss_pred             HHHHHHHHHHhC
Confidence            999999999974

Phospholipase D (PLD) pleckstrin homology (PH) domain. PLD hydrolyzes phosphatidylcholine to phosphatidic acid (PtdOH), which can bind target proteins. PLD contains a PH domain, a PX domain and four conserved PLD signature domains. The PLD PH domain is specific for bisphosphorylated inositides. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.19  E-value=1.1e-10  Score=110.51  Aligned_cols=140  Identities=21%  Similarity=0.231  Sum_probs=106.2

Q ss_pred             eEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC--CCccEEEEEEEcC---CEEEEEEe
Q 011287           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH--PGVVRLFFTFQDT---FSLYMALE  125 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~---~~lylV~E  125 (489)
                      +.||.|..+.||++...+ |..|++|+.......  .....+..|..+++.+.+  ..+.+++.+....   ...|+|||
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence            678999999999998743 689999997654221  123457789999999865  3456677766553   25689999


Q ss_pred             ccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 011287          126 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS------------------------------------------  163 (489)
Q Consensus       126 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~------------------------------------------  163 (489)
                      |++|.++.+.+.. +.+++.....++.+++.+|..||+                                          
T Consensus        81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9999888765432 457777777788888888888874                                          


Q ss_pred             --------------CCcEeeccCCCCeeeCC--CCCEEEeeccCccc
Q 011287          164 --------------MGLIHRDIKPENLLLTA--DGHIKIADFGSVKP  194 (489)
Q Consensus       164 --------------~gIiHrDLKpeNILl~~--~g~ikL~DFG~a~~  194 (489)
                                    ..++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          23599999999999998  66789999998763

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.17  E-value=3e-10  Score=102.12  Aligned_cols=144  Identities=21%  Similarity=0.248  Sum_probs=107.6

Q ss_pred             EeeEEeeeCceEEEEEEEcCCCcEEEEEEee-c----ccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           49 LGKIYGVGSYSKVVRAKKIDTGTVYALKIMD-K----KFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        49 ~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~-k----~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      .+.+|-+|+-+.|+.+..  .|+.+.||.-. |    ..+..........+|..+|.++.--+|.-.--+|.|...-.++
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            678889999999999987  68888888432 2    2222223345667799999888655665445556677777799


Q ss_pred             EeccCC-CChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCC---CEEEeeccCccc
Q 011287          124 LESCEG-GELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG---HIKIADFGSVKP  194 (489)
Q Consensus       124 ~E~~~g-g~L~~~l~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g---~ikL~DFG~a~~  194 (489)
                      |||.+| .++.+++....  .........++..|=..+.-||.++|||+||..+||++..+|   .+.|+|||++..
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            999987 46777776542  233333478888999999999999999999999999998776   358999999763

>cd01250 PH_centaurin Centaurin Pleckstrin homology (PH) domain

Probab=99.07  E-value=1.8e-10  Score=94.14  Aligned_cols=84  Identities=17%  Similarity=0.176  Sum_probs=64.8

Q ss_pred             EEEeeehhhhh---hccceeEEEecCCeEEEECCCC--CeeeeeeeccCCCCceEEEEc---CCCcEEEEcCCceEEEE-
Q 011287          400 MISMVKKLQKL---TSKKVQLILTNKPKLIYVDPSK--LVVKGNIIWSDNSNDLSIQVS---SPSHFKIVTPKKVLSFE-  470 (489)
Q Consensus       400 ~~g~~~k~~g~---~~k~r~~~lt~~p~l~y~d~~~--~~~kg~i~~~~~~~~~~~~~~---~~~~f~i~~p~r~y~~~-  470 (489)
                      ++|+|.|+++.   .|++|+|+|.++-..||.|+..  ....|.|+++.+.  +.....   ....|.|.||+|+|+|. 
T Consensus         1 k~G~L~kk~~~~~~~W~kr~~~L~~~~l~~y~~~~~~~~~~~~~i~l~~~~--v~~~~~~~~~~~~f~i~~~~~~~~f~a   78 (94)
T cd01250           1 KQGYLYKRSSKSNKEWKKRWFVLKNGQLTYHHRLKDYDNAHVKEIDLRRCT--VRHNGKQPDRRFCFEVISPTKTWHFQA   78 (94)
T ss_pred             CcceEEEECCCcCCCceEEEEEEeCCeEEEEcCCcccccccceEEeccceE--EecCccccCCceEEEEEcCCcEEEEEC
Confidence            47999887743   4999999999877778877764  5678999998641  222222   35689999999999998 


Q ss_pred             cCCccHHHHHHHHHH
Q 011287          471 DAKQRASQWKKAIEA  485 (489)
Q Consensus       471 d~~~~~~~W~~~i~~  485 (489)
                      +.+.++++|+.+|+.
T Consensus        79 ~s~~~~~~Wi~al~~   93 (94)
T cd01250          79 DSEEERDDWISAIQE   93 (94)
T ss_pred             CCHHHHHHHHHHHhc
Confidence            556899999999975

Centaurin Pleckstrin homology (PH) domain. Centaurin beta and gamma consist of a PH domain, an ArfGAP domain and three ankyrin repeats. Centaurain gamma also has an N-terminal Ras homology domain. Centaurin alpha has a different domain architecture and its PH domain is in a different subfamily. Centaurin can bind to phosphatidlyinositol (3,4,5)P3. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.06  E-value=2.9e-09  Score=108.98  Aligned_cols=202  Identities=24%  Similarity=0.282  Sum_probs=147.1

Q ss_pred             ceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEE----cCCEEEEEEeccCC-CCh
Q 011287           58 YSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ----DTFSLYMALESCEG-GEL  132 (489)
Q Consensus        58 ~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~----~~~~lylV~E~~~g-g~L  132 (489)
                      -.+.|+|...-+|..|++|.+.-......++.   ..-.+.++++.|+|||++.++|.    ....+++|++|.++ ++|
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~---t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL  365 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKD---TSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL  365 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccc---hHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence            35799999999999999999843333333222   22456789999999999998887    34568999999886 567


Q ss_pred             HHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCC
Q 011287          133 FDQITS---------------KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (489)
Q Consensus       133 ~~~l~~---------------~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~  197 (489)
                      .++.-.               ....+|..++.|+.||..||.++|+.|+..+-|.|.+||++.+.+++|..-|..-.+.+
T Consensus       366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            665421               12468899999999999999999999999999999999999999888887776544332


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCC-CCCCCHHHH-HHHHHhcCCCCC
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP-FKDTSEWLI-FQRIIARDIRFP  275 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~P-F~~~~~~~~-~~~i~~~~~~~p  275 (489)
                      +.                 +       |-+..   ..+-|.=.||.+++.|.||..- ++....... ...|       -
T Consensus       446 d~-----------------~-------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I-------~  491 (655)
T KOG3741|consen  446 DP-----------------T-------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI-------T  491 (655)
T ss_pred             CC-----------------C-------cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh-------h
Confidence            21                 0       11111   2346899999999999999533 222222111 2222       2


Q ss_pred             CCCCHHHHHHHHHhhccCCCC
Q 011287          276 NYFSDAARDLIDRLLDVDPSG  296 (489)
Q Consensus       276 ~~~~~~~~~Li~~~L~~dP~~  296 (489)
                      ..++.+++++|.-+...++++
T Consensus       492 ~~yS~D~rn~v~yl~s~~~~~  512 (655)
T KOG3741|consen  492 TTYSTDLRNVVEYLESLNFRE  512 (655)
T ss_pred             hhhhHHHHHHHHHHHhcCccc
Confidence            347889999999999999884

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.03  E-value=7.1e-09  Score=101.44  Aligned_cols=134  Identities=18%  Similarity=0.149  Sum_probs=93.7

Q ss_pred             ceEEEEEEEcCCCcEEEEEEeeccccc---ch-----hHHHHHHHHHHHHHhCCCCC--ccEEEEEEEc-----CCEEEE
Q 011287           58 YSKVVRAKKIDTGTVYALKIMDKKFIT---KE-----NKTAYVKLERIVLDQLDHPG--VVRLFFTFQD-----TFSLYM  122 (489)
Q Consensus        58 ~g~Vy~a~~~~tg~~vAiK~~~k~~~~---~~-----~~~~~~~~E~~il~~l~hpn--Iv~l~~~~~~-----~~~lyl  122 (489)
                      ...|+.+..  .|+.|.||........   +.     .-.....+|...+.+|..-+  ...+..++..     ....++
T Consensus        35 ~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~L  112 (268)
T PRK15123         35 GRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFI  112 (268)
T ss_pred             CceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEE
Confidence            334555543  5778999976432211   00     01113567888777773222  2344444432     235789


Q ss_pred             EEeccCCC-ChHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCC-------CCCEEEeeccCc
Q 011287          123 ALESCEGG-ELFDQITS--KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-------DGHIKIADFGSV  192 (489)
Q Consensus       123 V~E~~~gg-~L~~~l~~--~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~-------~g~ikL~DFG~a  192 (489)
                      |||++++. +|.+++..  ....+......++.+++..+..||..||+|+|+++.|||++.       ++.+.|+||+.+
T Consensus       113 Vte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~  192 (268)
T PRK15123        113 ITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA  192 (268)
T ss_pred             EEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence            99999885 78888764  245677788899999999999999999999999999999975       468999999987


Q ss_pred             c
Q 011287          193 K  193 (489)
Q Consensus       193 ~  193 (489)
                      .
T Consensus       193 ~  193 (268)
T PRK15123        193 Q  193 (268)
T ss_pred             c
Confidence            5

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.99  E-value=3.4e-09  Score=98.00  Aligned_cols=129  Identities=22%  Similarity=0.247  Sum_probs=84.5

Q ss_pred             EEEEEEEcCCCcEEEEEEeeccc-----------------------ccchhHHHHHHHHHHHHHhCCCCC--ccEEEEEE
Q 011287           60 KVVRAKKIDTGTVYALKIMDKKF-----------------------ITKENKTAYVKLERIVLDQLDHPG--VVRLFFTF  114 (489)
Q Consensus        60 ~Vy~a~~~~tg~~vAiK~~~k~~-----------------------~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~~  114 (489)
                      .||.|... .|..+|+|+.....                       ...........+|...|.++..-+  +.+++.+-
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            48999874 57899999985321                       011122345778999999997654  45565442


Q ss_pred             EcCCEEEEEEeccC--CCChHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHhCCcEeeccCCCCeeeCCCCCEEEeeccC
Q 011287          115 QDTFSLYMALESCE--GGELFDQITSKGHLSEDEARFYTAEVVDALEY-IHSMGLIHRDIKPENLLLTADGHIKIADFGS  191 (489)
Q Consensus       115 ~~~~~lylV~E~~~--gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~-LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~  191 (489)
                        .  -++||||++  |..+..+...  .++......++.+++..+.. +|..||+|+||.+.|||++++ .+.++|||.
T Consensus        80 --~--~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q  152 (188)
T PF01163_consen   80 --R--NVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ  152 (188)
T ss_dssp             --T--TEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred             --C--CEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence              2  359999998  6555443332  23355677788888886666 579999999999999999876 999999999


Q ss_pred             ccccC
Q 011287          192 VKPMQ  196 (489)
Q Consensus       192 a~~~~  196 (489)
                      +....
T Consensus       153 av~~~  157 (188)
T PF01163_consen  153 AVDSS  157 (188)
T ss_dssp             EEETT
T ss_pred             ceecC
Confidence            87543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF15409 PH_8: Pleckstrin homology domain

Probab=98.98  E-value=2.2e-09  Score=85.75  Aligned_cols=82  Identities=13%  Similarity=0.174  Sum_probs=67.0

Q ss_pred             Eeeehhhhhh---ccceeEEE--ecCCeEEEECCCCCeeeeeeeccCCCCceEEEEcCCCcEEEEcCCceEEEEcCC-cc
Q 011287          402 SMVKKLQKLT---SKKVQLIL--TNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAK-QR  475 (489)
Q Consensus       402 g~~~k~~g~~---~k~r~~~l--t~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~~~~~f~i~~p~r~y~~~d~~-~~  475 (489)
                      |++.|++.-.   |.||+|+|  .++-.-||.++.++.+.|.||++.+  ++++.. +...|.|.+...+|+|...+ .+
T Consensus         1 G~llKkrr~~lqG~~kRyFvL~~~~G~LsYy~~~~~~~~rGsi~v~~a--~is~~~-~~~~I~idsg~~i~hLKa~s~~~   77 (89)
T PF15409_consen    1 GWLLKKRRKPLQGWHKRYFVLDFEKGTLSYYRNQNSGKLRGSIDVSLA--VISANK-KSRRIDIDSGDEIWHLKAKSQED   77 (89)
T ss_pred             CcceeeccccCCCceeEEEEEEcCCcEEEEEecCCCCeeEeEEEccce--EEEecC-CCCEEEEEcCCeEEEEEcCCHHH
Confidence            5665554422   89999999  6777779999998899999999986  455554 45789999999999999654 89


Q ss_pred             HHHHHHHHHHh
Q 011287          476 ASQWKKAIEAL  486 (489)
Q Consensus       476 ~~~W~~~i~~~  486 (489)
                      .+.|+++++.+
T Consensus        78 f~~Wv~aL~~a   88 (89)
T PF15409_consen   78 FQRWVSALQKA   88 (89)
T ss_pred             HHHHHHHHHhc
Confidence            99999999985

>PF00169 PH: PH domain; InterPro: IPR001849 The pleckstrin homology (PH) domain is a domain of about 100 residues that occurs in a wide range of proteins involved in intracellular signalling or as constituents of the cytoskeleton [, , , , , , ]

Probab=98.92  E-value=5.4e-09  Score=86.09  Aligned_cols=86  Identities=21%  Similarity=0.305  Sum_probs=70.9

Q ss_pred             EEEEEeeehhhh--hhccceeEEEecCCeEEEECCC---CCeeeeeeeccCCCCceEEEE----------cCCCcEEEEc
Q 011287          398 VLMISMVKKLQK--LTSKKVQLILTNKPKLIYVDPS---KLVVKGNIIWSDNSNDLSIQV----------SSPSHFKIVT  462 (489)
Q Consensus       398 i~~~g~~~k~~g--~~~k~r~~~lt~~p~l~y~d~~---~~~~kg~i~~~~~~~~~~~~~----------~~~~~f~i~~  462 (489)
                      ++++|+|.|++.  ..||+|+|+|++.-.++|.++.   ....++.|++...    .+..          ...+.|.|.+
T Consensus         1 ~~~~G~L~~~~~~~~~wk~r~~vL~~~~L~~~~~~~~~~~~~~~~~i~l~~~----~v~~~~~~~~~~~~~~~~~f~i~~   76 (104)
T PF00169_consen    1 CIKEGWLLKKSSSRKKWKKRYFVLRDSYLLYYKSSKDKSDSKPKGSIPLDDC----TVRPDPSSDFLSNKKRKNCFEITT   76 (104)
T ss_dssp             EEEEEEEEEEESSSSSEEEEEEEEETTEEEEESSTTTTTESSESEEEEGTTE----EEEEETSSTSTSTSSSSSEEEEEE
T ss_pred             CEEEEEEEEECCCCCCeEEEEEEEECCEEEEEecCccccceeeeEEEEecCc----eEEEcCccccccccCCCcEEEEEe
Confidence            578999999984  3399999999998888888887   6899999999984    3333          2357999999


Q ss_pred             CCc-eEEEE-cCCccHHHHHHHHHHhc
Q 011287          463 PKK-VLSFE-DAKQRASQWKKAIEALQ  487 (489)
Q Consensus       463 p~r-~y~~~-d~~~~~~~W~~~i~~~~  487 (489)
                      +++ +|+|. +.+.++..|+++|++++
T Consensus        77 ~~~~~~~~~~~s~~~~~~W~~~i~~~~  103 (104)
T PF00169_consen   77 PNGKSYLFSAESEEERKRWIQAIQKAI  103 (104)
T ss_dssp             TTSEEEEEEESSHHHHHHHHHHHHHHH
T ss_pred             CCCcEEEEEcCCHHHHHHHHHHHHHHh
Confidence            886 99999 45589999999999975

The pleckstrin homology domain commonly found in eukaryotic signalling proteins. The domain family possesses multiple functions including the abilities to bind inositol phosphates, and various proteins. PH domains have been found to possess inserted domains (such as in PLC gamma, syntrophins) and to be inserted within other domains. Mutations in Brutons tyrosine kinase (Btk) within its PH domain cause X-linked agammaglobulinaemia (XLA) in patients. Point mutations cluster into the positively charged end of the molecule around the predicted binding site for phosphatidylinositol lipids. The 3D structure of several PH domains has been determined []. All known cases have a common structure consisting of two perpendicular anti-parallel beta sheets, followed by a C-terminal amphipathic helix. The loops connecting the beta-strands differ greatly in length, making the PH domain relatively difficult to detect. There are no totally invariant residues within the PH domain. Proteins reported to contain one more PH domains belong to the following families: Pleckstrin, the protein where this domain was first detected, is the major substrate of protein kinase C in platelets. Pleckstrin is one of the rare proteins to contains two PH domains. Ser/Thr protein kinases such as the Akt/Rac family, the beta-adrenergic receptor kinases, the mu isoform of PKC and the trypanosomal NrkA family. Tyrosine protein kinases belonging to the Btk/Itk/Tec subfamily. Insulin Receptor Substrate 1 (IRS-1). Regulators of small G-proteins like guanine nucleotide releasing factor GNRP (Ras-GRF) (which contains 2 PH domains), guanine nucleotide exchange proteins like vav, dbl, SoS and Saccharomyces cerevisiae CDC24, GTPase activating proteins like rasGAP and BEM2/IPL2, and the human break point cluster protein bcr. Cytoskeletal proteins such as dynamin (see IPR001401 from INTERPRO), Caenorhabditis elegans kinesin-like protein unc-104 (see IPR001752 from INTERPRO), spectrin beta-chain, syntrophin (2 PH domains) and S. cerevisiae nuclear migration protein NUM1. Mammalian phosphatidylinositol-specific phospholipase C (PI-PLC) (see IPR000909 from INTERPRO) isoforms gamma and delta. Isoform gamma contains two PH domains, the second one is split into two parts separated by about 400 residues. Oxysterol binding proteins OSBP, S. cerevisiae OSH1 and YHR073w. Mouse protein citron, a putative rho/rac effector that binds to the GTP-bound forms of rho and rac. Several S. cerevisiae proteins involved in cell cycle regulation and bud formation like BEM2, BEM3, BUD4 and the BEM1-binding proteins BOI2 (BEB1) and BOI1 (BOB1). C. elegans protein MIG-10. C. elegans hypothetical proteins C04D8.1, K06H7.4 and ZK632.12. S. cerevisiae hypothetical proteins YBR129c and YHR155w. ; GO: 0005515 protein binding; PDB: 1DYN_B 2DYN_B 3SNH_A 3ZYS_C 1X05_A 2I5F_A 1ZM0_B 1XX0_A 2I5C_C 3A8P_D ....

>cd01219 PH_FGD FGD (faciogenital dysplasia protein) pleckstrin homology (PH) domain

Probab=98.90  E-value=7e-09  Score=86.17  Aligned_cols=87  Identities=23%  Similarity=0.331  Sum_probs=69.4

Q ss_pred             EEEEEeeehhhhhh--ccceeEEEecCCeEEEECC-----CCCeeeeeeeccCCCCceEEEEc----CCCcEEEEcCCce
Q 011287          398 VLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDP-----SKLVVKGNIIWSDNSNDLSIQVS----SPSHFKIVTPKKV  466 (489)
Q Consensus       398 i~~~g~~~k~~g~~--~k~r~~~lt~~p~l~y~d~-----~~~~~kg~i~~~~~~~~~~~~~~----~~~~f~i~~p~r~  466 (489)
                      .+++|++.|.++.+  ||.|+|+|-|.-.+||...     ..-..++.|+++.    ++++..    .++.|.|.++.|+
T Consensus         2 ~ikeG~L~K~~~~~~~~k~RyffLFnd~Ll~~~~~~~~~~~~y~~~~~i~l~~----~~v~~~~~~~~~~~F~I~~~~rs   77 (101)
T cd01219           2 LLKEGSVLKISSTTEKTEERYLFLFNDLLLYCVPRKMIGGSKFKVRARIDVSG----MQVCEGDNLERPHSFLVSGKQRC   77 (101)
T ss_pred             cccceEEEEEecCCCCceeEEEEEeCCEEEEEEcccccCCCcEEEEEEEeccc----EEEEeCCCCCcCceEEEecCCcE
Confidence            47899999999865  8999999999944455431     1347789999997    466553    3689999999999


Q ss_pred             EEEEc-CCccHHHHHHHHHHhcC
Q 011287          467 LSFED-AKQRASQWKKAIEALQN  488 (489)
Q Consensus       467 y~~~d-~~~~~~~W~~~i~~~~~  488 (489)
                      |++.. ++.+.++|+++|+++++
T Consensus        78 f~l~A~s~eEk~~W~~ai~~~i~  100 (101)
T cd01219          78 LELQARTQKEKNDWVQAIFSIID  100 (101)
T ss_pred             EEEEcCCHHHHHHHHHHHHHHhh
Confidence            99995 55899999999999875

FGD (faciogenital dysplasia protein) pleckstrin homology (PH) domain. FGD has a RhoGEF (DH) domain, followed by a PH domain, a FYVE domain and a C-terminal PH domain. FGD is a guanine nucleotide exchange factor that activates the Rho GTPase Cdc42. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains. PH domains are found in cellular signaling proteins such as serine/threonine kinase, tyrosine kinases, regulators of G-proteins, endocytotic GTPases, adaptors, as well as cytoskeletal associated molecules and in lipid associated enzymes.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.85  E-value=2.4e-08  Score=95.56  Aligned_cols=138  Identities=22%  Similarity=0.234  Sum_probs=103.2

Q ss_pred             eEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccc------------------c-chhHHHHHHHHHHHHHhCCCC--
Q 011287           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFI------------------T-KENKTAYVKLERIVLDQLDHP--  105 (489)
Q Consensus        47 y~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~------------------~-~~~~~~~~~~E~~il~~l~hp--  105 (489)
                      +.++..||.|.-|.||.|.+. .|.++|||.=.-...                  . -.......++|..+|.+|...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            467899999999999999986 589999996431100                  0 011234566789999988544  


Q ss_pred             CccEEEEEEEcCCEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEE
Q 011287          106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIK  185 (489)
Q Consensus       106 nIv~l~~~~~~~~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ik  185 (489)
                      .+.+.++    .+...+|||+.+|-.|...     +++.+.+..++..|+.-+.-+-..||||+|+.+=||++++||.+.
T Consensus       172 ~VP~P~~----~nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~  242 (304)
T COG0478         172 KVPKPIA----WNRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV  242 (304)
T ss_pred             CCCCccc----cccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence            4555553    3567799999999777542     234666667777777777777789999999999999999999999


Q ss_pred             EeeccCccc
Q 011287          186 IADFGSVKP  194 (489)
Q Consensus       186 L~DFG~a~~  194 (489)
                      ++||--+..
T Consensus       243 vIDwPQ~v~  251 (304)
T COG0478         243 VIDWPQAVP  251 (304)
T ss_pred             EEeCccccc
Confidence            999976553

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.84  E-value=3.9e-08  Score=92.73  Aligned_cols=126  Identities=20%  Similarity=0.293  Sum_probs=92.1

Q ss_pred             CCcEEEEEEeecccccc----hhHHHHHHHHHHHHHhCCCCC--ccEEEEEEEcC----CEEEEEEeccCCC-ChHHHHH
Q 011287           69 TGTVYALKIMDKKFITK----ENKTAYVKLERIVLDQLDHPG--VVRLFFTFQDT----FSLYMALESCEGG-ELFDQIT  137 (489)
Q Consensus        69 tg~~vAiK~~~k~~~~~----~~~~~~~~~E~~il~~l~hpn--Iv~l~~~~~~~----~~lylV~E~~~gg-~L~~~l~  137 (489)
                      .++.|-+|.+.......    ........+|...+..|..-+  +.+.+.+....    ...|+|+|++++. +|.+++.
T Consensus        31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~  110 (206)
T PF06293_consen   31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ  110 (206)
T ss_pred             cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence            46667777543321111    123344666777776663222  34455555432    3468999999884 7999888


Q ss_pred             hCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCC---CEEEeeccCccc
Q 011287          138 SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG---HIKIADFGSVKP  194 (489)
Q Consensus       138 ~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g---~ikL~DFG~a~~  194 (489)
                      .....+......++.+++..+.-||.+||+|+|++|.|||++.++   .+.|+||+-++.
T Consensus       111 ~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  111 QWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             hhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            755578888899999999999999999999999999999999887   899999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0930 consensus Guanine nucleotide exchange factor Cytohesin, contains PH and Sec7 domains [Intracellular trafficking, secretion, and vesicular transport]

Probab=98.82  E-value=7.7e-09  Score=97.17  Aligned_cols=96  Identities=22%  Similarity=0.301  Sum_probs=73.0

Q ss_pred             ccccccCCCceEEEEEeeehhhh---hhccceeEEEecCCeEEEECC-CCCeeeeeeeccCCCCceEEEE-cCCCcEEEE
Q 011287          387 KWQQFLDPGESVLMISMVKKLQK---LTSKKVQLILTNKPKLIYVDP-SKLVVKGNIIWSDNSNDLSIQV-SSPSHFKIV  461 (489)
Q Consensus       387 ~~~~~~~~~~~i~~~g~~~k~~g---~~~k~r~~~lt~~p~l~y~d~-~~~~~kg~i~~~~~~~~~~~~~-~~~~~f~i~  461 (489)
                      .-|.|++++    .+||+.|.+|   ..||||||||||.=. ||.+- -..+.+|.|||...+ .-.|+. +.+..|++-
T Consensus       253 lthtffnpd----REGWLlKlgg~rvktWKrRWFiLtdNCL-YYFe~tTDKEPrGIIpLeNls-ir~VedP~kP~cfEly  326 (395)
T KOG0930|consen  253 LTHTFFNPD----REGWLLKLGGNRVKTWKRRWFILTDNCL-YYFEYTTDKEPRGIIPLENLS-IREVEDPKKPNCFELY  326 (395)
T ss_pred             chhhccCcc----ccceeeeecCCcccchhheeEEeeccee-eeeeeccCCCCCcceeccccc-eeeccCCCCCCeEEEe
Confidence            456777755    4899999998   669999999999754 55554 467899999999742 223333 667888886


Q ss_pred             cCCc----------------------eEEEEcCC-ccHHHHHHHHHHhcC
Q 011287          462 TPKK----------------------VLSFEDAK-QRASQWKKAIEALQN  488 (489)
Q Consensus       462 ~p~r----------------------~y~~~d~~-~~~~~W~~~i~~~~~  488 (489)
                      .|+-                      +|.|+.++ .+.++|+++|..++.
T Consensus       327 ~ps~~gq~IKACKTe~DGRvVEG~H~vYrIsA~~~Ee~~~Wi~sI~a~is  376 (395)
T KOG0930|consen  327 IPSNKGQVIKACKTEADGRVVEGNHSVYRISAPTPEEKDEWIKSIKAAIS  376 (395)
T ss_pred             cCCCCcCeeeeecccCCceeEeccceEEEeeCCCHHHHHHHHHHHHHHhc
Confidence            6643                      69999776 789999999998774

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.75  E-value=9.7e-08  Score=95.82  Aligned_cols=233  Identities=16%  Similarity=0.208  Sum_probs=154.6

Q ss_pred             EEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh-CCCCCccEEEEEE-------EcCCE
Q 011287           48 ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ-LDHPGVVRLFFTF-------QDTFS  119 (489)
Q Consensus        48 ~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~-------~~~~~  119 (489)
                      ..++.||+|+-+.+|..-..   ...+.|++.+.-....  .+    -+..|.. -.||-+-.=+.+-       .....
T Consensus        14 ~~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~--aq----k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~   84 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQ--AQ----KVAELAATPDAPLLNYRVAWPQATLHGGRRGKV   84 (637)
T ss_pred             CCCccccCCccceeeecchh---hchhheeecCCCchHH--HH----HHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence            35678999999999976442   2345688876532211  11    1122222 2566433211111       12233


Q ss_pred             EEEEEeccCCCChHHHHH----h---CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCc
Q 011287          120 LYMALESCEGGELFDQIT----S---KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  192 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~----~---~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a  192 (489)
                      +-|.|..+.|..--..+.    +   ...+.+.-+.+.+..|+.|...||..|-+-+|+.++|+|+++++.+.|.|-..-
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence            778898888753222221    1   134788899999999999999999999999999999999999999999987654


Q ss_pred             cccCCccccccCCCCCCCCccceecCCcCCChhhhc-----CCCCCCCCcchhhhHHHHHHhhC-CCCCCC-------CC
Q 011287          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN-----SSPATFGNDLWALGCTLYQMLSG-TSPFKD-------TS  259 (489)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~-----~~~~~~~sDiwSLG~ilyelltG-~~PF~~-------~~  259 (489)
                      ..-.           .......-+|.+.|.+||.-+     +..-+...|.|.||++||++|.| +.||.+       .+
T Consensus       165 qi~~-----------ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~  233 (637)
T COG4248         165 QINA-----------NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPN  233 (637)
T ss_pred             eecc-----------CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCC
Confidence            3221           123334568999999999865     33456778999999999999987 999975       22


Q ss_pred             HHHHHHHHHhcC----------CC-CC-----CCCCHHHHHHHHHhhcc--CCCCCCCCCC
Q 011287          260 EWLIFQRIIARD----------IR-FP-----NYFSDAARDLIDRLLDV--DPSGRPGAGP  302 (489)
Q Consensus       260 ~~~~~~~i~~~~----------~~-~p-----~~~~~~~~~Li~~~L~~--dP~~R~t~~~  302 (489)
                      ..+.  .|-.+.          +. -|     ..++++++.|+.+|+..  ++.-||++..
T Consensus       234 p~E~--~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         234 PLET--DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             cchh--hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence            3331  122111          11 11     23689999999999964  3668999853

>cd01263 PH_anillin Anillin Pleckstrin homology (PH) domain

Probab=98.66  E-value=3.8e-08  Score=83.91  Aligned_cols=74  Identities=16%  Similarity=0.188  Sum_probs=55.3

Q ss_pred             ccceeEEEecCCeEEEECCCC---CeeeeeeeccCCCCceEE------EEcCCCcEEEEc--CC----------------
Q 011287          412 SKKVQLILTNKPKLIYVDPSK---LVVKGNIIWSDNSNDLSI------QVSSPSHFKIVT--PK----------------  464 (489)
Q Consensus       412 ~k~r~~~lt~~p~l~y~d~~~---~~~kg~i~~~~~~~~~~~------~~~~~~~f~i~~--p~----------------  464 (489)
                      ||||||+|.++-..||.+|..   ....|.|+|..+. ...+      +...+++|.|.+  |+                
T Consensus        19 W~RRWFvL~g~~L~y~k~p~d~~~~~Plg~I~L~~c~-~~~v~~~~r~~c~Rp~tF~i~~~~~~~~~~~~~~~~~~~~~~   97 (122)
T cd01263          19 WHRRWCALEGGEIKYWKYPDDEKRKGPTGLIDLSTCT-SSEGASAVRDICARPNTFHLDVWRPKMETDDETLVSQCRRGI   97 (122)
T ss_pred             ceEEEEEEeCCEEEEEcCCCccccCCceEEEEhhhCc-ccccccCChhhcCCCCeEEEEEecccccccccceeeccCCce
Confidence            999999999665557766654   5677999999863 2445      345678999953  43                


Q ss_pred             -ceEEEE--cCCccHHHHHHHHHHh
Q 011287          465 -KVLSFE--DAKQRASQWKKAIEAL  486 (489)
Q Consensus       465 -r~y~~~--d~~~~~~~W~~~i~~~  486 (489)
                       |||++-  |...+.++|+++||++
T Consensus        98 ~r~~~~lsaDt~eer~~W~~ain~~  122 (122)
T cd01263          98 ERLRVMLSADTKEERQTWLSLLNST  122 (122)
T ss_pred             eEEEEEEecCCHHHHHHHHHHHhcC
Confidence             666644  7778999999999973

Anillin Pleckstrin homology (PH) domain. Anillin is an actin binding protein involved in cytokinesis. It has a C-terminal PH domain, which has been shown to be necessary, but not sufficient for targetting of anillin to ectopic septin containing foci . PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains. PH domains are found in cellular signaling proteins such as serine/threonine kinase, tyrosine kinsases, regulators of G-proteins, endocytotic GTPAses, adaptors, a well as cytoskeletal associated molecules and in lipid associated enzymes.

>PRK09902 hypothetical protein; Provisional

Probab=98.66  E-value=3.4e-07  Score=85.55  Aligned_cols=137  Identities=15%  Similarity=0.160  Sum_probs=100.0

Q ss_pred             eeeCceEEEEEEEcCCCcEEEEEEeeccc---ccchhHHHHHHHHHHHHHhCCCC--CccEEEEEEE-c----CCEEEEE
Q 011287           54 GVGSYSKVVRAKKIDTGTVYALKIMDKKF---ITKENKTAYVKLERIVLDQLDHP--GVVRLFFTFQ-D----TFSLYMA  123 (489)
Q Consensus        54 G~G~~g~Vy~a~~~~tg~~vAiK~~~k~~---~~~~~~~~~~~~E~~il~~l~hp--nIv~l~~~~~-~----~~~lylV  123 (489)
                      |+||.|.|+....  .|+.|=+|.-....   .....-...+.+|...|..|..-  .+.++. ++. .    ....++|
T Consensus        27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            6799999999875  34468888764211   11123456688899988888422  244444 222 1    2347899


Q ss_pred             EeccCC-CChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCC--EEEeeccCcc
Q 011287          124 LESCEG-GELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH--IKIADFGSVK  193 (489)
Q Consensus       124 ~E~~~g-g~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~--ikL~DFG~a~  193 (489)
                      +|-+.| -+|.+++...  .+.++.....++.+++.++.-||+.|+.|+|+-+.||+++.+|.  +.++||.-++
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            997764 5788877653  34577788899999999999999999999999999999987777  9999998765

>cd01220 PH_CDEP Chondrocyte-derived ezrin-like domain containing protein (CDEP) Pleckstrin homology (PH) domain

Probab=98.64  E-value=2.1e-07  Score=76.75  Aligned_cols=87  Identities=11%  Similarity=0.179  Sum_probs=64.4

Q ss_pred             EEEEEeeehhhhhhccceeEEEecCCeEEEECC----CCCeeeeeeeccCCCCceEEEE-----cCCCcEEEEcCCceEE
Q 011287          398 VLMISMVKKLQKLTSKKVQLILTNKPKLIYVDP----SKLVVKGNIIWSDNSNDLSIQV-----SSPSHFKIVTPKKVLS  468 (489)
Q Consensus       398 i~~~g~~~k~~g~~~k~r~~~lt~~p~l~y~d~----~~~~~kg~i~~~~~~~~~~~~~-----~~~~~f~i~~p~r~y~  468 (489)
                      .|++|+|.|..+.-.++|+|.|=+.-.||+...    ..-...|.||+..    +.|+.     ..++.|.|.+|+|+|.
T Consensus         2 ~ikEG~L~K~~~k~~~~R~~FLFnD~LlY~~~~~~~~~~y~~~~~i~L~~----~~V~~~~~~~~~~~~F~I~~~~ks~~   77 (99)
T cd01220           2 FIRQGCLLKLSKKGLQQRMFFLFSDLLLYTSKSPTDQNSFRILGHLPLRG----MLTEESEHEWGVPHCFTIFGGQCAIT   77 (99)
T ss_pred             eeeEEEEEEEeCCCCceEEEEEccceEEEEEeecCCCceEEEEEEEEcCc----eEEeeccCCcCCceeEEEEcCCeEEE
Confidence            478999999876555555555555555555421    2336889999997    45554     2358999999999999


Q ss_pred             EEcCC-ccHHHHHHHHHHhcC
Q 011287          469 FEDAK-QRASQWKKAIEALQN  488 (489)
Q Consensus       469 ~~d~~-~~~~~W~~~i~~~~~  488 (489)
                      |..++ .+.++|+++|++++.
T Consensus        78 l~A~s~~Ek~~Wi~~i~~aI~   98 (99)
T cd01220          78 VAASTRAEKEKWLADLSKAIA   98 (99)
T ss_pred             EECCCHHHHHHHHHHHHHHhh
Confidence            99655 899999999999874

Chondrocyte-derived ezrin-like domain containing protein (CDEP) Pleckstrin homology (PH) domain. CDEP consists of a Ferm domain, a rhoGEF (DH) domain followed by two PH domains. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains. PH domains are found in cellular signaling proteins such as serine/threonine kinase, tyrosine kinases, regulators of G-proteins, endocytotic GTPases, adaptors, as well as cytoskeletal associated molecules and in lipid associated enzymes.

>PF15413 PH_11: Pleckstrin homology domain; PDB: 3MDB_D 3FEH_A 3LJU_X 3FM8_C

Probab=98.64  E-value=4.9e-08  Score=82.64  Aligned_cols=87  Identities=22%  Similarity=0.279  Sum_probs=53.5

Q ss_pred             EEEeeehhhhhh---ccceeEEEe-cCCeEEEEC-------------CCCCeeeeeeeccCCCCceE-EE------EcCC
Q 011287          400 MISMVKKLQKLT---SKKVQLILT-NKPKLIYVD-------------PSKLVVKGNIIWSDNSNDLS-IQ------VSSP  455 (489)
Q Consensus       400 ~~g~~~k~~g~~---~k~r~~~lt-~~p~l~y~d-------------~~~~~~kg~i~~~~~~~~~~-~~------~~~~  455 (489)
                      ++|+|.|.+-.|   ||+|||+|- |+-.+||..             +.....+|....+....... +.      ....
T Consensus         1 k~G~l~K~~~~~~kgWk~RwFiL~k~~~L~YyK~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   80 (112)
T PF15413_consen    1 KEGYLYKWGNKFGKGWKKRWFILRKDGVLSYYKIPRDKKDVRIIGEESSRVIRKGDWSISRRSSRIQGIKDKNPFGEIHL   80 (112)
T ss_dssp             EEEEEEE--TTS-S--EEEEEEEE-TTEEEEESS-------------TT-SB-SEEEE---GGGT-EEEES-T--SS-SS
T ss_pred             CCceEEEecCCCCcCccccEEEEEeCCEEEEeecccccccccccccchhceEeecccCcccccccccccccCCcccCcCC
Confidence            579999888764   999999999 777777777             34444555554333211122 11      0113


Q ss_pred             CcEEEEcCCceEEEE-cCCccHHHHHHHHHHh
Q 011287          456 SHFKIVTPKKVLSFE-DAKQRASQWKKAIEAL  486 (489)
Q Consensus       456 ~~f~i~~p~r~y~~~-d~~~~~~~W~~~i~~~  486 (489)
                      +.|.|.||.|||+|. |.+.+..+|+++|.++
T Consensus        81 ~~~~i~T~~kt~~l~~~t~~d~~~Wi~aL~~~  112 (112)
T PF15413_consen   81 KVFSIFTPTKTFHLRCETREDRYDWIEALQEA  112 (112)
T ss_dssp             EEEEEE-SS-EEEEEESSHHHHHHHHHHHHH-
T ss_pred             CCcEEECCCcEEEEEECCHHHHHHHHHHHHhC
Confidence            578899999999999 5668999999999863

>cd01237 Unc112 Unc-112 pleckstrin homology (PH) domain

Probab=98.64  E-value=4.7e-08  Score=80.26  Aligned_cols=74  Identities=12%  Similarity=0.145  Sum_probs=62.7

Q ss_pred             ccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEE---cCCCcEEEEcCC----ceEEEE-cCCccHHHHHHHH
Q 011287          412 SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV---SSPSHFKIVTPK----KVLSFE-DAKQRASQWKKAI  483 (489)
Q Consensus       412 ~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~---~~~~~f~i~~p~----r~y~~~-d~~~~~~~W~~~i  483 (489)
                      ||+|||+|.+.-..||.++.....+|.|.++..++++..++   +.+..|.+.+|.    |+|+|. |.+.+..+|+.+.
T Consensus        20 ~KrrwF~lk~~~L~YyK~kee~~~~p~i~lnl~gcev~~dv~~~~~kf~I~l~~ps~~~~r~y~l~cdsEeqya~Wmaa~   99 (106)
T cd01237          20 YKQYWFTFRDTSISYYKSKEDSNGAPIGQLNLKGCEVTPDVNVAQQKFHIKLLIPTAEGMNEVWLRCDNEKQYAKWMAAC   99 (106)
T ss_pred             heeEEEEEeCCEEEEEccchhcCCCCeEEEecCceEEcccccccccceEEEEecCCccCCeEEEEECCCHHHHHHHHHHH
Confidence            89999999987777998888778899999999888887776   545666677888    999999 6679999999987


Q ss_pred             HH
Q 011287          484 EA  485 (489)
Q Consensus       484 ~~  485 (489)
                      .-
T Consensus       100 rl  101 (106)
T cd01237         100 RL  101 (106)
T ss_pred             HH
Confidence            54

Unc-112 pleckstrin homology (PH) domain. Unc-112 and related proteins contain two FERM domains with a PH domain between them. Both the PH and FERM domains have a PH-like fold. The FERM domains are likely responsible for the role of Unc-112 in organizing beta-integrin. The specific role of the Unc-112 PH domain is not known, but it is predicted to be involved in mediating membrane interactions. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.62  E-value=4.3e-07  Score=85.23  Aligned_cols=142  Identities=20%  Similarity=0.246  Sum_probs=93.4

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHH------HHHHHHHHHhC---CCCCccEEE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY------VKLERIVLDQL---DHPGVVRLF  111 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~------~~~E~~il~~l---~hpnIv~l~  111 (489)
                      .+.-.+|.+.+++-.....-|.+..-  +|+.+++|.........+.....      ..++...+.++   .--.+..++
T Consensus        27 ~i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~y  104 (229)
T PF06176_consen   27 KILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPY  104 (229)
T ss_pred             HHHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccce
Confidence            34457889999998877777777654  67999999886543332222221      22233333333   222233333


Q ss_pred             EEEE-----cCCEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEE
Q 011287          112 FTFQ-----DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI  186 (489)
Q Consensus       112 ~~~~-----~~~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL  186 (489)
                      .+..     -....+++|||++|..|.+...    +++    .++..|+.++.-||+.|++|+|.+|.|++++++ .+++
T Consensus       105 l~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~i  175 (229)
T PF06176_consen  105 LAAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRI  175 (229)
T ss_pred             eeeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEE
Confidence            2222     2334568999999988766432    333    245677788999999999999999999999855 5999


Q ss_pred             eeccCcc
Q 011287          187 ADFGSVK  193 (489)
Q Consensus       187 ~DFG~a~  193 (489)
                      +||+..+
T Consensus       176 ID~~~k~  182 (229)
T PF06176_consen  176 IDTQGKR  182 (229)
T ss_pred             EECcccc
Confidence            9998755

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.55  E-value=7e-07  Score=99.60  Aligned_cols=203  Identities=24%  Similarity=0.342  Sum_probs=150.1

Q ss_pred             HHHHHHHHHHHHhCCCCCccEEEEEEEcCCE----EEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 011287           89 TAYVKLERIVLDQLDHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM  164 (489)
Q Consensus        89 ~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~----lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~  164 (489)
                      ......|...+....|+|++.++.+-.....    +.+..++|..-++...++..+..+..+.+.+..+++.+|.++|+.
T Consensus       226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~  305 (1351)
T KOG1035|consen  226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL  305 (1351)
T ss_pred             HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence            4455667778888899999999887754433    234458999999999999999999999999999999999999999


Q ss_pred             CcEeeccCCC---CeeeCCCCCEEEe--eccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCC--Cc
Q 011287          165 GLIHRDIKPE---NLLLTADGHIKIA--DFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFG--ND  237 (489)
Q Consensus       165 gIiHrDLKpe---NILl~~~g~ikL~--DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~--sD  237 (489)
                      ...|.-+...   +--++..+.+..+  ||+..+.+....           ......-+..+.+||.+....+..+  .|
T Consensus       306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~-----------~~~~~~~~~~~~~~e~~~~~~~~~~r~~d  374 (1351)
T KOG1035|consen  306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE-----------KSFSDLLAEIRNADEDLKENTAKKSRLTD  374 (1351)
T ss_pred             ccceeEEecccccccccCccceeecchhhhcccccCCCcc-----------cchhhcCccccccccccccccchhhhhhH
Confidence            7777666555   4455566677777  998887665432           2223345667888998877776554  69


Q ss_pred             chhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          238 LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       238 iwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      +|++|....++..|..+-...   .....++      +........+++.+|+.-++++|+++     .+++.|+|.+-
T Consensus       375 L~~lgll~~~~~~~~~i~~~~---~~~~~~l------~~~~~~~~~d~~~~~~~~~~~~Rl~~-----~~ll~~~f~~~  439 (1351)
T KOG1035|consen  375 LWCLGLLLLQLSQGEDISEKS---AVPVSLL------DVLSTSELLDALPKCLDEDSEERLSA-----LELLTHPFLRF  439 (1351)
T ss_pred             HHHHHHHHhhhhhcCcccccc---cchhhhh------ccccchhhhhhhhhhcchhhhhccch-----hhhhhchhccc
Confidence            999999999999886443211   0111111      11222378899999999999999999     77999998763

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.54  E-value=1.8e-07  Score=99.15  Aligned_cols=142  Identities=23%  Similarity=0.295  Sum_probs=92.5

Q ss_pred             eEEeeeCceEEEEEEEcCCCcEEEEEEeeccccc---------------------------c----hhHHH------HHH
Q 011287           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---------------------------K----ENKTA------YVK   93 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~---------------------------~----~~~~~------~~~   93 (489)
                      ..|+.+|-|+||.|+.+. |+.||||+....-..                           .    +....      ...
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            788999999999999965 999999997432100                           0    00111      122


Q ss_pred             HHHHHHHhC-----CCCCccEEEEEEEcCCEEEEEEeccCCCChHHH--HHhCCCCCHHHHHHHHHHHHHH-HHHHHhCC
Q 011287           94 LERIVLDQL-----DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQ--ITSKGHLSEDEARFYTAEVVDA-LEYIHSMG  165 (489)
Q Consensus        94 ~E~~il~~l-----~hpnIv~l~~~~~~~~~lylV~E~~~gg~L~~~--l~~~~~l~e~~~~~i~~qil~a-L~~LH~~g  165 (489)
                      +|...+.++     +.|+|.-..-+.+-...-.++|||++|-.+.+.  +.. ..++...   ++..++.+ +..+-..|
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~---ia~~~~~~f~~q~~~dg  285 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKE---LAELLVRAFLRQLLRDG  285 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHH---HHHHHHHHHHHHHHhcC
Confidence            344444443     244443222233345567899999999888776  444 3355333   33333332 23334589


Q ss_pred             cEeeccCCCCeeeCCCCCEEEeeccCccccCC
Q 011287          166 LIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (489)
Q Consensus       166 IiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~  197 (489)
                      ++|.|.+|.||+++.+|++.+.|||....+.+
T Consensus       286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            99999999999999999999999999887654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.49  E-value=9e-09  Score=107.82  Aligned_cols=242  Identities=20%  Similarity=0.228  Sum_probs=166.4

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC-ccEEEEEEEcCCEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG-VVRLFFTFQDTFSLYM  122 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~lyl  122 (489)
                      ..-|.+...+++|+++.+++.+...+...+ .+.+...        ....-++++|.+++||| .+..++-++.+...++
T Consensus       241 ~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i  311 (829)
T KOG0576|consen  241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI  311 (829)
T ss_pred             ccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence            344678888899999999999876654444 5554332        33445788999999999 6777777777888999


Q ss_pred             EEeccCCC-ChHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          123 ALESCEGG-ELFDQIT-SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       123 V~E~~~gg-~L~~~l~-~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      +++++.++ +-...+. ..-.+.+-+.......-..+|++||+.--+|||    ||+..+ +..++.||+....+...  
T Consensus       312 ~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~--  384 (829)
T KOG0576|consen  312 PMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRT--  384 (829)
T ss_pred             hhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcc--
Confidence            99999887 2211111 111234444555666778889999998778998    777754 68999999987655332  


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCC----
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN----  276 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~----  276 (489)
                               ...+++.+|+.++|||+.....+....|.|++|+--.+|.-|-+|-...-.  ....+-.+ ..-|.    
T Consensus       385 ---------~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~~~~g~~-p~s~~L~~~  452 (829)
T KOG0576|consen  385 ---------MKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPA--VLPMIGNG-PNSPMLTDK  452 (829)
T ss_pred             ---------cccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCcc--ccCCCCCC-CCccccchh
Confidence                     135678899999999999999999999999999877788878777544110  00000000 00000    


Q ss_pred             -CCCHHHH-HHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 011287          277 -YFSDAAR-DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (489)
Q Consensus       277 -~~~~~~~-~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~  318 (489)
                       .+++... ++...||..-|..|+..     ....-|.+|.+..
T Consensus       453 ~aw~~~~~~~~~~~~~~g~P~~pkv~-----mgacfsKvfngCp  491 (829)
T KOG0576|consen  453 SAWSPVFHRDFPAPCLNGLPPTPKVH-----MGACFSKVFNGCP  491 (829)
T ss_pred             hhcCcccccCCcccccCCCCCCCcch-----hhHHHHHHhccCc
Confidence             1111122 47778898999999888     5677888888754

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.47  E-value=2e-06  Score=82.26  Aligned_cols=133  Identities=17%  Similarity=0.158  Sum_probs=83.5

Q ss_pred             eEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--ccEEEEEEEcCCEEEEEEeccC
Q 011287           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG--VVRLFFTFQDTFSLYMALESCE  128 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~~~~~~~lylV~E~~~  128 (489)
                      ..||.|..+.||+.    .|..+++|......     ....+.+|..+++.+..-+  +.+++.+..+.....+|||+++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence            57899999999984    25578899875432     2234678999998885433  4667777777788899999999


Q ss_pred             CCC-hH--------------HHH-------HhC--CCCCHHH-HHHHHH----------HHHHH-HHHHHh----CCcEe
Q 011287          129 GGE-LF--------------DQI-------TSK--GHLSEDE-ARFYTA----------EVVDA-LEYIHS----MGLIH  168 (489)
Q Consensus       129 gg~-L~--------------~~l-------~~~--~~l~e~~-~~~i~~----------qil~a-L~~LH~----~gIiH  168 (489)
                      |.+ +.              ..+       ...  ....... ...+..          .+... ..+|..    ..++|
T Consensus        78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H  157 (226)
T TIGR02172        78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH  157 (226)
T ss_pred             CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence            863 11              111       100  0011000 000100          01111 122221    24789


Q ss_pred             eccCCCCeeeCCCCCEEEeeccCcc
Q 011287          169 RDIKPENLLLTADGHIKIADFGSVK  193 (489)
Q Consensus       169 rDLKpeNILl~~~g~ikL~DFG~a~  193 (489)
                      +|+.|.||++++++ +.++||+.+.
T Consensus       158 gD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       158 GDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             cCCCCCcEEEcCCC-cEEEechhcC
Confidence            99999999999888 9999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.42  E-value=2.7e-06  Score=80.84  Aligned_cols=140  Identities=19%  Similarity=0.148  Sum_probs=96.3

Q ss_pred             eeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccch---------------------hHHHHHHHHHHHHHhCC--CCC
Q 011287           50 GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE---------------------NKTAYVKLERIVLDQLD--HPG  106 (489)
Q Consensus        50 ~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~---------------------~~~~~~~~E~~il~~l~--hpn  106 (489)
                      ...|+.|.-+.||+|.. .++..+|+|++......-.                     ....-...|...|+++.  +-.
T Consensus        53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            33777888899999986 4689999999864321111                     11223445777777773  333


Q ss_pred             ccEEEEEEEcCCEEEEEEeccCCC-ChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeeccCCCCeeeCCCCCE
Q 011287          107 VVRLFFTFQDTFSLYMALESCEGG-ELFDQITSKGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHI  184 (489)
Q Consensus       107 Iv~l~~~~~~~~~lylV~E~~~gg-~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~-~gIiHrDLKpeNILl~~~g~i  184 (489)
                      +.+.+.++.    -.+||||+... .-...|.. -.+...++..+..+++..+.-|-. .|+||+||+.=|||+. +|.+
T Consensus       132 vP~Pi~~~~----nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p  205 (268)
T COG1718         132 VPEPIAFRN----NVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP  205 (268)
T ss_pred             CCCceeecC----CeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence            445555444    35999998543 11112221 123444788889999999998876 8999999999999998 8899


Q ss_pred             EEeeccCccccC
Q 011287          185 KIADFGSVKPMQ  196 (489)
Q Consensus       185 kL~DFG~a~~~~  196 (489)
                      .++|||-|....
T Consensus       206 ~iID~~QaV~~~  217 (268)
T COG1718         206 YIIDVSQAVTID  217 (268)
T ss_pred             EEEECccccccC
Confidence            999999987654

>KOG1090 consensus Predicted dual-specificity phosphatase [General function prediction only]

Probab=98.38  E-value=1.1e-07  Score=102.52  Aligned_cols=101  Identities=23%  Similarity=0.279  Sum_probs=77.4

Q ss_pred             ccccccC-CCceEEEEEeeehhhhhh--ccceeEEEec-CCeEEEECC-CCCeeeeeeeccCCCCceEEEEc---CCCcE
Q 011287          387 KWQQFLD-PGESVLMISMVKKLQKLT--SKKVQLILTN-KPKLIYVDP-SKLVVKGNIIWSDNSNDLSIQVS---SPSHF  458 (489)
Q Consensus       387 ~~~~~~~-~~~~i~~~g~~~k~~g~~--~k~r~~~lt~-~p~l~y~d~-~~~~~kg~i~~~~~~~~~~~~~~---~~~~f  458 (489)
                      .+.+|-. +.|.-+.+|.+.|||.+-  ||.|||||.. .+.|+|+|- ...+.||.|.|-...++.-+-.|   .++-|
T Consensus      1622 ly~qf~s~~teNr~~eG~LyKrGA~lK~Wk~RwFVLd~~khqlrYYd~~edt~pkG~IdLaevesv~~~~~k~vdekgff 1701 (1732)
T KOG1090|consen 1622 LYRQFMSPPTENRIPEGYLYKRGAKLKLWKPRWFVLDPDKHQLRYYDDFEDTKPKGCIDLAEVESVALIGPKTVDEKGFF 1701 (1732)
T ss_pred             hhhhhcCCcccccCcccchhhcchhhcccccceeEecCCccceeeecccccccccchhhhhhhhhhcccCccccCcccee
Confidence            3555544 355568899999999866  9999999987 888877665 56789999999875333221112   24678


Q ss_pred             EEEcCCceEEEEcCC-ccHHHHHHHHHHhc
Q 011287          459 KIVTPKKVLSFEDAK-QRASQWKKAIEALQ  487 (489)
Q Consensus       459 ~i~~p~r~y~~~d~~-~~~~~W~~~i~~~~  487 (489)
                      .++|.+|+|.|..-+ +.|++|+++|+..+
T Consensus      1702 dlktt~rvynf~a~nin~AqqWve~iqscl 1731 (1732)
T KOG1090|consen 1702 DLKTTNRVYNFCAQNINLAQQWVECIQSCL 1731 (1732)
T ss_pred             eeehhhHHHHHHhccchHHHHHHHHHHHhh
Confidence            899999999999666 89999999999865

>smart00233 PH Pleckstrin homology domain

Probab=98.36  E-value=1e-06  Score=71.42  Aligned_cols=87  Identities=20%  Similarity=0.235  Sum_probs=67.4

Q ss_pred             EEEEeeehhhh---hhccceeEEEecCCeEEEECCCC---CeeeeeeeccCCCCceEEEEc-----CCCcEEEEcCCc-e
Q 011287          399 LMISMVKKLQK---LTSKKVQLILTNKPKLIYVDPSK---LVVKGNIIWSDNSNDLSIQVS-----SPSHFKIVTPKK-V  466 (489)
Q Consensus       399 ~~~g~~~k~~g---~~~k~r~~~lt~~p~l~y~d~~~---~~~kg~i~~~~~~~~~~~~~~-----~~~~f~i~~p~r-~  466 (489)
                      +++|+|.++.+   ..|++|+++|++.-..+|.++..   ....+.|+++..  .+.....     ....|.|.++++ +
T Consensus         2 ~~~G~l~~~~~~~~~~~~~~~~~L~~~~l~~~~~~~~~~~~~~~~~i~l~~~--~v~~~~~~~~~~~~~~f~l~~~~~~~   79 (102)
T smart00233        2 IKEGWLYKKSGGKKKSWKKRYFVLFNSTLLYYKSEKAKKDYKPKGSIDLSGI--TVREAPDPDSAKKPHCFEIKTADRRS   79 (102)
T ss_pred             ceeEEEEEeCCCccCCceEEEEEEECCEEEEEeCCCccccCCCceEEECCcC--EEEeCCCCccCCCceEEEEEecCCce
Confidence            67899988774   33999999999977777777654   567899999985  2222222     367899998887 9


Q ss_pred             EEEEcC-CccHHHHHHHHHHhc
Q 011287          467 LSFEDA-KQRASQWKKAIEALQ  487 (489)
Q Consensus       467 y~~~d~-~~~~~~W~~~i~~~~  487 (489)
                      |+|..+ ..++.+|+++|+.++
T Consensus        80 ~~f~~~s~~~~~~W~~~i~~~~  101 (102)
T smart00233       80 YLLQAESEEEREEWVDALRKAI  101 (102)
T ss_pred             EEEEcCCHHHHHHHHHHHHHhh
Confidence            999855 589999999999865

Domain commonly found in eukaryotic signalling proteins. The domain family possesses multiple functions including the abilities to bind inositol phosphates, and various proteins. PH domains have been found to possess inserted domains (such as in PLC gamma, syntrophins) and to be inserted within other domains. Mutations in Brutons tyrosine kinase (Btk) within its PH domain cause X-linked agammaglobulinaemia (XLA) in patients. Point mutations cluster into the positively charged end of the molecule around the predicted binding site for phosphatidylinositol lipids.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.34  E-value=9e-06  Score=77.05  Aligned_cols=137  Identities=26%  Similarity=0.292  Sum_probs=81.8

Q ss_pred             eeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCC--CccEEEEEEE---cCCEEEEEE
Q 011287           50 GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP--GVVRLFFTFQ---DTFSLYMAL  124 (489)
Q Consensus        50 ~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp--nIv~l~~~~~---~~~~lylV~  124 (489)
                      ++.|+.|..+.||++....  ..+++|+....     .....+..|..+++.+...  .+.+++....   .....+++|
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~   74 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM   74 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence            5789999999999999854  59999986443     3455677788888877433  2455665432   334579999


Q ss_pred             eccCCCChHH----------------HHH---hC----CCCCHHH------HHHH---------------HHHHHH-HHH
Q 011287          125 ESCEGGELFD----------------QIT---SK----GHLSEDE------ARFY---------------TAEVVD-ALE  159 (489)
Q Consensus       125 E~~~gg~L~~----------------~l~---~~----~~l~e~~------~~~i---------------~~qil~-aL~  159 (489)
                      ++++|..+..                .+.   ..    ..+....      ....               ...+.. .+.
T Consensus        75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (239)
T PF01636_consen   75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ  154 (239)
T ss_dssp             EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred             EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence            9999987766                111   11    0111000      0000               111222 233


Q ss_pred             HHHh-------CCcEeeccCCCCeeeC-CCCCEEEeeccCcc
Q 011287          160 YIHS-------MGLIHRDIKPENLLLT-ADGHIKIADFGSVK  193 (489)
Q Consensus       160 ~LH~-------~gIiHrDLKpeNILl~-~~g~ikL~DFG~a~  193 (489)
                      .++.       ..++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus       155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            3332       3599999999999999 66677899999875

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd01253 PH_beta_spectrin Beta-spectrin pleckstrin homology (PH) domain

Probab=98.33  E-value=1.9e-06  Score=71.89  Aligned_cols=76  Identities=16%  Similarity=0.244  Sum_probs=54.2

Q ss_pred             hhccceeEEEecCCeEEEECCCCC--eeeeeeeccCCCCceEEE---EcCCCcEEEEcC-CceEEEE-cCCccHHHHHHH
Q 011287          410 LTSKKVQLILTNKPKLIYVDPSKL--VVKGNIIWSDNSNDLSIQ---VSSPSHFKIVTP-KKVLSFE-DAKQRASQWKKA  482 (489)
Q Consensus       410 ~~~k~r~~~lt~~p~l~y~d~~~~--~~kg~i~~~~~~~~~~~~---~~~~~~f~i~~p-~r~y~~~-d~~~~~~~W~~~  482 (489)
                      -.|++|+++|++.-..||.|+...  ...|+||++-....+.+.   .+.++.|.|.++ +++|+|. +.+.++++|+.+
T Consensus        21 ~~Wk~r~~vL~~~~L~~ykd~~~~~~~~~~~~~i~l~~~~i~~~~~~~k~~~~F~l~~~~~~~~~f~a~s~e~~~~Wi~a  100 (104)
T cd01253          21 RSWDNVYGVLCGQSLSFYKDEKMAAENVHGEPPVDLTGAQCEVASDYTKKKHVFRLRLPDGAEFLFQAPDEEEMSSWVRA  100 (104)
T ss_pred             CCcceEEEEEeCCEEEEEecCcccccCCCCCCcEeccCCEEEecCCcccCceEEEEEecCCCEEEEECCCHHHHHHHHHH
Confidence            459999999999888899988643  445655655422222222   144688999765 6999998 556899999999


Q ss_pred             HHH
Q 011287          483 IEA  485 (489)
Q Consensus       483 i~~  485 (489)
                      |+.
T Consensus       101 L~~  103 (104)
T cd01253         101 LKS  103 (104)
T ss_pred             Hhc
Confidence            974

Beta-spectrin pleckstrin homology (PH) domain. Beta spectrin binds actin and functions as a major component of the cytoskeleton underlying cellular membranes. Beta spectrin consists of multiple spectrin repeats followed by a PH domain, which binds to Inositol-1,4,5-Trisphosphate. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. PH domains are often involved in targeting proteins to the plasma membrane via lipid binding. PH domains are found in cellular signaling proteins such as serine/threonine kinase, tyrosine kinsases, regulators of G-proteins, endocytotic GTPases, adaptors, as well as cytoskeletal associated molecules and in lipid associated enzymes.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.22  E-value=4.5e-05  Score=70.93  Aligned_cols=128  Identities=23%  Similarity=0.308  Sum_probs=89.0

Q ss_pred             CCeEEeeEEeeeCc-eEEEEEEEcCCCcEEEEEEeec---cc-------ccc-h-------hHHHHHHHHHHHHHhC---
Q 011287           45 QDFELGKIYGVGSY-SKVVRAKKIDTGTVYALKIMDK---KF-------ITK-E-------NKTAYVKLERIVLDQL---  102 (489)
Q Consensus        45 ~dy~~~~~LG~G~~-g~Vy~a~~~~tg~~vAiK~~~k---~~-------~~~-~-------~~~~~~~~E~~il~~l---  102 (489)
                      .++++++.||.|+- |.||+++-  .|+.||+|++..   ..       ... +       ....-+..|-....+|   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            79999999999999 99999987  688999999422   00       000 0       1223355566665555   


Q ss_pred             CCCCc--cEEEEEEEcC------------------CEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 011287          103 DHPGV--VRLFFTFQDT------------------FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH  162 (489)
Q Consensus       103 ~hpnI--v~l~~~~~~~------------------~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH  162 (489)
                      ++.++  |++++++.-.                  ...-+|.||+....         .++..    -+.+|+.-|..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~----~~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR----DIPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh----HHHHHHHHHHHHH
Confidence            45566  8999888311                  11356778776543         22333    3467777788899


Q ss_pred             hCCcEeeccCCCCeeeCCCCCEEEeeccCc
Q 011287          163 SMGLIHRDIKPENLLLTADGHIKIADFGSV  192 (489)
Q Consensus       163 ~~gIiHrDLKpeNILl~~~g~ikL~DFG~a  192 (489)
                      ..||+-+|+++.|..     .-+|+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HCCeeeccCcccccc-----CCEEEecccC
Confidence            999999999999976     2389999864

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.15  E-value=1.8e-05  Score=76.30  Aligned_cols=134  Identities=16%  Similarity=0.061  Sum_probs=82.2

Q ss_pred             EEeeeCc-eEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCEEEEEEeccCC
Q 011287           52 IYGVGSY-SKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLYMALESCEG  129 (489)
Q Consensus        52 ~LG~G~~-g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~lylV~E~~~g  129 (489)
                      .|..|.. +.||++...  +..+.+|+.....      ...+.+|..+++.+. +--+.+++.+.......++|||+++|
T Consensus         5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G   76 (244)
T cd05150           5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG   76 (244)
T ss_pred             ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence            3445555 789999753  4688889875432      234566888888773 33456778877776678999999998


Q ss_pred             CChHHHH----------------HhCC-------CCCHH------HHHHHHH----------------HHHHHHHHHH--
Q 011287          130 GELFDQI----------------TSKG-------HLSED------EARFYTA----------------EVVDALEYIH--  162 (489)
Q Consensus       130 g~L~~~l----------------~~~~-------~l~e~------~~~~i~~----------------qil~aL~~LH--  162 (489)
                      .+|....                .+-.       .+...      .....+.                .+...+..|-  
T Consensus        77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  156 (244)
T cd05150          77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT  156 (244)
T ss_pred             ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence            7665331                1000       01100      0000000                0111122221  


Q ss_pred             -----hCCcEeeccCCCCeeeCCCCCEEEeeccCcc
Q 011287          163 -----SMGLIHRDIKPENLLLTADGHIKIADFGSVK  193 (489)
Q Consensus       163 -----~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~  193 (489)
                           ...++|+|+.|.|||+++++.+.|+||+.|.
T Consensus       157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence                 2348999999999999988778899999875

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.13  E-value=1.4e-05  Score=84.63  Aligned_cols=140  Identities=21%  Similarity=0.326  Sum_probs=88.2

Q ss_pred             eeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccch-----------------------------hHHHHH------HH
Q 011287           50 GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE-----------------------------NKTAYV------KL   94 (489)
Q Consensus        50 ~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~-----------------------------~~~~~~------~~   94 (489)
                      -+.||..+.|+||+|+.+. |+.||||+-+.. +.+.                             +....+      .+
T Consensus       166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~-l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~  243 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPG-LEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTK  243 (538)
T ss_pred             cchhhhcchhheEEEEecC-CCEEEEEecCcC-hHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHH
Confidence            3688999999999999976 999999986432 1110                             001111      12


Q ss_pred             HHHHH----HhCCCCC------ccEEEEEEEcCCEEEEEEeccCCCChHH--HHHhCCCCCHHHHHHHHHHHHHHHHH-H
Q 011287           95 ERIVL----DQLDHPG------VVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVVDALEY-I  161 (489)
Q Consensus        95 E~~il----~~l~hpn------Iv~l~~~~~~~~~lylV~E~~~gg~L~~--~l~~~~~l~e~~~~~i~~qil~aL~~-L  161 (489)
                      |.+..    +.+.|-+      |.++|-.+  ...-.++||||+|..+.+  .|.+.| ++...+   +..+.++... +
T Consensus       244 EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i---~~~l~~~~~~qI  317 (538)
T KOG1235|consen  244 EAKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRG-ISPHDI---LNKLVEAYLEQI  317 (538)
T ss_pred             HHHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcC-CCHHHH---HHHHHHHHHHHH
Confidence            22222    2223433      33333332  235679999999976644  555554 555533   3333333222 3


Q ss_pred             HhCCcEeeccCCCCeeeCC----CCCEEEeeccCccccCC
Q 011287          162 HSMGLIHRDIKPENLLLTA----DGHIKIADFGSVKPMQD  197 (489)
Q Consensus       162 H~~gIiHrDLKpeNILl~~----~g~ikL~DFG~a~~~~~  197 (489)
                      -..|++|+|=+|.||+++.    ++.+.+.|||+...+..
T Consensus       318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            3578999999999999994    56899999999876544

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.10  E-value=2e-05  Score=71.09  Aligned_cols=129  Identities=22%  Similarity=0.284  Sum_probs=93.7

Q ss_pred             EEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcc-EEEEEEEcCCEEEEEEec
Q 011287           48 ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV-RLFFTFQDTFSLYMALES  126 (489)
Q Consensus        48 ~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv-~l~~~~~~~~~lylV~E~  126 (489)
                      .+.+.||+|.+|.||++.+  .|.++|+|+-..     +.....+..|.++|..+.-.++. ++|.+-.+.    +.|||
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~-----ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~~----i~me~   93 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRR-----DSPRRNLEKEAKILEILAGEGVTPEVYFYGEDF----IRMEY   93 (201)
T ss_pred             hhhhhhhcccccEEEEeec--cCceEEEEEecC-----CcchhhHHHHHHHHHHhhhcCCCceEEEechhh----hhhhh
Confidence            5678899999999999998  567999998643     34556688899999999877665 455554432    55999


Q ss_pred             cCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccC-CCCeeeCCCCCEEEeeccCccc
Q 011287          127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIK-PENLLLTADGHIKIADFGSVKP  194 (489)
Q Consensus       127 ~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLK-peNILl~~~g~ikL~DFG~a~~  194 (489)
                      +.|-.|.+.-...   +    +.-...++++---|-..||-|..|. |..++|-.++.+.|+||..|+.
T Consensus        94 i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          94 IDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            9997776644321   1    3334455555445677899999986 5555665667999999999874

>cd01218 PH_phafin2 Phafin2 Pleckstrin Homology (PH) domain

Probab=98.08  E-value=2.8e-05  Score=64.52  Aligned_cols=88  Identities=18%  Similarity=0.255  Sum_probs=67.2

Q ss_pred             CceEEEEEeeehhhhhhccceeEEEecCCeEEEECC----CCCeeeeeeeccCCCCceEEEEc-C----CCcEEEEcCCc
Q 011287          395 GESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDP----SKLVVKGNIIWSDNSNDLSIQVS-S----PSHFKIVTPKK  465 (489)
Q Consensus       395 ~~~i~~~g~~~k~~g~~~k~r~~~lt~~p~l~y~d~----~~~~~kg~i~~~~~~~~~~~~~~-~----~~~f~i~~p~r  465 (489)
                      |+..+++|.+.|.-..-.+.|+|.|=+. .|+|-..    ..-+..+.||+..    +.++.. .    ++.|.|.+|.|
T Consensus         1 gR~li~eG~L~K~~rk~~~~R~ffLFnD-~LvY~~~~~~~~~~~~~~~i~L~~----~~v~~~~d~~~~~n~f~I~~~~k   75 (104)
T cd01218           1 GRVLVGEGVLTKMCRKKPKQRQFFLFND-ILVYGNIVISKKKYNKQHILPLEG----VQVESIEDDGIERNGWIIKTPTK   75 (104)
T ss_pred             CCEEEecCcEEEeecCCCceEEEEEecC-EEEEEEeecCCceeeEeeEEEccc----eEEEecCCcccccceEEEecCCe
Confidence            4456889999987766677899999888 6666543    1235568999997    455432 2    48999999999


Q ss_pred             eEEEEcCC-ccHHHHHHHHHHhc
Q 011287          466 VLSFEDAK-QRASQWKKAIEALQ  487 (489)
Q Consensus       466 ~y~~~d~~-~~~~~W~~~i~~~~  487 (489)
                      ++.+..++ .+-.+|+++|++++
T Consensus        76 Sf~v~A~s~~eK~eWl~~i~~ai   98 (104)
T cd01218          76 SFAVYAATETEKREWMLHINKCV   98 (104)
T ss_pred             EEEEEcCCHHHHHHHHHHHHHHH
Confidence            99999655 78999999999876

Phafin2 Pleckstrin Homology (PH) domain. Phafin contains a PH domain and a FYVE domain. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains. PH domains are found in cellular signaling proteins such as serine/threonine kinase, tyrosine kinsases, regulators of G-proteins, endocytotic GTPases, adaptors, as well as cytoskeletal associated molecules and in lipid associated enzymes.

>cd00821 PH Pleckstrin homology (PH) domain

Probab=98.08  E-value=9.8e-06  Score=64.79  Aligned_cols=83  Identities=20%  Similarity=0.281  Sum_probs=64.5

Q ss_pred             EEeeehhhhh---hccceeEEEecCCeEEEECCCC---CeeeeeeeccCCCCceEEEEc---CCCcEEEEcCC-ceEEEE
Q 011287          401 ISMVKKLQKL---TSKKVQLILTNKPKLIYVDPSK---LVVKGNIIWSDNSNDLSIQVS---SPSHFKIVTPK-KVLSFE  470 (489)
Q Consensus       401 ~g~~~k~~g~---~~k~r~~~lt~~p~l~y~d~~~---~~~kg~i~~~~~~~~~~~~~~---~~~~f~i~~p~-r~y~~~  470 (489)
                      .|+|.++.+.   .|++|+++|++.-.++|.++..   ...++.|++...  .+.....   ....|.|.+++ ++|+|.
T Consensus         2 ~G~l~~~~~~~~~~w~~~~~~L~~~~l~~~~~~~~~~~~~~~~~i~l~~~--~v~~~~~~~~~~~~f~i~~~~~~~~~~~   79 (96)
T cd00821           2 EGYLLKKTGKLRKGWKRRWFVLFNDLLLYYKKKSSKKSYKPKGSIPLSGA--EVEESPDDSGRKNCFEIRTPDGRSYLLQ   79 (96)
T ss_pred             cchhhhhhChhhCCccEEEEEEECCEEEEEECCCCCcCCCCcceEEcCCC--EEEECCCcCCCCcEEEEecCCCcEEEEE
Confidence            5888777653   5999999999887777777765   688899999974  2333333   25799999877 999998


Q ss_pred             cC-CccHHHHHHHHHH
Q 011287          471 DA-KQRASQWKKAIEA  485 (489)
Q Consensus       471 d~-~~~~~~W~~~i~~  485 (489)
                      .. ..+++.|+++|+.
T Consensus        80 ~~s~~~~~~W~~~l~~   95 (96)
T cd00821          80 AESEEEREEWIEALQS   95 (96)
T ss_pred             eCCHHHHHHHHHHHhc
Confidence            55 4799999999986

Pleckstrin homology (PH) domain. PH domains are only found in eukaryotes. They share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains. PH domains are found in cellular signaling proteins such as serine/threonine kinase, tyrosine kinases, regulators of G-proteins, endocytotic GTPases, adaptors, as well as cytoskeletal associated molecules and in lipid associated enzymes.

>cd01256 PH_dynamin Dynamin pleckstrin homology (PH) domain

Probab=98.07  E-value=1.9e-05  Score=63.12  Aligned_cols=84  Identities=19%  Similarity=0.256  Sum_probs=60.9

Q ss_pred             EEEEEeeehhh-hhh---ccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEE------cCCCcEEEEcCC---
Q 011287          398 VLMISMVKKLQ-KLT---SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV------SSPSHFKIVTPK---  464 (489)
Q Consensus       398 i~~~g~~~k~~-g~~---~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~------~~~~~f~i~~p~---  464 (489)
                      ||..||+.-.. |+.   .|+||||||+.-..+|.|....+.||.|||..    +++..      +++..|.+.-|.   
T Consensus         1 virkgwl~~~n~~~m~ggsK~~WFVLt~~~L~wykd~eeKE~kyilpLdn----Lk~Rdve~gf~sk~~~FeLfnpd~rn   76 (110)
T cd01256           1 VIRKGWLSISNVGIMKGGSKDYWFVLTSESLSWYKDDEEKEKKYMLPLDG----LKLRDIEGGFMSRNHKFALFYPDGRN   76 (110)
T ss_pred             CeeeeeEEeeccceecCCCcceEEEEecceeeeecccccccccceeeccc----cEEEeecccccCCCcEEEEEcCcccc
Confidence            35677776544 222   69999999999999999999999999999976    44433      445788887553   


Q ss_pred             -----ceEEEE-cCCccHHHHHHHHHH
Q 011287          465 -----KVLSFE-DAKQRASQWKKAIEA  485 (489)
Q Consensus       465 -----r~y~~~-d~~~~~~~W~~~i~~  485 (489)
                           |+-.|. +...+.+.|...+-.
T Consensus        77 vykd~k~lel~~~~~e~vdswkasflr  103 (110)
T cd01256          77 VYKDYKQLELGCETLEEVDSWKASFLR  103 (110)
T ss_pred             cccchheeeecCCCHHHHHHHHHHHHh
Confidence                 344455 344788999877644

Dynamin pleckstrin homology (PH) domain. Dynamin is a GTPase that regulates endocytic vesicle formation. It has an N-terminal GTPase domain, followed by a PH domain, a GTPase effector domain and a C-terminal proline arginine rich domain. Dynamin-like proteins, which are found in metazoa, plants and yeast have the same domain architecture as dynamin, but lack the PH domain. PH domains share little sequence conservation, but all have a common fold, which is electrostatically polarized. PH domains also have diverse functions. They are often involved in targeting proteins to the plasma membrane, but few display strong specificity in lipid binding. Any specificity is usually determined by loop regions or insertions in the N-terminus of the domain, which are not conserved across all PH domains.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=98.04  E-value=2.9e-07  Score=104.43  Aligned_cols=250  Identities=14%  Similarity=0.035  Sum_probs=165.2

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEee---cccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc--C
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMD---KKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD--T  117 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~---k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~  117 (489)
                      .+.++++.--+|-|.++.--.-+.+..  -+.+|+.+   -....+. ..+....|++-++...|+++...+.-..+  .
T Consensus      1227 ~~e~~EV~l~i~~~~~~R~k~Lr~kid--~Fk~~I~ke~d~e~LseP-lkemll~e~de~~~~~h~~~~~~p~rI~ps~s 1303 (2724)
T KOG1826|consen 1227 AMEHSEVNLGISNHFHFRNKWLRSKID--WFKFSIYKEYDFENLSEP-LKEMLLSERDELREAKHYLTEVDPLRIPPSES 1303 (2724)
T ss_pred             HhhhhheeeecccceeeccchHhhhhc--eeEEEeehhhhHHHHhhH-HHHhhhhhhhhhhhhhceeeecccccCCCCCC
Confidence            456667666666666654322222222  23444432   1222222 23344456777777889998877665543  3


Q ss_pred             CEEEEEEeccCCCChHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC-C----cEeeccCCCCeeeCCCCCEEEee
Q 011287          118 FSLYMALESCEGGELFDQITSKG----HLSEDEARFYTAEVVDALEYIHSM-G----LIHRDIKPENLLLTADGHIKIAD  188 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~~----~l~e~~~~~i~~qil~aL~~LH~~-g----IiHrDLKpeNILl~~~g~ikL~D  188 (489)
                      ...|.+++||.+|.+++.|.+.-    .++..-+.....+.+.+..-+|+. +    .+|+++|+-|.+|..+..+++.+
T Consensus      1304 ~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk 1383 (2724)
T KOG1826|consen 1304 TEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGK 1383 (2724)
T ss_pred             hHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccc
Confidence            45689999999999999997642    233333333333436666666654 2    68999999999999999999999


Q ss_pred             ccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHH
Q 011287          189 FGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII  268 (489)
Q Consensus       189 FG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~  268 (489)
                      +|+.+...+.          ....+..++++.|++|++.+.-.++.++|+|.+|+-+|....|..+|..     ..+.++
T Consensus      1384 ~gLdKIknp~----------~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~-----flq~~L 1448 (2724)
T KOG1826|consen 1384 GGLDKIKNPV----------LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIF-----FLQPAL 1448 (2724)
T ss_pred             cccccccCch----------HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHH-----HHHHHH
Confidence            9999843321          2345577889999999999998899889999999999999999888744     333444


Q ss_pred             hcC------CCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 011287          269 ARD------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (489)
Q Consensus       269 ~~~------~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~  315 (489)
                      ++.      .+.+...|.++-.....+|-..-..||+-     ...+.-+.|.
T Consensus      1449 kgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q-----~isls~d~~a 1496 (2724)
T KOG1826|consen 1449 KGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQ-----YISLSRDHFA 1496 (2724)
T ss_pred             cCcccccccccccccCCCcccHHHHHHHHHHhhhcchh-----hhhccccccc
Confidence            432      23444456666666666666677788876     4555555553

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	489
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-70
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		8e-70
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		8e-70
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		9e-70
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-69
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-69
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-69
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-69
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-69
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-69
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-69
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-69
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-69
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-69
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-69
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-69
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-69
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		6e-69
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		8e-69
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-68
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-68
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		5e-51
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-50
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-49
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		6e-49
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		7e-49
3g51_A	325	Structural Diversity Of The Active Conformation Of		8e-49
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-47
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-46
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-46
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-46
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		6e-46
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		7e-46
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		7e-46
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		8e-46
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		9e-46
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-45
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-45
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-45
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-45
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-45
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-45
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-45
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-45
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-45
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-45
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		5e-45
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-45
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-45
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		8e-45
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		9e-45
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		9e-45
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-44
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-44
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-44
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-44
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-44
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-44
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-44
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-44
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-44
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-44
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-44
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-44
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-44
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-44
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-44
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-44
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-44
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		5e-44
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		6e-44
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		6e-44
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		6e-44
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		7e-44
4ae9_A	343	Structure And Function Of The Human Sperm-specific		8e-44
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-43
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-43
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-43
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-43
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-43
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-43
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-43
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-43
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-43
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-43
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-43
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-43
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-43
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-43
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		5e-43
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		5e-43
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-43
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-43
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		5e-43
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		6e-43
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		7e-43
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-42
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-42
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		5e-42
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		5e-42
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		5e-42
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		6e-42
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-41
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		6e-40
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-39
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-39
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		6e-39
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-38
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-38
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-38
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-38
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-38
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		5e-38
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-35
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-35
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-35
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-35
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-35
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-35
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-35
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-34
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-34
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-34
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-34
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-34
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		6e-34
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-34
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		7e-34
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		7e-34
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		8e-34
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		8e-34
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-33
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-33
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-33
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-33
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-33
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-33
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-33
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-33
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-33
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-33
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-33
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-33
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-33
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-33
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-33
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-33
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-33
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-33
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-33
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-33
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-33
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-33
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-33
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-33
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-33
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		8e-33
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		8e-33
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-33
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		8e-33
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-32
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-32
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-32
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-32
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-32
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-32
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-32
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		5e-32
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		5e-32
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-31
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-30
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-30
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-30
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-30
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-30
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-30
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-30
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-30
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-30
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-30
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-30
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-30
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-30
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-30
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		7e-30
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		8e-30
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-29
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-29
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-29
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-29
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-29
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-29
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		5e-29
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		5e-29
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		5e-29
3soa_A	444	Full-Length Human Camkii Length = 444		5e-29
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		6e-29
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		8e-29
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		9e-29
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-28
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-28
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-28
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-28
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-28
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-28
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-28
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-28
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		5e-28
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-28
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-28
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		7e-28
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-27
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-27
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-27
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-27
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-27
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-27
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-27
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		6e-27
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-27
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		7e-27
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-26
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-26
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-26
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-26
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-26
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-26
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-26
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-25
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-25
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-25
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-25
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-25
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-25
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-25
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-25
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-25
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-25
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-25
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-25
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-25
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-25
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-25
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-25
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-25
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-25
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-25
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-25
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-25
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-25
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-25
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-25
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		5e-25
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-25
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-25
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		6e-25
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		6e-25
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		6e-25
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		6e-25
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		7e-25
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		7e-25
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-24
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-24
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-24
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-24
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-24
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		5e-24
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-24
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-24
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		7e-24
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		7e-24
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		8e-24
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		8e-24
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		9e-24
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		9e-24
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-23
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-23
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-23
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-23
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-23
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-23
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-23
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-23
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-23
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-23
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-23
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-23
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-23
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-23
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-23
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-23
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-23
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-23
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-23
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-23
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-23
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		5e-23
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		5e-23
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-23
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		6e-23
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		7e-23
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		8e-23
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		9e-23
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-22
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-22
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-22
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-22
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-22
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-22
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-22
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-22
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-22
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-22
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-22
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-22
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		7e-22
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-22
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-21
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-21
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-21
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-21
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-21
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-21
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-21
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-21
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-21
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-21
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-21
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-21
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-20
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-20
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-20
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-20
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-20
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-20
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-20
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-20
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-20
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-20
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-20
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-20
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-20
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-20
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-20
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-20
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-20
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-20
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-20
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-20
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-20
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-20
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-20
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-20
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		3e-20
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-20
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		3e-20
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-20
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-20
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		7e-20
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		8e-20
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-19
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-19
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-19
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-19
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-19
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-19
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-19
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-19
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		7e-19
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		7e-19
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		7e-19
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		7e-19
2oza_A	356	Structure Of P38alpha Complex Length = 356		8e-19
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		8e-19
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		8e-19
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		8e-19
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		9e-19
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		9e-19
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-18
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-18
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-18
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-18
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-18
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-18
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-18
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-18
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-18
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-18
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		4e-18
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		6e-18
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-18
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		8e-18
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-18
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		9e-18
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		9e-18
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-17
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-17
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-17
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-17
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-17
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-17
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-17
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-17
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-17
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-17
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-17
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-17
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-17
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-17
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-17
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-17
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-17
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-17
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-17
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-17
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-17
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-17
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-17
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-17
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-17
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-17
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-17
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-17
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-17
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-17
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-17
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-17
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-17
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-17
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-17
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-17
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-17
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-17
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-17
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-17
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-17
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-17
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-17
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-17
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-17
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-17
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-17
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-17
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-17
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-17
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-17
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-17
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-17
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-17
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-17
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-17
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-17
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-17
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-17
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-17
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-17
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-17
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-17
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-17
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-17
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-17
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		5e-17
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-17
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		6e-17
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		6e-17
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-17
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-17
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		8e-17
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		8e-17
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		8e-17
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-17
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		9e-17
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		9e-17
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		9e-17
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		9e-17
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-16
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-16
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-16
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-16
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-16
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-16
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-16
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-16
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-16
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-16
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-16
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-16
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-16
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-16
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-16
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-16
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-16
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-16
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-16
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-16
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-16
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-16
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-16
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-16
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-16
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-16
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		5e-16
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		5e-16
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-16
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		5e-16
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		6e-16
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		6e-16
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-16
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-16
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		6e-16
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-16
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		7e-16
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-16
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-15
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-15
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-15
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-15
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-15
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-15
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-15
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-15
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-15
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-15
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-15
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-15
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-15
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-15
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-15
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-15
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-15
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-15
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-15
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-15
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-15
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-15
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-15
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-15
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-15
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-15
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-15
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-15
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-15
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-15
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-15
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-15
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-15
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-15
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-15
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-15
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-15
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-15
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		5e-15
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		5e-15
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		5e-15
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		6e-15
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		6e-15
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-15
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		7e-15
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		8e-15
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		9e-15
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		9e-15
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-14
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-14
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-14
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-14
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-14
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-14
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-14
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-14
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-14
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-14
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-14
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-14
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-14
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-14
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-14
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-14
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-14
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-14
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		2e-14
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-14
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-14
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-14
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-14
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-14
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-14
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-14
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-14
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-14
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-14
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-14
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-14
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-14
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-14
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-14
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-14
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-14
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-14
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-14
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-14
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-14
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-14
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		5e-14
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		5e-14
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		5e-14
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		6e-14
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-14
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		7e-14
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-14
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		9e-14
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		9e-14
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-14
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-13
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-13
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-13
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-13
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-13
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-13
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-13
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-13
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-13
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		2e-13
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-13
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-13
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-13
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-13
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-13
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-13
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		3e-13
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-13
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		3e-13
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-13
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-13
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		4e-13
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		5e-13
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		5e-13
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		6e-13
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		6e-13
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		6e-13
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		7e-13
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		7e-13
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		7e-13
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		9e-13
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-12
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-12
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-12
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-12
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-12
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-12
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		5e-12
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		5e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		6e-12
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		7e-12
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-12
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		9e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		9e-12
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-11
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-11
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-11
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-11
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-11
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-11
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-11
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-11
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-11
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-11
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-11
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-11
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-11
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-11
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-11
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-11
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-11
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-11
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-11
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-11
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-11
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		4e-11
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-11
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-11
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-11
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-11
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		5e-11
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-11
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-11
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		6e-11
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		6e-11
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		7e-11
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-11
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		7e-11
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		7e-11
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		7e-11
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		8e-11
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		9e-11
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		1e-10
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-10
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-10
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-10
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-10
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-10
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		1e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-10
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-10
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-10
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		1e-10
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-10
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		1e-10
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		1e-10
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		1e-10
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		1e-10
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		1e-10
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		1e-10
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		1e-10
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-10
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-10
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		1e-10
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		1e-10
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		1e-10
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-10
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		1e-10
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-10
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		2e-10
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-10
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-10
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-10
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-10
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-10
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-10
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-10
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-10
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-10
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-10
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-10
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-10
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-10
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-10
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-10
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-10
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-10
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-10
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-10
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-10
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-10
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		6e-10
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		7e-10
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		7e-10
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		7e-10
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		7e-10
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		7e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		7e-10
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		7e-10
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		7e-10
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-10
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		9e-10
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		9e-10
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		9e-10
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		9e-10
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		9e-10
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-09
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-09
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-09
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-09
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-09
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-09
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		1e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-09
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-09
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-09
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-09
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-09
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		1e-09
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-09
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-09
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-09
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-09
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-09
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-09
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-09
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-09
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-09
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-09
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-09
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-09
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-09
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-09
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		2e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		2e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-09
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-09
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-09
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-09
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-09
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-09
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-09
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-09
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		4e-09
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-09
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-09
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-09
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-09
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		5e-09
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-09
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-09
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-09
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-09
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		8e-09
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		8e-09
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		8e-09
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		9e-09
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		9e-09
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		9e-09
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-08
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-08
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-08
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-08
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-08
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-08
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-08
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-08
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-08
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-08
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-08
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-08
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-08
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-08
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-08
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-08
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-08
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-08
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-08
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-08
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-08
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-08
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-08
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-08
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-08
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-08
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-08
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-08
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-08
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-08
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-08
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-08
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-08
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-08
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-08
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-08
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		4e-08
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-08
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-08
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-08
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-08
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		4e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-08
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-08
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		4e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		5e-08
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		5e-08
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		5e-08
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		5e-08
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		5e-08
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		5e-08
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		5e-08
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-08
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		5e-08
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-08
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		5e-08
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		6e-08
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		6e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		7e-08
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		8e-08
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		8e-08
3gni_B	389	Structure Of Strad And Mo25 Length = 389		8e-08
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		9e-08
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-07
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-07
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-07
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-07
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-07
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-07
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		1e-07
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-07
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-07
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-07
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-07
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-07
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-07
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-07
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-07
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-07
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-07
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-07
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-07
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-07
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-07
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-07
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-07
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-07
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-07
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-07
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-07
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-07
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-07
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-07
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-07
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-07
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-07
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-07
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-07
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-07
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-07
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-07
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-07
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-07
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-07
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		3e-07
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-07
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-07
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		3e-07
1w1d_A	151	Crystal Structure Of The Pdk1 Pleckstrin Homology (		3e-07
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		3e-07
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		3e-07
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-07
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-07
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-07
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-07
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-07
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-07
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-07
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		4e-07
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		4e-07
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-07
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-07
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		4e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		4e-07
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-07
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-07
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-07
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-07
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		5e-07
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		5e-07
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		5e-07
4hgl_A	330	Crystal Structure Of Ck1g3 With Compound 1 Length =		6e-07
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		6e-07
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		6e-07
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-07
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		7e-07
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		7e-07
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		8e-07
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		8e-07
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		9e-07
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		9e-07
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		9e-07
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		9e-07
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-06
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-06
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-06
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-06
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-06

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  261 bits (668), Expect = 5e-70,   Method: Compositional matrix adjust.
 Identities = 133/289 (46%), Positives = 175/289 (60%), Gaps = 9/289 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A +FVGTA YV P
Sbjct: 149 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANSFVGTAQYVSP 200
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 201 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 260
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLAS 332
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL +
Sbjct: 261 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLTA 309

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  261 bits (666), Expect = 8e-70,   Method: Compositional matrix adjust.
 Identities = 133/289 (46%), Positives = 174/289 (60%), Gaps = 9/289 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANAFVGTAQYVSP 201
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 261
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLAS 332
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL +
Sbjct: 262 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLTA 310

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  261 bits (666), Expect = 8e-70,   Method: Compositional matrix adjust.
 Identities = 133/289 (46%), Positives = 174/289 (60%), Gaps = 9/289 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 149 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 200
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 201 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 260
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLAS 332
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL +
Sbjct: 261 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLTA 309

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  260 bits (665), Expect = 9e-70,   Method: Compositional matrix adjust.
 Identities = 133/289 (46%), Positives = 174/289 (60%), Gaps = 9/289 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 201
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 261
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLAS 332
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL +
Sbjct: 262 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLTA 310

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  260 bits (665), Expect = 1e-69,   Method: Compositional matrix adjust.
 Identities = 133/287 (46%), Positives = 173/287 (60%), Gaps = 9/287 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 133
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 134 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 185
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 186 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 245
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 330
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 246 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 292

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  260 bits (665), Expect = 1e-69,   Method: Compositional matrix adjust.
 Identities = 133/287 (46%), Positives = 174/287 (60%), Gaps = 9/287 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A +FVGTA YV P
Sbjct: 153 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANSFVGTAQYVSP 204
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 205 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 264
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 330
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 265 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 311

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  260 bits (665), Expect = 1e-69,   Method: Compositional matrix adjust.
 Identities = 133/287 (46%), Positives = 173/287 (60%), Gaps = 9/287 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 201
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 261
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 330
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 262 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 308

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  260 bits (664), Expect = 1e-69,   Method: Compositional matrix adjust.
 Identities = 133/288 (46%), Positives = 173/288 (60%), Gaps = 9/288 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 129
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 130 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 181
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 182 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 241
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLA 331
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL 
Sbjct: 242 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 289

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  260 bits (664), Expect = 1e-69,   Method: Compositional matrix adjust.
 Identities = 133/287 (46%), Positives = 173/287 (60%), Gaps = 9/287 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 179
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 180 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 239
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 330
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 240 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 286

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  260 bits (664), Expect = 1e-69,   Method: Compositional matrix adjust.
 Identities = 133/288 (46%), Positives = 173/288 (60%), Gaps = 9/288 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 126
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 127 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 178
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 179 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 238
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLA 331
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL 
Sbjct: 239 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 286

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  260 bits (664), Expect = 1e-69,   Method: Compositional matrix adjust.
 Identities = 133/287 (46%), Positives = 173/287 (60%), Gaps = 9/287 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 203
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 263
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 330
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 310

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  259 bits (663), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 133/287 (46%), Positives = 173/287 (60%), Gaps = 9/287 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 203
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 263
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 330
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 310

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  259 bits (663), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 133/287 (46%), Positives = 173/287 (60%), Gaps = 9/287 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 203
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 263
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 330
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 310

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  259 bits (663), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 133/287 (46%), Positives = 173/287 (60%), Gaps = 9/287 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 153 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 204
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 205 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 264
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 330
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 265 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 311

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  259 bits (662), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 133/287 (46%), Positives = 173/287 (60%), Gaps = 9/287 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 154
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 155 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 206
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 207 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAAFFPKARD 266
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 330
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 267 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 313

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  258 bits (660), Expect = 4e-69,   Method: Compositional matrix adjust.
 Identities = 132/286 (46%), Positives = 172/286 (60%), Gaps = 9/286 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 128
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 129 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 180
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 181 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 240
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPK 329
                     + R G     GY  LK HPFF+ + W+N+  QTPPK
Sbjct: 241 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPK 286

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  258 bits (660), Expect = 4e-69,   Method: Compositional matrix adjust.
 Identities = 132/287 (45%), Positives = 172/287 (59%), Gaps = 9/287 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S  V A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 201
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 261
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 330
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 262 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 308

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  258 bits (658), Expect = 6e-69,   Method: Compositional matrix adjust.
 Identities = 132/287 (45%), Positives = 172/287 (59%), Gaps = 9/287 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+F FQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 156
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 157 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 208
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 209 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 268
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 330
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 269 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 315

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  258 bits (658), Expect = 8e-69,   Method: Compositional matrix adjust.
 Identities = 132/287 (45%), Positives = 174/287 (60%), Gaps = 9/287 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + G L   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A +FVGTA YV P
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANSFVGTAQYVSP 203
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A+  +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F      
Sbjct: 204 ELLTEKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 263
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 330
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 310

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  255 bits (651), Expect = 4e-68,   Method: Compositional matrix adjust.
 Identities = 132/287 (45%), Positives = 171/287 (59%), Gaps = 9/287 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 203
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E LIF +II  +  FP  F      
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARD 263
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 330
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 310

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  255 bits (651), Expect = 4e-68,   Method: Compositional matrix adjust.
 Identities = 132/287 (45%), Positives = 171/287 (59%), Gaps = 9/287 (3%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P  V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G+IHRD+KPEN+LL  D HI+I DFG+ K        VL   +   +A  FVGTA YV P
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAK--------VLSPESKQARANXFVGTAQYVSP 203
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXX 284
           E+L    A   +DLWALGC +YQ+++G  PF+  +E LIF +II  +  FP  F      
Sbjct: 204 ELLTEKSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARD 263
Query: 285 XXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL 330
                     + R G     GY  LK HPFF+ + W+N+  QTPPKL
Sbjct: 264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 310

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  198 bits (504), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 113/322 (35%), Positives = 169/322 (52%), Gaps = 22/322 (6%)
Query: 36  RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENK-TAY 91
           R P E    + FEL ++ G G Y KV + +K+   +TG ++A+K++ K  I +  K TA+
Sbjct: 9   RGP-EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAH 67
Query: 92  VKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYT 151
            K ER +L+++ HP +V L + FQ    LY+ LE   GGELF Q+  +G   ED A FY 
Sbjct: 68  TKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYL 127
Query: 152 AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP-MQDSRITVLPNAASDD 210
           AE+  AL ++H  G+I+RD+KPEN++L   GH+K+ DFG  K  + D  +T         
Sbjct: 128 AEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT--------- 178
Query: 211 KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR 270
              TF GT  Y+ PE+L  S      D W+LG  +Y ML+G  PF   +      +I+  
Sbjct: 179 --HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC 236
Query: 271 DIRFPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
            +  P Y +               + R GAGPG    ++ HPFF+ I+W+ +  R   PP
Sbjct: 237 KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPP 296
Query: 329 KLASEPMVQSGEGDDVHDSSWN 350
               +P++QS E     DS + 
Sbjct: 297 ---FKPLLQSEEDVSQFDSKFT 315

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  196 bits (498), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 112/322 (34%), Positives = 168/322 (52%), Gaps = 22/322 (6%)
Query: 36  RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENK-TAY 91
           R P E    + FEL ++ G G Y KV + +K+   +TG ++A+K++ K  I +  K TA+
Sbjct: 9   RGP-EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAH 67
Query: 92  VKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYT 151
            K ER +L+++ HP +V L + FQ    LY+ LE   GGELF Q+  +G   ED A FY 
Sbjct: 68  TKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYL 127
Query: 152 AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP-MQDSRITVLPNAASDD 210
           AE+  AL ++H  G+I+RD+KPEN++L   GH+K+ DFG  K  + D  +T         
Sbjct: 128 AEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT--------- 178
Query: 211 KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR 270
               F GT  Y+ PE+L  S      D W+LG  +Y ML+G  PF   +      +I+  
Sbjct: 179 --HXFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC 236
Query: 271 DIRFPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
            +  P Y +               + R GAGPG    ++ HPFF+ I+W+ +  R   PP
Sbjct: 237 KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPP 296
Query: 329 KLASEPMVQSGEGDDVHDSSWN 350
               +P++QS E     DS + 
Sbjct: 297 ---FKPLLQSEEDVSQFDSKFT 315

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  193 bits (491), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 101/304 (33%), Positives = 164/304 (53%), Gaps = 20/304 (6%)
Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
           +S+QDF++ +  G GS+ +V   +    G  YA+K++ K+ + +  +  +   ER++L  
Sbjct: 3   YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           + HP ++R++ TFQD   ++M ++  EGGELF  +          A+FY AEV  ALEY+
Sbjct: 63  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 122
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           HS  +I+RD+KPEN+LL  +GHIKI DFG  K + D                   GT  Y
Sbjct: 123 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-------------TYXLCGTPDY 169
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 281
           + PEV+++ P     D W+ G  +Y+ML+G +PF D++    +++I+  ++RFP +F+  
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNED 229
Query: 282 XXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG---QTPPKLASEPMVQS 338
                        S R G    G   +K HP+FK + W+ +     +TP     EP +Q 
Sbjct: 230 VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETP----YEPPIQQ 285
Query: 339 GEGD 342
           G+GD
Sbjct: 286 GQGD 289

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  191 bits (486), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 104/287 (36%), Positives = 156/287 (54%), Gaps = 16/287 (5%)
Query: 47  FELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           FEL K+ G GS+ KV   KKI   D   +YA+K++ KK   K       K+ER +L +++
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL-KKATLKVRDRVRTKMERDILVEVN 84
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +V+L + FQ    LY+ L+   GG+LF +++ +   +E++ +FY AE+  AL+++HS
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 144
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +G+I+RD+KPEN+LL  +GHIK+ DFG  K   D           + KA +F GT  Y+ 
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID----------HEKKAYSFCGTVEYMA 194
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PEV+N    T   D W+ G  +++ML+GT PF+          I+   +  P + S    
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQ 254
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
                     P+ R GAGP G   +K H FF  IDW  +  R   PP
Sbjct: 255 SLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPP 301

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  191 bits (485), Expect = 7e-49,   Method: Compositional matrix adjust.
 Identities = 104/287 (36%), Positives = 156/287 (54%), Gaps = 16/287 (5%)
Query: 47  FELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           FEL K+ G GS+ KV   KKI   D   +YA+K++ KK   K       K+ER +L +++
Sbjct: 27  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL-KKATLKVRDRVRTKMERDILVEVN 85
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +V+L + FQ    LY+ L+   GG+LF +++ +   +E++ +FY AE+  AL+++HS
Sbjct: 86  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 145
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +G+I+RD+KPEN+LL  +GHIK+ DFG  K   D           + KA +F GT  Y+ 
Sbjct: 146 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID----------HEKKAYSFCGTVEYMA 195
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PEV+N    T   D W+ G  +++ML+GT PF+          I+   +  P + S    
Sbjct: 196 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQ 255
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
                     P+ R GAGP G   +K H FF  IDW  +  R   PP
Sbjct: 256 SLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPP 302

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  191 bits (485), Expect = 8e-49,   Method: Compositional matrix adjust.
 Identities = 104/287 (36%), Positives = 156/287 (54%), Gaps = 16/287 (5%)
Query: 47  FELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           FEL K+ G GS+ KV   KKI   D   +YA+K++ KK   K       K+ER +L +++
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL-KKATLKVRDRVRTKMERDILVEVN 84
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +V+L + FQ    LY+ L+   GG+LF +++ +   +E++ +FY AE+  AL+++HS
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 144
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +G+I+RD+KPEN+LL  +GHIK+ DFG  K   D           + KA +F GT  Y+ 
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID----------HEKKAYSFCGTVEYMA 194
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PEV+N    T   D W+ G  +++ML+GT PF+          I+   +  P + S    
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQ 254
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
                     P+ R GAGP G   +K H FF  IDW  +  R   PP
Sbjct: 255 SLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPP 301

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  187 bits (474), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 99/287 (34%), Positives = 156/287 (54%), Gaps = 16/287 (5%)
Query: 47  FELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           FEL K+ G GS+ KV   +K+   D+G +YA+K++ KK   K       K+ER +L  ++
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVL-KKATLKVRDRVRTKMERDILADVN 88
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP VV+L + FQ    LY+ L+   GG+LF +++ +   +E++ +FY AE+   L+++HS
Sbjct: 89  HPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHS 148
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +G+I+RD+KPEN+LL  +GHIK+ DFG  K   D           + KA +F GT  Y+ 
Sbjct: 149 LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAID----------HEKKAYSFCGTVEYMA 198
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PEV+N    +   D W+ G  +++ML+G+ PF+          I+   +  P + S    
Sbjct: 199 PEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQFLSTEAQ 258
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
                     P+ R G+GP G   +K H F+  IDW  +  R   PP
Sbjct: 259 SLLRALFKRNPANRLGSGPDGAEEIKRHVFYSTIDWNKLYRREIKPP 305

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  184 bits (466), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 100/281 (35%), Positives = 145/281 (51%), Gaps = 12/281 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           ++ DF+  K+ G G++ KV+  ++  TG  YA+KI+ K+ I  +++ A+   E  VL   
Sbjct: 6   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 65
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP +  L + FQ    L   +E   GGELF  ++ +   +E+ ARFY AE+V ALEY+H
Sbjct: 66  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 125
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC-TFVGTAAY 221
           S  +++RDIK ENL+L  DGHIKI DFG  K              SD     TF GT  Y
Sbjct: 126 SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-----------EGISDGATMKTFCGTPEY 174
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 281
           + PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP   S  
Sbjct: 175 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE 234
Query: 282 XXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 322
                       P  R G GP     +  H FF  I+W+++
Sbjct: 235 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 275

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  184 bits (466), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 100/281 (35%), Positives = 145/281 (51%), Gaps = 12/281 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           ++ DF+  K+ G G++ KV+  ++  TG  YA+KI+ K+ I  +++ A+   E  VL   
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP +  L + FQ    L   +E   GGELF  ++ +   +E+ ARFY AE+V ALEY+H
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC-TFVGTAAY 221
           S  +++RDIK ENL+L  DGHIKI DFG  K              SD     TF GT  Y
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-----------EGISDGATMKTFCGTPEY 171
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 281
           + PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP   S  
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE 231
Query: 282 XXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 322
                       P  R G GP     +  H FF  I+W+++
Sbjct: 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  183 bits (465), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 100/281 (35%), Positives = 145/281 (51%), Gaps = 12/281 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           ++ DF+  K+ G G++ KV+  ++  TG  YA+KI+ K+ I  +++ A+   E  VL   
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP +  L + FQ    L   +E   GGELF  ++ +   +E+ ARFY AE+V ALEY+H
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC-TFVGTAAY 221
           S  +++RDIK ENL+L  DGHIKI DFG  K              SD     TF GT  Y
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-----------EGISDGATMKTFCGTPEY 171
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 281
           + PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP   S  
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE 231
Query: 282 XXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 322
                       P  R G GP     +  H FF  I+W+++
Sbjct: 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  181 bits (460), Expect = 6e-46,   Method: Compositional matrix adjust.
 Identities = 99/281 (35%), Positives = 144/281 (51%), Gaps = 12/281 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           ++ DF+  K+ G G++ KV+  ++  TG  YA+KI+ K+ I  +++ A+   E  VL   
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP +  L + FQ    L   +E   GGELF  ++ +   +E+ ARFY AE+V ALEY+H
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC-TFVGTAAY 221
           S  +++RDIK ENL+L  DGHIKI DFG  K              SD      F GT  Y
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-----------EGISDGATMKXFCGTPEY 171
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 281
           + PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP   S  
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE 231
Query: 282 XXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 322
                       P  R G GP     +  H FF  I+W+++
Sbjct: 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  181 bits (460), Expect = 7e-46,   Method: Compositional matrix adjust.
 Identities = 99/281 (35%), Positives = 144/281 (51%), Gaps = 12/281 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           ++ DF+  K+ G G++ KV+  ++  TG  YA+KI+ K+ I  +++ A+   E  VL   
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP +  L + FQ    L   +E   GGELF  ++ +   +E+ ARFY AE+V ALEY+H
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC-TFVGTAAY 221
           S  +++RDIK ENL+L  DGHIKI DFG  K              SD      F GT  Y
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-----------EGISDGATMKXFCGTPEY 171
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 281
           + PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP   S  
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE 231
Query: 282 XXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 322
                       P  R G GP     +  H FF  I+W+++
Sbjct: 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  181 bits (459), Expect = 7e-46,   Method: Compositional matrix adjust.
 Identities = 99/281 (35%), Positives = 144/281 (51%), Gaps = 12/281 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           ++ DF+  K+ G G++ KV+  ++  TG  YA+KI+ K+ I  +++ A+   E  VL   
Sbjct: 8   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 67
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP +  L + FQ    L   +E   GGELF  ++ +   +E+ ARFY AE+V ALEY+H
Sbjct: 68  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 127
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC-TFVGTAAY 221
           S  +++RDIK ENL+L  DGHIKI DFG  K              SD      F GT  Y
Sbjct: 128 SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-----------EGISDGATMKXFCGTPEY 176
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 281
           + PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP   S  
Sbjct: 177 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE 236
Query: 282 XXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 322
                       P  R G GP     +  H FF  I+W+++
Sbjct: 237 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 277

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  181 bits (459), Expect = 8e-46,   Method: Compositional matrix adjust.
 Identities = 99/281 (35%), Positives = 144/281 (51%), Gaps = 12/281 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           ++ DF+  K+ G G++ KV+  ++  TG  YA+KI+ K+ I  +++ A+   E  VL   
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP +  L + FQ    L   +E   GGELF  ++ +   +E+ ARFY AE+V ALEY+H
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC-TFVGTAAY 221
           S  +++RDIK ENL+L  DGHIKI DFG  K              SD      F GT  Y
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-----------EGISDGATMKXFCGTPEY 171
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 281
           + PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP   S  
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE 231
Query: 282 XXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 322
                       P  R G GP     +  H FF  I+W+++
Sbjct: 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  181 bits (459), Expect = 9e-46,   Method: Compositional matrix adjust.
 Identities = 97/290 (33%), Positives = 154/290 (53%), Gaps = 23/290 (7%)
Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
             +QDF+L ++ G GSY+KV+  +   T  +YA++++ K+ +  +    +V+ E+ V +Q
Sbjct: 49  LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQ 108
Query: 102 L-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
             +HP +V L   FQ    L+  +E   GG+L   +  +  L E+ ARFY+AE+  AL Y
Sbjct: 109 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 168
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           +H  G+I+RD+K +N+LL ++GHIK+ D+G  K                D   TF GT  
Sbjct: 169 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK----------EGLRPGDTTSTFCGTPN 218
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF----------KDTSEWLIFQRIIAR 270
           Y+ PE+L      F  D WALG  +++M++G SPF          ++T ++L FQ I+ +
Sbjct: 219 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL-FQVILEK 277
Query: 271 DIRFPNYFSXXXXXXXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDW 319
            IR P   S              P  R G  P  G+A ++ HPFF+ +DW
Sbjct: 278 QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 327

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  181 bits (458), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 95/276 (34%), Positives = 148/276 (53%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+IK+ADFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  180 bits (457), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 102/294 (34%), Positives = 150/294 (51%), Gaps = 13/294 (4%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P+   ++ +FE  K+ G G++ KV+  K+  TG  YA+KI+ K+ I  +++ A+   E  
Sbjct: 141 PKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR 200
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           VL    HP +  L ++FQ    L   +E   GGELF  ++ +   SED ARFY AE+V A
Sbjct: 201 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA 260
Query: 158 LEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L+Y+HS   +++RD+K ENL+L  DGHIKI DFG  K       T+           TF 
Sbjct: 261 LDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK----------TFC 310
Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           GT  Y+ PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP 
Sbjct: 311 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR 370
Query: 277 YFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
                            P  R G G      +  H FF GI W+++  +  +PP
Sbjct: 371 TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPP 424

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  180 bits (457), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 102/294 (34%), Positives = 150/294 (51%), Gaps = 13/294 (4%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P+   ++ +FE  K+ G G++ KV+  K+  TG  YA+KI+ K+ I  +++ A+   E  
Sbjct: 144 PKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR 203
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           VL    HP +  L ++FQ    L   +E   GGELF  ++ +   SED ARFY AE+V A
Sbjct: 204 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA 263
Query: 158 LEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L+Y+HS   +++RD+K ENL+L  DGHIKI DFG  K       T+           TF 
Sbjct: 264 LDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK----------TFC 313
Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           GT  Y+ PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP 
Sbjct: 314 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR 373
Query: 277 YFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
                            P  R G G      +  H FF GI W+++  +  +PP
Sbjct: 374 TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPP 427

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  180 bits (456), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 94/276 (34%), Positives = 148/276 (53%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +  T  GT  Y+ 
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWTLCGTPEYLA 207
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 268 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 303

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  179 bits (455), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 97/290 (33%), Positives = 153/290 (52%), Gaps = 23/290 (7%)
Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
             +QDF+L ++ G GSY+KV+  +   T  +YA+K++ K+ +  +    +V+ E+ V +Q
Sbjct: 2   LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 61
Query: 102 L-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
             +HP +V L   FQ    L+  +E   GG+L   +  +  L E+ ARFY+AE+  AL Y
Sbjct: 62  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 121
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           +H  G+I+RD+K +N+LL ++GHIK+ D+G  K                D    F GT  
Sbjct: 122 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK----------EGLRPGDTTSXFCGTPN 171
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF----------KDTSEWLIFQRIIAR 270
           Y+ PE+L      F  D WALG  +++M++G SPF          ++T ++L FQ I+ +
Sbjct: 172 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL-FQVILEK 230
Query: 271 DIRFPNYFSXXXXXXXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDW 319
            IR P   S              P  R G  P  G+A ++ HPFF+ +DW
Sbjct: 231 QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 280

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  179 bits (454), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 104/327 (31%), Positives = 166/327 (50%), Gaps = 28/327 (8%)
Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
             +QDF+L ++ G GSY+KV+  +   T  +YA+K++ K+ +  +    +V+ E+ V +Q
Sbjct: 17  LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 76
Query: 102 L-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
             +HP +V L   FQ    L+  +E   GG+L   +  +  L E+ ARFY+AE+  AL Y
Sbjct: 77  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 136
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           +H  G+I+RD+K +N+LL ++GHIK+ D+G  K                D    F GT  
Sbjct: 137 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK----------EGLRPGDTTSXFCGTPN 186
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF----------KDTSEWLIFQRIIAR 270
           Y+ PE+L      F  D WALG  +++M++G SPF          ++T ++L FQ I+ +
Sbjct: 187 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL-FQVILEK 245
Query: 271 DIRFPNYFSXXXXXXXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQ--TP 327
            IR P   S              P  R G  P  G+A ++ HPFF+ +DW  +  +   P
Sbjct: 246 QIRIPRSMSVKAASVLKSFLNKDPKERLGCLPQTGFADIQGHPFFRNVDWDMMEQKQVVP 305
Query: 328 PKLASEPMVQSGEGDDVHDSSWNPSHI 354
           P    +P +    G D  DS +    +
Sbjct: 306 P---FKPNISGEFGLDNFDSQFTNERV 329

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  179 bits (454), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 94/276 (34%), Positives = 148/276 (53%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 26  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 85
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 86  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 145
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +  T  GT  Y+ 
Sbjct: 146 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWTLCGTPEYLA 192
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 193 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 252
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 253 DLLRNLLQVDLTKRFGNLKDGVNDIKNHKWFATTDW 288

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  179 bits (453), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 94/276 (34%), Positives = 148/276 (53%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GG++F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+IK+ADFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  179 bits (453), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 94/276 (34%), Positives = 148/276 (53%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GG++F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+IK+ADFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  179 bits (453), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 97/290 (33%), Positives = 153/290 (52%), Gaps = 23/290 (7%)
Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
             +QDF+L ++ G GSY+KV+  +   T  +YA+K++ K+ +  +    +V+ E+ V +Q
Sbjct: 6   LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65
Query: 102 L-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
             +HP +V L   FQ    L+  +E   GG+L   +  +  L E+ ARFY+AE+  AL Y
Sbjct: 66  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 125
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           +H  G+I+RD+K +N+LL ++GHIK+ D+G  K                D    F GT  
Sbjct: 126 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK----------EGLRPGDTTSXFCGTPN 175
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF----------KDTSEWLIFQRIIAR 270
           Y+ PE+L      F  D WALG  +++M++G SPF          ++T ++L FQ I+ +
Sbjct: 176 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL-FQVILEK 234
Query: 271 DIRFPNYFSXXXXXXXXXXXXXXPSGRPGAGP-GGYAVLKMHPFFKGIDW 319
            IR P   S              P  R G  P  G+A ++ HPFF+ +DW
Sbjct: 235 QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 284

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  178 bits (452), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 93/276 (33%), Positives = 147/276 (53%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENL++   G+IK+ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  178 bits (452), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 93/276 (33%), Positives = 147/276 (53%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVN 99
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENL++   G+IK+ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVK-------------GRTWXLCGTPEYLA 206
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  178 bits (451), Expect = 8e-45,   Method: Compositional matrix adjust.
 Identities = 93/276 (33%), Positives = 147/276 (53%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 207
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 268 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 303

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  178 bits (451), Expect = 8e-45,   Method: Compositional matrix adjust.
 Identities = 93/276 (33%), Positives = 147/276 (53%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  177 bits (450), Expect = 9e-45,   Method: Compositional matrix adjust.
 Identities = 93/276 (33%), Positives = 147/276 (53%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  177 bits (450), Expect = 9e-45,   Method: Compositional matrix adjust.
 Identities = 93/276 (33%), Positives = 147/276 (53%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKDGVNDIKNHKWFATTDW 302

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  177 bits (449), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 147/276 (53%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENL++   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 93/276 (33%), Positives = 147/276 (53%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKDGVNDIKNHKWFATTDW 302

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 147/276 (53%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVN 99
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENL++   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVK-------------GRTWXLCGTPEYLA 206
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G   E  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENL++   G+IK+ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 92/277 (33%), Positives = 147/277 (53%), Gaps = 13/277 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
            +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  +
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           + P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYL 205
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 282
            PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS   
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 283 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                       + R G  P G   +K H +F   DW
Sbjct: 266 KDLLRNLLQVDLTKRFGNLPNGVNDIKNHKWFATTDW 302

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P + +L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENL++   G+IK+ DFG  K ++              +     GT  Y+ 
Sbjct: 161 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-------------GRTWXLCGTPEYLA 207
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 268 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 303

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  177 bits (448), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P + +L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENL++   G+IK+ DFG  K ++              +     GT  Y+ 
Sbjct: 161 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-------------GRTWXLCGTPEYLA 207
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 268 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 303

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  177 bits (448), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 93/276 (33%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K  +TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENL++   G+IK+ DFG  K ++              +     GT  Y+ 
Sbjct: 161 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-------------GRTWXLCGTPEYLA 207
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 268 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 303

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  176 bits (447), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 93/276 (33%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K  +TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 33  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 92
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 152
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 153 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 199
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 200 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 259
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 260 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 295

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  176 bits (447), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 94/276 (34%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  +  G GS+ +V+  K  +TG  YA+KI+DK+ + K  +  +   E+ +   ++
Sbjct: 41  LDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVN 100
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM LE   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+IK+ADFG  K ++              +     GT  Y+ 
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK-------------GRTWXLCGTPEYLA 207
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 268 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 303

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 93/276 (33%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K  +TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 207
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 268 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 303

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 93/276 (33%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K  +TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 207
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 268 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 303

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  176 bits (446), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G   E  ARFY A++V   EY+HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 160
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 207
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 268 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 303

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  176 bits (446), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G   E  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  176 bits (446), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 93/276 (33%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K  +TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 61  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 120
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 180
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 181 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 227
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 287
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 288 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 323

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  176 bits (445), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G   E  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  175 bits (444), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 91/276 (32%), Positives = 145/276 (52%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K ++TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P + +L F+F+D  +LYM +E   GGE+F  +   G   E  ARFY A++V   EY+HS
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 160
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENL++   G+IK+ DFG  K ++              +     GT  Y+ 
Sbjct: 161 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-------------GRTWXLCGTPEYLA 207
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 268 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 303

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  175 bits (444), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 92/277 (33%), Positives = 147/277 (53%), Gaps = 13/277 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
            +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  +
Sbjct: 60  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 119
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           + P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+H
Sbjct: 120 NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 179
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S+ LI+RD+KPENLL+   G+I++ DFG  K ++ +               T  GT  Y+
Sbjct: 180 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGA-------------TWTLCGTPEYL 226
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 282
            PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS   
Sbjct: 227 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 286
Query: 283 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                       + R G    G   +K H +F   DW
Sbjct: 287 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 323

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  175 bits (443), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 92/277 (33%), Positives = 146/277 (52%), Gaps = 13/277 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
            +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  +
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           + P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYL 205
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 282
            PE++ S       D WALG  +YQM +G  PF       I+++I++  +RFP++FS   
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 283 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                       + R G    G   +K H +F   DW
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  175 bits (443), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 100/289 (34%), Positives = 149/289 (51%), Gaps = 13/289 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           ++ +FE  K+ G G++ KV+  K+  TG  YA+KI+ K+ I  +++ A+   E  VL   
Sbjct: 6   TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 65
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP +  L ++FQ    L   +E   GGELF  ++ +   SED ARFY AE+V AL+Y+H
Sbjct: 66  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH 125
Query: 163 S-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           S   +++RD+K ENL+L  DGHIKI DFG  K         + + A+    C   GT  Y
Sbjct: 126 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-------EGIKDGATMKXFC---GTPEY 175
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 281
           + PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP      
Sbjct: 176 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPE 235
Query: 282 XXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
                       P  R G G      +  H FF GI W+++  +  +PP
Sbjct: 236 AKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPP 284

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  175 bits (443), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 100/289 (34%), Positives = 147/289 (50%), Gaps = 13/289 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           ++ +FE  K+ G G++ KV+  K+  TG  YA+KI+ K+ I  +++ A+   E  VL   
Sbjct: 7   TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 66
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP +  L ++FQ    L   +E   GGELF  ++ +   SED ARFY AE+V AL+Y+H
Sbjct: 67  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH 126
Query: 163 S-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           S   +++RD+K ENL+L  DGHIKI DFG  K       T+            F GT  Y
Sbjct: 127 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK----------XFCGTPEY 176
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 281
           + PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP      
Sbjct: 177 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPE 236
Query: 282 XXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
                       P  R G G      +  H FF GI W+++  +  +PP
Sbjct: 237 AKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPP 285

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  174 bits (442), Expect = 7e-44,   Method: Compositional matrix adjust.
 Identities = 100/289 (34%), Positives = 147/289 (50%), Gaps = 13/289 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           ++ +FE  K+ G G++ KV+  K+  TG  YA+KI+ K+ I  +++ A+   E  VL   
Sbjct: 8   TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 67
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP +  L ++FQ    L   +E   GGELF  ++ +   SED ARFY AE+V AL+Y+H
Sbjct: 68  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH 127
Query: 163 S-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           S   +++RD+K ENL+L  DGHIKI DFG  K       T+            F GT  Y
Sbjct: 128 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK----------XFCGTPEY 177
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 281
           + PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP      
Sbjct: 178 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPE 237
Query: 282 XXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
                       P  R G G      +  H FF GI W+++  +  +PP
Sbjct: 238 AKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPP 286

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  174 bits (442), Expect = 8e-44,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 145/276 (52%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K  +TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 33  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 92
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G   E  ARFY A++V   EY+HS
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 152
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 153 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 199
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 200 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 259
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 260 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 295

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  174 bits (441), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 145/276 (52%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K  +TG  YA+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 207
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +  H +F   DW
Sbjct: 268 DLLRNLLQVDLTKRFGNLKNGVNDIXNHKWFATTDW 303

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 91/277 (32%), Positives = 146/277 (52%), Gaps = 13/277 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
            +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  +
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           + P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLAGTPEYL 205
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 282
            PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS   
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 283 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                       + R G    G   +K H +F   DW
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 91/276 (32%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K  +TG  +A+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L ++F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 91/277 (32%), Positives = 146/277 (52%), Gaps = 13/277 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
            +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  +
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           + P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYL 205
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 282
            PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS   
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 283 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                       + R G    G   +K H +F   DW
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  173 bits (439), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 91/277 (32%), Positives = 146/277 (52%), Gaps = 13/277 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
            +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  +
Sbjct: 40  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           + P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+H
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYL 206
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 282
            PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS   
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 266
Query: 283 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                       + R G    G   +K H +F   DW
Sbjct: 267 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 303

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  173 bits (439), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 91/277 (32%), Positives = 146/277 (52%), Gaps = 13/277 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
            +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  +
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           + P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYL 205
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 282
            PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS   
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 283 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                       + R G    G   +K H +F   DW
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  173 bits (439), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 91/277 (32%), Positives = 146/277 (52%), Gaps = 13/277 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
            +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  +
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           + P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLXGTPEYL 205
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 282
            PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS   
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 283 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                       + R G    G   +K H +F   DW
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  173 bits (439), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 91/277 (32%), Positives = 146/277 (52%), Gaps = 13/277 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
            +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  +
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           + P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYL 205
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 282
            PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS   
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 283 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                       + R G    G   +K H +F   DW
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  173 bits (439), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 99/300 (33%), Positives = 159/300 (53%), Gaps = 20/300 (6%)
Query: 40  EHFSIQDFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTA-YVKLE 95
           E   I++FEL K+ G G+Y KV   +KI   DTG +YA+K++ K  I ++ KT  + + E
Sbjct: 49  EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE 108
Query: 96  RIVLDQLDH-PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 154
           R VL+ +   P +V L + FQ    L++ L+   GGELF  ++ +   +E E + Y  E+
Sbjct: 109 RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI 168
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           V ALE++H +G+I+RDIK EN+LL ++GH+ + DFG  K            A   ++A  
Sbjct: 169 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV---------ADETERAYD 219
Query: 215 FVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPF----KDTSEWLIFQRII 268
           F GT  Y+ P+++    +      D W+LG  +Y++L+G SPF    +  S+  I +RI+
Sbjct: 220 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 279
Query: 269 ARDIRFPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 328
             +  +P   S              P  R G GP     +K H FF+ I+W ++  +  P
Sbjct: 280 KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVP 339

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  173 bits (439), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 91/277 (32%), Positives = 146/277 (52%), Gaps = 13/277 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
            +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  +
Sbjct: 26  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 85
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           + P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+H
Sbjct: 86  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 145
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+
Sbjct: 146 SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYL 192
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 282
            PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS   
Sbjct: 193 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 252
Query: 283 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                       + R G    G   +K H +F   DW
Sbjct: 253 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 289

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 91/276 (32%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K  +TG  +A+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L ++F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKDGVNDIKNHKWFATTDW 302

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 91/276 (32%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  FE  K  G GS+ +V+  K  +TG  +A+KI+DK+ + K  +  +   E+ +L  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
            P +V+L ++F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+HS
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           + LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYLA 206
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXX 283
           PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS    
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 284 XXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                      + R G    G   +K H +F   DW
Sbjct: 267 DLLRNLLQVDLTKRFGNLKDGVNDIKNHKWFATTDW 302

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  172 bits (437), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 90/277 (32%), Positives = 146/277 (52%), Gaps = 13/277 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
            +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  +
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           + P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S+ LI+RD+KPENL++   G+I++ DFG  K ++              +     GT  Y+
Sbjct: 159 SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYL 205
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 282
            PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS   
Sbjct: 206 APEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 283 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                       + R G    G   +K H +F   DW
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  172 bits (437), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 90/277 (32%), Positives = 146/277 (52%), Gaps = 13/277 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
            +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  +
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           + P +V+L F+F+D  +LYM +E   GGE+F  +   G  +E  ARFY A++V   EY+H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLH 158
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYL 205
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 282
            PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS   
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 283 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                       + R G    G   +K H +F   DW
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  172 bits (435), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 90/277 (32%), Positives = 145/277 (52%), Gaps = 13/277 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
            +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  +
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           + P +V+L F+F+D  +LYM +E   GGE+F  +   G   E  ARFY A++V   EY+H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYL 205
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 282
            PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS   
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 283 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                       + R G    G   +K H +F   DW
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  172 bits (435), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 105/317 (33%), Positives = 162/317 (51%), Gaps = 21/317 (6%)
Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD- 100
             I +FE  ++ G GS+ KV+ A+  +TG +YA+K++ K  I +++       E+ +L  
Sbjct: 20  LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79
Query: 101 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
             +HP + +LF  FQ    L+  +E   GG+L   I       E  ARFY AE++ AL +
Sbjct: 80  ARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMF 139
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           +H  G+I+RD+K +N+LL  +GH K+ADFG  K    + +T            TF GT  
Sbjct: 140 LHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT----------TATFCGTPD 189
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSX 280
           Y+ PE+L         D WA+G  LY+ML G +PF+  +E  +F+ I+  ++ +P +   
Sbjct: 190 YIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHE 249
Query: 281 XXXXXXXXXXXXXPSGRPGA-GPGGYAVLKMHPFFKGIDWK--NIRGQTPPKLASEPMVQ 337
                        P+ R G+   GG   +  HPFFK IDW   N R   PP     P ++
Sbjct: 250 DATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPP---FRPRIK 306
Query: 338 SGEGDDVHDSSWNPSHI 354
           S E  DV  S+++P  I
Sbjct: 307 SRE--DV--SNFDPDFI 319

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  172 bits (435), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 90/277 (32%), Positives = 145/277 (52%), Gaps = 13/277 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
            +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  +
Sbjct: 34  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 93
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           + P +V+L F+F+D  +LYM +E   GGE+F  +   G   E  ARFY A++V   EY+H
Sbjct: 94  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 153
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+
Sbjct: 154 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYL 200
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 282
            PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS   
Sbjct: 201 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 260
Query: 283 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                       + R G    G   +K H +F   DW
Sbjct: 261 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 297

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  172 bits (435), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 90/277 (32%), Positives = 145/277 (52%), Gaps = 13/277 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
            +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  +
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           + P +V+L F+F+D  +LYM +E   GGE+F  +   G   E  ARFY A++V   EY+H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYL 205
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 282
            PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS   
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 283 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                       + R G    G   +K H +F   DW
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  172 bits (435), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 90/277 (32%), Positives = 145/277 (52%), Gaps = 13/277 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
            +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  +
Sbjct: 60  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 119
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           + P +V+L F+F+D  +LYM +E   GGE+F  +   G   E  ARFY A++V   EY+H
Sbjct: 120 NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 179
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+
Sbjct: 180 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYL 226
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 282
            PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS   
Sbjct: 227 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 286
Query: 283 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                       + R G    G   +K H +F   DW
Sbjct: 287 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 323

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  171 bits (434), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 90/277 (32%), Positives = 145/277 (52%), Gaps = 13/277 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
            +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  +
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           + P +V+L F+F+D  +LYM +E   GGE+F  +   G   E  ARFY A++V   EY+H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYL 205
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 282
            PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS   
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 283 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                       + R G    G   +K H +F   DW
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  171 bits (433), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 90/277 (32%), Positives = 145/277 (52%), Gaps = 13/277 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
            +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  +
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           + P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYL 205
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 282
            P ++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS   
Sbjct: 206 APAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 283 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                       + R G    G   +K H +F   DW
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  171 bits (432), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 90/277 (32%), Positives = 145/277 (52%), Gaps = 13/277 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
            +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  +
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           + P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT  Y+
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEYL 205
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 282
            PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS   
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 283 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                       +   G    G   +K H +F   DW
Sbjct: 266 KDLLRNLLQVDLTKAFGNLKNGVNDIKNHKWFATTDW 302

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  170 bits (431), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 90/277 (32%), Positives = 145/277 (52%), Gaps = 13/277 (4%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
            +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ +L  +
Sbjct: 39  QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           + P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V   EY+H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S+ LI+RD+KPENLL+   G+I++ DFG  K ++              +     GT   +
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------------GRTWXLCGTPEAL 205
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 282
            PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++FS   
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 283 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDW 319
                       + R G    G   +K H +F   DW
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score =  169 bits (427), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 103/312 (33%), Positives = 160/312 (51%), Gaps = 17/312 (5%)
Query: 27  VQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE 86
           ++ +K F     +     +DFE+ K+ G G++ +V   K  +T  +YA+KI++K  + K 
Sbjct: 72  LEWAKPFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKR 131
Query: 87  NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSED 145
            +TA  + ER VL   D   +  L + FQD   LY+ ++   GG+L   ++  +  L ED
Sbjct: 132 AETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPED 191
Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
            ARFY  E+V A++ IH +  +HRDIKP+N+LL  +GHI++ADFGS   M D   TV  +
Sbjct: 192 MARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDG-TVQSS 250
Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGN-----DLWALGCTLYQMLSGTSPFKDTSE 260
            A        VGT  Y+ PE+L +     G      D W+LG  +Y+ML G +PF   S 
Sbjct: 251 VA--------VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL 302
Query: 261 WLIFQRIIARDIR--FPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGID 318
              + +I+  + R  FP++ +               S     G  G    K H FF+G++
Sbjct: 303 VETYGKIMNHEERFQFPSHVTDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGLN 362
Query: 319 WKNIRGQTPPKL 330
           W+NIR    P +
Sbjct: 363 WENIRNLEAPYI 374

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score =  169 bits (427), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 103/312 (33%), Positives = 160/312 (51%), Gaps = 17/312 (5%)
Query: 27  VQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE 86
           ++ +K F     +     +DFE+ K+ G G++ +V   K  +T  +YA+KI++K  + K 
Sbjct: 56  LEWAKPFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKR 115
Query: 87  NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSED 145
            +TA  + ER VL   D   +  L + FQD   LY+ ++   GG+L   ++  +  L ED
Sbjct: 116 AETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPED 175
Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
            ARFY  E+V A++ IH +  +HRDIKP+N+LL  +GHI++ADFGS   M D   TV  +
Sbjct: 176 MARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDG-TVQSS 234
Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGN-----DLWALGCTLYQMLSGTSPFKDTSE 260
            A        VGT  Y+ PE+L +     G      D W+LG  +Y+ML G +PF   S 
Sbjct: 235 VA--------VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL 286
Query: 261 WLIFQRIIARDIR--FPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGID 318
              + +I+  + R  FP++ +               S     G  G    K H FF+G++
Sbjct: 287 VETYGKIMNHEERFQFPSHVTDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGLN 346
Query: 319 WKNIRGQTPPKL 330
           W+NIR    P +
Sbjct: 347 WENIRNLEAPYI 358

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score =  168 bits (426), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 102/313 (32%), Positives = 160/313 (51%), Gaps = 19/313 (6%)
Query: 27  VQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE 86
           ++ +K F  +  Q     +DFE+ K+ G G++ +V   K  +   V+A+KI++K  + K 
Sbjct: 56  LEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKR 115
Query: 87  NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSED 145
            +TA  + ER VL   D   +  L + FQD  +LY+ ++   GG+L   ++  +  L E+
Sbjct: 116 AETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEE 175
Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS-VKPMQDSRITVLP 204
            ARFY AE+V A++ +H +  +HRDIKP+N+L+  +GHI++ADFGS +K M+D  +    
Sbjct: 176 MARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV---- 231
Query: 205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGN-----DLWALGCTLYQMLSGTSPFKDTS 259
                 ++   VGT  Y+ PE+L +     G      D W+LG  +Y+ML G +PF   S
Sbjct: 232 ------QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 285
Query: 260 EWLIFQRIIARDIR--FPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
               + +I+    R  FP   +               S     G  G    K HPFF GI
Sbjct: 286 LVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345
Query: 318 DWKNIRGQTPPKL 330
           DW NIR    P +
Sbjct: 346 DWDNIRNCEAPYI 358

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  168 bits (425), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 96/288 (33%), Positives = 143/288 (49%), Gaps = 13/288 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           + DF    + G GS+ KV+ A +  T  +YA+KI+ K  + +++      +E+ VL  LD
Sbjct: 18  LTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLD 77
Query: 104 HPG-VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            P  + +L   FQ    LY  +E   GG+L   I   G   E +A FY AE+   L ++H
Sbjct: 78  KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLH 137
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
             G+I+RD+K +N++L ++GHIKIADFG  K      +T             F GT  Y+
Sbjct: 138 KRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTR----------EFCGTPDYI 187
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 282
            PE++   P     D WA G  LY+ML+G  PF    E  +FQ I+  ++ +P   S   
Sbjct: 188 APEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEA 247
Query: 283 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
                      P+ R G GP G   ++ H FF+ IDW+ +  R   PP
Sbjct: 248 VSICKGLMTKHPAKRLGCGPEGERDVREHAFFRRIDWEKLENREIQPP 295

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  167 bits (422), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 97/291 (33%), Positives = 145/291 (49%), Gaps = 14/291 (4%)
Query: 41  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER-IVL 99
           H    DF   K+ G GS+ KV+ A+       YA+K++ KK I K+ +  ++  ER ++L
Sbjct: 34  HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLL 93
Query: 100 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 159
             + HP +V L F+FQ    LY  L+   GGELF  +  +    E  ARFY AE+  AL 
Sbjct: 94  KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALG 153
Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           Y+HS+ +++RD+KPEN+LL + GHI + DFG  K           N   +    TF GT 
Sbjct: 154 YLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK----------ENIEHNSTTSTFCGTP 203
Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS 279
            Y+ PEVL+  P     D W LG  LY+ML G  PF   +   ++  I+ + ++     +
Sbjct: 204 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNIT 263
Query: 280 XXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ--TPP 328
                          + R GA    +  +K H FF  I+W ++  +  TPP
Sbjct: 264 NSARHLLEGLLQKDRTKRLGAK-DDFMEIKSHVFFSLINWDDLINKKITPP 313

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  161 bits (408), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 91/285 (31%), Positives = 141/285 (49%), Gaps = 11/285 (3%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           ++   + DF    + G GS+ KV+ +++  T  +YA+KI+ K  + +++      +E+ V
Sbjct: 335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV 394
Query: 99  LDQLDHPG-VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           L     P  + +L   FQ    LY  +E   GG+L   I   G   E  A FY AE+   
Sbjct: 395 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG 454
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           L ++ S G+I+RD+K +N++L ++GHIKIADFG  K      +T             F G
Sbjct: 455 LFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK----------XFCG 504
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
           T  Y+ PE++   P     D WA G  LY+ML+G +PF+   E  +FQ I+  ++ +P  
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS 564
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 322
            S              P  R G GP G   +K H FF+ IDW+ +
Sbjct: 565 MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL 609

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  160 bits (406), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 91/285 (31%), Positives = 140/285 (49%), Gaps = 11/285 (3%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           ++   + DF    + G GS+ KV+ +++  T  +YA+KI+ K  + +++      +E+ V
Sbjct: 14  RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV 73
Query: 99  LDQLDHPG-VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           L     P  + +L   FQ    LY  +E   GG+L   I   G   E  A FY AE+   
Sbjct: 74  LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG 133
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           L ++ S G+I+RD+K +N++L ++GHIKIADFG  K           N         F G
Sbjct: 134 LFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK----------ENIWDGVTTKXFCG 183
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
           T  Y+ PE++   P     D WA G  LY+ML+G +PF+   E  +FQ I+  ++ +P  
Sbjct: 184 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS 243
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 322
            S              P  R G GP G   +K H FF+ IDW+ +
Sbjct: 244 MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL 288

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  160 bits (404), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 94/293 (32%), Positives = 139/293 (47%), Gaps = 17/293 (5%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           Q    I+DFEL K+ G GS+ KV  A+   T   +A+K + K  +  ++      +E+ V
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 99  LD-QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           L    +HP +  +F TFQ   +L+  +E   GG+L   I S        A FY AE++  
Sbjct: 72  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILG 131
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           L+++HS G+++RD+K +N+LL  DGHIKIADFG  K           N   D K   F G
Sbjct: 132 LQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK----------ENMLGDAKTNEFCG 181
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
           T  Y+ PE+L         D W+ G  LY+ML G SPF    E  +F  I   +  +P +
Sbjct: 182 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW 241
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT--PP 328
                           P  R G        ++ HP F+ I+W+ +  +   PP
Sbjct: 242 LEKEAKDLLVKLFVREPEKRLGVR----GDIRQHPLFREINWEELERKEIDPP 290

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  158 bits (400), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 107/313 (34%), Positives = 163/313 (52%), Gaps = 24/313 (7%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +D+++ K+ G G++ +V   +   +  VYA+K++ K  + K + +A+   ER ++   + 
Sbjct: 75  EDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 134
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P VV+LF  FQD   LYM +E   GG+L + + S   + E  A+FYTAEVV AL+ IHSM
Sbjct: 135 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSM 193
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           GLIHRD+KP+N+LL   GH+K+ADFG+   M ++ +     A         VGT  Y+ P
Sbjct: 194 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTA---------VGTPDYISP 244
Query: 225 EVLNSS--PATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRII--ARDIRFPNYF 278
           EVL S      +G   D W++G  L++ML G +PF   S    + +I+     + FP   
Sbjct: 245 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPED- 303
Query: 279 SXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKG--IDWKNIR---GQTPPKLASE 333
           +                     G  G   +K HPFFK    +W NIR       P+L+S+
Sbjct: 304 AEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSSD 363
Query: 334 PMVQSGEGDDVHD 346
             + S   DD+ D
Sbjct: 364 --IDSSNFDDIED 374

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score =  157 bits (398), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 100/312 (32%), Positives = 150/312 (48%), Gaps = 19/312 (6%)
Query: 27  VQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE 86
           +Q ++    R  +      DFE+ K+ G G++S+V   K   TG VYA+KIM+K  + K 
Sbjct: 43  LQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKR 102
Query: 87  NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG-HLSED 145
            + +  + ER VL   D   + +L F FQD   LY+ +E   GG+L   ++  G  +  +
Sbjct: 103 GEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAE 162
Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
            ARFY AE+V A++ +H +G +HRDIKP+N+LL   GHI++ADFGS   ++         
Sbjct: 163 MARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR--------- 213
Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGN-------DLWALGCTLYQMLSGTSPFKDT 258
           A    ++   VGT  Y+ PE+L +     G        D WALG   Y+M  G +PF   
Sbjct: 214 ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD 273
Query: 259 SEWLIFQRII--ARDIRFPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKG 316
           S    + +I+     +  P                         G GG    + HPFF G
Sbjct: 274 STAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFG 333
Query: 317 IDWKNIRGQTPP 328
           +DW  +R   PP
Sbjct: 334 LDWDGLRDSVPP 345

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 93/293 (31%), Positives = 138/293 (47%), Gaps = 17/293 (5%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           Q    I+DF L K+ G GS+ KV  A+   T   +A+K + K  +  ++      +E+ V
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 99  LD-QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           L    +HP +  +F TFQ   +L+  +E   GG+L   I S        A FY AE++  
Sbjct: 71  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILG 130
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           L+++HS G+++RD+K +N+LL  DGHIKIADFG  K           N   D K   F G
Sbjct: 131 LQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK----------ENMLGDAKTNXFCG 180
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
           T  Y+ PE+L         D W+ G  LY+ML G SPF    E  +F  I   +  +P +
Sbjct: 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW 240
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT--PP 328
                           P  R G        ++ HP F+ I+W+ +  +   PP
Sbjct: 241 LEKEAKDLLVKLFVREPEKRLGVR----GDIRQHPLFREINWEELERKEIDPP 289

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  157 bits (396), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 101/292 (34%), Positives = 150/292 (51%), Gaps = 19/292 (6%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +D+E+ K+ G G++ +V   +   T  VYA+K++ K  + K + +A+   ER ++   + 
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P VV+LF+ FQD   LYM +E   GG+L + + S   + E  ARFYTAEVV AL+ IHSM
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSM 187
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G IHRD+KP+N+LL   GH+K+ADFG+   M    +          +  T VGT  Y+ P
Sbjct: 188 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV---------RCDTAVGTPDYISP 238
Query: 225 EVLNSS--PATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRII--ARDIRFPNYF 278
           EVL S      +G   D W++G  LY+ML G +PF   S    + +I+     + FP+  
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD- 297
Query: 279 SXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGID--WKNIRGQTPP 328
           +                     G  G   +K H FFK     W+ +R    P
Sbjct: 298 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAP 349

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 101/292 (34%), Positives = 150/292 (51%), Gaps = 19/292 (6%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +D+E+ K+ G G++ +V   +   T  VYA+K++ K  + K + +A+   ER ++   + 
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P VV+LF+ FQD   LYM +E   GG+L + + S   + E  ARFYTAEVV AL+ IHSM
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSM 192
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G IHRD+KP+N+LL   GH+K+ADFG+   M    +          +  T VGT  Y+ P
Sbjct: 193 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV---------RCDTAVGTPDYISP 243
Query: 225 EVLNSS--PATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRII--ARDIRFPNYF 278
           EVL S      +G   D W++G  LY+ML G +PF   S    + +I+     + FP+  
Sbjct: 244 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD- 302
Query: 279 SXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGID--WKNIRGQTPP 328
           +                     G  G   +K H FFK     W+ +R    P
Sbjct: 303 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAP 354

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  156 bits (394), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 101/292 (34%), Positives = 150/292 (51%), Gaps = 19/292 (6%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +D+E+ K+ G G++ +V   +   T  VYA+K++ K  + K + +A+   ER ++   + 
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P VV+LF+ FQD   LYM +E   GG+L + + S   + E  ARFYTAEVV AL+ IHSM
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSM 192
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           G IHRD+KP+N+LL   GH+K+ADFG+   M    +          +  T VGT  Y+ P
Sbjct: 193 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV---------RCDTAVGTPDYISP 243
Query: 225 EVLNSS--PATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRII--ARDIRFPNYF 278
           EVL S      +G   D W++G  LY+ML G +PF   S    + +I+     + FP+  
Sbjct: 244 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD- 302
Query: 279 SXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGID--WKNIRGQTPP 328
           +                     G  G   +K H FFK     W+ +R    P
Sbjct: 303 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAP 354

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  155 bits (392), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 80/237 (33%), Positives = 133/237 (56%), Gaps = 11/237 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           I+DF++G + G GS++ V RA+ I TG   A+K++DKK + K      V+ E  +  QL 
Sbjct: 10  IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIH 162
           HP ++ L+  F+D+  +Y+ LE C  GE+   + ++    SE+EAR +  +++  + Y+H
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S G++HRD+   NLLLT + +IKIADFG    ++      +P+    +K  T  GT  Y+
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLK------MPH----EKHYTLCGTPNYI 179
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS 279
            PE+   S     +D+W+LGC  Y +L G  PF   +      +++  D   P++ S
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLS 236

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score =  147 bits (372), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 97/315 (30%), Positives = 152/315 (48%), Gaps = 25/315 (7%)
Query: 41  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 100
           H ++ DF + +I G G + +V   +K DTG +YA+K +DKK I  +        ERI+L 
Sbjct: 184 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 243
Query: 101 QL---DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
            +   D P +V + + F     L   L+   GG+L   ++  G  SE + RFY AE++  
Sbjct: 244 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 303
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           LE++H+  +++RD+KP N+LL   GH++I+D G            L    S  K    VG
Sbjct: 304 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLG------------LACDFSKKKPHASVG 351
Query: 218 TAAYVPPEVLNSSPATFGN-DLWALGCTLYQMLSGTSPF-----KDTSEWLIFQRIIARD 271
           T  Y+ PEVL    A   + D ++LGC L+++L G SPF     KD  E  I +  +   
Sbjct: 352 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRMTLTMA 409
Query: 272 IRFPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT--PPK 329
           +  P+ FS               + R G    G   +K  PFF+ +DW+ +  Q   PP 
Sbjct: 410 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPL 469
Query: 330 LASEPMVQSGEGDDV 344
           +     V + +  D+
Sbjct: 470 IPPRGEVNAADAFDI 484

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 97/315 (30%), Positives = 152/315 (48%), Gaps = 25/315 (7%)
Query: 41  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 100
           H ++ DF + +I G G + +V   +K DTG +YA+K +DKK I  +        ERI+L 
Sbjct: 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 244
Query: 101 QL---DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
            +   D P +V + + F     L   L+   GG+L   ++  G  SE + RFY AE++  
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 304
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           LE++H+  +++RD+KP N+LL   GH++I+D G            L    S  K    VG
Sbjct: 305 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLG------------LACDFSKKKPHASVG 352
Query: 218 TAAYVPPEVLNSSPATFGN-DLWALGCTLYQMLSGTSPF-----KDTSEWLIFQRIIARD 271
           T  Y+ PEVL    A   + D ++LGC L+++L G SPF     KD  E  I +  +   
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRMTLTMA 410
Query: 272 IRFPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT--PPK 329
           +  P+ FS               + R G    G   +K  PFF+ +DW+ +  Q   PP 
Sbjct: 411 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPL 470
Query: 330 LASEPMVQSGEGDDV 344
           +     V + +  D+
Sbjct: 471 IPPRGEVNAADAFDI 485

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 97/315 (30%), Positives = 152/315 (48%), Gaps = 25/315 (7%)
Query: 41  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 100
           H ++ DF + +I G G + +V   +K DTG +YA+K +DKK I  +        ERI+L 
Sbjct: 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 244
Query: 101 QL---DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
            +   D P +V + + F     L   L+   GG+L   ++  G  SE + RFY AE++  
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 304
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           LE++H+  +++RD+KP N+LL   GH++I+D G            L    S  K    VG
Sbjct: 305 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLG------------LACDFSKKKPHASVG 352
Query: 218 TAAYVPPEVLNSSPATFGN-DLWALGCTLYQMLSGTSPF-----KDTSEWLIFQRIIARD 271
           T  Y+ PEVL    A   + D ++LGC L+++L G SPF     KD  E  I +  +   
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRMTLTMA 410
Query: 272 IRFPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT--PPK 329
           +  P+ FS               + R G    G   +K  PFF+ +DW+ +  Q   PP 
Sbjct: 411 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPL 470
Query: 330 LASEPMVQSGEGDDV 344
           +     V + +  D+
Sbjct: 471 IPPRGEVNAADAFDI 485

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 97/315 (30%), Positives = 152/315 (48%), Gaps = 25/315 (7%)
Query: 41  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 100
           H ++ DF + +I G G + +V   +K DTG +YA+K +DKK I  +        ERI+L 
Sbjct: 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 244
Query: 101 QL---DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
            +   D P +V + + F     L   L+   GG+L   ++  G  SE + RFY AE++  
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 304
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           LE++H+  +++RD+KP N+LL   GH++I+D G            L    S  K    VG
Sbjct: 305 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLG------------LACDFSKKKPHASVG 352
Query: 218 TAAYVPPEVLNSSPATFGN-DLWALGCTLYQMLSGTSPF-----KDTSEWLIFQRIIARD 271
           T  Y+ PEVL    A   + D ++LGC L+++L G SPF     KD  E  I +  +   
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRMTLTMA 410
Query: 272 IRFPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT--PPK 329
           +  P+ FS               + R G    G   +K  PFF+ +DW+ +  Q   PP 
Sbjct: 411 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPL 470
Query: 330 LASEPMVQSGEGDDV 344
           +     V + +  D+
Sbjct: 471 IPPRGEVNAADAFDI 485

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  147 bits (370), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 80/243 (32%), Positives = 120/243 (49%), Gaps = 14/243 (5%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P+  F+I DF++G+  G G +  V  A++     + ALK++ K  + KE     ++ E  
Sbjct: 8   PKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIE 67
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           +   L HP ++R++  F D   +Y+ LE    GEL+ ++   G   E  +  +  E+ DA
Sbjct: 68  IQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADA 127
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFV 216
           L Y H   +IHRDIKPENLL+   G +KIADFG SV              A   +     
Sbjct: 128 LHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVH-------------APSLRRRXMC 174
Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           GT  Y+PPE++         DLW  G   Y+ L G  PF   S     +RI+  D++FP 
Sbjct: 175 GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP 234
Query: 277 YFS 279
           + S
Sbjct: 235 FLS 237

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  147 bits (370), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 128/265 (48%), Gaps = 12/265 (4%)
Query: 34  AFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVK 93
           A  + +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++
Sbjct: 2   AMESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 61
Query: 94  LERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 153
            E  +   L HP ++RL+  F D   +Y+ LE    GE++ ++       E     Y  E
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITE 121
Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           + +AL Y HS  +IHRDIKPENLLL + G +KIADFG       SR T            
Sbjct: 122 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------------ 169
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR 273
           T  GT  Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  
Sbjct: 170 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 229
Query: 274 FPNYFSXXXXXXXXXXXXXXPSGRP 298
           FP++ +              PS RP
Sbjct: 230 FPDFVTEGARDLISRLLKHNPSQRP 254

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  143 bits (361), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 79/243 (32%), Positives = 119/243 (48%), Gaps = 14/243 (5%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P+  F+I DF++ +  G G +  V  A++     + ALK++ K  + KE     ++ E  
Sbjct: 7   PKRKFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIE 66
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           +   L HP ++R++  F D   +Y+ LE    GEL+ ++   G   E  +  +  E+ DA
Sbjct: 67  IQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADA 126
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFV 216
           L Y H   +IHRDIKPENLL+   G +KIADFG SV              A   +     
Sbjct: 127 LHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVH-------------APSLRRRXMC 173
Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           GT  Y+PPE++         DLW  G   Y+ L G  PF   S     +RI+  D++FP 
Sbjct: 174 GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP 233
Query: 277 YFS 279
           + S
Sbjct: 234 FLS 236

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 81/265 (30%), Positives = 127/265 (47%), Gaps = 12/265 (4%)
Query: 34  AFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVK 93
           A  + +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++
Sbjct: 2   AMESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 61
Query: 94  LERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 153
            E  +   L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 121
Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           + +AL Y HS  +IHRDIKPENLLL + G +KIADFG       SR T            
Sbjct: 122 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------------ 169
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR 273
           T  GT  Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  
Sbjct: 170 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 229
Query: 274 FPNYFSXXXXXXXXXXXXXXPSGRP 298
           FP++ +              PS RP
Sbjct: 230 FPDFVTEGARDLISRLLKHNPSQRP 254

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 81/266 (30%), Positives = 128/266 (48%), Gaps = 14/266 (5%)
Query: 34  AFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVK 93
           A  + +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++
Sbjct: 2   AMESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 61
Query: 94  LERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 153
            E  +   L HP ++RL+  F D   +Y+ LE    GE++ ++       E     Y  E
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITE 121
Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKA 212
           + +AL Y HS  +IHRDIKPENLLL + G +KIADFG SV              A   + 
Sbjct: 122 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH-------------APSSRR 168
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI 272
               GT  Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   + 
Sbjct: 169 XXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 228
Query: 273 RFPNYFSXXXXXXXXXXXXXXPSGRP 298
            FP++ +              PS RP
Sbjct: 229 TFPDFVTEGARDLISRLLKHNPSQRP 254

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  142 bits (359), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 125/260 (48%), Gaps = 12/260 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 28  KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 87
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 88  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 147
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
            Y HS  +IHRDIKPENLLL + G +KIADFG       SR T            T  GT
Sbjct: 148 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------------TLCGT 195
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 196 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 255
Query: 279 SXXXXXXXXXXXXXXPSGRP 298
           +              PS RP
Sbjct: 256 TEGARDLISRLLKHNPSQRP 275

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  142 bits (358), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 125/260 (48%), Gaps = 12/260 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 19  KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 78
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 79  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 138
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
            Y HS  +IHRDIKPENLLL + G +KIADFG       SR T            T  GT
Sbjct: 139 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------------TLCGT 186
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 187 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 246
Query: 279 SXXXXXXXXXXXXXXPSGRP 298
           +              PS RP
Sbjct: 247 TEGARDLISRLLKHNPSQRP 266

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  142 bits (357), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 89/249 (35%), Positives = 134/249 (53%), Gaps = 23/249 (9%)
Query: 37  APQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           A  E   I ++ L K  G G+++KV  A+ + TG   A+KI+DK   T+ N T+  KL R
Sbjct: 7   ATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDK---TQLNPTSLQKLFR 63
Query: 97  IV--LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 154
            V  +  L+HP +V+LF   +   +LY+ +E   GGE+FD + + G + E EAR    ++
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 123
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           V A++Y H   ++HRD+K ENLLL  D +IKIADFG       +  TV       +K  T
Sbjct: 124 VSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGF-----SNEFTV------GNKLDT 172
Query: 215 FVGTAAYVPPEVLNS----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR 270
           F G+  Y  PE+        P     D+W+LG  LY ++SG+ PF   +   + +R++  
Sbjct: 173 FCGSPPYAAPELFQGKKYDGPEV---DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG 229
Query: 271 DIRFPNYFS 279
             R P Y S
Sbjct: 230 KYRIPFYMS 238

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  142 bits (357), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 81/261 (31%), Positives = 128/261 (49%), Gaps = 14/261 (5%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 28  KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 87
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 88  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 147
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVG 217
            Y HS  +IHRDIKPENLLL + G +KIADFG SV           P++  DD      G
Sbjct: 148 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA---------PSSRRDD----LCG 194
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
           T  Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++
Sbjct: 195 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 254
Query: 278 FSXXXXXXXXXXXXXXPSGRP 298
            +              PS RP
Sbjct: 255 VTEGARDLISRLLKHNPSQRP 275

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  141 bits (356), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 125/260 (48%), Gaps = 12/260 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 5   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 64
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 65  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 124
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
            Y HS  +IHRDIKPENLLL + G +KIADFG       SR T            T  GT
Sbjct: 125 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------------TLCGT 172
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 232
Query: 279 SXXXXXXXXXXXXXXPSGRP 298
           +              PS RP
Sbjct: 233 TEGARDLISRLLKHNPSQRP 252

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  141 bits (356), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 124/257 (48%), Gaps = 12/257 (4%)
Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
           ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +   
Sbjct: 5   WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 64
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL Y 
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           HS  +IHRDIKPENLLL + G +KIADFG       SR T            T  GT  Y
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------------TLCGTLDY 172
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 281
           +PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ +  
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG 232
Query: 282 XXXXXXXXXXXXPSGRP 298
                       PS RP
Sbjct: 233 ARDLISRLLKHNPSQRP 249

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  141 bits (356), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 90/246 (36%), Positives = 133/246 (54%), Gaps = 23/246 (9%)
Query: 40  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV- 98
           E   I ++ L K  G G+++KV  A+ I TG   A+KI+DK   T+ N T+  KL R V 
Sbjct: 7   EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDK---TQLNPTSLQKLFREVR 63
Query: 99  -LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
            +  L+HP +V+LF   +   +LY+ +E   GGE+FD + + G + E EAR    ++V A
Sbjct: 64  IMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSA 123
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           ++Y H   ++HRD+K ENLLL AD +IKIADFG       +  TV        K  TF G
Sbjct: 124 VQYCHQKRIVHRDLKAENLLLDADMNIKIADFGF-----SNEFTV------GGKLDTFCG 172
Query: 218 TAAYVPPEVLNS----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR 273
           +  Y  PE+        P     D+W+LG  LY ++SG+ PF   +   + +R++    R
Sbjct: 173 SPPYAAPELFQGKKYDGPEV---DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR 229
Query: 274 FPNYFS 279
            P Y S
Sbjct: 230 IPFYMS 235

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  141 bits (356), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 124/260 (47%), Gaps = 12/260 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 7   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 66
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 67  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 126
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
            Y HS  +IHRDIKPENLLL + G +KIADFG       SR T            T  GT
Sbjct: 127 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------------TLCGT 174
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+PPE +         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 175 LDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 234
Query: 279 SXXXXXXXXXXXXXXPSGRP 298
           +              PS RP
Sbjct: 235 TEGARDLISRLLKHNPSQRP 254

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  141 bits (355), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 125/260 (48%), Gaps = 12/260 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 6   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 65
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 66  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 125
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
            Y HS  +IHRDIKPENLLL + G +KIADFG       SR T            T  GT
Sbjct: 126 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------------TLCGT 173
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 174 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 233
Query: 279 SXXXXXXXXXXXXXXPSGRP 298
           +              PS RP
Sbjct: 234 TEGARDLISRLLKHNPSQRP 253

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  141 bits (355), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 125/260 (48%), Gaps = 12/260 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 3   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 62
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 63  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 122
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
            Y HS  +IHRDIKPENLLL + G +KIADFG       SR T            T  GT
Sbjct: 123 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRT------------TLSGT 170
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 230
Query: 279 SXXXXXXXXXXXXXXPSGRP 298
           +              PS RP
Sbjct: 231 TEGARDLISRLLKHNPSQRP 250

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 125/260 (48%), Gaps = 12/260 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 1   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 60
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 61  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 120
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
            Y HS  +IHRDIKPENLLL + G +KIADFG       SR T            T  GT
Sbjct: 121 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------------TLCGT 168
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 169 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 228
Query: 279 SXXXXXXXXXXXXXXPSGRP 298
           +              PS RP
Sbjct: 229 TEGARDLISRLLKHNPSQRP 248

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 81/261 (31%), Positives = 128/261 (49%), Gaps = 14/261 (5%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 3   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 62
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 63  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 122
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVG 217
            Y HS  +IHRDIKPENLLL + G +KIADFG SV           P++  D    T  G
Sbjct: 123 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA---------PSSRRD----TLCG 169
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
           T  Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 229
Query: 278 FSXXXXXXXXXXXXXXPSGRP 298
            +              PS RP
Sbjct: 230 VTEGARDLISRLLKHNPSQRP 250

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 125/260 (48%), Gaps = 12/260 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 5   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 64
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 65  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 124
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
            Y HS  +IHRDIKPENLLL + G +KIADFG       SR T            T  GT
Sbjct: 125 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------------TLCGT 172
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 232
Query: 279 SXXXXXXXXXXXXXXPSGRP 298
           +              PS RP
Sbjct: 233 TEGARDLISRLLKHNPSQRP 252

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  140 bits (353), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 90/264 (34%), Positives = 134/264 (50%), Gaps = 23/264 (8%)
Query: 40  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV- 98
           E   I ++ L K  G G+++KV  A+ I TG   A+KI+DK   T+ N ++  KL R V 
Sbjct: 9   EQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDK---TQLNSSSLQKLFREVR 65
Query: 99  -LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
            +  L+HP +V+LF   +   +LY+ +E   GGE+FD + + G + E EAR    ++V A
Sbjct: 66  IMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSA 125
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           ++Y H   ++HRD+K ENLLL AD +IKIADFG                   +K  TF G
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF-----------TFGNKLDTFCG 174
Query: 218 TAAYVPPEVLNS----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR 273
           +  Y  PE+        P     D+W+LG  LY ++SG+ PF   +   + +R++    R
Sbjct: 175 SPPYAAPELFQGKKYDGPEV---DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR 231
Query: 274 FPNYFSXXXXXXXXXXXXXXPSGR 297
            P Y S              PS R
Sbjct: 232 IPFYMSTDCENLLKKFLILNPSKR 255

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  140 bits (353), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 90/264 (34%), Positives = 134/264 (50%), Gaps = 23/264 (8%)
Query: 40  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV- 98
           E   I ++ L K  G G+++KV  A+ I TG   A+KI+DK   T+ N ++  KL R V 
Sbjct: 9   EQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDK---TQLNSSSLQKLFREVR 65
Query: 99  -LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
            +  L+HP +V+LF   +   +LY+ +E   GGE+FD + + G + E EAR    ++V A
Sbjct: 66  IMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSA 125
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           ++Y H   ++HRD+K ENLLL AD +IKIADFG                   +K  TF G
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF-----------TFGNKLDTFCG 174
Query: 218 TAAYVPPEVLNS----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR 273
           +  Y  PE+        P     D+W+LG  LY ++SG+ PF   +   + +R++    R
Sbjct: 175 SPPYAAPELFQGKKYDGPEV---DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR 231
Query: 274 FPNYFSXXXXXXXXXXXXXXPSGR 297
            P Y S              PS R
Sbjct: 232 IPFYMSTDCENLLKKFLILNPSKR 255

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 79/260 (30%), Positives = 125/260 (48%), Gaps = 12/260 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 4   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 63
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 64  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 123
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
            Y HS  +IHRDIKPENLLL + G +KIA+FG       SR T            T  GT
Sbjct: 124 SYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRT------------TLCGT 171
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 172 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 231
Query: 279 SXXXXXXXXXXXXXXPSGRP 298
           +              PS RP
Sbjct: 232 TEGARDLISRLLKHNPSQRP 251

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 124/257 (48%), Gaps = 12/257 (4%)
Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
           ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +   
Sbjct: 5   WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 64
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL Y 
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           HS  +IHRDIKPENLLL + G +KIADFG       SR T L             GT  Y
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTEL------------CGTLDY 172
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 281
           +PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ +  
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG 232
Query: 282 XXXXXXXXXXXXPSGRP 298
                       PS RP
Sbjct: 233 ARDLISRLLKHNPSQRP 249

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 125/260 (48%), Gaps = 12/260 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
            Y HS  +IHRDIKPENLLL + G +KIADFG       SR T L             GT
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXL------------CGT 169
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 229
Query: 279 SXXXXXXXXXXXXXXPSGRP 298
           +              PS RP
Sbjct: 230 TEGARDLISRLLKHNPSQRP 249

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 125/260 (48%), Gaps = 12/260 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 3   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 62
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 63  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 122
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
            Y HS  +IHRDIKPENLLL + G +KIADFG       SR T L             GT
Sbjct: 123 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL------------CGT 170
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 230
Query: 279 SXXXXXXXXXXXXXXPSGRP 298
           +              PS RP
Sbjct: 231 TEGARDLISRLLKHNPSQRP 250

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 81/258 (31%), Positives = 127/258 (49%), Gaps = 14/258 (5%)
Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
           ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +   
Sbjct: 8   WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 67
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL Y 
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           HS  +IHRDIKPENLLL + G +KIADFG SV           P++  DD      GT  
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA---------PSSRRDD----LCGTLD 174
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSX 280
           Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ + 
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 234
Query: 281 XXXXXXXXXXXXXPSGRP 298
                        PS RP
Sbjct: 235 GARDLISRLLKHNPSQRP 252

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  139 bits (351), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 125/260 (48%), Gaps = 12/260 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 7   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 66
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 67  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 126
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
            Y HS  +IHRDIKPENLLL + G +KIADFG       SR T L             GT
Sbjct: 127 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL------------CGT 174
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 234
Query: 279 SXXXXXXXXXXXXXXPSGRP 298
           +              PS RP
Sbjct: 235 TEGARDLISRLLKHNPSQRP 254

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  139 bits (351), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 127/261 (48%), Gaps = 14/261 (5%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           +  ++++DFE+G+  G G +  V  A++ ++  + ALK++ K  + K      ++ E  +
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
              L HP ++RL+  F D+  +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 62  QSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVG 217
            Y HS  +IHRDIKPENLLL + G +KIADFG SV              A   +     G
Sbjct: 122 SYCHSKKVIHRDIKPENLLLGSAGELKIADFGWSVH-------------APSSRRAALCG 168
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
           T  Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDF 228
Query: 278 FSXXXXXXXXXXXXXXPSGRP 298
            +              PS RP
Sbjct: 229 VTEGARDLISRLLKHNPSQRP 249

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  139 bits (351), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 79/260 (30%), Positives = 125/260 (48%), Gaps = 12/260 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 5   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 64
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 65  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 124
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
            Y HS  +IHRDIKPENLLL + G +KIA+FG       SR T            T  GT
Sbjct: 125 SYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRT------------TLCGT 172
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 232
Query: 279 SXXXXXXXXXXXXXXPSGRP 298
           +              PS RP
Sbjct: 233 TEGARDLISRLLKHNPSQRP 252

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  139 bits (351), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 125/260 (48%), Gaps = 12/260 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
            Y HS  +IHRDIKPENLLL + G +KIADFG       SR T L             GT
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL------------CGT 169
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 229
Query: 279 SXXXXXXXXXXXXXXPSGRP 298
           +              PS RP
Sbjct: 230 TEGARDLISRLLKHNPSQRP 249

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  139 bits (351), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 125/260 (48%), Gaps = 12/260 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
            Y HS  +IHRDIKPENLLL + G +KIADFG       SR T L             GT
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL------------CGT 169
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 229
Query: 279 SXXXXXXXXXXXXXXPSGRP 298
           +              PS RP
Sbjct: 230 TEGARDLISRLLKHNPSQRP 249

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  139 bits (351), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 134/264 (50%), Gaps = 23/264 (8%)
Query: 40  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV- 98
           E   I ++ L K  G G+++KV  A+ I TG   A++I+DK   T+ N ++  KL R V 
Sbjct: 9   EQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDK---TQLNSSSLQKLFREVR 65
Query: 99  -LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
            +  L+HP +V+LF   +   +LY+ +E   GGE+FD + + G + E EAR    ++V A
Sbjct: 66  IMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSA 125
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           ++Y H   ++HRD+K ENLLL AD +IKIADFG                   +K  TF G
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF-----------TFGNKLDTFCG 174
Query: 218 TAAYVPPEVLNS----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR 273
           +  Y  PE+        P     D+W+LG  LY ++SG+ PF   +   + +R++    R
Sbjct: 175 SPPYAAPELFQGKKYDGPEV---DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR 231
Query: 274 FPNYFSXXXXXXXXXXXXXXPSGR 297
            P Y S              PS R
Sbjct: 232 IPFYMSTDCENLLKKFLILNPSKR 255

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 79/258 (30%), Positives = 124/258 (48%), Gaps = 14/258 (5%)
Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
           ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +   
Sbjct: 8   WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 67
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL Y 
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           HS  +IHRDIKPENLLL + G +KIADFG SV              A   +     GT  
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVH-------------APSSRRAALCGTLD 174
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSX 280
           Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ + 
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 234
Query: 281 XXXXXXXXXXXXXPSGRP 298
                        PS RP
Sbjct: 235 GARDLISRLLKHNPSQRP 252

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 123/257 (47%), Gaps = 12/257 (4%)
Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
           ++++DFE+G+  G G +  V  A++     + ALK++ K  + K      ++ E  +   
Sbjct: 2   WALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 61
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL Y 
Sbjct: 62  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 121
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           HS  +IHRDIKPENLLL + G +KIADFG       SR T            T  GT  Y
Sbjct: 122 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------------TLCGTLDY 169
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 281
           +PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ +  
Sbjct: 170 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG 229
Query: 282 XXXXXXXXXXXXPSGRP 298
                       PS RP
Sbjct: 230 ARDLISRLLKHNPSQRP 246

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  139 bits (350), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 80/231 (34%), Positives = 128/231 (55%), Gaps = 16/231 (6%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           FE  +  G G++S+VV A++  TG ++A+K + KK +  + K + ++ E  VL ++ H  
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKAL--KGKESSIENEIAVLRKIKHEN 81
Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           +V L   ++    LY+ ++   GGELFD+I  KG  +E +A     +V+DA+ Y+H MG+
Sbjct: 82  IVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGI 141
Query: 167 IHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +HRD+KPENLL  +   +  I I+DFG  K M+             D   T  GT  YV 
Sbjct: 142 VHRDLKPENLLYYSQDEESKIMISDFGLSK-ME----------GKGDVMSTACGTPGYVA 190
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF 274
           PEVL   P +   D W++G   Y +L G  PF D ++  +F++I+  +  F
Sbjct: 191 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEF 241

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 89/246 (36%), Positives = 131/246 (53%), Gaps = 23/246 (9%)
Query: 40  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV- 98
           E   I ++ L K  G G+++KV  A+ I TG   A+KI+DK   T+ N T+  KL R V 
Sbjct: 10  EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDK---TQLNPTSLQKLFREVR 66
Query: 99  -LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
            +  L+HP +V+LF   +   +LY+ +E   GGE+FD + + G + E EAR    ++V A
Sbjct: 67  IMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSA 126
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           ++Y H   ++HRD+K ENLLL AD +IKIADFG       +  TV        K   F G
Sbjct: 127 VQYCHQKRIVHRDLKAENLLLDADMNIKIADFGF-----SNEFTV------GGKLDAFCG 175
Query: 218 TAAYVPPEVLNS----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR 273
              Y  PE+        P     D+W+LG  LY ++SG+ PF   +   + +R++    R
Sbjct: 176 APPYAAPELFQGKKYDGPEV---DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR 232
Query: 274 FPNYFS 279
            P Y S
Sbjct: 233 IPFYMS 238

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 79/260 (30%), Positives = 124/260 (47%), Gaps = 12/260 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 4   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 63
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 64  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 123
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
            Y HS  +IHRDIKPENLLL + G +KIADFG       SR   L             GT
Sbjct: 124 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXL------------CGT 171
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 172 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 231
Query: 279 SXXXXXXXXXXXXXXPSGRP 298
           +              PS RP
Sbjct: 232 TEGARDLISRLLKHNPSQRP 251

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 125/261 (47%), Gaps = 14/261 (5%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVG 217
            Y HS  +IHRDIKPENLLL + G +KIADFG SV              A   +     G
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH-------------APSSRRAALCG 168
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
           T  Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 228
Query: 278 FSXXXXXXXXXXXXXXPSGRP 298
            +              PS RP
Sbjct: 229 VTEGARDLISRLLKHNPSQRP 249

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  139 bits (349), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 89/262 (33%), Positives = 133/262 (50%), Gaps = 23/262 (8%)
Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV--L 99
             I ++ L K  G G+++KV  A+ I TG   A+KI+DK   T+ N ++  KL R V  +
Sbjct: 4   LHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDK---TQLNSSSLQKLFREVRIM 60
Query: 100 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 159
             L+HP +V+LF   +   +LY+ +E   GGE+FD + + G + E EAR    ++V A++
Sbjct: 61  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQ 120
Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           Y H   ++HRD+K ENLLL AD +IKIADFG                   +K  TF G+ 
Sbjct: 121 YCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF-----------TFGNKLDTFCGSP 169
Query: 220 AYVPPEVLNS----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP 275
            Y  PE+        P     D+W+LG  LY ++SG+ PF   +   + +R++    R P
Sbjct: 170 PYAAPELFQGKKYDGPEV---DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP 226
Query: 276 NYFSXXXXXXXXXXXXXXPSGR 297
            Y S              PS R
Sbjct: 227 FYMSTDCENLLKKFLILNPSKR 248

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  138 bits (347), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 125/261 (47%), Gaps = 14/261 (5%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 5   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 64
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 65  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 124
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVG 217
            Y HS  +IHRDIKPENLLL + G +KIADFG SV              A   +     G
Sbjct: 125 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH-------------APSSRRXXLCG 171
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
           T  Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 231
Query: 278 FSXXXXXXXXXXXXXXPSGRP 298
            +              PS RP
Sbjct: 232 VTEGARDLISRLLKHNPSQRP 252

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  138 bits (347), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 132/264 (50%), Gaps = 23/264 (8%)
Query: 40  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV- 98
           E   I ++ L K  G G+++KV  A+ I TG   A+KI+DK   T+ N ++  KL R V 
Sbjct: 9   EQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDK---TQLNSSSLQKLFREVR 65
Query: 99  -LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
            +  L+HP +V+LF   +   +LY+ +E   GGE+FD + + G + E EAR    ++V A
Sbjct: 66  IMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSA 125
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           ++Y H   ++HRD+K ENLLL AD +IKIADFG                   +K   F G
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF-----------TFGNKLDAFCG 174
Query: 218 TAAYVPPEVLNS----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR 273
              Y  PE+        P     D+W+LG  LY ++SG+ PF   +   + +R++    R
Sbjct: 175 APPYAAPELFQGKKYDGPEV---DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR 231
Query: 274 FPNYFSXXXXXXXXXXXXXXPSGR 297
            P Y S              PS R
Sbjct: 232 IPFYMSTDCENLLKKFLILNPSKR 255

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  138 bits (347), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 125/261 (47%), Gaps = 14/261 (5%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVG 217
            Y HS  +IHRDIKPENLLL + G +KIADFG SV              A   +     G
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH-------------APSSRRXXLCG 168
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
           T  Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 228
Query: 278 FSXXXXXXXXXXXXXXPSGRP 298
            +              PS RP
Sbjct: 229 VTEGARDLISRLLKHNPSQRP 249

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 81/231 (35%), Positives = 129/231 (55%), Gaps = 16/231 (6%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           ++   + G G++S+V+ A+   T  + A+K + KK +  E K   ++ E  VL ++ HP 
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKHPN 77
Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           +V L   ++    LY+ ++   GGELFD+I  KG  +E +A     +V+DA++Y+H +G+
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 167 IHRDIKPENLL---LTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +HRD+KPENLL   L  D  I I+DFG  K M+D   +VL  A          GT  YV 
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPG-SVLSTAC---------GTPGYVA 186
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF 274
           PEVL   P +   D W++G   Y +L G  PF D ++  +F++I+  +  F
Sbjct: 187 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF 237

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 88/264 (33%), Positives = 133/264 (50%), Gaps = 23/264 (8%)
Query: 40  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV- 98
           E   I ++ L K  G G+++KV  A+ I TG   A++I+DK   T+ N ++  KL R V 
Sbjct: 9   EQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDK---TQLNSSSLQKLFREVR 65
Query: 99  -LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
            +  L+HP +V+LF   +   +LY+ +E   GGE+FD + + G + E EAR    ++V A
Sbjct: 66  IMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSA 125
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           ++Y H   ++HRD+K ENLLL AD +IKIADFG                   +K   F G
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF-----------TFGNKLDEFCG 174
Query: 218 TAAYVPPEVLNS----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR 273
           +  Y  PE+        P     D+W+LG  LY ++SG+ PF   +   + +R++    R
Sbjct: 175 SPPYAAPELFQGKKYDGPEV---DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR 231
Query: 274 FPNYFSXXXXXXXXXXXXXXPSGR 297
            P Y S              PS R
Sbjct: 232 IPFYMSTDCENLLKKFLILNPSKR 255

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 75/241 (31%), Positives = 122/241 (50%), Gaps = 12/241 (4%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           +  ++++DF++G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 6   KRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEI 65
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 66  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANAL 125
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
            Y HS  +IHRDIKPENLLL ++G +KIADFG       SR T            T  GT
Sbjct: 126 SYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRT------------TLCGT 173
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ 
Sbjct: 174 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFV 233
Query: 279 S 279
           +
Sbjct: 234 T 234

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 83/236 (35%), Positives = 120/236 (50%), Gaps = 14/236 (5%)
Query: 41  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 100
           HF+I DFE+G+  G G +  V  A++  +  + ALK++ K  I KE     ++ E  +  
Sbjct: 19  HFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQA 78
Query: 101 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
            L HP ++RL+  F D   +Y+ LE    GEL+ ++       E        E+ DAL Y
Sbjct: 79  HLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMY 138
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H   +IHRDIKPENLLL   G +KIADFG SV              A   +  T  GT 
Sbjct: 139 CHGKKVIHRDIKPENLLLGLKGELKIADFGWSVH-------------APSLRRKTMCGTL 185
Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP 275
            Y+PPE++         DLW +G   Y++L G  PF+  S    ++RI+  D++FP
Sbjct: 186 DYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFP 241

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 76/242 (31%), Positives = 125/242 (51%), Gaps = 14/242 (5%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           +  ++++DF++G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +
Sbjct: 6   KRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEI 65
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
              L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL
Sbjct: 66  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANAL 125
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVG 217
            Y HS  +IHRDIKPENLLL ++G +KIADFG SV           P++  D    T  G
Sbjct: 126 SYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHA---------PSSRRD----TLCG 172
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
           T  Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++
Sbjct: 173 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDF 232
Query: 278 FS 279
            +
Sbjct: 233 VT 234

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 80/231 (34%), Positives = 129/231 (55%), Gaps = 16/231 (6%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           ++   + G G++S+V+ A+   T  + A+K + K+ +  E K   ++ E  VL ++ HP 
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEAL--EGKEGSMENEIAVLHKIKHPN 77
Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           +V L   ++    LY+ ++   GGELFD+I  KG  +E +A     +V+DA++Y+H +G+
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 167 IHRDIKPENLL---LTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +HRD+KPENLL   L  D  I I+DFG  K M+D   +VL  A          GT  YV 
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPG-SVLSTAC---------GTPGYVA 186
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF 274
           PEVL   P +   D W++G   Y +L G  PF D ++  +F++I+  +  F
Sbjct: 187 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF 237

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  135 bits (340), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 80/231 (34%), Positives = 129/231 (55%), Gaps = 16/231 (6%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           ++   + G G++S+V+ A+   T  + A+K + K+ +  E K   ++ E  VL ++ HP 
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEAL--EGKEGSMENEIAVLHKIKHPN 77
Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           +V L   ++    LY+ ++   GGELFD+I  KG  +E +A     +V+DA++Y+H +G+
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 167 IHRDIKPENLL---LTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +HRD+KPENLL   L  D  I I+DFG  K M+D   +VL  A          GT  YV 
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPG-SVLSTAC---------GTPGYVA 186
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF 274
           PEVL   P +   D W++G   Y +L G  PF D ++  +F++I+  +  F
Sbjct: 187 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF 237

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  135 bits (340), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 118/219 (53%), Gaps = 14/219 (6%)
Query: 40  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL 99
           E  +   FE+ +  G GS+ KV   +K DT  +YA+K M+K+   + N+   V  E  ++
Sbjct: 10  EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIM 69
Query: 100 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 159
             L+HP +V L+++FQD   ++M ++   GG+L   +    H  E+  + +  E+V AL+
Sbjct: 70  QGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALD 129
Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           Y+ +  +IHRD+KP+N+LL   GH+ I DF            +LP    + +  T  GT 
Sbjct: 130 YLQNQRIIHRDMKPDNILLDEHGHVHITDFNIA--------AMLP---RETQITTMAGTK 178
Query: 220 AYVPPEVLNSSPA---TFGNDLWALGCTLYQMLSGTSPF 255
            Y+ PE+ +S      +F  D W+LG T Y++L G  P+
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY 217

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  135 bits (340), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 80/231 (34%), Positives = 129/231 (55%), Gaps = 16/231 (6%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           ++   + G G++S+V+ A+   T  + A+K + K+ +  E K   ++ E  VL ++ HP 
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEAL--EGKEGSMENEIAVLHKIKHPN 77
Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           +V L   ++    LY+ ++   GGELFD+I  KG  +E +A     +V+DA++Y+H +G+
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 167 IHRDIKPENLL---LTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +HRD+KPENLL   L  D  I I+DFG  K M+D   +VL  A          GT  YV 
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPG-SVLSTAC---------GTPGYVA 186
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF 274
           PEVL   P +   D W++G   Y +L G  PF D ++  +F++I+  +  F
Sbjct: 187 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF 237

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 129/264 (48%), Gaps = 23/264 (8%)
Query: 40  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV- 98
           E   I ++ L K  G G+++KV  A+ I TG   A+KI+DK   T+ N ++  KL R V 
Sbjct: 9   EQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDK---TQLNSSSLQKLFREVR 65
Query: 99  -LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
               L+HP +V+LF   +   +LY+  E   GGE+FD + + G   E EAR    ++V A
Sbjct: 66  IXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSA 125
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           ++Y H   ++HRD+K ENLLL AD +IKIADFG                   +K   F G
Sbjct: 126 VQYCHQKFIVHRDLKAENLLLDADXNIKIADFGFSNEF-----------TFGNKLDAFCG 174
Query: 218 TAAYVPPEVLNS----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR 273
              Y  PE+        P     D+W+LG  LY ++SG+ PF   +   + +R++    R
Sbjct: 175 APPYAAPELFQGKKYDGPEV---DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR 231
Query: 274 FPNYFSXXXXXXXXXXXXXXPSGR 297
            P Y S              PS R
Sbjct: 232 IPFYXSTDCENLLKKFLILNPSKR 255

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 78/219 (35%), Positives = 119/219 (54%), Gaps = 16/219 (7%)
Query: 52  IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLF 111
           + G GS+ +V++ K   T   YA+K+++K    K   T+ +  E  +L +LDHP +++LF
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKA-SAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 112 FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDI 171
              +D+ S Y+  E   GGELFD+I  +   SE +A     +V   + Y+H   ++HRD+
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDL 147
Query: 172 KPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN 228
           KPEN+LL +   D  IKI DFG     Q        N    D+    +GTA Y+ PEVL 
Sbjct: 148 KPENILLESKEKDCDIKIIDFGLSTCFQ-------QNTKMKDR----IGTAYYIAPEVLR 196
Query: 229 SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
            +      D+W+ G  LY +LSGT PF   +E+ I +R+
Sbjct: 197 GTYDE-KCDVWSAGVILYILLSGTPPFYGKNEYDILKRV 234

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 74/220 (33%), Positives = 121/220 (55%), Gaps = 15/220 (6%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           ++ G GS+ +V+  K   TG   A+K++ K+ + ++     +  E  +L QLDHP +++L
Sbjct: 55  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 114
Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 170
           +  F+D    Y+  E   GGELFD+I S+   SE +A     +V+  + Y+H   ++HRD
Sbjct: 115 YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRD 174
Query: 171 IKPENLLL---TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 227
           +KPENLLL   + D +I+I DFG     + S+           K    +GTA Y+ PEVL
Sbjct: 175 LKPENLLLESKSKDANIRIIDFGLSTHFEASK-----------KMKDKIGTAYYIAPEVL 223
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
           + +      D+W+ G  LY +LSG  PF   +E+ I +++
Sbjct: 224 HGTYDE-KCDVWSTGVILYILLSGCPPFNGANEYDILKKV 262

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 74/220 (33%), Positives = 121/220 (55%), Gaps = 15/220 (6%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           ++ G GS+ +V+  K   TG   A+K++ K+ + ++     +  E  +L QLDHP +++L
Sbjct: 56  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 115
Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 170
           +  F+D    Y+  E   GGELFD+I S+   SE +A     +V+  + Y+H   ++HRD
Sbjct: 116 YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRD 175
Query: 171 IKPENLLL---TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 227
           +KPENLLL   + D +I+I DFG     + S+           K    +GTA Y+ PEVL
Sbjct: 176 LKPENLLLESKSKDANIRIIDFGLSTHFEASK-----------KMKDKIGTAYYIAPEVL 224
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
           + +      D+W+ G  LY +LSG  PF   +E+ I +++
Sbjct: 225 HGTYDE-KCDVWSTGVILYILLSGCPPFNGANEYDILKKV 263

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 74/220 (33%), Positives = 121/220 (55%), Gaps = 15/220 (6%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           ++ G GS+ +V+  K   TG   A+K++ K+ + ++     +  E  +L QLDHP +++L
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 170
           +  F+D    Y+  E   GGELFD+I S+   SE +A     +V+  + Y+H   ++HRD
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRD 151
Query: 171 IKPENLLL---TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 227
           +KPENLLL   + D +I+I DFG     + S+           K    +GTA Y+ PEVL
Sbjct: 152 LKPENLLLESKSKDANIRIIDFGLSTHFEASK-----------KMKDKIGTAYYIAPEVL 200
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
           + +      D+W+ G  LY +LSG  PF   +E+ I +++
Sbjct: 201 HGTYDE-KCDVWSTGVILYILLSGCPPFNGANEYDILKKV 239

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 75/220 (34%), Positives = 122/220 (55%), Gaps = 15/220 (6%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           ++ G GS+ +V+  K   TG   A+K++ K+ + ++     +  E  +L QLDHP +++L
Sbjct: 38  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 97
Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 170
           +  F+D    Y+  E   GGELFD+I S+   SE +A     +V+  + Y+H   ++HRD
Sbjct: 98  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRD 157
Query: 171 IKPENLLL---TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 227
           +KPENLLL   + D +I+I DFG     + S+          DK    +GTA Y+ PEVL
Sbjct: 158 LKPENLLLESKSKDANIRIIDFGLSTHFEASK-------KMKDK----IGTAYYIAPEVL 206
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
           + +      D+W+ G  LY +LSG  PF   +E+ I +++
Sbjct: 207 HGTYDE-KCDVWSTGVILYILLSGCPPFNGANEYDILKKV 245

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 78/217 (35%), Positives = 118/217 (54%), Gaps = 16/217 (7%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS+ +V++ K   T   YA+K+++K    K   T+ +  E  +L +LDHP +++LF  
Sbjct: 31  GKGSFGEVLKCKDRITQQEYAVKVINKA-SAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
            +D+ S Y+  E   GGELFD+I  +   SE +A     +V   + Y+H   ++HRD+KP
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKP 149
Query: 174 ENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 230
           EN+LL +   D  IKI DFG     Q        N    D+    +GTA Y+ PEVL  +
Sbjct: 150 ENILLESKEKDCDIKIIDFGLSTCFQQ-------NTKMKDR----IGTAYYIAPEVLRGT 198
Query: 231 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
                 D+W+ G  LY +LSGT PF   +E+ I +R+
Sbjct: 199 YDE-KCDVWSAGVILYILLSGTPPFYGKNEYDILKRV 234

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 78/217 (35%), Positives = 118/217 (54%), Gaps = 16/217 (7%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS+ +V++ K   T   YA+K+++K    K   T+ +  E  +L +LDHP +++LF  
Sbjct: 31  GKGSFGEVLKCKDRITQQEYAVKVINKA-SAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
            +D+ S Y+  E   GGELFD+I  +   SE +A     +V   + Y+H   ++HRD+KP
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKP 149
Query: 174 ENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 230
           EN+LL +   D  IKI DFG     Q        N    D+    +GTA Y+ PEVL  +
Sbjct: 150 ENILLESKEKDCDIKIIDFGLSTCFQQ-------NTKMKDR----IGTAYYIAPEVLRGT 198
Query: 231 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
                 D+W+ G  LY +LSGT PF   +E+ I +R+
Sbjct: 199 YDE-KCDVWSAGVILYILLSGTPPFYGKNEYDILKRV 234

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 78/236 (33%), Positives = 117/236 (49%), Gaps = 11/236 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           I ++++ K  G GS+ KV  A    TG   ALKI++KK + K +    ++ E   L  L 
Sbjct: 13  IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 72
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +++L+   +    + M +E   G ELFD I  +  +SE EAR +  +++ A+EY H 
Sbjct: 73  HPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 131
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
             ++HRD+KPENLLL    ++KIADFG    M D         + +  A   +    Y  
Sbjct: 132 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 191
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS 279
           PEV          D+W+ G  LY ML    PF D S  ++F+ I       P + S
Sbjct: 192 PEV----------DVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLS 237

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 78/236 (33%), Positives = 117/236 (49%), Gaps = 11/236 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           I ++++ K  G GS+ KV  A    TG   ALKI++KK + K +    ++ E   L  L 
Sbjct: 12  IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 71
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +++L+   +    + M +E   G ELFD I  +  +SE EAR +  +++ A+EY H 
Sbjct: 72  HPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 130
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
             ++HRD+KPENLLL    ++KIADFG    M D         + +  A   +    Y  
Sbjct: 131 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 190
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS 279
           PEV          D+W+ G  LY ML    PF D S  ++F+ I       P + S
Sbjct: 191 PEV----------DVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLS 236

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 80/237 (33%), Positives = 126/237 (53%), Gaps = 20/237 (8%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER--IVLDQLD 103
           +++L +  G G++S V R  KI TG  YA KI++ K ++  +   + KLER   +   L 
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARD---HQKLEREARICRLLK 61
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +VRL  +  +    Y+  +   GGELF+ I ++ + SE +A     ++++++ + H 
Sbjct: 62  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHL 121
Query: 164 MGLIHRDIKPENLLLTAD---GHIKIADFGSVKPMQDSRITVLPNAASDDKAC-TFVGTA 219
            G++HRD+KPENLLL +      +K+ADFG    +Q            D +A   F GT 
Sbjct: 122 NGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQ-----------GDQQAWFGFAGTP 170
Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
            Y+ PEVL   P     D+WA G  LY +L G  PF D  +  ++Q+I A    FP+
Sbjct: 171 GYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPS 227

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  129 bits (324), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 78/236 (33%), Positives = 117/236 (49%), Gaps = 11/236 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           I ++++ K  G GS+ KV  A    TG   ALKI++KK + K +    ++ E   L  L 
Sbjct: 3   IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 62
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +++L+   +    + M +E   G ELFD I  +  +SE EAR +  +++ A+EY H 
Sbjct: 63  HPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 121
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
             ++HRD+KPENLLL    ++KIADFG    M D         + +  A   +    Y  
Sbjct: 122 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 181
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS 279
           PEV          D+W+ G  LY ML    PF D S  ++F+ I       P + S
Sbjct: 182 PEV----------DVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLS 227

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  129 bits (324), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 78/236 (33%), Positives = 117/236 (49%), Gaps = 11/236 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           I ++++ K  G GS+ KV  A    TG   ALKI++KK + K +    ++ E   L  L 
Sbjct: 7   IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 66
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +++L+   +    + M +E   G ELFD I  +  +SE EAR +  +++ A+EY H 
Sbjct: 67  HPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 125
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
             ++HRD+KPENLLL    ++KIADFG    M D         + +  A   +    Y  
Sbjct: 126 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 185
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS 279
           PEV          D+W+ G  LY ML    PF D S  ++F+ I       P + S
Sbjct: 186 PEV----------DVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLS 231

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  129 bits (323), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 80/237 (33%), Positives = 126/237 (53%), Gaps = 20/237 (8%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER--IVLDQLD 103
           +++L +  G G++S V R  KI TG  YA KI++ K ++  +   + KLER   +   L 
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARD---HQKLEREARICRLLK 61
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +VRL  +  +    Y+  +   GGELF+ I ++ + SE +A     ++++++ + H 
Sbjct: 62  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHL 121
Query: 164 MGLIHRDIKPENLLLTAD---GHIKIADFGSVKPMQDSRITVLPNAASDDKAC-TFVGTA 219
            G++HRD+KPENLLL +      +K+ADFG    +Q            D +A   F GT 
Sbjct: 122 NGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQ-----------GDQQAWFGFAGTP 170
Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
            Y+ PEVL   P     D+WA G  LY +L G  PF D  +  ++Q+I A    FP+
Sbjct: 171 GYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPS 227

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  129 bits (323), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 74/220 (33%), Positives = 119/220 (54%), Gaps = 15/220 (6%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           ++ G GS+ +V+  K   TG   A+K++ K+ + ++     +  E  +L QLDHP + +L
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKL 91
Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 170
           +  F+D    Y+  E   GGELFD+I S+   SE +A     +V+  + Y H   ++HRD
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNKIVHRD 151
Query: 171 IKPENLLL---TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 227
           +KPENLLL   + D +I+I DFG     + S+           K    +GTA Y+ PEVL
Sbjct: 152 LKPENLLLESKSKDANIRIIDFGLSTHFEASK-----------KXKDKIGTAYYIAPEVL 200
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
           + +      D+W+ G  LY +LSG  PF   +E+ I +++
Sbjct: 201 HGTYDE-KCDVWSTGVILYILLSGCPPFNGANEYDILKKV 239

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  128 bits (322), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 88/264 (33%), Positives = 127/264 (48%), Gaps = 44/264 (16%)
Query: 41  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE-------------- 86
            ++++D E+GK    GSY  V  A   +  T YA+K++ KK + ++              
Sbjct: 14  QYTLKD-EIGK----GSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRP 68
Query: 87  ---------NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS--LYMALESCEGGELFDQ 135
                         V  E  +L +LDHP VV+L     D     LYM  E    G + + 
Sbjct: 69  APGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV 128
Query: 136 ITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM 195
            T K  LSED+ARFY  +++  +EY+H   +IHRDIKP NLL+  DGHIKIADFG     
Sbjct: 129 PTLKP-LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187
Query: 196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGN---DLWALGCTLYQMLSGT 252
           +           SD      VGT A++ PE L+ +   F     D+WA+G TLY  + G 
Sbjct: 188 K----------GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
Query: 253 SPFKDTSEWLIFQRIIARDIRFPN 276
            PF D     +  +I ++ + FP+
Sbjct: 238 CPFMDERIMCLHSKIKSQALEFPD 261

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  128 bits (321), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 78/235 (33%), Positives = 123/235 (52%), Gaps = 18/235 (7%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER--IVLDQLDH 104
           ++L +  G G++S V R  K+  G  YA KI++ K ++  +   + KLER   +   L H
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARD---HQKLEREARICRLLKH 80
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P +VRL  +  +    Y+  +   GGELF+ I ++ + SE +A     ++++A+ + H M
Sbjct: 81  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 140
Query: 165 GLIHRDIKPENLLLTAD---GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           G++HRD+KPENLLL +      +K+ADFG    ++  +               F GT  Y
Sbjct: 141 GVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF----------GFAGTPGY 190
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           + PEVL   P     DLWA G  LY +L G  PF D  +  ++Q+I A    FP+
Sbjct: 191 LSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPS 245

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 75/236 (31%), Positives = 125/236 (52%), Gaps = 19/236 (8%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER--IVLDQLD 103
           ++++ +  G G++S V R     TG  +A KI++ K ++  +   + KLER   +  +L 
Sbjct: 30  NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD---FQKLEREARICRKLQ 86
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +VRL  + Q+    Y+  +   GGELF+ I ++   SE +A     ++++++ Y HS
Sbjct: 87  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 146
Query: 164 MGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
            G++HR++KPENLLL +      +K+ADFG    + DS           +    F GT  
Sbjct: 147 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-----------EAWHGFAGTPG 195
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           Y+ PEVL   P +   D+WA G  LY +L G  PF D  +  ++ +I A    +P+
Sbjct: 196 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS 251

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 75/236 (31%), Positives = 113/236 (47%), Gaps = 10/236 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           I  + LG   GVG++ KV   +   TG   A+KI++++ I   +    +K E   L    
Sbjct: 10  IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR 69
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +++L+         +M +E   GGELFD I   G + E EAR    +++ A++Y H 
Sbjct: 70  HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR 129
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
             ++HRD+KPEN+LL A  + KIADFG    M D         + +  A   +    Y  
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAG 189
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS 279
           PEV          D+W+ G  LY +L GT PF D     +F++I       P Y +
Sbjct: 190 PEV----------DIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLN 235

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 75/236 (31%), Positives = 125/236 (52%), Gaps = 19/236 (8%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER--IVLDQLD 103
           ++++ +  G G++S V R     TG  +A KI++ K ++  +   + KLER   +  +L 
Sbjct: 6   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD---FQKLEREARICRKLQ 62
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +VRL  + Q+    Y+  +   GGELF+ I ++   SE +A     ++++++ Y HS
Sbjct: 63  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 122
Query: 164 MGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
            G++HR++KPENLLL +      +K+ADFG    + DS           +    F GT  
Sbjct: 123 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-----------EAWHGFAGTPG 171
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           Y+ PEVL   P +   D+WA G  LY +L G  PF D  +  ++ +I A    +P+
Sbjct: 172 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS 227

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 75/236 (31%), Positives = 125/236 (52%), Gaps = 19/236 (8%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER--IVLDQLD 103
           ++++ +  G G++S V R     TG  +A KI++ K ++  +   + KLER   +  +L 
Sbjct: 7   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD---FQKLEREARICRKLQ 63
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +VRL  + Q+    Y+  +   GGELF+ I ++   SE +A     ++++++ Y HS
Sbjct: 64  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 123
Query: 164 MGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
            G++HR++KPENLLL +      +K+ADFG    + DS           +    F GT  
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-----------EAWHGFAGTPG 172
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           Y+ PEVL   P +   D+WA G  LY +L G  PF D  +  ++ +I A    +P+
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS 228

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 75/217 (34%), Positives = 113/217 (52%), Gaps = 15/217 (6%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G+Y +V+  K   TG   A+KI+ K  +T  + +  +  E  VL QLDHP +++L+  
Sbjct: 30  GSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEF 89
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           F+D  + Y+ +E   GGELFD+I  +   SE +A     +V+    Y+H   ++HRD+KP
Sbjct: 90  FEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKP 149
Query: 174 ENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 230
           ENLLL +   D  IKI DFG           +  +     K    +GTA Y+ PEVL   
Sbjct: 150 ENLLLESKSRDALIKIVDFG-----------LSAHFEVGGKMKERLGTAYYIAPEVLRKK 198
Query: 231 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
                 D+W+ G  LY +L G  PF   ++  I +R+
Sbjct: 199 YDE-KCDVWSCGVILYILLCGYPPFGGQTDQEILKRV 234

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 75/236 (31%), Positives = 113/236 (47%), Gaps = 10/236 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           I  + LG   GVG++ KV   +   TG   A+KI++++ I   +    +K E   L    
Sbjct: 10  IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR 69
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +++L+         +M +E   GGELFD I   G + E EAR    +++ A++Y H 
Sbjct: 70  HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR 129
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
             ++HRD+KPEN+LL A  + KIADFG    M D         + +  A   +    Y  
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAG 189
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS 279
           PEV          D+W+ G  LY +L GT PF D     +F++I       P Y +
Sbjct: 190 PEV----------DIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLN 235

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 75/236 (31%), Positives = 125/236 (52%), Gaps = 19/236 (8%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER--IVLDQLD 103
           ++++ +  G G++S V R     TG  +A KI++ K ++  +   + KLER   +  +L 
Sbjct: 7   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD---FQKLEREARICRKLQ 63
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +VRL  + Q+    Y+  +   GGELF+ I ++   SE +A     ++++++ Y HS
Sbjct: 64  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 123
Query: 164 MGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
            G++HR++KPENLLL +      +K+ADFG    + DS           +    F GT  
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-----------EAWHGFAGTPG 172
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           Y+ PEVL   P +   D+WA G  LY +L G  PF D  +  ++ +I A    +P+
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS 228

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 80/232 (34%), Positives = 121/232 (52%), Gaps = 20/232 (8%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           FE+    G G+ S V R K+  T   YALK++ KK + K+     V+ E  VL +L HP 
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVL-KKTVDKK----IVRTEIGVLLRLSHPN 109
Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           +++L   F+    + + LE   GGELFD+I  KG+ SE +A     ++++A+ Y+H  G+
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGI 169
Query: 167 IHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +HRD+KPENLL      D  +KIADFG  K ++   +             T  GT  Y  
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK-----------TVCGTPGYCA 218
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT-SEWLIFQRIIARDIRF 274
           PE+L         D+W++G   Y +L G  PF D   +  +F+RI+  +  F
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYF 270

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 76/220 (34%), Positives = 114/220 (51%), Gaps = 15/220 (6%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           K  G G+Y +V+  K   TG   A+KI+ K  +T  + +  +  E  VL QLDHP +++L
Sbjct: 10  KKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 69
Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 170
           +  F+D  + Y+ +E   GGELFD+I  +   SE +A     +V+    Y+H   ++HRD
Sbjct: 70  YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRD 129
Query: 171 IKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 227
           +KPENLLL +   D  IKI DFG           +  +     K    +GTA Y+ PEVL
Sbjct: 130 LKPENLLLESKSRDALIKIVDFG-----------LSAHFEVGGKMKERLGTAYYIAPEVL 178
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
                    D+W+ G  LY +L G  PF   ++  I +R+
Sbjct: 179 RKKYDE-KCDVWSCGVILYILLCGYPPFGGQTDQEILKRV 217

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 76/237 (32%), Positives = 124/237 (52%), Gaps = 18/237 (7%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER--IVLDQL 102
           ++++L +  G G++S V R  K+  G  YA  I++ K ++  +   + KLER   +   L
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD---HQKLEREARICRLL 67
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP +VRL  +  +    Y+  +   GGELF+ I ++ + SE +A     ++++A+ + H
Sbjct: 68  KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH 127
Query: 163 SMGLIHRDIKPENLLLTAD---GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            MG++HR++KPENLLL +      +K+ADFG    ++  +               F GT 
Sbjct: 128 QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF----------GFAGTP 177
Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
            Y+ PEVL   P     DLWA G  LY +L G  PF D  +  ++Q+I A    FP+
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPS 234

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  125 bits (313), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 74/236 (31%), Positives = 113/236 (47%), Gaps = 10/236 (4%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           I  + LG   GVG++ KV   K   TG   A+KI++++ I   +    ++ E   L    
Sbjct: 15  IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR 74
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +++L+        ++M +E   GGELFD I   G L E E+R    +++  ++Y H 
Sbjct: 75  HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHR 134
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
             ++HRD+KPEN+LL A  + KIADFG    M D         + +  A   +    Y  
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAG 194
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS 279
           PEV          D+W+ G  LY +L GT PF D     +F++I       P Y +
Sbjct: 195 PEV----------DIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLN 240

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score =  125 bits (313), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 88/295 (29%), Positives = 142/295 (48%), Gaps = 18/295 (6%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           F   ++ G G + +V   +   TG +YA K ++KK I K    A    E+ +L++++   
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEAR--FYTAEVVDALEYIHSM 164
           VV L + ++   +L + L    GG+L   I   G     EAR  FY AE+   LE +H  
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
            +++RD+KPEN+LL   GHI+I+D G            +P   +       VGT  Y+ P
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLA--------VHVPEGQTIKGR---VGTVGYMAP 354
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI--IARDI--RFPNYFSX 280
           EV+ +   TF  D WALGC LY+M++G SPF+   + +  + +  + +++   +   FS 
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSP 414
Query: 281 XXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI-RGQTPPKLASEP 334
                        P+ R G   G    +K HP FK +++K +  G   P    +P
Sbjct: 415 QARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDP 469

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score =  124 bits (312), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 88/295 (29%), Positives = 142/295 (48%), Gaps = 18/295 (6%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           F   ++ G G + +V   +   TG +YA K ++KK I K    A    E+ +L++++   
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEAR--FYTAEVVDALEYIHSM 164
           VV L + ++   +L + L    GG+L   I   G     EAR  FY AE+   LE +H  
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
            +++RD+KPEN+LL   GHI+I+D G            +P   +       VGT  Y+ P
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLA--------VHVPEGQTIKGR---VGTVGYMAP 354
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI--IARDI--RFPNYFSX 280
           EV+ +   TF  D WALGC LY+M++G SPF+   + +  + +  + +++   +   FS 
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSP 414
Query: 281 XXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNI-RGQTPPKLASEP 334
                        P+ R G   G    +K HP FK +++K +  G   P    +P
Sbjct: 415 QARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDP 469

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 127/276 (46%), Gaps = 18/276 (6%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           +++ +  G+  G G ++K      +DT  V+A K++ K  + K ++   +  E  +   L
Sbjct: 40  TMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL 99
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           D+P VV     F+D   +Y+ LE C    L +    +  ++E EAR++  + +  ++Y+H
Sbjct: 100 DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLH 159
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           +  +IHRD+K  NL L  D  +KI DFG    ++             ++  T  GT  Y+
Sbjct: 160 NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE----------FDGERKKTLCGTPNYI 209
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 282
            PEVL     +F  D+W+LGC LY +L G  PF+ +     + RI   +   P + +   
Sbjct: 210 APEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVA 269
Query: 283 XXXXXXXXXXXPSGRPGAG--------PGGYAVLKM 310
                      P+ RP             GYA +++
Sbjct: 270 SALIRRMLHADPTLRPSVAELLTDEFFTSGYAPMRL 305

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 121/226 (53%), Gaps = 18/226 (7%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           + F   ++ G G++S+V   K+  TG ++ALK + K   +   + + ++ E  VL ++ H
Sbjct: 9   KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKK---SPAFRDSSLENEIAVLKKIKH 65
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
             +V L   ++ T   Y+ ++   GGELFD+I  +G  +E +A     +V+ A++Y+H  
Sbjct: 66  ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN 125
Query: 165 GLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           G++HRD+KPENLL      +  I I DFG  K  Q+  ++          AC   GT  Y
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST---------AC---GTPGY 173
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
           V PEVL   P +   D W++G   Y +L G  PF + +E  +F++I
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKI 219

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 79/237 (33%), Positives = 125/237 (52%), Gaps = 20/237 (8%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER--IVLDQLD 103
           +++L +  G G++S V R  K+ TG  YA KI++ K ++  +   + KLER   +   L 
Sbjct: 5   EYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARD---HQKLEREARICRLLK 61
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           H  +VRL  +  +    Y+  +   GGELF+ I ++ + SE +A     ++++A+ + H 
Sbjct: 62  HSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ 121
Query: 164 MGLIHRDIKPENLLLTAD---GHIKIADFGSVKPMQDSRITVLPNAASDDKAC-TFVGTA 219
           MG++HRD+KPENLLL +      +K+ADFG    +Q            D +A   F GT 
Sbjct: 122 MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQ-----------GDQQAWFGFAGTP 170
Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
            Y+ PEVL         D+WA G  LY +L G  PF D  +  ++Q+I A    FP+
Sbjct: 171 GYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPS 227

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  124 bits (310), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 123/219 (56%), Gaps = 15/219 (6%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMD-KKFITKENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G GS+ K +  K  + G  Y +K ++  +  +KE + +  + E  VL  + HP +V+   
Sbjct: 33  GEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREES--RREVAVLANMKHPNIVQYRE 90
Query: 113 TFQDTFSLYMALESCEGGELFDQITS-KGHL-SEDEARFYTAEVVDALEYIHSMGLIHRD 170
           +F++  SLY+ ++ CEGG+LF +I + KG L  ED+   +  ++  AL+++H   ++HRD
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRD 150
Query: 171 IKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 230
           IK +N+ LT DG +++ DFG  +        VL +     +AC  +GT  Y+ PE+  + 
Sbjct: 151 IKSQNIFLTKDGTVQLGDFGIAR--------VLNSTVELARAC--IGTPYYLSPEICENK 200
Query: 231 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA 269
           P    +D+WALGC LY++ +    F+  S   +  +II+
Sbjct: 201 PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS 239

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score =  123 bits (308), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 138/288 (47%), Gaps = 20/288 (6%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           ++ G G + +V   +   TG +YA K ++KK + K        +E+ +L ++    +V L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGH----LSEDEARFYTAEVVDALEYIHSMGL 166
            + F+    L + +    GG++   I +         E  A FYTA++V  LE++H   +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 167 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 226
           I+RD+KPEN+LL  DG+++I+D G    ++          A   K   + GT  ++ PE+
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELK----------AGQTKTKGYAGTPGFMAPEL 360
Query: 227 LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQRIIARDIRFPNYFSXXX 282
           L      F  D +ALG TLY+M++   PF+   E +    + QR++ + + +P+ FS   
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPAS 420
Query: 283 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ--TPP 328
                      P  R G   G    L+ HP F+ I W+ +     TPP
Sbjct: 421 KDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPP 468

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score =  123 bits (308), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 138/288 (47%), Gaps = 20/288 (6%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           ++ G G + +V   +   TG +YA K ++KK + K        +E+ +L ++    +V L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGH----LSEDEARFYTAEVVDALEYIHSMGL 166
            + F+    L + +    GG++   I +         E  A FYTA++V  LE++H   +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 167 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 226
           I+RD+KPEN+LL  DG+++I+D G    ++          A   K   + GT  ++ PE+
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELK----------AGQTKTKGYAGTPGFMAPEL 360
Query: 227 LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQRIIARDIRFPNYFSXXX 282
           L      F  D +ALG TLY+M++   PF+   E +    + QR++ + + +P+ FS   
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPAS 420
Query: 283 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ--TPP 328
                      P  R G   G    L+ HP F+ I W+ +     TPP
Sbjct: 421 KDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPP 468

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score =  123 bits (308), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 138/288 (47%), Gaps = 20/288 (6%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           ++ G G + +V   +   TG +YA K ++KK + K        +E+ +L ++    +V L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGH----LSEDEARFYTAEVVDALEYIHSMGL 166
            + F+    L + +    GG++   I +         E  A FYTA++V  LE++H   +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 167 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 226
           I+RD+KPEN+LL  DG+++I+D G    ++          A   K   + GT  ++ PE+
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELK----------AGQTKTKGYAGTPGFMAPEL 360
Query: 227 LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQRIIARDIRFPNYFSXXX 282
           L      F  D +ALG TLY+M++   PF+   E +    + QR++ + + +P+ FS   
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPAS 420
Query: 283 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ--TPP 328
                      P  R G   G    L+ HP F+ I W+ +     TPP
Sbjct: 421 KDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPP 468

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 138/288 (47%), Gaps = 20/288 (6%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           ++ G G + +V   +   TG +YA K ++KK + K        +E+ +L ++    +V L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGH----LSEDEARFYTAEVVDALEYIHSMGL 166
            + F+    L + +    GG++   I +         E  A FYTA++V  LE++H   +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 167 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 226
           I+RD+KPEN+LL  DG+++I+D G    ++          A   K   + GT  ++ PE+
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELK----------AGQTKTKGYAGTPGFMAPEL 360
Query: 227 LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQRIIARDIRFPNYFSXXX 282
           L      F  D +ALG TLY+M++   PF+   E +    + QR++ + + +P+ FS   
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPAS 420
Query: 283 XXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ--TPP 328
                      P  R G   G    L+ HP F+ I W+ +     TPP
Sbjct: 421 KDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPP 468

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  122 bits (306), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 126/276 (45%), Gaps = 18/276 (6%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           +++ +  G+  G G ++K      +DT  V+A K++ K  + K ++   +  E  +   L
Sbjct: 40  TMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL 99
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           D+P VV     F+D   +Y+ LE C    L +    +  ++E EAR++  + +  ++Y+H
Sbjct: 100 DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLH 159
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           +  +IHRD+K  NL L  D  +KI DFG    ++             ++     GT  Y+
Sbjct: 160 NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE----------FDGERKKXLCGTPNYI 209
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 282
            PEVL     +F  D+W+LGC LY +L G  PF+ +     + RI   +   P + +   
Sbjct: 210 APEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVA 269
Query: 283 XXXXXXXXXXXPSGRPGAG--------PGGYAVLKM 310
                      P+ RP             GYA +++
Sbjct: 270 SALIRRMLHADPTLRPSVAELLTDEFFTSGYAPMRL 305

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  122 bits (305), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 126/276 (45%), Gaps = 18/276 (6%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           +++ +  G+  G G ++K      +DT  V+A K++ K  + K ++   +  E  +   L
Sbjct: 40  TMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL 99
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           D+P VV     F+D   +Y+ LE C    L +    +  ++E EAR++  + +  ++Y+H
Sbjct: 100 DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLH 159
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           +  +IHRD+K  NL L  D  +KI DFG    ++             ++     GT  Y+
Sbjct: 160 NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE----------FDGERKKDLCGTPNYI 209
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 282
            PEVL     +F  D+W+LGC LY +L G  PF+ +     + RI   +   P + +   
Sbjct: 210 APEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVA 269
Query: 283 XXXXXXXXXXXPSGRPGAGP--------GGYAVLKM 310
                      P+ RP             GYA +++
Sbjct: 270 SALIRRMLHADPTLRPSVAELLTDEFFTSGYAPMRL 305

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  121 bits (304), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 126/276 (45%), Gaps = 18/276 (6%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           +++ +  G+  G G ++K      +DT  V+A K++ K  + K ++   +  E  +   L
Sbjct: 24  TMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL 83
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           D+P VV     F+D   +Y+ LE C    L +    +  ++E EAR++  + +  ++Y+H
Sbjct: 84  DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLH 143
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           +  +IHRD+K  NL L  D  +KI DFG    ++             ++     GT  Y+
Sbjct: 144 NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE----------FDGERKKDLCGTPNYI 193
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXX 282
            PEVL     +F  D+W+LGC LY +L G  PF+ +     + RI   +   P + +   
Sbjct: 194 APEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVA 253
Query: 283 XXXXXXXXXXXPSGRPGAGP--------GGYAVLKM 310
                      P+ RP             GYA +++
Sbjct: 254 SALIRRMLHADPTLRPSVAELLTDEFFTSGYAPMRL 289

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  121 bits (304), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 76/230 (33%), Positives = 114/230 (49%), Gaps = 19/230 (8%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS+ KV  A    T    ALK + ++ + K +    V+ E   L  L HP +++L+  
Sbjct: 18  GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDV 77
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
                 + M +E   GGELFD I  K  ++EDE R +  +++ A+EY H   ++HRD+KP
Sbjct: 78  ITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKP 136
Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN----S 229
           ENLLL  + ++KIADFG    M D                T  G+  Y  PEV+N    +
Sbjct: 137 ENLLLDDNLNVKIADFGLSNIMTDGNFLK-----------TSCGSPNYAAPEVINGKLYA 185
Query: 230 SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS 279
            P     D+W+ G  LY ML G  PF D     +F+++ +     P++ S
Sbjct: 186 GPEV---DVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLS 232

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 125/241 (51%), Gaps = 19/241 (7%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK-TAYVKLERIV--LDQLD 103
           +E+G+  G G ++ V + ++  TG  YA K + K+ ++   +  +  ++ER V  L ++ 
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP ++ L   F++   + + LE   GGELFD +  K  L+EDEA  +  +++D + Y+HS
Sbjct: 67  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 126
Query: 164 MGLIHRDIKPENLLL----TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
             + H D+KPEN++L      +  IK+ DFG    ++           + ++     GT 
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-----------AGNEFKNIFGTP 175
Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF-PNYF 278
            +V PE++N  P     D+W++G   Y +LSG SPF   ++      I A +  F   YF
Sbjct: 176 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYF 235
Query: 279 S 279
           S
Sbjct: 236 S 236

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 125/241 (51%), Gaps = 19/241 (7%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK-TAYVKLERIV--LDQLD 103
           +E+G+  G G ++ V + ++  TG  YA K + K+ ++   +  +  ++ER V  L ++ 
Sbjct: 14  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 73
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP ++ L   F++   + + LE   GGELFD +  K  L+EDEA  +  +++D + Y+HS
Sbjct: 74  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 133
Query: 164 MGLIHRDIKPENLLL----TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
             + H D+KPEN++L      +  IK+ DFG    ++           + ++     GT 
Sbjct: 134 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-----------AGNEFKNIFGTP 182
Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF-PNYF 278
            +V PE++N  P     D+W++G   Y +LSG SPF   ++      I A +  F   YF
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYF 242
Query: 279 S 279
           S
Sbjct: 243 S 243

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 76/236 (32%), Positives = 121/236 (51%), Gaps = 18/236 (7%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER--IVLDQLD 103
           D++L +  G G++S V R  K      YA KI++ K ++  +   + KLER   +   L 
Sbjct: 32  DYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARD---HQKLEREARICRLLK 88
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +VRL  +  +    Y+  +   GGELF+ I ++ + SE +A     ++++++ +IH 
Sbjct: 89  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQ 148
Query: 164 MGLIHRDIKPENLLLTAD---GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
             ++HRD+KPENLLL +      +K+ADFG    +Q  +               F GT  
Sbjct: 149 HDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWF----------GFAGTPG 198
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           Y+ PEVL   P     D+WA G  LY +L G  PF D  +  ++Q+I A    FP+
Sbjct: 199 YLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPS 254

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 69/245 (28%), Positives = 113/245 (46%), Gaps = 10/245 (4%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G ++K       DT  V+A KI+ K  + K ++   + +E  +   L H  VV     
Sbjct: 30  GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 89
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           F+D   +++ LE C    L +    +  L+E EAR+Y  ++V   +Y+H   +IHRD+K 
Sbjct: 90  FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKL 149
Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
            NL L  D  +KI DFG    ++             ++  T  GT  Y+ PEVL+    +
Sbjct: 150 GNLFLNEDLEVKIGDFGLATKVE----------YDGERKKTLCGTPNYIAPEVLSKKGHS 199
Query: 234 FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXXXXXXXXXXX 293
           F  D+W++GC +Y +L G  PF+ +     + RI   +   P + +              
Sbjct: 200 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTD 259
Query: 294 PSGRP 298
           P+ RP
Sbjct: 260 PTARP 264

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 69/245 (28%), Positives = 113/245 (46%), Gaps = 10/245 (4%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G ++K       DT  V+A KI+ K  + K ++   + +E  +   L H  VV     
Sbjct: 26  GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 85
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           F+D   +++ LE C    L +    +  L+E EAR+Y  ++V   +Y+H   +IHRD+K 
Sbjct: 86  FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKL 145
Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
            NL L  D  +KI DFG    ++             ++  T  GT  Y+ PEVL+    +
Sbjct: 146 GNLFLNEDLEVKIGDFGLATKVE----------YDGERKKTLCGTPNYIAPEVLSKKGHS 195
Query: 234 FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXXXXXXXXXXX 293
           F  D+W++GC +Y +L G  PF+ +     + RI   +   P + +              
Sbjct: 196 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTD 255
Query: 294 PSGRP 298
           P+ RP
Sbjct: 256 PTARP 260

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 69/245 (28%), Positives = 113/245 (46%), Gaps = 10/245 (4%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G ++K       DT  V+A KI+ K  + K ++   + +E  +   L H  VV     
Sbjct: 26  GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 85
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           F+D   +++ LE C    L +    +  L+E EAR+Y  ++V   +Y+H   +IHRD+K 
Sbjct: 86  FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKL 145
Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
            NL L  D  +KI DFG    ++             ++  T  GT  Y+ PEVL+    +
Sbjct: 146 GNLFLNEDLEVKIGDFGLATKVE----------YDGERKKTLCGTPNYIAPEVLSKKGHS 195
Query: 234 FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXXXXXXXXXXX 293
           F  D+W++GC +Y +L G  PF+ +     + RI   +   P + +              
Sbjct: 196 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTD 255
Query: 294 PSGRP 298
           P+ RP
Sbjct: 256 PTARP 260

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 124/241 (51%), Gaps = 19/241 (7%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK-TAYVKLERIV--LDQLD 103
           +E+G+  G G ++ V + ++  TG  YA K + K+ +    +  +  ++ER V  L ++ 
Sbjct: 28  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIR 87
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP ++ L   F++   + + LE   GGELFD +  K  L+EDEA  +  +++D + Y+HS
Sbjct: 88  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 147
Query: 164 MGLIHRDIKPENLLL----TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
             + H D+KPEN++L      +  IK+ DFG    ++           + ++     GT 
Sbjct: 148 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-----------AGNEFKNIFGTP 196
Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF-PNYF 278
            +V PE++N  P     D+W++G   Y +LSG SPF   ++      I A +  F   YF
Sbjct: 197 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYF 256
Query: 279 S 279
           S
Sbjct: 257 S 257

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  118 bits (296), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 81/238 (34%), Positives = 116/238 (48%), Gaps = 33/238 (13%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFI--TKENKTAYVKLERIVLDQLDHPGVV 108
           K  G GS+S   +     +   +A+KI+ K+    T++  TA    E        HP +V
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCE-------GHPNIV 69
Query: 109 RLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
           +L   F D    ++ +E   GGELF++I  K H SE EA +   ++V A+ ++H +G++H
Sbjct: 70  KLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVH 129
Query: 169 RDIKPENLLLTADG---HIKIADFG--SVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           RD+KPENLL T +     IKI DFG   +KP         P+       C    T  Y  
Sbjct: 130 RDLKPENLLFTDENDNLEIKIIDFGFARLKP---------PDNQPLKTPCF---TLHYAA 177
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD-------TSEWLIFQRIIARDIRF 274
           PE+LN +      DLW+LG  LY MLSG  PF+        TS   I ++I   D  F
Sbjct: 178 PELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF 235

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  118 bits (296), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 112/245 (45%), Gaps = 10/245 (4%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G ++K       DT  V+A KI+ K  + K ++   + +E  +   L H  VV     
Sbjct: 50  GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 109
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           F+D   +++ LE C    L +    +  L+E EAR+Y  ++V   +Y+H   +IHRD+K 
Sbjct: 110 FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKL 169
Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
            NL L  D  +KI DFG    ++             ++     GT  Y+ PEVL+    +
Sbjct: 170 GNLFLNEDLEVKIGDFGLATKVE----------YDGERKKVLCGTPNYIAPEVLSKKGHS 219
Query: 234 FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXXXXXXXXXXX 293
           F  D+W++GC +Y +L G  PF+ +     + RI   +   P + +              
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTD 279
Query: 294 PSGRP 298
           P+ RP
Sbjct: 280 PTARP 284

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  118 bits (296), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 112/245 (45%), Gaps = 10/245 (4%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G ++K       DT  V+A KI+ K  + K ++   + +E  +   L H  VV     
Sbjct: 48  GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 107
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           F+D   +++ LE C    L +    +  L+E EAR+Y  ++V   +Y+H   +IHRD+K 
Sbjct: 108 FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKL 167
Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
            NL L  D  +KI DFG    ++             ++     GT  Y+ PEVL+    +
Sbjct: 168 GNLFLNEDLEVKIGDFGLATKVE----------YDGERKKVLCGTPNYIAPEVLSKKGHS 217
Query: 234 FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXXXXXXXXXXX 293
           F  D+W++GC +Y +L G  PF+ +     + RI   +   P + +              
Sbjct: 218 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTD 277
Query: 294 PSGRP 298
           P+ RP
Sbjct: 278 PTARP 282

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 118/220 (53%), Gaps = 16/220 (7%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           K  G G+Y +V+  +   T    A+KI+ K  ++  + +  ++ E  VL  LDHP +++L
Sbjct: 43  KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE-EVAVLKLLDHPNIMKL 101
Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 170
           +  F+D  + Y+ +E  +GGELFD+I  +   +E +A     +V+  + Y+H   ++HRD
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRD 161
Query: 171 IKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 227
           +KPENLLL +   D  IKI DFG     ++ +           K    +GTA Y+ PEVL
Sbjct: 162 LKPENLLLESKEKDALIKIVDFGLSAVFENQK-----------KMKERLGTAYYIAPEVL 210
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
                    D+W++G  L+ +L+G  PF   ++  I +++
Sbjct: 211 RKKYDE-KCDVWSIGVILFILLAGYPPFGGQTDQEILRKV 249

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 112/245 (45%), Gaps = 10/245 (4%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G ++K       DT  V+A KI+ K  + K ++   + +E  +   L H  VV     
Sbjct: 24  GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 83
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           F+D   +++ LE C    L +    +  L+E EAR+Y  ++V   +Y+H   +IHRD+K 
Sbjct: 84  FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKL 143
Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
            NL L  D  +KI DFG    ++             ++     GT  Y+ PEVL+    +
Sbjct: 144 GNLFLNEDLEVKIGDFGLATKVE----------YDGERKKVLCGTPNYIAPEVLSKKGHS 193
Query: 234 FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXXXXXXXXXXXXXX 293
           F  D+W++GC +Y +L G  PF+ +     + RI   +   P + +              
Sbjct: 194 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTD 253
Query: 294 PSGRP 298
           P+ RP
Sbjct: 254 PTARP 258

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 72/231 (31%), Positives = 120/231 (51%), Gaps = 24/231 (10%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G++  V   ++  +G    +K ++K     +     ++ E  VL  LDHP ++++F  
Sbjct: 31  GSGAFGDVHLVEERSSGLERVIKTINKD--RSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV----VDALEYIHSMGLIHR 169
           F+D  ++Y+ +E+CEGGEL ++I S     +  +  Y AE+    ++AL Y HS  ++H+
Sbjct: 89  FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHK 148
Query: 170 DIKPENLLL---TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 226
           D+KPEN+L    +    IKI DFG  +  +           SD+ +    GTA Y+ PEV
Sbjct: 149 DLKPENILFQDTSPHSPIKIIDFGLAELFK-----------SDEHSTNAAGTALYMAPEV 197
Query: 227 LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
                 TF  D+W+ G  +Y +L+G  PF  TS   + Q+   ++   PNY
Sbjct: 198 FKRD-VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE---PNY 244

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 115/220 (52%), Gaps = 19/220 (8%)
Query: 44  IQDF-ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK-TAYVKLERIV--L 99
           ++DF ++G+  G G ++ V + ++  TG  YA K + K+      +     ++ER V  L
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSIL 69
Query: 100 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 159
            Q+ HP ++ L   +++   + + LE   GGELFD +  K  LSE+EA  +  +++D + 
Sbjct: 70  RQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 160 YIHSMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           Y+H+  + H D+KPEN++L        HIK+ DFG    ++D       N          
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKN---------I 178
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            GT  +V PE++N  P     D+W++G   Y +LSG SPF
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 71/208 (34%), Positives = 107/208 (51%), Gaps = 20/208 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           GVGSYS+  R     T   YA+K++DK   +K + +  ++   I+L    HP ++ L   
Sbjct: 36  GVGSYSECKRCVHKATNMEYAVKVIDK---SKRDPSEEIE---ILLRYGQHPNIITLKDV 89
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           + D   +Y+  E   GGEL D+I  +   SE EA F    +   +EY+HS G++HRD+KP
Sbjct: 90  YDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKP 149
Query: 174 ENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 229
            N+L   +      ++I DFG  K ++          A +    T   TA +V PEVL  
Sbjct: 150 SNILYVDESGNPECLRICDFGFAKQLR----------AENGLLMTPCYTANFVAPEVLKR 199
Query: 230 SPATFGNDLWALGCTLYQMLSGTSPFKD 257
                G D+W+LG  LY ML+G +PF +
Sbjct: 200 QGYDEGCDIWSLGILLYTMLAGYTPFAN 227

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  116 bits (291), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 71/208 (34%), Positives = 107/208 (51%), Gaps = 20/208 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           GVGSYS+  R     T   YA+K++DK   +K + +  ++   I+L    HP ++ L   
Sbjct: 36  GVGSYSECKRCVHKATNMEYAVKVIDK---SKRDPSEEIE---ILLRYGQHPNIITLKDV 89
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           + D   +Y+  E   GGEL D+I  +   SE EA F    +   +EY+HS G++HRD+KP
Sbjct: 90  YDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKP 149
Query: 174 ENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS 229
            N+L   +      ++I DFG  K ++          A +    T   TA +V PEVL  
Sbjct: 150 SNILYVDESGNPECLRICDFGFAKQLR----------AENGLLMTPCYTANFVAPEVLKR 199
Query: 230 SPATFGNDLWALGCTLYQMLSGTSPFKD 257
                G D+W+LG  LY ML+G +PF +
Sbjct: 200 QGYDEGCDIWSLGILLYTMLAGYTPFAN 227

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 84/231 (36%), Positives = 120/231 (51%), Gaps = 26/231 (11%)
Query: 47  FELGKIYGVGSY--SKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +EL K  G G++  ++++R K+     + A+K +++     EN    VK E I    L H
Sbjct: 21  YELVKDIGAGNFGVARLMRDKQ--ANELVAVKYIERGEKIDEN----VKREIINHRSLRH 74
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P +VR          L + +E   GGELF++I + G  SEDEARF+  +++  + Y H+M
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAM 134
Query: 165 GLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
            + HRD+K EN LL  DG     +KIADFG  K    S +   P +A        VGT A
Sbjct: 135 QVAHRDLKLENTLL--DGSPAPRLKIADFGYSKA---SVLHSQPKSA--------VGTPA 181
Query: 221 YVPPEVLNSSPATFG-NDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR 270
           Y+ PEVL          D+W+ G TLY ML G  PF+D  E   F++ I R
Sbjct: 182 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 232

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 71/242 (29%), Positives = 123/242 (50%), Gaps = 21/242 (8%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 102
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 163 SMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 180
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 277
            A+V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 181 PAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 278 FS 279
           FS
Sbjct: 241 FS 242

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 80/229 (34%), Positives = 115/229 (50%), Gaps = 22/229 (9%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           +EL K  G G++      +   +  + A+K +++     E   A VK E I    L HP 
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG----EKIAANVKREIINHRSLRHPN 76
Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           +VR          L + +E   GGELF++I + G  SEDEARF+  +++  + Y H+M +
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 136
Query: 167 IHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
            HRD+K EN LL  DG     +KI DFG       S+ +VL +        + VGT AY+
Sbjct: 137 CHRDLKLENTLL--DGSPAPRLKICDFGY------SKSSVLHSQPK-----STVGTPAYI 183
Query: 223 PPEVLNSSPATFG-NDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR 270
            PEVL          D+W+ G TLY ML G  PF+D  E   F++ I R
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 232

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 77/225 (34%), Positives = 118/225 (52%), Gaps = 27/225 (12%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDK-KFITKENKTA----YVKLERIVLD 100
           ++ + K  G G+  +V  A +  T    A+KI+ K KF     + A     V+ E  +L 
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 101 QLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
           +L+HP ++++  FF  +D    Y+ LE  EGGELFD++     L E   + Y  +++ A+
Sbjct: 71  KLNHPCIIKIKNFFDAED---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 127
Query: 159 EYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           +Y+H  G+IHRD+KPEN+LL++   D  IKI DFG  K + ++ +             T 
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR-----------TL 176
Query: 216 VGTAAYVPPEVLNSSPATFGN---DLWALGCTLYQMLSGTSPFKD 257
            GT  Y+ PEVL S      N   D W+LG  L+  LSG  PF +
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 77/225 (34%), Positives = 118/225 (52%), Gaps = 27/225 (12%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDK-KFITKENKTA----YVKLERIVLD 100
           ++ + K  G G+  +V  A +  T    A+KI+ K KF     + A     V+ E  +L 
Sbjct: 10  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 69
Query: 101 QLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
           +L+HP ++++  FF  +D    Y+ LE  EGGELFD++     L E   + Y  +++ A+
Sbjct: 70  KLNHPCIIKIKNFFDAED---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 126
Query: 159 EYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           +Y+H  G+IHRD+KPEN+LL++   D  IKI DFG  K + ++ +             T 
Sbjct: 127 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR-----------TL 175
Query: 216 VGTAAYVPPEVLNSSPATFGN---DLWALGCTLYQMLSGTSPFKD 257
            GT  Y+ PEVL S      N   D W+LG  L+  LSG  PF +
Sbjct: 176 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 220

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 77/225 (34%), Positives = 118/225 (52%), Gaps = 27/225 (12%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDK-KFITKENKTA----YVKLERIVLD 100
           ++ + K  G G+  +V  A +  T    A+KI+ K KF     + A     V+ E  +L 
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 101 QLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
           +L+HP ++++  FF  +D    Y+ LE  EGGELFD++     L E   + Y  +++ A+
Sbjct: 71  KLNHPCIIKIKNFFDAED---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 127
Query: 159 EYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           +Y+H  G+IHRD+KPEN+LL++   D  IKI DFG  K + ++ +             T 
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR-----------TL 176
Query: 216 VGTAAYVPPEVLNSSPATFGN---DLWALGCTLYQMLSGTSPFKD 257
            GT  Y+ PEVL S      N   D W+LG  L+  LSG  PF +
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 77/225 (34%), Positives = 118/225 (52%), Gaps = 27/225 (12%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDK-KFITKENKTA----YVKLERIVLD 100
           ++ + K  G G+  +V  A +  T    A+KI+ K KF     + A     V+ E  +L 
Sbjct: 17  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 76
Query: 101 QLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
           +L+HP ++++  FF  +D    Y+ LE  EGGELFD++     L E   + Y  +++ A+
Sbjct: 77  KLNHPCIIKIKNFFDAED---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 133
Query: 159 EYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           +Y+H  G+IHRD+KPEN+LL++   D  IKI DFG  K + ++ +             T 
Sbjct: 134 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR-----------TL 182
Query: 216 VGTAAYVPPEVLNSSPATFGN---DLWALGCTLYQMLSGTSPFKD 257
            GT  Y+ PEVL S      N   D W+LG  L+  LSG  PF +
Sbjct: 183 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 227

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 117/226 (51%), Gaps = 19/226 (8%)
Query: 38  PQEHFSIQDF-ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK-TAYVKLE 95
           P +   ++DF ++G+  G G ++ V + ++  TG  YA K + K+      +  +  ++E
Sbjct: 4   PFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE 63
Query: 96  RIV--LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 153
           R V  L Q+ H  V+ L   +++   + + LE   GGELFD +  K  LSE+EA  +  +
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASD 209
           ++D + Y+H+  + H D+KPEN++L        HIK+ DFG    ++D            
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---------- 173
Query: 210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +     GT  +V PE++N  P     D+W++G   Y +LSG SPF
Sbjct: 174 -EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 117/226 (51%), Gaps = 19/226 (8%)
Query: 38  PQEHFSIQDF-ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK-TAYVKLE 95
           P +   ++DF ++G+  G G ++ V + ++  TG  YA K + K+      +  +  ++E
Sbjct: 4   PFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE 63
Query: 96  RIV--LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 153
           R V  L Q+ H  V+ L   +++   + + LE   GGELFD +  K  LSE+EA  +  +
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASD 209
           ++D + Y+H+  + H D+KPEN++L        HIK+ DFG    ++D            
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---------- 173
Query: 210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +     GT  +V PE++N  P     D+W++G   Y +LSG SPF
Sbjct: 174 -EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 80/229 (34%), Positives = 115/229 (50%), Gaps = 22/229 (9%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           +EL K  G G++      +   +  + A+K +++     EN    VK E I    L HP 
Sbjct: 20  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDEN----VKREIINHRSLRHPN 75
Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           +VR          L + +E   GGELF++I + G  SEDEARF+  +++  + Y H+M +
Sbjct: 76  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 135
Query: 167 IHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
            HRD+K EN LL  DG     +KI DFG       S+ +VL +        + VGT AY+
Sbjct: 136 CHRDLKLENTLL--DGSPAPRLKICDFGY------SKSSVLHSQPK-----STVGTPAYI 182
Query: 223 PPEVLNSSPATFG-NDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR 270
            PEVL          D+W+ G TLY ML G  PF+D  E   F++ I R
Sbjct: 183 APEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 231

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 77/225 (34%), Positives = 118/225 (52%), Gaps = 27/225 (12%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDK-KFITKENKTA----YVKLERIVLD 100
           ++ + K  G G+  +V  A +  T    A+KI+ K KF     + A     V+ E  +L 
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 101 QLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
           +L+HP ++++  FF  +D    Y+ LE  EGGELFD++     L E   + Y  +++ A+
Sbjct: 71  KLNHPCIIKIKNFFDAED---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 127
Query: 159 EYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           +Y+H  G+IHRD+KPEN+LL++   D  IKI DFG  K + ++ +             T 
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR-----------TL 176
Query: 216 VGTAAYVPPEVLNSSPATFGN---DLWALGCTLYQMLSGTSPFKD 257
            GT  Y+ PEVL S      N   D W+LG  L+  LSG  PF +
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 83/260 (31%), Positives = 131/260 (50%), Gaps = 34/260 (13%)
Query: 18  NNSSTNCPTVQRSKSFAF-------RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTG 70
           NN+S    ++ R+K F F       ++        ++ + K  G G+  +V  A +  T 
Sbjct: 115 NNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTC 174
Query: 71  TVYALKIMDK-KFITKENKTA----YVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMA 123
              A++I+ K KF     + A     V+ E  +L +L+HP ++++  FF  +D    Y+ 
Sbjct: 175 KKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED---YYIV 231
Query: 124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA--- 180
           LE  EGGELFD++     L E   + Y  +++ A++Y+H  G+IHRD+KPEN+LL++   
Sbjct: 232 LELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEE 291
Query: 181 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGN---D 237
           D  IKI DFG  K + ++ +             T  GT  Y+ PEVL S      N   D
Sbjct: 292 DCLIKITDFGHSKILGETSLMR-----------TLCGTPTYLAPEVLVSVGTAGYNRAVD 340
Query: 238 LWALGCTLYQMLSGTSPFKD 257
            W+LG  L+  LSG  PF +
Sbjct: 341 CWSLGVILFICLSGYPPFSE 360

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 117/226 (51%), Gaps = 19/226 (8%)
Query: 38  PQEHFSIQDF-ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK-TAYVKLE 95
           P +   ++DF ++G+  G G ++ V + ++  TG  YA K + K+      +  +  ++E
Sbjct: 4   PFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE 63
Query: 96  RIV--LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 153
           R V  L Q+ H  V+ L   +++   + + LE   GGELFD +  K  LSE+EA  +  +
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASD 209
           ++D + Y+H+  + H D+KPEN++L        HIK+ DFG    ++D            
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---------- 173
Query: 210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +     GT  +V PE++N  P     D+W++G   Y +LSG SPF
Sbjct: 174 -EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 117/226 (51%), Gaps = 19/226 (8%)
Query: 38  PQEHFSIQDF-ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK-TAYVKLE 95
           P +   ++DF ++G+  G G ++ V + ++  TG  YA K + K+      +  +  ++E
Sbjct: 4   PFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE 63
Query: 96  RIV--LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 153
           R V  L Q+ H  V+ L   +++   + + LE   GGELFD +  K  LSE+EA  +  +
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASD 209
           ++D + Y+H+  + H D+KPEN++L        HIK+ DFG    ++D            
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---------- 173
Query: 210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +     GT  +V PE++N  P     D+W++G   Y +LSG SPF
Sbjct: 174 -EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 117/226 (51%), Gaps = 19/226 (8%)
Query: 38  PQEHFSIQDF-ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK-TAYVKLE 95
           P +   ++DF ++G+  G G ++ V + ++  TG  YA K + K+      +  +  ++E
Sbjct: 4   PFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE 63
Query: 96  RIV--LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 153
           R V  L Q+ H  V+ L   +++   + + LE   GGELFD +  K  LSE+EA  +  +
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASD 209
           ++D + Y+H+  + H D+KPEN++L        HIK+ DFG    ++D            
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---------- 173
Query: 210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +     GT  +V PE++N  P     D+W++G   Y +LSG SPF
Sbjct: 174 -EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/260 (31%), Positives = 131/260 (50%), Gaps = 34/260 (13%)
Query: 18  NNSSTNCPTVQRSKSFAF-------RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTG 70
           NN+S    ++ R+K F F       ++        ++ + K  G G+  +V  A +  T 
Sbjct: 101 NNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTC 160
Query: 71  TVYALKIMDK-KFITKENKTA----YVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMA 123
              A++I+ K KF     + A     V+ E  +L +L+HP ++++  FF  +D    Y+ 
Sbjct: 161 KKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED---YYIV 217
Query: 124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA--- 180
           LE  EGGELFD++     L E   + Y  +++ A++Y+H  G+IHRD+KPEN+LL++   
Sbjct: 218 LELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEE 277
Query: 181 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGN---D 237
           D  IKI DFG  K + ++ +             T  GT  Y+ PEVL S      N   D
Sbjct: 278 DCLIKITDFGHSKILGETSLMR-----------TLCGTPTYLAPEVLVSVGTAGYNRAVD 326
Query: 238 LWALGCTLYQMLSGTSPFKD 257
            W+LG  L+  LSG  PF +
Sbjct: 327 CWSLGVILFICLSGYPPFSE 346

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 77/231 (33%), Positives = 116/231 (50%), Gaps = 20/231 (8%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMD-KKFITKEN-KTAYVKLERIVLDQLDH 104
           +EL ++ G G++S V R    +TG  +A+KI+D  KF +     T  +K E  +   L H
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH----LSEDEARFYTAEVVDALEY 160
           P +V L  T+     LYM  E  +G +L  +I  +       SE  A  Y  ++++AL Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 161 IHSMGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
            H   +IHRD+KPEN+LL +  +   +K+ DFG    + +S +           A   VG
Sbjct: 146 CHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLV----------AGGRVG 195
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII 268
           T  ++ PEV+   P     D+W  G  L+ +LSG  PF  T E L F+ II
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERL-FEGII 245

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 82/231 (35%), Positives = 120/231 (51%), Gaps = 26/231 (11%)
Query: 47  FELGKIYGVGSY--SKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +EL K  G G++  ++++R K+  +  + A+K +++     EN    VK E I    L H
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQ--SNELVAVKYIERGEKIDEN----VKREIINHRSLRH 74
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P +VR          L + +E   GGELF++I + G  SEDEARF+  +++  + Y H+M
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 134
Query: 165 GLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
            + HRD+K EN LL  DG     +KI  FG       S+ +VL +   D      VGT A
Sbjct: 135 QVCHRDLKLENTLL--DGSPAPRLKICAFGY------SKSSVLHSQPKDT-----VGTPA 181
Query: 221 YVPPEVLNSSPATFG-NDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR 270
           Y+ PEVL          D+W+ G TLY ML G  PF+D  E   F++ I R
Sbjct: 182 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 232

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 122/242 (50%), Gaps = 21/242 (8%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 102
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 163 SMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 180
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 277
             +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 278 FS 279
           FS
Sbjct: 241 FS 242

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 71/215 (33%), Positives = 109/215 (50%), Gaps = 20/215 (9%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           +E+ +  GVGSYS   R     T   +A+KI+DK   +K + T  ++   I+L    HP 
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK---SKRDPTEEIE---ILLRYGQHPN 77
Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           ++ L   + D   +Y+  E  +GGEL D+I  +   SE EA      +   +EY+H+ G+
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 167 IHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           +HRD+KP N+L   +      I+I DFG  K ++          A +    T   TA +V
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLR----------AENGLLMTPCYTANFV 187
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD 257
            PEVL         D+W+LG  LY ML+G +PF +
Sbjct: 188 APEVLERQGYDAACDIWSLGVLLYTMLTGYTPFAN 222

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 110/224 (49%), Gaps = 17/224 (7%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G++  V R  +  TG V+  K ++  +   +     VK E  +++QL HP ++ L   
Sbjct: 60  GSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT---VKNEISIMNQLHHPKLINLHDA 116
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSMGLIHRDIK 172
           F+D + + + LE   GGELFD+I ++ + +SE E   Y  +  + L+++H   ++H DIK
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIK 176
Query: 173 PENLLLTAD--GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 230
           PEN++        +KI DFG    +    I  +  A           TA +  PE+++  
Sbjct: 177 PENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA-----------TAEFAAPEIVDRE 225
Query: 231 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF 274
           P  F  D+WA+G   Y +LSG SPF    +    Q +   D  F
Sbjct: 226 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF 269

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 122/242 (50%), Gaps = 21/242 (8%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 102
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 163 SMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 180
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 277
             +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 278 FS 279
           FS
Sbjct: 241 FS 242

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 122/242 (50%), Gaps = 21/242 (8%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 102
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 163 SMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 180
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 277
             +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 278 FS 279
           FS
Sbjct: 241 FS 242

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 122/242 (50%), Gaps = 21/242 (8%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 102
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 71  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 163 SMGLIHRDIKPENLLL----TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 179
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 277
             +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 239
Query: 278 FS 279
           FS
Sbjct: 240 FS 241

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 122/242 (50%), Gaps = 21/242 (8%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 102
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 163 SMGLIHRDIKPENLLL----TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 180
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 277
             +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 278 FS 279
           FS
Sbjct: 241 FS 242

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 122/242 (50%), Gaps = 21/242 (8%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 102
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 71  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 163 SMGLIHRDIKPENLLL----TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 179
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 277
             +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 239
Query: 278 FS 279
           FS
Sbjct: 240 FS 241

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 122/242 (50%), Gaps = 21/242 (8%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 102
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 163 SMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 180
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 277
             +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 278 FS 279
           FS
Sbjct: 241 FS 242

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 122/242 (50%), Gaps = 21/242 (8%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 102
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 163 SMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 180
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 277
             +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 278 FS 279
           FS
Sbjct: 241 FS 242

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  112 bits (279), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 72/237 (30%), Positives = 114/237 (48%), Gaps = 22/237 (9%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           Q + L    G GS+ +V  A +  T    A K + K F+   ++    K E  ++  LDH
Sbjct: 9   QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR---FKQEIEIMKSLDH 65
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P ++RL+ TF+D   +Y+ +E C GGELF+++  K    E +A     +V+ A+ Y H +
Sbjct: 66  PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125
Query: 165 GLIHRDIKPENLLL---TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
            + HRD+KPEN L    + D  +K+ DFG     +  ++             T VGT  Y
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR-----------TKVGTPYY 174
Query: 222 VPPEVLNSSPATFG--NDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           V P+VL      +G   D W+ G  +Y +L G  PF   ++  +  +I      FP 
Sbjct: 175 VSPQVLE---GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPE 228

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  112 bits (279), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 122/242 (50%), Gaps = 21/242 (8%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 102
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 163 SMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 180
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 277
             +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 278 FS 279
           FS
Sbjct: 241 FS 242

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  112 bits (279), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 72/237 (30%), Positives = 114/237 (48%), Gaps = 22/237 (9%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           Q + L    G GS+ +V  A +  T    A K + K F+   ++    K E  ++  LDH
Sbjct: 26  QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR---FKQEIEIMKSLDH 82
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P ++RL+ TF+D   +Y+ +E C GGELF+++  K    E +A     +V+ A+ Y H +
Sbjct: 83  PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 142
Query: 165 GLIHRDIKPENLLL---TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
            + HRD+KPEN L    + D  +K+ DFG     +  ++             T VGT  Y
Sbjct: 143 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR-----------TKVGTPYY 191
Query: 222 VPPEVLNSSPATFG--NDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           V P+VL      +G   D W+ G  +Y +L G  PF   ++  +  +I      FP 
Sbjct: 192 VSPQVLE---GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPE 245

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  112 bits (279), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 122/242 (50%), Gaps = 21/242 (8%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 102
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 163 SMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 180
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 277
             +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 278 FS 279
           FS
Sbjct: 241 FS 242

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  112 bits (279), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 122/242 (50%), Gaps = 21/242 (8%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 102
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 163 SMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 180
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 277
             +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 278 FS 279
           FS
Sbjct: 241 FS 242

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 122/242 (50%), Gaps = 21/242 (8%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 102
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 163 SMGLIHRDIKPENLLL----TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 180
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 277
             +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 278 FS 279
           FS
Sbjct: 241 FS 242

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 79/229 (34%), Positives = 114/229 (49%), Gaps = 22/229 (9%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           +EL K  G G++      +   +  + A+K +++     EN    VK E I    L HP 
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDEN----VKREIINHRSLRHPN 76
Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           +VR          L + +E   GGELF++I + G  SEDEARF+  +++  + Y H+M +
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 136
Query: 167 IHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
            HRD+K EN LL  DG     +KI  FG       S+ +VL +        + VGT AY+
Sbjct: 137 CHRDLKLENTLL--DGSPAPRLKICAFGY------SKSSVLHSQPK-----STVGTPAYI 183
Query: 223 PPEVLNSSPATFG-NDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR 270
            PEVL          D+W+ G TLY ML G  PF+D  E   F++ I R
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 232

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 117/225 (52%), Gaps = 23/225 (10%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           +I G G + +V + ++  TG   A KI+  + +  + +   VK E  V++QLDH  +++L
Sbjct: 95  EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEE---VKNEISVMNQLDHANLIQL 151
Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSMGLIHR 169
           +  F+    + + +E  +GGELFD+I  + + L+E +   +  ++ + + ++H M ++H 
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHL 211
Query: 170 DIKPENLLLTADG--HIKIADFG---SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           D+KPEN+L        IKI DFG     KP +  ++                GT  ++ P
Sbjct: 212 DLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF--------------GTPEFLAP 257
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA 269
           EV+N    +F  D+W++G   Y +LSG SPF   ++      I+A
Sbjct: 258 EVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILA 302

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 108/215 (50%), Gaps = 20/215 (9%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           +E+ +  GVGSYS   R     T   +A+KI+DK   +K + T  ++   I+L    HP 
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDK---SKRDPTEEIE---ILLRYGQHPN 77
Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           ++ L   + D   +Y+  E  +GGEL D+I  +   SE EA      +   +EY+H+ G+
Sbjct: 78  IITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 167 IHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           +HRD+KP N+L   +      I+I DFG  K ++          A +    T   TA +V
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLR----------AENGLLXTPCYTANFV 187
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD 257
            PEVL         D+W+LG  LY  L+G +PF +
Sbjct: 188 APEVLERQGYDAACDIWSLGVLLYTXLTGYTPFAN 222

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 69/242 (28%), Positives = 121/242 (50%), Gaps = 21/242 (8%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY----VKLERIVLDQL 102
           ++ G+  G G ++ V + ++  TG  YA K + KK  TK ++       ++ E  +L ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP V+ L   +++   + +  E   GGELFD +  K  L+E+EA  +  ++++ + Y+H
Sbjct: 72  QHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 163 SMGLIHRDIKPENLLL----TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           S+ + H D+KPEN++L         IKI DFG    +              ++     GT
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNEFKNIFGT 180
Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN-Y 277
             +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  F + Y
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 278 FS 279
           FS
Sbjct: 241 FS 242

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 77/231 (33%), Positives = 122/231 (52%), Gaps = 16/231 (6%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE-NKTAYVKLERIVLDQL 102
           I  + +G + G GSY KV      +T    A+KI+ KK + +  N  A VK E  +L +L
Sbjct: 4   IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL 63
Query: 103 DHPGVVRLFFTF--QDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDAL 158
            H  V++L      ++   +YM +E C  G  E+ D +  K      +A  Y  +++D L
Sbjct: 64  RHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-RFPVCQAHGYFCQLIDGL 122
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           EY+HS G++H+DIKP NLLLT  G +KI+  G  + +           A+DD   T  G+
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP--------FAADDTCRTSQGS 174
Query: 219 AAYVPPEVLNS--SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
            A+ PPE+ N   + + F  D+W+ G TLY + +G  PF+  + + +F+ I
Sbjct: 175 PAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI 225

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 118/228 (51%), Gaps = 16/228 (7%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ--LDH 104
           +ELG+I G G  S+V  A+ +      A+K++        + + Y++  R   +   L+H
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADL--ARDPSFYLRFRREAQNAAALNH 71
Query: 105 PGVVRLFFTFQDTFSL----YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
           P +V ++ T +         Y+ +E  +G  L D + ++G ++   A    A+   AL +
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
            H  G+IHRD+KP N++++A   +K+ DFG  + + DS  +V   AA        +GTA 
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA-------VIGTAQ 184
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK-DTSEWLIFQRI 267
           Y+ PE          +D+++LGC LY++L+G  PF  D+ + + +Q +
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHV 232

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 114/227 (50%), Gaps = 25/227 (11%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIM-----DKKFITKENKTAYVKLERI-----VLDQLD 103
           G G+Y +V+  K+ +  +  A+K++     DK   + +NK      E I     +L  LD
Sbjct: 45  GSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD 104
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +++LF  F+D    Y+  E  EGGELF+QI ++    E +A     +++  + Y+H 
Sbjct: 105 HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHK 164
Query: 164 MGLIHRDIKPENLLLTADG---HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
             ++HRDIKPEN+LL       +IKI DFG           +    + D K    +GTA 
Sbjct: 165 HNIVHRDIKPENILLENKNSLLNIKIVDFG-----------LSSFFSKDYKLRDRLGTAY 213
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
           Y+ PEVL         D+W+ G  +Y +L G  PF   ++  I +++
Sbjct: 214 YIAPEVLKKKYNE-KCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV 259

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 73/235 (31%), Positives = 116/235 (49%), Gaps = 14/235 (5%)
Query: 25  PTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT 84
           P  Q     A R    + ++ +F + K  G G +S+V RA  +  G   ALK +    + 
Sbjct: 12  PVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM 71
Query: 85  KENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT----SKG 140
                A    E  +L QL+HP V++ + +F +   L + LE  + G+L   I      K 
Sbjct: 72  DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKR 131
Query: 141 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 200
            + E     Y  ++  ALE++HS  ++HRDIKP N+ +TA G +K+ D G +     S+ 
Sbjct: 132 LIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLG-LGRFFSSKT 190
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           T          A + VGT  Y+ PE ++ +   F +D+W+LGC LY+M +  SPF
Sbjct: 191 TA---------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 236

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  108 bits (270), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 77/229 (33%), Positives = 114/229 (49%), Gaps = 22/229 (9%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           ++  K  G G++      +   T  + A+K +++     EN    V+ E I    L HP 
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN----VQREIINHRSLRHPN 77
Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           +VR          L + +E   GGEL+++I + G  SEDEARF+  +++  + Y HSM +
Sbjct: 78  IVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQI 137
Query: 167 IHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
            HRD+K EN LL  DG     +KI DFG       S+ +VL +        + VGT AY+
Sbjct: 138 CHRDLKLENTLL--DGSPAPRLKICDFGY------SKSSVLHSQPK-----STVGTPAYI 184
Query: 223 PPEVLNSSPATFG-NDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR 270
            PEVL          D+W+ G TLY ML G  PF+D  E   +++ I R
Sbjct: 185 APEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQR 233

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score =  108 bits (270), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 117/228 (51%), Gaps = 16/228 (7%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ--LDH 104
           +ELG+I G G  S+V  A+ +      A+K++        + + Y++  R   +   L+H
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADL--ARDPSFYLRFRREAQNAAALNH 71
Query: 105 PGVVRLFFTFQDTFSL----YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
           P +V ++ T +         Y+ +E  +G  L D + ++G ++   A    A+   AL +
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
            H  G+IHRD+KP N+L++A   +K+ DFG  + + DS  +V   AA        +GTA 
Sbjct: 132 SHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAA-------VIGTAQ 184
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK-DTSEWLIFQRI 267
           Y+ PE          +D+++LGC LY++L+G  PF  D+   + +Q +
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 232

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 136/276 (49%), Gaps = 33/276 (11%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G++ KV +AK  +TG + A K+++ K  ++E    Y+ +E  +L   DHP +V+L   
Sbjct: 28  GDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYI-VEIEILATCDHPYIVKLLGA 84
Query: 114 FQDTFSLYMALESCEGGELFDQIT---SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 170
           +     L++ +E C GG + D I     +G L+E + +    ++++AL ++HS  +IHRD
Sbjct: 85  YYHDGKLWIMIEFCPGGAV-DAIMLELDRG-LTEPQIQVVCRQMLEALNFLHSKRIIHRD 142
Query: 171 IKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV--- 226
           +K  N+L+T +G I++ADFG S K           N  +  K  +F+GT  ++ PEV   
Sbjct: 143 LKAGNVLMTLEGDIRLADFGVSAK-----------NLKTLQKRDSFIGTPYWMAPEVVMC 191
Query: 227 --LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRFPNYFSXX 281
             +  +P  +  D+W+LG TL +M     P  + +   +  +I   D   +  P+ +S  
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVE 251
Query: 282 XXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
                       P  RP A     A L  HPF   I
Sbjct: 252 FRDFLKIALDKNPETRPSA-----AQLLEHPFVSSI 282

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 115/222 (51%), Gaps = 19/222 (8%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           ++D++L +  G G+Y +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  YV 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPYVA 174
Query: 224 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 175 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  108 bits (269), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 115/222 (51%), Gaps = 19/222 (8%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           ++D++L +  G G+Y +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  YV 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPYVA 175
Query: 224 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 176 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score =  108 bits (269), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 117/228 (51%), Gaps = 16/228 (7%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ--LDH 104
           +ELG+I G G  S+V  A+ +      A+K++        + + Y++  R   +   L+H
Sbjct: 14  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADL--ARDPSFYLRFRREAQNAAALNH 71
Query: 105 PGVVRLFFTFQDTFSL----YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
           P +V ++ T +         Y+ +E  +G  L D + ++G ++   A    A+   AL +
Sbjct: 72  PAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
            H  G+IHRD+KP N++++A   +K+ DFG  + + DS  +V   AA        +GTA 
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA-------VIGTAQ 184
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK-DTSEWLIFQRI 267
           Y+ PE          +D+++LGC LY++L+G  PF  D+   + +Q +
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 232

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 136/276 (49%), Gaps = 33/276 (11%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G++ KV +AK  +TG + A K+++ K  ++E    Y+ +E  +L   DHP +V+L   
Sbjct: 20  GDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYI-VEIEILATCDHPYIVKLLGA 76
Query: 114 FQDTFSLYMALESCEGGELFDQIT---SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 170
           +     L++ +E C GG + D I     +G L+E + +    ++++AL ++HS  +IHRD
Sbjct: 77  YYHDGKLWIMIEFCPGGAV-DAIMLELDRG-LTEPQIQVVCRQMLEALNFLHSKRIIHRD 134
Query: 171 IKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV--- 226
           +K  N+L+T +G I++ADFG S K           N  +  K  +F+GT  ++ PEV   
Sbjct: 135 LKAGNVLMTLEGDIRLADFGVSAK-----------NLKTLQKRDSFIGTPYWMAPEVVMC 183
Query: 227 --LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRFPNYFSXX 281
             +  +P  +  D+W+LG TL +M     P  + +   +  +I   D   +  P+ +S  
Sbjct: 184 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVE 243
Query: 282 XXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
                       P  RP A     A L  HPF   I
Sbjct: 244 FRDFLKIALDKNPETRPSA-----AQLLEHPFVSSI 274

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 115/222 (51%), Gaps = 19/222 (8%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           ++D++L +  G G+Y +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  YV 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPYVA 175
Query: 224 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 176 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 115/222 (51%), Gaps = 19/222 (8%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           ++D++L +  G G+Y +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  YV 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPYVA 175
Query: 224 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 176 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 115/222 (51%), Gaps = 19/222 (8%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           ++D++L +  G G+Y +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  YV 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPYVA 175
Query: 224 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 176 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 117/228 (51%), Gaps = 16/228 (7%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ--LDH 104
           +ELG+I G G  S+V  A+ +      A+K++        + + Y++  R   +   L+H
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADL--ARDPSFYLRFRREAQNAAALNH 71
Query: 105 PGVVRLFFTFQDTFSL----YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
           P +V ++ T +         Y+ +E  +G  L D + ++G ++   A    A+   AL +
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
            H  G+IHRD+KP N++++A   +K+ DFG  + + DS  +V   AA        +GTA 
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA-------VIGTAQ 184
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK-DTSEWLIFQRI 267
           Y+ PE          +D+++LGC LY++L+G  PF  D+   + +Q +
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 232

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 79/267 (29%), Positives = 123/267 (46%), Gaps = 36/267 (13%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFI---TKENKTAYVKLERIVLDQL 102
           ++ LG + G G +  V    ++      A+K++ +  +   +  + +    LE  +L ++
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 103 D----HPGVVRLFFTFQDTFSLYMALE-SCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
                HPGV+RL   F+      + LE      +LFD IT KG L E  +R +  +VV A
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA 151
Query: 158 LEYIHSMGLIHRDIKPENLLL-TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           +++ HS G++HRDIK EN+L+    G  K+ DFGS   + D   T             F 
Sbjct: 152 IQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYT------------DFD 199
Query: 217 GTAAYVPPEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 271
           GT  Y PPE +     ++ PAT    +W+LG  LY M+ G  PF+        Q I+  +
Sbjct: 200 GTRVYSPPEWISRHQYHALPAT----VWSLGILLYDMVCGDIPFERD------QEILEAE 249
Query: 272 IRFPNYFSXXXXXXXXXXXXXXPSGRP 298
           + FP + S              PS RP
Sbjct: 250 LHFPAHVSPDCCALIRRCLAPKPSSRP 276

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 117/228 (51%), Gaps = 16/228 (7%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ--LDH 104
           +ELG+I G G  S+V  A+ +      A+K++        + + Y++  R   +   L+H
Sbjct: 14  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADL--ARDPSFYLRFRREAQNAAALNH 71
Query: 105 PGVVRLFFTFQDTFSL----YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
           P +V ++ T +         Y+ +E  +G  L D + ++G ++   A    A+   AL +
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
            H  G+IHRD+KP N++++A   +K+ DFG  + + DS  +V   AA        +GTA 
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA-------VIGTAQ 184
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK-DTSEWLIFQRI 267
           Y+ PE          +D+++LGC LY++L+G  PF  D+   + +Q +
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 232

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 115/222 (51%), Gaps = 19/222 (8%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           ++D++L +  G G+Y +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  YV 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPYVA 174
Query: 224 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 175 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 115/222 (51%), Gaps = 19/222 (8%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           ++D++L +  G G+Y +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  YV 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPYVA 174
Query: 224 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 175 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 115/222 (51%), Gaps = 19/222 (8%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           ++D++L +  G G+Y +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  YV 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPYVA 175
Query: 224 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 176 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 115/222 (51%), Gaps = 19/222 (8%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           ++D++L +  G G+Y +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 61
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  YV 
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPYVA 173
Query: 224 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 174 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 211

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 115/222 (51%), Gaps = 19/222 (8%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           ++D++L +  G G+Y +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  YV 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPYVA 174
Query: 224 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 175 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 115/222 (51%), Gaps = 19/222 (8%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           ++D++L +  G G+Y +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEIXINKMLN 62
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  YV 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPYVA 174
Query: 224 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 175 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 115/222 (51%), Gaps = 19/222 (8%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           ++D++L +  G G+Y +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  YV 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPYVA 174
Query: 224 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 175 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 115/222 (51%), Gaps = 19/222 (8%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           ++D++L +  G G+Y +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  YV 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPYVA 174
Query: 224 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 175 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 115/222 (51%), Gaps = 19/222 (8%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           ++D++L +  G G+Y +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINAMLN 63
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  YV 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPYVA 175
Query: 224 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 176 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 115/222 (51%), Gaps = 19/222 (8%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           ++D++L +  G G+Y +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  YV 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPYVA 175
Query: 224 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 176 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 117/228 (51%), Gaps = 16/228 (7%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ--LDH 104
           +ELG+I G G  S+V  A+ +      A+K++        + + Y++  R   +   L+H
Sbjct: 31  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADL--ARDPSFYLRFRREAQNAAALNH 88
Query: 105 PGVVRLFFTFQDTFSL----YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
           P +V ++ T +         Y+ +E  +G  L D + ++G ++   A    A+   AL +
Sbjct: 89  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 148
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
            H  G+IHRD+KP N++++A   +K+ DFG  + + DS  +V   AA        +GTA 
Sbjct: 149 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA-------VIGTAQ 201
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK-DTSEWLIFQRI 267
           Y+ PE          +D+++LGC LY++L+G  PF  D+   + +Q +
Sbjct: 202 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 249

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 112/222 (50%), Gaps = 19/222 (8%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           ++D++L +  G G+Y +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +G+ HRDIKPENLLL    ++KI+DFG          TV      +       GT  YV 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLA--------TVFRYNNRERLLNKMXGTLPYVA 174
Query: 224 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 175 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 112/222 (50%), Gaps = 19/222 (8%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           ++D++L +  G G+Y +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +G+ HRDIKPENLLL    ++KI+DFG          TV      +       GT  YV 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLA--------TVFRYNNRERLLNKMXGTLPYVA 174
Query: 224 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 175 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 112/222 (50%), Gaps = 19/222 (8%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           ++D++L +  G G+Y +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEIXINKMLN 62
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +G+ HRDIKPENLLL    ++KI+DFG          TV      +       GT  YV 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLA--------TVFRYNNRERLLNKMXGTLPYVA 174
Query: 224 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 175 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 74/231 (32%), Positives = 112/231 (48%), Gaps = 20/231 (8%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMD-KKFITKEN-KTAYVKLERIVLDQLDH 104
           +EL ++ G G +S V R    +TG  +A+KI+D  KF +     T  +K E  +   L H
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 87
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH----LSEDEARFYTAEVVDALEY 160
           P +V L  T+     LYM  E  +G +L  +I  +       SE  A  Y  ++++AL Y
Sbjct: 88  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 147
Query: 161 IHSMGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
            H   +IHRD+KP  +LL +  +   +K+  FG    + +S +           A   VG
Sbjct: 148 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV----------AGGRVG 197
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII 268
           T  ++ PEV+   P     D+W  G  L+ +LSG  PF  T E L F+ II
Sbjct: 198 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERL-FEGII 247

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 119/245 (48%), Gaps = 29/245 (11%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN---------KTAYVKLE 95
           Q ++   + G G  S V R     TG  +A+KIM+   +T E          + A  +  
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIME---VTAERLSPEQLEEVREATRRET 150
Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
            I+     HP ++ L  +++ +  +++  +    GELFD +T K  LSE E R     ++
Sbjct: 151 HILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLL 210
Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           +A+ ++H+  ++HRD+KPEN+LL  +  I+++DFG    ++             +K    
Sbjct: 211 EAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG-----------EKLREL 259
Query: 216 VGTAAYVPPEVLNSS----PATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA 269
            GT  Y+ PE+L  S       +G   DLWA G  L+ +L+G+ PF    + L+ + I+ 
Sbjct: 260 CGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIME 319
Query: 270 RDIRF 274
              +F
Sbjct: 320 GQYQF 324

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 112/222 (50%), Gaps = 19/222 (8%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           ++D++L +  G G+Y +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEIXINKMLN 63
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +G+ HRDIKPENLLL    ++KI+DFG          TV      +       GT  YV 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLA--------TVFRYNNRERLLNKMXGTLPYVA 175
Query: 224 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 176 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  105 bits (262), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 113/222 (50%), Gaps = 19/222 (8%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           ++D++L +  G G+Y +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +G+ HRDIKPENLLL    ++KI+DFG     + +    L N           GT  YV 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN--------KMXGTLPYVA 174
Query: 224 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 175 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 105/218 (48%), Gaps = 23/218 (10%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  +++ +  G G++  V R  +  TG  +A K +       E+    V+ E   +  L 
Sbjct: 50  LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV---MTPHESDKETVRKEIQTMSVLR 106
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIH 162
           HP +V L   F+D   + M  E   GGELF+++  + + +SEDEA  Y  +V   L ++H
Sbjct: 107 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 166
Query: 163 SMGLIHRDIKPENLLLTA--DGHIKIADFG---SVKPMQDSRITVLPNAASDDKACTFVG 217
               +H D+KPEN++ T      +K+ DFG    + P Q  ++T               G
Sbjct: 167 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--------------G 212
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           TA +  PEV    P  +  D+W++G   Y +LSG SPF
Sbjct: 213 TAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 250

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  105 bits (261), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 74/231 (32%), Positives = 112/231 (48%), Gaps = 20/231 (8%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMD-KKFITKEN-KTAYVKLERIVLDQLDH 104
           +EL ++ G G +S V R    +TG  +A+KI+D  KF +     T  +K E  +   L H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH----LSEDEARFYTAEVVDALEY 160
           P +V L  T+     LYM  E  +G +L  +I  +       SE  A  Y  ++++AL Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 161 IHSMGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
            H   +IHRD+KP  +LL +  +   +K+  FG    + +S +           A   VG
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV----------AGGRVG 195
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII 268
           T  ++ PEV+   P     D+W  G  L+ +LSG  PF  T E L F+ II
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERL-FEGII 245

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  104 bits (260), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 105/218 (48%), Gaps = 23/218 (10%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  +++ +  G G++  V R  +  TG  +A K +       E+    V+ E   +  L 
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV---MTPHESDKETVRKEIQTMSVLR 212
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIH 162
           HP +V L   F+D   + M  E   GGELF+++  + + +SEDEA  Y  +V   L ++H
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 272
Query: 163 SMGLIHRDIKPENLLLTA--DGHIKIADFG---SVKPMQDSRITVLPNAASDDKACTFVG 217
               +H D+KPEN++ T      +K+ DFG    + P Q  ++T               G
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--------------G 318
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           TA +  PEV    P  +  D+W++G   Y +LSG SPF
Sbjct: 319 TAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 356

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 122/247 (49%), Gaps = 24/247 (9%)
Query: 41  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 100
           H   +++E  +I G G  S V R     T   YA+KI+D       +     +L    L 
Sbjct: 13  HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 72
Query: 101 QLD-------HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 153
           ++D       HP +++L  T++     ++  +  + GELFD +T K  LSE E R     
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132
Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           +++ +  +H + ++HRD+KPEN+LL  D +IK+ DFG    +              +K  
Sbjct: 133 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-----------EKLR 181
Query: 214 TFVGTAAYVPPEV----LNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
           +  GT +Y+ PE+    +N +   +G   D+W+ G  +Y +L+G+ PF    + L+ + I
Sbjct: 182 SVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 241
Query: 268 IARDIRF 274
           ++ + +F
Sbjct: 242 MSGNYQF 248

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 72/220 (32%), Positives = 111/220 (50%), Gaps = 18/220 (8%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P+E F+    +L +I G GS+ +V +     T  V A+KI+D      E++   ++ E  
Sbjct: 17  PEELFT----KLDRI-GKGSFGEVYKGIDNHTKEVVAIKIID--LEEAEDEIEDIQQEIT 69
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           VL Q D P + R F ++  +  L++ +E   GG   D +   G L E        E++  
Sbjct: 70  VLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKG 128
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           L+Y+HS   IHRDIK  N+LL+  G +K+ADFG    + D++I          K   FVG
Sbjct: 129 LDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI----------KRNXFVG 178
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD 257
           T  ++ PEV+  S   F  D+W+LG T  ++  G  P  D
Sbjct: 179 TPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSD 218

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 124/250 (49%), Gaps = 30/250 (12%)
Query: 41  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 100
           H   +++E  +I G G  S V R     T   YA+KI+D       +     +L    L 
Sbjct: 13  HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 72
Query: 101 QLD-------HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 153
           ++D       HP +++L  T++     ++  +  + GELFD +T K  LSE E R     
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132
Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG---SVKPMQDSRITVLPNAASDD 210
           +++ +  +H + ++HRD+KPEN+LL  D +IK+ DFG    + P +  R           
Sbjct: 133 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR----------- 181
Query: 211 KACTFVGTAAYVPPEV----LNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIF 264
           + C   GT +Y+ PE+    +N +   +G   D+W+ G  +Y +L+G+ PF    + L+ 
Sbjct: 182 EVC---GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 238
Query: 265 QRIIARDIRF 274
           + I++ + +F
Sbjct: 239 RMIMSGNYQF 248

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 114/222 (51%), Gaps = 19/222 (8%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           ++D++L +  G G+  +V  A    T    A+KI+D K     +    +K E  +   L+
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +G+ HRDIKPENLLL    ++KI+DFG     + +    L N     K C   GT  YV 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-----KMC---GTLPYVA 174
Query: 224 PEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           PE+L     ++ P     D+W+ G  L  ML+G  P+   S+
Sbjct: 175 PELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 131/285 (45%), Gaps = 31/285 (10%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           DFE   + G G++ +VV+A+       YA+K    K    E K + +  E ++L  L+H 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIK----KIRHTEEKLSTILSEVMLLASLNHQ 62
Query: 106 GVVRLFFTF-------------QDTFSLYMALESCEGGELFDQITSKG-HLSEDEARFYT 151
            VVR +  +             +   +L++ +E CE G L+D I S+  +   DE     
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 152 AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV------LPN 205
            ++++AL YIHS G+IHRD+KP N+ +    ++KI DFG  K +  S   +      LP 
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP- 181
Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGN-DLWALGCTLYQMLSGTSPFKDTSEWL-I 263
             S D   + +GTA YV  EVL+ +       D+++LG   ++M+    PF    E + I
Sbjct: 182 -GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNI 237
Query: 264 FQRIIARDIRFPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVL 308
            +++ +  I FP  F                   P   PG   +L
Sbjct: 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 114/215 (53%), Gaps = 17/215 (7%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           ++ G G+Y+KV  A  +  G  YA+KI++K+     ++  + ++E +   Q  +  ++ L
Sbjct: 19  ELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRV-FREVETLYQCQ-GNKNILEL 76
Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 170
              F+D    Y+  E  +GG +   I  + H +E EA     +V  AL+++H+ G+ HRD
Sbjct: 77  IEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRD 136
Query: 171 IKPENLLLTADGH---IKIADF--GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 225
           +KPEN+L  +      +KI DF  GS   + +S   +     +  +  T  G+A Y+ PE
Sbjct: 137 LKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPI-----TTPELTTPCGSAEYMAPE 191
Query: 226 VLN--SSPATFGN---DLWALGCTLYQMLSGTSPF 255
           V+   +  ATF +   DLW+LG  LY MLSG  PF
Sbjct: 192 VVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPF 226

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 123/246 (50%), Gaps = 30/246 (12%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD- 103
           +++E  +I G G  S V R     T   YA+KI+D       +     +L    L ++D 
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 104 ------HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
                 HP +++L  T++     ++  +  + GELFD +T K  LSE E R     +++ 
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 123
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFG---SVKPMQDSRITVLPNAASDDKACT 214
           +  +H + ++HRD+KPEN+LL  D +IK+ DFG    + P +  R           + C 
Sbjct: 124 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR-----------EVC- 171
Query: 215 FVGTAAYVPPEV----LNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRII 268
             GT +Y+ PE+    +N +   +G   D+W+ G  +Y +L+G+ PF    + L+ + I+
Sbjct: 172 --GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 229
Query: 269 ARDIRF 274
           + + +F
Sbjct: 230 SGNYQF 235

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 106/223 (47%), Gaps = 21/223 (9%)
Query: 36  RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE 95
           + P+E F +    L K+ G GSY  V +A   +TG + A+K      +  E+    +  E
Sbjct: 25  KQPEEVFDV----LEKL-GEGSYGSVYKAIHKETGQIVAIK-----QVPVESDLQEIIKE 74
Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEV 154
             ++ Q D P VV+ + ++     L++ +E C  G + D I  +   L+EDE        
Sbjct: 75  ISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQST 134
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           +  LEY+H M  IHRDIK  N+LL  +GH K+ADFG    + D             K   
Sbjct: 135 LKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMA----------KRNX 184
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD 257
            +GT  ++ PEV+         D+W+LG T  +M  G  P+ D
Sbjct: 185 VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD 227

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 108/222 (48%), Gaps = 22/222 (9%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +D+E+    G GSY +  + ++   G +   K +D   +T+  K   V  E  +L +L H
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVS-EVNLLRELKH 64
Query: 105 PGVVRLFFTFQD--TFSLYMALESCEGGELFDQIT----SKGHLSEDEARFYTAEVVDAL 158
           P +VR +    D    +LY+ +E CEGG+L   IT     + +L E+       ++  AL
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 159 EYIHSMG-----LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           +  H        ++HRD+KP N+ L    ++K+ DFG  + +             +D A 
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD----------EDFAK 174
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            FVGT  Y+ PE +N       +D+W+LGC LY++ +   PF
Sbjct: 175 EFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 115/222 (51%), Gaps = 23/222 (10%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G++ KV +A+  +T  + A K++D K  ++E    Y+ +E  +L   DHP +V+L   
Sbjct: 46  GDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYM-VEIDILASCDHPNIVKLLDA 102
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSMGLIHRDI 171
           F    +L++ +E C GG + D +  +    L+E + +    + +DAL Y+H   +IHRD+
Sbjct: 103 FYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDL 161
Query: 172 KPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL--- 227
           K  N+L T DG IK+ADFG S K           N  +  +  +F+GT  ++ PEV+   
Sbjct: 162 KAGNILFTLDGDIKLADFGVSAK-----------NTRTIQRRDSFIGTPYWMAPEVVMCE 210
Query: 228 --NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
                P  +  D+W+LG TL +M     P  + +   +  +I
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI 252

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 112/227 (49%), Gaps = 22/227 (9%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +D+E+    G GSY +  + ++   G +   K +D   +T+  K   V  E  +L +L H
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVS-EVNLLRELKH 64
Query: 105 PGVVRLFFTFQD--TFSLYMALESCEGGELFDQIT----SKGHLSEDEARFYTAEVVDAL 158
           P +VR +    D    +LY+ +E CEGG+L   IT     + +L E+       ++  AL
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 159 EYIHSMG-----LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           +  H        ++HRD+KP N+ L    ++K+ DFG  +        +L +  S  K  
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR--------ILNHDTSFAK-- 174
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           TFVGT  Y+ PE +N       +D+W+LGC LY++ +   PF   S+
Sbjct: 175 TFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ 221

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 112/227 (49%), Gaps = 22/227 (9%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +D+E+    G GSY +  + ++   G +   K +D   +T+  K   V  E  +L +L H
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVS-EVNLLRELKH 64
Query: 105 PGVVRLFFTFQD--TFSLYMALESCEGGELFDQIT----SKGHLSEDEARFYTAEVVDAL 158
           P +VR +    D    +LY+ +E CEGG+L   IT     + +L E+       ++  AL
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 159 EYIHSMG-----LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           +  H        ++HRD+KP N+ L    ++K+ DFG  +        +L +  S  KA 
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR--------ILNHDTSFAKA- 175
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
            FVGT  Y+ PE +N       +D+W+LGC LY++ +   PF   S+
Sbjct: 176 -FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ 221

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 112/221 (50%), Gaps = 21/221 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G++ KV +A+  +T  + A K++D K  ++E    Y+ +E  +L   DHP +V+L   
Sbjct: 46  GDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYM-VEIDILASCDHPNIVKLLDA 102
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSMGLIHRDI 171
           F    +L++ +E C GG + D +  +    L+E + +    + +DAL Y+H   +IHRD+
Sbjct: 103 FYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDL 161
Query: 172 KPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL---- 227
           K  N+L T DG IK+ADFG              N     +  +F+GT  ++ PEV+    
Sbjct: 162 KAGNILFTLDGDIKLADFG----------VSAKNTRXIQRRDSFIGTPYWMAPEVVMCET 211
Query: 228 -NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
               P  +  D+W+LG TL +M     P  + +   +  +I
Sbjct: 212 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI 252

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  101 bits (252), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 110/217 (50%), Gaps = 18/217 (8%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P+E F+    +L KI G GS+ +V +     T  V A+KI+D      E++   ++ E  
Sbjct: 5   PEELFT----KLEKI-GKGSFGEVFKGIDNRTQKVVAIKIID--LEEAEDEIEDIQQEIT 57
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           VL Q D P V + + ++     L++ +E   GG   D +   G L E +      E++  
Sbjct: 58  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKG 116
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           L+Y+HS   IHRDIK  N+LL+  G +K+ADFG    + D++I          K  TFVG
Sbjct: 117 LDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI----------KRNTFVG 166
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 254
           T  ++ PEV+  S      D+W+LG T  ++  G  P
Sbjct: 167 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 111/222 (50%), Gaps = 18/222 (8%)
Query: 33  FAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYV 92
           F    P+E F+    +L KI G GS+ +V +     T  V A+KI+D      E++   +
Sbjct: 20  FQSMDPEELFT----KLEKI-GKGSFGEVFKGIDNRTQKVVAIKIID--LEEAEDEIEDI 72
Query: 93  KLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTA 152
           + E  VL Q D P V + + ++     L++ +E   GG   D +   G L E +      
Sbjct: 73  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILR 131
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           E++  L+Y+HS   IHRDIK  N+LL+  G +K+ADFG    + D++I          K 
Sbjct: 132 EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI----------KR 181
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 254
            TFVGT  ++ PEV+  S      D+W+LG T  ++  G  P
Sbjct: 182 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 223

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 113/222 (50%), Gaps = 23/222 (10%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G++ KV +A+  +T  + A K++D K  ++E    Y+ +E  +L   DHP +V+L   
Sbjct: 46  GDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYM-VEIDILASCDHPNIVKLLDA 102
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSMGLIHRDI 171
           F    +L++ +E C GG + D +  +    L+E + +    + +DAL Y+H   +IHRD+
Sbjct: 103 FYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDL 161
Query: 172 KPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL--- 227
           K  N+L T DG IK+ADFG S K           N     +   F+GT  ++ PEV+   
Sbjct: 162 KAGNILFTLDGDIKLADFGVSAK-----------NTRXIQRRDXFIGTPYWMAPEVVMCE 210
Query: 228 --NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
                P  +  D+W+LG TL +M     P  + +   +  +I
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI 252

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 130/285 (45%), Gaps = 31/285 (10%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           DFE   + G G++ +VV+A+       YA+K    K    E K + +  E ++L  L+H 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIK----KIRHTEEKLSTILSEVMLLASLNHQ 62
Query: 106 GVVRLFFTF-------------QDTFSLYMALESCEGGELFDQITSKG-HLSEDEARFYT 151
            VVR +  +             +   +L++ +E CE   L+D I S+  +   DE     
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLF 122
Query: 152 AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV------LPN 205
            ++++AL YIHS G+IHRD+KP N+ +    ++KI DFG  K +  S   +      LP 
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP- 181
Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGN-DLWALGCTLYQMLSGTSPFKDTSEWL-I 263
             S D   + +GTA YV  EVL+ +       D+++LG   ++M+    PF    E + I
Sbjct: 182 -GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNI 237
Query: 264 FQRIIARDIRFPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVL 308
            +++ +  I FP  F                   P   PG   +L
Sbjct: 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 120/281 (42%), Gaps = 54/281 (19%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN--KTAYVKLERIVLDQL 102
           + + L    G GSY  V  A +  T  + A+KIM+K  I + N      +K E  ++ +L
Sbjct: 26  KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTA----- 152
            HP + RL+  ++D   + + +E C GG L D++      S G  + D  +         
Sbjct: 86  HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145
Query: 153 ------------------------------EVVDALEYIHSMGLIHRDIKPENLLLTADG 182
                                         ++  AL Y+H+ G+ HRDIKPEN L + + 
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205
Query: 183 --HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFG--NDL 238
              IK+ DFG  K           N        T  GT  +V PEVLN++  ++G   D 
Sbjct: 206 SFEIKLVDFGLSKEFYKL------NNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259
Query: 239 WALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF--PNY 277
           W+ G  L+ +L G  PF   ++     +++ + + F  PNY
Sbjct: 260 WSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNY 300

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 109/214 (50%), Gaps = 14/214 (6%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS   V  A +  TG   A+K MD   + K+ +   +  E +++    H  VV ++ +
Sbjct: 54  GEGSTGIVCIATEKHTGKQVAVKKMD---LRKQQRRELLFNEVVIMRDYHHDNVVDMYSS 110
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +     L++ +E  EGG L D I +   ++E++       V+ AL Y+H+ G+IHRDIK 
Sbjct: 111 YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKS 169
Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
           +++LLT+DG IK++DFG    +          +    K    VGT  ++ PEV++  P  
Sbjct: 170 DSILLTSDGRIKLSDFGFCAQV----------SKEVPKRKXLVGTPYWMAPEVISRLPYG 219
Query: 234 FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
              D+W+LG  + +M+ G  P+ +       +RI
Sbjct: 220 TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI 253

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 108/202 (53%), Gaps = 14/202 (6%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS   V  A++  +G   A+K+MD   + K+ +   +  E +++    H  VV ++ +
Sbjct: 54  GEGSTGIVCLAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +     L++ +E  +GG L D I S+  L+E++       V+ AL Y+H+ G+IHRDIK 
Sbjct: 111 YLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKS 169
Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
           +++LLT DG +K++DFG    +       +P      K    VGT  ++ PEV++ S   
Sbjct: 170 DSILLTLDGRVKLSDFGFCAQISKD----VP------KRKXLVGTPYWMAPEVISRSLYA 219
Query: 234 FGNDLWALGCTLYQMLSGTSPF 255
              D+W+LG  + +M+ G  P+
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPPY 241

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 109/217 (50%), Gaps = 18/217 (8%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P+E F+    +L KI G GS+ +V +     T  V A+KI+D      E++   ++ E  
Sbjct: 20  PEELFT----KLEKI-GKGSFGEVFKGIDNRTQKVVAIKIID--LEEAEDEIEDIQQEIT 72
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           VL Q D P V + + ++     L++ +E   GG   D +   G L E +      E++  
Sbjct: 73  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKG 131
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           L+Y+HS   IHRDIK  N+LL+  G +K+ADFG    + D++I          K   FVG
Sbjct: 132 LDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI----------KRNXFVG 181
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 254
           T  ++ PEV+  S      D+W+LG T  ++  G  P
Sbjct: 182 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 114/216 (52%), Gaps = 21/216 (9%)
Query: 52  IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ-LDHPGVVRL 110
           + G G+Y  V   + +       ++I  K+   ++++ +    E I L + L H  +V+ 
Sbjct: 29  VLGKGTYGIVYAGRDLSN----QVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQY 84
Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEAR--FYTAEVVDALEYIHSMGLI 167
             +F +   + + +E   GG L   + SK G L ++E    FYT ++++ L+Y+H   ++
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 144
Query: 168 HRDIKPENLLL-TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 226
           HRDIK +N+L+ T  G +KI+DFG+ K +          A  +    TF GT  Y+ PE+
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRL----------AGINPCTETFTGTLQYMAPEI 194
Query: 227 LNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSE 260
           ++  P  +G   D+W+LGCT+ +M +G  PF +  E
Sbjct: 195 IDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE 230

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 109/217 (50%), Gaps = 18/217 (8%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P+E F+    +L KI G GS+ +V +     T  V A+KI+D      E++   ++ E  
Sbjct: 5   PEELFT----KLEKI-GKGSFGEVFKGIDNRTQKVVAIKIID--LEEAEDEIEDIQQEIT 57
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           VL Q D P V + + ++     L++ +E   GG   D +   G L E +      E++  
Sbjct: 58  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKG 116
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           L+Y+HS   IHRDIK  N+LL+  G +K+ADFG    + D++I          K   FVG
Sbjct: 117 LDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI----------KRNXFVG 166
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 254
           T  ++ PEV+  S      D+W+LG T  ++  G  P
Sbjct: 167 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 114/216 (52%), Gaps = 21/216 (9%)
Query: 52  IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ-LDHPGVVRL 110
           + G G+Y  V   + +       ++I  K+   ++++ +    E I L + L H  +V+ 
Sbjct: 15  VLGKGTYGIVYAGRDLSN----QVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQY 70
Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEAR--FYTAEVVDALEYIHSMGLI 167
             +F +   + + +E   GG L   + SK G L ++E    FYT ++++ L+Y+H   ++
Sbjct: 71  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 130
Query: 168 HRDIKPENLLL-TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 226
           HRDIK +N+L+ T  G +KI+DFG+ K +          A  +    TF GT  Y+ PE+
Sbjct: 131 HRDIKGDNVLINTYSGVLKISDFGTSKRL----------AGINPCTETFTGTLQYMAPEI 180
Query: 227 LNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSE 260
           ++  P  +G   D+W+LGCT+ +M +G  PF +  E
Sbjct: 181 IDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE 216

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL---ERIVLDQLDH 104
           ++GKI G GSY  V + +  DTG + A+K    KF+  E+     K+   E  +L QL H
Sbjct: 7   KIGKI-GEGSYGVVFKCRNRDTGQIVAIK----KFLESEDDPVIKKIALREIRMLKQLKH 61
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P +V L   F+    L++  E C+   L +    +  + E   +  T + + A+ + H  
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             IHRD+KPEN+L+T    IK+ DFG       +R+   P+   DD+    V T  Y  P
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGF------ARLLTGPSDYYDDE----VATRWYRSP 171
Query: 225 EVLNSSPATFGN--DLWALGCTLYQMLSGT 252
           E+L      +G   D+WA+GC   ++LSG 
Sbjct: 172 ELLVGD-TQYGPPVDVWAIGCVFAELLSGV 200

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 104 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 70  SGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 129
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 130 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 177
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 178 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 230
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 231 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 265

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 104 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 98  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 157
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 158 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 205
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 206 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQR 258
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 259 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 293

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 131/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 104 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 98  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 157
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 158 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 205
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 206 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQR 258
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 259 VSXECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 293

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 39  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 98
Query: 104 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 99  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 158
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 159 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 206
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 207 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQR 259
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 260 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 294

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 39  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 98
Query: 104 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 99  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 158
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 159 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 206
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 207 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQR 259
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 260 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 294

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 104 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 98  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 157
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 158 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 205
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 206 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQR 258
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 259 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 293

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 131/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 39  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 98
Query: 104 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 99  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 158
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 159 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 206
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 207 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQR 259
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 260 VSXECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 294

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 131/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 39  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 98
Query: 104 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 99  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 158
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 159 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 206
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 207 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQR 259
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 260 VSXECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 294

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 25  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 84
Query: 104 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 85  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 144
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 145 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 192
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 193 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 245
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 246 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 280

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 104 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 173
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 174 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQR 226
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 227 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 261

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 26  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 85
Query: 104 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 86  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 145
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 146 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 193
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 194 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 246
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 247 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 281

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 104 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 70  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 129
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 130 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 177
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 178 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 230
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 231 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 265

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 104 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 178
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 179 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 231
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 232 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 266

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 104 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 178
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 179 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 231
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 232 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 266

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 104 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 98  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 157
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 158 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 205
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 206 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 258
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 259 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 293

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 104 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 178
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 179 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 231
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 232 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 266

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 131/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 26  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 85
Query: 104 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 86  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 145
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 146 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 193
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 194 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 246
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 247 VSXECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 281

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 131/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 25  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 84
Query: 104 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 85  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 144
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 145 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 192
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 193 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 245
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 246 VSXECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 280

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 53  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 112
Query: 104 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 113 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 172
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 173 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 220
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 221 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 273
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 274 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 308

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 45  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104
Query: 104 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 105 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 164
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 165 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 212
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 213 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 265
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 266 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 300

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 90/173 (52%), Gaps = 11/173 (6%)
Query: 85  KENKTAYVKLERIVLD--QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHL 142
           +E +    + ER V +  QL H  +V +    ++    Y+ +E  EG  L + I S G L
Sbjct: 49  REKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPL 108
Query: 143 SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV 202
           S D A  +T +++D +++ H M ++HRDIKP+N+L+ ++  +KI DFG  K + ++ +T 
Sbjct: 109 SVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT- 167
Query: 203 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
                   +    +GT  Y  PE           D++++G  LY+ML G  PF
Sbjct: 168 --------QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPF 212

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 9   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 68
Query: 104 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 69  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 128
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 129 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 176
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 177 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 229
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 230 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 264

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 131/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 53  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 112
Query: 104 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 113 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 172
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 173 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 220
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 221 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 273
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 274 VSXECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 308

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 131/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 58  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 117
Query: 104 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 118 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 177
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 178 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 225
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 226 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 278
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 279 VSXECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 313

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 104 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 173
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 174 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 226
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 227 VSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 261

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 110/220 (50%), Gaps = 18/220 (8%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P+E F+    +L +I G GS+ +V +     T  V A+KI+D      E++   ++ E  
Sbjct: 21  PEELFT----KLERI-GKGSFGEVFKGIDNRTQQVVAIKIID--LEEAEDEIEDIQQEIT 73
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           VL Q D   V + + ++     L++ +E   GG   D + + G   E +      E++  
Sbjct: 74  VLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKG 132
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           L+Y+HS   IHRDIK  N+LL+  G +K+ADFG    + D++I          K  TFVG
Sbjct: 133 LDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI----------KRNTFVG 182
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD 257
           T  ++ PEV+  S      D+W+LG T  ++  G  P  D
Sbjct: 183 TPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSD 222

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 131/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 33  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 92
Query: 104 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 93  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 152
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 153 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 200
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 201 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 253
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 254 VSXECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 288

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 117/228 (51%), Gaps = 34/228 (14%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           FEL ++ G G+Y +V + + + TG + A+K+MD   +T + +   +K E  +L +  H  
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEE-IKQEINMLKKYSHH- 80
Query: 107 VVRLFFTFQDTF----------SLYMALESCEGGELFDQI-TSKGH-LSEDEARFYTAEV 154
             R   T+   F           L++ +E C  G + D I  +KG+ L E+   +   E+
Sbjct: 81  --RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 138
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           +  L ++H   +IHRDIK +N+LLT +  +K+ DFG V    D  +          +  T
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG-VSAQLDRTV---------GRRNT 188
Query: 215 FVGTAAYVPPEVL--NSSP-AT--FGNDLWALGCTLYQMLSGTSPFKD 257
           F+GT  ++ PEV+  + +P AT  F +DLW+LG T  +M  G  P  D
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 236

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 131/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 104 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 126 CHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 173
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 174 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 226
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              PS RP      +  ++ HP+ + +
Sbjct: 227 VSXECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 261

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT---AYVKLERIVLDQLD 103
           +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++ 
Sbjct: 26  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 85
Query: 104 --HPGVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEY 160
               GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ +
Sbjct: 86  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 145
Query: 161 IHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT 
Sbjct: 146 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTR 193
Query: 220 AYVPPEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
            Y PPE +       G    +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 194 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 246
Query: 278 FSXXXXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
            S              P  RP      +  ++ HP+ + +
Sbjct: 247 VSXECQHLIRWCLALRPXDRP-----TFEEIQNHPWMQDV 281

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 121/255 (47%), Gaps = 27/255 (10%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           + DFE  +  G G +  V  AK       YA+K +  +   +E     V  E   L +L+
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI--RLPNRELAREKVMREVKALAKLE 61
Query: 104 HPGVVRLFFTFQDTFS------------LYMALESCEGGELFDQITSKGHLSEDEARFYT 151
           HPG+VR F  + +  +            LY+ ++ C    L D +  +  + E E     
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 152 ---AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM--QDSRITVLPNA 206
               ++ +A+E++HS GL+HRD+KP N+  T D  +K+ DFG V  M   +   TVL   
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 207 ASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQR 266
            +  +    VGT  Y+ PE ++ +  +   D+++LG  L+++L    PF    E +   R
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFSTQMERV---R 235
Query: 267 II--ARDIRFPNYFS 279
            +   R+++FP  F+
Sbjct: 236 TLTDVRNLKFPPLFT 250

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 103/202 (50%), Gaps = 14/202 (6%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS   V  A    +G + A+K MD   + K+ +   +  E +++    H  VV ++ +
Sbjct: 160 GEGSTGIVCIATVRSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYNS 216
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +     L++ +E  EGG L D I +   ++E++       V+ AL  +H+ G+IHRDIK 
Sbjct: 217 YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKS 275
Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
           +++LLT DG +K++DFG    +          +    +    VGT  ++ PE+++  P  
Sbjct: 276 DSILLTHDGRVKLSDFGFCAQV----------SKEVPRRKXLVGTPYWMAPELISRLPYG 325
Query: 234 FGNDLWALGCTLYQMLSGTSPF 255
              D+W+LG  + +M+ G  P+
Sbjct: 326 PEVDIWSLGIMVIEMVDGEPPY 347

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 103/202 (50%), Gaps = 14/202 (6%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS   V  A    +G + A+K MD   + K+ +   +  E +++    H  VV ++ +
Sbjct: 83  GEGSTGIVCIATVRSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYNS 139
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +     L++ +E  EGG L D I +   ++E++       V+ AL  +H+ G+IHRDIK 
Sbjct: 140 YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKS 198
Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
           +++LLT DG +K++DFG    +          +    +    VGT  ++ PE+++  P  
Sbjct: 199 DSILLTHDGRVKLSDFGFCAQV----------SKEVPRRKXLVGTPYWMAPELISRLPYG 248
Query: 234 FGNDLWALGCTLYQMLSGTSPF 255
              D+W+LG  + +M+ G  P+
Sbjct: 249 PEVDIWSLGIMVIEMVDGEPPY 270

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/249 (29%), Positives = 123/249 (49%), Gaps = 23/249 (9%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER--IVLDQ 101
           ++ +EL K  G G+Y  V ++    TG V A+K   K F   +N T   +  R  ++L +
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK---KIFDAFQNSTDAQRTFREIMILTE 64
Query: 102 LD-HPGVVRLFFTFQ--DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
           L  H  +V L    +  +   +Y+  +  E       +     L     ++   +++  +
Sbjct: 65  LSGHENIVNLLNVLRADNDRDVYLVFDYMETD--LHAVIRANILEPVHKQYVVYQLIKVI 122
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR-------ITVLPNAAS--D 209
           +Y+HS GL+HRD+KP N+LL A+ H+K+ADFG  +   + R       +++  N  +  D
Sbjct: 123 KYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182
Query: 210 DKACT--FVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQR 266
           D+     +V T  Y  PE+ L S+  T G D+W+LGC L ++L G   F  +S     +R
Sbjct: 183 DQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242
Query: 267 IIARDIRFP 275
           II   I FP
Sbjct: 243 IIGV-IDFP 250

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 103/202 (50%), Gaps = 14/202 (6%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS   V  A    +G + A+K MD   + K+ +   +  E +++    H  VV ++ +
Sbjct: 40  GEGSTGIVCIATVRSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYNS 96
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +     L++ +E  EGG L D I +   ++E++       V+ AL  +H+ G+IHRDIK 
Sbjct: 97  YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKS 155
Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
           +++LLT DG +K++DFG    +          +    +    VGT  ++ PE+++  P  
Sbjct: 156 DSILLTHDGRVKLSDFGFCAQV----------SKEVPRRKXLVGTPYWMAPELISRLPYG 205
Query: 234 FGNDLWALGCTLYQMLSGTSPF 255
              D+W+LG  + +M+ G  P+
Sbjct: 206 PEVDIWSLGIMVIEMVDGEPPY 227

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 103/202 (50%), Gaps = 14/202 (6%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS   V  A    +G + A+K MD   + K+ +   +  E +++    H  VV ++ +
Sbjct: 38  GEGSTGIVCIATVRSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYNS 94
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +     L++ +E  EGG L D I +   ++E++       V+ AL  +H+ G+IHRDIK 
Sbjct: 95  YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKS 153
Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
           +++LLT DG +K++DFG    +          +    +    VGT  ++ PE+++  P  
Sbjct: 154 DSILLTHDGRVKLSDFGFCAQV----------SKEVPRRKXLVGTPYWMAPELISRLPYG 203
Query: 234 FGNDLWALGCTLYQMLSGTSPF 255
              D+W+LG  + +M+ G  P+
Sbjct: 204 PEVDIWSLGIMVIEMVDGEPPY 225

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 127/285 (44%), Gaps = 31/285 (10%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           DFE   + G G++ +VV+A+       YA+K    K    E K + +  E  +L  L+H 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIK----KIRHTEEKLSTILSEVXLLASLNHQ 62
Query: 106 GVVRLFFTF-------------QDTFSLYMALESCEGGELFDQITSKG-HLSEDEARFYT 151
            VVR +  +             +   +L++  E CE   L+D I S+  +   DE     
Sbjct: 63  YVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLF 122
Query: 152 AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV------LPN 205
            ++++AL YIHS G+IHR++KP N+ +    ++KI DFG  K +  S   +      LP 
Sbjct: 123 RQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP- 181
Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGN-DLWALGCTLYQMLSGTSPFKDTSEWL-I 263
             S D   + +GTA YV  EVL+ +       D ++LG   ++ +    PF    E + I
Sbjct: 182 -GSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI---YPFSTGXERVNI 237
Query: 264 FQRIIARDIRFPNYFSXXXXXXXXXXXXXXPSGRPGAGPGGYAVL 308
            +++ +  I FP  F                   P   PG   +L
Sbjct: 238 LKKLRSVSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLL 282

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 103/202 (50%), Gaps = 14/202 (6%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS   V  A    +G + A+K MD   + K+ +   +  E +++    H  VV ++ +
Sbjct: 29  GEGSTGIVCIATVRSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +     L++ +E  EGG L D I +   ++E++       V+ AL  +H+ G+IHRDIK 
Sbjct: 86  YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKS 144
Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
           +++LLT DG +K++DFG    +          +    +    VGT  ++ PE+++  P  
Sbjct: 145 DSILLTHDGRVKLSDFGFCAQV----------SKEVPRRKXLVGTPYWMAPELISRLPYG 194
Query: 234 FGNDLWALGCTLYQMLSGTSPF 255
              D+W+LG  + +M+ G  P+
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPY 216

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 103/202 (50%), Gaps = 14/202 (6%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS   V  A    +G + A+K MD   + K+ +   +  E +++    H  VV ++ +
Sbjct: 33  GEGSTGIVCIATVRSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYNS 89
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +     L++ +E  EGG L D I +   ++E++       V+ AL  +H+ G+IHRDIK 
Sbjct: 90  YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKS 148
Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT 233
           +++LLT DG +K++DFG    +          +    +    VGT  ++ PE+++  P  
Sbjct: 149 DSILLTHDGRVKLSDFGFCAQV----------SKEVPRRKXLVGTPYWMAPELISRLPYG 198
Query: 234 FGNDLWALGCTLYQMLSGTSPF 255
              D+W+LG  + +M+ G  P+
Sbjct: 199 PEVDIWSLGIMVIEMVDGEPPY 220

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 44  IQDFEL-GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           I D+++  ++ G+G   KV++     T   +ALK++      +     + +  +      
Sbjct: 60  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 114
Query: 103 DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 156
             P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + +
Sbjct: 115 --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 172
Query: 157 ALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           A++Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K              S +   
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTSHNSLT 221
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           T   T  YV PEVL         D+W+LG  +Y +L G  PF
Sbjct: 222 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 263

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 104/222 (46%), Gaps = 27/222 (12%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           +E+ +  G G +  V+R    DTG   A+K   ++ ++ +N+  +  LE  ++ +L+HP 
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIK-QCRQELSPKNRERWC-LEIQIMKKLNHPN 74
Query: 107 VVRLFFTFQDTFSL------YMALESCEGGEL---FDQITSKGHLSEDEARFYTAEVVDA 157
           VV           L       +A+E CEGG+L    +Q  +   L E   R   +++  A
Sbjct: 75  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 134
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI---KIADFGSVKPMQDSRITVLPNAASDDKACT 214
           L Y+H   +IHRD+KPEN++L         KI D G  K +    +            CT
Sbjct: 135 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL------------CT 182
Query: 215 -FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            FVGT  Y+ PE+L     T   D W+ G   ++ ++G  PF
Sbjct: 183 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 44  IQDFEL-GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           I D+++  ++ G+G   KV++     T   +ALK++      +     + +  +      
Sbjct: 66  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 120
Query: 103 DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 156
             P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + +
Sbjct: 121 --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 178
Query: 157 ALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           A++Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K              S +   
Sbjct: 179 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTSHNSLT 227
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           T   T  YV PEVL         D+W+LG  +Y +L G  PF
Sbjct: 228 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 269

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 104/222 (46%), Gaps = 27/222 (12%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           +E+ +  G G +  V+R    DTG   A+K   ++ ++ +N+  +  LE  ++ +L+HP 
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIK-QCRQELSPKNRERWC-LEIQIMKKLNHPN 73
Query: 107 VVRLFFTFQDTFSL------YMALESCEGGEL---FDQITSKGHLSEDEARFYTAEVVDA 157
           VV           L       +A+E CEGG+L    +Q  +   L E   R   +++  A
Sbjct: 74  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI---KIADFGSVKPMQDSRITVLPNAASDDKACT 214
           L Y+H   +IHRD+KPEN++L         KI D G  K +    +            CT
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL------------CT 181
Query: 215 -FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            FVGT  Y+ PE+L     T   D W+ G   ++ ++G  PF
Sbjct: 182 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 44  IQDFEL-GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           I D+++  ++ G+G   KV++     T   +ALK++      +     + +  +      
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 70
Query: 103 DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 156
             P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + +
Sbjct: 71  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 157 ALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           A++Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K              S +   
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTSHNSLT 177
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           T   T  YV PEVL         D+W+LG  +Y +L G  PF
Sbjct: 178 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 219

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 44  IQDFEL-GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           I D+++  ++ G+G   KV++     T   +ALK++      +     + +  +      
Sbjct: 21  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 75
Query: 103 DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 156
             P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + +
Sbjct: 76  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 133
Query: 157 ALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           A++Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K              S +   
Sbjct: 134 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTSHNSLT 182
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           T   T  YV PEVL         D+W+LG  +Y +L G  PF
Sbjct: 183 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 224

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 44  IQDFEL-GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           I D+++  ++ G+G   KV++     T   +ALK++      +     + +  +      
Sbjct: 20  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 74
Query: 103 DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 156
             P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + +
Sbjct: 75  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 132
Query: 157 ALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           A++Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K              S +   
Sbjct: 133 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTSHNSLT 181
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           T   T  YV PEVL         D+W+LG  +Y +L G  PF
Sbjct: 182 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 223

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 44  IQDFEL-GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           I D+++  ++ G+G   KV++     T   +ALK++      +     + +  +      
Sbjct: 22  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 76
Query: 103 DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 156
             P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + +
Sbjct: 77  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 134
Query: 157 ALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           A++Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K              S +   
Sbjct: 135 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTSHNSLT 183
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           T   T  YV PEVL         D+W+LG  +Y +L G  PF
Sbjct: 184 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 225

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 44  IQDFEL-GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           I D+++  ++ G+G   KV++     T   +ALK++      +     + +  +      
Sbjct: 14  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 68
Query: 103 DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 156
             P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + +
Sbjct: 69  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 126
Query: 157 ALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           A++Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K              S +   
Sbjct: 127 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTSHNSLT 175
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           T   T  YV PEVL         D+W+LG  +Y +L G  PF
Sbjct: 176 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 217

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 44  IQDFEL-GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           I D+++  ++ G+G   KV++     T   +ALK++      +     + +  +      
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 70
Query: 103 DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 156
             P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + +
Sbjct: 71  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 157 ALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           A++Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K              S +   
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTSHNSLT 177
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           T   T  YV PEVL         D+W+LG  +Y +L G  PF
Sbjct: 178 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 219

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 44  IQDFEL-GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           I D+++  ++ G+G   KV++     T   +ALK++      +     + +  +      
Sbjct: 15  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 69
Query: 103 DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 156
             P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + +
Sbjct: 70  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 127
Query: 157 ALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           A++Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K              S +   
Sbjct: 128 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTSHNSLT 176
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           T   T  YV PEVL         D+W+LG  +Y +L G  PF
Sbjct: 177 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 218

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 44  IQDFEL-GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           I D+++  ++ G+G   KV++     T   +ALK++      +     + +  +      
Sbjct: 30  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 84
Query: 103 DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 156
             P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + +
Sbjct: 85  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 142
Query: 157 ALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           A++Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K              S +   
Sbjct: 143 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTSHNSLT 191
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           T   T  YV PEVL         D+W+LG  +Y +L G  PF
Sbjct: 192 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 233

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 26/212 (12%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL--DHPGVVRLF 111
           G G ++ V +     TG  YA K + K+   ++ +     L  I + +L    P V+ L 
Sbjct: 38  GRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEI--LHEIAVLELAKSCPRVINLH 95
Query: 112 FTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHR 169
             +++T  + + LE   GGE+F     +    +SE++      ++++ + Y+H   ++H 
Sbjct: 96  EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHL 155
Query: 170 DIKPENLLLTAD---GHIKIADFGSVKPMQDSRITVLPNAASDDKACTF---VGTAAYVP 223
           D+KP+N+LL++    G IKI DFG  + +                AC     +GT  Y+ 
Sbjct: 156 DLKPQNILLSSIYPLGDIKIVDFGMSRKI--------------GHACELREIMGTPEYLA 201
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           PE+LN  P T   D+W +G   Y +L+ TSPF
Sbjct: 202 PEILNYDPITTATDMWNIGIIAYMLLTHTSPF 233

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 102/218 (46%), Gaps = 22/218 (10%)
Query: 41  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 100
           H++     LG+    GS+ +V R +   TG   A+K +  +    E        E +   
Sbjct: 74  HWATHQLRLGR----GSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE--------ELMACA 121
Query: 101 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
            L  P +V L+   ++   + + +E  EGG L   +  +G L ED A +Y  + ++ LEY
Sbjct: 122 GLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEY 181
Query: 161 IHSMGLIHRDIKPENLLLTADG-HIKIADFGSVKPMQDSRITVLPNAASDD--KACTFVG 217
           +HS  ++H D+K +N+LL++DG H  + DFG    +Q       P+    D        G
Sbjct: 182 LHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQ-------PDGLGKDLLTGDYIPG 234
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           T  ++ PEV+         D+W+  C +  ML+G  P+
Sbjct: 235 TETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPW 272

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 105/223 (47%), Gaps = 20/223 (8%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL---ERIVL 99
           S++ +E   + G GSY  V++ +  DTG + A+K    KF+  ++     K+   E  +L
Sbjct: 23  SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK----KFLESDDDKMVKKIAMREIKLL 78
Query: 100 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 159
            QL H  +V L    +     Y+  E  +   L D       L     + Y  ++++ + 
Sbjct: 79  KQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIG 138
Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           + HS  +IHRDIKPEN+L++  G +K+ DFG       +R    P    DD+    V T 
Sbjct: 139 FCHSHNIIHRDIKPENILVSQSGVVKLCDFGF------ARTLAAPGEVYDDE----VATR 188
Query: 220 AYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSE 260
            Y  PE+L      +G   D+WA+GC + +M  G   F   S+
Sbjct: 189 WYRAPELL-VGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD 230

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G+   V  A  + TG   A++ M+   + ++ K   +  E +V+ +  +P +V    +
Sbjct: 29  GQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +     L++ +E   GG L D +T    + E +      E + ALE++HS  +IHRDIK 
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIHRDIKS 144
Query: 174 ENLLLTADGHIKIADFG---SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 230
           +N+LL  DG +K+ DFG    + P Q  R              T VGT  ++ PEV+   
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITPEQSKR-------------STMVGTPYWMAPEVVTRK 191
Query: 231 PATFGNDLWALGCTLYQMLSGTSPF 255
                 D+W+LG    +M+ G  P+
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 102/216 (47%), Gaps = 28/216 (12%)
Query: 106 GVVRLFFTFQDTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ + H+ 
Sbjct: 117 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 176
Query: 165 GLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT  Y P
Sbjct: 177 GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGTRVYSP 224
Query: 224 PEVLNSSPATFGND--LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSXX 281
           PE +       G    +W+LG  LY M+ G  PF+   E      II   + F    S  
Sbjct: 225 PEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQRVSSE 277
Query: 282 XXXXXXXXXXXXPSGRPGAGPGGYAVLKMHPFFKGI 317
                       PS RP      +  ++ HP+ + +
Sbjct: 278 CQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDV 308

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 108/221 (48%), Gaps = 20/221 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           D+EL ++ G G+ + VV+A           K+  K+   ++ +T+  +L  E   + Q  
Sbjct: 16  DYELQEVIGSGA-TAVVQAAYCAPKKE---KVAIKRINLEKCQTSMDELLKEIQAMSQCH 71
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFD---QITSKGH-----LSEDEARFYTAEVV 155
           HP +V  + +F     L++ ++   GG + D    I +KG      L E        EV+
Sbjct: 72  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           + LEY+H  G IHRD+K  N+LL  DG ++IADFG       + +    +   +    TF
Sbjct: 132 EGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV-----SAFLATGGDITRNKVRKTF 186
Query: 216 VGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPF 255
           VGT  ++ PEV+       F  D+W+ G T  ++ +G +P+
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY 227

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 18/216 (8%)
Query: 41  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 100
           H++     LG+    GS+ +V R +   TG   A+K +  +    E        E +   
Sbjct: 93  HWATHQLRLGR----GSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE--------ELMACA 140
Query: 101 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
            L  P +V L+   ++   + + +E  EGG L   +  +G L ED A +Y  + ++ LEY
Sbjct: 141 GLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEY 200
Query: 161 IHSMGLIHRDIKPENLLLTADG-HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           +HS  ++H D+K +N+LL++DG H  + DFG    +Q   +       S        GT 
Sbjct: 201 LHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGL-----GKSLLTGDYIPGTE 255
Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            ++ PEV+         D+W+  C +  ML+G  P+
Sbjct: 256 THMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPW 291

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 108/221 (48%), Gaps = 20/221 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           D+EL ++ G G+ + VV+A           K+  K+   ++ +T+  +L  E   + Q  
Sbjct: 11  DYELQEVIGSGA-TAVVQAAYCAPKKE---KVAIKRINLEKCQTSMDELLKEIQAMSQCH 66
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFD---QITSKGH-----LSEDEARFYTAEVV 155
           HP +V  + +F     L++ ++   GG + D    I +KG      L E        EV+
Sbjct: 67  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 126
Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           + LEY+H  G IHRD+K  N+LL  DG ++IADFG       + +    +   +    TF
Sbjct: 127 EGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV-----SAFLATGGDITRNKVRKTF 181
Query: 216 VGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPF 255
           VGT  ++ PEV+       F  D+W+ G T  ++ +G +P+
Sbjct: 182 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY 222

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 106/222 (47%), Gaps = 28/222 (12%)
Query: 44  IQDFEL-GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           I D+++  ++ G+G   KV++     T   +ALK++      +     + +  +      
Sbjct: 14  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 68
Query: 103 DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 156
             P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + +
Sbjct: 69  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 126
Query: 157 ALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           A++Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K              S +   
Sbjct: 127 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTSHNSLT 175
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
               T  YV PEVL         D+W+LG  +Y +L G  PF
Sbjct: 176 EPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 217

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 21/221 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  +  + +G   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 60  GSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 117
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 118 VFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 177
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 178 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 224
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII 268
           N        D+W++GC + ++L+G + F  T      Q+I+
Sbjct: 225 NWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIM 265

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS+ +V R K   TG   A+K +  +    E        E +    L  P +V L+  
Sbjct: 67  GRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE--------ELVACAGLSSPRIVPLYGA 118
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
            ++   + + +E  EGG L   I   G L ED A +Y  + ++ LEY+H+  ++H D+K 
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKA 178
Query: 174 ENLLLTADG-HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA 232
           +N+LL++DG    + DFG    +Q   +    +  + D      GT  ++ PEV+   P 
Sbjct: 179 DNVLLSSDGSRAALCDFGHALCLQPDGLG--KSLLTGD---YIPGTETHMAPEVVMGKPC 233
Query: 233 TFGNDLWALGCTLYQMLSGTSPF 255
               D+W+  C +  ML+G  P+
Sbjct: 234 DAKVDIWSSCCMMLHMLNGCHPW 256

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/224 (31%), Positives = 113/224 (50%), Gaps = 24/224 (10%)
Query: 44  IQDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           I D E LG++ G G+  +V + +   TG V A+K M +    +ENK   + L+ +VL   
Sbjct: 24  INDLENLGEM-GSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLD-VVLKSH 81
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEY 160
           D P +V+ F TF     +++A+E    G   +++  +  G + E      T  +V AL Y
Sbjct: 82  DCPYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYY 139
Query: 161 I-HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           +    G+IHRD+KP N+LL   G IK+ DFG    + D +       A D  A    G A
Sbjct: 140 LKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK-------AKDRSA----GCA 188
Query: 220 AYVPPEVLNSSPAT-----FGNDLWALGCTLYQMLSGTSPFKDT 258
           AY+ PE ++    T        D+W+LG +L ++ +G  P+K+ 
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC 232

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS+ +V R K   TG   A+K +  +    E        E +    L  P +V L+  
Sbjct: 81  GRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE--------ELVACAGLSSPRIVPLYGA 132
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
            ++   + + +E  EGG L   I   G L ED A +Y  + ++ LEY+H+  ++H D+K 
Sbjct: 133 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKA 192
Query: 174 ENLLLTADG-HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA 232
           +N+LL++DG    + DFG    +Q   +    +  + D      GT  ++ PEV+   P 
Sbjct: 193 DNVLLSSDGSRAALCDFGHALCLQPDGLG--KSLLTGD---YIPGTETHMAPEVVMGKPC 247
Query: 233 TFGNDLWALGCTLYQMLSGTSPF 255
               D+W+  C +  ML+G  P+
Sbjct: 248 DAKVDIWSSCCMMLHMLNGCHPW 270

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G+   V  A  + TG   A++ M+   + ++ K   +  E +V+ +  +P +V    +
Sbjct: 30  GQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +     L++ +E   GG L D +T    + E +      E + ALE++HS  +IHR+IK 
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIHRNIKS 145
Query: 174 ENLLLTADGHIKIADFG---SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 230
           +N+LL  DG +K+ DFG    + P Q  R              T VGT  ++ PEV+   
Sbjct: 146 DNILLGMDGSVKLTDFGFCAQITPEQSKR-------------STMVGTPYWMAPEVVTRK 192
Query: 231 PATFGNDLWALGCTLYQMLSGTSPF 255
                 D+W+LG    +M+ G  P+
Sbjct: 193 AYGPKVDIWSLGIMAIEMIEGEPPY 217

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS+ +V R K   TG   A+K +  +    E        E +    L  P +V L+  
Sbjct: 83  GRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE--------ELVACAGLSSPRIVPLYGA 134
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
            ++   + + +E  EGG L   I   G L ED A +Y  + ++ LEY+H+  ++H D+K 
Sbjct: 135 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKA 194
Query: 174 ENLLLTADG-HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA 232
           +N+LL++DG    + DFG    +Q   +    +  + D      GT  ++ PEV+   P 
Sbjct: 195 DNVLLSSDGSRAALCDFGHALCLQPDGLG--KSLLTGD---YIPGTETHMAPEVVMGKPC 249
Query: 233 TFGNDLWALGCTLYQMLSGTSPF 255
               D+W+  C +  ML+G  P+
Sbjct: 250 DAKVDIWSSCCMMLHMLNGCHPW 272

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G+   V  A  + TG   A++ M+   + ++ K   +  E +V+ +  +P +V    +
Sbjct: 29  GQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +     L++ +E   GG L D +T    + E +      E + ALE++HS  +IHRDIK 
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIHRDIKS 144
Query: 174 ENLLLTADGHIKIADFG---SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 230
           +N+LL  DG +K+ DFG    + P Q  R                VGT  ++ PEV+   
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITPEQSKR-------------SXMVGTPYWMAPEVVTRK 191
Query: 231 PATFGNDLWALGCTLYQMLSGTSPF 255
                 D+W+LG    +M+ G  P+
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDSELKILDFGLCR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 27  GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 84
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 144
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   FV T  Y  PE+ L
Sbjct: 145 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMAGFVATRWYRAPEIML 191
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G+   V  A  + TG   A++ M+   + ++ K   +  E +V+ +  +P +V    +
Sbjct: 30  GQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +     L++ +E   GG L D +T    + E +      E + ALE++HS  +IHRDIK 
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIHRDIKS 145
Query: 174 ENLLLTADGHIKIADFG---SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 230
           +N+LL  DG +K+ DFG    + P Q  R                VGT  ++ PEV+   
Sbjct: 146 DNILLGMDGSVKLTDFGFCAQITPEQSKR-------------SXMVGTPYWMAPEVVTRK 192
Query: 231 PATFGNDLWALGCTLYQMLSGTSPF 255
                 D+W+LG    +M+ G  P+
Sbjct: 193 AYGPKVDIWSLGIMAIEMIEGEPPY 217

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G+   V  A  + TG   A++ M+   + ++ K   +  E +V+ +  +P +V    +
Sbjct: 29  GQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +     L++ +E   GG L D +T    + E +      E + ALE++HS  +IHRDIK 
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIHRDIKS 144
Query: 174 ENLLLTADGHIKIADFG---SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 230
           +N+LL  DG +K+ DFG    + P Q  R                VGT  ++ PEV+   
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITPEQSKR-------------SEMVGTPYWMAPEVVTRK 191
Query: 231 PATFGNDLWALGCTLYQMLSGTSPF 255
                 D+W+LG    +M+ G  P+
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N+       D+W++GC + ++L+G + F  T
Sbjct: 196 NAMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   FV T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMAGFVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   FV T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMAGFVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 115/260 (44%), Gaps = 47/260 (18%)
Query: 38  PQEHFSIQDFELGK-IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           P+++    D++L K + G+G   KV+      TG   ALK++      ++          
Sbjct: 21  PKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ---------- 70
Query: 97  IVLDQLDH-------PGVVRLFFTFQDTF----SLYMALESCEGGELFDQITSKGH--LS 143
               ++DH       P +V +   +++       L + +E  EGGELF +I  +G    +
Sbjct: 71  ----EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFT 126
Query: 144 EDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRI 200
           E EA     ++  A++++HS  + HRD+KPENLL T+   D  +K+ DFG  K    + +
Sbjct: 127 EREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL 186
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
                        T   T  YV PEVL         D+W+LG  +Y +L G  PF   + 
Sbjct: 187 Q------------TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG 234
Query: 261 WLIF----QRIIARDIRFPN 276
             I     +RI      FPN
Sbjct: 235 QAISPGMKRRIRLGQYGFPN 254

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 115/260 (44%), Gaps = 47/260 (18%)
Query: 38  PQEHFSIQDFELGK-IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           P+++    D++L K + G+G   KV+      TG   ALK++      ++          
Sbjct: 2   PKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ---------- 51
Query: 97  IVLDQLDH-------PGVVRLFFTFQDTF----SLYMALESCEGGELFDQITSKGH--LS 143
               ++DH       P +V +   +++       L + +E  EGGELF +I  +G    +
Sbjct: 52  ----EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFT 107
Query: 144 EDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRI 200
           E EA     ++  A++++HS  + HRD+KPENLL T+   D  +K+ DFG  K    + +
Sbjct: 108 EREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL 167
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
                        T   T  YV PEVL         D+W+LG  +Y +L G  PF   + 
Sbjct: 168 Q------------TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG 215
Query: 261 WLIF----QRIIARDIRFPN 276
             I     +RI      FPN
Sbjct: 216 QAISPGMKRRIRLGQYGFPN 235

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + K F +    K  Y +L   +L  + H  V+ L  
Sbjct: 43  GSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 100
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 160
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 161 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 207
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 208 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 238

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDXELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 106/215 (49%), Gaps = 19/215 (8%)
Query: 52  IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLF 111
           + G G++++V     + T   YA+KI++K+     ++  + ++E +   Q  H  V+ L 
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRV-FREVEMLYQCQ-GHRNVLELI 77
Query: 112 FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDI 171
             F++    Y+  E   GG +   I  + H +E EA     +V  AL+++H+ G+ HRD+
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDL 137
Query: 172 KPENLLLTADGH---IKIADFG---SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 225
           KPEN+L         +KI DFG    +K   D      P         T  G+A Y+ PE
Sbjct: 138 KPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELL------TPCGSAEYMAPE 191
Query: 226 VLN--SSPATFGN---DLWALGCTLYQMLSGTSPF 255
           V+   S  A+  +   DLW+LG  LY +LSG  PF
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 33  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 90
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 150
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 151 RDLKPSNLAVNEDSELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 197
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 198 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 228

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 37  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 94
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 154
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 155 RDLKPSNLAVNEDSELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 201
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 232

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 27  GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 84
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHSADIIH 144
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 145 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 191
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 79/160 (49%), Gaps = 20/160 (12%)
Query: 105 PGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDAL 158
           P +VR+   +++ ++    L +  E  +GGELF +I  +G    +E EA      + +A+
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAI 174
Query: 159 EYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           +Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K              S +   T 
Sbjct: 175 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTSHNSLTTP 223
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
             T  YV PEVL         D W+LG   Y +L G  PF
Sbjct: 224 CYTPYYVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPPF 263

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 43  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 100
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 160
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 161 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 207
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 208 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 238

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 43  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 100
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 160
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 161 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 207
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 208 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 238

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 50  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 107
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 167
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 168 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 214
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 215 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 245

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 42  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 99
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 159
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 160 RDLKPSNLAVNEDXELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 206
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 207 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 237

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 54  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 111
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 171
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 172 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 218
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 219 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 249

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 42  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 99
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 159
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 160 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 206
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 207 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 237

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 51  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 108
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 168
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 169 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 215
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 216 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 246

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 33  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 90
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 150
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 151 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 197
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 198 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 228

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 36  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 93
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 153
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 154 RDLKPSNLAVNEDXELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 200
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 201 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 231

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 33  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 90
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 150
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 151 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 197
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 198 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 228

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 29  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 86
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 87  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 146
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 147 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 193
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 194 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 224

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 36  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 93
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 153
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 154 RDLKPSNLAVNEDXELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 200
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 201 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 231

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 36  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 93
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 153
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 154 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 200
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 201 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 231

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 51  GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 108
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 168
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 169 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 215
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 216 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 246

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 30  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 87
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 88  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 147
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 148 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 194
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 195 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 225

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 33  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 90
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 150
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 151 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 197
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 198 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 228

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 50  GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 107
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 167
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 168 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 214
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 215 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 245

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 37  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 94
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 154
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 155 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 201
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 232

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 36  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 93
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 153
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 154 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 200
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 201 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 231

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 27  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 84
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 144
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 145 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 191
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 37  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 94
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 154
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 155 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 201
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 232

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 38  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 95
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 155
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 156 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 202
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 108/220 (49%), Gaps = 37/220 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 110
Query: 109 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +    +   PN        +++
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNV-------SYI 217
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 218 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 257

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 37  GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 94
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 154
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 155 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 201
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 232

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 28  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 85
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 145
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 146 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 192
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 193 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 223

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 107/220 (48%), Gaps = 37/220 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 39  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 89
Query: 109 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 90  RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 147
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN        +++
Sbjct: 148 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNV-------SYI 196
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 197 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 236

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 28  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 85
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 145
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 146 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 192
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 193 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 223

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 110/227 (48%), Gaps = 33/227 (14%)
Query: 50  GKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           G+IY      G G  SKV +    +   +YA+K ++ +    +   +Y + E   L++L 
Sbjct: 8   GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQ 65
Query: 104 HPG--VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
                ++RL+ +   D + +YM +E C   +L   +  K  +   E + Y   +++A+  
Sbjct: 66  QHSDKIIRLYDYEITDQY-IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 123
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           IH  G++H D+KP N L+  DG +K+ DFG    MQ    +V+ ++         VGT  
Sbjct: 124 IHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ--------VGTVN 174
Query: 221 YVPPEVLNSSPATFGN-----------DLWALGCTLYQMLSGTSPFK 256
           Y+PPE +    ++  N           D+W+LGC LY M  G +PF+
Sbjct: 175 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 221

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 108/220 (49%), Gaps = 37/220 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 62  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 112
Query: 109 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 113 RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 170
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +    +   PN        +++
Sbjct: 171 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNV-------SYI 219
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 220 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 259

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 27  GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 84
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 144
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 145 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 191
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 107/220 (48%), Gaps = 37/220 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 76
Query: 109 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN        +++
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNV-------SYI 183
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 41  GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 98
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 99  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 158
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 159 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGYVATRWYRAPEIML 205
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 206 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 236

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 110/227 (48%), Gaps = 33/227 (14%)
Query: 50  GKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           G+IY      G G  SKV +    +   +YA+K ++ +    +   +Y + E   L++L 
Sbjct: 55  GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQ 112
Query: 104 HPG--VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
                ++RL+ +   D + +YM +E C   +L   +  K  +   E + Y   +++A+  
Sbjct: 113 QHSDKIIRLYDYEITDQY-IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 170
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           IH  G++H D+KP N L+  DG +K+ DFG    MQ    +V+ ++         VGT  
Sbjct: 171 IHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ--------VGTVN 221
Query: 221 YVPPEVLNSSPATFGN-----------DLWALGCTLYQMLSGTSPFK 256
           Y+PPE +    ++  N           D+W+LGC LY M  G +PF+
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 54  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 111
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 171
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+   +V T  Y  PE+ L
Sbjct: 172 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMXGYVATRWYRAPEIML 218
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 219 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 249

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 107/220 (48%), Gaps = 37/220 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 31  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 81
Query: 109 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 82  RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 139
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN        +++
Sbjct: 140 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNV-------SYI 188
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 189 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 228

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 108/220 (49%), Gaps = 37/220 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 64  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 114
Query: 109 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 115 RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 172
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +    +   PN        +++
Sbjct: 173 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNV-------SYI 221
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 222 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 261

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 110/227 (48%), Gaps = 33/227 (14%)
Query: 50  GKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           G+IY      G G  SKV +    +   +YA+K ++ +    +   +Y + E   L++L 
Sbjct: 55  GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQ 112
Query: 104 HPG--VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
                ++RL+ +   D + +YM +E C   +L   +  K  +   E + Y   +++A+  
Sbjct: 113 QHSDKIIRLYDYEITDQY-IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 170
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           IH  G++H D+KP N L+  DG +K+ DFG    MQ    +V+ ++         VGT  
Sbjct: 171 IHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ--------VGTVN 221
Query: 221 YVPPEVLNSSPATFGN-----------DLWALGCTLYQMLSGTSPFK 256
           Y+PPE +    ++  N           D+W+LGC LY M  G +PF+
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 107/220 (48%), Gaps = 37/220 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 54  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 104
Query: 109 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 105 RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 162
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN        +++
Sbjct: 163 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNV-------SYI 211
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 212 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 251

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 107/220 (48%), Gaps = 37/220 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 105 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 155
Query: 109 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 156 RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 213
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN        +++
Sbjct: 214 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNV-------SYI 262
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 263 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 302

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 110/227 (48%), Gaps = 33/227 (14%)
Query: 50  GKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           G+IY      G G  SKV +    +   +YA+K ++ +    +   +Y + E   L++L 
Sbjct: 27  GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQ 84
Query: 104 HPG--VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
                ++RL+ +   D + +YM +E C   +L   +  K  +   E + Y   +++A+  
Sbjct: 85  QHSDKIIRLYDYEITDQY-IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 142
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           IH  G++H D+KP N L+  DG +K+ DFG    MQ    +V+ ++         VGT  
Sbjct: 143 IHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ--------VGTVN 193
Query: 221 YVPPEVLNSSPATFGN-----------DLWALGCTLYQMLSGTSPFK 256
           Y+PPE +    ++  N           D+W+LGC LY M  G +PF+
Sbjct: 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 240

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 110/227 (48%), Gaps = 33/227 (14%)
Query: 50  GKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           G+IY      G G  SKV +    +   +YA+K ++ +    +   +Y + E   L++L 
Sbjct: 11  GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQ 68
Query: 104 HPG--VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
                ++RL+ +   D + +YM +E C   +L   +  K  +   E + Y   +++A+  
Sbjct: 69  QHSDKIIRLYDYEITDQY-IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 126
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           IH  G++H D+KP N L+  DG +K+ DFG    MQ    +V+ ++         VGT  
Sbjct: 127 IHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ--------VGTVN 177
Query: 221 YVPPEVLNSSPATFGN-----------DLWALGCTLYQMLSGTSPFK 256
           Y+PPE +    ++  N           D+W+LGC LY M  G +PF+
Sbjct: 178 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 224

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 110/227 (48%), Gaps = 33/227 (14%)
Query: 50  GKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           G+IY      G G  SKV +    +   +YA+K ++ +    +   +Y + E   L++L 
Sbjct: 7   GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQ 64
Query: 104 HPG--VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
                ++RL+ +   D + +YM +E C   +L   +  K  +   E + Y   +++A+  
Sbjct: 65  QHSDKIIRLYDYEITDQY-IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 122
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           IH  G++H D+KP N L+  DG +K+ DFG    MQ    +V+ ++         VGT  
Sbjct: 123 IHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ--------VGTVN 173
Query: 221 YVPPEVLNSSPATFGN-----------DLWALGCTLYQMLSGTSPFK 256
           Y+PPE +    ++  N           D+W+LGC LY M  G +PF+
Sbjct: 174 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 220

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 37/220 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 76
Query: 109 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 77  RLRYFFYSSGEKKDVVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN +        +
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSX-------I 183
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 23/210 (10%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE-NKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F ++   K AY +L   +L  + H  V+ L  
Sbjct: 34  GSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR--LLKHMRHENVIGLLD 91
Query: 113 TFQ-----DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLI 167
            F      D F+ +  +    G +L  ++     L ED  +F   +++  L YIH+ G+I
Sbjct: 92  VFTPDETLDDFTDFYLVMPFMGTDL-GKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGII 150
Query: 168 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV- 226
           HRD+KP NL +  D  +KI DFG  +              +D +    V T  Y  PEV 
Sbjct: 151 HRDLKPGNLAVNEDCELKILDFGLAR-------------QADSEMXGXVVTRWYRAPEVI 197
Query: 227 LNSSPATFGNDLWALGCTLYQMLSGTSPFK 256
           LN    T   D+W++GC + +M++G + FK
Sbjct: 198 LNWMRYTQTVDIWSVGCIMAEMITGKTLFK 227

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 109/227 (48%), Gaps = 33/227 (14%)
Query: 50  GKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           G+IY      G G  SKV +    +   +YA+K ++ +    +   +Y + E   L++L 
Sbjct: 27  GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQ 84
Query: 104 HPG--VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
                ++RL+ +   D + +YM +E C   +L   +  K  +   E + Y   +++A+  
Sbjct: 85  QHSDKIIRLYDYEITDQY-IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 142
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           IH  G++H D+KP N L+  DG +K+ DFG    MQ     V+ ++         VGT  
Sbjct: 143 IHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQ--------VGTVN 193
Query: 221 YVPPEVLNSSPATFGN-----------DLWALGCTLYQMLSGTSPFK 256
           Y+PPE +    ++  N           D+W+LGC LY M  G +PF+
Sbjct: 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 240

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI D+G  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDYGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 37/220 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 76
Query: 109 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN +        +
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSX-------I 183
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 37/220 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 45  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 95
Query: 109 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 96  RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 153
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN +        +
Sbjct: 154 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSX-------I 202
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 203 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 242

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 37/220 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 30  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 80
Query: 109 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 81  RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 138
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN +        +
Sbjct: 139 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSX-------I 187
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 188 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 227

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 37/220 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 76
Query: 109 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN +        +
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSX-------I 183
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 37/220 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 34  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 84
Query: 109 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 85  RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 142
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN +        +
Sbjct: 143 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSX-------I 191
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 192 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 231

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 37/220 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 38  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 88
Query: 109 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 146
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN +        +
Sbjct: 147 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSX-------I 195
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 196 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 235

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 107/220 (48%), Gaps = 37/220 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 110
Query: 109 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +    +   PN +        +
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNVSX-------I 217
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 218 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 257

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 37/220 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 38  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 88
Query: 109 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 146
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN +        +
Sbjct: 147 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSX-------I 195
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 196 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 235

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 37/220 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  + DK+F  +E +         ++ +LDH  +V
Sbjct: 27  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---------IMRKLDHCNIV 77
Query: 109 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 78  RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 135
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN +        +
Sbjct: 136 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSX-------I 184
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 185 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 224

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+    V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMTGXVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 105/215 (48%), Gaps = 19/215 (8%)
Query: 52  IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLF 111
           + G G++++V     + T   YA+KI++K+     ++  + ++E +   Q  H  V+ L 
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRV-FREVEMLYQCQ-GHRNVLELI 77
Query: 112 FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDI 171
             F++    Y+  E   GG +   I  + H +E EA     +V  AL+++H+ G+ HRD+
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDL 137
Query: 172 KPENLLLTADGH---IKIADF---GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 225
           KPEN+L         +KI DF     +K   D      P         T  G+A Y+ PE
Sbjct: 138 KPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL------TPCGSAEYMAPE 191
Query: 226 VLN--SSPATFGN---DLWALGCTLYQMLSGTSPF 255
           V+   S  A+  +   DLW+LG  LY +LSG  PF
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 109/227 (48%), Gaps = 33/227 (14%)
Query: 50  GKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           G+IY      G G  SKV +    +   +YA+K ++ +    +   +Y + E   L++L 
Sbjct: 55  GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQ 112
Query: 104 HPG--VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
                ++RL+ +   D + +YM +E C   +L   +  K  +   E + Y   +++A+  
Sbjct: 113 QHSDKIIRLYDYEITDQY-IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 170
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           IH  G++H D+KP N L+  DG +K+ DFG    MQ    +V+ ++         VG   
Sbjct: 171 IHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ--------VGAVN 221
Query: 221 YVPPEVLNSSPATFGN-----------DLWALGCTLYQMLSGTSPFK 256
           Y+PPE +    ++  N           D+W+LGC LY M  G +PF+
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 51  GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 108
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 168
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              +DD+    V T  Y  PE+ L
Sbjct: 169 RDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMXGXVATRWYRAPEIML 215
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 216 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 246

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI  FG  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILGFGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 38  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 95
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 155
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              + D+   +V T  Y  PE+ L
Sbjct: 156 RDLKPSNLAVNEDCELKILDFGLAR-------------HTADEMTGYVATRWYRAPEIML 202
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 38  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 95
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 155
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              + D+   +V T  Y  PE+ L
Sbjct: 156 RDLKPSNLAVNEDCELKILDFGLAR-------------HTADEMTGYVATRWYRAPEIML 202
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 38  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 95
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 155
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DFG  +              + D+   +V T  Y  PE+ L
Sbjct: 156 RDLKPSNLAVNEDCELKILDFGLAR-------------HTADEMTGYVATRWYRAPEIML 202
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 92/192 (47%), Gaps = 23/192 (11%)
Query: 81  KFITKEN----------KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG 130
           KFI KE           K   V LE  +L +++H  ++++   F++     + +E    G
Sbjct: 55  KFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSG 114
Query: 131 -ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADF 189
            +LF  I     L E  A +   ++V A+ Y+    +IHRDIK EN+++  D  IK+ DF
Sbjct: 115 LDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDF 174
Query: 190 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGN-DLWALGCTLYQM 248
           GS   ++  ++             TF GT  Y  PEVL  +P      ++W+LG TLY +
Sbjct: 175 GSAAYLERGKLFY-----------TFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTL 223
Query: 249 LSGTSPFKDTSE 260
           +   +PF +  E
Sbjct: 224 VFEENPFCELEE 235

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 21/214 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQL 102
           DFE     G G+   V +     +G V     M +K I  E K A    +  E  VL + 
Sbjct: 69  DFEKISELGAGNGGVVFKVSHKPSGLV-----MARKLIHLEIKPAIRNQIIRELQVLHEC 123
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           + P +V  +  F     + + +E  +GG L   +   G + E      +  V+  L Y+ 
Sbjct: 124 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 183
Query: 163 S-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
               ++HRD+KP N+L+ + G IK+ DFG    + DS             A +FVGT +Y
Sbjct: 184 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM------------ANSFVGTRSY 231
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           + PE L  +  +  +D+W++G +L +M  G  P 
Sbjct: 232 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 110/225 (48%), Gaps = 30/225 (13%)
Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           L  I G G+ + V R +   TG ++A+K+ +     +       + E  VL +L+H  +V
Sbjct: 13  LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFE--VLKKLNHKNIV 70
Query: 109 RLFFTFQDTFSLY--MALESCEGGELF---DQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           +LF   ++T + +  + +E C  G L+   ++ ++   L E E      +VV  + ++  
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 164 MGLIHRDIKPENLL--LTADGH--IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            G++HR+IKP N++  +  DG    K+ DFG+ + ++D           D++  +  GT 
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-----------DEQFVSLYGTE 179
Query: 220 AYVPPEVLNSS------PATFGN--DLWALGCTLYQMLSGTSPFK 256
            Y+ P++   +         +G   DLW++G T Y   +G+ PF+
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 21/214 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQL 102
           DFE     G G+   V +     +G V     M +K I  E K A    +  E  VL + 
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLV-----MARKLIHLEIKPAIRNQIIRELQVLHEC 61
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           + P +V  +  F     + + +E  +GG L   +   G + E      +  V+  L Y+ 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 163 S-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
               ++HRD+KP N+L+ + G IK+ DFG    + DS             A +FVGT +Y
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM------------ANSFVGTRSY 169
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           + PE L  +  +  +D+W++G +L +M  G  P 
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 105/227 (46%), Gaps = 27/227 (11%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 62
Query: 103 DHPGVVRLFFTFQDTFSLYMALE--SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
           +HP +V+L         LY+  E  S +  +  D     G +     + Y  +++  L +
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAF 121
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKAC 213
            HS  ++HRD+KPENLL+  +G IK+ADFG        V+      +T+   A      C
Sbjct: 122 CHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 181
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
            +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 182 KYYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 212

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI D G  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDRGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 105/227 (46%), Gaps = 27/227 (11%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 60
Query: 103 DHPGVVRLFFTFQDTFSLYMALE--SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
           +HP +V+L         LY+  E  S +  +  D     G +     + Y  +++  L +
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAF 119
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKAC 213
            HS  ++HRD+KPENLL+  +G IK+ADFG        V+      +T+   A      C
Sbjct: 120 CHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 179
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
            +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 180 KYYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 210

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI D G  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDAGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 101/219 (46%), Gaps = 23/219 (10%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQL 102
           DFE     G G+   V +     +G V     M +K I  E K A    +  E  VL + 
Sbjct: 26  DFEKISELGAGNGGVVFKVSHKPSGLV-----MARKLIHLEIKPAIRNQIIRELQVLHEC 80
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYI 161
           + P +V  +  F     + + +E  +GG L DQ+  K G + E      +  V+  L Y+
Sbjct: 81  NSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYL 139
Query: 162 HS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
                ++HRD+KP N+L+ + G IK+ DFG    + DS             A +FVGT +
Sbjct: 140 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM------------ANSFVGTRS 187
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 259
           Y+ PE L  +  +  +D+W++G +L +M  G  P    S
Sbjct: 188 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGS 226

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI DF   +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDFYLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A    TG   A+K + + F +    K  Y +L   +L  + H  V+ L  
Sbjct: 31  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR--LLKHMKHENVIGLLD 88
Query: 113 TFQDTFSLY----MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
            F    SL     + L +   G   + I     L++D  +F   +++  L+YIHS  +IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-L 227
           RD+KP NL +  D  +KI D G  +              +DD+   +V T  Y  PE+ L
Sbjct: 149 RDLKPSNLAVNEDCELKILDGGLAR-------------HTDDEMTGYVATRWYRAPEIML 195
Query: 228 NSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           N        D+W++GC + ++L+G + F  T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 23/215 (10%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQL 102
           DFE     G G+   V +     +G V     M +K I  E K A    +  E  VL + 
Sbjct: 34  DFEKISELGAGNGGVVFKVSHKPSGLV-----MARKLIHLEIKPAIRNQIIRELQVLHEC 88
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYI 161
           + P +V  +  F     + + +E  +GG L DQ+  K G + E      +  V+  L Y+
Sbjct: 89  NSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYL 147
Query: 162 HS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
                ++HRD+KP N+L+ + G IK+ DFG    + DS             A +FVGT +
Sbjct: 148 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM------------ANSFVGTRS 195
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           Y+ PE L  +  +  +D+W++G +L +M  G  P 
Sbjct: 196 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 23/215 (10%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQL 102
           DFE     G G+   V +     +G V     M +K I  E K A    +  E  VL + 
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLV-----MARKLIHLEIKPAIRNQIIRELQVLHEC 61
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYI 161
           + P +V  +  F     + + +E  +GG L DQ+  K G + E      +  V+  L Y+
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 162 HS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
                ++HRD+KP N+L+ + G IK+ DFG    + DS             A +FVGT +
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM------------ANSFVGTRS 168
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           Y+ PE L  +  +  +D+W++G +L +M  G  P 
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 23/215 (10%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQL 102
           DFE     G G+   V +     +G V     M +K I  E K A    +  E  VL + 
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLV-----MARKLIHLEIKPAIRNQIIRELQVLHEC 61
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYI 161
           + P +V  +  F     + + +E  +GG L DQ+  K G + E      +  V+  L Y+
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 162 HS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
                ++HRD+KP N+L+ + G IK+ DFG    + DS             A +FVGT +
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM------------ANSFVGTRS 168
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           Y+ PE L  +  +  +D+W++G +L +M  G  P 
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 109/225 (48%), Gaps = 30/225 (13%)
Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           L  I G G+ + V R +   TG ++A+K+ +     +       + E  VL +L+H  +V
Sbjct: 13  LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFE--VLKKLNHKNIV 70
Query: 109 RLFFTFQDTFSLY--MALESCEGGELF---DQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           +LF   ++T + +  + +E C  G L+   ++ ++   L E E      +VV  + ++  
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 164 MGLIHRDIKPENLL--LTADGH--IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            G++HR+IKP N++  +  DG    K+ DFG+ + ++D           D++     GT 
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-----------DEQFVXLYGTE 179
Query: 220 AYVPPEVLNSS------PATFGN--DLWALGCTLYQMLSGTSPFK 256
            Y+ P++   +         +G   DLW++G T Y   +G+ PF+
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 23/215 (10%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQL 102
           DFE     G G+   V +     +G V     M +K I  E K A    +  E  VL + 
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLV-----MARKLIHLEIKPAIRNQIIRELQVLHEC 61
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYI 161
           + P +V  +  F     + + +E  +GG L DQ+  K G + E      +  V+  L Y+
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 162 HS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
                ++HRD+KP N+L+ + G IK+ DFG    + DS             A +FVGT +
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM------------ANSFVGTRS 168
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           Y+ PE L  +  +  +D+W++G +L +M  G  P 
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 23/215 (10%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQL 102
           DFE     G G+   V +     +G V     M +K I  E K A    +  E  VL + 
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLV-----MARKLIHLEIKPAIRNQIIRELQVLHEC 61
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYI 161
           + P +V  +  F     + + +E  +GG L DQ+  K G + E      +  V+  L Y+
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 162 HS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
                ++HRD+KP N+L+ + G IK+ DFG    + DS             A +FVGT +
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM------------ANSFVGTRS 168
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           Y+ PE L  +  +  +D+W++G +L +M  G  P 
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 18/224 (8%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G +  V R  +  +   Y  K +      K      VK E  +L+   H  ++ L  +
Sbjct: 14  GRGEFGIVHRCVETSSKKTYMAKFVK----VKGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 114 FQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIK 172
           F+    L M  E   G ++F++I TS   L+E E   Y  +V +AL+++HS  + H DI+
Sbjct: 70  FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIR 129
Query: 173 PENLLLTA--DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS 230
           PEN++        IKI +FG  + ++            D+    F     Y  PEV    
Sbjct: 130 PENIIYQTRRSSTIKIIEFGQARQLK----------PGDNFRLLFTA-PEYYAPEVHQHD 178
Query: 231 PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF 274
             +   D+W+LG  +Y +LSG +PF   +   I + I+  +  F
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF 222

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A         A+K + + F +    +  Y +L   +L  L H  V+ L  
Sbjct: 37  GSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELR--LLKHLKHENVIGLLD 94
Query: 113 TFQ-----DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLI 167
            F      + FS    + +  G +L + + S+  LS++  +F   +++  L+YIHS G+I
Sbjct: 95  VFTPATSIEDFSEVYLVTTLMGADLNNIVKSQA-LSDEHVQFLVYQLLRGLKYIHSAGII 153
Query: 168 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV- 226
           HRD+KP N+ +  D  ++I DFG  +              +D++   +V T  Y  PE+ 
Sbjct: 154 HRDLKPSNVAVNEDSELRILDFGLAR-------------QADEEMTGYVATRWYRAPEIM 200
Query: 227 LNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           LN        D+W++GC + ++L G + F
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLQGKALF 229

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 107/219 (48%), Gaps = 29/219 (13%)
Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           +G+  G GS+  V + K    G V A+K+++    T +   A+ K E  VL +  H  ++
Sbjct: 16  VGQRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQQLQAF-KNEVGVLRKTRHVNIL 71
Query: 109 RLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD-------ALEYI 161
            LF  +     L +  + CEG  L+       HL   E +F   +++D        ++Y+
Sbjct: 72  -LFMGYSTKPQLAIVTQWCEGSSLYH------HLHASETKFEMKKLIDIARQTARGMDYL 124
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H+  +IHRD+K  N+ L  D  +KI DFG          TV    +   +     G+  +
Sbjct: 125 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA--------TVKSRWSGSHQFEQLSGSILW 176
Query: 222 VPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKD 257
           + PEV+   +S+P +F +D++A G  LY++++G  P+ +
Sbjct: 177 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 215

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 105/220 (47%), Gaps = 37/220 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  +  K F  +E +         ++ +LDH  +V
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQ---------IMRKLDHCNIV 76
Query: 109 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN        +++
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNV-------SYI 183
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 105/220 (47%), Gaps = 37/220 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  +  K F  +E +         ++ +LDH  +V
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQ---------IMRKLDHCNIV 76
Query: 109 RLFFTF------QDTFSLYMALESCEGGELFDQIT-----SKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+     E   ++      +K  L     + Y  ++  +
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN        +++
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNV-------SYI 183
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 100/214 (46%), Gaps = 18/214 (8%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIM---DKKFITKENKTAYVKLERI-VLDQ 101
           DF+L  + G G+Y  V  A    TG + A+K +   DK         A   L  I +L  
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLF------ALRTLREIKILKH 65
Query: 102 LDHPGVVRLFF-----TFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD 156
             H  ++ +F      +F++   +Y+  E  +      ++ S   LS+D  +++  + + 
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQTLR 123
Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           A++ +H   +IHRD+KP NLL+ ++  +K+ DFG  + + +S                FV
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183
Query: 217 GTAAYVPPEV-LNSSPATFGNDLWALGCTLYQML 249
            T  Y  PEV L S+  +   D+W+ GC L ++ 
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 105/227 (46%), Gaps = 27/227 (11%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 62
Query: 103 DHPGVVRLFFTFQDTFSLYMALE--SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
           +HP +V+L         LY+  E  S +  +  D     G +     + Y  +++  L +
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTG-IPLPLIKSYLFQLLQGLAF 121
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKAC 213
            HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C
Sbjct: 122 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 181
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
            +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 182 KYYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 212

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 61
Query: 103 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 214
           HS  ++HRD+KPENLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 122 HSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 182 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 211

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 23/214 (10%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQL 102
           DFE     G G+   V +     +G V     M +K I  E K A    +  E  VL + 
Sbjct: 10  DFEKISELGAGNGGVVFKVSHKPSGLV-----MARKLIHLEIKPAIRNQIIRELQVLHEC 64
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYI 161
           + P +V  +  F     + + +E  +GG L DQ+  K G + E      +  V+  L Y+
Sbjct: 65  NSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYL 123
Query: 162 HS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
                ++HRD+KP N+L+ + G IK+ DFG            +     D+ A  FVGT +
Sbjct: 124 REKHKIMHRDVKPSNILVNSRGEIKLCDFG------------VSGQLIDEMANEFVGTRS 171
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 254
           Y+ PE L  +  +  +D+W++G +L +M  G  P
Sbjct: 172 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 105/227 (46%), Gaps = 27/227 (11%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 61
Query: 103 DHPGVVRLFFTFQDTFSLYMALE--SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
           +HP +V+L         LY+  E  S +  +  D     G +     + Y  +++  L +
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTG-IPLPLIKSYLFQLLQGLAF 120
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKAC 213
            HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C
Sbjct: 121 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 180
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
            +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 181 KYYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 211

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 62
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGG-ELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           +HP +V+L         LY+  E  +   + F   ++   +     + Y  +++  L + 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 214
           HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 183 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 212

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 60
Query: 103 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 214
           HS  ++HRD+KPENLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 121 HSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 181 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 210

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 62
Query: 103 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 214
           HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 183 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 212

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 59
Query: 103 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 214
           HS  ++HRD+KPENLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 120 HSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 180 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 209

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 109/220 (49%), Gaps = 29/220 (13%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           ++ E+ ++ G G++  V +AK       +  K +  K I  E++     +E   L +++H
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAK-------WRAKDVAIKQIESESERKAFIVELRQLSRVNH 60
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHL---SEDEARFYTAEVVDALEYI 161
           P +V+L+    +   L M  E  EGG L++ +     L   +   A  +  +    + Y+
Sbjct: 61  PNIVKLYGACLNPVCLVM--EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 162 HSM---GLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           HSM    LIHRD+KP NLLL A G + KI DFG+   +Q           +++K     G
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ--------THMTNNK-----G 165
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD 257
           +AA++ PEV   S  +   D+++ G  L+++++   PF +
Sbjct: 166 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDE 205

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 109/220 (49%), Gaps = 29/220 (13%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           ++ E+ ++ G G++  V +AK       +  K +  K I  E++     +E   L +++H
Sbjct: 9   KEIEVEEVVGRGAFGVVCKAK-------WRAKDVAIKQIESESERKAFIVELRQLSRVNH 61
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHL---SEDEARFYTAEVVDALEYI 161
           P +V+L+    +   L M  E  EGG L++ +     L   +   A  +  +    + Y+
Sbjct: 62  PNIVKLYGACLNPVCLVM--EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 119
Query: 162 HSM---GLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           HSM    LIHRD+KP NLLL A G + KI DFG+   +Q           +++K     G
Sbjct: 120 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ--------THMTNNK-----G 166
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD 257
           +AA++ PEV   S  +   D+++ G  L+++++   PF +
Sbjct: 167 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDE 206

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 23/209 (11%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A         A+K + + F +    +  Y +L   +L  L H  V+ L  
Sbjct: 37  GSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELR--LLKHLKHENVIGLLD 94
Query: 113 TFQ-----DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLI 167
            F      + FS    + +  G +L + +  +  LS++  +F   +++  L+YIHS G+I
Sbjct: 95  VFTPATSIEDFSEVYLVTTLMGADLNNIVKCQA-LSDEHVQFLVYQLLRGLKYIHSAGII 153
Query: 168 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV- 226
           HRD+KP N+ +  D  ++I DFG  +              +D++   +V T  Y  PE+ 
Sbjct: 154 HRDLKPSNVAVNEDSELRILDFGLAR-------------QADEEMTGYVATRWYRAPEIM 200
Query: 227 LNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           LN        D+W++GC + ++L G + F
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLQGKALF 229

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 61
Query: 103 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 214
           HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 122 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 182 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 211

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 62
Query: 103 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 214
           HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 183 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 212

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 62
Query: 103 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 214
           HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 183 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 212

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 61
Query: 103 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 214
           HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 122 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 182 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 211

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 63
Query: 103 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 123
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 214
           HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 124 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 183
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 184 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 213

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 15/212 (7%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           ++E+ +  G G+Y  V  A++  TG   A+K +   F    N    ++ E  +L    H 
Sbjct: 56  EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR-ELKILKHFKHD 114
Query: 106 GVVRLFFTFQDTF------SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 159
            ++ +    + T       S+Y+ L+  E  +L   I S   L+ +  R++  +++  L+
Sbjct: 115 NIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLK 173
Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           Y+HS  +IHRD+KP NLL+  +  +KI DFG  + +  S       A        +V T 
Sbjct: 174 YMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS------PAEHQYFMTEYVATR 227
Query: 220 AYVPPEVLNS-SPATFGNDLWALGCTLYQMLS 250
            Y  PE++ S    T   DLW++GC   +ML+
Sbjct: 228 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA 259

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 18/214 (8%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIM---DKKFITKENKTAYVKLERI-VLDQ 101
           DF+L  + G G+Y  V  A    TG + A+K +   DK         A   L  I +L  
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLF------ALRTLREIKILKH 65
Query: 102 LDHPGVVRLFF-----TFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD 156
             H  ++ +F      +F++   +Y+  E  +      ++ S   LS+D  +++  + + 
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQTLR 123
Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           A++ +H   +IHRD+KP NLL+ ++  +K+ DFG  + + +S                +V
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYV 183
Query: 217 GTAAYVPPEV-LNSSPATFGNDLWALGCTLYQML 249
            T  Y  PEV L S+  +   D+W+ GC L ++ 
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 15/217 (6%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           ++E+ +  G G+Y  V  A++  TG   A+K +   F    N    ++ E  +L    H 
Sbjct: 55  EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR-ELKILKHFKHD 113
Query: 106 GVVRLFFTFQDTF------SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 159
            ++ +    + T       S+Y+ L+  E  +L   I S   L+ +  R++  +++  L+
Sbjct: 114 NIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLK 172
Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           Y+HS  +IHRD+KP NLL+  +  +KI DFG  + +  S       A        +V T 
Sbjct: 173 YMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS------PAEHQYFMTEYVATR 226
Query: 220 AYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPF 255
            Y  PE++ S    T   DLW++GC   +ML+    F
Sbjct: 227 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLF 263

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 60
Query: 103 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 214
           HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 181 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 210

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 59
Query: 103 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 214
           HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 180 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 209

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 60
Query: 103 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 214
           HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 180
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 181 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 210

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 59
Query: 103 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 214
           HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 180 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 209

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 59
Query: 103 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 214
           HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 180 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 209

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S+++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 59
Query: 103 DHPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           +HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACT 214
           HS  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           +  TA                 D+W+LGC   +M++  + F   SE
Sbjct: 180 YYSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 209

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 25/225 (11%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 59
Query: 104 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACTF 215
           S  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C +
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
             TA                 D+W+LGC   +M++  + F   SE
Sbjct: 180 YSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 208

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 23/209 (11%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+Y  V  A         A+K + + F +    +  Y +L   +L  L H  V+ L  
Sbjct: 29  GSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELR--LLKHLKHENVIGLLD 86
Query: 113 TFQ-----DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLI 167
            F      + FS    + +  G +L + I     LS++  +F   +++  L+YIHS G+I
Sbjct: 87  VFTPATSIEDFSEVYLVTTLMGADL-NNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGII 145
Query: 168 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV- 226
           HRD+KP N+ +  D  ++I DFG  +              +D++   +V T  Y  PE+ 
Sbjct: 146 HRDLKPSNVAVNEDCELRILDFGLAR-------------QADEEMTGYVATRWYRAPEIM 192
Query: 227 LNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           LN        D+W++GC + ++L G + F
Sbjct: 193 LNWMHYNQTVDIWSVGCIMAELLQGKALF 221

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 37/220 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           K+ G GS+  V +AK  D+G + A+K  +  K F  +E +         ++ +LDH  +V
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQ---------IMRKLDHCNIV 76
Query: 109 RLFFTF------QDTFSLYMALESCEG-----GELFDQITSKGHLSEDEARFYTAEVVDA 157
           RL + F      +D   L + L+            + +  +K  L     + Y  ++  +
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSR--AKQTLPVIYVKLYMYQLFRS 134
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           L YIHS G+ HRDIKP+NLLL  D  + K+ DFGS K +        PN +        +
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSX-------I 183
Query: 217 GTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            +  Y  PE +  ++  T   D+W+ GC L ++L G   F
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQL 102
           DFE     G G+   V + +   +G      IM +K I  E K A    +  E  VL + 
Sbjct: 17  DFERISELGAGNGGVVTKVQHRPSGL-----IMARKLIHLEIKPAIRNQIIRELQVLHEC 71
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           + P +V  +  F     + + +E  +GG L   +     + E+     +  V+  L Y+ 
Sbjct: 72  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLR 131
Query: 163 S-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
               ++HRD+KP N+L+ + G IK+ DFG    + DS             A +FVGT +Y
Sbjct: 132 EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS------------MANSFVGTRSY 179
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           + PE L  +  +  +D+W++G +L ++  G  P 
Sbjct: 180 MAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 106/219 (48%), Gaps = 29/219 (13%)
Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           +G+  G GS+  V + K    G V A+K+++    T +   A+ K E  VL +  H  ++
Sbjct: 28  VGQRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQQLQAF-KNEVGVLRKTRHVNIL 83
Query: 109 RLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD-------ALEYI 161
            LF  +     L +  + CEG  L+       HL   E +F   +++D        ++Y+
Sbjct: 84  -LFMGYSTAPQLAIVTQWCEGSSLYH------HLHASETKFEMKKLIDIARQTARGMDYL 136
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H+  +IHRD+K  N+ L  D  +KI DFG          T     +   +     G+  +
Sbjct: 137 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA--------TEKSRWSGSHQFEQLSGSILW 188
Query: 222 VPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKD 257
           + PEV+   +S+P +F +D++A G  LY++++G  P+ +
Sbjct: 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 227

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/257 (28%), Positives = 115/257 (44%), Gaps = 42/257 (16%)
Query: 39  QEHFSIQDFELG-------KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY 91
           Q  F  Q  ELG       ++   G ++ V  A+ + +G  YALK   +    +E K   
Sbjct: 15  QSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALK---RLLSNEEEKNRA 71
Query: 92  VKLERIVLDQLD-HPGVVRLFF----------TFQDTFSLYMALESCEGG--ELFDQITS 138
           +  E   + +L  HP +V+             T Q  F L   L  C+G   E   ++ S
Sbjct: 72  IIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTEL--CKGQLVEFLKKMES 129
Query: 139 KGHLSEDEARFYTAEVVDALEYIHSMG--LIHRDIKPENLLLTADGHIKIADFGSVKPMQ 196
           +G LS D       +   A++++H     +IHRD+K ENLLL+  G IK+ DFGS     
Sbjct: 130 RGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA---- 185
Query: 197 DSRITVLPN-------AASDDKACTFVGTAAYVPPEVLN---SSPATFGNDLWALGCTLY 246
            + I+  P+        A  ++  T   T  Y  PE+++   + P     D+WALGC LY
Sbjct: 186 -TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILY 244
Query: 247 QMLSGTSPFKDTSEWLI 263
            +     PF+D ++  I
Sbjct: 245 LLCFRQHPFEDGAKLRI 261

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 116/243 (47%), Gaps = 31/243 (12%)
Query: 29  RSKSFAFRAPQEHFSIQDFEL--GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE 86
           R K+   R   + + I D ++  G+  G GS+  V + K    G V A+K+++    T +
Sbjct: 18  RMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQ 74
Query: 87  NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDE 146
              A+ K E  VL +  H  ++ LF  +     L +  + CEG  L+       HL   E
Sbjct: 75  QLQAF-KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYH------HLHIIE 126
Query: 147 ARFYTAEVVD-------ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR 199
            +F   +++D        ++Y+H+  +IHRD+K  N+ L  D  +KI DFG         
Sbjct: 127 TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA------- 179
Query: 200 ITVLPNAASDDKACTFVGTAAYVPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFK 256
            TV    +   +     G+  ++ PEV+   + +P +F +D++A G  LY++++G  P+ 
Sbjct: 180 -TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 238
Query: 257 DTS 259
           + +
Sbjct: 239 NIN 241

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 116/243 (47%), Gaps = 31/243 (12%)
Query: 29  RSKSFAFRAPQEHFSIQDFEL--GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE 86
           R K+   R   + + I D ++  G+  G GS+  V + K    G V A+K+++    T +
Sbjct: 17  RMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQ 73
Query: 87  NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDE 146
              A+ K E  VL +  H  ++ LF  +     L +  + CEG  L+       HL   E
Sbjct: 74  QLQAF-KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYH------HLHIIE 125
Query: 147 ARFYTAEVVD-------ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR 199
            +F   +++D        ++Y+H+  +IHRD+K  N+ L  D  +KI DFG         
Sbjct: 126 TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA------- 178
Query: 200 ITVLPNAASDDKACTFVGTAAYVPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFK 256
            TV    +   +     G+  ++ PEV+   + +P +F +D++A G  LY++++G  P+ 
Sbjct: 179 -TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 237
Query: 257 DTS 259
           + +
Sbjct: 238 NIN 240

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 106/219 (48%), Gaps = 29/219 (13%)
Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           +G+  G GS+  V + K    G V A+K+++    T +   A+ K E  VL +  H  ++
Sbjct: 28  VGQRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQQLQAF-KNEVGVLRKTRHVNIL 83
Query: 109 RLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD-------ALEYI 161
            LF  +     L +  + CEG  L+       HL   E +F   +++D        ++Y+
Sbjct: 84  -LFMGYSTKPQLAIVTQWCEGSSLYH------HLHASETKFEMKKLIDIARQTARGMDYL 136
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H+  +IHRD+K  N+ L  D  +KI DFG          T     +   +     G+  +
Sbjct: 137 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA--------TEKSRWSGSHQFEQLSGSILW 188
Query: 222 VPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKD 257
           + PEV+   +S+P +F +D++A G  LY++++G  P+ +
Sbjct: 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 227

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 32/224 (14%)
Query: 47  FELGKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE-NKTAYVKLERIVL 99
           +EL K Y      G G+Y  V  A    +G   A+K + + F ++   K AY +L  ++L
Sbjct: 38  WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYREL--LLL 95
Query: 100 DQLDHPGVVRLFFTF------QDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 153
             + H  V+ L   F      ++ +  Y+ +   +      Q       SE++ ++   +
Sbjct: 96  KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDL---QKIMGMEFSEEKIQYLVYQ 152
Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           ++  L+YIHS G++HRD+KP NL +  D  +KI DFG  +              +D +  
Sbjct: 153 MLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR-------------HADAEMT 199
Query: 214 TFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFK 256
            +V T  Y  PEV+ S        D+W++GC + +ML+G + FK
Sbjct: 200 GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK 243

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 25/225 (11%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 67
Query: 104 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACTF 215
           S  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C +
Sbjct: 128 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 187
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
             TA                 D+W+LGC   +M++  + F   SE
Sbjct: 188 YSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 216

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 25/225 (11%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 104 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCH 120
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACTF 215
           S  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C +
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 180
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
             TA                 D+W+LGC   +M++  + F   SE
Sbjct: 181 YSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 209

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 25/225 (11%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 104 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACTF 215
           S  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C +
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 180
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
             TA                 D+W+LGC   +M++  + F   SE
Sbjct: 181 YSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 209

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 25/225 (11%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 59
Query: 104 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACTF 215
           S  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C +
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
             TA                 D+W+LGC   +M++  + F   SE
Sbjct: 180 YSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 208

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 25/225 (11%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+
Sbjct: 6   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 64
Query: 104 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 124
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACTF 215
           S  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C +
Sbjct: 125 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 184
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
             TA                 D+W+LGC   +M++  + F   SE
Sbjct: 185 YSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 213

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 25/225 (11%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 61
Query: 104 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACTF 215
           S  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C +
Sbjct: 122 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 181
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
             TA                 D+W+LGC   +M++  + F   SE
Sbjct: 182 YSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 210

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 25/225 (11%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 59
Query: 104 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACTF 215
           S  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C +
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 179
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
             TA                 D+W+LGC   +M++  + F   SE
Sbjct: 180 YSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 208

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 25/225 (11%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 59
Query: 104 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACTF 215
           S  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C +
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 179
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
             TA                 D+W+LGC   +M++  + F   SE
Sbjct: 180 YSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 208

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 25/225 (11%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 104 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACTF 215
           S  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C +
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 180
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
             TA                 D+W+LGC   +M++  + F   SE
Sbjct: 181 YSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 209

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 32/224 (14%)
Query: 47  FELGKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE-NKTAYVKLERIVL 99
           +EL K Y      G G+Y  V  A    +G   A+K + + F ++   K AY +L  ++L
Sbjct: 20  WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYREL--LLL 77
Query: 100 DQLDHPGVVRLFFTF------QDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 153
             + H  V+ L   F      ++ +  Y+ +   +      Q       SE++ ++   +
Sbjct: 78  KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDL---QKIMGLKFSEEKIQYLVYQ 134
Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           ++  L+YIHS G++HRD+KP NL +  D  +KI DFG  +              +D +  
Sbjct: 135 MLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR-------------HADAEMT 181
Query: 214 TFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFK 256
            +V T  Y  PEV+ S        D+W++GC + +ML+G + FK
Sbjct: 182 GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK 225

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 18/214 (8%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIM---DKKFITKENKTAYVKLERI-VLDQ 101
           DF+L  + G G+Y  V  A    TG + A+K +   DK         A   L  I +L  
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLF------ALRTLREIKILKH 65
Query: 102 LDHPGVVRLFF-----TFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD 156
             H  ++ +F      +F++   +Y+  E  +      ++ S   LS+D  +++  + + 
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQTLR 123
Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           A++ +H   +IHRD+KP NLL+ ++  +K+ DFG  + + +S                 V
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXV 183
Query: 217 GTAAYVPPEV-LNSSPATFGNDLWALGCTLYQML 249
            T  Y  PEV L S+  +   D+W+ GC L ++ 
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 107/249 (42%), Gaps = 34/249 (13%)
Query: 42  FSIQDFELGKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE 95
            +I  F+LG  Y      G G    V  A   D     A+K   K  +T      +   E
Sbjct: 2   MNIHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK---KIVLTDPQSVKHALRE 58
Query: 96  RIVLDQLDHPGVVRLFF--------------TFQDTFSLYMALESCEGGELFDQITSKGH 141
             ++ +LDH  +V++F               +  +  S+Y+  E  E       +  +G 
Sbjct: 59  IKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD--LANVLEQGP 116
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL-TADGHIKIADFGSVKPMQDSRI 200
           L E+ AR +  +++  L+YIHS  ++HRD+KP NL + T D  +KI DFG  + M     
Sbjct: 117 LLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD---- 172
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTS 259
              P+ +        + T  Y  P +L S +  T   D+WA GC   +ML+G + F    
Sbjct: 173 ---PHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229
Query: 260 EWLIFQRII 268
           E    Q I+
Sbjct: 230 ELEQMQLIL 238

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 106/219 (48%), Gaps = 13/219 (5%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 67
Query: 104 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S  ++HRD+KP+NLL+  +G IK+ADFG       +R   +P      +  T      Y 
Sbjct: 128 SHRVLHRDLKPQNLLINTEGAIKLADFGL------ARAFGVPVRTYTHEVVTL----WYR 177
Query: 223 PPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
            PE+ L     +   D+W+LGC   +M++  + F   SE
Sbjct: 178 APEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE 216

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 106/219 (48%), Gaps = 13/219 (5%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 104 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S  ++HRD+KP+NLL+  +G IK+ADFG       +R   +P      +  T      Y 
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGL------ARAFGVPVRTYTHEVVTL----WYR 170
Query: 223 PPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
            PE+ L     +   D+W+LGC   +M++  + F   SE
Sbjct: 171 APEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE 209

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 16/215 (7%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +Q +E  +  G G+Y  V +AK  +T  + ALK + +     E   +    E  +L +L 
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELK 59
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           H  +VRL         L +  E C+    + FD  +  G L  +  + +  +++  L + 
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFD--SCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           HS  ++HRD+KP+NLL+  +G +K+ADFG  +      I V   +A        V T  Y
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLADFGLARAFG---IPVRCYSAE-------VVTLWY 167
Query: 222 VPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
            PP+VL  +   +   D+W+ GC   ++ +   P 
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPL 202

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           ++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 60
Query: 105 PGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           P +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + HS
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACTFV 216
             ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C + 
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
            TA                 D+W+LGC   +M++  + F   SE
Sbjct: 181 STAV----------------DIWSLGCIFAEMVTRRALFPGDSE 208

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 67/128 (52%), Gaps = 9/128 (7%)
Query: 129 GGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIAD 188
           G +L+  + ++ HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI D
Sbjct: 129 GADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICD 187
Query: 189 FGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQ 247
           FG  +          P+         +V T  Y  PE+ LNS   T   D+W++GC L +
Sbjct: 188 FGLAR-------VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAE 240
Query: 248 MLSGTSPF 255
           MLS    F
Sbjct: 241 MLSNRPIF 248

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 107/228 (46%), Gaps = 22/228 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK--TAYVKLERIVLDQLDHPGVVRLF 111
           G G+Y  V +A+  + G  +ALK   K  + KE++   +    E  +L +L H  +V+L+
Sbjct: 11  GEGTYGVVYKAQN-NYGETFALK---KIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 112 FTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 169
                   L +  E  +    +L D    +G L    A+ +  ++++ + Y H   ++HR
Sbjct: 67  DVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHR 124
Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL-N 228
           D+KP+NLL+  +G +KIADFG  +                 K    V T  Y  P+VL  
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAF----------GIPVRKYTHEVVTLWYRAPDVLMG 174
Query: 229 SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           S   +   D+W++GC   +M++GT  F   SE     RI  R +  PN
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF-RILGTPN 221

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 109/229 (47%), Gaps = 28/229 (12%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVY-ALKIMDKKFITKENKTAYVKLERIV----L 99
           Q +E     G G+Y KV +A+ +  G  + ALK +  +  T E       +  +     L
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV--RVQTGEEGMPLSTIREVAVLRHL 68
Query: 100 DQLDHPGVVRLF------FTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYT 151
           +  +HP VVRLF       T ++T  L +  E  +       D++   G +  +  +   
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRET-KLTLVFEHVDQDLTTYLDKVPEPG-VPTETIKDMM 126
Query: 152 AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDK 211
            +++  L+++HS  ++HRD+KP+N+L+T+ G IK+ADFG       +RI     A +   
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL------ARIYSFQMALT--- 177
Query: 212 ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
             + V T  Y  PEVL  S      DLW++GC   +M      F+ +S+
Sbjct: 178 --SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 224

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 122/269 (45%), Gaps = 25/269 (9%)
Query: 6   KDFDSKLRIEG----------NNNSSTNCPTVQRSKSFAFRA-PQEHFSI--QDFELGKI 52
           +  D+  R+EG          ++  ST  P  ++S     RA P++ + +  +D  LG+ 
Sbjct: 62  QSLDNLYRLEGEGFPSIPLLIDHLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQ 121
Query: 53  YGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFF 112
            G G++ +V   +     T+ A+K   ++ +  + K  +++  RI L Q  HP +VRL  
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFLQEARI-LKQYSHPNIVRLIG 179
Query: 113 TFQDTFSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDI 171
                  +Y+ +E  +GG+    + ++G  L          +    +EY+ S   IHRD+
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDL 239
Query: 172 KPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP 231
              N L+T    +KI+DFG  +   D     +  A+   +      TA    PE LN   
Sbjct: 240 AARNCLVTEKNVLKISDFGMSREEADG----VXAASGGLRQVPVKWTA----PEALNYGR 291
Query: 232 ATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
            +  +D+W+ G  L++  S G SP+ + S
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPNLS 320

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 106/215 (49%), Gaps = 14/215 (6%)
Query: 40  EHFSIQDFELGKI--YGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           ++F ++  +L  I   G G+Y  V + + + +G + A+K +     ++E K   + L+ I
Sbjct: 44  QNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLD-I 102
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG--ELFDQITSKGH-LSEDEARFYTAEV 154
            +  +D P  V  +        +++ +E  +    + + Q+  KG  + ED        +
Sbjct: 103 SMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 162
Query: 155 VDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           V ALE++HS + +IHRD+KP N+L+ A G +K+ DFG    + DS       A + D  C
Sbjct: 163 VKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSV------AKTIDAGC 216
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQM 248
                   + PE LN    +  +D+W+LG T+ ++
Sbjct: 217 KPYMAPERINPE-LNQKGYSVKSDIWSLGITMIEL 250

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 109/229 (47%), Gaps = 28/229 (12%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVY-ALKIMDKKFITKENKTAYVKLERIV----L 99
           Q +E     G G+Y KV +A+ +  G  + ALK +  +  T E       +  +     L
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV--RVQTGEEGMPLSTIREVAVLRHL 68
Query: 100 DQLDHPGVVRLF------FTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYT 151
           +  +HP VVRLF       T ++T  L +  E  +       D++   G +  +  +   
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRET-KLTLVFEHVDQDLTTYLDKVPEPG-VPTETIKDMM 126
Query: 152 AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDK 211
            +++  L+++HS  ++HRD+KP+N+L+T+ G IK+ADFG       +RI     A +   
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL------ARIYSFQMALT--- 177
Query: 212 ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
             + V T  Y  PEVL  S      DLW++GC   +M      F+ +S+
Sbjct: 178 --SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 224

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 22/228 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK--TAYVKLERIVLDQLDHPGVVRLF 111
           G G+Y  V +A+  + G  +ALK   K  + KE++   +    E  +L +L H  +V+L+
Sbjct: 11  GEGTYGVVYKAQN-NYGETFALK---KIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 112 FTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 169
                   L +  E  +    +L D    +G L    A+ +  ++++ + Y H   ++HR
Sbjct: 67  DVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHR 124
Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL-N 228
           D+KP+NLL+  +G +KIADFG  +                 K    + T  Y  P+VL  
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAF----------GIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 229 SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           S   +   D+W++GC   +M++GT  F   SE     RI  R +  PN
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF-RILGTPN 221

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 109/229 (47%), Gaps = 28/229 (12%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVY-ALKIMDKKFITKENKTAYVKLERIV----L 99
           Q +E     G G+Y KV +A+ +  G  + ALK +  +  T E       +  +     L
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV--RVQTGEEGMPLSTIREVAVLRHL 68
Query: 100 DQLDHPGVVRLF------FTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYT 151
           +  +HP VVRLF       T ++T  L +  E  +       D++   G +  +  +   
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRET-KLTLVFEHVDQDLTTYLDKVPEPG-VPTETIKDMM 126
Query: 152 AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDK 211
            +++  L+++HS  ++HRD+KP+N+L+T+ G IK+ADFG       +RI     A +   
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL------ARIYSFQMALT--- 177
Query: 212 ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
             + V T  Y  PEVL  S      DLW++GC   +M      F+ +S+
Sbjct: 178 --SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 224

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 116/232 (50%), Gaps = 27/232 (11%)
Query: 37  APQEH--FSIQDF-ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVK 93
           +P++H  F+ +D  +LG+I G G+Y  V +     +G + A+K +      KE K   + 
Sbjct: 12  SPEQHWDFTAEDLKDLGEI-GRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMD 70
Query: 94  LERIVLDQLDHPGVVRLF---FTFQDTFSLYMALESCEGGELFDQITS--KGHLSEDEAR 148
           L+ +V+   D P +V+ +   F   D + + M L S    + +  + S     + E+   
Sbjct: 71  LD-VVMRSSDCPYIVQFYGALFREGDCW-ICMELMSTSFDKFYKYVYSVLDDVIPEEILG 128
Query: 149 FYTAEVVDALEYI-HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA 207
             T   V AL ++  ++ +IHRDIKP N+LL   G+IK+ DFG    + DS       A 
Sbjct: 129 KITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS------IAK 182
Query: 208 SDDKACTFVGTAAYVPPEVLNSSPATFG----NDLWALGCTLYQMLSGTSPF 255
           + D  C       Y+ PE ++ S +  G    +D+W+LG TLY++ +G  P+
Sbjct: 183 TRDAGCR-----PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY 229

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 121/269 (44%), Gaps = 25/269 (9%)
Query: 6   KDFDSKLRIEG----------NNNSSTNCPTVQRSKSFAFRA-PQEHFSI--QDFELGKI 52
           +  D+  R+EG          ++  ST  P  ++S     RA P++ + +  +D  LG+ 
Sbjct: 62  QSLDNLYRLEGEGFPSIPLLIDHLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQ 121
Query: 53  YGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFF 112
            G G++ +V   +     T+ A+K   ++ +  + K  +++  RI L Q  HP +VRL  
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFLQEARI-LKQYSHPNIVRLIG 179
Query: 113 TFQDTFSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDI 171
                  +Y+ +E  +GG+    + ++G  L          +    +EY+ S   IHRD+
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDL 239
Query: 172 KPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP 231
              N L+T    +KI+DFG  +   D        AAS       V   A   PE LN   
Sbjct: 240 AARNCLVTEKNVLKISDFGMSREEADGVY-----AASGGLRQVPVKWTA---PEALNYGR 291
Query: 232 ATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
            +  +D+W+ G  L++  S G SP+ + S
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPNLS 320

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           +G+  G GS+  V + K    G V A+K+++    T +   A+ K E  VL +  H  ++
Sbjct: 12  VGQRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQQLQAF-KNEVGVLRKTRHVNIL 67
Query: 109 RLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD-------ALEYI 161
            LF  +     L +  + CEG  L+       HL   E +F   +++D        ++Y+
Sbjct: 68  -LFMGYSTAPQLAIVTQWCEGSSLYH------HLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H+  +IHRD+K  N+ L  D  +KI DFG          TV    +   +     G+  +
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA--------TVKSRWSGSHQFEQLSGSILW 172
Query: 222 VPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 259
           + PEV+   + +P +F +D++A G  LY++++G  P+ + +
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           +G+  G GS+  V + K    G V A+K+++    T +   A+ K E  VL +  H  ++
Sbjct: 17  VGQRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQQLQAF-KNEVGVLRKTRHVNIL 72
Query: 109 RLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD-------ALEYI 161
            LF  +     L +  + CEG  L+       HL   E +F   +++D        ++Y+
Sbjct: 73  -LFMGYSTKPQLAIVTQWCEGSSLYH------HLHIIETKFEMIKLIDIARQTAQGMDYL 125
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H+  +IHRD+K  N+ L  D  +KI DFG          TV    +   +     G+  +
Sbjct: 126 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA--------TVKSRWSGSHQFEQLSGSILW 177
Query: 222 VPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 259
           + PEV+   + +P +F +D++A G  LY++++G  P+ + +
Sbjct: 178 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 218

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           +G+  G GS+  V + K    G V A+K+++    T +   A+ K E  VL +  H  ++
Sbjct: 14  VGQRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQQLQAF-KNEVGVLRKTRHVNIL 69
Query: 109 RLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD-------ALEYI 161
            LF  +     L +  + CEG  L+       HL   E +F   +++D        ++Y+
Sbjct: 70  -LFMGYSTKPQLAIVTQWCEGSSLYH------HLHIIETKFEMIKLIDIARQTAQGMDYL 122
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H+  +IHRD+K  N+ L  D  +KI DFG          TV    +   +     G+  +
Sbjct: 123 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA--------TVKSRWSGSHQFEQLSGSILW 174
Query: 222 VPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 259
           + PEV+   + +P +F +D++A G  LY++++G  P+ + +
Sbjct: 175 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 215

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           +G+  G GS+  V + K    G V A+K+++    T +   A+ K E  VL +  H  ++
Sbjct: 17  VGQRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQQLQAF-KNEVGVLRKTRHVNIL 72
Query: 109 RLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD-------ALEYI 161
            LF  +     L +  + CEG  L+       HL   E +F   +++D        ++Y+
Sbjct: 73  -LFMGYSTKPQLAIVTQWCEGSSLYH------HLHIIETKFEMIKLIDIARQTAQGMDYL 125
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H+  +IHRD+K  N+ L  D  +KI DFG          TV    +   +     G+  +
Sbjct: 126 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA--------TVKSRWSGSHQFEQLSGSILW 177
Query: 222 VPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 259
           + PEV+   + +P +F +D++A G  LY++++G  P+ + +
Sbjct: 178 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 218

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 115/243 (47%), Gaps = 31/243 (12%)
Query: 29  RSKSFAFRAPQEHFSIQDFEL--GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE 86
           R K+   R   + + I D ++  G+  G GS+  V + K    G V A+K+++    T +
Sbjct: 18  RMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQ 74
Query: 87  NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDE 146
              A+ K E  VL +  H  ++ LF  +     L +  + CEG  L+       HL   E
Sbjct: 75  QLQAF-KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYH------HLHIIE 126
Query: 147 ARFYTAEVVD-------ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR 199
            +F   +++D        ++Y+H+  +IHRD+K  N+ L  D  +KI DFG         
Sbjct: 127 TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA------- 179
Query: 200 ITVLPNAASDDKACTFVGTAAYVPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFK 256
            T     +   +     G+  ++ PEV+   + +P +F +D++A G  LY++++G  P+ 
Sbjct: 180 -TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 238
Query: 257 DTS 259
           + +
Sbjct: 239 NIN 241

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           +G+  G GS+  V + K    G V A+K+++    T +   A+ K E  VL +  H  ++
Sbjct: 12  VGQRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQQLQAF-KNEVGVLRKTRHVNIL 67
Query: 109 RLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD-------ALEYI 161
            LF  +     L +  + CEG  L+       HL   E +F   +++D        ++Y+
Sbjct: 68  -LFMGYSTKPQLAIVTQWCEGSSLYH------HLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H+  +IHRD+K  N+ L  D  +KI DFG          TV    +   +     G+  +
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA--------TVKSRWSGSHQFEQLSGSILW 172
Query: 222 VPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 259
           + PEV+   + +P +F +D++A G  LY++++G  P+ + +
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 141 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 200
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 122 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLAR------- 174
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 255
              P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 175 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 230

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 25/225 (11%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +++F+  +  G G+Y  V +A+   TG V AL  +     T+   +  ++ E  +L +L+
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 104 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACTF 215
           S  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C +
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 180
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
             TA                 D+W+LGC   +M++  + F   SE
Sbjct: 181 YSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 209

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 25/225 (11%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +++F+  +  G G+Y  V +A+   TG V AL  +     T+   +  ++ E  +L +L+
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-EISLLKELN 59
Query: 104 HPGVVRLFFTFQDTFSLYMALESC-EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           HP +V+L         LY+  E   +  + F   ++   +     + Y  +++  L + H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFG-------SVKPMQDSRITVLPNAASDDKACTF 215
           S  ++HRD+KP+NLL+  +G IK+ADFG        V+      +T+   A      C +
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
             TA                 D+W+LGC   +M++  + F   SE
Sbjct: 180 YSTAV----------------DIWSLGCIFAEMVTRRALFPGDSE 208

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 29/212 (13%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS+  V + K      V  LK++D    T E   A+ + E  VL +  H  ++ LF  
Sbjct: 45  GSGSFGTVYKGKWHGDVAVKILKVVDP---TPEQFQAF-RNEVAVLRKTRHVNIL-LFMG 99
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD-------ALEYIHSMGL 166
           +    +L +  + CEG  L+       HL   E +F   +++D        ++Y+H+  +
Sbjct: 100 YMTKDNLAIVTQWCEGSSLYK------HLHVQETKFQMFQLIDIARQTAQGMDYLHAKNI 153
Query: 167 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 226
           IHRD+K  N+ L     +KI DFG          TV    +   +     G+  ++ PEV
Sbjct: 154 IHRDMKSNNIFLHEGLTVKIGDFGLA--------TVKSRWSGSQQVEQPTGSVLWMAPEV 205
Query: 227 L---NSSPATFGNDLWALGCTLYQMLSGTSPF 255
           +   +++P +F +D+++ G  LY++++G  P+
Sbjct: 206 IRMQDNNPFSFQSDVYSYGIVLYELMTGELPY 237

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 88/170 (51%), Gaps = 19/170 (11%)
Query: 120 LYMALESCEGGELFDQITSKGHLSEDE---ARFYTAEVVDALEYIHSMGLIHRDIKPENL 176
           LY+ ++ C    L D +  +  L + E         ++ +A+E++HS GL+HRD+KP N+
Sbjct: 136 LYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNI 195
Query: 177 LLTADGHIKIADFGSVKPM-----QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP 231
             T D  +K+ DFG V  M     + + +T +P  A+       VGT  Y+ PE ++ + 
Sbjct: 196 FFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQ---VGTKLYMSPEQIHGNN 252
Query: 232 ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII--ARDIRFPNYFS 279
            +   D+++LG  L+++L     F    E +   RII   R+++FP  F+
Sbjct: 253 YSHKVDIFSLGLILFELLYS---FSTQMERV---RIITDVRNLKFPLLFT 296

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 115/243 (47%), Gaps = 31/243 (12%)
Query: 29  RSKSFAFRAPQEHFSIQDFEL--GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE 86
           R K+   R   + + I D ++  G+  G GS+  V + K    G V A+K+++    T +
Sbjct: 10  RMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQ 66
Query: 87  NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDE 146
              A+ K E  VL +  H  ++ LF  +     L +  + CEG  L+       HL   E
Sbjct: 67  QLQAF-KNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYH------HLHIIE 118
Query: 147 ARFYTAEVVD-------ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR 199
            +F   +++D        ++Y+H+  +IHRD+K  N+ L  D  +KI DFG         
Sbjct: 119 TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA------- 171
Query: 200 ITVLPNAASDDKACTFVGTAAYVPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFK 256
            T     +   +     G+  ++ PEV+   + +P +F +D++A G  LY++++G  P+ 
Sbjct: 172 -TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 230
Query: 257 DTS 259
           + +
Sbjct: 231 NIN 233

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 102/222 (45%), Gaps = 49/222 (22%)
Query: 44  IQDFEL-GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           I D+++  ++ G+G   KV++     T   +ALK++      +     + +  +      
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 70
Query: 103 DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 156
             P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + +
Sbjct: 71  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 157 ALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           A++Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K     +          DK+C
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEKY---------DKSC 179
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
                                  D+W+LG  +Y +L G  PF
Sbjct: 180 -----------------------DMWSLGVIMYILLCGYPPF 198

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 141 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 200
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 120 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLAR------- 172
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 255
              P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 173 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 141 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 200
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 124 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR------- 176
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 255
              P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 141 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 200
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 118 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR------- 170
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 255
              P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 171 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 226

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 141 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 200
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 118 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR------- 170
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 255
              P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 171 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 226

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 141 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 200
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 125 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR------- 177
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 255
              P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 178 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 233

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 141 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 200
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 126 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR------- 178
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 255
              P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 179 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 234

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 141 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 200
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 117 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR------- 169
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 255
              P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 170 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 225

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 141 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 200
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 124 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR------- 176
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 255
              P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 141 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 200
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 124 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLAR------- 176
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 255
              P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 141 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 200
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 124 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLAR------- 176
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 255
              P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 141 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 200
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 120 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR------- 172
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 255
              P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 173 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 141 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 200
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 122 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR------- 174
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 255
              P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 175 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 230

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 141 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 200
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 124 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR------- 176
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 255
              P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 141 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 200
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 120 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLAR------- 172
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 255
              P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 173 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 141 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 200
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 128 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR------- 180
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 255
              P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 181 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 236

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 141 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 200
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 120 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR------- 172
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 255
              P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 173 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 141 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 200
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 140 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR------- 192
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 255
              P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 193 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 106/228 (46%), Gaps = 22/228 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK--TAYVKLERIVLDQLDHPGVVRLF 111
           G G+Y  V +A+  + G  +ALK   K  + KE++   +    E  +L +L H  +V+L+
Sbjct: 11  GEGTYGVVYKAQN-NYGETFALK---KIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 112 FTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 169
                   L +  E  +    +L D    +G L    A+ +  ++++ + Y H   ++HR
Sbjct: 67  DVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHR 124
Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL-N 228
           D+KP+NLL+  +G +KIADFG  +                 K    V T  Y  P+VL  
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAF----------GIPVRKYTHEVVTLWYRAPDVLMG 174
Query: 229 SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           S   +   D+W++GC   +M++G   F   SE     RI  R +  PN
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIF-RILGTPN 221

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 141 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 200
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 122 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR------- 174
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 255
              P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 175 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 230

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 141 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 200
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 120 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLAR------- 172
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 255
              P+         +V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 173 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 16/215 (7%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +Q +E  +  G G+Y  V +AK  +T  + ALK + +     E   +    E  +L +L 
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELK 59
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           H  +VRL         L +  E C+    + FD  +  G L  +  + +  +++  L + 
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFD--SCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           HS  ++HRD+KP+NLL+  +G +K+A+FG  +      I V   +A        V T  Y
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFG---IPVRCYSAE-------VVTLWY 167
Query: 222 VPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
            PP+VL  +   +   D+W+ GC   ++ +   P 
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 15/204 (7%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G+Y+ V + K   T  + ALK  + +   +E        E  +L  L H  +V L   
Sbjct: 11  GEGTYATVYKGKSKLTDNLVALK--EIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHL-SEDEARFYTAEVVDALEYIHSMGLIHRDIK 172
                SL +  E  +  +L   +   G++ +    + +  +++  L Y H   ++HRD+K
Sbjct: 69  IHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLK 127
Query: 173 PENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSP 231
           P+NLL+   G +K+ADFG       +R   +P    D++    V T  Y PP++ L S+ 
Sbjct: 128 PQNLLINERGELKLADFGL------ARAKSIPTKTYDNE----VVTLWYRPPDILLGSTD 177
Query: 232 ATFGNDLWALGCTLYQMLSGTSPF 255
            +   D+W +GC  Y+M +G   F
Sbjct: 178 YSTQIDMWGVGCIFYEMATGRPLF 201

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  ELG+  G G +  V +   +       A+ I   K  T ++       E + + Q D
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSKGHLSEDEARFYTAEVVDALEYI 161
           HP +V+L     +   +++ +E C  GEL  F Q+  K  L       Y  ++  AL Y+
Sbjct: 70  HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYL 127
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
            S   +HRDI   N+L++++  +K+ DFG  + M+DS         +  KA        +
Sbjct: 128 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS---------TXXKASKGKLPIKW 178
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQML-SGTSPFK 256
           + PE +N    T  +D+W  G  ++++L  G  PF+
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 107/223 (47%), Gaps = 36/223 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIM-DKKFITKENKTAYVKLERIVLDQLDHPGVVR 109
           K+ G GS+  V +AK +++  V   K++ DK+F  +E     +++ RIV     HP VV 
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRE-----LQIMRIV----KHPNVVD 96
Query: 110 LFFTF------QDTFSLYMALESC-----EGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
           L   F      +D   L + LE            + ++  K  +     + Y  +++ +L
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKL--KQTMPMLLIKLYMYQLLRSL 154
Query: 159 EYIHSMGLIHRDIKPENLLL-TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
            YIHS+G+ HRDIKP+NLLL    G +K+ DFGS K +    I   PN +        + 
Sbjct: 155 AYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL----IAGEPNVSX-------IC 203
Query: 218 TAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 259
           +  Y  PE +  ++  T   D+W+ GC + +++ G   F   S
Sbjct: 204 SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES 246

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE----NKTAYVKLERIVLDQLDHPGVVR 109
           G G ++ V +A+  +T  + A+K +     ++     N+TA  +++  +L +L HP ++ 
Sbjct: 19  GEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK--LLQELSHPNIIG 76
Query: 110 LFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 169
           L   F    ++ +  +  E         +   L+    + Y    +  LEY+H   ++HR
Sbjct: 77  LLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHR 136
Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL-N 228
           D+KP NLLL  +G +K+ADFG  K          PN A   +    V T  Y  PE+L  
Sbjct: 137 DLKPNNLLLDENGVLKLADFGLAKSFGS------PNRAYXHQ----VVTRWYRAPELLFG 186
Query: 229 SSPATFGNDLWALGCTLYQML 249
           +     G D+WA+GC L ++L
Sbjct: 187 ARMYGVGVDMWAVGCILAELL 207

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 85/205 (41%), Gaps = 17/205 (8%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS+  V  A+ +    V A+K M         K   +  E   L +L HP  ++    
Sbjct: 63  GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGC 122
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +    + ++ +E C G         K  L E E    T   +  L Y+HS  +IHRD+K 
Sbjct: 123 YLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKA 182
Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV---LNSS 230
            N+LL+  G +K+ DFGS   M                A  FVGT  ++ PEV   ++  
Sbjct: 183 GNILLSEPGLVKLGDFGSASIMA--------------PANXFVGTPYWMAPEVILAMDEG 228
Query: 231 PATFGNDLWALGCTLYQMLSGTSPF 255
                 D+W+LG T  ++     P 
Sbjct: 229 QYDGKVDVWSLGITCIELAERKPPL 253

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 19/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-VLDQLDHPGVVRLFF 112
           G G+Y  V +AK    G + ALK +  +   ++       +  I +L +L HP +V L  
Sbjct: 30  GEGTYGVVYKAKD-SQGRIVALKRI--RLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 113 TFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 170
                  L +  E  E    ++ D+  +K  L + + + Y  +++  + + H   ++HRD
Sbjct: 87  VIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRD 144
Query: 171 IKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL-NS 229
           +KP+NLL+ +DG +K+ADFG       +R   +P  +   +  T      Y  P+VL  S
Sbjct: 145 LKPQNLLINSDGALKLADFGL------ARAFGIPVRSYTHEVVTL----WYRAPDVLMGS 194
Query: 230 SPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
              +   D+W++GC   +M++G   F   ++
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGKPLFPGVTD 225

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G+Y  V + + + +G + A+K +     ++E K   + L+ I +  +D P  V  +  
Sbjct: 16  GRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLD-ISMRTVDCPFTVTFYGA 74
Query: 114 FQDTFSLYMALESCEGG--ELFDQITSKGH-LSEDEARFYTAEVVDALEYIHS-MGLIHR 169
                 +++ +E  +    + + Q+  KG  + ED        +V ALE++HS + +IHR
Sbjct: 75  LFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHR 134
Query: 170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD-DKACTFVGTAAYVPPEVLN 228
           D+KP N+L+ A G +K+ DFG    + D       + A D D  C        + PE LN
Sbjct: 135 DVKPSNVLINALGQVKMCDFGISGYLVD-------DVAKDIDAGCKPYMAPERINPE-LN 186
Query: 229 SSPATFGNDLWALGCTLYQMLSGTSPF 255
               +  +D+W+LG T+ ++     P+
Sbjct: 187 QKGYSVKSDIWSLGITMIELAILRFPY 213

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 19/211 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-VLDQLDHPGVVRLFF 112
           G G+Y  V +AK    G + ALK +  +   ++       +  I +L +L HP +V L  
Sbjct: 30  GEGTYGVVYKAKD-SQGRIVALKRI--RLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 113 TFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRD 170
                  L +  E  E    ++ D+  +K  L + + + Y  +++  + + H   ++HRD
Sbjct: 87  VIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRD 144
Query: 171 IKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL-NS 229
           +KP+NLL+ +DG +K+ADFG       +R   +P  +   +  T      Y  P+VL  S
Sbjct: 145 LKPQNLLINSDGALKLADFGL------ARAFGIPVRSYTHEVVTL----WYRAPDVLMGS 194
Query: 230 SPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
              +   D+W++GC   +M++G   F   ++
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGKPLFPGVTD 225

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 85/205 (41%), Gaps = 17/205 (8%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G GS+  V  A+ +    V A+K M         K   +  E   L +L HP  ++    
Sbjct: 24  GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGC 83
Query: 114 FQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKP 173
           +    + ++ +E C G         K  L E E    T   +  L Y+HS  +IHRD+K 
Sbjct: 84  YLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKA 143
Query: 174 ENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV---LNSS 230
            N+LL+  G +K+ DFGS   M                A  FVGT  ++ PEV   ++  
Sbjct: 144 GNILLSEPGLVKLGDFGSASIMA--------------PANXFVGTPYWMAPEVILAMDEG 189
Query: 231 PATFGNDLWALGCTLYQMLSGTSPF 255
                 D+W+LG T  ++     P 
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPL 214

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  ELG+  G G +  V +   +       A+ I   K  T ++       E + + Q D
Sbjct: 38  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 97
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSKGHLSEDEARFYTAEVVDALEYI 161
           HP +V+L     +   +++ +E C  GEL  F Q+  K  L       Y  ++  AL Y+
Sbjct: 98  HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYL 155
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
            S   +HRDI   N+L++++  +K+ DFG  + M+DS        AS  K         +
Sbjct: 156 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY----KASKGKL-----PIKW 206
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQML-SGTSPFK 256
           + PE +N    T  +D+W  G  ++++L  G  PF+
Sbjct: 207 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 242

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 15/216 (6%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  ELG+  G G +  V +   +       A+ I   K  T ++       E + + Q D
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSKGHLSEDEARFYTAEVVDALEYI 161
           HP +V+L     +   +++ +E C  GEL  F Q+  K  L       Y  ++  AL Y+
Sbjct: 70  HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYL 127
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
            S   +HRDI   N+L++A   +K+ DFG  + M+DS        AS  K         +
Sbjct: 128 ESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYY----KASKGKL-----PIKW 178
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQML-SGTSPFK 256
           + PE +N    T  +D+W  G  ++++L  G  PF+
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 102/227 (44%), Gaps = 15/227 (6%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  ELG+  G G +  V +   +       A+ I   K  T ++       E + + Q D
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSKGHLSEDEARFYTAEVVDALEYI 161
           HP +V+L     +   +++ +E C  GEL  F Q+  K  L       Y  ++  AL Y+
Sbjct: 75  HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYL 132
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
            S   +HRDI   N+L++++  +K+ DFG  + M+DS        AS  K         +
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY----KASKGKL-----PIKW 183
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQML-SGTSPFKDTSEWLIFQRI 267
           + PE +N    T  +D+W  G  ++++L  G  PF+      +  RI
Sbjct: 184 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  ELG+  G G +  V +   +       A+ I   K  T ++       E + + Q D
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSKGHLSEDEARFYTAEVVDALEYI 161
           HP +V+L     +   +++ +E C  GEL  F Q+  K  L       Y  ++  AL Y+
Sbjct: 70  HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYL 127
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
            S   +HRDI   N+L++++  +K+ DFG  + M+DS        AS  K         +
Sbjct: 128 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY----KASKGKL-----PIKW 178
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQML-SGTSPFK 256
           + PE +N    T  +D+W  G  ++++L  G  PF+
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  ELG+  G G +  V +   +       A+ I   K  T ++       E + + Q D
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSKGHLSEDEARFYTAEVVDALEYI 161
           HP +V+L     +   +++ +E C  GEL  F Q+  K  L       Y  ++  AL Y+
Sbjct: 67  HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYL 124
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
            S   +HRDI   N+L++++  +K+ DFG  + M+DS        AS  K         +
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY----KASKGKL-----PIKW 175
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQML-SGTSPFK 256
           + PE +N    T  +D+W  G  ++++L  G  PF+
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 211

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  ELG+  G G +  V +   +       A+ I   K  T ++       E + + Q D
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSKGHLSEDEARFYTAEVVDALEYI 161
           HP +V+L     +   +++ +E C  GEL  F Q+  K  L       Y  ++  AL Y+
Sbjct: 70  HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYL 127
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
            S   +HRDI   N+L++++  +K+ DFG  + M+DS        AS  K         +
Sbjct: 128 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY----KASKGKL-----PIKW 178
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQML-SGTSPFK 256
           + PE +N    T  +D+W  G  ++++L  G  PF+
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  ELG+  G G +  V +   +       A+ I   K  T ++       E + + Q D
Sbjct: 12  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 71
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSKGHLSEDEARFYTAEVVDALEYI 161
           HP +V+L     +   +++ +E C  GEL  F Q+  K  L       Y  ++  AL Y+
Sbjct: 72  HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYL 129
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
            S   +HRDI   N+L++++  +K+ DFG  + M+DS        AS  K         +
Sbjct: 130 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY----KASKGKL-----PIKW 180
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQML-SGTSPFK 256
           + PE +N    T  +D+W  G  ++++L  G  PF+
Sbjct: 181 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 216

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 108/221 (48%), Gaps = 29/221 (13%)
Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
           +G+  G GS+  V + K    G V A+K+++    T +   A+ K E  VL +  H  ++
Sbjct: 12  VGQRIGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQQLQAF-KNEVGVLRKTRHVNIL 67
Query: 109 RLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD-------ALEYI 161
            LF  +     L +  + CEG  L+       HL   E +F   +++D        ++Y+
Sbjct: 68  -LFMGYSTKPQLAIVTQWCEGSSLYH------HLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H+  +IHRD+K  N+ L  D  +KI DFG     + SR       +   +     G+  +
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT--EKSR------WSGSHQFEQLSGSILW 172
Query: 222 VPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 259
           + PEV+   + +P +F +D++A G  LY++++G  P+ + +
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  ELG+  G G +  V +   +       A+ I   K  T ++       E + + Q D
Sbjct: 13  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 72
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSKGHLSEDEARFYTAEVVDALEYI 161
           HP +V+L     +   +++ +E C  GEL  F Q+  K  L       Y  ++  AL Y+
Sbjct: 73  HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYL 130
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
            S   +HRDI   N+L++++  +K+ DFG  + M+DS        AS  K         +
Sbjct: 131 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY----KASKGKL-----PIKW 181
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQML-SGTSPFK 256
           + PE +N    T  +D+W  G  ++++L  G  PF+
Sbjct: 182 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 217

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 59/116 (50%), Gaps = 8/116 (6%)
Query: 141 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 200
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 124 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR------- 176
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 255
              P+          V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 177 VADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 59/116 (50%), Gaps = 8/116 (6%)
Query: 141 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 200
           HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +       
Sbjct: 125 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR------- 177
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 255
              P+          V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 178 VADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 233

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 31/218 (14%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH- 104
           D++L +  G G YS+V  A  I       +KI+      K+NK   +K E  +L+ L   
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKNK---IKREIKILENLRGG 91
Query: 105 PGVVRLFFTFQDTFSLYMAL--ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           P ++ L    +D  S   AL  E     + F Q+     L++ + RFY  E++ AL+Y H
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 163 SMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQDSRITVLPNAASDDKACTFVGT 218
           SMG++HRD+KP N+++  +   +++ D+G  +   P Q+  +               V +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR--------------VAS 194
Query: 219 AAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
             +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 195 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 15/227 (6%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  ELG+  G G +  V +   +       A+ I   K  T ++       E + + Q D
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSKGHLSEDEARFYTAEVVDALEYI 161
           HP +V+L     +   +++ +E C  GEL  F Q+  K  L       Y  ++  AL Y+
Sbjct: 450 HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYL 507
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
            S   +HRDI   N+L++A   +K+ DFG  + M+DS        AS  K         +
Sbjct: 508 ESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYY----KASKGKL-----PIKW 558
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQML-SGTSPFKDTSEWLIFQRI 267
           + PE +N    T  +D+W  G  ++++L  G  PF+      +  RI
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 21/222 (9%)
Query: 36  RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIM--DKKFITKENKTAYVK 93
           + P +H + + +E+ K+ G GS+ +VV+A         ALK++  +K+F  +  +   + 
Sbjct: 89  QVPHDHVAYR-YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRIL 147
Query: 94  LERIVLDQLDHPGVVRLF--FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYT 151
                 D+ +   V+ +   FTF++   +   L S    EL  +   +G  S    R + 
Sbjct: 148 EHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVRKFA 206
Query: 152 AEVVDALEYIHSMGLIHRDIKPENLLLTADGH--IKIADFGSVKPMQDSRITVLPNAASD 209
             ++  L+ +H   +IH D+KPEN+LL   G   IK+ DFGS             +    
Sbjct: 207 HSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS-------------SCYEH 253
Query: 210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSG 251
            +  T + +  Y  PEV+  +      D+W+LGC L ++L+G
Sbjct: 254 QRVYTXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 8/217 (3%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P   F   D   G++ G G + + ++    +TG V  +K + +    +E +  ++K E  
Sbjct: 3   PHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLK-EVK 59
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF-YTAEVVD 156
           V+  L+HP V++          L    E  +GG L   I S         R  +  ++  
Sbjct: 60  VMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIAS 119
Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV--LPNAASDD--KA 212
            + Y+HSM +IHRD+   N L+  + ++ +ADFG  + M D +     L +    D  K 
Sbjct: 120 GMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKR 179
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQML 249
            T VG   ++ PE++N        D+++ G  L +++
Sbjct: 180 YTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 21/222 (9%)
Query: 36  RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIM--DKKFITKENKTAYVK 93
           + P +H + + +E+ K+ G GS+ +VV+A         ALK++  +K+F  +  +   + 
Sbjct: 89  QVPHDHVAYR-YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRIL 147
Query: 94  LERIVLDQLDHPGVVRLF--FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYT 151
                 D+ +   V+ +   FTF++   +   L S    EL  +   +G  S    R + 
Sbjct: 148 EHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVRKFA 206
Query: 152 AEVVDALEYIHSMGLIHRDIKPENLLLTADGH--IKIADFGSVKPMQDSRITVLPNAASD 209
             ++  L+ +H   +IH D+KPEN+LL   G   IK+ DFGS             +    
Sbjct: 207 HSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS-------------SCYEH 253
Query: 210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSG 251
            +  T + +  Y  PEV+  +      D+W+LGC L ++L+G
Sbjct: 254 QRVYTXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 102/227 (44%), Gaps = 15/227 (6%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  ELG+  G G +  V +   +       A+ I   K  T ++       E + + Q D
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSKGHLSEDEARFYTAEVVDALEYI 161
           HP +V+L     +   +++ +E C  GEL  F Q+  K  L       Y  ++  AL Y+
Sbjct: 450 HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYL 507
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
            S   +HRDI   N+L++++  +K+ DFG  + M+DS        AS  K         +
Sbjct: 508 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY----KASKGKL-----PIKW 558
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQML-SGTSPFKDTSEWLIFQRI 267
           + PE +N    T  +D+W  G  ++++L  G  PF+      +  RI
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 18/212 (8%)
Query: 40  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL 99
           E F  Q F+     G GSY +V + +  + G +YA+K     F   +++    KL  +  
Sbjct: 52  ESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRAR--KLAEVGS 109
Query: 100 DQL--DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVD 156
            +    HP  VRL   +++   LY+  E C G  L     + G  L E +   Y  + + 
Sbjct: 110 HEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLL 168
Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           AL ++HS GL+H D+KP N+ L   G  K+ DFG           +L    +        
Sbjct: 169 ALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFG-----------LLVELGTAGAGEVQE 217
Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQM 248
           G   Y+ PE+L  S  T   D+++LG T+ ++
Sbjct: 218 GDPRYMAPELLQGSYGT-AADVFSLGLTILEV 248

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 87/185 (47%), Gaps = 9/185 (4%)
Query: 72  VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGE 131
           + ALK+  +   +        + E     +L  P VV +    +    LY+      G +
Sbjct: 61  IVALKLXSETLSSDPVFRTRXQREARTAGRLQEPHVVPIHDFGEIDGQLYVDXRLINGVD 120
Query: 132 LFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS 191
           L   +  +G L+   A     ++  AL+  H+ G  HRD+KPEN+L++AD    + DFG 
Sbjct: 121 LAAXLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGI 180
Query: 192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSG 251
                D ++T L N          VGT  Y  PE  + S AT+  D++AL C LY+ L+G
Sbjct: 181 ASATTDEKLTQLGNT---------VGTLYYXAPERFSESHATYRADIYALTCVLYECLTG 231
Query: 252 TSPFK 256
           + P++
Sbjct: 232 SPPYQ 236

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 108/233 (46%), Gaps = 16/233 (6%)
Query: 30  SKSFAFRAPQEHFSIQDFELGKI--YGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN 87
           +++  F+   E+F ++  +L  I   G G+Y  V + + + +G + A+K +     ++E 
Sbjct: 17  TENLYFQGAXENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQ 76
Query: 88  KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG--ELFDQITSKGH-LSE 144
           K     L+ I    +D P  V  +        +++  E  +    + + Q+  KG  + E
Sbjct: 77  KRLLXDLD-ISXRTVDCPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPE 135
Query: 145 DEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL 203
           D        +V ALE++HS + +IHRD+KP N+L+ A G +K  DFG    + D      
Sbjct: 136 DILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVD------ 189
Query: 204 PNAASD-DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
            + A D D  C        + PE LN    +  +D+W+LG T  ++     P+
Sbjct: 190 -DVAKDIDAGCKPYXAPERINPE-LNQKGYSVKSDIWSLGITXIELAILRFPY 240

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 110/231 (47%), Gaps = 34/231 (14%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALK-IMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLF- 111
           G G +S V   + +  G  YALK I+  +   +E       + R+     +HP ++RL  
Sbjct: 38  GEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRL----FNHPNILRLVA 93
Query: 112 FTFQDT---FSLYMALESCEGGELFDQITS---KGH-LSEDEARFYTAEVVDALEYIHSM 164
           +  ++       ++ L   + G L+++I     KG+ L+ED+  +    +   LE IH+ 
Sbjct: 94  YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK 153
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKP----MQDSR--ITVLPNAASDDKACTFVGT 218
           G  HRD+KP N+LL  +G   + D GS+      ++ SR  +T+   AA   + CT    
Sbjct: 154 GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA---QRCTI--- 207
Query: 219 AAYVPPEVLNSSPATF---GNDLWALGCTLYQMLSGTSPFKDTSEWLIFQR 266
            +Y  PE+ +           D+W+LGC LY M+ G  P+      ++FQ+
Sbjct: 208 -SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD-----MVFQK 252

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 104/215 (48%), Gaps = 29/215 (13%)
Query: 55  VGSYSKVVRAKKIDT--GTVYALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF 111
           +GS ++ +     DT  G   A+K + + F  + + K AY +L  ++L  ++H  ++ L 
Sbjct: 32  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYREL--VLLKCVNHKNIISLL 89
Query: 112 --FTFQDTFS----LYMALESCEGGELFDQITSKGHLSEDEAR--FYTAEVVDALEYIHS 163
             FT Q T      +Y+ +E  +       +    H+  D  R  +   +++  ++++HS
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIHMELDHERMSYLLYQMLCGIKHLHS 144
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
            G+IHRD+KP N+++ +D  +KI DFG  +            A ++     +V T  Y  
Sbjct: 145 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TACTNFMMTPYVVTRYYRA 193
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           PEV+         D+W++GC + +++ G   F+ T
Sbjct: 194 PEVILGMGYAANVDIWSVGCIMGELVKGCVIFQGT 228

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 20/214 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT 113
           G G+Y+ V +     TG   ALK  + K  ++E   +    E  ++ +L H  +VRL+  
Sbjct: 14  GNGTYATVYKGLNKTTGVYVALK--EVKLDSEEGTPSTAIREISLMKELKHENIVRLYDV 71
Query: 114 FQDTFSLYMALESCEGG--ELFDQIT---SKGHLSEDEARFYTAEVVDALEYIHSMGLIH 168
                 L +  E  +    +  D  T   +   L  +  +++  +++  L + H   ++H
Sbjct: 72  IHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILH 131
Query: 169 RDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN 228
           RD+KP+NLL+   G +K+ DFG  +        +  N  S +     V T  Y  P+VL 
Sbjct: 132 RDLKPQNLLINKRGQLKLGDFGLARA-----FGIPVNTFSSE-----VVTLWYRAPDVLM 181
Query: 229 SSPATFGN--DLWALGCTLYQMLSGTSPFKDTSE 260
            S  T+    D+W+ GC L +M++G   F  T++
Sbjct: 182 GS-RTYSTSIDIWSCGCILAEMITGKPLFPGTND 214

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 106/215 (49%), Gaps = 29/215 (13%)
Query: 55  VGSYSKVVRAKKIDT--GTVYALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF 111
           +GS ++ +     DT  G   A+K + + F  + + K AY +L  ++L  ++H  ++ L 
Sbjct: 30  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYREL--VLLKCVNHKNIISLL 87
Query: 112 --FTFQDTFS----LYMALESCEGGELFDQITSKGHLSEDEAR--FYTAEVVDALEYIHS 163
             FT Q T      +Y+ +E  +       +    H+  D  R  +   +++  ++++HS
Sbjct: 88  NVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIHMELDHERMSYLLYQMLCGIKHLHS 142
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
            G+IHRD+KP N+++ +D  +KI DFG  +            A+++     +V T  Y  
Sbjct: 143 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TASTNFMMTPYVVTRYYRA 191
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           PEV+         D+W++GC + +++ G+  F+ T
Sbjct: 192 PEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 226

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 110/233 (47%), Gaps = 35/233 (15%)
Query: 37  APQEHFSIQDFELGKIYGVGSYSKVV-------RAKKIDTGTVYALKIMDKKFITKENKT 89
           +PQ   + +D  L +I G G + +V        + +KI+     A+K   KK  T +NK 
Sbjct: 16  SPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINV----AVKTC-KKDCTLDNKE 70
Query: 90  AYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT-SKGHLSEDEAR 148
            ++  E +++  LDHP +V+L    ++    ++ +E    GEL   +  +K  L      
Sbjct: 71  KFMS-EAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLV 128
Query: 149 FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD-----SRITVL 203
            Y+ ++  A+ Y+ S+  +HRDI   N+L+ +   +K+ DFG  + ++D     + +T L
Sbjct: 129 LYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL 188
Query: 204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           P                ++ PE +N    T  +D+W     ++++LS G  PF
Sbjct: 189 P--------------IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 227

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 104/228 (45%), Gaps = 29/228 (12%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY--VKLERI-VLDQLDH 104
           +L KI G G++ +V +A+   TG   ALK    K + +  K  +    L  I +L  L H
Sbjct: 22  KLAKI-GQGTFGEVFKARHRKTGQKVALK----KVLMENEKEGFPITALREIKILQLLKH 76
Query: 105 PGVVRLFFTFQDTFS--------LYMALESCEG--GELFDQITSKGHLSEDEARFYTAEV 154
             VV L    +   S        +Y+  + CE     L   +  K  LSE   +     +
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVMQML 134
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           ++ L YIH   ++HRD+K  N+L+T DG +K+ADFG       +R   L   +  ++   
Sbjct: 135 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL------ARAFSLAKNSQPNRYXN 188
Query: 215 FVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSE 260
            V T  Y PPE+L      +G   DLW  GC + +M + +   +  +E
Sbjct: 189 RVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 235

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 104/228 (45%), Gaps = 29/228 (12%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY--VKLERI-VLDQLDH 104
           +L KI G G++ +V +A+   TG   ALK    K + +  K  +    L  I +L  L H
Sbjct: 22  KLAKI-GQGTFGEVFKARHRKTGQKVALK----KVLMENEKEGFPITALREIKILQLLKH 76
Query: 105 PGVVRLFFTFQDTFS--------LYMALESCEG--GELFDQITSKGHLSEDEARFYTAEV 154
             VV L    +   S        +Y+  + CE     L   +  K  LSE   +     +
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVMQML 134
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           ++ L YIH   ++HRD+K  N+L+T DG +K+ADFG       +R   L   +  ++   
Sbjct: 135 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL------ARAFSLAKNSQPNRYXN 188
Query: 215 FVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSE 260
            V T  Y PPE+L      +G   DLW  GC + +M + +   +  +E
Sbjct: 189 RVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 235

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 104/228 (45%), Gaps = 29/228 (12%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY--VKLERI-VLDQLDH 104
           +L KI G G++ +V +A+   TG   ALK    K + +  K  +    L  I +L  L H
Sbjct: 21  KLAKI-GQGTFGEVFKARHRKTGQKVALK----KVLMENEKEGFPITALREIKILQLLKH 75
Query: 105 PGVVRLFFTFQDTFS--------LYMALESCEG--GELFDQITSKGHLSEDEARFYTAEV 154
             VV L    +   S        +Y+  + CE     L   +  K  LSE   +     +
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVMQML 133
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           ++ L YIH   ++HRD+K  N+L+T DG +K+ADFG       +R   L   +  ++   
Sbjct: 134 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL------ARAFSLAKNSQPNRYXN 187
Query: 215 FVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSE 260
            V T  Y PPE+L      +G   DLW  GC + +M + +   +  +E
Sbjct: 188 RVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 234

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 109/233 (46%), Gaps = 35/233 (15%)
Query: 37  APQEHFSIQDFELGKIYGVGSYSKVV-------RAKKIDTGTVYALKIMDKKFITKENKT 89
            PQ   + +D  L +I G G + +V        + +KI+     A+K   KK  T +NK 
Sbjct: 4   GPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINV----AVKTC-KKDCTLDNKE 58
Query: 90  AYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT-SKGHLSEDEAR 148
            ++  E +++  LDHP +V+L    ++    ++ +E    GEL   +  +K  L      
Sbjct: 59  KFMS-EAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLV 116
Query: 149 FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD-----SRITVL 203
            Y+ ++  A+ Y+ S+  +HRDI   N+L+ +   +K+ DFG  + ++D     + +T L
Sbjct: 117 LYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL 176
Query: 204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           P                ++ PE +N    T  +D+W     ++++LS G  PF
Sbjct: 177 P--------------IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 215

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 121/279 (43%), Gaps = 43/279 (15%)
Query: 8   FDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRA--- 64
           ++S+L++     SS N       + + +    E F  ++ E GK+ G G++ KV+ A   
Sbjct: 9   YESQLQMVQVTGSSDNEYFYVDFREYEYDLKWE-FPRENLEFGKVLGSGAFGKVMNATAY 67
Query: 65  --KKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLY 121
              K       A+K++ +K  + E +    +L+  ++ QL  H  +V L      +  +Y
Sbjct: 68  GISKTGVSIQVAVKMLKEKADSSEREALMSELK--MMTQLGSHENIVNLLGACTLSGPIY 125
Query: 122 MALESCEGGELFDQITSKGH-LSEDEARF----------------------YTAEVVDAL 158
           +  E C  G+L + + SK    SEDE  +                      +  +V   +
Sbjct: 126 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGM 185
Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP-MQDSRITVLPNAASDDKACTFVG 217
           E++     +HRD+   N+L+T    +KI DFG  +  M DS   V  NA    K      
Sbjct: 186 EFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVK------ 239
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
              ++ PE L     T  +D+W+ G  L+++ S G +P+
Sbjct: 240 ---WMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 104/228 (45%), Gaps = 29/228 (12%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY--VKLERI-VLDQLDH 104
           +L KI G G++ +V +A+   TG   ALK    K + +  K  +    L  I +L  L H
Sbjct: 22  KLAKI-GQGTFGEVFKARHRKTGQKVALK----KVLMENEKEGFPITALREIKILQLLKH 76
Query: 105 PGVVRLFFTFQDTFS--------LYMALESCEG--GELFDQITSKGHLSEDEARFYTAEV 154
             VV L    +   S        +Y+  + CE     L   +  K  LSE   +     +
Sbjct: 77  ENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVMQML 134
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           ++ L YIH   ++HRD+K  N+L+T DG +K+ADFG       +R   L   +  ++   
Sbjct: 135 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL------ARAFSLAKNSQPNRYXN 188
Query: 215 FVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSE 260
            V T  Y PPE+L      +G   DLW  GC + +M + +   +  +E
Sbjct: 189 RVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 235

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 106/223 (47%), Gaps = 27/223 (12%)
Query: 46  DFELGKIYGVGSYSKVVRAKKI-DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +  L +I G+G + KV RA  I D   V A +    + I++  +   V+ E  +   L H
Sbjct: 8   ELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIEN--VRQEAKLFAMLKH 65
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS- 163
           P ++ L        +L + +E   GG L +++ S   +  D    +  ++   + Y+H  
Sbjct: 66  PNIIALRGVCLKEPNLCLVMEFARGGPL-NRVLSGKRIPPDILVNWAVQIARGMNYLHDE 124
Query: 164 --MGLIHRDIKPENLLLT--------ADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
             + +IHRD+K  N+L+         ++  +KI DFG  +     R T +  A       
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH--RTTKMSAA------- 175
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK 256
              G  A++ PEV+ +S  + G+D+W+ G  L+++L+G  PF+
Sbjct: 176 ---GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR 215

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 109/232 (46%), Gaps = 35/232 (15%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVV-------RAKKIDTGTVYALKIMDKKFITKENKTA 90
           PQ   + +D  L +I G G + +V        + +KI+     A+K   KK  T +NK  
Sbjct: 1   PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINV----AVKTC-KKDCTLDNKEK 55
Query: 91  YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT-SKGHLSEDEARF 149
           ++  E +++  LDHP +V+L    ++    ++ +E    GEL   +  +K  L       
Sbjct: 56  FMS-EAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVL 113
Query: 150 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD-----SRITVLP 204
           Y+ ++  A+ Y+ S+  +HRDI   N+L+ +   +K+ DFG  + ++D     + +T LP
Sbjct: 114 YSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP 173
Query: 205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                           ++ PE +N    T  +D+W     ++++LS G  PF
Sbjct: 174 --------------IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 211

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 52  IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLF 111
           + G G+   +V     D   V   +I+ + F   + +   ++      +  +HP V+R F
Sbjct: 31  VLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLR------ESDEHPNVIRYF 84
Query: 112 FTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHR 169
            T +D    Y+A+E C    L + +  K   HL  +       +    L ++HS+ ++HR
Sbjct: 85  CTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITL-LQQTTSGLAHLHSLNIVHR 142
Query: 170 DIKPENLLLT---ADGHIK--IADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           D+KP N+L++   A G IK  I+DFG  K +   R        S  +     GT  ++ P
Sbjct: 143 DLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR-------HSFSRRSGVPGTEGWIAP 195
Query: 225 EVLNSSPA---TFGNDLWALGCTLYQMLS-GTSPF 255
           E+L+       T+  D+++ GC  Y ++S G+ PF
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF 230

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/263 (23%), Positives = 114/263 (43%), Gaps = 50/263 (19%)
Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL- 102
           I D+ + +    G ++K++  +K      YALK  +K  + K+        ++I +    
Sbjct: 30  INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 103 -DHPGVVRLFFTFQDTFSLYMALESCEG--------GELFDQITSKGHLSEDEARF---- 149
            D    +++    ++ + L     +CEG          +++ + +   L  DE  F    
Sbjct: 88  DDFKNELQIITDIKNEYCL-----TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK 142
Query: 150 -YTA------------EVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPM 195
            YT              V+++  YIH+   + HRD+KP N+L+  +G +K++DFG  + M
Sbjct: 143 NYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM 202
Query: 196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTS 253
            D +I       S        GT  ++PPE  ++  +  G   D+W+LG  LY M     
Sbjct: 203 VDKKI-----KGSR-------GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250
Query: 254 PFK-DTSEWLIFQRIIARDIRFP 275
           PF    S   +F  I  ++I +P
Sbjct: 251 PFSLKISLVELFNNIRTKNIEYP 273

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 102/222 (45%), Gaps = 21/222 (9%)
Query: 36  RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIM--DKKFITKENKTAYVK 93
           + P +H + + +E+ K+ G G + +VV+A         ALK++  +K+F  +  +   + 
Sbjct: 89  QVPHDHVAYR-YEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRIL 147
Query: 94  LERIVLDQLDHPGVVRLF--FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYT 151
                 D+ +   V+ +   FTF++   +   L S    EL  +   +G  S    R + 
Sbjct: 148 EHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVRKFA 206
Query: 152 AEVVDALEYIHSMGLIHRDIKPENLLLTADGH--IKIADFGSVKPMQDSRITVLPNAASD 209
             ++  L+ +H   +IH D+KPEN+LL   G   IK+ DFGS             +    
Sbjct: 207 HSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS-------------SCYEH 253
Query: 210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSG 251
            +    + +  Y  PEV+  +      D+W+LGC L ++L+G
Sbjct: 254 QRVYXXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 29/220 (13%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIM------DKKFITKENKTAYVKLERIVLDQLDHPGV 107
           GVG+Y  V +A+   +G   ALK +      +   I+   + A ++     L+  +HP V
Sbjct: 13  GVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRR----LEAFEHPNV 68
Query: 108 VRLFFTFQDT-----FSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEY 160
           VRL      +       + +  E  +       D+    G L  +  +    + +  L++
Sbjct: 69  VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLMRQFLRGLDF 127
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           +H+  ++HRD+KPEN+L+T+ G +K+ADFG  + +   ++ + P           V T  
Sbjct: 128 LHANCIVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMALFP----------VVVTLW 176
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           Y  PEVL  S      D+W++GC   +M      F   SE
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE 216

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 105/230 (45%), Gaps = 41/230 (17%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDH 104
           F++ ++ G G++  V   K+  TG   A+K  I D +F  +E +          L  L H
Sbjct: 25  FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQD------LAVLHH 78
Query: 105 PGVVRL---FFTF--QDTFSLYM---------ALESCEGGELFDQITSKGHLSEDEARFY 150
           P +V+L   F+T   +D   +Y+          L  C       Q+     L     + +
Sbjct: 79  PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPIL----IKVF 134
Query: 151 TAEVVDALEYIH--SMGLIHRDIKPENLLLT-ADGHIKIADFGSVKPMQDSRITVLPNAA 207
             +++ ++  +H  S+ + HRDIKP N+L+  ADG +K+ DFGS K +  S     PN A
Sbjct: 135 LFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE----PNVA 190
Query: 208 SDDKACTFVGTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLSGTSPFK 256
                  ++ +  Y  PE +  +   T   D+W++GC   +M+ G   F+
Sbjct: 191 -------YICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFR 233

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV-----LDQLDHPGVV 108
           GVG+Y  V +A+   +G   ALK +             +   R V     L+  +HP VV
Sbjct: 18  GVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVV 77
Query: 109 RLFFTFQDT-----FSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           RL      +       + +  E  +       D+    G L  +  +    + +  L+++
Sbjct: 78  RLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLMRQFLRGLDFL 136
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H+  ++HRD+KPEN+L+T+ G +K+ADFG  + +   ++ + P           V T  Y
Sbjct: 137 HANCIVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMALTP----------VVVTLWY 185
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
             PEVL  S      D+W++GC   +M      F   SE
Sbjct: 186 RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE 224

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 41/116 (35%), Positives = 59/116 (50%), Gaps = 8/116 (6%)
Query: 141 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 200
            LS D   ++  +++  L+YIHS  ++HRD+KP NLL+     +KI DFG  + + D   
Sbjct: 140 QLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLAR-IAD--- 195
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPF 255
              P           V T  Y  PE+ LNS   T   D+W++GC L +MLS    F
Sbjct: 196 ---PEHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 29/220 (13%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIM------DKKFITKENKTAYVKLERIVLDQLDHPGV 107
           GVG+Y  V +A+   +G   ALK +      +   I+   + A ++     L+  +HP V
Sbjct: 13  GVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRR----LEAFEHPNV 68
Query: 108 VRLFFTFQDT-----FSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEY 160
           VRL      +       + +  E  +       D+    G L  +  +    + +  L++
Sbjct: 69  VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLMRQFLRGLDF 127
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           +H+  ++HRD+KPEN+L+T+ G +K+ADFG  + +   ++ + P           V T  
Sbjct: 128 LHANCIVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMALAP----------VVVTLW 176
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           Y  PEVL  S      D+W++GC   +M      F   SE
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE 216

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 107/232 (46%), Gaps = 39/232 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           KI G GS   VV       G+     +  K+ +      A +++ +++ +  DHP V+R 
Sbjct: 39  KILGYGSSGTVVFQ-----GSFQGRPVAVKRMLIDFCDIALMEI-KLLTESDDHPNVIRY 92
Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF--------YTAEVVDALEYIH 162
           + +      LY+ALE C    L D + SK ++S++  +            ++   + ++H
Sbjct: 93  YCSETTDRFLYIALELCNLN-LQDLVESK-NVSDENLKLQKEYNPISLLRQIASGVAHLH 150
Query: 163 SMGLIHRDIKPENLLL------TADGH-------IKIADFGSVKPMQDSRITVLPNAASD 209
           S+ +IHRD+KP+N+L+      TAD         I I+DFG  K +   +     N  + 
Sbjct: 151 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNP 210
Query: 210 DKACTFVGTAAYVPPEVLNSSPA---TFGNDLWALGCTLYQMLS-GTSPFKD 257
                  GT+ +  PE+L  S     T   D++++GC  Y +LS G  PF D
Sbjct: 211 S------GTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 256

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 107/232 (46%), Gaps = 39/232 (16%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           KI G GS   VV       G+     +  K+ +      A +++ +++ +  DHP V+R 
Sbjct: 39  KILGYGSSGTVVFQ-----GSFQGRPVAVKRMLIDFCDIALMEI-KLLTESDDHPNVIRY 92
Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF--------YTAEVVDALEYIH 162
           + +      LY+ALE C    L D + SK ++S++  +            ++   + ++H
Sbjct: 93  YCSETTDRFLYIALELCNLN-LQDLVESK-NVSDENLKLQKEYNPISLLRQIASGVAHLH 150
Query: 163 SMGLIHRDIKPENLLL------TADGH-------IKIADFGSVKPMQDSRITVLPNAASD 209
           S+ +IHRD+KP+N+L+      TAD         I I+DFG  K +   +     N  + 
Sbjct: 151 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNP 210
Query: 210 DKACTFVGTAAYVPPEVLNSSPA---TFGNDLWALGCTLYQMLS-GTSPFKD 257
                  GT+ +  PE+L  S     T   D++++GC  Y +LS G  PF D
Sbjct: 211 S------GTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 256

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 103/237 (43%), Gaps = 40/237 (16%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV--LDQLD 103
           DF+  ++ G G + +V +AK          +I  K ++ K  K    K ER V  L +LD
Sbjct: 12  DFKEIELIGSGGFGQVFKAKH---------RIDGKTYVIKRVKYNNEKAEREVKALAKLD 62
Query: 104 HPGVVRLF-----FTFQ-----------DTFSLYMALESCEGGELFDQITSKGHLSEDE- 146
           H  +V        F +             T  L++ +E C+ G L   I  +     D+ 
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 147 -ARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
            A     ++   ++YIHS  LI+RD+KP N+ L     +KI DFG V  +++        
Sbjct: 123 LALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN-------- 174
Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL 262
              D K     GT  Y+ PE ++S       DL+ALG  L ++L       +TS++ 
Sbjct: 175 ---DGKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFF 228

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER------ 96
           +  + K+ G G + +V   +         LK+  KK I+   K  K  Y + +R      
Sbjct: 17  NISIDKVVGAGEFGEVCSGR---------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 67
Query: 97  -IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
             ++ Q DHP ++RL      +  + +  E  E G L         L + +A+F   ++V
Sbjct: 68  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL------DSFLRKHDAQFTVIQLV 121
Query: 156 DAL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 208
             L       +Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA 
Sbjct: 122 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAY 176
Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
             +         +  PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 177 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 226

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 29/220 (13%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIM------DKKFITKENKTAYVKLERIVLDQLDHPGV 107
           GVG+Y  V +A+   +G   ALK +      +   I+   + A ++     L+  +HP V
Sbjct: 13  GVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRR----LEAFEHPNV 68
Query: 108 VRLFFTFQDT-----FSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDALEY 160
           VRL      +       + +  E  +       D+    G L  +  +    + +  L++
Sbjct: 69  VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLMRQFLRGLDF 127
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           +H+  ++HRD+KPEN+L+T+ G +K+ADFG  + +   ++ + P           V T  
Sbjct: 128 LHANCIVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMALDP----------VVVTLW 176
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           Y  PEVL  S      D+W++GC   +M      F   SE
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE 216

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER------ 96
           +  + K+ G G + +V   +         LK+  KK I+   K  K  Y + +R      
Sbjct: 46  NISIDKVVGAGEFGEVCSGR---------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 97  -IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
             ++ Q DHP ++RL      +  + +  E  E G L         L + +A+F   ++V
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLV 150
Query: 156 DAL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 208
             L       +Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA 
Sbjct: 151 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDD-----PEAAY 205
Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
             +         +  PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 206 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER------ 96
           +  + K+ G G + +V   +         LK+  KK I+   K  K  Y + +R      
Sbjct: 46  NISIDKVVGAGEFGEVCSGR---------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 97  -IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
             ++ Q DHP ++RL      +  + +  E  E G L         L + +A+F   ++V
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL------DSFLRKHDAQFTVIQLV 150
Query: 156 DAL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 208
             L       +Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA 
Sbjct: 151 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAY 205
Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
             +         +  PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 206 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER------ 96
           +  + K+ G G + +V   +         LK+  KK I+   K  K  Y + +R      
Sbjct: 46  NISIDKVVGAGEFGEVCSGR---------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 97  -IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
             ++ Q DHP ++RL      +  + +  E  E G L         L + +A+F   ++V
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLV 150
Query: 156 DAL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 208
             L       +Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA 
Sbjct: 151 GMLRGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAY 205
Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
             +         +  PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 206 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER------ 96
           +  + K+ G G + +V   +         LK+  KK I+   K  K  Y + +R      
Sbjct: 34  NISIDKVVGAGEFGEVCSGR---------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 84
Query: 97  -IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
             ++ Q DHP ++RL      +  + +  E  E G L         L + +A+F   ++V
Sbjct: 85  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLV 138
Query: 156 DAL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 208
             L       +Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA 
Sbjct: 139 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAY 193
Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
             +         +  PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 194 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 243

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER------ 96
           +  + K+ G G + +V   +         LK+  KK I+   K  K  Y + +R      
Sbjct: 46  NISIDKVVGAGEFGEVCSGR---------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 97  -IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
             ++ Q DHP ++RL      +  + +  E  E G L         L + +A+F   ++V
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL------DSFLRKHDAQFTVIQLV 150
Query: 156 DAL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 208
             L       +Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA 
Sbjct: 151 GMLRGIASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAY 205
Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
             +         +  PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 206 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER------ 96
           +  + K+ G G + +V   +         LK+  KK I+   K  K  Y + +R      
Sbjct: 17  NISIDKVVGAGEFGEVCSGR---------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 67
Query: 97  -IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
             ++ Q DHP ++RL      +  + +  E  E G L         L + +A+F   ++V
Sbjct: 68  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLV 121
Query: 156 DAL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 208
             L       +Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA 
Sbjct: 122 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAY 176
Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
             +         +  PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 177 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 226

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 19/240 (7%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGT----VYALKIMDKKFITKENKTAYVKLERIVLD 100
           +D  L +  G GS+  VVR  + D  +      A+K +    +++         E   + 
Sbjct: 12  KDLRLLEKLGDGSFG-VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 70
Query: 101 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALE 159
            LDH  ++RL+     T  + M  E    G L D++   +GH        Y  +V + + 
Sbjct: 71  SLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 129
Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK--PMQDSRITVLPNAASDDKACTFVG 217
           Y+ S   IHRD+   NLLL     +KI DFG ++  P  D    +      + +   F  
Sbjct: 130 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM-----QEHRKVPF-- 182
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRFPN 276
             A+  PE L +   +  +D W  G TL++M + G  P+   +   I  +I     R P 
Sbjct: 183 --AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 240

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 19/240 (7%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGT----VYALKIMDKKFITKENKTAYVKLERIVLD 100
           +D  L +  G GS+  VVR  + D  +      A+K +    +++         E   + 
Sbjct: 18  KDLRLLEKLGDGSFG-VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 76
Query: 101 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALE 159
            LDH  ++RL+     T  + M  E    G L D++   +GH        Y  +V + + 
Sbjct: 77  SLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 135
Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK--PMQDSRITVLPNAASDDKACTFVG 217
           Y+ S   IHRD+   NLLL     +KI DFG ++  P  D    +      + +   F  
Sbjct: 136 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVM-----QEHRKVPF-- 188
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRFPN 276
             A+  PE L +   +  +D W  G TL++M + G  P+   +   I  +I     R P 
Sbjct: 189 --AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 246

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 18/215 (8%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           D  + +  G GS+  V RA+    G+  A+KI+ ++    E    +++ E  ++ +L HP
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLR-EVAIMKRLRHP 94
Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSE-DEARFYTA--EVVDALEYIH 162
            +V          +L +  E    G L+  +   G   + DE R  +   +V   + Y+H
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 163 SMG--LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           +    ++HRD+K  NLL+     +K+ DFG       SR+       S   A    GT  
Sbjct: 155 NRNPPIVHRDLKSPNLLVDKKYTVKVCDFGL------SRLKASXFLXSKXAA----GTPE 204
Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
           ++ PEVL   P+   +D+++ G  L+++ +   P+
Sbjct: 205 WMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW 239

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 102/221 (46%), Gaps = 30/221 (13%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           D  + +  G GS+  V RA+    G+  A+KI+ ++    E    +++ E  ++ +L HP
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLR-EVAIMKRLRHP 94
Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSE-DEARFYTA--EVVDALEYIH 162
            +V          +L +  E    G L+  +   G   + DE R  +   +V   + Y+H
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 163 SMG--LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV---- 216
           +    ++HR++K  NLL+     +K+ DFG       SR+          KA TF+    
Sbjct: 155 NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGL------SRL----------KASTFLSSKS 198
Query: 217 --GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF 255
             GT  ++ PEVL   P+   +D+++ G  L+++ +   P+
Sbjct: 199 AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW 239

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 19/240 (7%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGT----VYALKIMDKKFITKENKTAYVKLERIVLD 100
           +D  L +  G GS+  VVR  + D  +      A+K +    +++         E   + 
Sbjct: 18  KDLRLLEKLGDGSFG-VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 76
Query: 101 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALE 159
            LDH  ++RL+     T  + M  E    G L D++   +GH        Y  +V + + 
Sbjct: 77  SLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 135
Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK--PMQDSRITVLPNAASDDKACTFVG 217
           Y+ S   IHRD+   NLLL     +KI DFG ++  P  D    +      + +   F  
Sbjct: 136 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM-----QEHRKVPF-- 188
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRFPN 276
             A+  PE L +   +  +D W  G TL++M + G  P+   +   I  +I     R P 
Sbjct: 189 --AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 246

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 92/192 (47%), Gaps = 23/192 (11%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 55  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 112
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 113 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 169
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +    S + V            FV T  Y  PEV+         D+W++GC + 
Sbjct: 170 LDFGLARTAGTSFMMV-----------PFVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 218
Query: 247 QMLSGTSPFKDT 258
           +M+ G   F  T
Sbjct: 219 EMIKGGVLFPGT 230

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 110/239 (46%), Gaps = 49/239 (20%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           KI G GS   VV       G+     +  K+ +      A +++ +++ +  DHP V+R 
Sbjct: 21  KILGYGSSGTVVFQ-----GSFQGRPVAVKRMLIDFCDIALMEI-KLLTESDDHPNVIRY 74
Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF--------YTAEVVDALEYIH 162
           + +      LY+ALE C    L D + SK ++S++  +            ++   + ++H
Sbjct: 75  YCSETTDRFLYIALELCNLN-LQDLVESK-NVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 163 SMGLIHRDIKPENLLL------TADGH-------IKIADFGSVKPM---QDSRITVLPNA 206
           S+ +IHRD+KP+N+L+      TAD         I I+DFG  K +   Q S  T L N 
Sbjct: 133 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192
Query: 207 ASDDKACTFVGTAAYVPPEVLNSS-------PATFGNDLWALGCTLYQMLS-GTSPFKD 257
           +         GT+ +  PE+L  S         T   D++++GC  Y +LS G  PF D
Sbjct: 193 S---------GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 102/235 (43%), Gaps = 31/235 (13%)
Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYA-LKI---MDKKFITKENKTAYVKLERI 97
           F   + + GK  G G++ KVV A     G   A LK+   M K     + K A +   +I
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF-------- 149
           +     H  +V L         + +  E C  G+L + +  K  + E +  F        
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 150 ------YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKP-MQDSRIT 201
                 ++++V   + ++ S   IHRD+   N+LLT +GH+ KI DFG  +  M DS   
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYI 221
Query: 202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           V  NA    K         ++ PE +     T  +D+W+ G  L+++ S G +P+
Sbjct: 222 VKGNARLPVK---------WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER------ 96
           +  + K+ G G + +V   +         LK+  KK I+   K  K  Y + +R      
Sbjct: 46  NISIDKVVGAGEFGEVCSGR---------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 97  -IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
             ++ Q DHP ++RL      +  + +  E  E G L         L + +A+F   ++V
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLV 150
Query: 156 DAL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 208
             L       +Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA 
Sbjct: 151 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAY 205
Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
             +         +  PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 206 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER------ 96
           +  + K+ G G + +V   +         LK+  KK I+   K  K  Y + +R      
Sbjct: 46  NISIDKVVGAGEFGEVCSGR---------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 97  -IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
             ++ Q DHP ++RL      +  + +  E  E G L         L + +A+F   ++V
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLV 150
Query: 156 DAL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 208
             L       +Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA 
Sbjct: 151 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAY 205
Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
             +         +  PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 206 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER------ 96
           +  + K+ G G + +V   +         LK+  KK I+   K  K  Y + +R      
Sbjct: 46  NISIDKVVGAGEFGEVCSGR---------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 97  -IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
             ++ Q DHP ++RL      +  + +  E  E G L         L + +A+F   ++V
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLV 150
Query: 156 DAL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 208
             L       +Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA 
Sbjct: 151 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAY 205
Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
             +         +  PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 206 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER------ 96
           +  + K+ G G + +V   +         LK+  KK I+   K  K  Y + +R      
Sbjct: 46  NISIDKVVGAGEFGEVCSGR---------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 97  -IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
             ++ Q DHP ++RL      +  + +  E  E G L         L + +A+F   ++V
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLV 150
Query: 156 DAL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 208
             L       +Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA 
Sbjct: 151 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAY 205
Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
             +         +  PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 206 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 19/240 (7%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGT----VYALKIMDKKFITKENKTAYVKLERIVLD 100
           +D  L +  G GS+  VVR  + D  +      A+K +    +++         E   + 
Sbjct: 12  KDLRLLEKLGDGSFG-VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 70
Query: 101 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALE 159
            LDH  ++RL+     T  + M  E    G L D++   +GH        Y  +V + + 
Sbjct: 71  SLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 129
Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK--PMQDSRITVLPNAASDDKACTFVG 217
           Y+ S   IHRD+   NLLL     +KI DFG ++  P  D    +      + +   F  
Sbjct: 130 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM-----QEHRKVPF-- 182
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRFPN 276
             A+  PE L +   +  +D W  G TL++M + G  P+   +   I  +I     R P 
Sbjct: 183 --AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 240

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER------ 96
           +  + K+ G G + +V   +         LK+  KK I+   K  K  Y + +R      
Sbjct: 44  NISIDKVVGAGEFGEVCSGR---------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 94
Query: 97  -IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
             ++ Q DHP ++RL      +  + +  E  E G L         L + +A+F   ++V
Sbjct: 95  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLV 148
Query: 156 DAL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 208
             L       +Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA 
Sbjct: 149 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAAY 203
Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
             +         +  PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 204 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 253

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 102/235 (43%), Gaps = 31/235 (13%)
Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYA-LKI---MDKKFITKENKTAYVKLERI 97
           F   + + GK  G G++ KVV A     G   A LK+   M K     + K A +   +I
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF-------- 149
           +     H  +V L         + +  E C  G+L + +  K  + E +  F        
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLS 162
Query: 150 ------YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKP-MQDSRIT 201
                 ++++V   + ++ S   IHRD+   N+LLT +GH+ KI DFG  +  M DS   
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYI 221
Query: 202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           V  NA    K         ++ PE +     T  +D+W+ G  L+++ S G +P+
Sbjct: 222 VKGNARLPVK---------WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 91/192 (47%), Gaps = 23/192 (11%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LSQVI-QMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKI 167
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 247 QMLSGTSPFKDT 258
           +M+ G   F  T
Sbjct: 217 EMIKGGVLFPGT 228

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 19/240 (7%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGT----VYALKIMDKKFITKENKTAYVKLERIVLD 100
           +D  L +  G GS+  VVR  + D  +      A+K +    +++         E   + 
Sbjct: 8   KDLRLLEKLGDGSFG-VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66
Query: 101 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALE 159
            LDH  ++RL+     T  + M  E    G L D++   +GH        Y  +V + + 
Sbjct: 67  SLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK--PMQDSRITVLPNAASDDKACTFVG 217
           Y+ S   IHRD+   NLLL     +KI DFG ++  P  D    +      + +   F  
Sbjct: 126 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVM-----QEHRKVPF-- 178
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRFPN 276
             A+  PE L +   +  +D W  G TL++M + G  P+   +   I  +I     R P 
Sbjct: 179 --AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 236

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 91/192 (47%), Gaps = 23/192 (11%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LSQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKI 167
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 247 QMLSGTSPFKDT 258
           +M+ G   F  T
Sbjct: 217 EMIKGGVLFPGT 228

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 19/240 (7%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGT----VYALKIMDKKFITKENKTAYVKLERIVLD 100
           +D  L +  G GS+  VVR  + D  +      A+K +    +++         E   + 
Sbjct: 8   KDLRLLEKLGDGSFG-VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66
Query: 101 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALE 159
            LDH  ++RL+     T  + M  E    G L D++   +GH        Y  +V + + 
Sbjct: 67  SLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK--PMQDSRITVLPNAASDDKACTFVG 217
           Y+ S   IHRD+   NLLL     +KI DFG ++  P  D    +      + +   F  
Sbjct: 126 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM-----QEHRKVPF-- 178
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRFPN 276
             A+  PE L +   +  +D W  G TL++M + G  P+   +   I  +I     R P 
Sbjct: 179 --AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 236

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 91/192 (47%), Gaps = 23/192 (11%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LSQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKI 167
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 247 QMLSGTSPFKDT 258
           +M+ G   F  T
Sbjct: 217 EMIKGGVLFPGT 228

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---KENKTAYVKLER------ 96
           +  + K+ G G + +V   +         LK+  KK I+   K  K  Y + +R      
Sbjct: 46  NISIDKVVGAGEFGEVCSGR---------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 97  -IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
             ++ Q DHP ++RL      +  + +  E  E G L         L + +A+F   ++V
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLV 150
Query: 156 DAL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 208
             L       +Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA 
Sbjct: 151 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD-----PEAAY 205
Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
             +         +  PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 206 TTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 19/240 (7%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGT----VYALKIMDKKFITKENKTAYVKLERIVLD 100
           +D  L +  G GS+  VVR  + D  +      A+K +    +++         E   + 
Sbjct: 8   KDLRLLEKLGDGSFG-VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66
Query: 101 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALE 159
            LDH  ++RL+     T  + M  E    G L D++   +GH        Y  +V + + 
Sbjct: 67  SLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK--PMQDSRITVLPNAASDDKACTFVG 217
           Y+ S   IHRD+   NLLL     +KI DFG ++  P  D    +      + +   F  
Sbjct: 126 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM-----QEHRKVPF-- 178
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRFPN 276
             A+  PE L +   +  +D W  G TL++M + G  P+   +   I  +I     R P 
Sbjct: 179 --AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 236

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 103/231 (44%), Gaps = 27/231 (11%)
Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYA-LKI---MDKKFITKENKTAYVKLERI 97
           F   + + GK  G G++ KVV A     G   A LK+   M K     + K A +   +I
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEAR------- 148
           +     H  +V L         + +  E C  G+L + +  K    L +++ R       
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDL 162
Query: 149 -FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKP-MQDSRITVLPN 205
             ++++V   + ++ S   IHRD+   N+LLT +GH+ KI DFG  +  M DS   V  N
Sbjct: 163 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGN 221
Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           A    K         ++ PE +     T  +D+W+ G  L+++ S G +P+
Sbjct: 222 ARLPVK---------WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 263

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 108/239 (45%), Gaps = 30/239 (12%)
Query: 38  PQEHFSIQD-FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           P   + I D +E+  + G GSY  V  A       V A+K + + F    +    ++ E 
Sbjct: 45  PHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EI 103
Query: 97  IVLDQLDHPGVVRLFFTF-----QDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARF 149
            +L++L+H  VV++         +    LY+ LE  +    +LF    +  +L+E   + 
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLF---RTPVYLTELHIKT 160
Query: 150 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG---------------SVKP 194
               ++  ++Y+HS G++HRD+KP N L+  D  +K+ DFG                + P
Sbjct: 161 LLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220
Query: 195 MQDS-RITVLPNAASDDKACT-FVGTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLS 250
            +D   +   P+  +  +  T  V T  Y  PE +L     T   D+W++GC   ++L+
Sbjct: 221 REDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 103/231 (44%), Gaps = 27/231 (11%)
Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYA-LKI---MDKKFITKENKTAYVKLERI 97
           F   + + GK  G G++ KVV A     G   A LK+   M K     + K A +   +I
Sbjct: 35  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 94
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEAR------- 148
           +     H  +V L         + +  E C  G+L + +  K    L +++ R       
Sbjct: 95  MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDL 154
Query: 149 -FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKP-MQDSRITVLPN 205
             ++++V   + ++ S   IHRD+   N+LLT +GH+ KI DFG  +  M DS   V  N
Sbjct: 155 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGN 213
Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           A    K         ++ PE +     T  +D+W+ G  L+++ S G +P+
Sbjct: 214 ARLPVK---------WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 255

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 107/236 (45%), Gaps = 43/236 (18%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL 110
           KI G GS   VV       G+     +  K+ +      A +++ +++ +  DHP V+R 
Sbjct: 21  KILGYGSSGTVVFQ-----GSFQGRPVAVKRMLIDFCDIALMEI-KLLTESDDHPNVIRY 74
Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF--------YTAEVVDALEYIH 162
           + +      LY+ALE C    L D + SK ++S++  +            ++   + ++H
Sbjct: 75  YCSETTDRFLYIALELCNLN-LQDLVESK-NVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 163 SMGLIHRDIKPENLLL------TADGH-------IKIADFGSVKPMQDSRITVLPNAASD 209
           S+ +IHRD+KP+N+L+      TAD         I I+DFG  K +   +     N  + 
Sbjct: 133 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNP 192
Query: 210 DKACTFVGTAAYVPPEVLNSS-------PATFGNDLWALGCTLYQMLS-GTSPFKD 257
                  GT+ +  PE+L  S         T   D++++GC  Y +LS G  PF D
Sbjct: 193 S------GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 91/192 (47%), Gaps = 23/192 (11%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LSQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 247 QMLSGTSPFKDT 258
           +M+ G   F  T
Sbjct: 217 EMIKGGVLFPGT 228

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 70/148 (47%), Gaps = 13/148 (8%)
Query: 117 TFSLYMALESCEGGELFDQITSKGHLSEDE--ARFYTAEVVDALEYIHSMGLIHRDIKPE 174
           T  L++ +E C+ G L   I  +     D+  A     ++   ++YIHS  LIHRD+KP 
Sbjct: 106 TKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPS 165
Query: 175 NLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATF 234
           N+ L     +KI DFG V  +++           D K     GT  Y+ PE ++S     
Sbjct: 166 NIFLVDTKQVKIGDFGLVTSLKN-----------DGKRTRSKGTLRYMSPEQISSQDYGK 214
Query: 235 GNDLWALGCTLYQMLSGTSPFKDTSEWL 262
             DL+ALG  L ++L       +TS++ 
Sbjct: 215 EVDLYALGLILAELLHVCDTAFETSKFF 242

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 12/161 (7%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVV 155
           ++  L H  +VRL+        +Y+  E    G L D + S   G +   +   ++A++ 
Sbjct: 61  LMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIA 120
Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           + + YI     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 121 EGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK---- 176
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                +  PE +N    T  +D+W+ G  LY++++ G  P+
Sbjct: 177 -----WTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIPY 212

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 72/171 (42%), Gaps = 23/171 (13%)
Query: 112 FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDI 171
           + F+    + +A+   E     D + S   LS  E R Y   +  AL+ IH  G++HRD+
Sbjct: 87  YCFRKNDHVVIAMPYLEHESFLDILNS---LSFQEVREYMLNLFKALKRIHQFGIVHRDV 143
Query: 172 KPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKA-------CTFV------- 216
           KP N L         + DFG  +   D++I +L    S+ +        C+         
Sbjct: 144 KPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQV 203
Query: 217 ----GTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDTSEWL 262
               GT  +  PEVL   P  T   D+W+ G     +LSG  PF   S+ L
Sbjct: 204 APRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDL 254

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/237 (21%), Positives = 100/237 (42%), Gaps = 26/237 (10%)
Query: 34  AFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTA 90
           A R   +       ++ K+ GVG + +V   +    G      A+K +   +  K+ +  
Sbjct: 3   AVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDF 62
Query: 91  YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFY 150
               E  ++ Q DHP ++ L         + +  E  E G L         L +++ RF 
Sbjct: 63  LS--EASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL------DAFLRKNDGRFT 114
Query: 151 TAEVVDAL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL 203
             ++V  L       +Y+  M  +HRD+   N+L+ ++   K++DFG  + ++D      
Sbjct: 115 VIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD----- 169
Query: 204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
           P AA   +         +  PE +     T  +D+W+ G  +++++S G  P+ D S
Sbjct: 170 PEAAYTTRGGKI--PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 224

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LXQVI-QMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKI 167
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 247 QML 249
           +M+
Sbjct: 217 EMV 219

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 91/192 (47%), Gaps = 23/192 (11%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 247 QMLSGTSPFKDT 258
           +M+ G   F  T
Sbjct: 217 EMIKGGVLFPGT 228

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 91/192 (47%), Gaps = 23/192 (11%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 54  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 111
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 112 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 168
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 169 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 217
Query: 247 QMLSGTSPFKDT 258
           +M+ G   F  T
Sbjct: 218 EMIKGGVLFPGT 229

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/237 (21%), Positives = 100/237 (42%), Gaps = 26/237 (10%)
Query: 34  AFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTA 90
           A R   +       ++ K+ GVG + +V   +    G      A+K +   +  K+ +  
Sbjct: 18  AVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDF 77
Query: 91  YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFY 150
               E  ++ Q DHP ++ L         + +  E  E G L         L +++ RF 
Sbjct: 78  LS--EASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL------DAFLRKNDGRFT 129
Query: 151 TAEVVDAL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL 203
             ++V  L       +Y+  M  +HRD+   N+L+ ++   K++DFG  + ++D      
Sbjct: 130 VIQLVGMLRGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD----- 184
Query: 204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
           P AA   +         +  PE +     T  +D+W+ G  +++++S G  P+ D S
Sbjct: 185 PEAAYTTRGGKI--PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 239

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/224 (22%), Positives = 97/224 (43%), Gaps = 26/224 (11%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
            ++ K+ GVG + +V   +    G      A+K +   +  K+ +      E  ++ Q D
Sbjct: 10  IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLS--EASIMGQFD 67
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL----- 158
           HP ++ L         + +  E  E G L         L +++ RF   ++V  L     
Sbjct: 68  HPNIIHLEGVVTKCKPVMIITEYMENGSL------DAFLRKNDGRFTVIQLVGMLRGIGS 121
Query: 159 --EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
             +Y+  M  +HRD+   N+L+ ++   K++DFG  + ++D      P AA   +     
Sbjct: 122 GMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD-----PEAAYTTRGGKI- 175
Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
               +  PE +     T  +D+W+ G  +++++S G  P+ D S
Sbjct: 176 -PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 218

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 91/192 (47%), Gaps = 23/192 (11%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 247 QMLSGTSPFKDT 258
           +M+ G   F  T
Sbjct: 217 EMIKGGVLFPGT 228

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 28/220 (12%)
Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL-ERIVLD 100
            ++++ +L +  G G +  V+       G   A+K +      K + TA   L E  V+ 
Sbjct: 9   LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCI------KNDATAQAFLAEASVMT 60
Query: 101 QLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDA 157
           QL H  +V+L     ++   LY+  E    G L D + S+G   L  D    ++ +V +A
Sbjct: 61  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 120
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT-VLPNAASDDKACTFV 216
           +EY+     +HRD+   N+L++ D   K++DFG  K    ++ T  LP            
Sbjct: 121 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP------------ 168
Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
               +  PE L  +  +  +D+W+ G  L+++ S G  P+
Sbjct: 169 --VKWTAPEALREAAFSTKSDVWSFGILLWEIYSFGRVPY 206

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 39/120 (32%), Positives = 63/120 (52%), Gaps = 11/120 (9%)
Query: 150 YTAEVVDALEYIHSMGLIHRDIKPENLLLTA-DGHIKIADFGSVKPMQDSRITVLPNAAS 208
           Y  ++  A+ +IHS+G+ HRDIKP+NLL+ + D  +K+ DFGS K        ++P+  S
Sbjct: 146 YIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAK-------KLIPSEPS 198
Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII 268
               C+    A   P  +L ++  T   DLW++GC   +++ G   F   +      RII
Sbjct: 199 VAXICSRFYRA---PELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRII 255

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 101/229 (44%), Gaps = 36/229 (15%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD--- 103
           +E+  + G GS+ +VV+A         A+KI+       +NK A++   +I +  L+   
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-------KNKKAFLNQAQIEVRLLELMN 108
Query: 104 -HPGVVRLF-------FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
            H   ++ +       F F++   L   + S    +L      +G +S +  R +  ++ 
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRG-VSLNLTRKFAQQMC 167
Query: 156 DALEYIHS--MGLIHRDIKPENLLLT--ADGHIKIADFGSVKPMQDSRITVLPNAASDDK 211
            AL ++ +  + +IH D+KPEN+LL       IKI DFGS             +     +
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS-------------SCQLGQR 214
Query: 212 ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
               + +  Y  PEVL   P     D+W+LGC L +M +G   F   +E
Sbjct: 215 IYQXIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LXQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKI 167
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 247 QML 249
           +M+
Sbjct: 217 EMV 219

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 46  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 103
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 104 MDAN--LXQVI-QMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKI 160
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 161 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 209
Query: 247 QML 249
           +M+
Sbjct: 210 EMV 212

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LXQVI-QMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKI 167
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 247 QML 249
           +M+
Sbjct: 217 EMV 219

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 197
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+L+  +   +++ D+G  +   P Q+
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQE 187
Query: 198 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 188 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 101/229 (44%), Gaps = 36/229 (15%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD--- 103
           +E+  + G GS+ +VV+A         A+KI+       +NK A++   +I +  L+   
Sbjct: 37  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-------KNKKAFLNQAQIEVRLLELMN 89
Query: 104 -HPGVVRLF-------FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
            H   ++ +       F F++   L   + S    +L      +G +S +  R +  ++ 
Sbjct: 90  KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRG-VSLNLTRKFAQQMC 148
Query: 156 DALEYIHS--MGLIHRDIKPENLLLT--ADGHIKIADFGSVKPMQDSRITVLPNAASDDK 211
            AL ++ +  + +IH D+KPEN+LL       IKI DFGS             +     +
Sbjct: 149 TALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS-------------SCQLGQR 195
Query: 212 ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
               + +  Y  PEVL   P     D+W+LGC L +M +G   F   +E
Sbjct: 196 IYQXIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 244

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 101/229 (44%), Gaps = 36/229 (15%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD--- 103
           +E+  + G GS+ +VV+A         A+KI+       +NK A++   +I +  L+   
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-------KNKKAFLNQAQIEVRLLELMN 108
Query: 104 -HPGVVRLF-------FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
            H   ++ +       F F++   L   + S    +L      +G +S +  R +  ++ 
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRG-VSLNLTRKFAQQMC 167
Query: 156 DALEYIHS--MGLIHRDIKPENLLLTADGH--IKIADFGSVKPMQDSRITVLPNAASDDK 211
            AL ++ +  + +IH D+KPEN+LL       IKI DFGS             +     +
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGS-------------SCQLGQR 214
Query: 212 ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
               + +  Y  PEVL   P     D+W+LGC L +M +G   F   +E
Sbjct: 215 IYQXIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 82/159 (51%), Gaps = 25/159 (15%)
Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSL-----YMALESCEGGELFDQITSKGH-LSEDEARF 149
           R  L ++ HP +V++F   + T        Y+ +E   GG+   +  SKG  L   EA  
Sbjct: 130 RQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYV-GGQSLKR--SKGQKLPVAEAIA 186
Query: 150 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 209
           Y  E++ AL Y+HS+GL++ D+KPEN++LT +  +K+ D G+V     SRI         
Sbjct: 187 YLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAV-----SRI--------- 231
Query: 210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQM 248
           +      GT  +  PE++ + P T   D++ +G TL  +
Sbjct: 232 NSFGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAAL 269

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 106/233 (45%), Gaps = 40/233 (17%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKV------VRAKKIDTGTVYALKIMDKKFITKENKTAYV 92
           +++  I D ELG     G++  V      +R K+ID     A+K++ +   T++  T  +
Sbjct: 8   RDNLLIADIELG----CGNFGSVRQGVYRMRKKQIDV----AIKVLKQG--TEKADTEEM 57
Query: 93  KLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTA 152
             E  ++ QLD+P +VRL    Q   +L + +E   GG L   +  K    E+      A
Sbjct: 58  MREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGK---REEIPVSNVA 113
Query: 153 EVVD----ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 208
           E++      ++Y+     +HRD+   N+LL    + KI+DFG  K +            +
Sbjct: 114 ELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL-----------GA 162
Query: 209 DDKACTFVGTA----AYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
           DD   T          +  PE +N    +  +D+W+ G T+++ LS G  P+K
Sbjct: 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 215

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFF 112
           G G+   VV A         A+K + + F  + + K AY +L  +++  ++H  ++ L  
Sbjct: 33  GSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYREL--VLMKVVNHKNIIGLLN 90
Query: 113 TFQDTFSL------YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
            F    SL      Y+ +E  +      Q+  +  L  +   +   +++  ++++HS G+
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDAN--LSQVI-QMELDHERMSYLLYQMLVGIKHLHSAGI 147
Query: 167 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 226
           IHRD+KP N+++ +D  +KI DFG  +            A +      +V T  Y  PEV
Sbjct: 148 IHRDLKPSNIVVKSDATLKILDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEV 196
Query: 227 LNSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
           +         D+W++G  + +M+ G   F  T
Sbjct: 197 ILGMGYKENVDIWSVGVIMGEMIKGGVLFPGT 228

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 101/237 (42%), Gaps = 33/237 (13%)
Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYA-LKI---MDKKFITKENKTAYVKLERI 97
           F   + + GK  G G++ KVV A     G   A LK+   M K     + K A +   +I
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG----------------H 141
           +     H  +V L         + +  E C  G+L + +  K                  
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQ 162
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVKP-MQDSR 199
           LS  +   ++++V   + ++ S   IHRD+   N+LLT +GH+ KI DFG  +  M DS 
Sbjct: 163 LSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSN 221
Query: 200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             V  NA    K         ++ PE +     T  +D+W+ G  L+++ S G +P+
Sbjct: 222 YIVKGNARLPVK---------WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 269

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 82/177 (46%), Gaps = 20/177 (11%)
Query: 85  KENKTAYVKL-ERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH- 141
           K + TA   L E  V+ QL H  +V+L     ++   LY+  E    G L D + S+G  
Sbjct: 53  KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS 112
Query: 142 -LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 200
            L  D    ++ +V +A+EY+     +HRD+   N+L++ D   K++DFG  K    ++ 
Sbjct: 113 VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 172
Query: 201 T-VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           T  LP                +  PE L     +  +D+W+ G  L+++ S G  P+
Sbjct: 173 TGKLP--------------VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 215

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 77/166 (46%), Gaps = 19/166 (11%)
Query: 95  ERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYT 151
           E  V+ QL H  +V+L     ++   LY+  E    G L D + S+G   L  D    ++
Sbjct: 49  EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 108
Query: 152 AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT-VLPNAASDD 210
            +V +A+EY+     +HRD+   N+L++ D   K++DFG  K    ++ T  LP      
Sbjct: 109 LDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP------ 162
Query: 211 KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                     +  PE L     +  +D+W+ G  L+++ S G  P+
Sbjct: 163 --------VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKI 167
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 247 QML 249
           +M+
Sbjct: 217 EMV 219

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 197
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++  +   +++ D+G  +   P Q+
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 187
Query: 198 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 188 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 32/227 (14%)
Query: 47  FELGKIYGVGSYSKVVRAK-KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
            ++ ++ G G + +V   + K+      A+ I   K    E +      E  ++ Q DHP
Sbjct: 45  IKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHP 104
Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE------ 159
            VV L         + + +E  E G L         L + + +F   ++V  L       
Sbjct: 105 NVVHLEGVVTRGKPVMIVIEFMENGAL------DAFLRKHDGQFTVIQLVGMLRGIAAGM 158
Query: 160 -YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
            Y+  MG +HRD+   N+L+ ++   K++DFG            L     DD    +  T
Sbjct: 159 RYLADMGYVHRDLAARNILVNSNLVCKVSDFG------------LSRVIEDDPEAVYTTT 206
Query: 219 AAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
              +P     PE +     T  +D+W+ G  +++++S G  P+ D S
Sbjct: 207 GGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 253

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 79/173 (45%), Gaps = 29/173 (16%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE- 153
           E  V+  L H  +V+L+        +++  E    G L +      +L E   RF T + 
Sbjct: 69  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN------YLREMRHRFQTQQL 122
Query: 154 ------VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA 207
                 V +A+EY+ S   +HRD+   N L+   G +K++DFG            L    
Sbjct: 123 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG------------LSRYV 170
Query: 208 SDDKACTFVGT---AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
            DD+  + VG+     + PPEVL  S  +  +D+WA G  ++++ S G  P++
Sbjct: 171 LDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 118/254 (46%), Gaps = 28/254 (11%)
Query: 30  SKSFAFRAPQEHFSIQDF-------ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKF 82
           ++SF  +A Q    +Q++       E+G++ G G + +V   +    G V A++++D + 
Sbjct: 11  ARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRW--HGEV-AIRLIDIER 67
Query: 83  ITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT-SKGH 141
             ++   A+ K E +   Q  H  VV           L +    C+G  L+  +  +K  
Sbjct: 68  DNEDQLKAF-KREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV 126
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT 201
           L  ++ R    E+V  + Y+H+ G++H+D+K +N+    +G + I DFG       S   
Sbjct: 127 LDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLF-----SISG 180
Query: 202 VLPNAASDDKACTFVGTAAYVPPEVL---------NSSPATFGNDLWALGCTLYQMLSGT 252
           VL     +DK     G   ++ PE++         +  P +  +D++ALG   Y++ +  
Sbjct: 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
Query: 253 SPFKDT-SEWLIFQ 265
            PFK   +E +I+Q
Sbjct: 241 WPFKTQPAEAIIWQ 254

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 102/233 (43%), Gaps = 46/233 (19%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVK---LERIVLDQLDHPGVVRL 110
           G G++ +V+  + ID    YA+K++  + I K  ++A ++   L++I  D +++  +V+ 
Sbjct: 44  GDGTFGRVLLCQHIDNKKYYAVKVV--RNIKKYTRSAKIEADILKKIQNDDINNNNIVKY 101
Query: 111 FFTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSMGLIH 168
              F     + +  E   G  L++ IT   +     ++ + Y  E++ AL Y+  M L H
Sbjct: 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTH 160
Query: 169 RDIKPENLLL--------------TADGH-----------IKIADFGSVKPMQDSRITVL 203
            D+KPEN+LL                DG            IK+ DFG             
Sbjct: 161 TDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA----------- 209
Query: 204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK 256
                 D   + + T  Y  PEV+ +      +D+W+ GC L ++ +G+  F+
Sbjct: 210 --TFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR 260

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 77/166 (46%), Gaps = 19/166 (11%)
Query: 95  ERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYT 151
           E  V+ QL H  +V+L     ++   LY+  E    G L D + S+G   L  D    ++
Sbjct: 236 EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 295
Query: 152 AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT-VLPNAASDD 210
            +V +A+EY+     +HRD+   N+L++ D   K++DFG  K    ++ T  LP      
Sbjct: 296 LDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP------ 349
Query: 211 KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                     +  PE L     +  +D+W+ G  L+++ S G  P+
Sbjct: 350 --------VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 387

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 197
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++  +   +++ D+G  +   P Q+
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 187
Query: 198 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 188 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 197
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++  +   +++ D+G  +   P Q+
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 187
Query: 198 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 188 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 197
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++  +   +++ D+G  +   P Q+
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 187
Query: 198 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 188 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 197
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++  +   +++ D+G  +   P Q+
Sbjct: 127 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 186
Query: 198 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 187 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 197
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++  +   +++ D+G  +   P Q+
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 187
Query: 198 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 188 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 197
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++  +   +++ D+G  +   P Q+
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 187
Query: 198 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 188 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 197
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++  +   +++ D+G  +   P Q+
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 187
Query: 198 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 188 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 79/173 (45%), Gaps = 29/173 (16%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE- 153
           E  V+  L H  +V+L+        +++  E    G L +      +L E   RF T + 
Sbjct: 53  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN------YLREMRHRFQTQQL 106
Query: 154 ------VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA 207
                 V +A+EY+ S   +HRD+   N L+   G +K++DFG            L    
Sbjct: 107 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG------------LSRYV 154
Query: 208 SDDKACTFVGT---AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
            DD+  + VG+     + PPEVL  S  +  +D+WA G  ++++ S G  P++
Sbjct: 155 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 207

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 100/223 (44%), Gaps = 20/223 (8%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           ++ +  + G GSY  V  A   +T    A+K +++ F    +    ++ E  +L++L   
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-EITILNRLKSD 85
Query: 106 GVVRLF-FTFQDTF----SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
            ++RL+     D       LY+ LE  +  +L     +   L+E+  +     ++    +
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENF 144
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDD---------- 210
           IH  G+IHRD+KP N LL  D  +K+ DFG  + +   + T + N   ++          
Sbjct: 145 IHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 211 --KACTFVGTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLS 250
             +  + V T  Y  PE +L     T   D+W+ GC   ++L+
Sbjct: 205 KKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 197
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++  +   +++ D+G  +   P Q+
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 187
Query: 198 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 188 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 197
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++  +   +++ D+G  +   P Q+
Sbjct: 126 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 185
Query: 198 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 186 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 197
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++  +   +++ D+G  +   P Q+
Sbjct: 127 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 186
Query: 198 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 187 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 79/173 (45%), Gaps = 29/173 (16%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE- 153
           E  V+  L H  +V+L+        +++  E    G L +      +L E   RF T + 
Sbjct: 54  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN------YLREMRHRFQTQQL 107
Query: 154 ------VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA 207
                 V +A+EY+ S   +HRD+   N L+   G +K++DFG            L    
Sbjct: 108 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG------------LSRYV 155
Query: 208 SDDKACTFVGT---AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
            DD+  + VG+     + PPEVL  S  +  +D+WA G  ++++ S G  P++
Sbjct: 156 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 208

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 197
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++  +   +++ D+G  +   P Q+
Sbjct: 133 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 192
Query: 198 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 193 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 237

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 76/161 (47%), Gaps = 12/161 (7%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVV 155
           ++  L H  +VRL+        +Y+  E    G L D + S   G +   +   ++A++ 
Sbjct: 60  LMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIA 119
Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           + + YI     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 120 EGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK---- 175
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                +  PE +N    T  +++W+ G  LY++++ G  P+
Sbjct: 176 -----WTAPEAINFGCFTIKSNVWSFGILLYEIVTYGKIPY 211

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 19/119 (15%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-IKIADFGSVK---PMQD 197
           L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++  +   +++ D+G  +   P Q+
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 187
Query: 198 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 188 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 79/173 (45%), Gaps = 29/173 (16%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE- 153
           E  V+  L H  +V+L+        +++  E    G L +      +L E   RF T + 
Sbjct: 60  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN------YLREMRHRFQTQQL 113
Query: 154 ------VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA 207
                 V +A+EY+ S   +HRD+   N L+   G +K++DFG            L    
Sbjct: 114 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG------------LSRYV 161
Query: 208 SDDKACTFVGT---AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
            DD+  + VG+     + PPEVL  S  +  +D+WA G  ++++ S G  P++
Sbjct: 162 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 214

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 54  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 111
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 112 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 168
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 169 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 217
Query: 247 QML 249
           +M+
Sbjct: 218 EMV 220

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 247 QML 249
           +M+
Sbjct: 217 EMV 219

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 52  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 109
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 110 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 166
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 167 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 215
Query: 247 QML 249
           +M+
Sbjct: 216 EMV 218

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 247 QML 249
           +M+
Sbjct: 217 EMV 219

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 79/173 (45%), Gaps = 29/173 (16%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE- 153
           E  V+  L H  +V+L+        +++  E    G L +      +L E   RF T + 
Sbjct: 69  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN------YLREMRHRFQTQQL 122
Query: 154 ------VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA 207
                 V +A+EY+ S   +HRD+   N L+   G +K++DFG            L    
Sbjct: 123 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG------------LSRYV 170
Query: 208 SDDKACTFVGT---AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
            DD+  + VG+     + PPEVL  S  +  +D+WA G  ++++ S G  P++
Sbjct: 171 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/256 (20%), Positives = 113/256 (44%), Gaps = 31/256 (12%)
Query: 34  AFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTA 90
           A R   +   +   ++ ++ G G + +V R +    G   +  A+K +   + T+  +  
Sbjct: 5   AVREFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGY-TERQRRE 63
Query: 91  YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFY 150
           ++  E  ++ Q +HP ++RL     ++  + +  E  E G L         L  ++ +F 
Sbjct: 64  FLS-EASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGAL------DSFLRLNDGQFT 116
Query: 151 TAEVVDALE-------YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL 203
             ++V  L        Y+  M  +HRD+   N+L+ ++   K++DFG  + ++++     
Sbjct: 117 VIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEEN----- 171
Query: 204 PNAASDDKACTFVGTA---AYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
              +SD    + +G      +  PE +     T  +D W+ G  +++++S G  P+ D S
Sbjct: 172 ---SSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMS 228
Query: 260 EWLIFQRIIARDIRFP 275
              +    I +D R P
Sbjct: 229 NQDVIN-AIEQDYRLP 243

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 78/170 (45%), Gaps = 29/170 (17%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE---- 153
           V+  L H  +V+L+        +++  E    G L +      +L E   RF T +    
Sbjct: 52  VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN------YLREMRHRFQTQQLLEM 105
Query: 154 ---VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDD 210
              V +A+EY+ S   +HRD+   N L+   G +K++DFG            L     DD
Sbjct: 106 CKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG------------LSRYVLDD 153
Query: 211 KACTFVGT---AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
           +  + VG+     + PPEVL  S  +  +D+WA G  ++++ S G  P++
Sbjct: 154 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 203

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 54  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 111
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 112 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 168
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 169 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 217
Query: 247 QML 249
           +M+
Sbjct: 218 EMV 220

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 46  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 103
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 104 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 160
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 161 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 209
Query: 247 QML 249
           +M+
Sbjct: 210 EMV 212

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/192 (23%), Positives = 90/192 (46%), Gaps = 23/192 (11%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LSQVI-QMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKI 167
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++G  + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMG 216
Query: 247 QMLSGTSPFKDT 258
           +M+ G   F  T
Sbjct: 217 EMIKGGVLFPGT 228

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 47  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 104
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 105 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 161
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 162 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 210
Query: 247 QML 249
           +M+
Sbjct: 211 EMV 213

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 91  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 148
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 149 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 205
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 206 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 254
Query: 247 QML 249
           +M+
Sbjct: 255 EMV 257

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 47  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 104
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 105 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 161
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 162 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 210
Query: 247 QML 249
           +M+
Sbjct: 211 EMV 213

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFS----LYMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   FT Q T      +Y+ +E 
Sbjct: 91  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 148
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 149 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 205
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         D+W++GC + 
Sbjct: 206 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 254
Query: 247 QML 249
           +M+
Sbjct: 255 EMV 257

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 88/184 (47%), Gaps = 23/184 (12%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 58  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 115
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 116 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 172
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         DLW++GC + 
Sbjct: 173 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMG 221
Query: 247 QMLS 250
           +M+ 
Sbjct: 222 EMVC 225

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 102/235 (43%), Gaps = 19/235 (8%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +  +L K  G G + +V  A   +  T  A+K M    ++ E   A    E  V+  L H
Sbjct: 15  ESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVEAFLA----EANVMKTLQH 69
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF--YTAEVVDALEYIH 162
             +V+L         +Y+  E    G L D + S     +   +   ++A++ + + +I 
Sbjct: 70  DKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 128
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
               IHRD++  N+L++A    KIADFG  + ++D+  T    A    K         + 
Sbjct: 129 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK---------WT 179
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRFPN 276
            PE +N    T  +D+W+ G  L ++++ G  P+   S   +  R + R  R P 
Sbjct: 180 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI-RALERGYRMPR 233

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 90/192 (46%), Gaps = 23/192 (11%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +       V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 247 QMLSGTSPFKDT 258
           +M+ G   F  T
Sbjct: 217 EMIKGGVLFPGT 228

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 102/235 (43%), Gaps = 19/235 (8%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +  +L K  G G + +V  A   +  T  A+K M    ++ E   A    E  V+  L H
Sbjct: 188 ESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVEAFLA----EANVMKTLQH 242
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF--YTAEVVDALEYIH 162
             +V+L         +Y+  E    G L D + S     +   +   ++A++ + + +I 
Sbjct: 243 DKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 301
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
               IHRD++  N+L++A    KIADFG  + ++D+  T    A    K         + 
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK---------WT 352
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRFPN 276
            PE +N    T  +D+W+ G  L ++++ G  P+   S   +  R + R  R P 
Sbjct: 353 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI-RALERGYRMPR 406

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 88/184 (47%), Gaps = 23/184 (12%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 47  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 104
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 105 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 161
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +      +V T  Y  PEV+         DLW++GC + 
Sbjct: 162 LDFGLAR-----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMG 210
Query: 247 QMLS 250
           +M+ 
Sbjct: 211 EMVC 214

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/242 (21%), Positives = 109/242 (45%), Gaps = 31/242 (12%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           ++ ++ G G + +V R +    G   +  A+K +   + T+  +  ++  E  ++ Q +H
Sbjct: 17  KIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGY-TERQRREFLS-EASIMGQFEH 74
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE----- 159
           P ++RL     ++  + +  E  E G L         L  ++ +F   ++V  L      
Sbjct: 75  PNIIRLEGVVTNSMPVMILTEFMENGAL------DSFLRLNDGQFTVIQLVGMLRGIASG 128
Query: 160 --YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
             Y+  M  +HRD+   N+L+ ++   K++DFG  + ++++        +SD    + +G
Sbjct: 129 MRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEEN--------SSDPTYTSSLG 180
Query: 218 ---TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIR 273
                 +  PE +     T  +D W+ G  +++++S G  P+ D S   +    I +D R
Sbjct: 181 GKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVIN-AIEQDYR 239
Query: 274 FP 275
            P
Sbjct: 240 LP 241

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 103/244 (42%), Gaps = 40/244 (16%)
Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYA-LKI---MDKKFITKENKTAYVKLERI 97
           F   + + GK  G G++ KVV A     G   A LK+   M K     + K A +   +I
Sbjct: 28  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 87
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH---------------L 142
           +     H  +V L         + +  E C  G+L + +  K                 L
Sbjct: 88  MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGL 147
Query: 143 SEDEAR--------FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI-KIADFGSVK 193
            +++ R         ++++V   + ++ S   IHRD+   N+LLT +GH+ KI DFG  +
Sbjct: 148 DKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT-NGHVAKIGDFGLAR 206
Query: 194 P-MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-G 251
             M DS   V  NA    K         ++ PE +     T  +D+W+ G  L+++ S G
Sbjct: 207 DIMNDSNYIVKGNARLPVK---------WMAPESIFDCVYTVQSDVWSYGILLWEIFSLG 257
Query: 252 TSPF 255
            +P+
Sbjct: 258 LNPY 261

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 96/214 (44%), Gaps = 12/214 (5%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY-VKLERIVLDQLDHP 105
           F LG+  G GS+ ++     I T    A+K+ + K  TK  +  Y  K+ RI+      P
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLLYESKIYRILQGGTGIP 66
Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 165
            V R F    D   L M L      +LF+  + K  LS         ++++ +E++HS  
Sbjct: 67  NV-RWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKS 123
Query: 166 LIHRDIKPENLLL---TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
            +HRDIKP+N L+        + I DFG  K  +D+  T       ++K  T  GTA Y 
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS-THQHIPYRENKNLT--GTARYA 180
Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK 256
                     +  +DL +LG  L   L G+ P++
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 214

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 78/170 (45%), Gaps = 23/170 (13%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE- 153
           E  V+  L H  +V+L+        +++  E    G L +      +L E   RF T + 
Sbjct: 54  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN------YLREMRHRFQTQQL 107
Query: 154 ------VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA 207
                 V +A+EY+ S   +HRD+   N L+   G +K++DFG  +        VL +  
Sbjct: 108 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR-------YVLDDEY 160
Query: 208 SDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
           +  +   F     + PPEVL  S  +  +D+WA G  ++++ S G  P++
Sbjct: 161 TSSRGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 208

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 73/164 (44%), Gaps = 12/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 152
           E  V+ ++ HP +V+L          Y+ +E    G L D +   ++  +S     +   
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK- 177
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 178 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 106/233 (45%), Gaps = 40/233 (17%)
Query: 39  QEHFSIQDFELGKIYGVGSYSKV------VRAKKIDTGTVYALKIMDKKFITKENKTAYV 92
           +++  I D ELG     G++  V      +R K+ID     A+K++ +   T++  T  +
Sbjct: 334 RDNLLIADIELG----CGNFGSVRQGVYRMRKKQIDV----AIKVLKQG--TEKADTEEM 383
Query: 93  KLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTA 152
             E  ++ QLD+P +VRL    Q   +L + +E   GG L   +  K    E+      A
Sbjct: 384 MREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGK---REEIPVSNVA 439
Query: 153 EVVD----ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 208
           E++      ++Y+     +HR++   N+LL    + KI+DFG  K +            +
Sbjct: 440 ELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL-----------GA 488
Query: 209 DDKACTFVGTA----AYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
           DD   T          +  PE +N    +  +D+W+ G T+++ LS G  P+K
Sbjct: 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 541

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 73/164 (44%), Gaps = 12/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 152
           E  V+ ++ HP +V+L          Y+ +E    G L D +   ++  +S     +   
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK- 177
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 178 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 67/297 (22%), Positives = 119/297 (40%), Gaps = 32/297 (10%)
Query: 25  PTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMD 79
           P  +  +   + A +  F     +LGK  G G++ +V+ A      K  T    A+K++ 
Sbjct: 9   PLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLK 68
Query: 80  KKFITKENKTAYVKLERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS 138
           +     E++    +L +I++    H  VV L     +    L + +E C+ G L   + S
Sbjct: 69  EGATHSEHRALMSEL-KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 127
Query: 139 KGH--------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI 184
           K +              L+ +    Y+ +V   +E++ S   IHRD+   N+LL+    +
Sbjct: 128 KRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVV 187
Query: 185 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCT 244
           KI DFG  + +        P+      A        ++ PE +     T  +D+W+ G  
Sbjct: 188 KICDFGLARDIXKD-----PDXVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVL 239
Query: 245 LYQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSXXXXXXXXXXXXXXPSGRP 298
           L+++ S G SP+        F R +    R   P+Y +              PS RP
Sbjct: 240 LWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 296

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 23/226 (10%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           ++E+  + G GSY  V  A   +     A+K +++ F    +    ++ E  +L++L   
Sbjct: 29  NYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILR-EITILNRLKSD 87
Query: 106 GVVRL--FFTFQDTF---SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
            ++RL      +D      LY+ LE  +  +L     +   L+E   +     ++   ++
Sbjct: 88  YIIRLHDLIIPEDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEQHVKTILYNLLLGEKF 146
Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ-DSRITVL-------------PNA 206
           IH  G+IHRD+KP N LL  D  +KI DFG  + +  D  I ++             P+ 
Sbjct: 147 IHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHN 206
Query: 207 ASDDKACT-FVGTAAYVPPE-VLNSSPATFGNDLWALGCTLYQMLS 250
            +  K  T  V T  Y  PE +L     T   D+W+ GC   ++L+
Sbjct: 207 KNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLN 252

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 79/181 (43%), Gaps = 31/181 (17%)
Query: 37  APQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKF---ITKENKTAYVK 93
           A +  ++ +  EL KI G G +  V +  K   G +YA+K   K     + ++N    V 
Sbjct: 2   AMKSRYTTEFHELEKI-GSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREV- 59
Query: 94  LERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----GHLSEDEARF 149
               VL Q  H  VVR F  + +   + +  E C GG L D I+       +  E E + 
Sbjct: 60  YAHAVLGQ--HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 117
Query: 150 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 209
              +V   L YIHSM L+H DIKP N+ ++                     T +PNAAS+
Sbjct: 118 LLLQVGRGLRYIHSMSLVHMDIKPSNIFISR--------------------TSIPNAASE 157
Query: 210 D 210
           +
Sbjct: 158 E 158

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 73/164 (44%), Gaps = 12/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 152
           E  V+ ++ HP +V+L          Y+ +E    G L D +   ++  +S     +   
Sbjct: 57  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 116
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 117 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK- 175
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 176 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVV 155
           ++ QL H  +VRL+        +Y+  E  E G L D  +  S   L+ ++     A++ 
Sbjct: 61  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIK---- 175
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 176 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVV 155
           ++ QL H  +VRL+        +Y+  E  E G L D  +  S   L+ ++     A++ 
Sbjct: 67  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 125
Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 126 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK---- 181
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 182 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 217

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVV 155
           ++ QL H  +VRL+        +Y+  E  E G L D  +  S   L+ ++     A++ 
Sbjct: 61  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK---- 175
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 176 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVV 155
           ++ QL H  +VRL+        +Y+  E  E G L D  +  S   L+ ++     A++ 
Sbjct: 62  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 120
Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 121 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK---- 176
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 177 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 212

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVV 155
           ++ QL H  +VRL+        +Y+  E  E G L D  +  S   L+ ++     A++ 
Sbjct: 67  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 125
Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 126 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK---- 181
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 182 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 217

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVV 155
           ++ QL H  +VRL+        +Y+  E  E G L D  +  S   L+ ++     A++ 
Sbjct: 66  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 124
Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 125 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK---- 180
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 181 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 216

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVV 155
           ++ QL H  +VRL+        +Y+  E  E G L D  +  S   L+ ++     A++ 
Sbjct: 69  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 127
Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 128 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK---- 183
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 184 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 219

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 20/214 (9%)
Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-VLDQLDHPGVVRLFF 112
           G G+Y +V +A  IDT T   + I   +   +E       +  + +L +L H  ++ L  
Sbjct: 43  GEGTYGEVYKA--IDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKS 100
Query: 113 TFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIK 172
                  L++  E  E  +L   +     +S    + +  ++++ + + HS   +HRD+K
Sbjct: 101 VIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLK 159
Query: 173 PENLLLTADGH-----IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV- 226
           P+NLLL+         +KI DFG       +R   +P      +  T      Y PPE+ 
Sbjct: 160 PQNLLLSVSDASETPVLKIGDFGL------ARAFGIPIRQFTHEIITL----WYRPPEIL 209
Query: 227 LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           L S   +   D+W++ C   +ML  T  F   SE
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE 243

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVV 155
           ++ QL H  +VRL+        +Y+  E  E G L D + +     L+ ++     A++ 
Sbjct: 61  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK---- 175
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 176 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/264 (21%), Positives = 108/264 (40%), Gaps = 38/264 (14%)
Query: 33  FAFRAPQE-------HFSIQDFELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKF 82
           F F  P E          I   ++ ++ G G + +V        G      A+K +   +
Sbjct: 14  FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 73
Query: 83  ITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHL 142
             K+ +      E  ++ Q DHP V+ L      +  + +  E  E G L         L
Sbjct: 74  TEKQRRDFLS--EASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL------DSFL 125
Query: 143 SEDEARFYTAEVVDAL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM 195
            +++ +F   ++V  L       +Y+  M  +HRD+   N+L+ ++   K++DFG  + +
Sbjct: 126 RQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 185
Query: 196 QDSRITVLPNAASDDKACTFVG---TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-G 251
           +D          SD    + +G      +  PE +     T  +D+W+ G  +++++S G
Sbjct: 186 EDD--------TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG 237
Query: 252 TSPFKDTSEWLIFQRIIARDIRFP 275
             P+ D +   +    I +D R P
Sbjct: 238 ERPYWDMTNQDVIN-AIEQDYRLP 260

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVV 155
           ++ QL H  +VRL+        +Y+  E  E G L D  +  S   L+ ++     A++ 
Sbjct: 63  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 121
Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 122 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK---- 177
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 178 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 213

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 77/176 (43%), Gaps = 31/176 (17%)
Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKF---ITKENKTAYVKLERIV 98
           ++ +  EL KI G G +  V +  K   G +YA+K   K     + ++N    V     V
Sbjct: 9   YTTEFHELEKI-GSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREV-YAHAV 66
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----GHLSEDEARFYTAEV 154
           L Q  H  VVR F  + +   + +  E C GG L D I+       +  E E +    +V
Sbjct: 67  LGQ--HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 124
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDD 210
              L YIHSM L+H DIKP N+ ++                     T +PNAAS++
Sbjct: 125 GRGLRYIHSMSLVHMDIKPSNIFISR--------------------TSIPNAASEE 160

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/298 (22%), Positives = 118/298 (39%), Gaps = 33/298 (11%)
Query: 25  PTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMD 79
           P  +  +   + A +  F      LGK  G G++ +V+ A      K  T    A+K++ 
Sbjct: 8   PLDEHCERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK 67
Query: 80  KKFITKENKTAYVKLERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS 138
           +     E++    +L +I++    H  VV L     +    L + +E C+ G L   + S
Sbjct: 68  EGATHSEHRALMSEL-KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 126
Query: 139 KGH---------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH 183
           K +               L+ +    Y+ +V   +E++ S   IHRD+   N+LL+    
Sbjct: 127 KRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 186
Query: 184 IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGC 243
           +KI DFG  + +        P+      A        ++ PE +     T  +D+W+ G 
Sbjct: 187 VKICDFGLARDIXKD-----PDXVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGV 238
Query: 244 TLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSXXXXXXXXXXXXXXPSGRP 298
            L+++ S G SP+        F R +    R   P+Y +              PS RP
Sbjct: 239 LLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 296

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVV 155
           ++ QL H  +VRL+        +Y+  E  E G L D  +  S   L+ ++     A++ 
Sbjct: 70  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 128
Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 129 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK---- 184
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 185 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 220

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVV 155
           ++ QL H  +VRL+        +Y+  E  E G L D  +  S   L+ ++     A++ 
Sbjct: 61  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK---- 175
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 176 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 118/295 (40%), Gaps = 30/295 (10%)
Query: 25  PTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMD 79
           P  +  +   + A +  F      LGK  G G++ +V+ A      K  T    A+K++ 
Sbjct: 7   PLDEHCERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLK 66
Query: 80  KKFITKENKTAYVKLERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS 138
           +     E++    +L +I++    H  VV L     +    L + +E C+ G L   + S
Sbjct: 67  EGATHSEHRALMSEL-KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 125
Query: 139 KGH------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
           K +            L+ +    Y+ +V   +E++ S   IHRD+   N+LL+    +KI
Sbjct: 126 KRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKI 185
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  + +        P+      A        ++ PE +     T  +D+W+ G  L+
Sbjct: 186 XDFGLARDIYKD-----PDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLW 237
Query: 247 QMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSXXXXXXXXXXXXXXPSGRP 298
           ++ S G SP+        F R +    R   P+Y +              PS RP
Sbjct: 238 EIFSLGASPYPGVKIDEEFXRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 292

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 77/176 (43%), Gaps = 31/176 (17%)
Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKF---ITKENKTAYVKLERIV 98
           ++ +  EL KI G G +  V +  K   G +YA+K   K     + ++N    V     V
Sbjct: 7   YTTEFHELEKI-GSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREV-YAHAV 64
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----GHLSEDEARFYTAEV 154
           L Q  H  VVR F  + +   + +  E C GG L D I+       +  E E +    +V
Sbjct: 65  LGQ--HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 122
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDD 210
              L YIHSM L+H DIKP N+ ++                     T +PNAAS++
Sbjct: 123 GRGLRYIHSMSLVHMDIKPSNIFISR--------------------TSIPNAASEE 158

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/299 (22%), Positives = 119/299 (39%), Gaps = 34/299 (11%)
Query: 25  PTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMD 79
           P  +  +   + A +  F     +LGK  G G++ +V+ A      K  T    A+K++ 
Sbjct: 7   PLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK 66
Query: 80  KKFITKENKTAYVKLERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS 138
           +     E++    +L +I++    H  VV L     +    L + +E C+ G L   + S
Sbjct: 67  EGATHSEHRALMSEL-KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 125
Query: 139 KGH----------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG 182
           K +                L+ +    Y+ +V   +E++ S   IHRD+   N+LL+   
Sbjct: 126 KRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 185
Query: 183 HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALG 242
            +KI DFG  + +        P+      A        ++ PE +     T  +D+W+ G
Sbjct: 186 VVKICDFGLARDIXKD-----PDXVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFG 237
Query: 243 CTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSXXXXXXXXXXXXXXPSGRP 298
             L+++ S G SP+        F R +    R   P+Y +              PS RP
Sbjct: 238 VLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 296

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVV 155
           ++ QL H  +VRL+        +Y+  E  E G L D  +  S   L+ ++     A++ 
Sbjct: 71  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 129
Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 130 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK---- 185
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 186 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 221

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 77/176 (43%), Gaps = 31/176 (17%)
Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKF---ITKENKTAYVKLERIV 98
           ++ +  EL KI G G +  V +  K   G +YA+K   K     + ++N    V     V
Sbjct: 5   YTTEFHELEKI-GSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREV-YAHAV 62
Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----GHLSEDEARFYTAEV 154
           L Q  H  VVR F  + +   + +  E C GG L D I+       +  E E +    +V
Sbjct: 63  LGQ--HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 120
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDD 210
              L YIHSM L+H DIKP N+ ++                     T +PNAAS++
Sbjct: 121 GRGLRYIHSMSLVHMDIKPSNIFISR--------------------TSIPNAASEE 156

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVV 155
           ++ QL H  +VRL+        +Y+  E  E G L D  +  S   L+ ++     A++ 
Sbjct: 56  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 114
Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           + + +I     IHRD++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 115 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK---- 170
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 171 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 206

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 118/295 (40%), Gaps = 30/295 (10%)
Query: 25  PTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMD 79
           P  +  +   + A +  F      LGK  G G++ +V+ A      K  T    A+K++ 
Sbjct: 7   PLDEHCERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLK 66
Query: 80  KKFITKENKTAYVKLERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS 138
           +     E++    +L +I++    H  VV L     +    L + +E C+ G L   + S
Sbjct: 67  EGATHSEHRALMSEL-KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 125
Query: 139 KGH------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
           K +            L+ +    Y+ +V   +E++ S   IHRD+   N+LL+    +KI
Sbjct: 126 KRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKI 185
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  + +        P+      A        ++ PE +     T  +D+W+ G  L+
Sbjct: 186 CDFGLARDIYKD-----PDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLW 237
Query: 247 QMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSXXXXXXXXXXXXXXPSGRP 298
           ++ S G SP+        F R +    R   P+Y +              PS RP
Sbjct: 238 EIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 292

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 79/167 (47%), Gaps = 17/167 (10%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVD 156
           V+ +L HP +V+L+    +   + +  E  E G L D + T +G  + +       +V +
Sbjct: 55  VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 114
Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
            + Y+    +IHRD+   N L+  +  IK++DFG            +     DD+  +  
Sbjct: 115 GMAYLEEASVIHRDLAARNCLVGENQVIKVSDFG------------MTRFVLDDQYTSST 162
Query: 217 GT---AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
           GT     +  PEV + S  +  +D+W+ G  ++++ S G  P+++ S
Sbjct: 163 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 209

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 79/167 (47%), Gaps = 17/167 (10%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVD 156
           V+ +L HP +V+L+    +   + +  E  E G L D + T +G  + +       +V +
Sbjct: 58  VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 117
Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
            + Y+    +IHRD+   N L+  +  IK++DFG            +     DD+  +  
Sbjct: 118 GMAYLEEACVIHRDLAARNCLVGENQVIKVSDFG------------MTRFVLDDQYTSST 165
Query: 217 GT---AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
           GT     +  PEV + S  +  +D+W+ G  ++++ S G  P+++ S
Sbjct: 166 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 212

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 72/164 (43%), Gaps = 12/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 152
           E  V+ ++ HP +V+L          Y+  E    G L D +   ++  +S     +   
Sbjct: 57  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 116
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 117 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIK- 175
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 176 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 79/167 (47%), Gaps = 17/167 (10%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVD 156
           V+ +L HP +V+L+    +   + +  E  E G L D + T +G  + +       +V +
Sbjct: 75  VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 134
Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
            + Y+    +IHRD+   N L+  +  IK++DFG            +     DD+  +  
Sbjct: 135 GMAYLEEACVIHRDLAARNCLVGENQVIKVSDFG------------MTRFVLDDQYTSST 182
Query: 217 GT---AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
           GT     +  PEV + S  +  +D+W+ G  ++++ S G  P+++ S
Sbjct: 183 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 229

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/299 (22%), Positives = 119/299 (39%), Gaps = 34/299 (11%)
Query: 25  PTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMD 79
           P  +  +   + A +  F     +LGK  G G++ +V+ A      K  T    A+K++ 
Sbjct: 7   PLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK 66
Query: 80  KKFITKENKTAYVKLERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS 138
           +     E++    +L +I++    H  VV L     +    L + +E C+ G L   + S
Sbjct: 67  EGATHSEHRALMSEL-KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 125
Query: 139 KGH----------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG 182
           K +                L+ +    Y+ +V   +E++ S   IHRD+   N+LL+   
Sbjct: 126 KRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 185
Query: 183 HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALG 242
            +KI DFG  + +        P+      A        ++ PE +     T  +D+W+ G
Sbjct: 186 VVKICDFGLARDIYKD-----PDXVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFG 237
Query: 243 CTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSXXXXXXXXXXXXXXPSGRP 298
             L+++ S G SP+        F R +    R   P+Y +              PS RP
Sbjct: 238 VLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 296

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 72/164 (43%), Gaps = 12/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 152
           E  V+ ++ HP +V+L          Y+  E    G L D +   ++  +S     +   
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK- 177
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 178 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 79/167 (47%), Gaps = 17/167 (10%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVD 156
           V+ +L HP +V+L+    +   + +  E  E G L D + T +G  + +       +V +
Sbjct: 53  VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 112
Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
            + Y+    +IHRD+   N L+  +  IK++DFG            +     DD+  +  
Sbjct: 113 GMAYLEEACVIHRDLAARNCLVGENQVIKVSDFG------------MTRFVLDDQYTSST 160
Query: 217 GT---AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
           GT     +  PEV + S  +  +D+W+ G  ++++ S G  P+++ S
Sbjct: 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 207

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 79/167 (47%), Gaps = 17/167 (10%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVD 156
           V+ +L HP +V+L+    +   + +  E  E G L D + T +G  + +       +V +
Sbjct: 55  VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 114
Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
            + Y+    +IHRD+   N L+  +  IK++DFG            +     DD+  +  
Sbjct: 115 GMAYLEEACVIHRDLAARNCLVGENQVIKVSDFG------------MTRFVLDDQYTSST 162
Query: 217 GT---AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
           GT     +  PEV + S  +  +D+W+ G  ++++ S G  P+++ S
Sbjct: 163 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 209

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 72/164 (43%), Gaps = 12/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 152
           E  V+ ++ HP +V+L          Y+  E    G L D +   ++  +S     +   
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 123
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 124 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK- 182
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 183 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 72/160 (45%), Gaps = 17/160 (10%)
Query: 101 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALE 159
           +L HP +V+ +      + +Y+  E    G L + + S G  L   +      +V + + 
Sbjct: 59  KLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMA 118
Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT- 218
           ++ S   IHRD+   N L+  D  +K++DFG            +     DD+  + VGT 
Sbjct: 119 FLESHQFIHRDLAARNCLVDRDLCVKVSDFG------------MTRYVLDDQYVSSVGTK 166
Query: 219 --AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
               +  PEV +    +  +D+WA G  ++++ S G  P+
Sbjct: 167 FPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY 206

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 72/164 (43%), Gaps = 12/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 152
           E  V+ ++ HP +V+L          Y+  E    G L D +   ++  +S     +   
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK- 177
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 178 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/299 (22%), Positives = 119/299 (39%), Gaps = 34/299 (11%)
Query: 25  PTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMD 79
           P  +  +   + A +  F     +LGK  G G++ +V+ A      K  T    A+K++ 
Sbjct: 44  PLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK 103
Query: 80  KKFITKENKTAYVKLERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS 138
           +     E++    +L +I++    H  VV L     +    L + +E C+ G L   + S
Sbjct: 104 EGATHSEHRALMSEL-KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 162
Query: 139 KGH----------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG 182
           K +                L+ +    Y+ +V   +E++ S   IHRD+   N+LL+   
Sbjct: 163 KRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 222
Query: 183 HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALG 242
            +KI DFG  + +        P+      A        ++ PE +     T  +D+W+ G
Sbjct: 223 VVKICDFGLARDIYKD-----PDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFG 274
Query: 243 CTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSXXXXXXXXXXXXXXPSGRP 298
             L+++ S G SP+        F R +    R   P+Y +              PS RP
Sbjct: 275 VLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 333

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 72/164 (43%), Gaps = 12/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 152
           E  V+ ++ HP +V+L          Y+  E    G L D +   ++  +S     +   
Sbjct: 57  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 116
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 117 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK- 175
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 176 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 73/164 (44%), Gaps = 12/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 152
           E  V+ ++ HP +V+L          Y+ +E    G L D +   ++  ++     +   
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 123
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 124 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK- 182
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 183 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/299 (22%), Positives = 119/299 (39%), Gaps = 34/299 (11%)
Query: 25  PTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMD 79
           P  +  +   + A +  F     +LGK  G G++ +V+ A      K  T    A+K++ 
Sbjct: 9   PLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK 68
Query: 80  KKFITKENKTAYVKLERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS 138
           +     E++    +L +I++    H  VV L     +    L + +E C+ G L   + S
Sbjct: 69  EGATHSEHRALMSEL-KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 127
Query: 139 KGH----------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG 182
           K +                L+ +    Y+ +V   +E++ S   IHRD+   N+LL+   
Sbjct: 128 KRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 187
Query: 183 HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALG 242
            +KI DFG  + +        P+      A        ++ PE +     T  +D+W+ G
Sbjct: 188 VVKICDFGLARDIYKD-----PDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFG 239
Query: 243 CTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSXXXXXXXXXXXXXXPSGRP 298
             L+++ S G SP+        F R +    R   P+Y +              PS RP
Sbjct: 240 VLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 298

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 73/164 (44%), Gaps = 12/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 152
           E  V+ ++ HP +V+L          Y+ +E    G L D +   ++  ++     +   
Sbjct: 60  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 119
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 120 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK- 178
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 179 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 214

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/296 (22%), Positives = 119/296 (40%), Gaps = 34/296 (11%)
Query: 28  QRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKF 82
           + ++   + A +  F     +LGK  G G++ +V+ A      K  T    A+K++ +  
Sbjct: 1   EHAERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 60
Query: 83  ITKENKTAYVKLERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH 141
              E++    +L +I++    H  VV L     +    L + +E C+ G L   + SK +
Sbjct: 61  THSEHRALMSEL-KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN 119
Query: 142 ----------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIK 185
                           L+ +    Y+ +V   +E++ S   IHRD+   N+LL+    +K
Sbjct: 120 EFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 179
Query: 186 IADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTL 245
           I DFG  + +        P+      A        ++ PE +     T  +D+W+ G  L
Sbjct: 180 ICDFGLARDIXKD-----PDXVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLL 231
Query: 246 YQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSXXXXXXXXXXXXXXPSGRP 298
           +++ S G SP+        F R +    R   P+Y +              PS RP
Sbjct: 232 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 287

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 79/167 (47%), Gaps = 17/167 (10%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVD 156
           V+ +L HP +V+L+    +   + +  E  E G L D + T +G  + +       +V +
Sbjct: 56  VMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 115
Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
            + Y+    +IHRD+   N L+  +  IK++DFG            +     DD+  +  
Sbjct: 116 GMAYLEEACVIHRDLAARNCLVGENQVIKVSDFG------------MTRFVLDDQYTSST 163
Query: 217 GT---AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
           GT     +  PEV + S  +  +D+W+ G  ++++ S G  P+++ S
Sbjct: 164 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 210

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/119 (28%), Positives = 61/119 (51%), Gaps = 19/119 (15%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL-TADGHIKIADFGSVK---PMQD 197
           L++ + RFY  E++ AL+Y HS G++HRD+KP N+++      +++ D+G  +   P Q+
Sbjct: 134 LTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQE 193
Query: 198 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 194 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPF 238

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/299 (22%), Positives = 119/299 (39%), Gaps = 34/299 (11%)
Query: 25  PTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMD 79
           P  +  +   + A +  F     +LGK  G G++ +V+ A      K  T    A+K++ 
Sbjct: 7   PLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK 66
Query: 80  KKFITKENKTAYVKLERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS 138
           +     E++    +L +I++    H  VV L     +    L + +E C+ G L   + S
Sbjct: 67  EGATHSEHRALMSEL-KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 125
Query: 139 KGH----------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG 182
           K +                L+ +    Y+ +V   +E++ S   IHRD+   N+LL+   
Sbjct: 126 KRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 185
Query: 183 HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALG 242
            +KI DFG  + +        P+      A        ++ PE +     T  +D+W+ G
Sbjct: 186 VVKICDFGLARDIYKD-----PDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFG 237
Query: 243 CTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSXXXXXXXXXXXXXXPSGRP 298
             L+++ S G SP+        F R +    R   P+Y +              PS RP
Sbjct: 238 VLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 296

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/119 (28%), Positives = 61/119 (51%), Gaps = 19/119 (15%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL-TADGHIKIADFGSVK---PMQD 197
           L++ + RFY  E++ AL+Y HS G++HRD+KP N+++      +++ D+G  +   P Q+
Sbjct: 129 LTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQE 188
Query: 198 SRITVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
             +               V +  +  PE+L +     +  D+W+LGC L  M+    PF
Sbjct: 189 YNVR--------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPF 233

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/296 (22%), Positives = 117/296 (39%), Gaps = 34/296 (11%)
Query: 28  QRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKF 82
           + ++   + A +  F     +LGK  G G++ +V+ A      K  T    A+K++ +  
Sbjct: 1   EHAERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 60
Query: 83  ITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL-ESCEGGELFDQITSKGH 141
              E++    +L +I++    H  VV L           M + E C+ G L   + SK +
Sbjct: 61  THSEHRALMSEL-KILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRN 119
Query: 142 ----------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIK 185
                           L+ +    Y+ +V   +E++ S   IHRD+   N+LL+    +K
Sbjct: 120 EFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 179
Query: 186 IADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTL 245
           I DFG  + +        P+      A        ++ PE +     T  +D+W+ G  L
Sbjct: 180 ICDFGLARDIXKD-----PDXVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLL 231
Query: 246 YQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSXXXXXXXXXXXXXXPSGRP 298
           +++ S G SP+        F R +    R   P+Y +              PS RP
Sbjct: 232 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 287

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/232 (22%), Positives = 101/232 (43%), Gaps = 37/232 (15%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVY--ALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           D +   + G G++ +V++A+    G     A+K M K++ +K++   +     ++     
Sbjct: 16  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGH 74
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQI----------------TSKGHLSEDEA 147
           HP ++ L    +    LY+A+E    G L D +                ++   LS  + 
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 148 RFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ---DSRITVLP 204
             + A+V   ++Y+     IHRD+   N+L+  +   KIADFG  +  +      +  LP
Sbjct: 135 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 194
Query: 205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                           ++  E LN S  T  +D+W+ G  L++++S G +P+
Sbjct: 195 --------------VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 232

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/232 (22%), Positives = 101/232 (43%), Gaps = 37/232 (15%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVY--ALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           D +   + G G++ +V++A+    G     A+K M K++ +K++   +     ++     
Sbjct: 26  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGH 84
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQI----------------TSKGHLSEDEA 147
           HP ++ L    +    LY+A+E    G L D +                ++   LS  + 
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 148 RFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ---DSRITVLP 204
             + A+V   ++Y+     IHRD+   N+L+  +   KIADFG  +  +      +  LP
Sbjct: 145 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 204
Query: 205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                           ++  E LN S  T  +D+W+ G  L++++S G +P+
Sbjct: 205 --------------VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 242

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVV 155
           ++ QL H  +VRL+        +Y+  E  E G L D  +  S   L+ ++     A++ 
Sbjct: 57  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 115
Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           + + +I     IHR+++  N+L++     KIADFG  + ++D+  T    A    K    
Sbjct: 116 EGMAFIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK---- 171
Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                +  PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 172 -----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 207

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 89/213 (41%), Gaps = 16/213 (7%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           D  +    G G Y +V            A+K + +  +  E    ++K E  V+ ++ HP
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLK-EAAVMKEIKHP 276
Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTAEVVDALEYIHS 163
            +V+L          Y+  E    G L D +   ++  +S     +   ++  A+EY+  
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
              IHR++   N L+  +  +K+ADFG  + M     T    A    K         +  
Sbjct: 337 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK---------WTA 387
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 388 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 420

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 72/164 (43%), Gaps = 12/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 152
           E  V+ ++ HP +V+L          Y+  E    G L D +   ++  ++     +   
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 123
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 124 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK- 182
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 183 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 72/164 (43%), Gaps = 12/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 152
           E  V+ ++ HP +V+L          Y+  E    G L D +   ++  ++     +   
Sbjct: 72  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 131
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 132 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK- 190
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 191 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 226

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 72/164 (43%), Gaps = 12/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 152
           E  V+ ++ HP +V+L          Y+  E    G L D +   ++  ++     +   
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 118
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK- 177
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 178 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 72/164 (43%), Gaps = 12/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 152
           E  V+ ++ HP +V+L          Y+  E    G L D +   ++  ++     +   
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 118
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK- 177
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 178 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 87/184 (47%), Gaps = 23/184 (12%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +       V T  Y  PEV+         DLW++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMG 216
Query: 247 QMLS 250
           +M+ 
Sbjct: 217 EMVC 220

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 72/164 (43%), Gaps = 12/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 152
           E  V+ ++ HP +V+L          Y+  E    G L D +   ++  ++     +   
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 123
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 124 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK- 182
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 183 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 72/164 (43%), Gaps = 12/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 152
           E  V+ ++ HP +V+L          Y+  E    G L D +   ++  ++     +   
Sbjct: 63  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 122
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 123 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK- 181
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 182 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 72/164 (43%), Gaps = 12/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 152
           E  V+ ++ HP +V+L          Y+  E    G L D +   ++  ++     +   
Sbjct: 61  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 120
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 121 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK- 179
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 180 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 72/164 (43%), Gaps = 12/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 152
           E  V+ ++ HP +V+L          Y+  E    G L D +   ++  ++     +   
Sbjct: 61  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 120
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 121 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK- 179
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 180 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 72/164 (43%), Gaps = 12/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 152
           E  V+ ++ HP +V+L          Y+  E    G L D +   ++  ++     +   
Sbjct: 60  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 119
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 120 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIK- 178
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 179 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 214

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 72/164 (43%), Gaps = 12/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 152
           E  V+ ++ HP +V+L          Y+  E    G L D +   ++  ++     +   
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 123
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 124 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK- 182
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 183 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/296 (22%), Positives = 117/296 (39%), Gaps = 34/296 (11%)
Query: 28  QRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKF 82
           + ++   + A +  F     +LGK  G G++ +V+ A      K  T    A+K++ +  
Sbjct: 1   EHAERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 60
Query: 83  ITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL-ESCEGGELFDQITSKGH 141
              E++    +L +I++    H  VV L           M + E C+ G L   + SK +
Sbjct: 61  THSEHRALMSEL-KILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRN 119
Query: 142 ----------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIK 185
                           L+ +    Y+ +V   +E++ S   IHRD+   N+LL+    +K
Sbjct: 120 EFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 179
Query: 186 IADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTL 245
           I DFG  + +        P+      A        ++ PE +     T  +D+W+ G  L
Sbjct: 180 ICDFGLARDIYKD-----PDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLL 231
Query: 246 YQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSXXXXXXXXXXXXXXPSGRP 298
           +++ S G SP+        F R +    R   P+Y +              PS RP
Sbjct: 232 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 287

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 72/164 (43%), Gaps = 12/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 152
           E  V+ ++ HP +V+L          Y+  E    G L D +   ++  ++     +   
Sbjct: 78  EAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMAT 137
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 138 QISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIK- 196
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 197 --------WTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPY 232

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 72/164 (43%), Gaps = 12/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTA 152
           E  V+ ++ HP +V+L          Y+  E    G L D +   ++  ++     +   
Sbjct: 61  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 120
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++  A+EY+     IHRD+   N L+  +  +K+ADFG  + M     T    A    K 
Sbjct: 121 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIK- 179
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 180 --------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 66/296 (22%), Positives = 116/296 (39%), Gaps = 34/296 (11%)
Query: 28  QRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKF 82
           +  +   + A +  F     +LGK  G G++ +V+ A      K  T    A+K++ +  
Sbjct: 1   EHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 60
Query: 83  ITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL-ESCEGGELFDQITSKGH 141
              E++    +L +I++    H  VV L           M + E C+ G L   + SK +
Sbjct: 61  THSEHRALMSEL-KILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRN 119
Query: 142 ----------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIK 185
                           L+ +    Y+ +V   +E++ S   IHRD+   N+LL+    +K
Sbjct: 120 EFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 179
Query: 186 IADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTL 245
           I DFG  + +        P+      A        ++ PE +     T  +D+W+ G  L
Sbjct: 180 ICDFGLARDIYKD-----PDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLL 231
Query: 246 YQMLS-GTSPFKDTSEWLIFQRIIARDIRF--PNYFSXXXXXXXXXXXXXXPSGRP 298
           +++ S G SP+        F R +    R   P+Y +              PS RP
Sbjct: 232 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 287

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/232 (21%), Positives = 97/232 (41%), Gaps = 17/232 (7%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           D  +    G G Y +V            A+K + +  +  E    ++K E  V+ ++ HP
Sbjct: 260 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLK-EAAVMKEIKHP 315
Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQI--TSKGHLSEDEARFYTAEVVDALEYIHS 163
            +V+L          Y+  E    G L D +   ++  ++     +   ++  A+EY+  
Sbjct: 316 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 375
Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
              IHR++   N L+  +  +K+ADFG  + M     T    A    K         +  
Sbjct: 376 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK---------WTA 426
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF 274
           PE L  +  +  +D+WA G  L+++ + G SP+       +++ ++ +D R 
Sbjct: 427 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKDYRM 477

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/184 (23%), Positives = 87/184 (47%), Gaps = 23/184 (12%)
Query: 74  ALKIMDKKFITKEN-KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL------YMALES 126
           A+K + + F  + + K AY +L  +++  ++H  ++ L   F    SL      Y+ +E 
Sbjct: 53  AIKKLSRPFQNQTHAKRAYREL--VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            +      Q+  +  L  +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI
Sbjct: 111 MDAN--LCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  +            A +       V T  Y  PEV+         D+W++GC + 
Sbjct: 168 LDFGLAR-----------TAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 247 QMLS 250
           +M+ 
Sbjct: 217 EMVC 220

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/242 (21%), Positives = 99/242 (40%), Gaps = 33/242 (13%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTA 90
           P+  F      LGK  G G++ +VV A+ +             A+K++      K+    
Sbjct: 28  PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 87
Query: 91  YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------- 139
             ++E + +    H  ++ L         LY+ +E    G L + + ++           
Sbjct: 88  VSEMEMMKMIG-KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDI 146
Query: 140 GHLSEDEARF-----YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
             + E++  F      T ++   +EY+ S   IHRD+   N+L+T +  +KIADFG  + 
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
           +         N     K         ++ PE L     T  +D+W+ G  ++++ + G S
Sbjct: 207 IN--------NIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 254 PF 255
           P+
Sbjct: 259 PY 260

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 77/169 (45%), Gaps = 21/169 (12%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 154
           E  ++ Q DHP ++ L      +  + +  E  E G L         L +++ +F   ++
Sbjct: 73  EASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSL------DTFLKKNDGQFTVIQL 126
Query: 155 VDAL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA 207
           V  L       +Y+  MG +HRD+   N+L+ ++   K++DFG  + ++D      P AA
Sbjct: 127 VGMLRGISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-----PEAA 181
Query: 208 SDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
              +         +  PE +     T  +D+W+ G  +++++S G  P+
Sbjct: 182 YTTRGGKI--PIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPY 228

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 85/184 (46%), Gaps = 12/184 (6%)
Query: 69  TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT--FSLYMALES 126
           TG + A+K + K     ++++ + K E  +L  L H  +++     +D    SL + +E 
Sbjct: 59  TGEMVAVKAL-KADAGPQHRSGW-KQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEY 116
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
              G L D +  +  +   +   +  ++ + + Y+H+   IHRD+   N+LL  D  +KI
Sbjct: 117 VPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKI 175
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  K + +           D  +  F     +  PE L      + +D+W+ G TLY
Sbjct: 176 GDFGLAKAVPEGHEXY--RVREDGDSPVF-----WYAPECLKEYKFYYASDVWSFGVTLY 228
Query: 247 QMLS 250
           ++L+
Sbjct: 229 ELLT 232

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/242 (21%), Positives = 99/242 (40%), Gaps = 33/242 (13%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTA 90
           P+  F      LGK  G G++ +VV A+ +             A+K++      K+    
Sbjct: 28  PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 87
Query: 91  YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------- 139
             ++E + +    H  ++ L         LY+ +E    G L + + ++           
Sbjct: 88  VSEMEMMKMIG-KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 140 GHLSEDEARF-----YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
             + E++  F      T ++   +EY+ S   IHRD+   N+L+T +  +KIADFG  + 
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
           +         N     K         ++ PE L     T  +D+W+ G  ++++ + G S
Sbjct: 207 IN--------NIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 254 PF 255
           P+
Sbjct: 259 PY 260

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 101/232 (43%), Gaps = 37/232 (15%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVY--ALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           D +   + G G++ +V++A+    G     A+K M K++ +K++   +     ++     
Sbjct: 23  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGH 81
Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQI----------------TSKGHLSEDEA 147
           HP ++ L    +    LY+A+E    G L D +                ++   LS  + 
Sbjct: 82  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 148 RFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ---DSRITVLP 204
             + A+V   ++Y+     IHR++   N+L+  +   KIADFG  +  +      +  LP
Sbjct: 142 LHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 201
Query: 205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                           ++  E LN S  T  +D+W+ G  L++++S G +P+
Sbjct: 202 --------------VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 239

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 102/247 (41%), Gaps = 40/247 (16%)
Query: 38  PQEH---FSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKT 89
           P +H   F       GK  G G++ KVV A      K D     A+K++       E + 
Sbjct: 29  PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA 88
Query: 90  AYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--------- 139
              +L+  VL  L +H  +V L           +  E C  G+L + +  K         
Sbjct: 89  LMSELK--VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKT 146
Query: 140 ---------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 190
                      L  ++   ++ +V   + ++ S   IHRD+   N+LLT     KI DFG
Sbjct: 147 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG 206
Query: 191 SVKPMQ-DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQML 249
             + ++ DS   V  NA    K         ++ PE + +   TF +D+W+ G  L+++ 
Sbjct: 207 LARDIKNDSNYVVKGNARLPVK---------WMAPESIFNCVYTFESDVWSYGIFLWELF 257
Query: 250 S-GTSPF 255
           S G+SP+
Sbjct: 258 SLGSSPY 264

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/269 (20%), Positives = 108/269 (40%), Gaps = 34/269 (12%)
Query: 12  LRIEGNNNSSTNCPTVQRSKSFAF-RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKI--- 67
           +RI    +S+ + P +     +     P+  F      LGK  G G + +VV A+ +   
Sbjct: 47  VRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGID 106
Query: 68  ----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA 123
                     A+K++      K+      ++E + +    H  ++ L         LY+ 
Sbjct: 107 KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-KHKNIINLLGACTQDGPLYVI 165
Query: 124 LESCEGGELFDQITSK-----------GHLSEDEARF-----YTAEVVDALEYIHSMGLI 167
           +E    G L + + ++             + E++  F      T ++   +EY+ S   I
Sbjct: 166 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI 225
Query: 168 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 227
           HRD+   N+L+T +  +KIADFG  + +         N     K         ++ PE L
Sbjct: 226 HRDLAARNVLVTENNVMKIADFGLARDIN--------NIDYYKKTTNGRLPVKWMAPEAL 277
Query: 228 NSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                T  +D+W+ G  ++++ + G SP+
Sbjct: 278 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 306

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 108/254 (42%), Gaps = 30/254 (11%)
Query: 30  SKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITK 85
           S +F  R P + F  +  +  +  G G++  V   +    + +TG V A+K +     T+
Sbjct: 1   SGAFEDRDPTQ-FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TE 57
Query: 86  ENKTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQITS-KGHL 142
           E+   + + E  +L  L H  +V+           +L + +E    G L D +   K  +
Sbjct: 58  EHLRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 116
Query: 143 SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV 202
              +   YT+++   +EY+ +   IHRD+   N+L+  +  +KI DFG  K        V
Sbjct: 117 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK--------V 168
Query: 203 LPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD 257
           LP     DK    V      P     PE L  S  +  +D+W+ G  LY++ +     K 
Sbjct: 169 LPQ----DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE--KS 222
Query: 258 TSEWLIFQRIIARD 271
            S    F R+I  D
Sbjct: 223 KSPPAEFMRMIGND 236

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 108/254 (42%), Gaps = 30/254 (11%)
Query: 30  SKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITK 85
           S +F  R P + F  +  +  +  G G++  V   +    + +TG V A+K +     T+
Sbjct: 3   SGAFEDRDPTQ-FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TE 59
Query: 86  ENKTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQITS-KGHL 142
           E+   + + E  +L  L H  +V+           +L + +E    G L D +   K  +
Sbjct: 60  EHLRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 118
Query: 143 SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV 202
              +   YT+++   +EY+ +   IHRD+   N+L+  +  +KI DFG  K        V
Sbjct: 119 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK--------V 170
Query: 203 LPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD 257
           LP     DK    V      P     PE L  S  +  +D+W+ G  LY++ +     K 
Sbjct: 171 LPQ----DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE--KS 224
Query: 258 TSEWLIFQRIIARD 271
            S    F R+I  D
Sbjct: 225 KSPPAEFMRMIGND 238

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 102/247 (41%), Gaps = 40/247 (16%)
Query: 38  PQEH---FSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKT 89
           P +H   F       GK  G G++ KVV A      K D     A+K++       E + 
Sbjct: 13  PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA 72
Query: 90  AYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--------- 139
              +L+  VL  L +H  +V L           +  E C  G+L + +  K         
Sbjct: 73  LMSELK--VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKT 130
Query: 140 ---------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 190
                      L  ++   ++ +V   + ++ S   IHRD+   N+LLT     KI DFG
Sbjct: 131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG 190
Query: 191 SVKPMQ-DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQML 249
             + ++ DS   V  NA    K         ++ PE + +   TF +D+W+ G  L+++ 
Sbjct: 191 LARDIKNDSNYVVKGNARLPVK---------WMAPESIFNCVYTFESDVWSYGIFLWELF 241
Query: 250 S-GTSPF 255
           S G+SP+
Sbjct: 242 SLGSSPY 248

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/242 (22%), Positives = 101/242 (41%), Gaps = 33/242 (13%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTA 90
           P+  F      LGK  G G++ +VV A+ +             A+K++ K   T+E+ + 
Sbjct: 28  PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEEDLSD 86
Query: 91  YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------- 139
            V    ++     H  ++ L         LY+ +E    G L + + ++           
Sbjct: 87  LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 140 GHLSEDEARF-----YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
             + E++  F      T ++   +EY+ S   IHRD+   N+L+T +  +KIADFG  + 
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
           +         N     K         ++ PE L     T  +D+W+ G  ++++ + G S
Sbjct: 207 IN--------NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 254 PF 255
           P+
Sbjct: 259 PY 260

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/214 (22%), Positives = 93/214 (43%), Gaps = 23/214 (10%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY--VKLERIVLDQLDHPGVV 108
           K+ G G +  V +   I  G    + +  K    K  + ++  V    + +  LDH  +V
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 109 RLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLI 167
           RL      + SL +  +    G L D +   +G L       +  ++   + Y+   G++
Sbjct: 97  RLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMV 155
Query: 168 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 227
           HR++   N+LL +   +++ADFG           +LP    DDK   +  + A  P + +
Sbjct: 156 HRNLAARNVLLKSPSQVQVADFGVAD--------LLP---PDDKQLLY--SEAKTPIKWM 202
Query: 228 NSSPATFG-----NDLWALGCTLYQMLS-GTSPF 255
                 FG     +D+W+ G T++++++ G  P+
Sbjct: 203 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPY 236

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 102/247 (41%), Gaps = 40/247 (16%)
Query: 38  PQEH---FSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKT 89
           P +H   F       GK  G G++ KVV A      K D     A+K++       E + 
Sbjct: 36  PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA 95
Query: 90  AYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--------- 139
              +L+  VL  L +H  +V L           +  E C  G+L + +  K         
Sbjct: 96  LMSELK--VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKT 153
Query: 140 ---------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 190
                      L  ++   ++ +V   + ++ S   IHRD+   N+LLT     KI DFG
Sbjct: 154 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG 213
Query: 191 SVKPMQ-DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQML 249
             + ++ DS   V  NA    K         ++ PE + +   TF +D+W+ G  L+++ 
Sbjct: 214 LARDIKNDSNYVVKGNARLPVK---------WMAPESIFNCVYTFESDVWSYGIFLWELF 264
Query: 250 S-GTSPF 255
           S G+SP+
Sbjct: 265 SLGSSPY 271

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 102/247 (41%), Gaps = 40/247 (16%)
Query: 38  PQEH---FSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKT 89
           P +H   F       GK  G G++ KVV A      K D     A+K++       E + 
Sbjct: 31  PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA 90
Query: 90  AYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--------- 139
              +L+  VL  L +H  +V L           +  E C  G+L + +  K         
Sbjct: 91  LMSELK--VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKT 148
Query: 140 ---------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 190
                      L  ++   ++ +V   + ++ S   IHRD+   N+LLT     KI DFG
Sbjct: 149 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG 208
Query: 191 SVKPMQ-DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQML 249
             + ++ DS   V  NA    K         ++ PE + +   TF +D+W+ G  L+++ 
Sbjct: 209 LARDIKNDSNYVVKGNARLPVK---------WMAPESIFNCVYTFESDVWSYGIFLWELF 259
Query: 250 S-GTSPF 255
           S G+SP+
Sbjct: 260 SLGSSPY 266

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/236 (22%), Positives = 104/236 (44%), Gaps = 18/236 (7%)
Query: 41  HFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           HF  +  +  +  G G + KV   +      +TG   A+K +  +  +  N  A +K E 
Sbjct: 17  HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHIADLKKEI 74
Query: 97  IVLDQLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAE 153
            +L  L H  +V+     T      + + +E    G L + +  +K  ++  +   Y  +
Sbjct: 75  EILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQ 134
Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           +   ++Y+ S   +HRD+   N+L+ ++  +KI DFG  K ++  +         DD+  
Sbjct: 135 ICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXX---TVKDDRD- 190
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA 269
                  +  PE L  S     +D+W+ G TL+++L+      D+S   +F ++I 
Sbjct: 191 ---SPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCD--SDSSPMALFLKMIG 241

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 102/247 (41%), Gaps = 40/247 (16%)
Query: 38  PQEH---FSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKT 89
           P +H   F       GK  G G++ KVV A      K D     A+K++       E + 
Sbjct: 36  PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA 95
Query: 90  AYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--------- 139
              +L+  VL  L +H  +V L           +  E C  G+L + +  K         
Sbjct: 96  LMSELK--VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKT 153
Query: 140 ---------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 190
                      L  ++   ++ +V   + ++ S   IHRD+   N+LLT     KI DFG
Sbjct: 154 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG 213
Query: 191 SVKPMQ-DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQML 249
             + ++ DS   V  NA    K         ++ PE + +   TF +D+W+ G  L+++ 
Sbjct: 214 LARHIKNDSNYVVKGNARLPVK---------WMAPESIFNCVYTFESDVWSYGIFLWELF 264
Query: 250 S-GTSPF 255
           S G+SP+
Sbjct: 265 SLGSSPY 271

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/236 (22%), Positives = 104/236 (44%), Gaps = 18/236 (7%)
Query: 41  HFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           HF  +  +  +  G G + KV   +      +TG   A+K +  +  +  N  A +K E 
Sbjct: 5   HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHIADLKKEI 62
Query: 97  IVLDQLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAE 153
            +L  L H  +V+     T      + + +E    G L + +  +K  ++  +   Y  +
Sbjct: 63  EILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQ 122
Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           +   ++Y+ S   +HRD+   N+L+ ++  +KI DFG  K ++  +         DD+  
Sbjct: 123 ICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXX---TVKDDRD- 178
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA 269
                  +  PE L  S     +D+W+ G TL+++L+      D+S   +F ++I 
Sbjct: 179 ---SPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCD--SDSSPMALFLKMIG 229

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/214 (22%), Positives = 93/214 (43%), Gaps = 23/214 (10%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY--VKLERIVLDQLDHPGVV 108
           K+ G G +  V +   I  G    + +  K    K  + ++  V    + +  LDH  +V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 109 RLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLI 167
           RL      + SL +  +    G L D +   +G L       +  ++   + Y+   G++
Sbjct: 79  RLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMV 137
Query: 168 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL 227
           HR++   N+LL +   +++ADFG           +LP    DDK   +  + A  P + +
Sbjct: 138 HRNLAARNVLLKSPSQVQVADFGVAD--------LLP---PDDKQLLY--SEAKTPIKWM 184
Query: 228 NSSPATFG-----NDLWALGCTLYQMLS-GTSPF 255
                 FG     +D+W+ G T++++++ G  P+
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPY 218

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 63/135 (46%), Gaps = 12/135 (8%)
Query: 119 SLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLL 177
           SL + +E    G L D +   +  L       Y++++   +EY+ S   +HRD+   N+L
Sbjct: 87  SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNIL 146
Query: 178 LTADGHIKIADFGSVK--PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFG 235
           + ++ H+KIADFG  K  P+      V     S            +  PE L+ +  +  
Sbjct: 147 VESEAHVKIADFGLAKLLPLDKDYYVVREPGQS---------PIFWYAPESLSDNIFSRQ 197
Query: 236 NDLWALGCTLYQMLS 250
           +D+W+ G  LY++ +
Sbjct: 198 SDVWSFGVVLYELFT 212

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 63/135 (46%), Gaps = 12/135 (8%)
Query: 119 SLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLL 177
           SL + +E    G L D +   +  L       Y++++   +EY+ S   +HRD+   N+L
Sbjct: 88  SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNIL 147
Query: 178 LTADGHIKIADFGSVK--PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFG 235
           + ++ H+KIADFG  K  P+      V     S            +  PE L+ +  +  
Sbjct: 148 VESEAHVKIADFGLAKLLPLDKDYYVVREPGQS---------PIFWYAPESLSDNIFSRQ 198
Query: 236 NDLWALGCTLYQMLS 250
           +D+W+ G  LY++ +
Sbjct: 199 SDVWSFGVVLYELFT 213

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 25/212 (11%)
Query: 68  DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALE 125
           +TG V A+K +     T+E+   + + E  +L  L H  +V+           +L + +E
Sbjct: 40  NTGEVVAVKKLQHS--TEEHLRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 96
Query: 126 SCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI 184
               G L D +   K  +   +   YT+++   +EY+ +   IHRD+   N+L+  +  +
Sbjct: 97  YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 156
Query: 185 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLW 239
           KI DFG  K        VLP     DK    V      P     PE L  S  +  +D+W
Sbjct: 157 KIGDFGLTK--------VLPQ----DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVW 204
Query: 240 ALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 271
           + G  LY++ +     K  S    F R+I  D
Sbjct: 205 SFGVVLYELFTYIE--KSKSPPAEFMRMIGND 234

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 63/135 (46%), Gaps = 12/135 (8%)
Query: 119 SLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLL 177
           SL + +E    G L D +   +  L       Y++++   +EY+ S   +HRD+   N+L
Sbjct: 100 SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNIL 159
Query: 178 LTADGHIKIADFGSVK--PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFG 235
           + ++ H+KIADFG  K  P+      V     S            +  PE L+ +  +  
Sbjct: 160 VESEAHVKIADFGLAKLLPLDKDYYVVREPGQS---------PIFWYAPESLSDNIFSRQ 210
Query: 236 NDLWALGCTLYQMLS 250
           +D+W+ G  LY++ +
Sbjct: 211 SDVWSFGVVLYELFT 225

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 107/252 (42%), Gaps = 30/252 (11%)
Query: 32  SFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKEN 87
           +F  R P + F  +  +  +  G G++  V   +    + +TG V A+K +     T+E+
Sbjct: 4   AFEDRDPTQ-FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEH 60
Query: 88  KTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQITS-KGHLSE 144
              + + E  +L  L H  +V+           +L + +E    G L D +   K  +  
Sbjct: 61  LRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH 119
Query: 145 DEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP 204
            +   YT+++   +EY+ +   IHRD+   N+L+  +  +KI DFG  K        VLP
Sbjct: 120 IKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK--------VLP 171
Query: 205 NAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 259
                DK    V      P     PE L  S  +  +D+W+ G  LY++ +     K  S
Sbjct: 172 Q----DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE--KSKS 225
Query: 260 EWLIFQRIIARD 271
               F R+I  D
Sbjct: 226 PPAEFMRMIGND 237

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 25/212 (11%)
Query: 68  DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALE 125
           +TG V A+K +     T+E+   + + E  +L  L H  +V+           +L + +E
Sbjct: 55  NTGEVVAVKKLQHS--TEEHLRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 111
Query: 126 SCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI 184
               G L D +   K  +   +   YT+++   +EY+ +   IHRD+   N+L+  +  +
Sbjct: 112 YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 171
Query: 185 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLW 239
           KI DFG  K        VLP     DK    V      P     PE L  S  +  +D+W
Sbjct: 172 KIGDFGLTK--------VLPQ----DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVW 219
Query: 240 ALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 271
           + G  LY++ +     K  S    F R+I  D
Sbjct: 220 SFGVVLYELFTYIE--KSKSPPAEFMRMIGND 249

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 107/252 (42%), Gaps = 30/252 (11%)
Query: 32  SFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKEN 87
           +F  R P + F  +  +  +  G G++  V   +    + +TG V A+K +     T+E+
Sbjct: 2   AFEDRDPTQ-FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEH 58
Query: 88  KTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQITS-KGHLSE 144
              + + E  +L  L H  +V+           +L + +E    G L D +   K  +  
Sbjct: 59  LRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH 117
Query: 145 DEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP 204
            +   YT+++   +EY+ +   IHRD+   N+L+  +  +KI DFG  K        VLP
Sbjct: 118 IKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK--------VLP 169
Query: 205 NAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 259
                DK    V      P     PE L  S  +  +D+W+ G  LY++ +     K  S
Sbjct: 170 Q----DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE--KSKS 223
Query: 260 EWLIFQRIIARD 271
               F R+I  D
Sbjct: 224 PPAEFMRMIGND 235

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/242 (21%), Positives = 99/242 (40%), Gaps = 33/242 (13%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTA 90
           P+  F      LGK  G G++ +VV A+ +             A+K++      K+    
Sbjct: 28  PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 87
Query: 91  YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------- 139
             ++E + +    H  ++ L         LY+ +E    G L + + ++           
Sbjct: 88  VSEMEMMKMIG-KHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 140 GHLSEDEARF-----YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
             + E++  F      T ++   +EY+ S   IHRD+   N+L+T +  +KIADFG  + 
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
           +         N     K         ++ PE L     T  +D+W+ G  ++++ + G S
Sbjct: 207 IN--------NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 254 PF 255
           P+
Sbjct: 259 PY 260

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 25/212 (11%)
Query: 68  DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALE 125
           +TG V A+K +     T+E+   + + E  +L  L H  +V+           +L + +E
Sbjct: 37  NTGEVVAVKKLQHS--TEEHLRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 93
Query: 126 SCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI 184
               G L D +   K  +   +   YT+++   +EY+ +   IHRD+   N+L+  +  +
Sbjct: 94  YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 153
Query: 185 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLW 239
           KI DFG  K        VLP     DK    V      P     PE L  S  +  +D+W
Sbjct: 154 KIGDFGLTK--------VLPQ----DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVW 201
Query: 240 ALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 271
           + G  LY++ +     K  S    F R+I  D
Sbjct: 202 SFGVVLYELFTYIE--KSKSPPAEFMRMIGND 231

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 25/212 (11%)
Query: 68  DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALE 125
           +TG V A+K +     T+E+   + + E  +L  L H  +V+           +L + +E
Sbjct: 37  NTGEVVAVKKLQHS--TEEHLRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 93
Query: 126 SCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI 184
               G L D +   K  +   +   YT+++   +EY+ +   IHRD+   N+L+  +  +
Sbjct: 94  YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 153
Query: 185 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLW 239
           KI DFG  K        VLP     DK    V      P     PE L  S  +  +D+W
Sbjct: 154 KIGDFGLTK--------VLPQ----DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVW 201
Query: 240 ALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 271
           + G  LY++ +     K  S    F R+I  D
Sbjct: 202 SFGVVLYELFTYIE--KSKSPPAEFMRMIGND 231

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 25/212 (11%)
Query: 68  DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALE 125
           +TG V A+K +     T+E+   + + E  +L  L H  +V+           +L + +E
Sbjct: 55  NTGEVVAVKKLQHS--TEEHLRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 111
Query: 126 SCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI 184
               G L D +   K  +   +   YT+++   +EY+ +   IHRD+   N+L+  +  +
Sbjct: 112 YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 171
Query: 185 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLW 239
           KI DFG  K        VLP     DK    V      P     PE L  S  +  +D+W
Sbjct: 172 KIGDFGLTK--------VLPQ----DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVW 219
Query: 240 ALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 271
           + G  LY++ +     K  S    F R+I  D
Sbjct: 220 SFGVVLYELFTYIE--KSKSPPAEFMRMIGND 249

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 107/252 (42%), Gaps = 30/252 (11%)
Query: 32  SFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKEN 87
           +F  R P + F  +  +  +  G G++  V   +    + +TG V A+K +     T+E+
Sbjct: 29  AFEDRDPTQ-FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEH 85
Query: 88  KTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALESCEGGELFDQITS-KGHLSE 144
              + + E  +L  L H  +V+           +L + +E    G L D +   K  +  
Sbjct: 86  LRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH 144
Query: 145 DEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP 204
            +   YT+++   +EY+ +   IHRD+   N+L+  +  +KI DFG  K        VLP
Sbjct: 145 IKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK--------VLP 196
Query: 205 NAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS 259
                DK    V      P     PE L  S  +  +D+W+ G  LY++ +     K  S
Sbjct: 197 Q----DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE--KSKS 250
Query: 260 EWLIFQRIIARD 271
               F R+I  D
Sbjct: 251 PPAEFMRMIGND 262

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/250 (20%), Positives = 104/250 (41%), Gaps = 31/250 (12%)
Query: 40  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKLER 96
           +   I   ++ ++ G G + +V        G      A+K +   +  K+ +      E 
Sbjct: 2   KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLS--EA 59
Query: 97  IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD 156
            ++ Q DHP V+ L      +  + +  E  E G L         L +++ +F   ++V 
Sbjct: 60  SIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL------DSFLRQNDGQFTVIQLVG 113
Query: 157 AL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 209
            L       +Y+  M  +HR +   N+L+ ++   K++DFG  + ++D          SD
Sbjct: 114 MLRGIAAGMKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDD--------TSD 165
Query: 210 DKACTFVGTAA---YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQ 265
               + +G      +  PE +     T  +D+W+ G  +++++S G  P+ D +   +  
Sbjct: 166 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVIN 225
Query: 266 RIIARDIRFP 275
             I +D R P
Sbjct: 226 -AIEQDYRLP 234

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 57/127 (44%), Gaps = 19/127 (14%)
Query: 150 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 209
           YT+++   +EY+ +   IHRD+   N+L+  +  +KI DFG  K        VLP     
Sbjct: 122 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK--------VLPQ---- 169
Query: 210 DKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIF 264
           DK    V      P     PE L  S  +  +D+W+ G  LY++ +     K  S    F
Sbjct: 170 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE--KSKSPPAEF 227
Query: 265 QRIIARD 271
            R+I  D
Sbjct: 228 MRMIGND 234

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 85/184 (46%), Gaps = 12/184 (6%)
Query: 69  TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF--SLYMALES 126
           TG + A+K + K     ++++ + K E  +L  L H  +++     +D    SL + +E 
Sbjct: 42  TGEMVAVKAL-KADCGPQHRSGW-KQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEY 99
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
              G L D +  +  +   +   +  ++ + + Y+HS   IHR++   N+LL  D  +KI
Sbjct: 100 VPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKI 158
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  K + +           D  +  F     +  PE L      + +D+W+ G TLY
Sbjct: 159 GDFGLAKAVPEGHEYY--RVREDGDSPVF-----WYAPECLKEYKFYYASDVWSFGVTLY 211
Query: 247 QMLS 250
           ++L+
Sbjct: 212 ELLT 215

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 25/212 (11%)
Query: 68  DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALE 125
           +TG V A+K +     T+E+   + + E  +L  L H  +V+           +L + +E
Sbjct: 36  NTGEVVAVKKLQHS--TEEHLRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 92
Query: 126 SCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI 184
               G L D +   K  +   +   YT+++   +EY+ +   IHRD+   N+L+  +  +
Sbjct: 93  YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 152
Query: 185 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLW 239
           KI DFG  K        VLP     DK    V      P     PE L  S  +  +D+W
Sbjct: 153 KIGDFGLTK--------VLPQ----DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVW 200
Query: 240 ALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 271
           + G  LY++ +     K  S    F R+I  D
Sbjct: 201 SFGVVLYELFTYIE--KSKSPPAEFMRMIGND 230

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 25/212 (11%)
Query: 68  DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALE 125
           +TG V A+K +     T+E+   + + E  +L  L H  +V+           +L + +E
Sbjct: 35  NTGEVVAVKKLQHS--TEEHLRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 91
Query: 126 SCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI 184
               G L D +   K  +   +   YT+++   +EY+ +   IHRD+   N+L+  +  +
Sbjct: 92  YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 151
Query: 185 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLW 239
           KI DFG  K        VLP     DK    V      P     PE L  S  +  +D+W
Sbjct: 152 KIGDFGLTK--------VLPQ----DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVW 199
Query: 240 ALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 271
           + G  LY++ +     K  S    F R+I  D
Sbjct: 200 SFGVVLYELFTYIE--KSKSPPAEFMRMIGND 229

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/242 (21%), Positives = 98/242 (40%), Gaps = 33/242 (13%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTA 90
           P+  F      LGK  G G + +VV A+ +             A+K++      K+    
Sbjct: 17  PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 76
Query: 91  YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------- 139
             ++E + +    H  ++ L         LY+ +E    G L + + ++           
Sbjct: 77  VSEMEMMKMIG-KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 135
Query: 140 GHLSEDEARF-----YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
             + E++  F      T ++   +EY+ S   IHRD+   N+L+T +  +KIADFG  + 
Sbjct: 136 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 195
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
           +         N     K         ++ PE L     T  +D+W+ G  ++++ + G S
Sbjct: 196 IN--------NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 247
Query: 254 PF 255
           P+
Sbjct: 248 PY 249

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/242 (21%), Positives = 101/242 (41%), Gaps = 33/242 (13%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTA 90
           P+  F      LGK  G G++ +VV A+ +             A+K++      K+    
Sbjct: 28  PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 87
Query: 91  YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------- 139
             ++E + +    H  ++ L         LY+ +E    G L + + ++           
Sbjct: 88  VSEMEMMKMIG-KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 140 GHLSEDEARF-----YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
             + E++  F      T ++   +EY+ S   IHRD+   N+L+T +  +KIADFG  + 
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
           + +  I    N  +      ++       PE L     T  +D+W+ G  ++++ + G S
Sbjct: 207 INN--IDYYKNTTNGRLPVKWMA------PEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 254 PF 255
           P+
Sbjct: 259 PY 260

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 72/163 (44%), Gaps = 9/163 (5%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 154
           E  V+ QLD+P +VR+     +  S  + +E  E G L   +    H+ +        +V
Sbjct: 62  EANVMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 120
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
              ++Y+     +HRD+   N+LL    + KI+DFG  K ++         A +  K   
Sbjct: 121 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXY--KAQTHGK--- 175
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
                 +  PE +N    +  +D+W+ G  +++  S G  P++
Sbjct: 176 --WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 216

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/242 (21%), Positives = 98/242 (40%), Gaps = 33/242 (13%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTA 90
           P+  F      LGK  G G + +VV A+ +             A+K++      K+    
Sbjct: 15  PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 74
Query: 91  YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------- 139
             ++E + +    H  ++ L         LY+ +E    G L + + ++           
Sbjct: 75  VSEMEMMKMIG-KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 133
Query: 140 GHLSEDEARF-----YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
             + E++  F      T ++   +EY+ S   IHRD+   N+L+T +  +KIADFG  + 
Sbjct: 134 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARD 193
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
           +         N     K         ++ PE L     T  +D+W+ G  ++++ + G S
Sbjct: 194 IN--------NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 245
Query: 254 PF 255
           P+
Sbjct: 246 PY 247

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 57/127 (44%), Gaps = 19/127 (14%)
Query: 150 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 209
           YT+++   +EY+ +   IHRD+   N+L+  +  +KI DFG  K        VLP     
Sbjct: 122 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK--------VLPQ---- 169
Query: 210 DKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIF 264
           DK    V      P     PE L  S  +  +D+W+ G  LY++ +     K  S    F
Sbjct: 170 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE--KSKSPPAEF 227
Query: 265 QRIIARD 271
            R+I  D
Sbjct: 228 MRMIGND 234

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/242 (21%), Positives = 99/242 (40%), Gaps = 33/242 (13%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTA 90
           P+  F      LGK  G G++ +VV A+ +             A+K++      K+    
Sbjct: 28  PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 87
Query: 91  YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------- 139
             ++E + +    H  ++ L         LY+ +E    G L + + ++           
Sbjct: 88  VSEMEMMKMIG-KHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 140 GHLSEDEARF-----YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
             + E++  F      T ++   +EY+ S   IHRD+   N+L+T +  +KIADFG  + 
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
           +         N     K         ++ PE L     T  +D+W+ G  ++++ + G S
Sbjct: 207 IN--------NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 254 PF 255
           P+
Sbjct: 259 PY 260

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/135 (24%), Positives = 64/135 (47%), Gaps = 14/135 (10%)
Query: 120 LYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL 178
           L + +E    G L D +   +  L       Y++++   +EY+ S   +HRD+   N+L+
Sbjct: 85  LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV 144
Query: 179 TADGHIKIADFGSVKPM---QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFG 235
            ++ H+KIADFG  K +   +D  +   P  +             +  PE L+ +  +  
Sbjct: 145 ESEAHVKIADFGLAKLLPLDKDXXVVREPGQS----------PIFWYAPESLSDNIFSRQ 194
Query: 236 NDLWALGCTLYQMLS 250
           +D+W+ G  LY++ +
Sbjct: 195 SDVWSFGVVLYELFT 209

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/213 (21%), Positives = 91/213 (42%), Gaps = 21/213 (9%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLDHPGVV 108
           K+ G G++  V +   +  G    + +  K         A V+   E +++  +DHP +V
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 109 RLF-FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           RL       T  L   L     G L + +   K ++       +  ++   + Y+    L
Sbjct: 104 RLLGVCLSPTIQLVTQLMP--HGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL 161
Query: 167 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG---TAAYVP 223
           +HRD+   N+L+ +  H+KI DFG  + ++            D+K     G      ++ 
Sbjct: 162 VHRDLAARNVLVKSPNHVKITDFGLARLLE-----------GDEKEYNADGGKMPIKWMA 210
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
            E ++    T  +D+W+ G T++++++ G  P+
Sbjct: 211 LECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 243

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 72/163 (44%), Gaps = 9/163 (5%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 154
           E  V+ QLD+P +VR+     +  S  + +E  E G L   +    H+ +        +V
Sbjct: 62  EANVMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 120
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
              ++Y+     +HRD+   N+LL    + KI+DFG  K ++         A +  K   
Sbjct: 121 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY--KAQTHGK--- 175
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
                 +  PE +N    +  +D+W+ G  +++  S G  P++
Sbjct: 176 --WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 216

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/242 (21%), Positives = 98/242 (40%), Gaps = 33/242 (13%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTA 90
           P+  F      LGK  G G + +VV A+ +             A+K++      K+    
Sbjct: 20  PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 79
Query: 91  YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------- 139
             ++E + +    H  ++ L         LY+ +E    G L + + ++           
Sbjct: 80  VSEMEMMKMIG-KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 138
Query: 140 GHLSEDEARF-----YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
             + E++  F      T ++   +EY+ S   IHRD+   N+L+T +  +KIADFG  + 
Sbjct: 139 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 198
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
           +         N     K         ++ PE L     T  +D+W+ G  ++++ + G S
Sbjct: 199 IN--------NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 250
Query: 254 PF 255
           P+
Sbjct: 251 PY 252

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 25/212 (11%)
Query: 68  DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALE 125
           +TG V A+K +     T+E+   + + E  +L  L H  +V+           +L + +E
Sbjct: 37  NTGEVVAVKKLQHS--TEEHLRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 93
Query: 126 SCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI 184
               G L D +   K  +   +   YT+++   +EY+ +   IHRD+   N+L+  +  +
Sbjct: 94  YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 153
Query: 185 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLW 239
           KI DFG  K        VLP     DK    V      P     PE L  S  +  +D+W
Sbjct: 154 KIGDFGLTK--------VLPQ----DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVW 201
Query: 240 ALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 271
           + G  LY++ +     K  S    F R+I  D
Sbjct: 202 SFGVVLYELFTYIE--KSKSPPAEFMRMIGND 231

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 13/116 (11%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRI 200
           L++ + R+Y  E++ AL+Y HS G++HRD+KP N+++  +   +++ D+G  +     + 
Sbjct: 122 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 180
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
                     +    V +  +  PE+L +     +  D+W+LGC    M+    PF
Sbjct: 181 ----------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 95/231 (41%), Gaps = 33/231 (14%)
Query: 49  LGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
           LGK  G G++ +VV A+ I       +  T  A+K++      K+      ++E + +  
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG----------------HLSED 145
             H  ++ L         LY+ +E    G L + + ++                  LS  
Sbjct: 92  -KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSK 150
Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
           +      +V   +EY+ S   IHRD+   N+L+T D  +KIADFG  + +         +
Sbjct: 151 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH--------H 202
Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                K         ++ PE L     T  +D+W+ G  L+++ + G SP+
Sbjct: 203 IDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 72/163 (44%), Gaps = 9/163 (5%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 154
           E  V+ QLD+P +VR+     +  S  + +E  E G L   +    H+ +        +V
Sbjct: 76  EANVMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 134
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
              ++Y+     +HRD+   N+LL    + KI+DFG  K ++         A +  K   
Sbjct: 135 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY--KAQTHGK--- 189
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
                 +  PE +N    +  +D+W+ G  +++  S G  P++
Sbjct: 190 --WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 230

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/160 (23%), Positives = 71/160 (44%), Gaps = 9/160 (5%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           V+ QLD+P +VR+     +  S  + +E  E G L   +    H+ +        +V   
Sbjct: 71  VMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG 129
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           ++Y+     +HRD+   N+LL    + KI+DFG  K ++         A +  K      
Sbjct: 130 MKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY--KAQTHGK-----W 182
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
              +  PE +N    +  +D+W+ G  +++  S G  P++
Sbjct: 183 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 222

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/213 (21%), Positives = 91/213 (42%), Gaps = 21/213 (9%)
Query: 51  KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLDHPGVV 108
           K+ G G++  V +   +  G    + +  K         A V+   E +++  +DHP +V
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 109 RLF-FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           RL       T  L   L     G L + +   K ++       +  ++   + Y+    L
Sbjct: 81  RLLGVCLSPTIQLVTQLMP--HGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL 138
Query: 167 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG---TAAYVP 223
           +HRD+   N+L+ +  H+KI DFG  + ++            D+K     G      ++ 
Sbjct: 139 VHRDLAARNVLVKSPNHVKITDFGLARLLE-----------GDEKEYNADGGKMPIKWMA 187
Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
            E ++    T  +D+W+ G T++++++ G  P+
Sbjct: 188 LECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 220

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/203 (21%), Positives = 84/203 (41%), Gaps = 38/203 (18%)
Query: 85  KENKTAYVKLERI-------VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT 137
           K  K  Y + +R+       ++ Q  H  ++RL         + +  E  E G L     
Sbjct: 79  KTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGAL----- 133
Query: 138 SKGHLSEDEARFYTAEVVDAL-------EYIHSMGLIHRDIKPENLLLTADGHIKIADFG 190
               L E +  F   ++V  L       +Y+ +M  +HRD+   N+L+ ++   K++DFG
Sbjct: 134 -DKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFG 192
Query: 191 SVKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTL 245
                       L     DD   T+  +   +P     PE ++    T  +D+W+ G  +
Sbjct: 193 ------------LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVM 240
Query: 246 YQMLS-GTSPFKDTSEWLIFQRI 267
           +++++ G  P+ + S   + + I
Sbjct: 241 WEVMTYGERPYWELSNHEVMKAI 263

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/160 (23%), Positives = 71/160 (44%), Gaps = 9/160 (5%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           V+ QLD+P +VR+     +  S  + +E  E G L   +    H+ +        +V   
Sbjct: 81  VMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG 139
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           ++Y+     +HRD+   N+LL    + KI+DFG  K ++         A +  K      
Sbjct: 140 MKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY--KAQTHGK-----W 192
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
              +  PE +N    +  +D+W+ G  +++  S G  P++
Sbjct: 193 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 232

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/160 (23%), Positives = 71/160 (44%), Gaps = 9/160 (5%)
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           V+ QLD+P +VR+     +  S  + +E  E G L   +    H+ +        +V   
Sbjct: 81  VMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG 139
Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           ++Y+     +HRD+   N+LL    + KI+DFG  K ++         A +  K      
Sbjct: 140 MKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY--KAQTHGK-----W 192
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
              +  PE +N    +  +D+W+ G  +++  S G  P++
Sbjct: 193 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 232

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 13/116 (11%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRI 200
           L++ + R+Y  E++ AL+Y HS G++HRD+KP N+++  +   +++ D+G  +     + 
Sbjct: 123 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 181
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
                     +    V +  +  PE+L +     +  D+W+LGC    M+    PF
Sbjct: 182 ----------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 227

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 72/163 (44%), Gaps = 9/163 (5%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 154
           E  V+ QLD+P +VR+     +  S  + +E  E G L   +    H+ +        +V
Sbjct: 58  EANVMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 116
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
              ++Y+     +HRD+   N+LL    + KI+DFG  K ++         A +  K   
Sbjct: 117 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY--KAQTHGK--- 171
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
                 +  PE +N    +  +D+W+ G  +++  S G  P++
Sbjct: 172 --WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 212

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/242 (21%), Positives = 99/242 (40%), Gaps = 33/242 (13%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTA 90
           P+  F      LGK  G G++ +VV A+ +             A+K++      K+    
Sbjct: 28  PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 87
Query: 91  YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------- 139
             ++E + +    H  ++ L         LY+ +E    G L + + ++           
Sbjct: 88  VSEMEMMKMIG-KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 140 GHLSEDEARF-----YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
             + E++  F      T ++   +EY+ S   IHRD+   N+L+T +  ++IADFG  + 
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARD 206
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
           +         N     K         ++ PE L     T  +D+W+ G  ++++ + G S
Sbjct: 207 IN--------NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 254 PF 255
           P+
Sbjct: 259 PY 260

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 13/116 (11%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRI 200
           L++ + R+Y  E++ AL+Y HS G++HRD+KP N+++  +   +++ D+G  +     + 
Sbjct: 122 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 180
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
                     +    V +  +  PE+L +     +  D+W+LGC    M+    PF
Sbjct: 181 ----------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 72/163 (44%), Gaps = 9/163 (5%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 154
           E  V+ QLD+P +VR+     +  S  + +E  E G L   +    H+ +        +V
Sbjct: 56  EANVMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 114
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
              ++Y+     +HRD+   N+LL    + KI+DFG  K ++         A +  K   
Sbjct: 115 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY--KAQTHGK--- 169
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
                 +  PE +N    +  +D+W+ G  +++  S G  P++
Sbjct: 170 --WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 210

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 13/116 (11%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRI 200
           L++ + R+Y  E++ AL+Y HS G++HRD+KP N+++  +   +++ D+G  +     + 
Sbjct: 122 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 180
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
                     +    V +  +  PE+L +     +  D+W+LGC    M+    PF
Sbjct: 181 ----------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 13/116 (11%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRI 200
           L++ + R+Y  E++ AL+Y HS G++HRD+KP N+++  +   +++ D+G  +     + 
Sbjct: 122 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 180
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
                     +    V +  +  PE+L +     +  D+W+LGC    M+    PF
Sbjct: 181 ----------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 13/116 (11%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRI 200
           L++ + R+Y  E++ AL+Y HS G++HRD+KP N+++  +   +++ D+G  +     + 
Sbjct: 124 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 182
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
                     +    V +  +  PE+L +     +  D+W+LGC    M+    PF
Sbjct: 183 ----------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 228

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 13/116 (11%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRI 200
           L++ + R+Y  E++ AL+Y HS G++HRD+KP N+++  +   +++ D+G  +     + 
Sbjct: 122 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 180
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
                     +    V +  +  PE+L +     +  D+W+LGC    M+    PF
Sbjct: 181 ----------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 13/116 (11%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRI 200
           L++ + R+Y  E++ AL+Y HS G++HRD+KP N+++  +   +++ D+G  +     + 
Sbjct: 123 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 181
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
                     +    V +  +  PE+L +     +  D+W+LGC    M+    PF
Sbjct: 182 ----------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 227

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 13/116 (11%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRI 200
           L++ + R+Y  E++ AL+Y HS G++HRD+KP N+++  +   +++ D+G  +     + 
Sbjct: 143 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 201
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
                     +    V +  +  PE+L +     +  D+W+LGC    M+    PF
Sbjct: 202 ----------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 247

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 72/163 (44%), Gaps = 9/163 (5%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 154
           E  V+ QLD+P +VR+     +  S  + +E  E G L   +    H+ +        +V
Sbjct: 420 EANVMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 478
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
              ++Y+     +HRD+   N+LL    + KI+DFG  K ++         A +  K   
Sbjct: 479 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY--KAQTHGKW-- 534
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
                 +  PE +N    +  +D+W+ G  +++  S G  P++
Sbjct: 535 ---PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 574

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 30/116 (25%), Positives = 59/116 (50%), Gaps = 13/116 (11%)
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRI 200
           L++ + R+Y  E++ AL+Y HS G++HRD+KP N+++  +   +++ D+G  +     + 
Sbjct: 122 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 180
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPF 255
                     +    V +  +  PE+L +     +  D+W+LGC    M+    PF
Sbjct: 181 ----------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 72/163 (44%), Gaps = 9/163 (5%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 154
           E  V+ QLD+P +VR+     +  S  + +E  E G L   +    H+ +        +V
Sbjct: 421 EANVMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 479
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
              ++Y+     +HRD+   N+LL    + KI+DFG  K ++         A +  K   
Sbjct: 480 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY--KAQTHGKW-- 535
Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK 256
                 +  PE +N    +  +D+W+ G  +++  S G  P++
Sbjct: 536 ---PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 575

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/184 (23%), Positives = 85/184 (46%), Gaps = 12/184 (6%)
Query: 69  TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF--SLYMALES 126
           TG + A+K + K     ++++ + K E  +L  L H  +++     +D    SL + +E 
Sbjct: 42  TGEMVAVKAL-KADCGPQHRSGW-KQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEY 99
Query: 127 CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
              G L D +  +  +   +   +  ++ + + Y+H+   IHR++   N+LL  D  +KI
Sbjct: 100 VPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKI 158
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG  K + +           D  +  F     +  PE L      + +D+W+ G TLY
Sbjct: 159 GDFGLAKAVPEGHEYY--RVREDGDSPVF-----WYAPECLKEYKFYYASDVWSFGVTLY 211
Query: 247 QMLS 250
           ++L+
Sbjct: 212 ELLT 215

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 56/113 (49%), Gaps = 20/113 (17%)
Query: 151 TAEVVDALEYIHS-MGLIHRDIKPENLLL-TADG-----HIKIADFGSVKPMQDSRITVL 203
           + +++  L+Y+H   G+IH DIKPEN+L+   D       IKIAD G+            
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----------- 185
Query: 204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK 256
                D+     + T  Y  PEVL  +P   G D+W+  C ++++++G   F+
Sbjct: 186 --CWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 236

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 56/113 (49%), Gaps = 20/113 (17%)
Query: 151 TAEVVDALEYIHS-MGLIHRDIKPENLLL-TADG-----HIKIADFGSVKPMQDSRITVL 203
           + +++  L+Y+H   G+IH DIKPEN+L+   D       IKIAD G+            
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----------- 185
Query: 204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK 256
                D+     + T  Y  PEVL  +P   G D+W+  C ++++++G   F+
Sbjct: 186 --CWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 236

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/247 (21%), Positives = 99/247 (40%), Gaps = 37/247 (14%)
Query: 45  QDFELGKIYGVGSYSKVVRAK-KIDTGTVY--ALKIMDKKFITKENKTAYVKLERIVLDQ 101
           Q F LG++ G G +  V  A+ K + G+    A+K++    I   +   +++ E   + +
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR-EAACMKE 81
Query: 102 LDHPGVVRL------------------FFTFQDTFSLYMALESCEGGELFDQITSKGHLS 143
            DHP V +L                     F     L+  L +   GE      +  +L 
Sbjct: 82  FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGE------NPFNLP 135
Query: 144 EDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL 203
                 +  ++   +EY+ S   IHRD+   N +L  D  + +ADFG  + +        
Sbjct: 136 LQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY-- 193
Query: 204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWL 262
                  + C       ++  E L  +  T  +D+WA G T++++++ G +P+       
Sbjct: 194 ------RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247
Query: 263 IFQRIIA 269
           I+  +I 
Sbjct: 248 IYNYLIG 254

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 98/221 (44%), Gaps = 18/221 (8%)
Query: 47  FELGKIYGVG--SYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +EL  + G G      V  A+   TG    ++ ++ +  + E  T +++ E  V    +H
Sbjct: 11  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVT-FLQGELHVSKLFNH 69
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIH 162
           P +V    TF     L++       G   D I +     ++E    +    V+ AL+YIH
Sbjct: 70  PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH 129
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPM----QDSRITVLPNAASDDKACTFVGT 218
            MG +HR +K  ++L++ DG + ++   S   M    Q  R+         D     V  
Sbjct: 130 HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVV-------HDFPKYSVKV 182
Query: 219 AAYVPPEVLNSSPATFG--NDLWALGCTLYQMLSGTSPFKD 257
             ++ PEVL  +   +   +D++++G T  ++ +G  PFKD
Sbjct: 183 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 223

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/228 (20%), Positives = 97/228 (42%), Gaps = 29/228 (12%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLER--IVLDQ 101
           + E  K  G G +  V + + +   +V A+K  I+       E    + + +R   ++  
Sbjct: 20  EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF-YTAEVVDALEY 160
           L+HP +V+L+    +   + M    C  G+L+ ++  K H  +   +     ++   +EY
Sbjct: 80  LNHPNIVKLYGLMHNPPRMVMEFVPC--GDLYHRLLDKAHPIKWSVKLRLMLDIALGIEY 137
Query: 161 IHSMG--LIHRDIKPENLLL-----TADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           + +    ++HRD++  N+ L      A    K+ADFG+             +  S     
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGT-------------SQQSVHSVS 184
Query: 214 TFVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTS 259
             +G   ++ PE + +   ++    D ++    LY +L+G  PF + S
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 98/221 (44%), Gaps = 18/221 (8%)
Query: 47  FELGKIYGVG--SYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +EL  + G G      V  A+   TG    ++ ++ +  + E  T +++ E  V    +H
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVT-FLQGELHVSKLFNH 85
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIH 162
           P +V    TF     L++       G   D I +     ++E    +    V+ AL+YIH
Sbjct: 86  PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH 145
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPM----QDSRITVLPNAASDDKACTFVGT 218
            MG +HR +K  ++L++ DG + ++   S   M    Q  R+         D     V  
Sbjct: 146 HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVV-------HDFPKYSVKV 198
Query: 219 AAYVPPEVLNSSPATFG--NDLWALGCTLYQMLSGTSPFKD 257
             ++ PEVL  +   +   +D++++G T  ++ +G  PFKD
Sbjct: 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/112 (29%), Positives = 55/112 (49%), Gaps = 10/112 (8%)
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTAD----GHIKIADFGSVKPMQDSRITVLPNAAS 208
           +++D + Y+H+  ++HRD+KP N+L+  +    G +KIAD G  +        + P A  
Sbjct: 136 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP---LKPLADL 192
Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           D    TF   A   P  +L +   T   D+WA+GC   ++L+    F    E
Sbjct: 193 DPVVVTFWYRA---PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 107 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 164
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++Y+ S 
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 151
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMAL------ 205
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 277
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 206 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 260

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 94/218 (43%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L M L     G L D +   K ++       +  ++   + Y+
Sbjct: 78  NPHVCRLLGICLTSTVQLIMQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 136 EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL-----------GAEEKEYHAEGGKVP 184
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 95/231 (41%), Gaps = 33/231 (14%)
Query: 49  LGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
           LGK  G G++ +VV A+ I       +  T  A+K++      K+      ++E + +  
Sbjct: 21  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 80
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG----------------HLSED 145
             H  ++ L         LY+ +E    G L + + ++                  LS  
Sbjct: 81  -KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 139
Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
           +      +V   +EY+ S   IHRD+   N+L+T D  +KIADFG  + +         +
Sbjct: 140 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH--------H 191
Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                K         ++ PE L     T  +D+W+ G  L+++ + G SP+
Sbjct: 192 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 242

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 94/218 (43%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L M L     G L D +   K ++       +  ++   + Y+
Sbjct: 77  NPHVCRLLGICLTSTVQLIMQLMPF--GXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 134
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 135 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 183
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 184 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 221

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 94/218 (43%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L M L     G L D +   K ++       +  ++   + Y+
Sbjct: 78  NPHVCRLLGICLTSTVQLIMQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 136 EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL-----------GAEEKEYHAEGGKVP 184
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 25/212 (11%)
Query: 68  DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL--FFTFQDTFSLYMALE 125
           +TG V A+K +     T+E+   + + E  +L  L H  +V+           +L + +E
Sbjct: 38  NTGEVVAVKKLQHS--TEEHLRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 94
Query: 126 SCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI 184
               G L D +   K  +   +   YT+++   +EY+ +   IHR++   N+L+  +  +
Sbjct: 95  YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRNLATRNILVENENRV 154
Query: 185 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLW 239
           KI DFG  K        VLP     DK    V      P     PE L  S  +  +D+W
Sbjct: 155 KIGDFGLTK--------VLPQ----DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVW 202
Query: 240 ALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 271
           + G  LY++ +     K  S    F R+I  D
Sbjct: 203 SFGVVLYELFTYIE--KSKSPPAEFMRMIGND 232

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/257 (23%), Positives = 101/257 (39%), Gaps = 55/257 (21%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVY-ALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           +E+    G G++ KVV       G  + A+KI+       +N   Y +  R  +  L+H 
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV-------KNVDRYCEAARSEIQVLEHL 68
Query: 106 G---------VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHL--SEDEARFYTAEV 154
                      V++   F+    + +  E   G   +D I   G L    D  R    ++
Sbjct: 69  NTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQI 127
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGH-------------------IKIADFGSVKPM 195
             ++ ++HS  L H D+KPEN+L     +                   IK+ DFGS    
Sbjct: 128 CKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--- 184
Query: 196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTS-- 253
                        D+   T V T  Y  PEV+ +   +   D+W++GC L +   G +  
Sbjct: 185 ----------TYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234
Query: 254 PFKDTSEWL-IFQRIIA 269
           P  D+ E L + +RI+ 
Sbjct: 235 PTHDSKEHLAMMERILG 251

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 95/231 (41%), Gaps = 33/231 (14%)
Query: 49  LGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
           LGK  G G++ +VV A+ I       +  T  A+K++      K+      ++E + +  
Sbjct: 25  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 84
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG----------------HLSED 145
             H  ++ L         LY+ +E    G L + + ++                  LS  
Sbjct: 85  -KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 143
Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
           +      +V   +EY+ S   IHRD+   N+L+T D  +KIADFG  + +         +
Sbjct: 144 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH--------H 195
Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                K         ++ PE L     T  +D+W+ G  L+++ + G SP+
Sbjct: 196 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 246

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 95/231 (41%), Gaps = 33/231 (14%)
Query: 49  LGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
           LGK  G G++ +VV A+ I       +  T  A+K++      K+      ++E + +  
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG----------------HLSED 145
             H  ++ L         LY+ +E    G L + + ++                  LS  
Sbjct: 92  -KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 150
Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
           +      +V   +EY+ S   IHRD+   N+L+T D  +KIADFG  + +         +
Sbjct: 151 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH--------H 202
Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                K         ++ PE L     T  +D+W+ G  L+++ + G SP+
Sbjct: 203 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 95/231 (41%), Gaps = 33/231 (14%)
Query: 49  LGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
           LGK  G G++ +VV A+ I       +  T  A+K++      K+      ++E + +  
Sbjct: 24  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 83
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG----------------HLSED 145
             H  ++ L         LY+ +E    G L + + ++                  LS  
Sbjct: 84  -KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 142
Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
           +      +V   +EY+ S   IHRD+   N+L+T D  +KIADFG  + +         +
Sbjct: 143 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH--------H 194
Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                K         ++ PE L     T  +D+W+ G  L+++ + G SP+
Sbjct: 195 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 245

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 94/218 (43%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L M L     G L D +   K ++       +  ++   + Y+
Sbjct: 80  NPHVCRLLGICLTSTVQLIMQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 137
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 138 EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL-----------GAEEKEYHAEGGKVP 186
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 187 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 224

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 51  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 110
Query: 107 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 164
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++Y+ S 
Sbjct: 111 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 170
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 171 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL------ 224
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 277
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 225 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 279

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 95/231 (41%), Gaps = 33/231 (14%)
Query: 49  LGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
           LGK  G G++ +VV A+ I       +  T  A+K++      K+      ++E + +  
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG----------------HLSED 145
             H  ++ L         LY+ +E    G L + + ++                  LS  
Sbjct: 92  -KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSK 150
Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
           +      +V   +EY+ S   IHRD+   N+L+T D  +KIADFG  + +         +
Sbjct: 151 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH--------H 202
Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                K         ++ PE L     T  +D+W+ G  L+++ + G SP+
Sbjct: 203 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 95/231 (41%), Gaps = 33/231 (14%)
Query: 49  LGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
           LGK  G G++ +VV A+ I       +  T  A+K++      K+      ++E + +  
Sbjct: 17  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG----------------HLSED 145
             H  ++ L         LY+ +E    G L + + ++                  LS  
Sbjct: 77  -KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSK 135
Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
           +      +V   +EY+ S   IHRD+   N+L+T D  +KIADFG  + +         +
Sbjct: 136 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH--------H 187
Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                K         ++ PE L     T  +D+W+ G  L+++ + G SP+
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 238

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/242 (21%), Positives = 98/242 (40%), Gaps = 33/242 (13%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTA 90
           P+  F      LGK  G G++ +VV A+ +             A+K++      K+    
Sbjct: 28  PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 87
Query: 91  YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------- 139
             ++E + +    H  ++ L         LY+ +     G L + + ++           
Sbjct: 88  VSEMEMMKMIG-KHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDI 146
Query: 140 GHLSEDEARF-----YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
             + E++  F      T ++   +EY+ S   IHRD+   N+L+T +  +KIADFG  + 
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
           +         N     K         ++ PE L     T  +D+W+ G  ++++ + G S
Sbjct: 207 IN--------NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 254 PF 255
           P+
Sbjct: 259 PY 260

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/248 (22%), Positives = 105/248 (42%), Gaps = 40/248 (16%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTG-----TVYALKIMDKKFITKENKTAYV 92
           P+  F  ++  LGK  G G + KVV+A           T  A+K++ +     E +    
Sbjct: 16  PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLS 75
Query: 93  KLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSK---GHLSE--- 144
           +    VL Q++HP V++L+        L + +E  + G L  F + + K   G+L     
Sbjct: 76  EFN--VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 145 ---------DEARF-------YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIAD 188
                    DE          +  ++   ++Y+  M L+HRD+   N+L+     +KI+D
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISD 193
Query: 189 FGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQM 248
           FG  + + +    V        K         ++  E L     T  +D+W+ G  L+++
Sbjct: 194 FGLSRDVYEEDSXV--------KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 249 LS-GTSPF 255
           ++ G +P+
Sbjct: 246 VTLGGNPY 253

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/190 (24%), Positives = 80/190 (42%), Gaps = 26/190 (13%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFY---- 150
           E  ++ +L H  +V+L+    +   +Y+  E    G L D       L + E R      
Sbjct: 54  EAQIMKKLKHDKLVQLYAVVSEE-PIYIVTEYMNKGSLLD------FLKDGEGRALKLPN 106
Query: 151 ----TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNA 206
                A+V   + YI  M  IHRD++  N+L+      KIADFG  + ++D+  T    A
Sbjct: 107 LVDMAAQVAAGMAYIERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGA 166
Query: 207 ASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQ 265
               K         +  PE       T  +D+W+ G  L ++++ G  P+   +   + +
Sbjct: 167 KFPIK---------WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLE 217
Query: 266 RIIARDIRFP 275
           + + R  R P
Sbjct: 218 Q-VERGYRMP 226

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 107 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 164
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++Y+ S 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 152
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL------ 206
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 277
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 261

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 95/231 (41%), Gaps = 33/231 (14%)
Query: 49  LGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
           LGK  G G++ +VV A+ I       +  T  A+K++      K+      ++E + +  
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG----------------HLSED 145
             H  ++ L         LY+ +E    G L + + ++                  LS  
Sbjct: 92  -KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSK 150
Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
           +      +V   +EY+ S   IHRD+   N+L+T D  +KIADFG  + +         +
Sbjct: 151 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH--------H 202
Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                K         ++ PE L     T  +D+W+ G  L+++ + G SP+
Sbjct: 203 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 107 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 164
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++Y+ S 
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 151
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL------ 205
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 277
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 206 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 260

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/262 (22%), Positives = 113/262 (43%), Gaps = 28/262 (10%)
Query: 21  STNCPT----VQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALK 76
           +T CPT     Q     A+  P+E   + + +LG+    G + +V       T  V A+K
Sbjct: 244 TTVCPTSKPQTQGLAKDAWEIPRESLRL-EVKLGQ----GCFGEVWMGTWNGTTRV-AIK 297
Query: 77  IMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI 136
            +    ++ E   A+++ E  V+ +L H  +V+L+    +   +Y+  E    G L D +
Sbjct: 298 TLKPGTMSPE---AFLQ-EAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFL 352
Query: 137 TSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
             +   +L   +     A++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + 
Sbjct: 353 KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 412
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
           ++D+  T    A    K         +  PE       T  +D+W+ G  L ++ + G  
Sbjct: 413 IEDNEYTARQGAKFPIK---------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 463
Query: 254 PFKDTSEWLIFQRIIARDIRFP 275
           P+       +  + + R  R P
Sbjct: 464 PYPGMVNREVLDQ-VERGYRMP 484

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 25  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 84
Query: 107 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 164
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++Y+ S 
Sbjct: 85  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 144
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 145 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL------ 198
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 277
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 199 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 253

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 52  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 111
Query: 107 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 164
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++Y+ S 
Sbjct: 112 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 171
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 172 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL------ 225
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 277
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 226 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 280

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/242 (21%), Positives = 98/242 (40%), Gaps = 33/242 (13%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTA 90
           P+  F      LGK  G G++ +VV A+ +             A+K++      K+    
Sbjct: 28  PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 87
Query: 91  YVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----------- 139
             ++E + +    H  ++ L         LY+ +     G L + + ++           
Sbjct: 88  VSEMEMMKMIG-KHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDI 146
Query: 140 GHLSEDEARF-----YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
             + E++  F      T ++   +EY+ S   IHRD+   N+L+T +  +KIADFG  + 
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
           +         N     K         ++ PE L     T  +D+W+ G  ++++ + G S
Sbjct: 207 IN--------NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 254 PF 255
           P+
Sbjct: 259 PY 260

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 107/242 (44%), Gaps = 27/242 (11%)
Query: 21  STNCPT----VQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALK 76
           +T CPT     Q     A+  P+E   + + +LG+    G + +V       T  V A+K
Sbjct: 161 TTVCPTSKPQTQGLAKDAWEIPRESLRL-EVKLGQ----GCFGEVWMGTWNGTTRV-AIK 214
Query: 77  IMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI 136
            +    ++ E   A+++ E  V+ +L H  +V+L+    +   +Y+  E    G L D +
Sbjct: 215 TLKPGTMSPE---AFLQ-EAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFL 269
Query: 137 TSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
             +   +L   +     A++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + 
Sbjct: 270 KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 329
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
           ++D+  T    A    K         +  PE       T  +D+W+ G  L ++ + G  
Sbjct: 330 IEDNEYTARQGAKFPIK---------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 380
Query: 254 PF 255
           P+
Sbjct: 381 PY 382

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 107 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 164
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++Y+ S 
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 149
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL------ 203
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 277
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 258

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 107/242 (44%), Gaps = 27/242 (11%)
Query: 21  STNCPT----VQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALK 76
           +T CPT     Q     A+  P+E   + + +LG+    G + +V       T  V A+K
Sbjct: 161 TTVCPTSKPQTQGLAKDAWEIPRESLRL-EVKLGQ----GCFGEVWMGTWNGTTRV-AIK 214
Query: 77  IMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI 136
            +    ++ E   A+++ E  V+ +L H  +V+L+    +   +Y+  E    G L D +
Sbjct: 215 TLKPGTMSPE---AFLQ-EAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFL 269
Query: 137 TSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
             +   +L   +     A++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + 
Sbjct: 270 KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 329
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
           ++D+  T    A    K         +  PE       T  +D+W+ G  L ++ + G  
Sbjct: 330 IEDNEYTARQGAKFPIK---------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 380
Query: 254 PF 255
           P+
Sbjct: 381 PY 382

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 107 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 164
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++Y+ S 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 152
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL------ 206
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 277
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 261

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/248 (22%), Positives = 105/248 (42%), Gaps = 40/248 (16%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTG-----TVYALKIMDKKFITKENKTAYV 92
           P+  F  ++  LGK  G G + KVV+A           T  A+K++ +     E +    
Sbjct: 16  PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLS 75
Query: 93  KLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSK---GHLSE--- 144
           +    VL Q++HP V++L+        L + +E  + G L  F + + K   G+L     
Sbjct: 76  EFN--VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 145 ---------DEARF-------YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIAD 188
                    DE          +  ++   ++Y+  M L+HRD+   N+L+     +KI+D
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISD 193
Query: 189 FGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQM 248
           FG  + + +    V        K         ++  E L     T  +D+W+ G  L+++
Sbjct: 194 FGLSRDVYEEDSXV--------KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 249 LS-GTSPF 255
           ++ G +P+
Sbjct: 246 VTLGGNPY 253

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 95/231 (41%), Gaps = 33/231 (14%)
Query: 49  LGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
           LGK  G G++ +VV A+ I       +  T  A+K++      K+      ++E + +  
Sbjct: 73  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG----------------HLSED 145
             H  ++ L         LY+ +E    G L + + ++                  LS  
Sbjct: 133 -KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
           +      +V   +EY+ S   IHRD+   N+L+T D  +KIADFG  + +         +
Sbjct: 192 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH--------H 243
Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                K         ++ PE L     T  +D+W+ G  L+++ + G SP+
Sbjct: 244 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 294

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 107 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 164
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++Y+ S 
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 147
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL------ 201
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 277
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 256

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 107 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 164
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++Y+ S 
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 150
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL------ 204
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 277
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 205 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 259

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 94/218 (43%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L M L     G L D +   K ++       +  ++   + Y+
Sbjct: 80  NPHVCRLLGICLTSTVQLIMQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 137
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 138 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 186
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 187 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 224

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 94/218 (43%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L M L     G L D +   K ++       +  ++   + Y+
Sbjct: 77  NPHVCRLLGICLTSTVQLIMQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 134
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 135 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 183
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 184 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 221

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 94/218 (43%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L M L     G L D +   K ++       +  ++   + Y+
Sbjct: 78  NPHVCRLLGICLTSTVQLIMQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 136 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 184
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 74/164 (45%), Gaps = 13/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTA 152
           E  V+ +L H  +V+L+    +   +Y+ +E    G L D +  +   +L   +     A
Sbjct: 63  EAQVMKKLRHEKLVQLYAVVSEE-PIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + ++D+  T    A    K 
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 180
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE       T  +D+W+ G  L ++ + G  P+
Sbjct: 181 --------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 74/164 (45%), Gaps = 13/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTA 152
           E  V+ +L H  +V+L+    +   +Y+ +E    G L D +  +   +L   +     A
Sbjct: 63  EAQVMKKLRHEKLVQLYAVVSEE-PIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + ++D+  T    A    K 
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIK- 180
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE       T  +D+W+ G  L ++ + G  P+
Sbjct: 181 --------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 94/218 (43%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L M L     G L D +   K ++       +  ++   + Y+
Sbjct: 79  NPHVCRLLGICLTSTVQLIMQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 136
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 137 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 185
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 223

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/228 (20%), Positives = 96/228 (42%), Gaps = 29/228 (12%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLER--IVLDQ 101
           + E  K  G G +  V + + +   +V A+K  I+       E    + + +R   ++  
Sbjct: 20  EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF-YTAEVVDALEY 160
           L+HP +V+L+    +   + M    C  G+L+ ++  K H  +   +     ++   +EY
Sbjct: 80  LNHPNIVKLYGLMHNPPRMVMEFVPC--GDLYHRLLDKAHPIKWSVKLRLMLDIALGIEY 137
Query: 161 IHSMG--LIHRDIKPENLLL-----TADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           + +    ++HRD++  N+ L      A    K+ADFG              +  S     
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL-------------SQQSVHSVS 184
Query: 214 TFVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTS 259
             +G   ++ PE + +   ++    D ++    LY +L+G  PF + S
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 94/218 (43%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L M L     G L D +   K ++       +  ++   + Y+
Sbjct: 76  NPHVCRLLGICLTSTVQLIMQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 182
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/168 (23%), Positives = 75/168 (44%), Gaps = 19/168 (11%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAE 153
           E  ++ Q DHP ++RL           +  E  E G L   + T  G  +  +       
Sbjct: 100 EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRG 159
Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           V   + Y+  +G +HRD+   N+L+ ++   K++DFG  + ++D      P+AA      
Sbjct: 160 VGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD-----PDAA------ 208
Query: 214 TFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
            +  T   +P     PE +     +  +D+W+ G  ++++L+ G  P+
Sbjct: 209 -YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY 255

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/248 (22%), Positives = 105/248 (42%), Gaps = 40/248 (16%)
Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTG-----TVYALKIMDKKFITKENKTAYV 92
           P+  F  ++  LGK  G G + KVV+A           T  A+K++ +     E +    
Sbjct: 16  PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLS 75
Query: 93  KLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL--FDQITSK---GHLSE--- 144
           +    VL Q++HP V++L+        L + +E  + G L  F + + K   G+L     
Sbjct: 76  EFN--VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 145 ---------DEARF-------YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIAD 188
                    DE          +  ++   ++Y+  M L+HRD+   N+L+     +KI+D
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISD 193
Query: 189 FGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQM 248
           FG  + + +    V        K         ++  E L     T  +D+W+ G  L+++
Sbjct: 194 FGLSRDVYEEDSYV--------KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 249 LS-GTSPF 255
           ++ G +P+
Sbjct: 246 VTLGGNPY 253

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 26/102 (25%), Positives = 46/102 (45%), Gaps = 7/102 (6%)
Query: 149 FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 208
            +  ++ + + Y+H+   IHR +   N+LL  D  +KI DFG  K + +           
Sbjct: 116 LFAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 175
Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS 250
           D           +  PE L      + +D+W+ G TLY++L+
Sbjct: 176 DS-------PVFWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 52/129 (40%), Gaps = 32/129 (24%)
Query: 147 ARFYTAEVVDALEYIHSMGLIHRDIKPENLLL-------------------TADGHIKIA 187
            R    ++  AL ++H   L H D+KPEN+L                      +  I++A
Sbjct: 134 VRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 193
Query: 188 DFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQ 247
           DFGS     +   T+             V T  Y PPEV+         D+W++GC L++
Sbjct: 194 DFGSATFDHEHHTTI-------------VATRHYRPPEVILELGWAQPCDVWSIGCILFE 240
Query: 248 MLSGTSPFK 256
              G + F+
Sbjct: 241 YYRGFTLFQ 249

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 107 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 164
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++++ S 
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 211
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL------ 265
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 277
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 320

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 26/102 (25%), Positives = 46/102 (45%), Gaps = 7/102 (6%)
Query: 149 FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 208
            +  ++ + + Y+H+   IHR +   N+LL  D  +KI DFG  K + +           
Sbjct: 115 LFAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 174
Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS 250
           D           +  PE L      + +D+W+ G TLY++L+
Sbjct: 175 DS-------PVFWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 115/246 (46%), Gaps = 29/246 (11%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDT---GTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
           + +E+    G G++ +VV+   +D    G   ALKI+  K + K  + A  +LE  VL++
Sbjct: 33  ERYEIVSTLGEGTFGRVVQC--VDHRRGGARVALKII--KNVEKYKEAA--RLEINVLEK 86
Query: 102 LDHPG------VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSE--DEARFYTAE 153
           ++          V++F  F     + ++ E   G   FD +    +L     + R    +
Sbjct: 87  INEKDPDNKNLCVQMFDWFDYHGHMCISFELL-GLSTFDFLKDNNYLPYPIHQVRHMAFQ 145
Query: 154 VVDALEYIHSMGLIHRDIKPENLL-LTADGHI-----KIADFGSVKPMQDSRITVLPNAA 207
           +  A++++H   L H D+KPEN+L + +D  +     K  D  SVK     R+    +A 
Sbjct: 146 LCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTA-VRVVDFGSAT 204
Query: 208 SD-DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK--DTSEWL-I 263
            D +   T V T  Y  PEV+     +   D+W++GC +++   G + F+  D  E L +
Sbjct: 205 FDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAM 264
Query: 264 FQRIIA 269
            +RI+ 
Sbjct: 265 MERILG 270

>pdb|1W1D|A Chain A, Crystal Structure Of The Pdk1 Pleckstrin Homology (Ph) Domain Bound To Inositol (1,3,4,5)-Tetrakisphosphate Length = 151

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 50/99 (50%), Gaps = 4/99 (4%)
Query: 388 WQQFLDPGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSND 447
           W QF++    +L +  V K + L +++ QL+LT  P L YVDP   V+KG I W   S +
Sbjct: 43  WHQFVE-NNLILKMGPVDKRKGLFARRRQLLLTEGPHLYYVDPVNKVLKGEIPW---SQE 98
Query: 448 LSIQVSSPSHFKIVTPKKVLSFEDAKQRASQWKKAIEAL 486
           L  +  +   F + TP +     D    A +W + I+ +
Sbjct: 99  LRPEAKNFKTFFVHTPNRTYYLMDPSGNAHKWCRKIQEV 137

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 52/129 (40%), Gaps = 32/129 (24%)
Query: 147 ARFYTAEVVDALEYIHSMGLIHRDIKPENLLL-------------------TADGHIKIA 187
            R    ++  AL ++H   L H D+KPEN+L                      +  I++A
Sbjct: 157 VRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 216
Query: 188 DFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQ 247
           DFGS     +   T+             V T  Y PPEV+         D+W++GC L++
Sbjct: 217 DFGSATFDHEHHTTI-------------VATRHYRPPEVILELGWAQPCDVWSIGCILFE 263
Query: 248 MLSGTSPFK 256
              G + F+
Sbjct: 264 YYRGFTLFQ 272

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 52/129 (40%), Gaps = 32/129 (24%)
Query: 147 ARFYTAEVVDALEYIHSMGLIHRDIKPENLLL-------------------TADGHIKIA 187
            R    ++  AL ++H   L H D+KPEN+L                      +  I++A
Sbjct: 125 VRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184
Query: 188 DFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQ 247
           DFGS     +   T+             V T  Y PPEV+         D+W++GC L++
Sbjct: 185 DFGSATFDHEHHTTI-------------VATRHYRPPEVILELGWAQPCDVWSIGCILFE 231
Query: 248 MLSGTSPFK 256
              G + F+
Sbjct: 232 YYRGFTLFQ 240

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 38  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 97
Query: 107 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 164
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++++ S 
Sbjct: 98  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 157
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 158 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL------ 211
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 277
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 212 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 266

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 74/164 (45%), Gaps = 13/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTA 152
           E  V+ +L H  +V+L+    +   +Y+ +E    G L D +  +   +L   +     A
Sbjct: 63  EAQVMKKLRHEKLVQLYAVVSEE-PIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + ++D+  T    A    K 
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 180
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE       T  +D+W+ G  L ++ + G  P+
Sbjct: 181 --------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 74/164 (45%), Gaps = 13/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTA 152
           E  V+ +L H  +V+L+    +   +Y+  E    G L D +  +   +L   +    +A
Sbjct: 60  EAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSA 118
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + ++D+  T    A    K 
Sbjct: 119 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 177
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE       T  +D+W+ G  L ++ + G  P+
Sbjct: 178 --------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 213

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 97/238 (40%), Gaps = 35/238 (14%)
Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +  +L K  G G + +V  A   +  T  A+K M    ++ E   A    E  V+  L H
Sbjct: 182 ESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVEAFLA----EANVMKTLQH 236
Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF--YTAEVVDALEYIH 162
             +V+L         +Y+  E    G L D + S     +   +   ++A++ + + +I 
Sbjct: 237 DKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 295
Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA--- 219
               IHRD++  N+L++A    KIADFG  +                      VG     
Sbjct: 296 QRNYIHRDLRAANILVSASLVCKIADFGLAR----------------------VGAKFPI 333
Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRFPN 276
            +  PE +N    T  +D+W+ G  L ++++ G  P+   S   +  R + R  R P 
Sbjct: 334 KWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI-RALERGYRMPR 390

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 107 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 164
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++++ S 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 152
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL------ 206
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 277
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 261

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 107/242 (44%), Gaps = 27/242 (11%)
Query: 21  STNCPT----VQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALK 76
           +T CPT     Q     A+  P+E   + + +LG+    G + +V       T  V A+K
Sbjct: 161 TTVCPTSKPQTQGLAKDAWEIPRESLRL-EVKLGQ----GCFGEVWMGTWNGTTRV-AIK 214
Query: 77  IMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI 136
            +    ++ E   A+++ E  V+ +L H  +V+L+    +   +Y+  E    G L D +
Sbjct: 215 TLKPGTMSPE---AFLQ-EAQVMKKLRHEKLVQLYAVVSEE-PIYIVGEYMSKGSLLDFL 269
Query: 137 TSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
             +   +L   +     A++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + 
Sbjct: 270 KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 329
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
           ++D+  T    A    K         +  PE       T  +D+W+ G  L ++ + G  
Sbjct: 330 IEDNEYTARQGAKFPIK---------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 380
Query: 254 PF 255
           P+
Sbjct: 381 PY 382

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 74/164 (45%), Gaps = 13/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTA 152
           E  V+ +L H  +V+L+    +   +Y+  E    G L D +  +   +L   +    +A
Sbjct: 60  EAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSA 118
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + ++D+  T    A    K 
Sbjct: 119 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIK- 177
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE       T  +D+W+ G  L ++ + G  P+
Sbjct: 178 --------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 213

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 13/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTA 152
           E  V+ +L H  +V+L+    +   +Y+  E    G L D +  +   +L   +     A
Sbjct: 63  EAQVMKKLRHEKLVQLYAVVSEE-PIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + ++D+  T    A    K 
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 180
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE       T  +D+W+ G  L ++ + G  P+
Sbjct: 181 --------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 107 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 164
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++++ S 
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 153
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL------ 207
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 277
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 208 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 262

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 107 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 164
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++++ S 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 152
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL------ 206
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 277
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 261

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/163 (22%), Positives = 72/163 (44%), Gaps = 9/163 (5%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAE 153
           E  ++ Q DHP ++RL           +  E  E G L   + T  G  +  +       
Sbjct: 100 EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRG 159
Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           V   + Y+  +G +HRD+   N+L+ ++   K++DFG  + ++D      P+AA      
Sbjct: 160 VGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD-----PDAAXTTTGG 214
Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                  +  PE +     +  +D+W+ G  ++++L+ G  P+
Sbjct: 215 KI--PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY 255

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 107 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 164
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++++ S 
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 150
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL------ 204
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 277
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 205 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 259

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 88/203 (43%), Gaps = 28/203 (13%)
Query: 75  LKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL---FFTFQD--TFSLYMALESCE- 128
           + I+   F+ K      V  E  +L+   HP ++ L   F  F++     LY+  E    
Sbjct: 64  VNILSDSFLCKR-----VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT 118
Query: 129 --GGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
                + DQ   +  +S    +++   ++  L  +H  G++HRD+ P N+LL  +  I I
Sbjct: 119 DLAQVIHDQ---RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI 175
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE-VLNSSPATFGNDLWALGCTL 245
            DF   +  +D+         +D     +V    Y  PE V+     T   D+W+ GC +
Sbjct: 176 CDFNLAR--EDT---------ADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVM 224
Query: 246 YQMLSGTSPFKDTSEWLIFQRII 268
            +M +  + F+ ++ +    +I+
Sbjct: 225 AEMFNRKALFRGSTFYNQLNKIV 247

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 88/203 (43%), Gaps = 28/203 (13%)
Query: 75  LKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL---FFTFQD--TFSLYMALESCE- 128
           + I+   F+ K      V  E  +L+   HP ++ L   F  F++     LY+  E    
Sbjct: 64  VNILSDSFLCKR-----VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT 118
Query: 129 --GGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
                + DQ   +  +S    +++   ++  L  +H  G++HRD+ P N+LL  +  I I
Sbjct: 119 DLAQVIHDQ---RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI 175
Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE-VLNSSPATFGNDLWALGCTL 245
            DF   +  +D+         +D     +V    Y  PE V+     T   D+W+ GC +
Sbjct: 176 CDFNLAR--EDT---------ADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVM 224
Query: 246 YQMLSGTSPFKDTSEWLIFQRII 268
            +M +  + F+ ++ +    +I+
Sbjct: 225 AEMFNRKALFRGSTFYNQLNKIV 247

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/235 (20%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 48  ELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
              ++ G G +  V     +D  G      +     IT   + +    E I++    HP 
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 107 VVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 164
           V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++++ S 
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 153
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
             +HRD+   N +L     +K+ADFG  + M D     + N         ++        
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMAL------ 207
Query: 225 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 277
           E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y
Sbjct: 208 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 262

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 13/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTA 152
           E  V+ +L H  +V+L+    +   +Y+  E    G L D +  +   +L   +     A
Sbjct: 54  EAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 112
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + ++D+  T    A    K 
Sbjct: 113 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 171
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE       T  +D+W+ G  L ++ + G  P+
Sbjct: 172 --------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 207

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 13/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTA 152
           E  V+ +L H  +V+L+    +   +Y+  E    G L D +  +   +L   +     A
Sbjct: 63  EAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + ++D+  T    A    K 
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 180
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE       T  +D+W+ G  L ++ + G  P+
Sbjct: 181 --------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 13/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTA 152
           E  V+ +L H  +V+L+    +   +Y+  E    G L D +  +   +L   +     A
Sbjct: 52  EAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 110
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + ++D+  T    A    K 
Sbjct: 111 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 169
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE       T  +D+W+ G  L ++ + G  P+
Sbjct: 170 --------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 205

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 13/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTA 152
           E  V+ +L H  +V+L+    +   +Y+  E    G L D +  +   +L   +     A
Sbjct: 56  EAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 114
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + ++D+  T    A    K 
Sbjct: 115 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 173
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE       T  +D+W+ G  L ++ + G  P+
Sbjct: 174 --------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 209

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/242 (22%), Positives = 106/242 (43%), Gaps = 23/242 (9%)
Query: 17  NNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALK 76
            N   T+ P  Q     A+  P+E   + + +LG+    G + +V       T  V A+K
Sbjct: 162 TNVCPTSKPQTQGLAKDAWEIPRESLRL-EVKLGQ----GCFGEVWMGTWNGTTRV-AIK 215
Query: 77  IMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI 136
            +    ++ E   A+++ E  V+ +L H  +V+L+    +   +Y+  E    G L D +
Sbjct: 216 TLKPGNMSPE---AFLQ-EAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFL 270
Query: 137 TSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
             +   +L   +     A++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + 
Sbjct: 271 KGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLGRL 330
Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
           ++D+  T    A    K         +  PE       T  +D+W+ G  L ++ + G  
Sbjct: 331 IEDNEYTARQGAKFPIK---------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 381
Query: 254 PF 255
           P+
Sbjct: 382 PY 383

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 92/218 (42%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTG--TVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +F+  K+ G G++  V +   I  G      + IM+ +  T       +  E  V+  +D
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVD 109
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L   L     G L D +   K ++       +  ++   + Y+
Sbjct: 110 NPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 167
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 168 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 216
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 217 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 254

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 86/210 (40%), Gaps = 23/210 (10%)
Query: 50  GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVR 109
           G   G G +  VV    ++  TV   K+     IT E        E  V+ +  H  +V 
Sbjct: 36  GNKMGEGGFG-VVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 94
Query: 110 LFFTFQDTFSLYMALESCEGGELFDQITSKG-------HLSEDEARFYTAE-VVDALEYI 161
           L     D   L +       G L D+++          H+     R   A+   + + ++
Sbjct: 95  LLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM-----RCKIAQGAANGINFL 149
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H    IHRDIK  N+LL      KI+DFG  +  +    TV+ +          VGT AY
Sbjct: 150 HENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXS--------RIVGTTAY 201
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSG 251
           + PE L     T  +D+++ G  L ++++G
Sbjct: 202 MAPEALRGE-ITPKSDIYSFGVVLLEIITG 230

>pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 91/219 (41%), Gaps = 18/219 (8%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL--- 102
           +F +GK  G G++ ++   K + T    A+K+   K     ++   + LE     QL   
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMK-----SRAPQLHLEYRFYKQLGSG 64
Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           D    V  F       ++ + L      +LFD        S         +++  +EY+H
Sbjct: 65  DGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRT--FSLKTVLMIAIQLISRMEYVH 122
Query: 163 SMGLIHRDIKPENLLLTADGH-----IKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           S  LI+RD+KPEN L+   G+     I I DFG  K   D   T       + K+ T  G
Sbjct: 123 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFGLAKEYIDPE-TKKHIPYREHKSLT--G 179
Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK 256
           TA Y+          +  +DL ALG      L G+ P++
Sbjct: 180 TARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQ 218

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/218 (21%), Positives = 93/218 (42%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L   L     G L D +   K ++       +  ++   + Y+
Sbjct: 78  NPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 136 EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL-----------GAEEKEYHAEGGKVP 184
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/257 (23%), Positives = 100/257 (38%), Gaps = 55/257 (21%)
Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVY-ALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           +E+    G G++ KVV       G  + A+KI+       +N   Y +  R  +  L+H 
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV-------KNVDRYCEAARSEIQVLEHL 68
Query: 106 G---------VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHL--SEDEARFYTAEV 154
                      V++   F+    + +  E   G   +D I   G L    D  R    ++
Sbjct: 69  NTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQI 127
Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGH-------------------IKIADFGSVKPM 195
             ++ ++HS  L H D+KPEN+L     +                   IK+ DFGS    
Sbjct: 128 CKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--- 184
Query: 196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTS-- 253
                        D+   T V    Y  PEV+ +   +   D+W++GC L +   G +  
Sbjct: 185 ----------TYDDEHHSTLVXXRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234
Query: 254 PFKDTSEWL-IFQRIIA 269
           P  D+ E L + +RI+ 
Sbjct: 235 PTHDSKEHLAMMERILG 251

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/218 (21%), Positives = 93/218 (42%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L   L     G L D +   K ++       +  ++   + Y+
Sbjct: 76  NPHVCRLLGICLTSTVQLITQLMPF--GXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 182
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/218 (21%), Positives = 93/218 (42%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L   L     G L D +   K ++       +  ++   + Y+
Sbjct: 83  NPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 140
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 141 EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL-----------GAEEKEYHAEGGKVP 189
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 227

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/218 (21%), Positives = 93/218 (42%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L   L     G L D +   K ++       +  ++   + Y+
Sbjct: 76  NPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL-----------GAEEKEYHAEGGKVP 182
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 85/210 (40%), Gaps = 23/210 (10%)
Query: 50  GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVR 109
           G   G G +  VV    ++  TV   K+     IT E        E  V+ +  H  +V 
Sbjct: 36  GNKMGEGGFG-VVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 94
Query: 110 LFFTFQDTFSLYMALESCEGGELFDQITSKG-------HLSEDEARFYTAE-VVDALEYI 161
           L     D   L +       G L D+++          H+     R   A+   + + ++
Sbjct: 95  LLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM-----RCKIAQGAANGINFL 149
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H    IHRDIK  N+LL      KI+DFG  +  +    TV+            VGT AY
Sbjct: 150 HENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXX--------RIVGTTAY 201
Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSG 251
           + PE L     T  +D+++ G  L ++++G
Sbjct: 202 MAPEALRGE-ITPKSDIYSFGVVLLEIITG 230

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/218 (21%), Positives = 94/218 (43%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L   L     G L D +   K ++       +  ++ + + Y+
Sbjct: 73  NPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYL 130
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 131 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 179
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 180 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 217

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 42/190 (22%), Positives = 73/190 (38%), Gaps = 25/190 (13%)
Query: 94  LERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEAR----- 148
           +E +++ + +H  +VR       +   ++ LE   GG+L      K  L E   R     
Sbjct: 83  MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDL------KSFLRETRPRPSQPS 136
Query: 149 --------FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 200
                       ++    +Y+     IHRDI   N LLT  G  ++A  G     QD   
Sbjct: 137 SLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQD--- 193
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
             +  A+   K    +    ++PPE       T   D W+ G  L+++ S G  P+   S
Sbjct: 194 --IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 251
Query: 260 EWLIFQRIIA 269
              + + + +
Sbjct: 252 NQEVLEFVTS 261

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 13/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTA 152
           E  V+ +L H  +V+L+    +   +Y+  E    G L D +  +   +L   +     A
Sbjct: 63  EAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + ++D+  T    A    K 
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 180
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE       T  +D+W+ G  L ++ + G  P+
Sbjct: 181 --------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 37/164 (22%), Positives = 73/164 (44%), Gaps = 13/164 (7%)
Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTA 152
           E  V+ ++ H  +V+L+    +   +Y+  E    G L D +  +   +L   +     A
Sbjct: 63  EAQVMKKIRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           ++   + Y+  M  +HRD++  N+L+  +   K+ADFG  + ++D+  T    A    K 
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 180
Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                   +  PE       T  +D+W+ G  L ++ + G  P+
Sbjct: 181 --------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/217 (22%), Positives = 90/217 (41%), Gaps = 29/217 (13%)
Query: 51  KIYGVGSYSKVVRAKKIDTG----TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           K+ G G++  V +   I  G       A+K++ +    K NK   +  E  V+  +  P 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKE--ILDEAYVMAGVGSPY 80
Query: 107 VVRLF-FTFQDTFSLYMALESCEGGELFDQIT-SKGHLSEDEARFYTAEVVDALEYIHSM 164
           V RL       T  L   L     G L D +  ++G L   +   +  ++   + Y+  +
Sbjct: 81  VSRLLGICLTSTVQLVTQLMPY--GCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDV 138
Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP- 223
            L+HRD+   N+L+ +  H+KI DFG  + +             D     +      VP 
Sbjct: 139 RLVHRDLAARNVLVKSPNHVKITDFGLARLL-------------DIDETEYHADGGKVPI 185
Query: 224 ----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                E +     T  +D+W+ G T++++++ G  P+
Sbjct: 186 KWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPY 222

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/190 (22%), Positives = 74/190 (38%), Gaps = 25/190 (13%)
Query: 94  LERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEAR----- 148
           +E +++ +L+H  +VR       +   ++ LE   GG+L      K  L E   R     
Sbjct: 83  MEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDL------KSFLRETRPRPSQPS 136
Query: 149 --------FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 200
                       ++    +Y+     IHRDI   N LLT  G  ++A  G     +D   
Sbjct: 137 SLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--- 193
Query: 201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
             +  A+   K    +    ++PPE       T   D W+ G  L+++ S G  P+   S
Sbjct: 194 --IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 251
Query: 260 EWLIFQRIIA 269
              + + + +
Sbjct: 252 NQEVLEFVTS 261

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/218 (21%), Positives = 93/218 (42%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 81
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L   L     G L D +   K ++       +  ++   + Y+
Sbjct: 82  NPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 139
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 140 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 188
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 189 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 226

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/241 (21%), Positives = 97/241 (40%), Gaps = 39/241 (16%)
Query: 40  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-- 97
           +H   +D  L +  G G++ KV  A+  +        ++  K +      A    +R   
Sbjct: 10  QHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAE 69
Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI----------------TSKGH 141
           +L  L H  +V+ +    D   L M  E  + G+L   +                 +KG 
Sbjct: 70  LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 129
Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS--- 198
           L   +     +++   + Y+ S   +HRD+   N L+ A+  +KI DFG  + +  +   
Sbjct: 130 LGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY 189
Query: 199 RI---TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSP 254
           R+   T+LP                ++PPE +     T  +D+W+ G  L+++ + G  P
Sbjct: 190 RVGGHTMLP--------------IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
Query: 255 F 255
           +
Sbjct: 236 W 236

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/218 (21%), Positives = 93/218 (42%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L   L     G L D +   K ++       +  ++   + Y+
Sbjct: 86  NPHVCRLLGICLTSTVQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 143
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 144 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 192
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 193 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 230

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/218 (21%), Positives = 93/218 (42%), Gaps = 21/218 (9%)
Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +F+  K+   G++  V +   I  G    + +  K+     +  A  ++  E  V+  +D
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 104 HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYI 161
           +P V RL       T  L M L     G L D +   K ++       +  ++   + Y+
Sbjct: 83  NPHVCRLLGICLTSTVQLIMQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 140
Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA- 220
               L+HRD+   N+L+    H+KI DFG  K +            +++K     G    
Sbjct: 141 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GAEEKEYHAEGGKVP 189
Query: 221 --YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             ++  E +     T  +D+W+ G T++++++ G+ P+
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 227
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	489
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-141
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-111
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-108
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-104
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-104
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-103
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-102
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-102
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-101
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-101
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-101
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-101
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-101
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-101
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-100
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-99
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-99
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-99
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-99
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-98
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-97
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-97
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-96
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-96
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-90
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-89
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-88
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-84
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-84
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-84
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-81
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-81
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	9e-81
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-80
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	8e-79
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-78
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-78
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-78
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-78
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-78
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	6e-78
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-77
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-77
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-77
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-76
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-76
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-76
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-76
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	5e-76
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	7e-76
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	7e-76
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	7e-76
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	8e-76
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-75
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-75
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-75
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-75
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-75
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-74
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-74
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-74
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-74
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-73
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-73
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-73
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	6e-73
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-72
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-72
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	6e-72
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-72
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-72
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-72
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	7e-72
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	8e-72
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-71
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-71
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-71
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	8e-71
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-70
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	9e-70
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	6e-69
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-68
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-67
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	8e-67
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-66
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-66
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-65
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-65
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	7e-65
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	9e-65
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-63
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-62
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-60
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-58
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-57
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-56
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-55
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	8e-52
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	9e-08
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-50
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-49
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-47
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-46
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-46
2dyl_A	318	Dual specificity mitogen-activated protein kinase	8e-46
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-45
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	5e-45
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	9e-45
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-44
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-44
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-44
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-44
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	5e-44
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-43
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-43
3aln_A	327	Dual specificity mitogen-activated protein kinase;	6e-43
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	6e-42
3ork_A	311	Serine/threonine protein kinase; structural genomi	7e-42
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-39
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-37
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-37
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	7e-35
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-34
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-34
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-34
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	8e-34
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-33
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-33
3uqc_A	286	Probable conserved transmembrane protein; structur	5e-33
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-32
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-32
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-32
1w1g_A	151	HPDK1, 3-phosphoinositide dependent protein kinase	4e-32
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-32
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-32
3o0g_A	292	Cell division protein kinase 5; kinase activator c	5e-32
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	5e-32
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-31
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-31
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	8e-31
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-30
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-30
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-30
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-30
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	8e-30
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-29
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-29
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-29
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	5e-29
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-29
3rp9_A	458	Mitogen-activated protein kinase; structural genom	5e-29
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-28
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-28
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	8e-28
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	8e-28
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-27
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-27
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-27
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-26
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-26
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-25
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-25
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-25
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-23
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	7e-23
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-22
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-22
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-21
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-20
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-19
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-19
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-19
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	6e-19
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-18
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-18
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-18
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-17
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-17
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-17
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-16
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-16
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-16
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-16
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-16
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-16
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	6e-16
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	9e-16
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-15
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-15
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-15
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-15
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-15
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-15
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	6e-15
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	7e-15
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	7e-15
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	8e-15
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	8e-15
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-14
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-14
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-14
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-14
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-14
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	7e-14
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	8e-14
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	9e-14
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-13
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-13
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-13
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-13
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-13
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-13
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	6e-13
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	7e-13
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-12
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-11
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-11
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-11
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	5e-11
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	6e-11
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-10
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-10
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-10
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	7e-10
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	8e-10
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	9e-10
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-09
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-09
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-09
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-09
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-09
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-09
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-09
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	8e-09
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	8e-09
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-04
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-05

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  406 bits (1047), Expect = e-141
 Identities = 144/317 (45%), Positives = 193/317 (60%), Gaps = 10/317 (3%)

Query: 18  NNSSTNCPTVQRSKSFAFRAPQ-EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALK 76
           + ++        S   A   PQ      +DF+ GKI G GS+S VV A+++ T   YA+K
Sbjct: 2   DGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIK 61

Query: 77  IMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI 136
           I++K+ I KENK  YV  ER V+ +LDHP  V+L+FTFQD   LY  L   + GEL   I
Sbjct: 62  ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI 121

Query: 137 TSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ 196
              G   E   RFYTAE+V ALEY+H  G+IHRD+KPEN+LL  D HI+I DFG+ K   
Sbjct: 122 RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAK--- 178

Query: 197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK 256
                VL   +   +A +FVGTA YV PE+L    A   +DLWALGC +YQ+++G  PF+
Sbjct: 179 -----VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR 233

Query: 257 DTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFK 315
             +E+LIFQ+II  +  FP  F   ARDL+++LL +D + R G     GY  LK HPFF+
Sbjct: 234 AGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 293

Query: 316 GIDWKNIRGQTPPKLAS 332
            + W+N+  QTPPKL +
Sbjct: 294 SVTWENLHQQTPPKLTA 310

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  330 bits (848), Expect = e-111
 Identities = 107/303 (35%), Positives = 172/303 (56%), Gaps = 18/303 (5%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
           +S+QDF++ +  G GS+ +V   +    G  YA+K++ K+ + +  +  +   ER++L  
Sbjct: 3   YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62

Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           + HP ++R++ TFQD   ++M ++  EGGELF  +          A+FY AEV  ALEY+
Sbjct: 63  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 122

Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           HS  +I+RD+KPEN+LL  +GHIKI DFG  K                D   T  GT  Y
Sbjct: 123 HSKDIIYRDLKPENILLDKNGHIKITDFGFAK-------------YVPDVTYTLCGTPDY 169

Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDA 281
           + PEV+++ P     D W+ G  +Y+ML+G +PF D++    +++I+  ++RFP +F++ 
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNED 229

Query: 282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPPKLASEPMVQSG 339
            +DL+ RL+  D S R G    G   +K HP+FK + W+ +  R    P    EP +Q G
Sbjct: 230 VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETP---YEPPIQQG 286

Query: 340 EGD 342
           +GD
Sbjct: 287 QGD 289

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  324 bits (832), Expect = e-108
 Identities = 101/295 (34%), Positives = 156/295 (52%), Gaps = 15/295 (5%)

Query: 36  RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE 95
              Q    +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91

Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
           + +L  ++ P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
              EY+HS+ LI+RD+KPENLL+   G+I++ DFG  K                 +  T 
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-------------RVKGRTWTL 198

Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP 275
            GT   + PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP
Sbjct: 199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP 258

Query: 276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
           ++FS   +DL+  LL VD + R G    G   +K H +F   DW  I  R    P
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAP 313

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  314 bits (806), Expect = e-104
 Identities = 109/305 (35%), Positives = 163/305 (53%), Gaps = 16/305 (5%)

Query: 30  SKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFI-TK 85
           S   +     E    + FEL ++ G G Y KV + +K+   +TG ++A+K++ K  I   
Sbjct: 2   SSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN 61

Query: 86  ENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSED 145
              TA+ K ER +L+++ HP +V L + FQ    LY+ LE   GGELF Q+  +G   ED
Sbjct: 62  AKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMED 121

Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
            A FY AE+  AL ++H  G+I+RD+KPEN++L   GH+K+ DFG  K           +
Sbjct: 122 TACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK----------ES 171

Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQ 265
                   TF GT  Y+ PE+L  S      D W+LG  +Y ML+G  PF   +      
Sbjct: 172 IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID 231

Query: 266 RIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--R 323
           +I+   +  P Y +  ARDL+ +LL  + + R GAGPG    ++ HPFF+ I+W+ +  R
Sbjct: 232 KILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLAR 291

Query: 324 GQTPP 328
              PP
Sbjct: 292 KVEPP 296

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  312 bits (802), Expect = e-104
 Identities = 106/302 (35%), Positives = 165/302 (54%), Gaps = 16/302 (5%)

Query: 32  SFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENK 88
           +   +   E      FEL K+ G GS+ KV   KKI   D   +YA+K++ K  + K   
Sbjct: 11  THHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL-KVRD 69

Query: 89  TAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEAR 148
               K+ER +L +++HP +V+L + FQ    LY+ L+   GG+LF +++ +   +E++ +
Sbjct: 70  RVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVK 129

Query: 149 FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 208
           FY AE+  AL+++HS+G+I+RD+KPEN+LL  +GHIK+ DFG  K           +   
Sbjct: 130 FYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK----------ESIDH 179

Query: 209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII 268
           + KA +F GT  Y+ PEV+N    T   D W+ G  +++ML+GT PF+          I+
Sbjct: 180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL 239

Query: 269 ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQT 326
              +  P + S  A+ L+  L   +P+ R GAGP G   +K H FF  IDW  +  R   
Sbjct: 240 KAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIH 299

Query: 327 PP 328
           PP
Sbjct: 300 PP 301

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  313 bits (803), Expect = e-103
 Identities = 108/315 (34%), Positives = 157/315 (49%), Gaps = 25/315 (7%)

Query: 27  VQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE 86
           +Q ++    R  +      DFE+ K+ G G++S+V   K   TG VYA+KIM+K  + K 
Sbjct: 43  LQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKR 102

Query: 87  NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG-HLSED 145
            + +  + ER VL   D   + +L F FQD   LY+ +E   GG+L   ++  G  +  +
Sbjct: 103 GEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAE 162

Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
            ARFY AE+V A++ +H +G +HRDIKP+N+LL   GHI++ADFGS   +          
Sbjct: 163 MARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKL---------R 213

Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGN-------DLWALGCTLYQMLSGTSPFKDT 258
           A    ++   VGT  Y+ PE+L +     G        D WALG   Y+M  G +PF   
Sbjct: 214 ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD 273

Query: 259 SEWLIFQRIIARDIRFP-----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 313
           S    + +I+                + ARD I RLL   P  R G   GG    + HPF
Sbjct: 274 STAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLL-CPPETRLGR--GGAGDFRTHPF 330

Query: 314 FKGIDWKNIRGQTPP 328
           F G+DW  +R   PP
Sbjct: 331 FFGLDWDGLRDSVPP 345

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  312 bits (802), Expect = e-102
 Identities = 105/313 (33%), Positives = 162/313 (51%), Gaps = 23/313 (7%)

Query: 27  VQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE 86
           ++ +K F  +  Q     +DFE+ K+ G G++ +V   K  +   V+A+KI++K  + K 
Sbjct: 56  LEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKR 115

Query: 87  NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT-SKGHLSED 145
            +TA  + ER VL   D   +  L + FQD  +LY+ ++   GG+L   ++  +  L E+
Sbjct: 116 AETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEE 175

Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
            ARFY AE+V A++ +H +  +HRDIKP+N+L+  +GHI++ADFGS   +          
Sbjct: 176 MARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL---------M 226

Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGN-----DLWALGCTLYQMLSGTSPFKDTSE 260
                ++   VGT  Y+ PE+L +     G      D W+LG  +Y+ML G +PF   S 
Sbjct: 227 EDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 286

Query: 261 WLIFQRIIARDIRFP-----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
              + +I+    RF         S+ A+DLI RL+      R   G  G    K HPFF 
Sbjct: 287 VETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLI-CSREHR--LGQNGIEDFKKHPFFS 343

Query: 316 GIDWKNIRGQTPP 328
           GIDW NIR    P
Sbjct: 344 GIDWDNIRNCEAP 356

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  310 bits (797), Expect = e-102
 Identities = 110/312 (35%), Positives = 158/312 (50%), Gaps = 23/312 (7%)

Query: 27  VQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE 86
           + R K    +        +D+E+ K+ G G++ +V   +   T  VYA+K++ K  + K 
Sbjct: 51  LSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR 110

Query: 87  NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDE 146
           + +A+   ER ++   + P VV+LF+ FQD   LYM +E   GG+L   + S   + E  
Sbjct: 111 SDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKW 169

Query: 147 ARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNA 206
           ARFYTAEVV AL+ IHSMG IHRD+KP+N+LL   GH+K+ADFG+   M         N 
Sbjct: 170 ARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM---------NK 220

Query: 207 ASDDKACTFVGTAAYVPPEVLNSSPATFGN----DLWALGCTLYQMLSGTSPFKDTSEWL 262
               +  T VGT  Y+ PEVL S           D W++G  LY+ML G +PF   S   
Sbjct: 221 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 280

Query: 263 IFQRIIA--RDIRFPN--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID 318
            + +I+     + FP+    S  A++LI   L  D   R   G  G   +K H FFK   
Sbjct: 281 TYSKIMNHKNSLTFPDDNDISKEAKNLICAFL-TDREVR--LGRNGVEEIKRHLFFKNDQ 337

Query: 319 WK--NIRGQTPP 328
           W    +R    P
Sbjct: 338 WAWETLRDTVAP 349

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  306 bits (786), Expect = e-101
 Identities = 105/289 (36%), Positives = 154/289 (53%), Gaps = 12/289 (4%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
            ++ DF+  K+ G G++ KV+  ++  TG  YA+KI+ K+ I  +++ A+   E  VL  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
             HP +  L + FQ    L   +E   GGELF  ++ +   +E+ ARFY AE+V ALEY+
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121

Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           HS  +++RDIK ENL+L  DGHIKI DFG  K             +      TF GT  Y
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCK----------EGISDGATMKTFCGTPEY 171

Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDA 281
           + PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP   S  
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE 231

Query: 282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
           A+ L+  LL  DP  R G GP     +  H FF  I+W+++  +   PP
Sbjct: 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPP 280

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  304 bits (780), Expect = e-101
 Identities = 99/306 (32%), Positives = 143/306 (46%), Gaps = 26/306 (8%)

Query: 34  AFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVK 93
               P+  F+I DF++G+  G G +  V  A++     + ALK++ K  + KE     ++
Sbjct: 3   LAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR 62

Query: 94  LERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 153
            E  +   L HP ++R++  F D   +Y+ LE    GEL+ ++   G   E  +  +  E
Sbjct: 63  REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE 122

Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKA 212
           + DAL Y H   +IHRDIKPENLL+   G +KIADFG SV      R T           
Sbjct: 123 LADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT----------M 172

Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI 272
           C   GT  Y+PPE++         DLW  G   Y+ L G  PF   S     +RI+  D+
Sbjct: 173 C---GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL 229

Query: 273 RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLAS 332
           +FP + SD ++DLI +LL   P  R          +  HP+ K     N R   PP    
Sbjct: 230 KFPPFLSDGSKDLISKLLRYHPPQRLPL-----KGVMEHPWVK----ANSRRVLPP---V 277

Query: 333 EPMVQS 338
               QS
Sbjct: 278 YQSTQS 283

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  312 bits (802), Expect = e-101
 Identities = 88/319 (27%), Positives = 151/319 (47%), Gaps = 21/319 (6%)

Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
            +      F   ++ G G + +V   +   TG +YA K ++KK + K        +E+ +
Sbjct: 179 AQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI 238

Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH----LSEDEARFYTAEV 154
           L ++    +V L + F+    L + +    GG++   I +         E  A FYTA++
Sbjct: 239 LAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI 298

Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           V  LE++H   +I+RD+KPEN+LL  DG+++I+D G                A   K   
Sbjct: 299 VSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV----------ELKAGQTKTKG 348

Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQRIIAR 270
           + GT  ++ PE+L      F  D +ALG TLY+M++   PF+   E +    + QR++ +
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ 408

Query: 271 DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI-RGQTPPK 329
            + +P+ FS A++D  + LL  DP  R G   G    L+ HP F+ I W+ +  G   P 
Sbjct: 409 AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPP 468

Query: 330 LASEPMVQSGEGDDVHDSS 348
               P  ++    ++ D  
Sbjct: 469 F--VPDSRTVYAKNIQDVG 485

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  306 bits (785), Expect = e-101
 Identities = 108/338 (31%), Positives = 173/338 (51%), Gaps = 24/338 (7%)

Query: 5   EKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRA 64
                +    +G +            ++       E   I++FEL K+ G G+Y KV   
Sbjct: 14  SSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLV 73

Query: 65  KKI---DTGTVYALKIMDKKFI-TKENKTAYVKLERIVLDQLDH-PGVVRLFFTFQDTFS 119
           +KI   DTG +YA+K++ K  I  K   T + + ER VL+ +   P +V L + FQ    
Sbjct: 74  RKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133

Query: 120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT 179
           L++ L+   GGELF  ++ +   +E E + Y  E+V ALE++H +G+I+RDIK EN+LL 
Sbjct: 134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD 193

Query: 180 ADGHIKIADFGSVK-PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGN-- 236
           ++GH+ + DFG  K  + D            ++A  F GT  Y+ P+++    +      
Sbjct: 194 SNGHVVLTDFGLSKEFVAD----------ETERAYDFCGTIEYMAPDIVRGGDSGHDKAV 243

Query: 237 DLWALGCTLYQMLSGTSPF----KDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDV 292
           D W+LG  +Y++L+G SPF    +  S+  I +RI+  +  +P   S  A+DLI RLL  
Sbjct: 244 DWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMK 303

Query: 293 DPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
           DP  R G GP     +K H FF+ I+W ++  +    P
Sbjct: 304 DPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAP 341

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  303 bits (778), Expect = e-101
 Identities = 91/290 (31%), Positives = 141/290 (48%), Gaps = 17/290 (5%)

Query: 37  APQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           + +  ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E 
Sbjct: 1   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60

Query: 97  IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD 156
            +   L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 120

Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           AL Y HS  +IHRDIKPENLLL + G +KIADFG       SR T               
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------------DLC 168

Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           GT  Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP+
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 228

Query: 277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQT 326
           + ++ ARDLI RLL  +PS RP         +  HP+      K    Q 
Sbjct: 229 FVTEGARDLISRLLKHNPSQRPML-----REVLEHPWITANSSKPSNCQN 273

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  306 bits (786), Expect = e-101
 Identities = 106/313 (33%), Positives = 161/313 (51%), Gaps = 14/313 (4%)

Query: 19  NSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIM 78
           N++   P     +     +   H    DF   K+ G GS+ KV+ A+       YA+K++
Sbjct: 12  NANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVL 71

Query: 79  DKKFITKENKTAYVKLERIVLDQ-LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT 137
            KK I K+ +  ++  ER VL + + HP +V L F+FQ    LY  L+   GGELF  + 
Sbjct: 72  QKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ 131

Query: 138 SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD 197
            +    E  ARFY AE+  AL Y+HS+ +++RD+KPEN+LL + GHI + DFG  K    
Sbjct: 132 RERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK---- 187

Query: 198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD 257
                  N   +    TF GT  Y+ PEVL+  P     D W LG  LY+ML G  PF  
Sbjct: 188 ------ENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 241

Query: 258 TSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI 317
            +   ++  I+ + ++     +++AR L++ LL  D + R GA    +  +K H FF  I
Sbjct: 242 RNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGA-KDDFMEIKSHVFFSLI 300

Query: 318 DWKNI--RGQTPP 328
           +W ++  +  TPP
Sbjct: 301 NWDDLINKKITPP 313

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  305 bits (783), Expect = e-100
 Identities = 98/306 (32%), Positives = 150/306 (49%), Gaps = 13/306 (4%)

Query: 26  TVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK 85
           T      F     ++   + DF    + G GS+ KV+ +++  T  +YA+KI+ K  + +
Sbjct: 1   TTNTVSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ 60

Query: 86  ENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSE 144
           ++      +E+ VL      P + +L   FQ    LY  +E   GG+L   I   G   E
Sbjct: 61  DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE 120

Query: 145 DEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP 204
             A FY AE+   L ++ S G+I+RD+K +N++L ++GHIKIADFG  K           
Sbjct: 121 PHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK----------E 170

Query: 205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIF 264
           N        TF GT  Y+ PE++   P     D WA G  LY+ML+G +PF+   E  +F
Sbjct: 171 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 230

Query: 265 QRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI-- 322
           Q I+  ++ +P   S  A  +   L+   P  R G GP G   +K H FF+ IDW+ +  
Sbjct: 231 QSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLER 290

Query: 323 RGQTPP 328
           +   PP
Sbjct: 291 KEIQPP 296

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  305 bits (784), Expect = 1e-99
 Identities = 107/313 (34%), Positives = 160/313 (51%), Gaps = 13/313 (4%)

Query: 19  NSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIM 78
           + S +  +       +   P+   ++ +FE  K+ G G++ KV+  K+  TG  YA+KI+
Sbjct: 122 SGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKIL 181

Query: 79  DKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS 138
            K+ I  +++ A+   E  VL    HP +  L ++FQ    L   +E   GGELF  ++ 
Sbjct: 182 KKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR 241

Query: 139 KGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD 197
           +   SED ARFY AE+V AL+Y+HS   +++RD+K ENL+L  DGHIKI DFG  K    
Sbjct: 242 ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---- 297

Query: 198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD 257
                           TF GT  Y+ PEVL  +      D W LG  +Y+M+ G  PF +
Sbjct: 298 ------EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 351

Query: 258 TSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI 317
                +F+ I+  +IRFP      A+ L+  LL  DP  R G G      +  H FF GI
Sbjct: 352 QDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411

Query: 318 DWKNI--RGQTPP 328
            W+++  +  +PP
Sbjct: 412 VWQHVYEKKLSPP 424

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  303 bits (778), Expect = 1e-99
 Identities = 83/298 (27%), Positives = 145/298 (48%), Gaps = 23/298 (7%)

Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
            E  +   FE+ +  G GS+ KV   +K DT  +YA+K M+K+   + N+   V  E  +
Sbjct: 9   NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQI 68

Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
           +  L+HP +V L+++FQD   ++M ++   GG+L   +    H  E+  + +  E+V AL
Sbjct: 69  MQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMAL 128

Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           +Y+ +  +IHRD+KP+N+LL   GH+ I DF     +             + +  T  GT
Sbjct: 129 DYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR-----------ETQITTMAGT 177

Query: 219 AAYVPPEVLNSSPA---TFGNDLWALGCTLYQMLSGTSPF---KDTSEWLIFQRIIARDI 272
             Y+ PE+ +S      +F  D W+LG T Y++L G  P+     TS   I        +
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV 237

Query: 273 RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
            +P+ +S     L+ +LL+ +P  R        + ++  P+   I+W  +  +   P 
Sbjct: 238 TYPSAWSQEMVSLLKKLLEPNPDQR----FSQLSDVQNFPYMNDINWDAVFQKRLIPG 291

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  309 bits (793), Expect = 2e-99
 Identities = 96/314 (30%), Positives = 151/314 (48%), Gaps = 20/314 (6%)

Query: 40  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL 99
           +  +   F   ++ G G + +V   +   TG +YA K ++KK I K    A    E+ +L
Sbjct: 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL 238

Query: 100 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDA 157
           ++++   VV L + ++   +L + L    GG+L   I   G     E  A FY AE+   
Sbjct: 239 EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG 298

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           LE +H   +++RD+KPEN+LL   GHI+I+D G    + +                  VG
Sbjct: 299 LEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE-----------GQTIKGRVG 347

Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQRIIARDIR 273
           T  Y+ PEV+ +   TF  D WALGC LY+M++G SPF+   + +    + + +      
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE 407

Query: 274 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI-RGQTPPKLAS 332
           +   FS  AR L  +LL  DP+ R G   G    +K HP FK +++K +  G   P    
Sbjct: 408 YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPF-- 465

Query: 333 EPMVQSGEGDDVHD 346
           +P  Q+    DV D
Sbjct: 466 KPDPQAIYCKDVLD 479

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  301 bits (774), Expect = 3e-99
 Identities = 96/295 (32%), Positives = 153/295 (51%), Gaps = 14/295 (4%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
                 I +FE  ++ G GS+ KV+ A+  +TG +YA+K++ K  I +++       E+ 
Sbjct: 16  SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKR 75

Query: 98  VLDQ-LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD 156
           +L    +HP + +LF  FQ    L+  +E   GG+L   I       E  ARFY AE++ 
Sbjct: 76  ILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIIS 135

Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           AL ++H  G+I+RD+K +N+LL  +GH K+ADFG  K              +     TF 
Sbjct: 136 ALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK----------EGICNGVTTATFC 185

Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
           GT  Y+ PE+L         D WA+G  LY+ML G +PF+  +E  +F+ I+  ++ +P 
Sbjct: 186 GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT 245

Query: 277 YFSDAARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNI--RGQTPP 328
           +  + A  ++   +  +P+ R G+   GG   +  HPFFK IDW  +  R   PP
Sbjct: 246 WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPP 300

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  309 bits (793), Expect = 4e-98
 Identities = 102/321 (31%), Positives = 155/321 (48%), Gaps = 26/321 (8%)

Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
             H ++ DF + +I G G + +V   +K DTG +YA+K +DKK I  +        ERI+
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM 242

Query: 99  LDQL---DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
           L  +   D P +V + + F     L   L+   GG+L   ++  G  SE + RFY AE++
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 302

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
             LE++H+  +++RD+KP N+LL   GH++I+D G            L    S  K    
Sbjct: 303 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG------------LACDFSKKKPHAS 350

Query: 216 VGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPF-----KDTSEWLIFQRIIA 269
           VGT  Y+ PEVL          D ++LGC L+++L G SPF     KD  E  I +  + 
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRMTLT 408

Query: 270 RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI-RGQTPP 328
             +  P+ FS   R L++ LL  D + R G    G   +K  PFF+ +DW+ +   + PP
Sbjct: 409 MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 468

Query: 329 KLASEPMVQSGEGDDVHDSSW 349
            L   P        D  D   
Sbjct: 469 PL--IPPRGEVNAADAFDIGS 487

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  297 bits (762), Expect = 1e-97
 Identities = 98/295 (33%), Positives = 148/295 (50%), Gaps = 17/295 (5%)

Query: 37  APQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           + Q    I+DF L K+ G GS+ KV  A+   T   +A+K + K  +  ++      +E+
Sbjct: 9   SLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEK 68

Query: 97  IVLDQ-LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
            VL    +HP +  +F TFQ   +L+  +E   GG+L   I S        A FY AE++
Sbjct: 69  RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEII 128

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
             L+++HS G+++RD+K +N+LL  DGHIKIADFG  K           N   D K  TF
Sbjct: 129 LGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK----------ENMLGDAKTNTF 178

Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP 275
            GT  Y+ PE+L         D W+ G  LY+ML G SPF    E  +F  I   +  +P
Sbjct: 179 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP 238

Query: 276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
            +    A+DL+ +L   +P  R G        ++ HP F+ I+W+ +  +   PP
Sbjct: 239 RWLEKEAKDLLVKLFVREPEKRLGVRGD----IRQHPLFREINWEELERKEIDPP 289

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  296 bits (760), Expect = 2e-97
 Identities = 102/303 (33%), Positives = 162/303 (53%), Gaps = 23/303 (7%)

Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
            +   +QDF+L ++ G GSY+KV+  +   T  +YA+K++ K+ +  +    +V+ E+ V
Sbjct: 3   MDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV 62

Query: 99  LDQ-LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
            +Q  +HP +V L   FQ    L+  +E   GG+L   +  +  L E+ ARFY+AE+  A
Sbjct: 63  FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 122

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           L Y+H  G+I+RD+K +N+LL ++GHIK+ D+G  K                D   TF G
Sbjct: 123 LNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK----------EGLRPGDTTSTFCG 172

Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF---------KDTSEWLIFQRII 268
           T  Y+ PE+L      F  D WALG  +++M++G SPF            +E  +FQ I+
Sbjct: 173 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 232

Query: 269 ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNI--RGQ 325
            + IR P   S  A  ++   L+ DP  R G  P  G+A ++ HPFF+ +DW  +  +  
Sbjct: 233 EKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQV 292

Query: 326 TPP 328
            PP
Sbjct: 293 VPP 295

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  304 bits (779), Expect = 2e-96
 Identities = 99/316 (31%), Positives = 152/316 (48%), Gaps = 13/316 (4%)

Query: 16  GNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYAL 75
           G    +    T      F     ++   + DF    + G GS+ KV+ +++  T  +YA+
Sbjct: 312 GQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAV 371

Query: 76  KIMDKKFITKENKTAYVKLERIVLDQ-LDHPGVVRLFFTFQDTFSLYMALESCEGGELFD 134
           KI+ K  + +++      +E+ VL      P + +L   FQ    LY  +E   GG+L  
Sbjct: 372 KILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMY 431

Query: 135 QITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP 194
            I   G   E  A FY AE+   L ++ S G+I+RD+K +N++L ++GHIKIADFG  K 
Sbjct: 432 HIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK- 490

Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 254
                     N        TF GT  Y+ PE++   P     D WA G  LY+ML+G +P
Sbjct: 491 ---------ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541

Query: 255 FKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 314
           F+   E  +FQ I+  ++ +P   S  A  +   L+   P  R G GP G   +K H FF
Sbjct: 542 FEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 601

Query: 315 KGIDWKNI--RGQTPP 328
           + IDW+ +  +   PP
Sbjct: 602 RYIDWEKLERKEIQPP 617

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  295 bits (756), Expect = 4e-96
 Identities = 101/304 (33%), Positives = 161/304 (52%), Gaps = 23/304 (7%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
                 +QDF+L ++ G GSY+KV+  +   T  +YA++++ K+ +  +    +V+ E+ 
Sbjct: 45  ASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKH 104

Query: 98  VLDQ-LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD 156
           V +Q  +HP +V L   FQ    L+  +E   GG+L   +  +  L E+ ARFY+AE+  
Sbjct: 105 VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL 164

Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           AL Y+H  G+I+RD+K +N+LL ++GHIK+ D+G  K                D   TF 
Sbjct: 165 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK----------EGLRPGDTTSTFC 214

Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF---------KDTSEWLIFQRI 267
           GT  Y+ PE+L      F  D WALG  +++M++G SPF            +E  +FQ I
Sbjct: 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 274

Query: 268 IARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNI--RG 324
           + + IR P   S  A  ++   L+ DP  R G  P  G+A ++ HPFF+ +DW  +  + 
Sbjct: 275 LEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQ 334

Query: 325 QTPP 328
             PP
Sbjct: 335 VVPP 338

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  275 bits (707), Expect = 2e-90
 Identities = 90/275 (32%), Positives = 147/275 (53%), Gaps = 18/275 (6%)

Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
            I+DF++G + G GS++ V RA+ I TG   A+K++DKK + K      V+ E  +  QL
Sbjct: 9   KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL 68

Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYI 161
            HP ++ L+  F+D+  +Y+ LE C  GE+   + ++    SE+EAR +  +++  + Y+
Sbjct: 69  KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYL 128

Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           HS G++HRD+   NLLLT + +IKIADFG + +                +K  T  GT  
Sbjct: 129 HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP-----------HEKHYTLCGTPN 177

Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSD 280
           Y+ PE+   S     +D+W+LGC  Y +L G  PF   +      +++  D   P++ S 
Sbjct: 178 YISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSI 237

Query: 281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
            A+DLI +LL  +P+ R        + +  HPF  
Sbjct: 238 EAKDLIHQLLRRNPADRLSL-----SSVLDHPFMS 267

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  274 bits (703), Expect = 1e-89
 Identities = 83/289 (28%), Positives = 132/289 (45%), Gaps = 24/289 (8%)

Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S + +  G+  G G ++K       DT  V+A KI+ K  + K ++   + +E  +   L
Sbjct: 13  SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL 72

Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            H  VV     F+D   +++ LE C    L +    +  L+E EAR+Y  ++V   +Y+H
Sbjct: 73  AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH 132

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
              +IHRD+K  NL L  D  +KI DFG + K   D            ++     GT  Y
Sbjct: 133 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-----------GERKKVLCGTPNY 181

Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDA 281
           + PEVL+    +F  D+W++GC +Y +L G  PF+ +     + RI   +   P + +  
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPV 241

Query: 282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKL 330
           A  LI ++L  DP+ RP         L    FF         G  P +L
Sbjct: 242 AASLIQKMLQTDPTARPTI-----NELLNDEFFT-------SGYIPARL 278

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  273 bits (701), Expect = 1e-88
 Identities = 83/296 (28%), Positives = 133/296 (44%), Gaps = 24/296 (8%)

Query: 36  RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE 95
               +  S + +  G+  G G ++K       DT  V+A KI+ K  + K ++   + +E
Sbjct: 32  EVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME 91

Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
             +   L H  VV     F+D   +++ LE C    L +    +  L+E EAR+Y  ++V
Sbjct: 92  ISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV 151

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACT 214
              +Y+H   +IHRD+K  NL L  D  +KI DFG + K   D            ++   
Sbjct: 152 LGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-----------GERKKV 200

Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF 274
             GT  Y+ PEVL+    +F  D+W++GC +Y +L G  PF+ +     + RI   +   
Sbjct: 201 LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI 260

Query: 275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKL 330
           P + +  A  LI ++L  DP+ RP         L    FF         G  P +L
Sbjct: 261 PKHINPVAASLIQKMLQTDPTARPTI-----NELLNDEFFT-------SGYIPARL 304

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  262 bits (671), Expect = 1e-84
 Identities = 81/295 (27%), Positives = 137/295 (46%), Gaps = 36/295 (12%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
            DFE   + G G++ +VV+A+       YA+K +       E K + +  E ++L  L+H
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNH 61

Query: 105 PGVVRLFFTFQDTFS-------------LYMALESCEGGELFDQITSKG-HLSEDEARFY 150
             VVR +  + +  +             L++ +E CE G L+D I S+  +   DE    
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121

Query: 151 TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS----RITVLPNA 206
             ++++AL YIHS G+IHRD+KP N+ +    ++KI DFG  K +  S    ++      
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181

Query: 207 ASDDKACTFVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIF 264
            S D   + +GTA YV  EVL+ +   +    D+++LG   ++M+             I 
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTG-HYNEKIDMYSLGIIFFEMIYP--FSTGMERVNIL 238

Query: 265 QRIIARDIRFPNYF----SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
           +++ +  I FP  F        + +I  L+D DP+ RPGA       L    +  
Sbjct: 239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGA-----RTLLNSGWLP 288

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  262 bits (671), Expect = 2e-84
 Identities = 70/311 (22%), Positives = 119/311 (38%), Gaps = 24/311 (7%)

Query: 8   FDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKI 67
           F S  +++    S     +          +  E F  Q F+     G GSY +V + +  
Sbjct: 20  FQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSK 79

Query: 68  DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESC 127
           + G +YA+K     F   +++   +           HP  VRL   +++   LY+  E C
Sbjct: 80  EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC 139

Query: 128 EGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI 186
            G  L     + G  L E +   Y  + + AL ++HS GL+H D+KP N+ L   G  K+
Sbjct: 140 -GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKL 198

Query: 187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLY 246
            DFG +  +            +        G   Y+ PE+L         D+++LG T+ 
Sbjct: 199 GDFGLLVEL-----------GTAGAGEVQEGDPRYMAPELLQ-GSYGTAADVFSLGLTIL 246

Query: 247 QMLSGTSPFKDTSEWLIFQRIIARDI--RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGG 304
           ++            W   Q++    +   F    S   R ++  +L+ DP  R  A    
Sbjct: 247 EVACNMELPHGGEGW---QQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATA---- 299

Query: 305 YAVLKMHPFFK 315
              L   P  +
Sbjct: 300 -EALLALPVLR 309

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  263 bits (673), Expect = 3e-84
 Identities = 64/350 (18%), Positives = 126/350 (36%), Gaps = 70/350 (20%)

Query: 19  NSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIM 78
           ++ +N   + +         ++   I D+ + +    G ++K++  +K      YALK  
Sbjct: 11  SNYSNLIYLNKYVK------EKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKY 62

Query: 79  DKKFITKENKTAY--------------VKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL 124
           +K  + K+                    K E  ++  + +   +       +   +Y+  
Sbjct: 63  EKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIY 122

Query: 125 ESCEGGELFDQITSKGHL--------SEDEARFYTAEVVDALEYIHS-MGLIHRDIKPEN 175
           E  E   +         L             +     V+++  YIH+   + HRD+KP N
Sbjct: 123 EYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182

Query: 176 LLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFG 235
           +L+  +G +K++DFG                  D K     GT  ++PPE  ++  +  G
Sbjct: 183 ILMDKNGRVKLSDFG------------ESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNG 230

Query: 236 N--DLWALGCTLYQMLSGTSPF-KDTSEWLIFQRIIARDIRFP----------------- 275
              D+W+LG  LY M     PF    S   +F  I  ++I +P                 
Sbjct: 231 AKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTC 290

Query: 276 --NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR 323
             N+ S+   D +   L  +P+ R  +          H +    + +++R
Sbjct: 291 SNNFLSNEDIDFLKLFLRKNPAERITS-----EDALKHEWLADTNIEDLR 335

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  254 bits (650), Expect = 1e-81
 Identities = 83/279 (29%), Positives = 139/279 (49%), Gaps = 24/279 (8%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
            ++++ +  G G++S V R     TG  +A KI++ K ++  +    ++ E  +  +L H
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQH 64

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P +VRL  + Q+    Y+  +   GGELF+ I ++   SE +A     ++++++ Y HS 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124

Query: 165 GLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           G++HR++KPENLLL +      +K+ADFG    + D            +    F GT  Y
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND-----------SEAWHGFAGTPGY 173

Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP-NYF-- 278
           + PEVL   P +   D+WA G  LY +L G  PF D  +  ++ +I A    +P   +  
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDT 233

Query: 279 -SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 316
            +  A+ LID +L V+P  R  A       LK  P+   
Sbjct: 234 VTPEAKSLIDSMLTVNPKKRITA----DQALK-VPWICN 267

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  252 bits (646), Expect = 4e-81
 Identities = 88/295 (29%), Positives = 145/295 (49%), Gaps = 30/295 (10%)

Query: 43  SIQDF-ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTA---YVKLERIV 98
            ++D  E+G+  G G ++ V + ++  TG  YA K + K+ ++   +      ++ E  +
Sbjct: 2   MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61

Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
           L ++ HP ++ L   F++   + + LE   GGELFD +  K  L+EDEA  +  +++D +
Sbjct: 62  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 121

Query: 159 EYIHSMGLIHRDIKPENLLLT----ADGHIKIADFG-SVKPMQDSRITVLPNAASDDKAC 213
            Y+HS  + H D+KPEN++L      +  IK+ DFG + K    +               
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK------------ 169

Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR 273
              GT  +V PE++N  P     D+W++G   Y +LSG SPF   ++      I A +  
Sbjct: 170 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYD 229

Query: 274 FP-NYF---SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG 324
           F   YF   S+ A+D I RLL  DP  R          L+ H + K I  +N+RG
Sbjct: 230 FDEEYFSNTSELAKDFIRRLLVKDPKRRMTI----AQSLE-HSWIKAIRRRNVRG 279

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  252 bits (645), Expect = 9e-81
 Identities = 81/296 (27%), Positives = 140/296 (47%), Gaps = 33/296 (11%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI------V 98
           +++E  +I G G  S V R     T   YA+KI+D       +     +L         +
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76

Query: 99  LDQLD-HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           L ++  HP +++L  T++     ++  +  + GELFD +T K  LSE E R     +++ 
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           +  +H + ++HRD+KPEN+LL  D +IK+ DFG    +              +K     G
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-----------GEKLREVCG 185

Query: 218 TAAYVPPEVLNSSPATFGN------DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 271
           T +Y+ PE++  S            D+W+ G  +Y +L+G+ PF    + L+ + I++ +
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 245

Query: 272 IRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR 323
            +F     + +SD  +DL+ R L V P  R  A       L  HPFF+    + +R
Sbjct: 246 YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTA----EEALA-HPFFQQYVVEEVR 296

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  252 bits (645), Expect = 1e-80
 Identities = 86/279 (30%), Positives = 142/279 (50%), Gaps = 27/279 (9%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           + F   ++ G G++S+V   K+  TG ++ALK + K    +++    ++ E  VL ++ H
Sbjct: 9   KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSS---LENEIAVLKKIKH 65

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
             +V L   ++ T   Y+ ++   GGELFD+I  +G  +E +A     +V+ A++Y+H  
Sbjct: 66  ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN 125

Query: 165 GLIHRDIKPENLLLT---ADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           G++HRD+KPENLL      +  I I DFG  K  Q+  ++            T  GT  Y
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS------------TACGTPGY 173

Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP-NYF-- 278
           V PEVL   P +   D W++G   Y +L G  PF + +E  +F++I      F   ++  
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDD 233

Query: 279 -SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 316
            S++A+D I  LL+ DP+ R          L  HP+  G
Sbjct: 234 ISESAKDFICHLLEKDPNERYTC----EKALS-HPWIDG 267

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  249 bits (637), Expect = 8e-79
 Identities = 89/304 (29%), Positives = 146/304 (48%), Gaps = 26/304 (8%)

Query: 20  SSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMD 79
           S T    + R   F        FS  ++++ +  G G++S V R     TG  +A KI++
Sbjct: 6   SMTGGQQMGRGSEFMMN-ASTKFS-DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN 63

Query: 80  KKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK 139
            K ++  +    ++ E  +  +L HP +VRL  + Q+    Y+  +   GGELF+ I ++
Sbjct: 64  TKKLSARDFQK-LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR 122

Query: 140 GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQ 196
              SE +A     ++++++ Y HS G++HR++KPENLLL +      +K+ADFG    + 
Sbjct: 123 EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182

Query: 197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK 256
           D            +    F GT  Y+ PEVL   P +   D+WA G  LY +L G  PF 
Sbjct: 183 D-----------SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 231

Query: 257 DTSEWLIFQRIIARDIRFP-NYF---SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHP 312
           D  +  ++ +I A    +P   +   +  A+ LID +L V+P  R  A       LK  P
Sbjct: 232 DEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITA----DQALK-VP 286

Query: 313 FFKG 316
           +   
Sbjct: 287 WICN 290

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  246 bits (630), Expect = 1e-78
 Identities = 90/282 (31%), Positives = 146/282 (51%), Gaps = 31/282 (10%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           + + +  + G GS+ +V++ K   T   YA+K+++K     ++ +  +  E  +L +LDH
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST-ILREVELLKKLDH 80

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P +++LF   +D+ S Y+  E   GGELFD+I  +   SE +A     +V   + Y+H  
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140

Query: 165 GLIHRDIKPENLLLTA---DGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAA 220
            ++HRD+KPEN+LL +   D  IKI DFG S    Q++++               +GTA 
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK------------DRIGTAY 188

Query: 221 YVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP--- 275
           Y+ PEVL  +   +    D+W+ G  LY +LSGT PF   +E+ I +R+      F    
Sbjct: 189 YIAPEVLRGT---YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ 245

Query: 276 -NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 316
               SD A+DLI ++L   PS R  A       L+ HP+ + 
Sbjct: 246 WRTISDDAKDLIRKMLTFHPSLRITA----TQCLE-HPWIQK 282

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  246 bits (630), Expect = 3e-78
 Identities = 78/303 (25%), Positives = 137/303 (45%), Gaps = 29/303 (9%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTA---YVKLERIVLDQ 101
             +++G+  G G ++ V + ++  TG  YA K + K+      +      ++ E  +L Q
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71

Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           + H  V+ L   +++   + + LE   GGELFD +  K  LSE+EA  +  +++D + Y+
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131

Query: 162 HSMGLIHRDIKPENLLLTA----DGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFV 216
           H+  + H D+KPEN++L        HIK+ DFG + +                       
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK------------NIF 179

Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP- 275
           GT  +V PE++N  P     D+W++G   Y +LSG SPF   ++      I +    F  
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDE 239

Query: 276 NYF---SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLAS 332
            +F   S+ A+D I +LL  +   R          L+ HP+   +D +    +    +  
Sbjct: 240 EFFSHTSELAKDFIRKLLVKETRKRLTI----QEALR-HPWITPVDNQQAMVRRESVVNL 294

Query: 333 EPM 335
           E  
Sbjct: 295 ENF 297

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  244 bits (626), Expect = 3e-78
 Identities = 84/281 (29%), Positives = 127/281 (45%), Gaps = 31/281 (11%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           Q + L    G GS+ +V  A +  T    A K + K F+   ++    K E  ++  LDH
Sbjct: 9   QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR---FKQEIEIMKSLDH 65

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P ++RL+ TF+D   +Y+ +E C GGELF+++  K    E +A     +V+ A+ Y H +
Sbjct: 66  PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125

Query: 165 GLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
            + HRD+KPEN L      D  +K+ DFG     +                 T VGT  Y
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP-----------GKMMRTKVGTPYY 174

Query: 222 VPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP---- 275
           V P+VL      +G   D W+ G  +Y +L G  PF   ++  +  +I      FP    
Sbjct: 175 VSPQVLEGL---YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW 231

Query: 276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 316
              S  A  LI RLL   P  R  +       L+ H +F+ 
Sbjct: 232 LNVSPQAESLIRRLLTKSPKQRITS----LQALE-HEWFEK 267

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  246 bits (629), Expect = 4e-78
 Identities = 87/293 (29%), Positives = 137/293 (46%), Gaps = 33/293 (11%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-----VL 99
            ++ + K  G G+  +V  A +  T    A+KI+ K+     +         +     +L
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69

Query: 100 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 159
            +L+HP ++++   F      Y+ LE  EGGELFD++     L E   + Y  +++ A++
Sbjct: 70  KKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128

Query: 160 YIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           Y+H  G+IHRD+KPEN+LL++   D  IKI DFG  K + +                T  
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-----------TSLMRTLC 177

Query: 217 GTAAYVPPEVLNSSPATFGN---DLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIARDI 272
           GT  Y+ PEVL S      N   D W+LG  L+  LSG  PF +  ++  +  +I +   
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 237

Query: 273 RFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN 321
            F        S+ A DL+ +LL VDP  R          L+ HP+ +  D K 
Sbjct: 238 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTT----EEALR-HPWLQDEDMKR 285

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  247 bits (633), Expect = 4e-78
 Identities = 83/287 (28%), Positives = 136/287 (47%), Gaps = 32/287 (11%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-----VL 99
           Q ++   + G G  S V R     TG  +A+KIM+        +      E       +L
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153

Query: 100 DQL-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
            Q+  HP ++ L  +++ +  +++  +    GELFD +T K  LSE E R     +++A+
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAV 213

Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
            ++H+  ++HRD+KPEN+LL  +  I+++DFG    ++             +K     GT
Sbjct: 214 SFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP-----------GEKLRELCGT 262

Query: 219 AAYVPPEVLNSSPATFGN------DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI 272
             Y+ PE+L  S            DLWA G  L+ +L+G+ PF    + L+ + I+    
Sbjct: 263 PGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY 322

Query: 273 RFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
           +F     +  S   +DLI RLL VDP  R  A       L+ HPFF+
Sbjct: 323 QFSSPEWDDRSSTVKDLISRLLQVDPEARLTA----EQALQ-HPFFE 364

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  245 bits (628), Expect = 6e-78
 Identities = 84/306 (27%), Positives = 142/306 (46%), Gaps = 30/306 (9%)

Query: 43  SIQDF-ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTA---YVKLERIV 98
           ++ D+ + G+  G G ++ V + ++  TG  YA K + K+      +      ++ E  +
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67

Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
           L ++ HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  ++++ +
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127

Query: 159 EYIHSMGLIHRDIKPENLLLT----ADGHIKIADFG-SVKPMQDSRITVLPNAASDDKAC 213
            Y+HS+ + H D+KPEN++L         IKI DFG + K    +               
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK------------ 175

Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR 273
              GT  +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +  
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 235

Query: 274 FP-NYF---SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPK 329
           F   YF   S  A+D I RLL  DP  R          L+ HP+ K  D +    +    
Sbjct: 236 FEDEYFSNTSALAKDFIRRLLVKDPKKRMTI----QDSLQ-HPWIKPKDTQQALSRKASA 290

Query: 330 LASEPM 335
           +  E  
Sbjct: 291 VNMEKF 296

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  244 bits (624), Expect = 2e-77
 Identities = 74/287 (25%), Positives = 129/287 (44%), Gaps = 33/287 (11%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           + + + K  G G  SKV +    +   +YA+K ++ +    +   +Y + E   L++L  
Sbjct: 28  RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQQ 85

Query: 105 P--GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
               ++RL+        +YM +E C   +L   +  K  +   E + Y   +++A+  IH
Sbjct: 86  HSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 144

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
             G++H D+KP N L+  DG +K+ DFG    MQ    +V+ +        + VGT  Y+
Sbjct: 145 QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKD--------SQVGTVNYM 195

Query: 223 PPEVLNSSPATFGN-----------DLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIAR 270
           PPE +    ++  N           D+W+LGC LY M  G +PF+   ++      II  
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 255

Query: 271 D--IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
           +  I FP+      +D++   L  DP  R          L  HP+ +
Sbjct: 256 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI-----PELLAHPYVQ 297

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  247 bits (633), Expect = 2e-77
 Identities = 86/293 (29%), Positives = 139/293 (47%), Gaps = 33/293 (11%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-----VL 99
            ++ + K  G G+  +V  A +  T    A++I+ K+     +         +     +L
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194

Query: 100 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 159
            +L+HP ++++   F      Y+ LE  EGGELFD++     L E   + Y  +++ A++
Sbjct: 195 KKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253

Query: 160 YIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           Y+H  G+IHRD+KPEN+LL++   D  IKI DFG  K + ++ +             T  
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR-----------TLC 302

Query: 217 GTAAYVPPEVLNSSPATFGN---DLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIARDI 272
           GT  Y+ PEVL S      N   D W+LG  L+  LSG  PF +  ++  +  +I +   
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 362

Query: 273 RFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN 321
            F        S+ A DL+ +LL VDP  R          L+ HP+ +  D K 
Sbjct: 363 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTT----EEALR-HPWLQDEDMKR 410

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  244 bits (626), Expect = 4e-77
 Identities = 78/289 (26%), Positives = 135/289 (46%), Gaps = 29/289 (10%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQ 101
             +++G+  G G ++ V + ++  TG  YA K + K+      +      ++ E  +L Q
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71

Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           + HP ++ L   +++   + + LE   GGELFD +  K  LSE+EA  +  +++D + Y+
Sbjct: 72  VLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131

Query: 162 HSMGLIHRDIKPENLLLTA----DGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFV 216
           H+  + H D+KPEN++L        HIK+ DFG + +                       
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK------------NIF 179

Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP- 275
           GT  +V PE++N  P     D+W++G   Y +LSG SPF   ++      I A    F  
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDE 239

Query: 276 NYF---SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN 321
            +F   S+ A+D I +LL  +   R          L+ HP+   +D + 
Sbjct: 240 EFFSQTSELAKDFIRKLLVKETRKRLTI----QEALR-HPWITPVDTQQ 283

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  243 bits (621), Expect = 1e-76
 Identities = 82/337 (24%), Positives = 134/337 (39%), Gaps = 62/337 (18%)

Query: 29  RSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK 88
           R   +           + + L    G GSY  V  A +  T  + A+KIM+K  I + N 
Sbjct: 11  RENLYFQGGSLLELQ-KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINP 69

Query: 89  TAYVKLER--IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH----- 141
               +++    ++ +L HP + RL+  ++D   + + +E C GG L D++          
Sbjct: 70  KDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGK 129

Query: 142 -----------------------------------LSEDEARFYTAEVVDALEYIHSMGL 166
                                                E        ++  AL Y+H+ G+
Sbjct: 130 CAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGI 189

Query: 167 IHRDIKPENLLLTADG--HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
            HRDIKPEN L + +    IK+ DFG       S+     N        T  GT  +V P
Sbjct: 190 CHRDIKPENFLFSTNKSFEIKLVDFGL------SKEFYKLNNGEYYGMTTKAGTPYFVAP 243

Query: 225 EVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----NYF 278
           EVLN++  ++G   D W+ G  L+ +L G  PF   ++     +++ + + F     N  
Sbjct: 244 EVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVL 303

Query: 279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
           S  ARDL+  LL+ +   R  A       L+ HP+  
Sbjct: 304 SPLARDLLSNLLNRNVDERFDA----MRALQ-HPWIS 335

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  241 bits (617), Expect = 2e-76
 Identities = 72/287 (25%), Positives = 121/287 (42%), Gaps = 30/287 (10%)

Query: 40  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL 99
           +    + + + +  G G +  V R  +  +   Y  K +  K   +      VK E  +L
Sbjct: 1   KELY-EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL----VKKEISIL 55

Query: 100 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDAL 158
           +   H  ++ L  +F+    L M  E   G ++F++I +    L+E E   Y  +V +AL
Sbjct: 56  NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115

Query: 159 EYIHSMGLIHRDIKPENLLLTA--DGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTF 215
           +++HS  + H DI+PEN++        IKI +FG + +        +L            
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL------------ 163

Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP 275
                Y  PEV      +   D+W+LG  +Y +LSG +PF   +   I + I+  +  F 
Sbjct: 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD 223

Query: 276 -NYF---SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID 318
              F   S  A D +DRLL  +   R  A       L+ HP+ K   
Sbjct: 224 EEAFKEISIEAMDFVDRLLVKERKSRMTA----SEALQ-HPWLKQKI 265

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  241 bits (618), Expect = 3e-76
 Identities = 79/306 (25%), Positives = 134/306 (43%), Gaps = 33/306 (10%)

Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
              + +   ELG+    G ++ V +     TG  YA K + K+   ++ +   +  E  V
Sbjct: 27  NNFYILTSKELGR----GKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAE-ILHEIAV 81

Query: 99  LDQLDH-PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVV 155
           L+     P V+ L   +++T  + + LE   GGE+F     +    +SE++      +++
Sbjct: 82  LELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQIL 141

Query: 156 DALEYIHSMGLIHRDIKPENLLL---TADGHIKIADFG-SVKPMQDSRITVLPNAASDDK 211
           + + Y+H   ++H D+KP+N+LL      G IKI DFG S K      +           
Sbjct: 142 EGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELR---------- 191

Query: 212 ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 271
               +GT  Y+ PE+LN  P T   D+W +G   Y +L+ TSPF        +  I   +
Sbjct: 192 --EIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVN 249

Query: 272 IRFP-NYF---SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTP 327
           + +    F   S  A D I  LL  +P  RP A       L  H + +  D++N+     
Sbjct: 250 VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTA----EICLS-HSWLQQWDFENLFHPEE 304

Query: 328 PKLASE 333
              +S+
Sbjct: 305 TSSSSQ 310

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  242 bits (619), Expect = 3e-76
 Identities = 77/299 (25%), Positives = 146/299 (48%), Gaps = 23/299 (7%)

Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           S++ +   +  G GS+ K +  K  + G  Y +K ++   ++ + +    + E  VL  +
Sbjct: 22  SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRR-EVAVLANM 80

Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS--KGHLSEDEARFYTAEVVDALEY 160
            HP +V+   +F++  SLY+ ++ CEGG+LF +I +       ED+   +  ++  AL++
Sbjct: 81  KHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKH 140

Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           +H   ++HRDIK +N+ LT DG +++ DFG  + +           ++ + A   +GT  
Sbjct: 141 VHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN----------STVELARACIGTPY 190

Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-RFPNYFS 279
           Y+ PE+  + P    +D+WALGC LY++ +    F+  S   +  +II+        ++S
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYS 250

Query: 280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQS 338
              R L+ +L   +P  RP       ++L+   F      K I     P+L +E     
Sbjct: 251 YDLRSLVSQLFKRNPRDRPSVN----SILE-KGFIA----KRIEKFLSPQLIAEEFCLK 300

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  244 bits (626), Expect = 5e-76
 Identities = 86/279 (30%), Positives = 141/279 (50%), Gaps = 23/279 (8%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           ++++L +  G G++S V R  K+  G  YA  I++ K ++  +    ++ E  +   L H
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK-LEREARICRLLKH 69

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P +VRL  +  +    Y+  +   GGELF+ I ++ + SE +A     ++++A+ + H M
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129

Query: 165 GLIHRDIKPENLLLT---ADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           G++HR++KPENLLL        +K+ADFG    ++                  F GT  Y
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG----------EQQAWFGFAGTPGY 179

Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----NY 277
           + PEVL   P     DLWA G  LY +L G  PF D  +  ++Q+I A    FP    + 
Sbjct: 180 LSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDT 239

Query: 278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 316
            +  A+DLI+++L ++PS R  A       LK HP+   
Sbjct: 240 VTPEAKDLINKMLTINPSKRITA----AEALK-HPWISH 273

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  245 bits (627), Expect = 7e-76
 Identities = 91/293 (31%), Positives = 144/293 (49%), Gaps = 29/293 (9%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           + + +  + G GS+ +V++ K   T   YA+K+++K     ++ +  +  E  +L +LDH
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST-ILREVELLKKLDH 80

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P +++LF   +D+ S Y+  E   GGELFD+I  +   SE +A     +V   + Y+H  
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140

Query: 165 GLIHRDIKPENLLLT---ADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
            ++HRD+KPEN+LL     D  IKI DFG     Q            + K    +GTA Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ-----------NTKMKDRIGTAYY 189

Query: 222 VPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP---- 275
           + PEVL  +   +    D+W+ G  LY +LSGT PF   +E+ I +R+      F     
Sbjct: 190 IAPEVLRGT---YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW 246

Query: 276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 328
              SD A+DLI ++L   PS R  A       L+ HP+ +    +       P
Sbjct: 247 RTISDDAKDLIRKMLTFHPSLRITA----TQCLE-HPWIQKYSSETPTISDLP 294

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  241 bits (616), Expect = 7e-76
 Identities = 82/352 (23%), Positives = 145/352 (41%), Gaps = 39/352 (11%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           + + + K  G G  SKV +    +   +YA+K ++ +    +   +Y + E   L++L  
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQQ 66

Query: 105 P--GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
               ++RL+        +YM +E C   +L   +  K  +   E + Y   +++A+  IH
Sbjct: 67  HSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 125

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
             G++H D+KP N L+  DG +K+ DFG    MQ    +V+ +        + VGT  Y+
Sbjct: 126 QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKD--------SQVGTVNYM 176

Query: 223 PPEVLNSSPATFGN-----------DLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIAR 270
           PPE +    ++  N           D+W+LGC LY M  G +PF+   ++      II  
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 236

Query: 271 D--IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP 328
           +  I FP+      +D++   L  DP  R          L  HP+ +             
Sbjct: 237 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI-----PELLAHPYVQ----IQTHPVNQM 287

Query: 329 KLASEPMVQSGEGDDVHDSSWNPSH--IGDISAKINDGNGGASSSEGSITRL 378
              +   ++   G  V  +S N        +    + G    SSS  +  + 
Sbjct: 288 AKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKK 339

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  241 bits (616), Expect = 7e-76
 Identities = 88/308 (28%), Positives = 138/308 (44%), Gaps = 30/308 (9%)

Query: 25  PTVQRSKSFAFRAPQEHFSIQD-FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFI 83
           P +            +    +D +EL ++ G G +S V R    +TG  +A+KI+D    
Sbjct: 3   PGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKF 62

Query: 84  TKENKTAYVKLER--IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH 141
           T     +   L+R   +   L HP +V L  T+     LYM  E  +G +L  +I  +  
Sbjct: 63  TSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRAD 122

Query: 142 ----LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKP 194
                SE  A  Y  ++++AL Y H   +IHRD+KP  +LL +      +K+  FG    
Sbjct: 123 AGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182

Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 254
           + +          S   A   VGT  ++ PEV+   P     D+W  G  L+ +LSG  P
Sbjct: 183 LGE----------SGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

Query: 255 FKDTSEWLIFQRIIARDIRFP-NYF---SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM 310
           F  T E  +F+ II    +     +   S++A+DL+ R+L +DP+ R       Y  L  
Sbjct: 233 FYGTKE-RLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITV----YEALN- 286

Query: 311 HPFFKGID 318
           HP+ K  D
Sbjct: 287 HPWLKERD 294

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  241 bits (616), Expect = 8e-76
 Identities = 92/310 (29%), Positives = 147/310 (47%), Gaps = 32/310 (10%)

Query: 17  NNNSSTNCPTVQRSKSFAFRAPQEHFSIQDF-ELGKIYGVGSYSKVVRAKKIDTGTVYAL 75
           ++ +++  P         +       ++ DF E+    G G+ S V R K+  T   YAL
Sbjct: 24  SSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYAL 83

Query: 76  KIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQ 135
           K++ K           V+ E  VL +L HP +++L   F+    + + LE   GGELFD+
Sbjct: 84  KVLKKT-----VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDR 138

Query: 136 ITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT---ADGHIKIADFG-S 191
           I  KG+ SE +A     ++++A+ Y+H  G++HRD+KPENLL      D  +KIADFG S
Sbjct: 139 IVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLS 198

Query: 192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSG 251
                   +             T  GT  Y  PE+L         D+W++G   Y +L G
Sbjct: 199 KIVEHQVLMK------------TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

Query: 252 TSPFKD-TSEWLIFQRIIARDIRFP-NYF---SDAARDLIDRLLDVDPSGRPGAGPGGYA 306
             PF D   +  +F+RI+  +  F   ++   S  A+DL+ +L+ +DP  R       + 
Sbjct: 247 FEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTT----FQ 302

Query: 307 VLKMHPFFKG 316
            L+ HP+  G
Sbjct: 303 ALQ-HPWVTG 311

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  238 bits (609), Expect = 1e-75
 Identities = 81/283 (28%), Positives = 135/283 (47%), Gaps = 33/283 (11%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
             F   +  G G++  V   ++  +G    +K ++K       +   ++ E  VL  LDH
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQ--IEAEIEVLKSLDH 79

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK----GHLSEDEARFYTAEVVDALEY 160
           P ++++F  F+D  ++Y+ +E+CEGGEL ++I S       LSE        ++++AL Y
Sbjct: 80  PNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139

Query: 161 IHSMGLIHRDIKPENLLLT---ADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
            HS  ++H+D+KPEN+L         IKI DFG  +  +            D+ +    G
Sbjct: 140 FHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS-----------DEHSTNAAG 188

Query: 218 TAAYVPPEVLNS--SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP 275
           TA Y+ PEV     +      D+W+ G  +Y +L+G  PF  TS   + Q+   ++  + 
Sbjct: 189 TALYMAPEVFKRDVTFKC---DIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA 245

Query: 276 NYF---SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
                 +  A DL+ ++L  DP  RP A      VL  H +FK
Sbjct: 246 VECRPLTPQAVDLLKQMLTKDPERRPSA----AQVLH-HEWFK 283

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  244 bits (624), Expect = 2e-75
 Identities = 86/279 (30%), Positives = 141/279 (50%), Gaps = 24/279 (8%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
             ++  ++ G GS+ +V+  K   TG   A+K++ K+ + ++     +  E  +L QLDH
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P +++L+  F+D    Y+  E   GGELFD+I S+   SE +A     +V+  + Y+H  
Sbjct: 86  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 145

Query: 165 GLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
            ++HRD+KPENLLL +   D +I+I DFG     +              K    +GTA Y
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-----------SKKMKDKIGTAYY 194

Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----NY 277
           + PEVL+ +      D+W+ G  LY +LSG  PF   +E+ I +++      F       
Sbjct: 195 IAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKK 253

Query: 278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 316
            S++A+DLI ++L   PS R  A       L  H + + 
Sbjct: 254 VSESAKDLIRKMLTYVPSMRISA----RDALD-HEWIQT 287

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  243 bits (623), Expect = 4e-75
 Identities = 91/325 (28%), Positives = 154/325 (47%), Gaps = 30/325 (9%)

Query: 17  NNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALK 76
              +      +Q +      + + H S + ++  K  G G+Y +V+  +   T    A+K
Sbjct: 10  GRENLYFQGDLQATPGMFITSKKGHLS-EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIK 68

Query: 77  IMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI 136
           I+ K  ++  + +  +  E  VL  LDHP +++L+  F+D  + Y+ +E  +GGELFD+I
Sbjct: 69  IIRKTSVSTSSNSK-LLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI 127

Query: 137 TSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT---ADGHIKIADFGSVK 193
             +   +E +A     +V+  + Y+H   ++HRD+KPENLLL     D  IKI DFG   
Sbjct: 128 IHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187

Query: 194 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSG 251
             ++             K    +GTA Y+ PEVL      +    D+W++G  L+ +L+G
Sbjct: 188 VFEN-----------QKKMKERLGTAYYIAPEVLRKK---YDEKCDVWSIGVILFILLAG 233

Query: 252 TSPFKDTSEWLIFQRIIARDIRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAV 307
             PF   ++  I +++      F        S+ A+DLI ++L  D   R  A       
Sbjct: 234 YPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISA----QQA 289

Query: 308 LKMHPFFKGIDWKNIRGQTPPKLAS 332
           L+ HP+ K +  K   G   P LA+
Sbjct: 290 LE-HPWIKEMCSKKESGIELPSLAN 313

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  238 bits (610), Expect = 4e-75
 Identities = 69/325 (21%), Positives = 124/325 (38%), Gaps = 42/325 (12%)

Query: 29  RSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK 88
           ++      A  E    Q +      G G++  V  A   +      +K + K+ + ++  
Sbjct: 8   KAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCW 67

Query: 89  TAYVKLERI-----VLDQLDHPGVVRLFFTFQDTFSLYMALES-CEGGELFDQITSKGHL 142
               KL ++     +L +++H  ++++   F++     + +E    G +LF  I     L
Sbjct: 68  IEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRL 127

Query: 143 SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV 202
            E  A +   ++V A+ Y+    +IHRDIK EN+++  D  IK+ DFGS   ++      
Sbjct: 128 DEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER----- 182

Query: 203 LPNAASDDKACTFVGTAAYVPPEVLN----SSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
                      TF GT  Y  PEVL       P     ++W+LG TLY ++   +PF + 
Sbjct: 183 ------GKLFYTFCGTIEYCAPEVLMGNPYRGPEL---EMWSLGVTLYTLVFEENPFCE- 232

Query: 259 SEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID 318
                 +  +   I  P   S     L+  LL   P  R          L   P+     
Sbjct: 233 -----LEETVEAAIHPPYLVSKELMSLVSGLLQPVPERRT-----TLEKLVTDPWVT--- 279

Query: 319 WKNIRGQTPPKLASEPMVQSGEGDD 343
               +         E + +  + + 
Sbjct: 280 ----QPVNLADYTWEEVFRVNKPES 300

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  239 bits (611), Expect = 4e-75
 Identities = 92/286 (32%), Positives = 134/286 (46%), Gaps = 34/286 (11%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE-RIVLDQLD 103
             +E+ +  GVGSYS   R     T   +A+KI+DK    K +       E  I+L    
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKS---KRD----PTEEIEILLRYGQ 74

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP ++ L   + D   +Y+  E  +GGEL D+I  +   SE EA      +   +EY+H+
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA 134

Query: 164 MGLIHRDIKPENLLLTADGH----IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
            G++HRD+KP N+L   +      I+I DFG  K ++          A +    T   TA
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR----------AENGLLMTPCYTA 184

Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF---KDTSEWLIFQRIIARDIRFP- 275
            +V PEVL         D+W+LG  LY ML+G +PF    D +   I  RI +       
Sbjct: 185 NFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSG 244

Query: 276 ---NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID 318
              N  SD A+DL+ ++L VDP  R  A      VL+ HP+    D
Sbjct: 245 GYWNSVSDTAKDLVSKMLHVDPHQRLTA----ALVLR-HPWIVHWD 285

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  236 bits (603), Expect = 1e-74
 Identities = 95/305 (31%), Positives = 142/305 (46%), Gaps = 52/305 (17%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY------------ 91
           +  + L    G GSY  V  A   +  T YA+K++ KK + ++                 
Sbjct: 12  LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPG 71

Query: 92  -----------VKLERIVLDQLDHPGVVRLF--FTFQDTFSLYMALESCEGGELFDQITS 138
                      V  E  +L +LDHP VV+L       +   LYM  E    G + + + +
Sbjct: 72  GCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPT 130

Query: 139 KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS 198
              LSED+ARFY  +++  +EY+H   +IHRDIKP NLL+  DGHIKIADFG     +  
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG- 189

Query: 199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATF---GNDLWALGCTLYQMLSGTSPF 255
                    SD      VGT A++ PE L+ +   F     D+WA+G TLY  + G  PF
Sbjct: 190 ---------SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240

Query: 256 KDTSEWLIFQRIIARDIRFPNY--FSDAARDLIDRLLDVDPSGR---PGAGPGGYAVLKM 310
            D     +  +I ++ + FP+    ++  +DLI R+LD +P  R   P         +K+
Sbjct: 241 MDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPE--------IKL 292

Query: 311 HPFFK 315
           HP+  
Sbjct: 293 HPWVT 297

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  235 bits (602), Expect = 1e-74
 Identities = 71/289 (24%), Positives = 114/289 (39%), Gaps = 45/289 (15%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
            DF+  ++ G G + +V +AK    G  Y +K +       E      + E   L +LDH
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN---NEK----AEREVKALAKLDH 63

Query: 105 PGVVRLFFTFQDTFS----------------LYMALESCEGGELFDQI--TSKGHLSEDE 146
             +V     +                     L++ +E C+ G L   I       L +  
Sbjct: 64  VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123

Query: 147 ARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNA 206
           A     ++   ++YIHS  LI+RD+KP N+ L     +KI DFG V  ++          
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK---------- 173

Query: 207 ASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQR 266
            +D K     GT  Y+ PE ++S       DL+ALG  L ++L       +TS+   F  
Sbjct: 174 -NDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK--FFTD 230

Query: 267 IIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
           +  RD    + F    + L+ +LL   P  RP        +L+      
Sbjct: 231 L--RDGIISDIFDKKEKTLLQKLLSKKPEDRPNT----SEILR-TLTVW 272

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  238 bits (609), Expect = 3e-74
 Identities = 83/280 (29%), Positives = 135/280 (48%), Gaps = 28/280 (10%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
             +++ +  G G++  V R  +  TG V+  K ++       +K   VK E  +++QL H
Sbjct: 51  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYT-VKNEISIMNQLHH 107

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHS 163
           P ++ L   F+D + + + LE   GGELFD+I ++ + +SE E   Y  +  + L+++H 
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 167

Query: 164 MGLIHRDIKPENLLLTA--DGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAA 220
             ++H DIKPEN++        +KI DFG + K   D  + V               TA 
Sbjct: 168 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT------------TATAE 215

Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP-NYF- 278
           +  PE+++  P  F  D+WA+G   Y +LSG SPF    +    Q +   D  F  + F 
Sbjct: 216 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS 275

Query: 279 --SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 316
             S  A+D I  LL  +P  R       +  L+ HP+ KG
Sbjct: 276 SVSPEAKDFIKNLLQKEPRKRLTV----HDALE-HPWLKG 310

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  238 bits (608), Expect = 3e-74
 Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 33/288 (11%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
            + + + K  G G  SKV +    +   +YA+K ++ +    +   +Y + E   L++L 
Sbjct: 55  GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQ 112

Query: 104 HP--GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
                ++RL+        +YM +E C   +L   +  K  +   E + Y   +++A+  I
Sbjct: 113 QHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 171

Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H  G++H D+KP N L+  DG +K+ DFG    MQ    +V+ +        + VG   Y
Sbjct: 172 HQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKD--------SQVGAVNY 222

Query: 222 VPPEVLNSSPATFGN-----------DLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIA 269
           +PPE +    ++  N           D+W+LGC LY M  G +PF+   ++      II 
Sbjct: 223 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 282

Query: 270 RD--IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
            +  I FP+      +D++   L  DP  R          L  HP+ +
Sbjct: 283 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI-----PELLAHPYVQ 325

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  239 bits (612), Expect = 2e-73
 Identities = 81/316 (25%), Positives = 135/316 (42%), Gaps = 35/316 (11%)

Query: 18  NNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKI 77
              +     +  +     R  +     + +   +  G G+Y +V+  K+ +  +  A+K+
Sbjct: 10  GRENLYFQGIAINPGMYVRKKEGKIG-ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKV 68

Query: 78  MDKKFITKENKTAY----------VKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESC 127
           + K    K   +            +  E  +L  LDHP +++LF  F+D    Y+  E  
Sbjct: 69  IKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFY 128

Query: 128 EGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT---ADGHI 184
           EGGELF+QI ++    E +A     +++  + Y+H   ++HRDIKPEN+LL    +  +I
Sbjct: 129 EGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNI 188

Query: 185 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCT 244
           KI DFG                  D K    +GTA Y+ PEVL         D+W+ G  
Sbjct: 189 KIVDFGLSSFFSK-----------DYKLRDRLGTAYYIAPEVLKKK-YNEKCDVWSCGVI 236

Query: 245 LYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----NYFSDAARDLIDRLLDVDPSGRPGA 300
           +Y +L G  PF   ++  I +++      F        SD A++LI  +L  D + R  A
Sbjct: 237 MYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTA 296

Query: 301 GPGGYAVLKMHPFFKG 316
                  L    + K 
Sbjct: 297 ----EEALN-SRWIKK 307

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  235 bits (601), Expect = 2e-73
 Identities = 51/329 (15%), Positives = 95/329 (28%), Gaps = 72/329 (21%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL--- 102
               G + G       + A   +TG  + + +         N    +K E + L  L   
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 103 ----------------------DHPGVVRLFFTFQDT-----FSLYMALESC---EGGEL 132
                                     ++R+    +D      F LY  ++S     G  L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 133 FDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV 192
               ++   L        T +V+  L  +H  GL+H  ++P +++L   G + +  F  +
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253

Query: 193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-----------SPATFGNDLWAL 241
                                    +  + PPE+              +  TF  D WAL
Sbjct: 254 VRDGARV--------------VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWAL 299

Query: 242 GCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAG 301
           G  +Y +     P    +     + I     R         R L++  L      R    
Sbjct: 300 GLVIYWIWCADLPITKDAALGGSEWI----FRSCKNIPQPVRALLEGFLRYPKEDRLLPL 355

Query: 302 PGGYAVLKMHPFFKGIDWKNIRGQTPPKL 330
                 ++  P +     + +R +    L
Sbjct: 356 ----QAME-TPEY-----EQLRTELSAAL 374

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  233 bits (596), Expect = 2e-73
 Identities = 91/321 (28%), Positives = 150/321 (46%), Gaps = 29/321 (9%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQL 102
           I  + +G + G GSY KV      +T    A+KI+ KK + +  N  A VK E  +L +L
Sbjct: 4   IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL 63

Query: 103 DHPGVVRLF--FTFQDTFSLYMALESCEGG--ELFDQITSKGHLSEDEARFYTAEVVDAL 158
            H  V++L      ++   +YM +E C  G  E+ D +  +      +A  Y  +++D L
Sbjct: 64  RHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV-PEKRFPVCQAHGYFCQLIDGL 122

Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           EY+HS G++H+DIKP NLLLT  G +KI+  G  + +            +DD   T  G+
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA--------ADDTCRTSQGS 174

Query: 219 AAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN 276
            A+ PPE+ N      G   D+W+ G TLY + +G  PF+  + + +F+ I       P 
Sbjct: 175 PAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPG 234

Query: 277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMV 336
                  DL+  +L+ +P+ R          ++ H +F+         + PP  A  P+ 
Sbjct: 235 DCGPPLSDLLKGMLEYEPAKR-----FSIRQIRQHSWFR--------KKHPPAEAPVPIP 281

Query: 337 QSGEGDDVHDSSWNPSHIGDI 357
            S +  D   S     ++ D+
Sbjct: 282 PSPDTKDRWRSMTVVPYLEDL 302

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  231 bits (591), Expect = 6e-73
 Identities = 88/277 (31%), Positives = 134/277 (48%), Gaps = 25/277 (9%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           I  + LG   GVG++ KV   +   TG   A+KI++++ I   +    +K E   L    
Sbjct: 10  IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR 69

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +++L+         +M +E   GGELFD I   G + E EAR    +++ A++Y H 
Sbjct: 70  HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR 129

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC-TFVGTAAYV 222
             ++HRD+KPEN+LL A  + KIADFG            L N  SD +   T  G+  Y 
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFG------------LSNMMSDGEFLRTSCGSPNYA 177

Query: 223 PPEVLN----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
            PEV++    + P     D+W+ G  LY +L GT PF D     +F++I       P Y 
Sbjct: 178 APEVISGRLYAGPEV---DIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYL 234

Query: 279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
           + +   L+  +L VDP  R          ++ H +FK
Sbjct: 235 NRSVATLLMHMLQVDPLKR-----ATIKDIREHEWFK 266

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  229 bits (587), Expect = 2e-72
 Identities = 78/284 (27%), Positives = 131/284 (46%), Gaps = 28/284 (9%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
            +D+E+    G GSY +  + ++   G +   K +D   +T+  K   V  E  +L +L 
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVS-EVNLLRELK 63

Query: 104 HPGVVRLFFTFQDTFS--LYMALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDA 157
           HP +VR +    D  +  LY+ +E CEGG+L   IT     + +L E+       ++  A
Sbjct: 64  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123

Query: 158 LEYIHSMGL-----IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           L+  H         +HRD+KP N+ L    ++K+ DFG  + +                A
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN----------HDTSFA 173

Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI 272
            TFVGT  Y+ PE +N       +D+W+LGC LY++ +   PF   S+  +  +I     
Sbjct: 174 KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF 233

Query: 273 -RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
            R P  +SD   ++I R+L++    RP        +L+ +P   
Sbjct: 234 RRIPYRYSDELNEIITRMLNLKDYHRPSV----EEILE-NPLIL 272

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  230 bits (589), Expect = 4e-72
 Identities = 94/315 (29%), Positives = 144/315 (45%), Gaps = 35/315 (11%)

Query: 37  APQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER 96
              E   I ++ L K  G G+++KV  A+ I TG   A+KI+DK   T+ N T+  KL R
Sbjct: 7   CADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDK---TQLNPTSLQKLFR 63

Query: 97  --IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 154
              ++  L+HP +V+LF   +   +LY+ +E   GGE+FD + + G + E EAR    ++
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI 123

Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           V A++Y H   ++HRD+K ENLLL AD +IKIADFG                    K   
Sbjct: 124 VSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV-----------GGKLDA 172

Query: 215 FVGTAAYVPPEVLN----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR 270
           F G   Y  PE+        P     D+W+LG  LY ++SG+ PF   +   + +R++  
Sbjct: 173 FCGAPPYAAPELFQGKKYDGPEV---DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG 229

Query: 271 DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKL 330
             R P Y S    +L+ R L ++P  R          +    +          G    +L
Sbjct: 230 KYRIPFYMSTDCENLLKRFLVLNPIKRGTL-----EQIMKDRWIN-------AGHEEDEL 277

Query: 331 ASEPMVQSGEGDDVH 345
                 +    D   
Sbjct: 278 KPFVEPELDISDQKR 292

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  229 bits (587), Expect = 6e-72
 Identities = 83/292 (28%), Positives = 124/292 (42%), Gaps = 36/292 (12%)

Query: 21  STNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDK 80
               P    + +             ++ LG + G G +  V    ++      A+K++ +
Sbjct: 7   LQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPR 66

Query: 81  KFITKENKTAY---VKLE----RIVLDQLDHPGVVRLFFTFQDTFSLYMALE-SCEGGEL 132
             +   +  +      LE      V     HPGV+RL   F+      + LE      +L
Sbjct: 67  NRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDL 126

Query: 133 FDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGS 191
           FD IT KG L E  +R +  +VV A+++ HS G++HRDIK EN+L+    G  K+ DFGS
Sbjct: 127 FDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS 186

Query: 192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-----SPATFGNDLWALGCTLY 246
              + D   T             F GT  Y PPE ++       PA     +W+LG  LY
Sbjct: 187 GALLHDEPYT------------DFDGTRVYSPPEWISRHQYHALPA----TVWSLGILLY 230

Query: 247 QMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRP 298
            M+ G  PF+        Q I+  ++ FP + S     LI R L   PS RP
Sbjct: 231 DMVCGDIPFERD------QEILEAELHFPAHVSPDCCALIRRCLAPKPSSRP 276

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  229 bits (587), Expect = 6e-72
 Identities = 84/301 (27%), Positives = 137/301 (45%), Gaps = 40/301 (13%)

Query: 45  QDFELGK-IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL- 102
             ++L + + G G++++V     + T   YA+KI++K+     ++   V  E  +L Q  
Sbjct: 12  DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSR---VFREVEMLYQCQ 68

Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            H  V+ L   F++    Y+  E   GG +   I  + H +E EA     +V  AL+++H
Sbjct: 69  GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH 128

Query: 163 SMGLIHRDIKPENLLLT---ADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           + G+ HRD+KPEN+L         +KI DF     ++ +      +  S  +  T  G+A
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC---SPISTPELLTPCGSA 185

Query: 220 AYVPPEVLNSSPATFGN-----DLWALGCTLYQMLSGTSPF---------------KDTS 259
            Y+ PEV+ +            DLW+LG  LY +LSG  PF                   
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245

Query: 260 EWLIFQRIIARDIRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
           + ++F+ I      FP     + S AA+DLI +LL  D   R  A      VL+ HP+ +
Sbjct: 246 QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSA----AQVLQ-HPWVQ 300

Query: 316 G 316
           G
Sbjct: 301 G 301

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  229 bits (587), Expect = 6e-72
 Identities = 80/292 (27%), Positives = 132/292 (45%), Gaps = 34/292 (11%)

Query: 19  NSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIM 78
             S   P      +      ++      +++G + G G +  V    ++      A+K +
Sbjct: 17  RGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHV 76

Query: 79  DKKFITKENKTAY---VKLERIVLDQLDH--PGVVRLFFTFQDTFSLYMALESCEG-GEL 132
           +K  I+   +      V +E ++L ++     GV+RL   F+   S  + LE  E   +L
Sbjct: 77  EKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDL 136

Query: 133 FDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGS 191
           FD IT +G L E+ AR +  +V++A+ + H+ G++HRDIK EN+L+  + G +K+ DFGS
Sbjct: 137 FDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 196

Query: 192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-----SPATFGNDLWALGCTLY 246
              ++D+  T             F GT  Y PPE +         A     +W+LG  LY
Sbjct: 197 GALLKDTVYT------------DFDGTRVYSPPEWIRYHRYHGRSA----AVWSLGILLY 240

Query: 247 QMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRP 298
            M+ G  PF+        + II   + F    S   + LI   L + PS RP
Sbjct: 241 DMVCGDIPFEHD------EEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRP 286

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  230 bits (588), Expect = 6e-72
 Identities = 92/312 (29%), Positives = 134/312 (42%), Gaps = 42/312 (13%)

Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGV 107
             K  G GS+S   +     +   +A+KI+ K+        A  + E   L   + HP +
Sbjct: 15  KDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNI 68

Query: 108 VRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLI 167
           V+L   F D    ++ +E   GGELF++I  K H SE EA +   ++V A+ ++H +G++
Sbjct: 69  VKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVV 128

Query: 168 HRDIKPENLLLT---ADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
           HRD+KPENLL T    +  IKI DFG  +               +    T   T  Y  P
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPP----------DNQPLKTPCFTLHYAAP 178

Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL-------IFQRIIARDIRFP-- 275
           E+LN +      DLW+LG  LY MLSG  PF+     L       I ++I   D  F   
Sbjct: 179 ELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE 238

Query: 276 --NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASE 333
                S  A+DLI  LL VDP+ R         +   + + +         Q        
Sbjct: 239 AWKNVSQEAKDLIQGLLTVDPNKRLKM----SGLRY-NEWLQD------GSQLSSNPLMT 287

Query: 334 PMVQSGEGDDVH 345
           P +    G  VH
Sbjct: 288 PDILGSSGAAVH 299

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  228 bits (583), Expect = 7e-72
 Identities = 77/283 (27%), Positives = 130/283 (45%), Gaps = 33/283 (11%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           ++D++L +  G G+Y +V  A    T    A+KI+D K      +   +K E  +   L+
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLN 63

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           +G+ HRDIKPENLLL    ++KI+DFG +     ++R  +L             GT  YV
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN---------KMCGTLPYV 174

Query: 223 PPEVLNS-----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL-IFQRIIARDIRFP- 275
            PE+L        P     D+W+ G  L  ML+G  P+   S+    +     +      
Sbjct: 175 APELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP 230

Query: 276 -NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAV--LKMHPFFK 315
                 A   L+ ++L  +PS R         +  +K   ++ 
Sbjct: 231 WKKIDSAPLALLHKILVENPSAR-------ITIPDIKKDRWYN 266

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  229 bits (587), Expect = 8e-72
 Identities = 85/317 (26%), Positives = 144/317 (45%), Gaps = 38/317 (11%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           ++D++L +  G G+Y +V  A    T    A+KI+D K      +   +K E  +   L+
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLN 63

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           +G+ HRDIKPENLLL    ++KI+DFG +     ++R  +L             GT  YV
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN---------KMCGTLPYV 174

Query: 223 PPEVLNS-----SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL-IFQRIIARDIRFP- 275
            PE+L        P     D+W+ G  L  ML+G  P+   S+    +     +      
Sbjct: 175 APELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP 230

Query: 276 -NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAV--LKMHPFFKGIDWKNI-RGQTPPKLA 331
                 A   L+ ++L  +PS R         +  +K   ++     K + +G   P++ 
Sbjct: 231 WKKIDSAPLALLHKILVENPSAR-------ITIPDIKKDRWYN----KPLKKGAKRPRVT 279

Query: 332 SEPMVQSGEGDDVHDSS 348
           S  + +S  G   H  S
Sbjct: 280 SGGVSESPSGFSKHIQS 296

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  231 bits (590), Expect = 1e-71
 Identities = 78/279 (27%), Positives = 136/279 (48%), Gaps = 28/279 (10%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
                +I G G + +V + ++  TG   A KI+  +    ++K   VK E  V++QLDH 
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR--GMKDKEE-VKNEISVMNQLDHA 146

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 164
            +++L+  F+    + + +E  +GGELFD+I  + + L+E +   +  ++ + + ++H M
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM 206

Query: 165 GLIHRDIKPENLLLT--ADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
            ++H D+KPEN+L        IKI DFG + +     ++ V              GT  +
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN------------FGTPEF 254

Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP-NYF-- 278
           + PEV+N    +F  D+W++G   Y +LSG SPF   ++      I+A         F  
Sbjct: 255 LAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQD 314

Query: 279 -SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 316
            S+ A++ I +LL  + S R  A       LK HP+   
Sbjct: 315 ISEEAKEFISKLLIKEKSWRISA----SEALK-HPWLSD 348

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  228 bits (583), Expect = 3e-71
 Identities = 62/268 (23%), Positives = 109/268 (40%), Gaps = 18/268 (6%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           + +   +  G G +S V   + +  G  YALK +      ++      + E  +    +H
Sbjct: 29  KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL---CHEQQDREEAQREADMHRLFNH 85

Query: 105 PGVVRLFFTFQD----TFSLYMALESCEGGELFDQI----TSKGHLSEDEARFYTAEVVD 156
           P ++RL              ++ L   + G L+++I         L+ED+  +    +  
Sbjct: 86  PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145

Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
            LE IH+ G  HRD+KP N+LL  +G   + D GS+       +     A +        
Sbjct: 146 GLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC-IHVEGSRQALTLQDWAAQR 204

Query: 217 GTAAYVPPEVLNSSPATFGN---DLWALGCTLYQMLSGTSPFKDTSEWL-IFQRIIARDI 272
            T +Y  PE+ +       +   D+W+LGC LY M+ G  P+    +        +   +
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264

Query: 273 RFPNY--FSDAARDLIDRLLDVDPSGRP 298
             P     S A   L++ ++ VDP  RP
Sbjct: 265 SIPQSPRHSSALWQLLNSMMTVDPHQRP 292

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  227 bits (580), Expect = 5e-71
 Identities = 79/294 (26%), Positives = 138/294 (46%), Gaps = 19/294 (6%)

Query: 16  GNNNSSTNCPTVQRSKSFAFRAPQEHFS-IQDFELGKIYGVGSYSKVVRAKKIDTGTVYA 74
              +     P V + +      P   ++ + +F + K  G G +S+V RA  +  G   A
Sbjct: 2   DEQSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVA 61

Query: 75  LKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD 134
           LK +    +      A    E  +L QL+HP V++ + +F +   L + LE  + G+L  
Sbjct: 62  LKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSR 121

Query: 135 QI----TSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 190
            I      K  + E     Y  ++  ALE++HS  ++HRDIKP N+ +TA G +K+ D G
Sbjct: 122 MIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLG 181

Query: 191 SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS 250
             +             +    A + VGT  Y+ PE ++ +   F +D+W+LGC LY+M +
Sbjct: 182 LGRFFS----------SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA 231

Query: 251 GTSPF--KDTSEWLIFQRIIARDIR--FPNYFSDAARDLIDRLLDVDPSGRPGA 300
             SPF     + + + ++I   D      +++S+  R L++  ++ DP  RP  
Sbjct: 232 LQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDV 285

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  233 bits (595), Expect = 3e-70
 Identities = 82/327 (25%), Positives = 139/327 (42%), Gaps = 33/327 (10%)

Query: 5   EKDFDSKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQD-----FELGKIYGVGSYS 59
             D D + +I     + ++         +    PQ      D     +++ +  G G++ 
Sbjct: 112 GYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFG 171

Query: 60  KVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS 119
            V R  +  TG  +A K +       E+    V+ E   +  L HP +V L   F+D   
Sbjct: 172 VVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE 228

Query: 120 LYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL 178
           + M  E   GGELF+++  +   +SEDEA  Y  +V   L ++H    +H D+KPEN++ 
Sbjct: 229 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMF 288

Query: 179 T--ADGHIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFG 235
           T      +K+ DFG +        + V              GTA +  PEV    P  + 
Sbjct: 289 TTKRSNELKLIDFGLTAHLDPKQSVKVT------------TGTAEFAAPEVAEGKPVGYY 336

Query: 236 NDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP-NYF---SDAARDLIDRLLD 291
            D+W++G   Y +LSG SPF   ++    + + + D     + F   S+  +D I +LL 
Sbjct: 337 TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLL 396

Query: 292 VDPSGRPGAGPGGYAVLKMHPFFKGID 318
            DP+ R       +  L+ HP+    +
Sbjct: 397 ADPNTRMTI----HQALE-HPWLTPGN 418

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  229 bits (585), Expect = 9e-70
 Identities = 91/305 (29%), Positives = 140/305 (45%), Gaps = 32/305 (10%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           I  + LG   GVG++ KV   K   TG   A+KI++++ I   +    ++ E   L    
Sbjct: 15  IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR 74

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +++L+        ++M +E   GGELFD I   G L E E+R    +++  ++Y H 
Sbjct: 75  HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHR 134

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC-TFVGTAAYV 222
             ++HRD+KPEN+LL A  + KIADFG            L N  SD +   T  G+  Y 
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFG------------LSNMMSDGEFLRTSCGSPNYA 182

Query: 223 PPEVLN----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
            PEV++    + P     D+W+ G  LY +L GT PF D     +F++I       P Y 
Sbjct: 183 APEVISGRLYAGPEV---DIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYL 239

Query: 279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQS 338
           + +   L+  +L VDP  R          ++ H +FK       +         +P   S
Sbjct: 240 NPSVISLLKHMLQVDPMKR-----ATIKDIREHEWFK-------QDLPKYLFPEDPSYSS 287

Query: 339 GEGDD 343
              DD
Sbjct: 288 TMIDD 292

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  222 bits (569), Expect = 6e-69
 Identities = 87/283 (30%), Positives = 135/283 (47%), Gaps = 26/283 (9%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
                 I  + + +  G GS+ KV  A    T    ALK + ++ + K +    V+ E  
Sbjct: 2   AISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREIS 61

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
            L  L HP +++L+        + M +E   GGELFD I  K  ++EDE R +  +++ A
Sbjct: 62  YLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICA 120

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC-TFV 216
           +EY H   ++HRD+KPENLLL  + ++KIADFG            L N  +D     T  
Sbjct: 121 IEYCHRHKIVHRDLKPENLLLDDNLNVKIADFG------------LSNIMTDGNFLKTSC 168

Query: 217 GTAAYVPPEVLN----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI 272
           G+  Y  PEV+N    + P     D+W+ G  LY ML G  PF D     +F+++ +   
Sbjct: 169 GSPNYAAPEVINGKLYAGPEV---DVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVY 225

Query: 273 RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
             P++ S  A+ LI R++  DP  R          ++  P+F 
Sbjct: 226 VMPDFLSPGAQSLIRRMIVADPMQR-----ITIQEIRRDPWFN 263

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  221 bits (566), Expect = 3e-68
 Identities = 91/312 (29%), Positives = 134/312 (42%), Gaps = 43/312 (13%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
              ++  K  G G++      +   T  + A+K +++     EN    V+ E I    L 
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN----VQREIINHRSLR 74

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           HP +VR          L + +E   GGEL+++I + G  SEDEARF+  +++  + Y HS
Sbjct: 75  HPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHS 134

Query: 164 MGLIHRDIKPENLLLTAD--GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           M + HRD+K EN LL       +KI DFG  K                 +  + VGT AY
Sbjct: 135 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-----------HSQPKSTVGTPAY 183

Query: 222 VPPEVLN----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIF----QRIIARDIR 273
           + PEVL             D+W+ G TLY ML G  PF+D  E   +    QRI++    
Sbjct: 184 IAPEVLLRQEYDGKIA---DVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYS 240

Query: 274 FPN--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLA 331
            P+    S     LI R+   DP+ R          +K H +F     KN+    P  L 
Sbjct: 241 IPDDIRISPECCHLISRIFVADPATR-----ISIPEIKTHSWFL----KNL----PADLM 287

Query: 332 SEPMVQSGEGDD 343
           +E    S   + 
Sbjct: 288 NESNTGSQFQEP 299

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  221 bits (564), Expect = 2e-67
 Identities = 43/310 (13%), Positives = 82/310 (26%), Gaps = 56/310 (18%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL---- 102
              G + G       + A   +TG  + + +         N    +K E + L  L    
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 103 ---------------------DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQIT 137
                                    ++R+    +D +                   + + 
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 138 SK----GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK 193
           S       L        T +V+  L  +H  GL+H  ++P +++L   G + +  F  + 
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259

Query: 194 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA-----TFGNDLWALGCTLYQM 248
               S ++                        +L          TF  D W LG  +Y +
Sbjct: 260 RDGASAVS---------PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310

Query: 249 LSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVL 308
                P  D +     + I       P       R L++  L      R           
Sbjct: 311 WCADLPNTDDAALGGSEWIFRSCKNIP----QPVRALLEGFLRYPKEDRLLP-----LQA 361

Query: 309 KMHPFFKGID 318
              P ++ + 
Sbjct: 362 METPEYEQLR 371

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  216 bits (553), Expect = 8e-67
 Identities = 58/308 (18%), Positives = 116/308 (37%), Gaps = 59/308 (19%)

Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
            +  S   + L  I G G+ + V R +   TG ++A+K+ +     +         E  V
Sbjct: 3   SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDV--QMREFEV 60

Query: 99  LDQLDHPGVVRLFFTFQDTFS--LYMALESCEGGELFDQITSKGH---LSEDEARFYTAE 153
           L +L+H  +V+LF   ++T +    + +E C  G L+  +    +   L E E      +
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120

Query: 154 VVDALEYIHSMGLIHRDIKPENLLLT----ADGHIKIADFGSVKPMQDSRITVLPNAASD 209
           VV  + ++   G++HR+IKP N++           K+ DFG+ + ++D           D
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-----------D 169

Query: 210 DKACTFVGTAAYVPPEVLNSSPATFGN--------DLWALGCTLYQMLSGTSPFKDT--- 258
           ++  +  GT  Y+ P++   +     +        DLW++G T Y   +G+ PF+     
Sbjct: 170 EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229

Query: 259 --------------------------SEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDV 292
                                     +  + +   +                ++  +L+ 
Sbjct: 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA 289

Query: 293 DPSGRPGA 300
           D     G 
Sbjct: 290 DQEKCWGF 297

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  215 bits (550), Expect = 1e-66
 Identities = 74/295 (25%), Positives = 128/295 (43%), Gaps = 31/295 (10%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           + DFE  +  G G +  V  AK       YA+K +         +      E   L +L+
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKV--MREVKALAKLE 61

Query: 104 HPGVVRLFFTFQD------------TFSLYMALESCEGGELFDQITSKGHLSEDEARF-- 149
           HPG+VR F  + +               LY+ ++ C    L D +  +  + E E     
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 150 -YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ--DSRITVLPNA 206
               ++ +A+E++HS GL+HRD+KP N+  T D  +K+ DFG V  M   +   TVL   
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 207 ASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQR 266
            +  +    VGT  Y+ PE ++ +  +   D+++LG  L+++L    PF    E +    
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFSTQMERVRTLT 238

Query: 267 IIARDIRFP---NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID 318
            + R+++FP            ++  +L   P  RP A       +  +  F+ +D
Sbjct: 239 DV-RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEA-----INIIENAVFEDLD 287

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  216 bits (552), Expect = 2e-66
 Identities = 80/291 (27%), Positives = 122/291 (41%), Gaps = 44/291 (15%)

Query: 45  QDFELGK-IYGVGSYSKVVRAKKIDTGTVYALKIMDK-KFITKENKTAYVKLERIVLDQL 102
            D++L K + G+G   KV+      TG   ALK++       +E                
Sbjct: 28  DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQE--------VDHHWQAS 79

Query: 103 DHPGVVRLFFTFQDTF----SLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 156
             P +V +   +++       L + +E  EGGELF +I  +G    +E EA     ++  
Sbjct: 80  GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGT 139

Query: 157 ALEYIHSMGLIHRDIKPENLLLT---ADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           A++++HS  + HRD+KPENLL T    D  +K+ DFG  K    + +             
Sbjct: 140 AIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ------------ 187

Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW----LIFQRIIA 269
           T   T  YV PEVL         D+W+LG  +Y +L G  PF   +       + +RI  
Sbjct: 188 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL 247

Query: 270 RDIRFPN----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 316
               FPN      S+ A+ LI  LL  DP+ R          +  HP+   
Sbjct: 248 GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTI----TQFMN-HPWINQ 293

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  215 bits (548), Expect = 1e-65
 Identities = 49/344 (14%), Positives = 98/344 (28%), Gaps = 66/344 (19%)

Query: 20  SSTNCPTVQRSKSFAFRAPQEHFSI-----QDFELGKIYGVGSYSKVVRAKKIDTGTVYA 74
                     +  +   A     S+     +  +L +   VG  S V   + ++    +A
Sbjct: 32  EPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFA 91

Query: 75  LKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ------------------- 115
           LK+         ++   +        +L            +                   
Sbjct: 92  LKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQL 151

Query: 116 -------DTFSLYMALESCEG------GELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
                     +  + + +           L      +G          TA+++     + 
Sbjct: 152 SPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ 211

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S GL+H    P+NL +  DG + + D  ++  +               +         Y 
Sbjct: 212 SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV-------------GTRGPASSVPVTYA 258

Query: 223 PPEVLNSS--PATFGNDLWALGCTLYQMLSGTSPFKDTSEWL--IFQRIIARDIRFPNY- 277
           P E LN+S    T   + W LG ++Y++     PF   +  +   ++R   R     +  
Sbjct: 259 PREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLA 318

Query: 278 ------FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
                   D  + LI R L+ D   R          ++  P F 
Sbjct: 319 FGSCTPLPDFVKTLIGRFLNFDRRRRLLPL----EAME-TPEFL 357

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  214 bits (547), Expect = 5e-65
 Identities = 58/308 (18%), Positives = 115/308 (37%), Gaps = 59/308 (19%)

Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
            +  S   + L  I G G+ + V R +   TG ++A+K+ +     +         E  V
Sbjct: 3   SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVD--VQMREFEV 60

Query: 99  LDQLDHPGVVRLFFTFQD--TFSLYMALESCEGGELFDQITSKGH---LSEDEARFYTAE 153
           L +L+H  +V+LF   ++  T    + +E C  G L+  +    +   L E E      +
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120

Query: 154 VVDALEYIHSMGLIHRDIKPENLLLT----ADGHIKIADFGSVKPMQDSRITVLPNAASD 209
           VV  + ++   G++HR+IKP N++           K+ DFG+ + ++D           D
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-----------D 169

Query: 210 DKACTFVGTAAYVPPEVLNSSPATFGN--------DLWALGCTLYQMLSGTSPFKDT--- 258
           ++  +  GT  Y+ P++   +     +        DLW++G T Y   +G+ PF+     
Sbjct: 170 EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229

Query: 259 --------------------------SEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDV 292
                                     +  + +   +                ++  +L+ 
Sbjct: 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA 289

Query: 293 DPSGRPGA 300
           D     G 
Sbjct: 290 DQEKCWGF 297

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  215 bits (549), Expect = 7e-65
 Identities = 75/309 (24%), Positives = 129/309 (41%), Gaps = 39/309 (12%)

Query: 27  VQRSKSFAFRAPQEHFSI-----QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKK 81
           +  S S       E  S+       F    + G G+   +V           A+K +  +
Sbjct: 1   MGSSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRILPE 59

Query: 82  FITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG 140
             +  ++      E  +L + D HP V+R F T +D    Y+A+E C    L + +  K 
Sbjct: 60  CFSFADR------EVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKD 112

Query: 141 H-LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-----IKIADFGSVKP 194
                 E      +    L ++HS+ ++HRD+KP N+L++           I+DFG  K 
Sbjct: 113 FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172

Query: 195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP---ATFGNDLWALGCTLYQMLS- 250
           +   R        S  +     GT  ++ PE+L+       T+  D+++ GC  Y ++S 
Sbjct: 173 LAVGR-------HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225

Query: 251 GTSPFKDTSEWLIFQRIIARDIRFPNYF---SDAARDLIDRLLDVDPSGRPGAGPGGYAV 307
           G+ PF  + +      + A  +   +        AR+LI++++ +DP  RP A      V
Sbjct: 226 GSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAK----HV 281

Query: 308 LKMHPFFKG 316
           LK HPFF  
Sbjct: 282 LK-HPFFWS 289

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  210 bits (536), Expect = 9e-65
 Identities = 64/287 (22%), Positives = 106/287 (36%), Gaps = 19/287 (6%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
            +F   +  G G +  V +  K   G +YA+K   K      ++   ++          H
Sbjct: 11  TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQIT----SKGHLSEDEARFYTAEVVDALEY 160
             VVR F  + +   + +  E C GG L D I+       +  E E +    +V   L Y
Sbjct: 71  SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130

Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV-----LPNAASDDKACTF 215
           IHSM L+H DIKP N+ ++       A     +    S   +     L +          
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE 190

Query: 216 VGTAAYVPPEVLN-SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-R 273
            G + ++  EVL  +       D++AL  T+          ++  +W     I    + R
Sbjct: 191 EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW---HEIRQGRLPR 247

Query: 274 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK 320
            P   S    +L+  ++  DP  RP A     A++K H        K
Sbjct: 248 IPQVLSQEFTELLKVMIHPDPERRPSA----MALVK-HSVLLSASRK 289

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  211 bits (538), Expect = 1e-63
 Identities = 79/323 (24%), Positives = 139/323 (43%), Gaps = 48/323 (14%)

Query: 17  NNNSSTNCPTVQRSKSFAFRA---PQEHFSIQDFEL-GKIYGVGSYSKVVRAKKIDTGTV 72
           +  +    P  Q+   F  ++    +++  I D+++  ++ G+G   KV++     T   
Sbjct: 30  HPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEK 89

Query: 73  YALKIMDKKFITKENKTAYVKLE-RIVLDQLDHPGVVRLFFTFQDTFS----LYMALESC 127
           +ALK++      +         E  +       P +VR+   +++ ++    L + +E  
Sbjct: 90  FALKMLQDCPKARR--------EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 141

Query: 128 EGGELFDQITSKGHL--SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT---ADG 182
           +GGELF +I  +G    +E EA      + +A++Y+HS+ + HRD+KPENLL T    + 
Sbjct: 142 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA 201

Query: 183 HIKIADFG-SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWAL 241
            +K+ DFG + +    + +T            T   T  YV PEVL         D+W+L
Sbjct: 202 ILKLTDFGFAKETTSHNSLT------------TPCYTPYYVAPEVLGPEKYDKSCDMWSL 249

Query: 242 GCTLYQMLSGTSPFKDTSEWL----IFQRIIARDIRFPNYF----SDAARDLIDRLLDVD 293
           G  +Y +L G  PF           +  RI      FPN      S+  + LI  LL  +
Sbjct: 250 GVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTE 309

Query: 294 PSGRPGAGPGGYAVLKMHPFFKG 316
           P+ R          +  HP+   
Sbjct: 310 PTQRMTI----TEFMN-HPWIMQ 327

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  209 bits (534), Expect = 1e-62
 Identities = 80/308 (25%), Positives = 118/308 (38%), Gaps = 57/308 (18%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD- 103
                 KI G GS   VV       G   A+K M   F           +E  +L + D 
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDI------ALMEIKLLTESDD 67

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE-------VVD 156
           HP V+R + +      LY+ALE C    L D + SK    E+               +  
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126

Query: 157 ALEYIHSMGLIHRDIKPENLLLT-------------ADGHIKIADFGSVKPMQDSRITVL 203
            + ++HS+ +IHRD+KP+N+L++              +  I I+DFG  K +   + +  
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186

Query: 204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGN-------DLWALGCTLYQMLS-GTSPF 255
            N           GT+ +  PE+L  S             D++++GC  Y +LS G  PF
Sbjct: 187 TNLN------NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240

Query: 256 KDTSEWLIFQRIIARDIRFPNY-------FSDAARDLIDRLLDVDPSGRPGAGPGGYAVL 308
            D         II                    A DLI +++D DP  RP A      VL
Sbjct: 241 GDKYS--RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAM----KVL 294

Query: 309 KMHPFFKG 316
           + HP F  
Sbjct: 295 R-HPLFWP 301

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  200 bits (510), Expect = 2e-60
 Identities = 76/315 (24%), Positives = 127/315 (40%), Gaps = 38/315 (12%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHP 105
             + ++   G ++ V  A+ + +G  YALK +      +E K   +  E   + +L  HP
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHP 86

Query: 106 GVVRLFFTFQDTFS-------LYMALESCEGGELFDQIT---SKGHLSEDEARFYTAEVV 155
            +V+                  ++ L     G+L + +    S+G LS D       +  
Sbjct: 87  NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146

Query: 156 DALEYIHSMG--LIHRDIKPENLLLTADGHIKIADFGSVKPMQ---DSRITVLPNAASDD 210
            A++++H     +IHRD+K ENLLL+  G IK+ DFGS   +    D   +    A  ++
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206

Query: 211 KACTFVGTAAYVPPEVLNSS---PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
           +  T   T  Y  PE+++     P     D+WALGC LY +     PF+D +      RI
Sbjct: 207 EI-TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA----KLRI 261

Query: 268 IARDIRFPNY--FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ 325
           +      P +         LI  +L V+P  R         V+         +    R  
Sbjct: 262 VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSI----AEVVH-QLQ----EIAAARNV 312

Query: 326 TPPKLASEPMVQSGE 340
            P    +E + Q+G 
Sbjct: 313 NPKSPITELLEQNGG 327

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  202 bits (514), Expect = 6e-58
 Identities = 71/312 (22%), Positives = 116/312 (37%), Gaps = 54/312 (17%)

Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           +   +E+ +  G G +  V+R    DTG   A+K   ++   K  +     LE  ++ +L
Sbjct: 12  TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRER--WCLEIQIMKKL 69

Query: 103 DHPGVVRLFFTFQDTFSL------YMALESCEGGELFDQITSKGH---LSEDEARFYTAE 153
           +HP VV           L       +A+E CEGG+L   +    +   L E   R   ++
Sbjct: 70  NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129

Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPNAASDD 210
           +  AL Y+H   +IHRD+KPEN++L         KI D G  K +              +
Sbjct: 130 ISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ-----------GE 178

Query: 211 KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR 270
               FVGT  Y+ PE+L     T   D W+ G   ++ ++G  PF    + + +   +  
Sbjct: 179 LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE 238

Query: 271 DIRF--------------------PNYFSDAARDLIDRL----LDVDPSGRPGAGPGGYA 306
                                   PN+ S      ++R     L      R     G   
Sbjct: 239 KSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQR-----GTDP 293

Query: 307 VLKMHPFFKGID 318
                  F+ +D
Sbjct: 294 QNPNVGCFQALD 305

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  190 bits (485), Expect = 4e-57
 Identities = 67/294 (22%), Positives = 117/294 (39%), Gaps = 68/294 (23%)

Query: 44  IQDFEL-GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE-RIVLDQ 101
           I D+++  ++ G+G   KV++     T   +ALK++      +         E  +    
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRA 67

Query: 102 LDHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGHL--SEDEARFYTAEVV 155
              P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + 
Sbjct: 68  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 127

Query: 156 DALEYIHSMGLIHRDIKPENLLLT---ADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           +A++Y+HS+ + HRD+KPENLL T    +  +K+ DFG                      
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG---------------------- 165

Query: 213 CTFVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWL----IFQR 266
                       E        +    D+W+LG  +Y +L G  PF           +  R
Sbjct: 166 ---------FAKETTGEK---YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 213

Query: 267 IIARDIRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 316
           I      FP    +  S+  + LI  LL  +P+ R          +  HP+   
Sbjct: 214 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI----TEFMN-HPWIMQ 262

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  190 bits (485), Expect = 1e-56
 Identities = 72/312 (23%), Positives = 121/312 (38%), Gaps = 31/312 (9%)

Query: 10  SKLRIEGNNNSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDT 69
            +L  E  +N         +   + +R      + Q   +G+    GS+ +V R K   T
Sbjct: 28  QRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPR-VGR----GSFGEVHRMKDKQT 82

Query: 70  GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG 129
           G   A+K +  +    E        E +    L  P +V L+   ++   + + +E  EG
Sbjct: 83  GFQCAVKKVRLEVFRVE--------ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134

Query: 130 GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-HIKIAD 188
           G L   I   G L ED A +Y  + ++ LEY+H+  ++H D+K +N+LL++DG    + D
Sbjct: 135 GSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCD 194

Query: 189 FGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQM 248
           FG         +       S        GT  ++ PEV+   P     D+W+  C +  M
Sbjct: 195 FGHAL-----CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHM 249

Query: 249 LSGTSPFKDTSEW-LIFQRIIARD----IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPG 303
           L+G  P+       L  +  IA +       P   +      I   L  +P  R  A   
Sbjct: 250 LNGCHPWTQYFRGPLCLK--IASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASA--- 304

Query: 304 GYAVLKMHPFFK 315
               L+      
Sbjct: 305 --MELRRKVGKA 314

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  188 bits (478), Expect = 2e-55
 Identities = 41/284 (14%), Positives = 86/284 (30%), Gaps = 42/284 (14%)

Query: 41  HFSIQDFELGKIYGVGSYSKVVRAKKID-----TGTVYALKIMDKKFITKENKTAYVKLE 95
               +   +  + G G++++V  A + D         + LK+       +          
Sbjct: 61  QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIG---TQL 117

Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-----TSKGHLSEDEARFY 150
              L        ++ +          +  E    G L + I     T +  + +     +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177

Query: 151 TAEVVDALEYIHSMGLIHRDIKPENLLLT-----------ADGHIKIADFGSVKPMQDSR 199
              ++  +E +H   +IH DIKP+N +L                + + D G    M+   
Sbjct: 178 AMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237

Query: 200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF--KD 257
                             T+ +   E+L++ P  +  D + +  T+Y ML GT      +
Sbjct: 238 --------KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNE 289

Query: 258 TSEWLIFQRIIARDIRFPNYF-SDAARDLIDRLLDVDPSGRPGA 300
             E             F      D   +    +L++       +
Sbjct: 290 GGECKPEG-------LFRRLPHLDMWNEFFHVMLNIPDCHHLPS 326

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  177 bits (451), Expect = 8e-52
 Identities = 56/254 (22%), Positives = 106/254 (41%), Gaps = 19/254 (7%)

Query: 73  YALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL 132
           +         ++  +      ++   +D       V           LY+ ++ C    L
Sbjct: 89  WLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENL 148

Query: 133 FDQITSKGHLSEDE---ARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADF 189
            D +  +  L + E         ++ +A+E++HS GL+HRD+KP N+  T D  +K+ DF
Sbjct: 149 KDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 208

Query: 190 GSVKPMQDS--RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQ 247
           G V  M       TVL    +       VGT  Y+ PE ++ +  +   D+++LG  L++
Sbjct: 209 GLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE 268

Query: 248 MLSGTSPFKDTSE-WLIFQRIIARDIRFPNYF---SDAARDLIDRLLDVDPSGRPGAGPG 303
           +L     F    E   I   +  R+++FP  F         ++  +L   P+ RP A   
Sbjct: 269 LL---YSFSTQMERVRIITDV--RNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEA--- 320

Query: 304 GYAVLKMHPFFKGI 317
              +++ +  F+ +
Sbjct: 321 -TDIIE-NAIFENL 332

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 53.0 bits (127), Expect = 9e-08
 Identities = 23/83 (27%), Positives = 33/83 (39%), Gaps = 2/83 (2%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
            DFE  +  G G +  V  AK       YA+K +         +   V  E   L +L+H
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREK--VMREVKALAKLEH 63

Query: 105 PGVVRLFFTFQDTFSLYMALESC 127
           PG+VR F  + +T       E  
Sbjct: 64  PGIVRYFNAWLETPPEKWQEEMD 86

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  172 bits (438), Expect = 3e-50
 Identities = 74/291 (25%), Positives = 129/291 (44%), Gaps = 33/291 (11%)

Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER-- 96
           +  +   +     + G G+Y  V   + +      A+K      I + +      L    
Sbjct: 16  EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKE-----IPERDSRYSQPLHEEI 70

Query: 97  IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEA--RFYTAE 153
            +   L H  +V+   +F +   + + +E   GG L   + SK G L ++E    FYT +
Sbjct: 71  ALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ 130

Query: 154 VVDALEYIHSMGLIHRDIKPENLLL-TADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           +++ L+Y+H   ++HRDIK +N+L+ T  G +KI+DFG+ K +                 
Sbjct: 131 ILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN----------PCT 180

Query: 213 CTFVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWL--IFQRII 268
            TF GT  Y+ PE+++  P  +G   D+W+LGCT+ +M +G  PF +  E    +F ++ 
Sbjct: 181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF-KVG 239

Query: 269 ARDIR--FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI 317
              +    P   S  A+  I +  + DP  R  A       L +  F K  
Sbjct: 240 MFKVHPEIPESMSAEAKAFILKCFEPDPDKRACA-----NDLLVDEFLKVS 285

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  170 bits (433), Expect = 2e-49
 Identities = 79/281 (28%), Positives = 134/281 (47%), Gaps = 28/281 (9%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P+E F+  + ++GK    GS+ +V +     T  V A+KI+D +    E++   ++ E  
Sbjct: 20  PEELFTKLE-KIGK----GSFGEVFKGIDNRTQKVVAIKIIDLE--EAEDEIEDIQQEIT 72

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           VL Q D P V + + ++     L++ +E   GG   D +     L E +      E++  
Sbjct: 73  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREILKG 131

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           L+Y+HS   IHRDIK  N+LL+  G +K+ADFG    + D++           K  TFVG
Sbjct: 132 LDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ----------IKRNTFVG 181

Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE-WLIFQRIIARDI--RF 274
           T  ++ PEV+  S      D+W+LG T  ++  G  P  +     ++F  +I ++     
Sbjct: 182 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF--LIPKNNPPTL 239

Query: 275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
              +S   ++ ++  L+ +PS RP A       L  H F  
Sbjct: 240 EGNYSKPLKEFVEACLNKEPSFRPTA-----KELLKHKFIL 275

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  164 bits (417), Expect = 4e-47
 Identities = 80/287 (27%), Positives = 134/287 (46%), Gaps = 32/287 (11%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P E + I   ELG     G++ KV +AK  +TG + A K+++      E +     +E  
Sbjct: 17  PNEVWEIVG-ELGD----GAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIE 68

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVD 156
           +L   DHP +V+L   +     L++ +E C GG +   +      L+E + +    ++++
Sbjct: 69  ILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLE 128

Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           AL ++HS  +IHRD+K  N+L+T +G I++ADFG       +            K  +F+
Sbjct: 129 ALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL----------QKRDSFI 178

Query: 217 GTAAYVPPEVLNSSPATFGN-----DLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 271
           GT  ++ PEV+              D+W+LG TL +M     P  + +   +  +I   D
Sbjct: 179 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD 238

Query: 272 ---IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
              +  P+ +S   RD +   LD +P  RP A     A L  HPF  
Sbjct: 239 PPTLLTPSKWSVEFRDFLKIALDKNPETRPSA-----AQLLEHPFVS 280

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  162 bits (412), Expect = 2e-46
 Identities = 76/308 (24%), Positives = 128/308 (41%), Gaps = 38/308 (12%)

Query: 28  QRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN 87
           + S +  +   ++ + +Q+     I G G+ + V  A         A+K ++      + 
Sbjct: 3   EDSSALPWSINRDDYELQE----VI-GSGATAVVQAAYCAPKKEKVAIKRIN--LEKCQT 55

Query: 88  KTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-------- 139
               +  E   + Q  HP +V  + +F     L++ ++   GG + D I           
Sbjct: 56  SMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKS 115

Query: 140 GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG-SVKPMQDS 198
           G L E        EV++ LEY+H  G IHRD+K  N+LL  DG ++IADFG S      +
Sbjct: 116 GVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS------A 169

Query: 199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKD 257
            +    +   +    TFVGT  ++ PEV+       F  D+W+ G T  ++ +G +P+  
Sbjct: 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK 229

Query: 258 TSE----WLIFQ------RIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAV 307
                   L  Q          +D      +  + R +I   L  DP  RP A      +
Sbjct: 230 YPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAA----EL 285

Query: 308 LKMHPFFK 315
           L+ H FF+
Sbjct: 286 LR-HKFFQ 292

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  162 bits (411), Expect = 5e-46
 Identities = 79/281 (28%), Positives = 134/281 (47%), Gaps = 27/281 (9%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P+           KI G GS   V  A++  +G   A+K+MD   + K+ +   +  E +
Sbjct: 43  PRLLLDS----YVKI-GEGSTGIVCLAREKHSGRQVAVKMMD---LRKQQRRELLFNEVV 94

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           ++    H  VV ++ ++     L++ +E  +GG L D I S+  L+E++       V+ A
Sbjct: 95  IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQA 153

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           L Y+H+ G+IHRDIK +++LLT DG +K++DFG    +               K  + VG
Sbjct: 154 LAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV----------PKRKSLVG 203

Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRF 274
           T  ++ PEV++ S      D+W+LG  + +M+ G  P+   S     +R+       ++ 
Sbjct: 204 TPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKN 263

Query: 275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
            +  S   RD ++R+L  DP  R  A       L  HPF  
Sbjct: 264 SHKVSPVLRDFLERMLVRDPQERATA-----QELLDHPFLL 299

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  161 bits (409), Expect = 8e-46
 Identities = 77/291 (26%), Positives = 128/291 (43%), Gaps = 27/291 (9%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
             I D E     G G+  +V + +   TG V A+K M +    +ENK   + L+ +VL  
Sbjct: 22  AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLD-VVLKS 80

Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
            D P +V+ F TF     +++A+E         +   +G + E      T  +V AL Y+
Sbjct: 81  HDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYL 140

Query: 162 HS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
               G+IHRD+KP N+LL   G IK+ DFG    + D +                 G AA
Sbjct: 141 KEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK-----------AKDRSAGCAA 189

Query: 221 YVPPEVLNSSPATFGN-----DLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIARDI-R 273
           Y+ PE ++    T  +     D+W+LG +L ++ +G  P+K+  +++ +  +++  +   
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL 249

Query: 274 FPN--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 322
            P    FS   +  +   L  D   RP      Y  L  H F K  +   +
Sbjct: 250 LPGHMGFSGDFQSFVKDCLTKDHRKRP-----KYNKLLEHSFIKRYETLEV 295

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  160 bits (406), Expect = 1e-45
 Identities = 73/281 (25%), Positives = 127/281 (45%), Gaps = 27/281 (9%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P++ ++       KI G G+   V  A  + TG   A++ M+   + ++ K   +  E +
Sbjct: 18  PKKKYTR----FEKI-GQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEIL 69

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           V+ +  +P +V    ++     L++ +E   GG L D + ++  + E +      E + A
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQA 128

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           LE++HS  +IHRDIK +N+LL  DG +K+ DFG    +   +           K  T VG
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ----------SKRSTMVG 178

Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRF 274
           T  ++ PEV+         D+W+LG    +M+ G  P+ + +       I       ++ 
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN 238

Query: 275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
           P   S   RD ++R L++D   R  A       L  H F K
Sbjct: 239 PEKLSAIFRDFLNRCLEMDVEKRGSA-----KELLQHQFLK 274

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  161 bits (408), Expect = 5e-45
 Identities = 73/381 (19%), Positives = 128/381 (33%), Gaps = 63/381 (16%)

Query: 34  AFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVK 93
           +F      + +    +GK  G      V  A+   TG    ++ ++ +  + E  T    
Sbjct: 19  SFLPEGGCYELLT-VIGK--GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQG 75

Query: 94  LERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITS--KGHLSEDEARFYT 151
            E  V    +HP +V    TF     L++       G   D I +     ++E    +  
Sbjct: 76  -ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYIL 134

Query: 152 AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDK 211
             V+ AL+YIH MG +HR +K  ++L++ DG + ++   S   M              D 
Sbjct: 135 QGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS---HGQRQRVVHDF 191

Query: 212 ACTFVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKD------------ 257
               V    ++ PEVL  +   +    D++++G T  ++ +G  PFKD            
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN 251

Query: 258 ----------------------------------TSEWLIFQRIIARDIRFPNYFSDAAR 283
                                             T+         +    +   FS    
Sbjct: 252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFH 311

Query: 284 DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEGDD 343
             +++ L  +P  RP A     + L  H FFK I  +      P  L     + + EG  
Sbjct: 312 HFVEQCLQRNPDARPSA-----STLLNHSFFKQIK-RRASEALPELLRPVTPITNFEGSQ 365

Query: 344 VHDSSWNPSHIGDISAKINDG 364
             D S     + ++     D 
Sbjct: 366 SQDHSGIFGLVTNLEELEVDD 386

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  159 bits (404), Expect = 9e-45
 Identities = 75/301 (24%), Positives = 120/301 (39%), Gaps = 30/301 (9%)

Query: 25  PTVQRSKSFAFRAPQEHFSIQD----FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDK 80
           P   R+ S       E F   D    F   +  G GS+  V  A+ +    V A+K M  
Sbjct: 30  PAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSY 89

Query: 81  KFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG 140
                  K   +  E   L +L HP  ++    +    + ++ +E C G         K 
Sbjct: 90  SGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK 149

Query: 141 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 200
            L E E    T   +  L Y+HS  +IHRD+K  N+LL+  G +K+ DFGS         
Sbjct: 150 PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGS--------- 200

Query: 201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGN---DLWALGCTLYQMLSGTSPFKD 257
                A+    A +FVGT  ++ PEV+ +      +   D+W+LG T  ++     P  +
Sbjct: 201 -----ASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 255

Query: 258 TSEWLIFQRIIARD---IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 314
            +       I   +   ++  + +S+  R+ +D  L   P  RP +      VL  H F 
Sbjct: 256 MNAMSALYHIAQNESPALQSGH-WSEYFRNFVDSCLQKIPQDRPTS-----EVLLKHRFV 309

Query: 315 K 315
            
Sbjct: 310 L 310

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  157 bits (399), Expect = 2e-44
 Identities = 84/284 (29%), Positives = 129/284 (45%), Gaps = 33/284 (11%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P+E F + +    K+ G GSY  V +A   +TG + A+K +    +  + +   +  E  
Sbjct: 27  PEEVFDVLE----KL-GEGSYGSVYKAIHKETGQIVAIKQVP---VESDLQE--IIKEIS 76

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVD 156
           ++ Q D P VV+ + ++     L++ +E C  G + D I      L+EDE        + 
Sbjct: 77  IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLK 136

Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
            LEY+H M  IHRDIK  N+LL  +GH K+ADFG    + D+            K  T +
Sbjct: 137 GLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM----------AKRNTVI 186

Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQRIIARD---- 271
           GT  ++ PEV+         D+W+LG T  +M  G  P+ D      IF  +I  +    
Sbjct: 187 GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF--MIPTNPPPT 244

Query: 272 IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
            R P  +SD   D + + L   P  R  A       L  HPF +
Sbjct: 245 FRKPELWSDNFTDFVKQCLVKSPEQRATA-----TQLLQHPFVR 283

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  156 bits (397), Expect = 2e-44
 Identities = 68/292 (23%), Positives = 123/292 (42%), Gaps = 28/292 (9%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
               D E     G G+Y  V + + + +G + A+K +     ++E K   + L+ I +  
Sbjct: 4   VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLD-ISMRT 62

Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGG--ELFDQITSK-GHLSEDEARFYTAEVVDAL 158
           +D P  V  +        +++ +E  +    + + Q+  K   + ED        +V AL
Sbjct: 63  VDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122

Query: 159 EYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           E++HS + +IHRD+KP N+L+ A G +K+ DFG    + D                   G
Sbjct: 123 EHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV-----------AKDIDAG 171

Query: 218 TAAYVPPEVLNSSPATFG----NDLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIARDI 272
              Y+ PE +N      G    +D+W+LG T+ ++     P+    + +   ++++    
Sbjct: 172 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS 231

Query: 273 -RFP-NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 322
            + P + FS    D   + L  +   RP      Y  L  HPFF   + K  
Sbjct: 232 PQLPADKFSAEFVDFTSQCLKKNSKERP-----TYPELMQHPFFTLHESKGT 278

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  156 bits (397), Expect = 3e-44
 Identities = 71/264 (26%), Positives = 115/264 (43%), Gaps = 30/264 (11%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIM------DKKFITK---ENKTAYVKLERI 97
           + L ++ G G    V  A+      + ALK+M      D  F T+   E +TA       
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTA------- 88

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
              +L  P VV +    +    LY+ +    G +L   +  +G L+   A     ++  A
Sbjct: 89  --GRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSA 146

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           L+  H+ G  HRD+KPEN+L++AD    + DFG      D ++T         +    VG
Sbjct: 147 LDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT---------QLGNTVG 197

Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI---IARDIRF 274
           T  Y+ PE  + S AT+  D++AL C LY+ L+G+ P++     ++   I   I R    
Sbjct: 198 TLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTV 257

Query: 275 PNYFSDAARDLIDRLLDVDPSGRP 298
                 A   +I R +  +P  R 
Sbjct: 258 RPGIPVAFDAVIARGMAKNPEDRY 281

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  155 bits (395), Expect = 5e-44
 Identities = 54/277 (19%), Positives = 107/277 (38%), Gaps = 29/277 (10%)

Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVV 108
                G GS+  V +    +T    A   +  + +TK  +    K E  +L  L HP +V
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQR-FKEEAEMLKGLQHPNIV 88

Query: 109 RLFFTFQDTF----SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           R + +++ T      + +  E    G L   +     +     R +  +++  L+++H+ 
Sbjct: 89  RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR 148

Query: 165 G--LIHRDIKPENLLLTA-DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
              +IHRD+K +N+ +T   G +KI D G     + S             A   +GT  +
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS------------FAKAVIGTPEF 196

Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR---FPNYF 278
           + PE+          D++A G  + +M +   P+ +        R +   ++   F    
Sbjct: 197 MAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA 255

Query: 279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
               +++I+  +  +   R          L  H FF+
Sbjct: 256 IPEVKEIIEGCIRQNKDERYSI-----KDLLNHAFFQ 287

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  155 bits (395), Expect = 5e-44
 Identities = 63/266 (23%), Positives = 116/266 (43%), Gaps = 32/266 (12%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIM------DKKFITK---ENKTAYVKLERI 97
           +++    G G  S V  A+        A+K +       ++ + +   E   +       
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNS------- 65

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
              QL H  +V +    ++    Y+ +E  EG  L + I S G LS D A  +T +++D 
Sbjct: 66  --SQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDG 123

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           +++ H M ++HRDIKP+N+L+ ++  +KI DFG  K + ++ +T         +    +G
Sbjct: 124 IKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT---------QTNHVLG 174

Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK-DTSEWLIFQRIIARDIRFPN 276
           T  Y  PE           D++++G  LY+ML G  PF  +T+  +  + I         
Sbjct: 175 TVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTT 234

Query: 277 YF----SDAARDLIDRLLDVDPSGRP 298
                   +  ++I R  + D + R 
Sbjct: 235 DVRKDIPQSLSNVILRATEKDKANRY 260

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  155 bits (394), Expect = 3e-43
 Identities = 72/343 (20%), Positives = 125/343 (36%), Gaps = 67/343 (19%)

Query: 28  QRSKSFAFRAPQEH---FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT 84
           QR +  AF   ++        DFE     G G+   V +     +G V A K++  +   
Sbjct: 13  QRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--I 70

Query: 85  KENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSE 144
           K      +  E  VL + + P +V  +  F     + + +E  +GG L   +   G + E
Sbjct: 71  KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE 130

Query: 145 DEARFYTAEVVDALEYIHSMG-LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL 203
                 +  V+  L Y+     ++HRD+KP N+L+ + G IK+ DFG    + DS     
Sbjct: 131 QILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----- 185

Query: 204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLI 263
                   A +FVGT +Y+ PE L  +  +  +D+W++G +L +M  G  P        +
Sbjct: 186 -------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 238

Query: 264 FQRIIARDIRF--------------------------------------------PNYFS 279
                 +                                                   FS
Sbjct: 239 ELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFS 298

Query: 280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 322
              +D +++ L  +P+ R          L +H F K  D + +
Sbjct: 299 LEFQDFVNKCLIKNPAERA-----DLKQLMVHAFIKRSDAEEV 336

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  154 bits (390), Expect = 6e-43
 Identities = 73/304 (24%), Positives = 128/304 (42%), Gaps = 36/304 (11%)

Query: 38  PQEHFSIQ--DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE 95
           P++H+     D +     G G+Y  V +     +G + A+K +      KE K   + L+
Sbjct: 13  PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLD 72

Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG--ELFDQITSK--GHLSEDEARFYT 151
            +V+   D P +V+ +         ++ +E       + +  + S     + E+     T
Sbjct: 73  -VVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKIT 131

Query: 152 AEVVDALEYIHSMG-LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDD 210
              V AL ++     +IHRDIKP N+LL   G+IK+ DFG    + DS            
Sbjct: 132 LATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI----------- 180

Query: 211 KACTFVGTAAYVPPEVLNSSPATFG----NDLWALGCTLYQMLSGTSPFKD--TSEWLIF 264
                 G   Y+ PE ++ S +  G    +D+W+LG TLY++ +G  P+    +    + 
Sbjct: 181 AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT 240

Query: 265 QRIIARDI-RFPNY----FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW 319
           Q ++  D  +  N     FS +  + ++  L  D S RP      Y  L  HPF    + 
Sbjct: 241 Q-VVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRP-----KYKELLKHPFILMYEE 294

Query: 320 KNIR 323
           + + 
Sbjct: 295 RAVE 298

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  151 bits (383), Expect = 6e-42
 Identities = 70/295 (23%), Positives = 122/295 (41%), Gaps = 42/295 (14%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P   F + +  +G     G+Y +V + + + TG + A+K+MD   +T + +    +   +
Sbjct: 22  PAGIFELVE-LVGN----GTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINM 73

Query: 98  VLDQLDHPGVVRLFFTF------QDTFSLYMALESCEGGELFD--QITSKGHLSEDEARF 149
           +     H  +   +  F           L++ +E C  G + D  + T    L E+   +
Sbjct: 74  LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY 133

Query: 150 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 209
              E++  L ++H   +IHRDIK +N+LLT +  +K+ DFG    +  +           
Sbjct: 134 ICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV---------- 183

Query: 210 DKACTFVGTAAYVPPEVLNSSPATFGN-----DLWALGCTLYQMLSGTSPFKDTS-EWLI 263
            +  TF+GT  ++ PEV+              DLW+LG T  +M  G  P  D      +
Sbjct: 184 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL 243

Query: 264 FQRIIARD---IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
           F   I R+         +S   +  I+  L  + S RP         L  HPF +
Sbjct: 244 FL--IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPAT-----EQLMKHPFIR 291

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  150 bits (381), Expect = 7e-42
 Identities = 72/270 (26%), Positives = 126/270 (46%), Gaps = 35/270 (12%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIM------DKKFITK---ENKTAYVKLERI 97
           +ELG+I G G  S+V  A+ +      A+K++      D  F  +   E + A       
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNA------- 66

Query: 98  VLDQLDHPGVVRLFFTFQDTFSL----YMALESCEGGELFDQITSKGHLSEDEARFYTAE 153
               L+HP +V ++ T +         Y+ +E  +G  L D + ++G ++   A    A+
Sbjct: 67  --AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIAD 124

Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
              AL + H  G+IHRD+KP N++++A   +K+ DFG  + + DS  +V   A       
Sbjct: 125 ACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA------- 177

Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK-DTSEWLIFQRIIARDI 272
             +GTA Y+ PE          +D+++LGC LY++L+G  PF  D+   + +Q  +  D 
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH-VREDP 236

Query: 273 RFPNYF----SDAARDLIDRLLDVDPSGRP 298
             P+      S     ++ + L  +P  R 
Sbjct: 237 IPPSARHEGLSADLDAVVLKALAKNPENRY 266

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  151 bits (383), Expect = 1e-39
 Identities = 61/266 (22%), Positives = 103/266 (38%), Gaps = 48/266 (18%)

Query: 47  FELGKIYGVGSYSKVVRAK--KIDTGTVYALKIM----DKKFITKENKTAYVKLERIVLD 100
           +E+      G    +  A    ++   V  LK +    D +             ER  L 
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPV-VLKGLVHSGDAEAQAM------AMAERQFLA 134

Query: 101 QLDHPGVVRLFFTFQDT-----FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
           ++ HP +V++F   + T        Y+ +E   G  L         L   EA  Y  E++
Sbjct: 135 EVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEIL 192

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM-QDSRITVLPNAASDDKACT 214
            AL Y+HS+GL++ D+KPEN++LT +  +K+ D G+V  +     +              
Sbjct: 193 PALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSFGYL-------------- 237

Query: 215 FVGTAAYVPPEVLN--SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI 272
             GT  +  PE++    + AT   D++ +G TL  +                  +   D 
Sbjct: 238 -YGTPGFQAPEIVRTGPTVAT---DIYTVGRTLAALTLDLPTRNGRYV----DGLPEDDP 289

Query: 273 RFPNYFSDAARDLIDRLLDVDPSGRP 298
               Y  D+   L+ R +D DP  R 
Sbjct: 290 VLKTY--DSYGRLLRRAIDPDPRQRF 313

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  138 bits (351), Expect = 2e-37
 Identities = 80/326 (24%), Positives = 133/326 (40%), Gaps = 59/326 (18%)

Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALK-IMDKKFITKENKTAY--VKLERIVLDQLDHP 105
           +GKI G GSY  V + +  DTG + A+K  ++ +      K A   +++    L QL HP
Sbjct: 8   IGKI-GEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRM----LKQLKHP 62

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIHSM 164
            +V L   F+    L++  E C+   +  ++   +  + E   +  T + + A+ + H  
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT-FVGTAAYVP 223
             IHRD+KPEN+L+T    IK+ DFG       +R+   P+           V T  Y  
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGF------ARLLTGPS-----DYYDDEVATRWYRS 170

Query: 224 PEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRI----------- 267
           PE+L          D+WA+GC   ++LSG   +   S+    +LI + +           
Sbjct: 171 PELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVF 230

Query: 268 ----IARDIRFPNY------------FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH 311
                   ++ P+              S  A  L+   L +DP+ R         +L  H
Sbjct: 231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTC----EQLLH-H 285

Query: 312 PFFKGIDWKNIRGQTPPKLASEPMVQ 337
           P+F+ I       +   K A     Q
Sbjct: 286 PYFENIREIEDLAKEHDKPAENLYFQ 311

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  137 bits (348), Expect = 5e-37
 Identities = 81/335 (24%), Positives = 130/335 (38%), Gaps = 71/335 (21%)

Query: 25  PTVQRSKSFAFRAPQEHF-SIQDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKF 82
                S          +F S++ +E LG + G GSY  V++ +  DTG + A+K    KF
Sbjct: 4   HHHHHSSGVDLGTENLYFQSMEKYENLGLV-GEGSYGMVMKCRNKDTGRIVAIK----KF 58

Query: 83  ITKE-----NKTAY--VKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG--GELF 133
           +  +      K A   +KL    L QL H  +V L    +     Y+  E  +    +  
Sbjct: 59  LESDDDKMVKKIAMREIKL----LKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDL 114

Query: 134 DQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK 193
           +       L     + Y  ++++ + + HS  +IHRDIKPEN+L++  G +K+ DFG   
Sbjct: 115 E--LFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGF-- 170

Query: 194 PMQDSRITVLPNAASDDKACT-FVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSG 251
               +R    P      +     V T  Y  PE+L          D+WA+GC + +M  G
Sbjct: 171 ----ARTLAAPG-----EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG 221

Query: 252 TSPFKDTSE----WLIFQRI---------------IARDIRFPNY------------FSD 280
              F   S+    + I   +               +   +R P               S+
Sbjct: 222 EPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSE 281

Query: 281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
              DL  + L +DP  RP        +L  H FF+
Sbjct: 282 VVIDLAKKCLHIDPDKRPFC----AELLH-HDFFQ 311

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  131 bits (332), Expect = 7e-35
 Identities = 64/265 (24%), Positives = 113/265 (42%), Gaps = 34/265 (12%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           ++ E+ ++ G G++  V +AK        A+K ++ +   K         E   L +++H
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIV-----ELRQLSRVNH 60

Query: 105 PGVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKG---HLSEDEARFYTAEVVDALEY 160
           P +V+L+         + + +E  EGG L++ +       + +   A  +  +    + Y
Sbjct: 61  PNIVKLYGACLN---PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117

Query: 161 IHSM---GLIHRDIKPENLLLTADG-HIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           +HSM    LIHRD+KP NLLL A G  +KI DFG+   +Q                    
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN-------------K 164

Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLI-FQRIIARDIR-- 273
           G+AA++ PEV   S  +   D+++ G  L+++++   PF +           +    R  
Sbjct: 165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP 224

Query: 274 FPNYFSDAARDLIDRLLDVDPSGRP 298
                      L+ R    DPS RP
Sbjct: 225 LIKNLPKPIESLMTRCWSKDPSQRP 249

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  131 bits (331), Expect = 2e-34
 Identities = 84/326 (25%), Positives = 131/326 (40%), Gaps = 77/326 (23%)

Query: 43  SIQDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKE--NKTAY--VKLE 95
            +  +E L KI G G++ +V +A+   TG   ALK  +M+ +   KE    TA   +K+ 
Sbjct: 15  EVSKYEKLAKI-GQGTFGEVFKARHRKTGQKVALKKVLMENE---KEGFPITALREIKI- 69

Query: 96  RIVLDQLDHPGVVRLF--------FTFQDTFSLYMALESCEG--GELFDQITSKGHLSED 145
              L  L H  VV L            +   S+Y+  + CE     L          +  
Sbjct: 70  ---LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS--NVLVKFTLS 124

Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
           E +     +++ L YIH   ++HRD+K  N+L+T DG +K+ADFG       +R   L  
Sbjct: 125 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL------ARAFSLAK 178

Query: 206 AASDDKACTFVGTAAYVPPEVL----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE- 260
            +  ++    V T  Y PPE+L    +  P     DLW  GC + +M + +   +  +E 
Sbjct: 179 NSQPNRYTNRVVTLWYRPPELLLGERDYGPPI---DLWGAGCIMAEMWTRSPIMQGNTEQ 235

Query: 261 -----------------W-----------LIFQRIIARDIR--FPNYF-SDAARDLIDRL 289
                            W           L   +   R ++     Y     A DLID+L
Sbjct: 236 HQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKL 295

Query: 290 LDVDPSGRPGAGPGGYAVLKMHPFFK 315
           L +DP+ R  +       L  H FF 
Sbjct: 296 LVLDPAQRIDSD----DALN-HDFFW 316

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  130 bits (328), Expect = 4e-34
 Identities = 79/347 (22%), Positives = 135/347 (38%), Gaps = 69/347 (19%)

Query: 18  NNSSTNCPTVQRSKSFAFRAPQEHFSIQDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALK 76
           ++  T     Q   S +  A     SI  +  + K+ G G+Y +V +A    T    A+K
Sbjct: 7   HHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKL-GEGTYGEVYKAIDTVTNETVAIK 65

Query: 77  --IMDKKFITKE--NKTAY--VKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG 130
              ++ +   +E    TA   V L    L +L H  ++ L         L++  E  E  
Sbjct: 66  RIRLEHE---EEGVPGTAIREVSL----LKELQHRNIIELKSVIHHNHRLHLIFEYAEN- 117

Query: 131 ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-----DGHIK 185
           +L   +     +S    + +  ++++ + + HS   +HRD+KP+NLLL+         +K
Sbjct: 118 DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLK 177

Query: 186 IADFGSVKPMQDSRITVLPNAASDDKACTF-VGTAAYVPPEVLNSSPA-TFGNDLWALGC 243
           I DFG       +R   +P      +  T  + T  Y PPE+L  S   +   D+W++ C
Sbjct: 178 IGDFGL------ARAFGIPI-----RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIAC 226

Query: 244 TLYQMLSGTSPFKDTSE------------------W----------LIFQRIIARDIR-- 273
              +ML  T  F   SE                  W            F +   + ++  
Sbjct: 227 IWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRV 286

Query: 274 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK 320
                 D   DL+  +L++DP  R  A       L+ HP+F   D+ 
Sbjct: 287 LGALLDDEGLDLLTAMLEMDPVKRISA----KNALE-HPYFSHNDFD 328

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  128 bits (324), Expect = 8e-34
 Identities = 53/261 (20%), Positives = 112/261 (42%), Gaps = 22/261 (8%)

Query: 46  DFELGKIYGVGSYSKVVRAK-KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           D  + +  G GS+  V RA+     G+  A+KI+ ++    E    +++ E  ++ +L H
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWH---GSDVAVKILMEQDFHAERVNEFLR-EVAIMKRLRH 93

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQI---TSKGHLSEDEARFYTAEVVDALEYI 161
           P +V          +L +  E    G L+  +    ++  L E        +V   + Y+
Sbjct: 94  PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYL 153

Query: 162 HSMG--LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           H+    ++HR++K  NLL+     +K+ DFG  +    + ++            +  GT 
Sbjct: 154 HNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSK----------SAAGTP 203

Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR--FPNY 277
            ++ PEVL   P+   +D+++ G  L+++ +   P+ + +   +   +  +  R   P  
Sbjct: 204 EWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRN 263

Query: 278 FSDAARDLIDRLLDVDPSGRP 298
            +     +I+     +P  RP
Sbjct: 264 LNPQVAAIIEGCWTNEPWKRP 284

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  128 bits (323), Expect = 1e-33
 Identities = 74/316 (23%), Positives = 119/316 (37%), Gaps = 64/316 (20%)

Query: 43  SIQDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALK----IMDKKFITKENKTAY--VKLE 95
           +   +E + +I GVG+Y  V +A+   +G   ALK                +    V L 
Sbjct: 7   ATSRYEPVAEI-GVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65

Query: 96  RIVLDQLDHPGVVRLF-----FTFQDTFSLYMALESCEG--GELFDQITSKGHLSEDEAR 148
           R  L+  +HP VVRL              + +  E  +       D+    G L  +  +
Sbjct: 66  R-RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIK 123

Query: 149 FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS 208
               + +  L+++H+  ++HRD+KPEN+L+T+ G +K+ADFG            L    S
Sbjct: 124 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG------------LARIYS 171

Query: 209 DDKACT-FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLI 263
              A T  V T  Y  PEVL  S      D+W++GC   +M      F   SE      I
Sbjct: 172 YQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 231

Query: 264 FQ----------------------RIIARDIR--FPNYFSDAARDLIDRLLDVDPSGRPG 299
           F                           R ++   P    ++   L+  +L  +P  R  
Sbjct: 232 FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRIS 290

Query: 300 AGPGGYAVLKMHPFFK 315
           A    +  L+ H +  
Sbjct: 291 A----FRALQ-HSYLH 301

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  128 bits (323), Expect = 3e-33
 Identities = 76/313 (24%), Positives = 124/313 (39%), Gaps = 64/313 (20%)

Query: 43  SIQDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKE--NKTAY--VKLE 95
             + +E L  + G G ++ V +A+  +T  + A+K   +  +   K+  N+TA   +KL 
Sbjct: 8   RAKRYEKLDFL-GEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKL- 65

Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG--GELFDQITSKGHLSEDEARFYTAE 153
              L +L HP ++ L   F    ++ +  +  E     +     +   L+    + Y   
Sbjct: 66  ---LQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIK--DNSLVLTPSHIKAYMLM 120

Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
            +  LEY+H   ++HRD+KP NLLL  +G +K+ADFG  K          PN     +A 
Sbjct: 121 TLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS------PN-----RAY 169

Query: 214 T-FVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSE----------- 260
           T  V T  Y  PE+L  +     G D+WA+GC L ++L         S+           
Sbjct: 170 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETL 229

Query: 261 ----------------WLIFQRIIARDIR--FPNYFSDAARDLIDRLLDVDPSGRPGAGP 302
                           ++ F+      +   F     D   DLI  L   +P  R  A  
Sbjct: 230 GTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSA-AGDDLLDLIQGLFLFNPCARITA-- 286

Query: 303 GGYAVLKMHPFFK 315
                LK   +F 
Sbjct: 287 --TQALK-MKYFS 296

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  126 bits (317), Expect = 5e-33
 Identities = 40/261 (15%), Positives = 74/261 (28%), Gaps = 46/261 (17%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
           + L   +G     +  +A         AL  +D + +  ++         + L ++D PG
Sbjct: 33  YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 107 VVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
           V R+           +  E   GG L +        S   A      +  A +  H  G+
Sbjct: 93  VARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRAGV 150

Query: 167 IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV 226
                 P  + ++ DG + +A                                  +P   
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPA------------------------------TMPDA- 179

Query: 227 LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARD-- 284
              +P     D+  +G +LY +L    P  +                 P   +D  RD  
Sbjct: 180 ---NPQD---DIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIP 233

Query: 285 -----LIDRLLDVDPSGRPGA 300
                +  R +  D   R  +
Sbjct: 234 FQISAVAARSVQGDGGIRSAS 254

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  127 bits (322), Expect = 1e-32
 Identities = 78/311 (25%), Positives = 124/311 (39%), Gaps = 67/311 (21%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDH 104
           +   K+ G GS+  V +AK  D+G + A+K  + DK+F  +E     +++    + +LDH
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE-----LQI----MRKLDH 106

Query: 105 PGVVRL---FFTFQDTFS---LYMALESCEG---GELFDQITSKGHLSEDEARFYTAEVV 155
             +VRL   F++  +      L + L+               +K  L     + Y  ++ 
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166

Query: 156 DALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
            +L YIHS G+ HRDIKP+NLLL  D   +K+ DFGS K +      V           +
Sbjct: 167 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-----------S 215

Query: 215 FVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII----- 268
           ++ +  Y  PE+   ++  T   D+W+ GC L ++L G   F   S       II     
Sbjct: 216 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 275

Query: 269 ------------ARDIRFPNY------------FSDAARDLIDRLLDVDPSGRPGAGPGG 304
                         + +FP                  A  L  RLL+  P+ R       
Sbjct: 276 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP---- 331

Query: 305 YAVLKMHPFFK 315
                 H FF 
Sbjct: 332 LEACA-HSFFD 341

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  125 bits (316), Expect = 1e-32
 Identities = 77/311 (24%), Positives = 123/311 (39%), Gaps = 69/311 (22%)

Query: 49  LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE--NKTAY--VKLERIVLDQLDH 104
           L K+ G G+Y+ V + K   T  + ALK +  +   +E    TA   V L    L  L H
Sbjct: 7   LDKL-GEGTYATVYKGKSKLTDNLVALKEI--RLEHEEGAPCTAIREVSL----LKDLKH 59

Query: 105 PGVVRLFFTFQDTFSLYMALESCEG--GELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
             +V L        SL +  E  +    +  D       ++    + +  +++  L Y H
Sbjct: 60  ANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLD--DCGNIINMHNVKLFLFQLLRGLAYCH 117

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF---VGTA 219
              ++HRD+KP+NLL+   G +K+ADFG       +R   +P         T+   V T 
Sbjct: 118 RQKVLHRDLKPQNLLINERGELKLADFGL------ARAKSIPTK-------TYDNEVVTL 164

Query: 220 AYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRII------ 268
            Y PP++L  S   +   D+W +GC  Y+M +G   F  ++       IF RI+      
Sbjct: 165 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIF-RILGTPTEE 223

Query: 269 ----------ARDIRFPNY-----------FSDAARDLIDRLLDVDPSGRPGAGPGGYAV 307
                      +   +P Y                 DL+ +LL  +   R  A       
Sbjct: 224 TWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISA----EDA 279

Query: 308 LKMHPFFKGID 318
           +K HPFF  + 
Sbjct: 280 MK-HPFFLSLG 289

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  125 bits (315), Expect = 2e-32
 Identities = 80/320 (25%), Positives = 135/320 (42%), Gaps = 68/320 (21%)

Query: 43  SIQDFE-LGKIYGVGSYSKVVRAKKI-DTGTVYALK--IMDKKFITKE--NKTAY--VKL 94
           + Q +E + +I G G+Y KV +A+ + + G   ALK   +      +E    +    V +
Sbjct: 9   ADQQYECVAEI-GEGAYGKVFKARDLKNGGRFVALKRVRVQT---GEEGMPLSTIREVAV 64

Query: 95  ERIVLDQLDHPGVVRLF-----FTFQDTFSLYMALESCEG--GELFDQITSKGHLSEDEA 147
            R  L+  +HP VVRLF             L +  E  +       D++   G +  +  
Sbjct: 65  LR-HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG-VPTETI 122

Query: 148 RFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA 207
           +    +++  L+++HS  ++HRD+KP+N+L+T+ G IK+ADFG            L    
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG------------LARIY 170

Query: 208 SDDKACT-FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WL 262
           S   A T  V T  Y  PEVL  S      DLW++GC   +M      F+ +S+      
Sbjct: 171 SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK 230

Query: 263 IFQ----------------------RIIARDIR--FPNYFSDAARDLIDRLLDVDPSGRP 298
           I                           A+ I     +   +  +DL+ + L  +P+ R 
Sbjct: 231 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTD-IDELGKDLLLKCLTFNPAKRI 289

Query: 299 GAGPGGYAVLKMHPFFKGID 318
            A    Y+ L  HP+F+ ++
Sbjct: 290 SA----YSALS-HPYFQDLE 304

>1w1g_A HPDK1, 3-phosphoinositide dependent protein kinase-1; transferase, PKB, pleckstrin homology domain, inositol phosphate, signal transduction; HET: 4PT; 1.45A {Homo sapiens} SCOP: b.55.1.1 PDB: 1w1d_A* 1w1h_A 2vki_A Length = 151

 Score =  119 bits (299), Expect = 4e-32
 Identities = 35/131 (26%), Positives = 56/131 (42%), Gaps = 4/131 (3%)

Query: 358 SAKINDGNGGASSSEGSITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQL 417
               N        SE     L    +  + W QF++    +L +  V K + L +++ QL
Sbjct: 13  DLDSNSFELDLQFSEDEKRLLLEKQAGGNPWHQFVE-NNLILKMGPVDKRKGLFARRRQL 71

Query: 418 ILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRAS 477
           +LT  P L YVDP   V+KG I W   S +L  +  +   F + TP +     D    A 
Sbjct: 72  LLTEGPHLYYVDPVNKVLKGEIPW---SQELRPEAKNFKTFFVHTPNRTYYLMDPSGNAH 128

Query: 478 QWKKAIEALQN 488
           +W + I+ +  
Sbjct: 129 KWCRKIQEVWR 139

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  124 bits (313), Expect = 4e-32
 Identities = 82/334 (24%), Positives = 139/334 (41%), Gaps = 71/334 (21%)

Query: 25  PTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALK-I-MDKKF 82
                 ++  F+   E +      L K+ G G+Y  V +AK    G + ALK I +D + 
Sbjct: 6   HHSSGRENLYFQGLMEKYQK----LEKV-GEGTYGVVYKAKDS-QGRIVALKRIRLDAE- 58

Query: 83  ITKE--NKTAY--VKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG--GELFDQI 136
              E    TA   + L    L +L HP +V L         L +  E  E    ++ D  
Sbjct: 59  --DEGIPSTAIREISL----LKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLD-- 110

Query: 137 TSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ 196
            +K  L + + + Y  +++  + + H   ++HRD+KP+NLL+ +DG +K+ADFG      
Sbjct: 111 ENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGL----- 165

Query: 197 DSRITVLPNAASDDKACTF-VGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSP 254
            +R   +P      ++ T  V T  Y  P+VL  S   +   D+W++GC   +M++G   
Sbjct: 166 -ARAFGIPV-----RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPL 219

Query: 255 FKDTSE----WLIFQRI---------------IARDIRFPNY-----------FSDAARD 284
           F   ++      IF  +               + +   F  +           F     D
Sbjct: 220 FPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGID 279

Query: 285 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID 318
           L+  +L  DP+ R  A       +  HP+FK +D
Sbjct: 280 LLSNMLCFDPNKRISA----RDAMN-HPYFKDLD 308

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  123 bits (311), Expect = 5e-32
 Identities = 76/316 (24%), Positives = 133/316 (42%), Gaps = 69/316 (21%)

Query: 44  IQDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKE--NKTAY--VKLER 96
           ++ +  L KI G G+Y  V +A+  + G  +ALK   ++K+    E    T    + +  
Sbjct: 1   MEKYHGLEKI-GEGTYGVVYKAQN-NYGETFALKKIRLEKE---DEGIPSTTIREISI-- 53

Query: 97  IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG--GELFDQITSKGHLSEDEARFYTAEV 154
             L +L H  +V+L+        L +  E  +    +L D    +G L    A+ +  ++
Sbjct: 54  --LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQL 109

Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           ++ + Y H   ++HRD+KP+NLL+  +G +KIADFG       +R   +P      +  T
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGL------ARAFGIPV-----RKYT 158

Query: 215 F-VGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSE------------ 260
             + T  Y  P+VL  S   +   D+W++GC   +M++GT  F   SE            
Sbjct: 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILG 218

Query: 261 ------W----------LIFQRIIARDIR--FPNYFSDAARDLIDRLLDVDPSGRPGAGP 302
                 W            F                 ++  DL+ ++L +DP+ R  A  
Sbjct: 219 TPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKG-LDESGIDLLSKMLKLDPNQRITA-- 275

Query: 303 GGYAVLKMHPFFKGID 318
                L+ H +FK  +
Sbjct: 276 --KQALE-HAYFKENN 288

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  123 bits (310), Expect = 5e-32
 Identities = 78/314 (24%), Positives = 128/314 (40%), Gaps = 69/314 (21%)

Query: 44  IQDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALK-I-MDKKFITKE--NKTAY--VKLER 96
           +Q +E L KI G G+Y  V +AK  +T  + ALK + +D      E    +A   + L  
Sbjct: 1   MQKYEKLEKI-GEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSALREICL-- 54

Query: 97  IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEG--GELFDQITSKGHLSEDEARFYTAEV 154
             L +L H  +VRL         L +  E C+    + FD     G L  +  + +  ++
Sbjct: 55  --LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQL 110

Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           +  L + HS  ++HRD+KP+NLL+  +G +K+A+FG       +R   +P      +  +
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGL------ARAFGIPV-----RCYS 159

Query: 215 F-VGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSP-FKDTSE----WLIFQ-- 265
             V T  Y PP+VL  +   +   D+W+ GC   ++ +   P F           IF+  
Sbjct: 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219

Query: 266 ----------------------RIIARDIR--FPNYFSDAARDLIDRLLDVDPSGRPGAG 301
                                       +    P   +   RDL+  LL  +P  R  A 
Sbjct: 220 GTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPK-LNATGRDLLQNLLKCNPVQRISA- 277

Query: 302 PGGYAVLKMHPFFK 315
                 L+ HP+F 
Sbjct: 278 ---EEALQ-HPYFS 287

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  123 bits (310), Expect = 5e-32
 Identities = 56/273 (20%), Positives = 106/273 (38%), Gaps = 35/273 (12%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL----ERIVLD 100
            + E  K  G G +  V + + +   +V A+K +       E +          E  ++ 
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 101 QLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDAL 158
            L+HP +V+L+           M +E    G+L+ ++  K H +          ++   +
Sbjct: 79  NLNHPNIVKLYGLMHN---PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGI 135

Query: 159 EYIHSMG--LIHRDIKPENLLLTADG-----HIKIADFGSVKPMQDSRITVLPNAASDDK 211
           EY+ +    ++HRD++  N+ L +         K+ADFG       S+        S   
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL------SQQ-------SVHS 182

Query: 212 ACTFVGTAAYVPPEVLNSSPATFGN--DLWALGCTLYQMLSGTSPFKDTSEWLI--FQRI 267
               +G   ++ PE + +   ++    D ++    LY +L+G  PF + S   I     I
Sbjct: 183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242

Query: 268 IARDIR--FPNYFSDAARDLIDRLLDVDPSGRP 298
               +R   P       R++I+     DP  RP
Sbjct: 243 REEGLRPTIPEDCPPRLRNVIELCWSGDPKKRP 275

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  124 bits (313), Expect = 2e-31
 Identities = 84/335 (25%), Positives = 135/335 (40%), Gaps = 83/335 (24%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDH 104
           +   K+ G GS+  V +AK +++  V A+K  + DK+F  +E     +++    +  + H
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEV-AIKKVLQDKRFKNRE-----LQI----MRIVKH 91

Query: 105 PGVVRLFFTF------QDTFSLYMALESCEGGELFDQ---------ITSKGHLSEDEARF 149
           P VV L   F      +D   L + LE         +            K  +     + 
Sbjct: 92  PNVVDLKAFFYSNGDKKDEVFLNLVLE------YVPETVYRASRHYAKLKQTMPMLLIKL 145

Query: 150 YTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAAS 208
           Y  +++ +L YIHS+G+ HRDIKP+NLLL    G +K+ DFGS K +      V      
Sbjct: 146 YMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV------ 199

Query: 209 DDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
                +++ +  Y  PE+   ++  T   D+W+ GC + +++ G   F   S       I
Sbjct: 200 -----SYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEI 254

Query: 268 I-----------------ARDIRFPNY------------FSDAARDLIDRLLDVDPSGRP 298
           I                   + +FP                  A DLI RLL+  PS R 
Sbjct: 255 IKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARL 314

Query: 299 GAGPGGYAVLKMHPFFKGI---DWKNIRGQTPPKL 330
            A       L  HPFF  +   + +   G+  P L
Sbjct: 315 TA----IEALC-HPFFDELRTGEARMPNGRELPPL 344

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  121 bits (306), Expect = 4e-31
 Identities = 74/319 (23%), Positives = 124/319 (38%), Gaps = 69/319 (21%)

Query: 43  SIQDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE--NKTAY--VKLERI 97
           S   F+ L K+ G G+Y+ V +     TG   ALK +  K  ++E    TA   + L   
Sbjct: 3   SSSQFKQLEKL-GNGTYATVYKGLNKTTGVYVALKEV--KLDSEEGTPSTAIREISL--- 56

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGG-----ELFDQITSKGHLSEDEARFYTA 152
            + +L H  +VRL+        L +  E  +       +      +   L  +  +++  
Sbjct: 57  -MKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW 115

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           +++  L + H   ++HRD+KP+NLL+   G +K+ DFG       +R   +P        
Sbjct: 116 QLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGL------ARAFGIPV-----NT 164

Query: 213 CTF-VGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSE---------- 260
            +  V T  Y  P+VL  S   +   D+W+ GC L +M++G   F  T++          
Sbjct: 165 FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDI 224

Query: 261 --------W----------LIFQRIIARDIR------FPNYFSDAARDLIDRLLDVDPSG 296
                   W             Q+   RD+R                D +  LL ++P  
Sbjct: 225 MGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDM 284

Query: 297 RPGAGPGGYAVLKMHPFFK 315
           R  A       L  HP+F 
Sbjct: 285 RLSA----KQALH-HPWFA 298

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  121 bits (305), Expect = 8e-31
 Identities = 73/328 (22%), Positives = 124/328 (37%), Gaps = 76/328 (23%)

Query: 42  FSIQD-FELGKIYGVGSYSKVVRAKKIDTGTVYALK-------IMDKKFITKENKTAYVK 93
           ++I   F+L  + G G+Y  V  A    TG + A+K        +      +E     +K
Sbjct: 7   YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLRE-----IK 61

Query: 94  LERIVLDQLDHPGVVRL--------FFTFQDTFSLYMALESCEGGELFD----QITSKGH 141
           +    L    H  ++ +        F  F +   +Y+  E      L      ++ S   
Sbjct: 62  I----LKHFKHENIITIFNIQRPDSFENFNE---VYIIQE------LMQTDLHRVISTQM 108

Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT 201
           LS+D  +++  + + A++ +H   +IHRD+KP NLL+ ++  +K+ DFG  + + +S   
Sbjct: 109 LSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168

Query: 202 VLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
                        FV T  Y  PEV L S+  +   D+W+ GC L ++      F     
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY 228

Query: 261 ----WLIFQ------------RIIARDIR-------------FPNYFSDA---ARDLIDR 288
                LIF              I +   R                 F        DL+ R
Sbjct: 229 RHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQR 288

Query: 289 LLDVDPSGRPGAGPGGYAVLKMHPFFKG 316
           +L  DP+ R  A       L+ HP+ + 
Sbjct: 289 MLVFDPAKRITAK----EALE-HPYLQT 311

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  120 bits (302), Expect = 1e-30
 Identities = 60/296 (20%), Positives = 123/296 (41%), Gaps = 37/296 (12%)

Query: 26  TVQRSKSFAFRAPQEHFSIQDFE-------LGKIYGVGSYSKVVRAK-KIDTGTVYALKI 77
           ++  ++SF  +A Q    +Q+++       +G++ G G + +V   +     G V A+++
Sbjct: 7   SLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWH---GEV-AIRL 62

Query: 78  MDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQIT 137
           +D +   ++   A+ K E +   Q  H  VV           L +    C+G  L+  + 
Sbjct: 63  IDIERDNEDQLKAF-KREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR 121

Query: 138 S-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ 196
             K  L  ++ R    E+V  + Y+H+ G++H+D+K +N+    +G + I DFG      
Sbjct: 122 DAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGL----- 175

Query: 197 DSRITVLPNAASDDKACTF-VGTAAYVPPEVLNSSPATFGN---------DLWALGCTLY 246
              I+ +  A   +       G   ++ PE++                  D++ALG   Y
Sbjct: 176 -FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWY 234

Query: 247 QMLSGTSPFKD-TSEWLIFQRIIARDIRF---PNYFSDAARDLIDRLLDVDPSGRP 298
           ++ +   PFK   +E +I+Q  +   ++             D++      +   RP
Sbjct: 235 ELHAREWPFKTQPAEAIIWQ--MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERP 288

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  118 bits (298), Expect = 2e-30
 Identities = 59/269 (21%), Positives = 108/269 (40%), Gaps = 31/269 (11%)

Query: 45  QDFELGKIYGVGSYSKVVRAK-KIDTGTVYALKIMDK-KFITKENKTAYVKLERIVLDQL 102
            +  L +I G+G + KV RA      G   A+K                V+ E  +   L
Sbjct: 7   AELTLEEIIGIGGFGKVYRAFWI---GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63

Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP ++ L        +L + +E   GG L   ++ K  +  D    +  ++   + Y+H
Sbjct: 64  KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLH 122

Query: 163 SMG---LIHRDIKPENLLLTADGH--------IKIADFGSVKPMQDSRITVLPNAASDDK 211
                 +IHRD+K  N+L+             +KI DFG  +    +             
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM---------- 172

Query: 212 ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 271
             +  G  A++ PEV+ +S  + G+D+W+ G  L+++L+G  PF+      +   +    
Sbjct: 173 --SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK 230

Query: 272 IR--FPNYFSDAARDLIDRLLDVDPSGRP 298
           +    P+   +    L++   + DP  RP
Sbjct: 231 LALPIPSTCPEPFAKLMEDCWNPDPHSRP 259

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  119 bits (301), Expect = 2e-30
 Identities = 76/356 (21%), Positives = 139/356 (39%), Gaps = 89/356 (25%)

Query: 23  NCPTVQRSKSFA---FRAPQEH---------FSIQD-FELGKIYGVGSYSKVVRAKKIDT 69
           + P   R++ +       P+E+         +  QD ++L +  G G YS+V  A  I  
Sbjct: 1   SGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITN 60

Query: 70  GTVYALKIM---DKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQD--TFSLYMA 123
                +KI+    KK I +E     +K+    L+ L   P ++ L    +D  + +  + 
Sbjct: 61  NEKVVVKILKPVKKKKIKRE-----IKI----LENLRGGPNIITLADIVKDPVSRTPALV 111

Query: 124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL-TADG 182
            E     +      +   L++ + RFY  E++ AL+Y HSMG++HRD+KP N+++     
Sbjct: 112 FEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR 168

Query: 183 HIKIADFGSVKPMQDSRITVLPNAASDDKACT-FVGTAAYVPPEVL-NSSPATFGNDLWA 240
            +++ D+G            L       +     V +  +  PE+L +     +  D+W+
Sbjct: 169 KLRLIDWG------------LAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWS 216

Query: 241 LGCTLYQMLSGTSPF-------------------KDTSEWLIFQRI-IARD--------- 271
           LGC L  M+    PF                   +D  +++    I +            
Sbjct: 217 LGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHS 276

Query: 272 -IRFPNYF--------SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID 318
             R+  +         S  A D +D+LL  D   R  A       ++ HP+F  + 
Sbjct: 277 RKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR----EAME-HPYFYTVV 327

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  120 bits (302), Expect = 3e-30
 Identities = 81/325 (24%), Positives = 128/325 (39%), Gaps = 85/325 (26%)

Query: 45  QDFELGKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN-KTAY--VKLE 95
             +E+ + Y      G G+Y  V  A    TG   A+K + + F +  + K  Y  ++L 
Sbjct: 23  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL- 81

Query: 96  RIVLDQLDHPGVVRL---------FFTFQDTFSLYMALESCEGGELFD----QITSKGHL 142
              L  + H  V+ L            F D   +Y+         L       I     L
Sbjct: 82  ---LKHMKHENVIGLLDVFTPARSLEEFND---VYLVTH------LMGADLNNIVKCQKL 129

Query: 143 SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV 202
           ++D  +F   +++  L+YIHS  +IHRD+KP NL +  D  +KI DFG            
Sbjct: 130 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFG------------ 177

Query: 203 LPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE- 260
           L    +D+    +V T  Y  PE+ LN        D+W++GC + ++L+G + F  T   
Sbjct: 178 LARHTADEMT-GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 236

Query: 261 ---WLIFQ-----------RIIARDIR-------------FPNYFSDA---ARDLIDRLL 290
               LI +           +I +   R             F N F  A   A DL++++L
Sbjct: 237 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKML 296

Query: 291 DVDPSGRPGAGPGGYAVLKMHPFFK 315
            +D   R  A       L  H +F 
Sbjct: 297 VLDSDKRITAA----QALA-HAYFA 316

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  118 bits (299), Expect = 8e-30
 Identities = 81/326 (24%), Positives = 135/326 (41%), Gaps = 85/326 (26%)

Query: 45  QDFELGKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN-KTAY--VKLE 95
             +E+  +Y      G G+Y  V  A    TG   A+K + + F ++   K AY  ++L 
Sbjct: 19  TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRL- 77

Query: 96  RIVLDQLDHPGVVRL---------FFTFQDTFSLYMALESCEGGELFD----QITSKGHL 142
              L  + H  V+ L            F D    Y+ +              ++     L
Sbjct: 78  ---LKHMRHENVIGLLDVFTPDETLDDFTD---FYLVMP------FMGTDLGKLMKHEKL 125

Query: 143 SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV 202
            ED  +F   +++  L YIH+ G+IHRD+KP NL +  D  +KI DFG  +   DS +T 
Sbjct: 126 GEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ-ADSEMT- 183

Query: 203 LPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE- 260
                       +V T  Y  PEV LN    T   D+W++GC + +M++G + FK +   
Sbjct: 184 -----------GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL 232

Query: 261 ---WLIFQ-----------RIIARDIR-------------FPNYFSDA---ARDLIDRLL 290
                I +           R+ + + +             F +  ++A   A +L++++L
Sbjct: 233 DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKML 292

Query: 291 DVDPSGRPGAGPGGYAVLKMHPFFKG 316
            +D   R  AG      L  HP+F+ 
Sbjct: 293 VLDAEQRVTAG----EALA-HPYFES 313

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  116 bits (293), Expect = 1e-29
 Identities = 59/272 (21%), Positives = 109/272 (40%), Gaps = 17/272 (6%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           P   F   D   G++ G G + + ++    +TG V  +K + +    +E +  ++K E  
Sbjct: 3   PHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLK-EVK 59

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVD 156
           V+  L+HP V++          L    E  +GG L   I +        +   +  ++  
Sbjct: 60  VMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIAS 119

Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG----SVKPMQDSRITVLPNAASDDKA 212
            + Y+HSM +IHRD+   N L+  + ++ +ADFG     V                  K 
Sbjct: 120 GMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKR 179

Query: 213 CTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI 272
            T VG   ++ PE++N        D+++ G  L +++   +   D   +L        ++
Sbjct: 180 YTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD---YLPRTMDFGLNV 236

Query: 273 R------FPNYFSDAARDLIDRLLDVDPSGRP 298
           R       P     +   +  R  D+DP  RP
Sbjct: 237 RGFLDRYCPPNCPPSFFPITVRCCDLDPEKRP 268

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  115 bits (291), Expect = 2e-29
 Identities = 38/273 (13%), Positives = 93/273 (34%), Gaps = 33/273 (12%)

Query: 40  EHFSI--QDFELGKIYGVGSYSKVVRAK-KIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           +H  I  +              ++ + + +   G    +K++  +  +      + + E 
Sbjct: 3   KHSGIDFKQLNFLTKLNENHSGELWKGRWQ---GNDIVVKVLKVRDWSTRKSRDFNE-EC 58

Query: 97  IVLDQLDHPGVVRLF--FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYT--A 152
             L    HP V+ +             +       G L++ +    +   D+++      
Sbjct: 59  PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFAL 118

Query: 153 EVVDALEYIHSMG--LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDD 210
           ++   + ++H++   +    +   ++++  D   +I+        Q              
Sbjct: 119 DMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP------------ 166

Query: 211 KACTFVGTAAYVPPEVLNSSPATFGN---DLWALGCTLYQMLSGTSPFKDTSEWLIFQRI 267
                +   A+V PE L   P        D+W+    L+++++   PF D S   I  ++
Sbjct: 167 ---GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV 223

Query: 268 IARDIR--FPNYFSDAARDLIDRLLDVDPSGRP 298
               +R   P   S     L+   ++ DP+ RP
Sbjct: 224 ALEGLRPTIPPGISPHVSKLMKICMNEDPAKRP 256

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  115 bits (290), Expect = 3e-29
 Identities = 56/268 (20%), Positives = 114/268 (42%), Gaps = 33/268 (12%)

Query: 46  DFELGKIYGVGSYSKVVRAK-KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
              +G+  G GS+  V + K     G V A+K+++    T +   A+   E  VL +  H
Sbjct: 25  QITVGQRIGSGSFGTVYKGKWH---GDV-AVKMLNVTAPTPQQLQAFKN-EVGVLRKTRH 79

Query: 105 PGVVRLF-FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIH 162
             ++    ++     ++    + CEG  L+  +  S+      +      +    ++Y+H
Sbjct: 80  VNILLFMGYSTAPQLAIVT--QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH 137

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           +  +IHRD+K  N+ L  D  +KI DFG       +      + +   +  +  G+  ++
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGL------ATEKSRWSGSHQFEQLS--GSILWM 189

Query: 223 PPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA---------R 270
            PEV+   +S+P +F +D++A G  LY++++G  P+ + +      +II           
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN---RDQIIEMVGRGSLSPD 246

Query: 271 DIRFPNYFSDAARDLIDRLLDVDPSGRP 298
             +  +      + L+   L      RP
Sbjct: 247 LSKVRSNCPKRMKRLMAECLKKKRDERP 274

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  116 bits (292), Expect = 5e-29
 Identities = 81/319 (25%), Positives = 134/319 (42%), Gaps = 72/319 (22%)

Query: 45  QDFELGKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN-KTAY--VKLE 95
             +EL K Y      G G+Y  V  A    +G   A+K + + F ++   K AY  + L 
Sbjct: 18  TAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLL- 76

Query: 96  RIVLDQLDHPGVVRLFFTFQ-----DTFS-LYMALESCEGGELFDQITSKGHLSEDEARF 149
              L  + H  V+ L   F        F   Y+ +   +  +L   +  K   SE++ ++
Sbjct: 77  ---LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLK--FSEEKIQY 130

Query: 150 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 209
              +++  L+YIHS G++HRD+KP NL +  D  +KI DFG  +   D+ +T        
Sbjct: 131 LVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH-ADAEMT-------- 181

Query: 210 DKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIF 264
                +V T  Y  PEV L+        D+W++GC + +ML+G + FK          I 
Sbjct: 182 ----GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 237

Query: 265 Q-----------RIIARDIR-------------FPNYFSDA---ARDLIDRLLDVDPSGR 297
           +           ++  +  +             F   F  A   A DL++++L++D   R
Sbjct: 238 KVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKR 297

Query: 298 PGAGPGGYAVLKMHPFFKG 316
             A       L  HPFF+ 
Sbjct: 298 LTAA----QALT-HPFFEP 311

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  116 bits (293), Expect = 5e-29
 Identities = 78/345 (22%), Positives = 126/345 (36%), Gaps = 83/345 (24%)

Query: 28  QRSKSFAFRAPQEHFSI--QDFELGKIY------GVGSYSKVVRAKKIDTGTVYALK--- 76
                 A  A      +  Q F++G  Y      G G+Y  V  A         A+K   
Sbjct: 2   HHHHHMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS 61

Query: 77  ----IMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ----DTFS-LYMALESC 127
                   +   +E     +K+    L +  H  ++ +    +    +    +Y+  +  
Sbjct: 62  PFEHQTYCQRTLRE-----IKI----LLRFRHENIIGINDIIRAPTIEQMKDVYIVQD-- 110

Query: 128 EGGELFD----QITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH 183
               L +    ++    HLS D   ++  +++  L+YIHS  ++HRD+KP NLLL     
Sbjct: 111 ----LMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD 166

Query: 184 IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALG 242
           +KI DFG       +R+   P+         +V T  Y  PE+ LNS   T   D+W++G
Sbjct: 167 LKICDFGL------ARVAD-PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVG 219

Query: 243 CTLYQMLSGTSPFKDTSE----WLIF-----------QRIIARDIR-------------F 274
           C L +MLS    F           I              II    R             +
Sbjct: 220 CILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPW 279

Query: 275 PNYFSDA---ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 316
              F +A   A DL+D++L  +P  R          L  HP+ + 
Sbjct: 280 NRLFPNADSKALDLLDKMLTFNPHKRIEVE----QALA-HPYLEQ 319

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  118 bits (296), Expect = 5e-29
 Identities = 76/385 (19%), Positives = 137/385 (35%), Gaps = 111/385 (28%)

Query: 28  QRSKSFAFRAPQEHFSIQD-FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE 86
               + +   P   + I D +E+  + G GSY  V  A       V A+K + + F   E
Sbjct: 35  SSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF---E 91

Query: 87  N----KTAY--VKLERIVLDQLDHPGVVRLF--------FTFQDTFSLYMALESCEGGEL 132
           +    K     + +    L++L+H  VV++           F +   LY+ LE  +  + 
Sbjct: 92  DLIDCKRILREIAI----LNRLNHDHVVKVLDIVIPKDVEKFDE---LYVVLEIADS-DF 143

Query: 133 FDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG-- 190
                +  +L+E   +     ++  ++Y+HS G++HRD+KP N L+  D  +K+ DFG  
Sbjct: 144 KKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLA 203

Query: 191 -SVKPMQDSRITVLPNAASDDKACTFVGTAA--------YV------PPEV-LNSSPATF 234
            +V   ++    +  +   DD                  +V       PE+ L     T 
Sbjct: 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTE 263

Query: 235 GNDLWALGCTLYQMLS-----------------GTSPFKDTSEW---------------- 261
             D+W++GC   ++L+                 G+S F  + +                 
Sbjct: 264 AIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQ 323

Query: 262 --LIFQRI--------------IARD----------IRFPNYFSDA---ARDLIDRLLDV 292
             +IF  +               A+                 F  +   A  L+ R+L  
Sbjct: 324 LNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVF 383

Query: 293 DPSGRPGAGPGGYAVLKMHPFFKGI 317
           +P+ R          L  HPFFK +
Sbjct: 384 NPNKRITIN----ECLA-HPFFKEV 403

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  113 bits (286), Expect = 2e-28
 Identities = 77/335 (22%), Positives = 123/335 (36%), Gaps = 85/335 (25%)

Query: 42  FSIQDFELGKIY------GVGSYSKVVRAKKIDTGTVYALK------IMDKKFITKENKT 89
            +I  F+LG  Y      G G    V  A   D     A+K          K   +E   
Sbjct: 2   MNIHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALRE--- 58

Query: 90  AYVKLERIVLDQLDHPGVVRLF-------------FTFQDTFS-LYMALESCEGGELFD- 134
             +K+    + +LDH  +V++F                    + +Y+  E  E     D 
Sbjct: 59  --IKI----IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET----DL 108

Query: 135 -QITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-DGHIKIADFGSV 192
             +  +G L E+ AR +  +++  L+YIHS  ++HRD+KP NL +   D  +KI DFG  
Sbjct: 109 ANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGL- 167

Query: 193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSG 251
                +R  + P+ +        + T  Y  P + L+ +  T   D+WA GC   +ML+G
Sbjct: 168 -----AR-IMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221

Query: 252 TSPFKDTSE----WLIFQRI----------IARDIR-------------FPNYFSDA--- 281
            + F    E     LI + I          +   I                         
Sbjct: 222 KTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISRE 281

Query: 282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 316
           A D ++++L   P  R  A       L  HP+   
Sbjct: 282 AVDFLEQILTFSPMDRLTAE----EALS-HPYMSI 311

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  114 bits (287), Expect = 3e-28
 Identities = 63/338 (18%), Positives = 114/338 (33%), Gaps = 68/338 (20%)

Query: 28  QRSKSFAFRAPQEHFSIQD-FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE 86
            + ++       E  ++Q  + + +    GSY  V      +   V A+K +        
Sbjct: 4   AKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPV-AIKRVFNTVSDGR 62

Query: 87  NKTAYVKL--------ERIVLDQLDHPGVVRLFFTF----QDTFS-LYMALESCEGGELF 133
                           E  +L+   HP ++ L   F    +     LY+  E     +L 
Sbjct: 63  TVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLA 121

Query: 134 DQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV 192
             I   +  +S    +++   ++  L  +H  G++HRD+ P N+LL  +  I I DF   
Sbjct: 122 QVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN-- 179

Query: 193 KPMQDSRITVLPNAASDDKACT-FVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLS 250
                     L    + D   T +V    Y  PE+ +     T   D+W+ GC + +M +
Sbjct: 180 ----------LAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229

Query: 251 GTSPF--KDTSE--WLIFQ-----------RIIARDIR--------------FPNYFSDA 281
             + F           I +              +   R              +      A
Sbjct: 230 RKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTA 289

Query: 282 ---ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 316
              A DLI ++L+ +P  R          L+ HP+F+ 
Sbjct: 290 DPVALDLIAKMLEFNPQRRISTE----QALR-HPYFES 322

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  113 bits (284), Expect = 8e-28
 Identities = 76/342 (22%), Positives = 125/342 (36%), Gaps = 99/342 (28%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFITKENKTAYVKLERIVLDQLDH 104
           + LGK  G GS+  V     I++G  +ALK  + D ++  +E           ++  LDH
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELD---------IMKVLDH 59

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGG--------------------------------EL 132
             +++L   F  T                                             E 
Sbjct: 60  VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119

Query: 133 FDQ---------ITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-DG 182
                       I S   +  +    Y  ++  A+ +IHS+G+ HRDIKP+NLL+ + D 
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179

Query: 183 HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWAL 241
            +K+ DFGS K +  S  +V            ++ +  Y  PE+ L ++  T   DLW++
Sbjct: 180 TLKLCDFGSAKKLIPSEPSV-----------AYICSRFYRAPELMLGATEYTPSIDLWSI 228

Query: 242 GCTLYQMLSGTSPFKDTSE----WLI-----------------------FQRIIARDIR- 273
           GC   +++ G   F   +       I                       F  + A+D R 
Sbjct: 229 GCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRK 288

Query: 274 -FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF 314
             P      A DL++++L  +P  R       Y  +  HPFF
Sbjct: 289 ILPEGTPSLAIDLLEQILRYEPDLRINP----YEAMA-HPFF 325

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  114 bits (286), Expect = 8e-28
 Identities = 66/323 (20%), Positives = 117/323 (36%), Gaps = 55/323 (17%)

Query: 44  IQDFELGKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT----AY-- 91
           I++  +   Y      G GSY  V  A   +T    A+K +++ F   E+          
Sbjct: 19  IKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF---EDLIDCKRILRE 75

Query: 92  VKLERIVLDQLDHPGVVRL--------FFTFQDTFSLYMALESCEGGELFDQITSKGHLS 143
           + +    L++L    ++RL           F +   LY+ LE  +  +L     +   L+
Sbjct: 76  ITI----LNRLKSDYIIRLYDLIIPDDLLKFDE---LYIVLEIADS-DLKKLFKTPIFLT 127

Query: 144 EDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG---SVKPMQDSRI 200
           E+  +     ++    +IH  G+IHRD+KP N LL  D  +K+ DFG   ++   +D+ I
Sbjct: 128 EEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNI 187

Query: 201 TVLPNAASDDKACTFVGTAA---YV------PPEV-LNSSPATFGNDLWALGCTLYQMLS 250
                   +              +V       PE+ L     T   D+W+ GC   ++L+
Sbjct: 188 VNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

Query: 251 GTSPFKDTSEWL--IFQ-RIIARDIRFPNYFSDAARDLIDRL-LDVDPSGRPGA------ 300
                 +       +F            N      +   D+L +  +  G P        
Sbjct: 248 MLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNI 307

Query: 301 -GPGGYAVLKMHPFFKGIDWKNI 322
             P     +K+ P  K I+ K  
Sbjct: 308 NKPEVIKYIKLFPHRKPINLKQK 330

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  112 bits (283), Expect = 1e-27
 Identities = 72/330 (21%), Positives = 125/330 (37%), Gaps = 88/330 (26%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT----AY--VKLERIV 98
           + ++  K  G G+   V  A         A+K + + F   +N+T    AY  + L    
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF---QNQTHAKRAYRELVL---- 77

Query: 99  LDQLDHPGVVRL---------FFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARF 149
           +  ++H  ++ L            FQD   +Y+ +E  +   L   I  +  L  +   +
Sbjct: 78  MKCVNHKNIIGLLNVFTPQKSLEEFQD---VYIVMELMDA-NLCQVI--QMELDHERMSY 131

Query: 150 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 209
              +++  ++++HS G+IHRD+KP N+++ +D  +KI DFG            L   A  
Sbjct: 132 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG------------LARTAGT 179

Query: 210 DKACT-FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII 268
               T +V T  Y  PEV+         D+W++GC + +M+ G   F  T     + ++I
Sbjct: 180 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 239

Query: 269 -----------------ARD----------IRFPNYFSDA---------------ARDLI 286
                             R             F   F D                ARDL+
Sbjct: 240 EQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLL 299

Query: 287 DRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 316
            ++L +D S R          L+ HP+   
Sbjct: 300 SKMLVIDASKRISVD----EALQ-HPYINV 324

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  111 bits (281), Expect = 2e-27
 Identities = 73/347 (21%), Positives = 131/347 (37%), Gaps = 87/347 (25%)

Query: 27  VQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALK--IMDKKFIT 84
           +  + + A          + F++ ++ G G++  V   K+  TG   A+K  I D +F  
Sbjct: 6   MSLNAAAAADERSRKEMDR-FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRN 64

Query: 85  KENKTAYVKLERI-VLDQLDHPGVVRL---FFT-----FQDTFSLYMALESCEGGELFDQ 135
           +E       L+ +  L  L HP +V+L   F+T      +D + L + +E          
Sbjct: 65  RE-------LQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY-LNVVME------YVPD 110

Query: 136 ---------ITSKGHLSEDEARFYTAEVVDALEYIH--SMGLIHRDIKPENLLL-TADGH 183
                       +        + +  +++ ++  +H  S+ + HRDIKP N+L+  ADG 
Sbjct: 111 TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT 170

Query: 184 IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEV-LNSSPATFGNDLWALG 242
           +K+ DFGS K +  S   V            ++ +  Y  PE+   +   T   D+W++G
Sbjct: 171 LKLCDFGSAKKLSPSEPNV-----------AYICSRYYRAPELIFGNQHYTTAVDIWSVG 219

Query: 243 CTLYQMLSGTSPFKDTSEWLIFQRII-------ARDIR---------------------- 273
           C   +M+ G   F+  +       I+          +R                      
Sbjct: 220 CIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNV 279

Query: 274 FPNYFSDA---ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI 317
           F ++       A DL+  LL   P  R       Y  L  HP+F  +
Sbjct: 280 FSDHSLKDAKEAYDLLSALLQYLPEERMKP----YEALC-HPYFDEL 321

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  111 bits (279), Expect = 1e-26
 Identities = 81/417 (19%), Positives = 148/417 (35%), Gaps = 109/417 (26%)

Query: 45  QDFELGKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT----AY--V 92
             F + K Y      G G+   V  A         A+K + + F   +N+T    AY  +
Sbjct: 56  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF---QNQTHAKRAYREL 112

Query: 93  KLERIVLDQLDHPGVVRL---------FFTFQDTFSLYMALESCEGGELFDQITSKGHLS 143
            L    +  ++H  ++ L            FQD   +Y+ +E  +   L   I  +  L 
Sbjct: 113 VL----MKCVNHKNIISLLNVFTPQKTLEEFQD---VYLVMELMDA-NLCQVIQME--LD 162

Query: 144 EDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL 203
            +   +   +++  ++++HS G+IHRD+KP N+++ +D  +KI DFG            L
Sbjct: 163 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG------------L 210

Query: 204 PNAASDDKACT-FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL 262
              A      T +V T  Y  PEV+         D+W++GC + +M+     F       
Sbjct: 211 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 270

Query: 263 IFQRII-----------------ARD----------IRFPNYFSDA-------------- 281
            + ++I                  R+          + FP  F D+              
Sbjct: 271 QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKAS 330

Query: 282 -ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGE 340
            ARDL+ ++L +DP+ R          L+ HP+     W +           +   +  +
Sbjct: 331 QARDLLSKMLVIDPAKRISVD----DALQ-HPYINV--WYDP--AEVEAPPPQIYDKQLD 381

Query: 341 GDDVHDSSW-----------NPSHIGDISAKINDGNGGASSSEGSITRLASIDSFDS 386
             +     W                  +       +G A +S  S+   +S++   S
Sbjct: 382 EREHTIEEWKELIYKEVMNSEEKTKNGVVKGQPSPSGAAVNSSESLPPSSSVNDISS 438

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  109 bits (274), Expect = 2e-26
 Identities = 77/349 (22%), Positives = 128/349 (36%), Gaps = 96/349 (27%)

Query: 46  DFELGKIY------GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT----AY--VK 93
           D  + + Y      G G+Y  V ++    TG V A+K +   F   +N T     +  + 
Sbjct: 4   DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF---QNSTDAQRTFREIM 60

Query: 94  LERIVLDQL-DHPGVVRLFFTFQ-DTFS-LYMALESCEGGELFD----QITSKGHLSEDE 146
           +    L +L  H  +V L    + D    +Y+  +        +     +     L    
Sbjct: 61  I----LTELSGHENIVNLLNVLRADNDRDVYLVFD------YMETDLHAVIRANILEPVH 110

Query: 147 ARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG---SVKPMQDSRITVL 203
            ++   +++  ++Y+HS GL+HRD+KP N+LL A+ H+K+ADFG   S   ++     + 
Sbjct: 111 KQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170

Query: 204 PNAASDDKACT--------FVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSP 254
            +   + +           +V T  Y  PE+ L S+  T G D+W+LGC L ++L G   
Sbjct: 171 LSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI 230

Query: 255 F--KDT----------------------------------------SEWLIFQRIIARDI 272
           F    T                                         +            
Sbjct: 231 FPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKN 290

Query: 273 RFPNYFSDA-----ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 316
                   A     A DL+D+LL  +P+ R  A       LK HPF   
Sbjct: 291 LLLKINPKADCNEEALDLLDKLLQFNPNKRISAN----DALK-HPFVSI 334

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  106 bits (266), Expect = 3e-25
 Identities = 68/347 (19%), Positives = 117/347 (33%), Gaps = 102/347 (29%)

Query: 43  SIQDFELGKIYGVGSYSKVVRA--KKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 100
            + ++E  K+ G G+Y  V +A  K       YALK      I     +     E  +L 
Sbjct: 20  DLFEYEGCKV-GRGTYGHVYKAKRKDGKDDKDYALKQ-----IEGTGISMSACREIALLR 73

Query: 101 QLDHPGVVRLF--FTFQDTFSLYMALESCE--------GGELFDQITSKGHLSEDEARFY 150
           +L HP V+ L   F       +++  +  E                     L     +  
Sbjct: 74  ELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSL 133

Query: 151 TAEVVDALEYIHSMGLIHRDIKPENLLLTAD----GHIKIADFG-------SVKPMQDSR 199
             +++D + Y+H+  ++HRD+KP N+L+  +    G +KIAD G        +KP+ D  
Sbjct: 134 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 193

Query: 200 ITVLPNAASDDKACTFVGTAAYVPPEVL----NSSPATFGNDLWALGCTLYQMLSGTSPF 255
             V+              T  Y  PE+L    + + A    D+WA+GC   ++L+    F
Sbjct: 194 PVVV--------------TFWYRAPELLLGARHYTKAI---DIWAIGCIFAELLTSEPIF 236

Query: 256 KDTSEWLIFQRIIARD--------------------IRFPNY------------------ 277
               E +        D                     + P +                  
Sbjct: 237 HCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLI 296

Query: 278 ---------FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
                        A  L+ +LL +DP  R  +       ++  P+F 
Sbjct: 297 KYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS----EQAMQ-DPYFL 338

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  104 bits (261), Expect = 4e-25
 Identities = 62/315 (19%), Positives = 109/315 (34%), Gaps = 65/315 (20%)

Query: 26  TVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK 85
           ++QR+ +            +D  L +  G G Y +V R      G   A+KI    F ++
Sbjct: 1   SMQRTVA------------RDITLLECVGKGRYGEVWRGSW--QGENVAVKI----FSSR 42

Query: 86  ENKTAYVKLERIVLDQLDHPGVVRLF----FTFQDTFSLYMALESCEGGELFDQITSKGH 141
           + K+ + + E      L H  ++        +   +  L++     E G L+D +     
Sbjct: 43  DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-T 101

Query: 142 LSEDEARFYTAEVVDALEYIHS--------MGLIHRDIKPENLLLTADGHIKIADFGSVK 193
           L           +   L ++H           + HRD+K +N+L+  +G   IAD G   
Sbjct: 102 LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL-- 159

Query: 194 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGN------DLWALGCTLYQ 247
               + +        D      VGT  Y+ PEVL+ +            D+WA G  L++
Sbjct: 160 ----AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWE 215

Query: 248 MLSGTSPFKDTSEWLI-FQRIIARDIRF-----------------PNYFSDAA----RDL 285
           +           ++   F  ++  D  F                   +FSD        L
Sbjct: 216 VARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKL 275

Query: 286 IDRLLDVDPSGRPGA 300
           +      +PS R  A
Sbjct: 276 MKECWYQNPSARLTA 290

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  105 bits (263), Expect = 5e-25
 Identities = 77/379 (20%), Positives = 131/379 (34%), Gaps = 110/379 (29%)

Query: 40  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVK---LER 96
           E +    + L +  G G +S V  AK +   T  A+KI+            Y +    E 
Sbjct: 14  EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-------RGDKVYTEAAEDEI 66

Query: 97  IVLDQL--------DHPG---VVRLF--FTFQDTFSLYMALESCE--GGELFDQITSKGH 141
            +L ++        D  G   +++L   F  +    +++ +   E  G  L   I    H
Sbjct: 67  KLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVM-VFEVLGENLLALIKKYEH 125

Query: 142 --LSEDEARFYTAEVVDALEYIHSM-GLIHRDIKPENLLL------TADGHIKIADFGSV 192
             +     +  + +++  L+Y+H   G+IH DIKPEN+L+           IKIAD G+ 
Sbjct: 126 RGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGN- 184

Query: 193 KPMQDSRITVLPNAAS--DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS 250
                         A   D+     + T  Y  PEVL  +P   G D+W+  C ++++++
Sbjct: 185 --------------ACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 230

Query: 251 GTSPF--KDTSEWLIFQRIIARDIR----FPNYFSDAAR--------------------- 283
           G   F   +   +      IA+ I      P+Y     +                     
Sbjct: 231 GDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFW 290

Query: 284 ---------------------DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI 322
                                D +  +L +DP  R  AG      L  HP+ K       
Sbjct: 291 PLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG-----LVNHPWLKD-----T 340

Query: 323 RGQTPPKLASEPMVQSGEG 341
            G    ++    +  SG  
Sbjct: 341 LGMEEIRVPDRELYGSGSD 359

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 98.7 bits (246), Expect = 7e-23
 Identities = 62/297 (20%), Positives = 107/297 (36%), Gaps = 55/297 (18%)

Query: 45  QDFELGKIYGVGSYSKVVRAK-KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  ++ K  G G Y +V   K +   G   A+K+    F T E  + + + E      + 
Sbjct: 37  KQIQMVKQIGKGRYGEVWMGKWR---GEKVAVKV----FFTTEEASWFRETEIYQTVLMR 89

Query: 104 HPGVVRLF----FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 159
           H  ++               LY+  +  E G L+D + S   L            V  L 
Sbjct: 90  HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLC 148

Query: 160 YIHS--------MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDK 211
           ++H+          + HRD+K +N+L+  +G   IAD G       +   +      D  
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL------AVKFISDTNEVDIP 202

Query: 212 ACTFVGTAAYVPPEVLNSSPATFGN------DLWALGCTLYQMLSGTSPFKDTSEWLI-- 263
             T VGT  Y+PPEVL+ S            D+++ G  L+++           E+ +  
Sbjct: 203 PNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262

Query: 264 ------------FQRIIARD-IR--FPNYFSDAA-----RDLIDRLLDVDPSGRPGA 300
                        + I+    +R  FPN +S          L+      +P+ R  A
Sbjct: 263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA 319

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 97.2 bits (242), Expect = 2e-22
 Identities = 56/296 (18%), Positives = 104/296 (35%), Gaps = 53/296 (17%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +   L +  G G + +V R K    G   A+KI    F ++E ++ + + E      L H
Sbjct: 42  RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKI----FSSREERSWFREAEIYQTVMLRH 95

Query: 105 PGVVRLF----FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
             ++               L++  +  E G LFD +     ++ +            L +
Sbjct: 96  ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAH 154

Query: 161 IHS--------MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           +H           + HRD+K +N+L+  +G   IAD G       +          D   
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL------AVRHDSATDTIDIAP 208

Query: 213 CTFVGTAAYVPPEVLNSSPATFGN------DLWALGCTLYQMLSGTS----------PFK 256
              VGT  Y+ PEVL+ S            D++A+G   +++    S          P+ 
Sbjct: 209 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268

Query: 257 -----DTSEWLIFQRIIARDIR--FPNYFSD-----AARDLIDRLLDVDPSGRPGA 300
                D S   + + +  + +R   PN +           ++      + + R  A
Sbjct: 269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 324

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 97.1 bits (242), Expect = 4e-22
 Identities = 62/254 (24%), Positives = 107/254 (42%), Gaps = 40/254 (15%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVK---LERIVLDQL- 102
           +E+  + G GS+ +VV+A         A+KI+       +NK A++    +E  +L+ + 
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-------KNKKAFLNQAQIEVRLLELMN 108

Query: 103 -----DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVV 155
                    +V L   F     L +  E      L+D + +     +S +  R +  ++ 
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMC 167

Query: 156 DALEYIHS--MGLIHRDIKPENLLLTADGH--IKIADFGSVKPMQDSRITVLPNAAS--D 209
            AL ++ +  + +IH D+KPEN+LL       IKI DFGS               +    
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS---------------SCQLG 212

Query: 210 DKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA 269
            +   ++ +  Y  PEVL   P     D+W+LGC L +M +G   F   +E     +I+ 
Sbjct: 213 QRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVE 272

Query: 270 RDIRFPNYFSDAAR 283
                P +  D A 
Sbjct: 273 VLGIPPAHILDQAP 286

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 96.0 bits (239), Expect = 1e-21
 Identities = 63/261 (24%), Positives = 108/261 (41%), Gaps = 56/261 (21%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVK---LERIVLDQL- 102
           +E+ K+ G GS+ +VV+A         ALK++        N+  + +    E  +L+ L 
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV-------RNEKRFHRQAAEEIRILEHLR 151

Query: 103 -----DHPGVVRL--FFTFQD----TF-----SLYMALESCEGGELFDQITSKGHLSEDE 146
                +   V+ +   FTF++    TF     +LY         EL  +   +G  S   
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLY---------ELIKKNKFQG-FSLPL 201

Query: 147 ARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH--IKIADFGSVKPMQDSRITVLP 204
            R +   ++  L+ +H   +IH D+KPEN+LL   G   IK+ DFGS             
Sbjct: 202 VRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS------------- 248

Query: 205 NAAS--DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL 262
             +     +  T++ +  Y  PEV+  +      D+W+LGC L ++L+G        E  
Sbjct: 249 --SCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD 306

Query: 263 IFQRIIARDIRFPNYFSDAAR 283
               +I           DA++
Sbjct: 307 QLACMIELLGMPSQKLLDASK 327

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 91.8 bits (228), Expect = 1e-20
 Identities = 46/233 (19%), Positives = 87/233 (37%), Gaps = 34/233 (14%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV--LDQLD 103
           + +L ++ G G Y  V +          A+K+         N+  ++  E+ +  +  ++
Sbjct: 14  NLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSF-----ANRQNFIN-EKNIYRVPLME 65

Query: 104 HPGVVRLF-----FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
           H  + R        T        + +E    G L   ++         +      V   L
Sbjct: 66  HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGL 124

Query: 159 EYIHSM---------GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 209
            Y+H+           + HRD+   N+L+  DG   I+DFG    +  +R+        D
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV--RPGEED 182

Query: 210 DKACTFVGTAAYVPPEVLNSS-------PATFGNDLWALGCTLYQMLSGTSPF 255
           + A + VGT  Y+ PEVL  +        A    D++ALG   +++    +  
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 89.3 bits (222), Expect = 1e-19
 Identities = 63/343 (18%), Positives = 113/343 (32%), Gaps = 93/343 (27%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVK--------LERIV 98
           F + +  G G++ +V+  + ID    YA+K++        N   Y +        L++I 
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV-------RNIKKYTRSAKIEADILKKIQ 89

Query: 99  LDQLDHPGVVRLF--FTFQD----TFSLYMALESCEGGELFDQITSKGH--LSEDEARFY 150
            D +++  +V+    F + D     F          G  L++ IT   +     ++ + Y
Sbjct: 90  NDDINNNNIVKYHGKFMYYDHMCLIFEPL-------GPSLYEIITRNNYNGFHIEDIKLY 142

Query: 151 TAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS-- 208
             E++ AL Y+  M L H D+KPEN+LL      K                    +    
Sbjct: 143 CIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202

Query: 209 ----------DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT 258
                      D   + + T  Y  PEV+ +      +D+W+ GC L ++ +G+  F+  
Sbjct: 203 LIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262

Query: 259 SEWLIFQRIIARDIRFPNYFSDAAR----------------------------------- 283
                   + +     P      A                                    
Sbjct: 263 EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLP 322

Query: 284 -----------DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
                      D +  +L +DP+ RP       A L  H F +
Sbjct: 323 LYKIIKHELFCDFLYSILQIDPTLRPSP-----AELLKHKFLE 360

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 87.5 bits (217), Expect = 3e-19
 Identities = 46/234 (19%), Positives = 87/234 (37%), Gaps = 34/234 (14%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
             +L ++   G +  V +A+        A+KI       ++ ++   + E   L  + H 
Sbjct: 25  PLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFP----IQDKQSWQNEYEVYSLPGMKHE 78

Query: 106 GVVRLF----FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
            +++              L++     E G L D + +   +S +E       +   L Y+
Sbjct: 79  NILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYL 137

Query: 162 HSMGL----------IHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDK 211
           H               HRDIK +N+LL  +    IADFG     +  +     +      
Sbjct: 138 HEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ---- 193

Query: 212 ACTFVGTAAYVPPEVLNSSPATFGN-----DLWALGCTLYQMLSGTSPFKDTSE 260
               VGT  Y+ PEVL  +     +     D++A+G  L+++ S  +      +
Sbjct: 194 ----VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 87.8 bits (218), Expect = 3e-19
 Identities = 72/354 (20%), Positives = 111/354 (31%), Gaps = 117/354 (33%)

Query: 47  FELGKIYGVGSYSKVVRAK-KIDTGTVYALKIMDKKFITKENKTAYV---KLERIVLDQL 102
           +E+    G G++ KVV         +  ALKI+        N   Y    +LE  VL ++
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKII-------RNVGKYREAARLEINVLKKI 73

Query: 103 ------DHPGVVRLF--FTFQD----TFSLYMALESCEGGELFDQITSKGH--LSEDEAR 148
                 +    V +   F F       F L        G   F+ +             R
Sbjct: 74  KEKDKENKFLCVLMSDWFNFHGHMCIAFELL-------GKNTFEFLKENNFQPYPLPHVR 126

Query: 149 FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-------------------IKIADF 189
               ++  AL ++H   L H D+KPEN+L                         I++ADF
Sbjct: 127 HMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186

Query: 190 GSVKPMQDSRITVLPNAAS--DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQ 247
           GS               A+   +   T V T  Y PPEV+         D+W++GC L++
Sbjct: 187 GS---------------ATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFE 231

Query: 248 MLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAAR------------------------ 283
              G + F+          +       P++     R                        
Sbjct: 232 YYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKE 291

Query: 284 --------------------DLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI 317
                               DL+ R+L+ DP+ R          L  HPFF G+
Sbjct: 292 NCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL----AEALL-HPFFAGL 340

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 87.3 bits (217), Expect = 6e-19
 Identities = 64/262 (24%), Positives = 111/262 (42%), Gaps = 25/262 (9%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           D  LG+  G G++ +V   +     T+ A+K   ++ +  + K  +++ E  +L Q  HP
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFLQ-EARILKQYSHP 172

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSM 164
            +VRL         +Y+ +E  +GG+    + ++G  L          +    +EY+ S 
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP- 223
             IHRD+   N L+T    +KI+DFG  +   D                   G    VP 
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA-------------SGGLRQVPV 279

Query: 224 ----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIR--FPN 276
               PE LN    +  +D+W+ G  L++  S G SP+ + S     + +  +  R   P 
Sbjct: 280 KWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-KGGRLPCPE 338

Query: 277 YFSDAARDLIDRLLDVDPSGRP 298
              DA   L+++    +P  RP
Sbjct: 339 LCPDAVFRLMEQCWAYEPGQRP 360

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 87.1 bits (216), Expect = 2e-18
 Identities = 50/216 (23%), Positives = 85/216 (39%), Gaps = 20/216 (9%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQL 102
            D  +    G G Y +V            A+K +      KE+     +   E  V+ ++
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTMEVEEFLKEAAVMKEI 273

Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEY 160
            HP +V+L          Y+  E    G L D +       +S     +   ++  A+EY
Sbjct: 274 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 333

Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           +     IHR++   N L+  +  +K+ADFG  + M     T     A          TA 
Sbjct: 334 LEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT-----AHAGAKFPIKWTA- 387

Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
              PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 388 ---PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 420

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 73/348 (20%), Positives = 116/348 (33%), Gaps = 105/348 (30%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVY-ALKIMDKKFITKENKTAYV---KLERIVLDQL 102
           +E+    G G++ KVV       G  + A+KI+       +N   Y    + E  VL+ L
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV-------KNVDRYCEAARSEIQVLEHL 68

Query: 103 ------DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEV 154
                      V++   F+    + +  E   G   +D I   G      D  R    ++
Sbjct: 69  NTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQI 127

Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGH-------------------IKIADFGSVKPM 195
             ++ ++HS  L H D+KPEN+L     +                   IK+ DFGS    
Sbjct: 128 CKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS---- 183

Query: 196 QDSRITVLPNAAS--DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTS 253
                      A+  D+   T V T  Y  PEV+ +   +   D+W++GC L +   G +
Sbjct: 184 -----------ATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFT 232

Query: 254 PFKDTSEWLIFQRIIA----------RDIRFPNYFSD----------------------- 280
            F           +            +  R   YF                         
Sbjct: 233 VFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLK 292

Query: 281 -----------AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI 317
                         DLI ++L+ DP+ R          LK HPFF  +
Sbjct: 293 EFMLSQDVEHERLFDLIQKMLEYDPAKRITL----REALK-HPFFDLL 335

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 83.6 bits (207), Expect = 6e-18
 Identities = 54/244 (22%), Positives = 99/244 (40%), Gaps = 28/244 (11%)

Query: 19  NSSTNCPTVQRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYA 74
            +           +F  R P + F  +  +  +  G G++  V   +    + +TG V A
Sbjct: 16  TTENLYFQGAMGSAFEDRDPTQ-FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVA 74

Query: 75  LKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLF--FTFQDTFSLYMALESCEGGEL 132
           +K +  +  T+E+   + + E  +L  L H  +V+           +L + +E    G L
Sbjct: 75  VKKL--QHSTEEHLRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 131

Query: 133 FDQI-TSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS 191
            D +   K  +   +   YT+++   +EY+ +   IHRD+   N+L+  +  +KI DFG 
Sbjct: 132 RDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG- 190

Query: 192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLY 246
                      L      DK    V      P     PE L  S  +  +D+W+ G  LY
Sbjct: 191 -----------LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 239

Query: 247 QMLS 250
           ++ +
Sbjct: 240 ELFT 243

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 83.1 bits (206), Expect = 1e-17
 Identities = 46/234 (19%), Positives = 96/234 (41%), Gaps = 29/234 (12%)

Query: 46  DFELGKIYGVGSYSKVVRAK-KIDTGTVY---ALKIMDKKFITKENKTAYVKLERIVLDQ 101
           +F+  K+ G G++  V +     +   V    A+K + ++  + +     +  E  V+  
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILD-EAYVMAS 73

Query: 102 LDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALE 159
           +D+P V RL       T  + +  +    G L D +   K ++       +  ++   + 
Sbjct: 74  VDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131

Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           Y+    L+HRD+   N+L+    H+KI DFG  K +             ++K   +    
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA-----------EEK--EYHAEG 178

Query: 220 AYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRI 267
             VP      E +     T  +D+W+ G T++++++ G+ P+       I   +
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 52/250 (20%), Positives = 100/250 (40%), Gaps = 35/250 (14%)

Query: 29  RSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFIT 84
            ++ +A + P   F  +  +     G G++  V   +      +TG + A+K +      
Sbjct: 8   HAQLYACQDPTI-FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL------ 60

Query: 85  KENKTAYVK---LERIVLDQLDHPGVVRLF--FTFQDTFSLYMALESCEGGELFDQI-TS 138
           + +     +    E  +L  L    +V+           SL + +E    G L D +   
Sbjct: 61  QHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH 120

Query: 139 KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS 198
           +  L       Y++++   +EY+ S   +HRD+   N+L+ ++ H+KIADFG        
Sbjct: 121 RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFG-------- 172

Query: 199 RITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GT 252
               L      DK    V      P     PE L+ +  +  +D+W+ G  LY++ +   
Sbjct: 173 ----LAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCD 228

Query: 253 SPFKDTSEWL 262
                ++E+L
Sbjct: 229 KSCSPSAEFL 238

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 51/222 (22%), Positives = 93/222 (41%), Gaps = 27/222 (12%)

Query: 41  HFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKENKTAYVKLER 96
            F  +  +  +  G G++  V   +    + +TG V A+K +  +  T+E+   + + E 
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFER-EI 62

Query: 97  IVLDQLDHPGVVRLF--FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAE 153
            +L  L H  +V+           +L + +E    G L D +   K  +   +   YT++
Sbjct: 63  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 122

Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           +   +EY+ +   IHRD+   N+L+  +  +KI DFG            L      DK  
Sbjct: 123 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG------------LTKVLPQDKEF 170

Query: 214 TFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS 250
             V      P     PE L  S  +  +D+W+ G  LY++ +
Sbjct: 171 FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 52/238 (21%), Positives = 96/238 (40%), Gaps = 27/238 (11%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
           F  +  +  +  G G + KV           TG + A+K + K     ++++ + + E  
Sbjct: 28  FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADAGPQHRSGWKQ-EID 85

Query: 98  VLDQLDHPGVVRLF--FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
           +L  L H  +++           SL + +E    G L D +  +  +   +   +  ++ 
Sbjct: 86  ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQIC 144

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           + + Y+H+   IHRD+   N+LL  D  +KI DFG            L  A  +      
Sbjct: 145 EGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFG------------LAKAVPEGHEYYR 192

Query: 216 VGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRI 267
           V      P     PE L      + +D+W+ G TLY++L+   S     +++L    I
Sbjct: 193 VREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 81.0 bits (200), Expect = 1e-16
 Identities = 48/215 (22%), Positives = 87/215 (40%), Gaps = 22/215 (10%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
              L    G G + +V       T  V A+K +      K    +      E  V+ +L 
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTL------KPGTMSPEAFLQEAQVMKKLR 237

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYI 161
           H  +V+L+    +   +Y+  E    G L D +  +   +L   +     A++   + Y+
Sbjct: 238 HEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 296

Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
             M  +HRD++  N+L+  +   K+ADFG  + ++D+  T     A          TA  
Sbjct: 297 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-----ARQGAKFPIKWTA-- 349

Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             PE       T  +D+W+ G  L ++ + G  P+
Sbjct: 350 --PEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 382

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 51/222 (22%), Positives = 91/222 (40%), Gaps = 26/222 (11%)

Query: 41  HFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           HF  +  +  +  G G + KV   +      +TG   A+K + K      +     K E 
Sbjct: 17  HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKK-EI 74

Query: 97  IVLDQLDHPGVVRLF--FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAE 153
            +L  L H  +V+     T      + + +E    G L + +  +K  ++  +   Y  +
Sbjct: 75  EILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQ 134

Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           +   ++Y+ S   +HRD+   N+L+ ++  +KI DFG            L  A   DK  
Sbjct: 135 ICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFG------------LTKAIETDKEY 182

Query: 214 TFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS 250
             V      P     PE L  S     +D+W+ G TL+++L+
Sbjct: 183 YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 48/235 (20%), Positives = 97/235 (41%), Gaps = 31/235 (13%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTG-----TVYALKIMDKKFITKENKTAYVKLERIVLD 100
           +F+  K+ G G++  V +   I  G      V A+K + ++  + +     +  E  V+ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKEL-REATSPKANKEILD-EAYVMA 72

Query: 101 QLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDAL 158
            +D+P V RL       T  + +  +    G L D +   K ++       +  ++   +
Sbjct: 73  SVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130

Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
            Y+    L+HRD+   N+L+    H+KI DFG  K +             ++K   +   
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA-----------EEK--EYHAE 177

Query: 219 AAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRI 267
              VP      E +     T  +D+W+ G T++++++ G+ P+       I   +
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 80.3 bits (198), Expect = 3e-16
 Identities = 48/215 (22%), Positives = 87/215 (40%), Gaps = 22/215 (10%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
              L    G G + +V       T  V A+K +      K    +      E  V+ +L 
Sbjct: 268 SLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTL------KPGTMSPEAFLQEAQVMKKLR 320

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYI 161
           H  +V+L+    +   +Y+  E    G L D +  +   +L   +     A++   + Y+
Sbjct: 321 HEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 379

Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
             M  +HRD++  N+L+  +   K+ADFG  + ++D+  T     A          TA  
Sbjct: 380 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-----ARQGAKFPIKWTA-- 432

Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             PE       T  +D+W+ G  L ++ + G  P+
Sbjct: 433 --PEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 465

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 80.7 bits (199), Expect = 3e-16
 Identities = 53/224 (23%), Positives = 97/224 (43%), Gaps = 27/224 (12%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVY---ALKIMDKKFITKENKTAYVKLERIVLDQL 102
             ELG+  G G +  V +   +         A+K   K   +   +  +++ E + + Q 
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFLQ-EALTMRQF 448

Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYI 161
           DHP +V+L     +   +++ +E C  GEL   +   K  L       Y  ++  AL Y+
Sbjct: 449 DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL 507

Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
            S   +HRDI   N+L++++  +K+ DFG  + M+DS                +  +   
Sbjct: 508 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--------------TYYKASKGK 553

Query: 222 VP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
           +P     PE +N    T  +D+W  G  ++++L  G  PF+   
Sbjct: 554 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 597

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 77.3 bits (191), Expect = 6e-16
 Identities = 55/231 (23%), Positives = 101/231 (43%), Gaps = 28/231 (12%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAK-KIDTGTVY-ALKIMDKKFITKENKTAYVKLE 95
            +++  I D ELG     G++  V +   ++    +  A+K++ K+   K +    ++ E
Sbjct: 7   KRDNLLIADIELGC----GNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMR-E 60

Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEV 154
             ++ QLD+P +VRL    Q   +L + +E   GG L   +   +  +          +V
Sbjct: 61  AQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 119

Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
              ++Y+     +HRD+   N+LL    + KI+DFG            L  A   D +  
Sbjct: 120 SMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFG------------LSKALGADDSYY 167

Query: 215 FVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
              +A   P     PE +N    +  +D+W+ G T+++ LS G  P+K   
Sbjct: 168 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 218

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 78.0 bits (192), Expect = 9e-16
 Identities = 71/365 (19%), Positives = 111/365 (30%), Gaps = 117/365 (32%)

Query: 54  GVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-----DHPG-- 106
           G G +S V  +  I      A+K++  K      +TA    E  +L  +     + P   
Sbjct: 46  GWGHFSTVWLSWDIQGKKFVAMKVV--KSAEHYTETA--LDEIRLLKSVRNSDPNDPNRE 101

Query: 107 -VVRLFFTFQDTFSLY--------MALESCEGGELFDQITSKGH--LSEDEARFYTAEVV 155
            VV+L     D F +         M  E   G  L   I    +  L     +    +V+
Sbjct: 102 MVVQLL----DDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVL 156

Query: 156 DALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS---------------- 198
             L+Y+H+   +IH DIKPEN+LL+ +              Q S                
Sbjct: 157 QGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216

Query: 199 -------------------RITVLPNAASDDKACTF-VGTAAYVPPEVLNSSPATFGNDL 238
                              +I  L NA    K  T  + T  Y   EVL  S      D+
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADI 276

Query: 239 WALGCTLYQMLSGTSPF--KDTSEWLIFQRIIARDIR----FP-----------NYFSD- 280
           W+  C  +++ +G   F      E+   +  IA  I      P            +F+  
Sbjct: 277 WSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKK 336

Query: 281 ------------------------------AARDLIDRLLDVDPSGRPGAGPGGYAVLKM 310
                                            D +  +L++ P  R  A       L+ 
Sbjct: 337 GDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAA----ECLR- 391

Query: 311 HPFFK 315
           HP+  
Sbjct: 392 HPWLN 396

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 77.0 bits (190), Expect = 1e-15
 Identities = 49/224 (21%), Positives = 94/224 (41%), Gaps = 24/224 (10%)

Query: 46  DFELGKIYGVGSYSKVVRA--KKIDTGTVY-ALKIMDKKFITKENKTAYVKLERIVLDQL 102
              + KI G G   +V     +      V  A+K + K   T+  +  ++  E  ++ Q 
Sbjct: 50  RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQRRDFLS-EASIMGQF 107

Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYI 161
           DHP ++RL           +  E  E G L   + T  G  +  +       V   + Y+
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL 167

Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
             +G +HRD+   N+L+ ++   K++DFG    +  SR+        DD    +  T   
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFG----L--SRVL------EDDPDAAYTTTGGK 215

Query: 222 VP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
           +P     PE +     +  +D+W+ G  ++++L+ G  P+ + +
Sbjct: 216 IPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT 259

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 76.1 bits (188), Expect = 1e-15
 Identities = 54/226 (23%), Positives = 98/226 (43%), Gaps = 31/226 (13%)

Query: 46  DFELGKIYGVGSYSKVVRA--KKIDTGTVY-ALKIMDKKFITKENKTAYVKLERIVLDQL 102
             ELG+  G G +  V +      +   +  A+K   K   +   +  +++ E + + Q 
Sbjct: 16  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQ-EALTMRQF 73

Query: 103 DHPGVVRLF--FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALE 159
           DHP +V+L    T      +++ +E C  GEL   +   K  L       Y  ++  AL 
Sbjct: 74  DHPHIVKLIGVITEN---PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 130

Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           Y+ S   +HRDI   N+L++++  +K+ DFG  + M+DS                +  + 
Sbjct: 131 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--------------TYYKASK 176

Query: 220 AYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
             +P     PE +N    T  +D+W  G  ++++L  G  PF+   
Sbjct: 177 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 222

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 78.1 bits (192), Expect = 2e-15
 Identities = 54/232 (23%), Positives = 101/232 (43%), Gaps = 28/232 (12%)

Query: 35  FRAPQEHFSIQDFELGKIYGVGSYSKVVRAK-KIDTGTVY-ALKIMDKKFITKENKTAYV 92
               +++  I D ELG     G++  V +   ++    +  A+K++ K+   K +    +
Sbjct: 330 LFLKRDNLLIADIELGC----GNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMM 384

Query: 93  KLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYT 151
           + E  ++ QLD+P +VRL    Q   +L + +E   GG L   +   +  +         
Sbjct: 385 R-EAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL 442

Query: 152 AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDK 211
            +V   ++Y+     +HR++   N+LL    + KI+DFG            L  A   D 
Sbjct: 443 HQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFG------------LSKALGADD 490

Query: 212 ACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKD 257
           +     +A   P     PE +N    +  +D+W+ G T+++ LS G  P+K 
Sbjct: 491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 542

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 47/225 (20%), Positives = 98/225 (43%), Gaps = 25/225 (11%)

Query: 46  DFELGKIYGVGSYSKVVRAK-KIDTGTVY---ALKIMDKKFITKENKTAYVKLERIVLDQ 101
                K+ G G + +V +   K  +G      A+K + K   T++ +  ++  E  ++ Q
Sbjct: 45  CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLG-EAGIMGQ 102

Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEY 160
             H  ++RL         + +  E  E G L   +    G  S  +       +   ++Y
Sbjct: 103 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 162

Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           + +M  +HRD+   N+L+ ++   K++DFG    +  SR+        DD   T+  +  
Sbjct: 163 LANMNYVHRDLAARNILVNSNLVCKVSDFG----L--SRVL------EDDPEATYTTSGG 210

Query: 221 YVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
            +P     PE ++    T  +D+W+ G  ++++++ G  P+ + S
Sbjct: 211 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS 255

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 75.4 bits (186), Expect = 3e-15
 Identities = 54/229 (23%), Positives = 90/229 (39%), Gaps = 31/229 (13%)

Query: 45  QDFELGKIYGVGSYSKVVRAK-KIDTGTVY--ALKIMDKKFITKENKTAYVKLERIVLDQ 101
           +D  L +  G GS+  V R +    +G     A+K +    +++         E   +  
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 102 LDHPGVVRLF--FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDAL 158
           LDH  ++RL+          + M  E    G L D++   +GH        Y  +V + +
Sbjct: 78  LDHRNLIRLYGVVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 134

Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG- 217
            Y+ S   IHRD+   NLLL     +KI DFG ++ +            +DD        
Sbjct: 135 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ----------NDDHYVMQEHR 184

Query: 218 ------TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
                  A    PE L +   +  +D W  G TL++M + G  P+   +
Sbjct: 185 KVPFAWCA----PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 229

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 75.8 bits (187), Expect = 3e-15
 Identities = 44/234 (18%), Positives = 93/234 (39%), Gaps = 29/234 (12%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVY----ALKIMDKKFITKENKTAYVKLERIVLDQ 101
           +    K+ G G +  V +   I  G        +K++ +    +++  A      + +  
Sbjct: 14  ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQAVTD-HMLAIGS 71

Query: 102 LDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALE 159
           LDH  +VRL       +  L +  +    G L D +   +G L       +  ++   + 
Sbjct: 72  LDHAHIVRLLGLCPGSS--LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMY 129

Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           Y+   G++HR++   N+LL +   +++ADFG    +             DDK      + 
Sbjct: 130 YLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP-----------DDKQLL--YSE 176

Query: 220 AYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRI 267
           A  P      E ++    T  +D+W+ G T++++++ G  P+       +   +
Sbjct: 177 AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL 230

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 74.2 bits (183), Expect = 6e-15
 Identities = 51/221 (23%), Positives = 88/221 (39%), Gaps = 30/221 (13%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQL 102
            D  +    G G Y +V            A+K +      KE+     +   E  V+ ++
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTMEVEEFLKEAAVMKEI 66

Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVVDALEY 160
            HP +V+L          Y+  E    G L D  +  ++  +S     +   ++  A+EY
Sbjct: 67  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126

Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           +     IHRD+   N L+  +  +K+ADFG  + M     T    A +  K         
Sbjct: 127 LEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT----AHAGAK--------- 173

Query: 221 YVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
             P     PE L  +  +  +D+WA G  L+++ + G SP+
Sbjct: 174 -FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 73.8 bits (182), Expect = 7e-15
 Identities = 50/218 (22%), Positives = 94/218 (43%), Gaps = 26/218 (11%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQL 102
            +    +  G G +  V     ++   V A+K +      +E   +      E  V+ +L
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTI------REGAMSEEDFIEEAEVMMKL 60

Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYI 161
            HP +V+L+    +   + +  E  E G L D + T +G  + +       +V + + Y+
Sbjct: 61  SHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120

Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
               +IHRD+   N L+  +  IK++DFG       +R         DD+  +  GT   
Sbjct: 121 EEACVIHRDLAARNCLVGENQVIKVSDFGM------TRFV------LDDQYTSSTGTKFP 168

Query: 222 V---PPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
           V    PEV + S  +  +D+W+ G  ++++ S G  P+
Sbjct: 169 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 206

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 75.1 bits (185), Expect = 7e-15
 Identities = 47/224 (20%), Positives = 96/224 (42%), Gaps = 24/224 (10%)

Query: 46  DFELGKIYGVGSYSKVVRA--KKIDTGTVY-ALKIMDKKFITKENKTAYVKLERIVLDQL 102
           +  + K+ G G + +V     K      +  A+K + K   T++ +  ++  E  ++ Q 
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLG-EASIMGQF 103

Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYI 161
           DHP ++RL      +  + +  E  E G L   +       +  +       +   ++Y+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163

Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
             MG +HRD+   N+L+ ++   K++DFG    +   R+        DD    +      
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFG----L--GRVL------EDDPEAAYTTRGGK 211

Query: 222 VP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
           +P     PE +     T  +D+W+ G  L++++S G  P+ + S
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 73.8 bits (182), Expect = 8e-15
 Identities = 53/226 (23%), Positives = 97/226 (42%), Gaps = 31/226 (13%)

Query: 46  DFELGKIYGVGSYSKVVRA--KKIDTGTVY-ALKIMDKKFITKENKTAYVKLERIVLDQL 102
           D  L +I G G + +V            +  A+K   KK  T +NK  ++  E +++  L
Sbjct: 13  DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFMS-EAVIMKNL 70

Query: 103 DHPGVVRLF--FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALE 159
           DHP +V+L      +     ++ +E    GEL   +  +K  L       Y+ ++  A+ 
Sbjct: 71  DHPHIVKLIGIIEEE---PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127

Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           Y+ S+  +HRDI   N+L+ +   +K+ DFG  + ++D                 +  + 
Sbjct: 128 YLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE--------------DYYKASV 173

Query: 220 AYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
             +P     PE +N    T  +D+W     ++++LS G  PF    
Sbjct: 174 TRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE 219

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 73.8 bits (182), Expect = 8e-15
 Identities = 51/228 (22%), Positives = 95/228 (41%), Gaps = 26/228 (11%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAK-KIDTGTVY-ALKIMDKKFITKENKTAYVKLE 95
            ++  +++D ELG     G++  V +   ++       A+KI+  +      K   +  E
Sbjct: 14  DRKLLTLEDKELGS----GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA-E 68

Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
             V+ QLD+P +VR+    +   S  + +E  E G L   +    H+ +        +V 
Sbjct: 69  ANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVS 127

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
             ++Y+     +HRD+   N+LL    + KI+DFG            L  A   D+    
Sbjct: 128 MGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFG------------LSKALRADENYYK 175

Query: 216 VGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKD 257
             T    P     PE +N    +  +D+W+ G  +++  S G  P++ 
Sbjct: 176 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 223

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 74.0 bits (182), Expect = 1e-14
 Identities = 58/218 (26%), Positives = 90/218 (41%), Gaps = 22/218 (10%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH-P 105
           F +GK  G G++ ++   K + T    A+K+   K     ++   + LE     QL    
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMK-----SRAPQLHLEYRFYKQLGSGD 65

Query: 106 GVVRLFFTFQDTFSLYMALE----SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           G+ ++++         M LE    S E  +LFD        S         +++  +EY+
Sbjct: 66  GIPQVYYFGPCGKYNAMVLELLGPSLE--DLFDL--CDRTFSLKTVLMIAIQLISRMEYV 121

Query: 162 HSMGLIHRDIKPENLLLTADGH-----IKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           HS  LI+RD+KPEN L+   G+     I I DF   K   D   T       + K+    
Sbjct: 122 HSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE-TKKHIPYREHKS--LT 178

Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 254
           GTA Y+          +  +DL ALG      L G+ P
Sbjct: 179 GTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 72.6 bits (179), Expect = 2e-14
 Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 26/217 (11%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           +  L K  G G +  V   K      V A+K++      KE   +  +   E   + +L 
Sbjct: 9   EITLLKELGSGQFGVVKLGKWKGQYDV-AVKMI------KEGSMSEDEFFQEAQTMMKLS 61

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIH 162
           HP +V+ +      + +Y+  E    G L + + S G  L   +      +V + + ++ 
Sbjct: 62  HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE 121

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S   IHRD+   N L+  D  +K++DFG    M  +R         DD+  + VGT   V
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFG----M--TRYV------LDDQYVSSVGTKFPV 169

Query: 223 ---PPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
               PEV +    +  +D+WA G  ++++ S G  P+
Sbjct: 170 KWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY 206

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 45/231 (19%), Positives = 93/231 (40%), Gaps = 24/231 (10%)

Query: 48  ELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
              ++ G G +  V     +D        A+K +  +       + ++  E I++    H
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLT-EGIIMKDFSH 149

Query: 105 PGVVRLF-FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIH 162
           P V+ L     +   S  + L   + G+L + I     + +  +   +  +V   ++++ 
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 209

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S   +HRD+   N +L     +K+ADFG  + M D            +       T A +
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD-----------KEFDSVHNKTGAKL 258

Query: 223 P-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRI 267
           P      E L +   T  +D+W+ G  L+++++ G  P+ D + + I   +
Sbjct: 259 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 309

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 72.8 bits (179), Expect = 2e-14
 Identities = 46/218 (21%), Positives = 87/218 (39%), Gaps = 22/218 (10%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH-P 105
           +++G+  G GS+  +     +      A+K   ++     +    ++ E      L    
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-----SDAPQLRDEYRTYKLLAGCT 66

Query: 106 GVVRLFFTFQDTFSLYMALE----SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           G+  +++  Q+     + ++    S E  +L D        S         +++  ++ I
Sbjct: 67  GIPNVYYFGQEGLHNVLVIDLLGPSLE--DLLDL--CGRKFSVKTVAMAAKQMLARVQSI 122

Query: 162 HSMGLIHRDIKPENLLL----TADGH-IKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
           H   L++RDIKP+N L+    + + + I + DFG VK  +D   T       + K     
Sbjct: 123 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV-TKQHIPYREKKN--LS 179

Query: 217 GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 254
           GTA Y+          +  +DL ALG      L G+ P
Sbjct: 180 GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 72.0 bits (177), Expect = 4e-14
 Identities = 53/217 (24%), Positives = 87/217 (40%), Gaps = 22/217 (10%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH-P 105
           + LG+  G GS+  +     I  G   A+K+   K      K   + +E  +   +    
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-----TKHPQLHIESKIYKMMQGGV 65

Query: 106 GVVRLFFTFQDTFSLYMALE----SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           G+  + +   +     M +E    S E  +LF+        S         +++  +EYI
Sbjct: 66  GIPTIRWCGAEGDYNVMVMELLGPSLE--DLFNF--CSRKFSLKTVLLLADQMISRIEYI 121

Query: 162 HSMGLIHRDIKPENLLL--TADGH-IKIADFGSVKPMQDSRI-TVLPNAASDDKACTFVG 217
           HS   IHRD+KP+N L+     G+ + I DFG  K  +D+R    +P      +     G
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY----RENKNLTG 177

Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 254
           TA Y           +  +DL +LG  L     G+ P
Sbjct: 178 TARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 71.1 bits (175), Expect = 7e-14
 Identities = 50/229 (21%), Positives = 95/229 (41%), Gaps = 46/229 (20%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKI-----MDKKFITKENKTAYVKLER 96
            ++++ +L +  G G +  V+         V A+K        + F+           E 
Sbjct: 18  LNMKELKLLQTIGKGEFGDVMLGDYRGN-KV-AVKCIKNDATAQAFLA----------EA 65

Query: 97  IVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAE 153
            V+ QL H  +V+L     ++   LY+  E    G L D  +   +  L  D    ++ +
Sbjct: 66  SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 125

Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           V +A+EY+     +HRD+   N+L++ D   K++DFG    +  ++         +  + 
Sbjct: 126 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG----L--TK---------EASST 170

Query: 214 TFVG------TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
              G      TA    PE L     +  +D+W+ G  L+++ S G  P+
Sbjct: 171 QDTGKLPVKWTA----PEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 215

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 72.4 bits (178), Expect = 8e-14
 Identities = 54/224 (24%), Positives = 90/224 (40%), Gaps = 40/224 (17%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
             +L K  G G + +V  A       V A+K M      K    +      E  V+  L 
Sbjct: 189 SLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTM------KPGSMSVEAFLAEANVMKTLQ 241

Query: 104 HPGVVRLF--FTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALE 159
           H  +V+L    T +    +Y+  E    G L D + S         +   ++A++ + + 
Sbjct: 242 HDKLVKLHAVVTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 298

Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG-- 217
           +I     IHRD++  N+L++A    KIADFG            L     D++     G  
Sbjct: 299 FIEQRNYIHRDLRAANILVSASLVCKIADFG------------LARVIEDNEYTAREGAK 346

Query: 218 -----TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                TA    PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 347 FPIKWTA----PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 386

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 70.8 bits (174), Expect = 9e-14
 Identities = 45/231 (19%), Positives = 94/231 (40%), Gaps = 24/231 (10%)

Query: 48  ELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
              ++ G G +  V     +D        A+K +  +       + ++  E I++    H
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLT-EGIIMKDFSH 85

Query: 105 PGVVRLF-FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIH 162
           P V+ L     +   S  + L   + G+L + I     + +  +   +  +V   ++Y+ 
Sbjct: 86  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 145

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S   +HRD+   N +L     +K+ADFG    +  +R     +    +       T A +
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFG----L--AR-----DMYDKEYYSVHNKTGAKL 194

Query: 223 P-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRI 267
           P      E L +   T  +D+W+ G  L+++++ G  P+ D + + I   +
Sbjct: 195 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 245

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 72.3 bits (177), Expect = 1e-13
 Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 20/216 (9%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHP 105
           F LG+  G GS+ ++     I T    A+K+ + K      K   +  E  +   L    
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKIYRILQGGT 63

Query: 106 GVVRLFFTFQDTFSLYMALE----SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           G+  + +   +     + ++    S E  +LF+       LS         ++++ +E++
Sbjct: 64  GIPNVRWFGVEGDYNVLVMDLLGPSLE--DLFNFC--SRKLSLKTVLMLADQMINRVEFV 119

Query: 162 HSMGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           HS   +HRDIKP+N L+        + I DFG  K  +D+  T       ++K     GT
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS-THQHIPYRENKN--LTGT 176

Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 254
           A Y           +  +DL +LG  L   L G+ P
Sbjct: 177 ARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 69.6 bits (171), Expect = 2e-13
 Identities = 46/241 (19%), Positives = 96/241 (39%), Gaps = 27/241 (11%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKL 94
           P E          ++ G G +  V   + ID        A+K +  +    +   A+++ 
Sbjct: 17  PHERVVTH---SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SRITEMQQVEAFLR- 71

Query: 95  ERIVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTA 152
           E +++  L+HP V+ L           ++ L     G+L   I + + + +  +   +  
Sbjct: 72  EGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL 131

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKA 212
           +V   +EY+     +HRD+   N +L     +K+ADFG  + + D            +  
Sbjct: 132 QVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILD-----------REYY 180

Query: 213 CTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQR 266
                  A +P      E L +   T  +D+W+ G  L+++L+ G  P++    + +   
Sbjct: 181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF 240

Query: 267 I 267
           +
Sbjct: 241 L 241

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 69.2 bits (170), Expect = 3e-13
 Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 26/217 (11%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
           D    K  G G +  V   K      V A+K++      KE   +  +   E  V+  L 
Sbjct: 25  DLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMI------KEGSMSEDEFIEEAKVMMNLS 77

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIH 162
           H  +V+L+        +++  E    G L + +   +      +      +V +A+EY+ 
Sbjct: 78  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 137

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S   +HRD+   N L+   G +K++DFG       SR         DD+  + VG+   V
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGL------SRY------VLDDEYTSSVGSKFPV 185

Query: 223 ---PPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
              PPEVL  S  +  +D+WA G  ++++ S G  P+
Sbjct: 186 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 222

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 70.5 bits (173), Expect = 3e-13
 Identities = 39/154 (25%), Positives = 69/154 (44%), Gaps = 20/154 (12%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALK-----IMDKKFITKENKTAYVKLERIVL 99
           ++ +L +  G G +  V+         V A+K        + F+           E  V+
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYRGN-KV-AVKCIKNDATAQAFLA----------EASVM 240

Query: 100 DQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVD 156
            QL H  +V+L     ++   LY+  E    G L D + S+G   L  D    ++ +V +
Sbjct: 241 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 300

Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 190
           A+EY+     +HRD+   N+L++ D   K++DFG
Sbjct: 301 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG 334

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 69.7 bits (171), Expect = 3e-13
 Identities = 48/232 (20%), Positives = 91/232 (39%), Gaps = 35/232 (15%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
           Q F LG++ G G +  V  A+           A+K++    I   +   +++ E   + +
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR-EAACMKE 81

Query: 102 LDHPGVVRLF------FTFQDTFSLYMALESCEGGELFD------QITSKGHLSEDEARF 149
            DHP V +L                 + L   + G+L           +  +L       
Sbjct: 82  FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141

Query: 150 YTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASD 209
           +  ++   +EY+ S   IHRD+   N +L  D  + +ADFG  + +              
Sbjct: 142 FMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR------- 194

Query: 210 DKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                  G A+ +P      E L  +  T  +D+WA G T++++++ G +P+
Sbjct: 195 ------QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY 240

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 68.8 bits (169), Expect = 4e-13
 Identities = 53/224 (23%), Positives = 93/224 (41%), Gaps = 40/224 (17%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLD 103
             +L +  G G + +V          V A+K +      K+   +      E  ++ QL 
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSL------KQGSMSPDAFLAEANLMKQLQ 66

Query: 104 HPGVVRLF--FTFQDTFSLYMALESCEGGELFD--QITSKGHLSEDEARFYTAEVVDALE 159
           H  +VRL+   T +    +Y+  E  E G L D  +  S   L+ ++     A++ + + 
Sbjct: 67  HQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123

Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG-- 217
           +I     IHRD++  N+L++     KIADFG            L     D++     G  
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFG------------LARLIEDNEYTAREGAK 171

Query: 218 -----TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                TA    PE +N    T  +D+W+ G  L ++++ G  P+
Sbjct: 172 FPIKWTA----PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 68.5 bits (168), Expect = 6e-13
 Identities = 42/236 (17%), Positives = 84/236 (35%), Gaps = 36/236 (15%)

Query: 41  HFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLE 95
             + +   + +  G GS+  V         K +  T  A+K    +  +   +  ++  E
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIK-TVNEAASMRERIEFLN-E 78

Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL----------FDQITSKGHLSED 145
             V+ + +   VVRL           + +E    G+L                    S  
Sbjct: 79  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 138

Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
           +      E+ D + Y+++   +HRD+   N ++  D  +KI DFG  + + ++       
Sbjct: 139 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR--- 195

Query: 206 AASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                      G    +P     PE L     T  +D+W+ G  L+++ +    P+
Sbjct: 196 ----------KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY 241

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 68.6 bits (168), Expect = 7e-13
 Identities = 41/232 (17%), Positives = 80/232 (34%), Gaps = 32/232 (13%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTV--------YALKI--------MDKKFITKENKTA 90
           ++L       +   +  A    T T         ++LK+         ++ F  +  K  
Sbjct: 44  WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103

Query: 91  YVKLERIVLDQLDHPGV--VRLFFTFQDTFSLYMALE----SCEGGELFDQITSKGHLSE 144
            V   +  L       +     F   QD +  ++ L     S +     D  + K  LSE
Sbjct: 104 QVNKWKK-LYSTPLLAIPTCMGFGVHQDKYR-FLVLPSLGRSLQ--SALDV-SPKHVLSE 158

Query: 145 DEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL--TADGHIKIADFGSVKPMQDSRITV 202
                    ++DALE++H    +H ++  EN+ +       + +A +G       S   V
Sbjct: 159 RSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHV 218

Query: 203 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 254
              A  +       G   ++  ++      +  +DL +LG  + + L G  P
Sbjct: 219 ---AYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 66.2 bits (162), Expect = 3e-12
 Identities = 48/228 (21%), Positives = 84/228 (36%), Gaps = 34/228 (14%)

Query: 48  ELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
            LGKI G G +  V+              A+K M     ++     ++  E   +    H
Sbjct: 37  ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLS-EAACMKDFSH 95

Query: 105 PGVVRLF-----FTFQDTFSLYMALESCEGGELFD------QITSKGHLSEDEARFYTAE 153
           P V+RL       + Q      + L   + G+L          T   H+       +  +
Sbjct: 96  PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155

Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           +   +EY+ +   +HRD+   N +L  D  + +ADFG  K +                  
Sbjct: 156 IALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR----------- 204

Query: 214 TFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
              G  A +P      E L     T  +D+WA G T++++ + G +P+
Sbjct: 205 --QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY 250

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 63.1 bits (154), Expect = 3e-11
 Identities = 41/232 (17%), Positives = 85/232 (36%), Gaps = 35/232 (15%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVY-------ALKIMDKKFITKENKTAYVKLERIV 98
           D    +  G G+++K+ +  + + G           LK++DK    +    ++ +    +
Sbjct: 9   DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFE-AASM 65

Query: 99  LDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDA 157
           + +L H  +V  +          +  E  + G L   +  +K  ++         ++  A
Sbjct: 66  MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAA 125

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGH--------IKIADFGSVKPMQDSRITVLPNAASD 209
           + ++    LIH ++  +N+LL  +          IK++D G    +    I         
Sbjct: 126 MHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQER----- 180

Query: 210 DKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS 259
                      +VPPE + N        D W+ G TL+++ S G  P     
Sbjct: 181 ---------IPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD 223

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 64.0 bits (156), Expect = 3e-11
 Identities = 29/104 (27%), Positives = 41/104 (39%), Gaps = 5/104 (4%)

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLL--TADGHIKIADFGSVKPMQDSRITVLPNAASDD 210
            ++D LEYIH    +H DIK  NLLL       + + D+G               AA   
Sbjct: 160 RILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG-VHKAYAADPK 218

Query: 211 KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 254
           +     GT  +   +  N    +   DL  LG  + Q L+G  P
Sbjct: 219 RC--HDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 26/104 (25%), Positives = 41/104 (39%), Gaps = 5/104 (4%)

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLL--TADGHIKIADFGSVKPMQDSRITVLPNAASDD 210
            ++D LEYIH    +H DIK  NLLL       + +AD+G       +         +  
Sbjct: 159 RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG-NHKQYQENPR 217

Query: 211 KACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP 254
           K     GT  +   +       +  +D+  LG  + + L G  P
Sbjct: 218 KG--HNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 62.7 bits (153), Expect = 5e-11
 Identities = 46/236 (19%), Positives = 90/236 (38%), Gaps = 36/236 (15%)

Query: 41  HFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLE 95
               ++  L +  G G++ +V   +        +    A+K    +  +++++  ++  E
Sbjct: 26  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK-TLPEVCSEQDELDFLM-E 83

Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD-------QITSKGHLSEDEAR 148
            +++ + +H  +VR       +   ++ +E   GG+L         + +    L+  +  
Sbjct: 84  ALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 143

Query: 149 FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPN 205
               ++    +Y+     IHRDI   N LLT  G     KI DFG    M  +R     +
Sbjct: 144 HVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG----M--AR-----D 192

Query: 206 AASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                      G  A +P     PE       T   D W+ G  L+++ S G  P+
Sbjct: 193 IYRAS--YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 246

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 62.8 bits (153), Expect = 6e-11
 Identities = 47/236 (19%), Positives = 90/236 (38%), Gaps = 36/236 (15%)

Query: 41  HFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLE 95
               ++  L +  G G++ +V   +        +    A+K    +  +++++  ++  E
Sbjct: 67  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK-TLPEVCSEQDELDFLM-E 124

Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD-------QITSKGHLSEDEAR 148
            +++ + +H  +VR       +   ++ LE   GG+L         + +    L+  +  
Sbjct: 125 ALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 184

Query: 149 FYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPN 205
               ++    +Y+     IHRDI   N LLT  G     KI DFG    M  +R     +
Sbjct: 185 HVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG----M--AR-----D 233

Query: 206 AASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
                      G  A +P     PE       T   D W+ G  L+++ S G  P+
Sbjct: 234 IYRAG--YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 287

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 61.1 bits (149), Expect = 1e-10
 Identities = 43/168 (25%), Positives = 71/168 (42%), Gaps = 25/168 (14%)

Query: 46  DFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 100
             +LGK  G G++ +V+ A      K  T    A+K++ K+  T     A +  E  +L 
Sbjct: 28  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALMS-ELKILI 85

Query: 101 QLD-HPGVVRLF-FTFQDTFSLYMALESCEGGELFD----------------QITSKGHL 142
            +  H  VV L     +    L + +E C+ G L                  +   K  L
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145

Query: 143 SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 190
           + +    Y+ +V   +E++ S   IHRD+   N+LL+    +KI DFG
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG 193

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 60.1 bits (146), Expect = 5e-10
 Identities = 44/204 (21%), Positives = 82/204 (40%), Gaps = 27/204 (13%)

Query: 12  LRIEGNNNSSTNCPTVQRSKSFAFRAPQE-HFSIQDFELGKIYGVGSYSKVVRAK----- 65
           +RI    +S+ + P +     +      +  F      LGK  G G + +VV A+     
Sbjct: 47  VRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGID 106

Query: 66  --KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYM 122
             K       A+K++ K   T+++ +  V  E  ++  +  H  ++ L         LY+
Sbjct: 107 KDKPKEAVTVAVKML-KDDATEKDLSDLVS-EMEMMKMIGKHKNIINLLGACTQDGPLYV 164

Query: 123 ALESCEGGELFD----------------QITSKGHLSEDEARFYTAEVVDALEYIHSMGL 166
            +E    G L +                    +  ++  +    T ++   +EY+ S   
Sbjct: 165 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC 224

Query: 167 IHRDIKPENLLLTADGHIKIADFG 190
           IHRD+   N+L+T +  +KIADFG
Sbjct: 225 IHRDLAARNVLVTENNVMKIADFG 248

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 60.0 bits (146), Expect = 5e-10
 Identities = 42/169 (24%), Positives = 67/169 (39%), Gaps = 22/169 (13%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           F   + + GK  G G++ KVV A      K D     A+K M K     + K A +  E 
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK-MLKSTAHADEKEALMS-EL 100

Query: 97  IVLDQLD-HPGVVRLFFTFQDTFSLYMALESCEGGELFD--------------QITSKGH 141
            ++  L  H  +V L         + +  E C  G+L +                 +   
Sbjct: 101 KIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160

Query: 142 LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 190
            S  +   ++++V   + ++ S   IHRD+   N+LLT     KI DFG
Sbjct: 161 ASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFG 209

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 59.2 bits (144), Expect = 7e-10
 Identities = 39/175 (22%), Positives = 72/175 (41%), Gaps = 31/175 (17%)

Query: 45  QDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVL 99
           ++  LGK  G G + KVV+A           T  A+K++ K+  +       +  E  VL
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRDLLS-EFNVL 80

Query: 100 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD------------------------Q 135
            Q++HP V++L+        L + +E  + G L                           
Sbjct: 81  KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140

Query: 136 ITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 190
              +  L+  +   +  ++   ++Y+  M L+HRD+   N+L+     +KI+DFG
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFG 195

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 59.2 bits (144), Expect = 8e-10
 Identities = 43/174 (24%), Positives = 75/174 (43%), Gaps = 21/174 (12%)

Query: 36  RAPQEHFSIQDFELGKIYGVGSYSKVVRA--KKIDTGTVYALKIMDKKFITKENKTAYVK 93
                     D +   + G G++ +V++A  KK       A+K M K++ +K++   +  
Sbjct: 16  PTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAG 74

Query: 94  LERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEGGELFD----------------QI 136
            E  VL +L  HP ++ L    +    LY+A+E    G L D                  
Sbjct: 75  -ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 133

Query: 137 TSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 190
           ++   LS  +   + A+V   ++Y+     IHRD+   N+L+  +   KIADFG
Sbjct: 134 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG 187

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 58.8 bits (143), Expect = 9e-10
 Identities = 45/173 (26%), Positives = 63/173 (36%), Gaps = 26/173 (15%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           F       GK  G G++ KVV A      K D     A+K M K       + A +  E 
Sbjct: 20  FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK-MLKPSAHLTEREALMS-EL 77

Query: 97  IVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEGGEL----------FDQITSKGHLSED 145
            VL  L +H  +V L           +  E C  G+L          F    +   + ED
Sbjct: 78  KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137

Query: 146 EARFYT--------AEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 190
           +              +V   + ++ S   IHRD+   N+LLT     KI DFG
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG 190

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 58.8 bits (143), Expect = 1e-09
 Identities = 42/201 (20%), Positives = 81/201 (40%), Gaps = 28/201 (13%)

Query: 15  EGNNNSSTNCPTVQRSKSFAFRAPQEH-FSIQDFELGKIYGVGSYSKVVRAK-------K 66
             +++ S + P +     +      +  F      LGK  G G++ +VV A+       K
Sbjct: 5   HHHHHHSQD-PMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDK 63

Query: 67  IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYMALE 125
                  A+K++ K   T+++ +  V  E  ++  +  H  ++ L         LY+ +E
Sbjct: 64  PKEAVTVAVKML-KDDATEKDLSDLVS-EMEMMKMIGKHKNIINLLGACTQDGPLYVIVE 121

Query: 126 SCEGGELFD----------------QITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHR 169
               G L +                    +  ++  +    T ++   +EY+ S   IHR
Sbjct: 122 YASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR 181

Query: 170 DIKPENLLLTADGHIKIADFG 190
           D+   N+L+T +  +KIADFG
Sbjct: 182 DLAARNVLVTENNVMKIADFG 202

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 57/284 (20%), Positives = 103/284 (36%), Gaps = 55/284 (19%)

Query: 10  SKLRIEGNNNSSTNCPTVQRSKSFAFRAPQE-HFSIQDFELGKIYGVGSYSKVVRAK--- 65
           + L  E   +     P  QR             +   + E  +  G G++ +V +A+   
Sbjct: 11  TTLPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPG 70

Query: 66  --KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA 123
               +  T+ A+K M K+  + + +  + + E  ++ + D+P +V+L         + + 
Sbjct: 71  LLPYEPFTMVAVK-MLKEEASADMQADFQR-EAALMAEFDNPNIVKLLGVCAVGKPMCLL 128

Query: 124 LESCEGGEL------------------------FDQITSKGHLSEDEARFYTAEVVDALE 159
            E    G+L                                 LS  E      +V   + 
Sbjct: 129 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMA 188

Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDD--KACTFVG 217
           Y+     +HRD+   N L+  +  +KIADFG    +  SR     N  S D  K      
Sbjct: 189 YLSERKFVHRDLATRNCLVGENMVVKIADFG----L--SR-----NIYSADYYK----AD 233

Query: 218 TAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF 255
               +P     PE +  +  T  +D+WA G  L+++ S G  P+
Sbjct: 234 GNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 58.0 bits (139), Expect = 2e-09
 Identities = 39/213 (18%), Positives = 64/213 (30%), Gaps = 53/213 (24%)

Query: 28  QRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN 87
           +    F+   P E          KI G G + +V +   I   T  A+KI+  +     N
Sbjct: 8   KGPVPFSHCLPTEKLQR----CEKI-GEGVFGEVFQT--IADHTPVAIKIIAIEGPDLVN 60

Query: 88  KTAYVKLERIV--------------LDQLDHPGVVRLF---------------------- 111
            +     E I+                     G + L                       
Sbjct: 61  GSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNS 120

Query: 112 -----FTFQDTFS---LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH- 162
                    D F    L++ LE   GG   +Q+ +K   S   A+    ++  +L     
Sbjct: 121 TKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEA 179

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPM 195
           S+   HRD+   N+LL      K+    + K  
Sbjct: 180 SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSS 212

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 58.0 bits (141), Expect = 2e-09
 Identities = 48/206 (23%), Positives = 71/206 (34%), Gaps = 54/206 (26%)

Query: 16  GNNNS-STNCPTVQRSKSFAFRAPQEHFSIQD-------FELGKIYGVGSYSKVVRAKKI 67
           G+  S +TN      S S+          + D       F+   + G G + KV +   +
Sbjct: 2   GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGV-L 60

Query: 68  DTGTVYALKIMD-------KKFITKENKTAYVKLERIVLDQLDHPGVVRLF-FTFQDTFS 119
             G   ALK          ++F T          E   L    HP +V L  F  +    
Sbjct: 61  RDGAKVALKRRTPESSQGIEEFET----------EIETLSFCRHPHLVSLIGFCDERNEM 110

Query: 120 L----YMA---LESCEGGELFDQITSKGHLS--------EDEARFYTAEVVDALEYIHSM 164
           +    YM    L+      L+        +S           AR         L Y+H+ 
Sbjct: 111 ILIYKYMENGNLKRH----LYGSDLPTMSMSWEQRLEICIGAAR--------GLHYLHTR 158

Query: 165 GLIHRDIKPENLLLTADGHIKIADFG 190
            +IHRD+K  N+LL  +   KI DFG
Sbjct: 159 AIIHRDVKSINILLDENFVPKITDFG 184

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 49/241 (20%), Positives = 90/241 (37%), Gaps = 42/241 (17%)

Query: 41  HFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLE 95
           H   +D  L    G G++ KV  A+           + A+K +  K  ++  +  + + E
Sbjct: 37  HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQR-E 93

Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL---------------FDQITSKG 140
             +L  L H  +VR F    +   L M  E    G+L                 +  + G
Sbjct: 94  AELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPG 153

Query: 141 HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI 200
            L   +     ++V   + Y+  +  +HRD+   N L+     +KI DFG  + +  +  
Sbjct: 154 PLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY 213

Query: 201 TVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTSP 254
                          VG    +P     PE +     T  +D+W+ G  L+++ + G  P
Sbjct: 214 YR-------------VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

Query: 255 F 255
           +
Sbjct: 261 W 261

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 57.6 bits (140), Expect = 2e-09
 Identities = 35/171 (20%), Positives = 62/171 (36%), Gaps = 23/171 (13%)

Query: 41  HFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLE 95
             S+      +  G   + KV +         +     A+K + K       +  +   E
Sbjct: 5   EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRH-E 62

Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGEL----------------FDQITSK 139
            ++  +L HP VV L         L M    C  G+L                 D  T K
Sbjct: 63  AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122

Query: 140 GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 190
             L   +     A++   +EY+ S  ++H+D+   N+L+    ++KI+D G
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLG 173

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 56.9 bits (138), Expect = 4e-09
 Identities = 51/242 (21%), Positives = 93/242 (38%), Gaps = 43/242 (17%)

Query: 41  HFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLE 95
           H   +D  L +  G G++ KV  A+           + A+K +  K  T   +  + + E
Sbjct: 11  HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL--KDPTLAARKDFQR-E 67

Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD----------------QITSK 139
             +L  L H  +V+ +    D   L M  E  + G+L                     +K
Sbjct: 68  AELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK 127

Query: 140 GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR 199
           G L   +     +++   + Y+ S   +HRD+   N L+ A+  +KI DFG  + +  + 
Sbjct: 128 GELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 187

Query: 200 ITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWALGCTLYQMLS-GTS 253
                           VG    +P     PE +     T  +D+W+ G  L+++ + G  
Sbjct: 188 YYR-------------VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 234

Query: 254 PF 255
           P+
Sbjct: 235 PW 236

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 56.1 bits (136), Expect = 8e-09
 Identities = 34/144 (23%), Positives = 60/144 (41%), Gaps = 19/144 (13%)

Query: 158 LEYIH---SMGLIHRDIKPENLLLTADGHIKIADFGSVK--PMQDSRITVLPNAASDDKA 212
           L Y+H      +IHRD+K  N+LL  +    + DFG  K    +D+ +T           
Sbjct: 144 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT----------- 192

Query: 213 CTFV-GTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 271
            T V GT  ++ PE L++  ++   D++  G  L ++++G   F D +       ++  D
Sbjct: 193 -TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF-DLARLANDDDVMLLD 250

Query: 272 IRFPNYFSDAARDLIDRLLDVDPS 295
                        L+D  L  +  
Sbjct: 251 WVKGLLKEKKLEALVDVDLQGNYK 274

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 56.2 bits (136), Expect = 8e-09
 Identities = 42/173 (24%), Positives = 72/173 (41%), Gaps = 26/173 (15%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAK-------KIDTGTVYALKIMDKKFITKENKTAYVKL 94
                  LGK  G G++ +VV A+       K +  T  A+K++ K   T+++ +  +  
Sbjct: 66  LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLIS- 123

Query: 95  ERIVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEGGELFD----------------QIT 137
           E  ++  +  H  ++ L         LY+ +E    G L +                   
Sbjct: 124 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183

Query: 138 SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 190
            +  LS  +      +V   +EY+ S   IHRD+   N+L+T D  +KIADFG
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFG 236

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 39/172 (22%), Positives = 69/172 (40%), Gaps = 31/172 (18%)

Query: 48  ELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           E GK+ G G++ KV+ A      K       A+K M K+      + A +  E  ++ QL
Sbjct: 48  EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVK-MLKEKADSSEREALMS-ELKMMTQL 105

Query: 103 -DHPGVVRLFFTFQDTFSLYMALESCEGGEL-----------------------FDQITS 138
             H  +V L      +  +Y+  E C  G+L                        ++   
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165

Query: 139 KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG 190
              L+ ++   +  +V   +E++     +HRD+   N+L+T    +KI DFG
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFG 217

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 53.4 bits (128), Expect = 6e-08
 Identities = 43/181 (23%), Positives = 71/181 (39%), Gaps = 21/181 (11%)

Query: 126 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIK 185
           S    E   +   K  L+ +    Y+ +V   +E++ S   IHRD+   N+LL+    +K
Sbjct: 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 233

Query: 186 IADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP-----PEVLNSSPATFGNDLWA 240
           I DFG  + +      V                 A +P     PE +     T  +D+W+
Sbjct: 234 ICDFGLARDIYKDPDYV-------------RKGDARLPLKWMAPETIFDRVYTIQSDVWS 280

Query: 241 LGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIR--FPNYFSDAARDLIDRLLDVDPSGR 297
            G  L+++ S G SP+        F R +    R   P+Y +      +      +PS R
Sbjct: 281 FGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 340

Query: 298 P 298
           P
Sbjct: 341 P 341

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 41.1 bits (96), Expect = 6e-04
 Identities = 39/176 (22%), Positives = 63/176 (35%), Gaps = 13/176 (7%)

Query: 46  DFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 100
             +LGK  G G++ +V+ A      K  T    A+K M K+  T     A +  E  +L 
Sbjct: 23  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK-MLKEGATHSEHRALMS-ELKILI 80

Query: 101 QLD-HPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDAL 158
            +  H  VV L     +    L + +E C+ G L   + SK +        Y  +     
Sbjct: 81  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP----YKTKGARFR 136

Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           +    +G I  D+K     +T+      + F   K + D      P     D    
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTL 192

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 51.0 bits (123), Expect = 3e-07
 Identities = 31/103 (30%), Positives = 50/103 (48%), Gaps = 9/103 (8%)

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           + ++H    IHRDIK  N+LL      KI+DFG  +  +    TV+ +          VG
Sbjct: 146 INFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSR--------IVG 197

Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE 260
           T AY+ PE L     T  +D+++ G  L ++++G     +  E
Sbjct: 198 TTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHRE 239

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 51.0 bits (121), Expect = 6e-07
 Identities = 81/564 (14%), Positives = 157/564 (27%), Gaps = 190/564 (33%)

Query: 3   AMEKDFD---SKLRIEGNNNSSTN----------CPTVQR-SKSFAFRAPQEHFSIQD-- 46
            +  ++    S ++ E    S                 Q  +K    R  Q +  ++   
Sbjct: 86  VLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSR-LQPYLKLRQAL 144

Query: 47  FELGK-----IYGVGSYSK------VVRAKKIDT---GTVYALKIMDKKFITKENKTAYV 92
            EL       I GV    K      V  + K+       ++ L +               
Sbjct: 145 LELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNL------------KNC 192

Query: 93  KLERIVLDQLDHPGVVRLFFTFQDTFSLYMALES--CEGGELFDQITSKGHLSEDEARFY 150
                VL+ L                 L   ++       +    I  + H  + E R  
Sbjct: 193 NSPETVLEMLQ---------------KLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRL 237

Query: 151 TAEVVDALEYIHSMGLIHRDIKPEN-----------LLLTADGHIKIADFGSVKPMQDSR 199
                    Y + + L+  +++              LL T     ++ DF S        
Sbjct: 238 LKS----KPYENCL-LVLLNVQNAKAWNAFNLSCKILLTTRF--KQVTDFLSAATTTHIS 290

Query: 200 ITVLPNAASDDKACTFVGTAAYV-------PPEVLNSSP--------------ATFGN-- 236
           +       + D+  + +    Y+       P EVL ++P              AT+ N  
Sbjct: 291 LDHHSMTLTPDEVKSLL--LKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWK 348

Query: 237 --DLWALGCTLYQMLSGTSP------FKDTSEWLIFQRIIARDIRFP---------NYFS 279
             +   L   +   L+   P      F   S   +F          P         +   
Sbjct: 349 HVNCDKLTTIIESSLNVLEPAEYRKMFDRLS---VFPP----SAHIPTILLSLIWFDVIK 401

Query: 280 DAARDLID-----RLLDVDPSGRPGAGPGGYAVLK--------MHPFFKGIDWKNIRGQT 326
                +++      L++  P     + P  Y  LK        +H        ++I    
Sbjct: 402 SDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALH--------RSIVDHY 453

Query: 327 PPKLASEPMVQSGEGDDVHDSSWNPSHIG--------------------D---ISAKIND 363
                 +            D  +  SHIG                    D   +  KI  
Sbjct: 454 NIPKTFDS---DDLIPPYLDQYFY-SHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRH 509

Query: 364 GNGGASSSEGSITRLASIDSFDSKWQQFL---DPGESVLMISMVKKLQK-----LTSKK- 414
            +  A ++ GSI  L ++      ++ ++   DP    L+ +++  L K     + SK  
Sbjct: 510 -DSTAWNASGSI--LNTLQQLK-FYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYT 565

Query: 415 --VQLILTNKPKLIYVDPSKLVVK 436
             +++ L  + + I+ +  K V +
Sbjct: 566 DLLRIALMAEDEAIFEEAHKQVQR 589

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 45.6 bits (107), Expect = 3e-05
 Identities = 55/350 (15%), Positives = 109/350 (31%), Gaps = 87/350 (24%)

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
               ++DI         D  +   +F   K +QD   ++L     D              
Sbjct: 14  HQYQYKDILSVFE----DAFVD--NF-DCKDVQDMPKSILSKEEIDH------------- 53

Query: 224 PEVLNSSPATFGND--LWAL---GCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF 278
             ++ S  A  G     W L      + Q        +   ++L+    I  + R P+  
Sbjct: 54  --IIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEV-LRINYKFLMSP--IKTEQRQPSMM 108

Query: 279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW-KNIR-------------G 324
           +    +  DRL + +           Y V ++ P+ K       +R             G
Sbjct: 109 TRMYIEQRDRLYNDNQVFAK------YNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG 162

Query: 325 QTPPKLASE----PMVQSGEGDDVHDSSWNPSHIGDISAKINDGNGGASSSEGSITRLAS 380
           +T   +A +      VQ      +    W           +N  N   +S E  +  L  
Sbjct: 163 KT--WVALDVCLSYKVQCKMDFKIF---W-----------LNLKN--CNSPETVLEMLQK 204

Query: 381 IDS-FDSKWQQFLDPGESV-LMISMVK-KLQKLTSKKVQ----LILTN--KPKLI-YVDP 430
           +    D  W    D   ++ L I  ++ +L++L   K      L+L N    K     + 
Sbjct: 205 LLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNL 264

Query: 431 S-KLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQRASQW 479
           S K+++              +  ++ +H  +      L+ ++ K    ++
Sbjct: 265 SCKILL----TTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKY 310

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	489
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
1w1g_A	151	HPDK1, 3-phosphoinositide dependent protein kinase	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.86
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.75
2cod_A	115	Centaurin-delta 1; ARF GAP and RHO GAP with ankyri	99.55
2rsg_A	94	Collagen type IV alpha-3-binding protein; pleckstr	99.53
1x1f_A	149	Signal-transducing adaptor protein 1; docking prot	99.53
2dn6_A	115	KIAA0640 protein; PH domain, structural genomics,	99.47
2dhk_A	119	TBC1 domain family member 2; PH domain, paris-1, s	99.46
1eaz_A	125	Tandem PH domain containing protein-1; lipid-bindi	99.46
1v5u_A	117	SBF1, SET binding factor 1; MTMR5, the pleckstrin	99.45
1pls_A	113	Pleckstrin homology domain; phosphorylation; NMR {	99.45
1v5p_A	126	Pleckstrin homology domain-containing, family A; T	99.44
2d9v_A	130	Pleckstrin homology domain-containing protein fami	99.43
1btk_A	169	Bruton'S tyrosine kinase; transferase, PH domain,	99.42
1x1g_A	129	Pleckstrin 2; PH domain, structural genomics, rike	99.41
1fao_A	126	Dual adaptor of phosphotyrosine and 3- phosphoinos	99.41
2d9x_A	120	Oxysterol binding protein-related protein 11; PH d	99.4
1v88_A	130	Oxysterol binding protein-related protein 8; vesic	99.4
1wi1_A	126	Calcium-dependent activator protein for secretion,	99.39
2i5f_A	109	Pleckstrin; PH domain, protein-inositol phosphate	99.39
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.39
2lul_A	164	Tyrosine-protein kinase TEC; structural genomics,	99.38
1u5d_A	108	SKAP55, SRC kinase-associated phosphoprotein of 55	99.38
2dkp_A	128	Pleckstrin homology domain-containing family A mem	99.38
1upq_A	123	PEPP1; PH domain, phosphoinositide binding, signal	99.38
2rlo_A	128	Centaurin-gamma 1; split PH domain, alternative sp	99.38
3aj4_A	112	Pleckstrin homology domain-containing family B ME;	99.38
1x05_A	129	Pleckstrin; PH domain, structural genomics, NPPSFA	99.38
1dyn_A	125	Dynamin; signal transduction protein; 2.20A {Homo	99.37
1v89_A	118	Hypothetical protein KIAA0053; pleckstrin homology	99.37
1u5f_A	148	SRC-associated adaptor protein; PH domain of SKAP-	99.36
3rcp_A	103	Pleckstrin homology domain-containing family A ME;	99.36
1fgy_A	127	GRP1; PH domain, signaling protein; HET: 4IP; 1.50	99.36
1wg7_A	150	Dedicator of cytokinesis protein 9; pleckstrin hom	99.36
1unq_A	125	RAC-alpha serine/threonine kinase; transferase, pl	99.35
1wgq_A	109	FYVE, rhogef and PH domain containing 6; ethanol d	99.35
2da0_A	114	130-kDa phosphatidylinositol 4,5-biphosphate- depe	99.34
2d9y_A	117	Pleckstrin homology domain-containing protein fami	99.33
2yry_A	122	Pleckstrin homology domain-containing family A mem	99.32
1u5e_A	211	SRC-associated adaptor protein; novel dimerization	99.31
2j59_M	168	RHO-GTPase activating protein 10; ARF, ARF1, ARFBD	99.28
3tfm_A	228	Myosin X; split PH domain, motor protein; 2.53A {R	99.27
2w2x_D	124	1-phosphatidylinositol-4,5-bisphosphate phosphodie	99.27
2cof_A	107	Protein KIAA1914; PH domain, structural genomics,	99.26
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.24
2p0d_A	129	RHO GTPase-activating protein 9; protein-phosphoin	99.24
2y7b_A	134	Actin-binding protein anillin; cell cycle; 1.90A {	99.23
3lju_X	386	ARF-GAP with dual PH domain-containing protein 1;	99.22
1qqg_A	264	IRS-1, insulin receptor substrate 1; beta-sandwhic	99.2
4a6h_A	120	Phosphatidylinositol 4,5-bisphosphate-binding Pro	99.19
3cxb_B	112	Pleckstrin homology domain-containing family M mem	99.17
2coc_A	112	FYVE, rhogef and PH domain containing protein 3; s	99.15
1wjm_A	123	Beta-spectrin III; PH domain, signal transduction,	99.14
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.12
2r09_A	347	Cytohesin-3; autoinhibition, GRP1, PIP3, ARF, 3-ph	99.1
1btn_A	106	Beta-spectrin; signal transduction protein; HET: I	99.1
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.05
3a8p_A	263	T-lymphoma invasion and metastasis-inducing protei	99.04
2q13_A	385	DCC-interacting protein 13 alpha; APPL1, BAR domai	98.96
3lju_X	386	ARF-GAP with dual PH domain-containing protein 1;	98.92
4h8s_A	407	DCC-interacting protein 13-beta; BAR domain, pleck	98.85
1dro_A	122	Beta-spectrin; cytoskeleton; NMR {Drosophila melan	98.84
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	98.83
2d9w_A	127	Docking protein 2; PH domain, structural genomics,	98.81
2rov_A	117	RHO-associated protein kinase 2; ATP-binding, coil	98.79
3pp2_A	124	RHO GTPase-activating protein 27; PH domain, GTPas	98.79
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.77
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.6
3tca_A	291	Amyloid beta A4 precursor protein-binding family 1	98.56
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.56
2dtc_A	126	RAL guanine nucleotide exchange factor ralgps1A; P	98.56
2fjl_A	150	1-phosphatidylinositol-4,5-bisphosphate phosphodie	98.52
2ys3_A	137	UNC-112-related protein 2; PH domain, kindlin-3, s	98.48
2coa_A	125	Protein kinase C, D2 type; protein kinase D2, PH d	98.41
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.38
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.29
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.23
2d9z_A	129	Protein kinase C, NU type; PH domain, structural g	98.15
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.09
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.05
3a8n_A	279	TIAM-1, T-lymphoma invasion and metastasis-inducin	97.77
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.75
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.71
3hk0_A	256	Growth factor receptor-bound protein 10; GRB10, RA	97.65
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.55
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.3
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.3
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.25
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.21
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.15
4gmv_A	281	RAS-associated and pleckstrin homology domains-CO	97.11
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.08
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.07
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.06
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.92
3mpx_A	434	FYVE, rhogef and PH domain-containing protein 5; s	96.9
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.78
1v5m_A	136	SH2 and PH domain-containing adapter protein APS;	96.77
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.72
3tfm_A	228	Myosin X; split PH domain, motor protein; 2.53A {R	96.56
1v61_A	132	RAC/CDC42 guanine nucleotide exchange factor (GEF)	96.43
4f7h_A	173	Fermitin family homolog 2; beta-barrel, membrane b	95.87
4bbk_A	165	Kindlin-1, fermitin family homolog 1; PH domain, c	95.77
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.73
3ml4_A	224	Protein DOK-7; tyrosine phosphorylation, adapter p	95.68
1zc3_B	113	Exocyst complex protein EXO84; exocytosis, small G	95.58
1dbh_A	354	Protein (human SOS 1); guanine nucleotide exchange	95.35
1xcg_A	368	PDZ-rhogef, RHO guanine nucleotide exchange factor	94.23
3t06_A	418	PDZ-rhogef, RHO guanine nucleotide exchange factor	94.16
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.15
2z0q_A	346	XPLN, RHO guanine nucleotide exchange factor 3; DH	93.96
2dfk_A	402	Collybistin II; DH domain, PH domain, cell cycle;	93.79
3jzy_A	510	Intersectin 2; C2 domain, structural genomics cons	92.32
2pz1_A	466	RHO guanine nucleotide exchange factor 4; helical	92.01
2lg1_A	185	A-kinase anchor protein 13; metal binding protein;	91.69
1txd_A	385	RHO guanine nucleotide exchange factor 12; helical	90.86
1mai_A	131	Phospholipase C delta-1; pleckstrin, inositol tris	90.19
3qwm_A	140	Iqsec1, IQ motif and SEC7 domain-containing protei	89.89
3odw_A	536	RHO guanine nucleotide exchange factor 1; regulati	89.67
2vrw_B	406	P95VAV, VAV1, proto-oncogene VAV; lipoprotein, GTP	89.57
3p6a_A	377	RHO guanine nucleotide exchange factor 1; regulati	88.44
1kz7_A	353	Guanine nucleotide exchange factor DBS; guanine nu	88.37
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	88.2
1nty_A	311	Triple functional domain protein; DBL, pleckstrin,	87.68
2rgn_B	354	RHOA/RAC/CDC42 exchange factor; heterotrimeric G-p	87.13
3ky9_A	587	Proto-oncogene VAV; calponin homology domain, DBL	86.76
1foe_A	377	T-lymphoma invasion and metastasis inducing protei	83.91
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	83.65

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=4e-77  Score=642.77  Aligned_cols=423  Identities=26%  Similarity=0.438  Sum_probs=329.7

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHH---HHHHhCCCCCccEEEEEEEc
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER---IVLDQLDHPGVVRLFFTFQD  116 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~---~il~~l~hpnIv~l~~~~~~  116 (489)
                      .+++++||+++++||+|+||+||+|+++.||+.||||++.+..+........+.+|+   .+++.++|||||+++++|++
T Consensus       184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~  263 (689)
T 3v5w_A          184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT  263 (689)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred             CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence            478999999999999999999999999999999999999887665555555555554   45566799999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccC
Q 011287          117 TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (489)
Q Consensus       117 ~~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~  196 (489)
                      ...+|+|||||+||+|.++|.+.+.|++..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+.
T Consensus       264 ~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          264 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999998654


Q ss_pred             CccccccCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCC---CHHHHHHHHHhcCC
Q 011287          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDT---SEWLIFQRIIARDI  272 (489)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~---~~~~~~~~i~~~~~  272 (489)
                      .            ....+++||+.|||||++.. ..|+.++||||||||+|+|++|++||.+.   +...+++.+....+
T Consensus       344 ~------------~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~  411 (689)
T 3v5w_A          344 K------------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV  411 (689)
T ss_dssp             S------------CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCC
T ss_pred             C------------CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC
Confidence            2            23457899999999999964 57999999999999999999999999763   45677888999999


Q ss_pred             CCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC-CCCCCCCCCccCCCCCCCCCCCCCCC
Q 011287          273 RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLASEPMVQSGEGDDVHDSSWNP  351 (489)
Q Consensus       273 ~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~  351 (489)
                      .+|..+|+++++||.+||+.||++|+|+...+++++++||||++++|+.+..+ .+|++.|........ +..+.+.++.
T Consensus       412 ~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P~~~~~~~~-~~fD~~~fd~  490 (689)
T 3v5w_A          412 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAA-DAFDIGSFDE  490 (689)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCCCCTTCSSTT-BCCC------
T ss_pred             CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCccCCCCCCCcC-CCCCCccCCc
Confidence            99999999999999999999999999987778899999999999999998654 455555533222110 1011111111


Q ss_pred             C---CCCCcc--ccccCCCCCCC-CC------CCc-------cccccc----ccccCcccccccCCCceEEEEEeeehhh
Q 011287          352 S---HIGDIS--AKINDGNGGAS-SS------EGS-------ITRLAS----IDSFDSKWQQFLDPGESVLMISMVKKLQ  408 (489)
Q Consensus       352 ~---~~~~~~--~~~~~~~~~~~-~~------~~~-------~~~~~~----~~~~~~~~~~~~~~~~~i~~~g~~~k~~  408 (489)
                      .   .+....  ...-.+.+... +.      +..       ..++..    .+.....+.++. .|+.|++.|.+.|++
T Consensus       491 e~~~~~~~~~~d~~~f~~Fs~~~~~~~q~e~~et~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~~G~~~k~~  569 (689)
T 3v5w_A          491 EDTKGIKLLDSDQELYRNFPLTISERWQQEVAETVFDTINAETDRLEARKKAKNKQLGHEEDYA-LGKDCIMHGYMSKMG  569 (689)
T ss_dssp             ---CCCCCCHHHHTTTTTCCEECHHHHHHHHHTTTHHHHHHHHHHHHHHHHHHHHHTSCCSCTT-SSSCCCEEEEEEEC-
T ss_pred             cccCCCCCCchHHHHHhCCCccCccchhhhhhhhhhhhhccchhhHHHhHHHhhhhhccccccc-cCCcceeecccccCC
Confidence            0   000000  00000000000 00      000       000000    001111234455 378899999999999


Q ss_pred             hhh---ccceeEEE-----------ecCCeEEEECCCCCeeeeeeeccCCCCceEEEEcCCCcEEEEcCCceEEEEcCCc
Q 011287          409 KLT---SKKVQLIL-----------TNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDAKQ  474 (489)
Q Consensus       409 g~~---~k~r~~~l-----------t~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~~~~~f~i~~p~r~y~~~d~~~  474 (489)
                      |+|   ||+|+|.|           +..+++||+|+..++.||+|||+++   +.++.+++++|+|+||+        +.
T Consensus       570 g~f~~~~~rR~~~l~p~r~e~~~e~~~~~~l~~~~~v~~v~k~~i~~~~~---l~~~~k~~k~f~~~t~~--------~~  638 (689)
T 3v5w_A          570 NPFLTQWQRRYFYLFPNRLEWRGEGEAPQSLLTMEEIQSVEETQIKERKC---LLLKIRGGKQFILQCDS--------DP  638 (689)
T ss_dssp             ------CEEEEEEEETTEEEEECTTSCCCEEEEGGGEEEEEEEESSSCEE---EEEEETTTEEEEEECSS--------HH
T ss_pred             CcccchhhhhccccCCCcccccccCCCCcceeeeccccccccCcCCCCcc---eeeeecCCcEEEEECCC--------hH
Confidence            988   79999999           3456789999999999999999997   99999999999999997        33


Q ss_pred             cHHHHHHHHHHhc
Q 011287          475 RASQWKKAIEALQ  487 (489)
Q Consensus       475 ~~~~W~~~i~~~~  487 (489)
                      .+.+|+++|.++.
T Consensus       639 ~~~~W~~~i~~~~  651 (689)
T 3v5w_A          639 ELVQWKKELRDAY  651 (689)
T ss_dssp             HHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHH
Confidence            5899999998754

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.3e-74  Score=572.14  Aligned_cols=284  Identities=48%  Similarity=0.847  Sum_probs=264.8

Q ss_pred             CCCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 011287           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (489)
Q Consensus        39 ~~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  118 (489)
                      +.+...+||++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+|+.++|||||+++++|+++.
T Consensus        26 ~~~~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  105 (311)
T 4aw0_A           26 PRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE  105 (311)
T ss_dssp             -CCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             CCCCCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence            34567899999999999999999999999999999999999877666677788999999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      .+|+|||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.+...
T Consensus       106 ~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          106 KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999976432


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF  278 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~  278 (489)
                      .        ......+++||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+..+++++|....+.+|..+
T Consensus       186 ~--------~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~  257 (311)
T 4aw0_A          186 S--------KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKF  257 (311)
T ss_dssp             T--------TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTC
T ss_pred             C--------CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccc
Confidence            1        23345678999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCCC-CCHHHHhcCCCCCCCCcccccCCCCCCC
Q 011287          279 SDAARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKL  330 (489)
Q Consensus       279 ~~~~~~Li~~~L~~dP~~R~t~~~-~~~~~l~~hpff~~i~~~~~~~~~~p~~  330 (489)
                      ++++++||.+||+.||++|||+.+ .+...|++||||++++|+.+..++||.+
T Consensus       258 s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~~~pP~l  310 (311)
T 4aw0_A          258 FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL  310 (311)
T ss_dssp             CHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCC
T ss_pred             CHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcCCCCCCC
Confidence            999999999999999999999977 5677899999999999999998888864

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=6.9e-69  Score=533.34  Aligned_cols=281  Identities=37%  Similarity=0.700  Sum_probs=248.7

Q ss_pred             CCCCCCCCeEEeeEEeeeCceEEEEEEEc---CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 011287           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  115 (489)
Q Consensus        39 ~~~~~~~dy~~~~~LG~G~~g~Vy~a~~~---~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  115 (489)
                      .++..+++|++++.||+|+||+||+|++.   .+++.||||++.+........ ..+.+|+.+|+.++|||||+++++|+
T Consensus        18 ~~~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~-~~~~~E~~il~~l~HpnIv~l~~~~~   96 (304)
T 3ubd_A           18 HEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR-VRTKMERDILVEVNHPFIVKLHYAFQ   96 (304)
T ss_dssp             CCCCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEEC-C------CCCCCCCCTTEECEEEEEE
T ss_pred             cccCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHH-HHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence            34566789999999999999999999984   478999999998765443332 34677999999999999999999999


Q ss_pred             cCCEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCcccc
Q 011287          116 DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (489)
Q Consensus       116 ~~~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~  195 (489)
                      ++..+|+|||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+..
T Consensus        97 ~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A           97 TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             ETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             ECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999864


Q ss_pred             CCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCC
Q 011287          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP  275 (489)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p  275 (489)
                      ...          .....+++||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+..+++.+|....+.+|
T Consensus       177 ~~~----------~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p  246 (304)
T 3ubd_A          177 IDH----------EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP  246 (304)
T ss_dssp             --------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             cCC----------CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC
Confidence            322          2344578999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC-CCCCC
Q 011287          276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKL  330 (489)
Q Consensus       276 ~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~-~~p~~  330 (489)
                      ..+|+++++||.+||+.||++|||+...+++++++||||++++|+.+..+ .+|++
T Consensus       247 ~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~~pP~  302 (304)
T 3ubd_A          247 QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPF  302 (304)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSS
T ss_pred             CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHhCCCCcCc
Confidence            99999999999999999999999997778899999999999999998654 34443

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.3e-65  Score=500.15  Aligned_cols=255  Identities=35%  Similarity=0.558  Sum_probs=222.1

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      +++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+|+.++|||||+++++|+++..+|+|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            58999999999999999999999999999999999988777666777899999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      |||| +|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.....     
T Consensus        92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-----  165 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-----  165 (275)
T ss_dssp             EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred             EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC-----
Confidence            9999 6799999999999999999999999999999999999999999999999999999999999999865332     


Q ss_pred             CCCCCCCCccceecCCcCCChhhhcCCCC-CCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHH
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAA  282 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~-~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~~  282 (489)
                            ....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|++||.+.+...+++.|....+.+|..+|+++
T Consensus       166 ------~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~  239 (275)
T 3hyh_A          166 ------NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGA  239 (275)
T ss_dssp             ---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHH
T ss_pred             ------CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHH
Confidence                  23346799999999999998876 57999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 011287          283 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (489)
Q Consensus       283 ~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~  315 (489)
                      ++||.+||+.||++|||+     +++++||||+
T Consensus       240 ~~li~~~L~~dP~~R~s~-----~eil~hpw~k  267 (275)
T 3hyh_A          240 AGLIKRMLIVNPLNRISI-----HEIMQDDWFK  267 (275)
T ss_dssp             HHHHHHHSCSSGGGSCCH-----HHHHHCHHHH
T ss_pred             HHHHHHHccCChhHCcCH-----HHHHcCcccc
Confidence            999999999999999998     8999999996

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.5e-64  Score=510.66  Aligned_cols=258  Identities=28%  Similarity=0.527  Sum_probs=230.4

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lyl  122 (489)
                      ++++|++++.||+|+||+||+|+++.+|+.||||++.+..... .....+.+|+.+|+.|+|||||+++++|++...+|+
T Consensus        22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi  100 (350)
T 4b9d_A           22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKHPNIVQYRESFEENGSLYI  100 (350)
T ss_dssp             CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence            5789999999999999999999999999999999998775543 345678899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          123 ALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      |||||+||+|.++|...  ..+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.+.... 
T Consensus       101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-  179 (350)
T 4b9d_A          101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-  179 (350)
T ss_dssp             EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred             EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence            99999999999999754  457999999999999999999999999999999999999999999999999998764321 


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCC
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-RFPNYFS  279 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~-~~p~~~~  279 (489)
                               ....+++||+.|||||++.+..|+.++||||||||+|+|++|++||.+.+..+++.+|....+ .++..+|
T Consensus       180 ---------~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s  250 (350)
T 4b9d_A          180 ---------ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYS  250 (350)
T ss_dssp             ---------HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSC
T ss_pred             ---------ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCC
Confidence                     223467999999999999999999999999999999999999999999999999999998775 4677899


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       280 ~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      +++++||.+||+.||++|||+     +++++||||+.
T Consensus       251 ~~~~~li~~~L~~dP~~R~s~-----~e~l~hp~~~~  282 (350)
T 4b9d_A          251 YDLRSLVSQLFKRNPRDRPSV-----NSILEKGFIAK  282 (350)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCH-----HHHHTSHHHHT
T ss_pred             HHHHHHHHHHccCChhHCcCH-----HHHhcCHHhhc
Confidence            999999999999999999998     89999999974

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1e-63  Score=503.71  Aligned_cols=253  Identities=28%  Similarity=0.450  Sum_probs=230.5

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      ++|++++.||+|+||+||+|+++.||+.||||++.+....   ..+.+.+|+.+|+.++|||||+++++|++.+.+|+||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm  150 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  150 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            5699999999999999999999999999999999765322   3345778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccC
Q 011287          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (489)
Q Consensus       125 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~  204 (489)
                      |||+||+|.+++.+ +.+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.+...      
T Consensus       151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~------  223 (346)
T 4fih_A          151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE------  223 (346)
T ss_dssp             CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS------
T ss_pred             eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCC------
Confidence            99999999999876 57999999999999999999999999999999999999999999999999999876432      


Q ss_pred             CCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC---CCCCCCCCHH
Q 011287          205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRFPNYFSDA  281 (489)
Q Consensus       205 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~---~~~p~~~~~~  281 (489)
                          .....+++||+.|||||++.+..|+.++||||||||+|+|++|++||.+.+..+++..|....   +..+..++++
T Consensus       224 ----~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~  299 (346)
T 4fih_A          224 ----VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPS  299 (346)
T ss_dssp             ----SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHH
T ss_pred             ----CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHH
Confidence                234457899999999999999999999999999999999999999999999999998887753   3344578999


Q ss_pred             HHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       282 ~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      +++||.+||+.||++|||+     +++++||||+.
T Consensus       300 ~~dli~~~L~~dP~~R~ta-----~e~l~Hp~~~~  329 (346)
T 4fih_A          300 LKGFLDRLLVRDPAQRATA-----AELLKHPFLAK  329 (346)
T ss_dssp             HHHHHHHHSCSSTTTSCCH-----HHHTTCGGGGG
T ss_pred             HHHHHHHHcCCChhHCcCH-----HHHhcCHhhcC
Confidence            9999999999999999998     89999999974

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.6e-62  Score=504.24  Aligned_cols=253  Identities=28%  Similarity=0.451  Sum_probs=230.9

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      ++|++++.||+|+||.||+|+++.+|+.||||++.+...   ...+.+.+|+.+|+.++|||||+++++|.+.+.+|+||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm  227 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  227 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC---SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence            569999999999999999999999999999999986532   23345788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccC
Q 011287          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (489)
Q Consensus       125 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~  204 (489)
                      |||+||+|.+++.. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+...      
T Consensus       228 Ey~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~------  300 (423)
T 4fie_A          228 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE------  300 (423)
T ss_dssp             ECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS------
T ss_pred             eCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC------
Confidence            99999999999876 57999999999999999999999999999999999999999999999999999876432      


Q ss_pred             CCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC---CCCCCCCCHH
Q 011287          205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRFPNYFSDA  281 (489)
Q Consensus       205 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~---~~~p~~~~~~  281 (489)
                          .....+++||+.|||||++.+..|+.++||||||||+|+|++|++||.+.+...++..|....   +..+..++++
T Consensus       301 ----~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~  376 (423)
T 4fie_A          301 ----VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPS  376 (423)
T ss_dssp             ----CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHH
T ss_pred             ----CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHH
Confidence                234457899999999999999999999999999999999999999999999999998887753   3445678999


Q ss_pred             HHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       282 ~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      +++||.+||+.||++|||+     +++++||||+.
T Consensus       377 ~~dli~~~L~~dP~~R~ta-----~ell~Hp~~~~  406 (423)
T 4fie_A          377 LKGFLDRLLVRDPAQRATA-----AELLKHPFLAK  406 (423)
T ss_dssp             HHHHHHHHSCSSTTTSCCH-----HHHTTCGGGGG
T ss_pred             HHHHHHHHcCCChhHCcCH-----HHHhcCHHhcC
Confidence            9999999999999999998     89999999975

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=5.5e-62  Score=489.62  Aligned_cols=257  Identities=26%  Similarity=0.389  Sum_probs=225.9

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lyl  122 (489)
                      ..++|++.+.||+|+||+||+|+++.+|+.||||++++....        .+|+.+|+.++|||||+++++|++...+|+
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~i  127 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVNI  127 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            457899999999999999999999999999999999765322        359999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCC-CEEEeeccCccccCCcccc
Q 011287          123 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-HIKIADFGSVKPMQDSRIT  201 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g-~ikL~DFG~a~~~~~~~~~  201 (489)
                      |||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++||+||||||+||||+.+| ++||+|||+|+.+......
T Consensus       128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            999999999999999989999999999999999999999999999999999999999988 6999999999876543211


Q ss_pred             ccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC---CCCCCC
Q 011287          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI---RFPNYF  278 (489)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~---~~p~~~  278 (489)
                           .......+++||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+...++.+|.....   .+|+.+
T Consensus       208 -----~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  282 (336)
T 4g3f_A          208 -----KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSC  282 (336)
T ss_dssp             -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTS
T ss_pred             -----cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccC
Confidence                 011233467899999999999999999999999999999999999999999888888888887664   467889


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCCCCCHHHH-------------hcCCCCCCC
Q 011287          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVL-------------KMHPFFKGI  317 (489)
Q Consensus       279 ~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l-------------~~hpff~~i  317 (489)
                      ++++++||.+||+.||++|||+     .++             ++|||+...
T Consensus       283 s~~~~~li~~~L~~dP~~R~sa-----~el~~~l~~~l~~~~~l~hPw~~~~  329 (336)
T 4g3f_A          283 APLTAQAIQEGLRKEPVHRASA-----MELRRKVGKALQEVGGLKSPWKGEY  329 (336)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCH-----HHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred             CHHHHHHHHHHccCCHhHCcCH-----HHHHHHHHHHHhhhhhccCCCcCCC
Confidence            9999999999999999999998     665             578998753

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=6.5e-61  Score=473.53  Aligned_cols=251  Identities=21%  Similarity=0.379  Sum_probs=220.6

Q ss_pred             eEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc----CCEEEE
Q 011287           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD----TFSLYM  122 (489)
Q Consensus        47 y~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~lyl  122 (489)
                      |++.+.||+|+||+||+|+++.++..||+|++.+...... ....+.+|+.+|+.|+|||||+++++|.+    ...+|+
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l  106 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH-HHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHH-HHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence            4888999999999999999999999999999987654443 45678889999999999999999999975    456899


Q ss_pred             EEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeeccCCCCeeeCC-CCCEEEeeccCccccCCcc
Q 011287          123 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG--LIHRDIKPENLLLTA-DGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~g--IiHrDLKpeNILl~~-~g~ikL~DFG~a~~~~~~~  199 (489)
                      |||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++|  |+||||||+||||+. +|++||+|||+|+....  
T Consensus       107 vmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~--  184 (290)
T 3fpq_A          107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--  184 (290)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT--
T ss_pred             EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC--
Confidence            9999999999999999899999999999999999999999998  999999999999984 79999999999975322  


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCC-HHHHHHHHHhcC--CCCCC
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS-EWLIFQRIIARD--IRFPN  276 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~-~~~~~~~i~~~~--~~~p~  276 (489)
                                ....+++||+.|||||++.+ .|+.++|||||||++|+|+||++||.+.+ ...+++.+....  ..++.
T Consensus       185 ----------~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~  253 (290)
T 3fpq_A          185 ----------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDK  253 (290)
T ss_dssp             ----------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGG
T ss_pred             ----------CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCc
Confidence                      23457799999999999875 59999999999999999999999997654 455666665543  23566


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      .+++++++||.+||+.||++|||+     +++++||||+.
T Consensus       254 ~~~~~~~~li~~~L~~dP~~R~s~-----~e~l~Hp~~~~  288 (290)
T 3fpq_A          254 VAIPEVKEIIEGCIRQNKDERYSI-----KDLLNHAFFQE  288 (290)
T ss_dssp             CCCHHHHHHHHHHSCSSGGGSCCH-----HHHHTSGGGC-
T ss_pred             cCCHHHHHHHHHHccCChhHCcCH-----HHHhcCccccC
Confidence            789999999999999999999998     89999999974

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.5e-60  Score=486.43  Aligned_cols=262  Identities=27%  Similarity=0.398  Sum_probs=226.8

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc------CC
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD------TF  118 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~  118 (489)
                      ++|++++.||+|+||+||+|+++.||+.||||++.+..... .....+.+|+.+|+.|+|||||++++++..      ..
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVV-TNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSH-HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccch-HHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            57999999999999999999999999999999997664333 344567789999999999999999999864      46


Q ss_pred             EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      .+|+|||||+ |+|.+++.+.+.+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.+...
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~  211 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS  211 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred             EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence            7999999996 689999999899999999999999999999999999999999999999999999999999999876432


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCC--
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP--  275 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p--  275 (489)
                      ..      .......+++||+.|+|||++.+. .++.++||||||||+|+|++|++||.+.+..++++.|.......+  
T Consensus       212 ~~------~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~  285 (398)
T 4b99_A          212 PA------EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA  285 (398)
T ss_dssp             ----------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             cc------ccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence            21      122345578999999999998875 579999999999999999999999999999999988875322211  


Q ss_pred             -----------------------------CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 011287          276 -----------------------------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (489)
Q Consensus       276 -----------------------------~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~  319 (489)
                                                   +.++++++|||.+||+.||++|||+     +++++||||+....
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta-----~e~L~Hp~f~~~~~  353 (398)
T 4b99_A          286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISA-----AAALRHPFLAKYHD  353 (398)
T ss_dssp             GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCH-----HHHTTSGGGTTTCC
T ss_pred             HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCH-----HHHhcCHhhCcCCC
Confidence                                         2468999999999999999999999     89999999987643

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.5e-59  Score=464.13  Aligned_cols=265  Identities=26%  Similarity=0.459  Sum_probs=206.2

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-----
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-----  118 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----  118 (489)
                      ++||++++.||+|+||+||+|+++.+|+.||||++.+..  .+...+.+.+|+.+|+.|+|||||+++++|.+.+     
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~   81 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL   81 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence            368999999999999999999999999999999997643  3444567889999999999999999999997543     


Q ss_pred             -------EEEEEEeccCCCChHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEee
Q 011287          119 -------SLYMALESCEGGELFDQITSKGH---LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIAD  188 (489)
Q Consensus       119 -------~lylV~E~~~gg~L~~~l~~~~~---l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~D  188 (489)
                             .+|+|||||+||+|.+++...+.   .++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|
T Consensus        82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEcc
Confidence                   47999999999999999988765   45567899999999999999999999999999999999999999999


Q ss_pred             ccCccccCCcccccc--CCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHH-HHHH
Q 011287          189 FGSVKPMQDSRITVL--PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQ  265 (489)
Q Consensus       189 FG~a~~~~~~~~~~~--~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~-~~~~  265 (489)
                      ||+|+.+........  ..........+.+||+.|||||++.+..|+.++|||||||++|||++   ||.+..+. ..+.
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~  238 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT  238 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence            999998755432111  01112234456799999999999999999999999999999999996   88654332 2233


Q ss_pred             HHHhcCCCCCC---CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 011287          266 RIIARDIRFPN---YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (489)
Q Consensus       266 ~i~~~~~~~p~---~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~  320 (489)
                      .+..  ..+|+   ..++.+.+||.+||+.||++|||+     .++++||||++++|.
T Consensus       239 ~~~~--~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~-----~eil~h~~~~~~~~p  289 (299)
T 4g31_A          239 DVRN--LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEA-----INIIENAVFEDLDFP  289 (299)
T ss_dssp             HHHT--TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCH-----HHHHTSGGGCCC---
T ss_pred             HHhc--CCCCCCCcccCHHHHHHHHHHcCCChhHCcCH-----HHHhcCHhhCCCCCC
Confidence            3333  34443   356788999999999999999998     899999999999984

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.3e-57  Score=460.79  Aligned_cols=281  Identities=37%  Similarity=0.645  Sum_probs=256.1

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ly  121 (489)
                      +++++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+|+.++||||++++++|++...+|
T Consensus         2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~   81 (337)
T 1o6l_A            2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence            57899999999999999999999999999999999998765545555677888999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccc
Q 011287          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~  201 (489)
                      +||||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.....   
T Consensus        82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~---  158 (337)
T 1o6l_A           82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---  158 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT---
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC---
Confidence            99999999999999998889999999999999999999999999999999999999999999999999999853221   


Q ss_pred             ccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHH
Q 011287          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDA  281 (489)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~  281 (489)
                             .....+++||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+...+++.+....+.+|..++++
T Consensus       159 -------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~  231 (337)
T 1o6l_A          159 -------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE  231 (337)
T ss_dssp             -------TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred             -------CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHH
Confidence                   2234577999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC-CCCCCCC
Q 011287          282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLAS  332 (489)
Q Consensus       282 ~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~-~~p~~~~  332 (489)
                      +++||.+||+.||++||++...+++++++||||.+++|+.+... .+|++.|
T Consensus       232 ~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~~pp~~p  283 (337)
T 1o6l_A          232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKP  283 (337)
T ss_dssp             HHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred             HHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCCCC
Confidence            99999999999999999876667799999999999999998653 3444444

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.9e-58  Score=468.58  Aligned_cols=283  Identities=33%  Similarity=0.646  Sum_probs=249.8

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCC
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTF  118 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  118 (489)
                      ..+.+++|++++.||+|+||.||+|+++.+|+.||||++.+...........+.+|+.+++.+ +||||++++++|++..
T Consensus        18 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~   97 (353)
T 3txo_A           18 NRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD   97 (353)
T ss_dssp             -----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             CCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence            467889999999999999999999999999999999999887665666677788899999988 7999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      .+|+|||||+||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.....
T Consensus        98 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~  177 (353)
T 3txo_A           98 RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN  177 (353)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence            99999999999999999998889999999999999999999999999999999999999999999999999999853221


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF  278 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~  278 (489)
                                .....+++||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+...++++|....+.+|..+
T Consensus       178 ----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~  247 (353)
T 3txo_A          178 ----------GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWL  247 (353)
T ss_dssp             ------------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTS
T ss_pred             ----------CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence                      2344577999999999999998999999999999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCC-CCCHHHHhcCCCCCCCCcccccCC-CCCCCCC
Q 011287          279 SDAARDLIDRLLDVDPSGRPGAG-PGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLAS  332 (489)
Q Consensus       279 ~~~~~~Li~~~L~~dP~~R~t~~-~~~~~~l~~hpff~~i~~~~~~~~-~~p~~~~  332 (489)
                      ++++.+||++||+.||++||++. +.+.+++++||||++++|+.+... .+|++.|
T Consensus       248 ~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p  303 (353)
T 3txo_A          248 HEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRP  303 (353)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred             CHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCCCccC
Confidence            99999999999999999999983 356789999999999999998543 4444443

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=6.8e-58  Score=465.81  Aligned_cols=286  Identities=33%  Similarity=0.602  Sum_probs=255.6

Q ss_pred             CCCCCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEE
Q 011287           37 APQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQ  115 (489)
Q Consensus        37 ~~~~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~  115 (489)
                      ....++.+++|++++.||+|+||.||+|+++.+|+.||||++.+...........+..|+.++..+ +||||++++++|+
T Consensus        12 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~   91 (353)
T 2i0e_A           12 GNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ   91 (353)
T ss_dssp             -------CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE
T ss_pred             CCcCCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE
Confidence            344567899999999999999999999999999999999999877655555667788899999888 8999999999999


Q ss_pred             cCCEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCcccc
Q 011287          116 DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (489)
Q Consensus       116 ~~~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~  195 (489)
                      +...+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++..
T Consensus        92 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A           92 TMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            99999999999999999999998889999999999999999999999999999999999999999999999999999853


Q ss_pred             CCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCC
Q 011287          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP  275 (489)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p  275 (489)
                      ...          .....+++||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+...++++|....+.+|
T Consensus       172 ~~~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p  241 (353)
T 2i0e_A          172 IWD----------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP  241 (353)
T ss_dssp             CCT----------TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             ccC----------CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence            221          2234577999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC-CCCCCCC
Q 011287          276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLAS  332 (489)
Q Consensus       276 ~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~-~~p~~~~  332 (489)
                      ..+++++++||.+||+.||.+||++...+++++++||||++++|+.+... .+|++.|
T Consensus       242 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p~~p  299 (353)
T 2i0e_A          242 KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKP  299 (353)
T ss_dssp             TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred             CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCcCC
Confidence            99999999999999999999999987778899999999999999998653 3444443

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.6e-57  Score=469.54  Aligned_cols=284  Identities=35%  Similarity=0.696  Sum_probs=250.9

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCC
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTF  118 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  118 (489)
                      ..+.+++|+++++||+|+||.||+|+++.+++.||+|++.+...........+..|+.++..+ +||||++++++|++..
T Consensus        47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~  126 (396)
T 4dc2_A           47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES  126 (396)
T ss_dssp             --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence            467789999999999999999999999999999999999987766666666788899999876 8999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      .+|+|||||+||+|..++.+.+.+++..++.+++||+.||+|||++||+||||||+||||+.+|++||+|||+|+.... 
T Consensus       127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~-  205 (396)
T 4dc2_A          127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-  205 (396)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred             EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc-
Confidence            9999999999999999999888999999999999999999999999999999999999999999999999999985322 


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCC---------CCHHHHHHHHHh
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD---------TSEWLIFQRIIA  269 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~---------~~~~~~~~~i~~  269 (489)
                               ......+++||+.|+|||++.+..++.++|||||||++|+|++|++||..         .....+++.+..
T Consensus       206 ---------~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~  276 (396)
T 4dc2_A          206 ---------PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE  276 (396)
T ss_dssp             ---------TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH
T ss_pred             ---------CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc
Confidence                     12345578999999999999999999999999999999999999999963         234557888999


Q ss_pred             cCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCC-CCHHHHhcCCCCCCCCcccccCC-CCCCCCCC
Q 011287          270 RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQ-TPPKLASE  333 (489)
Q Consensus       270 ~~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~-~~~~~l~~hpff~~i~~~~~~~~-~~p~~~~~  333 (489)
                      ..+.+|..+++++++||++||+.||++||++.. .+++++++||||++++|+.+... .+|++.|.
T Consensus       277 ~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~pp~~p~  342 (396)
T 4dc2_A          277 KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPN  342 (396)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCCSCCCC
T ss_pred             cccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCCCCcCC
Confidence            999999999999999999999999999999853 46899999999999999998654 45554443

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-57  Score=453.13  Aligned_cols=272  Identities=36%  Similarity=0.711  Sum_probs=252.2

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~l  120 (489)
                      ++++++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++.++||||++++++|++...+
T Consensus         2 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~   81 (318)
T 1fot_A            2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI   81 (318)
T ss_dssp             -CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred             CCChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEE
Confidence            46789999999999999999999999999999999999876555555567788899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      |+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++....   
T Consensus        82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~---  158 (318)
T 1fot_A           82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---  158 (318)
T ss_dssp             EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS---
T ss_pred             EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC---
Confidence            99999999999999999988999999999999999999999999999999999999999999999999999986432   


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCH
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSD  280 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~  280 (489)
                                ...+.+||+.|+|||++.+..++.++|+|||||++|+|++|++||.+.+....+.+|....+.+|..+++
T Consensus       159 ----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~  228 (318)
T 1fot_A          159 ----------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNE  228 (318)
T ss_dssp             ----------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCH
T ss_pred             ----------ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCH
Confidence                      2346789999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC
Q 011287          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  325 (489)
Q Consensus       281 ~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~  325 (489)
                      ++++||.+||+.||++||+..+.+++++++||||++++|+.+..+
T Consensus       229 ~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~  273 (318)
T 1fot_A          229 DVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSR  273 (318)
T ss_dssp             HHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTT
T ss_pred             HHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHHHhC
Confidence            999999999999999999776666799999999999999998654

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1e-57  Score=491.81  Aligned_cols=261  Identities=28%  Similarity=0.481  Sum_probs=238.7

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      +++|++++.||+|+||+||+|+++.+|+.||||++.+..   ......+.+|+.+|+.|+|||||+++++|++...+|+|
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv  232 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI  232 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            578999999999999999999999999999999997653   33456788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCC--CCEEEeeccCccccCCccc
Q 011287          124 LESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD--GHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~--g~ikL~DFG~a~~~~~~~~  200 (489)
                      ||||+||+|.++|.+ .+.+++..++.|+.||+.||+|||++||+||||||+|||++.+  |++||+|||+|+.+...  
T Consensus       233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~--  310 (573)
T 3uto_A          233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--  310 (573)
T ss_dssp             EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT--
T ss_pred             EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC--
Confidence            999999999999964 4689999999999999999999999999999999999999854  89999999999876432  


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCC----C
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----N  276 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p----~  276 (489)
                               ....+.+||+.|||||++.+..|+.++||||||||+|+|++|++||.+.+..+++.+|....+.++    .
T Consensus       311 ---------~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  381 (573)
T 3uto_A          311 ---------QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFS  381 (573)
T ss_dssp             ---------SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGT
T ss_pred             ---------CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCccccc
Confidence                     234577999999999999999999999999999999999999999999999999999999887776    3


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCccccc
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR  323 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~  323 (489)
                      .+++++++||.+||+.||++|||+     +++++||||+..+|....
T Consensus       382 ~~s~~~~dli~~~L~~dp~~R~t~-----~e~l~Hpw~~~~~~~~~~  423 (573)
T 3uto_A          382 GISEDGKDFIRKLLLADPNTRMTI-----HQALEHPWLTPGNAPGRD  423 (573)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCH-----HHHHHSTTTSCCCCTTTT
T ss_pred             CCCHHHHHHHHHHccCChhHCcCH-----HHHhcCcCcCCCCCCCch
Confidence            589999999999999999999998     899999999988886543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3e-57  Score=464.40  Aligned_cols=282  Identities=36%  Similarity=0.648  Sum_probs=247.0

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHH-HHhCCCCCccEEEEEEEcCC
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV-LDQLDHPGVVRLFFTFQDTF  118 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~i-l~~l~hpnIv~l~~~~~~~~  118 (489)
                      .....++|++++.||+|+||.||+|+++.+++.||||++.+...........+..|..+ ++.++||||++++++|++..
T Consensus        33 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~  112 (373)
T 2r5t_A           33 PHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD  112 (373)
T ss_dssp             TTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred             CCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence            46788999999999999999999999999999999999998876666666667778776 57789999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      .+|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus       113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            99999999999999999998889999999999999999999999999999999999999999999999999999853221


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF  278 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~  278 (489)
                                .....+++||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+++++|......+|..+
T Consensus       193 ----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  262 (373)
T 2r5t_A          193 ----------NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNI  262 (373)
T ss_dssp             ----------CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSS
T ss_pred             ----------CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCC
Confidence                      2344577999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC-CCCCCCC
Q 011287          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLAS  332 (489)
Q Consensus       279 ~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~-~~p~~~~  332 (489)
                      ++++++||.+||+.||.+||++. .++.++++||||++++|+.+... .+|++.|
T Consensus       263 ~~~~~~li~~lL~~dp~~R~~~~-~~~~~i~~h~~f~~~~w~~l~~~~~~pp~~p  316 (373)
T 2r5t_A          263 TNSARHLLEGLLQKDRTKRLGAK-DDFMEIKSHVFFSLINWDDLINKKITPPFNP  316 (373)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTTT-TTHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred             CHHHHHHHHHHcccCHHhCCCCC-CCHHHHhCCccccCCCHHHHHhCCCCCCCCC
Confidence            99999999999999999999996 46899999999999999998654 3444444

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.3e-57  Score=464.56  Aligned_cols=262  Identities=28%  Similarity=0.452  Sum_probs=213.6

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEc---CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFS  119 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~---~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  119 (489)
                      .++|++++.||+|+||+||+|+++   .+++.||+|++.+.     .....+.+|+.+|+.+ +|||||+++++|++.+.
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~-----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~   94 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT-----SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH   94 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT-----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc-----cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence            367999999999999999999985   46889999998654     2234577899999988 69999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCC-CCEEEeeccCccccCCc
Q 011287          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDS  198 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~-g~ikL~DFG~a~~~~~~  198 (489)
                      +|+|||||+||+|.+++.   .+++.+++.|+.||+.||+|||++||+||||||+|||++.+ +++||+|||+|+.....
T Consensus        95 ~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~  171 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT  171 (361)
T ss_dssp             EEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred             EEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence            999999999999999884   59999999999999999999999999999999999999877 89999999999876544


Q ss_pred             cccccCC------------------CCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCC-CC
Q 011287          199 RITVLPN------------------AASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFK-DT  258 (489)
Q Consensus       199 ~~~~~~~------------------~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~-~~  258 (489)
                      .......                  ........+.+||+.|+|||++.+. .|+.++||||+|||+|+|++|++||. +.
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~  251 (361)
T 4f9c_A          172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS  251 (361)
T ss_dssp             SCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence            3211100                  0011234467999999999999876 48999999999999999999999995 45


Q ss_pred             CHHHHHHHHHhc--------------------------------------C----------------CCCCCCCCHHHHH
Q 011287          259 SEWLIFQRIIAR--------------------------------------D----------------IRFPNYFSDAARD  284 (489)
Q Consensus       259 ~~~~~~~~i~~~--------------------------------------~----------------~~~p~~~~~~~~~  284 (489)
                      ++..++..|...                                      .                ......++++++|
T Consensus       252 ~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~D  331 (361)
T 4f9c_A          252 DDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYD  331 (361)
T ss_dssp             SHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHH
T ss_pred             CHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHH
Confidence            555555554320                                      0                0112357899999


Q ss_pred             HHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 011287          285 LIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (489)
Q Consensus       285 Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~  318 (489)
                      ||++||+.||++|||+     +++++||||++++
T Consensus       332 Ll~~lL~~dP~~R~ta-----~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          332 LLDKLLDLNPASRITA-----EEALLHPFFKDMS  360 (361)
T ss_dssp             HHHHHTCSCTTTSCCH-----HHHHTSGGGTTC-
T ss_pred             HHHHHCcCChhHCcCH-----HHHhcCcccCCCC
Confidence            9999999999999999     8999999999874

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.6e-56  Score=454.36  Aligned_cols=283  Identities=36%  Similarity=0.700  Sum_probs=253.9

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCC
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTF  118 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  118 (489)
                      .++.+++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++.+ +||||++++++|++..
T Consensus         4 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~   83 (345)
T 3a8x_A            4 DPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES   83 (345)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             CCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC
Confidence            356789999999999999999999999999999999999988776777778888999999987 8999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      .+|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus        84 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           84 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence            99999999999999999998889999999999999999999999999999999999999999999999999999853221


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCC---------CCHHHHHHHHHh
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD---------TSEWLIFQRIIA  269 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~---------~~~~~~~~~i~~  269 (489)
                                .....+++||+.|+|||++.+..++.++|||||||++|+|++|++||..         .+...+++.+..
T Consensus       164 ----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~  233 (345)
T 3a8x_A          164 ----------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE  233 (345)
T ss_dssp             ----------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH
T ss_pred             ----------CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc
Confidence                      2234567999999999999999999999999999999999999999975         345667888889


Q ss_pred             cCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCC-CCHHHHhcCCCCCCCCcccccCC-CCCCCCC
Q 011287          270 RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQ-TPPKLAS  332 (489)
Q Consensus       270 ~~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~-~~~~~l~~hpff~~i~~~~~~~~-~~p~~~~  332 (489)
                      ..+.+|..+++++++||.+||+.||.+||++.. .+++++++||||++++|+.+... .+|++.|
T Consensus       234 ~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~~~~~~p~~p  298 (345)
T 3a8x_A          234 KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKP  298 (345)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred             CCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHhCCCCCCcCC
Confidence            999999999999999999999999999999853 46799999999999999998653 3444433

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.5e-56  Score=452.64  Aligned_cols=281  Identities=35%  Similarity=0.630  Sum_probs=256.6

Q ss_pred             CCCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 011287           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (489)
Q Consensus        39 ~~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  118 (489)
                      .....+++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++.++||||++++++|.+..
T Consensus        35 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  114 (350)
T 1rdq_E           35 QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS  114 (350)
T ss_dssp             CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccCCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            35677899999999999999999999999999999999998765555555677888999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      .+|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.... 
T Consensus       115 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~-  193 (350)
T 1rdq_E          115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-  193 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred             EEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC-
Confidence            9999999999999999999888999999999999999999999999999999999999999999999999999986532 


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF  278 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~  278 (489)
                                  ...+.+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+...++.+|....+.+|..+
T Consensus       194 ------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~  261 (350)
T 1rdq_E          194 ------------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF  261 (350)
T ss_dssp             ------------CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTC
T ss_pred             ------------CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence                        23467899999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC-CCCCCCC
Q 011287          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLAS  332 (489)
Q Consensus       279 ~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~-~~p~~~~  332 (489)
                      ++++.+||.+||+.||.+||+....+++++++||||++++|..+... .+|++.|
T Consensus       262 ~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p~~p  316 (350)
T 1rdq_E          262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP  316 (350)
T ss_dssp             CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred             CHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhhccCCCCCCC
Confidence            99999999999999999999965556799999999999999998643 3444333

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=6.5e-57  Score=457.17  Aligned_cols=279  Identities=34%  Similarity=0.624  Sum_probs=248.0

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCC
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTF  118 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  118 (489)
                      .++..++|++++.||+|+||.||+|+++.+|+.||||++.+...........+..|+.++..+ +||||++++++|++..
T Consensus        12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~   91 (345)
T 1xjd_A           12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE   91 (345)
T ss_dssp             ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence            457789999999999999999999999999999999999876554455566777899998876 9999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      .+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus        92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  171 (345)
T 1xjd_A           92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  171 (345)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence            99999999999999999998889999999999999999999999999999999999999999999999999999854221


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF  278 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~  278 (489)
                                .....+++||+.|+|||++.+..++.++|+|||||++|+|++|++||.+.+...++++|......+|..+
T Consensus       172 ----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~  241 (345)
T 1xjd_A          172 ----------DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWL  241 (345)
T ss_dssp             ----------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTS
T ss_pred             ----------CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCccc
Confidence                      2234577999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC-CCCCCCC
Q 011287          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLAS  332 (489)
Q Consensus       279 ~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~-~~p~~~~  332 (489)
                      ++++++||.+||+.||++||++.    .++++||||++++|+.+... .+|++.|
T Consensus       242 s~~~~~li~~lL~~dp~~R~~~~----~~i~~hp~f~~~~w~~l~~~~~~~p~~p  292 (345)
T 1xjd_A          242 EKEAKDLLVKLFVREPEKRLGVR----GDIRQHPLFREINWEELERKEIDPPFRP  292 (345)
T ss_dssp             CHHHHHHHHHHSCSSGGGSBTTB----SCGGGSGGGTTCCHHHHHTTCSCC----
T ss_pred             CHHHHHHHHHHhcCCHhHcCCCh----HHHHcCccccCCCHHHHhhCCCCCCcCC
Confidence            99999999999999999999993    27999999999999998653 3444433

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.2e-57  Score=449.67  Aligned_cols=250  Identities=20%  Similarity=0.354  Sum_probs=221.0

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEc-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEE
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTF  114 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~-----~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  114 (489)
                      +.+..++|.+.+.||+|+||+||+|++.     .++..||||+++..   .....+.+.+|+.+|++++|||||++++++
T Consensus         8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~   84 (299)
T 4asz_A            8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVC   84 (299)
T ss_dssp             CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence            4566789999999999999999999875     46889999999754   344556788999999999999999999999


Q ss_pred             EcCCEEEEEEeccCCCChHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCC
Q 011287          115 QDTFSLYMALESCEGGELFDQITSKG-------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD  181 (489)
Q Consensus       115 ~~~~~lylV~E~~~gg~L~~~l~~~~-------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~  181 (489)
                      .+...+|+|||||++|+|.++|.+.+             .+++..+..++.||+.||.|||+++|+||||||+||||+.+
T Consensus        85 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~  164 (299)
T 4asz_A           85 VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN  164 (299)
T ss_dssp             CSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred             eeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC
Confidence            99999999999999999999997643             59999999999999999999999999999999999999999


Q ss_pred             CCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCH
Q 011287          182 GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSE  260 (489)
Q Consensus       182 g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~  260 (489)
                      +++||+|||+|+.......        .......+||+.|||||++.+..|+.++|||||||++|||+| |++||.+.+.
T Consensus       165 ~~~Ki~DFGla~~~~~~~~--------~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~  236 (299)
T 4asz_A          165 LLVKIGDFGMSRDVYSTDY--------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN  236 (299)
T ss_dssp             GCEEECCCSCHHHHTGGGC--------EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             CcEEECCcccceecCCCCc--------eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            9999999999986543321        112235689999999999999999999999999999999998 9999999999


Q ss_pred             HHHHHHHHhcC-CCCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          261 WLIFQRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       261 ~~~~~~i~~~~-~~~p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      .+++..+..+. +.+|..+|+++.+|+.+||+.||++|||+
T Consensus       237 ~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~  277 (299)
T 4asz_A          237 NEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNI  277 (299)
T ss_dssp             HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCH
Confidence            99999888765 57889999999999999999999999998

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.6e-56  Score=450.49  Aligned_cols=255  Identities=21%  Similarity=0.326  Sum_probs=218.1

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEc-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEE
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTF  114 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~-----~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  114 (489)
                      ..+..+||.+.+.||+|+||+||+|+.+     .+++.||||+++..   .....+.+.+|+.+|++++|||||++++++
T Consensus        36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~  112 (329)
T 4aoj_A           36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVC  112 (329)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            4566789999999999999999999865     46899999999754   344556788999999999999999999999


Q ss_pred             EcCCEEEEEEeccCCCChHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeC
Q 011287          115 QDTFSLYMALESCEGGELFDQITSK---------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT  179 (489)
Q Consensus       115 ~~~~~lylV~E~~~gg~L~~~l~~~---------------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~  179 (489)
                      .+...+|+|||||++|+|.+++.+.               +++++.++..++.||+.||.|||+++|+||||||+||||+
T Consensus       113 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~  192 (329)
T 4aoj_A          113 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG  192 (329)
T ss_dssp             CSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred             EECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence            9999999999999999999999764               3589999999999999999999999999999999999999


Q ss_pred             CCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCC
Q 011287          180 ADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDT  258 (489)
Q Consensus       180 ~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~  258 (489)
                      .++++||+|||+|+.+.....        .......+||+.|||||++.+..++.++|||||||++|||+| |+.||.+.
T Consensus       193 ~~~~~Ki~DFGla~~~~~~~~--------~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~  264 (329)
T 4aoj_A          193 QGLVVKIGDFGMSRDIYSTDY--------YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL  264 (329)
T ss_dssp             TTTEEEECCCC------------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS
T ss_pred             CCCcEEEcccccceeccCCCc--------ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCC
Confidence            999999999999986543221        122345689999999999999999999999999999999999 99999999


Q ss_pred             CHHHHHHHHHhc-CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          259 SEWLIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       259 ~~~~~~~~i~~~-~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      +..+++..+..+ .+.+|..+++++.+|+.+||+.||++|||+     .+++.
T Consensus       265 ~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~-----~ei~~  312 (329)
T 4aoj_A          265 SNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSI-----KDVHA  312 (329)
T ss_dssp             CHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCH-----HHHHH
T ss_pred             CHHHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCH-----HHHHH
Confidence            999988888775 467899999999999999999999999998     66654

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.2e-55  Score=485.06  Aligned_cols=284  Identities=33%  Similarity=0.607  Sum_probs=256.3

Q ss_pred             CCCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcC
Q 011287           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDT  117 (489)
Q Consensus        39 ~~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  117 (489)
                      ...+.+++|+++++||+|+||.||+|+++.+++.||||++.+...........+..|+.++..+ +||+|++++++|++.
T Consensus       335 ~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~  414 (674)
T 3pfq_A          335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM  414 (674)
T ss_dssp             -----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS
T ss_pred             cccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC
Confidence            3456789999999999999999999999999999999999876555555667778899999887 799999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCC
Q 011287          118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~  197 (489)
                      ..+|+||||++||+|..++.+.+.+++..++.|++||+.||+|||++||+||||||+||||+.+|++||+|||+|+....
T Consensus       415 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          415 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             CEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            99999999999999999999988999999999999999999999999999999999999999999999999999985322


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY  277 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~  277 (489)
                      .          .....+++||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+++++|....+.+|..
T Consensus       495 ~----------~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~  564 (674)
T 3pfq_A          495 D----------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS  564 (674)
T ss_dssp             T----------TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTT
T ss_pred             C----------CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCcc
Confidence            1          233457899999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC-CCCCCCC
Q 011287          278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLAS  332 (489)
Q Consensus       278 ~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~-~~p~~~~  332 (489)
                      +++++++||++||+.||++||++...+.+++++||||++++|+.+... .+|++.|
T Consensus       565 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p  620 (674)
T 3pfq_A          565 MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKP  620 (674)
T ss_dssp             SCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCC
T ss_pred             CCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCC
Confidence            999999999999999999999997778899999999999999998654 4454444

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.7e-55  Score=460.16  Aligned_cols=287  Identities=37%  Similarity=0.642  Sum_probs=244.4

Q ss_pred             cCCCCCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 011287           36 RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  115 (489)
Q Consensus        36 ~~~~~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  115 (489)
                      ..+...+..++|++++.||+|+||.||+|++..+|+.||||++.+...........+.+|+.+++.++||||++++++|.
T Consensus       139 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~  218 (446)
T 4ejn_A          139 AKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ  218 (446)
T ss_dssp             -----CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEE
T ss_pred             cCcccCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe
Confidence            44455678899999999999999999999999999999999998765555555566778999999999999999999999


Q ss_pred             cCCEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeeccCCCCeeeCCCCCEEEeeccCccc
Q 011287          116 DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (489)
Q Consensus       116 ~~~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~-~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~  194 (489)
                      +...+|+|||||++|+|.+++.+.+.+++..++.++.||+.||+|||+ .||+||||||+||||+.+|++||+|||+|+.
T Consensus       219 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~  298 (446)
T 4ejn_A          219 THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE  298 (446)
T ss_dssp             ETTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred             eCCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence            999999999999999999999988899999999999999999999998 9999999999999999999999999999975


Q ss_pred             cCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCC
Q 011287          195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF  274 (489)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~  274 (489)
                      ....          .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+......+
T Consensus       299 ~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~  368 (446)
T 4ejn_A          299 GIKD----------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF  368 (446)
T ss_dssp             TCC---------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred             ccCC----------CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC
Confidence            4321          123346789999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC-CCCCCCC
Q 011287          275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLAS  332 (489)
Q Consensus       275 p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~-~~p~~~~  332 (489)
                      |..+++++.+||.+||+.||.+||+....+++++++||||++++|+.+... .+|++.|
T Consensus       369 p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~~pp~~p  427 (446)
T 4ejn_A          369 PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKP  427 (446)
T ss_dssp             CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred             CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcCCCCccC
Confidence            999999999999999999999999655556699999999999999987553 4444444

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.6e-55  Score=439.23  Aligned_cols=255  Identities=20%  Similarity=0.331  Sum_probs=222.8

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEc-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  115 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~-----~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  115 (489)
                      .+...++++++.||+|+||+||+|+..     .+++.||||++....  .....+.+.+|+.+|++++|||||++++++.
T Consensus        22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~   99 (308)
T 4gt4_A           22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVT   99 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence            456789999999999999999999853     467899999996542  2233466888999999999999999999999


Q ss_pred             cCCEEEEEEeccCCCChHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeC
Q 011287          116 DTFSLYMALESCEGGELFDQITSK----------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT  179 (489)
Q Consensus       116 ~~~~lylV~E~~~gg~L~~~l~~~----------------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~  179 (489)
                      +...+|+|||||++|+|.++|...                +.+++..+..++.||+.||+|||+++||||||||+||||+
T Consensus       100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~  179 (308)
T 4gt4_A          100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY  179 (308)
T ss_dssp             SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence            999999999999999999999653                3589999999999999999999999999999999999999


Q ss_pred             CCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCC
Q 011287          180 ADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDT  258 (489)
Q Consensus       180 ~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~  258 (489)
                      +++++||+|||+|+.+....        ......+.+||+.|||||++.+..++.++|||||||++|||+| |..||.+.
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~--------~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~  251 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAAD--------YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY  251 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGG--------CBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC
T ss_pred             CCCCEEECCcccceeccCCC--------ceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Confidence            99999999999998664322        1123345689999999999999999999999999999999998 89999999


Q ss_pred             CHHHHHHHHHhcC-CCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          259 SEWLIFQRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       259 ~~~~~~~~i~~~~-~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      +..++...+..+. .+.|+.+|+++.+|+.+||+.||++||++     .+|++
T Consensus       252 ~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~-----~ei~~  299 (308)
T 4gt4_A          252 SNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRF-----KDIHS  299 (308)
T ss_dssp             CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CHHHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCH-----HHHHH
Confidence            9999988887754 46788999999999999999999999998     66654

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=9.7e-55  Score=447.14  Aligned_cols=280  Identities=30%  Similarity=0.576  Sum_probs=250.3

Q ss_pred             CCCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 011287           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (489)
Q Consensus        39 ~~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  118 (489)
                      ...+..++|++++.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+|+.++||||++++++|++..
T Consensus         9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   88 (384)
T 4fr4_A            9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE   88 (384)
T ss_dssp             CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            35677899999999999999999999999999999999998766555556677888999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      .+|+|||||.||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+++.+...
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            99999999999999999999889999999999999999999999999999999999999999999999999999865322


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcC---CCCCCCCcchhhhHHHHHHhhCCCCCCC---CCHHHHHHHHHhcCC
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNS---SPATFGNDLWALGCTLYQMLSGTSPFKD---TSEWLIFQRIIARDI  272 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~---~~~~~~sDiwSLG~ilyelltG~~PF~~---~~~~~~~~~i~~~~~  272 (489)
                                 ....+++||+.|+|||++..   ..++.++|||||||++|+|++|+.||..   .....+...+.....
T Consensus       169 -----------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  237 (384)
T 4fr4_A          169 -----------TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV  237 (384)
T ss_dssp             -----------CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCC
T ss_pred             -----------CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhccc
Confidence                       23456789999999999964   4589999999999999999999999974   445667778888889


Q ss_pred             CCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC-CCCCCCCC
Q 011287          273 RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLASE  333 (489)
Q Consensus       273 ~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~-~~p~~~~~  333 (489)
                      .+|..+++++.+||.+||+.||.+||++    ++++++||||++++|+.+... ..|++.|.
T Consensus       238 ~~p~~~s~~~~~li~~lL~~dP~~R~s~----~~~l~~hp~f~~~~w~~~~~~~~~p~~~p~  295 (384)
T 4fr4_A          238 TYPSAWSQEMVSLLKKLLEPNPDQRFSQ----LSDVQNFPYMNDINWDAVFQKRLIPGFIPN  295 (384)
T ss_dssp             CCCTTSCHHHHHHHHHHSCSSGGGSCCS----HHHHHTSGGGTTCCHHHHHTTCSCCCCCCS
T ss_pred             CCCCcCCHHHHHHHHHHhcCCHhHhccc----HHHHHcChhhhcCCHHHHHhCCCCCCCCCC
Confidence            9999999999999999999999999985    489999999999999998653 45555444

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-55  Score=438.81  Aligned_cols=259  Identities=20%  Similarity=0.320  Sum_probs=209.9

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ly  121 (489)
                      +..++|++++.||+|+||+||+|+..   ..||||+++.... .....+.+.+|+.+|++++|||||++++++.+ ..+|
T Consensus        33 i~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~  107 (307)
T 3omv_A           33 IEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLA  107 (307)
T ss_dssp             CCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred             EcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEE
Confidence            45679999999999999999999864   3699999865433 33445678899999999999999999998765 5689


Q ss_pred             EEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          122 MALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      +|||||+||+|.+++... +.+++..+..++.||+.||+|||++|||||||||+||||++++++||+|||+|+...... 
T Consensus       108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~-  186 (307)
T 3omv_A          108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS-  186 (307)
T ss_dssp             EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCC-
Confidence            999999999999999764 679999999999999999999999999999999999999999999999999998654321 


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcC---CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC-----
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNS---SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-----  272 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~---~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~-----  272 (489)
                             ......+.+||+.|||||++.+   ..|+.++|||||||++|||+||+.||.+.+.......+.....     
T Consensus       187 -------~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~  259 (307)
T 3omv_A          187 -------GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDL  259 (307)
T ss_dssp             --------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCS
T ss_pred             -------cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCc
Confidence                   1223446789999999999964   4589999999999999999999999998766555555544332     


Q ss_pred             -CCCCCCCHHHHHHHHHhhccCCCCCCCCCC-CCHHHHhcCCC
Q 011287          273 -RFPNYFSDAARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPF  313 (489)
Q Consensus       273 -~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~-~~~~~l~~hpf  313 (489)
                       .++..+|+++.+||.+||+.||++|||+.+ ...-+.++|++
T Consensus       260 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l  302 (307)
T 3omv_A          260 SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL  302 (307)
T ss_dssp             TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred             ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence             245678999999999999999999999833 11113355665

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-55  Score=455.26  Aligned_cols=277  Identities=38%  Similarity=0.668  Sum_probs=243.2

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCE
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  119 (489)
                      ..+..++|++++.||+|+||.||+|+++.+|+.||||++.+...........+.+|+.++..++||||++++++|++...
T Consensus        56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~  135 (412)
T 2vd5_A           56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY  135 (412)
T ss_dssp             HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred             ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence            35678999999999999999999999999999999999987654444455567889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          120 LYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      +|+|||||+||+|.+++.+.+ .+++..++.+++||+.||+|||++||+||||||+|||++.+|++||+|||+++.+...
T Consensus       136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~  215 (412)
T 2vd5_A          136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD  215 (412)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence            999999999999999998754 7999999999999999999999999999999999999999999999999999865432


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhc-------CCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc-
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLN-------SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-  270 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~-------~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~-  270 (489)
                      .         .......+||+.|+|||++.       ...++.++|||||||++|+|++|++||.+.+..+++.+|... 
T Consensus       216 ~---------~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~  286 (412)
T 2vd5_A          216 G---------TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK  286 (412)
T ss_dssp             S---------CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred             C---------ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence            1         11233578999999999997       356899999999999999999999999999999999998763 


Q ss_pred             -CCCCC---CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCCCCC
Q 011287          271 -DIRFP---NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP  328 (489)
Q Consensus       271 -~~~~p---~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~~~p  328 (489)
                       .+.+|   ..+++++++||++||+ +|.+|++.  .+++++++||||++++|+.+....||
T Consensus       287 ~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr--~~~~ei~~Hpff~~i~w~~l~~~~~p  345 (412)
T 2vd5_A          287 EHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGR--GGAGDFRTHPFFFGLDWDGLRDSVPP  345 (412)
T ss_dssp             HHCCCC----CCCHHHHHHHHTTSS-CGGGCTTT--TTHHHHHTSGGGTTCCSTTSTTSCCS
T ss_pred             cCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCC--CCHHHHhcCCCcCCCCHHHHhhcCCC
Confidence             24455   5799999999999999 99999854  24699999999999999999765444

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=4.2e-55  Score=457.12  Aligned_cols=274  Identities=36%  Similarity=0.645  Sum_probs=242.8

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~l  120 (489)
                      .+..++|+++++||+|+||+||+|+++.+++.||+|++.+...........+.+|+.++..++||||++++++|++...+
T Consensus        70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  149 (437)
T 4aw2_A           70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL  149 (437)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence            45678999999999999999999999999999999999875444444445578899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcc
Q 011287          121 YMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      |+|||||+||+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.+....
T Consensus       150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~  229 (437)
T 4aw2_A          150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  229 (437)
T ss_dssp             EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence            999999999999999987 4789999999999999999999999999999999999999999999999999997654321


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhc-----CCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc--CC
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLN-----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR--DI  272 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~-----~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~--~~  272 (489)
                               .......+||+.|+|||++.     ...++.++|||||||++|+|++|++||.+.+..+++.+|...  .+
T Consensus       230 ---------~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~  300 (437)
T 4aw2_A          230 ---------TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF  300 (437)
T ss_dssp             ---------CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred             ---------CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc
Confidence                     11233568999999999997     456899999999999999999999999999999999998763  35


Q ss_pred             CCCCC---CCHHHHHHHHHhhccCCCC--CCCCCCCCHHHHhcCCCCCCCCcccccCCCCC
Q 011287          273 RFPNY---FSDAARDLIDRLLDVDPSG--RPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP  328 (489)
Q Consensus       273 ~~p~~---~~~~~~~Li~~~L~~dP~~--R~t~~~~~~~~l~~hpff~~i~~~~~~~~~~p  328 (489)
                      .+|..   +++++++||++||+.+|++  |+++     +++++||||++++|+.+....||
T Consensus       301 ~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~-----~eil~Hpff~~i~w~~l~~~~~p  356 (437)
T 4aw2_A          301 QFPTQVTDVSENAKDLIRRLICSREHRLGQNGI-----EDFKKHPFFSGIDWDNIRNCEAP  356 (437)
T ss_dssp             CCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTT-----HHHHTSGGGTTCCTTTGGGSCCS
T ss_pred             cCCcccccCCHHHHHHHHHHhcccccccCCCCH-----HHHhCCCccCCCCHHHHhhCCCC
Confidence            66654   8999999999999998888  8888     89999999999999999765554

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.9e-54  Score=435.54  Aligned_cols=276  Identities=38%  Similarity=0.715  Sum_probs=239.8

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEc---CCCcEEEEEEeecccccc-hhHHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  115 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~---~tg~~vAiK~~~k~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  115 (489)
                      ..+..++|++++.||+|+||.||+|++.   .+|+.||+|++.+..... ......+.+|+.+++.++||||+++++++.
T Consensus        12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   91 (327)
T 3a62_A           12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ   91 (327)
T ss_dssp             -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence            4567899999999999999999999985   689999999998764432 233456778999999999999999999999


Q ss_pred             cCCEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCcccc
Q 011287          116 DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (489)
Q Consensus       116 ~~~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~  195 (489)
                      +...+|+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++..
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           92 TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             CSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            99999999999999999999998889999999999999999999999999999999999999999999999999998754


Q ss_pred             CCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCC
Q 011287          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP  275 (489)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p  275 (489)
                      ...          .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+......+|
T Consensus       172 ~~~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p  241 (327)
T 3a62_A          172 IHD----------GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP  241 (327)
T ss_dssp             -----------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC
T ss_pred             ccC----------CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence            321          1223456899999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC
Q 011287          276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  325 (489)
Q Consensus       276 ~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~  325 (489)
                      ..+++++.+||.+||+.||++||++...++.++++||||++++|+.+...
T Consensus       242 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~~~  291 (327)
T 3a62_A          242 PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLAR  291 (327)
T ss_dssp             TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHHTT
T ss_pred             CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHhhc
Confidence            99999999999999999999999887667899999999999999987543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=5.4e-54  Score=458.98  Aligned_cols=284  Identities=29%  Similarity=0.549  Sum_probs=254.5

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCE
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  119 (489)
                      ..+..++|+++++||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++.++||||++++++|++...
T Consensus       180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  259 (543)
T 3c4z_A          180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD  259 (543)
T ss_dssp             SCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             ccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE
Confidence            45778999999999999999999999999999999999987765555556778889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCcccc
Q 011287          120 LYMALESCEGGELFDQITSK----GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~----~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~  195 (489)
                      +|+||||++||+|.+++.+.    ..+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+++.+
T Consensus       260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~  339 (543)
T 3c4z_A          260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL  339 (543)
T ss_dssp             EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence            99999999999999999764    36999999999999999999999999999999999999999999999999999865


Q ss_pred             CCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCC----CHHHHHHHHHhcC
Q 011287          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT----SEWLIFQRIIARD  271 (489)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~----~~~~~~~~i~~~~  271 (489)
                      ....          .....++||+.|+|||++.+..++.++|||||||++|+|++|++||.+.    +...+.+.+....
T Consensus       340 ~~~~----------~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~  409 (543)
T 3c4z_A          340 KAGQ----------TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA  409 (543)
T ss_dssp             CTTC----------CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC
T ss_pred             cCCC----------cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc
Confidence            4321          2234568999999999999999999999999999999999999999875    4567888899999


Q ss_pred             CCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC-CCCCCCCC
Q 011287          272 IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLASE  333 (489)
Q Consensus       272 ~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~-~~p~~~~~  333 (489)
                      ..+|..+++++++||.+||+.||++||++.+.+.+++++||||++++|+.+... ..|++.|.
T Consensus       410 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~~~~~pp~~P~  472 (543)
T 3c4z_A          410 VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPD  472 (543)
T ss_dssp             CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred             cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHcCCCCCCCCCC
Confidence            999999999999999999999999999987777799999999999999998653 34544443

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.2e-54  Score=450.32  Aligned_cols=277  Identities=37%  Similarity=0.600  Sum_probs=241.9

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~l  120 (489)
                      .+..++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.++||||++++++|++...+
T Consensus        65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~  144 (410)
T 3v8s_A           65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL  144 (410)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            45678999999999999999999999999999999999875444444445677899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      |+|||||+||+|.+++.+ +.+++..++.+++||+.||+|||++||+||||||+|||++.+|++||+|||+|+.+.... 
T Consensus       145 ~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~-  222 (410)
T 3v8s_A          145 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-  222 (410)
T ss_dssp             EEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-
T ss_pred             EEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC-
Confidence            999999999999999876 469999999999999999999999999999999999999999999999999998654322 


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCC----CCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC--CCC
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSP----ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--IRF  274 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~----~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~--~~~  274 (489)
                              .....+.+||+.|+|||++.+..    ++.++|||||||++|+|++|++||.+.+...++.+|....  +.+
T Consensus       223 --------~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~  294 (410)
T 3v8s_A          223 --------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF  294 (410)
T ss_dssp             --------EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC
T ss_pred             --------cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccC
Confidence                    11234678999999999997765    7889999999999999999999999999999999998643  556


Q ss_pred             CC--CCCHHHHHHHHHhhccCCCC--CCCCCCCCHHHHhcCCCCCCCCcccccC-CCCCCCCC
Q 011287          275 PN--YFSDAARDLIDRLLDVDPSG--RPGAGPGGYAVLKMHPFFKGIDWKNIRG-QTPPKLAS  332 (489)
Q Consensus       275 p~--~~~~~~~~Li~~~L~~dP~~--R~t~~~~~~~~l~~hpff~~i~~~~~~~-~~~p~~~~  332 (489)
                      |.  .+++++++||.+||+.+|.+  |+++     +++++||||++++|+.+.. +.+|++.|
T Consensus       295 p~~~~~s~~~~~li~~lL~~~~~rlgR~~~-----~ei~~Hp~f~~~~w~~~~~~~~~~p~~p  352 (410)
T 3v8s_A          295 PDDNDISKEAKNLICAFLTDREVRLGRNGV-----EEIKRHLFFKNDQWAWETLRDTVAPVVP  352 (410)
T ss_dssp             CTTCCCCHHHHHHHHHHSSCGGGCTTSSCH-----HHHHTSGGGCCSSCCSTTGGGSCCSCCC
T ss_pred             CCcccccHHHHHHHHHHccChhhhCCCCCH-----HHHhcCccccCCCHHHHhhcccCCCCCC
Confidence            64  68999999999999988888  8877     9999999999999986543 23343433

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4.9e-54  Score=460.96  Aligned_cols=284  Identities=32%  Similarity=0.551  Sum_probs=253.4

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCE
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  119 (489)
                      .++..++|++++.||+|+||.||+|+++.+|+.||+|++.+..+........+.+|+.+|+.++||||++++++|++...
T Consensus       179 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  258 (576)
T 2acx_A          179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA  258 (576)
T ss_dssp             SCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCE
Confidence            45778999999999999999999999999999999999987765555556778889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCC
Q 011287          120 LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~~~--l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~  197 (489)
                      +|+||||++||+|.+++...+.  +++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+++.+..
T Consensus       259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            9999999999999999987644  99999999999999999999999999999999999999999999999999986543


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCC----CHHHHHHHHHhcCCC
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT----SEWLIFQRIIARDIR  273 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~----~~~~~~~~i~~~~~~  273 (489)
                      .           ......+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.    ....+.+.+......
T Consensus       339 ~-----------~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~  407 (576)
T 2acx_A          339 G-----------QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE  407 (576)
T ss_dssp             T-----------CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCC
T ss_pred             C-----------ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccccc
Confidence            2           2233568999999999999989999999999999999999999999875    346677788888888


Q ss_pred             CCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC-CCCCCCCCC
Q 011287          274 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLASEP  334 (489)
Q Consensus       274 ~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~-~~p~~~~~~  334 (489)
                      +|..+++++++||.+||+.||.+||++...+++++++||||++++|+.+... .+|++.|.+
T Consensus       408 ~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~~~~~pp~~p~~  469 (576)
T 2acx_A          408 YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDP  469 (576)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred             CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhcCCCCCCCCCCc
Confidence            9999999999999999999999999876667799999999999999998653 445554433

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.3e-53  Score=428.10  Aligned_cols=261  Identities=32%  Similarity=0.543  Sum_probs=239.6

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~l  120 (489)
                      ....++|++++.||+|+||.||+|++..+|+.||||++.+.... ......+.+|+.+++.++||||+++++++.+...+
T Consensus        11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~   89 (328)
T 3fe3_A           11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTL   89 (328)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence            34578999999999999999999999999999999999876543 33456677899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      |+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++......  
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--  167 (328)
T 3fe3_A           90 YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--  167 (328)
T ss_dssp             EEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS--
T ss_pred             EEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC--
Confidence            999999999999999998889999999999999999999999999999999999999999999999999999765432  


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCC-CCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPAT-FGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS  279 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~-~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~  279 (489)
                               ......+||+.|+|||++.+..+. .++|||||||++|+|++|++||.+.+...+..++....+.+|..++
T Consensus       168 ---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s  238 (328)
T 3fe3_A          168 ---------GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMS  238 (328)
T ss_dssp             ---------CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSC
T ss_pred             ---------CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCC
Confidence                     233466899999999999888764 7899999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 011287          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (489)
Q Consensus       280 ~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~  318 (489)
                      +++.+||++||+.||.+|||+     +++++||||+...
T Consensus       239 ~~~~~li~~~L~~dP~~R~t~-----~eil~h~~~~~~~  272 (328)
T 3fe3_A          239 TDCENLLKRFLVLNPIKRGTL-----EQIMKDRWINAGH  272 (328)
T ss_dssp             HHHHHHHHHHCCSSTTTSCCH-----HHHTTCTTTTTTC
T ss_pred             HHHHHHHHHHCCCChhHCcCH-----HHHhcCHhhcCCC
Confidence            999999999999999999998     8999999998654

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=4.8e-53  Score=431.30  Aligned_cols=263  Identities=29%  Similarity=0.521  Sum_probs=239.9

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE---NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~l  120 (489)
                      .++|++++.||+|+||.||+|+++.+|+.||+|++.+......   .....+.+|+.+|+.++||||++++++|.+...+
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            4679999999999999999999999999999999987644322   1346788899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCC----CEEEeeccCccccC
Q 011287          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQ  196 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g----~ikL~DFG~a~~~~  196 (489)
                      |+|||||+||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++    ++||+|||+++.+.
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~  170 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence            99999999999999999888999999999999999999999999999999999999998877    79999999998654


Q ss_pred             CccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCC-
Q 011287          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP-  275 (489)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p-  275 (489)
                      ..           ......+||+.|+|||++.+..++.++||||||||+|+|++|.+||.+.+..+++..|....+.++ 
T Consensus       171 ~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~  239 (361)
T 2yab_A          171 DG-----------VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDE  239 (361)
T ss_dssp             TT-----------CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH
T ss_pred             CC-----------CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCc
Confidence            32           223456899999999999999999999999999999999999999999999999999999888776 


Q ss_pred             ---CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccc
Q 011287          276 ---NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI  322 (489)
Q Consensus       276 ---~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~  322 (489)
                         ..+++++++||.+||+.||++|||+     .++++||||.+++|...
T Consensus       240 ~~~~~~s~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~~~~~~~~~~  284 (361)
T 2yab_A          240 EFFSQTSELAKDFIRKLLVKETRKRLTI-----QEALRHPWITPVDTQQA  284 (361)
T ss_dssp             HHHTTSCHHHHHHHHHHSCSSTTTSCCH-----HHHHTSTTTSCSSHHHH
T ss_pred             hhccCCCHHHHHHHHHHCCCChhHCcCH-----HHHhcCcCcCCCchhhh
Confidence               4689999999999999999999998     89999999999998654

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=5.7e-54  Score=435.53  Aligned_cols=255  Identities=24%  Similarity=0.383  Sum_probs=216.9

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCC-----CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC-CCccEEEEEEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDT-----GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH-PGVVRLFFTFQ  115 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~t-----g~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~  115 (489)
                      +..++|++++.||+|+||+||+|++..+     ++.||||++....  .......+.+|+.+|.+++| ||||++++++.
T Consensus        61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~  138 (353)
T 4ase_A           61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT  138 (353)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence            3457999999999999999999998654     4689999987543  23345668889999999965 99999999986


Q ss_pred             c-CCEEEEEEeccCCCChHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeee
Q 011287          116 D-TFSLYMALESCEGGELFDQITSK----------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL  178 (489)
Q Consensus       116 ~-~~~lylV~E~~~gg~L~~~l~~~----------------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl  178 (489)
                      + ...+|+|||||++|+|.++|.+.                ..+++..+..++.||+.||+|||+++||||||||+|||+
T Consensus       139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl  218 (353)
T 4ase_A          139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL  218 (353)
T ss_dssp             CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee
Confidence            5 46799999999999999999753                348999999999999999999999999999999999999


Q ss_pred             CCCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCC
Q 011287          179 TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKD  257 (489)
Q Consensus       179 ~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~  257 (489)
                      +.++++||+|||+|+.+....        ......+.+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+
T Consensus       219 ~~~~~vKi~DFGlar~~~~~~--------~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          219 SEKNVVKICDFGLARDIYKDP--------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             CGGGCEEECCCGGGSCTTTCT--------TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CCCCCEEECcchhhhhcccCC--------CceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence            999999999999998664322        1123346789999999999999999999999999999999998 9999998


Q ss_pred             CCHHH-HHHHHHhc-CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 011287          258 TSEWL-IFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (489)
Q Consensus       258 ~~~~~-~~~~i~~~-~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~h  311 (489)
                      .+... +...+..+ .+.+|+.+++++.+|+.+||+.||++|||+     .++++|
T Consensus       291 ~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~-----~eil~~  341 (353)
T 4ase_A          291 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF-----SELVEH  341 (353)
T ss_dssp             CCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             CCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCH-----HHHHHH
Confidence            76444 44444443 467889999999999999999999999998     778765

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.1e-51  Score=411.01  Aligned_cols=262  Identities=30%  Similarity=0.526  Sum_probs=236.8

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE---NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~l  120 (489)
                      .++|++++.||+|+||.||+|+++.+|+.||+|++.+......   .....+.+|+.+++.++||||++++++|.+...+
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            4679999999999999999999999999999999987543322   1356688899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCC----CEEEeeccCccccC
Q 011287          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQ  196 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g----~ikL~DFG~a~~~~  196 (489)
                      |+|||||++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++    ++||+|||+++...
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~  169 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID  169 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence            99999999999999999888899999999999999999999999999999999999999887    89999999998654


Q ss_pred             CccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCC-
Q 011287          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP-  275 (489)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p-  275 (489)
                      ..           ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+......++ 
T Consensus       170 ~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~  238 (326)
T 2y0a_A          170 FG-----------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED  238 (326)
T ss_dssp             TT-----------SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCH
T ss_pred             CC-----------CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCc
Confidence            32           122356799999999999999999999999999999999999999999999999888888777766 


Q ss_pred             ---CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCccc
Q 011287          276 ---NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  321 (489)
Q Consensus       276 ---~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~  321 (489)
                         ..+++.+++||.+||+.||++|||+     .++++||||.+.+|..
T Consensus       239 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~e~l~hp~~~~~~~~~  282 (326)
T 2y0a_A          239 EYFSNTSALAKDFIRRLLVKDPKKRMTI-----QDSLQHPWIKPKDTQQ  282 (326)
T ss_dssp             HHHTTSCHHHHHHHHHHSCSSGGGSCCH-----HHHHHSTTTSCCSHHH
T ss_pred             cccccCCHHHHHHHHHHccCChhhCCCH-----HHHhcCCCccCCcchh
Confidence               4689999999999999999999998     8999999999887754

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2e-52  Score=422.61  Aligned_cols=259  Identities=33%  Similarity=0.536  Sum_probs=233.3

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~l  120 (489)
                      ....++|++++.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+...+
T Consensus         5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~   84 (336)
T 3h4j_B            5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI   84 (336)
T ss_dssp             CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            34578999999999999999999999999999999999876544444456788899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      |+||||+ +|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++......  
T Consensus        85 ~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~--  161 (336)
T 3h4j_B           85 VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--  161 (336)
T ss_dssp             EEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS--
T ss_pred             EEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC--
Confidence            9999999 6799999988889999999999999999999999999999999999999999999999999999865432  


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCC-CCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS  279 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~-~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~  279 (489)
                               ....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+....++++....+.+|..++
T Consensus       162 ---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s  232 (336)
T 3h4j_B          162 ---------NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLS  232 (336)
T ss_dssp             ---------BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSC
T ss_pred             ---------cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCC
Confidence                     22345689999999999988776 78999999999999999999999987766666666677788899999


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       280 ~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      +++.+||++||+.||.+|||+     +++++||||+.
T Consensus       233 ~~~~~li~~~L~~dP~~Rpt~-----~eil~hp~~~~  264 (336)
T 3h4j_B          233 PGAQSLIRRMIVADPMQRITI-----QEIRRDPWFNV  264 (336)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCH-----HHHTTCHHHHT
T ss_pred             HHHHHHHHHHcCCChhHCcCH-----HHHHhChhhcc
Confidence            999999999999999999998     99999999974

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=5.6e-51  Score=426.98  Aligned_cols=257  Identities=33%  Similarity=0.572  Sum_probs=232.4

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      .++|++++.||+|+||.||+|.++.+|+.||+|++.+..... .....+.+|+.+++.++||||+++++++.+....|+|
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA-RDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHH-HHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            468999999999999999999999999999999998764433 3456688899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeC---CCCCEEEeeccCccccCCccc
Q 011287          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT---ADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~---~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      ||||.||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++....... 
T Consensus        89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~-  167 (444)
T 3soa_A           89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-  167 (444)
T ss_dssp             ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC-
T ss_pred             EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC-
Confidence            99999999999999989999999999999999999999999999999999999998   46789999999998654321 


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCC----
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN----  276 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~----  276 (489)
                               ......+||+.|+|||++.+..++.++||||||||+|+|++|.+||.+.+....++.+..+.+.+|.    
T Consensus       168 ---------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  238 (444)
T 3soa_A          168 ---------QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWD  238 (444)
T ss_dssp             ---------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTT
T ss_pred             ---------ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccc
Confidence                     2233568999999999999999999999999999999999999999999999999999998887764    


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      .+++++++||.+||+.||++||++     .++++||||.+
T Consensus       239 ~~s~~~~~li~~~L~~dP~~Rpta-----~e~L~hp~~~~  273 (444)
T 3soa_A          239 TVTPEAKDLINKMLTINPSKRITA-----AEALKHPWISH  273 (444)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCH-----HHHHHSCTTHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCCCH-----HHHhcCccccC
Confidence            689999999999999999999999     89999999964

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.9e-51  Score=404.97  Aligned_cols=255  Identities=28%  Similarity=0.451  Sum_probs=228.1

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      .++|++++.||+|+||+||+|++..+|+.||+|++.....   .....+.+|+.+++.++||||++++++|.+...+|+|
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   95 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc---cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence            4689999999999999999999999999999999976532   2345678899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      ||||+||+|.+++.+. .+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++.......    
T Consensus        96 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----  170 (297)
T 3fxz_A           96 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ----  170 (297)
T ss_dssp             EECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT----
T ss_pred             EECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc----
Confidence            9999999999999875 69999999999999999999999999999999999999999999999999988654321    


Q ss_pred             CCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc---CCCCCCCCCH
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFSD  280 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~---~~~~p~~~~~  280 (489)
                            ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+...   ....|..+++
T Consensus       171 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (297)
T 3fxz_A          171 ------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA  244 (297)
T ss_dssp             ------CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCH
T ss_pred             ------cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCH
Confidence                  2334568999999999999999999999999999999999999999998887776665543   3445778999


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       281 ~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                      .+.+||.+||+.||++||++     +++++||||+..
T Consensus       245 ~~~~li~~~l~~dp~~Rps~-----~ell~h~~~~~~  276 (297)
T 3fxz_A          245 IFRDFLNRCLEMDVEKRGSA-----KELLQHQFLKIA  276 (297)
T ss_dssp             HHHHHHHHHSCSSTTTSCCH-----HHHTTCGGGGGC
T ss_pred             HHHHHHHHHccCChhHCcCH-----HHHhhChhhccc
Confidence            99999999999999999998     899999999753

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=4.7e-51  Score=400.25  Aligned_cols=260  Identities=33%  Similarity=0.609  Sum_probs=237.6

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCE
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  119 (489)
                      ..+.+++|++++.||+|+||.||+|++..++..||+|++.+...........+.+|+.+++.++||||+++++++.+...
T Consensus         4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   83 (279)
T 3fdn_A            4 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR   83 (279)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             ceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE
Confidence            36788999999999999999999999999999999999977655555556678889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcc
Q 011287          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      .|+||||+++|+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.+++++|+|||++.....  
T Consensus        84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~--  161 (279)
T 3fdn_A           84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--  161 (279)
T ss_dssp             EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc--
Confidence            999999999999999999888899999999999999999999999999999999999999999999999999864332  


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS  279 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~  279 (489)
                                .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.....+.+......+|..++
T Consensus       162 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  231 (279)
T 3fdn_A          162 ----------SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT  231 (279)
T ss_dssp             ----------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSC
T ss_pred             ----------ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCC
Confidence                      1223567999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       280 ~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      +++.+||.+||+.||.+||++     .++++||||++
T Consensus       232 ~~~~~li~~~l~~~p~~Rps~-----~e~l~h~~~~~  263 (279)
T 3fdn_A          232 EGARDLISRLLKHNPSQRPML-----REVLEHPWITA  263 (279)
T ss_dssp             HHHHHHHHHHCCSSGGGSCCH-----HHHHHCHHHHH
T ss_pred             HHHHHHHHHHhccChhhCCCH-----HHHhhCccccC
Confidence            999999999999999999998     99999999975

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.9e-51  Score=401.82  Aligned_cols=265  Identities=34%  Similarity=0.612  Sum_probs=239.9

Q ss_pred             cCCCCCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 011287           36 RAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  115 (489)
Q Consensus        36 ~~~~~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  115 (489)
                      +.|...+..++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.
T Consensus         5 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   84 (284)
T 2vgo_A            5 EMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH   84 (284)
T ss_dssp             -----CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hCCccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE
Confidence            34556788999999999999999999999999999999999997654444444567888999999999999999999999


Q ss_pred             cCCEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCcccc
Q 011287          116 DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (489)
Q Consensus       116 ~~~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~  195 (489)
                      +...+|+||||+++|+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+||+++.+++++|+|||++...
T Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~  164 (284)
T 2vgo_A           85 DRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHA  164 (284)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccC
Confidence            99999999999999999999998888999999999999999999999999999999999999999999999999998754


Q ss_pred             CCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCC
Q 011287          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP  275 (489)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p  275 (489)
                      ..            .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+......+|
T Consensus       165 ~~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  232 (284)
T 2vgo_A          165 PS------------LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP  232 (284)
T ss_dssp             SS------------SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC
T ss_pred             cc------------cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCC
Confidence            32            122356799999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       276 ~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                      ..++.++++||.+||+.||.+||++     .++++||||+..
T Consensus       233 ~~~~~~~~~li~~~l~~~p~~Rps~-----~~ll~h~~~~~~  269 (284)
T 2vgo_A          233 PFLSDGSKDLISKLLRYHPPQRLPL-----KGVMEHPWVKAN  269 (284)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCCH-----HHHHTCHHHHHH
T ss_pred             CcCCHHHHHHHHHHhhcCHhhCCCH-----HHHhhCHHHHhh
Confidence            9999999999999999999999998     899999999753

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=6.7e-51  Score=415.63  Aligned_cols=256  Identities=32%  Similarity=0.576  Sum_probs=232.8

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      .++|++++.||+|+||.||+|.++.+|+.||+|++.+..... .....+.+|+.+++.++||||+++++++.+....|+|
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            468999999999999999999999999999999998764433 3456688899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCC---CEEEeeccCccccCCccc
Q 011287          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG---HIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g---~ikL~DFG~a~~~~~~~~  200 (489)
                      ||||.||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++   .+||+|||++......  
T Consensus       107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~--  184 (362)
T 2bdw_A          107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--  184 (362)
T ss_dssp             ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC--
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC--
Confidence            99999999999999888899999999999999999999999999999999999998654   5999999999865432  


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCC----
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN----  276 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~----  276 (489)
                               ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+...++..+....+.+|.    
T Consensus       185 ---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  255 (362)
T 2bdw_A          185 ---------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWD  255 (362)
T ss_dssp             ---------CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGG
T ss_pred             ---------cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCccccc
Confidence                     1233568999999999999999999999999999999999999999999999999999988887764    


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      .+++++++||.+||+.||++||++     .++++||||.+
T Consensus       256 ~~~~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~~~~  290 (362)
T 2bdw_A          256 TVTPEAKSLIDSMLTVNPKKRITA-----DQALKVPWICN  290 (362)
T ss_dssp             GSCHHHHHHHHHHSCSSGGGSCCH-----HHHTTSHHHHT
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCH-----HHHhcCcccCC
Confidence            579999999999999999999998     89999999974

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3.2e-51  Score=432.10  Aligned_cols=262  Identities=32%  Similarity=0.548  Sum_probs=240.7

Q ss_pred             CCCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 011287           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (489)
Q Consensus        39 ~~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  118 (489)
                      ......++|.+++.||+|+||.||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+..
T Consensus        10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~   89 (476)
T 2y94_A           10 DGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS   89 (476)
T ss_dssp             CSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             CCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            34567899999999999999999999999999999999998765444445667889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      .+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||++......
T Consensus        90 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           90 DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             EEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            99999999999999999998889999999999999999999999999999999999999999999999999999865432


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCCCC-CCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY  277 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~-~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~  277 (489)
                                 ....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+....+.++..+.+..|..
T Consensus       170 -----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~  238 (476)
T 2y94_A          170 -----------EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQY  238 (476)
T ss_dssp             -----------CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTT
T ss_pred             -----------ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCcc
Confidence                       22345689999999999988775 689999999999999999999999999889999999999999999


Q ss_pred             CCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       278 ~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      +++++.+||.+||+.||++|||+     .++++||||+.
T Consensus       239 ~s~~~~~Li~~~L~~dP~~Rpt~-----~eil~hp~~~~  272 (476)
T 2y94_A          239 LNPSVISLLKHMLQVDPMKRATI-----KDIREHEWFKQ  272 (476)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSCCH-----HHHHTCHHHHT
T ss_pred             CCHHHHHHHHHHcCCCchhCcCH-----HHHHhCHHhhh
Confidence            99999999999999999999998     89999999975

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.5e-51  Score=409.98  Aligned_cols=253  Identities=28%  Similarity=0.474  Sum_probs=231.5

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      .++|++++.||+|+||.||+|++..+++.||+|++...    ......+.+|+.+++.++||||+++++++.+...+|+|
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   79 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence            57999999999999999999999999999999998643    23445678899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCC--CCCEEEeeccCccccCCccc
Q 011287          124 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA--DGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~--~g~ikL~DFG~a~~~~~~~~  200 (489)
                      ||||+||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.  ++.+||+|||+++.+...  
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~--  157 (321)
T 1tki_A           80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--  157 (321)
T ss_dssp             ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred             EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC--
Confidence            9999999999999875 47999999999999999999999999999999999999987  789999999999865432  


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCC----
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN----  276 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~----  276 (489)
                               ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+...++..+....+.++.    
T Consensus       158 ---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  228 (321)
T 1tki_A          158 ---------DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFK  228 (321)
T ss_dssp             ---------CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred             ---------CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhc
Confidence                     2234568999999999999988999999999999999999999999999999999999998888773    


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      .+++++++||.+||+.||.+|||+     .++++||||+.
T Consensus       229 ~~s~~~~~li~~~L~~dp~~Rpt~-----~e~l~hp~~~~  263 (321)
T 1tki_A          229 EISIEAMDFVDRLLVKERKSRMTA-----SEALQHPWLKQ  263 (321)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCH-----HHHHHSHHHHS
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCH-----HHHhcChhhcc
Confidence            689999999999999999999999     89999999975

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-51  Score=414.32  Aligned_cols=280  Identities=38%  Similarity=0.695  Sum_probs=240.8

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEc---CCCcEEEEEEeeccccc-chhHHHHHHHHHHHHHhC-CCCCccEEEEEE
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFIT-KENKTAYVKLERIVLDQL-DHPGVVRLFFTF  114 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~---~tg~~vAiK~~~k~~~~-~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~  114 (489)
                      ..+..++|++++.||+|+||.||+|++.   .+|+.||||++.+.... .......+.+|+.+++.+ +||||+++++++
T Consensus        49 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  128 (355)
T 1vzo_A           49 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF  128 (355)
T ss_dssp             CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred             ccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence            5667789999999999999999999994   58999999999765332 122334456689999998 699999999999


Q ss_pred             EcCCEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccc
Q 011287          115 QDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (489)
Q Consensus       115 ~~~~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~  194 (489)
                      .+...+|+||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.
T Consensus       129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          129 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            99999999999999999999999888899999999999999999999999999999999999999999999999999986


Q ss_pred             cCCccccccCCCCCCCCccceecCCcCCChhhhcC--CCCCCCCcchhhhHHHHHHhhCCCCCCCC----CHHHHHHHHH
Q 011287          195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS--SPATFGNDLWALGCTLYQMLSGTSPFKDT----SEWLIFQRII  268 (489)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~--~~~~~~sDiwSLG~ilyelltG~~PF~~~----~~~~~~~~i~  268 (489)
                      +....         ......++||+.|+|||++.+  ..++.++|||||||++|+|++|+.||...    ....+.+.+.
T Consensus       209 ~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  279 (355)
T 1vzo_A          209 FVADE---------TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL  279 (355)
T ss_dssp             CCGGG---------GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH
T ss_pred             cccCC---------CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh
Confidence            54321         122345689999999999986  34788999999999999999999999743    4456667777


Q ss_pred             hcCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCCCCC
Q 011287          269 ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP  328 (489)
Q Consensus       269 ~~~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~~~p  328 (489)
                      .....+|..++..+.+||.+||+.||++||++...+++++++||||..++|+.+..+..|
T Consensus       280 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~~~~~  339 (355)
T 1vzo_A          280 KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVP  339 (355)
T ss_dssp             HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred             ccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhhccCC
Confidence            888889999999999999999999999999765556799999999999999998766533

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.7e-51  Score=411.55  Aligned_cols=266  Identities=25%  Similarity=0.363  Sum_probs=218.8

Q ss_pred             CCCCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 011287           38 PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (489)
Q Consensus        38 ~~~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  117 (489)
                      .......++|++++.||+|+||+||+|++..+|+.||||++...... ......+.+|+.+++.++||||+++++++.+.
T Consensus        27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (329)
T 3gbz_A           27 APSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE-EGVPGTAIREVSLLKELQHRNIIELKSVIHHN  105 (329)
T ss_dssp             -----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEET
T ss_pred             CCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccc-cccchhHHHHHHHHHHcCCCCcceEEEEEecC
Confidence            33456689999999999999999999999999999999999765322 23345566899999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeC-----CCCCEEEeeccCc
Q 011287          118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT-----ADGHIKIADFGSV  192 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~-----~~g~ikL~DFG~a  192 (489)
                      ..+|+||||+++ +|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++     .++.+||+|||++
T Consensus       106 ~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          106 HRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             TEEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             CEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            999999999985 9999999988999999999999999999999999999999999999994     4556999999999


Q ss_pred             cccCCccccccCCCCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC
Q 011287          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD  271 (489)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~  271 (489)
                      +.+...          .......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+.......+....
T Consensus       185 ~~~~~~----------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  254 (329)
T 3gbz_A          185 RAFGIP----------IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVL  254 (329)
T ss_dssp             HHHC---------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             cccCCc----------ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHh
Confidence            865422          1223355789999999999875 48999999999999999999999999999888877775421


Q ss_pred             CC------------------C------------CCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 011287          272 IR------------------F------------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (489)
Q Consensus       272 ~~------------------~------------p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~  320 (489)
                      ..                  +            +..+++++.+||.+||+.||++|||+     +++++||||++++|+
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~f~~~~~~  328 (329)
T 3gbz_A          255 GLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISA-----KNALEHPYFSHNDFD  328 (329)
T ss_dssp             CCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCH-----HHHHTSGGGSSSCSC
T ss_pred             CCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCH-----HHHhCCcccCCCCCC
Confidence            10                  0            11268999999999999999999998     899999999999986

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.7e-50  Score=397.64  Aligned_cols=257  Identities=27%  Similarity=0.437  Sum_probs=219.9

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      +++|++++.||+|+||+||+|+++.+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+...+|+|
T Consensus         1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   79 (292)
T 3o0g_A            1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence            4789999999999999999999999999999999986643 334456677899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccc
Q 011287          124 LESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~  202 (489)
                      |||+.+ +|.+.+.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.....    
T Consensus        80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~----  154 (292)
T 3o0g_A           80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP----  154 (292)
T ss_dssp             EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC----
T ss_pred             EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc----
Confidence            999986 56565554 578999999999999999999999999999999999999999999999999999865422    


Q ss_pred             cCCCCCCCCccceecCCcCCChhhhcCCC-CCCCCcchhhhHHHHHHhhCCCC-CCCCCHHHHHHHHHhcC---------
Q 011287          203 LPNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSP-FKDTSEWLIFQRIIARD---------  271 (489)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~-~~~~sDiwSLG~ilyelltG~~P-F~~~~~~~~~~~i~~~~---------  271 (489)
                            .......+||+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+.......+....         
T Consensus       155 ------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~  228 (292)
T 3o0g_A          155 ------VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP  228 (292)
T ss_dssp             ------CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCT
T ss_pred             ------cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhh
Confidence                  12234568899999999997766 79999999999999999987666 66777777776665411         


Q ss_pred             --------------------CCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          272 --------------------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       272 --------------------~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                                          ...+..+++++++||++||+.||++|||+     +++++||||+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~f~~~  289 (292)
T 3o0g_A          229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA-----EEALQHPYFSDF  289 (292)
T ss_dssp             TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCH-----HHHHTSGGGTTC
T ss_pred             hhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCH-----HHHhcCcccccC
Confidence                                11223478999999999999999999998     899999999864

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=4.3e-50  Score=404.75  Aligned_cols=262  Identities=30%  Similarity=0.532  Sum_probs=241.5

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~l  120 (489)
                      ....++|.+++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  116 (335)
T 2owb_A           37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV  116 (335)
T ss_dssp             TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence            34567899999999999999999999999999999999887666666777888999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      |+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus       117 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-  195 (335)
T 2owb_A          117 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-  195 (335)
T ss_dssp             EEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred             EEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc-
Confidence            9999999999999999988889999999999999999999999999999999999999999999999999998654221 


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCH
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSD  280 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~  280 (489)
                               .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+....+..+....+.+|..+++
T Consensus       196 ---------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  266 (335)
T 2owb_A          196 ---------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINP  266 (335)
T ss_dssp             ---------CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCH
T ss_pred             ---------ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCH
Confidence                     22335679999999999999899999999999999999999999999999988888898889999999999


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       281 ~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                      ++.+||.+||+.||++||++     +++++||||...
T Consensus       267 ~~~~li~~~l~~dp~~Rps~-----~ell~~~~~~~~  298 (335)
T 2owb_A          267 VAASLIQKMLQTDPTARPTI-----NELLNDEFFTSG  298 (335)
T ss_dssp             HHHHHHHHHTCSSGGGSCCG-----GGGGGSHHHHTS
T ss_pred             HHHHHHHHHccCChhHCcCH-----HHHhcCccccCC
Confidence            99999999999999999999     889999999753

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1e-50  Score=417.46  Aligned_cols=270  Identities=23%  Similarity=0.360  Sum_probs=224.3

Q ss_pred             CCCCeEEeeEEeee--CceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEE
Q 011287           43 SIQDFELGKIYGVG--SYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (489)
Q Consensus        43 ~~~dy~~~~~LG~G--~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~l  120 (489)
                      ..++|++++.||+|  +||.||+|+++.+|+.||||++...... ......+.+|+.+++.++||||++++++|.+...+
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  101 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL  101 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence            45789999999999  9999999999999999999999876433 34567788899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          121 YMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      |+|||||++|+|.+++...  +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||.+......
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~  181 (389)
T 3gni_B          102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH  181 (389)
T ss_dssp             EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred             EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence            9999999999999999876  67999999999999999999999999999999999999999999999999998755332


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcC--CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC-----
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNS--SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----  271 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~--~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~-----  271 (489)
                      .....   .........+||+.|+|||++.+  ..++.++|||||||++|+|++|++||.+.+.......+....     
T Consensus       182 ~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  258 (389)
T 3gni_B          182 GQRQR---VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL  258 (389)
T ss_dssp             TEECS---CBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred             ccccc---ccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence            21100   01122334589999999999987  578999999999999999999999998866555444333221     


Q ss_pred             -----------------------------------------CCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          272 -----------------------------------------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       272 -----------------------------------------~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                                                               ..++..+++++.+||.+||+.||++|||+     +++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta-----~ell~  333 (389)
T 3gni_B          259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSA-----STLLN  333 (389)
T ss_dssp             -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCH-----HHHTT
T ss_pred             cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCH-----HHHhc
Confidence                                                     12455689999999999999999999998     89999


Q ss_pred             CCCCCCCCccc
Q 011287          311 HPFFKGIDWKN  321 (489)
Q Consensus       311 hpff~~i~~~~  321 (489)
                      ||||+++.+..
T Consensus       334 hp~f~~~~~~~  344 (389)
T 3gni_B          334 HSFFKQIKRRA  344 (389)
T ss_dssp             SGGGGGC---C
T ss_pred             CHHHHHHhhcc
Confidence            99999887753

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.2e-50  Score=411.78  Aligned_cols=262  Identities=32%  Similarity=0.498  Sum_probs=227.8

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccc--hhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK--ENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  119 (489)
                      .-.++|++++.||+|+||.||+|+++.+|+.||||++.+.....  ......+.+|+.+++.++||||+++++++.+...
T Consensus        21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  100 (351)
T 3c0i_A           21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM  100 (351)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            33468999999999999999999999999999999997543221  1134668889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCC---EEEeeccCc
Q 011287          120 LYMALESCEGGELFDQITSK----GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH---IKIADFGSV  192 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~----~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~---ikL~DFG~a  192 (489)
                      +|+|||||+||+|.+.+.+.    ..+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++
T Consensus       101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            99999999999998887643    35899999999999999999999999999999999999987654   999999999


Q ss_pred             cccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC
Q 011287          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI  272 (489)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~  272 (489)
                      .......          ......+||+.|+|||++.+..++.++||||||||+|+|++|.+||.+. ....+..+....+
T Consensus       181 ~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~  249 (351)
T 3c0i_A          181 IQLGESG----------LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKY  249 (351)
T ss_dssp             EECCTTS----------CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCC
T ss_pred             eEecCCC----------eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCC
Confidence            8664321          1233568999999999999999999999999999999999999999885 4566777777776


Q ss_pred             CCC----CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 011287          273 RFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (489)
Q Consensus       273 ~~p----~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~  319 (489)
                      .++    ..+++++++||.+||+.||++||++     .++++||||++.++
T Consensus       250 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~-----~e~l~hp~~~~~~~  295 (351)
T 3c0i_A          250 KMNPRQWSHISESAKDLVRRMLMLDPAERITV-----YEALNHPWLKERDR  295 (351)
T ss_dssp             CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSHHHHTHHH
T ss_pred             CCCccccccCCHHHHHHHHHHCCCChhHCcCH-----HHHhcChhhcCCcc
Confidence            665    4689999999999999999999998     89999999987544

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=5.4e-50  Score=401.32  Aligned_cols=264  Identities=29%  Similarity=0.509  Sum_probs=237.9

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE---NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  119 (489)
                      ..++|++++.||+|+||.||+|++..+|+.||+|++.+......   .....+.+|+.+++.++||||+++++++.+...
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD   89 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            35679999999999999999999999999999999987543322   135668889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCC----CEEEeeccCcccc
Q 011287          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG----HIKIADFGSVKPM  195 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g----~ikL~DFG~a~~~  195 (489)
                      +|+||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++    +++|+|||++...
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~  169 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI  169 (321)
T ss_dssp             EEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred             EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence            999999999999999999888899999999999999999999999999999999999999888    8999999999865


Q ss_pred             CCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCC
Q 011287          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP  275 (489)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p  275 (489)
                      ...           .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+......++
T Consensus       170 ~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  238 (321)
T 2a2a_A          170 EDG-----------VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD  238 (321)
T ss_dssp             CTT-----------CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred             Ccc-----------ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccC
Confidence            432           122355799999999999999999999999999999999999999999999999888888777665


Q ss_pred             ----CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccc
Q 011287          276 ----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI  322 (489)
Q Consensus       276 ----~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~  322 (489)
                          ..+++.+.+||.+||+.||++|||+     .++++||||.+++|...
T Consensus       239 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~e~l~hp~~~~~~~~~~  284 (321)
T 2a2a_A          239 EEFFSHTSELAKDFIRKLLVKETRKRLTI-----QEALRHPWITPVDNQQA  284 (321)
T ss_dssp             HHHHTTCCHHHHHHHHTTSCSSTTTSCCH-----HHHHHSTTTSCSSHHHH
T ss_pred             hhhhcccCHHHHHHHHHHcCCChhhCcCH-----HHHhcCccccCCCcccc
Confidence                4689999999999999999999998     89999999999888654

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.4e-50  Score=402.59  Aligned_cols=261  Identities=26%  Similarity=0.401  Sum_probs=219.5

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ly  121 (489)
                      -..++|++++.||+|+||+||+|++. +|+.||+|++..... .......+.+|+.+++.++||||+++++++.+...+|
T Consensus        18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   95 (311)
T 3niz_A           18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLT   95 (311)
T ss_dssp             CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEE
T ss_pred             chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEE
Confidence            34689999999999999999999995 599999999975532 2334566778999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          122 MALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      +||||+++ +|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... 
T Consensus        96 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-  173 (311)
T 3niz_A           96 LVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV-  173 (311)
T ss_dssp             EEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-
T ss_pred             EEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc-
Confidence            99999985 888888765 459999999999999999999999999999999999999999999999999998654321 


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC-------
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-------  272 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~-------  272 (489)
                               ......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+.....       
T Consensus       174 ---------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  244 (311)
T 3niz_A          174 ---------RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREW  244 (311)
T ss_dssp             ---------C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTS
T ss_pred             ---------ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHh
Confidence                     22234578999999999976 5689999999999999999999999998877766666543110       


Q ss_pred             -----------------------CCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 011287          273 -----------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (489)
Q Consensus       273 -----------------------~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~  320 (489)
                                             .+.+.+++++.+||.+||+.||++|||+     +++++||||++++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~f~~~~~~  310 (311)
T 3niz_A          245 PQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISA-----RDAMNHPYFKDLDPQ  310 (311)
T ss_dssp             GGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCH-----HHHHTSGGGTTSCTT
T ss_pred             hhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCH-----HHHhcCcccccCCcc
Confidence                                   0123468899999999999999999999     899999999998753

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.8e-50  Score=412.48  Aligned_cols=267  Identities=30%  Similarity=0.494  Sum_probs=213.6

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCC--E
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTF--S  119 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~--~  119 (489)
                      ..++|++++.||+|+||.||+|.+..+|+.||||++.+... .......+.+|+.+++.+. ||||++++++|....  .
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQ-NSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--C-CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            35799999999999999999999999999999999976533 3344556778999999997 999999999997544  7


Q ss_pred             EEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcc
Q 011287          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      +|+|||||+ |+|..++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++.++++||+|||+|+.+....
T Consensus        86 ~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  163 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR  163 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred             EEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence            999999997 599998876 579999999999999999999999999999999999999999999999999998764321


Q ss_pred             cccc-----------CCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHH
Q 011287          200 ITVL-----------PNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI  267 (489)
Q Consensus       200 ~~~~-----------~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i  267 (489)
                      ....           ...........++||+.|+|||++.+ ..++.++||||||||+|+|++|++||.+.+....+..|
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i  243 (388)
T 3oz6_A          164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI  243 (388)
T ss_dssp             CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            1000           00011223456799999999999976 67899999999999999999999999999998888777


Q ss_pred             HhcCCCC------------------------------------------------CCCCCHHHHHHHHHhhccCCCCCCC
Q 011287          268 IARDIRF------------------------------------------------PNYFSDAARDLIDRLLDVDPSGRPG  299 (489)
Q Consensus       268 ~~~~~~~------------------------------------------------p~~~~~~~~~Li~~~L~~dP~~R~t  299 (489)
                      ... ..+                                                +..+++++.+||.+||+.||++|||
T Consensus       244 ~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t  322 (388)
T 3oz6_A          244 IGV-IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS  322 (388)
T ss_dssp             HHH-HCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred             HHh-cCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence            531 111                                                1257899999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCCC
Q 011287          300 AGPGGYAVLKMHPFFKGID  318 (489)
Q Consensus       300 ~~~~~~~~l~~hpff~~i~  318 (489)
                      +     +++++||||+.+.
T Consensus       323 ~-----~e~l~Hp~~~~~~  336 (388)
T 3oz6_A          323 A-----NDALKHPFVSIFH  336 (388)
T ss_dssp             H-----HHHTTSTTTTTTC
T ss_pred             H-----HHHhCCHHHHHhc
Confidence            8     8999999998654

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4.1e-50  Score=407.70  Aligned_cols=257  Identities=35%  Similarity=0.537  Sum_probs=213.3

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ly  121 (489)
                      ...++|++.+.||+|+||.||+|++..+++.||||++.+..     ....+.+|+.+++.++||||+++++++.+...+|
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  124 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS  124 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence            34577999999999999999999999999999999997542     2345778999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCC---CCCEEEeeccCccccCCc
Q 011287          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~---~g~ikL~DFG~a~~~~~~  198 (489)
                      +||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++.....
T Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  204 (349)
T 2w4o_A          125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ  204 (349)
T ss_dssp             EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence            99999999999999998888999999999999999999999999999999999999975   889999999999865322


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHH-HHHHHHHhcCCCCC--
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQRIIARDIRFP--  275 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~-~~~~~i~~~~~~~p--  275 (489)
                                 ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.... ..+..+......++  
T Consensus       205 -----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~  273 (349)
T 2w4o_A          205 -----------VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISP  273 (349)
T ss_dssp             -------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTT
T ss_pred             -----------cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCc
Confidence                       1233568999999999999999999999999999999999999999776544 46777777665544  


Q ss_pred             --CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 011287          276 --NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (489)
Q Consensus       276 --~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~  319 (489)
                        ..++.++++||++||+.||++||++     .++++||||.+..+
T Consensus       274 ~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~e~l~hp~~~~~~~  314 (349)
T 2w4o_A          274 WWDEVSLNAKDLVRKLIVLDPKKRLTT-----FQALQHPWVTGKAA  314 (349)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCH-----HHHHHSTTTTSTTC
T ss_pred             hhhhCCHHHHHHHHHHccCChhhCcCH-----HHHhcCcccCCCcc
Confidence              4689999999999999999999999     89999999987543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.8e-49  Score=391.91  Aligned_cols=261  Identities=30%  Similarity=0.535  Sum_probs=240.6

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ly  121 (489)
                      ...++|.+++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+|
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (294)
T 2rku_A           12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF   91 (294)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence            45689999999999999999999999999999999998776666666778889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccc
Q 011287          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~  201 (489)
                      +||||+++++|.+++...+.+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.......  
T Consensus        92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--  169 (294)
T 2rku_A           92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--  169 (294)
T ss_dssp             EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc--
Confidence            999999999999999988889999999999999999999999999999999999999999999999999998654221  


Q ss_pred             ccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHH
Q 011287          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDA  281 (489)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~  281 (489)
                              .......||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+..+.+..+......+|..+++.
T Consensus       170 --------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (294)
T 2rku_A          170 --------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPV  241 (294)
T ss_dssp             --------CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHH
T ss_pred             --------cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHH
Confidence                    223356799999999999998899999999999999999999999999999888888988889999999999


Q ss_pred             HHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       282 ~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                      +.+||.+||+.||++||++     +++++||||...
T Consensus       242 ~~~li~~~l~~~p~~Rps~-----~~ll~~~~~~~~  272 (294)
T 2rku_A          242 AASLIQKMLQTDPTARPTI-----NELLNDEFFTSG  272 (294)
T ss_dssp             HHHHHHHHTCSSGGGSCCG-----GGGGGSHHHHTS
T ss_pred             HHHHHHHHcccChhhCcCH-----HHHhhChheecC
Confidence            9999999999999999999     889999999754

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=8.3e-51  Score=404.93  Aligned_cols=243  Identities=22%  Similarity=0.292  Sum_probs=191.7

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC----EE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF----SL  120 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----~l  120 (489)
                      .+|.+.+.||+|+||+||+|++  +|+.||||++...    .......+.|+..+..++|||||++++++.+..    .+
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~----~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~   76 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc----chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence            5799999999999999999987  6899999998653    222223344666667889999999999997653    68


Q ss_pred             EEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcEeeccCCCCeeeCCCCCEEEeeccCc
Q 011287          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM--------GLIHRDIKPENLLLTADGHIKIADFGSV  192 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~--------gIiHrDLKpeNILl~~~g~ikL~DFG~a  192 (489)
                      |+|||||++|+|.+++.+. .++++.+..++.|++.||+|||++        ||+||||||+||||+.+|++||+|||+|
T Consensus        77 ~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            9999999999999999874 699999999999999999999987        9999999999999999999999999999


Q ss_pred             cccCCccccccCCCCCCCCccceecCCcCCChhhhcCC------CCCCCCcchhhhHHHHHHhhCCCCCCCC--------
Q 011287          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS------PATFGNDLWALGCTLYQMLSGTSPFKDT--------  258 (489)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~------~~~~~sDiwSLG~ilyelltG~~PF~~~--------  258 (489)
                      +........      ......+.+||+.|||||++.+.      .++.++|||||||++|||+||.+||...        
T Consensus       156 ~~~~~~~~~------~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~  229 (303)
T 3hmm_A          156 VRHDSATDT------IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY  229 (303)
T ss_dssp             EEEETTTTE------ESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred             ccccCCCCc------eeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccch
Confidence            876443211      11223456899999999999765      3567899999999999999998776422        


Q ss_pred             -------CHHHHHHHHHhcC--CCCCCCC-----CHHHHHHHHHhhccCCCCCCCC
Q 011287          259 -------SEWLIFQRIIARD--IRFPNYF-----SDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       259 -------~~~~~~~~i~~~~--~~~p~~~-----~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                             ....+...+....  +.+|...     +..+.+|+.+||+.||++|||+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~  285 (303)
T 3hmm_A          230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA  285 (303)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCH
T ss_pred             hcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCH
Confidence                   2233344444332  3344432     3468899999999999999998

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=6.9e-50  Score=420.30  Aligned_cols=274  Identities=24%  Similarity=0.329  Sum_probs=208.8

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc-----CC
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD-----TF  118 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----~~  118 (489)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+.+|+.++||||+++++++..     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            478999999999999999999999999999999997643 233445668889999999999999999999943     35


Q ss_pred             EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      .+|+||||+. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++++||+|||+|+.....
T Consensus       131 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  209 (458)
T 3rp9_A          131 ELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP  209 (458)
T ss_dssp             CEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred             eEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence            7999999985 699999998888999999999999999999999999999999999999999999999999999876533


Q ss_pred             cccccCC-----------------CCCCCCccceecCCcCCChhhh-cCCCCCCCCcchhhhHHHHHHhh----------
Q 011287          199 RITVLPN-----------------AASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLS----------  250 (489)
Q Consensus       199 ~~~~~~~-----------------~~~~~~~~~~~gt~~Y~aPE~l-~~~~~~~~sDiwSLG~ilyellt----------  250 (489)
                      .......                 ..........+||+.|+|||++ ....++.++||||||||+|+|++          
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~  289 (458)
T 3rp9_A          210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA  289 (458)
T ss_dssp             TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred             cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence            2110000                 0001234567899999999986 56679999999999999999998          


Q ss_pred             -CCCCCCCCCH--------------------HHHHHHHHhcC-------------------------------CCCCCCC
Q 011287          251 -GTSPFKDTSE--------------------WLIFQRIIARD-------------------------------IRFPNYF  278 (489)
Q Consensus       251 -G~~PF~~~~~--------------------~~~~~~i~~~~-------------------------------~~~p~~~  278 (489)
                       |+++|.+.+.                    ...+..|....                               ....+..
T Consensus       290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (458)
T 3rp9_A          290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS  369 (458)
T ss_dssp             GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred             cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence             7888877542                    22222222100                               0011346


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 011287          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (489)
Q Consensus       279 ~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~  324 (489)
                      ++++.+||++||+.||++|||+     +++++||||++++|.....
T Consensus       370 s~~~~dLl~~mL~~dP~~R~t~-----~e~L~Hp~f~~~~~~~~e~  410 (458)
T 3rp9_A          370 SADAIHLLKRMLVFNPNKRITI-----NECLAHPFFKEVRIAEVET  410 (458)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCH-----HHHHHSGGGTTTCCGGGCC
T ss_pred             CHHHHHHHHHHhccCccccCCH-----HHHhcCHhhhhcCCCccCC
Confidence            8999999999999999999998     8999999999999987654

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2e-50  Score=409.05  Aligned_cols=256  Identities=34%  Similarity=0.572  Sum_probs=225.5

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~lyl  122 (489)
                      .++|++++.||+|+||.||+|+++.+|+.||+|++.+....       ..+|+.++.++ +||||++++++|.+...+|+
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l   93 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYV   93 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence            56899999999999999999999999999999999775322       23477777776 79999999999999999999


Q ss_pred             EEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCC-C---CEEEeeccCccccCCc
Q 011287          123 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-G---HIKIADFGSVKPMQDS  198 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~-g---~ikL~DFG~a~~~~~~  198 (489)
                      |||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+..+ +   .+||+|||+++.+...
T Consensus        94 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~  173 (342)
T 2qr7_A           94 VTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE  173 (342)
T ss_dssp             EECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence            99999999999999998899999999999999999999999999999999999998543 3   5999999999865432


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCC---CCHHHHHHHHHhcCCCCC
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD---TSEWLIFQRIIARDIRFP  275 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~---~~~~~~~~~i~~~~~~~p  275 (489)
                                .....+.+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+   .+..+++..+..+.+.++
T Consensus       174 ----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~  243 (342)
T 2qr7_A          174 ----------NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLS  243 (342)
T ss_dssp             ----------TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCC
T ss_pred             ----------CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccC
Confidence                      1233466899999999999888889999999999999999999999986   466778888888877765


Q ss_pred             ----CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCccccc
Q 011287          276 ----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR  323 (489)
Q Consensus       276 ----~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~  323 (489)
                          ..+++++++||++||+.||++||++     +++++||||.  +|+.+.
T Consensus       244 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~-----~~il~hp~~~--~~~~~~  288 (342)
T 2qr7_A          244 GGYWNSVSDTAKDLVSKMLHVDPHQRLTA-----ALVLRHPWIV--HWDQLP  288 (342)
T ss_dssp             STTTTTSCHHHHHHHHHHTCSSTTTSCCH-----HHHTTSHHHH--TGGGSC
T ss_pred             ccccccCCHHHHHHHHHHCCCChhHCcCH-----HHHhcCCeec--Cccccc
Confidence                4689999999999999999999998     8999999995  576654

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.8e-50  Score=403.05  Aligned_cols=260  Identities=24%  Similarity=0.393  Sum_probs=209.5

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lyl  122 (489)
                      +.++|++++.||+|+||.||+|+++.+|+.||+|++....  .......+.+|+.+++.++||||+++++++.+...+|+
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   80 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTL   80 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEE
Confidence            3578999999999999999999999999999999997653  22233457789999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccC
Q 011287          123 ALESCEGGELFDQITSK------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~  196 (489)
                      ||||++ |+|.+++...      ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus        81 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           81 VFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             EEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             EEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            999998 5999988754      359999999999999999999999999999999999999999999999999998654


Q ss_pred             CccccccCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC----
Q 011287          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD----  271 (489)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~----  271 (489)
                      ...          ......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+....    
T Consensus       160 ~~~----------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  229 (317)
T 2pmi_A          160 IPV----------NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN  229 (317)
T ss_dssp             SCC----------CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred             CCc----------ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            221          12235578999999999976 468999999999999999999999999999888777765421    


Q ss_pred             ------------------------------CCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 011287          272 ------------------------------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (489)
Q Consensus       272 ------------------------------~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~  320 (489)
                                                    ...+..++.++.+||.+||+.||++|||+     +++++||||++..+.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~-----~e~l~hp~f~~~~~~  303 (317)
T 2pmi_A          230 ESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSA-----KQALHHPWFAEYYHH  303 (317)
T ss_dssp             TTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCH-----HHHTTSGGGGGGCC-
T ss_pred             hhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCH-----HHHhCChhhhcccch
Confidence                                          01123578899999999999999999999     899999999977654

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3e-49  Score=387.85  Aligned_cols=260  Identities=32%  Similarity=0.568  Sum_probs=234.5

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            58999999999999999999999999999999999766443 33446678899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCC---EEEeeccCccccCCccc
Q 011287          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRI  200 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~---ikL~DFG~a~~~~~~~~  200 (489)
                      |||+++++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.   +||+|||++......  
T Consensus        84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~--  161 (284)
T 3kk8_A           84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--  161 (284)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS--
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC--
Confidence            999999999999988888999999999999999999999999999999999999987665   999999999765432  


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCC----C
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----N  276 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p----~  276 (489)
                               .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......+|    .
T Consensus       162 ---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T 3kk8_A          162 ---------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWD  232 (284)
T ss_dssp             ---------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTT
T ss_pred             ---------ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhc
Confidence                     122346799999999999999999999999999999999999999999999999988888777666    3


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~  320 (489)
                      .+++++.+||.+||+.||++||++     +++++||||.+..+.
T Consensus       233 ~~~~~~~~li~~~l~~dp~~Rps~-----~~~l~h~~~~~~~~~  271 (284)
T 3kk8_A          233 TVTPEAKSLIDSMLTVNPKKRITA-----DQALKVPWICNRERV  271 (284)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCH-----HHHTTSHHHHSCCCG
T ss_pred             ccCHHHHHHHHHHcccChhhCCCH-----HHHhcCccccCChhH
Confidence            689999999999999999999999     899999999876554

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-49  Score=409.82  Aligned_cols=257  Identities=30%  Similarity=0.529  Sum_probs=230.5

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      .++|++++.||+|+||.||+|+++.+|+.||+|++....   ......+.+|+.+|+.++||||++++++|.+...+|+|
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  126 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  126 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence            468999999999999999999999999999999997652   22345678899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCC--CCCEEEeeccCccccCCccc
Q 011287          124 LESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA--DGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~--~g~ikL~DFG~a~~~~~~~~  200 (489)
                      ||||.||+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.  ++.+||+|||+++.+...  
T Consensus       127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~--  204 (387)
T 1kob_A          127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--  204 (387)
T ss_dssp             EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred             EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC--
Confidence            99999999999997653 6999999999999999999999999999999999999974  478999999999865432  


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCC----C
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----N  276 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p----~  276 (489)
                               ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+......++    .
T Consensus       205 ---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  275 (387)
T 1kob_A          205 ---------EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS  275 (387)
T ss_dssp             ---------SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTT
T ss_pred             ---------cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccc
Confidence                     223356899999999999999999999999999999999999999999999999998888776655    3


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~  319 (489)
                      .+++++++||.+||+.||++||++     .++++||||++..+
T Consensus       276 ~~s~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~~~~~~~  313 (387)
T 1kob_A          276 SVSPEAKDFIKNLLQKEPRKRLTV-----HDALEHPWLKGDHS  313 (387)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCH-----HHHHTSTTTSSCCT
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCH-----HHHhhCccccCCcc
Confidence            579999999999999999999998     89999999987543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.9e-50  Score=394.12  Aligned_cols=259  Identities=35%  Similarity=0.654  Sum_probs=208.2

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lyl  122 (489)
                      .+++|++++.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+...+|+
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL   88 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence            36799999999999999999999999999999999976544444445678889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccc
Q 011287          123 ALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~  201 (489)
                      ||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.+++++|+|||++.......  
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~--  166 (278)
T 3cok_A           89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH--  166 (278)
T ss_dssp             EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred             EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC--
Confidence            99999999999999875 679999999999999999999999999999999999999999999999999998654221  


Q ss_pred             ccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHH
Q 011287          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDA  281 (489)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~  281 (489)
                              .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+....+.+|..++.+
T Consensus       167 --------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (278)
T 3cok_A          167 --------EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIE  238 (278)
T ss_dssp             ---------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHH
T ss_pred             --------CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHH
Confidence                    122356799999999999998899999999999999999999999998776666677777777888999999


Q ss_pred             HHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       282 ~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      +.+||.+||+.||++||++     +++++||||..
T Consensus       239 ~~~li~~~l~~dp~~Rps~-----~~~l~h~~~~~  268 (278)
T 3cok_A          239 AKDLIHQLLRRNPADRLSL-----SSVLDHPFMSR  268 (278)
T ss_dssp             HHHHHHHHSCSSGGGSCCH-----HHHTTSTTTC-
T ss_pred             HHHHHHHHcccCHhhCCCH-----HHHhcCccccC
Confidence            9999999999999999998     89999999975

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=4.5e-50  Score=402.97  Aligned_cols=259  Identities=29%  Similarity=0.470  Sum_probs=221.0

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      .++|++++.||+|+||.||+|++..+++.||+|++......  .....+.+|+.+++.++||||+++++++.+....|+|
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   83 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            58999999999999999999999999999999999754322  2235577899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      ||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+....    
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~----  159 (323)
T 3tki_A           84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN----  159 (323)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT----
T ss_pred             EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCC----
Confidence            9999999999999888889999999999999999999999999999999999999999999999999998654321    


Q ss_pred             CCCCCCCCccceecCCcCCChhhhcCCCC-CCCCcchhhhHHHHHHhhCCCCCCCCCHH-HHHHHHHhcCCCCC--CCCC
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQRIIARDIRFP--NYFS  279 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~-~~~sDiwSLG~ilyelltG~~PF~~~~~~-~~~~~i~~~~~~~p--~~~~  279 (489)
                          ........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.. ..+..........+  ..++
T Consensus       160 ----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (323)
T 3tki_A          160 ----RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID  235 (323)
T ss_dssp             ----EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSC
T ss_pred             ----cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCC
Confidence                1122345689999999999987765 77899999999999999999999876553 23333333333222  5689


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       280 ~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                      +++.+||.+||+.||++|||+     .++++||||...
T Consensus       236 ~~~~~li~~~L~~dP~~R~t~-----~eil~h~~~~~~  268 (323)
T 3tki_A          236 SAPLALLHKILVENPSARITI-----PDIKKDRWYNKP  268 (323)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCH-----HHHTTCTTTTCC
T ss_pred             HHHHHHHHHHccCChhhCcCH-----HHHhhChhhccc
Confidence            999999999999999999998     899999999864

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2e-50  Score=427.37  Aligned_cols=261  Identities=33%  Similarity=0.547  Sum_probs=236.5

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lyl  122 (489)
                      ..++|++++.||+|+||.||+|+++.+|+.||||++.+...........+.+|+.+++.++||||++++++|.+...+|+
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            34789999999999999999999999999999999987766555566778899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeee---CCCCCEEEeeccCccccCCcc
Q 011287          123 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL---TADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl---~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      |||||.+|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.+... 
T Consensus       104 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-  182 (484)
T 3nyv_A          104 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-  182 (484)
T ss_dssp             EECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC-
T ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc-
Confidence            99999999999999988899999999999999999999999999999999999999   56789999999999865432 


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCC----
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----  275 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p----  275 (489)
                                ......+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+...++..+....+.++    
T Consensus       183 ----------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  251 (484)
T 3nyv_A          183 ----------KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW  251 (484)
T ss_dssp             ----------CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGG
T ss_pred             ----------cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence                      22345689999999999976 689999999999999999999999999999999999998877665    


Q ss_pred             CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 011287          276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (489)
Q Consensus       276 ~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~  320 (489)
                      ..+++++++||.+||+.||++|||+     .++++||||+...++
T Consensus       252 ~~~s~~~~~li~~~L~~dp~~R~s~-----~e~l~h~~~~~~~~~  291 (484)
T 3nyv_A          252 KKVSESAKDLIRKMLTYVPSMRISA-----RDALDHEWIQTYTKE  291 (484)
T ss_dssp             GGSCHHHHHHHHHHTCSSGGGSCCH-----HHHHTSHHHHHHTC-
T ss_pred             ccCCHHHHHHHHHHCCCChhHCcCH-----HHHhhChhhcccccc
Confidence            4689999999999999999999999     899999999865543

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.9e-49  Score=394.67  Aligned_cols=262  Identities=28%  Similarity=0.400  Sum_probs=220.1

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      +++|++++.||+|+||.||+|++..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+....|+|
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV   80 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence            5789999999999999999999999999999999866532 233455677899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      |||+++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......    
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----  156 (311)
T 4agu_A           81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS----  156 (311)
T ss_dssp             EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc----
Confidence            9999999999998888889999999999999999999999999999999999999999999999999998654321    


Q ss_pred             CCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC-----------
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----------  271 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~-----------  271 (489)
                            ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+....           
T Consensus       157 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (311)
T 4agu_A          157 ------DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVF  230 (311)
T ss_dssp             ---------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred             ------cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccc
Confidence                  22235579999999999976 568999999999999999999999999988877665554310           


Q ss_pred             --------CCCC------------CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCccc
Q 011287          272 --------IRFP------------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  321 (489)
Q Consensus       272 --------~~~p------------~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~  321 (489)
                              ...|            ..+++++.+||.+||+.||++|||+     +++++||||+++.+..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~f~~~~~~~  295 (311)
T 4agu_A          231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTC-----EQLLHHPYFENIREIE  295 (311)
T ss_dssp             HTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCH-----HHHHTSGGGTTCC---
T ss_pred             ccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCH-----HHHhcChHHHhccCHH
Confidence                    1111            3578899999999999999999998     8999999999987754

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.4e-50  Score=396.69  Aligned_cols=258  Identities=36%  Similarity=0.624  Sum_probs=221.7

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccch-----------------------hHHHHHHHHHHH
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE-----------------------NKTAYVKLERIV   98 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~-----------------------~~~~~~~~E~~i   98 (489)
                      ...++|++.+.||+|+||.||+|++..+|+.||||++.+......                       .....+.+|+.+
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            457899999999999999999999999999999999976543221                       123557889999


Q ss_pred             HHhCCCCCccEEEEEEEc--CCEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCe
Q 011287           99 LDQLDHPGVVRLFFTFQD--TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENL  176 (489)
Q Consensus        99 l~~l~hpnIv~l~~~~~~--~~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNI  176 (489)
                      ++.++||||+++++++.+  ...+|+||||+++++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus        90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni  168 (298)
T 2zv2_A           90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL  168 (298)
T ss_dssp             HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence            999999999999999987  678999999999999988654 45799999999999999999999999999999999999


Q ss_pred             eeCCCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCC---CCCCCcchhhhHHHHHHhhCCC
Q 011287          177 LLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP---ATFGNDLWALGCTLYQMLSGTS  253 (489)
Q Consensus       177 Ll~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~---~~~~sDiwSLG~ilyelltG~~  253 (489)
                      |++.+|++||+|||+++.+....          ......+||+.|+|||++.+..   ++.++|||||||++|+|++|+.
T Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~  238 (298)
T 2zv2_A          169 LVGEDGHIKIADFGVSNEFKGSD----------ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC  238 (298)
T ss_dssp             EECTTSCEEECCCTTCEECSSSS----------CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred             EECCCCCEEEecCCCcccccccc----------ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence            99999999999999998654321          1223458999999999998765   3778999999999999999999


Q ss_pred             CCCCCCHHHHHHHHHhcCCCCCC--CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 011287          254 PFKDTSEWLIFQRIIARDIRFPN--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (489)
Q Consensus       254 PF~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~  315 (489)
                      ||.+.+.......+......+|.  .+++++.+||.+||+.||++||++     .++++||||+
T Consensus       239 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~-----~e~l~hp~~~  297 (298)
T 2zv2_A          239 PFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVV-----PEIKLHPWVT  297 (298)
T ss_dssp             SSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCH-----HHHTTCHHHH
T ss_pred             CCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCH-----HHHhcCcccc
Confidence            99999888888888877776664  689999999999999999999998     8999999985

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.3e-49  Score=392.23  Aligned_cols=256  Identities=27%  Similarity=0.434  Sum_probs=217.1

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      +++|++++.||+|+||.||+|++ .+|+.||+|++...... ......+.+|+.+++.++||||+++++++.+...+|+|
T Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (288)
T 1ob3_A            1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (288)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence            47899999999999999999999 67999999999765322 22335567899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccc
Q 011287          124 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~  202 (489)
                      |||+.+ +|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......   
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---  154 (288)
T 1ob3_A           79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV---  154 (288)
T ss_dssp             EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc---
Confidence            999986 999988864 679999999999999999999999999999999999999999999999999997653221   


Q ss_pred             cCCCCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC----------
Q 011287          203 LPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD----------  271 (489)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~----------  271 (489)
                             ......+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+.......+....          
T Consensus       155 -------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (288)
T 1ob3_A          155 -------RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN  227 (288)
T ss_dssp             --------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             -------cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchh
Confidence                   122345789999999999764 58999999999999999999999999998888777665410          


Q ss_pred             -------------------CCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          272 -------------------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       272 -------------------~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                                         ..++..+++++.+||.+||+.||++|||+     +++++||||++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~e~l~hp~f~~~  287 (288)
T 1ob3_A          228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA-----KQALEHAYFKEN  287 (288)
T ss_dssp             GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSGGGGC-
T ss_pred             hhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCH-----HHHhcCcchhhc
Confidence                               01224578999999999999999999999     899999999864

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.2e-49  Score=406.09  Aligned_cols=255  Identities=33%  Similarity=0.510  Sum_probs=215.1

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ly  121 (489)
                      ...++|++++.||+|+||.||+|+++.+|+.||+|++.+.....    ..+.+|+.+++.++||||+++++++.+...+|
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   92 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLA   92 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence            45689999999999999999999999999999999997653322    44678999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCC--EEEeeccCccccCCcc
Q 011287          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH--IKIADFGSVKPMQDSR  199 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~--ikL~DFG~a~~~~~~~  199 (489)
                      +|||||++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++....  
T Consensus        93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~--  170 (361)
T 3uc3_A           93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--  170 (361)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc--
Confidence            99999999999999988889999999999999999999999999999999999999987765  99999999874321  


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCCCCCCC-CcchhhhHHHHHHhhCCCCCCCCCH----HHHHHHHHhcCCCC
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFG-NDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRIIARDIRF  274 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~-sDiwSLG~ilyelltG~~PF~~~~~----~~~~~~i~~~~~~~  274 (489)
                               .......+||+.|+|||++.+..++.+ +|||||||++|+|++|++||.+.+.    ....+.+......+
T Consensus       171 ---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  241 (361)
T 3uc3_A          171 ---------HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSI  241 (361)
T ss_dssp             -------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCC
T ss_pred             ---------cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCC
Confidence                     122345689999999999988777655 8999999999999999999987544    45666677777777


Q ss_pred             CC--CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          275 PN--YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       275 p~--~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      |.  .+++++++||.+||+.||++|||+     .++++||||..
T Consensus       242 ~~~~~~s~~~~~li~~~L~~dP~~Rps~-----~ell~hp~f~~  280 (361)
T 3uc3_A          242 PDDIRISPECCHLISRIFVADPATRISI-----PEIKTHSWFLK  280 (361)
T ss_dssp             CTTSCCCHHHHHHHHHHSCSCTTTSCCH-----HHHHTSHHHHT
T ss_pred             CCcCCCCHHHHHHHHHHccCChhHCcCH-----HHHHhCcchhc
Confidence            76  579999999999999999999998     89999999953

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.5e-49  Score=396.27  Aligned_cols=266  Identities=32%  Similarity=0.493  Sum_probs=219.0

Q ss_pred             CCCeEEe-eEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCEEE
Q 011287           44 IQDFELG-KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        44 ~~dy~~~-~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~ly  121 (489)
                      .+.|++. +.||+|+||.||+|++..+++.||||++.+..   ......+.+|+.++.++ +||||+++++++.+...+|
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~   87 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY   87 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence            4689995 78999999999999999999999999997652   23345677899999885 7999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCC---EEEeeccCccccCCc
Q 011287          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH---IKIADFGSVKPMQDS  198 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~---ikL~DFG~a~~~~~~  198 (489)
                      +||||+++|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++......
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  167 (316)
T 2ac3_A           88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN  167 (316)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred             EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence            99999999999999998888999999999999999999999999999999999999998776   999999998765432


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcC-----CCCCCCCcchhhhHHHHHHhhCCCCCCCCC--------------
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNS-----SPATFGNDLWALGCTLYQMLSGTSPFKDTS--------------  259 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-----~~~~~~sDiwSLG~ilyelltG~~PF~~~~--------------  259 (489)
                      ....   ..........+||+.|+|||++.+     ..++.++|||||||++|+|++|+.||.+.+              
T Consensus       168 ~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  244 (316)
T 2ac3_A          168 GDCS---PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA  244 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred             Cccc---cccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence            1100   001122335679999999999975     457899999999999999999999998764              


Q ss_pred             -HHHHHHHHHhcCCCCCC----CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 011287          260 -EWLIFQRIIARDIRFPN----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (489)
Q Consensus       260 -~~~~~~~i~~~~~~~p~----~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~  320 (489)
                       ...++..+....+.+|.    .+++++++||.+||+.||++||++     +++++||||++..+.
T Consensus       245 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~-----~e~l~hp~~~~~~~~  305 (316)
T 2ac3_A          245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSA-----AQVLQHPWVQGCAPE  305 (316)
T ss_dssp             HHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCH-----HHHHHSTTCC-----
T ss_pred             HHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCH-----HHHhcChhhcCCCCc
Confidence             34566777788787773    589999999999999999999999     899999999987654

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.8e-49  Score=385.98  Aligned_cols=253  Identities=32%  Similarity=0.543  Sum_probs=230.3

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      .++|++.+.||+|+||.||+|++..++..||+|++.+....   ....+.+|+.+++.++||||+++++++.+...+|+|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV   84 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence            36799999999999999999999999999999999765322   245678899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeee---CCCCCEEEeeccCccccCCccc
Q 011287          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL---TADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl---~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      |||+++++|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||+   +.++.++|+|||++..+...  
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~--  162 (277)
T 3f3z_A           85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--  162 (277)
T ss_dssp             EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT--
T ss_pred             EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc--
Confidence            9999999999999988889999999999999999999999999999999999999   78899999999999865432  


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCC----
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN----  276 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~----  276 (489)
                               .......||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+.......+......+|.    
T Consensus       163 ---------~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (277)
T 3f3z_A          163 ---------KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWL  232 (277)
T ss_dssp             ---------SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHT
T ss_pred             ---------cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhh
Confidence                     223356799999999998765 899999999999999999999999999999999999998888875    


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      .+++++.+||.+||+.||.+||++     .++++||||+.
T Consensus       233 ~~~~~~~~li~~~l~~dp~~R~s~-----~~~l~h~~~~~  267 (277)
T 3f3z_A          233 NVSPQAESLIRRLLTKSPKQRITS-----LQALEHEWFEK  267 (277)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCH-----HHHTTSHHHHH
T ss_pred             cCCHHHHHHHHHHccCChhhCcCH-----HHHhcCHHHhc
Confidence            689999999999999999999998     89999999974

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=5.5e-49  Score=410.72  Aligned_cols=274  Identities=24%  Similarity=0.381  Sum_probs=218.4

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC-----C
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT-----F  118 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~  118 (489)
                      .++|++++.||+|+||.||+|+++.+|+.||||++.+.. ........+.+|+.+|+.++||||+++++++...     .
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            578999999999999999999999999999999997653 2334456788899999999999999999999766     5


Q ss_pred             EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      .+|+||||+. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++++||+|||+|+.....
T Consensus       104 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  182 (432)
T 3n9x_A          104 ELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE  182 (432)
T ss_dssp             CEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred             eEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence            7999999997 599999998888999999999999999999999999999999999999999999999999999876543


Q ss_pred             cccccCC------------CCCCCCccceecCCcCCChhhh-cCCCCCCCCcchhhhHHHHHHhh-----------CCCC
Q 011287          199 RITVLPN------------AASDDKACTFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLS-----------GTSP  254 (489)
Q Consensus       199 ~~~~~~~------------~~~~~~~~~~~gt~~Y~aPE~l-~~~~~~~~sDiwSLG~ilyellt-----------G~~P  254 (489)
                      .......            ..........+||+.|+|||++ ....++.++||||||||+|+|++           |.++
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~  262 (432)
T 3n9x_A          183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL  262 (432)
T ss_dssp             ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCS
T ss_pred             ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccccc
Confidence            2110000            0001234577999999999986 56679999999999999999998           5566


Q ss_pred             CCCCC-----------------HHHHHHHHHh------------------------cCCCCC-------CCCCHHHHHHH
Q 011287          255 FKDTS-----------------EWLIFQRIIA------------------------RDIRFP-------NYFSDAARDLI  286 (489)
Q Consensus       255 F~~~~-----------------~~~~~~~i~~------------------------~~~~~p-------~~~~~~~~~Li  286 (489)
                      |.+.+                 ....+..|..                        .....+       +.+++++.+||
T Consensus       263 f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl  342 (432)
T 3n9x_A          263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLL  342 (432)
T ss_dssp             CCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHH
T ss_pred             CCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHH
Confidence            65543                 1222222221                        111111       35799999999


Q ss_pred             HHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 011287          287 DRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (489)
Q Consensus       287 ~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~  324 (489)
                      ++||+.||++|||+     +++++||||++++|.....
T Consensus       343 ~~mL~~dP~~R~ta-----~e~L~Hp~f~~~~~~~~e~  375 (432)
T 3n9x_A          343 ESMLKFNPNKRITI-----DQALDHPYLKDVRKKKLEN  375 (432)
T ss_dssp             HHHSCSSTTTSCCH-----HHHHTCGGGTTTCCTTTC-
T ss_pred             HHHhcCCcccCCCH-----HHHhcChhhhhccCcccCc
Confidence            99999999999998     8999999999999876543

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=4.5e-49  Score=400.44  Aligned_cols=260  Identities=25%  Similarity=0.445  Sum_probs=224.0

Q ss_pred             ccccCCCCCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-----CCCc
Q 011287           33 FAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-----HPGV  107 (489)
Q Consensus        33 ~~~~~~~~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~-----hpnI  107 (489)
                      ............++|++++.||+|+||.||+|++..+++.||||++...    .........|..+++.+.     ||||
T Consensus        23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~i   98 (360)
T 3llt_A           23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNI   98 (360)
T ss_dssp             GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred             eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCe
Confidence            3334444455668999999999999999999999999999999998642    234455677999999986     9999


Q ss_pred             cEEEEEEEcCCEEEEEEeccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCC-----
Q 011287          108 VRLFFTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-----  180 (489)
Q Consensus       108 v~l~~~~~~~~~lylV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~-----  180 (489)
                      +++++++.+...+|+||||+ +++|.+++.+.+  .+++..++.++.||+.||.|||++||+||||||+|||++.     
T Consensus        99 v~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~  177 (360)
T 3llt_A           99 VKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEK  177 (360)
T ss_dssp             CCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCE
T ss_pred             ecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccc
Confidence            99999999999999999999 889999998764  5999999999999999999999999999999999999975     


Q ss_pred             --------------------CCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchh
Q 011287          181 --------------------DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWA  240 (489)
Q Consensus       181 --------------------~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwS  240 (489)
                                          ++.+||+|||+|+....             .....+||+.|+|||++.+..++.++||||
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diws  244 (360)
T 3llt_A          178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-------------YHGSIINTRQYRAPEVILNLGWDVSSDMWS  244 (360)
T ss_dssp             EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-------------CCCSCCSCGGGCCHHHHTTCCCCTTHHHHH
T ss_pred             cccchhcccccccccccccCCCCEEEEeccCceecCC-------------CCcCccCcccccCcHHHcCCCCCCccchHH
Confidence                                78999999999975332             223568999999999999999999999999


Q ss_pred             hhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCC--------------------------------------------
Q 011287          241 LGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN--------------------------------------------  276 (489)
Q Consensus       241 LG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~--------------------------------------------  276 (489)
                      |||++|+|++|+.||.+.+..+....+......+|.                                            
T Consensus       245 lG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~  324 (360)
T 3llt_A          245 FGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLY  324 (360)
T ss_dssp             HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHH
T ss_pred             HHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccccc
Confidence            999999999999999999888877776554333331                                            


Q ss_pred             --CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 011287          277 --YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (489)
Q Consensus       277 --~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~  315 (489)
                        ..++.+.+||.+||+.||++|||+     +++++||||+
T Consensus       325 ~~~~~~~l~~li~~~L~~dP~~Rpta-----~elL~hp~f~  360 (360)
T 3llt_A          325 KIIKHELFCDFLYSILQIDPTLRPSP-----AELLKHKFLE  360 (360)
T ss_dssp             HHCCCHHHHHHHHHHCCSSGGGSCCH-----HHHTTSGGGC
T ss_pred             ccchHHHHHHHHHHHhcCChhhCCCH-----HHHhcCcccC
Confidence              123778899999999999999999     8999999995

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.6e-49  Score=388.24  Aligned_cols=261  Identities=33%  Similarity=0.547  Sum_probs=228.8

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCE
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  119 (489)
                      ..+..++|++++.||+|+||.||+|++..+|+.||+|++.............+.+|+.+++.++||||+++++++.+...
T Consensus         6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   85 (276)
T 2h6d_A            6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD   85 (276)
T ss_dssp             -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence            35567899999999999999999999999999999999976544344455678889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcc
Q 011287          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      .|+||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++...... 
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~-  164 (276)
T 2h6d_A           86 FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-  164 (276)
T ss_dssp             EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC-
Confidence            9999999999999999998888999999999999999999999999999999999999999999999999999865432 


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCCCC-CCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF  278 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~-~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~  278 (489)
                                .......||+.|+|||++.+..+ +.++|+|||||++|+|++|..||...+....++.+......+|..+
T Consensus       165 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  234 (276)
T 2h6d_A          165 ----------EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYL  234 (276)
T ss_dssp             ----------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTS
T ss_pred             ----------cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhc
Confidence                      12234579999999999988765 6889999999999999999999999999888889988888899999


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       279 ~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      +.++.+||.+||+.||++||++     .++++||||+.
T Consensus       235 ~~~l~~li~~~l~~~p~~Rps~-----~~~l~h~~~~~  267 (276)
T 2h6d_A          235 NRSVATLLMHMLQVDPLKRATI-----KDIREHEWFKQ  267 (276)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCH-----HHHHHSHHHHT
T ss_pred             CHHHHHHHHHHccCChhhCCCH-----HHHHhChhhcc
Confidence            9999999999999999999998     89999999974

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.7e-49  Score=399.12  Aligned_cols=251  Identities=35%  Similarity=0.593  Sum_probs=204.3

Q ss_pred             CCeEEe---eEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCEE
Q 011287           45 QDFELG---KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSL  120 (489)
Q Consensus        45 ~dy~~~---~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~l  120 (489)
                      ++|++.   +.||+|+||.||+|+++.+|+.||||++.+.      ......+|+.+++.+. ||||+++++++.+....
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~   81 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHT   81 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence            567775   8899999999999999999999999998653      2345677999999996 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCC---CEEEeeccCccccCC
Q 011287          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG---HIKIADFGSVKPMQD  197 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g---~ikL~DFG~a~~~~~  197 (489)
                      |+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~  161 (325)
T 3kn6_A           82 FLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP  161 (325)
T ss_dssp             EEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred             EEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence            99999999999999999988999999999999999999999999999999999999998766   899999999986543


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCC-------HHHHHHHHHhc
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS-------EWLIFQRIIAR  270 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~-------~~~~~~~i~~~  270 (489)
                      .          .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+       ..+.+..+...
T Consensus       162 ~----------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~  231 (325)
T 3kn6_A          162 D----------NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG  231 (325)
T ss_dssp             --------------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT
T ss_pred             C----------CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC
Confidence            2          122345688999999999999999999999999999999999999998744       35677788888


Q ss_pred             CCCCCC----CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          271 DIRFPN----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       271 ~~~~p~----~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      .+.++.    .+++++++||.+||+.||.+||++     +++++||||++
T Consensus       232 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~-----~ell~h~w~~~  276 (325)
T 3kn6_A          232 DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKM-----SGLRYNEWLQD  276 (325)
T ss_dssp             CCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCT-----TTSTTCGGGCT
T ss_pred             CCCCCcccccCCCHHHHHHHHHHCCCChhHCCCH-----HHHhcChhhcc
Confidence            777764    589999999999999999999999     77999999985

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=5.4e-49  Score=418.63  Aligned_cols=258  Identities=30%  Similarity=0.477  Sum_probs=229.4

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccch----------hHHHHHHHHHHHHHhCCCCCccEEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE----------NKTAYVKLERIVLDQLDHPGVVRLFF  112 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~----------~~~~~~~~E~~il~~l~hpnIv~l~~  112 (489)
                      ..++|++++.||+|+||+||+|+++.+++.||+|++.+......          .....+.+|+.+++.++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            45789999999999999999999999999999999987643321          33567888999999999999999999


Q ss_pred             EEEcCCEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCC---CEEEeec
Q 011287          113 TFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG---HIKIADF  189 (489)
Q Consensus       113 ~~~~~~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g---~ikL~DF  189 (489)
                      ++.+...+|+|||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+||
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  193 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF  193 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence            9999999999999999999999998888999999999999999999999999999999999999999876   6999999


Q ss_pred             cCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHh
Q 011287          190 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA  269 (489)
Q Consensus       190 G~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~  269 (489)
                      |+++.+...           ......+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+...++..+..
T Consensus       194 g~a~~~~~~-----------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  261 (504)
T 3q5i_A          194 GLSSFFSKD-----------YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK  261 (504)
T ss_dssp             TTCEECCTT-----------SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CCCEEcCCC-----------CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence            999865432           22345689999999999874 589999999999999999999999999999999999999


Q ss_pred             cCCCCC----CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          270 RDIRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       270 ~~~~~p----~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                      +.+.++    ..+++++++||++||+.||.+|||+     +++++||||+..
T Consensus       262 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~-----~e~l~h~~~~~~  308 (504)
T 3q5i_A          262 GKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTA-----EEALNSRWIKKY  308 (504)
T ss_dssp             CCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSHHHHHT
T ss_pred             CCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCH-----HHHhcCHhhhhc
Confidence            888776    5789999999999999999999999     899999999754

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4.9e-49  Score=391.64  Aligned_cols=260  Identities=24%  Similarity=0.347  Sum_probs=216.2

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccc--hhHHHHHHHHHHHHHhC---CCCCccEEEEEEE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK--ENKTAYVKLERIVLDQL---DHPGVVRLFFTFQ  115 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~--~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~  115 (489)
                      .+..++|++++.||+|+||+||+|++..+|+.||+|++.......  ........+|+.+++.+   +||||+++++++.
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~   84 (308)
T 3g33_A            5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA   84 (308)
T ss_dssp             -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence            345689999999999999999999999999999999997543211  11123455677777666   5999999999998


Q ss_pred             cCC-----EEEEEEeccCCCChHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEee
Q 011287          116 DTF-----SLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIAD  188 (489)
Q Consensus       116 ~~~-----~lylV~E~~~gg~L~~~l~~~~~--l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~D  188 (489)
                      +..     .+|+||||+. |+|.+++.....  +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~D  163 (308)
T 3g33_A           85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLAD  163 (308)
T ss_dssp             ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECS
T ss_pred             ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEee
Confidence            755     5899999997 599999987654  99999999999999999999999999999999999999999999999


Q ss_pred             ccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHH
Q 011287          189 FGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII  268 (489)
Q Consensus       189 FG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~  268 (489)
                      ||+++.....           ......+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+......++.
T Consensus       164 fg~a~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~  232 (308)
T 3g33_A          164 FGLARIYSYQ-----------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF  232 (308)
T ss_dssp             CSCTTTSTTC-----------CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHH
T ss_pred             CccccccCCC-----------cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999865322           22345689999999999999999999999999999999999999999999988888776


Q ss_pred             hcCCC---------------------------CCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          269 ARDIR---------------------------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       269 ~~~~~---------------------------~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                      .....                           ....+++++.+||.+||+.||++|||+     .++++||||+..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~e~l~h~~~~~~  303 (308)
T 3g33_A          233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISA-----FRALQHSYLHKD  303 (308)
T ss_dssp             HHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSTTC---
T ss_pred             HHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCH-----HHHhcCccccCC
Confidence            52110                           113478999999999999999999999     899999999863

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.2e-49  Score=417.48  Aligned_cols=253  Identities=23%  Similarity=0.416  Sum_probs=213.4

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC------
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT------  117 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------  117 (489)
                      .++|++++.||+|+||.||+|++..+|+.||||++.+... .......+.+|+.+|+.++||||++++++|...      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGG-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcccc-ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            5789999999999999999999999999999999987533 334456677899999999999999999999654      


Q ss_pred             CEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCC
Q 011287          118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~  197 (489)
                      ..+|+||||+++ +|.+.+..  .+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+....
T Consensus       140 ~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  216 (464)
T 3ttj_A          140 QDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (464)
T ss_dssp             CEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred             CeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence            468999999976 57777754  499999999999999999999999999999999999999999999999999986532


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC------
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD------  271 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~------  271 (489)
                      .           ......+||+.|+|||++.+..++.++||||||||+|+|++|++||.+.+...++.+|....      
T Consensus       217 ~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~  285 (464)
T 3ttj_A          217 S-----------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE  285 (464)
T ss_dssp             C-----------CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             C-----------cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            1           23346789999999999999999999999999999999999999999999888887776421      


Q ss_pred             ---------------------CCC----CCC-----------CCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 011287          272 ---------------------IRF----PNY-----------FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (489)
Q Consensus       272 ---------------------~~~----p~~-----------~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~  315 (489)
                                           ..+    |..           .++++++||++||+.||++|||+     +++++||||+
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta-----~e~L~Hp~~~  360 (464)
T 3ttj_A          286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV-----DDALQHPYIN  360 (464)
T ss_dssp             HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCH-----HHHHTSTTTG
T ss_pred             HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCH-----HHHhcChhhh
Confidence                                 011    111           15679999999999999999999     8999999998


Q ss_pred             C
Q 011287          316 G  316 (489)
Q Consensus       316 ~  316 (489)
                      .
T Consensus       361 ~  361 (464)
T 3ttj_A          361 V  361 (464)
T ss_dssp             G
T ss_pred             h
Confidence            4

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-49  Score=403.70  Aligned_cols=256  Identities=27%  Similarity=0.423  Sum_probs=216.6

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-----
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-----  118 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----  118 (489)
                      .++|++++.||+|+||.||+|++..+|+.||||++.+... .......+.+|+.+++.++||||+++++++....     
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            4789999999999999999999999999999999966532 3344566788999999999999999999998653     


Q ss_pred             -EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCC
Q 011287          119 -SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (489)
Q Consensus       119 -~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~  197 (489)
                       .+|+||||+ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  180 (367)
T 1cm8_A          103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS  180 (367)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence             469999999 7899999887 5799999999999999999999999999999999999999999999999999986432


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC----
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI----  272 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~----  272 (489)
                                   .....+||+.|+|||++.+ ..++.++||||||||+|+|++|++||.+.+....+..|.....    
T Consensus       181 -------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~  247 (367)
T 1cm8_A          181 -------------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA  247 (367)
T ss_dssp             -------------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             -------------ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence                         2235689999999999877 6799999999999999999999999999998887777654211    


Q ss_pred             ---------------------------CCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 011287          273 ---------------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (489)
Q Consensus       273 ---------------------------~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~  320 (489)
                                                 .+....++++.+||.+||+.||++|||+     +++++||||+.+.+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~-----~e~l~hp~f~~~~~~  317 (367)
T 1cm8_A          248 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA-----GEALAHPYFESLHDT  317 (367)
T ss_dssp             HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCH-----HHHHHSGGGTTTC--
T ss_pred             HHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCH-----HHHhcChHHHhhcCC
Confidence                                       1234578999999999999999999999     899999999976543

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.6e-49  Score=398.72  Aligned_cols=259  Identities=24%  Similarity=0.388  Sum_probs=214.8

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      +++|++++.||+|+||.||+|++..+++.||+|++......  .....+.+|+.+++.++||||+++++++.+...+|+|
T Consensus         1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (324)
T 3mtl_A            1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV   78 (324)
T ss_dssp             CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence            47899999999999999999999999999999998654211  1111234689999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccc
Q 011287          124 LESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~  202 (489)
                      |||+.+ +|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....    
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~----  153 (324)
T 3mtl_A           79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP----  153 (324)
T ss_dssp             EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC----
Confidence            999975 9999888754 5999999999999999999999999999999999999999999999999999754322    


Q ss_pred             cCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC---------
Q 011287          203 LPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI---------  272 (489)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~---------  272 (489)
                            .......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+.....         
T Consensus       154 ------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  227 (324)
T 3mtl_A          154 ------TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPG  227 (324)
T ss_dssp             ---------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             ------ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchh
Confidence                  122335578999999999876 5689999999999999999999999999998887777654210         


Q ss_pred             ----------CC-----------CCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 011287          273 ----------RF-----------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (489)
Q Consensus       273 ----------~~-----------p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~  320 (489)
                                .+           +..+++++.+||.+||+.||++|||+     +++++||||.++...
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~f~~~~~~  291 (324)
T 3mtl_A          228 ILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISA-----EDAMKHPFFLSLGER  291 (324)
T ss_dssp             GGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCH-----HHHTTSGGGGGGCST
T ss_pred             hhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCH-----HHHhcChhhhhcccc
Confidence                      11           12468899999999999999999998     999999999976543

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.2e-48  Score=386.12  Aligned_cols=265  Identities=30%  Similarity=0.509  Sum_probs=231.7

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeeccccc------chhHHHHHHHHHHHHHhCC-CCCccEEEEEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT------KENKTAYVKLERIVLDQLD-HPGVVRLFFTFQ  115 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~------~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~  115 (489)
                      ..++|++.+.||+|+||.||+|+++.+|+.||||++......      .......+.+|+.+++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            368999999999999999999999999999999999765311      1223456778999999995 999999999999


Q ss_pred             cCCEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCcccc
Q 011287          116 DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (489)
Q Consensus       116 ~~~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~  195 (489)
                      +....|+||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  174 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL  174 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence            99999999999999999999998888999999999999999999999999999999999999999999999999999865


Q ss_pred             CCccccccCCCCCCCCccceecCCcCCChhhhc------CCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHh
Q 011287          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLN------SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA  269 (489)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~------~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~  269 (489)
                      ...           .......||+.|+|||++.      ...++.++|||||||++|+|++|..||.+.+.......+..
T Consensus       175 ~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  243 (298)
T 1phk_A          175 DPG-----------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS  243 (298)
T ss_dssp             CTT-----------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CCC-----------cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhc
Confidence            432           1233567999999999985      45678899999999999999999999999999888888888


Q ss_pred             cCCCCC----CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCccccc
Q 011287          270 RDIRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR  323 (489)
Q Consensus       270 ~~~~~p----~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~  323 (489)
                      ....++    ..++.++.+||.+||+.||++||++     +++++||||++..++.++
T Consensus       244 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~h~~~~~~~~~~~~  296 (298)
T 1phk_A          244 GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTA-----EEALAHPFFQQYVVEEVR  296 (298)
T ss_dssp             TCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCH-----HHHTTSGGGCTTC-----
T ss_pred             CCcccCcccccccCHHHHHHHHHHccCCcccCCCH-----HHHHhChHhhhccchhhc
Confidence            776665    3589999999999999999999998     899999999998887654

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=5.2e-49  Score=395.53  Aligned_cols=263  Identities=29%  Similarity=0.494  Sum_probs=228.9

Q ss_pred             CCeEEe-eEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCEEEE
Q 011287           45 QDFELG-KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        45 ~dy~~~-~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~lyl  122 (489)
                      ++|.+. +.||+|+||.||+|++..+|+.||+|++.+..... .....+.+|+.+++.+ +||||+++++++.+...+|+
T Consensus        28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l  106 (327)
T 3lm5_A           28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL  106 (327)
T ss_dssp             HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence            467877 89999999999999999999999999998764333 3345677899999998 56999999999999999999


Q ss_pred             EEeccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCC---CCCEEEeeccCccccCC
Q 011287          123 ALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQD  197 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~---~g~ikL~DFG~a~~~~~  197 (489)
                      ||||+.+|+|.+++...  +.+++..++.++.||+.||+|||++||+||||||+|||++.   ++.+||+|||+++....
T Consensus       107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  186 (327)
T 3lm5_A          107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH  186 (327)
T ss_dssp             EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred             EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence            99999999999998653  67999999999999999999999999999999999999998   78999999999986543


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCC--
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP--  275 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p--  275 (489)
                      .           ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+......++  
T Consensus       187 ~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  255 (327)
T 3lm5_A          187 A-----------CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEE  255 (327)
T ss_dssp             ------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred             c-----------cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCch
Confidence            2           122356899999999999999999999999999999999999999999999888888877665544  


Q ss_pred             --CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccC
Q 011287          276 --NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRG  324 (489)
Q Consensus       276 --~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~  324 (489)
                        ..+++.+.+||.+||+.||.+|||+     +++++||||++++|+++..
T Consensus       256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~~ll~h~~~~~~~~~~~~~  301 (327)
T 3lm5_A          256 TFSSVSQLATDFIQSLLVKNPEKRPTA-----EICLSHSWLQQWDFENLFH  301 (327)
T ss_dssp             TTTTSCHHHHHHHHHHSCSSGGGSCCH-----HHHTTCGGGCCCCTTCC--
T ss_pred             hhcccCHHHHHHHHHHcCCChhhCcCH-----HHHhCCHhhcccccccccC
Confidence              4589999999999999999999998     8999999999999987753

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.6e-49  Score=387.13  Aligned_cols=262  Identities=31%  Similarity=0.571  Sum_probs=232.2

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE---NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ly  121 (489)
                      ++|++++.||+|+||.||+|++..+|+.||+|++.+......   .....+.+|+.+++.++||||+++++++.+....|
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            579999999999999999999999999999999987643322   23567888999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCC----CEEEeeccCccccCC
Q 011287          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQD  197 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g----~ikL~DFG~a~~~~~  197 (489)
                      +||||+++++|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+||+++.++    .++|+|||++.....
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~  164 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA  164 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred             EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence            9999999999999998888899999999999999999999999999999999999999877    899999999986543


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCC--
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP--  275 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p--  275 (489)
                      .           .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+......++  
T Consensus       165 ~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T 3bhy_A          165 G-----------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEE  233 (283)
T ss_dssp             ------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHH
T ss_pred             C-----------CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcch
Confidence            2           122345799999999999999999999999999999999999999999999888888887766655  


Q ss_pred             --CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccc
Q 011287          276 --NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI  322 (489)
Q Consensus       276 --~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~  322 (489)
                        ..+++.+.+||.+||+.||++||++     .++++||||+.+.+...
T Consensus       234 ~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~~l~h~~~~~~~~~~~  277 (283)
T 3bhy_A          234 YFSNTSELAKDFIRRLLVKDPKRRMTI-----AQSLEHSWIKAIRRRNV  277 (283)
T ss_dssp             HHTTCCHHHHHHHHTTSCSSGGGSCCH-----HHHHHCHHHHHHHHCCC
T ss_pred             hcccCCHHHHHHHHHHccCCHhHCcCH-----HHHHhCHHHHHHHHHhh
Confidence              4689999999999999999999998     89999999998766543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3e-49  Score=405.00  Aligned_cols=256  Identities=29%  Similarity=0.502  Sum_probs=223.3

Q ss_pred             CeEE--eeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           46 DFEL--GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        46 dy~~--~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      .|.+  .+.||+|+||.||+|++..+|+.||+|++....   ......+.+|+.+++.++||||+++++++.+...+|+|
T Consensus        88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  164 (373)
T 2x4f_A           88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV  164 (373)
T ss_dssp             TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            3444  678999999999999999999999999997653   23456688899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeee--CCCCCEEEeeccCccccCCccc
Q 011287          124 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL--TADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl--~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      |||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+  +.++.+||+|||+++.+...  
T Consensus       165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~--  242 (373)
T 2x4f_A          165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR--  242 (373)
T ss_dssp             EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT--
T ss_pred             EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc--
Confidence            9999999999988764 469999999999999999999999999999999999999  56789999999999865432  


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCC----C
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----N  276 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p----~  276 (489)
                               ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+......++    .
T Consensus       243 ---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  313 (373)
T 2x4f_A          243 ---------EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQ  313 (373)
T ss_dssp             ---------CBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGT
T ss_pred             ---------cccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhc
Confidence                     122345799999999999998999999999999999999999999999999999999988776665    4


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~  320 (489)
                      .+++++++||.+||+.||.+||++     .++++||||.+..+.
T Consensus       314 ~~~~~~~~li~~~L~~dp~~Rps~-----~e~l~hp~~~~~~~~  352 (373)
T 2x4f_A          314 DISEEAKEFISKLLIKEKSWRISA-----SEALKHPWLSDHKLH  352 (373)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCH-----HHHHHSHHHHCHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhhCCCH-----HHHhcCcCcCCCchh
Confidence            689999999999999999999998     899999999987654

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.5e-49  Score=418.23  Aligned_cols=257  Identities=35%  Similarity=0.584  Sum_probs=229.4

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+...... ....+.+|+.+++.++||||+++++++.+...+|+|
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch-HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            5789999999999999999999999999999999976543322 345678899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeC---CCCCEEEeeccCccccCCccc
Q 011287          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT---ADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~---~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      ||||.+|+|.+.+.+.+.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.+...  
T Consensus       100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~--  177 (486)
T 3mwu_A          100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--  177 (486)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred             EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC--
Confidence            99999999999998888999999999999999999999999999999999999995   4568999999999865432  


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCC----C
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----N  276 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p----~  276 (489)
                               ......+||+.|+|||++.+ .++.++||||||||+|+|++|.+||.+.+..+++..+....+.++    .
T Consensus       178 ---------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  247 (486)
T 3mwu_A          178 ---------TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWR  247 (486)
T ss_dssp             -------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGG
T ss_pred             ---------CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccC
Confidence                     22335689999999999976 489999999999999999999999999999999999988876654    3


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~  318 (489)
                      .+++++++||.+||+.||++|||+     .++++||||+...
T Consensus       248 ~~s~~~~~li~~~L~~dp~~R~t~-----~~~l~hp~~~~~~  284 (486)
T 3mwu_A          248 TISDDAKDLIRKMLTFHPSLRITA-----TQCLEHPWIQKYS  284 (486)
T ss_dssp             GSCHHHHHHHHHHTCSSTTTSCCH-----HHHHHCHHHHHTC
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCH-----HHHhcCHhhccCc
Confidence            589999999999999999999999     8999999998654

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.4e-48  Score=389.98  Aligned_cols=253  Identities=29%  Similarity=0.471  Sum_probs=225.2

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEe
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E  125 (489)
                      .|...+.||+|+||.||+|++..+|+.||||++....   ......+.+|+.+++.++||||+++++++.....+|+|||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  122 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME  122 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            4899999999999999999999999999999997543   2334567789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCC
Q 011287          126 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  205 (489)
Q Consensus       126 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~  205 (489)
                      |+++|+|.+++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......      
T Consensus       123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~------  195 (321)
T 2c30_A          123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV------  195 (321)
T ss_dssp             CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS------
T ss_pred             cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc------
Confidence            9999999998875 479999999999999999999999999999999999999999999999999988654321      


Q ss_pred             CCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC---CCCCCCCHHH
Q 011287          206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI---RFPNYFSDAA  282 (489)
Q Consensus       206 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~---~~p~~~~~~~  282 (489)
                          ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.....   ..+..+++++
T Consensus       196 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  271 (321)
T 2c30_A          196 ----PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVL  271 (321)
T ss_dssp             ----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHH
T ss_pred             ----cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHH
Confidence                223456899999999999999999999999999999999999999999988888777766533   2334689999


Q ss_pred             HHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          283 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       283 ~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                      .+||.+||+.||++||++     .++++||||...
T Consensus       272 ~~li~~~l~~dp~~Rps~-----~ell~hp~~~~~  301 (321)
T 2c30_A          272 RDFLERMLVRDPQERATA-----QELLDHPFLLQT  301 (321)
T ss_dssp             HHHHHHHSCSSTTTSCCH-----HHHHTSGGGGGC
T ss_pred             HHHHHHHccCChhhCcCH-----HHHhcChhhccC
Confidence            999999999999999998     899999999753

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4.2e-49  Score=407.63  Aligned_cols=251  Identities=30%  Similarity=0.515  Sum_probs=211.6

Q ss_pred             CCCCCeEEe-eEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHH-HhCCCCCccEEEEEEEc---
Q 011287           42 FSIQDFELG-KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL-DQLDHPGVVRLFFTFQD---  116 (489)
Q Consensus        42 ~~~~dy~~~-~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il-~~l~hpnIv~l~~~~~~---  116 (489)
                      ...++|.+. +.||+|+||+||+|+++.+|+.||||++...        ..+.+|+.++ +..+||||++++++|..   
T Consensus        58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~  129 (400)
T 1nxk_A           58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA  129 (400)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence            346789887 7999999999999999999999999998642        2355677776 55689999999999875   


Q ss_pred             -CCEEEEEEeccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCC---CCCEEEeecc
Q 011287          117 -TFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFG  190 (489)
Q Consensus       117 -~~~lylV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~---~g~ikL~DFG  190 (489)
                       ...+|+|||||+||+|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||
T Consensus       130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence             667999999999999999998754  5999999999999999999999999999999999999998   7899999999


Q ss_pred             CccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHH----HHHH
Q 011287          191 SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL----IFQR  266 (489)
Q Consensus       191 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~----~~~~  266 (489)
                      +++.....           ....+.+||+.|+|||++.+..++.++||||||||+|+|++|+.||.+.+...    +...
T Consensus       210 ~a~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  278 (400)
T 1nxk_A          210 FAKETTSH-----------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR  278 (400)
T ss_dssp             TCEECC----------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH
T ss_pred             cccccCCC-----------CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH
Confidence            99864321           22346789999999999999999999999999999999999999998765422    4566


Q ss_pred             HHhcCCCCC----CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          267 IIARDIRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       267 i~~~~~~~p----~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      +....+.+|    ..+++++++||++||+.||++|||+     .++++||||.+
T Consensus       279 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~-----~eil~hp~~~~  327 (400)
T 1nxk_A          279 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI-----TEFMNHPWIMQ  327 (400)
T ss_dssp             HHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCH-----HHHHHSHHHHT
T ss_pred             HHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCH-----HHHhcCccccC
Confidence            677777666    4689999999999999999999998     89999999975

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.7e-48  Score=383.81  Aligned_cols=254  Identities=32%  Similarity=0.577  Sum_probs=220.4

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      .++|++.+.||+|+||.||+|++..++..||+|++.+...  ......+.+|+.+++.++||||+++++++.+...+|+|
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   98 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV   98 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc--chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence            4789999999999999999999999999999999976532  22356688899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeee---CCCCCEEEeeccCccccC
Q 011287          124 LESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL---TADGHIKIADFGSVKPMQ  196 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl---~~~g~ikL~DFG~a~~~~  196 (489)
                      |||+++|+|.+++..    ...+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++..+.
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A           99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            999999999998854    3679999999999999999999999999999999999999   456889999999997654


Q ss_pred             CccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCC-
Q 011287          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP-  275 (489)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p-  275 (489)
                      ..           .......||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+.....+.+......++ 
T Consensus       179 ~~-----------~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~  246 (285)
T 3is5_A          179 SD-----------EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAV  246 (285)
T ss_dssp             -------------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC
T ss_pred             Cc-----------ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccc
Confidence            32           1233567999999999986 4678899999999999999999999999998888877776655544 


Q ss_pred             --CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          276 --NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       276 --~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                        ..+++++.+||.+||+.||++||++     +++++||||+.
T Consensus       247 ~~~~~~~~~~~li~~~L~~dP~~Rps~-----~e~l~hp~f~~  284 (285)
T 3is5_A          247 ECRPLTPQAVDLLKQMLTKDPERRPSA-----AQVLHHEWFKQ  284 (285)
T ss_dssp             --CCCCHHHHHHHHHHTCSCTTTSCCH-----HHHHTSGGGGC
T ss_pred             ccCcCCHHHHHHHHHHccCChhhCcCH-----HHHhcCHHhhc
Confidence              3479999999999999999999999     89999999975

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.8e-48  Score=385.73  Aligned_cols=250  Identities=26%  Similarity=0.377  Sum_probs=218.5

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ly  121 (489)
                      ...++|++++.||+|+||.||+|++..+++.||+|++.............+.+|+.+++.++||||+++++++.+...+|
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   87 (294)
T 4eqm_A            8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY   87 (294)
T ss_dssp             CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred             HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence            44578999999999999999999999999999999997766666666778899999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccc
Q 011287          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~  201 (489)
                      +||||++|++|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+++.+....  
T Consensus        88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  165 (294)
T 4eqm_A           88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS--  165 (294)
T ss_dssp             EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred             EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc--
Confidence            999999999999999988899999999999999999999999999999999999999999999999999998654321  


Q ss_pred             ccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCC-----CCC
Q 011287          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR-----FPN  276 (489)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~-----~p~  276 (489)
                             .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+......+.......     ++.
T Consensus       166 -------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (294)
T 4eqm_A          166 -------LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRK  238 (294)
T ss_dssp             ----------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCT
T ss_pred             -------ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhccc
Confidence                   12234568999999999999999999999999999999999999999999887766665554322     346


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCC
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      .+++.+.++|.+||+.||.+||+.
T Consensus       239 ~~~~~l~~li~~~l~~dp~~R~~~  262 (294)
T 4eqm_A          239 DIPQSLSNVILRATEKDKANRYKT  262 (294)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCSS
T ss_pred             CCCHHHHHHHHHHhcCCHhHcccc
Confidence            789999999999999999999976

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.7e-49  Score=399.32  Aligned_cols=266  Identities=30%  Similarity=0.475  Sum_probs=226.3

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeeccccc--chhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT--KENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ly  121 (489)
                      .++|++++.||+|+||.||+|++..+++.||+|++.+....  .......+.+|+.+++.++||||+++++++.+...+|
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            36899999999999999999999999999999999765332  2345567888999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh----------------------------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 011287          122 MALESCEGGELFDQITS----------------------------------------KGHLSEDEARFYTAEVVDALEYI  161 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~----------------------------------------~~~l~e~~~~~i~~qil~aL~~L  161 (489)
                      +|||||+||+|.+++..                                        ...+++..++.++.||+.||.||
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            99999999999998852                                        11246888999999999999999


Q ss_pred             HhCCcEeeccCCCCeeeCCCC--CEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcC--CCCCCCCc
Q 011287          162 HSMGLIHRDIKPENLLLTADG--HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS--SPATFGND  237 (489)
Q Consensus       162 H~~gIiHrDLKpeNILl~~~g--~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~--~~~~~~sD  237 (489)
                      |++||+||||||+|||++.++  .+||+|||+++.+.....      ..........||+.|+|||++.+  ..++.++|
T Consensus       185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN------GEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTC------C--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCc------cccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            999999999999999998776  899999999986533210      01112345689999999999975  67889999


Q ss_pred             chhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCC----CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCC
Q 011287          238 LWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF  313 (489)
Q Consensus       238 iwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpf  313 (489)
                      ||||||++|+|++|+.||.+.+.......+......++.    .+++++.+||.+||+.||.+||++     .++++|||
T Consensus       259 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~~l~hp~  333 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDA-----MRALQHPW  333 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCH-----HHHHHSHH
T ss_pred             HHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCH-----HHHhcChh
Confidence            999999999999999999999999998888887766553    479999999999999999999998     89999999


Q ss_pred             CCCCCcc
Q 011287          314 FKGIDWK  320 (489)
Q Consensus       314 f~~i~~~  320 (489)
                      |+++.+.
T Consensus       334 ~~~~~~~  340 (345)
T 3hko_A          334 ISQFSDK  340 (345)
T ss_dssp             HHTTSSC
T ss_pred             hccChHh
Confidence            9987653

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=8.8e-49  Score=416.01  Aligned_cols=257  Identities=32%  Similarity=0.548  Sum_probs=225.4

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      .++|++++.||+|+||+||+|+++.++..||+|++.+....... ...+.+|+.+++.++||||++++++|.+...+|+|
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS-NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CT-THHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchH-HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            35799999999999999999999999999999999876443332 45577899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCC---CCEEEeeccCccccCCccc
Q 011287          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD---GHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~---g~ikL~DFG~a~~~~~~~~  200 (489)
                      ||||.+|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++..+...  
T Consensus       115 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~--  192 (494)
T 3lij_A          115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ--  192 (494)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT--
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC--
Confidence            9999999999999888899999999999999999999999999999999999999764   45999999999865432  


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCC----C
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----N  276 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p----~  276 (489)
                               ......+||+.|+|||++. ..++.++|||||||++|+|++|.+||.+.+..+++..+....+.++    .
T Consensus       193 ---------~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  262 (494)
T 3lij_A          193 ---------KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWK  262 (494)
T ss_dssp             ---------BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGT
T ss_pred             ---------ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcc
Confidence                     2234568999999999986 4689999999999999999999999999999999999998887765    3


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~  318 (489)
                      .+++++++||.+||+.||.+|||+     .++++||||+...
T Consensus       263 ~~s~~~~~li~~~L~~dp~~R~s~-----~e~l~hp~~~~~~  299 (494)
T 3lij_A          263 NVSEGAKDLIKQMLQFDSQRRISA-----QQALEHPWIKEMC  299 (494)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCH-----HHHHTCHHHHHHH
T ss_pred             cCCHHHHHHHHHHCCCChhhCccH-----HHHhcCcccccCc
Confidence            589999999999999999999998     8999999998643

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.1e-48  Score=388.32  Aligned_cols=253  Identities=34%  Similarity=0.580  Sum_probs=226.9

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      .++|++++.||+|+||.||+|++..+|+.||+|++.....   .....+.+|+.+++.++||||+++++++.+...+|+|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV   84 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence            4689999999999999999999999999999999976432   2335677899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeee---CCCCCEEEeeccCccccCCccc
Q 011287          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL---TADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl---~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      |||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++.....   
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~---  161 (304)
T 2jam_A           85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN---  161 (304)
T ss_dssp             ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC---
T ss_pred             EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC---
Confidence            9999999999999888889999999999999999999999999999999999999   7789999999999875322   


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCC----C
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----N  276 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p----~  276 (489)
                               ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+....+.++    .
T Consensus       162 ---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  232 (304)
T 2jam_A          162 ---------GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWD  232 (304)
T ss_dssp             ---------BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTT
T ss_pred             ---------CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccc
Confidence                     123356799999999999999999999999999999999999999999999988888888765544    5


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      .+++++.+||.+||+.||++||++     .++++||||.+
T Consensus       233 ~~~~~~~~li~~~l~~dp~~Rps~-----~~~l~h~~~~~  267 (304)
T 2jam_A          233 DISESAKDFICHLLEKDPNERYTC-----EKALSHPWIDG  267 (304)
T ss_dssp             TSCHHHHHHHHHHHCSSTTTSCCH-----HHHHTSHHHHS
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCH-----HHHhcCccccC
Confidence            689999999999999999999998     89999999975

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.7e-49  Score=396.94  Aligned_cols=264  Identities=28%  Similarity=0.411  Sum_probs=223.7

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ly  121 (489)
                      ..+++|++++.||+|+||.||+|++..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+...+|
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  100 (331)
T 4aaa_A           22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY  100 (331)
T ss_dssp             BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence            357899999999999999999999999999999999876532 2334456778999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccc
Q 011287          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~  201 (489)
                      +||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....  
T Consensus       101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  178 (331)
T 4aaa_A          101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--  178 (331)
T ss_dssp             EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc--
Confidence            999999999998888877889999999999999999999999999999999999999999999999999997654321  


Q ss_pred             ccCCCCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC---------
Q 011287          202 VLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---------  271 (489)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~---------  271 (489)
                              ......+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+.......+....         
T Consensus       179 --------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  250 (331)
T 4aaa_A          179 --------EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQE  250 (331)
T ss_dssp             -------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             --------cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Confidence                    222345799999999999875 68999999999999999999999999998877766654311         


Q ss_pred             ----------CCCC------------CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCccc
Q 011287          272 ----------IRFP------------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  321 (489)
Q Consensus       272 ----------~~~p------------~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~  321 (489)
                                ..+|            ..+++++.+||.+||+.||++|||+     +++++||||+..++..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~-----~ell~hp~f~~~~~~~  317 (331)
T 4aaa_A          251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFC-----AELLHHDFFQMDGFAE  317 (331)
T ss_dssp             HHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCG-----GGGGGSHHHHGGGHHH
T ss_pred             HhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCH-----HHHhcCchhccCChhh
Confidence                      1111            2478999999999999999999999     8899999998765543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.3e-49  Score=396.75  Aligned_cols=262  Identities=26%  Similarity=0.429  Sum_probs=223.2

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC----
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF----  118 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----  118 (489)
                      ..++|++++.||+|+||.||+|++..+++.||||++.............+.+|+.+++.++||||+++++++....    
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            3578999999999999999999999999999999998766555566677889999999999999999999987643    


Q ss_pred             EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      ..|+||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  169 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS  169 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred             ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence            35999999999999999998889999999999999999999999999999999999999999999999999999866433


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCC---
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP---  275 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p---  275 (489)
                      ..       ........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.......+   
T Consensus       170 ~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  242 (311)
T 3ork_A          170 GN-------SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR  242 (311)
T ss_dssp             -------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHH
T ss_pred             cc-------ccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccc
Confidence            21       11223456899999999999999999999999999999999999999999998887777766554433   


Q ss_pred             -CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          276 -NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       276 -~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                       ..+++++.+||.+||+.||.+||++     .+++.|+|++.
T Consensus       243 ~~~~~~~l~~li~~~l~~dP~~R~~~-----~~~l~~~l~~~  279 (311)
T 3ork_A          243 HEGLSADLDAVVLKALAKNPENRYQT-----AAEMRADLVRV  279 (311)
T ss_dssp             STTCCHHHHHHHHHHTCSSGGGSCSS-----HHHHHHHHHHH
T ss_pred             cCCCCHHHHHHHHHHHhcCHhhChhh-----HHHHHHHHHHH
Confidence             4589999999999999999999999     88999999863

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.7e-49  Score=400.92  Aligned_cols=251  Identities=27%  Similarity=0.447  Sum_probs=222.1

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccch-----hHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE-----NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  118 (489)
                      .++|++++.||+|+||.||+|+++.+|+.||||++.+......     .....+.+|+.+++.++||||++++++|.+..
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            4789999999999999999999999999999999987643322     13334667999999999999999999999999


Q ss_pred             EEEEEEeccCCC-ChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCC
Q 011287          119 SLYMALESCEGG-ELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (489)
Q Consensus       119 ~lylV~E~~~gg-~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~  197 (489)
                      .+|+||||+.+| +|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  182 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER  182 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCC
Confidence            999999999776 9999999988999999999999999999999999999999999999999999999999999986543


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcCCCC-CCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN  276 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~-~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~  276 (489)
                      .           ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||....      .........|.
T Consensus       183 ~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~~~~~  245 (335)
T 3dls_A          183 G-----------KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------ETVEAAIHPPY  245 (335)
T ss_dssp             T-----------CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG------GGTTTCCCCSS
T ss_pred             C-----------CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH------HHHhhccCCCc
Confidence            2           23345789999999999988876 788999999999999999999997632      23445566777


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      .+++++.+||.+||+.||++||++     +++++||||+.
T Consensus       246 ~~~~~l~~li~~~L~~dP~~Rps~-----~ell~hp~~~~  280 (335)
T 3dls_A          246 LVSKELMSLVSGLLQPVPERRTTL-----EKLVTDPWVTQ  280 (335)
T ss_dssp             CCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHCTTTTC
T ss_pred             ccCHHHHHHHHHHccCChhhCcCH-----HHHhcCccccC
Confidence            899999999999999999999998     89999999965

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=4.6e-48  Score=394.94  Aligned_cols=255  Identities=32%  Similarity=0.565  Sum_probs=227.8

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeeccccc-----chhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCC
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT-----KENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTF  118 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~-----~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  118 (489)
                      ++|++.+.||+|+||.||+|++..+|+.||||++......     .......+.+|..+++.+ +||||+++++++....
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            5799999999999999999999999999999999765311     122345677899999998 8999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      ..|+||||++|++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++..+...
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~  253 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG  253 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred             EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCC
Confidence            99999999999999999998888999999999999999999999999999999999999999999999999999865432


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcC------CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNS------SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI  272 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~------~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~  272 (489)
                                 ......+||+.|+|||++.+      ..++.++|||||||++|+|++|..||.+.+.......+....+
T Consensus       254 -----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  322 (365)
T 2y7j_A          254 -----------EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY  322 (365)
T ss_dssp             -----------CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred             -----------cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence                       22345689999999999863      3578899999999999999999999999999888888888777


Q ss_pred             CCC----CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 011287          273 RFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (489)
Q Consensus       273 ~~p----~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~  315 (489)
                      .++    ..+++++.+||.+||+.||++||++     +++++||||+
T Consensus       323 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~-----~ell~hp~f~  364 (365)
T 2y7j_A          323 QFSSPEWDDRSSTVKDLISRLLQVDPEARLTA-----EQALQHPFFE  364 (365)
T ss_dssp             CCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCH-----HHHHHSGGGC
T ss_pred             CCCCcccccCCHHHHHHHHHHcCCChhHCcCH-----HHHhcCcccC
Confidence            665    4689999999999999999999998     8999999996

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.7e-48  Score=395.09  Aligned_cols=263  Identities=26%  Similarity=0.351  Sum_probs=221.8

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc------
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD------  116 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------  116 (489)
                      ..++|++++.||+|+||.||+|++..+|+.||+|++....... .....+.+|+.+++.++||||+++++++.+      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYN   93 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence            3689999999999999999999999999999999987654332 233456679999999999999999999987      


Q ss_pred             --CCEEEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCcc
Q 011287          117 --TFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK  193 (489)
Q Consensus       117 --~~~lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~  193 (489)
                        ...+|+|||||++ +|.+.+... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  172 (351)
T 3mi9_A           94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR  172 (351)
T ss_dssp             ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence              4568999999986 777777654 679999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCccccccCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC
Q 011287          194 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI  272 (489)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~  272 (489)
                      .+.....      .........+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+.....
T Consensus       173 ~~~~~~~------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  246 (351)
T 3mi9_A          173 AFSLAKN------SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG  246 (351)
T ss_dssp             ECCCCSS------SSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ccccccc------ccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            7643221      11233345689999999999876 4589999999999999999999999999998888777765332


Q ss_pred             CCCCC--------------------------------CCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 011287          273 RFPNY--------------------------------FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (489)
Q Consensus       273 ~~p~~--------------------------------~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~  318 (489)
                      .++..                                .++++.+||.+||+.||++|||+     +++++||||....
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~f~~~~  319 (351)
T 3mi9_A          247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS-----DDALNHDFFWSDP  319 (351)
T ss_dssp             CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCH-----HHHHTSGGGGSSS
T ss_pred             CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCH-----HHHhCCCCcCCCC
Confidence            22211                                27789999999999999999999     8999999997543

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-48  Score=394.81  Aligned_cols=263  Identities=25%  Similarity=0.367  Sum_probs=217.7

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccch--hHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE--NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~l  120 (489)
                      ..++|++++.||+|+||.||+|++..+|+.||+|++........  .....+.+|+.+++.++||||++++++|.+...+
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            35789999999999999999999999999999999975432221  1223567899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcc
Q 011287          121 YMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      |+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+....
T Consensus        88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  166 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  166 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence            999999986 898888765 469999999999999999999999999999999999999999999999999998654321


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC-----C
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-----R  273 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~-----~  273 (489)
                                ......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+....+.++.....     .
T Consensus       167 ----------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~  236 (346)
T 1ua2_A          167 ----------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQ  236 (346)
T ss_dssp             ----------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ----------ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhh
Confidence                      223356899999999999764 588999999999999999999999999999888877765210     0


Q ss_pred             C-----------------------CCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCccc
Q 011287          274 F-----------------------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  321 (489)
Q Consensus       274 ~-----------------------p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~  321 (489)
                      +                       ...+++++.+||.+||+.||++|||+     .++++||||.+..+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~h~~f~~~~~~~  302 (346)
T 1ua2_A          237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA-----TQALKMKYFSNRPGPT  302 (346)
T ss_dssp             SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCH-----HHHHTSGGGTSSSCCC
T ss_pred             hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCH-----HHHhcChhhhcCCCCC
Confidence            1                       13457899999999999999999999     8999999998765543

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.2e-48  Score=385.65  Aligned_cols=262  Identities=31%  Similarity=0.548  Sum_probs=227.6

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccc-hhHHHHHHHHHHHHHhCCCCCccEEEEEEE--cCCEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFFTFQ--DTFSL  120 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~l  120 (489)
                      .++|++++.||+|+||.||+|.+..+++.||+|++.+..... ......+.+|+.+++.++||||+++++++.  +...+
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            578999999999999999999999999999999997653322 234567888999999999999999999984  45679


Q ss_pred             EEEEeccCCCChHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          121 YMALESCEGGELFDQITS--KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~--~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      |+||||+.++ |.+++..  .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~  162 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF  162 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence            9999999876 7777765  356999999999999999999999999999999999999999999999999999865432


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCCC--CCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSP--ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN  276 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~--~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~  276 (489)
                      .        .........||+.|+|||++.+..  ++.++|||||||++|+|++|..||.+.+.......+......+|.
T Consensus       163 ~--------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  234 (305)
T 2wtk_C          163 A--------ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPG  234 (305)
T ss_dssp             C--------SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCS
T ss_pred             c--------cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCC
Confidence            1        112233567999999999998654  377899999999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~  319 (489)
                      .+++.+.+||.+||+.||.+||++     .++++||||+....
T Consensus       235 ~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          235 DCGPPLSDLLKGMLEYEPAKRFSI-----RQIRQHSWFRKKHP  272 (305)
T ss_dssp             SSCHHHHHHHHHHTCSSTTTSCCH-----HHHHHSHHHHSCCC
T ss_pred             ccCHHHHHHHHHHccCChhhCCCH-----HHHhcCcccccCCC
Confidence            999999999999999999999998     89999999987554

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3.2e-48  Score=396.84  Aligned_cols=255  Identities=24%  Similarity=0.404  Sum_probs=211.1

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC----
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF----  118 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----  118 (489)
                      ..++|++++.||+|+||.||+|++..+|+.||||++.+... .......+.+|+.+++.++||||+++++++....    
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  101 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  101 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence            35799999999999999999999999999999999976532 3344566778999999999999999999998664    


Q ss_pred             --EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccC
Q 011287          119 --SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (489)
Q Consensus       119 --~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~  196 (489)
                        .+|+||||+.+ +|.+.+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus       102 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~  178 (371)
T 2xrw_A          102 FQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  178 (371)
T ss_dssp             CCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred             ccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence              78999999975 7888886  359999999999999999999999999999999999999999999999999998653


Q ss_pred             CccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCC---
Q 011287          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR---  273 (489)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~---  273 (489)
                      ..           ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+......   
T Consensus       179 ~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  247 (371)
T 2xrw_A          179 TS-----------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP  247 (371)
T ss_dssp             ----------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCH
T ss_pred             cc-----------cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            21           1233568999999999999999999999999999999999999999999988887777643111   


Q ss_pred             ---------------------------------CCC------CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          274 ---------------------------------FPN------YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       274 ---------------------------------~p~------~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                                                       +|.      ..++++++||.+||+.||++|||+     +++++||||
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~-----~e~l~hp~~  322 (371)
T 2xrw_A          248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV-----DEALQHPYI  322 (371)
T ss_dssp             HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCH-----HHHHHSHHH
T ss_pred             HHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCH-----HHHhCCcch
Confidence                                             011      015689999999999999999999     899999999


Q ss_pred             CCC
Q 011287          315 KGI  317 (489)
Q Consensus       315 ~~i  317 (489)
                      +..
T Consensus       323 ~~~  325 (371)
T 2xrw_A          323 NVW  325 (371)
T ss_dssp             HTT
T ss_pred             hhh
Confidence            853

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.4e-48  Score=386.85  Aligned_cols=252  Identities=25%  Similarity=0.374  Sum_probs=209.6

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      .++|++++.||+|+||+||+|++..+|+.||||++.............+..+..+.+..+||||+++++++.+...+|+|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            47899999999999999999999999999999998765444444444444344444555999999999999999999999


Q ss_pred             EeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccc
Q 011287          124 LESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~  202 (489)
                      |||+ +++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||++......    
T Consensus       136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~----  210 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA----  210 (311)
T ss_dssp             EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred             Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC----
Confidence            9999 56998888765 46999999999999999999999999999999999999999999999999998765432    


Q ss_pred             cCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC--CCCCCCCCH
Q 011287          203 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--IRFPNYFSD  280 (489)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~--~~~p~~~~~  280 (489)
                             .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+...   ...+....  ..++..+++
T Consensus       211 -------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  279 (311)
T 3p1a_A          211 -------GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSS  279 (311)
T ss_dssp             -----------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCH
T ss_pred             -------CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCH
Confidence                   12234579999999999876 689999999999999999999777765433   23333322  224567899


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       281 ~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      ++.+||.+||+.||++||++     +++++||||+.
T Consensus       280 ~l~~li~~~L~~dP~~Rpt~-----~ell~hp~~~~  310 (311)
T 3p1a_A          280 ELRSVLVMMLEPDPKLRATA-----EALLALPVLRQ  310 (311)
T ss_dssp             HHHHHHHHHSCSSTTTSCCH-----HHHHTSGGGSC
T ss_pred             HHHHHHHHHcCCChhhCcCH-----HHHHhCccccC
Confidence            99999999999999999999     99999999974

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.9e-48  Score=389.77  Aligned_cols=263  Identities=26%  Similarity=0.431  Sum_probs=212.8

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-----
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-----  118 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----  118 (489)
                      .++|++++.||+|+||.||+|+++.+|+.||||++....  .......+.+|+.+++.++||||++++++|.+..     
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   82 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ   82 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence            468999999999999999999999999999999997653  3445567889999999999999999999986543     


Q ss_pred             ----------------------------------------------------EEEEEEeccCCCChHHHHHhCCC---CC
Q 011287          119 ----------------------------------------------------SLYMALESCEGGELFDQITSKGH---LS  143 (489)
Q Consensus       119 ----------------------------------------------------~lylV~E~~~gg~L~~~l~~~~~---l~  143 (489)
                                                                          .+|+|||||++|+|.+++.+.+.   .+
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  162 (332)
T 3qd2_B           83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE  162 (332)
T ss_dssp             HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred             hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence                                                                38999999999999999987643   56


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccC--CCCCCCCccceecCCcC
Q 011287          144 EDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP--NAASDDKACTFVGTAAY  221 (489)
Q Consensus       144 e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~--~~~~~~~~~~~~gt~~Y  221 (489)
                      +..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...........  ...........+||+.|
T Consensus       163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  242 (332)
T 3qd2_B          163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY  242 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred             hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence            6678999999999999999999999999999999999999999999999876543211100  00011233456899999


Q ss_pred             CChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCC---CCCCHHHHHHHHHhhccCCCCCC
Q 011287          222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP---NYFSDAARDLIDRLLDVDPSGRP  298 (489)
Q Consensus       222 ~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p---~~~~~~~~~Li~~~L~~dP~~R~  298 (489)
                      +|||++.+..++.++|||||||++|+|++|..|+...  ......+...  .+|   ...++++.+||.+||+.||++||
T Consensus       243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  318 (332)
T 3qd2_B          243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVRNL--KFPLLFTQKYPQEHMMVQDMLSPSPTERP  318 (332)
T ss_dssp             SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHTT--CCCHHHHHHCHHHHHHHHHHHCSSGGGSC
T ss_pred             cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhcc--CCCcccccCChhHHHHHHHHccCCCCcCC
Confidence            9999999999999999999999999999997775321  2222233322  333   34678899999999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCC
Q 011287          299 GAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       299 t~~~~~~~~l~~hpff~~i  317 (489)
                      ++     +++++||||+++
T Consensus       319 s~-----~~~l~~~~f~~~  332 (332)
T 3qd2_B          319 EA-----TDIIENAIFENL  332 (332)
T ss_dssp             CH-----HHHHHSTTCCCC
T ss_pred             CH-----HHHhhchhhhcC
Confidence            98     899999999874

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.1e-47  Score=385.04  Aligned_cols=254  Identities=27%  Similarity=0.467  Sum_probs=214.2

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccEEEEEEEc--CC
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQD--TF  118 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~--~~  118 (489)
                      ...++|++++.||+|+||.||+|++..+++.||+|++...      ....+.+|+.+++.++ ||||+++++++.+  ..
T Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~  106 (330)
T 3nsz_A           33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSR  106 (330)
T ss_dssp             EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred             cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC
Confidence            3467899999999999999999999999999999998643      2355778999999997 9999999999997  67


Q ss_pred             EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCC-CEEEeeccCccccCC
Q 011287          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-HIKIADFGSVKPMQD  197 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g-~ikL~DFG~a~~~~~  197 (489)
                      ..++||||+.+++|.+++..   +++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.+..
T Consensus       107 ~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          107 TPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             CEEEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             ceEEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            89999999999999988753   89999999999999999999999999999999999999777 899999999986543


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCC-CCHHHHHHHHHh------
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIA------  269 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~-~~~~~~~~~i~~------  269 (489)
                      .           ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.. .+....+..+..      
T Consensus       184 ~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~  252 (330)
T 3nsz_A          184 G-----------QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED  252 (330)
T ss_dssp             T-----------CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHH
T ss_pred             C-----------CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCch
Confidence            2           22335679999999999977 6689999999999999999999999954 334333332221      


Q ss_pred             -------cCCCC------------------------CCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 011287          270 -------RDIRF------------------------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (489)
Q Consensus       270 -------~~~~~------------------------p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~  318 (489)
                             ....+                        +..+++++.+||.+||+.||++|||+     +++++||||+++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta-----~e~l~hp~f~~~~  327 (330)
T 3nsz_A          253 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA-----REAMEHPYFYTVV  327 (330)
T ss_dssp             HHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCH-----HHHHTSGGGTTCC
T ss_pred             hhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCH-----HHHhcCccHhhhc
Confidence                   11111                        22379999999999999999999999     9999999999987


Q ss_pred             cc
Q 011287          319 WK  320 (489)
Q Consensus       319 ~~  320 (489)
                      ++
T Consensus       328 ~~  329 (330)
T 3nsz_A          328 KD  329 (330)
T ss_dssp             --
T ss_pred             cC
Confidence            65

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.6e-48  Score=396.64  Aligned_cols=264  Identities=27%  Similarity=0.446  Sum_probs=227.2

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCE
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  119 (489)
                      ..+..++|++++.||+|+||.||+|++..+|+.||+|++....  .......+.+|+.+++.++||||+++++++.+...
T Consensus        28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  105 (360)
T 3eqc_A           28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE  105 (360)
T ss_dssp             CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTE
T ss_pred             cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCE
Confidence            3566789999999999999999999999999999999997652  34445678889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM-GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~-gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      +|+||||+++++|.+++.+.+.+++..+..++.||+.||.|||+. ||+||||||+|||++.+++++|+|||++..+...
T Consensus       106 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  185 (360)
T 3eqc_A          106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  185 (360)
T ss_dssp             EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             EEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence            999999999999999999888999999999999999999999996 9999999999999999999999999998754221


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHH-------------
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQ-------------  265 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~-------------  265 (489)
                                  .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+......             
T Consensus       186 ------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  253 (360)
T 3eqc_A          186 ------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET  253 (360)
T ss_dssp             ------------C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------
T ss_pred             ------------cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCC
Confidence                        2235689999999999999999999999999999999999999998876644322             


Q ss_pred             -----------------------------HHHhcC-CCCC-CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          266 -----------------------------RIIARD-IRFP-NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       266 -----------------------------~i~~~~-~~~p-~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                                                   .+.... ...+ ..++.++.+||.+||+.||++|||+     +++++||||
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~~  328 (360)
T 3eqc_A          254 PPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL-----KQLMVHAFI  328 (360)
T ss_dssp             --------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCH-----HHHHTSHHH
T ss_pred             CCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCH-----HHHhhChHh
Confidence                                         222221 1222 3478999999999999999999999     899999999


Q ss_pred             CCCCcccc
Q 011287          315 KGIDWKNI  322 (489)
Q Consensus       315 ~~i~~~~~  322 (489)
                      ++.+|+.+
T Consensus       329 ~~~~~~~~  336 (360)
T 3eqc_A          329 KRSDAEEV  336 (360)
T ss_dssp             HHHHHSCC
T ss_pred             hcchHhhh
Confidence            88776554

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.1e-47  Score=375.97  Aligned_cols=251  Identities=26%  Similarity=0.389  Sum_probs=214.4

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~lyl  122 (489)
                      .++|++++.||+|+||.||+|++..+++.||+|++........ ....+.+|...+..+ +||||+++++++.+...+|+
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV-DEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSH-HHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            4689999999999999999999999999999999986544333 345566788888888 99999999999999999999


Q ss_pred             EEeccCCCChHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCC-----------------
Q 011287          123 ALESCEGGELFDQITSK----GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-----------------  181 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~----~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~-----------------  181 (489)
                      ||||+++|+|.+++.+.    +.+++..++.++.||+.||.|||++||+||||||+|||++.+                 
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~  168 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS  168 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence            99999999999999865    679999999999999999999999999999999999999854                 


Q ss_pred             --CCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCC
Q 011287          182 --GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDT  258 (489)
Q Consensus       182 --g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~  258 (489)
                        +.++|+|||++......              ....||+.|+|||++.+. .++.++|||||||++|+|++|.+|+...
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~--------------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~  234 (289)
T 1x8b_A          169 NKVMFKIGDLGHVTRISSP--------------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG  234 (289)
T ss_dssp             -CCCEEECCCTTCEETTCS--------------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred             CceEEEEcccccccccCCc--------------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence              47999999999865332              134599999999999876 5668999999999999999999888665


Q ss_pred             CHHHHHHHHHhc-CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          259 SEWLIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       259 ~~~~~~~~i~~~-~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                      ..   ...+... ...+|..+++++.+||.+||+.||++||++     .++++||||.+.
T Consensus       235 ~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~ll~h~~~~~~  286 (289)
T 1x8b_A          235 DQ---WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSA-----MALVKHSVLLSA  286 (289)
T ss_dssp             HH---HHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCH-----HHHHTCTTC---
T ss_pred             hH---HHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCH-----HHHhhChHhhhh
Confidence            33   3344443 345778899999999999999999999998     899999999864

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2e-48  Score=398.09  Aligned_cols=255  Identities=26%  Similarity=0.413  Sum_probs=203.9

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC------
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT------  117 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------  117 (489)
                      .++|++++.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+++.++||||+++++++...      
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            4789999999999999999999999999999999976432 333455677899999999999999999999754      


Q ss_pred             CEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCC
Q 011287          118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~  197 (489)
                      ..+|+|||++ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       107 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~  184 (367)
T 2fst_X          107 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD  184 (367)
T ss_dssp             CCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred             CeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence            5689999999 6799998876 5799999999999999999999999999999999999999999999999999975432


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC-----
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----  271 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~-----  271 (489)
                                   .....+||+.|+|||++.+ ..++.++||||||||+|+|++|++||.+.+....+..|....     
T Consensus       185 -------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~  251 (367)
T 2fst_X          185 -------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA  251 (367)
T ss_dssp             -------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred             -------------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence                         1235689999999999977 678999999999999999999999999999887777665411     


Q ss_pred             ------------------CCC--------CCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 011287          272 ------------------IRF--------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (489)
Q Consensus       272 ------------------~~~--------p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~  319 (489)
                                        ...        ....++++.+||++||+.||++|||+     +++++||||+....
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~-----~e~L~hp~~~~~~~  320 (367)
T 2fst_X          252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA-----AQALAHAYFAQYHD  320 (367)
T ss_dssp             HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCH-----HHHHTSGGGTTTCC
T ss_pred             HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCH-----HHHhcChhhhhccC
Confidence                              001        12468899999999999999999999     89999999997654

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=6e-48  Score=376.70  Aligned_cols=259  Identities=29%  Similarity=0.460  Sum_probs=222.7

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      .++|++++.||+|+||.||+|++..+|+.||+|++.....  ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence            4689999999999999999999999999999999975432  23456788899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      |||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..+.....   
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~---  160 (276)
T 2yex_A           84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR---  160 (276)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE---
T ss_pred             EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc---
Confidence            99999999999998877899999999999999999999999999999999999999999999999999986543211   


Q ss_pred             CCCCCCCCccceecCCcCCChhhhcCCCC-CCCCcchhhhHHHHHHhhCCCCCCCCCHH-HHHHHHHhcCCCC--CCCCC
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQRIIARDIRF--PNYFS  279 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~-~~~sDiwSLG~ilyelltG~~PF~~~~~~-~~~~~i~~~~~~~--p~~~~  279 (489)
                           ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.. ..+..+......+  +..++
T Consensus       161 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (276)
T 2yex_A          161 -----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID  235 (276)
T ss_dssp             -----ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSC
T ss_pred             -----hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcC
Confidence                 122335679999999999987764 77899999999999999999999876543 2333333333222  34689


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       280 ~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                      +.+.+||.+||+.||++||++     +++++||||+..
T Consensus       236 ~~~~~li~~~l~~~p~~Rps~-----~~il~~~~~~~~  268 (276)
T 2yex_A          236 SAPLALLHKILVENPSARITI-----PDIKKDRWYNKP  268 (276)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCH-----HHHTTCTTTTCC
T ss_pred             HHHHHHHHHHCCCCchhCCCH-----HHHhcCccccCh
Confidence            999999999999999999998     899999999864

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.2e-47  Score=388.35  Aligned_cols=269  Identities=24%  Similarity=0.385  Sum_probs=220.2

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC-----C
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT-----F  118 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~  118 (489)
                      .++|++++.||+|+||.||+|++..+|+.||||++...  ........+.+|+.+++.++||||+++++++...     .
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   87 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN   87 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence            57999999999999999999999999999999999643  2334455677899999999999999999988654     6


Q ss_pred             EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      .+|+||||+. |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus        88 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  165 (353)
T 2b9h_A           88 EVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES  165 (353)
T ss_dssp             CEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             eEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence            7999999997 599998886 57999999999999999999999999999999999999999999999999999876543


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc-------
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-------  270 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~-------  270 (489)
                      ................++||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+...       
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  245 (353)
T 2b9h_A          166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD  245 (353)
T ss_dssp             --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCST
T ss_pred             cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchh
Confidence            2211111111122345689999999998764 67899999999999999999999999998877665554321       


Q ss_pred             -----------------CCC--------CCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCccc
Q 011287          271 -----------------DIR--------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  321 (489)
Q Consensus       271 -----------------~~~--------~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~  321 (489)
                                       ...        .+..+++++.+||.+||+.||++|||+     +++++||||+.+.+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~~~~~~~~~  316 (353)
T 2b9h_A          246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITA-----KEALEHPYLQTYHDPN  316 (353)
T ss_dssp             TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCH-----HHHHTSGGGTTTCCTT
T ss_pred             ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCH-----HHHhcCccccccCCcc
Confidence                             000        123678999999999999999999999     8999999999877644

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.1e-48  Score=406.99  Aligned_cols=261  Identities=33%  Similarity=0.535  Sum_probs=215.4

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccc-----hhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-----ENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~-----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  118 (489)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|++.+.....     ......+.+|+.+|+.++||||+++++++.. .
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence            478999999999999999999999999999999998754321     1222347789999999999999999999865 4


Q ss_pred             EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCC---CEEEeeccCcccc
Q 011287          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG---HIKIADFGSVKPM  195 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g---~ikL~DFG~a~~~  195 (489)
                      ..|+||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+|+..
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  292 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  292 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred             ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence            5899999999999999998888999999999999999999999999999999999999997654   5999999999865


Q ss_pred             CCccccccCCCCCCCCccceecCCcCCChhhhcC---CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHH-HHHHHHHhcC
Q 011287          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS---SPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQRIIARD  271 (489)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~---~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~-~~~~~i~~~~  271 (489)
                      ...           ......+||+.|+|||++.+   ..++.++|||||||++|+|++|++||.+.... .....+....
T Consensus       293 ~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~  361 (419)
T 3i6u_A          293 GET-----------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK  361 (419)
T ss_dssp             C----------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTC
T ss_pred             CCC-----------ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCC
Confidence            432           22346789999999999853   56788999999999999999999999875433 3444555555


Q ss_pred             CCCC----CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCccc
Q 011287          272 IRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  321 (489)
Q Consensus       272 ~~~p----~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~  321 (489)
                      ..++    ..+++++.+||.+||+.||++||++     +++++||||++.+|..
T Consensus       362 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~-----~e~l~hp~~~~~~~~~  410 (419)
T 3i6u_A          362 YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTT-----EEALRHPWLQDEDMKR  410 (419)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCH-----HHHHHSGGGCCHHHHH
T ss_pred             CCCCchhhcccCHHHHHHHHHHccCChhHCcCH-----HHHhCCcccCChhHHH
Confidence            5543    4589999999999999999999999     8999999999877654

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.2e-47  Score=389.61  Aligned_cols=252  Identities=28%  Similarity=0.405  Sum_probs=223.8

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      +.|++++.||+|+||.||+|++..+|+.||||++.............+.+|+.+++.++||||+++++++.+....|+||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            45999999999999999999999999999999998765555555677889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          125 ESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       125 E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      ||+. |+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....      
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~------  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------  206 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC------
Confidence            9997 588887753 56799999999999999999999999999999999999999999999999999976432      


Q ss_pred             CCCCCCCCccceecCCcCCChhhhc---CCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCC--CCCCC
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLN---SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR--FPNYF  278 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~---~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~--~p~~~  278 (489)
                              ....+||+.|+|||++.   ...++.++|||||||++|+|++|++||.+.+.......+......  .+..+
T Consensus       207 --------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (348)
T 1u5q_A          207 --------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW  278 (348)
T ss_dssp             --------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTS
T ss_pred             --------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Confidence                    22568999999999984   567899999999999999999999999998888777777665432  34578


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       279 ~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      ++.+.+||.+||+.||++||++     +++++||||..
T Consensus       279 ~~~l~~li~~~l~~dP~~Rps~-----~~ll~h~~~~~  311 (348)
T 1u5q_A          279 SEYFRNFVDSCLQKIPQDRPTS-----EVLLKHRFVLR  311 (348)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCH-----HHHTTCHHHHS
T ss_pred             CHHHHHHHHHHcccChhhCcCH-----HHHhhChhhhc
Confidence            9999999999999999999998     89999999964

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=6.1e-48  Score=398.08  Aligned_cols=256  Identities=29%  Similarity=0.440  Sum_probs=214.1

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC----
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT----  117 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~----  117 (489)
                      ....+|++++.||+|+||.||+|++..++. ||+|.+.+....       ..+|+.+++.++||||++++++|...    
T Consensus        37 ~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~  108 (394)
T 4e7w_A           37 QREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKK  108 (394)
T ss_dssp             EEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSS
T ss_pred             cccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCC
Confidence            345689999999999999999999987766 888887654222       23599999999999999999999543    


Q ss_pred             --CEEEEEEeccCCCChHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeC-CCCCEEEeecc
Q 011287          118 --FSLYMALESCEGGELFDQIT----SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT-ADGHIKIADFG  190 (489)
Q Consensus       118 --~~lylV~E~~~gg~L~~~l~----~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~-~~g~ikL~DFG  190 (489)
                        ..+|+||||++++ +...+.    ....+++..++.++.||+.||.|||++||+||||||+|||++ .++++||+|||
T Consensus       109 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG  187 (394)
T 4e7w_A          109 DEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFG  187 (394)
T ss_dssp             SCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             CceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence              3489999999874 444333    346799999999999999999999999999999999999999 78999999999


Q ss_pred             CccccCCccccccCCCCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHh
Q 011287          191 SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA  269 (489)
Q Consensus       191 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~  269 (489)
                      +|+.+...           ......+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+....+..+..
T Consensus       188 ~a~~~~~~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~  256 (394)
T 4e7w_A          188 SAKILIAG-----------EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIK  256 (394)
T ss_dssp             TCEECCTT-----------CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CcccccCC-----------CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            99865332           223356889999999999765 589999999999999999999999999998877776654


Q ss_pred             c-----------------CCC------------CCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 011287          270 R-----------------DIR------------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (489)
Q Consensus       270 ~-----------------~~~------------~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~  320 (489)
                      .                 ...            ++..+++++.+||.+||+.||++|||+     .++++||||+++.|.
T Consensus       257 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~f~~~~~~  331 (394)
T 4e7w_A          257 VLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTA-----IEALCHPFFDELRTG  331 (394)
T ss_dssp             HHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH-----HHHHTSGGGSTTTSS
T ss_pred             HhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCH-----HHHhcChhhhhhccc
Confidence            2                 011            334588999999999999999999998     899999999998876


Q ss_pred             cc
Q 011287          321 NI  322 (489)
Q Consensus       321 ~~  322 (489)
                      ..
T Consensus       332 ~~  333 (394)
T 4e7w_A          332 EA  333 (394)
T ss_dssp             CC
T ss_pred             cc
Confidence            54

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.5e-47  Score=375.83  Aligned_cols=254  Identities=21%  Similarity=0.370  Sum_probs=219.3

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc----CCE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD----TFS  119 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~  119 (489)
                      ...|++.+.||+|+||.||+|.+..++..||+|++....... .....+.+|..+++.++||||+++++++.+    ...
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  103 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence            345999999999999999999999999999999998664443 345667889999999999999999999875    466


Q ss_pred             EEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeeccCCCCeeeC-CCCCEEEeeccCccccC
Q 011287          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG--LIHRDIKPENLLLT-ADGHIKIADFGSVKPMQ  196 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~g--IiHrDLKpeNILl~-~~g~ikL~DFG~a~~~~  196 (489)
                      +|+||||+++|+|.+++.+.+.+++..++.++.||+.||.|||+.|  |+||||||+|||++ .++.+||+|||++....
T Consensus       104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~  183 (290)
T 1t4h_A          104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence            9999999999999999998888999999999999999999999999  99999999999998 78999999999997533


Q ss_pred             CccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCH-HHHHHHHHhc--CCC
Q 011287          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE-WLIFQRIIAR--DIR  273 (489)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~-~~~~~~i~~~--~~~  273 (489)
                      .            .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||..... ......+...  ...
T Consensus       184 ~------------~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  250 (290)
T 1t4h_A          184 A------------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS  250 (290)
T ss_dssp             T------------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG
T ss_pred             c------------cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccc
Confidence            2            22335679999999999875 588999999999999999999999988544 4444444443  233


Q ss_pred             CCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          274 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       274 ~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      ++...++++.+||.+||+.||.+||++     +++++||||++
T Consensus       251 ~~~~~~~~l~~li~~~l~~dp~~Rps~-----~ell~h~~f~~  288 (290)
T 1t4h_A          251 FDKVAIPEVKEIIEGCIRQNKDERYSI-----KDLLNHAFFQE  288 (290)
T ss_dssp             GGGCCCHHHHHHHHHHSCSSGGGSCCH-----HHHHTSGGGC-
T ss_pred             cCCCCCHHHHHHHHHHccCChhhCCCH-----HHHhhCccccc
Confidence            556788999999999999999999998     89999999985

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-47  Score=394.32  Aligned_cols=252  Identities=28%  Similarity=0.484  Sum_probs=214.1

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEE-------
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ-------  115 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-------  115 (489)
                      ..++|++++.||+|+||.||+|++..+|+.||||++......       ..+|+.+++.++||||++++++|.       
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            357899999999999999999999999999999998654222       235999999999999999999984       


Q ss_pred             -------------------------------cCCEEEEEEeccCCCChHHHHH----hCCCCCHHHHHHHHHHHHHHHHH
Q 011287          116 -------------------------------DTFSLYMALESCEGGELFDQIT----SKGHLSEDEARFYTAEVVDALEY  160 (489)
Q Consensus       116 -------------------------------~~~~lylV~E~~~gg~L~~~l~----~~~~l~e~~~~~i~~qil~aL~~  160 (489)
                                                     +...+|+||||+++ +|.+.+.    ..+.+++..++.++.||+.||.|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                           34458999999985 7766654    45679999999999999999999


Q ss_pred             HHhCCcEeeccCCCCeeeC-CCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCC-CCCCCcc
Q 011287          161 IHSMGLIHRDIKPENLLLT-ADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDL  238 (489)
Q Consensus       161 LH~~gIiHrDLKpeNILl~-~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~-~~~~sDi  238 (489)
                      ||++||+||||||+|||++ .++.+||+|||+|+.+...           ......+||+.|+|||++.+.. ++.++||
T Consensus       157 LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di  225 (383)
T 3eb0_A          157 IHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-----------EPSVAYICSRFYRAPELMLGATEYTPSIDL  225 (383)
T ss_dssp             HHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-----------SCCCCCCCCSSCCCHHHHTTCSSCCTHHHH
T ss_pred             HHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-----------CCCcCcccCCCccCHHHhcCCCCCCcchhh
Confidence            9999999999999999997 6889999999999865432           2233567899999999987754 8999999


Q ss_pred             hhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc-----------------CC------------CCCCCCCHHHHHHHHHh
Q 011287          239 WALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-----------------DI------------RFPNYFSDAARDLIDRL  289 (489)
Q Consensus       239 wSLG~ilyelltG~~PF~~~~~~~~~~~i~~~-----------------~~------------~~p~~~~~~~~~Li~~~  289 (489)
                      |||||++|+|++|++||.+.+..+.+..+...                 ..            .+|..+++++.+||.+|
T Consensus       226 wslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  305 (383)
T 3eb0_A          226 WSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQI  305 (383)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHH
T ss_pred             hhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHH
Confidence            99999999999999999999988887777541                 11            14566899999999999


Q ss_pred             hccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 011287          290 LDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (489)
Q Consensus       290 L~~dP~~R~t~~~~~~~~l~~hpff~~i~  318 (489)
                      |+.||++|||+     .++++||||+.+.
T Consensus       306 L~~dP~~R~t~-----~e~l~hp~f~~~~  329 (383)
T 3eb0_A          306 LRYEPDLRINP-----YEAMAHPFFDHLR  329 (383)
T ss_dssp             CCSSGGGSCCH-----HHHHTSGGGHHHH
T ss_pred             ccCChhhCCCH-----HHHhcCHHHHHHH
Confidence            99999999999     8999999998654

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=8.2e-48  Score=396.64  Aligned_cols=257  Identities=28%  Similarity=0.469  Sum_probs=217.4

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC--CCCccEEEEEEEcCCEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD--HPGVVRLFFTFQDTFSL  120 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~~~l  120 (489)
                      ...+|++++.||+|+||.||+|.+.. ++.||||++.+... .......+.+|+.+|+.+.  ||||+++++++.+...+
T Consensus        54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~  131 (390)
T 2zmd_A           54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI  131 (390)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence            34569999999999999999999865 99999999976543 3345567888999999996  59999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      |+||| +.+++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.+.....
T Consensus       132 ~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~  209 (390)
T 2zmd_A          132 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  209 (390)
T ss_dssp             EEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred             EEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence            99999 56789999999988999999999999999999999999999999999999995 68999999999987643221


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcC-----------CCCCCCCcchhhhHHHHHHhhCCCCCCCCC-HHHHHHHHH
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNS-----------SPATFGNDLWALGCTLYQMLSGTSPFKDTS-EWLIFQRII  268 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-----------~~~~~~sDiwSLG~ilyelltG~~PF~~~~-~~~~~~~i~  268 (489)
                              .......+||+.|+|||++.+           ..++.++||||||||+|+|++|++||.+.. ....+..+.
T Consensus       210 --------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~  281 (390)
T 2zmd_A          210 --------SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII  281 (390)
T ss_dssp             ------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH
T ss_pred             --------cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHh
Confidence                    112345689999999999865           368889999999999999999999998753 445555665


Q ss_pred             hcC--CCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          269 ARD--IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       269 ~~~--~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      ...  ..+|...+.++.+||.+||+.||.+||++     .++++||||+.
T Consensus       282 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~-----~ell~hp~~~~  326 (390)
T 2zmd_A          282 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI-----PELLAHPYVQI  326 (390)
T ss_dssp             CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSHHHHS
T ss_pred             CccccCCCCccchHHHHHHHHHHcccChhhCCCH-----HHHhhCcCccc
Confidence            543  45678889999999999999999999998     89999999974

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=8.8e-48  Score=380.78  Aligned_cols=261  Identities=30%  Similarity=0.515  Sum_probs=223.4

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lyl  122 (489)
                      ..++|++++.||+|+||.||+|++..+|+.||+|++....   ......+.+|+.+++.++||||+++++++.+...+|+
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   93 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI   93 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence            3578999999999999999999999999999999987542   2334567789999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccc
Q 011287          123 ALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~  201 (489)
                      ||||+++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......   
T Consensus        94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---  170 (302)
T 2j7t_A           94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT---  170 (302)
T ss_dssp             EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH---
T ss_pred             EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc---
Confidence            9999999999998876 467999999999999999999999999999999999999999999999999987542211   


Q ss_pred             ccCCCCCCCCccceecCCcCCChhhh-----cCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC---C
Q 011287          202 VLPNAASDDKACTFVGTAAYVPPEVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI---R  273 (489)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~Y~aPE~l-----~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~---~  273 (489)
                             ........||+.|+|||++     .+..++.++|||||||++|+|++|..||...+.......+.....   .
T Consensus       171 -------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  243 (302)
T 2j7t_A          171 -------LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLL  243 (302)
T ss_dssp             -------HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS
T ss_pred             -------ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccC
Confidence                   0112345799999999998     466789999999999999999999999999988887777766543   2


Q ss_pred             CCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCccc
Q 011287          274 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  321 (489)
Q Consensus       274 ~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~  321 (489)
                      .|..++.++.+||.+||+.||++||++     .++++||||.++.+..
T Consensus       244 ~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~h~~~~~~~~~~  286 (302)
T 2j7t_A          244 TPSKWSVEFRDFLKIALDKNPETRPSA-----AQLLEHPFVSSITSNK  286 (302)
T ss_dssp             SGGGSCHHHHHHHHHHSCSCTTTSCCH-----HHHTTSTTTTTCCCCH
T ss_pred             CccccCHHHHHHHHHHcccChhhCCCH-----HHHhcChHHhhhccch
Confidence            356789999999999999999999998     8999999999988754

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1e-48  Score=395.51  Aligned_cols=265  Identities=23%  Similarity=0.440  Sum_probs=233.9

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchh--------------HHHHHHHHHHHHHhCCCC
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKEN--------------KTAYVKLERIVLDQLDHP  105 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~--------------~~~~~~~E~~il~~l~hp  105 (489)
                      .....++|++++.||+|+||.||+|++  +|+.||+|++.........              ....+.+|+.+++.++||
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~  103 (348)
T 2pml_X           26 KDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNE  103 (348)
T ss_dssp             SCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCT
T ss_pred             cccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCC
Confidence            345678999999999999999999999  8999999999765433221              126788899999999999


Q ss_pred             CccEEEEEEEcCCEEEEEEeccCCCChHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeeccCCCCe
Q 011287          106 GVVRLFFTFQDTFSLYMALESCEGGELFDQ------ITS--KGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENL  176 (489)
Q Consensus       106 nIv~l~~~~~~~~~lylV~E~~~gg~L~~~------l~~--~~~l~e~~~~~i~~qil~aL~~LH~-~gIiHrDLKpeNI  176 (489)
                      ||+++++++.+...+|+||||+++|+|.++      +.+  .+.+++..++.++.||+.||.|||+ +||+||||||+||
T Consensus       104 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni  183 (348)
T 2pml_X          104 YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI  183 (348)
T ss_dssp             TBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred             CcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence            999999999999999999999999999998      665  5679999999999999999999999 9999999999999


Q ss_pred             eeCCCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCC-CCCC-CCcchhhhHHHHHHhhCCCC
Q 011287          177 LLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATF-GNDLWALGCTLYQMLSGTSP  254 (489)
Q Consensus       177 Ll~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~-~sDiwSLG~ilyelltG~~P  254 (489)
                      +++.+++++|+|||++......            ......||+.|+|||++.+. .++. ++|||||||++|+|++|..|
T Consensus       184 l~~~~~~~kl~dfg~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p  251 (348)
T 2pml_X          184 LMDKNGRVKLSDFGESEYMVDK------------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP  251 (348)
T ss_dssp             EECTTSCEEECCCTTCEECBTT------------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             EEcCCCcEEEeccccccccccc------------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCC
Confidence            9999999999999999865332            22345799999999999887 5665 89999999999999999999


Q ss_pred             CCCCCH-HHHHHHHHhcCCCCC-------------------CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          255 FKDTSE-WLIFQRIIARDIRFP-------------------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       255 F~~~~~-~~~~~~i~~~~~~~p-------------------~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                      |.+.+. ......+......+|                   ..+++++.+||.+||+.||.+||++     +++++||||
T Consensus       252 f~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~-----~e~l~hp~f  326 (348)
T 2pml_X          252 FSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITS-----EDALKHEWL  326 (348)
T ss_dssp             SCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCH-----HHHHTSGGG
T ss_pred             CCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCH-----HHHhcCccc
Confidence            998877 778888888877777                   6789999999999999999999998     899999999


Q ss_pred             CCCCccccc
Q 011287          315 KGIDWKNIR  323 (489)
Q Consensus       315 ~~i~~~~~~  323 (489)
                      ++.+|..+.
T Consensus       327 ~~~~~~~~~  335 (348)
T 2pml_X          327 ADTNIEDLR  335 (348)
T ss_dssp             TTCCHHHHH
T ss_pred             cCCCHHHHH
Confidence            999987654

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.9e-47  Score=387.50  Aligned_cols=257  Identities=25%  Similarity=0.378  Sum_probs=219.4

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC-----CE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT-----FS  119 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~  119 (489)
                      ++|++++.||+|+||.||+|++..+++.||||++...  ........+.+|+.+++.++||||+++++++...     ..
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT--TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc--cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            5899999999999999999999999999999999643  2334456678899999999999999999999754     46


Q ss_pred             EEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcc
Q 011287          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      +|+||||+.+ +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       105 ~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  182 (364)
T 3qyz_A          105 VYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  182 (364)
T ss_dssp             EEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             EEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence            8999999975 99998876 469999999999999999999999999999999999999999999999999998664332


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhc-CCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC------
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLN-SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI------  272 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~-~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~------  272 (489)
                      .       ........+||+.|+|||++. ...++.++|||||||++|+|++|++||.+.+....+..+.....      
T Consensus       183 ~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  255 (364)
T 3qyz_A          183 D-------HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED  255 (364)
T ss_dssp             C-------BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred             C-------ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            1       112234568999999999865 45589999999999999999999999999887776666643100      


Q ss_pred             -------------------------CCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          273 -------------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       273 -------------------------~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                                               .++..+++++.+||.+||+.||++|||+     +++++||||+..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~~~~~  320 (364)
T 3qyz_A          256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV-----EQALAHPYLEQY  320 (364)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSGGGTTT
T ss_pred             HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCH-----HHHhcCcchhhc
Confidence                                     0124578999999999999999999998     999999999875

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.7e-47  Score=398.16  Aligned_cols=255  Identities=29%  Similarity=0.462  Sum_probs=214.4

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc------
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD------  116 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------  116 (489)
                      ...+|++++.||+|+||.||+|++..+|+.||||++.+...       ...+|+.+|+.++||||++++++|..      
T Consensus        52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~  124 (420)
T 1j1b_A           52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD  124 (420)
T ss_dssp             EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred             ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence            34579999999999999999999999999999999865421       12369999999999999999998843      


Q ss_pred             CCEEEEEEeccCCCChHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCC-CCEEEeeccC
Q 011287          117 TFSLYMALESCEGGELFDQIT----SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGS  191 (489)
Q Consensus       117 ~~~lylV~E~~~gg~L~~~l~----~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~-g~ikL~DFG~  191 (489)
                      ...+++||||+++ +|.+.+.    ....+++..++.++.||+.||.|||++||+||||||+||||+.+ +.+||+|||+
T Consensus       125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~  203 (420)
T 1j1b_A          125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS  203 (420)
T ss_dssp             EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchh
Confidence            2347899999986 6666554    34679999999999999999999999999999999999999965 5689999999


Q ss_pred             ccccCCccccccCCCCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc
Q 011287          192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR  270 (489)
Q Consensus       192 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~  270 (489)
                      ++.+...           ......+||+.|+|||++.+. .++.++||||||||+|+|++|++||.+.+..+.+..|...
T Consensus       204 a~~~~~~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~  272 (420)
T 1j1b_A          204 AKQLVRG-----------EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV  272 (420)
T ss_dssp             CEECCTT-----------CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             hhhcccC-----------CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            9865322           122356899999999999765 6899999999999999999999999999887777666541


Q ss_pred             -----------------CCC------------CCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCccc
Q 011287          271 -----------------DIR------------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  321 (489)
Q Consensus       271 -----------------~~~------------~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~  321 (489)
                                       .+.            ++..+++++.+||.+||+.||.+||++     .++++||||+++.+..
T Consensus       273 lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~-----~e~l~hp~f~~~~~~~  347 (420)
T 1j1b_A          273 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP-----LEACAHSFFDELRDPN  347 (420)
T ss_dssp             HCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCH-----HHHHTSGGGGGGGCTT
T ss_pred             hCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCH-----HHHhCCHhhccccccc
Confidence                             122            234578999999999999999999999     8999999998776544

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.5e-47  Score=377.12  Aligned_cols=259  Identities=34%  Similarity=0.574  Sum_probs=229.5

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      .++|++++.||+|+||.||+|++..+++.||+|++.+..... .....+.+|+.+++.++||||+++++++.+...+|+|
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   99 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch-HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence            478999999999999999999999999999999997654332 3345677899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCC---CCEEEeeccCccccCCccc
Q 011287          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD---GHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~---g~ikL~DFG~a~~~~~~~~  200 (489)
                      |||+.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.+   +.+||+|||++......  
T Consensus       100 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~--  177 (287)
T 2wei_A          100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--  177 (287)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC--
T ss_pred             EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC--
Confidence            9999999999999888889999999999999999999999999999999999999764   47999999998865332  


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCC----C
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----N  276 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p----~  276 (489)
                               .......||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+.......+......++    .
T Consensus       178 ---------~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (287)
T 2wei_A          178 ---------TKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWR  247 (287)
T ss_dssp             ---------SSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGT
T ss_pred             ---------CccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhh
Confidence                     122345789999999998764 88999999999999999999999999999988888888766554    4


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~  320 (489)
                      .+++++.+||.+||+.||++||++     .++++||||+..+++
T Consensus       248 ~~~~~~~~li~~~l~~dp~~Rps~-----~ell~hp~~~~~~~~  286 (287)
T 2wei_A          248 TISDDAKDLIRKMLTFHPSLRITA-----TQCLEHPWIQKYSSE  286 (287)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCH-----HHHHHSHHHHHHCCC
T ss_pred             hcCHHHHHHHHHHcccChhhCcCH-----HHHhcCHHHhccccC
Confidence            689999999999999999999998     899999999876553

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.5e-47  Score=397.86  Aligned_cols=251  Identities=25%  Similarity=0.381  Sum_probs=216.6

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC------CCCCccEEEEEEEc
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL------DHPGVVRLFFTFQD  116 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l------~hpnIv~l~~~~~~  116 (489)
                      ...+|++++.||+|+||+||+|.+..+++.||||++...    ......+.+|+.+++.+      +|+||+++++++..
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~  170 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF  170 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence            356899999999999999999999999999999999653    23344566677777766      67899999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCC--EEEeeccCc
Q 011287          117 TFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH--IKIADFGSV  192 (489)
Q Consensus       117 ~~~lylV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~--ikL~DFG~a  192 (489)
                      ...+|+||||+. ++|.+++....  .+++..++.++.||+.||.|||++||+||||||+||||+.++.  +||+|||+|
T Consensus       171 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          171 RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence            999999999996 59999998764  4999999999999999999999999999999999999999987  999999999


Q ss_pred             cccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC
Q 011287          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI  272 (489)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~  272 (489)
                      +...             ....+.+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+....-
T Consensus       250 ~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~  316 (429)
T 3kvw_A          250 CYEH-------------QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLG  316 (429)
T ss_dssp             EETT-------------CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             eecC-------------CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence            7532             223356899999999999999999999999999999999999999999998887776653200


Q ss_pred             C-----------------------------------------------------------CCCCCCHHHHHHHHHhhccC
Q 011287          273 R-----------------------------------------------------------FPNYFSDAARDLIDRLLDVD  293 (489)
Q Consensus       273 ~-----------------------------------------------------------~p~~~~~~~~~Li~~~L~~d  293 (489)
                      .                                                           ++...++++.+||.+||+.|
T Consensus       317 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~d  396 (429)
T 3kvw_A          317 MPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWD  396 (429)
T ss_dssp             CCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSS
T ss_pred             CCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCC
Confidence            0                                                           11224788999999999999


Q ss_pred             CCCCCCCCCCCHHHHhcCCCCCC
Q 011287          294 PSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       294 P~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      |++|||+     +++++||||+.
T Consensus       397 P~~Rpta-----~e~L~Hpw~~~  414 (429)
T 3kvw_A          397 PAVRMTP-----GQALRHPWLRR  414 (429)
T ss_dssp             TTTSCCH-----HHHHTSTTTC-
T ss_pred             hhhCCCH-----HHHhCChhhcc
Confidence            9999999     89999999985

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.8e-47  Score=378.53  Aligned_cols=261  Identities=31%  Similarity=0.487  Sum_probs=223.2

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ly  121 (489)
                      ...++|++++.||+|+||.||+|++..+|+.||+|++....     ....+.+|+.+++.++||||+++++++.+...+|
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW  100 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence            34678999999999999999999999999999999997542     2345777999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          122 MALESCEGGELFDQIT-SKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~-~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      +||||+++++|.+++. ..+.+++..+..++.||+.||.|||+.||+||||||+||+++.+++++|+|||++....... 
T Consensus       101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-  179 (314)
T 3com_A          101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-  179 (314)
T ss_dssp             EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-
T ss_pred             EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-
Confidence            9999999999999997 45679999999999999999999999999999999999999999999999999997654321 


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC---CCCCCC
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRFPNY  277 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~---~~~p~~  277 (489)
                               .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+....   ...|..
T Consensus       180 ---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (314)
T 3com_A          180 ---------AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPEL  250 (314)
T ss_dssp             ---------SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGG
T ss_pred             ---------cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCccc
Confidence                     12335679999999999999999999999999999999999999999988776665554432   334667


Q ss_pred             CCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccc
Q 011287          278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI  322 (489)
Q Consensus       278 ~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~  322 (489)
                      +++++.+||.+||+.||.+||++     .++++||||++..+...
T Consensus       251 ~~~~l~~li~~~l~~dp~~Rpt~-----~~ll~~~~~~~~~~~~~  290 (314)
T 3com_A          251 WSDNFTDFVKQCLVKSPEQRATA-----TQLLQHPFVRSAKGVSI  290 (314)
T ss_dssp             SCHHHHHHHHHHTCSCTTTSCCH-----HHHTTSHHHHTCCCGGG
T ss_pred             CCHHHHHHHHHHccCChhhCcCH-----HHHHhCHHHhcCCcchH
Confidence            89999999999999999999998     89999999998766543

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=9.5e-48  Score=376.18  Aligned_cols=258  Identities=29%  Similarity=0.512  Sum_probs=226.5

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEE--cCCEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ--DTFSL  120 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~l  120 (489)
                      ..++|++++.||+|+||.||+|++..+|+.||+|++...... ......+.+|+.+++.++||||+++++++.  ....+
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   82 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL   82 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence            468999999999999999999999999999999999866443 334567888999999999999999999885  46789


Q ss_pred             EEEEeccCCCChHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC-----cEeeccCCCCeeeCCCCCEEEeeccC
Q 011287          121 YMALESCEGGELFDQITSK----GHLSEDEARFYTAEVVDALEYIHSMG-----LIHRDIKPENLLLTADGHIKIADFGS  191 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~----~~l~e~~~~~i~~qil~aL~~LH~~g-----IiHrDLKpeNILl~~~g~ikL~DFG~  191 (489)
                      |+||||+++++|.+++...    ..+++..+..++.||+.||+|||+.|     |+||||||+|||++.++++||+|||+
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~  162 (279)
T 2w5a_A           83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  162 (279)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred             EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence            9999999999999999764    34999999999999999999999999     99999999999999999999999999


Q ss_pred             ccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC
Q 011287          192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD  271 (489)
Q Consensus       192 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~  271 (489)
                      +.......          .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+...+...+....
T Consensus       163 ~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~  232 (279)
T 2w5a_A          163 ARILNHDT----------SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK  232 (279)
T ss_dssp             HHHC---C----------HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             heeecccc----------ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcc
Confidence            97654321          11234579999999999999899999999999999999999999999999888888887765


Q ss_pred             C-CCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          272 I-RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       272 ~-~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      . .+|..+++++.+||.+||+.||.+||++     .++++|+|+.+
T Consensus       233 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~ll~~~~~~~  273 (279)
T 2w5a_A          233 FRRIPYRYSDELNEIITRMLNLKDYHRPSV-----EEILENPLILE  273 (279)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHHTSTTCCG
T ss_pred             cccCCcccCHHHHHHHHHHcCCCcccCCCH-----HHHHhChhhhh
Confidence            5 5778899999999999999999999998     89999999974

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.6e-47  Score=389.00  Aligned_cols=255  Identities=28%  Similarity=0.444  Sum_probs=217.8

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEE---
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL---  120 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~l---  120 (489)
                      .++|.+++.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+++.++||||+++++++.+....   
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc-chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            4789999999999999999999999999999999976532 334456677899999999999999999999877655   


Q ss_pred             ---EEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCC
Q 011287          121 ---YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (489)
Q Consensus       121 ---ylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~  197 (489)
                         |+||||+. ++|.+++..  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       120 ~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  196 (371)
T 4exu_A          120 YDFYLVMPFMQ-TDLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA  196 (371)
T ss_dssp             CCCEEEEECCC-EEHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred             eeEEEEEcccc-ccHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence               99999997 588887743  599999999999999999999999999999999999999999999999999975432


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC----
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI----  272 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~----  272 (489)
                                   .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.....    
T Consensus       197 -------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  263 (371)
T 4exu_A          197 -------------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGT  263 (371)
T ss_dssp             ----------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred             -------------CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcH
Confidence                         2234578999999999987 6789999999999999999999999999988877776654110    


Q ss_pred             ---------------------------CCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 011287          273 ---------------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (489)
Q Consensus       273 ---------------------------~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~  320 (489)
                                                 .++..+++++.+||.+||+.||++|||+     +++++||||+.+...
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~f~~~~~~  333 (371)
T 4exu_A          264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTA-----AQALTHPFFEPFRDP  333 (371)
T ss_dssp             HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCH-----HHHHTSGGGTTTCCG
T ss_pred             HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCH-----HHHhcCcccccCCCc
Confidence                                       0123578999999999999999999998     899999999976543

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=4e-47  Score=379.13  Aligned_cols=255  Identities=21%  Similarity=0.371  Sum_probs=214.9

Q ss_pred             CCCCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 011287           38 PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (489)
Q Consensus        38 ~~~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  117 (489)
                      ..-.+..++|++.+.||+|+||.||+|++  +|+.||+|++...... ......+.+|+.++++++||||+++++++.+.
T Consensus        30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  106 (309)
T 3p86_A           30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFH-AERVNEFLREVAIMKRLRHPNIVLFMGAVTQP  106 (309)
T ss_dssp             --CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCS-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             ccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence            33456678999999999999999999987  6899999999765433 33456678899999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCC--cEeeccCCCCeeeCCCCCEEEeeccCc
Q 011287          118 FSLYMALESCEGGELFDQITSKGH---LSEDEARFYTAEVVDALEYIHSMG--LIHRDIKPENLLLTADGHIKIADFGSV  192 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~~~---l~e~~~~~i~~qil~aL~~LH~~g--IiHrDLKpeNILl~~~g~ikL~DFG~a  192 (489)
                      ..+|+||||+++|+|.+++.+.+.   +++..+..++.||+.||.|||++|  |+||||||+|||++.++.+||+|||++
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  186 (309)
T 3p86_A          107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS  186 (309)
T ss_dssp             TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred             CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence            999999999999999999987654   999999999999999999999999  999999999999999999999999999


Q ss_pred             cccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHH--hc
Q 011287          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII--AR  270 (489)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~--~~  270 (489)
                      +.....          ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.  ..
T Consensus       187 ~~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  256 (309)
T 3p86_A          187 RLKAST----------FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK  256 (309)
T ss_dssp             -------------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCC
T ss_pred             cccccc----------ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC
Confidence            754322          122345689999999999999999999999999999999999999999999888777664  34


Q ss_pred             CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          271 DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       271 ~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      ...+|..+++++.+||.+||+.||.+||++     +++++
T Consensus       257 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~~ll~  291 (309)
T 3p86_A          257 RLEIPRNLNPQVAAIIEGCWTNEPWKRPSF-----ATIMD  291 (309)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCCCCccCCHHHHHHHHHHccCChhhCcCH-----HHHHH
Confidence            567888999999999999999999999998     66664

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.3e-49  Score=407.75  Aligned_cols=250  Identities=17%  Similarity=0.229  Sum_probs=209.1

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHH---HHHhCCCCCccEEE-------EE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI---VLDQLDHPGVVRLF-------FT  113 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~---il~~l~hpnIv~l~-------~~  113 (489)
                      .++|++++.||+|+||+||+|++..+|+.||||++.+...........+.+|+.   +++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            478999999999999999999999999999999998765556666778889994   55556899999998       77


Q ss_pred             EEcCCE-----------------EEEEEeccCCCChHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHhCCcEee
Q 011287          114 FQDTFS-----------------LYMALESCEGGELFDQITSKGHLSE-------DEARFYTAEVVDALEYIHSMGLIHR  169 (489)
Q Consensus       114 ~~~~~~-----------------lylV~E~~~gg~L~~~l~~~~~l~e-------~~~~~i~~qil~aL~~LH~~gIiHr  169 (489)
                      +.+.+.                 .|+||||+ +|+|.+++.+.+.+++       ..+..++.||+.||+|||++||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            776542                 89999999 5799999987666666       7888899999999999999999999


Q ss_pred             ccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCC-----------CCCCCCcc
Q 011287          170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-----------PATFGNDL  238 (489)
Q Consensus       170 DLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-----------~~~~~sDi  238 (489)
                      ||||+|||++.+|.+||+|||+|+...             ......+| +.|+|||++.+.           .++.++||
T Consensus       231 Dikp~NIll~~~~~~kL~DFG~a~~~~-------------~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv  296 (377)
T 3byv_A          231 YLRPVDIVLDQRGGVFLTGFEHLVRDG-------------ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA  296 (377)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETT-------------CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred             CCCHHHEEEcCCCCEEEEechhheecC-------------CcccCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence            999999999999999999999998532             12335678 999999999887           79999999


Q ss_pred             hhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          239 WALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       239 wSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                      |||||++|+|++|+.||.+.+.......+.    ..+..+++++.+||.+||+.||++||++     .++++||||+++
T Consensus       297 wSlG~il~elltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~-----~e~l~hp~f~~~  366 (377)
T 3byv_A          297 WALGLVIYWIWCADLPITKDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLP-----LQAMETPEYEQL  366 (377)
T ss_dssp             HHHHHHHHHHHHSSCCC------CCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGCCCH-----HHHHTSHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCcccccccchhhhh----hhccCCCHHHHHHHHHHcCCCchhCCCH-----HHHhhChHHHHH
Confidence            999999999999999998766544433332    2346789999999999999999999998     899999999764

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=8.2e-48  Score=385.42  Aligned_cols=260  Identities=33%  Similarity=0.541  Sum_probs=218.5

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeeccccc-----chhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT-----KENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~-----~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  118 (489)
                      .++|++++.||+|+||.||+|++..+++.||||++.+....     .......+.+|+.+++.++||||+++++++....
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            36899999999999999999999999999999999765322     1222345778999999999999999999998765


Q ss_pred             EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCC---EEEeeccCcccc
Q 011287          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH---IKIADFGSVKPM  195 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~---ikL~DFG~a~~~  195 (489)
                       .|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++..
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  167 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  167 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred             -eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence             8999999999999999998889999999999999999999999999999999999999987665   999999999865


Q ss_pred             CCccccccCCCCCCCCccceecCCcCCChhhhc---CCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHH-HHHHHHHhcC
Q 011287          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLN---SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQRIIARD  271 (489)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~---~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~-~~~~~i~~~~  271 (489)
                      ....           ......||+.|+|||++.   ...++.++|||||||++|+|++|..||...... .....+....
T Consensus       168 ~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  236 (322)
T 2ycf_A          168 GETS-----------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK  236 (322)
T ss_dssp             CCCH-----------HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTC
T ss_pred             cccc-----------ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCc
Confidence            4321           223567999999999974   566889999999999999999999999765433 3344455554


Q ss_pred             CCCC----CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 011287          272 IRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (489)
Q Consensus       272 ~~~p----~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~  320 (489)
                      ..++    ..+++++.+||.+||+.||++||++     +++++||||.+.+|.
T Consensus       237 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~-----~~~l~h~~~~~~~~~  284 (322)
T 2ycf_A          237 YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTT-----EEALRHPWLQDEDMK  284 (322)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCH-----HHHHTSGGGCCHHHH
T ss_pred             cccCchhhhhcCHHHHHHHHHHcccCHhhCCCH-----HHHhhCcCcCCHHHH
Confidence            4443    4689999999999999999999998     899999999987765

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=5.5e-48  Score=386.40  Aligned_cols=275  Identities=20%  Similarity=0.339  Sum_probs=208.1

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGT---VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  116 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~---~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  116 (489)
                      ..+..++|++++.||+|+||.||+|++..++.   .||+|++....... .....+.+|+.+++.++||||+++++++.+
T Consensus        18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   96 (323)
T 3qup_A           18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSLR   96 (323)
T ss_dssp             TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred             cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence            34556789999999999999999999887765   89999997654333 345667889999999999999999999987


Q ss_pred             CCEE------EEEEeccCCCChHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCE
Q 011287          117 TFSL------YMALESCEGGELFDQITSKG------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHI  184 (489)
Q Consensus       117 ~~~l------ylV~E~~~gg~L~~~l~~~~------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~i  184 (489)
                      ....      |+||||+.+|+|.+++....      .+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus        97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A           97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCE
T ss_pred             cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCE
Confidence            7655      99999999999999986542      59999999999999999999999999999999999999999999


Q ss_pred             EEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHH
Q 011287          185 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLI  263 (489)
Q Consensus       185 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~  263 (489)
                      ||+|||+++.......        ........+++.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+....
T Consensus       177 kl~Dfg~a~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~  248 (323)
T 3qup_A          177 CVADFGLSRKIYSGDY--------YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI  248 (323)
T ss_dssp             EECCCCC-------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred             EEeecccccccccccc--------ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH
Confidence            9999999986543221        112224457889999999999999999999999999999999 9999999888888


Q ss_pred             HHHHHhcC-CCCCCCCCHHHHHHHHHhhccCCCCCCCCCC--CCHHHHhcCCCCCCCCccccc
Q 011287          264 FQRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGAGP--GGYAVLKMHPFFKGIDWKNIR  323 (489)
Q Consensus       264 ~~~i~~~~-~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~--~~~~~l~~hpff~~i~~~~~~  323 (489)
                      ...+.... ...|..+++++.+||.+||+.||.+||++.+  ..+++++.|||+.+...+.+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl~  311 (323)
T 3qup_A          249 YNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLY  311 (323)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------------
T ss_pred             HHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCCC
Confidence            87776654 5677889999999999999999999999654  345889999999876655544

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-47  Score=385.92  Aligned_cols=258  Identities=28%  Similarity=0.483  Sum_probs=215.6

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC--CCccEEEEEEEcCCE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH--PGVVRLFFTFQDTFS  119 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~~~  119 (489)
                      +.-++|++++.||+|+||.||+|.+ .+++.||||++..... .......+.+|+.+|+.++|  |||+++++++.+...
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~   83 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY   83 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence            3457899999999999999999998 4689999999976543 33445667889999999976  999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcc
Q 011287          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      +|+||| +.+|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.+....
T Consensus        84 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           84 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             EEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             EEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            999999 45789999999988999999999999999999999999999999999999996 6899999999998664321


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcC-----------CCCCCCCcchhhhHHHHHHhhCCCCCCCCC-HHHHHHHH
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNS-----------SPATFGNDLWALGCTLYQMLSGTSPFKDTS-EWLIFQRI  267 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-----------~~~~~~sDiwSLG~ilyelltG~~PF~~~~-~~~~~~~i  267 (489)
                              ........+||+.|+|||++.+           ..++.++|||||||++|+|++|+.||.+.. ....+..+
T Consensus       162 --------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~  233 (343)
T 3dbq_A          162 --------TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI  233 (343)
T ss_dssp             ----------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred             --------ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHH
Confidence                    1112335689999999999865           668889999999999999999999998743 33444455


Q ss_pred             Hh--cCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          268 IA--RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       268 ~~--~~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      ..  ....+|...+.++.+||.+||+.||.+|||+     .++++||||+.
T Consensus       234 ~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~-----~e~l~hp~~~~  279 (343)
T 3dbq_A          234 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI-----PELLAHPYVQI  279 (343)
T ss_dssp             HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSHHHHS
T ss_pred             hcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCH-----HHHHhCccccc
Confidence            43  3456788889999999999999999999998     89999999973

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.2e-47  Score=380.26  Aligned_cols=260  Identities=28%  Similarity=0.461  Sum_probs=218.3

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEc----
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQD----  116 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~----  116 (489)
                      ...++|++++.||+|+||.||+|++..+|+.||+|++.....    ....+.+|+.+++.+ +||||+++++++..    
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   96 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   96 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence            346899999999999999999999999999999999975422    234577899999998 89999999999986    


Q ss_pred             --CCEEEEEEeccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCc
Q 011287          117 --TFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  192 (489)
Q Consensus       117 --~~~lylV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a  192 (489)
                        ...+|+||||+++|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  176 (326)
T 2x7f_A           97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS  176 (326)
T ss_dssp             CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred             cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence              56899999999999999999864  56999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCccccccCCCCCCCCccceecCCcCCChhhhc-----CCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHH
Q 011287          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN-----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI  267 (489)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~-----~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i  267 (489)
                      ......          ........||+.|+|||++.     +..++.++|||||||++|+|++|..||.+.+.......+
T Consensus       177 ~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  246 (326)
T 2x7f_A          177 AQLDRT----------VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI  246 (326)
T ss_dssp             C-----------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             eecCcC----------ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh
Confidence            765322          11234568999999999997     566889999999999999999999999998887776666


Q ss_pred             HhcCCC--CCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 011287          268 IARDIR--FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (489)
Q Consensus       268 ~~~~~~--~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~  320 (489)
                      ......  .+..+++.+.+||.+||..||.+||++     +++++||||++..+.
T Consensus       247 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~hp~~~~~~~~  296 (326)
T 2x7f_A          247 PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPAT-----EQLMKHPFIRDQPNE  296 (326)
T ss_dssp             HHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCH-----HHHHTSHHHHCCTTH
T ss_pred             hcCccccCCccccCHHHHHHHHHHhccChhhCCCH-----HHHhhChHHhhCccc
Confidence            554332  245689999999999999999999998     899999999876544

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.6e-47  Score=382.02  Aligned_cols=253  Identities=19%  Similarity=0.307  Sum_probs=218.7

Q ss_pred             CCCCCCCCeEEeeEEeeeCceEEEEEEEcCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 011287           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGT---VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  115 (489)
Q Consensus        39 ~~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~---~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  115 (489)
                      ...+..++|++.+.||+|+||.||+|++..+++   .||||++....  .......+.+|+.+++.++||||+++++++.
T Consensus        43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  120 (325)
T 3kul_A           43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVT  120 (325)
T ss_dssp             CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            345677899999999999999999999986655   59999997542  3344566888999999999999999999999


Q ss_pred             cCCEEEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccc
Q 011287          116 DTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (489)
Q Consensus       116 ~~~~lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~  194 (489)
                      +...+|+||||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          121 RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             GGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             eCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence            999999999999999999999755 6799999999999999999999999999999999999999999999999999987


Q ss_pred             cCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CC
Q 011287          195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DI  272 (489)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~  272 (489)
                      +......       ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+... ..
T Consensus       201 ~~~~~~~-------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~  273 (325)
T 3kul_A          201 LEDDPDA-------AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRL  273 (325)
T ss_dssp             CC----C-------CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC
T ss_pred             cccCccc-------eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCC
Confidence            6443211       111223356788999999998899999999999999999999 99999999998888887765 45


Q ss_pred             CCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          273 RFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       273 ~~p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      ..|..+++++.+||.+||+.||++||++
T Consensus       274 ~~~~~~~~~l~~li~~~l~~dp~~Rps~  301 (325)
T 3kul_A          274 PAPMGCPHALHQLMLDCWHKDRAQRPRF  301 (325)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCCcCHHHHHHHHHHccCChhhCcCH
Confidence            6778899999999999999999999998

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.6e-47  Score=389.10  Aligned_cols=255  Identities=22%  Similarity=0.373  Sum_probs=221.0

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEc-------CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFF  112 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~-------~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~  112 (489)
                      .+..++|++++.||+|+||.||+|++.       .++..||+|++...  ........+.+|+.+++.+ +||||+++++
T Consensus        77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  154 (370)
T 2psq_A           77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLG  154 (370)
T ss_dssp             BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT--CBHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred             cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC--cCHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence            456789999999999999999999975       34668999999765  2344556788899999999 8999999999


Q ss_pred             EEEcCCEEEEEEeccCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCe
Q 011287          113 TFQDTFSLYMALESCEGGELFDQITSKG----------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENL  176 (489)
Q Consensus       113 ~~~~~~~lylV~E~~~gg~L~~~l~~~~----------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNI  176 (489)
                      ++.+...+|+||||+++|+|.+++...+                .+++..+..++.||+.||+|||++||+||||||+||
T Consensus       155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI  234 (370)
T 2psq_A          155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV  234 (370)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred             EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence            9999999999999999999999998753                489999999999999999999999999999999999


Q ss_pred             eeCCCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCC
Q 011287          177 LLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF  255 (489)
Q Consensus       177 Ll~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF  255 (489)
                      |++.+|++||+|||+++.......        ........||+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus       235 ll~~~~~~kl~DFG~a~~~~~~~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~  306 (370)
T 2psq_A          235 LVTENNVMKIADFGLARDINNIDY--------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY  306 (370)
T ss_dssp             EECTTCCEEECCCSSCEETTCCCT--------TCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             EECCCCCEEEccccCCcccCcccc--------eecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCC
Confidence            999999999999999986543221        112233467889999999999999999999999999999999 99999


Q ss_pred             CCCCHHHHHHHHHhc-CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          256 KDTSEWLIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       256 ~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      .+.+..+++..+... ....|..+++++.+||.+||+.||++||++     .++++
T Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~ell~  357 (370)
T 2psq_A          307 PGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF-----KQLVE  357 (370)
T ss_dssp             TTCCGGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCH-----HHHHH
Confidence            998887777776655 356788899999999999999999999998     55653

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.6e-47  Score=381.31  Aligned_cols=255  Identities=25%  Similarity=0.396  Sum_probs=217.1

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEE-cCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCC------CccEEEEE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKK-IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP------GVVRLFFT  113 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~-~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp------nIv~l~~~  113 (489)
                      ....++|++++.||+|+||.||+|.+ ..+|+.||+|++...    ......+.+|+.+++.++|+      +|++++++
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~   85 (339)
T 1z57_A           10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEW   85 (339)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEE
T ss_pred             CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecc
Confidence            44467999999999999999999999 568999999999653    23455677888888888654      59999999


Q ss_pred             EEcCCEEEEEEeccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCC-----------
Q 011287          114 FQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-----------  180 (489)
Q Consensus       114 ~~~~~~lylV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~-----------  180 (489)
                      +.+...+|+||||+ +++|.+++...+  .+++..++.++.||+.||+|||++||+||||||+|||++.           
T Consensus        86 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~  164 (339)
T 1z57_A           86 FEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKI  164 (339)
T ss_dssp             EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC---
T ss_pred             cccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcc
Confidence            99999999999999 789999998765  6899999999999999999999999999999999999987           


Q ss_pred             --------CCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCC
Q 011287          181 --------DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGT  252 (489)
Q Consensus       181 --------~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~  252 (489)
                              ++.+||+|||+++....             .....+||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus       165 ~~~~~~~~~~~~kl~Dfg~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~  231 (339)
T 1z57_A          165 KRDERTLINPDIKVVDFGSATYDDE-------------HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGF  231 (339)
T ss_dssp             -CEEEEESCCCEEECCCSSCEETTS-------------CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             ccccccccCCCceEeeCcccccCcc-------------ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCC
Confidence                    67899999999975322             223568999999999999999999999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHHhcCCCCC--------------------------------------------CCCCHHHHHHHHH
Q 011287          253 SPFKDTSEWLIFQRIIARDIRFP--------------------------------------------NYFSDAARDLIDR  288 (489)
Q Consensus       253 ~PF~~~~~~~~~~~i~~~~~~~p--------------------------------------------~~~~~~~~~Li~~  288 (489)
                      .||.+.+..+....+......+|                                            ...++++.+||.+
T Consensus       232 ~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  311 (339)
T 1z57_A          232 TVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQK  311 (339)
T ss_dssp             CSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHH
T ss_pred             CCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHH
Confidence            99999888766555433221111                                            2235778999999


Q ss_pred             hhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 011287          289 LLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (489)
Q Consensus       289 ~L~~dP~~R~t~~~~~~~~l~~hpff~~i~  318 (489)
                      ||+.||.+|||+     +++++||||+.+.
T Consensus       312 ~L~~dP~~Rpt~-----~ell~hp~f~~~~  336 (339)
T 1z57_A          312 MLEYDPAKRITL-----REALKHPFFDLLK  336 (339)
T ss_dssp             HTCSSTTTSCCH-----HHHTTSGGGGGGG
T ss_pred             HhCcCcccccCH-----HHHhcCHHHHHHh
Confidence            999999999998     8999999998653

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=8.6e-47  Score=374.35  Aligned_cols=255  Identities=30%  Similarity=0.479  Sum_probs=227.9

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      .+.|++++.||+|+||.||+|++..+++.||+|++.....  ......+.+|+.+++.++||||+++++++.+...+|+|
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   98 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII   98 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence            3679999999999999999999999999999999976532  23456688899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      |||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..+....    
T Consensus        99 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~----  173 (303)
T 3a7i_A           99 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ----  173 (303)
T ss_dssp             EECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB----
T ss_pred             EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc----
Confidence            999999999998875 579999999999999999999999999999999999999999999999999998654321    


Q ss_pred             CCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC-CCCCCCCCHHH
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-IRFPNYFSDAA  282 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~-~~~p~~~~~~~  282 (489)
                            .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.... ..++..++..+
T Consensus       174 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  247 (303)
T 3a7i_A          174 ------IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPL  247 (303)
T ss_dssp             ------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHH
T ss_pred             ------cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHH
Confidence                  12345689999999999999999999999999999999999999999988887776665543 45677899999


Q ss_pred             HHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          283 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       283 ~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      .+||.+||+.||++||++     .++++||||..
T Consensus       248 ~~li~~~l~~dp~~Rps~-----~~ll~~~~~~~  276 (303)
T 3a7i_A          248 KEFVEACLNKEPSFRPTA-----KELLKHKFILR  276 (303)
T ss_dssp             HHHHHHHCCSSGGGSCCH-----HHHTTCHHHHH
T ss_pred             HHHHHHHcCCChhhCcCH-----HHHhhChhhhc
Confidence            999999999999999998     89999999963

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3.7e-47  Score=383.96  Aligned_cols=261  Identities=26%  Similarity=0.396  Sum_probs=220.1

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCC-cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC------ccEEEE
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTG-TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG------VVRLFF  112 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg-~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpn------Iv~l~~  112 (489)
                      .....++|++++.||+|+||.||+|++..++ ..||+|++...    ......+.+|+.+++.++|++      ++.+++
T Consensus        14 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~   89 (355)
T 2eu9_A           14 GDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSD   89 (355)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEE
T ss_pred             CceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeee
Confidence            3445689999999999999999999998777 79999999653    234456777999998886655      999999


Q ss_pred             EEEcCCEEEEEEeccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeee------------
Q 011287          113 TFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL------------  178 (489)
Q Consensus       113 ~~~~~~~lylV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl------------  178 (489)
                      ++.....+|+||||+ +++|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||+            
T Consensus        90 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~  168 (355)
T 2eu9_A           90 WFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEH  168 (355)
T ss_dssp             EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred             eeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccc
Confidence            999999999999999 567878777653  69999999999999999999999999999999999999            


Q ss_pred             -------CCCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhC
Q 011287          179 -------TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSG  251 (489)
Q Consensus       179 -------~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG  251 (489)
                             +.++.+||+|||+++....             .....+||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus       169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g  235 (355)
T 2eu9_A          169 KSCEEKSVKNTSIRVADFGSATFDHE-------------HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG  235 (355)
T ss_dssp             -CCCEEEESCCCEEECCCTTCEETTS-------------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             ccccccccCCCcEEEeecCccccccc-------------cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhC
Confidence                   5678999999999975322             22356899999999999999999999999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHHhcCCCCCC--------------------------------------------CCCHHHHHHHH
Q 011287          252 TSPFKDTSEWLIFQRIIARDIRFPN--------------------------------------------YFSDAARDLID  287 (489)
Q Consensus       252 ~~PF~~~~~~~~~~~i~~~~~~~p~--------------------------------------------~~~~~~~~Li~  287 (489)
                      ..||.+.+.......+......+|.                                            ..+.++.+||.
T Consensus       236 ~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  315 (355)
T 2eu9_A          236 FTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMR  315 (355)
T ss_dssp             SCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHH
Confidence            9999998877665554432222221                                            12457899999


Q ss_pred             HhhccCCCCCCCCCCCCHHHHhcCCCCCCCCccccc
Q 011287          288 RLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR  323 (489)
Q Consensus       288 ~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~  323 (489)
                      +||+.||++|||+     +++++||||++++|+...
T Consensus       316 ~~L~~dP~~Rpt~-----~e~l~hp~f~~~~~~~~~  346 (355)
T 2eu9_A          316 RMLEFDPAQRITL-----AEALLHPFFAGLTPEERS  346 (355)
T ss_dssp             HHTCSSTTTSCCH-----HHHTTSGGGGGCCHHHHC
T ss_pred             HHhcCChhhCcCH-----HHHhcChhhcCCChhhcc
Confidence            9999999999999     899999999999987654

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.9e-47  Score=379.20  Aligned_cols=260  Identities=27%  Similarity=0.383  Sum_probs=215.4

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEE--------
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ--------  115 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--------  115 (489)
                      .++|++++.||+|+||.||+|++..+|+.||+|++...   .......+.+|+.+++.++||||+++++++.        
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   86 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD   86 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence            47899999999999999999999999999999998654   3445567788999999999999999999884        


Q ss_pred             ------cCCEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeC-CCCCEEEee
Q 011287          116 ------DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT-ADGHIKIAD  188 (489)
Q Consensus       116 ------~~~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~-~~g~ikL~D  188 (489)
                            +...+|+||||++ |+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus        87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D  164 (320)
T 2i6l_A           87 DVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD  164 (320)
T ss_dssp             ----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred             ccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence                  4478999999998 599998865 6799999999999999999999999999999999999997 567999999


Q ss_pred             ccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHH
Q 011287          189 FGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI  267 (489)
Q Consensus       189 FG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i  267 (489)
                      ||+++.......       .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.....+.+
T Consensus       165 fg~~~~~~~~~~-------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  237 (320)
T 2i6l_A          165 FGLARIMDPHYS-------HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI  237 (320)
T ss_dssp             CTTCBCC---------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CccccccCCCcc-------cccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999987543210       1122335578999999999865 67899999999999999999999999999988877776


Q ss_pred             HhcCCC------------------------------CCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          268 IARDIR------------------------------FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       268 ~~~~~~------------------------------~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                      ......                              ++..+++++.+||.+||+.||++||++     +++++||||+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~~~~~  312 (320)
T 2i6l_A          238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTA-----EEALSHPYMSIY  312 (320)
T ss_dssp             HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCH-----HHHHTSHHHHTT
T ss_pred             HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCH-----HHHhCCcccccc
Confidence            543211                              124589999999999999999999998     899999999987


Q ss_pred             Ccc
Q 011287          318 DWK  320 (489)
Q Consensus       318 ~~~  320 (489)
                      +|.
T Consensus       313 ~~p  315 (320)
T 2i6l_A          313 SFP  315 (320)
T ss_dssp             CC-
T ss_pred             cCc
Confidence            764

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.9e-47  Score=374.57  Aligned_cols=257  Identities=24%  Similarity=0.392  Sum_probs=205.2

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ly  121 (489)
                      +..++|++++.||+|+||.||+|++..+|+.||+|++..... .......+..+...++.++||||+++++++.+....|
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~   82 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW   82 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence            567899999999999999999999999999999999976532 2233344555666688899999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeeccCCCCeeeCCCCCEEEeeccCccccC
Q 011287          122 MALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSM-GLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~aL~~LH~~-gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~  196 (489)
                      +||||+++ +|.+++..    .+.+++..++.++.||+.||.|||++ ||+||||||+||+++.++++||+|||+++...
T Consensus        83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99999975 88776653    46799999999999999999999998 99999999999999999999999999998654


Q ss_pred             CccccccCCCCCCCCccceecCCcCCChhhh----cCCCCCCCCcchhhhHHHHHHhhCCCCCCC-CCHHHHHHHHHh-c
Q 011287          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVL----NSSPATFGNDLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIA-R  270 (489)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l----~~~~~~~~sDiwSLG~ilyelltG~~PF~~-~~~~~~~~~i~~-~  270 (489)
                      ..           .......||+.|+|||++    .+..++.++|||||||++|+|++|..||.. ............ .
T Consensus       162 ~~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  230 (290)
T 3fme_A          162 DD-----------VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP  230 (290)
T ss_dssp             -------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSC
T ss_pred             cc-----------ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccC
Confidence            32           122344799999999996    556688999999999999999999999986 344444444433 3


Q ss_pred             CCCCC-CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          271 DIRFP-NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       271 ~~~~p-~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      ...++ ..+++++.+||.+||+.||++|||+     .++++||||+.
T Consensus       231 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~-----~e~l~hp~f~~  272 (290)
T 3fme_A          231 SPQLPADKFSAEFVDFTSQCLKKNSKERPTY-----PELMQHPFFTL  272 (290)
T ss_dssp             CCCCCTTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHTTSHHHHH
T ss_pred             CCCcccccCCHHHHHHHHHHhhcChhhCcCH-----HHHHhCccccc
Confidence            33333 4689999999999999999999998     89999999964

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.2e-46  Score=376.57  Aligned_cols=259  Identities=27%  Similarity=0.430  Sum_probs=220.1

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEc-CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCccEEEEEEE----
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKI-DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL---DHPGVVRLFFTFQ----  115 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~-~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~----  115 (489)
                      .++|++++.||+|+||.||+|++. .+|+.||+|++........ ....+.+|+.+++.+   +||||+++++++.    
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc-CCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            478999999999999999999995 6789999999975432221 112344566666655   8999999999987    


Q ss_pred             -cCCEEEEEEeccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCc
Q 011287          116 -DTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  192 (489)
Q Consensus       116 -~~~~lylV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a  192 (489)
                       ....+|+||||+. |+|.+++....  .+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~  167 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA  167 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence             5677999999998 59999998753  4999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC-
Q 011287          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-  271 (489)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~-  271 (489)
                      ......           .......||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+.......+.... 
T Consensus       168 ~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~  236 (326)
T 1blx_A          168 RIYSFQ-----------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG  236 (326)
T ss_dssp             CCCCGG-----------GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ccccCC-----------CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcC
Confidence            865422           12235678999999999999999999999999999999999999999999888877776420 


Q ss_pred             --------------------------CCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 011287          272 --------------------------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (489)
Q Consensus       272 --------------------------~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~  320 (489)
                                                ..++..+++.+++||.+||+.||.+||++     .++++||||+++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~e~l~hp~~~~~~~~  306 (326)
T 1blx_A          237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA-----YSALSHPYFQDLERC  306 (326)
T ss_dssp             CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCH-----HHHHTSGGGTTCCCC
T ss_pred             CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCH-----HHHhcCccccccchh
Confidence                                      11335689999999999999999999998     899999999988764

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2e-47  Score=382.05  Aligned_cols=252  Identities=23%  Similarity=0.428  Sum_probs=212.8

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC--EE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF--SL  120 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--~l  120 (489)
                      ..++|++++.||+|+||+||+|++..+|+.||||++......  .....+.+|+.+++.++||||+++++++.+..  .+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence            457899999999999999999999999999999999764322  23455678999999999999999999998655  78


Q ss_pred             EEEEeccCCCChHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeee----CCCCCEEEeeccCcc
Q 011287          121 YMALESCEGGELFDQITSKGH---LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL----TADGHIKIADFGSVK  193 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~~~---l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl----~~~g~ikL~DFG~a~  193 (489)
                      |+||||+++|+|.+++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+++
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999999987533   9999999999999999999999999999999999999    778889999999998


Q ss_pred             ccCCccccccCCCCCCCCccceecCCcCCChhhhc--------CCCCCCCCcchhhhHHHHHHhhCCCCCCCCC----HH
Q 011287          194 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN--------SSPATFGNDLWALGCTLYQMLSGTSPFKDTS----EW  261 (489)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~--------~~~~~~~sDiwSLG~ilyelltG~~PF~~~~----~~  261 (489)
                      .+...           ......+||+.|+|||++.        +..++.++|||||||++|+|++|+.||....    ..
T Consensus       165 ~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  233 (319)
T 4euu_A          165 ELEDD-----------EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK  233 (319)
T ss_dssp             ECCTT-----------CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCH
T ss_pred             ecCCC-----------CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhH
Confidence            65432           2233567999999999986        5678999999999999999999999997432    24


Q ss_pred             HHHHHHHhcCC-------------------------CCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCC
Q 011287          262 LIFQRIIARDI-------------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHP  312 (489)
Q Consensus       262 ~~~~~i~~~~~-------------------------~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hp  312 (489)
                      ....++....+                         .++..++..+.+||++||+.||++|||+     +++++||
T Consensus       234 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~-----~ell~h~  304 (319)
T 4euu_A          234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF-----DQFFAET  304 (319)
T ss_dssp             HHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCH-----HHHHHHH
T ss_pred             HHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccH-----HHhhhcc
Confidence            45555554332                         1223356789999999999999999999     8899887

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=8.9e-48  Score=380.32  Aligned_cols=270  Identities=28%  Similarity=0.462  Sum_probs=201.3

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~l  120 (489)
                      .+..++|++++.||+|+||.||+|++..+++.||||++.....  ......+.+|+.+++.++||||+++++++.+....
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   88 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL   88 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence            4567899999999999999999999999999999999865422  22345577899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCc
Q 011287          121 YMALESCEGGELFDQITS--------KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  192 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~--------~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a  192 (489)
                      |+||||+++++|.+++..        .+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence            999999999999999874        456999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCccccccCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC
Q 011287          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD  271 (489)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~  271 (489)
                      .........     ..........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+............
T Consensus       169 ~~~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  243 (303)
T 2vwi_A          169 AFLATGGDI-----TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND  243 (303)
T ss_dssp             HHCC--------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS
T ss_pred             heeccCCCc-----cchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC
Confidence            765432110     01122345689999999999876 568999999999999999999999999877665555444332


Q ss_pred             C----------CCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccc
Q 011287          272 I----------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI  322 (489)
Q Consensus       272 ~----------~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~  322 (489)
                      .          ..+..+++++.+||.+||+.||.+||++     .++++||||+...++.+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~ll~h~~~~~~~~~~~  299 (303)
T 2vwi_A          244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTA-----AELLRHKFFQKAKNKEF  299 (303)
T ss_dssp             CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCH-----HHHHTSTTC--------
T ss_pred             CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCH-----HHHhhChhhhcCCCCcc
Confidence            2          2234678999999999999999999998     89999999998766543

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.2e-46  Score=382.00  Aligned_cols=254  Identities=28%  Similarity=0.451  Sum_probs=216.5

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCE----
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS----  119 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~----  119 (489)
                      .++|.+.+.||+|+||.||+|++..+|+.||||++.... ........+.+|+.+++.++||||+++++++.+...    
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  101 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  101 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence            478999999999999999999999999999999997653 233445667889999999999999999999987654    


Q ss_pred             --EEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCC
Q 011287          120 --LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (489)
Q Consensus       120 --lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~  197 (489)
                        +|+||||+. ++|.+++..  .+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++....
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  178 (353)
T 3coi_A          102 YDFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA  178 (353)
T ss_dssp             CCCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred             eeEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence              499999997 588887753  599999999999999999999999999999999999999999999999999975432


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC-----
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----  271 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~-----  271 (489)
                                   .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+....     
T Consensus       179 -------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  245 (353)
T 3coi_A          179 -------------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGT  245 (353)
T ss_dssp             ------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCH
T ss_pred             -------------CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence                         1234678999999999987 678999999999999999999999999988877666654310     


Q ss_pred             --------------------------CCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 011287          272 --------------------------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (489)
Q Consensus       272 --------------------------~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~  319 (489)
                                                ...+..+++++.+||.+||+.||++||++     +++++||||+.+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~-----~e~l~hp~f~~~~~  314 (353)
T 3coi_A          246 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTA-----AQALTHPFFEPFRD  314 (353)
T ss_dssp             HHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCH-----HHHHTSGGGTTTCC
T ss_pred             HHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCH-----HHHhcCcchhhccC
Confidence                                      11234679999999999999999999999     89999999987654

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=5e-47  Score=389.21  Aligned_cols=251  Identities=25%  Similarity=0.346  Sum_probs=210.2

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC--------CCCccEEEEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD--------HPGVVRLFFTF  114 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~--------hpnIv~l~~~~  114 (489)
                      ..++|++++.||+|+||+||+|++..+++.||||++...    ......+.+|+.+++.+.        ||||++++++|
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~  110 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF  110 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence            357899999999999999999999999999999999653    334556778999998884        78899999999


Q ss_pred             E----cCCEEEEEEeccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CcEeeccCCCCeeeCCCC-----
Q 011287          115 Q----DTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSM-GLIHRDIKPENLLLTADG-----  182 (489)
Q Consensus       115 ~----~~~~lylV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~-gIiHrDLKpeNILl~~~g-----  182 (489)
                      .    +...+|+||||+ +++|.+.+.+.  +.+++..++.++.||+.||.|||++ ||+||||||+||||+.++     
T Consensus       111 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          111 KISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             EEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHH
T ss_pred             eecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhh
Confidence            8    567899999999 55777777654  4699999999999999999999998 999999999999999776     


Q ss_pred             --------------------------------------------CEEEeeccCccccCCccccccCCCCCCCCccceecC
Q 011287          183 --------------------------------------------HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT  218 (489)
Q Consensus       183 --------------------------------------------~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt  218 (489)
                                                                  .+||+|||++.....             .....+||
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-------------~~~~~~gt  256 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-------------HFTEDIQT  256 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-------------CSCSCCSC
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-------------cCccCCCC
Confidence                                                        899999999986532             12345799


Q ss_pred             CcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCC------HHHHHHHHHhc----------------------
Q 011287          219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS------EWLIFQRIIAR----------------------  270 (489)
Q Consensus       219 ~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~------~~~~~~~i~~~----------------------  270 (489)
                      +.|+|||++.+..++.++|||||||++|+|++|+.||.+.+      .......+...                      
T Consensus       257 ~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  336 (397)
T 1wak_A          257 RQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKK  336 (397)
T ss_dssp             GGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTT
T ss_pred             CcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCc
Confidence            99999999999999999999999999999999999998654      23333333221                      


Q ss_pred             --------------------CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          271 --------------------DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       271 --------------------~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                                          .+.++...++++.+||.+||+.||++|||+     +++++||||++
T Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~e~l~hp~~~~  397 (397)
T 1wak_A          337 GDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATA-----AECLRHPWLNS  397 (397)
T ss_dssp             SSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCH-----HHHHTSGGGGC
T ss_pred             cccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCH-----HHHhhCccccC
Confidence                                112233445778999999999999999999     99999999963

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.3e-46  Score=366.72  Aligned_cols=251  Identities=20%  Similarity=0.340  Sum_probs=220.3

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ly  121 (489)
                      +..++|++++.||+|+||.||+|++. +++.||+|++......    ...+.+|+.++++++||||+++++++.+...+|
T Consensus         7 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (269)
T 4hcu_A            7 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   81 (269)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             eChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceE
Confidence            45689999999999999999999986 5788999999765332    245778999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          122 MALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      +||||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++.......
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  161 (269)
T 4hcu_A           82 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  161 (269)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred             EEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence            999999999999999764 5699999999999999999999999999999999999999999999999999986543321


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCCCC
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYF  278 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~  278 (489)
                      .         ......||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+.......+... ....|..+
T Consensus       162 ~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  232 (269)
T 4hcu_A          162 T---------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA  232 (269)
T ss_dssp             H---------STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTS
T ss_pred             c---------cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcC
Confidence            1         1223456888999999999999999999999999999999 99999999999888888765 45567788


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 011287          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (489)
Q Consensus       279 ~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~h  311 (489)
                      ++++.+||.+||+.||++||++     .++++|
T Consensus       233 ~~~~~~li~~~l~~~p~~Rps~-----~~ll~~  260 (269)
T 4hcu_A          233 STHVYQIMNHCWRERPEDRPAF-----SRLLRQ  260 (269)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             CHHHHHHHHHHccCCcccCcCH-----HHHHHH
Confidence            9999999999999999999998     666643

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.6e-47  Score=386.99  Aligned_cols=258  Identities=23%  Similarity=0.354  Sum_probs=203.9

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC--
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF--  118 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--  118 (489)
                      ...+++|++++.||+|+||.||+|++..+|+.||||++........    ....+...++.++||||++++++|....  
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRN----RELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCC----HHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccH----HHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            3457899999999999999999999999999999999865432222    2344677788889999999999996533  


Q ss_pred             -----EEEEEEeccCCCChHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHH--hCCcEeeccCCCCeeeCC-CCCEEE
Q 011287          119 -----SLYMALESCEGGELFDQI----TSKGHLSEDEARFYTAEVVDALEYIH--SMGLIHRDIKPENLLLTA-DGHIKI  186 (489)
Q Consensus       119 -----~lylV~E~~~gg~L~~~l----~~~~~l~e~~~~~i~~qil~aL~~LH--~~gIiHrDLKpeNILl~~-~g~ikL  186 (489)
                           .+|+||||+.+ +|...+    .....+++..++.++.||+.||.|||  ++||+||||||+|||++. ++++||
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl  173 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKL  173 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEE
Confidence                 38999999987 554433    34567999999999999999999999  999999999999999997 899999


Q ss_pred             eeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCC-CCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHH
Q 011287          187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQ  265 (489)
Q Consensus       187 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~-~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~  265 (489)
                      +|||+++.+...           ......+||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+....+.
T Consensus       174 ~Dfg~a~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  242 (360)
T 3e3p_A          174 CDFGSAKKLSPS-----------EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH  242 (360)
T ss_dssp             CCCTTCBCCCTT-----------SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             eeCCCceecCCC-----------CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHH
Confidence            999999865432           1223557899999999997654 8999999999999999999999999999888777


Q ss_pred             HHHhcC--------------------------------CCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCC
Q 011287          266 RIIARD--------------------------------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF  313 (489)
Q Consensus       266 ~i~~~~--------------------------------~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpf  313 (489)
                      .+....                                ...+...++++.+||.+||+.||.+|||+     .++++|||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~e~l~hp~  317 (360)
T 3e3p_A          243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKP-----YEALCHPY  317 (360)
T ss_dssp             HHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCH-----HHHTTSGG
T ss_pred             HHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCH-----HHHhcCcc
Confidence            765421                                01122256899999999999999999999     89999999


Q ss_pred             CCCCCc
Q 011287          314 FKGIDW  319 (489)
Q Consensus       314 f~~i~~  319 (489)
                      |+++..
T Consensus       318 f~~~~~  323 (360)
T 3e3p_A          318 FDELHD  323 (360)
T ss_dssp             GGGGGC
T ss_pred             ccccCC
Confidence            997653

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-47  Score=390.69  Aligned_cols=261  Identities=20%  Similarity=0.333  Sum_probs=224.3

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEE-----EcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEE
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTF  114 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~-----~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  114 (489)
                      ..+..++|++++.||+|+||.||+|+     +..+++.||||++...  ........+.+|+.+++.++||||+++++++
T Consensus        66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  143 (367)
T 3l9p_A           66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVS  143 (367)
T ss_dssp             CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            34567899999999999999999999     4567889999998643  2334445677899999999999999999999


Q ss_pred             EcCCEEEEEEeccCCCChHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCC---CE
Q 011287          115 QDTFSLYMALESCEGGELFDQITSKG-------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG---HI  184 (489)
Q Consensus       115 ~~~~~lylV~E~~~gg~L~~~l~~~~-------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g---~i  184 (489)
                      .+....|+|||||++|+|.+++...+       .+++..+..++.||+.||.|||++||+||||||+|||++.+|   .+
T Consensus       144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~  223 (367)
T 3l9p_A          144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA  223 (367)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred             ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence            99999999999999999999998653       499999999999999999999999999999999999999655   49


Q ss_pred             EEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHH
Q 011287          185 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLI  263 (489)
Q Consensus       185 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~  263 (489)
                      ||+|||+++.+....        .........||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+....
T Consensus       224 kL~DFG~a~~~~~~~--------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~  295 (367)
T 3l9p_A          224 KIGDFGMARDIYRAG--------YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV  295 (367)
T ss_dssp             EECCCHHHHHHHHHS--------SCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             EECCCcccccccccc--------ccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            999999997543221        1123345678999999999999999999999999999999998 9999999999888


Q ss_pred             HHHHHhcC-CCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 011287          264 FQRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (489)
Q Consensus       264 ~~~i~~~~-~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~  315 (489)
                      ...+.... ...|..+++.+.+||.+||+.||++||++     .++++|.++-
T Consensus       296 ~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~eil~~l~~~  343 (367)
T 3l9p_A          296 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNF-----AIILERIEYC  343 (367)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHHHHHH
T ss_pred             HHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCH-----HHHHHHHHHH
Confidence            88877654 55677899999999999999999999998     8888887664

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=4.2e-48  Score=395.66  Aligned_cols=258  Identities=18%  Similarity=0.239  Sum_probs=201.3

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC--CCCCccEEE-------EEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL--DHPGVVRLF-------FTF  114 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l--~hpnIv~l~-------~~~  114 (489)
                      ..+|++++.||+|+||.||+|++..+|+.||||++.+...........+.+|..+++.|  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            45699999999999999999999999999999999887655556667778885544444  699988865       455


Q ss_pred             EcC-----------------CEEEEEEeccCCCChHHHHHhCC-CCCHHHH------HHHHHHHHHHHHHHHhCCcEeec
Q 011287          115 QDT-----------------FSLYMALESCEGGELFDQITSKG-HLSEDEA------RFYTAEVVDALEYIHSMGLIHRD  170 (489)
Q Consensus       115 ~~~-----------------~~lylV~E~~~gg~L~~~l~~~~-~l~e~~~------~~i~~qil~aL~~LH~~gIiHrD  170 (489)
                      ...                 ..+|+|||||+ |+|.+++...+ .+++...      ..++.||+.||+|||++||+|||
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD  219 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH  219 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence            433                 34899999998 79999998743 3444444      56779999999999999999999


Q ss_pred             cCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcC--CCCCCCCcchhhhHHHHHH
Q 011287          171 IKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS--SPATFGNDLWALGCTLYQM  248 (489)
Q Consensus       171 LKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~--~~~~~~sDiwSLG~ilyel  248 (489)
                      |||+||||+.+|++||+|||+|+.....             .....||+.|+|||++.+  ..++.++|||||||++|+|
T Consensus       220 ikp~NIll~~~~~~kL~DFG~a~~~~~~-------------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~el  286 (371)
T 3q60_A          220 FTPDNLFIMPDGRLMLGDVSALWKVGTR-------------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRV  286 (371)
T ss_dssp             CSGGGEEECTTSCEEECCGGGEEETTCE-------------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHH
T ss_pred             CCHHHEEECCCCCEEEEecceeeecCCC-------------ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHH
Confidence            9999999999999999999999865321             114467799999999987  6799999999999999999


Q ss_pred             hhCCCCCCCCCHHHH--HH-----HHHhcCCCCC--CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 011287          249 LSGTSPFKDTSEWLI--FQ-----RIIARDIRFP--NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (489)
Q Consensus       249 ltG~~PF~~~~~~~~--~~-----~i~~~~~~~p--~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~  319 (489)
                      ++|+.||.+......  +.     ......+.+|  ..+++++.+||.+||+.||++||++     .++++||||+++.|
T Consensus       287 ltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~e~l~hp~f~~~~~  361 (371)
T 3q60_A          287 WCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLP-----LEAMETPEFLQLQN  361 (371)
T ss_dssp             HHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCH-----HHHTTSHHHHHHHH
T ss_pred             HhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCH-----HHHhcCHHHHHHHH
Confidence            999999987643210  00     0111223333  4789999999999999999999999     89999999998876


Q ss_pred             c
Q 011287          320 K  320 (489)
Q Consensus       320 ~  320 (489)
                      .
T Consensus       362 ~  362 (371)
T 3q60_A          362 E  362 (371)
T ss_dssp             H
T ss_pred             H
Confidence            5

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=374.45  Aligned_cols=261  Identities=23%  Similarity=0.366  Sum_probs=215.6

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCE
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  119 (489)
                      ..+..++|++++.||+|+||+||+|++..+++.||+|++...   .......+.+|+.+++.++||||+++++++.+...
T Consensus         5 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   81 (310)
T 3s95_A            5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKR   81 (310)
T ss_dssp             EEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             eeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCe
Confidence            346789999999999999999999999999999999988543   34556678889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          120 LYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      .|+||||+++|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+++.+...
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  161 (310)
T 3s95_A           82 LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE  161 (310)
T ss_dssp             EEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred             eEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence            9999999999999999987 467999999999999999999999999999999999999999999999999999876543


Q ss_pred             cccccC----CCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHH-----HHHHHHh
Q 011287          199 RITVLP----NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWL-----IFQRIIA  269 (489)
Q Consensus       199 ~~~~~~----~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~-----~~~~i~~  269 (489)
                      ......    ...........+||+.|+|||++.+..++.++|||||||++|+|++|..||.......     ...... 
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~-  240 (310)
T 3s95_A          162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL-  240 (310)
T ss_dssp             ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH-
T ss_pred             cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc-
Confidence            321100    0001122336789999999999999999999999999999999999999997532211     011111 


Q ss_pred             cCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          270 RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       270 ~~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                       ...+|..+++.+.+||.+||+.||++||++     .++++
T Consensus       241 -~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~~l~~  275 (310)
T 3s95_A          241 -DRYCPPNCPPSFFPITVRCCDLDPEKRPSF-----VKLEH  275 (310)
T ss_dssp             -HHTCCTTCCTTHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             -cccCCCCCCHHHHHHHHHHccCChhhCcCH-----HHHHH
Confidence             123577889999999999999999999998     66653

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.7e-46  Score=370.07  Aligned_cols=259  Identities=27%  Similarity=0.480  Sum_probs=217.3

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~l  120 (489)
                      .+..++|.....||+|+||.||+|++..+++.||+|++....   ......+.+|+.+++.++||||+++++++.+...+
T Consensus        18 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   94 (295)
T 2clq_A           18 DYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFI   94 (295)
T ss_dssp             EECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             cccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcE
Confidence            344556666679999999999999999999999999997642   33446678899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCC-CCCEEEeeccCccccC
Q 011287          121 YMALESCEGGELFDQITSK---GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-DGHIKIADFGSVKPMQ  196 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~---~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~-~g~ikL~DFG~a~~~~  196 (489)
                      |+||||+++++|.+++...   ..+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||++....
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~  174 (295)
T 2clq_A           95 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA  174 (295)
T ss_dssp             EEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred             EEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence            9999999999999999875   24679999999999999999999999999999999999987 8999999999998654


Q ss_pred             CccccccCCCCCCCCccceecCCcCCChhhhcCCC--CCCCCcchhhhHHHHHHhhCCCCCCCCCHHH--HHH-HHHhcC
Q 011287          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP--ATFGNDLWALGCTLYQMLSGTSPFKDTSEWL--IFQ-RIIARD  271 (489)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~--~~~~sDiwSLG~ilyelltG~~PF~~~~~~~--~~~-~i~~~~  271 (489)
                      ...          .......||+.|+|||++.+..  ++.++|||||||++|+|++|+.||.......  ... ......
T Consensus       175 ~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  244 (295)
T 2clq_A          175 GIN----------PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH  244 (295)
T ss_dssp             C---------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCC
T ss_pred             CCC----------CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccc
Confidence            321          1223567999999999997654  7889999999999999999999997643322  222 223445


Q ss_pred             CCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          272 IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       272 ~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                      ..+|..+++++.+||.+||+.||++||++     +++++||||+..
T Consensus       245 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~ll~~~~~~~~  285 (295)
T 2clq_A          245 PEIPESMSAEAKAFILKCFEPDPDKRACA-----NDLLVDEFLKVS  285 (295)
T ss_dssp             CCCCTTSCHHHHHHHHHTTCSSTTTSCCH-----HHHHTSGGGCC-
T ss_pred             ccccccCCHHHHHHHHHHccCChhhCCCH-----HHHhcChhhhhc
Confidence            67788899999999999999999999998     899999999854

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.6e-46  Score=370.92  Aligned_cols=252  Identities=25%  Similarity=0.364  Sum_probs=207.6

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCE
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  119 (489)
                      .....++|++++.||+|+||.||+|++..+++.||+|++.............+.+|+.+++.++||||+++++++.+...
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~  108 (309)
T 2h34_A           29 EGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQ  108 (309)
T ss_dssp             -----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             CCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCe
Confidence            44567999999999999999999999999999999999987655555556778899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcc
Q 011287          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      +|+||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  188 (309)
T 2h34_A          109 LYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK  188 (309)
T ss_dssp             EEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence            99999999999999999988889999999999999999999999999999999999999999999999999987654321


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC---CCCCC
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRFPN  276 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~---~~~p~  276 (489)
                               ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...+...+....   ..++.
T Consensus       189 ---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  259 (309)
T 2h34_A          189 ---------LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRP  259 (309)
T ss_dssp             -----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTST
T ss_pred             ---------cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCC
Confidence                     112235679999999999999999999999999999999999999999877664444443322   23456


Q ss_pred             CCCHHHHHHHHHhhccCCCCCC-CC
Q 011287          277 YFSDAARDLIDRLLDVDPSGRP-GA  300 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~-t~  300 (489)
                      .+++++.+||.+||+.||++|| ++
T Consensus       260 ~~~~~l~~li~~~l~~dP~~Rp~s~  284 (309)
T 2h34_A          260 GIPVAFDAVIARGMAKNPEDRYVTC  284 (309)
T ss_dssp             TCCTHHHHHHHHHTCSSGGGSCSSH
T ss_pred             CCCHHHHHHHHHhccCCHHHHHHhH
Confidence            7899999999999999999999 55

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.7e-46  Score=375.87  Aligned_cols=268  Identities=24%  Similarity=0.294  Sum_probs=219.1

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~lyl  122 (489)
                      .++|++++.||+|+||.||+|++..+|+.||||++......     ..+.+|+.+++.+ +||||+++++++.+....|+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l   82 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM   82 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence            47899999999999999999999999999999998754322     2467799999999 99999999999999999999


Q ss_pred             EEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCC-----EEEeeccCccccC
Q 011287          123 ALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-----IKIADFGSVKPMQ  196 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~-----ikL~DFG~a~~~~  196 (489)
                      ||||+ +++|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.+++     +||+|||+++.+.
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           83 VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred             EEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence            99999 89999999874 67999999999999999999999999999999999999999887     9999999998764


Q ss_pred             CccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCC---CCHHHHHHHHHhcCCC
Q 011287          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD---TSEWLIFQRIIARDIR  273 (489)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~---~~~~~~~~~i~~~~~~  273 (489)
                      .......   .........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+   .+..+.++.+......
T Consensus       162 ~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~  238 (330)
T 2izr_A          162 DPETKKH---IPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA  238 (330)
T ss_dssp             CTTTCCB---CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred             cCCCCcc---ccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence            4321100   011123467899999999999999999999999999999999999999987   4445566666554433


Q ss_pred             CC-----CCCCHHHHHHHHHhhccCCCCCCCCCC--CCHHHHh---cCCCCCCCCccc
Q 011287          274 FP-----NYFSDAARDLIDRLLDVDPSGRPGAGP--GGYAVLK---MHPFFKGIDWKN  321 (489)
Q Consensus       274 ~p-----~~~~~~~~~Li~~~L~~dP~~R~t~~~--~~~~~l~---~hpff~~i~~~~  321 (489)
                      .|     ..++ ++.+||.+||+.||.+||++.+  ..+.++.   ...+...++|..
T Consensus       239 ~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~  295 (330)
T 2izr_A          239 TPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIG  295 (330)
T ss_dssp             SCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTTT
T ss_pred             CCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCCC
Confidence            33     2345 9999999999999999999843  1111111   244556788873

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.1e-46  Score=384.64  Aligned_cols=255  Identities=28%  Similarity=0.413  Sum_probs=214.6

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CC-----CccEEEEEEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HP-----GVVRLFFTFQ  115 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hp-----nIv~l~~~~~  115 (489)
                      .-.++|++++.||+|+||+||+|++..+++.||||++...    ......+.+|+.+++.++ |+     +|+++++++.
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~  126 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM  126 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence            3468999999999999999999999999999999999653    233455667888888774 44     4999999999


Q ss_pred             cCCEEEEEEeccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH--hCCcEeeccCCCCeeeC--CCCCEEEeec
Q 011287          116 DTFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIH--SMGLIHRDIKPENLLLT--ADGHIKIADF  189 (489)
Q Consensus       116 ~~~~lylV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH--~~gIiHrDLKpeNILl~--~~g~ikL~DF  189 (489)
                      ....+|+||||+.+ +|.+++...  +.+++..++.++.||+.||.|||  +.||+||||||+|||++  .++.+||+||
T Consensus       127 ~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DF  205 (382)
T 2vx3_A          127 FRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF  205 (382)
T ss_dssp             ETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred             cCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence            99999999999965 999999875  46999999999999999999999  57999999999999995  4788999999


Q ss_pred             cCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHh
Q 011287          190 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA  269 (489)
Q Consensus       190 G~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~  269 (489)
                      |+++....             .....+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+....+..+..
T Consensus       206 G~a~~~~~-------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~  272 (382)
T 2vx3_A          206 GSSCQLGQ-------------RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVE  272 (382)
T ss_dssp             TTCEETTC-------------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             cCceeccc-------------ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            99986532             22356899999999999999999999999999999999999999999999888877764


Q ss_pred             cCCCCC------------------CC----------------------------------------------CCHHHHHH
Q 011287          270 RDIRFP------------------NY----------------------------------------------FSDAARDL  285 (489)
Q Consensus       270 ~~~~~p------------------~~----------------------------------------------~~~~~~~L  285 (489)
                      .....|                  ..                                              .++++++|
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl  352 (382)
T 2vx3_A          273 VLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDL  352 (382)
T ss_dssp             HHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHH
T ss_pred             HhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHH
Confidence            211100                  00                                              01378999


Q ss_pred             HHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 011287          286 IDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (489)
Q Consensus       286 i~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~  319 (489)
                      |.+||+.||++|||+     +++++||||++..+
T Consensus       353 i~~mL~~dP~~Rpta-----~e~L~hp~f~~~~~  381 (382)
T 2vx3_A          353 ILRMLDYDPKTRIQP-----YYALQHSFFKKTAD  381 (382)
T ss_dssp             HHHHTCSCTTTSCCH-----HHHTTSGGGCC---
T ss_pred             HHHhcCCChhhCCCH-----HHHhcCcccccCCC
Confidence            999999999999999     89999999987543

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.7e-46  Score=366.87  Aligned_cols=252  Identities=21%  Similarity=0.328  Sum_probs=217.8

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~l  120 (489)
                      .+..++|++++.||+|+||.||+|++. ++..||+|++......    ...+.+|+.+++.++||||+++++++.+...+
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   94 (283)
T 3gen_A           20 EIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI   94 (283)
T ss_dssp             BCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             cCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCe
Confidence            456789999999999999999999886 6788999999765332    24577899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcc
Q 011287          121 YMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      |+||||+++++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+||+++.+++++|+|||+++......
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  174 (283)
T 3gen_A           95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  174 (283)
T ss_dssp             EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred             EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence            999999999999999987 4679999999999999999999999999999999999999999999999999998664432


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhcC-CCCCCC
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRFPNY  277 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~~-~~~p~~  277 (489)
                      ..         ......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...+.......+.... ...|..
T Consensus       175 ~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  245 (283)
T 3gen_A          175 YT---------SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHL  245 (283)
T ss_dssp             HH---------STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTT
T ss_pred             cc---------cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCc
Confidence            11         1123356788999999998899999999999999999998 999999999988888887653 456677


Q ss_pred             CCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 011287          278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (489)
Q Consensus       278 ~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~h  311 (489)
                      .++.+.+||.+||+.||.+||++     .++++|
T Consensus       246 ~~~~l~~li~~~l~~~p~~Rps~-----~~ll~~  274 (283)
T 3gen_A          246 ASEKVYTIMYSCWHEKADERPTF-----KILLSN  274 (283)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCH-----HHHHHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCH-----HHHHHH
Confidence            89999999999999999999998     666653

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.5e-46  Score=382.11  Aligned_cols=256  Identities=22%  Similarity=0.378  Sum_probs=210.6

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeeccccc--------chhHHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT--------KENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  115 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~--------~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  115 (489)
                      .++|++++.||+|+||.||+|.+.. |+.||||++......        .......+.+|+.+++.++||||+++++++.
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   99 (362)
T 3pg1_A           21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV   99 (362)
T ss_dssp             TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred             ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence            4789999999999999999999865 999999998654322        2233467888999999999999999999984


Q ss_pred             -----cCCEEEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeec
Q 011287          116 -----DTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADF  189 (489)
Q Consensus       116 -----~~~~lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DF  189 (489)
                           ....+|+||||+. |+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus       100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df  178 (362)
T 3pg1_A          100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF  178 (362)
T ss_dssp             ECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred             eccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEec
Confidence                 3447899999998 5888888765 46999999999999999999999999999999999999999999999999


Q ss_pred             cCccccCCccccccCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHH
Q 011287          190 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII  268 (489)
Q Consensus       190 G~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~  268 (489)
                      |+++.....           ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.
T Consensus       179 g~~~~~~~~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~  247 (362)
T 3pg1_A          179 NLAREDTAD-----------ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV  247 (362)
T ss_dssp             TC--------------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             Ccccccccc-----------cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            999754321           22335689999999999977 678999999999999999999999999999888777765


Q ss_pred             hcCC--------------------------------CCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          269 ARDI--------------------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       269 ~~~~--------------------------------~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      ....                                ..+..+++.+.+||.+||+.||++|||+     .++++||||++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~f~~  322 (362)
T 3pg1_A          248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIST-----EQALRHPYFES  322 (362)
T ss_dssp             HHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHHTSGGGTT
T ss_pred             HHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCH-----HHHHcCchhhh
Confidence            3110                                1123568899999999999999999998     89999999997


Q ss_pred             C
Q 011287          317 I  317 (489)
Q Consensus       317 i  317 (489)
                      +
T Consensus       323 ~  323 (362)
T 3pg1_A          323 L  323 (362)
T ss_dssp             T
T ss_pred             c
Confidence            6

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.1e-46  Score=378.17  Aligned_cols=258  Identities=18%  Similarity=0.300  Sum_probs=215.8

Q ss_pred             CCCCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcE----EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEE
Q 011287           38 PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTV----YALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT  113 (489)
Q Consensus        38 ~~~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~----vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  113 (489)
                      ....+..++|++++.||+|+||.||+|++..+++.    ||+|++.....  ......+.+|..+++.++||||++++++
T Consensus         6 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~   83 (325)
T 3kex_A            6 LARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLDHAHIVRLLGL   83 (325)
T ss_dssp             CCCBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTCCCTTBCCEEEE
T ss_pred             HHhhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc--HHHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence            34567789999999999999999999999888876    66666543321  1122345668999999999999999999


Q ss_pred             EEcCCEEEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCc
Q 011287          114 FQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  192 (489)
Q Consensus       114 ~~~~~~lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a  192 (489)
                      +.+ ...|+||||+.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||++
T Consensus        84 ~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a  162 (325)
T 3kex_A           84 CPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVA  162 (325)
T ss_dssp             ECB-SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred             EcC-CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcc
Confidence            875 5689999999999999999875 57999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-
Q 011287          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-  270 (489)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-  270 (489)
                      +.+....        .........||..|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+... 
T Consensus       163 ~~~~~~~--------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~  234 (325)
T 3kex_A          163 DLLPPDD--------KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE  234 (325)
T ss_dssp             GGSCCCT--------TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC
T ss_pred             cccCccc--------ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC
Confidence            8764432        1122345678889999999999999999999999999999999 99999998877777776665 


Q ss_pred             CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 011287          271 DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (489)
Q Consensus       271 ~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~h  311 (489)
                      ....|..++.++.+||.+||+.||.+||++     .++++|
T Consensus       235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~el~~~  270 (325)
T 3kex_A          235 RLAQPQICTIDVYMVMVKCWMIDENIRPTF-----KELANE  270 (325)
T ss_dssp             BCCCCTTBCTTTTHHHHHHTCSCTTTSCCH-----HHHHHH
T ss_pred             CCCCCCcCcHHHHHHHHHHcCCChhhCcCH-----HHHHHH
Confidence            456777899999999999999999999998     566654

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2e-46  Score=372.83  Aligned_cols=259  Identities=22%  Similarity=0.367  Sum_probs=223.5

Q ss_pred             CCCCCCCCCCeEEeeEEeeeCceEEEEEEEc-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEE
Q 011287           37 APQEHFSIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLF  111 (489)
Q Consensus        37 ~~~~~~~~~dy~~~~~LG~G~~g~Vy~a~~~-----~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~  111 (489)
                      .+.-.+..++|.+++.||+|+||.||+|++.     .++..||+|++....  .......+.+|+.+++.++||||++++
T Consensus        15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~   92 (314)
T 2ivs_A           15 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLY   92 (314)
T ss_dssp             CTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             CcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEE
Confidence            3445667789999999999999999999983     456899999997542  334456788899999999999999999


Q ss_pred             EEEEcCCEEEEEEeccCCCChHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCcE
Q 011287          112 FTFQDTFSLYMALESCEGGELFDQITSKGH------------------------LSEDEARFYTAEVVDALEYIHSMGLI  167 (489)
Q Consensus       112 ~~~~~~~~lylV~E~~~gg~L~~~l~~~~~------------------------l~e~~~~~i~~qil~aL~~LH~~gIi  167 (489)
                      +++.+...+|+||||+++|+|.+++...+.                        +++..+..++.||+.||.|||++||+
T Consensus        93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv  172 (314)
T 2ivs_A           93 GACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLV  172 (314)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             EEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence            999999999999999999999999987543                        89999999999999999999999999


Q ss_pred             eeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHH
Q 011287          168 HRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQ  247 (489)
Q Consensus       168 HrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilye  247 (489)
                      ||||||+|||++.++.+||+|||+++........        .......+|+.|+|||++.+..++.++|||||||++|+
T Consensus       173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e  244 (314)
T 2ivs_A          173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY--------VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE  244 (314)
T ss_dssp             CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCE--------ECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHH
T ss_pred             ccccchheEEEcCCCCEEEccccccccccccccc--------eeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHH
Confidence            9999999999999999999999999865432211        12234467889999999999889999999999999999


Q ss_pred             Hhh-CCCCCCCCCHHHHHHHHHhc-CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          248 MLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       248 llt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      |++ |..||.+.+.......+... ....|..+++++.+||.+||+.||++||++     .++++
T Consensus       245 l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~l~~  304 (314)
T 2ivs_A          245 IVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVF-----ADISK  304 (314)
T ss_dssp             HHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             HHhCCCCCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCH-----HHHHH
Confidence            999 99999998887777766654 355778899999999999999999999998     66654

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=4.1e-46  Score=367.74  Aligned_cols=266  Identities=31%  Similarity=0.525  Sum_probs=212.7

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc-------
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD-------  116 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-------  116 (489)
                      .++|++++.||+|+||.||+|++..+|+.||||++...    ......+.+|+.+++.++||||+++++++.+       
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP   80 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence            36899999999999999999999999999999999643    3445678889999999999999999998865       


Q ss_pred             ------CCEEEEEEeccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeec
Q 011287          117 ------TFSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADF  189 (489)
Q Consensus       117 ------~~~lylV~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DF  189 (489)
                            ...+|+||||+++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus        81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~df  160 (303)
T 1zy4_A           81 MTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF  160 (303)
T ss_dssp             -----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred             hcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeC
Confidence                  457899999999999999998653 5889999999999999999999999999999999999999999999999


Q ss_pred             cCccccCCccccccCC----CCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCC-CCHHHH
Q 011287          190 GSVKPMQDSRITVLPN----AASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKD-TSEWLI  263 (489)
Q Consensus       190 G~a~~~~~~~~~~~~~----~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~-~~~~~~  263 (489)
                      |++.............    ...........||+.|+|||++.+. .++.++|||||||++|+|++   ||.. .+....
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~  237 (303)
T 1zy4_A          161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI  237 (303)
T ss_dssp             CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred             cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence            9998764321100000    0011233466899999999999865 68999999999999999998   5653 334455


Q ss_pred             HHHHHhcCCCCCC----CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCccc
Q 011287          264 FQRIIARDIRFPN----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKN  321 (489)
Q Consensus       264 ~~~i~~~~~~~p~----~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~  321 (489)
                      ...+......+|.    ..++.+++||.+||+.||.+|||+     .++++||||....++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~ll~h~~~~~~~~~~  294 (303)
T 1zy4_A          238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGA-----RTLLNSGWLPVKHQDE  294 (303)
T ss_dssp             HHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCH-----HHHHHSSCSCCCCHHH
T ss_pred             HHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCH-----HHHhCCCCcCCCChHH
Confidence            5666655555554    456779999999999999999998     8999999998766654

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.3e-47  Score=376.42  Aligned_cols=255  Identities=31%  Similarity=0.550  Sum_probs=211.7

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhC----CCCCccEEEEE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE---NKTAYVKLERIVLDQL----DHPGVVRLFFT  113 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~---~~~~~~~~E~~il~~l----~hpnIv~l~~~  113 (489)
                      ....++|++++.||+|+||.||+|++..+|+.||+|++........   .....+.+|+.+++++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            3446789999999999999999999999999999999976543321   1223345688888888    89999999999


Q ss_pred             EEcCCEEEEEEec-cCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeC-CCCCEEEeeccC
Q 011287          114 FQDTFSLYMALES-CEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT-ADGHIKIADFGS  191 (489)
Q Consensus       114 ~~~~~~lylV~E~-~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~-~~g~ikL~DFG~  191 (489)
                      +.+....|+|||+ +.+++|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+||+++ .++.+||+|||+
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~  186 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS  186 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence            9999999999999 78999999999888899999999999999999999999999999999999999 789999999999


Q ss_pred             ccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCC-CCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc
Q 011287          192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR  270 (489)
Q Consensus       192 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~-~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~  270 (489)
                      +......            ......||..|+|||++.+..+ +.++|||||||++|+|++|+.||...      ..+...
T Consensus       187 ~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~~~~  248 (312)
T 2iwi_A          187 GALLHDE------------PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEA  248 (312)
T ss_dssp             CEECCSS------------CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHT
T ss_pred             hhhcccC------------cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh------HHHhhh
Confidence            9865432            2235579999999999977665 45899999999999999999999764      235566


Q ss_pred             CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 011287          271 DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (489)
Q Consensus       271 ~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~  318 (489)
                      ...+|..+++++.+||.+||+.||++||++     +++++||||+...
T Consensus       249 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~e~l~~~~~~~~~  291 (312)
T 2iwi_A          249 ELHFPAHVSPDCCALIRRCLAPKPSSRPSL-----EEILLDPWMQTPA  291 (312)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSTTTSCCH-----HHHHHSTTTCC--
T ss_pred             ccCCcccCCHHHHHHHHHHccCChhhCcCH-----HHHhcChhhcCch
Confidence            778899999999999999999999999998     8999999998643

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.2e-46  Score=381.99  Aligned_cols=255  Identities=25%  Similarity=0.393  Sum_probs=215.2

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEE-----EcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQ  115 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~-----~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~  115 (489)
                      +..++|++++.||+|+||.||+|+     +..+++.||||++....  .......+.+|+.+++.+ +||||+++++++.
T Consensus        19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~   96 (359)
T 3vhe_A           19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT   96 (359)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence            456899999999999999999999     55677999999997542  233456688899999999 7899999999998


Q ss_pred             cCC-EEEEEEeccCCCChHHHHHhCCC-----------------------------------------------------
Q 011287          116 DTF-SLYMALESCEGGELFDQITSKGH-----------------------------------------------------  141 (489)
Q Consensus       116 ~~~-~lylV~E~~~gg~L~~~l~~~~~-----------------------------------------------------  141 (489)
                      +.. .+|+|||||++|+|.+++.....                                                     
T Consensus        97 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (359)
T 3vhe_A           97 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV  176 (359)
T ss_dssp             STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred             cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence            754 48999999999999999987543                                                     


Q ss_pred             -------------CCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCC
Q 011287          142 -------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS  208 (489)
Q Consensus       142 -------------l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~  208 (489)
                                   +++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+++.+....        .
T Consensus       177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~--------~  248 (359)
T 3vhe_A          177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP--------D  248 (359)
T ss_dssp             -------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT--------T
T ss_pred             hhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccc--------c
Confidence                         8999999999999999999999999999999999999999999999999998654321        1


Q ss_pred             CCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHH-HHh-cCCCCCCCCCHHHHHH
Q 011287          209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQR-IIA-RDIRFPNYFSDAARDL  285 (489)
Q Consensus       209 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~-i~~-~~~~~p~~~~~~~~~L  285 (489)
                      ........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+....... +.. .....|..+++++.+|
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  328 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT  328 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHH
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence            122345678999999999999999999999999999999998 9999988764443333 332 3456788899999999


Q ss_pred             HHHhhccCCCCCCCCCCCCHHHHhcC
Q 011287          286 IDRLLDVDPSGRPGAGPGGYAVLKMH  311 (489)
Q Consensus       286 i~~~L~~dP~~R~t~~~~~~~~l~~h  311 (489)
                      |.+||+.||.+||++     .++++|
T Consensus       329 i~~~l~~dP~~Rps~-----~ell~~  349 (359)
T 3vhe_A          329 MLDCWHGEPSQRPTF-----SELVEH  349 (359)
T ss_dssp             HHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             HHHHccCChhhCCCH-----HHHHHH
Confidence            999999999999998     667654

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-46  Score=376.55  Aligned_cols=254  Identities=20%  Similarity=0.330  Sum_probs=221.9

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEc-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  115 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~-----~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  115 (489)
                      .+..++|++++.||+|+||.||+|++.     .+++.||+|++.+..  .......+.+|+.+++.++||||+++++++.
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            456689999999999999999999997     456899999997542  3344567888999999999999999999999


Q ss_pred             cCCEEEEEEeccCCCChHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecc
Q 011287          116 DTFSLYMALESCEGGELFDQITSK------------------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDI  171 (489)
Q Consensus       116 ~~~~lylV~E~~~gg~L~~~l~~~------------------------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDL  171 (489)
                      +...+|+||||+++|+|.+++...                        +.+++..+..++.||+.||.|||++||+||||
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl  200 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL  200 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence            999999999999999999999874                        56999999999999999999999999999999


Q ss_pred             CCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-
Q 011287          172 KPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-  250 (489)
Q Consensus       172 KpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-  250 (489)
                      ||+|||++.++.+||+|||+++.......        ........||+.|+|||++.+..++.++|||||||++|+|++ 
T Consensus       201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~  272 (343)
T 1luf_A          201 ATRNCLVGENMVVKIADFGLSRNIYSADY--------YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY  272 (343)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGC--------BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             CcceEEECCCCeEEEeecCCCcccccCcc--------ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhc
Confidence            99999999999999999999986543221        112234578999999999999899999999999999999999 


Q ss_pred             CCCCCCCCCHHHHHHHHHhcCC-CCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHh
Q 011287          251 GTSPFKDTSEWLIFQRIIARDI-RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLK  309 (489)
Q Consensus       251 G~~PF~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~  309 (489)
                      |..||.+.+.......+..... .+|..+++++.+||.+||+.||++||++     .+++
T Consensus       273 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~~~  327 (343)
T 1luf_A          273 GLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSF-----CSIH  327 (343)
T ss_dssp             TCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHH
T ss_pred             CCCcCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCH-----HHHH
Confidence            9999999998888888776654 5788899999999999999999999998     5565

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.1e-45  Score=364.73  Aligned_cols=272  Identities=19%  Similarity=0.277  Sum_probs=220.5

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFS  119 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  119 (489)
                      ....++|++++.||+|+||.||+|++..+|+.||+|++.....     ...+.+|..+++.+ +|+|++++++++.+...
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~   80 (298)
T 1csn_A            6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH   80 (298)
T ss_dssp             CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred             cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence            3456789999999999999999999999999999999865432     23366789999999 79999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCC-----EEEeeccCcc
Q 011287          120 LYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH-----IKIADFGSVK  193 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~-----ikL~DFG~a~  193 (489)
                      .|+||||+ +++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.     +||+|||+++
T Consensus        81 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           81 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             eEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            99999999 899999998754 5999999999999999999999999999999999999988776     9999999998


Q ss_pred             ccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCC---CHHHHHHHHHhc
Q 011287          194 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT---SEWLIFQRIIAR  270 (489)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~---~~~~~~~~i~~~  270 (489)
                      ..........   ..........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.   +....+..+...
T Consensus       160 ~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  236 (298)
T 1csn_A          160 FYRDPVTKQH---IPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK  236 (298)
T ss_dssp             ESBCTTTCCB---CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred             cccccccccc---ccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence            7654321100   0112345678999999999999999999999999999999999999999874   444555555443


Q ss_pred             CCC-----CCCCCCHHHHHHHHHhhccCCCCCCCCCC--CCHHHH---hcCCCCCCCCccc
Q 011287          271 DIR-----FPNYFSDAARDLIDRLLDVDPSGRPGAGP--GGYAVL---KMHPFFKGIDWKN  321 (489)
Q Consensus       271 ~~~-----~p~~~~~~~~~Li~~~L~~dP~~R~t~~~--~~~~~l---~~hpff~~i~~~~  321 (489)
                      ...     ++..+++++.+||.+||+.||++||++.+  ..+.++   +.......++|+.
T Consensus       237 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~  297 (298)
T 1csn_A          237 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNL  297 (298)
T ss_dssp             HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGC
T ss_pred             ccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccCC
Confidence            222     23578999999999999999999999844  111222   2344455566654

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=9.5e-47  Score=390.24  Aligned_cols=259  Identities=26%  Similarity=0.376  Sum_probs=197.2

Q ss_pred             CCeEE-eeEEeeeCceEEEEEEEc--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEE--cCCE
Q 011287           45 QDFEL-GKIYGVGSYSKVVRAKKI--DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ--DTFS  119 (489)
Q Consensus        45 ~dy~~-~~~LG~G~~g~Vy~a~~~--~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~  119 (489)
                      +.|++ +++||+|+||.||+|+++  .+++.||||++......     ..+.+|+.+|+.++||||++++++|.  ....
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   94 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRK   94 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence            45777 668999999999999976  57899999999754322     34667999999999999999999995  4778


Q ss_pred             EEEEEeccCCCChHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeee----CCCCCEEE
Q 011287          120 LYMALESCEGGELFDQITSK---------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL----TADGHIKI  186 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~---------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl----~~~g~ikL  186 (489)
                      +|+||||+.+ +|.+++...         ..+++..++.++.||+.||.|||++||+||||||+||||    +.++.+||
T Consensus        95 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           95 VWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence            9999999975 888887632         249999999999999999999999999999999999999    67789999


Q ss_pred             eeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCCCHH----
Q 011287          187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEW----  261 (489)
Q Consensus       187 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~~~~----  261 (489)
                      +|||+|+.+....       .........+||+.|+|||++.+. .++.++||||||||+|+|++|++||.+.+..    
T Consensus       174 ~Dfg~a~~~~~~~-------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~  246 (405)
T 3rgf_A          174 ADMGFARLFNSPL-------KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS  246 (405)
T ss_dssp             CCTTCCC-----------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------
T ss_pred             EECCCceecCCCC-------cccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccc
Confidence            9999998764321       111233467899999999999874 5899999999999999999999999876552    


Q ss_pred             -----HHHHHHHhcCCC--------------------------------------CCCCCCHHHHHHHHHhhccCCCCCC
Q 011287          262 -----LIFQRIIARDIR--------------------------------------FPNYFSDAARDLIDRLLDVDPSGRP  298 (489)
Q Consensus       262 -----~~~~~i~~~~~~--------------------------------------~p~~~~~~~~~Li~~~L~~dP~~R~  298 (489)
                           ..+..+......                                      .....++++.+||.+||+.||++||
T Consensus       247 ~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~  326 (405)
T 3rgf_A          247 NPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI  326 (405)
T ss_dssp             CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSC
T ss_pred             ccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCC
Confidence                 344444321000                                      0011277899999999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCCCccc
Q 011287          299 GAGPGGYAVLKMHPFFKGIDWKN  321 (489)
Q Consensus       299 t~~~~~~~~l~~hpff~~i~~~~  321 (489)
                      |+     +++++||||.+..+..
T Consensus       327 ta-----~e~L~hp~f~~~~~~~  344 (405)
T 3rgf_A          327 TS-----EQAMQDPYFLEDPLPT  344 (405)
T ss_dssp             CH-----HHHHTSGGGTSSSCCC
T ss_pred             CH-----HHHhcChhhccCCCCc
Confidence            99     9999999998765543

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=5.9e-46  Score=361.59  Aligned_cols=252  Identities=20%  Similarity=0.326  Sum_probs=219.6

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~l  120 (489)
                      .+..++|++++.||+|+||.||+|++. ++..||+|++......    ...+.+|+.+++.++||||+++++++.+....
T Consensus         4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (268)
T 3sxs_A            4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI   78 (268)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence            356789999999999999999999885 5778999999765332    24577899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcc
Q 011287          121 YMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      |+||||+++++|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred             EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence            99999999999999998754 49999999999999999999999999999999999999999999999999998654432


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhcC-CCCCCC
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRFPNY  277 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~~-~~~p~~  277 (489)
                      ..         ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+.......+.... ...|..
T Consensus       159 ~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  229 (268)
T 3sxs_A          159 YV---------SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHL  229 (268)
T ss_dssp             EE---------ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTT
T ss_pred             hh---------cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCc
Confidence            11         1123456778999999998889999999999999999999 999999999888887777654 345677


Q ss_pred             CCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 011287          278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (489)
Q Consensus       278 ~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~h  311 (489)
                      .++++.+||.+||+.||++||++     .++++|
T Consensus       230 ~~~~l~~li~~~l~~~p~~Rps~-----~~ll~~  258 (268)
T 3sxs_A          230 ASDTIYQIMYSCWHELPEKRPTF-----QQLLSS  258 (268)
T ss_dssp             SCHHHHHHHHHTTCSSGGGSCCH-----HHHHHH
T ss_pred             ChHHHHHHHHHHcCCChhhCcCH-----HHHHHH
Confidence            89999999999999999999998     667653

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.8e-46  Score=369.02  Aligned_cols=247  Identities=19%  Similarity=0.300  Sum_probs=214.2

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCC-------cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTG-------TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT  113 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg-------~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  113 (489)
                      .+..++|++.+.||+|+||.||+|++..++       ..||+|++.+.   .......+.+|+.+++.++||||++++++
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   80 (289)
T 4fvq_A            4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---HRNYSESFFEAASMMSKLSHKHLVLNYGV   80 (289)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG---GGGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred             EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc---cHHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence            456789999999999999999999998877       47999998654   23445668889999999999999999999


Q ss_pred             EEcCCEEEEEEeccCCCChHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCC--------E
Q 011287          114 FQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH--------I  184 (489)
Q Consensus       114 ~~~~~~lylV~E~~~gg~L~~~l~~~~~-l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~--------i  184 (489)
                      +.+....|+||||+++|+|.+++.+.+. +++..+..++.||+.||.|||++||+||||||+|||++.++.        +
T Consensus        81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence            9999999999999999999999987654 999999999999999999999999999999999999999887        9


Q ss_pred             EEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhC-CCCCCCCCHHH
Q 011287          185 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSG-TSPFKDTSEWL  262 (489)
Q Consensus       185 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG-~~PF~~~~~~~  262 (489)
                      ||+|||++.....              .....||+.|+|||++.+ ..++.++|||||||++|+|++| .+||...+...
T Consensus       161 kl~Dfg~~~~~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~  226 (289)
T 4fvq_A          161 KLSDPGISITVLP--------------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR  226 (289)
T ss_dssp             EECCCCSCTTTSC--------------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred             eeccCcccccccC--------------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH
Confidence            9999999875432              224568999999999987 6789999999999999999995 55555555444


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          263 IFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       263 ~~~~i~~~~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                       ...+......+|...++++.+||.+||+.||++||++     .++++
T Consensus       227 -~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~  268 (289)
T 4fvq_A          227 -KLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSF-----RAIIR  268 (289)
T ss_dssp             -HHHHHHTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCH-----HHHHH
T ss_pred             -HHHHhhccCCCCCCCCHHHHHHHHHHcCCChhHCcCH-----HHHHH
Confidence             4445556677888889999999999999999999998     67764

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=7e-47  Score=378.88  Aligned_cols=257  Identities=30%  Similarity=0.515  Sum_probs=223.0

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhCC--CCCccEEEEEEE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE---NKTAYVKLERIVLDQLD--HPGVVRLFFTFQ  115 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~---~~~~~~~~E~~il~~l~--hpnIv~l~~~~~  115 (489)
                      ....++|++++.||+|+||.||+|++..+|+.||||++........   .....+.+|+.+++.++  ||||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            3446789999999999999999999999999999999976543321   11233556888999985  599999999999


Q ss_pred             cCCEEEEEEeccCC-CChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeC-CCCCEEEeeccCcc
Q 011287          116 DTFSLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT-ADGHIKIADFGSVK  193 (489)
Q Consensus       116 ~~~~lylV~E~~~g-g~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~-~~g~ikL~DFG~a~  193 (489)
                      +....++|||++.+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~  198 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA  198 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence            99999999999986 89999999888999999999999999999999999999999999999999 78999999999998


Q ss_pred             ccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCC-CCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC
Q 011287          194 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI  272 (489)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~-~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~  272 (489)
                      .....            ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....      .+.....
T Consensus       199 ~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~  260 (320)
T 3a99_A          199 LLKDT------------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQV  260 (320)
T ss_dssp             ECCSS------------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCC
T ss_pred             ccccc------------cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccc
Confidence            65432            2234579999999999987665 678899999999999999999997642      3455667


Q ss_pred             CCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 011287          273 RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (489)
Q Consensus       273 ~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~  320 (489)
                      .++..+++++.+||.+||+.||++||++     +++++||||+++.+.
T Consensus       261 ~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~ll~hp~~~~~~~~  303 (320)
T 3a99_A          261 FFRQRVSSECQHLIRWCLALRPSDRPTF-----EEIQNHPWMQDVLLP  303 (320)
T ss_dssp             CCSSCCCHHHHHHHHHHTCSSGGGSCCH-----HHHHTSGGGSSCCCH
T ss_pred             cccccCCHHHHHHHHHHccCChhhCcCH-----HHHhcCHhhcCccCc
Confidence            7888999999999999999999999998     899999999987654

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=378.64  Aligned_cols=256  Identities=23%  Similarity=0.363  Sum_probs=223.2

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCC-------CcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEE
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDT-------GTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLF  111 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~t-------g~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~  111 (489)
                      ..+..++|++++.||+|+||.||+|++..+       +..||+|++...  ........+.+|+.+++.+ +||||++++
T Consensus        64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~  141 (382)
T 3tt0_A           64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLL  141 (382)
T ss_dssp             TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc--cCHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence            355668999999999999999999997543       368999999765  2334456788899999999 999999999


Q ss_pred             EEEEcCCEEEEEEeccCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCC
Q 011287          112 FTFQDTFSLYMALESCEGGELFDQITSKG----------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPEN  175 (489)
Q Consensus       112 ~~~~~~~~lylV~E~~~gg~L~~~l~~~~----------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeN  175 (489)
                      +++.+...+|+||||+++|+|.+++...+                .+++..+..++.||+.||.|||++||+||||||+|
T Consensus       142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  221 (382)
T 3tt0_A          142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN  221 (382)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence            99999999999999999999999998754                49999999999999999999999999999999999


Q ss_pred             eeeCCCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCC
Q 011287          176 LLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSP  254 (489)
Q Consensus       176 ILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~P  254 (489)
                      ||++.++.+||+|||+++.......        ........||+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p  293 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHIDY--------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP  293 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCCT--------TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             EEEcCCCcEEEcccCcccccccccc--------cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999986643221        122234567899999999999999999999999999999999 9999


Q ss_pred             CCCCCHHHHHHHHHhc-CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          255 FKDTSEWLIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       255 F~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      |.+.+..+..+.+... ....|..+++++.+||.+||+.||++||++     .++++
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~  345 (382)
T 3tt0_A          294 YPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF-----KQLVE  345 (382)
T ss_dssp             STTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCH-----HHHHH
Confidence            9999988888877665 456788899999999999999999999998     66664

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=4.3e-46  Score=372.23  Aligned_cols=268  Identities=19%  Similarity=0.307  Sum_probs=228.9

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEc-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  115 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~-----~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  115 (489)
                      ....++|++.+.||+|+||.||+|++.     .+++.||+|++....  .......+.+|+.+++.++||||+++++++.
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   98 (322)
T 1p4o_A           21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVS   98 (322)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence            455688999999999999999999986     468899999997542  2233456778999999999999999999999


Q ss_pred             cCCEEEEEEeccCCCChHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEE
Q 011287          116 DTFSLYMALESCEGGELFDQITSK----------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIK  185 (489)
Q Consensus       116 ~~~~lylV~E~~~gg~L~~~l~~~----------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ik  185 (489)
                      +....|+||||+++|+|.+++...          ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~k  178 (322)
T 1p4o_A           99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK  178 (322)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred             cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEE
Confidence            999999999999999999998753          3579999999999999999999999999999999999999999999


Q ss_pred             EeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHH
Q 011287          186 IADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIF  264 (489)
Q Consensus       186 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~  264 (489)
                      |+|||+++.......        ........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.....
T Consensus       179 l~Dfg~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  250 (322)
T 1p4o_A          179 IGDFGMTRDIYETDY--------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL  250 (322)
T ss_dssp             ECCTTCCCGGGGGGC--------EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred             ECcCccccccccccc--------cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHH
Confidence            999999986543221        112234578899999999999899999999999999999999 89999999988888


Q ss_pred             HHHHhcC-CCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC------CCCCCCCccccc
Q 011287          265 QRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH------PFFKGIDWKNIR  323 (489)
Q Consensus       265 ~~i~~~~-~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~h------pff~~i~~~~~~  323 (489)
                      ..+.... ...|..+++++.+||.+||+.||.+||++     .++++|      ++|+.++|....
T Consensus       251 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~e~l~~L~~~~~~~~~~~~~~~~~  311 (322)
T 1p4o_A          251 RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF-----LEIISSIKEEMEPGFREVSFYYSE  311 (322)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHHHGGGSCTTHHHHCSTTST
T ss_pred             HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCH-----HHHHHHHHHhhccCCccccccccc
Confidence            8777654 45678899999999999999999999998     556644      777776665443

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=368.21  Aligned_cols=269  Identities=27%  Similarity=0.429  Sum_probs=209.0

Q ss_pred             ccccccCCCCCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEE
Q 011287           31 KSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRL  110 (489)
Q Consensus        31 ~s~~~~~~~~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l  110 (489)
                      +...+..+.-....++|++++.||+|+||.||+|++..+|+.||||++...... ......+..+..+++.++||||+++
T Consensus        11 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~   89 (318)
T 2dyl_A           11 GYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQC   89 (318)
T ss_dssp             CSEEESSSEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred             ceEEecchhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeE
Confidence            444455555566789999999999999999999999999999999999765322 2233445555667888899999999


Q ss_pred             EEEEEcCCEEEEEEeccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeeccCCCCeeeCCCCCEEEee
Q 011287          111 FFTFQDTFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSM-GLIHRDIKPENLLLTADGHIKIAD  188 (489)
Q Consensus       111 ~~~~~~~~~lylV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~aL~~LH~~-gIiHrDLKpeNILl~~~g~ikL~D  188 (489)
                      ++++.+...+|+||||+ ++.+..+... .+.+++..+..++.||+.||.|||+. ||+||||||+|||++.++++||+|
T Consensus        90 ~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~d  168 (318)
T 2dyl_A           90 FGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCD  168 (318)
T ss_dssp             EEEEECSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECC
T ss_pred             EEEEecCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEE
Confidence            99999999999999999 5556555543 46799999999999999999999995 999999999999999999999999


Q ss_pred             ccCccccCCccccccCCCCCCCCccceecCCcCCChhhhc-----CCCCCCCCcchhhhHHHHHHhhCCCCCCC-CCHHH
Q 011287          189 FGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN-----SSPATFGNDLWALGCTLYQMLSGTSPFKD-TSEWL  262 (489)
Q Consensus       189 FG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~-----~~~~~~~sDiwSLG~ilyelltG~~PF~~-~~~~~  262 (489)
                      ||++..+....           ......||+.|+|||++.     ...++.++|||||||++|+|++|+.||.. .+...
T Consensus       169 fg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  237 (318)
T 2dyl_A          169 FGISGRLVDDK-----------AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE  237 (318)
T ss_dssp             CTTC-------------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH
T ss_pred             CCCchhccCCc-----------cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH
Confidence            99987653321           223457999999999994     45688899999999999999999999987 45666


Q ss_pred             HHHHHHhcCCC-CC--CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          263 IFQRIIARDIR-FP--NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       263 ~~~~i~~~~~~-~p--~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                      .+..+...... +|  ..+++++.+||.+||+.||.+||++     +++++||||++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~h~~~~~~  290 (318)
T 2dyl_A          238 VLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKY-----NKLLEHSFIKRY  290 (318)
T ss_dssp             HHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCH-----HHHTTSHHHHHH
T ss_pred             HHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCH-----HHHhhCHHHHhc
Confidence            66666665433 33  3589999999999999999999998     899999999754

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.3e-46  Score=377.95  Aligned_cols=251  Identities=31%  Similarity=0.493  Sum_probs=185.7

Q ss_pred             CCCCCeEEee-EEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc----
Q 011287           42 FSIQDFELGK-IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD----  116 (489)
Q Consensus        42 ~~~~dy~~~~-~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----  116 (489)
                      ...++|++.+ +||+|+||.||+|+++.+|+.||||++....       .........++.++||||+++++++..    
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~   97 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYENMHHG   97 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHHHhhccCC
Confidence            3457899965 6999999999999999999999999986531       112223344677899999999999976    


Q ss_pred             CCEEEEEEeccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCC---CCEEEeeccC
Q 011287          117 TFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD---GHIKIADFGS  191 (489)
Q Consensus       117 ~~~lylV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~---g~ikL~DFG~  191 (489)
                      ...+|+|||||+||+|.+++.+.+  .+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||+
T Consensus        98 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~  177 (336)
T 3fhr_A           98 KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF  177 (336)
T ss_dssp             EEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             CceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence            556899999999999999998764  69999999999999999999999999999999999999864   5599999999


Q ss_pred             ccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHH----HHHH
Q 011287          192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLI----FQRI  267 (489)
Q Consensus       192 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~----~~~i  267 (489)
                      ++.....            .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....    ...+
T Consensus       178 ~~~~~~~------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  245 (336)
T 3fhr_A          178 AKETTQN------------ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRI  245 (336)
T ss_dssp             CEEC----------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------
T ss_pred             ceecccc------------ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhh
Confidence            9754321            22356789999999999888899999999999999999999999987665443    2333


Q ss_pred             HhcCCCCC----CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          268 IARDIRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       268 ~~~~~~~p----~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      ......+|    ..+++++.+||.+||+.||++|||+     +++++||||++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~~~~  293 (336)
T 3fhr_A          246 RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTI-----TQFMNHPWINQ  293 (336)
T ss_dssp             -----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCH-----HHHHHSHHHHT
T ss_pred             hccccccCchhhccCCHHHHHHHHHHCCCChhHCcCH-----HHHhcCccccc
Confidence            33334444    4689999999999999999999998     89999999975

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=4.4e-46  Score=379.56  Aligned_cols=255  Identities=26%  Similarity=0.410  Sum_probs=211.7

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-----------CCCcc
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-----------HPGVV  108 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~-----------hpnIv  108 (489)
                      ..+..++|++++.||+|+||.||+|++..+|+.||||++...    ......+.+|+.+++++.           ||||+
T Consensus        14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~   89 (373)
T 1q8y_A           14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHIL   89 (373)
T ss_dssp             CEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred             CcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHH
Confidence            345678999999999999999999999999999999999753    233455777888888875           89999


Q ss_pred             EEEEEEEcCC----EEEEEEeccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CcEeeccCCCCeeeCC-
Q 011287          109 RLFFTFQDTF----SLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSM-GLIHRDIKPENLLLTA-  180 (489)
Q Consensus       109 ~l~~~~~~~~----~lylV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~-gIiHrDLKpeNILl~~-  180 (489)
                      ++++++....    .+++||||+ +++|.+++...  +.+++..++.++.||+.||.|||++ ||+||||||+|||++. 
T Consensus        90 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~  168 (373)
T 1q8y_A           90 KLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV  168 (373)
T ss_dssp             CCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred             HHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEecc
Confidence            9999998654    799999999 88999999874  4599999999999999999999998 9999999999999953 


Q ss_pred             -----CCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCC
Q 011287          181 -----DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF  255 (489)
Q Consensus       181 -----~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF  255 (489)
                           ++.+||+|||+++....             .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus       169 ~~~~~~~~~kl~Dfg~a~~~~~-------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf  235 (373)
T 1q8y_A          169 DSPENLIQIKIADLGNACWYDE-------------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF  235 (373)
T ss_dssp             ETTTTEEEEEECCCTTCEETTB-------------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred             CCCcCcceEEEcccccccccCC-------------CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence                 44899999999986532             123457899999999999999999999999999999999999999


Q ss_pred             CCCCH------HHHHHHHH------------------------------------------hcCCCCCCCCCHHHHHHHH
Q 011287          256 KDTSE------WLIFQRII------------------------------------------ARDIRFPNYFSDAARDLID  287 (489)
Q Consensus       256 ~~~~~------~~~~~~i~------------------------------------------~~~~~~p~~~~~~~~~Li~  287 (489)
                      .+.+.      ......+.                                          .....+|...++++.+||.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  315 (373)
T 1q8y_A          236 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS  315 (373)
T ss_dssp             ---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHG
T ss_pred             CCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHH
Confidence            86542      22222222                                          2233455566788999999


Q ss_pred             HhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          288 RLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       288 ~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                      +||+.||++|||+     +++++||||++.
T Consensus       316 ~~L~~dP~~Rpt~-----~ell~hp~f~~~  340 (373)
T 1q8y_A          316 PMLQLDPRKRADA-----GGLVNHPWLKDT  340 (373)
T ss_dssp             GGGCSSTTTCBCH-----HHHHTCGGGTTC
T ss_pred             HHhccCccccCCH-----HHHhhChhhhcc
Confidence            9999999999999     899999999864

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=4.4e-46  Score=381.83  Aligned_cols=250  Identities=24%  Similarity=0.407  Sum_probs=217.9

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~l  120 (489)
                      .+..++|++++.||+|+||.||+|++..+++.||||++....  .......+.+|+.+|+.++||||+++++++.+...+
T Consensus       110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  187 (377)
T 3cbl_A          110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI  187 (377)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence            355689999999999999999999999999999999986542  233345577899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcc
Q 011287          121 YMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      |+||||+++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       188 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~  267 (377)
T 3cbl_A          188 YIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV  267 (377)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence            99999999999999998754 59999999999999999999999999999999999999999999999999998643321


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCCC
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNY  277 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~  277 (489)
                      ..        .......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+... ...+|..
T Consensus       268 ~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  339 (377)
T 3cbl_A          268 YA--------ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPEL  339 (377)
T ss_dssp             EE--------CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTT
T ss_pred             ee--------ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence            11        11123346788999999998889999999999999999998 99999999888777766554 4567888


Q ss_pred             CCHHHHHHHHHhhccCCCCCCCC
Q 011287          278 FSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       278 ~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      +++++.+||.+||+.||++|||+
T Consensus       340 ~~~~l~~li~~cl~~dP~~Rps~  362 (377)
T 3cbl_A          340 CPDAVFRLMEQCWAYEPGQRPSF  362 (377)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCHHHHHHHHHHcCCCchhCcCH
Confidence            99999999999999999999998

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=6.6e-46  Score=364.22  Aligned_cols=252  Identities=25%  Similarity=0.431  Sum_probs=206.9

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDT---GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~t---g~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  118 (489)
                      +..++|++++.||+|+||.||+|++..+   +..||+|++...  ........+.+|..+++.++||||+++++++.+ .
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~   88 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-N   88 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-S
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-C
Confidence            4568999999999999999999998654   557999998653  233445668889999999999999999999854 5


Q ss_pred             EEEEEEeccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCC
Q 011287          119 SLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~  197 (489)
                      ..|+||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+++....
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A           89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence            6899999999999999998654 699999999999999999999999999999999999999999999999999986643


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhcC-CCCC
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRFP  275 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~~-~~~p  275 (489)
                      ..         ........+|+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+.......+.... ..+|
T Consensus       169 ~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~  239 (281)
T 1mp8_A          169 ST---------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP  239 (281)
T ss_dssp             -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC
T ss_pred             cc---------ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCC
Confidence            22         111223457889999999998899999999999999999996 999999988877777776643 5678


Q ss_pred             CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       276 ~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      ..+++++.+||.+||+.||++||++     .++++
T Consensus       240 ~~~~~~l~~li~~~l~~~p~~Rps~-----~~l~~  269 (281)
T 1mp8_A          240 PNCPPTLYSLMTKCWAYDPSRRPRF-----TELKA  269 (281)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCH-----HHHHH
Confidence            8899999999999999999999998     55653

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.8e-45  Score=358.44  Aligned_cols=249  Identities=23%  Similarity=0.438  Sum_probs=206.2

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccc-hhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~l  120 (489)
                      +..++|++.+.||+|+||.||+|++  +|+.||+|++....... ......+.+|..+++.++||||+++++++.+....
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (271)
T 3dtc_A            4 IDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL   81 (271)
T ss_dssp             CCTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred             cchhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence            4578999999999999999999998  48999999987643322 23346688899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---cEeeccCCCCeeeCC--------CCCEEEeec
Q 011287          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG---LIHRDIKPENLLLTA--------DGHIKIADF  189 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~g---IiHrDLKpeNILl~~--------~g~ikL~DF  189 (489)
                      |+||||+++++|.+++.. +.+++..+..++.|++.||.|||++|   |+||||||+|||++.        ++.+||+||
T Consensus        82 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           82 CLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EEEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            999999999999998864 57999999999999999999999999   999999999999986        678999999


Q ss_pred             cCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHh
Q 011287          190 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA  269 (489)
Q Consensus       190 G~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~  269 (489)
                      |++......            ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus       161 g~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  228 (271)
T 3dtc_A          161 GLAREWHRT------------TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM  228 (271)
T ss_dssp             CC-------------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHT
T ss_pred             Ccccccccc------------cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhc
Confidence            999765322            12245799999999999999999999999999999999999999999988877776665


Q ss_pred             cC--CCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          270 RD--IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       270 ~~--~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      ..  ..+|..+++.+.+||.+||+.||.+||++     .++++
T Consensus       229 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~e~l~  266 (271)
T 3dtc_A          229 NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSF-----TNILD  266 (271)
T ss_dssp             SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCCCCCCCcccCHHHHHHHHHHhcCCcccCcCH-----HHHHH
Confidence            54  45677899999999999999999999998     66764

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.8e-45  Score=357.49  Aligned_cols=250  Identities=20%  Similarity=0.336  Sum_probs=219.1

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ly  121 (489)
                      +..++|++.+.||+|+||.||+|++. +++.||+|++......    ...+.+|+.+++.++||||+++++++.+...+|
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (267)
T 3t9t_A            5 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   79 (267)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             EchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence            45679999999999999999999996 6789999999765332    245778999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          122 MALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      +||||+++++|.+++... +.+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++........
T Consensus        80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~  159 (267)
T 3t9t_A           80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  159 (267)
T ss_dssp             EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred             EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccc
Confidence            999999999999999875 5699999999999999999999999999999999999999999999999999986543221


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCCCC
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYF  278 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~  278 (489)
                      .         ......||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+.......+... ....|..+
T Consensus       160 ~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~  230 (267)
T 3t9t_A          160 T---------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA  230 (267)
T ss_dssp             H---------STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTS
T ss_pred             c---------ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccC
Confidence            1         1123457889999999998899999999999999999999 99999999988888887765 34567788


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       279 ~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      ++.+.+||.+||+.||++||++     .++++
T Consensus       231 ~~~l~~li~~~l~~~p~~Rps~-----~~ll~  257 (267)
T 3t9t_A          231 STHVYQIMNHCWRERPEDRPAF-----SRLLR  257 (267)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             cHHHHHHHHHHccCChhhCcCH-----HHHHH
Confidence            9999999999999999999998     66654

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=8e-46  Score=364.21  Aligned_cols=247  Identities=21%  Similarity=0.349  Sum_probs=219.4

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~l  120 (489)
                      .+..++|++.+.||+|+||.||+|.+..++..||+|++...    ......+.+|+.+++.++||||+++++++.+...+
T Consensus         9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   84 (288)
T 3kfa_A            9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   84 (288)
T ss_dssp             BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence            35678999999999999999999999999999999999654    23456678899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          121 YMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      |+||||+++++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus        85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  164 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred             EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence            9999999999999999874  44999999999999999999999999999999999999999999999999999866433


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCC
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPN  276 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~  276 (489)
                      .         ........+|+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+.......+... ....|.
T Consensus       165 ~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T 3kfa_A          165 T---------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPE  235 (288)
T ss_dssp             S---------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCT
T ss_pred             c---------cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCC
Confidence            2         122234567889999999999999999999999999999999 99999998877776666554 456778


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCC
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      .+++++.+||.+||+.||.+||++
T Consensus       236 ~~~~~l~~li~~~l~~dp~~Rps~  259 (288)
T 3kfa_A          236 GCPEKVYELMRACWQWNPSDRPSF  259 (288)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCHHHHHHHHHHhCCChhhCcCH
Confidence            899999999999999999999998

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-45  Score=372.60  Aligned_cols=256  Identities=23%  Similarity=0.397  Sum_probs=216.0

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEE-----cCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKK-----IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTF  114 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~-----~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~  114 (489)
                      .+..++|++++.||+|+||.||+|++     ..++..||+|++....  .......+.+|+.+++.+ +||||+++++++
T Consensus        41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  118 (344)
T 1rjb_A           41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGAC  118 (344)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            45568999999999999999999997     3467789999997542  223345678899999999 899999999999


Q ss_pred             EcCCEEEEEEeccCCCChHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecc
Q 011287          115 QDTFSLYMALESCEGGELFDQITSKG-----------------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDI  171 (489)
Q Consensus       115 ~~~~~lylV~E~~~gg~L~~~l~~~~-----------------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDL  171 (489)
                      .+...+|+||||+++|+|.+++....                       .+++..+..++.||+.||.|||++||+||||
T Consensus       119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di  198 (344)
T 1rjb_A          119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL  198 (344)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence            99999999999999999999998653                       2799999999999999999999999999999


Q ss_pred             CCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-
Q 011287          172 KPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-  250 (489)
Q Consensus       172 KpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-  250 (489)
                      ||+|||++.++.+||+|||++.......        .........||+.|+|||++.+..++.++|||||||++|+|++ 
T Consensus       199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~--------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~  270 (344)
T 1rjb_A          199 AARNVLVTHGKVVKICDFGLARDIMSDS--------NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL  270 (344)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCT--------TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred             ChhhEEEcCCCcEEeCCCccCcccccCc--------cceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcC
Confidence            9999999999999999999998654321        1112335678899999999999999999999999999999998 


Q ss_pred             CCCCCCCCCHHHHHHHHHhc--CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 011287          251 GTSPFKDTSEWLIFQRIIAR--DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (489)
Q Consensus       251 G~~PF~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~h  311 (489)
                      |..||.+.+....+..+...  ....|..+++++.+||.+||+.||.+||++     .++++|
T Consensus       271 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~l~~~  328 (344)
T 1rjb_A          271 GVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSF-----PNLTSF  328 (344)
T ss_dssp             SCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             CCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCH-----HHHHHH
Confidence            99999887655555555444  345677899999999999999999999998     667653

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=4.1e-45  Score=359.21  Aligned_cols=250  Identities=21%  Similarity=0.362  Sum_probs=211.6

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHH----HHHHHHHHHHHhCCCCCccEEEEEEE
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKT----AYVKLERIVLDQLDHPGVVRLFFTFQ  115 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~  115 (489)
                      ..+..++|++.+.||+|+||.||+|++..+++.||+|++...........    ..+.+|+.+++.++||||+++++++.
T Consensus        14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   93 (287)
T 4f0f_A           14 PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH   93 (287)
T ss_dssp             CBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred             hhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence            34667899999999999999999999999999999999976543332221    56788999999999999999999998


Q ss_pred             cCCEEEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cEeeccCCCCeeeCCCCC-----EEEe
Q 011287          116 DTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMG--LIHRDIKPENLLLTADGH-----IKIA  187 (489)
Q Consensus       116 ~~~~lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~g--IiHrDLKpeNILl~~~g~-----ikL~  187 (489)
                      +..  ++||||+++|+|.+++... ..+++..+..++.|++.||.|||++|  |+||||||+|||++.++.     +||+
T Consensus        94 ~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~  171 (287)
T 4f0f_A           94 NPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA  171 (287)
T ss_dssp             TTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred             CCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence            776  6999999999999988655 46999999999999999999999999  999999999999988876     9999


Q ss_pred             eccCccccCCccccccCCCCCCCCccceecCCcCCChhhhc--CCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHH--HH
Q 011287          188 DFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN--SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW--LI  263 (489)
Q Consensus       188 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~--~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~--~~  263 (489)
                      |||+++....             ......||+.|+|||++.  ...++.++|||||||++|+|++|+.||...+..  ..
T Consensus       172 Dfg~~~~~~~-------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~  238 (287)
T 4f0f_A          172 DFGLSQQSVH-------------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF  238 (287)
T ss_dssp             CCTTCBCCSS-------------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH
T ss_pred             CCCccccccc-------------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH
Confidence            9999874322             233567999999999994  455788999999999999999999999875433  22


Q ss_pred             HHHHHhc--CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHh
Q 011287          264 FQRIIAR--DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLK  309 (489)
Q Consensus       264 ~~~i~~~--~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~  309 (489)
                      ...+...  ...+|..+++++.+||.+||+.||.+||++     .+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll  281 (287)
T 4f0f_A          239 INMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHF-----SYIV  281 (287)
T ss_dssp             HHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHH
T ss_pred             HHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCH-----HHHH
Confidence            3343333  345778899999999999999999999998     6665

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1e-45  Score=365.20  Aligned_cols=251  Identities=20%  Similarity=0.314  Sum_probs=206.8

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEE----EcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  115 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~----~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  115 (489)
                      ..+..++|++++.||+|+||.||+|+    +..+++.||+|++...   .......+.+|+.+++.++||||+++++++.
T Consensus         5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   81 (295)
T 3ugc_A            5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCY   81 (295)
T ss_dssp             -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            45678999999999999999999999    5678999999998754   3444567888999999999999999999985


Q ss_pred             c--CCEEEEEEeccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCc
Q 011287          116 D--TFSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  192 (489)
Q Consensus       116 ~--~~~lylV~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a  192 (489)
                      +  ...+|+||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||++
T Consensus        82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~  161 (295)
T 3ugc_A           82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT  161 (295)
T ss_dssp             HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred             cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence            4  456899999999999999998754 4999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHH-----------
Q 011287          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-----------  261 (489)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~-----------  261 (489)
                      +........       ........|+..|+|||++.+..++.++|||||||++|+|++|..||......           
T Consensus       162 ~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~  234 (295)
T 3ugc_A          162 KVLPQDKEF-------FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG  234 (295)
T ss_dssp             C--------------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCT
T ss_pred             ccccCCcce-------eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCcccc
Confidence            876433211       11222345778899999999999999999999999999999999998754321           


Q ss_pred             -----HHHHHHH-hcCCCCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          262 -----LIFQRII-ARDIRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       262 -----~~~~~i~-~~~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                           .....+. ......|..+++++.+||.+||+.||++||++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  279 (295)
T 3ugc_A          235 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF  279 (295)
T ss_dssp             HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             chhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCH
Confidence                 1112222 23456678899999999999999999999998

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.6e-45  Score=369.64  Aligned_cols=252  Identities=24%  Similarity=0.382  Sum_probs=216.8

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEE--EEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcC
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVY--ALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDT  117 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~v--AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  117 (489)
                      .+..++|++.+.||+|+||.||+|++..+|..+  |+|.+....  .......+.+|+.+++++ +||||+++++++.+.
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~   98 (327)
T 1fvr_A           21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   98 (327)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred             cccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeC
Confidence            466799999999999999999999999998866  999886432  233445678899999999 899999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCC
Q 011287          118 FSLYMALESCEGGELFDQITSKG----------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD  181 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~~----------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~  181 (489)
                      ..+|+||||+++|+|.+++.+.+                .+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~  178 (327)
T 1fvr_A           99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN  178 (327)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred             CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCC
Confidence            99999999999999999998754                69999999999999999999999999999999999999999


Q ss_pred             CCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCH
Q 011287          182 GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSE  260 (489)
Q Consensus       182 g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~  260 (489)
                      +.+||+|||+++.....           .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.
T Consensus       179 ~~~kL~Dfg~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~  247 (327)
T 1fvr_A          179 YVAKIADFGLSRGQEVY-----------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC  247 (327)
T ss_dssp             GCEEECCTTCEESSCEE-----------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             CeEEEcccCcCcccccc-----------ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH
Confidence            99999999998743211           12223467889999999998889999999999999999998 9999999998


Q ss_pred             HHHHHHHHhc-CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          261 WLIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       261 ~~~~~~i~~~-~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      ......+... ....|..+++++.+||.+||+.||.+||++     +++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~ell~  293 (327)
T 1fvr_A          248 AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSF-----AQILV  293 (327)
T ss_dssp             HHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             HHHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCH-----HHHHH
Confidence            8888777665 355677899999999999999999999998     66664

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.4e-45  Score=368.46  Aligned_cols=259  Identities=22%  Similarity=0.373  Sum_probs=221.0

Q ss_pred             CCCCCCCCCCeEEeeEEeeeCceEEEEEEEc-------CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcc
Q 011287           37 APQEHFSIQDFELGKIYGVGSYSKVVRAKKI-------DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVV  108 (489)
Q Consensus        37 ~~~~~~~~~dy~~~~~LG~G~~g~Vy~a~~~-------~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv  108 (489)
                      .+.-.+..++|++++.||+|+||.||+|++.       .++..||+|++....  .......+.+|+.+++.+ +||||+
T Consensus        27 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv  104 (334)
T 2pvf_A           27 DPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNII  104 (334)
T ss_dssp             CTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEe
Confidence            3334556789999999999999999999985       467899999997542  334456688899999999 899999


Q ss_pred             EEEEEEEcCCEEEEEEeccCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccC
Q 011287          109 RLFFTFQDTFSLYMALESCEGGELFDQITSKG----------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIK  172 (489)
Q Consensus       109 ~l~~~~~~~~~lylV~E~~~gg~L~~~l~~~~----------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLK  172 (489)
                      ++++++.+...+|+||||+++|+|.+++....                .+++..+..++.||+.||.|||++||+|||||
T Consensus       105 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk  184 (334)
T 2pvf_A          105 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA  184 (334)
T ss_dssp             CEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             eEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCc
Confidence            99999999999999999999999999998754                38999999999999999999999999999999


Q ss_pred             CCCeeeCCCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-C
Q 011287          173 PENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-G  251 (489)
Q Consensus       173 peNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G  251 (489)
                      |+|||++.++++||+|||+++........        .......+|+.|+|||++.+..++.++|||||||++|+|++ |
T Consensus       185 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g  256 (334)
T 2pvf_A          185 ARNVLVTENNVMKIADFGLARDINNIDYY--------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG  256 (334)
T ss_dssp             GGGEEECTTCCEEECCCTTCEECTTTSSE--------ECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred             cceEEEcCCCCEEEccccccccccccccc--------cccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCC
Confidence            99999999999999999999865432211        11223467889999999998889999999999999999999 9


Q ss_pred             CCCCCCCCHHHHHHHHHhcC-CCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          252 TSPFKDTSEWLIFQRIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       252 ~~PF~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      ..||.+.+..+....+.... ...|..+++++.+||.+||+.||.+||++     .++++
T Consensus       257 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~ell~  311 (334)
T 2pvf_A          257 GSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF-----KQLVE  311 (334)
T ss_dssp             CCSSTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCCcCcCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCH-----HHHHH
Confidence            99999998888877776653 56778899999999999999999999998     55553

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=9.7e-45  Score=360.73  Aligned_cols=256  Identities=30%  Similarity=0.494  Sum_probs=208.5

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCE
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  119 (489)
                      .....++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.+...
T Consensus        27 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~  106 (310)
T 2wqm_A           27 GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE  106 (310)
T ss_dssp             TTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             ccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc
Confidence            44567899999999999999999999999999999999987555555666778889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCcccc
Q 011287          120 LYMALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~  195 (489)
                      +|+||||+++|+|.+++..    ...+++..+..++.||+.||.|||++||+||||||+||+++.+|.++|+|||++...
T Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            9999999999999998864    456999999999999999999999999999999999999999999999999998765


Q ss_pred             CCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCC--CHHHHHHHHHhcCCC
Q 011287          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT--SEWLIFQRIIARDIR  273 (489)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~--~~~~~~~~i~~~~~~  273 (489)
                      ....          .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.  +.......+......
T Consensus       187 ~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  256 (310)
T 2wqm_A          187 SSKT----------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP  256 (310)
T ss_dssp             ----------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSC
T ss_pred             cCCC----------ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCC
Confidence            4321          1223557999999999999999999999999999999999999999764  344455555544332


Q ss_pred             -C-CCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          274 -F-PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       274 -~-p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                       . +..+++++.+||.+||+.||++||++     .++++
T Consensus       257 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~il~  290 (310)
T 2wqm_A          257 PLPSDHYSEELRQLVNMCINPDPEKRPDV-----TYVYD  290 (310)
T ss_dssp             CCCTTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCcccccCHHHHHHHHHHcCCChhhCCCH-----HHHHH
Confidence             2 25689999999999999999999998     66653

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.1e-45  Score=371.22  Aligned_cols=256  Identities=19%  Similarity=0.298  Sum_probs=210.3

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEE----EEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVY----ALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  115 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~v----AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  115 (489)
                      ..+..++|++++.||+|+||.||+|++..+++.+    |+|.+....  .......+.+|+.+++.++||||+++++++.
T Consensus        10 ~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   87 (327)
T 3poz_A           10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICL   87 (327)
T ss_dssp             EECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEE
T ss_pred             hhcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEe
Confidence            4566789999999999999999999998888765    666654321  2233456788999999999999999999998


Q ss_pred             cCCEEEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccc
Q 011287          116 DTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (489)
Q Consensus       116 ~~~~lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~  194 (489)
                      +.. .++|+||+.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+|+.
T Consensus        88 ~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  166 (327)
T 3poz_A           88 TST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             SSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred             cCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeE
Confidence            765 78999999999999999874 6799999999999999999999999999999999999999999999999999987


Q ss_pred             cCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CC
Q 011287          195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DI  272 (489)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~  272 (489)
                      +.....        ........||..|+|||++.+..++.++|||||||++|+|++ |+.||.+.+...+...+... ..
T Consensus       167 ~~~~~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~  238 (327)
T 3poz_A          167 LGAEEK--------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL  238 (327)
T ss_dssp             HTTTCC---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC
T ss_pred             ccCCcc--------cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC
Confidence            643321        112224467889999999999999999999999999999999 99999998877766666554 35


Q ss_pred             CCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 011287          273 RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (489)
Q Consensus       273 ~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~h  311 (489)
                      ..|..++.++.+|+.+||+.||.+||++     .+++++
T Consensus       239 ~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~ell~~  272 (327)
T 3poz_A          239 PQPPICTIDVYMIMVKCWMIDADSRPKF-----RELIIE  272 (327)
T ss_dssp             CCCTTBCHHHHHHHHHHTCSCGGGSCCH-----HHHHHH
T ss_pred             CCCccCCHHHHHHHHHHcCCChhhCCCH-----HHHHHH
Confidence            6677899999999999999999999998     666643

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=6.2e-46  Score=378.59  Aligned_cols=279  Identities=16%  Similarity=0.165  Sum_probs=210.1

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCC-----CcEEEEEEeecccccchhH--------HHHHHHHHHHHHhCCCCCcc
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDT-----GTVYALKIMDKKFITKENK--------TAYVKLERIVLDQLDHPGVV  108 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~t-----g~~vAiK~~~k~~~~~~~~--------~~~~~~E~~il~~l~hpnIv  108 (489)
                      ...++|++++.||+|+||.||+|.+..+     ++.||||++..........        ......|...++.++||||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            3456999999999999999999999765     6899999987653111111        11233456677888999999


Q ss_pred             EEEEEEEcC----CEEEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeC--CC
Q 011287          109 RLFFTFQDT----FSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT--AD  181 (489)
Q Consensus       109 ~l~~~~~~~----~~lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~--~~  181 (489)
                      ++++++.+.    ..+|+||||| |++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++  .+
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~  190 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP  190 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence            999998764    5689999999 99999999876 6799999999999999999999999999999999999999  88


Q ss_pred             CCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHH
Q 011287          182 GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW  261 (489)
Q Consensus       182 g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~  261 (489)
                      +++||+|||+++.+........   .........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....
T Consensus       191 ~~~kl~DFG~a~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          191 DQVYLVDYGLAYRYCPEGVHKA---YAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             TCEEECCCTTCEESSGGGCCCC---SSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CeEEEEECCcceecccCCcccc---cccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence            9999999999987654331111   1122334667999999999999999999999999999999999999999864322


Q ss_pred             HHHHHHHh----cC------CC-CCCCCCHHHHHHHHHhhccCCCCCCCCCC--CCHHHH---hcCCCCCCCCcccccC
Q 011287          262 LIFQRIIA----RD------IR-FPNYFSDAARDLIDRLLDVDPSGRPGAGP--GGYAVL---KMHPFFKGIDWKNIRG  324 (489)
Q Consensus       262 ~~~~~i~~----~~------~~-~p~~~~~~~~~Li~~~L~~dP~~R~t~~~--~~~~~l---~~hpff~~i~~~~~~~  324 (489)
                      ........    ..      .. .+..+++++.+||..||..||.+||++.+  ..+.++   ...++...++|.....
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~  346 (364)
T 3op5_A          268 PKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVEN  346 (364)
T ss_dssp             HHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC-----
T ss_pred             HHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceEeccC
Confidence            21111111    00      01 12567999999999999999999999843  111111   1345666777765543

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.5e-45  Score=366.28  Aligned_cols=255  Identities=24%  Similarity=0.370  Sum_probs=217.6

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEE-----cCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKK-----IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTF  114 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~-----~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~  114 (489)
                      .+..++|++++.||+|+||.||+|++     ..+++.||+|++....  .......+.+|+.+++++ +||||+++++++
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   96 (313)
T 1t46_A           19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGAC   96 (313)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence            34567999999999999999999995     4578999999997553  233456788899999999 999999999999


Q ss_pred             EcCCEEEEEEeccCCCChHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCe
Q 011287          115 QDTFSLYMALESCEGGELFDQITSKG------------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENL  176 (489)
Q Consensus       115 ~~~~~lylV~E~~~gg~L~~~l~~~~------------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNI  176 (489)
                      .+....|+||||+++|+|.+++...+                  .+++..+..++.||+.||.|||++||+||||||+||
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni  176 (313)
T 1t46_A           97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI  176 (313)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence            99999999999999999999998754                  489999999999999999999999999999999999


Q ss_pred             eeCCCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCC
Q 011287          177 LLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPF  255 (489)
Q Consensus       177 Ll~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF  255 (489)
                      |++.++.+||+|||++........        ........||+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus       177 l~~~~~~~kl~Dfg~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~  248 (313)
T 1t46_A          177 LLTHGRITKICDFGLARDIKNDSN--------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY  248 (313)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTT--------SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             EEcCCCCEEEcccccccccccccc--------ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCC
Confidence            999999999999999986644321        112234568889999999999999999999999999999999 99999


Q ss_pred             CCCCHHHHHHHHHhcC--CCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          256 KDTSEWLIFQRIIARD--IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       256 ~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      .+.........+....  ...|..+++++.+||.+||+.||.+||++     .++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~ell~  300 (313)
T 1t46_A          249 PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTF-----KQIVQ  300 (313)
T ss_dssp             TTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCH-----HHHHH
Confidence            8876555444444433  34467799999999999999999999998     66654

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3.6e-45  Score=360.76  Aligned_cols=252  Identities=20%  Similarity=0.306  Sum_probs=214.9

Q ss_pred             CCCCCCCeEEee-EEeeeCceEEEEEEE--cCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Q 011287           40 EHFSIQDFELGK-IYGVGSYSKVVRAKK--IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  116 (489)
Q Consensus        40 ~~~~~~dy~~~~-~LG~G~~g~Vy~a~~--~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  116 (489)
                      ..+..++|++.+ .||+|+||.||+|.+  ..+++.||+|++..... .......+.+|+.+++.++||||+++++++ +
T Consensus        11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~   88 (291)
T 1xbb_A           11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC-E   88 (291)
T ss_dssp             CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred             eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence            345567899999 999999999999954  56789999999976532 233456788899999999999999999999 5


Q ss_pred             CCEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccC
Q 011287          117 TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (489)
Q Consensus       117 ~~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~  196 (489)
                      ....|+||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           89 AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence            56789999999999999999998889999999999999999999999999999999999999999999999999998664


Q ss_pred             CccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhcC-CCC
Q 011287          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRF  274 (489)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~~-~~~  274 (489)
                      ......       .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+.... ..+
T Consensus       169 ~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~  241 (291)
T 1xbb_A          169 ADENYY-------KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC  241 (291)
T ss_dssp             TTCSEE-------EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred             cCCCcc-------cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            332110       11123356789999999998889999999999999999999 999999999888877776643 567


Q ss_pred             CCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          275 PNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       275 p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      |..+++++.+||.+||+.||.+||++
T Consensus       242 ~~~~~~~l~~li~~~l~~dp~~Rps~  267 (291)
T 1xbb_A          242 PAGCPREMYDLMNLCWTYDVENRPGF  267 (291)
T ss_dssp             CTTCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCH
Confidence            78899999999999999999999998

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.8e-45  Score=366.16  Aligned_cols=252  Identities=18%  Similarity=0.298  Sum_probs=211.6

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCC----cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTG----TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  115 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg----~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  115 (489)
                      ..+..++|.+.+.||+|+||.||+|++..++    ..||+|++....  .......+.+|+.+++.++||||+++++++.
T Consensus        39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  116 (333)
T 1mqb_A           39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS  116 (333)
T ss_dssp             CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence            4566789999999999999999999987653    459999997542  3334556788999999999999999999999


Q ss_pred             cCCEEEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccc
Q 011287          116 DTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (489)
Q Consensus       116 ~~~~lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~  194 (489)
                      +...+|+||||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       117 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  196 (333)
T 1mqb_A          117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV  196 (333)
T ss_dssp             SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence            999999999999999999999865 6799999999999999999999999999999999999999999999999999987


Q ss_pred             cCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CC
Q 011287          195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DI  272 (489)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~  272 (489)
                      .......       ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+... ..
T Consensus       197 ~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~  269 (333)
T 1mqb_A          197 LEDDPEA-------TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL  269 (333)
T ss_dssp             ---------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC
T ss_pred             hcccccc-------ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC
Confidence            6432210       111223356789999999999999999999999999999999 99999999888888777665 45


Q ss_pred             CCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          273 RFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       273 ~~p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      ..|..+++++.+||.+||+.||++||++
T Consensus       270 ~~~~~~~~~l~~li~~~l~~~p~~Rps~  297 (333)
T 1mqb_A          270 PTPMDCPSAIYQLMMQCWQQERARRPKF  297 (333)
T ss_dssp             CCCTTCBHHHHHHHHHHTCSSTTTSCCH
T ss_pred             CCcccCCHHHHHHHHHHcCCChhhCcCH
Confidence            5677899999999999999999999998

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=4.2e-45  Score=354.98  Aligned_cols=246  Identities=15%  Similarity=0.263  Sum_probs=215.7

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC--C
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT--F  118 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~  118 (489)
                      .+..++|++.+.||+|+||.||+|++.  |+.||+|++....... .....+.+|+.+++.++||||+++++++.+.  .
T Consensus         6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   82 (271)
T 3kmu_A            6 GIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWST-RKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP   82 (271)
T ss_dssp             CCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCH-HHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSS
T ss_pred             CCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCchhheEEEEccCCCC
Confidence            467889999999999999999999984  8999999997654333 3445688899999999999999999999887  7


Q ss_pred             EEEEEEeccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC--cEeeccCCCCeeeCCCCCEEEeeccCccc
Q 011287          119 SLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMG--LIHRDIKPENLLLTADGHIKIADFGSVKP  194 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~aL~~LH~~g--IiHrDLKpeNILl~~~g~ikL~DFG~a~~  194 (489)
                      .+|+||||+++|+|.+++.+.+  .+++..+..++.||+.||.|||++|  |+||||||+||+++.+|.++|+|||++..
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~  162 (271)
T 3kmu_A           83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS  162 (271)
T ss_dssp             SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred             CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence            8999999999999999998765  4899999999999999999999999  99999999999999999999999998754


Q ss_pred             cCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCC---CCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc-
Q 011287          195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATF---GNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR-  270 (489)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~---~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~-  270 (489)
                      ..               .....||+.|+|||++.+..++.   ++|||||||++|+|++|+.||.+.+.......+... 
T Consensus       163 ~~---------------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~  227 (271)
T 3kmu_A          163 FQ---------------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEG  227 (271)
T ss_dssp             TS---------------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSC
T ss_pred             ec---------------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcC
Confidence            22               12357899999999998766554   799999999999999999999999888877776654 


Q ss_pred             -CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHh
Q 011287          271 -DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLK  309 (489)
Q Consensus       271 -~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~  309 (489)
                       ...+|..+++++.+||.+||+.||++||++     ++++
T Consensus       228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~il  262 (271)
T 3kmu_A          228 LRPTIPPGISPHVSKLMKICMNEDPAKRPKF-----DMIV  262 (271)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCChhhCcCH-----HHHH
Confidence             456788899999999999999999999998     5555

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.2e-45  Score=376.36  Aligned_cols=256  Identities=19%  Similarity=0.312  Sum_probs=208.6

Q ss_pred             CCCCCCCCCCeEEeeEEeeeCceEEEEEEEc---CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEE
Q 011287           37 APQEHFSIQDFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFT  113 (489)
Q Consensus        37 ~~~~~~~~~dy~~~~~LG~G~~g~Vy~a~~~---~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  113 (489)
                      .....+..++|++.+.||+|+||.||+|+++   .++..||||++....  .......+.+|+.+++.++||||++++++
T Consensus        37 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~  114 (373)
T 2qol_A           37 EFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGV  114 (373)
T ss_dssp             TTSCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             HHHhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            3335667789999999999999999999987   567889999997542  33445678889999999999999999999


Q ss_pred             EEcCCEEEEEEeccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCc
Q 011287          114 FQDTFSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  192 (489)
Q Consensus       114 ~~~~~~lylV~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a  192 (489)
                      +.+...+|+||||+++|+|.+++.+.+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus       115 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  194 (373)
T 2qol_A          115 VTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLG  194 (373)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred             EeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccc
Confidence            999999999999999999999998764 6999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-
Q 011287          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-  270 (489)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-  270 (489)
                      +........       ........+|..|+|||++.+..++.++|||||||++|+|++ |+.||.+.+.......+... 
T Consensus       195 ~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~  267 (373)
T 2qol_A          195 RVLEDDPEA-------AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY  267 (373)
T ss_dssp             --------------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTE
T ss_pred             cccccCCcc-------ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            876432210       011122345788999999999999999999999999999998 99999999888887777654 


Q ss_pred             CCCCCCCCCHHHHHHHHHhhccCCCCCCCCC
Q 011287          271 DIRFPNYFSDAARDLIDRLLDVDPSGRPGAG  301 (489)
Q Consensus       271 ~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~  301 (489)
                      ....|..++.++.+||.+||+.||++||++.
T Consensus       268 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~  298 (373)
T 2qol_A          268 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFE  298 (373)
T ss_dssp             ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCccccHHHHHHHHHHhCcChhhCcCHH
Confidence            3445667899999999999999999999983

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6e-45  Score=358.49  Aligned_cols=256  Identities=20%  Similarity=0.303  Sum_probs=219.0

Q ss_pred             CCCCCCeEEee-EEeeeCceEEEEEEEc--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 011287           41 HFSIQDFELGK-IYGVGSYSKVVRAKKI--DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (489)
Q Consensus        41 ~~~~~dy~~~~-~LG~G~~g~Vy~a~~~--~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  117 (489)
                      .+..++|.+.+ .||+|+||.||+|.+.  .++..||+|++....  .......+.+|+.+++.++||||+++++++. .
T Consensus         5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~   81 (287)
T 1u59_A            5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-A   81 (287)
T ss_dssp             BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-S
T ss_pred             cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEec-C
Confidence            34567888887 9999999999999864  468899999997642  3345667888999999999999999999995 4


Q ss_pred             CEEEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccC
Q 011287          118 FSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~  196 (489)
                      ...|+||||+++++|.+++... +.+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           82 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG  161 (287)
T ss_dssp             SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence            5699999999999999999754 569999999999999999999999999999999999999999999999999998764


Q ss_pred             CccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhcC-CCC
Q 011287          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRF  274 (489)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~~-~~~  274 (489)
                      .....       ........||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+.......+.... ..+
T Consensus       162 ~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~  234 (287)
T 1u59_A          162 ADDSY-------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC  234 (287)
T ss_dssp             TCSCE-------ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCC
T ss_pred             cCcce-------eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCC
Confidence            33211       112223457899999999998889999999999999999998 999999988888777776653 567


Q ss_pred             CCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 011287          275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (489)
Q Consensus       275 p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~h  311 (489)
                      |..+++++.+||.+||+.||++||++     .++++|
T Consensus       235 ~~~~~~~l~~li~~~l~~~p~~Rps~-----~~l~~~  266 (287)
T 1u59_A          235 PPECPPELYALMSDCWIYKWEDRPDF-----LTVEQR  266 (287)
T ss_dssp             CTTCCHHHHHHHHHTTCSSGGGSCCH-----HHHHHH
T ss_pred             CCCcCHHHHHHHHHHcCCChhhCcCH-----HHHHHH
Confidence            88999999999999999999999998     667654

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.2e-45  Score=370.45  Aligned_cols=260  Identities=19%  Similarity=0.321  Sum_probs=218.7

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEE-----EcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  115 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~-----~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  115 (489)
                      .+..++|++++.||+|+||.||+|+     +..++..||+|++....  .......+.+|+.+++.++||||+++++++.
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  103 (327)
T 2yfx_A           26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL  103 (327)
T ss_dssp             BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence            3567899999999999999999999     56788999999996432  3344556778999999999999999999999


Q ss_pred             cCCEEEEEEeccCCCChHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCC---CCEE
Q 011287          116 DTFSLYMALESCEGGELFDQITSKG-------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD---GHIK  185 (489)
Q Consensus       116 ~~~~lylV~E~~~gg~L~~~l~~~~-------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~---g~ik  185 (489)
                      +....|+||||+++|+|.+++...+       .+++..+..++.||+.||.|||++||+||||||+|||++.+   +.++
T Consensus       104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence            9999999999999999999998753       48999999999999999999999999999999999999954   4699


Q ss_pred             EeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHH
Q 011287          186 IADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIF  264 (489)
Q Consensus       186 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~  264 (489)
                      |+|||++.......        .........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.....
T Consensus       184 l~Dfg~~~~~~~~~--------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  255 (327)
T 2yfx_A          184 IGDFGMARDIYRAS--------YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL  255 (327)
T ss_dssp             ECCCHHHHHHHC--------------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             ECcccccccccccc--------ccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHH
Confidence            99999987543221        1122235578999999999998899999999999999999998 99999999888887


Q ss_pred             HHHHhc-CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 011287          265 QRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (489)
Q Consensus       265 ~~i~~~-~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~  315 (489)
                      ..+... ....|..+++.+.+||.+||+.||.+||++     .++++|.++-
T Consensus       256 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~~l~~~  302 (327)
T 2yfx_A          256 EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNF-----AIILERIEYC  302 (327)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHHHHHH
T ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCH-----HHHHHHHHHH
Confidence            777664 345677899999999999999999999998     8899887663

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.9e-45  Score=368.48  Aligned_cols=257  Identities=19%  Similarity=0.302  Sum_probs=210.4

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeeccc--ccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKF--ITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~--~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  117 (489)
                      ..+..++|++++.||+|+||.||+|++..+++.||+|+..|..  .........+.+|+.+++.++||||+++++++.+.
T Consensus        10 ~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   89 (327)
T 3lzb_A           10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             EECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred             cccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence            3456789999999999999999999999888876444433221  11233456678899999999999999999999876


Q ss_pred             CEEEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccC
Q 011287          118 FSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~  196 (489)
                      . .++|++|+.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+++.+.
T Consensus        90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            5 88999999999999999874 579999999999999999999999999999999999999999999999999998764


Q ss_pred             CccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCC
Q 011287          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRF  274 (489)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~  274 (489)
                      ....        ........||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+.......+... ....
T Consensus       169 ~~~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~  240 (327)
T 3lzb_A          169 AEEK--------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ  240 (327)
T ss_dssp             -------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC
T ss_pred             Cccc--------cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            3321        112223457889999999999999999999999999999999 99999998887777666554 3566


Q ss_pred             CCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       275 p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      |..++.++.+||.+||+.||.+||++     .++++
T Consensus       241 ~~~~~~~l~~li~~~l~~dp~~Rps~-----~ell~  271 (327)
T 3lzb_A          241 PPICTIDVYMIMRKCWMIDADSRPKF-----RELII  271 (327)
T ss_dssp             CTTBCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CccCCHHHHHHHHHHcCCChhHCcCH-----HHHHH
Confidence            77899999999999999999999998     56654

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1e-45  Score=370.78  Aligned_cols=262  Identities=24%  Similarity=0.361  Sum_probs=196.2

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHH-HHHhCCCCCccEEEEEEEcCC
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI-VLDQLDHPGVVRLFFTFQDTF  118 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~  118 (489)
                      -.+..++|++++.||+|+||.||+|.++.+|+.||||++.....  ......+..|.. +++.++||||+++++++.+..
T Consensus        17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~   94 (327)
T 3aln_A           17 WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG   94 (327)
T ss_dssp             ECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS
T ss_pred             cccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC
Confidence            35667999999999999999999999999999999999976532  222333444554 778889999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeeccCCCCeeeCCCCCEEEeeccCc
Q 011287          119 SLYMALESCEGGELFDQITS-----KGHLSEDEARFYTAEVVDALEYIHSM-GLIHRDIKPENLLLTADGHIKIADFGSV  192 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~-----~~~l~e~~~~~i~~qil~aL~~LH~~-gIiHrDLKpeNILl~~~g~ikL~DFG~a  192 (489)
                      ..|+||||+.+ +|.+++..     .+.+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++
T Consensus        95 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~  173 (327)
T 3aln_A           95 DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS  173 (327)
T ss_dssp             EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred             ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCc
Confidence            99999999986 88887763     56799999999999999999999999 9999999999999999999999999999


Q ss_pred             cccCCccccccCCCCCCCCccceecCCcCCChhhh----cCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHH-HHHHHH
Q 011287          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-LIFQRI  267 (489)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l----~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~-~~~~~i  267 (489)
                      +.+....           ......||+.|+|||++    .+..++.++|||||||++|+|++|..||.+.+.. .....+
T Consensus       174 ~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  242 (327)
T 3aln_A          174 GQLVDSI-----------AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV  242 (327)
T ss_dssp             CC-----------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCC
T ss_pred             eeccccc-----------ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHH
Confidence            7653321           12234799999999999    4566899999999999999999999999875432 222222


Q ss_pred             HhcC-CCCC----CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 011287          268 IARD-IRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (489)
Q Consensus       268 ~~~~-~~~p----~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~  320 (489)
                      .... ..++    ..+++++.+||.+||+.||++||++     .++++||||....+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~ell~hp~~~~~~~~  295 (327)
T 3aln_A          243 VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKY-----KELLKHPFILMYEER  295 (327)
T ss_dssp             CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCH-----HHHTTSHHHHHHHHS
T ss_pred             hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCH-----HHHHhChHHHHhHhh
Confidence            2222 1222    3589999999999999999999998     899999999765544

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=7.8e-45  Score=362.13  Aligned_cols=258  Identities=28%  Similarity=0.469  Sum_probs=213.8

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC--CCCccEEEEEEEcCCE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD--HPGVVRLFFTFQDTFS  119 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~~~  119 (489)
                      +..++|++++.||+|+||.||+|++. +++.||+|++...... ......+.+|+.+++.++  ||||+++++++.+...
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~  102 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY  102 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccccc-ccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence            34567999999999999999999985 5899999999765332 344566788999999996  5999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcc
Q 011287          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      +|+||| +.+++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.+....
T Consensus       103 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~  180 (313)
T 3cek_A          103 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  180 (313)
T ss_dssp             EEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC-----
T ss_pred             EEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCcc
Confidence            999999 55789999999988999999999999999999999999999999999999996 5899999999998654322


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcC-----------CCCCCCCcchhhhHHHHHHhhCCCCCCCCC-HHHHHHHH
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNS-----------SPATFGNDLWALGCTLYQMLSGTSPFKDTS-EWLIFQRI  267 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-----------~~~~~~sDiwSLG~ilyelltG~~PF~~~~-~~~~~~~i  267 (489)
                      .        .......+||+.|+|||++.+           ..++.++|||||||++|+|++|+.||.... ....+..+
T Consensus       181 ~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  252 (313)
T 3cek_A          181 T--------SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI  252 (313)
T ss_dssp             -----------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred             c--------cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHH
Confidence            1        112235679999999999875           467889999999999999999999998754 33444444


Q ss_pred             Hhc--CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          268 IAR--DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       268 ~~~--~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      ...  ...+|...+.++.+||.+||+.||.+||++     .++++||||+.
T Consensus       253 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~ell~h~~~~~  298 (313)
T 3cek_A          253 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI-----PELLAHPYVQI  298 (313)
T ss_dssp             HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSHHHHC
T ss_pred             HhcccccCCcccchHHHHHHHHHHccCCcccCcCH-----HHHhcCccccC
Confidence            443  345778889999999999999999999998     89999999974

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.6e-45  Score=366.64  Aligned_cols=256  Identities=25%  Similarity=0.392  Sum_probs=215.9

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEE-----cCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKK-----IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTF  114 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~-----~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~  114 (489)
                      .+..++|++++.||+|+||.||+|++     ..+++.||+|++....  .......+.+|+.+++.+ +||||+++++++
T Consensus        23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  100 (316)
T 2xir_A           23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC  100 (316)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence            34568999999999999999999985     4578999999997652  233445678899999999 799999999998


Q ss_pred             EcCC-EEEEEEeccCCCChHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCee
Q 011287          115 QDTF-SLYMALESCEGGELFDQITSKGH----------------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLL  177 (489)
Q Consensus       115 ~~~~-~lylV~E~~~gg~L~~~l~~~~~----------------l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNIL  177 (489)
                      .+.. .+|+||||+++|+|.+++...+.                +++..+..++.||+.||.|||++||+||||||+|||
T Consensus       101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil  180 (316)
T 2xir_A          101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL  180 (316)
T ss_dssp             CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence            7654 59999999999999999987654                899999999999999999999999999999999999


Q ss_pred             eCCCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCC
Q 011287          178 LTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK  256 (489)
Q Consensus       178 l~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~  256 (489)
                      ++.++++||+|||+++.+....        .........||+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus       181 ~~~~~~~kl~Dfg~~~~~~~~~--------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~  252 (316)
T 2xir_A          181 LSEKNVVKICDFGLARDIYKDP--------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  252 (316)
T ss_dssp             ECGGGCEEECCCGGGSCTTTCT--------TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ECCCCCEEECCCccccccccCc--------cceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence            9999999999999998654321        1122345678999999999999999999999999999999998 999998


Q ss_pred             CCCHHHHH-HHHHh-cCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 011287          257 DTSEWLIF-QRIIA-RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (489)
Q Consensus       257 ~~~~~~~~-~~i~~-~~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~h  311 (489)
                      +.+....+ ..+.. .....|..+++++.++|.+||+.||.+||++     .++++|
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~ell~~  304 (316)
T 2xir_A          253 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF-----SELVEH  304 (316)
T ss_dssp             TCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             ccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCH-----HHHHHH
Confidence            86643333 33333 2456778899999999999999999999998     667654

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=4.4e-45  Score=369.64  Aligned_cols=259  Identities=18%  Similarity=0.188  Sum_probs=205.1

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcC---CCcEEEEEEeecccccchh--------HHHHHHHHHHHHHhCCCCCccEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKID---TGTVYALKIMDKKFITKEN--------KTAYVKLERIVLDQLDHPGVVRL  110 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~---tg~~vAiK~~~k~~~~~~~--------~~~~~~~E~~il~~l~hpnIv~l  110 (489)
                      +..++|++++.||+|+||.||+|++..   ++..||+|++.........        ....+.+|...++.++||||+++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~  113 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF  113 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence            445789999999999999999999987   8899999999765321111        11235568888999999999999


Q ss_pred             EEEEEc----CCEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCC--CE
Q 011287          111 FFTFQD----TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG--HI  184 (489)
Q Consensus       111 ~~~~~~----~~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g--~i  184 (489)
                      ++++.+    ...+|+||||+ +++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++  .+
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~  192 (345)
T 2v62_A          114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV  192 (345)
T ss_dssp             EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred             ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence            999987    78899999999 999999998888899999999999999999999999999999999999999887  99


Q ss_pred             EEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCC--CCHHH
Q 011287          185 KIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD--TSEWL  262 (489)
Q Consensus       185 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~--~~~~~  262 (489)
                      ||+|||+++.+.......   ...........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+  .+...
T Consensus       193 kL~Dfg~a~~~~~~~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  269 (345)
T 2v62_A          193 YLADYGLSYRYCPNGNHK---QYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA  269 (345)
T ss_dssp             EECCCTTCEESSGGGCCC---CCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred             EEEeCCCceecccccccc---cchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence            999999998765432110   0112223466899999999999999999999999999999999999999965  33333


Q ss_pred             HHHHHHhcCCCCCC---------CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHh
Q 011287          263 IFQRIIARDIRFPN---------YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLK  309 (489)
Q Consensus       263 ~~~~i~~~~~~~p~---------~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~  309 (489)
                      ...........+|.         .+++++.+||.+||+.||++||++     ++++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~l~  320 (345)
T 2v62_A          270 VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNY-----QALK  320 (345)
T ss_dssp             HHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCH-----HHHH
T ss_pred             HHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCH-----HHHH
Confidence            32222222222332         789999999999999999999998     5565

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=5.3e-45  Score=366.30  Aligned_cols=255  Identities=21%  Similarity=0.386  Sum_probs=217.4

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCc-----EEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGT-----VYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTF  114 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~-----~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~  114 (489)
                      .+..++|++++.||+|+||.||+|.+..+++     .||+|++....  .......+.+|+.+++.+ +||||+++++++
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            4556899999999999999999999977665     79999997542  233456788899999999 899999999999


Q ss_pred             EcCCEEEEEEeccCCCChHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCC
Q 011287          115 QDTFSLYMALESCEGGELFDQITSK--------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA  180 (489)
Q Consensus       115 ~~~~~lylV~E~~~gg~L~~~l~~~--------------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~  180 (489)
                      .+...+|+||||+++|+|.+++...              ..+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~  199 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN  199 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEG
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECC
Confidence            9999999999999999999998753              35899999999999999999999999999999999999999


Q ss_pred             CCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCC
Q 011287          181 DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTS  259 (489)
Q Consensus       181 ~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~  259 (489)
                      ++.+||+|||++.......        .........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+..
T Consensus       200 ~~~~kl~Dfg~~~~~~~~~--------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  271 (333)
T 2i1m_A          200 GHVAKIGDFGLARDIMNDS--------NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL  271 (333)
T ss_dssp             GGEEEBCCCGGGCCGGGCT--------TSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             CCeEEECcccccccccccc--------ceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence            9999999999998654321        1112234567889999999999899999999999999999998 999998876


Q ss_pred             HHHHHHHHHhcC--CCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          260 EWLIFQRIIARD--IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       260 ~~~~~~~i~~~~--~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      ....+..+....  ...|...++++.+||.+||+.||.+||++     .++++
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~l~~  319 (333)
T 2i1m_A          272 VNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTF-----QQICS  319 (333)
T ss_dssp             SSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             hhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCH-----HHHHH
Confidence            555555554433  34567789999999999999999999998     66654

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.8e-44  Score=355.36  Aligned_cols=270  Identities=20%  Similarity=0.292  Sum_probs=211.9

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEE-EEEEcCCEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLF-FTFQDTFSLYM  122 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~-~~~~~~~~lyl  122 (489)
                      .++|++++.||+|+||.||+|++..+++.||+|++......     ..+.+|..+++.++|++++..+ .++.+....|+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence            47899999999999999999999999999999987654322     2366799999999887766554 45577888999


Q ss_pred             EEeccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeee---CCCCCEEEeeccCccccCCc
Q 011287          123 ALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL---TADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl---~~~g~ikL~DFG~a~~~~~~  198 (489)
                      ||||+ +++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.....
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~  161 (296)
T 4hgt_A           83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             EEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             EEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence            99999 8899999985 4579999999999999999999999999999999999999   78899999999999876543


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCH---HHHHHHHHhcCCCCC
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE---WLIFQRIIARDIRFP  275 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~---~~~~~~i~~~~~~~p  275 (489)
                      .....   ..........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.   ...+..+.......|
T Consensus       162 ~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 4hgt_A          162 RTHQH---IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             TTCCB---CCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             ccCcc---CCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence            21100   001233467899999999999999999999999999999999999999987432   233334443333333


Q ss_pred             -----CCCCHHHHHHHHHhhccCCCCCCCCCC--CCHHHHh---cCCCCCCCCcccc
Q 011287          276 -----NYFSDAARDLIDRLLDVDPSGRPGAGP--GGYAVLK---MHPFFKGIDWKNI  322 (489)
Q Consensus       276 -----~~~~~~~~~Li~~~L~~dP~~R~t~~~--~~~~~l~---~hpff~~i~~~~~  322 (489)
                           ..+++++.+||.+||+.||++||++.+  ..+.+++   ...+...++|+.+
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~~~  295 (296)
T 4hgt_A          239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML  295 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGGGC
T ss_pred             hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchhhc
Confidence                 678999999999999999999999843  1111111   3556666777764

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.2e-44  Score=358.24  Aligned_cols=255  Identities=20%  Similarity=0.309  Sum_probs=209.9

Q ss_pred             CCCCCCCCCCeEEeeEEeeeCceEEEEEE----EcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEE
Q 011287           37 APQEHFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFF  112 (489)
Q Consensus        37 ~~~~~~~~~dy~~~~~LG~G~~g~Vy~a~----~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  112 (489)
                      .....+..++|++++.||+|+||.||+|+    +..+++.||+|++....  .......+.+|+.+++.++||||+++++
T Consensus        13 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~   90 (302)
T 4e5w_A           13 VDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKG   90 (302)
T ss_dssp             CCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeee
Confidence            34455667889999999999999999999    56789999999997543  2234466888999999999999999999


Q ss_pred             EEEcC--CEEEEEEeccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeec
Q 011287          113 TFQDT--FSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADF  189 (489)
Q Consensus       113 ~~~~~--~~lylV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DF  189 (489)
                      ++.+.  ..+|+||||+++|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.+++++|+||
T Consensus        91 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Df  170 (302)
T 4e5w_A           91 ICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDF  170 (302)
T ss_dssp             EEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCC
T ss_pred             EEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcc
Confidence            99876  679999999999999999954 467999999999999999999999999999999999999999999999999


Q ss_pred             cCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCC-----------
Q 011287          190 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT-----------  258 (489)
Q Consensus       190 G~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~-----------  258 (489)
                      |++.........       ........||..|+|||++.+..++.++|||||||++|+|++|..|+...           
T Consensus       171 g~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  243 (302)
T 4e5w_A          171 GLTKAIETDKEY-------YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPT  243 (302)
T ss_dssp             TTCEECCTTCCE-------EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSC
T ss_pred             cccccccCCCcc-------eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCc
Confidence            999876543211       11223456888999999999988999999999999999999999886432           


Q ss_pred             ---CHHHH-HHHHHh-cCCCCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          259 ---SEWLI-FQRIIA-RDIRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       259 ---~~~~~-~~~i~~-~~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                         ..... ...+.. ....+|..+++++.+||.+||+.||.+||++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  290 (302)
T 4e5w_A          244 HGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSF  290 (302)
T ss_dssp             CGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCH
T ss_pred             ccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCH
Confidence               11222 222222 3455678899999999999999999999998

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.2e-44  Score=355.02  Aligned_cols=255  Identities=24%  Similarity=0.369  Sum_probs=214.4

Q ss_pred             CCCCCCCCeEEeeEEeeeCceEEEEEEEcC---CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 011287           39 QEHFSIQDFELGKIYGVGSYSKVVRAKKID---TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  115 (489)
Q Consensus        39 ~~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~---tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  115 (489)
                      .-.+..++|++.+.||+|+||.||+|++..   ++..||+|++.+..  .......+.+|+.+++.++||||+++++++.
T Consensus         6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   83 (281)
T 3cc6_A            6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE   83 (281)
T ss_dssp             CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred             cceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence            345667899999999999999999999754   34569999987652  2334567888999999999999999999987


Q ss_pred             cCCEEEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccc
Q 011287          116 DTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (489)
Q Consensus       116 ~~~~lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~  194 (489)
                      +. ..|+||||+++++|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+||+++.++++||+|||++..
T Consensus        84 ~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           84 EE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             SS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             CC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence            65 568999999999999999765 4599999999999999999999999999999999999999999999999999986


Q ss_pred             cCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CC
Q 011287          195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DI  272 (489)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~  272 (489)
                      .....         ........+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...+.......+... ..
T Consensus       163 ~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~  233 (281)
T 3cc6_A          163 IEDED---------YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL  233 (281)
T ss_dssp             C------------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC
T ss_pred             ccccc---------ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC
Confidence            54322         112233457889999999998899999999999999999998 99999887776666666554 45


Q ss_pred             CCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          273 RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       273 ~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      ..|..+++.+.+||.+||+.||++||++     .++++
T Consensus       234 ~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~ell~  266 (281)
T 3cc6_A          234 PKPDLCPPVLYTLMTRCWDYDPSDRPRF-----TELVC  266 (281)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCCCCCCHHHHHHHHHHccCCchhCcCH-----HHHHH
Confidence            6678899999999999999999999998     66654

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4.9e-45  Score=365.75  Aligned_cols=254  Identities=22%  Similarity=0.307  Sum_probs=202.6

Q ss_pred             cccccCCCCCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEE
Q 011287           32 SFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLF  111 (489)
Q Consensus        32 s~~~~~~~~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~  111 (489)
                      ....+.+.-.+..++|++++.||+|+||.||+|++.  ++.||||++...    ........+|+.+++.++||||++++
T Consensus        11 ~~~~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~   84 (322)
T 3soc_A           11 GVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMKHENILQFI   84 (322)
T ss_dssp             ---CCCCCEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEE
T ss_pred             ccccCccccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC----chHHHHHHHHHHHHhcCCCCCchhhc
Confidence            344455555677889999999999999999999884  799999999653    22334455688889999999999999


Q ss_pred             EEEEcCC----EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC----------CcEeeccCCCCee
Q 011287          112 FTFQDTF----SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM----------GLIHRDIKPENLL  177 (489)
Q Consensus       112 ~~~~~~~----~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~----------gIiHrDLKpeNIL  177 (489)
                      +++.+..    .+|+|||||++|+|.+++... .+++..+..++.||+.||.|||+.          ||+||||||+|||
T Consensus        85 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nil  163 (322)
T 3soc_A           85 GAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVL  163 (322)
T ss_dssp             EEEEEECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEE
T ss_pred             ceeccCCCCCceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEE
Confidence            9998743    479999999999999999874 699999999999999999999999          9999999999999


Q ss_pred             eCCCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCC-----CCCCCCcchhhhHHHHHHhhCC
Q 011287          178 LTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-----PATFGNDLWALGCTLYQMLSGT  252 (489)
Q Consensus       178 l~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-----~~~~~sDiwSLG~ilyelltG~  252 (489)
                      ++.++++||+|||+++.+....        ........+||+.|+|||++.+.     .++.++|||||||++|+|++|+
T Consensus       164 l~~~~~~kL~DFg~a~~~~~~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~  235 (322)
T 3soc_A          164 LKNNLTACIADFGLALKFEAGK--------SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRC  235 (322)
T ss_dssp             ECTTCCEEECCCTTCEEECTTS--------CCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred             ECCCCeEEEccCCccccccccc--------CccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCC
Confidence            9999999999999998664332        11223346899999999999873     4566789999999999999999


Q ss_pred             CCCCCCCH----------------HHHHHHHHhcCC--CCCCC-----CCHHHHHHHHHhhccCCCCCCCC
Q 011287          253 SPFKDTSE----------------WLIFQRIIARDI--RFPNY-----FSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       253 ~PF~~~~~----------------~~~~~~i~~~~~--~~p~~-----~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      .||.+...                ......+.....  .++..     .++++.+||.+||+.||++|||+
T Consensus       236 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  306 (322)
T 3soc_A          236 TAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA  306 (322)
T ss_dssp             TTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCH
Confidence            99976422                222222222211  12221     23559999999999999999998

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=6.2e-45  Score=365.30  Aligned_cols=252  Identities=20%  Similarity=0.295  Sum_probs=213.1

Q ss_pred             CCCCCCCCeEEeeEEeeeCceEEEEEE----EcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEE
Q 011287           39 QEHFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTF  114 (489)
Q Consensus        39 ~~~~~~~dy~~~~~LG~G~~g~Vy~a~----~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  114 (489)
                      ..-+..++|++++.||+|+||.||+|+    +..+++.||+|++...   .......+.+|+.+++.++||||+++++++
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   93 (327)
T 3lxl_A           17 PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVS   93 (327)
T ss_dssp             CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEE
Confidence            345677899999999999999999999    5678999999999764   344456688999999999999999999988


Q ss_pred             E--cCCEEEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccC
Q 011287          115 Q--DTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS  191 (489)
Q Consensus       115 ~--~~~~lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~  191 (489)
                      .  +...+|+||||+++++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  173 (327)
T 3lxl_A           94 YGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGL  173 (327)
T ss_dssp             ECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred             ecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccc
Confidence            6  566799999999999999999873 5699999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHH----------
Q 011287          192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW----------  261 (489)
Q Consensus       192 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~----------  261 (489)
                      +.........       ........||+.|+|||++.+..++.++|||||||++|+|++|..||......          
T Consensus       174 ~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~  246 (327)
T 3lxl_A          174 AKLLPLDKDY-------YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERD  246 (327)
T ss_dssp             CEECCTTCSE-------EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----
T ss_pred             ceecccCCcc-------ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccc
Confidence            9876433211       11223456888999999999988999999999999999999999999764432          


Q ss_pred             -----HHHHHHHh-cCCCCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          262 -----LIFQRIIA-RDIRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       262 -----~~~~~i~~-~~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                           .....+.. .....|..+++++.+||.+||+.||++||++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~  291 (327)
T 3lxl_A          247 VPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSF  291 (327)
T ss_dssp             CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             cccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCH
Confidence                 12222222 2355677899999999999999999999998

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.8e-45  Score=360.55  Aligned_cols=258  Identities=23%  Similarity=0.359  Sum_probs=210.2

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcC-CCc--EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKID-TGT--VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  116 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~-tg~--~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  116 (489)
                      ..+..++|++++.||+|+||.||+|++.. +++  .||+|++.............+.+|+.+++.++||||+++++++.+
T Consensus        13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   92 (291)
T 1u46_A           13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT   92 (291)
T ss_dssp             EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence            34567899999999999999999998643 333  699999977655555666778899999999999999999999987


Q ss_pred             CCEEEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCcccc
Q 011287          117 TFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (489)
Q Consensus       117 ~~~lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~  195 (489)
                      .. .++||||+.+++|.+++... +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus        93 ~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           93 PP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             SS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence            65 89999999999999999764 56999999999999999999999999999999999999999999999999999876


Q ss_pred             CCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhcC--C
Q 011287          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD--I  272 (489)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~~--~  272 (489)
                      ......       ........+|..|+|||++.+..++.++|||||||++|+|++ |+.||.+.+.......+....  .
T Consensus       172 ~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~  244 (291)
T 1u46_A          172 PQNDDH-------YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL  244 (291)
T ss_dssp             CC-CCE-------EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC
T ss_pred             cccccc-------hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC
Confidence            433211       112224567889999999998889999999999999999999 999999999988888887654  3


Q ss_pred             CCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          273 RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       273 ~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      ..+..+++++.+||.+||..||.+||++     .++++
T Consensus       245 ~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~l~~  277 (291)
T 1u46_A          245 PRPEDCPQDIYNVMVQCWAHKPEDRPTF-----VALRD  277 (291)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCCcCcCHHHHHHHHHHccCCcccCcCH-----HHHHH
Confidence            4556799999999999999999999998     66664

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.8e-44  Score=378.49  Aligned_cols=240  Identities=24%  Similarity=0.407  Sum_probs=210.9

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-E
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-S  119 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-~  119 (489)
                      .+..++|++++.||+|+||.||+|.+.  |+.||||++....     ....+.+|+.+|+.++||||+++++++.+.. .
T Consensus       189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  261 (450)
T 1k9a_A          189 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG  261 (450)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred             ccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence            456789999999999999999999984  7899999997542     3345778999999999999999999987654 7


Q ss_pred             EEEEEeccCCCChHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCC
Q 011287          120 LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~~~--l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~  197 (489)
                      +|+|||||++|+|.+++.+.+.  +++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+++....
T Consensus       262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  341 (450)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence            9999999999999999987654  79999999999999999999999999999999999999999999999999985322


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCC
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFP  275 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p  275 (489)
                      .             .....++..|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..+....+..+ ....|
T Consensus       342 ~-------------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p  408 (450)
T 1k9a_A          342 T-------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP  408 (450)
T ss_dssp             ------------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCC
T ss_pred             c-------------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            1             122357889999999999999999999999999999998 99999988777777777654 45678


Q ss_pred             CCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          276 NYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       276 ~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      ..+++++.+||.+||+.||++||++
T Consensus       409 ~~~~~~l~~li~~cl~~dp~~Rpt~  433 (450)
T 1k9a_A          409 DGCPPAVYDVMKNCWHLDAATRPTF  433 (450)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CcCCHHHHHHHHHHcCCChhHCcCH
Confidence            8999999999999999999999998

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.2e-44  Score=360.48  Aligned_cols=257  Identities=20%  Similarity=0.338  Sum_probs=209.0

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcC---CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKID---TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  116 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~---tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  116 (489)
                      -.+..++|.+++.||+|+||.||+|++..   ++..||+|++...... ......+.+|+.+++.++||||+++++++.+
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  107 (313)
T 3brb_A           29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS-QREIEEFLSEAACMKDFSHPNVIRLLGVCIE  107 (313)
T ss_dssp             TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCC-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred             cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccc-hhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence            44566789999999999999999998865   5668999999765332 3345667889999999999999999999986


Q ss_pred             CC-----EEEEEEeccCCCChHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEE
Q 011287          117 TF-----SLYMALESCEGGELFDQITS------KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIK  185 (489)
Q Consensus       117 ~~-----~lylV~E~~~gg~L~~~l~~------~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ik  185 (489)
                      ..     ..|+||||+++|+|.+++..      .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus       108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~k  187 (313)
T 3brb_A          108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVC  187 (313)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEE
T ss_pred             ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEE
Confidence            54     35999999999999999843      35699999999999999999999999999999999999999999999


Q ss_pred             EeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHH
Q 011287          186 IADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIF  264 (489)
Q Consensus       186 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~  264 (489)
                      |+|||+++.......        ........+++.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+.....
T Consensus       188 l~Dfg~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  259 (313)
T 3brb_A          188 VADFGLSKKIYSGDY--------YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY  259 (313)
T ss_dssp             ECSCSCC------------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred             EeecCcceecccccc--------cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH
Confidence            999999986543211        112224467889999999999999999999999999999999 99999998888777


Q ss_pred             HHHHhc-CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          265 QRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       265 ~~i~~~-~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      ..+... ...+|..+++++.+||.+||+.||.+||++     .++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~l~~  301 (313)
T 3brb_A          260 DYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTF-----SVLRL  301 (313)
T ss_dssp             HHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCH-----HHHHH
T ss_pred             HHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCH-----HHHHH
Confidence            777665 456778899999999999999999999998     66654

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.2e-44  Score=378.35  Aligned_cols=245  Identities=22%  Similarity=0.352  Sum_probs=213.8

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~l  120 (489)
                      .+..++|++.+.||+|+||.||+|++. ++..||||++.....    ....+.+|+.+|+.++||||+++++++. ...+
T Consensus       184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~  257 (454)
T 1qcf_A          184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI  257 (454)
T ss_dssp             BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred             eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence            456689999999999999999999985 478899999976432    3456788999999999999999999987 5578


Q ss_pred             EEEEeccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          121 YMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      |+|||||.+|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~  337 (454)
T 1qcf_A          258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN  337 (454)
T ss_dssp             EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence            9999999999999999854  36899999999999999999999999999999999999999999999999999876432


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCC
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPN  276 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~  276 (489)
                      ...         ......+|..|+|||++....++.++|||||||++|+|++ |+.||.+.+..++...+... ....|.
T Consensus       338 ~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~  408 (454)
T 1qcf_A          338 EYT---------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPE  408 (454)
T ss_dssp             HHH---------TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCT
T ss_pred             cee---------ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            211         1112346788999999998899999999999999999999 99999999988888777654 345678


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCC
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      .+++++.+||.+||+.||++||++
T Consensus       409 ~~~~~l~~li~~cl~~dp~~RPt~  432 (454)
T 1qcf_A          409 NCPEELYNIMMRCWKNRPEERPTF  432 (454)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCHHHHHHHHHHccCChhHCcCH
Confidence            899999999999999999999998

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.5e-44  Score=356.26  Aligned_cols=260  Identities=20%  Similarity=0.336  Sum_probs=199.6

Q ss_pred             cccccCCCCCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEE
Q 011287           32 SFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLF  111 (489)
Q Consensus        32 s~~~~~~~~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~  111 (489)
                      +.....+...+..++|++++.||+|+||.||+|++.   ..||+|++..... .......+.+|+.+++.++||||++++
T Consensus        11 ~~~~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (289)
T 3og7_A           11 GSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFM   86 (289)
T ss_dssp             -------CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             CCCCCCCCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEE
Confidence            333444445677789999999999999999999864   3599999976533 334456788899999999999999999


Q ss_pred             EEEEcCCEEEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeecc
Q 011287          112 FTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFG  190 (489)
Q Consensus       112 ~~~~~~~~lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG  190 (489)
                      ++. .....++||||+++++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||
T Consensus        87 ~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg  165 (289)
T 3og7_A           87 GYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFG  165 (289)
T ss_dssp             EEE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC
T ss_pred             eec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccce
Confidence            955 556789999999999999999654 569999999999999999999999999999999999999999999999999


Q ss_pred             CccccCCccccccCCCCCCCCccceecCCcCCChhhhc---CCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHH
Q 011287          191 SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN---SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI  267 (489)
Q Consensus       191 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~---~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i  267 (489)
                      ++.......        .........||+.|+|||++.   +..++.++|||||||++|+|++|+.||.+.+.......+
T Consensus       166 ~~~~~~~~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~  237 (289)
T 3og7_A          166 LATEKSRWS--------GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM  237 (289)
T ss_dssp             --------------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHH
T ss_pred             ecccccccc--------ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHH
Confidence            997553221        112233567999999999996   566888999999999999999999999886555444433


Q ss_pred             -HhcCCC-----CCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHh
Q 011287          268 -IARDIR-----FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLK  309 (489)
Q Consensus       268 -~~~~~~-----~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~  309 (489)
                       ......     ++..+++++.+||.+||+.||.+||++     .+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~ell  280 (289)
T 3og7_A          238 VGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSF-----PRIL  280 (289)
T ss_dssp             HHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHH
T ss_pred             hcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCH-----HHHH
Confidence             333222     234688999999999999999999998     5565

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3.2e-44  Score=351.38  Aligned_cols=243  Identities=22%  Similarity=0.353  Sum_probs=211.8

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lyl  122 (489)
                      ..++|++++.||+|+||.||+|++. ++..||+|++.....    ....+.+|+.+++.++||||+++++++.+ ...|+
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   84 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI   84 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence            4579999999999999999999975 577899999976432    23567789999999999999999999875 45899


Q ss_pred             EEeccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          123 ALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      ||||+++++|.+++....  .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  164 (279)
T 1qpc_A           85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (279)
T ss_dssp             EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence            999999999999987543  699999999999999999999999999999999999999999999999999987654321


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCCCC
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYF  278 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~  278 (489)
                      .         ......++..|+|||++.+..++.++|||||||++|+|++ |+.||.+.+.....+.+... ....|..+
T Consensus       165 ~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  235 (279)
T 1qpc_A          165 T---------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC  235 (279)
T ss_dssp             E---------CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred             c---------cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccc
Confidence            1         1223457889999999998889999999999999999999 99999999888888777654 34567789


Q ss_pred             CHHHHHHHHHhhccCCCCCCCC
Q 011287          279 SDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       279 ~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      ++++.+||.+||..||++||++
T Consensus       236 ~~~l~~li~~~l~~~p~~Rps~  257 (279)
T 1qpc_A          236 PEELYQLMRLCWKERPEDRPTF  257 (279)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCH
T ss_pred             cHHHHHHHHHHhccChhhCCCH
Confidence            9999999999999999999998

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=4.8e-44  Score=352.65  Aligned_cols=249  Identities=21%  Similarity=0.306  Sum_probs=205.9

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEE-EEEEcCCEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLF-FTFQDTFSLYM  122 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~-~~~~~~~~lyl  122 (489)
                      .++|++++.||+|+||.||+|++..+|+.||+|++......     ..+.+|..+++.++|++++..+ .++.+....|+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence            47899999999999999999999999999999998754322     2467799999999887766554 45567888999


Q ss_pred             EEeccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeC---CCCCEEEeeccCccccCCc
Q 011287          123 ALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT---ADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~---~~g~ikL~DFG~a~~~~~~  198 (489)
                      ||||+ +++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            99999 8899999984 45799999999999999999999999999999999999994   7899999999999876543


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCC---HHHHHHHHHhcCCCCC
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS---EWLIFQRIIARDIRFP  275 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~---~~~~~~~i~~~~~~~p  275 (489)
                      .....   ..........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+   ....+..+.......|
T Consensus       162 ~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          162 RTHQH---IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             TTCCB---CCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             ccccc---cccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence            21110   00122346689999999999999999999999999999999999999998743   2234444444333333


Q ss_pred             -----CCCCHHHHHHHHHhhccCCCCCCCCC
Q 011287          276 -----NYFSDAARDLIDRLLDVDPSGRPGAG  301 (489)
Q Consensus       276 -----~~~~~~~~~Li~~~L~~dP~~R~t~~  301 (489)
                           ..+++++.+||.+||+.||++||++.
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  269 (296)
T 3uzp_A          239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYS  269 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHH
T ss_pred             hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHH
Confidence                 67899999999999999999999984

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.3e-45  Score=369.37  Aligned_cols=252  Identities=20%  Similarity=0.262  Sum_probs=208.2

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lyl  122 (489)
                      ..++|++.+.||+|+||.||+|++. +|+.||+|++...   .......+.+|+.+++.++||||+++++++.+...+|+
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  112 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPE---SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL  112 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSC---CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred             HHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEeccc---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence            4689999999999999999999964 6899999988654   23345668889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          123 ALESCEGGELFDQITSKG----HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~~----~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      ||||+++|+|.+++....    .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  192 (321)
T 2qkw_B          113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL  192 (321)
T ss_dssp             EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred             EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            999999999999987643    5899999999999999999999999999999999999999999999999999864322


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHH-------HHHHhcC
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIF-------QRIIARD  271 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~-------~~i~~~~  271 (489)
                      .        .........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.......       .......
T Consensus       193 ~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  264 (321)
T 2qkw_B          193 D--------QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ  264 (321)
T ss_dssp             S--------CCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred             c--------ccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence            1        112233567999999999999889999999999999999999999999765432111       1111111


Q ss_pred             ------C----CCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 011287          272 ------I----RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (489)
Q Consensus       272 ------~----~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~h  311 (489)
                            .    .++...+..+.+|+.+||+.||++||++     .++++|
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~~  309 (321)
T 2qkw_B          265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSM-----GDVLWK  309 (321)
T ss_dssp             CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCH-----HHHHHH
Confidence                  1    1222345778999999999999999998     667643

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=4e-45  Score=381.57  Aligned_cols=259  Identities=26%  Similarity=0.434  Sum_probs=202.7

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSL  120 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~l  120 (489)
                      ....+|.+.+.||+|+||+||. ....+|+.||||++......      ...+|+.+|+.+ +||||+++++++.+...+
T Consensus        21 i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~   93 (432)
T 3p23_A           21 VGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQ   93 (432)
T ss_dssp             ETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEE
T ss_pred             EccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEE
Confidence            3445799999999999999764 44467999999999664322      245689999998 799999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCC---C--CCEEEeeccCccc
Q 011287          121 YMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA---D--GHIKIADFGSVKP  194 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~---~--g~ikL~DFG~a~~  194 (489)
                      |+|||||. |+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.   +  ..+||+|||+|+.
T Consensus        94 ~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~  172 (432)
T 3p23_A           94 YIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK  172 (432)
T ss_dssp             EEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred             EEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence            99999996 59999998753 4666778899999999999999999999999999999953   2  3588999999987


Q ss_pred             cCCccccccCCCCCCCCccceecCCcCCChhhhc---CCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc
Q 011287          195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLN---SSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR  270 (489)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~---~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~  270 (489)
                      +.....       ........+||+.|+|||++.   ...++.++|||||||++|+|++ |..||...........+...
T Consensus       173 ~~~~~~-------~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~  245 (432)
T 3p23_A          173 LAVGRH-------SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGAC  245 (432)
T ss_dssp             C-------------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCC
T ss_pred             ccCCCc-------ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccC
Confidence            643221       112334568999999999997   4557889999999999999999 99999766554433222222


Q ss_pred             CCCC---CCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcc
Q 011287          271 DIRF---PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWK  320 (489)
Q Consensus       271 ~~~~---p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~  320 (489)
                      ....   +...+..+++||.+||+.||++|||+     +++++||||.+++|.
T Consensus       246 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~-----~evl~hp~f~~~~~~  293 (432)
T 3p23_A          246 SLDCLHPEKHEDVIARELIEKMIAMDPQKRPSA-----KHVLKHPFFWSLEKQ  293 (432)
T ss_dssp             CCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCH-----HHHHTSTTTCCHHHH
T ss_pred             CccccCccccccHHHHHHHHHHHhCCHhhCCCH-----HHHHhCccccChHHH
Confidence            2211   22345678999999999999999998     899999999998873

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.6e-44  Score=353.63  Aligned_cols=240  Identities=23%  Similarity=0.407  Sum_probs=204.5

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC-CE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT-FS  119 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~  119 (489)
                      .+..++|++++.||+|+||.||+|++  +|+.||+|++...     .....+.+|+.+++.++||||+++++++.+. ..
T Consensus        17 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (278)
T 1byg_A           17 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG   89 (278)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC-----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred             cCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch-----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence            45678999999999999999999987  4899999998654     2345677899999999999999999987554 47


Q ss_pred             EEEEEeccCCCChHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCC
Q 011287          120 LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~~~--l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~  197 (489)
                      +|+||||+++|+|.+++.+.+.  +++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            8999999999999999987543  89999999999999999999999999999999999999999999999999875432


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCC
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFP  275 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p  275 (489)
                      .             .....+++.|+|||++.+..++.++|||||||++|+|++ |..||...+.......+... ...+|
T Consensus       170 ~-------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~  236 (278)
T 1byg_A          170 T-------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP  236 (278)
T ss_dssp             -------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCC
T ss_pred             c-------------ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCc
Confidence            1             123467889999999999899999999999999999998 99999988877777766554 45677


Q ss_pred             CCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          276 NYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       276 ~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      ..+++.+.+||.+||+.||++||++
T Consensus       237 ~~~~~~l~~li~~~l~~~p~~Rps~  261 (278)
T 1byg_A          237 DGCPPAVYEVMKNCWHLDAAMRPSF  261 (278)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             ccCCHHHHHHHHHHhcCChhhCCCH
Confidence            8899999999999999999999998

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.6e-44  Score=352.49  Aligned_cols=248  Identities=21%  Similarity=0.355  Sum_probs=210.8

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEE-
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGT---VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL-  120 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~---~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~l-  120 (489)
                      -.|.+.+.||+|+||+||+|++..++.   .||+|++...  ........+.+|+.+++.++||||+++++++.+.... 
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   98 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP   98 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence            467888999999999999999766554   8999998653  2334556778899999999999999999999876655 


Q ss_pred             EEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcc
Q 011287          121 YMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      |+||||+.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+++.+....
T Consensus        99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            9999999999999999873 569999999999999999999999999999999999999999999999999998664432


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhcC-CCCCCC
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRFPNY  277 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~~-~~~p~~  277 (489)
                      ..      .........+|+.|+|||.+.+..++.++|||||||++|+|++ |.+||...+.......+.... ...|..
T Consensus       179 ~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (298)
T 3pls_A          179 YY------SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEY  252 (298)
T ss_dssp             GG------CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTT
T ss_pred             cc------ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCcc
Confidence            11      1122334578899999999999999999999999999999999 666677777766666665543 556778


Q ss_pred             CCHHHHHHHHHhhccCCCCCCCC
Q 011287          278 FSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       278 ~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      +++++.+||.+||+.||.+|||+
T Consensus       253 ~~~~l~~li~~~l~~~p~~Rps~  275 (298)
T 3pls_A          253 CPDSLYQVMQQCWEADPAVRPTF  275 (298)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             chHHHHHHHHHHccCChhhCcCH
Confidence            99999999999999999999998

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=9.9e-45  Score=385.01  Aligned_cols=251  Identities=21%  Similarity=0.354  Sum_probs=219.6

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~l  120 (489)
                      .+..++|++.+.||+|+||.||+|+++.++..||||++.....    ....+.+|+.+|+.++||||+++++++.+...+
T Consensus       216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  291 (495)
T 1opk_A          216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF  291 (495)
T ss_dssp             BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence            3456789999999999999999999999999999999975432    245677899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          121 YMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      |+|||||++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  371 (495)
T 1opk_A          292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD  371 (495)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred             EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence            9999999999999999864  45999999999999999999999999999999999999999999999999999876432


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCC
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPN  276 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~  276 (489)
                      ...         ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+...+.+.+... ....|.
T Consensus       372 ~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~  442 (495)
T 1opk_A          372 TYT---------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPE  442 (495)
T ss_dssp             CEE---------CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCT
T ss_pred             cee---------ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            211         1123356789999999998889999999999999999999 99999998877776666543 355678


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHh
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLK  309 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~  309 (489)
                      .+++++.+||.+||+.||++||++     .+++
T Consensus       443 ~~~~~l~~li~~cl~~dP~~RPs~-----~el~  470 (495)
T 1opk_A          443 GCPEKVYELMRACWQWNPSDRPSF-----AEIH  470 (495)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCH-----HHHH
T ss_pred             CCCHHHHHHHHHHcCcChhHCcCH-----HHHH
Confidence            899999999999999999999998     5665

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3.4e-44  Score=354.58  Aligned_cols=250  Identities=20%  Similarity=0.334  Sum_probs=209.9

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEE-EcCC
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDT---GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTF-QDTF  118 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~t---g~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-~~~~  118 (489)
                      ...+|++.+.||+|+||.||+|++..+   +..||+|.+...  ........+.+|..+++.++||||+++++++ .+..
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  100 (298)
T 3f66_A           23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG  100 (298)
T ss_dssp             GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred             cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence            346799999999999999999997543   346899998653  2344556788899999999999999999985 5567


Q ss_pred             EEEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCC
Q 011287          119 SLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~  197 (489)
                      ..|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+++.+..
T Consensus       101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            889999999999999999764 5689999999999999999999999999999999999999999999999999987654


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhcCC-CCC
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDI-RFP  275 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~~~-~~p  275 (489)
                      ....      .........||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+.......+..... ..|
T Consensus       181 ~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (298)
T 3f66_A          181 KEYY------SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP  254 (298)
T ss_dssp             GGGC------BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCC
T ss_pred             cchh------ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCC
Confidence            3211      1122334578899999999999999999999999999999999 7888888777777666666543 457


Q ss_pred             CCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          276 NYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       276 ~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      ..+++.+.+||.+||+.||++||++
T Consensus       255 ~~~~~~l~~li~~~l~~~p~~Rps~  279 (298)
T 3f66_A          255 EYCPDPLYEVMLKCWHPKAEMRPSF  279 (298)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCH
Confidence            7889999999999999999999998

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.9e-45  Score=375.91  Aligned_cols=246  Identities=24%  Similarity=0.438  Sum_probs=205.7

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC--EE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF--SL  120 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--~l  120 (489)
                      ..++|++++.||+|+||.||+|++..+|+.||||++......  .....+.+|+.+++.++||||+++++++.+..  ..
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~   84 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence            357899999999999999999999999999999999764322  22455678999999999999999999998755  78


Q ss_pred             EEEEeccCCCChHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeee----CCCCCEEEeeccCcc
Q 011287          121 YMALESCEGGELFDQITSKG---HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL----TADGHIKIADFGSVK  193 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~~---~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl----~~~g~ikL~DFG~a~  193 (489)
                      |+|||||++|+|.+++....   .+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+++
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            99999999999999997653   39999999999999999999999999999999999999    777889999999998


Q ss_pred             ccCCccccccCCCCCCCCccceecCCcCCChhhhcC--------CCCCCCCcchhhhHHHHHHhhCCCCCCC----CCHH
Q 011287          194 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS--------SPATFGNDLWALGCTLYQMLSGTSPFKD----TSEW  261 (489)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~--------~~~~~~sDiwSLG~ilyelltG~~PF~~----~~~~  261 (489)
                      ......           .....+||+.|+|||++.+        ..++.++|||||||++|+|++|+.||..    ....
T Consensus       165 ~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~  233 (396)
T 4eut_A          165 ELEDDE-----------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK  233 (396)
T ss_dssp             ECCCGG-----------GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH
T ss_pred             EccCCC-----------ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH
Confidence            654321           2235679999999999865        4577889999999999999999999964    2334


Q ss_pred             HHHHHHHhcCCC-------------------------CCCCCCHHHHHHHHHhhccCCCCCCCCC
Q 011287          262 LIFQRIIARDIR-------------------------FPNYFSDAARDLIDRLLDVDPSGRPGAG  301 (489)
Q Consensus       262 ~~~~~i~~~~~~-------------------------~p~~~~~~~~~Li~~~L~~dP~~R~t~~  301 (489)
                      +.+.++....+.                         ++..++..+.+||++||+.||++||++.
T Consensus       234 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~  298 (396)
T 4eut_A          234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFD  298 (396)
T ss_dssp             HHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHH
T ss_pred             HHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHH
Confidence            555555554321                         1123456789999999999999999984

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.3e-44  Score=352.51  Aligned_cols=244  Identities=27%  Similarity=0.406  Sum_probs=210.5

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc-------
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD-------  116 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-------  116 (489)
                      ..+|++++.||+|+||.||+|++..+|+.||+|++....       ..+.+|+.+++.++||||+++++++.+       
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET   82 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence            367999999999999999999999999999999997542       235579999999999999999998864       


Q ss_pred             ---------CCEEEEEEeccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEE
Q 011287          117 ---------TFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIK  185 (489)
Q Consensus       117 ---------~~~lylV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ik  185 (489)
                               ...+|+||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k  162 (284)
T 2a19_B           83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVK  162 (284)
T ss_dssp             ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred             ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEE
Confidence                     45689999999999999999754  5799999999999999999999999999999999999999999999


Q ss_pred             EeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHH
Q 011287          186 IADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQ  265 (489)
Q Consensus       186 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~  265 (489)
                      |+|||++.......           ......||+.|+|||++.+..++.++|||||||++|+|++|..||...  .....
T Consensus       163 l~Dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~  229 (284)
T 2a19_B          163 IGDFGLVTSLKNDG-----------KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFT  229 (284)
T ss_dssp             ECCCTTCEESSCCS-----------CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHH
T ss_pred             ECcchhheeccccc-----------cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHH
Confidence            99999998654321           223457999999999999999999999999999999999999998542  22333


Q ss_pred             HHHhcCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          266 RIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       266 ~i~~~~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                      .+..  ..++..+++.+.+||.+||+.||.+||++     .++++|.++
T Consensus       230 ~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~e~l~~l~~  271 (284)
T 2a19_B          230 DLRD--GIISDIFDKKEKTLLQKLLSKKPEDRPNT-----SEILRTLTV  271 (284)
T ss_dssp             HHHT--TCCCTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHHHHHHH
T ss_pred             Hhhc--ccccccCCHHHHHHHHHHccCChhhCcCH-----HHHHHHHHH
Confidence            3333  34677899999999999999999999998     888887654

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=6.7e-45  Score=362.80  Aligned_cols=261  Identities=24%  Similarity=0.379  Sum_probs=206.3

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEE----cC
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ----DT  117 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~----~~  117 (489)
                      +..++|++++.||+|+||.||+|++..+|+.||+|++...   .......+.+|+.+++.++||||+++++++.    ..
T Consensus        26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (317)
T 2buj_A           26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK  102 (317)
T ss_dssp             ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred             ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence            4457899999999999999999999999999999998653   3445567888999999999999999999986    34


Q ss_pred             CEEEEEEeccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCcc
Q 011287          118 FSLYMALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK  193 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~  193 (489)
                      ...|+||||+.+|+|.+++..    .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.
T Consensus       103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~  182 (317)
T 2buj_A          103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMN  182 (317)
T ss_dssp             EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence            578999999999999999876    4679999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCccccccCCCCCCCCccceecCCcCCChhhhcCCC---CCCCCcchhhhHHHHHHhhCCCCCCCCCHH--HHHHHHH
Q 011287          194 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP---ATFGNDLWALGCTLYQMLSGTSPFKDTSEW--LIFQRII  268 (489)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~---~~~~sDiwSLG~ilyelltG~~PF~~~~~~--~~~~~i~  268 (489)
                      ........... ...........||+.|+|||++.+..   ++.++|||||||++|+|++|+.||......  .....+.
T Consensus       183 ~~~~~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~  261 (317)
T 2buj_A          183 QACIHVEGSRQ-ALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ  261 (317)
T ss_dssp             ESCEEEESHHH-HHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH
T ss_pred             hcccccccccc-cccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh
Confidence            54321100000 00000112446799999999997654   688999999999999999999999542110  1111111


Q ss_pred             h-cCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 011287          269 A-RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (489)
Q Consensus       269 ~-~~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~h  311 (489)
                      . .....+..+++++.+||.+||+.||.+||++     .+++++
T Consensus       262 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~~  300 (317)
T 2buj_A          262 NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHI-----PLLLSQ  300 (317)
T ss_dssp             CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             ccCCCCccccCCHHHHHHHHHHhhcChhhCCCH-----HHHHHH
Confidence            1 1233345789999999999999999999998     777753

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=7.5e-44  Score=376.46  Aligned_cols=273  Identities=19%  Similarity=0.290  Sum_probs=222.5

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC-CCccEEEEEEEcCCEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH-PGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~ly  121 (489)
                      ..++|++++.||+|+||.||+|++..+++.||||++......     ..+.+|..+++.+.| ++|..+..++.+....|
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~   79 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV   79 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence            457899999999999999999999999999999998754322     236679999999976 56666777778888999


Q ss_pred             EEEeccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeee---CCCCCEEEeeccCccccCC
Q 011287          122 MALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL---TADGHIKIADFGSVKPMQD  197 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl---~~~g~ikL~DFG~a~~~~~  197 (489)
                      +||||+ +++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+||||   +.++++||+|||+++.+..
T Consensus        80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~  158 (483)
T 3sv0_A           80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD  158 (483)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence            999999 8899999985 4679999999999999999999999999999999999999   5889999999999987654


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCC---HHHHHHHHHhcCC--
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS---EWLIFQRIIARDI--  272 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~---~~~~~~~i~~~~~--  272 (489)
                      ......   .........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..   ....+.++.....  
T Consensus       159 ~~~~~~---~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (483)
T 3sv0_A          159 TSTHQH---IPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT  235 (483)
T ss_dssp             TTTCCB---CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS
T ss_pred             Cccccc---cccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc
Confidence            321100   00122336789999999999999999999999999999999999999998743   3444444443322  


Q ss_pred             ---CCCCCCCHHHHHHHHHhhccCCCCCCCCCC--C---CHHHHhcCCCCCCCCcccccC
Q 011287          273 ---RFPNYFSDAARDLIDRLLDVDPSGRPGAGP--G---GYAVLKMHPFFKGIDWKNIRG  324 (489)
Q Consensus       273 ---~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~--~---~~~~l~~hpff~~i~~~~~~~  324 (489)
                         .++..+++++.+||.+||+.||.+||++.+  .   .+.....++|+..+||+.+..
T Consensus       236 ~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~~  295 (483)
T 3sv0_A          236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKY  295 (483)
T ss_dssp             CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC
T ss_pred             cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhcc
Confidence               233678999999999999999999999854  1   122224689999999997754

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.9e-44  Score=364.49  Aligned_cols=246  Identities=16%  Similarity=0.212  Sum_probs=202.9

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCC--------CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccE------
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDT--------GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVR------  109 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~t--------g~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~------  109 (489)
                      .++|++++.||+|+||.||+|++..+        ++.||+|++.+.        ..+.+|+.+++.++||||++      
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~  112 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY  112 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence            47999999999999999999999874        899999998754        24667999999999999987      


Q ss_pred             ---------EEEEEEc-CCEEEEEEeccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCee
Q 011287          110 ---------LFFTFQD-TFSLYMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLL  177 (489)
Q Consensus       110 ---------l~~~~~~-~~~lylV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNIL  177 (489)
                               +++++.. ...+|+||||+ +++|.+++...  +.+++..+..++.||+.||.|||++||+||||||+|||
T Consensus       113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl  191 (352)
T 2jii_A          113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF  191 (352)
T ss_dssp             TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred             cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence                     5666665 78899999999 99999999986  78999999999999999999999999999999999999


Q ss_pred             eCCCC--CEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCC
Q 011287          178 LTADG--HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF  255 (489)
Q Consensus       178 l~~~g--~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF  255 (489)
                      ++.++  .+||+|||+++.+........   ..........||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf  268 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVA---YVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW  268 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCC---CCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             EcCCCCceEEEecCcceeeccCCCcccc---ccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            99998  999999999987654321110   1122334568999999999999999999999999999999999999999


Q ss_pred             CCCC--HHHHHHHH---HhcCCCCC------CCCCHHHHHHHHHhhccCCCCCCCCC
Q 011287          256 KDTS--EWLIFQRI---IARDIRFP------NYFSDAARDLIDRLLDVDPSGRPGAG  301 (489)
Q Consensus       256 ~~~~--~~~~~~~i---~~~~~~~p------~~~~~~~~~Li~~~L~~dP~~R~t~~  301 (489)
                      .+..  ...+...+   ......++      ..+++++.+||.+||+.||++||++.
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  325 (352)
T 2jii_A          269 TNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYA  325 (352)
T ss_dssp             GGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHH
T ss_pred             ccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHH
Confidence            8753  33333222   22222222      24699999999999999999999984

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.1e-44  Score=359.93  Aligned_cols=260  Identities=27%  Similarity=0.417  Sum_probs=190.7

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccEEEEEEE----
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQ----  115 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~----  115 (489)
                      .+...+|++.+.||+|+||.||+|++..+|+.||+|++...   .......+.+|+.+++.+. ||||+++++++.    
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~  100 (337)
T 3ll6_A           24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE  100 (337)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred             eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence            34456899999999999999999999999999999998554   3344566788999999995 999999999993    


Q ss_pred             ----cCCEEEEEEeccCCCChHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeeccCCCCeeeCCCCCEEE
Q 011287          116 ----DTFSLYMALESCEGGELFDQITS---KGHLSEDEARFYTAEVVDALEYIHSMG--LIHRDIKPENLLLTADGHIKI  186 (489)
Q Consensus       116 ----~~~~lylV~E~~~gg~L~~~l~~---~~~l~e~~~~~i~~qil~aL~~LH~~g--IiHrDLKpeNILl~~~g~ikL  186 (489)
                          ....+|+||||+. |+|.+++..   .+.+++..+..++.||+.||.|||+.|  |+||||||+|||++.++++||
T Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl  179 (337)
T 3ll6_A          101 ESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKL  179 (337)
T ss_dssp             TSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEB
T ss_pred             ccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEE
Confidence                4456899999996 699988865   467999999999999999999999999  999999999999999999999


Q ss_pred             eeccCccccCCccccccCC--CCCCCCccceecCCcCCChhhh---cCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHH
Q 011287          187 ADFGSVKPMQDSRITVLPN--AASDDKACTFVGTAAYVPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW  261 (489)
Q Consensus       187 ~DFG~a~~~~~~~~~~~~~--~~~~~~~~~~~gt~~Y~aPE~l---~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~  261 (489)
                      +|||+++............  ...........||+.|+|||++   .+..++.++|||||||++|+|++|..||......
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~  259 (337)
T 3ll6_A          180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL  259 (337)
T ss_dssp             CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence            9999998765432110000  0001122356799999999998   5667889999999999999999999999876554


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 011287          262 LIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (489)
Q Consensus       262 ~~~~~i~~~~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~h  311 (489)
                      .......  ....+...+..+.+||.+||+.||.+||++     .++++|
T Consensus       260 ~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~e~l~~  302 (337)
T 3ll6_A          260 RIVNGKY--SIPPHDTQYTVFHSLIRAMLQVNPEERLSI-----AEVVHQ  302 (337)
T ss_dssp             ------C--CCCTTCCSSGGGHHHHHHHSCSSGGGSCCH-----HHHHHH
T ss_pred             HhhcCcc--cCCcccccchHHHHHHHHHccCChhhCcCH-----HHHHHH
Confidence            4332221  223345678899999999999999999998     777765

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.1e-43  Score=370.83  Aligned_cols=253  Identities=30%  Similarity=0.425  Sum_probs=197.1

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~lyl  122 (489)
                      .+.|.+.+.||+|+||+||.+. ..+|+.||||++...      ....+.+|+.+++.+ +||||+++++++.+...+|+
T Consensus        14 ~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~l   86 (434)
T 2rio_A           14 KNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYI   86 (434)
T ss_dssp             SSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred             hheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEE
Confidence            3456778999999999998764 467999999998653      234467799999875 89999999999999999999


Q ss_pred             EEeccCCCChHHHHHhCCCCC-------HHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCC-------------C
Q 011287          123 ALESCEGGELFDQITSKGHLS-------EDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-------------G  182 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~~~l~-------e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~-------------g  182 (489)
                      |||||. |+|.+++...+...       +..+..++.||+.||+|||++||+||||||+|||++.+             +
T Consensus        87 v~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~  165 (434)
T 2rio_A           87 ALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENL  165 (434)
T ss_dssp             EECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred             EEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCce
Confidence            999996 59999998764332       33456799999999999999999999999999999754             4


Q ss_pred             CEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcC-------CCCCCCCcchhhhHHHHHHhh-CCCC
Q 011287          183 HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-------SPATFGNDLWALGCTLYQMLS-GTSP  254 (489)
Q Consensus       183 ~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-------~~~~~~sDiwSLG~ilyellt-G~~P  254 (489)
                      ++||+|||+++.+......      ........+||+.|+|||++.+       ..++.++|||||||++|+|++ |..|
T Consensus       166 ~~kL~DFG~a~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~P  239 (434)
T 2rio_A          166 RILISDFGLCKKLDSGQSS------FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP  239 (434)
T ss_dssp             EEEECCCTTCEECCC--------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCT
T ss_pred             EEEEcccccceecCCCCcc------ceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCC
Confidence            8999999999876543211      0112335689999999999976       568999999999999999999 9999


Q ss_pred             CCCCCHHHHHHHHHhcCCCCCC-------CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          255 FKDTSEWLIFQRIIARDIRFPN-------YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       255 F~~~~~~~~~~~i~~~~~~~p~-------~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                      |.+.....  ..+......++.       .+++++.+||.+||+.||++|||+     .++++||||.+.
T Consensus       240 f~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~-----~eil~hp~f~~~  302 (434)
T 2rio_A          240 FGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTA-----MKVLRHPLFWPK  302 (434)
T ss_dssp             TCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCH-----HHHHTSGGGSCH
T ss_pred             CCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCH-----HHHHhCCccCCc
Confidence            98765433  344444444332       245889999999999999999998     899999999753

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.8e-43  Score=384.22  Aligned_cols=246  Identities=21%  Similarity=0.321  Sum_probs=209.1

Q ss_pred             CeEE-eeEEeeeCceEEEEEEE--cCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEE
Q 011287           46 DFEL-GKIYGVGSYSKVVRAKK--IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        46 dy~~-~~~LG~G~~g~Vy~a~~--~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lyl  122 (489)
                      .+.+ .+.||+|+||.||+|.+  +.+++.||||++..... .......+.+|+.+|+.++|||||++++++.++ .+|+
T Consensus       369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~l  446 (635)
T 4fl3_A          369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWML  446 (635)
T ss_dssp             GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CEEE
Confidence            3444 34899999999999955  56789999999976533 233456688899999999999999999999754 5899


Q ss_pred             EEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccc
Q 011287          123 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~  202 (489)
                      |||||++|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+...... 
T Consensus       447 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~-  525 (635)
T 4fl3_A          447 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-  525 (635)
T ss_dssp             EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             EEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc-
Confidence            9999999999999998888999999999999999999999999999999999999999999999999999876433211 


Q ss_pred             cCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhcC-CCCCCCCCH
Q 011287          203 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRFPNYFSD  280 (489)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~~-~~~p~~~~~  280 (489)
                            ........||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..++.+.+.... ..+|..+++
T Consensus       526 ------~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~  599 (635)
T 4fl3_A          526 ------YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR  599 (635)
T ss_dssp             ---------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred             ------cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence                  111223457889999999999999999999999999999998 999999999988888877653 567889999


Q ss_pred             HHHHHHHHhhccCCCCCCCC
Q 011287          281 AARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       281 ~~~~Li~~~L~~dP~~R~t~  300 (489)
                      ++.+||.+||+.||++||++
T Consensus       600 ~l~~li~~cl~~dP~~RPs~  619 (635)
T 4fl3_A          600 EMYDLMNLCWTYDVENRPGF  619 (635)
T ss_dssp             HHHHHHHHHTCSSTTTSCCH
T ss_pred             HHHHHHHHHcCCCHhHCcCH
Confidence            99999999999999999998

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.2e-43  Score=350.57  Aligned_cols=249  Identities=24%  Similarity=0.353  Sum_probs=198.0

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh--CCCCCccEEEEEEEc--
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ--LDHPGVVRLFFTFQD--  116 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~~--  116 (489)
                      ....++|++++.||+|+||+||+|++  +|+.||||++...      .......|.+++..  ++||||+++++++.+  
T Consensus         4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~   75 (301)
T 3q4u_A            4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR------DEKSWFRETELYNTVMLRHENILGFIASDMTSR   75 (301)
T ss_dssp             CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred             ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc------cchhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence            34568999999999999999999988  6899999998643      22334456666665  799999999988653  


Q ss_pred             --CCEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCcEeeccCCCCeeeCCCCCEEE
Q 011287          117 --TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH--------SMGLIHRDIKPENLLLTADGHIKI  186 (489)
Q Consensus       117 --~~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH--------~~gIiHrDLKpeNILl~~~g~ikL  186 (489)
                        ...+|+||||+++|+|.+++.. +.+++..+..++.||+.||.|||        +.||+||||||+|||++.++++||
T Consensus        76 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl  154 (301)
T 3q4u_A           76 HSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI  154 (301)
T ss_dssp             TTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred             CCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence              3568999999999999999965 57999999999999999999999        999999999999999999999999


Q ss_pred             eeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCC------CCCCCCcchhhhHHHHHHhhC---------
Q 011287          187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS------PATFGNDLWALGCTLYQMLSG---------  251 (489)
Q Consensus       187 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~------~~~~~sDiwSLG~ilyelltG---------  251 (489)
                      +|||+++.........      .......+||+.|+|||++.+.      .++.++|||||||++|+|++|         
T Consensus       155 ~Dfg~a~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~  228 (301)
T 3q4u_A          155 ADLGLAVMHSQSTNQL------DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED  228 (301)
T ss_dssp             CCCTTCEEEETTTTEE------ECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred             eeCCCeeecccccccc------cccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccc
Confidence            9999997654332111      1122345899999999999876      345689999999999999999         


Q ss_pred             -CCCCCCCC----HHHHHHHHHhcC---CCCCC-----CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHh
Q 011287          252 -TSPFKDTS----EWLIFQRIIARD---IRFPN-----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLK  309 (489)
Q Consensus       252 -~~PF~~~~----~~~~~~~i~~~~---~~~p~-----~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~  309 (489)
                       ..||....    .......+....   ..+|.     ..++++.+||.+||+.||++|||+     .+++
T Consensus       229 ~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~~i~  294 (301)
T 3q4u_A          229 YKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTA-----LRIK  294 (301)
T ss_dssp             CCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCH-----HHHH
T ss_pred             ccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCH-----HHHH
Confidence             89996532    223333333222   22332     245789999999999999999998     5665

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=7.8e-44  Score=356.25  Aligned_cols=253  Identities=21%  Similarity=0.301  Sum_probs=208.0

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEE----cCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc-
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKK----IDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD-  116 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~----~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-  116 (489)
                      +....|++++.||+|+||.||+|..    ..+|+.||||++...  ........+.+|+.+++.++||||+++++++.+ 
T Consensus        28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (318)
T 3lxp_A           28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA  105 (318)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc--cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence            4444569999999999999988754    457899999999765  233445678889999999999999999999987 


Q ss_pred             -CCEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCcccc
Q 011287          117 -TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (489)
Q Consensus       117 -~~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~  195 (489)
                       ...+|+||||+++|+|.+++.+. .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  184 (318)
T 3lxp_A          106 GAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  184 (318)
T ss_dssp             TTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             CCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence             46899999999999999999875 5999999999999999999999999999999999999999999999999999876


Q ss_pred             CCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHH--------------
Q 011287          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW--------------  261 (489)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~--------------  261 (489)
                      ......       ........||..|+|||++.+..++.++|||||||++|+|++|..||......              
T Consensus       185 ~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~  257 (318)
T 3lxp_A          185 PEGHEY-------YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV  257 (318)
T ss_dssp             CTTCSE-------EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHH
T ss_pred             cccccc-------cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhH
Confidence            443211       11223456888999999999988999999999999999999999999764321              


Q ss_pred             -HHHHHHHh-cCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHh
Q 011287          262 -LIFQRIIA-RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLK  309 (489)
Q Consensus       262 -~~~~~i~~-~~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~  309 (489)
                       .....+.. .....|..+++++.+||.+||+.||++||++     .+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell  302 (318)
T 3lxp_A          258 LRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTF-----ENLI  302 (318)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHH
T ss_pred             HHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCH-----HHHH
Confidence             11111111 2445678899999999999999999999998     5565

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.3e-43  Score=372.17  Aligned_cols=249  Identities=20%  Similarity=0.333  Sum_probs=211.3

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ly  121 (489)
                      +..++|++.+.||+|+||.||+|++.. +..||||++......    .+.+.+|+.+|+.++||||+++++++.+ ..+|
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~  254 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY  254 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence            456789999999999999999999965 567999999765322    3457789999999999999999999876 6789


Q ss_pred             EEEeccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcc
Q 011287          122 MALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      +||||+++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  334 (452)
T 1fmk_A          255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  334 (452)
T ss_dssp             EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence            999999999999999753  469999999999999999999999999999999999999999999999999998654321


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCCC
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNY  277 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~  277 (489)
                      .         .......++..|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..+....+..+ ....|..
T Consensus       335 ~---------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~  405 (452)
T 1fmk_A          335 Y---------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE  405 (452)
T ss_dssp             -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred             e---------ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence            1         11223457789999999999899999999999999999999 99999999988888777654 3566788


Q ss_pred             CCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       278 ~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      +++.+.+||.+||+.||++|||+     ++++.
T Consensus       406 ~~~~l~~li~~cl~~dP~~Rpt~-----~~l~~  433 (452)
T 1fmk_A          406 CPESLHDLMCQCWRKEPEERPTF-----EYLQA  433 (452)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCHHHHHHHHHHccCChhhCcCH-----HHHHH
Confidence            99999999999999999999998     66654

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.3e-43  Score=351.32  Aligned_cols=230  Identities=30%  Similarity=0.526  Sum_probs=193.2

Q ss_pred             CCCCCeEEe-eEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHH-HhCCCCCccEEEEEEEc---
Q 011287           42 FSIQDFELG-KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL-DQLDHPGVVRLFFTFQD---  116 (489)
Q Consensus        42 ~~~~dy~~~-~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il-~~l~hpnIv~l~~~~~~---  116 (489)
                      ...++|.+. +.||+|+||.||+|++..+++.||+|++...        ....+|+.++ +.++||||+++++++.+   
T Consensus        14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   85 (299)
T 3m2w_A           14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA   85 (299)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence            346789888 8899999999999999999999999998642        2355677777 66799999999999987   


Q ss_pred             -CCEEEEEEeccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCC---CCCEEEeecc
Q 011287          117 -TFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFG  190 (489)
Q Consensus       117 -~~~lylV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~---~g~ikL~DFG  190 (489)
                       ...+|+||||+++|+|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.++|+|||
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence             778999999999999999998764  6999999999999999999999999999999999999998   7899999999


Q ss_pred             CccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHH----H
Q 011287          191 SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQ----R  266 (489)
Q Consensus       191 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~----~  266 (489)
                      ++....                                +..++.++|||||||++|+|++|+.||.+.+......    .
T Consensus       166 ~a~~~~--------------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  213 (299)
T 3m2w_A          166 FAKETT--------------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR  213 (299)
T ss_dssp             TCEECT--------------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCS
T ss_pred             cccccc--------------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHH
Confidence            986432                                1345678999999999999999999998766544322    2


Q ss_pred             HHhcCCCCC----CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          267 IIARDIRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       267 i~~~~~~~p----~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      +......+|    ..+++++.+||.+||+.||++||++     .++++||||.+
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~-----~e~l~hp~~~~  262 (299)
T 3m2w_A          214 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI-----TEFMNHPWIMQ  262 (299)
T ss_dssp             SCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSHHHHT
T ss_pred             HhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCH-----HHHhcChhhcc
Confidence            222334444    5689999999999999999999998     89999999975

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.8e-43  Score=349.65  Aligned_cols=243  Identities=26%  Similarity=0.466  Sum_probs=201.2

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~l  120 (489)
                      .+..++|++.+.||+|+||.||+|++  .++.||+|++...     .....+.+|+.++++++||||+++++++.+.  .
T Consensus         4 ~i~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~   74 (307)
T 2eva_A            4 MIDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLNP--V   74 (307)
T ss_dssp             BCCGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTTT--T
T ss_pred             cCCHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--c
Confidence            35678999999999999999999998  4789999998543     3456678899999999999999999988754  7


Q ss_pred             EEEEeccCCCChHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHh---CCcEeeccCCCCeeeCCCCC-EEEeeccCcc
Q 011287          121 YMALESCEGGELFDQITSKG---HLSEDEARFYTAEVVDALEYIHS---MGLIHRDIKPENLLLTADGH-IKIADFGSVK  193 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~~---~l~e~~~~~i~~qil~aL~~LH~---~gIiHrDLKpeNILl~~~g~-ikL~DFG~a~  193 (489)
                      |+||||+++|+|.+++...+   .+++..+..++.||+.||.|||+   +||+||||||+|||++.++. +||+|||++.
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~  154 (307)
T 2eva_A           75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC  154 (307)
T ss_dssp             EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred             EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence            89999999999999998764   37899999999999999999999   89999999999999998887 7999999997


Q ss_pred             ccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCC--HHHHHHHHHh-c
Q 011287          194 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS--EWLIFQRIIA-R  270 (489)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~--~~~~~~~i~~-~  270 (489)
                      .....             .....||+.|+|||++.+..++.++|||||||++|+|++|+.||....  .......+.. .
T Consensus       155 ~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~  221 (307)
T 2eva_A          155 DIQTH-------------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT  221 (307)
T ss_dssp             -----------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC
T ss_pred             ccccc-------------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC
Confidence            54321             123469999999999999999999999999999999999999998543  3333333333 3


Q ss_pred             CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          271 DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       271 ~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      ...++..+++.+.+||.+||+.||++||++     +++++
T Consensus       222 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~ell~  256 (307)
T 2eva_A          222 RPPLIKNLPKPIESLMTRCWSKDPSQRPSM-----EEIVK  256 (307)
T ss_dssp             CCCCBTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCCcccccCHHHHHHHHHHhcCChhhCcCH-----HHHHH
Confidence            455677899999999999999999999998     55654

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.9e-43  Score=380.44  Aligned_cols=249  Identities=20%  Similarity=0.305  Sum_probs=209.9

Q ss_pred             CCCCCeEEee-EEeeeCceEEEEEEEc--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 011287           42 FSIQDFELGK-IYGVGSYSKVVRAKKI--DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (489)
Q Consensus        42 ~~~~dy~~~~-~LG~G~~g~Vy~a~~~--~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  118 (489)
                      +..+++.+.+ .||+|+||.||+|.++  .++..||||++....  .......+.+|+.+|+.++||||+++++++.+ .
T Consensus       332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~  408 (613)
T 2ozo_A          332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E  408 (613)
T ss_dssp             CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S
T ss_pred             ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C
Confidence            3445677777 8999999999999875  456789999997652  23345668889999999999999999999987 4


Q ss_pred             EEEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCC
Q 011287          119 SLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~  197 (489)
                      .+|+|||||.+|+|.+++... +.+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus       409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~  488 (613)
T 2ozo_A          409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA  488 (613)
T ss_dssp             SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred             CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence            699999999999999999754 4699999999999999999999999999999999999999999999999999987643


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhcC-CCCC
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRFP  275 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~~-~~~p  275 (489)
                      ....       ........+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..++...+..+. ..+|
T Consensus       489 ~~~~-------~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p  561 (613)
T 2ozo_A          489 DDSY-------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP  561 (613)
T ss_dssp             --------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCC
T ss_pred             CCce-------eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            2210       011123346789999999999999999999999999999998 999999988888888877653 5678


Q ss_pred             CCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          276 NYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       276 ~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      ..+++++.+||.+||+.||++||++
T Consensus       562 ~~~~~~l~~li~~cl~~dP~~RPs~  586 (613)
T 2ozo_A          562 PECPPELYALMSDCWIYKWEDRPDF  586 (613)
T ss_dssp             TTCCHHHHHHHHHTTCSSTTTSCCH
T ss_pred             CcCCHHHHHHHHHHcCCChhHCcCH
Confidence            8899999999999999999999998

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-44  Score=365.49  Aligned_cols=249  Identities=20%  Similarity=0.338  Sum_probs=200.4

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCC---cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEE-cCCE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ-DTFS  119 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg---~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~  119 (489)
                      ...|++.+.||+|+||.||+|++..++   ..||+|.+...  ........+.+|..+++.++||||+++++++. ....
T Consensus        88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  165 (373)
T 3c1x_A           88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS  165 (373)
T ss_dssp             TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSC
T ss_pred             hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCC
Confidence            346899999999999999999986433   46899988653  23345667888999999999999999999864 4567


Q ss_pred             EEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          120 LYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      .|+||||+++|+|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+++.+...
T Consensus       166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~  245 (373)
T 3c1x_A          166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  245 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence            89999999999999999865 45899999999999999999999999999999999999999999999999999865432


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhcC-CCCCC
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRFPN  276 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~~-~~~p~  276 (489)
                      ...      .........+|+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+....+.... ...|.
T Consensus       246 ~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~  319 (373)
T 3c1x_A          246 EFD------SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE  319 (373)
T ss_dssp             ------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCT
T ss_pred             ccc------cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            211      0112234467889999999999999999999999999999999 889998877666666665543 45677


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCC
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      .+++.+.+||.+||+.||++||++
T Consensus       320 ~~~~~l~~li~~cl~~dp~~RPs~  343 (373)
T 3c1x_A          320 YCPDPLYEVMLKCWHPKAEMRPSF  343 (373)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCH
Confidence            899999999999999999999998

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=361.38  Aligned_cols=240  Identities=16%  Similarity=0.221  Sum_probs=197.7

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEE-----EEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC---CCCccEEEEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRA-----KKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD---HPGVVRLFFT  113 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a-----~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~  113 (489)
                      +..++|.+.+.||+|+||+||+|     .+..+++.||+|++...      ....+.+|..+++.++   |+||++++++
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~l~~~~~~~iv~~~~~  135 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------NPWEFYIGTQLMERLKPSMQHMFMKFYSA  135 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------CHHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------ChhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence            45578999999999999999999     46778999999998654      2334666888888886   9999999999


Q ss_pred             EEcCCEEEEEEeccCCCChHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCC--------
Q 011287          114 FQDTFSLYMALESCEGGELFDQITS-----KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA--------  180 (489)
Q Consensus       114 ~~~~~~lylV~E~~~gg~L~~~l~~-----~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~--------  180 (489)
                      +......|+|||||++|+|.+++..     .+.+++..++.++.||+.||+|||++||+||||||+||||+.        
T Consensus       136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~  215 (365)
T 3e7e_A          136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE  215 (365)
T ss_dssp             EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC---
T ss_pred             eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccc
Confidence            9999999999999999999999974     456999999999999999999999999999999999999998        


Q ss_pred             ---CCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCC
Q 011287          181 ---DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD  257 (489)
Q Consensus       181 ---~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~  257 (489)
                         ++++||+|||+|+.+....        ........+||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus       216 ~~~~~~~kl~DFG~a~~~~~~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~  287 (365)
T 3e7e_A          216 DDLSAGLALIDLGQSIDMKLFP--------KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK  287 (365)
T ss_dssp             ---CTTEEECCCTTCEEGGGSC--------TTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred             ccccCCEEEeeCchhhhhhccC--------CCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence               8999999999997553211        12233456899999999999999999999999999999999999999965


Q ss_pred             CCHHHHHHHHHhcCCCCCC-CCCHHHHHHHHHhhccCCCCCCCC
Q 011287          258 TSEWLIFQRIIARDIRFPN-YFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       258 ~~~~~~~~~i~~~~~~~p~-~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      .....     ......++. ..++.+.+++.+||+.+|.+|++.
T Consensus       288 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~  326 (365)
T 3e7e_A          288 NEGGE-----CKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPS  326 (365)
T ss_dssp             EETTE-----EEECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCC
T ss_pred             CCCCc-----eeechhccccCcHHHHHHHHHHHcCCCCCCcchH
Confidence            43211     001111111 246789999999999999999766

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2e-44  Score=361.01  Aligned_cols=255  Identities=18%  Similarity=0.256  Sum_probs=205.9

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~l  120 (489)
                      ....++|++.+.||+|+||.||+|++ .+|+.||||++........  ...+.+|+.+++.++||||+++++++.+....
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  102 (326)
T 3uim_A           26 QVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRGFCMTPTER  102 (326)
T ss_dssp             HTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----C--CCHHHHHHHGGGTCCCTTBCCCCEEECCSSCC
T ss_pred             HHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchH--HHHHHHHHHHHHhccCCCccceEEEEecCCce
Confidence            44568999999999999999999985 4699999999976532221  22477899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CcEeeccCCCCeeeCCCCCEEEeeccCcc
Q 011287          121 YMALESCEGGELFDQITSKG----HLSEDEARFYTAEVVDALEYIHSM---GLIHRDIKPENLLLTADGHIKIADFGSVK  193 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~~----~l~e~~~~~i~~qil~aL~~LH~~---gIiHrDLKpeNILl~~~g~ikL~DFG~a~  193 (489)
                      |+||||+.+|+|.+++....    .+++..+..++.||+.||.|||++   ||+||||||+|||++.++++||+|||+++
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~  182 (326)
T 3uim_A          103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK  182 (326)
T ss_dssp             EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence            99999999999999998653    399999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCC----HHHHHHHHHh
Q 011287          194 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS----EWLIFQRIIA  269 (489)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~----~~~~~~~i~~  269 (489)
                      ......         ........||+.|+|||++.+..++.++|||||||++|+|++|+.||....    ..........
T Consensus       183 ~~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  253 (326)
T 3uim_A          183 LMDYKD---------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK  253 (326)
T ss_dssp             ECCSSS---------SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred             ccCccc---------ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence            664322         122334569999999999988889999999999999999999999995211    0000111111


Q ss_pred             c---------------CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCC
Q 011287          270 R---------------DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHP  312 (489)
Q Consensus       270 ~---------------~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hp  312 (489)
                      .               ...++...+..+.+|+.+||+.||.+|||+     .++++|-
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~ell~~L  306 (326)
T 3uim_A          254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKM-----SEVVRML  306 (326)
T ss_dssp             TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCH-----HHHHHHH
T ss_pred             HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCH-----HHHHHHh
Confidence            0               011222234779999999999999999998     7777654

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.4e-43  Score=353.75  Aligned_cols=251  Identities=20%  Similarity=0.318  Sum_probs=208.7

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEE----EcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAK----KIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQ  115 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~----~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  115 (489)
                      ..+..++|++++.||+|+||.||+|+    +..+|+.||+|++...   .......+.+|+.+++.++||||+++++++.
T Consensus        36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  112 (326)
T 2w1i_A           36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCY  112 (326)
T ss_dssp             -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence            45678899999999999999999999    4668999999998754   3445567888999999999999999999987


Q ss_pred             cCC--EEEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCc
Q 011287          116 DTF--SLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV  192 (489)
Q Consensus       116 ~~~--~lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a  192 (489)
                      +..  .+|+||||+++++|.+++.+. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus       113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~  192 (326)
T 2w1i_A          113 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT  192 (326)
T ss_dssp             C----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             ecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence            543  789999999999999999876 46999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHH-----------
Q 011287          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEW-----------  261 (489)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~-----------  261 (489)
                      ..........       .......++..|+|||++.+..++.++|||||||++|+|++|..||......           
T Consensus       193 ~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~  265 (326)
T 2w1i_A          193 KVLPQDKEYY-------KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG  265 (326)
T ss_dssp             EECCSSCSEE-------ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCT
T ss_pred             hhcccccccc-------ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccch
Confidence            8765432110       1112345778899999999888999999999999999999999998653211           


Q ss_pred             -----HHHHHHHh-cCCCCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          262 -----LIFQRIIA-RDIRFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       262 -----~~~~~i~~-~~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                           .+...+.. .....|..+++++.+||.+||+.||++||++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  310 (326)
T 2w1i_A          266 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF  310 (326)
T ss_dssp             HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             hhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCH
Confidence                 11111211 2355678899999999999999999999998

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.1e-43  Score=350.20  Aligned_cols=248  Identities=24%  Similarity=0.340  Sum_probs=196.5

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC--CCCCccEEEEEEEcC---
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL--DHPGVVRLFFTFQDT---  117 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l--~hpnIv~l~~~~~~~---  117 (489)
                      ..++|++++.||+|+||.||+|++.  |+.||||++...      .......|.+++..+  +||||+++++++.+.   
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~  106 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT------EEASWFRETEIYQTVLMRHENILGFIAADIKGTGS  106 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred             cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc------ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence            3578999999999999999999984  899999998543      122334455555554  899999999999877   


Q ss_pred             -CEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcEeeccCCCCeeeCCCCCEEEee
Q 011287          118 -FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM--------GLIHRDIKPENLLLTADGHIKIAD  188 (489)
Q Consensus       118 -~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~--------gIiHrDLKpeNILl~~~g~ikL~D  188 (489)
                       ..+|+||||+++|+|.+++... .+++..+..++.|++.||.|||++        ||+||||||+|||++.++++||+|
T Consensus       107 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D  185 (337)
T 3mdy_A          107 WTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD  185 (337)
T ss_dssp             GCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred             CCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence             7899999999999999999764 699999999999999999999999        999999999999999999999999


Q ss_pred             ccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCC------CcchhhhHHHHHHhhC----------C
Q 011287          189 FGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFG------NDLWALGCTLYQMLSG----------T  252 (489)
Q Consensus       189 FG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~------sDiwSLG~ilyelltG----------~  252 (489)
                      ||+++.+......      ........+||+.|+|||++.+......      +|||||||++|+|++|          .
T Consensus       186 fg~a~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~  259 (337)
T 3mdy_A          186 LGLAVKFISDTNE------VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ  259 (337)
T ss_dssp             CTTCEECC---------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CCCceeecccccc------ccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence            9999766433211      1112235689999999999988777665      8999999999999999          7


Q ss_pred             CCCCCCC----HHHHHHHHHh---cCCCCCC-----CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          253 SPFKDTS----EWLIFQRIIA---RDIRFPN-----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       253 ~PF~~~~----~~~~~~~i~~---~~~~~p~-----~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      .||....    .......+..   ....+|.     .+++++.+||.+||+.||++||++     .++++
T Consensus       260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~  324 (337)
T 3mdy_A          260 LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA-----LRVKK  324 (337)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCH-----HHHHH
T ss_pred             ccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCH-----HHHHH
Confidence            7776432    2222223222   1233443     356779999999999999999998     66664

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2e-43  Score=350.58  Aligned_cols=249  Identities=22%  Similarity=0.281  Sum_probs=203.6

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccc-cchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFI-TKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      .|..++.||+|+||.||+|.+  +++.||+|++..... ........+.+|+.+++.++||||+++++++.+....|+||
T Consensus        32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  109 (307)
T 2nru_A           32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVY  109 (307)
T ss_dssp             TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEE
Confidence            355679999999999999986  689999999975432 23445677889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccc
Q 011287          125 ESCEGGELFDQITS---KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (489)
Q Consensus       125 E~~~gg~L~~~l~~---~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~  201 (489)
                      ||+++|+|.+++..   ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......  
T Consensus       110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--  187 (307)
T 2nru_A          110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA--  187 (307)
T ss_dssp             ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCS--
T ss_pred             EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccc--
Confidence            99999999999874   3469999999999999999999999999999999999999999999999999998654321  


Q ss_pred             ccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHH----HHHHHhcC------
Q 011287          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLI----FQRIIARD------  271 (489)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~----~~~i~~~~------  271 (489)
                            .........||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+....    ...+....      
T Consensus       188 ------~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (307)
T 2nru_A          188 ------QTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDY  260 (307)
T ss_dssp             ------SCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHH
T ss_pred             ------ccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhh
Confidence                  1112234579999999999875 478899999999999999999999987544221    12222111      


Q ss_pred             -----CCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          272 -----IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       272 -----~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                           ...+...+..+.+||.+||+.||.+||++     .++++
T Consensus       261 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~-----~~l~~  299 (307)
T 2nru_A          261 IDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDI-----KKVQQ  299 (307)
T ss_dssp             SCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCH-----HHHHH
T ss_pred             ccccccccchHHHHHHHHHHHHHcCCCcccCcCH-----HHHHH
Confidence                 11233456789999999999999999998     66653

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5.8e-43  Score=374.87  Aligned_cols=250  Identities=20%  Similarity=0.336  Sum_probs=216.1

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~l  120 (489)
                      .+..++|++.+.||+|+||.||+|++.. +..||||++......    .+.+.+|+.+|+.++||||+++++++.+ ..+
T Consensus       263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~  336 (535)
T 2h8h_A          263 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI  336 (535)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             ecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence            3456789999999999999999999965 567999999765322    3457789999999999999999999876 678


Q ss_pred             EEEEeccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          121 YMALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      |+|||||.+|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+...
T Consensus       337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  416 (535)
T 2h8h_A          337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  416 (535)
T ss_dssp             EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred             eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence            9999999999999999753  46999999999999999999999999999999999999999999999999999876432


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCC
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPN  276 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~  276 (489)
                      ...         ......++..|+|||++....++.++|||||||++|+|++ |+.||.+.+..++...+... ....|.
T Consensus       417 ~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~  487 (535)
T 2h8h_A          417 EYT---------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP  487 (535)
T ss_dssp             HHH---------TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCT
T ss_pred             cee---------cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            211         1112346788999999998899999999999999999999 99999999988888777654 345678


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      .++.++.+||.+||+.||++||++     ++|+.
T Consensus       488 ~~~~~l~~li~~cl~~dP~~RPt~-----~~l~~  516 (535)
T 2h8h_A          488 ECPESLHDLMCQCWRKEPEERPTF-----EYLQA  516 (535)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCCHHHHHHHHHHcCCChhHCcCH-----HHHHH
Confidence            899999999999999999999998     66654

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=4e-43  Score=352.85  Aligned_cols=250  Identities=21%  Similarity=0.357  Sum_probs=190.8

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHH--HHhCCCCCccEEEEEEE--
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV--LDQLDHPGVVRLFFTFQ--  115 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~i--l~~l~hpnIv~l~~~~~--  115 (489)
                      ..+.+++|++++.||+|+||.||+|++  +++.||||++....      ......|..+  +..++||||+++++.+.  
T Consensus         8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~   79 (336)
T 3g2f_A            8 PSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERV   79 (336)
T ss_dssp             -CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred             CCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheeccccc
Confidence            356789999999999999999999977  78999999986431      1223334444  44589999999997554  


Q ss_pred             ---cCCEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------CcEeeccCCCCeeeCCCCC
Q 011287          116 ---DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM---------GLIHRDIKPENLLLTADGH  183 (489)
Q Consensus       116 ---~~~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~---------gIiHrDLKpeNILl~~~g~  183 (489)
                         ....+|+|||||++|+|.+++... .+++..+..++.||+.||.|||+.         ||+||||||+|||++.++.
T Consensus        80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~  158 (336)
T 3g2f_A           80 TADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT  158 (336)
T ss_dssp             CTTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred             ccCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence               234689999999999999999875 469999999999999999999999         9999999999999999999


Q ss_pred             EEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcC-------CCCCCCCcchhhhHHHHHHhhCCCCCC
Q 011287          184 IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-------SPATFGNDLWALGCTLYQMLSGTSPFK  256 (489)
Q Consensus       184 ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-------~~~~~~sDiwSLG~ilyelltG~~PF~  256 (489)
                      +||+|||+++.+........  ..........+||+.|+|||++.+       ..++.++|||||||++|+|++|..||.
T Consensus       159 ~kL~DFG~a~~~~~~~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~  236 (336)
T 3g2f_A          159 CVISDFGLSMRLTGNRLVRP--GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF  236 (336)
T ss_dssp             EEECCCTTCEECSSSSCC-----------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred             EEEeeccceeecccccccCc--cccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence            99999999987654321110  011223335689999999999987       345678999999999999999976663


Q ss_pred             CCCH-----------------HHHHHHHHh---cCCCCCCCC------CHHHHHHHHHhhccCCCCCCCC
Q 011287          257 DTSE-----------------WLIFQRIIA---RDIRFPNYF------SDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       257 ~~~~-----------------~~~~~~i~~---~~~~~p~~~------~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      ....                 .........   ....+|..+      ++++.+||.+||+.||++|||+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  306 (336)
T 3g2f_A          237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTA  306 (336)
T ss_dssp             TTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCH
T ss_pred             CccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcch
Confidence            3211                 111122221   223444443      3479999999999999999999

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.9e-43  Score=352.30  Aligned_cols=256  Identities=20%  Similarity=0.318  Sum_probs=209.1

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCE
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  119 (489)
                      -.+..++|++++.||+|+||.||+|++..   .||+|++....... .....+.+|+.+++.++||||+++++++.+...
T Consensus        28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (319)
T 2y4i_B           28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENVVLFMGACMSPPH  103 (319)
T ss_dssp             SSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCC-CCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred             ccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCH-HHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence            34567899999999999999999999854   59999987643222 222345678999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          120 LYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      +|+||||+++++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++ ++.++|+|||++......
T Consensus       104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~  182 (319)
T 2y4i_B          104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL  182 (319)
T ss_dssp             EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred             eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence            999999999999999998764 699999999999999999999999999999999999998 789999999998765322


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcC---------CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHh
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNS---------SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA  269 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~---------~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~  269 (489)
                      ...     ..........||+.|+|||++.+         ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus       183 ~~~-----~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~  257 (319)
T 2y4i_B          183 QAG-----RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT  257 (319)
T ss_dssp             ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHT
T ss_pred             ccc-----ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc
Confidence            110     11223345579999999999974         3478899999999999999999999999988887777765


Q ss_pred             cCCCC--CCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          270 RDIRF--PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       270 ~~~~~--p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      .....  +..++.++.+||.+||..||++||++     .++++
T Consensus       258 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~-----~~l~~  295 (319)
T 2y4i_B          258 GMKPNLSQIGMGKEISDILLFCWAFEQEERPTF-----TKLMD  295 (319)
T ss_dssp             TCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCH-----HHHHH
T ss_pred             CCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCH-----HHHHH
Confidence            54322  23688999999999999999999998     66663

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.9e-42  Score=377.50  Aligned_cols=247  Identities=25%  Similarity=0.434  Sum_probs=211.8

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDT---GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~t---g~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  118 (489)
                      +..++|++++.||+|+||.||+|++..+   +..||+|++...  ........+.+|+.+++.++||||+++++++.+ .
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~  463 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-N  463 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-C
Confidence            3457899999999999999999998654   567999988653  233445678889999999999999999999854 5


Q ss_pred             EEEEEEeccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCC
Q 011287          119 SLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~  197 (489)
                      .+|+||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~  543 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  543 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred             ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence            6899999999999999998654 699999999999999999999999999999999999999999999999999987643


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhcC-CCCC
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRFP  275 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~~-~~~p  275 (489)
                      ..         ........||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+....+.... ..+|
T Consensus       544 ~~---------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~  614 (656)
T 2j0j_A          544 ST---------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP  614 (656)
T ss_dssp             -------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCC
T ss_pred             Cc---------ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            22         111223467889999999999999999999999999999997 999999999988888877653 5678


Q ss_pred             CCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          276 NYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       276 ~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      ..+++.+.+||.+||+.||++||++
T Consensus       615 ~~~~~~l~~li~~~l~~dP~~RPs~  639 (656)
T 2j0j_A          615 PNCPPTLYSLMTKCWAYDPSRRPRF  639 (656)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             ccccHHHHHHHHHHcCCChhHCcCH
Confidence            8999999999999999999999998

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.4e-43  Score=384.13  Aligned_cols=257  Identities=25%  Similarity=0.414  Sum_probs=210.3

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc------
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD------  116 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------  116 (489)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++....  .......+.+|+.+++.++||||+++++++.+      
T Consensus        12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~   89 (676)
T 3qa8_A           12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP   89 (676)
T ss_dssp             -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred             CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence            4589999999999999999999999999999999986542  33445668889999999999999999998765      


Q ss_pred             CCEEEEEEeccCCCChHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCC---EEEeecc
Q 011287          117 TFSLYMALESCEGGELFDQITSKG---HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGH---IKIADFG  190 (489)
Q Consensus       117 ~~~lylV~E~~~gg~L~~~l~~~~---~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~---ikL~DFG  190 (489)
                      ....|+|||||+||+|.+++...+   .+++..++.++.||+.||.|||+.||+||||||+||+++.++.   ++|+|||
T Consensus        90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            677899999999999999998754   5999999999999999999999999999999999999998775   9999999


Q ss_pred             CccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHH---
Q 011287          191 SVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI---  267 (489)
Q Consensus       191 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i---  267 (489)
                      ++......           .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+......+...   
T Consensus       170 ~a~~~~~~-----------~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~  238 (676)
T 3qa8_A          170 YAKELDQG-----------ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE  238 (676)
T ss_dssp             CCCBTTSC-----------CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-
T ss_pred             cccccccc-----------cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhc
Confidence            99865432           2234568999999999999999999999999999999999999999875443221100   


Q ss_pred             -----------HhcCCCC----------CCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          268 -----------IARDIRF----------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       268 -----------~~~~~~~----------p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                                 ..+...+          +..+++.+.+||.+||+.||++||++     +++++||||+.+
T Consensus       239 ~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa-----~elL~hp~F~~l  304 (676)
T 3qa8_A          239 KSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTD-----PQNPNVGCFQAL  304 (676)
T ss_dssp             -----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CC-----TTCCCCTTHHHH
T ss_pred             ccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCH-----HHHhcCHHHHHH
Confidence                       1111111          22357889999999999999999999     679999999863

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.9e-44  Score=363.38  Aligned_cols=245  Identities=17%  Similarity=0.221  Sum_probs=197.6

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeeccccc-----chhHHHHHHHHHHHHHhCC---------CCCc
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT-----KENKTAYVKLERIVLDQLD---------HPGV  107 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~-----~~~~~~~~~~E~~il~~l~---------hpnI  107 (489)
                      +..++|++++.||+|+||+||+|++  +|+.||||++.+....     .......+.+|+.+++.++         ||||
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni   94 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF   94 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred             cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence            4468999999999999999999998  7899999999876432     2233466778998888875         8888


Q ss_pred             cEEEEEEE------------------------------cCCEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHH
Q 011287          108 VRLFFTFQ------------------------------DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA  157 (489)
Q Consensus       108 v~l~~~~~------------------------------~~~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~a  157 (489)
                      +++++++.                              +...+|+|||||++|++.+.+.+ +.+++..++.++.||+.|
T Consensus        95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred             hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence            88777643                              26789999999999987777755 579999999999999999


Q ss_pred             HHHHH-hCCcEeeccCCCCeeeCCCC--------------------CEEEeeccCccccCCccccccCCCCCCCCcccee
Q 011287          158 LEYIH-SMGLIHRDIKPENLLLTADG--------------------HIKIADFGSVKPMQDSRITVLPNAASDDKACTFV  216 (489)
Q Consensus       158 L~~LH-~~gIiHrDLKpeNILl~~~g--------------------~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~  216 (489)
                      |.||| ++||+||||||+||||+.+|                    ++||+|||+|+....               ...+
T Consensus       174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~---------------~~~~  238 (336)
T 2vuw_A          174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD---------------GIVV  238 (336)
T ss_dssp             HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET---------------TEEE
T ss_pred             HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC---------------CcEE
Confidence            99999 99999999999999999987                    899999999986532               2458


Q ss_pred             cCCcCCChhhhcCCCCCCCCcchhhhHH-HHHHhhCCCCCCCCCH-HHHHHHHHhc-CC--C----CCCCCCHHHHHHHH
Q 011287          217 GTAAYVPPEVLNSSPATFGNDLWALGCT-LYQMLSGTSPFKDTSE-WLIFQRIIAR-DI--R----FPNYFSDAARDLID  287 (489)
Q Consensus       217 gt~~Y~aPE~l~~~~~~~~sDiwSLG~i-lyelltG~~PF~~~~~-~~~~~~i~~~-~~--~----~p~~~~~~~~~Li~  287 (489)
                      ||+.|+|||++.+.. +.++||||||++ .+++++|..||.+... ......+... ..  .    .+..+++++++||+
T Consensus       239 gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~  317 (336)
T 2vuw_A          239 FCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHR  317 (336)
T ss_dssp             CCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHH
T ss_pred             EeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHH
Confidence            999999999998776 889999998777 7889999999954321 1122333321 11  1    12247889999999


Q ss_pred             HhhccCCCCCCCCCCCCHHHHh-cCCCCC
Q 011287          288 RLLDVDPSGRPGAGPGGYAVLK-MHPFFK  315 (489)
Q Consensus       288 ~~L~~dP~~R~t~~~~~~~~l~-~hpff~  315 (489)
                      +||+.|     |+     ++++ +||||+
T Consensus       318 ~~L~~d-----sa-----~e~l~~Hp~f~  336 (336)
T 2vuw_A          318 TMLNFS-----SA-----TDLLCQHSLFK  336 (336)
T ss_dssp             HGGGSS-----SH-----HHHHHHCGGGC
T ss_pred             HHhccC-----CH-----HHHHhcCCCcC
Confidence            999977     66     8999 999995

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=7.8e-42  Score=344.02  Aligned_cols=247  Identities=22%  Similarity=0.306  Sum_probs=200.9

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh--CCCCCccEEEEEEEcCC---
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ--LDHPGVVRLFFTFQDTF---  118 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~~~~---  118 (489)
                      .++|++.+.||+|+||.||+|++  +|+.||||++...      ....+.+|..++..  ++||||+++++++.+..   
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~  112 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW  112 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred             cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence            46899999999999999999998  5899999998643      23445668888877  79999999999998876   


Q ss_pred             -EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCcEeeccCCCCeeeCCCCCEEEeec
Q 011287          119 -SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH--------SMGLIHRDIKPENLLLTADGHIKIADF  189 (489)
Q Consensus       119 -~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH--------~~gIiHrDLKpeNILl~~~g~ikL~DF  189 (489)
                       .+|+||||+++|+|.+++.+. .+++..+..++.||+.||.|||        +.||+||||||+|||++.++++||+||
T Consensus       113 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  191 (342)
T 1b6c_B          113 TQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  191 (342)
T ss_dssp             CCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred             ceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence             899999999999999999874 6999999999999999999999        899999999999999999999999999


Q ss_pred             cCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCC------CCCCCcchhhhHHHHHHhhC----------CC
Q 011287          190 GSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP------ATFGNDLWALGCTLYQMLSG----------TS  253 (489)
Q Consensus       190 G~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~------~~~~sDiwSLG~ilyelltG----------~~  253 (489)
                      |++..........      ........||+.|+|||++.+..      ++.++|||||||++|+|++|          ..
T Consensus       192 g~~~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~  265 (342)
T 1b6c_B          192 GLAVRHDSATDTI------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL  265 (342)
T ss_dssp             TTCEEEETTTTEE------EECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             CCceecccccccc------ccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence            9997654322110      01234568999999999998763      23689999999999999999          88


Q ss_pred             CCCCC-----CHHHHHHHHHhcC--CCCCC-----CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          254 PFKDT-----SEWLIFQRIIARD--IRFPN-----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       254 PF~~~-----~~~~~~~~i~~~~--~~~p~-----~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      ||...     ........+....  ..+|.     ..++.+.+||.+||+.||++||++     .++++
T Consensus       266 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~-----~~i~~  329 (342)
T 1b6c_B          266 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA-----LRIKK  329 (342)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCH-----HHHHH
T ss_pred             CccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCH-----HHHHH
Confidence            99764     2334444443332  23333     234578999999999999999998     66664

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=4.6e-43  Score=363.90  Aligned_cols=251  Identities=18%  Similarity=0.241  Sum_probs=197.9

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC-CCc---------------
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH-PGV---------------  107 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~h-pnI---------------  107 (489)
                      ...|..++.||+|+||.||+|++..+|+.||||++.............+.+|..+++.+.| ++.               
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            4569999999999999999999999999999999875443343445668889999999977 211               


Q ss_pred             ------cEEEEEEEc-----CCEEEEEEeccCCCChHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEee
Q 011287          108 ------VRLFFTFQD-----TFSLYMALESCEGGELFDQITS-------KGHLSEDEARFYTAEVVDALEYIHSMGLIHR  169 (489)
Q Consensus       108 ------v~l~~~~~~-----~~~lylV~E~~~gg~L~~~l~~-------~~~l~e~~~~~i~~qil~aL~~LH~~gIiHr  169 (489)
                            ..+..++..     ...++++|+++ +++|.+++..       .+.+++..+..++.||+.||+|||++||+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr  235 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  235 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence                  111122222     23467778776 5699988851       2347888999999999999999999999999


Q ss_pred             ccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhh----------cCCCCCCCCcch
Q 011287          170 DIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVL----------NSSPATFGNDLW  239 (489)
Q Consensus       170 DLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l----------~~~~~~~~sDiw  239 (489)
                      ||||+||||+.+|.+||+|||+++....             .....+| +.|+|||++          ....++.++|||
T Consensus       236 DiKp~NILl~~~~~~kL~DFG~a~~~~~-------------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dvw  301 (413)
T 3dzo_A          236 YLRPVDIVLDQRGGVFLTGFEHLVRDGA-------------SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTW  301 (413)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTE-------------EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHH
T ss_pred             CcccceEEEecCCeEEEEeccceeecCC-------------ccccCCC-CceeCchhhhccccccccccCcCCCchhhHH
Confidence            9999999999999999999999875432             1345678 999999999          555688899999


Q ss_pred             hhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 011287          240 ALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (489)
Q Consensus       240 SLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~  318 (489)
                      ||||++|+|++|+.||.+.+.......+..    -...+|+++.+||.+||+.||++||++     .++++||||+.+.
T Consensus       302 SlGvil~elltg~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dP~~Rpt~-----~~~l~~~~~~~~~  371 (413)
T 3dzo_A          302 TLGLAIYWIWCADLPNTDDAALGGSEWIFR----SCKNIPQPVRALLEGFLRYPKEDRLLP-----LQAMETPEYEQLR  371 (413)
T ss_dssp             HHHHHHHHHHHSSCCCCTTGGGSCSGGGGS----SCCCCCHHHHHHHHHHTCSSGGGSCCH-----HHHTTSHHHHHHH
T ss_pred             HHHHHHHHHHHCCCCCCCcchhhhHHHHHh----hcccCCHHHHHHHHHHccCChhhCcCH-----HHHHhCHHHHHHH
Confidence            999999999999999988765544433333    234678999999999999999999998     8999999998654

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.4e-41  Score=335.51  Aligned_cols=219  Identities=18%  Similarity=0.170  Sum_probs=186.8

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ly  121 (489)
                      +..++|++.+.||+|+||.||+|++..+|+.||||++.............+.+|..+++.++||||+++++++.+.+..|
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  107 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL  107 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence            44578999999999999999999999999999999998776655566677888999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccc
Q 011287          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~  201 (489)
                      +||||++|++|.+++.+ + .....+..++.||+.||.|||++||+||||||+|||++.+|.+||+++|.          
T Consensus       108 lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~----------  175 (286)
T 3uqc_A          108 VVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT----------  175 (286)
T ss_dssp             EEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC----------
T ss_pred             EEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc----------
Confidence            99999999999999964 3 46667888999999999999999999999999999999999999985543          


Q ss_pred             ccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHH---HHHhcCCC----C
Q 011287          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQ---RIIARDIR----F  274 (489)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~---~i~~~~~~----~  274 (489)
                                          ++       .++.++|||||||++|+|++|+.||.+.+....+.   ++......    +
T Consensus       176 --------------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (286)
T 3uqc_A          176 --------------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADI  228 (286)
T ss_dssp             --------------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHH
T ss_pred             --------------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhc
Confidence                                22       36788999999999999999999998865432110   11112111    2


Q ss_pred             CCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          275 PNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       275 p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      +..+++++.+||.+||+.||++| |+
T Consensus       229 ~~~~~~~l~~li~~~l~~dP~~R-s~  253 (286)
T 3uqc_A          229 DRDIPFQISAVAARSVQGDGGIR-SA  253 (286)
T ss_dssp             CTTSCHHHHHHHHHHHCTTSSCC-CH
T ss_pred             ccCCCHHHHHHHHHHcccCCccC-CH
Confidence            35689999999999999999999 88

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4e-41  Score=370.68  Aligned_cols=239  Identities=26%  Similarity=0.369  Sum_probs=200.2

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcC-CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKID-TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~-tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  119 (489)
                      ....++|++++.||+|+||.||+|.+.. +|+.||||++....  .......+.+|+.+++.++||||+++++++.+...
T Consensus        76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  153 (681)
T 2pzi_A           76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDR  153 (681)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECT
T ss_pred             CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCC
Confidence            3445899999999999999999999976 79999999986532  23445567889999999999999999999987554


Q ss_pred             -----EEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccc
Q 011287          120 -----LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (489)
Q Consensus       120 -----lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~  194 (489)
                           .|+||||++|++|.+++..  .+++..+..++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++.
T Consensus       154 ~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          154 HGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             TSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             CCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence                 7999999999999988765  79999999999999999999999999999999999999875 999999999986


Q ss_pred             cCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCC
Q 011287          195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF  274 (489)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~  274 (489)
                      ....              ...+||+.|+|||++.+.. +.++|||||||++|+|++|.+||.+...           ...
T Consensus       231 ~~~~--------------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~-----------~~~  284 (681)
T 2pzi_A          231 INSF--------------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYV-----------DGL  284 (681)
T ss_dssp             TTCC--------------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEEC-----------SSC
T ss_pred             cccC--------------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccc-----------ccc
Confidence            5321              3567999999999997654 8899999999999999999999875311           011


Q ss_pred             CC-----CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 011287          275 PN-----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (489)
Q Consensus       275 p~-----~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~  315 (489)
                      |.     ..++.+.+||.+||+.||++||++     .+.+.|+|+.
T Consensus       285 ~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~-----~~~l~~~l~~  325 (681)
T 2pzi_A          285 PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTT-----AEEMSAQLTG  325 (681)
T ss_dssp             CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSS-----HHHHHHHHHH
T ss_pred             cccccccccCHHHHHHHhhhccCChhhCCCH-----HHHHHHHHHH
Confidence            11     236789999999999999999998     7788888764

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=1.4e-34  Score=311.53  Aligned_cols=191  Identities=15%  Similarity=0.169  Sum_probs=140.8

Q ss_pred             eEEeeeCceEEEEEEEcCCCcEEEEEEeeccccc-------chhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCEEEE
Q 011287           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT-------KENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~-------~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~lyl  122 (489)
                      ..++.|+.|.+..++..-.|+.||+|++.+....       .+...+.+.+|+++|+++ .|+||++++++++++..+|+
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL  319 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL  319 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence            3456777888888777778999999999875432       133445688999999999 79999999999999999999


Q ss_pred             EEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccc
Q 011287          123 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~  202 (489)
                      |||||+|++|.++|.+.+++++.   .|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....    
T Consensus       320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~----  392 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD----  392 (569)
T ss_dssp             EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC------
T ss_pred             EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC----
Confidence            99999999999999999989875   47899999999999999999999999999999999999999999865432    


Q ss_pred             cCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCC
Q 011287          203 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPF  255 (489)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF  255 (489)
                            .....+.+||+.|+|||++.+. +..++|+||+|+++|+|+++..+|
T Consensus       393 ------~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          393 ------CSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             -------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             ------CccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence                  2344578999999999999764 566899999999999887765443

>1w1g_A HPDK1, 3-phosphoinositide dependent protein kinase-1; transferase, PKB, pleckstrin homology domain, inositol phosphate, signal transduction; HET: 4PT; 1.45A {Homo sapiens} SCOP: b.55.1.1 PDB: 1w1d_A* 1w1h_A 2vki_A

Probab=100.00  E-value=3.6e-34  Score=247.75  Aligned_cols=106  Identities=30%  Similarity=0.531  Sum_probs=101.1

Q ss_pred             cccccccCcccccccCCCceEEEEEeeehhhhhhccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEEcCCCc
Q 011287          378 LASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSH  457 (489)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~i~~~g~~~k~~g~~~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~~~~~  457 (489)
                      +.+.|++++.||+|+ +||.|+++|.|.|++|+|||+||||||+.|+|||+||..|++||+|||++.   ++|+.+++++
T Consensus        33 ~~~~q~~~~~w~~f~-~ge~Ilk~G~v~KrkGl~~kkR~liLT~~PrL~Yvdp~~~~~KGeIpls~~---l~ve~k~~~~  108 (151)
T 1w1g_A           33 LLEKQAGGNPWHQFV-ENNLILKMGPVDKRKGLFARRRQLLLTEGPHLYYVDPVNKVLKGEIPWSQE---LRPEAKNFKT  108 (151)
T ss_dssp             HHHHHHHHCTTGGGT-TTCCEEEEEEEEEEETTEEEEEEEEEETTTEEEEEETTTTEEEEEECCCTT---CEEEESSSSE
T ss_pred             hhhhccccchhhccC-CCCcEEEEEEEEecccCcceeEEEEEcCCceEEEEcCccccccceEecCCC---eeEEEcCCCE
Confidence            445677889999998 699999999999999999999999999999999999999999999999986   9999999999


Q ss_pred             EEEEcCCceEEEEcCCccHHHHHHHHHHhc
Q 011287          458 FKIVTPKKVLSFEDAKQRASQWKKAIEALQ  487 (489)
Q Consensus       458 f~i~~p~r~y~~~d~~~~~~~W~~~i~~~~  487 (489)
                      |+|+||+|||+|+|++++|++||++|++++
T Consensus       109 F~I~Tp~RtY~~~d~~~~AqeWv~aI~~~~  138 (151)
T 1w1g_A          109 FFVHTPNRTYYLMDPSGNAHKWCRKIQEVW  138 (151)
T ss_dssp             EEEEETTEEEEEECTTSCHHHHHHHHHHHH
T ss_pred             EEEECCCceEEEEcCccCHHHHHHHHHHHH
Confidence            999999999999999999999999999986

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=2.4e-28  Score=261.47  Aligned_cols=194  Identities=15%  Similarity=0.084  Sum_probs=146.0

Q ss_pred             EEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccch-----hHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEE
Q 011287           48 ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE-----NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        48 ~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lyl  122 (489)
                      ...+.||+|+||.||+|+  ..+..+|+|..........     .....+.+|+.++++++||||+++..++.+....|+
T Consensus       339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            456799999999999994  4678999998755433221     224457899999999999999944444445566799


Q ss_pred             EEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccc
Q 011287          123 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~  202 (489)
                      |||||+|++|.+++..        +..++.||+.||.|||++||+||||||+|||++.  ++||+|||+|+.........
T Consensus       417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~  486 (540)
T 3en9_A          417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA  486 (540)
T ss_dssp             EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred             EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence            9999999999999876        6789999999999999999999999999999998  99999999999765432100


Q ss_pred             cCCCCCCCCccceecCCcCCChhhhcC--CCCCCCCcchhhhHHHHHHhhCCCCCC
Q 011287          203 LPNAASDDKACTFVGTAAYVPPEVLNS--SPATFGNDLWALGCTLYQMLSGTSPFK  256 (489)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~--~~~~~~sDiwSLG~ilyelltG~~PF~  256 (489)
                      .+   ......+++||+.|+|||++..  ..|+..+|+|+...-..+...++.+|.
T Consensus       487 ~~---~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          487 VD---LIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HH---HHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             cc---hhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            00   0001246799999999999987  567888999999988888877776663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=3.6e-26  Score=224.82  Aligned_cols=143  Identities=16%  Similarity=0.157  Sum_probs=115.0

Q ss_pred             eEEeeeCceEEEEEEEcCCCcEEEEEEeecccccch---------------hHHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 011287           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE---------------NKTAYVKLERIVLDQLDHPGVVRLFFTFQ  115 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~---------------~~~~~~~~E~~il~~l~hpnIv~l~~~~~  115 (489)
                      +.||+|+||.||+|++ .+|+.||+|++........               .....+.+|..+++.++|   ++++.++.
T Consensus        96 ~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~~~~  171 (282)
T 1zar_A           96 KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPKVYA  171 (282)
T ss_dssp             EEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCCEEE
T ss_pred             CEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCeEEe
Confidence            9999999999999999 8899999999964322111               234567889999999984   44444443


Q ss_pred             cCCEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCcccc
Q 011287          116 DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (489)
Q Consensus       116 ~~~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~  195 (489)
                      . ...|+||||++||+|.+ +.      ......++.||+.||.|||++||+||||||+|||++ +|++||+|||+|+  
T Consensus       172 ~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~--  240 (282)
T 1zar_A          172 W-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV--  240 (282)
T ss_dssp             E-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCE--
T ss_pred             c-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCe--
Confidence            3 45699999999999987 42      234567999999999999999999999999999999 9999999999986  


Q ss_pred             CCccccccCCCCCCCCccceecCCcCCChhhhcC
Q 011287          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS  229 (489)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~  229 (489)
                                           .+..|.|||++..
T Consensus       241 ---------------------~~~~~~a~e~l~r  253 (282)
T 1zar_A          241 ---------------------EVGEEGWREILER  253 (282)
T ss_dssp             ---------------------ETTSTTHHHHHHH
T ss_pred             ---------------------ECCCCCHHHHHHH
Confidence                                 3456789998853

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.86  E-value=7.9e-22  Score=191.15  Aligned_cols=140  Identities=19%  Similarity=0.236  Sum_probs=109.8

Q ss_pred             eEEeeEEeeeCceEEEEEEEcCCCcE--EEEEEeeccccc---------------------chhHHHHHHHHHHHHHhCC
Q 011287           47 FELGKIYGVGSYSKVVRAKKIDTGTV--YALKIMDKKFIT---------------------KENKTAYVKLERIVLDQLD  103 (489)
Q Consensus        47 y~~~~~LG~G~~g~Vy~a~~~~tg~~--vAiK~~~k~~~~---------------------~~~~~~~~~~E~~il~~l~  103 (489)
                      |++.+.||+|+||.||+|.+..+|+.  ||||++......                     .......+.+|..+|..+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            78999999999999999999788999  999997543211                     0111235778999999998


Q ss_pred             CCCc--cEEEEEEEcCCEEEEEEeccCC-C----ChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCcEeeccCCCC
Q 011287          104 HPGV--VRLFFTFQDTFSLYMALESCEG-G----ELFDQITSKGHLSEDEARFYTAEVVDALEYIH-SMGLIHRDIKPEN  175 (489)
Q Consensus       104 hpnI--v~l~~~~~~~~~lylV~E~~~g-g----~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH-~~gIiHrDLKpeN  175 (489)
                      |++|  ..++..    ...++||||+.+ |    +|.+....   .++..+..++.||+.||.||| +.||+||||||+|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N  201 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN  201 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence            7754  344432    246899999942 3    66665432   345678899999999999999 9999999999999


Q ss_pred             eeeCCCCCEEEeeccCcccc
Q 011287          176 LLLTADGHIKIADFGSVKPM  195 (489)
Q Consensus       176 ILl~~~g~ikL~DFG~a~~~  195 (489)
                      ||++.  .++|+|||+|...
T Consensus       202 ILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          202 IMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             EEESS--SEEECCCTTCEET
T ss_pred             EEEcC--cEEEEECcccccC
Confidence            99988  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.75  E-value=2.1e-18  Score=175.24  Aligned_cols=137  Identities=18%  Similarity=0.198  Sum_probs=101.5

Q ss_pred             eEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeeccccc------------chhH-------HHHHHHHHHHHHhCCCCCc
Q 011287           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT------------KENK-------TAYVKLERIVLDQLDHPGV  107 (489)
Q Consensus        47 y~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~------------~~~~-------~~~~~~E~~il~~l~hpnI  107 (489)
                      |++++.||.|++|.||+|.+. +|+.||||+++.....            ....       ......|...|.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            899999999999999999984 6999999998642111            0000       1112356777777755544


Q ss_pred             c--EEEEEEEcCCEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCC---
Q 011287          108 V--RLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG---  182 (489)
Q Consensus       108 v--~l~~~~~~~~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g---  182 (489)
                      .  ..+..  ..  .++||||++|++|..+.      ....+..++.||+.+|.+||++|||||||||.|||++++|   
T Consensus       176 ~vp~p~~~--~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~  245 (397)
T 4gyi_A          176 PVPEPIAQ--SR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE  245 (397)
T ss_dssp             SCCCEEEE--ET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred             CCCeeeec--cC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence            2  22322  22  37999999998886532      2234567889999999999999999999999999999877   


Q ss_pred             -------CEEEeeccCccc
Q 011287          183 -------HIKIADFGSVKP  194 (489)
Q Consensus       183 -------~ikL~DFG~a~~  194 (489)
                             .+.|+||+-+..
T Consensus       246 d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          246 DPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             CTTSEEEEEEECCCTTCEE
T ss_pred             cccccccceEEEEeCCccc
Confidence                   389999997764

>2cod_A Centaurin-delta 1; ARF GAP and RHO GAP with ankyrin repeat and PH domains (ARAP) 2, PH domain, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.55.1.1

Probab=99.55  E-value=7.3e-15  Score=123.90  Aligned_cols=90  Identities=16%  Similarity=0.221  Sum_probs=78.6

Q ss_pred             CceEEEEEeeehhhh-hh--ccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEEcCCCcEEEEcCCceEEEEc
Q 011287          395 GESVLMISMVKKLQK-LT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFED  471 (489)
Q Consensus       395 ~~~i~~~g~~~k~~g-~~--~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~~~~~f~i~~p~r~y~~~d  471 (489)
                      +..++++|||.|+++ ..  ||+|||+|++....||.++.....+|.|+|+..   ..++......|.|+|++|+|+|..
T Consensus         5 ~~~~~~~G~L~K~~~~~~~~WkkR~fvL~~~~L~yy~~~~~~~~~g~i~l~~~---~~v~~~~~~~F~i~~~~r~~~l~a   81 (115)
T 2cod_A            5 SSGKVKSGWLDKLSPQGKRMFQKRWVKFDGLSISYYNNEKEMYSKGIIPLSAI---STVRVQGDNKFEVVTTQRTFVFRV   81 (115)
T ss_dssp             CSCCCEEEEEEECCSSSSSCCEEEEEEECSSEEEEEESSCCSSCCCEEETTTE---EEEEEETTTEEEEEESSCCEEEEC
T ss_pred             CCCccEEEEEEEcCCCCCCCCceEEEEEECCEEEEEcCCCCcccCCEEECCcc---eEEEeCCCCEEEEEeCCcEEEEEC
Confidence            344789999999987 33  999999999998889999988899999999986   677777789999999999999994


Q ss_pred             -CCccHHHHHHHHHHhc
Q 011287          472 -AKQRASQWKKAIEALQ  487 (489)
Q Consensus       472 -~~~~~~~W~~~i~~~~  487 (489)
                       .+.++++|+++|+.++
T Consensus        82 ~s~~e~~~Wi~~l~~~~   98 (115)
T 2cod_A           82 EKEEERNDWISILLNAL   98 (115)
T ss_dssp             SSHHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHH
Confidence             5589999999999875

>2rsg_A Collagen type IV alpha-3-binding protein; pleckstrin homology, lipid transport; NMR {Homo sapiens}

Probab=99.53  E-value=1.1e-14  Score=118.10  Aligned_cols=88  Identities=18%  Similarity=0.232  Sum_probs=71.9

Q ss_pred             EEEEEeeehhhhhh--ccceeEEEecCCeEEEECCCC--CeeeeeeeccCCCCceEEEEcCCCcEEEEcCCceEEEE-cC
Q 011287          398 VLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSK--LVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFE-DA  472 (489)
Q Consensus       398 i~~~g~~~k~~g~~--~k~r~~~lt~~p~l~y~d~~~--~~~kg~i~~~~~~~~~~~~~~~~~~f~i~~p~r~y~~~-d~  472 (489)
                      |.|+|+|.|+++++  ||+|||||+++-..||.++..  ...+|.|++..+  .+.+....+..|.|.||+|+|+|. +.
T Consensus         1 V~k~G~L~K~g~~~k~WkkR~FvL~~~~L~Yy~~~~~~~~~~~~~i~l~~~--~~~~~~~~~~~F~i~~~~r~~~l~A~s   78 (94)
T 2rsg_A            1 VERCGVLSKWTNYIHGWQDRWVVLKNNALSYYKSEDETEYGCRGSICLSKA--VITPHDFDECRFDISVNDSVWYLRAQD   78 (94)
T ss_dssp             CCEEEEEEEESSSTTCEEEEEEEEETTEEEEESSTTGGGTCCSEEEETTTC--EEEECSSCSSEEEEEETTEEEEEECCS
T ss_pred             CCEEEEEEEeCCCCCCceEEEEEEECCEEEEEEecccccccceeeEeccee--eeecCcccceeEEEEeCCeEEEEECCC
Confidence            56899999999877  999999999877767776654  346799999875  334444556899999999999999 55


Q ss_pred             CccHHHHHHHHHHhc
Q 011287          473 KQRASQWKKAIEALQ  487 (489)
Q Consensus       473 ~~~~~~W~~~i~~~~  487 (489)
                      +.++++|+++|++++
T Consensus        79 ~~e~~~Wi~aLq~Ak   93 (94)
T 2rsg_A           79 PDHRQQWIDAIEQHK   93 (94)
T ss_dssp             SCCTHHHHHHHHHHC
T ss_pred             HHHHHHHHHHHHhhc
Confidence            689999999999863

>1x1f_A Signal-transducing adaptor protein 1; docking protein BRDG1, PH domain, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.55.1.1

Probab=99.53  E-value=5.7e-15  Score=130.27  Aligned_cols=89  Identities=13%  Similarity=0.210  Sum_probs=74.1

Q ss_pred             EEEEEeeehhhhhh--ccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEE---cCCCcEEEEcCCceEEEEc-
Q 011287          398 VLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV---SSPSHFKIVTPKKVLSFED-  471 (489)
Q Consensus       398 i~~~g~~~k~~g~~--~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~---~~~~~f~i~~p~r~y~~~d-  471 (489)
                      ++++|||.|+++.+  ||+|||+|.+.-..||.|+.....+|.|+|+..++ +..+.   +....|.|.||+|+|+|.. 
T Consensus        18 v~keG~L~Kkg~~~k~WkrRWFvLk~~~L~Yyk~~~d~~~~g~I~L~~~~~-~~~~~~~~~~~~~F~I~t~~r~~~f~A~   96 (149)
T 1x1f_A           18 LYFEGFLLIKRSGYREYEHYWTELRGTTLFFYTDKKSIIYVDKLDIVDLTC-LTEQNSTEKNCAKFTLVLPKEEVQLKTE   96 (149)
T ss_dssp             EEEEEEEEEECTTCCSCEEEEEEEETTEEEEESCSSCSSCSEECCCSSCCE-EEECCCTTSCCCEEEEECSSCCEEEECS
T ss_pred             ccEEEEEEEeCCCCCCceeEEEEEcCCEEEEEeCCCccccCcEEECCCceE-EeeccCCCCcCcEEEEEcCCCEEEEEcC
Confidence            89999999999876  99999999999777888888888899999998621 11121   2246899999999999995 


Q ss_pred             CCccHHHHHHHHHHhc
Q 011287          472 AKQRASQWKKAIEALQ  487 (489)
Q Consensus       472 ~~~~~~~W~~~i~~~~  487 (489)
                      ...++++|+++|+.+.
T Consensus        97 s~ee~~eWi~aI~~v~  112 (149)
T 1x1f_A           97 NTESGEEWRGFILTVT  112 (149)
T ss_dssp             SHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHH
Confidence            4589999999999875

>2dn6_A KIAA0640 protein; PH domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=99.47  E-value=9.7e-14  Score=116.67  Aligned_cols=90  Identities=18%  Similarity=0.235  Sum_probs=75.4

Q ss_pred             CceEEEEEeeehhhhhh--ccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEE-----cCCCcEEEEcCCceE
Q 011287          395 GESVLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV-----SSPSHFKIVTPKKVL  467 (489)
Q Consensus       395 ~~~i~~~g~~~k~~g~~--~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~-----~~~~~f~i~~p~r~y  467 (489)
                      ++.++++|||.|+++..  ||+|||+|++.-..||.++.....+|.|+|...   ..++.     .....|.|.|++|+|
T Consensus         5 ~~~~~~~G~L~K~~~~~~~Wk~R~fvL~~~~L~yy~~~~~~~~~g~i~L~~~---~~v~~~~~~~~~~~~F~i~~~~r~~   81 (115)
T 2dn6_A            5 SSGVLKQGYMMKKGHRRKNWTERWFVLKPNIISYYVSEDLKDKKGDILLDEN---CCVESLPDKDGKKCLFLVKCFDKTF   81 (115)
T ss_dssp             CCSCSEEEEEEEECTTSSCEEEEEEEECSSCEEEESSTTCSSEEEEECCCTT---CEEEEECCCTTCCSEEEEECSSCEE
T ss_pred             CCCceEEEEEEecCCCCCCcEEeEEEEECCEEEEeCCCCCcccCcEEEecCc---EEEEECCCCCCCeeEEEEEeCCCEE
Confidence            45689999999998755  999999999988888888888899999999975   34433     234689999999999


Q ss_pred             EEEc-CCccHHHHHHHHHHhc
Q 011287          468 SFED-AKQRASQWKKAIEALQ  487 (489)
Q Consensus       468 ~~~d-~~~~~~~W~~~i~~~~  487 (489)
                      +|.. .+.++++|+++|+.++
T Consensus        82 ~l~a~s~~e~~~Wi~ai~~~~  102 (115)
T 2dn6_A           82 EISASDKKKKQEWIQAIHSTI  102 (115)
T ss_dssp             EEECSSHHHHHHHHHHHHHHH
T ss_pred             EEEcCCHHHHHHHHHHHHHHH
Confidence            9994 5589999999999875

>2dhk_A TBC1 domain family member 2; PH domain, paris-1, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=99.46  E-value=5.1e-14  Score=119.62  Aligned_cols=88  Identities=15%  Similarity=0.159  Sum_probs=71.1

Q ss_pred             eEEEEEeeehhhh--hh--ccceeEEEecCC-eE-EEECCCCCeeeeeeeccCCCCceEEEE--cCCCcEEEEcCCceEE
Q 011287          397 SVLMISMVKKLQK--LT--SKKVQLILTNKP-KL-IYVDPSKLVVKGNIIWSDNSNDLSIQV--SSPSHFKIVTPKKVLS  468 (489)
Q Consensus       397 ~i~~~g~~~k~~g--~~--~k~r~~~lt~~p-~l-~y~d~~~~~~kg~i~~~~~~~~~~~~~--~~~~~f~i~~p~r~y~  468 (489)
                      .++++|||.|+++  .+  ||+|||||++.+ .| ||.++.....+|.|+|+.+   ..+..  +....|.|+|++|+|+
T Consensus         7 ~~~~~G~L~K~g~~~~~k~WkkRwfvL~~~~~~L~Yy~~~~~~~~~g~I~L~~~---~~~~~~~~~~~~F~i~~~~r~~~   83 (119)
T 2dhk_A            7 GKKLCGYLSKFGGKGPIRGWKSRWFFYDERKCQLYYSRTAQDANPLDSIDLSSA---VFDCKADAEEGIFEIKTPSRVIT   83 (119)
T ss_dssp             CCCCEEEEEECSCSSSSCCCEEEEEEEETTTTEEEEESSTTCCSCSEEEEGGGC---EEEECTTGGGCEEEEECSSCCEE
T ss_pred             CCcEEEEEEecCCCCCCCCceeEEEEEECCccEEEEECCCCCcccccEEECCCC---EEEecCCCCCCEEEEEeCCcEEE
Confidence            3578999999986  44  999999999973 44 6667777789999999986   33322  3457999999999999


Q ss_pred             EE-cCCccHHHHHHHHHHhc
Q 011287          469 FE-DAKQRASQWKKAIEALQ  487 (489)
Q Consensus       469 ~~-d~~~~~~~W~~~i~~~~  487 (489)
                      |. +.+.++++|+++|+.++
T Consensus        84 l~a~s~~e~~~Wi~al~~~~  103 (119)
T 2dhk_A           84 LKAATKQAMLYWLQQLQMKR  103 (119)
T ss_dssp             EECSSHHHHHHHHHHHHHHH
T ss_pred             EECCCHHHHHHHHHHHHHHH
Confidence            99 55689999999999875

>1eaz_A Tandem PH domain containing protein-1; lipid-binding protein, lipid degradation, phosphatidylinositol (3, 4)-bisphosphate, signalling; HET: CIT; 1.40A {Homo sapiens} SCOP: b.55.1.1

Probab=99.46  E-value=8.1e-14  Score=118.97  Aligned_cols=90  Identities=16%  Similarity=0.159  Sum_probs=76.1

Q ss_pred             CceEEEEEeeehhhhhh--ccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEE-------cCCCcEEEEcCCc
Q 011287          395 GESVLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV-------SSPSHFKIVTPKK  465 (489)
Q Consensus       395 ~~~i~~~g~~~k~~g~~--~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~-------~~~~~f~i~~p~r  465 (489)
                      +..++++|||.|+++.+  ||+|||+|++.-..||.++.....+|.|+|+..   ..+..       +....|.|.|++|
T Consensus        11 ~~~~~~~G~L~K~g~~~~~Wk~R~fvL~~~~L~yy~~~~~~~~~g~i~l~~~---~~v~~~~~~~~~~~~~~F~i~~~~r   87 (125)
T 1eaz_A           11 DSAVIKAGYCVKQGAVMKNWKRRYFQLDENTIGYFKSELEKEPLRVIPLKEV---HKVQECKQSDIMMRDNLFEIVTTSR   87 (125)
T ss_dssp             -CCCSEEEEEEEECTTTCCEEEEEEEECSSEEEEESSTTCSSCSEEEEGGGC---CEEEECTTHHHHTCSSEEEEECSSC
T ss_pred             CCCccEEEEEEEeCCCCCCcceEEEEEeCCEEEEEcCCCCCcceeEEEcccc---eEEeeccccccCCcCCEEEEEeCCc
Confidence            44579999999998865  999999999987778888887889999999986   44544       3467999999999


Q ss_pred             eEEEE-cCCccHHHHHHHHHHhc
Q 011287          466 VLSFE-DAKQRASQWKKAIEALQ  487 (489)
Q Consensus       466 ~y~~~-d~~~~~~~W~~~i~~~~  487 (489)
                      +|+|. +.+.++++|+++|+.++
T Consensus        88 ~~~l~a~s~~e~~~W~~al~~~i  110 (125)
T 1eaz_A           88 TFYVQADSPEEMHSWIKAVSGAI  110 (125)
T ss_dssp             EEEEECSSHHHHHHHHHHHHHHH
T ss_pred             EEEEEcCCHHHHHHHHHHHHHHH
Confidence            99998 55689999999999875

>1v5u_A SBF1, SET binding factor 1; MTMR5, the pleckstrin homology domain, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Mus musculus} SCOP: b.55.1.1

Probab=99.45  E-value=7.8e-14  Score=117.63  Aligned_cols=90  Identities=17%  Similarity=0.193  Sum_probs=73.4

Q ss_pred             ceEEEEEeeehhhhhh--ccceeEEEe--cCCeEEEECCCCCeeeeeeeccCCCCceEEEE-----------cCCCcEEE
Q 011287          396 ESVLMISMVKKLQKLT--SKKVQLILT--NKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV-----------SSPSHFKI  460 (489)
Q Consensus       396 ~~i~~~g~~~k~~g~~--~k~r~~~lt--~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~-----------~~~~~f~i  460 (489)
                      +.++++|||.|+++..  ||+|||||+  +.-..||.++.....+|.|+|+..   ..+..           .....|.|
T Consensus         6 ~~~~~~G~L~K~g~~~~~Wk~R~fvL~~~~~~L~yy~~~~~~~~~g~i~L~~~---~~v~~~~~~~~~~~~~~~~~~F~i   82 (117)
T 1v5u_A            6 SGRSYEGILYKKGAFMKPWKARWFVLDKTKHQLRYYDHRMDTECKGVIDLAEV---EAVAPGTPTIGAPKTVDEKAFFDV   82 (117)
T ss_dssp             CSSSEEEEEEECCCSSSCCEEEEEEEETTTTEEEEESSSSCSSCCCEEEGGGE---EEEECCCCCTTSCSSSCTTTCEEE
T ss_pred             CCccEEEEEEecCCCCCCceeeEEEEECCCCEEEEeecCCCCccceEEEccCc---EEEeecCccccccccCCCCeEEEE
Confidence            3478999999998865  999999999  556667777777889999999985   44442           12369999


Q ss_pred             EcCCceEEEEc-CCccHHHHHHHHHHhcC
Q 011287          461 VTPKKVLSFED-AKQRASQWKKAIEALQN  488 (489)
Q Consensus       461 ~~p~r~y~~~d-~~~~~~~W~~~i~~~~~  488 (489)
                      .|++|+|+|.. .+.++++|+++|+.++.
T Consensus        83 ~~~~r~~~l~a~s~~e~~~Wi~al~~~i~  111 (117)
T 1v5u_A           83 KTTRRVYNFCAQDVPSAQQWVDRIQSCLS  111 (117)
T ss_dssp             EESSCEEEEECSSHHHHHHHHHHHHTTCC
T ss_pred             ECCCceEEEECCCHHHHHHHHHHHHHHhc
Confidence            99999999994 45899999999999873

>1pls_A Pleckstrin homology domain; phosphorylation; NMR {Homo sapiens} SCOP: b.55.1.1

Probab=99.45  E-value=9e-14  Score=116.69  Aligned_cols=91  Identities=19%  Similarity=0.128  Sum_probs=73.7

Q ss_pred             eEEEEEeeehhhhhh--ccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEE--EcCCCcEEEEcCC-ceEEEEc
Q 011287          397 SVLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQ--VSSPSHFKIVTPK-KVLSFED  471 (489)
Q Consensus       397 ~i~~~g~~~k~~g~~--~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~--~~~~~~f~i~~p~-r~y~~~d  471 (489)
                      .++++|||.|+++.+  ||+|||+|++....||.++.....+|.|+|+....+....  .+....|.|.|++ |+|+|..
T Consensus         4 ~~~~~G~L~K~g~~~~~Wk~R~fvL~~~~L~yy~~~~~~~~~g~i~L~~~~~~~~~~~~~~~~~~F~i~~~~~r~~~l~a   83 (113)
T 1pls_A            4 KRIREGYLVKKGSVFNTWKPMWVVLLEDGIEFYKKKSDNSPKGMIPLKGSTLTSPCQDFGKRMFVFKITTTKQQDHFFQA   83 (113)
T ss_dssp             CCSEEEEEEEESSSSSCCEEEEEEEETTEEEEESSTTCSSCSEEEESSSCCEESSCCSSCCSSSEEEEEETTTEEEEEEC
T ss_pred             CCcEEEEEEEeCCCCCCceEEEEEEECCEEEEEeCCCCCCcceEEEcCCCEEEEecCCCCCCccEEEEEcCCCCEEEEEC
Confidence            478999999998855  9999999999887788888888999999999872211011  2345699999986 9999994


Q ss_pred             -CCccHHHHHHHHHHhc
Q 011287          472 -AKQRASQWKKAIEALQ  487 (489)
Q Consensus       472 -~~~~~~~W~~~i~~~~  487 (489)
                       .+.++++|+++|+.++
T Consensus        84 ~s~~e~~~Wi~ai~~~~  100 (113)
T 1pls_A           84 AFLEERDAWVRDINKAI  100 (113)
T ss_dssp             SSHHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHH
Confidence             5589999999999875

>1v5p_A Pleckstrin homology domain-containing, family A; TAPP2, the pleckstrin homology domain, structural genomics; NMR {Mus musculus} SCOP: b.55.1.1

Probab=99.44  E-value=1.7e-13  Score=117.60  Aligned_cols=87  Identities=11%  Similarity=0.180  Sum_probs=68.4

Q ss_pred             EEEEeeehhh-hhh--ccceeEEEec--CCeEEEE-C----CCCCeeeeeeeccCCCCceEEEEc-------CCCcEEEE
Q 011287          399 LMISMVKKLQ-KLT--SKKVQLILTN--KPKLIYV-D----PSKLVVKGNIIWSDNSNDLSIQVS-------SPSHFKIV  461 (489)
Q Consensus       399 ~~~g~~~k~~-g~~--~k~r~~~lt~--~p~l~y~-d----~~~~~~kg~i~~~~~~~~~~~~~~-------~~~~f~i~  461 (489)
                      .++|||.|++ +..  ||||||||+.  +-.|||. |    +...+.+|.|+|+..   ..|...       ....|.|+
T Consensus        16 ~~~G~L~K~g~~~~k~WkrRwFvL~~~~~~~L~Y~k~~~~~~~~~~~~G~I~L~~~---~~V~~~~~~~~~~~~~~F~i~   92 (126)
T 1v5p_A           16 RICGFLDIEDNENSGKFLRRYFILDTQANCLLWYMDNPQNLAVGAGAVGSLQLTYI---SKVSIATPKQKPKTPFCFVIN   92 (126)
T ss_dssp             CEECCEEEECTTCSSCEEEEEEEEETTTTEEEEESSCTTTSCTTCCCSEEEETTTC---CEEEECCTTTSCSCSSEEEEE
T ss_pred             ceEEEEEEeCCCCCCCccceEEEEecCCCCEEEEECCCCCCCCCceeeEEEECCCc---cEEecCCcccCCCCCEEEEEE
Confidence            5799999997 434  9999999993  5577774 5    456788999999975   344432       23589999


Q ss_pred             cCCceEEEEc-CCccHHHHHHHHHHhcC
Q 011287          462 TPKKVLSFED-AKQRASQWKKAIEALQN  488 (489)
Q Consensus       462 ~p~r~y~~~d-~~~~~~~W~~~i~~~~~  488 (489)
                      ||.|||+|.. .+.++++|+++|+.+..
T Consensus        93 t~~r~y~l~A~s~~e~~~Wi~al~~a~~  120 (126)
T 1v5p_A           93 ALSQRYFLQANDQKDLKDWVEALNQASK  120 (126)
T ss_dssp             CSSCEEEEECSSHHHHHHHHHHHHHTTT
T ss_pred             CCCEEEEEECCCHHHHHHHHHHHHHHHh
Confidence            9999999994 56899999999998753

>2d9v_A Pleckstrin homology domain-containing protein family B member 1; PH domain, phret1, structural genomics, NPPSFA; NMR {Mus musculus}

Probab=99.43  E-value=1.9e-13  Score=118.04  Aligned_cols=92  Identities=14%  Similarity=0.155  Sum_probs=70.0

Q ss_pred             ceEEEEEeeehhhhhh--ccceeEEE-ecCCeEEEECCCCCeeeeeeeccCCCCceE-------EE----EcCCCcEEEE
Q 011287          396 ESVLMISMVKKLQKLT--SKKVQLIL-TNKPKLIYVDPSKLVVKGNIIWSDNSNDLS-------IQ----VSSPSHFKIV  461 (489)
Q Consensus       396 ~~i~~~g~~~k~~g~~--~k~r~~~l-t~~p~l~y~d~~~~~~kg~i~~~~~~~~~~-------~~----~~~~~~f~i~  461 (489)
                      ..|+++|||.|+++.+  ||+||||| +++-..||.|+.....+|.|+++.....+.       +.    ......|.|.
T Consensus         6 ~~v~~~G~L~K~g~~~k~WkkRwFVL~~~~~L~Yyk~~~~~~~~g~i~l~~~~~~i~~~~~~~~v~~~~~~~~~~~F~I~   85 (130)
T 2d9v_A            6 SGLVRGGWLWRQSSILRRWKRNWFALWLDGTLGYYHDETAQDEEDRVVIHFNVRDIKVGQECQDVQPPEGRSRDGLLTVN   85 (130)
T ss_dssp             CCEEEEEEEEEECSSSCCEEEEEEEEETTTEEEEESSSSTTSEEEEEECTTTEEEEEEGGGCSSCCCCSSCCTTTEEEEE
T ss_pred             CceeEEEEEEeecCccCCceeeEEEEccCCEEEEEeCCCCCCcCceEecccceeEEeccccccccCCCCCCCcCcEEEEE
Confidence            3589999999998866  99999999 666666777777678899998875310011       11    1234689999


Q ss_pred             cC-CceEEEE-cCCccHHHHHHHHHHhc
Q 011287          462 TP-KKVLSFE-DAKQRASQWKKAIEALQ  487 (489)
Q Consensus       462 ~p-~r~y~~~-d~~~~~~~W~~~i~~~~  487 (489)
                      |+ +|||+|. +.+.++++|+++|+.++
T Consensus        86 ~~~~r~~~l~A~s~~e~~~Wi~al~~a~  113 (130)
T 2d9v_A           86 LREGSRLHLCAETRDDAIAWKTALMEAN  113 (130)
T ss_dssp             ETTSCEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             eCCCCEEEEEcCCHHHHHHHHHHHHHHH
Confidence            95 5999999 55689999999999876

>1btk_A Bruton'S tyrosine kinase; transferase, PH domain, BTK motif, zinc binding, X-linked agammaglobulinemia, tyrosine-protein kinase; 1.60A {Homo sapiens} SCOP: b.55.1.1 PDB: 1b55_A* 2z0p_A* 1bwn_A*

Probab=99.42  E-value=1.3e-13  Score=124.45  Aligned_cols=88  Identities=18%  Similarity=0.199  Sum_probs=69.8

Q ss_pred             EEEEEeeehhhh-------hhccceeEEEecCCeEEEEC----CCCCeeeeeeeccCCCCceEEEEc---C------C--
Q 011287          398 VLMISMVKKLQK-------LTSKKVQLILTNKPKLIYVD----PSKLVVKGNIIWSDNSNDLSIQVS---S------P--  455 (489)
Q Consensus       398 i~~~g~~~k~~g-------~~~k~r~~~lt~~p~l~y~d----~~~~~~kg~i~~~~~~~~~~~~~~---~------~--  455 (489)
                      |+++|||.|++.       ..||+|||||++.-..||.+    ......+|.|+|+..   ..++..   .      .  
T Consensus         3 vikeG~L~Kr~~~~~~~~~k~WKkRwFVL~~~~L~Yyk~~~~~~~~~~~~G~I~L~~~---~~ve~~~~~~~~~~~~~~~   79 (169)
T 1btk_A            3 VILESIFLKRSQQKKKTSPLNFKKCLFLLTVHKLSYYEYDFERGRRGSKKGSIDVEKI---TCVETVVPEKNPPPERQIP   79 (169)
T ss_dssp             CCEEEEEEEECCCSSTTCCCCEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEEGGGE---EEEEECCCCSSCCGGGCC-
T ss_pred             eEEEEEEEEecCCCCCcccCCCceEEEEEcCCEEEEEecCCccCCCCceeeEEECcce---EEEEeccCCCCcchhcccc
Confidence            689999999752       13999999999986667776    456789999999975   334432   1      1  


Q ss_pred             -------------------CcEEEEcCCceEEEE-cCCccHHHHHHHHHHhcC
Q 011287          456 -------------------SHFKIVTPKKVLSFE-DAKQRASQWKKAIEALQN  488 (489)
Q Consensus       456 -------------------~~f~i~~p~r~y~~~-d~~~~~~~W~~~i~~~~~  488 (489)
                                         ..|.|+||+|||||. +.+.++++|+++|..++.
T Consensus        80 ~~~~~~~~~~~~~i~~~~~~~F~I~t~~rt~yl~A~s~~E~~eWi~aI~~~i~  132 (169)
T 1btk_A           80 RRGEESSEMEQISIIERFPYPFQVVYDEGPLYVFSPTEELRKRWIHQLKNVIR  132 (169)
T ss_dssp             --------CCTTHHHHCCCEEEEEEETTCCEEEEESCHHHHHHHHHHHHHHHT
T ss_pred             cccCcccccccccccccccccEEEEeCCceEEEEcCCHHHHHHHHHHHHHHHH
Confidence                               479999999999999 455899999999999873

>1x1g_A Pleckstrin 2; PH domain, structural genomics, riken structural genomics/proteomics initiative, RSGI, NPPSFA; NMR {Homo sapiens} SCOP: b.55.1.1

Probab=99.41  E-value=4e-13  Score=115.41  Aligned_cols=93  Identities=18%  Similarity=0.259  Sum_probs=73.4

Q ss_pred             CceEEEEEeeehhhhhh--ccceeEEEec-CCeEEEECC--CCCeeeeeeeccCCCCceEEEEc----------CCCcEE
Q 011287          395 GESVLMISMVKKLQKLT--SKKVQLILTN-KPKLIYVDP--SKLVVKGNIIWSDNSNDLSIQVS----------SPSHFK  459 (489)
Q Consensus       395 ~~~i~~~g~~~k~~g~~--~k~r~~~lt~-~p~l~y~d~--~~~~~kg~i~~~~~~~~~~~~~~----------~~~~f~  459 (489)
                      ...++++|||.|+++..  ||+|||+|++ ...|+|.+.  .....+|.|+|..+. +..++..          ....|.
T Consensus        15 ~~~~~~~G~L~K~g~~~~~Wk~R~fvL~~d~~~L~yy~~~~~~~~~~g~i~L~~~~-v~~~~~~~~p~~~~~~~~~~~F~   93 (129)
T 1x1g_A           15 SGTVVKQGYLAKQGHKRKNWKVRRFVLRKDPAFLHYYDPSKEENRPVGGFSLRGSL-VSALEDNGVPTGVKGNVQGNLFK   93 (129)
T ss_dssp             CSEEEEEEEEEEECSSSSSEEEEEEEEEESSCEEEEECSSSCCSSCSCCEESTTCC-CEECCSSSSCSSCSSCCCSSCEE
T ss_pred             CCCEEEEEEEEEECCCCCCeeeEEEEEeCCCCeEEEeCCCCcCCccceEEECcCCE-EEEeCCCCCcccccCCCCCceEE
Confidence            55799999999998755  9999999995 577766665  577899999999752 1233222          357999


Q ss_pred             EEcCC-ceEEEE-cCCccHHHHHHHHHHhcC
Q 011287          460 IVTPK-KVLSFE-DAKQRASQWKKAIEALQN  488 (489)
Q Consensus       460 i~~p~-r~y~~~-d~~~~~~~W~~~i~~~~~  488 (489)
                      |.|++ |+|+|. +.+.++++|+++|+.+++
T Consensus        94 I~~~~~r~~~l~a~s~~e~~~Wi~al~~~~~  124 (129)
T 1x1g_A           94 VITKDDTHYYIQASSKAERAEWIEAIKKLTS  124 (129)
T ss_dssp             ECCTTCCCEEECCSSHHHHHHHHHHHHHHSS
T ss_pred             EEcCCCCEEEEEcCCHHHHHHHHHHHHHHHh
Confidence            99996 889998 556899999999999864

>1fao_A Dual adaptor of phosphotyrosine and 3- phosphoinositides; pleckstrin, inositol tetrakisphosphate signal transduction protein, adaptor protein; HET: 4IP; 1.80A {Homo sapiens} SCOP: b.55.1.1 PDB: 1fb8_A

Probab=99.41  E-value=2.8e-13  Score=115.91  Aligned_cols=90  Identities=13%  Similarity=0.062  Sum_probs=74.2

Q ss_pred             eEEEEEeeehhhhhh--ccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEE--cCCCcEEEEcCCceEEEEc-
Q 011287          397 SVLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV--SSPSHFKIVTPKKVLSFED-  471 (489)
Q Consensus       397 ~i~~~g~~~k~~g~~--~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~--~~~~~f~i~~p~r~y~~~d-  471 (489)
                      .++++|||.|+++..  ||+|||+|++.-..||.++.....+|.|+|..+.. +.+..  +.+..|.|.||+|+|+|.. 
T Consensus        17 ~~~~~G~L~K~g~~~~~Wk~R~fvL~~~~L~yy~~~~~~~~~g~i~L~~~~~-v~~~~~~~~~~~F~i~~~~r~~~l~a~   95 (126)
T 1fao_A           17 LGTKEGYLTKQGGLVKTWKTRWFTLHRNELKYFKDQMSPEPIRILDLTECSA-VQFDYSQERVNCFCLVFPFRTFYLCAK   95 (126)
T ss_dssp             TTCEEEEEEEECSSSCCEEEEEEEEETTEEEEESSTTCSSCSEEEEGGGCCE-EEEECSSSSSSEEEEEETTEEEEEECS
T ss_pred             CccEEEEEEEcCCCCCCcccEEEEEECCEEEEeCCCCCCCceeEEEccceEE-EEecccCCCCCEEEEEeCCcEEEEECC
Confidence            468999999998855  99999999998777888888889999999998721 22222  3347899999999999994 


Q ss_pred             CCccHHHHHHHHHHhc
Q 011287          472 AKQRASQWKKAIEALQ  487 (489)
Q Consensus       472 ~~~~~~~W~~~i~~~~  487 (489)
                      .+.++++|+++|+.++
T Consensus        96 s~~e~~~Wi~al~~~i  111 (126)
T 1fao_A           96 TGVEADEWIKILRWKL  111 (126)
T ss_dssp             SHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHH
Confidence            5589999999999875

>2d9x_A Oxysterol binding protein-related protein 11; PH domain, OSBP-related protein 11, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=99.40  E-value=9.8e-14  Score=117.95  Aligned_cols=89  Identities=11%  Similarity=0.180  Sum_probs=69.9

Q ss_pred             eEEEEEeeehhhhhh--ccceeEEEec-CCeEEEE-CCCC--CeeeeeeeccCCCCceEEEEcCCCcEEEEcCC-ceEEE
Q 011287          397 SVLMISMVKKLQKLT--SKKVQLILTN-KPKLIYV-DPSK--LVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPK-KVLSF  469 (489)
Q Consensus       397 ~i~~~g~~~k~~g~~--~k~r~~~lt~-~p~l~y~-d~~~--~~~kg~i~~~~~~~~~~~~~~~~~~f~i~~p~-r~y~~  469 (489)
                      .++++|||.|+++..  ||+|||||+. ...|+|. ++..  ...+|.|+|..+  .+.+.......|.|.||+ |+|+|
T Consensus         7 ~~~~~G~L~K~~~~~~~Wk~R~fvL~~~~~~L~Yyk~~~~~~~~~~g~I~L~~~--~v~~~~~~~~~F~i~~~~~r~~~l   84 (120)
T 2d9x_A            7 GENVYGYLMKYTNLVTGWQYRFFVLNNEAGLLEYFVNEQSRNQKPRGTLQLAGA--VISPSDEDSHTFTVNAASGEQYKL   84 (120)
T ss_dssp             CCCCEEEEEEEEETTTEEEEEEEEECTTTCEEEEESSGGGSSSCCSEEEECTTC--CEECCSSSSSCEEECCSSSCCEEE
T ss_pred             CCcEEEEEEecCCCCCCceEEEEEEECCCCEEEEEecCcccCCCccceEEcceE--EEEecCCCCCEEEEEcCCCCEEEE
Confidence            467899999999865  9999999995 4566554 5443  267999999986  233333556899999996 99999


Q ss_pred             E-cCCccHHHHHHHHHHhc
Q 011287          470 E-DAKQRASQWKKAIEALQ  487 (489)
Q Consensus       470 ~-d~~~~~~~W~~~i~~~~  487 (489)
                      . +.+.++++|+++|+.++
T Consensus        85 ~a~s~~e~~~Wi~al~~~~  103 (120)
T 2d9x_A           85 RATDAKERQHWVSRLQICT  103 (120)
T ss_dssp             CCSSHHHHHHHHHHHHHHH
T ss_pred             ECCCHHHHHHHHHHHHHHH
Confidence            8 55689999999999875

>1v88_A Oxysterol binding protein-related protein 8; vesicle transport, pleckstrin homology domain, phosphatidylinositol binding, structural genomics; NMR {Homo sapiens} SCOP: b.55.1.1

Probab=99.40  E-value=1.1e-13  Score=119.42  Aligned_cols=92  Identities=17%  Similarity=0.176  Sum_probs=71.2

Q ss_pred             eEEEEEeeehhhhhh-ccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEEcCCCcEEEEcCC-----------
Q 011287          397 SVLMISMVKKLQKLT-SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPK-----------  464 (489)
Q Consensus       397 ~i~~~g~~~k~~g~~-~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~~~~~f~i~~p~-----------  464 (489)
                      .|+++|||.|++++- ||+|||||.++-..||.++.....+|.|+|..+.+......+....|.|.+|.           
T Consensus         7 ~v~k~GwL~K~g~~k~WkrRWfVLk~~~L~yyk~~~~~~p~G~I~L~~~~v~~~~~~~~~~~F~i~~~~~~~i~~~~g~~   86 (130)
T 1v88_A            7 GIVMADWLKIRGTLKSWTKLWCVLKPGVLLIYKTQKNGQWVGTVLLNACEIIERPSKKDGFCFKLFHPLEQSIWAVKGPK   86 (130)
T ss_dssp             SCCEEEEEEECCSSSSCEEEEEEEETTEEEEESCSSSCCCCEEEECSSCEECCCCTTTSSCEEEEECTTCCCCSCSSCTT
T ss_pred             ceEEEeEEEEeCCCCCceEEEEEEECCEEEEECCCCCCCceEEEEcCCCEEEECCCCCCCeEEEEEcCCccccccccCCc
Confidence            478999999977433 99999999998888888988888999999998621101111233699998763           


Q ss_pred             -------------ceEEEE-cCCccHHHHHHHHHHhcC
Q 011287          465 -------------KVLSFE-DAKQRASQWKKAIEALQN  488 (489)
Q Consensus       465 -------------r~y~~~-d~~~~~~~W~~~i~~~~~  488 (489)
                                   |+|+|. |.+.++++|+++|+.+++
T Consensus        87 ~~~~g~~~~~~~~~~~~f~A~s~~e~~~Wi~ai~~a~~  124 (130)
T 1v88_A           87 GEAVGSITQPLPSSYLIIRATSESDGRCWMDALELALK  124 (130)
T ss_dssp             SCSCSCCCSCCCSSCCEEECSSHHHHHHHHHHHHHHHT
T ss_pred             ccccccccccCCceEEEEECCCHHHHHHHHHHHHHHHh
Confidence                         458888 666899999999999864

>1wi1_A Calcium-dependent activator protein for secretion, CAPS; PH domain, PIP2 binding site, structural genomics; NMR {Homo sapiens} SCOP: b.55.1.1

Probab=99.39  E-value=4.4e-13  Score=113.26  Aligned_cols=86  Identities=14%  Similarity=0.192  Sum_probs=72.4

Q ss_pred             EEEEEeeehhhh-h--hccceeEEEecCCeEEEE----CCCCCeeeeeeeccCCCCceEEEE--------cCCCcEEEEc
Q 011287          398 VLMISMVKKLQK-L--TSKKVQLILTNKPKLIYV----DPSKLVVKGNIIWSDNSNDLSIQV--------SSPSHFKIVT  462 (489)
Q Consensus       398 i~~~g~~~k~~g-~--~~k~r~~~lt~~p~l~y~----d~~~~~~kg~i~~~~~~~~~~~~~--------~~~~~f~i~~  462 (489)
                      ..++||+.|+++ .  -||||||||++.-..||.    |..+.+..|.|+|...    +|+.        ..+..|.|++
T Consensus         8 ~~~~G~L~KqG~~~~K~WKrRwFVL~~~~LyYfk~~~~~~~~~~p~G~I~L~g~----tV~~~~~~~~~~~~k~~F~~v~   83 (126)
T 1wi1_A            8 MKHSGYLWAIGKNVWKRWKKRFFVLVQVSQYTFAMCSYREKKAEPQELLQLDGY----TVDYTDPQPGLEGGRAFFNAVK   83 (126)
T ss_dssp             EEEEEEEEEECSSSCCSCEEEEEEEEEEETTEEEEEECCSSSSCCSEEEECSSC----EEEECCCCSSCCSCSSEEEEEC
T ss_pred             CceeEEEEEeCCCcccccceEEEEEeCCEEEEEEcccccccCCCCceEEECCCc----EEEEecCCcccccCceEEEEec
Confidence            689999999987 3  399999999999777887    8888899999999974    3331        2346799999


Q ss_pred             CCceEEEE-cCCccHHHHHHHHHHhc
Q 011287          463 PKKVLSFE-DAKQRASQWKKAIEALQ  487 (489)
Q Consensus       463 p~r~y~~~-d~~~~~~~W~~~i~~~~  487 (489)
                      ++++|+|. |.+.++..|+++|..+.
T Consensus        84 ~~~ty~~~Adseee~~~WikAi~~A~  109 (126)
T 1wi1_A           84 EGDTVIFASDDEQDRILWVQAMYRAT  109 (126)
T ss_dssp             SSCEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             CCceEEEEcCCHHHHHHHHHHHHHHh
Confidence            99999999 67799999999999875

>2i5f_A Pleckstrin; PH domain, protein-inositol phosphate complex, lipid binding protein; HET: 5IP; 1.35A {Homo sapiens} SCOP: b.55.1.1 PDB: 2i5c_A* 1zm0_A

Probab=99.39  E-value=7e-13  Score=110.23  Aligned_cols=91  Identities=18%  Similarity=0.183  Sum_probs=70.6

Q ss_pred             ceEEEEEeeehhhhhh--ccceeEEEecC-CeEE-EECCCCCeeeeeeeccCCCCceEEEE-------cCCCcEEEEcCC
Q 011287          396 ESVLMISMVKKLQKLT--SKKVQLILTNK-PKLI-YVDPSKLVVKGNIIWSDNSNDLSIQV-------SSPSHFKIVTPK  464 (489)
Q Consensus       396 ~~i~~~g~~~k~~g~~--~k~r~~~lt~~-p~l~-y~d~~~~~~kg~i~~~~~~~~~~~~~-------~~~~~f~i~~p~  464 (489)
                      +.++++|+|.|+++..  ||+|||+|++. ..|+ |.++.....+|.|+|..+. +..+..       .....|.|.|++
T Consensus         5 ~~~~~~G~L~K~g~~~~~Wk~R~fvL~~~~~~L~yyk~~~~~~~~g~i~L~~~~-v~~~~~~~~~~~~~~~~~F~i~~~~   83 (109)
T 2i5f_A            5 GVIIKQGCLLKQGHRRKNWKVRKFILREDPAYLHYYDPAGAEDPLGAIHLRGCV-VTSVESNSNGRKSEEENLFEIITAD   83 (109)
T ss_dssp             CCEEEEEEEEEECTTTCCEEEEEEEEETTTTEEEEECTTSCSSCSEEEECTTCE-EEEECC--------CCSEEEEECTT
T ss_pred             CceeEEEEEEEcCCCCCCceEEEEEEeCCCcEEEEECCCCCCCccEEEECCCCE-EEEccCCcccccCCCceEEEEEeCC
Confidence            3589999999998765  99999999996 3665 4466677899999999851 112211       146799999986


Q ss_pred             -ceEEEE-cCCccHHHHHHHHHHhc
Q 011287          465 -KVLSFE-DAKQRASQWKKAIEALQ  487 (489)
Q Consensus       465 -r~y~~~-d~~~~~~~W~~~i~~~~  487 (489)
                       |+|+|. +.+.++++|+++|+.++
T Consensus        84 ~~~~~l~a~s~~e~~~Wi~ai~~~~  108 (109)
T 2i5f_A           84 EVHYFLQAATPKERTEWIKAIQMAS  108 (109)
T ss_dssp             CCEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             CCEEEEEcCCHHHHHHHHHHHHHHh
Confidence             779998 55589999999999875

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.39  E-value=8.3e-13  Score=127.19  Aligned_cols=140  Identities=16%  Similarity=0.134  Sum_probs=112.2

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~lyl  122 (489)
                      +.+|.+...+|.|+.+.||++..  .+..+++|+.......   ....+.+|..+++.+. +..+.+++.++.+....|+
T Consensus        13 l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~---~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l   87 (263)
T 3tm0_A           13 IEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             hccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCC---CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence            46799999999999999999975  3789999998653211   1234778999998884 6678889999999999999


Q ss_pred             EEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 011287          123 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS---------------------------------------  163 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~---------------------------------------  163 (489)
                      |||+++|.+|.+.+     .+......++.++..+|..||+                                       
T Consensus        88 v~e~i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T 3tm0_A           88 LMSEADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             EEECCSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred             EEEecCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence            99999999987652     1223345788899999999998                                       


Q ss_pred             --------------------CCcEeeccCCCCeeeCCCCCEEEeeccCcc
Q 011287          164 --------------------MGLIHRDIKPENLLLTADGHIKIADFGSVK  193 (489)
Q Consensus       164 --------------------~gIiHrDLKpeNILl~~~g~ikL~DFG~a~  193 (489)
                                          ..++|+|++|.|||+++++.+.|+||+.+.
T Consensus       163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                458999999999999865556799999875

>2lul_A Tyrosine-protein kinase TEC; structural genomics, northeast structural genomics consortiu PSI-biology, protein structure initiative, transferase; NMR {Homo sapiens}

Probab=99.38  E-value=8.8e-13  Score=118.50  Aligned_cols=91  Identities=18%  Similarity=0.185  Sum_probs=71.3

Q ss_pred             CceEEEEEeeehhhh---h----hccceeEEEecCCeEEEECCC-CCeeeeeeeccCCCCceEEEE----------cCCC
Q 011287          395 GESVLMISMVKKLQK---L----TSKKVQLILTNKPKLIYVDPS-KLVVKGNIIWSDNSNDLSIQV----------SSPS  456 (489)
Q Consensus       395 ~~~i~~~g~~~k~~g---~----~~k~r~~~lt~~p~l~y~d~~-~~~~kg~i~~~~~~~~~~~~~----------~~~~  456 (489)
                      +..||++|+|.|++.   .    -||+|||||++.-..||.++. ....+|.|+|...   ..++.          ....
T Consensus        12 ~~~~i~EG~L~Kr~~~kk~~~~knWKkRwFVL~~~~L~Yyk~~~~~~~~~G~I~L~~~---~~v~~~~~~~~~~~~~~~~   88 (164)
T 2lul_A           12 NFNTILEEILIKRSQQKKKTSPLNYKERLFVLTKSMLTYYEGRAEKKYRKGFIDVSKI---KCVEIVKNDDGVIPCQNKY   88 (164)
T ss_dssp             CSSEEEEEEEEEECCCCSSSCCCCEEEEEEEEESSEEEEECCCSSSCCCCCEEEGGGC---CEEEECCCCSSSCCSSSCS
T ss_pred             CCCeeEEEEEEEecCCCCCCCCCCceeEEEEEECCEEEEEeccCcccccccEEEEeee---EEEEeccccccCcccccce
Confidence            345899999999863   1    299999999998766777764 3457899999976   33433          2235


Q ss_pred             cEEEEcCCceEEEE-cCCccHHHHHHHHHHhcC
Q 011287          457 HFKIVTPKKVLSFE-DAKQRASQWKKAIEALQN  488 (489)
Q Consensus       457 ~f~i~~p~r~y~~~-d~~~~~~~W~~~i~~~~~  488 (489)
                      .|.|.||+|||||. +.+.++++|+++|++++.
T Consensus        89 ~f~i~t~~rt~~l~A~s~~e~~~Wi~aL~~~i~  121 (164)
T 2lul_A           89 PFQVVHDANTLYIFAPSPQSRDLWVKKLKEEIK  121 (164)
T ss_dssp             EEEEECSSCEEEEECSSHHHHHHHHHHHHHHHT
T ss_pred             eEEEecCCcEEEEECCCHHHHHHHHHHHHHHHH
Confidence            79999999999999 455899999999999874

>1u5d_A SKAP55, SRC kinase-associated phosphoprotein of 55 kDa; PH domain, signaling protein; 1.70A {Homo sapiens} SCOP: b.55.1.1

Probab=99.38  E-value=6.4e-13  Score=110.04  Aligned_cols=87  Identities=18%  Similarity=0.281  Sum_probs=72.6

Q ss_pred             eEEEEEeeehhhh------hhccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEE--------cCCCcEEEEc
Q 011287          397 SVLMISMVKKLQK------LTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV--------SSPSHFKIVT  462 (489)
Q Consensus       397 ~i~~~g~~~k~~g------~~~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~--------~~~~~f~i~~  462 (489)
                      .|+++|+|.|+++      -.||+|||+|++.-..||.++.....+|.|+|+..    .+..        +....|.|.|
T Consensus         2 ~v~~~G~L~K~~~~~~~~~~~Wk~R~fvL~~~~L~yy~~~~~~~~~g~i~L~~~----~v~~~~~~~~~~~~~~~F~i~~   77 (108)
T 1u5d_A            2 SVIKQGYLEKKSKDHSFFGSEWQKRWCVVSRGLFYYYANEKSKQPKGTFLIKGY----SVRMAPHLRRDSKKESCFELTS   77 (108)
T ss_dssp             CEEEEEEEEEEEECSSSSCEEEEEEEEEEETTEEEEESSTTCSSCSEEEECTTC----EEEECGGGCSSGGGGGEEEEEC
T ss_pred             CccEEEEEEEcCCCCCccccCceeeEEEEeCCEEEEecCCCCCCCCEEEEecce----EEEeCCccccccCCcceEEEEc
Confidence            4899999999884      34999999999887778888888889999999986    2322        2347899999


Q ss_pred             CC-ceEEEEc-CCccHHHHHHHHHHhc
Q 011287          463 PK-KVLSFED-AKQRASQWKKAIEALQ  487 (489)
Q Consensus       463 p~-r~y~~~d-~~~~~~~W~~~i~~~~  487 (489)
                      |+ |+|+|.. .+.++++|+++|+.++
T Consensus        78 ~~~r~~~l~a~s~~e~~~Wi~ai~~~i  104 (108)
T 1u5d_A           78 QDRRTYEFTATSPAEARDWVDQISFLL  104 (108)
T ss_dssp             SSSCCEEEECSSHHHHHHHHHHHHHHH
T ss_pred             CCCcEEEEECCCHHHHHHHHHHHHHHH
Confidence            97 9999995 5589999999999876

>2dkp_A Pleckstrin homology domain-containing family A member 5; PH domain, pleckstrin homology domain-containing protein family A member 5; NMR {Homo sapiens}

Probab=99.38  E-value=6.8e-13  Score=113.75  Aligned_cols=90  Identities=20%  Similarity=0.262  Sum_probs=74.2

Q ss_pred             CCceEEEEEeeehhhh-hh--ccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEE-------cCCCcEEEEcC
Q 011287          394 PGESVLMISMVKKLQK-LT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV-------SSPSHFKIVTP  463 (489)
Q Consensus       394 ~~~~i~~~g~~~k~~g-~~--~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~-------~~~~~f~i~~p  463 (489)
                      +++.++++|||.|+++ ..  ||+|||+|++.-..||.++.....+|.|+|...    .+..       +....|.|.|+
T Consensus        17 ~~~~~~~~G~L~K~~~~~~~~Wk~R~fvL~~~~L~yy~~~~~~~~~g~i~L~~~----~v~~~~~~~~~~~~~~F~i~~~   92 (128)
T 2dkp_A           17 PNAPVVRRGWLYKQDSTGMKLWKKRWFVLSDLCLFYYRDEKEEGILGSILLPSF----QIALLTSEDHINRKYAFKAAHP   92 (128)
T ss_dssp             TTSCCCEEEEEEEECCSSSCCEEEEEEEEETTEEEEESSTTCCSEEEEECGGGS----EEEECCGGGCCSSCSEEEEECS
T ss_pred             CCCCcEEEEEEEEeCCCCCCCceeEEEEEeCCEEEEECCCCCcccceEEEcCce----EEEEcCCcccCCCCeEEEEEcC
Confidence            4667899999999987 33  999999999887778888888899999999864    3333       33468999998


Q ss_pred             C-ceEEEEc-CCccHHHHHHHHHHhc
Q 011287          464 K-KVLSFED-AKQRASQWKKAIEALQ  487 (489)
Q Consensus       464 ~-r~y~~~d-~~~~~~~W~~~i~~~~  487 (489)
                      + |+|+|.. .+.++++|+++|+++.
T Consensus        93 ~~r~~~l~a~s~~e~~~Wi~al~~a~  118 (128)
T 2dkp_A           93 NMRTYYFCTDTGKEMELWMKAMLDAA  118 (128)
T ss_dssp             SSCCEEEECSSHHHHHHHHHHHHHHH
T ss_pred             CCCEEEEEcCCHHHHHHHHHHHHHHH
Confidence            5 9999995 5689999999998864

>1upq_A PEPP1; PH domain, phosphoinositide binding, signal transduction; 1.48A {Homo sapiens} SCOP: b.55.1.1 PDB: 1upr_A*

Probab=99.38  E-value=1.1e-12  Score=111.68  Aligned_cols=91  Identities=16%  Similarity=0.253  Sum_probs=74.5

Q ss_pred             CCceEEEEEeeehhhh-hh--ccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEEc-------CCCcEEEEcC
Q 011287          394 PGESVLMISMVKKLQK-LT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVS-------SPSHFKIVTP  463 (489)
Q Consensus       394 ~~~~i~~~g~~~k~~g-~~--~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~-------~~~~f~i~~p  463 (489)
                      ++..++++|||.|+++ .+  ||+|||+|++.-..||.++.....+|.|+|...    .+...       ....|.|.++
T Consensus         7 p~~~~~~~G~L~K~~~~~~~~WkkR~fvL~~~~L~yy~~~~~~~~~g~i~l~~~----~v~~~~~~~~~~~~~~f~i~~~   82 (123)
T 1upq_A            7 PNLPVHIRGWLHKQDSSGLRLWKRRWFVLSGHCLFYYKDSREESVLGSVLLPSY----NIRPDGPGAPRGRRFTFTAEHP   82 (123)
T ss_dssp             TTSCEEEEEEEEEECSSSSCCEEEEEEEEETTEEEEESSTTCCSCCEEEEGGGC----EEEECCSSCTTSSSSEEEEECT
T ss_pred             CCCCceEEEEEEeeCCCCCCCceeEEEEEeCCEEEEECCCCCcccceEEECCCC----EEEECCCCccCCCcEEEEEECC
Confidence            4556899999999985 33  999999999887778888888899999999874    34332       3468888888


Q ss_pred             C-ceEEEE-cCCccHHHHHHHHHHhcC
Q 011287          464 K-KVLSFE-DAKQRASQWKKAIEALQN  488 (489)
Q Consensus       464 ~-r~y~~~-d~~~~~~~W~~~i~~~~~  488 (489)
                      + |+|+|. +.+.++++|+++|+.++.
T Consensus        83 ~~r~~~l~a~s~~e~~~Wi~al~~a~~  109 (123)
T 1upq_A           83 GMRTYVLAADTLEDLRGWLRALGRASR  109 (123)
T ss_dssp             TSCCEEEECSSHHHHHHHHHHHHHHHC
T ss_pred             CCeEEEEECCCHHHHHHHHHHHHHHHh
Confidence            7 999998 556899999999999763

>2rlo_A Centaurin-gamma 1; split PH domain, alternative splicing, ANK repeat, cytoplasm, GTP-binding, GTPase activation, metal-binding, nucleotide-binding; NMR {Homo sapiens}

Probab=99.38  E-value=3.6e-13  Score=115.82  Aligned_cols=91  Identities=20%  Similarity=0.162  Sum_probs=63.8

Q ss_pred             eEEEEEeeehhhh--hh--ccceeEEEecCCeEEEECCC-----C-------------CeeeeeeeccCCCCc------e
Q 011287          397 SVLMISMVKKLQK--LT--SKKVQLILTNKPKLIYVDPS-----K-------------LVVKGNIIWSDNSND------L  448 (489)
Q Consensus       397 ~i~~~g~~~k~~g--~~--~k~r~~~lt~~p~l~y~d~~-----~-------------~~~kg~i~~~~~~~~------~  448 (489)
                      .++++|||.|++|  +.  ||+|||||++...|||.+..     .             ....|.||+..+...      .
T Consensus         3 ~~~k~G~L~K~~g~~~~k~WkkRwFvL~~~~~l~Y~~~~~d~~~~~~~~~i~l~~~~~~~~~~~i~l~~~~~~~~~~~~~   82 (128)
T 2rlo_A            3 IPIKQSFLLKRSGNSLNKEWKKKYVTLSSNGFLLYHPSINDYIHSTHGKEMDLLRTTVKVPGKRPPRAISAFGPSASGSA   82 (128)
T ss_dssp             CEEEEEEEEEECSCSTTCCEEEEEEEEETTTEEEEESSHHHHHHTCSCEEEESSSCEEECSSCCCCCSSCCCSCCSCCCC
T ss_pred             cceeEEEEEEecCCCccCCccEEEEEEeCCCEEEEecchhhhccccCCCeeeeeeeEEecCCCccccccccccccccccc
Confidence            4689999999954  44  99999999988889888641     0             112234444432110      0


Q ss_pred             EEEEcCCCcEEEEcCC-ceEEEEc-CCccHHHHHHHHHHhc
Q 011287          449 SIQVSSPSHFKIVTPK-KVLSFED-AKQRASQWKKAIEALQ  487 (489)
Q Consensus       449 ~~~~~~~~~f~i~~p~-r~y~~~d-~~~~~~~W~~~i~~~~  487 (489)
                      .........|.|+||+ |||+|.. .+.++++|+++|+.++
T Consensus        83 ~~~~~~~~~F~I~t~~~r~~~l~A~s~~e~~~Wi~ai~~~i  123 (128)
T 2rlo_A           83 GQAEEENFEFLIVSSTGQTWHFEAASFEERDAWVQAIESQI  123 (128)
T ss_dssp             SSCCCCCCCEEEECTTSCEEEEEESSHHHHHHHHHHHHHHH
T ss_pred             cccccCCceEEEEcCCCCEEEEEcCCHHHHHHHHHHHHHHH
Confidence            0011345799999998 9999994 5589999999999875

>3aj4_A Pleckstrin homology domain-containing family B ME; antiparallel beta sheet, protein transport; HET: SEP EDO; 1.00A {Homo sapiens} PDB: 3via_A 2dhi_A

Probab=99.38  E-value=1.1e-13  Score=115.85  Aligned_cols=91  Identities=13%  Similarity=0.206  Sum_probs=70.1

Q ss_pred             EEEEEeeehhhhhh--ccceeEEE-ecCCeEEEECCCCCeeeeeeeccCCCCce----EEE---E---cC-CCcEEEEcC
Q 011287          398 VLMISMVKKLQKLT--SKKVQLIL-TNKPKLIYVDPSKLVVKGNIIWSDNSNDL----SIQ---V---SS-PSHFKIVTP  463 (489)
Q Consensus       398 i~~~g~~~k~~g~~--~k~r~~~l-t~~p~l~y~d~~~~~~kg~i~~~~~~~~~----~~~---~---~~-~~~f~i~~p  463 (489)
                      |+++|||.|+++.+  ||+||||| .++-..||.++.....+|.|++...+..+    .+.   .   ++ +..|.|.||
T Consensus         5 ~~~~G~L~K~g~~~k~WkkR~fvL~~~~~L~yyk~~~~~~~~g~i~l~~~~i~l~~~~~v~~v~~~~~~~~~~~F~i~~~   84 (112)
T 3aj4_A            5 FVKSGWLLRQSTILKRWKKNWFDLWSDGHLIYYDDQTRQNIEDKVHMPMDCINIRTGQECRDTQPPDGKSKDCMLQIVCR   84 (112)
T ss_dssp             CSEEEEEEEECSSSCCEEEEEEEECTTSEEEEESSTTCCSEEEEEEHHHHEEEEEEGGGCCSCCCSTTCCGGGEEEEEET
T ss_pred             eeEEEEEEeeCCCCCCeeceEEEEeeCCEEEEEcCCCCCCCCccccccccceeecccccccccCCCCCCCcCcEEEEEec
Confidence            68999999998865  99999999 66666688888878999999998642000    111   1   12 348999876


Q ss_pred             -CceEEEE-cCCccHHHHHHHHHHhcC
Q 011287          464 -KKVLSFE-DAKQRASQWKKAIEALQN  488 (489)
Q Consensus       464 -~r~y~~~-d~~~~~~~W~~~i~~~~~  488 (489)
                       +|+|+|. +.+.++++|+++|++++.
T Consensus        85 ~~r~~~l~a~s~~e~~~Wi~al~~a~~  111 (112)
T 3aj4_A           85 DGKTISLCAESTDDCLAWKFTLQDSRT  111 (112)
T ss_dssp             TSCEEEEECSSHHHHHHHHHHHHHHHT
T ss_pred             CCcEEEEEeCCHHHHHHHHHHHHHHhh
Confidence             8999999 456899999999999763

>1x05_A Pleckstrin; PH domain, structural genomics, NPPSFA, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: b.55.1.1 PDB: 1xx0_A

Probab=99.38  E-value=6.4e-13  Score=114.19  Aligned_cols=92  Identities=18%  Similarity=0.217  Sum_probs=71.3

Q ss_pred             ceEEEEEeeehhhhhh--ccceeEEEecCC-eE-EEECCCCCeeeeeeeccCCCCceEEEEc-------CCCcEEEEcCC
Q 011287          396 ESVLMISMVKKLQKLT--SKKVQLILTNKP-KL-IYVDPSKLVVKGNIIWSDNSNDLSIQVS-------SPSHFKIVTPK  464 (489)
Q Consensus       396 ~~i~~~g~~~k~~g~~--~k~r~~~lt~~p-~l-~y~d~~~~~~kg~i~~~~~~~~~~~~~~-------~~~~f~i~~p~  464 (489)
                      ..++++|||.|+++..  ||+|||||++.+ .| ||.++.....+|.|+|..+. +..+...       ....|.|.|++
T Consensus        16 ~~~~~~G~L~K~g~~~~~Wk~R~fvL~~~~~~L~yy~~~~~~~~~g~i~L~~~~-v~~~~~~~~~~~~~~~~~F~i~~~~   94 (129)
T 1x05_A           16 GVIIKQGCLLKQGHRRKNWKVRKFILREDPAYLHYYDPAGAEDPLGAIHLRGCV-VTSVESNSNGRKSEEENLFEIITAD   94 (129)
T ss_dssp             SEEEEEEEEEECCSSCCCCEEEEEEEEETTTEEEEECSSCCSSCSEEEECTTCE-EEECCCCCCSSSCSSCSEEEEECTT
T ss_pred             CCceEEEEEEecCCCCCCCeeEEEEEeCCCCEEEEECCCCCCcceeEEEccCCE-EEEccCCccccccCCCeEEEEEcCC
Confidence            3589999999998755  999999999974 66 55566678899999999851 1111111       45789999985


Q ss_pred             -ceEEEE-cCCccHHHHHHHHHHhcC
Q 011287          465 -KVLSFE-DAKQRASQWKKAIEALQN  488 (489)
Q Consensus       465 -r~y~~~-d~~~~~~~W~~~i~~~~~  488 (489)
                       |+|+|. +.+.++++|+++|+.+++
T Consensus        95 ~~~~~l~a~s~~e~~~Wi~al~~~~~  120 (129)
T 1x05_A           95 EVHYFLQAATPKERTEWIKAIQMASR  120 (129)
T ss_dssp             CCCCEEECSSHHHHHHHHHHHHHHHT
T ss_pred             CCEEEEECCCHHHHHHHHHHHHHHHH
Confidence             889998 555899999999999763

>1dyn_A Dynamin; signal transduction protein; 2.20A {Homo sapiens} SCOP: b.55.1.1 PDB: 2dyn_A 3zys_C 2ys1_A

Probab=99.37  E-value=1.6e-12  Score=108.57  Aligned_cols=85  Identities=18%  Similarity=0.198  Sum_probs=70.7

Q ss_pred             EEEEEeeehh-hhhh---ccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEE------cCCCcEEEEcCC---
Q 011287          398 VLMISMVKKL-QKLT---SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV------SSPSHFKIVTPK---  464 (489)
Q Consensus       398 i~~~g~~~k~-~g~~---~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~------~~~~~f~i~~p~---  464 (489)
                      |++.|||.|+ +|+.   ||+||||||+.-..||.|....+.+|.|||..    +.+..      ..+..|.|..|+   
T Consensus        12 VirkGWL~k~~~g~~k~~wk~rWFVLt~~~L~yyKd~~eke~~G~IpL~~----~~vr~v~~~~~~rk~~F~l~~~d~r~   87 (125)
T 1dyn_A           12 VIRKGWLTINNIGIMKGGSKEYWFVLTAENLSWYKDDEEKEKKYMLSVDN----LKLRDVEKGFMSSKHIFALFNTEQRN   87 (125)
T ss_dssp             EEEEEEEEESCCCGGGTSSEEEEEEEESSEEEEESSTTCSCEEEEEECTT----EEEEECCSCSSSSCEEEEEEETTSSC
T ss_pred             eEEEEEEEEecCccccCCceeeEEEEeccceeeecCCcccccceEEECCC----ceEeccCCCCCCCceEEEEECCCCcc
Confidence            8999999995 4433   99999999999999999999999999999976    45544      234699998764   


Q ss_pred             -----ceEEEEcCC-ccHHHHHHHHHHh
Q 011287          465 -----KVLSFEDAK-QRASQWKKAIEAL  486 (489)
Q Consensus       465 -----r~y~~~d~~-~~~~~W~~~i~~~  486 (489)
                           |+|.|...+ .++++|+.+|.++
T Consensus        88 v~~~h~~y~LsA~t~ee~~~Wi~s~~ra  115 (125)
T 1dyn_A           88 VYKDYRQLELACETQEEVDSWKASFLRA  115 (125)
T ss_dssp             SSTTCSSEEEEESSHHHHHHHHHHHHHT
T ss_pred             ccccceEEEEeCCCHHHHHHHHHHHHhC
Confidence                 499999655 8999999999654

>1v89_A Hypothetical protein KIAA0053; pleckstrin homology domain, phosphatidylinositol binding, structural genomics; NMR {Homo sapiens} SCOP: b.55.1.1

Probab=99.37  E-value=1.1e-12  Score=110.65  Aligned_cols=89  Identities=11%  Similarity=0.227  Sum_probs=73.4

Q ss_pred             ceEEEEEeeehhhhhh--ccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEE------cCCCcEEEEc-----
Q 011287          396 ESVLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV------SSPSHFKIVT-----  462 (489)
Q Consensus       396 ~~i~~~g~~~k~~g~~--~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~------~~~~~f~i~~-----  462 (489)
                      +.++++|||.|+++..  ||+|||+|++.-..||.++.....+|.|+|..+   ..++.      .....|.|.|     
T Consensus         6 ~~~~~~G~L~K~g~~~~~Wk~R~fvL~~~~L~yy~~~~~~~~~g~i~L~~~---~v~~~~~~~~~~~~~~f~i~~~~~~~   82 (118)
T 1v89_A            6 SGPIKMGWLKKQRSIVKNWQQRYFVLRAQQLYYYKDEEDTKPQGCMYLPGC---TIKEIATNPEEAGKFVFEIIPASWDQ   82 (118)
T ss_dssp             SCEEEEEEEEEECSSSSCEEEEEEEEETTEEEEESSSSCCSCSEEECSTTE---EEEEECCCSSCCCCCEEEEEESCCSS
T ss_pred             CCCcEEEEEEecCCCCCCccEEEEEEECCEEEEEeCCCCCCceEEEECCCC---EEEEcCcCcccCCcceEEEECCcccc
Confidence            4589999999998765  999999999987778888888889999999975   22222      2356899998     


Q ss_pred             ---CCceEEEE-cCCccHHHHHHHHHHhc
Q 011287          463 ---PKKVLSFE-DAKQRASQWKKAIEALQ  487 (489)
Q Consensus       463 ---p~r~y~~~-d~~~~~~~W~~~i~~~~  487 (489)
                         ++|+|+|. +.+.++++|+++|+.++
T Consensus        83 ~~~~~~~~~l~a~s~~e~~~Wi~al~~~~  111 (118)
T 1v89_A           83 NRMGQDSYVLMASSQAEMEEWVKFLRRVA  111 (118)
T ss_dssp             CCSSCCCEEEECSSHHHHHHHHHHHHHHH
T ss_pred             ccCCCcEEEEECCCHHHHHHHHHHHHHHH
Confidence               78999999 55689999999999976

>1u5f_A SRC-associated adaptor protein; PH domain of SKAP-HOM, artefactual dimerization induced by V derived sequence, signaling protein; 1.90A {Mus musculus} SCOP: b.55.1.1 PDB: 1u5g_A

Probab=99.36  E-value=6.9e-13  Score=116.99  Aligned_cols=88  Identities=16%  Similarity=0.271  Sum_probs=73.0

Q ss_pred             eEEEEEeeehhhhh------hccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEE--------cCCCcEEEEc
Q 011287          397 SVLMISMVKKLQKL------TSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV--------SSPSHFKIVT  462 (489)
Q Consensus       397 ~i~~~g~~~k~~g~------~~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~--------~~~~~f~i~~  462 (489)
                      .++++|||.|+++.      .||+|||+|+++-..||.++.....+|.|+|+..    .+..        +....|.|.|
T Consensus        16 ~~~~~G~L~K~g~~~~~~~k~WkkR~fvL~~~~L~yyk~~~~~~~~g~i~L~~~----~v~~~~~~~~~~~~~~~F~I~~   91 (148)
T 1u5f_A           16 FVIKAGYLEKRRKDHSFLGFEWQKRWCALSKTVFYYYGSDKDKQQKGEFAIDGY----DVRMNNTLRKDGKKDCCFEICA   91 (148)
T ss_dssp             SEEEEEEEEEECCCSSCSSCSEEEEEEEEETTEEEEESSTTCSSCSEEEECTTC----EEEECTTSCSSTTGGGEEEEEC
T ss_pred             CccEEEEEEEeCCCCCCcCCCceeEEEEEECCEEEEEcCCCCcccceEEEcCCc----EEEECCCcccCCCCccEEEEEC
Confidence            48999999999842      4999999999988888888888889999999986    2331        2236899999


Q ss_pred             CC-ceEEEEc-CCccHHHHHHHHHHhcC
Q 011287          463 PK-KVLSFED-AKQRASQWKKAIEALQN  488 (489)
Q Consensus       463 p~-r~y~~~d-~~~~~~~W~~~i~~~~~  488 (489)
                      ++ |+|+|.. .+.++++|+++|+.++.
T Consensus        92 ~~~r~~~l~a~s~~e~~~Wi~al~~~i~  119 (148)
T 1u5f_A           92 PDKRIYQFTAASPKDAEEWVQQLKFILQ  119 (148)
T ss_dssp             TTSCEEEEECSSHHHHHHHHHHHHHHCC
T ss_pred             CCCcEEEEECCCHHHHHHHHHHHHHHHH
Confidence            87 9999994 56899999999999864

>3rcp_A Pleckstrin homology domain-containing family A ME; FAPP1, PH domain, lipid-binding, membrane, membrane protein; 1.90A {Homo sapiens} PDB: 2kcj_A

Probab=99.36  E-value=4.9e-13  Score=110.18  Aligned_cols=86  Identities=12%  Similarity=0.195  Sum_probs=67.4

Q ss_pred             EEeeehhhhhh--ccceeEEEecCCeEEEECCCC--CeeeeeeeccCCCCceEEEEcCCCcEEEEcC-CceEEEE-cCCc
Q 011287          401 ISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSK--LVVKGNIIWSDNSNDLSIQVSSPSHFKIVTP-KKVLSFE-DAKQ  474 (489)
Q Consensus       401 ~g~~~k~~g~~--~k~r~~~lt~~p~l~y~d~~~--~~~kg~i~~~~~~~~~~~~~~~~~~f~i~~p-~r~y~~~-d~~~  474 (489)
                      +|||.|+++.+  ||+|||||+++-..||.++..  ...+|.|+|+.+  .+.+.......|.|.+| +|+|+|. +.+.
T Consensus         2 eG~L~K~g~~~k~Wk~R~fvL~~~~L~Yy~~~~~~~~~~~g~i~L~~~--~v~~~~~~~~~F~i~~~~~r~~~l~a~s~~   79 (103)
T 3rcp_A            2 EGVLYKWTNYLTGWQPRWFVLDNGILSYYDSQDDVCKGSKGSIKMAVC--EIKVHSADNTRMELIIPGEQHFYMKAVNAA   79 (103)
T ss_dssp             EEEEEEECCTTTCEEEEEEEEETTEEEEESSCC---CCCSCEEEGGGC--EEECCTTCSSEEEEEETTTEEEEEECSSHH
T ss_pred             ceEEEEccCCCCCeeceEEEEECCEEEEEecCCcccCCcccEEEeeee--EEEEcCCCCceEEEEeCCCCEEEEECCCHH
Confidence            79999999876  999999999765556666653  358999999753  22223345689999998 7999999 4558


Q ss_pred             cHHHHHHHHHHhcC
Q 011287          475 RASQWKKAIEALQN  488 (489)
Q Consensus       475 ~~~~W~~~i~~~~~  488 (489)
                      ++++|+++|+.+++
T Consensus        80 e~~~Wi~al~~a~~   93 (103)
T 3rcp_A           80 ERQRWLVALGSSKA   93 (103)
T ss_dssp             HHHHHHHHHHTTSC
T ss_pred             HHHHHHHHHHHHHH
Confidence            99999999998763

>1fgy_A GRP1; PH domain, signaling protein; HET: 4IP; 1.50A {Mus musculus} SCOP: b.55.1.1 PDB: 1fgz_A 1u2b_A 1fhw_A* 1fhx_A* 1u29_A* 1u27_A*

Probab=99.36  E-value=4.1e-13  Score=114.83  Aligned_cols=89  Identities=19%  Similarity=0.192  Sum_probs=71.6

Q ss_pred             EEEEEeeehhhhhh--ccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEE-EcCCCcEEEEcCC----------
Q 011287          398 VLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQ-VSSPSHFKIVTPK----------  464 (489)
Q Consensus       398 i~~~g~~~k~~g~~--~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~-~~~~~~f~i~~p~----------  464 (489)
                      ++++|||.|+++..  ||+|||+|++.-..||.++.....+|.|+|+.+. +..+. .+.+..|.|.+|+          
T Consensus         5 ~~~~G~L~K~g~~~~~Wk~R~fvL~~~~L~yy~~~~~~~~~g~i~L~~~~-v~~~~~~~~~~~f~i~~~~~~~~~~~~~~   83 (127)
T 1fgy_A            5 PDREGWLLKLGGRVKTWKRRWFILTDNCLYYFEYTTDKEPRGIIPLENLS-IREVLDPRKPNCFELYNPSHKGQVIKACK   83 (127)
T ss_dssp             CSEEEEEEEECSSSCCEEEEEEEEETTEEEEESSTTCSSCSEEEECTTCE-EEEECCSSCSSEEEEECSSSTTCCCCCEE
T ss_pred             CceEeEEEEECCCCCCeEEEEEEEECCEEEEeCCCCCCCcceEEECCceE-EEEccCCCCCceEEEecCCcccccccccc
Confidence            68999999998765  9999999999877788888888999999999861 11111 1345789998764          


Q ss_pred             ------------ceEEEE-cCCccHHHHHHHHHHhc
Q 011287          465 ------------KVLSFE-DAKQRASQWKKAIEALQ  487 (489)
Q Consensus       465 ------------r~y~~~-d~~~~~~~W~~~i~~~~  487 (489)
                                  |+|+|. +.+.++++|+++|+.++
T Consensus        84 ~~~~~~~v~~~~r~~~l~a~s~~e~~~Wi~al~~~i  119 (127)
T 1fgy_A           84 TEADGRVVEGNHVVYRISAPSPEEKEEWMKSIKASI  119 (127)
T ss_dssp             ECTTSCEEECCCSEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             ccCCcceecCCceEEEEECCCHHHHHHHHHHHHHHh
Confidence                        899998 45689999999999876

>1wg7_A Dedicator of cytokinesis protein 9; pleckstrin homology domain, zizimin1, structural genomics, riken structural genomics/proteomics initiative; NMR {Homo sapiens} SCOP: b.55.1.1

Probab=99.36  E-value=4.3e-13  Score=118.54  Aligned_cols=92  Identities=12%  Similarity=0.099  Sum_probs=71.8

Q ss_pred             ceEEEEEeeehhh------hhh--ccceeEEEecC-----CeEEEECCC-CCeeeeeeeccCCCCceEEEEcCCCcEEEE
Q 011287          396 ESVLMISMVKKLQ------KLT--SKKVQLILTNK-----PKLIYVDPS-KLVVKGNIIWSDNSNDLSIQVSSPSHFKIV  461 (489)
Q Consensus       396 ~~i~~~g~~~k~~------g~~--~k~r~~~lt~~-----p~l~y~d~~-~~~~kg~i~~~~~~~~~~~~~~~~~~f~i~  461 (489)
                      ..++++|||.|++      +..  ||+|||||++.     -.+||.++. ....+|.|+|..+..+.....+....|.|.
T Consensus        16 ~~~~~~G~L~K~~~~~~~~~~~k~Wk~RwfvL~~~~~g~~~L~yy~~~~~~~~~~g~I~L~~~~~~~~~~~~~~~~F~i~   95 (150)
T 1wg7_A           16 GGITKHGWLYKGNMNSAISVTMRSFKRRFFHLIQLGDGSYNLNFYKDEKISKEPKGSIFLDSCMGVVQNNKVRRFAFELK   95 (150)
T ss_dssp             CCCCCEEEEEECCCCSSHHHHHSSCEEEEEEEEECSSSCEEEEEESSSCCSSCCSEEECTTTCCEECCCCSSCTTEEEEE
T ss_pred             CCeeEEEEEEEecCCccccccccCeeEEEEEEecCCCCceEEEEECCCCCCCCcCcEEecccCEEEecCCCCCceEEEEE
Confidence            3478999999997      333  99999999997     555777776 678999999998632211112445799999


Q ss_pred             cCC-ceEEEE-cCCccHHHHHHHHHHhc
Q 011287          462 TPK-KVLSFE-DAKQRASQWKKAIEALQ  487 (489)
Q Consensus       462 ~p~-r~y~~~-d~~~~~~~W~~~i~~~~  487 (489)
                      |++ |+|+|. +.+.++++|+.+|+.++
T Consensus        96 ~~~~r~~~l~A~s~~e~~~Wi~al~~ai  123 (150)
T 1wg7_A           96 MQDKSSYLLAADSEVEMEEWITILNKIL  123 (150)
T ss_dssp             CSSSCEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             eCCCcEEEEEeCCHHHHHHHHHHHHHHH
Confidence            995 999999 45589999999999875

>1unq_A RAC-alpha serine/threonine kinase; transferase, pleckstrin homology domain, PKB, AKT, phosphoinositide, serine/threonine-protein kinase; HET: 4IP; 0.98A {Homo sapiens} SCOP: b.55.1.1 PDB: 1h10_A* 1unr_A 2uzs_A* 2uzr_A 2uvm_A* 1unp_A 2x18_A* 1p6s_A

Probab=99.35  E-value=2e-13  Score=116.79  Aligned_cols=92  Identities=15%  Similarity=0.207  Sum_probs=71.7

Q ss_pred             ceEEEEEeeehhhhhh--ccceeEEEecC-CeEEEECCCCCeeeeeeeccCCCCc-eE---EEEcCCCcEEEE----cCC
Q 011287          396 ESVLMISMVKKLQKLT--SKKVQLILTNK-PKLIYVDPSKLVVKGNIIWSDNSND-LS---IQVSSPSHFKIV----TPK  464 (489)
Q Consensus       396 ~~i~~~g~~~k~~g~~--~k~r~~~lt~~-p~l~y~d~~~~~~kg~i~~~~~~~~-~~---~~~~~~~~f~i~----~p~  464 (489)
                      ..++++|||.|+++..  ||+|||||++. -.+||.++.....+|.|||...... ..   .+.+....|.|.    ++.
T Consensus         6 ~~~~~~G~L~K~g~~~k~WkkRwfvL~~~~~L~yy~~~~~~~~~g~i~L~~~~~~~~~~~~~~~~~~~~F~I~~~~~~~~   85 (125)
T 1unq_A            6 VAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTV   85 (125)
T ss_dssp             GCEEEEEEEEEECSSSCCEEEEEEEEETTSEEEEESSCCCSHHHHTSCSEEEECTTCEEEEECSSSTTEEEEEEEETTEE
T ss_pred             CCeeEEeeEEeccCCccCccCcEEEEecCCEEEEEeCCCCCCCCceeEccceeEEeeeecccccCCCCEEEEEecCCCCc
Confidence            4589999999998755  99999999965 4557777777788999999875221 11   222556799998    568


Q ss_pred             ceEEEE-cCCccHHHHHHHHHHhc
Q 011287          465 KVLSFE-DAKQRASQWKKAIEALQ  487 (489)
Q Consensus       465 r~y~~~-d~~~~~~~W~~~i~~~~  487 (489)
                      |+|+|. +.+.++++|+++|+.++
T Consensus        86 ~~~~~~a~s~~e~~~Wi~al~~~~  109 (125)
T 1unq_A           86 IERTFHVETPEEREEWTTAIQTVA  109 (125)
T ss_dssp             EEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             eeEEEEeCCHHHHHHHHHHHHHHH
Confidence            999999 45589999999999875

>1wgq_A FYVE, rhogef and PH domain containing 6; ethanol decreased 4; pleckstrin homoloy domain, signal transduction, structural genomics; NMR {Mus musculus} SCOP: b.55.1.1

Probab=99.35  E-value=4.2e-13  Score=111.87  Aligned_cols=89  Identities=13%  Similarity=0.172  Sum_probs=71.8

Q ss_pred             ceEEEEEeeehhhhhh--ccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEE----cCCCcEEEEcCC-ceEE
Q 011287          396 ESVLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV----SSPSHFKIVTPK-KVLS  468 (489)
Q Consensus       396 ~~i~~~g~~~k~~g~~--~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~----~~~~~f~i~~p~-r~y~  468 (489)
                      +.++++|||.|+++..  ||+|||||++.-..||.++.....+|.|+|+..   ..+..    +.+..|.|.|++ |+|+
T Consensus         6 ~~~~~~G~L~K~~~~~~~Wk~RwfvL~~~~L~yyk~~~~~~~~~~i~L~~~---~~~~~~~~~~~~~~F~i~~~~~~~~~   82 (109)
T 1wgq_A            6 SGSTMSGYLYRSKGSKKPWKHLWFVIKNKVLYTYAASEDVAALESQPLLGF---TVTLVKDENSESKVFQLLHKGMVFYV   82 (109)
T ss_dssp             CSCSCEEEEEEESSTTSCCEEEEEEEETTEEEEESCTTCSSCSEEEECSSE---EEEECCCSSCSSSEEEEEETTEEEEE
T ss_pred             CCCeEEEEEEeCCCCCCCceeEEEEEeCCEEEEECCCCcCccCceEECCCC---EEEECCCCCCCCcEEEEEeCCCeEEE
Confidence            3467899999998754  999999999877778888887889999999985   22222    124689999874 8899


Q ss_pred             EE-cCCccHHHHHHHHHHhc
Q 011287          469 FE-DAKQRASQWKKAIEALQ  487 (489)
Q Consensus       469 ~~-d~~~~~~~W~~~i~~~~  487 (489)
                      |. +.+.++++|+++|+.+.
T Consensus        83 ~~a~s~~e~~~Wi~al~~a~  102 (109)
T 1wgq_A           83 FKADDAHSTQRWIDAFQEGT  102 (109)
T ss_dssp             EECSSHHHHHHHHHHHHHHH
T ss_pred             EECCCHHHHHHHHHHHHHHh
Confidence            99 55689999999999875

>2da0_A 130-kDa phosphatidylinositol 4,5-biphosphate- dependent ARF1 GTPase-activating protein...; PH domain, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=99.34  E-value=7.6e-13  Score=111.38  Aligned_cols=88  Identities=9%  Similarity=0.108  Sum_probs=68.1

Q ss_pred             eEEEEEeeehhhh-h--hccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEEcCCCcEEEEcCCceEEEEc-C
Q 011287          397 SVLMISMVKKLQK-L--TSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFED-A  472 (489)
Q Consensus       397 ~i~~~g~~~k~~g-~--~~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~~~~~f~i~~p~r~y~~~d-~  472 (489)
                      .++++|||.|+++ +  .||+|||||++.-..||.++..... |.|++..+  .+.+....+..|.|.||+|+|+|.. .
T Consensus         9 ~~~~~G~L~K~~~~~~k~WkkR~fvL~~~~L~yyk~~~~~~~-~~i~l~~~--~v~~~~~~~~~F~I~~~~r~~~l~a~s   85 (114)
T 2da0_A            9 GSEKKGYLLKKSDGIRKVWQRRKCSVKNGILTISHATSNRQP-AKLNLLTC--QVKPNAEDKKSFDLISHNRTYHFQAED   85 (114)
T ss_dssp             CSCEEEEEEEECSSSCCCEEEEEEEEETTEEEECCSSCCSCC-EEEETTTS--EEEECSSSSSCEEEEETTEEEEEECSS
T ss_pred             CccEEEEEEEeCCCCCCCceeEEEEEeCCEEEEEcCCCCCCC-CEEEeeee--EEEECCCCCCEEEEEcCCcEEEEEcCC
Confidence            3689999999987 3  4999999998877777777665444 55555433  2444445567999999999999994 5


Q ss_pred             CccHHHHHHHHHHhc
Q 011287          473 KQRASQWKKAIEALQ  487 (489)
Q Consensus       473 ~~~~~~W~~~i~~~~  487 (489)
                      +.++++|+++|+.++
T Consensus        86 ~~e~~~Wi~al~~~~  100 (114)
T 2da0_A           86 EQDYVAWISVLTNSK  100 (114)
T ss_dssp             HHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHH
Confidence            589999999999875

>2d9y_A Pleckstrin homology domain-containing protein family A member 6; PH domain, PEPP-3, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=99.33  E-value=2.5e-12  Score=108.24  Aligned_cols=91  Identities=15%  Similarity=0.181  Sum_probs=73.1

Q ss_pred             CCceEEEEEeeehhhh-hh--ccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEE-------cCCCcEEEEc-
Q 011287          394 PGESVLMISMVKKLQK-LT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV-------SSPSHFKIVT-  462 (489)
Q Consensus       394 ~~~~i~~~g~~~k~~g-~~--~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~-------~~~~~f~i~~-  462 (489)
                      +++.|+++|||.|+++ ..  ||+|||+|++.-..||.++.....+|.|+|...    .+..       ..+..|.|.+ 
T Consensus         7 p~~~~~~~G~L~K~~~~~~~~Wk~R~fvL~~~~L~yy~~~~~~~~~g~i~L~~~----~v~~~~~~~~~~~~~~F~i~~~   82 (117)
T 2d9y_A            7 GNAPVTKAGWLFKQASSGVKQWNKRWFVLVDRCLFYYKDEKEESILGSIPLLSF----RVAAVQPSDNISRKHTFKAEHA   82 (117)
T ss_dssp             SSCCCCEEEEEEEECTTSSSCEEEEEEEEETTEEEEESSTTCCSCCEEEECSSC----EEEECCTTTTCCCSSEEEEECS
T ss_pred             CCCCeeEEEEEEEeCCCCCCCceEEEEEECCCEEEEECCCCCCCcCCEEEeCCe----EEEEcCccccCCCccEEEEEcC
Confidence            3556899999999974 33  999999999887778888888899999999985    2322       2245899975 


Q ss_pred             CCceEEEE-cCCccHHHHHHHHHHhcC
Q 011287          463 PKKVLSFE-DAKQRASQWKKAIEALQN  488 (489)
Q Consensus       463 p~r~y~~~-d~~~~~~~W~~~i~~~~~  488 (489)
                      ++|+|+|. +.+.++++|+++|+.++.
T Consensus        83 ~~r~~~l~a~s~~e~~~Wi~al~~~~~  109 (117)
T 2d9y_A           83 GVRTYFFSAESPEEQEAWIQAMGEAAR  109 (117)
T ss_dssp             SSCEEEEECSSHHHHHHHHHHHHHTTC
T ss_pred             CCcEEEEEcCCHHHHHHHHHHHHHHHh
Confidence            56999999 456899999999999763

>2yry_A Pleckstrin homology domain-containing family A member 6; PH domain, PEPP-3, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=99.32  E-value=3.8e-12  Score=108.04  Aligned_cols=94  Identities=17%  Similarity=0.199  Sum_probs=73.8

Q ss_pred             CCceEEEEEeeehhhh-hh--ccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEE----cCCCcEEEEcC-Cc
Q 011287          394 PGESVLMISMVKKLQK-LT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV----SSPSHFKIVTP-KK  465 (489)
Q Consensus       394 ~~~~i~~~g~~~k~~g-~~--~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~----~~~~~f~i~~p-~r  465 (489)
                      ++..++++|||.|+++ ..  ||+|||+|++.-..||.++.....+|.|+|..... ..+..    ..+..|.|.++ +|
T Consensus        18 ~~~~~~~~G~L~K~~~~~~~~Wk~R~fvL~~~~L~yy~~~~~~~~~g~i~L~~~~v-~~~~~~~~~~~~~~F~i~~~~~r   96 (122)
T 2yry_A           18 PNAPVTKAGWLFKQASSGVKQWNKRWFVLVDRCLFYYKDEKEESILGSIPLLSFRV-AAVQPSDNISRKHTFKAEHAGVR   96 (122)
T ss_dssp             TTCCEEEEEEEEEECCSSSCCEEEEEEEEETTEEEEESSTTCCSCCEEEESTTCCC-EECCTTCSCSSSSEEEEECSSSC
T ss_pred             CCCCccEEEEEEEECCCCCCCcEEEEEEEeCCEEEEECCCCCCCcccEEEcCCCEE-EEcCccccCCcccEEEEecCCCc
Confidence            4567999999999874 33  99999999987777887888889999999998631 12211    23469999765 79


Q ss_pred             eEEEEc-CCccHHHHHHHHHHhcC
Q 011287          466 VLSFED-AKQRASQWKKAIEALQN  488 (489)
Q Consensus       466 ~y~~~d-~~~~~~~W~~~i~~~~~  488 (489)
                      +|+|.. .+.++++|+++|+.+.+
T Consensus        97 ~~~l~a~s~~e~~~Wi~al~~a~~  120 (122)
T 2yry_A           97 TYFFSAESPEEQEAWIQAMGEAAR  120 (122)
T ss_dssp             EEEEECSSHHHHHHHHHHHHHHHC
T ss_pred             EEEEEcCCHHHHHHHHHHHHHHHh
Confidence            999995 55899999999999764

>1u5e_A SRC-associated adaptor protein; novel dimerization domain, PH domain, signaling protein; 2.60A {Mus musculus} SCOP: b.55.1.1 PDB: 2otx_A

Probab=99.31  E-value=2.9e-12  Score=119.84  Aligned_cols=89  Identities=16%  Similarity=0.203  Sum_probs=73.7

Q ss_pred             eEEEEEeeehhhhh------hccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEE-------cCCCcEEEEcC
Q 011287          397 SVLMISMVKKLQKL------TSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV-------SSPSHFKIVTP  463 (489)
Q Consensus       397 ~i~~~g~~~k~~g~------~~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~-------~~~~~f~i~~p  463 (489)
                      .++++|||.|+++.      .||+|||||++....||.++.....+|.|+|...   ..+..       +....|.|.||
T Consensus       105 ~v~k~G~L~Kkg~~~~~~~k~WkkRwfVL~~~~L~Yyk~~~~~~p~g~I~L~~~---~~v~~~~~~~~~~k~~~F~I~t~  181 (211)
T 1u5e_A          105 FVIKAGYLEKRRKDHSFLGFEWQKRWCALSKTVFYYYGSDKDKQQKGEFAIDGY---DVRMNNTLRKDGKKDCCFEICAP  181 (211)
T ss_dssp             SEEEEEEEEEEEHHHHTTTCCCEEEEEEEETTEEEEESSTTCSSCSEEEECTTC---EEEECGGGCSSTTGGGEEEEECS
T ss_pred             CccEEEEEEEECCCCCcCCCCcEeEEEEEECCEEEEEcCCCCccceEEEEeCCc---EEEEcCCccccCCCCCEEEEEcC
Confidence            48999999999863      4999999999988888888888889999999986   33332       22468999998


Q ss_pred             C-ceEEEEc-CCccHHHHHHHHHHhcC
Q 011287          464 K-KVLSFED-AKQRASQWKKAIEALQN  488 (489)
Q Consensus       464 ~-r~y~~~d-~~~~~~~W~~~i~~~~~  488 (489)
                      + |+|+|.. .+.++++|+++|+.+++
T Consensus       182 ~~r~~~l~A~s~~e~~~Wi~aL~~ai~  208 (211)
T 1u5e_A          182 DKRIYQFTAASPKDAEEWVQQLKFILQ  208 (211)
T ss_dssp             SSCEEEEECSSHHHHHHHHHHHHHHHH
T ss_pred             CCCEEEEEcCCHHHHHHHHHHHHHHHH
Confidence            6 9999995 55899999999999863

>2j59_M RHO-GTPase activating protein 10; ARF, ARF1, ARFBD, arhgap21, myristate, transport, nucleotide-binding, rhogap protein, hydrolase; HET: GTP; 2.1A {Homo sapiens} SCOP: b.55.1.1 PDB: 2dhj_A

Probab=99.28  E-value=3.7e-12  Score=114.79  Aligned_cols=91  Identities=15%  Similarity=0.196  Sum_probs=62.6

Q ss_pred             EEEEEeee----------hhhhhh--ccceeEEEecCCeEEEECCCC--CeeeeeeeccCCCCceEEEE---cCCCcEEE
Q 011287          398 VLMISMVK----------KLQKLT--SKKVQLILTNKPKLIYVDPSK--LVVKGNIIWSDNSNDLSIQV---SSPSHFKI  460 (489)
Q Consensus       398 i~~~g~~~----------k~~g~~--~k~r~~~lt~~p~l~y~d~~~--~~~kg~i~~~~~~~~~~~~~---~~~~~f~i  460 (489)
                      ++++|||.          |+++..  ||+|||||++.-..||.++..  ...+|.|+++.....+.+..   +..+.|.|
T Consensus         3 v~~eG~L~~k~~~~~~gkK~g~~~k~WkkRwfvL~~~~L~yyk~~~~~~~~~~g~i~l~~~~~~~~~~~~~~~~~~~F~I   82 (168)
T 2j59_M            3 AAKEGWLHFRPLVTDKGKRVGGSIRPWKQMYVVLRGHSLYLYKDKREQTTPSEEEQPISVNACLIDISYSETKRKNVFRL   82 (168)
T ss_dssp             CCEEEEEEEEECC------------CCEEEEEEEETTEEEEESCTTCC--------CEECSSCEEEECSSSCSCSSEEEE
T ss_pred             CcEEEEEeeeeecccCCcccCCCCCCceEEEEEEeCCEEEEEECCcccccccCCceEecccceEEEeccccCCCCCEEEE
Confidence            57899999          554444  999999999987778888743  57889999998533333332   34679999


Q ss_pred             EcCCceEEEEc-CCccHHHHHHHHHHhcC
Q 011287          461 VTPKKVLSFED-AKQRASQWKKAIEALQN  488 (489)
Q Consensus       461 ~~p~r~y~~~d-~~~~~~~W~~~i~~~~~  488 (489)
                      .|++|+|+|.. .+.++++|+++|+.++.
T Consensus        83 ~t~~r~~~l~A~s~~e~~~Wi~ai~~~~~  111 (168)
T 2j59_M           83 TTSDCECLFQAEDRDDMLAWIKTIQESSN  111 (168)
T ss_dssp             ECSSCEEEEECSSHHHHHHHHHHHHHHCC
T ss_pred             EeCCceEEEEcCCHHHHHHHHHHHHHHHh
Confidence            99999999994 55899999999998763

>3tfm_A Myosin X; split PH domain, motor protein; 2.53A {Rattus norvegicus}

Probab=99.27  E-value=6.4e-12  Score=119.02  Aligned_cols=93  Identities=13%  Similarity=0.215  Sum_probs=76.1

Q ss_pred             CceEEEEEeeehhhh-------hhccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEEcCCCcEEEEcCCceE
Q 011287          395 GESVLMISMVKKLQK-------LTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVL  467 (489)
Q Consensus       395 ~~~i~~~g~~~k~~g-------~~~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~~~~~f~i~~p~r~y  467 (489)
                      ...++++|||.|+++       ..||+|||||+++-..||.++.....+|.|+|+.+.. +.........|.|.|++|+|
T Consensus        55 ~~~~~k~G~L~K~g~~~~~~~~k~WkkRwfvL~~~~L~Yyk~~~~~~~~g~I~L~~~~~-v~~~~~k~~~F~I~t~~r~~  133 (228)
T 3tfm_A           55 KQEALKQGWLHNNGGGSSTLSRRNWKKRWFVLRQSKLMYFENDSEEKLKGTVEVRSAKE-IIDNTNKENGIDIIMADRTF  133 (228)
T ss_dssp             CCCSSEEEEEEECGGGCSSSCGGGCEEEEEEECSSEEEEESSTTCCSEEEEEEGGGCSE-EEEETTTTSEEEEECSSCEE
T ss_pred             CCCcceEEEEEEECCCcCCcccCCceEEEEEEeCCEEEEEeCCCCcceeEEEEcCCCEE-eccCCCCCcEEEEEcCCcEE
Confidence            444789999999987       4499999999998777888888789999999998722 22222445789999999999


Q ss_pred             EEE-cCCccHHHHHHHHHHhcC
Q 011287          468 SFE-DAKQRASQWKKAIEALQN  488 (489)
Q Consensus       468 ~~~-d~~~~~~~W~~~i~~~~~  488 (489)
                      +|. +.+.++++|+++|++++.
T Consensus       134 ~l~A~s~~e~~~Wv~aL~~~i~  155 (228)
T 3tfm_A          134 HLIAESPEDASQWFSVLSQVHS  155 (228)
T ss_dssp             EEECSSHHHHHHHHHHHHHHHT
T ss_pred             EEEcCCHHHHHHHHHHHHHHHh
Confidence            999 555899999999999864

>2w2x_D 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2; hydrolase, phospholipase C, phosphoinositides, RHO gtpases, RAC, SH2 domain; HET: GSP; 2.30A {Homo sapiens} PDB: 2w2w_A* 2w2x_C* 2k2j_A

Probab=99.27  E-value=5.6e-13  Score=114.06  Aligned_cols=87  Identities=8%  Similarity=0.087  Sum_probs=66.5

Q ss_pred             eEEEEEeeehhhhhh--ccceeEEEecCCeEEEECCCC---------CeeeeeeeccCCCCceEEEE------cCCCcEE
Q 011287          397 SVLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSK---------LVVKGNIIWSDNSNDLSIQV------SSPSHFK  459 (489)
Q Consensus       397 ~i~~~g~~~k~~g~~--~k~r~~~lt~~p~l~y~d~~~---------~~~kg~i~~~~~~~~~~~~~------~~~~~f~  459 (489)
                      .++++|||.|+++..  ||+|||||++.-..||.++..         ...+|.|+|+.+    .++.      +.+..|.
T Consensus        11 ~~~k~G~L~K~g~~~k~Wk~RwfVL~~~~L~yyk~~~~~~~e~~plg~~~~G~I~L~~~----~v~~~~~~~~~k~~~F~   86 (124)
T 2w2x_D           11 EHKQQGELYMWDSIDQKWTRHFCAIADAKLSFSDDIEQTMEEDNPLGSLCRGILDLNTY----NVVKAPQGKNQKSFVFI   86 (124)
T ss_dssp             --CCEEEEEEEETTTTEEEEEEEEEETTEEEEEEEHHHHHHCSSCCCCSCSEEEEGGGE----EEEECTTCBTTBSEEEE
T ss_pred             hcceeEEEEEECCCCCCceEeEEEEECCEEEEEcccccccccccccCCccccEEECCCC----EEEEccCCcCCCCEEEE
Confidence            368999999998755  999999999887667776421         345899999985    3332      2345899


Q ss_pred             EEcC---CceEEEE-cCCccHHHHHHHHHHhc
Q 011287          460 IVTP---KKVLSFE-DAKQRASQWKKAIEALQ  487 (489)
Q Consensus       460 i~~p---~r~y~~~-d~~~~~~~W~~~i~~~~  487 (489)
                      |.++   .|+|+|. |...++++|+++|.++.
T Consensus        87 I~~~~~~~~~~~~~A~s~ee~~~Wi~ai~~a~  118 (124)
T 2w2x_D           87 LEPKQQGDPPVEFATDKVEELFEWFQSIREIT  118 (124)
T ss_dssp             EEECC--CCCEEEEECCCHHHHHHHHHHHHHH
T ss_pred             EECCCCCCceEEEEECCHHHHHHHHHHHHHHH
Confidence            9876   4899988 56689999999999875

>2cof_A Protein KIAA1914; PH domain, structural genomics, riken structural genomics/proteomics initiative, RSGI, NPPSFA; NMR {Homo sapiens} SCOP: b.55.1.1

Probab=99.26  E-value=3.5e-12  Score=105.96  Aligned_cols=90  Identities=11%  Similarity=0.097  Sum_probs=68.4

Q ss_pred             eEEEEEeeehhhhhhccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEE--cCCCcEEEEcC-CceEEEE-cC
Q 011287          397 SVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV--SSPSHFKIVTP-KKVLSFE-DA  472 (489)
Q Consensus       397 ~i~~~g~~~k~~g~~~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~--~~~~~f~i~~p-~r~y~~~-d~  472 (489)
                      .++++|||.|+..-.||+|||+|++.-..||.++.. ..+|.|+++..+..+.+..  +.+..|.|.|+ .|+|+|. +.
T Consensus         7 ~~~~~G~L~K~~~k~Wk~RwfvL~~~~L~yyk~~~~-~~~~~~~i~l~~~~v~~~~~~~~~~~F~i~~~~~r~~~l~A~s   85 (107)
T 2cof_A            7 GLETSSYLNVLVNSQWKSRWCSVRDNHLHFYQDRNR-SKVAQQPLSLVGCEVVPDPSPDHLYSFRILHKGEELAKLEAKS   85 (107)
T ss_dssp             CCTTCCEEEEEETTEEEEEEEEECSSCEEEECSSTT-CSEEEEEECTTTCEEECCCBTTBSCEEEEEETTEEEEEEECSS
T ss_pred             CCcEeEEEEEecCCCcceEEEEEECCEEEEEeCCcc-cCCCeeEEeccceEEEECCCCCCCeEEEEEeCCCeEEEEEcCC
Confidence            467899999993344999999999996667777754 5667777776543232222  34579999999 8999999 55


Q ss_pred             CccHHHHHHHHHHhc
Q 011287          473 KQRASQWKKAIEALQ  487 (489)
Q Consensus       473 ~~~~~~W~~~i~~~~  487 (489)
                      +.++++|+++|+.+.
T Consensus        86 ~~e~~~Wi~al~~~~  100 (107)
T 2cof_A           86 SEEMGHWLGLLLSES  100 (107)
T ss_dssp             HHHHHHHHHHHHHHS
T ss_pred             HHHHHHHHHHHHHHH
Confidence            689999999999875

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.24  E-value=1.5e-11  Score=117.48  Aligned_cols=135  Identities=16%  Similarity=0.176  Sum_probs=100.4

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--ccEEEEEEEcCCEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG--VVRLFFTFQDTFSLY  121 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~~~~~~~ly  121 (489)
                      ..+|.+..+.+.|+.+.||++.. .+|..+++|+....      ....+..|..+++.+.+.+  +.+++.+..+....|
T Consensus        19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~   91 (264)
T 1nd4_A           19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW   91 (264)
T ss_dssp             TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred             cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCE
Confidence            45677766555677799999964 56788999997543      1134667888888885434  456888888888899


Q ss_pred             EEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 011287          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG------------------------------------  165 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~g------------------------------------  165 (489)
                      +||||++|.+|.  ..   ..+   ...++.+++.+|..||+..                                    
T Consensus        92 ~v~e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (264)
T 1nd4_A           92 LLLGEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ  163 (264)
T ss_dssp             EEEECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred             EEEEecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence            999999998883  11   122   2356677777888888653                                    


Q ss_pred             ----------------------cEeeccCCCCeeeCCCCCEEEeeccCcc
Q 011287          166 ----------------------LIHRDIKPENLLLTADGHIKIADFGSVK  193 (489)
Q Consensus       166 ----------------------IiHrDLKpeNILl~~~g~ikL~DFG~a~  193 (489)
                                            ++|+|++|.|||+++++.+.|+|||.+.
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                  9999999999999876666799999875

>2p0d_A RHO GTPase-activating protein 9; protein-phosphoinositide complex, pleckstrin homology domain, ligand binding protein; HET: I3P; 1.81A {Homo sapiens} PDB: 2p0f_A 2p0h_A*

Probab=99.24  E-value=2.1e-11  Score=104.95  Aligned_cols=90  Identities=13%  Similarity=0.181  Sum_probs=69.9

Q ss_pred             ceEEEEEeeehh----hh----hhccceeEEEecCCeEEEECCC-----------CCeeeeeeeccCCCCceEEE---Ec
Q 011287          396 ESVLMISMVKKL----QK----LTSKKVQLILTNKPKLIYVDPS-----------KLVVKGNIIWSDNSNDLSIQ---VS  453 (489)
Q Consensus       396 ~~i~~~g~~~k~----~g----~~~k~r~~~lt~~p~l~y~d~~-----------~~~~kg~i~~~~~~~~~~~~---~~  453 (489)
                      ..++++|+|.|+    +|    -.||+|||||++...+||.|+.           .....|.|+|..+.  +...   .+
T Consensus        10 ~~~~k~G~L~kk~~~~~G~~~~k~Wk~rwfvL~~~~L~yykd~~~~~~~~~~~~~~~~p~g~I~L~~~~--v~~~~~~~k   87 (129)
T 2p0d_A           10 HEVEKSGLLNMTKIAQGGRKLRKNWGPSWVVLTGNSLVFYREPPPTAPSSGWGPAGSRPESSVDLRGAA--LAHGRHLSS   87 (129)
T ss_dssp             CSEEEEEEEEEEEEEETTEECCCCCEEEEEEEESSEEEEESCC--------------CCSEEEECTTCE--EEECTTSCS
T ss_pred             cceeEEEEEEEeeeccCCCcCCCCceEEEEEEeCCEEEEEcCcccccccccccccCCCCccEEEeCCcE--EEECCCCCC
Confidence            358899999985    45    2499999999999999999983           45788999999762  1111   13


Q ss_pred             CCCcEEEEcCC-ceEEEE-cCCccHHHHHHHHHHhc
Q 011287          454 SPSHFKIVTPK-KVLSFE-DAKQRASQWKKAIEALQ  487 (489)
Q Consensus       454 ~~~~f~i~~p~-r~y~~~-d~~~~~~~W~~~i~~~~  487 (489)
                      .++.|.|.|++ |+|+|. +.+.++++|+++|+.++
T Consensus        88 r~~~F~l~t~~~~~yl~qA~s~~e~~~Wi~aI~~~i  123 (129)
T 2p0d_A           88 RRNVLHIRTIPGHEFLLQSDHETELRAWHRALRTVI  123 (129)
T ss_dssp             SSSEEEEECTTSCEEEEECSCHHHHHHHHHHHHHHH
T ss_pred             CCcEEEEEcCCCCEEEEECCCHHHHHHHHHHHHHHH
Confidence            35799999985 889998 56689999999999876

>2y7b_A Actin-binding protein anillin; cell cycle; 1.90A {Homo sapiens}

Probab=99.23  E-value=3.3e-12  Score=110.35  Aligned_cols=93  Identities=13%  Similarity=0.185  Sum_probs=69.8

Q ss_pred             CceEEEEEeeehh--hhhh--ccceeEEEecCCeEEEECC---CCCeeeeeeeccCCCC-ceEEEE----cCCCcEEEEc
Q 011287          395 GESVLMISMVKKL--QKLT--SKKVQLILTNKPKLIYVDP---SKLVVKGNIIWSDNSN-DLSIQV----SSPSHFKIVT  462 (489)
Q Consensus       395 ~~~i~~~g~~~k~--~g~~--~k~r~~~lt~~p~l~y~d~---~~~~~kg~i~~~~~~~-~~~~~~----~~~~~f~i~~  462 (489)
                      +..|+++|||.|+  ++..  ||+|||||++.-..||.++   .....+|.|+|..+.. .+....    +.++.|.|.|
T Consensus         2 ~~~v~~~G~L~K~~~~~~~~~WkrRwfvL~~~~L~yyk~~~d~~~~~p~g~I~L~~~~~~~v~~~~~~~~~~~~~F~i~~   81 (134)
T 2y7b_A            2 NSSVEERGFLTIFEDVSGFGAWHRRWCVLSGNCISYWTYPDDEKRKNPIGRINLANCTSRQIEPANREFCARRNTFELIT   81 (134)
T ss_dssp             CCCCCEEEEEEEEEEETTEEEEEEEEEEEETTEEEEESSHHHHTTSCCSEEEEGGGBCSSSCEECCTTTCCCTTEEEEEE
T ss_pred             CCCceEEeeEEEEcCCCCCCCcEEEEEEEECCEEEEECCCCcccccCceEEEEhhhCccccccccchhhccCCCEEEEEe
Confidence            3457899999998  5544  9999999999855566643   3378899999998632 122221    3467999987


Q ss_pred             --CC------------------ceEEEE-cCCccHHHHHHHHHHhc
Q 011287          463 --PK------------------KVLSFE-DAKQRASQWKKAIEALQ  487 (489)
Q Consensus       463 --p~------------------r~y~~~-d~~~~~~~W~~~i~~~~  487 (489)
                        |+                  |+|+|. +.+.++++|+++|+.++
T Consensus        82 ~~p~~~~~~~~~~~~~~~~~~~r~~~l~A~s~~e~~~Wi~al~~~i  127 (134)
T 2y7b_A           82 VRPQREDDRETLVSQCRDTLCVTKNWLSADTKEERDLWMQKLNQVL  127 (134)
T ss_dssp             EEECCTTCCCCSSEEEETTEEEEEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             cCCCcccccccccccccCCCceEEEEEECCCHHHHHHHHHHHHHHH
Confidence              55                  589999 55689999999999875

>3lju_X ARF-GAP with dual PH domain-containing protein 1; structural genomics consortium, GTPase activation, SGC, binding, nucleus, phosphoprotein; HET: IP9; 1.70A {Homo sapiens} PDB: 3feh_A* 3fm8_C 3mdb_C*

Probab=99.22  E-value=9e-12  Score=126.98  Aligned_cols=91  Identities=15%  Similarity=0.333  Sum_probs=75.0

Q ss_pred             eEEEEEeeehhhhhh---ccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEE------cC---CCcEEEEcCC
Q 011287          397 SVLMISMVKKLQKLT---SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV------SS---PSHFKIVTPK  464 (489)
Q Consensus       397 ~i~~~g~~~k~~g~~---~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~------~~---~~~f~i~~p~  464 (489)
                      .++++|||.|+++.+   ||+|||||++.-..||.++.....+|.|+|........+..      +.   ...|.|+||+
T Consensus       268 ~~~k~G~L~K~g~~~~k~WKkRwFVL~~~~L~YYk~~~d~~~~G~I~L~~~~~~~~v~~~~~~~~~~~~~~~~F~I~t~~  347 (386)
T 3lju_X          268 NYLKEGYMEKTGPKQTEGFRKRWFTMDDRRLMYFKDPLDAFARGEVFIGSKESGYTVLHGFPPSTQGHHWPHGITIVTPD  347 (386)
T ss_dssp             CCSEEEEEEECCTTSCSCCEEEEEEEETTEEEEESSTTCSBCSEEEECCCGGGTCEEEESCCTTCCSCCSCEEEEEECSS
T ss_pred             ccceeeeEEEECCCCCCCCcccEEEEECCEEEEEecCCCcccceEEEeecceeeeeecccCCccccccCCCcEEEEEeCC
Confidence            478999999998765   99999999988888999988888999999987643333332      11   3569999999


Q ss_pred             ceEEEE-cCCccHHHHHHHHHHhc
Q 011287          465 KVLSFE-DAKQRASQWKKAIEALQ  487 (489)
Q Consensus       465 r~y~~~-d~~~~~~~W~~~i~~~~  487 (489)
                      |||+|. +.+.++++|+++|+.++
T Consensus       348 rty~l~A~s~~e~~~Wi~aL~~~i  371 (386)
T 3lju_X          348 RKFLFACETESDQREWVAAFQKAV  371 (386)
T ss_dssp             CEEEEEESSHHHHHHHHHHHHHHH
T ss_pred             eEEEEEcCCHHHHHHHHHHHHHHH
Confidence            999999 55589999999999987

>1qqg_A IRS-1, insulin receptor substrate 1; beta-sandwhich, signal transduction; 2.30A {Homo sapiens} SCOP: b.55.1.2 b.55.1.2 PDB: 1irs_A*

Probab=99.20  E-value=1.3e-11  Score=119.21  Aligned_cols=89  Identities=18%  Similarity=0.257  Sum_probs=70.0

Q ss_pred             CceEEEEEeeehhhhhhccceeEEEecCC------eEEEECCC-C-----CeeeeeeeccCCCCceEEEE----cCCCcE
Q 011287          395 GESVLMISMVKKLQKLTSKKVQLILTNKP------KLIYVDPS-K-----LVVKGNIIWSDNSNDLSIQV----SSPSHF  458 (489)
Q Consensus       395 ~~~i~~~g~~~k~~g~~~k~r~~~lt~~p------~l~y~d~~-~-----~~~kg~i~~~~~~~~~~~~~----~~~~~f  458 (489)
                      .+.++++|||.|+  ..||||||||.+..      +|+|++.. .     ...+|.|+|+.+   ..|..    +....|
T Consensus         7 ~~~v~k~G~L~K~--K~WkkRwFVL~~~~~~G~~~~L~YYk~~~~~~~~~~~p~g~I~L~~~---~~V~~~~~~~~~~~F   81 (264)
T 1qqg_A            7 FSDVRKVGYLRKP--KSMHKRFFVLRAASEAGGPARLEYYENEKKWRHKSSAPKRSIPLESC---FNINKRADSKNKHLV   81 (264)
T ss_dssp             --CEEEEEEEECT--TTCCEEEEEEECCBTTTBSSEEEEESSHHHHHTTCSCCSEEEEGGGE---EEEEEECCSSCSSEE
T ss_pred             CCCccEEEEEEEC--CCCEeEEEEEECCCCCCCCCEEEEECCCccccccccCcceEEEeece---EEEEeccCCCCCcEE
Confidence            3458999999999  57999999999872      77555543 3     479999999986   44432    345799


Q ss_pred             EEEcCCceEEEE-cCCccHHHHHHHHHHhcC
Q 011287          459 KIVTPKKVLSFE-DAKQRASQWKKAIEALQN  488 (489)
Q Consensus       459 ~i~~p~r~y~~~-d~~~~~~~W~~~i~~~~~  488 (489)
                      .|.|+.|+|+|. |.+.++++|+++|+.++.
T Consensus        82 ~I~t~~rty~l~A~se~e~~~Wi~aL~~~~~  112 (264)
T 1qqg_A           82 ALYTRDEHFAIAADSEAEQDSWYQALLQLHN  112 (264)
T ss_dssp             EEEESSCEEEEECSSHHHHHHHHHHHHHHC-
T ss_pred             EEEECCEEEEEEeCCHHHHHHHHHHHHHHHH
Confidence            999999999999 555899999999999763

>4a6h_A Phosphatidylinositol 4,5-bisphosphate-binding Pro SLM1; signaling protein; HET: I4C; 1.45A {Saccharomyces cerevisiae} PDB: 3nsu_A* 4a6f_A* 4a6k_A* 4a6f_B* 4a5k_A

Probab=99.19  E-value=2.5e-11  Score=102.97  Aligned_cols=91  Identities=14%  Similarity=0.179  Sum_probs=68.3

Q ss_pred             CCceEEEEEeeehhhhhh--ccceeEEEecCCeEEEECCC---CCeeeeeeeccCCCCceEEEEc-----------CCCc
Q 011287          394 PGESVLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPS---KLVVKGNIIWSDNSNDLSIQVS-----------SPSH  457 (489)
Q Consensus       394 ~~~~i~~~g~~~k~~g~~--~k~r~~~lt~~p~l~y~d~~---~~~~kg~i~~~~~~~~~~~~~~-----------~~~~  457 (489)
                      +.. ++++|||.|++++.  |++|||||++.-..||.+..   .....|.|+|..+  .+.....           ....
T Consensus         3 p~~-~~k~G~L~Kk~~~~k~W~~rwfVL~~~~L~yyK~~~~~~d~~P~gsI~L~~c--~v~~~~~~~~~~~~~~~~~~~~   79 (120)
T 4a6h_A            3 PFT-EIKSGFLERRSKFLKSYSKGYYVLTPNFLHEFKTADRKKDLVPVMSLALSEC--TVTEHSRKNSTSSPNSTGSDAK   79 (120)
T ss_dssp             CCC-CSEEEEEEEEETTTTEEEEEEEEECSSEEEEESSCCTTTCCSCSEEEEGGGE--EEEEECCCCC---------CCE
T ss_pred             CCc-ccEEEEEEEcCCCCCCCccEEEEEeCCEEEEEcCCCcCcCCCceEEEECCCC--EEEEcccccccccccccCCCcE
Confidence            344 79999999999866  99999999999555666654   4558899999764  2222111           3458


Q ss_pred             EEEEcCC-------ceEEEEc-CCccHHHHHHHHHHhc
Q 011287          458 FKIVTPK-------KVLSFED-AKQRASQWKKAIEALQ  487 (489)
Q Consensus       458 f~i~~p~-------r~y~~~d-~~~~~~~W~~~i~~~~  487 (489)
                      |.|.++.       ++|+|.. ...++++|+++|..+.
T Consensus        80 F~i~~~~~~~~~~~~~y~f~A~s~~e~~~Wv~aI~~~~  117 (120)
T 4a6h_A           80 FVLHAKQNGIIRRGHNWVFKADSYESMMSWFDNLKILT  117 (120)
T ss_dssp             EEEEESSSSSSCTTCEEEEECSSHHHHHHHHHHHHHHC
T ss_pred             EEEEeCCCCcccCceEEEEEcCCHHHHHHHHHHHHHHh
Confidence            9998654       6999995 5589999999999874

>3cxb_B Pleckstrin homology domain-containing family M member 2; SIFA, SKIP, complex, virulence, cytoplasm, membrane, polymorphism, signaling protein; 2.60A {Homo sapiens} PDB: 3hw2_B

Probab=99.17  E-value=2.6e-11  Score=101.68  Aligned_cols=89  Identities=11%  Similarity=0.183  Sum_probs=68.2

Q ss_pred             EEEeeehhhh------hhccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCc--eE-EEEcCCCcEEEEc-CCceEEE
Q 011287          400 MISMVKKLQK------LTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSND--LS-IQVSSPSHFKIVT-PKKVLSF  469 (489)
Q Consensus       400 ~~g~~~k~~g------~~~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~--~~-~~~~~~~~f~i~~-p~r~y~~  469 (489)
                      ++|||.|++|      -.||+|||||.+.-..||.|......+|.|++....+.  .. ...+.++.|.|.+ +.++|+|
T Consensus         2 keG~L~kK~g~~~~~~k~Wk~rwfvL~~~~L~~yk~~~~~~p~~~i~l~~~~~~~~~~~~~~~r~~~F~l~~~~~~~y~f   81 (112)
T 3cxb_B            2 KEGMLHYKAGTSYLGKEHWKTCFVVLSNGILYQYPDRTDVIPLLSVNMGGEQCGGCRRANTTDRPHAFQVILSDRPCLEL   81 (112)
T ss_dssp             EEEEEEECCSCCCSSCCCCEEEEEEEETTEEEEESSSSCCSCSEEEETTC-CEEEEEECCCSSCTTEEEEEETTSCCEEE
T ss_pred             ceEEEEEeCCCCCCCCCCceEEEEEEECCEEEEECCCCCCCccceEEecCCEEEeeeccCCCCCCeEEEEEcCCCCEEEE
Confidence            6899986654      23999999999988878888887888999999965221  00 1124468999985 5899999


Q ss_pred             E-cCCccHHHHHHHHHHhcC
Q 011287          470 E-DAKQRASQWKKAIEALQN  488 (489)
Q Consensus       470 ~-d~~~~~~~W~~~i~~~~~  488 (489)
                      . +.+.++++|+++|+.++.
T Consensus        82 ~A~s~ee~~~Wi~ai~~~~~  101 (112)
T 3cxb_B           82 SAESEAEMAEWMQHLCQAVS  101 (112)
T ss_dssp             ECSSHHHHHHHHHHHHHHHT
T ss_pred             EcCCHHHHHHHHHHHHHHhh
Confidence            9 456899999999998763

>2coc_A FYVE, rhogef and PH domain containing protein 3; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: b.55.1.1

Probab=99.15  E-value=2.8e-11  Score=101.24  Aligned_cols=86  Identities=13%  Similarity=0.124  Sum_probs=68.1

Q ss_pred             EEEEEeeehhhh-hhccceeEEEecC-C-eEE-EECCCCCeeeeeeeccCCCCceEEE-------EcCCCcEEEEcCCce
Q 011287          398 VLMISMVKKLQK-LTSKKVQLILTNK-P-KLI-YVDPSKLVVKGNIIWSDNSNDLSIQ-------VSSPSHFKIVTPKKV  466 (489)
Q Consensus       398 i~~~g~~~k~~g-~~~k~r~~~lt~~-p-~l~-y~d~~~~~~kg~i~~~~~~~~~~~~-------~~~~~~f~i~~p~r~  466 (489)
                      +++.|+|.|+++ --||||||||.+. | .|| |.++.....+|.|||...    .|.       ...+..|.|.+++|+
T Consensus         8 ~~~~G~L~k~~~~~~WkkrWfVL~~~~~~~Ly~Yk~~~d~~p~g~I~L~g~----~V~~~~~~~~~~~~~~Fki~~~~~~   83 (112)
T 2coc_A            8 SLLCGPLRLSESGETWSEVWAAIPMSDPQVLHLQGGSQDGRLPRTIPLPSC----KLSVPDPEERLDSGHVWKLQWAKQS   83 (112)
T ss_dssp             SSSEEEEEEESSSSCEEEEEEECCTTCTTCEEEECCTTCSSSCSEECGGGC----EEECCCSSSCCSSSEEEEEEETTEE
T ss_pred             ceEEEEEEecCCCCCceEEEEEEECCCccEEEEECCCCccCcceEEEcCCC----EEEecCcccccCCCCEEEEecCCeE
Confidence            345699988655 3399999999984 3 454 778888899999999975    333       123569999999999


Q ss_pred             EEEE-cCCccHHHHHHHHHHhc
Q 011287          467 LSFE-DAKQRASQWKKAIEALQ  487 (489)
Q Consensus       467 y~~~-d~~~~~~~W~~~i~~~~  487 (489)
                      |+|. |.+.++++|+++|+.+.
T Consensus        84 y~f~A~s~e~~~~Wl~al~~A~  105 (112)
T 2coc_A           84 WYLSASSAELQQQWLETLSTAA  105 (112)
T ss_dssp             EEEEESSHHHHHHHHHHHHHHH
T ss_pred             EEEEcCCHHHHHHHHHHHHHHh
Confidence            9999 56689999999999864

>1wjm_A Beta-spectrin III; PH domain, signal transduction, structural genomics, spectrin beta chain, brain 2, KIAA0302; NMR {Homo sapiens} SCOP: b.55.1.1

Probab=99.14  E-value=1.3e-11  Score=105.12  Aligned_cols=91  Identities=19%  Similarity=0.207  Sum_probs=67.5

Q ss_pred             eEEEEEeeehhhhh----------hccceeEEEecCCeEEEECCCCC----eeeeeeeccCCCCceEEE---EcCCCcEE
Q 011287          397 SVLMISMVKKLQKL----------TSKKVQLILTNKPKLIYVDPSKL----VVKGNIIWSDNSNDLSIQ---VSSPSHFK  459 (489)
Q Consensus       397 ~i~~~g~~~k~~g~----------~~k~r~~~lt~~p~l~y~d~~~~----~~kg~i~~~~~~~~~~~~---~~~~~~f~  459 (489)
                      .|.++|+|.|++..          .||+|||||.+.-..||.|+...    ..+|+++++.....+.+.   .+.++.|.
T Consensus         7 ~v~~eG~L~kk~~~~~~gk~~~~~~Wk~rwfvL~~~~L~yyk~~~~~~~~~~~~~~~~i~l~~~~~~~~~~~~~r~~~F~   86 (123)
T 1wjm_A            7 GEQMEGMLCRKQEMEAFGKKAANRSWQNVYCVLRRGSLGFYKDAKAASAGVPYHGEVPVSLARAQGSVAFDYRKRKHVFK   86 (123)
T ss_dssp             CCCEEEEEEEEEEEEETTEECSCCCCEEEEEEEETTEEEEESSHHHHTTTCBSSSCCCEECTTCEEEECTTCSSCSSEEE
T ss_pred             CeEEEEEEEEEEEEeCCCccCCCCCccEEEEEEECCEEEEEEcccccccCcccCCCceEEccCcEEeecccccCCCCEEE
Confidence            36799999988753          39999999999877777776432    346776666543223322   24467999


Q ss_pred             EEcCC-ceEEEE-cCCccHHHHHHHHHHhc
Q 011287          460 IVTPK-KVLSFE-DAKQRASQWKKAIEALQ  487 (489)
Q Consensus       460 i~~p~-r~y~~~-d~~~~~~~W~~~i~~~~  487 (489)
                      |.|++ |+|+|. +.+.++++|+++|+.++
T Consensus        87 i~~~~~~~~~f~A~s~~e~~~Wi~ai~~~~  116 (123)
T 1wjm_A           87 LGLQDGKEYLFQAKDEAEMSSWLRVVNAAI  116 (123)
T ss_dssp             EECSSSCEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             EEEcCCcEEEEECCCHHHHHHHHHHHHHHH
Confidence            99986 999999 45589999999999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.12  E-value=1.3e-10  Score=117.37  Aligned_cols=142  Identities=17%  Similarity=0.232  Sum_probs=107.2

Q ss_pred             eEEeeEEeeeCceEEEEEEEcCCCcEEEEEEee--cccccchhHHHHHHHHHHHHHhCC--CCCccEEEEEEEcC---CE
Q 011287           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMD--KKFITKENKTAYVKLERIVLDQLD--HPGVVRLFFTFQDT---FS  119 (489)
Q Consensus        47 y~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~--k~~~~~~~~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~---~~  119 (489)
                      ...++.|+.|.++.||++...  +..+++|+..  .....  .....+.+|..+++.|.  +..+.+++.++.+.   ..
T Consensus        40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~  115 (359)
T 3dxp_A           40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR  115 (359)
T ss_dssp             CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS
T ss_pred             CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC
Confidence            345778899999999999863  4688999775  32111  12346778999999886  45578888888776   45


Q ss_pred             EEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------
Q 011287          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS------------------------------------  163 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~------------------------------------  163 (489)
                      .|+||||++|..+.+..  ...++......++.+++.+|..||+                                    
T Consensus       116 ~~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (359)
T 3dxp_A          116 AFYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES  193 (359)
T ss_dssp             CEEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred             eEEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence            89999999998774421  1347888889999999999999997                                    


Q ss_pred             ----------------------CCcEeeccCCCCeeeCCCCC--EEEeeccCccc
Q 011287          164 ----------------------MGLIHRDIKPENLLLTADGH--IKIADFGSVKP  194 (489)
Q Consensus       164 ----------------------~gIiHrDLKpeNILl~~~g~--ikL~DFG~a~~  194 (489)
                                            .+++|+|++|.|||++.++.  +.|+||+.+..
T Consensus       194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                  36899999999999998764  68999998864

>2r09_A Cytohesin-3; autoinhibition, GRP1, PIP3, ARF, 3-phosphoinositide, pleckst homology domain, guanine-nucleotide releasing factor, signa protein; HET: 4IP PGE PE5; 1.90A {Mus musculus} SCOP: a.118.3.1 b.55.1.1 PDB: 2r0d_A*

Probab=99.10  E-value=4.4e-11  Score=120.33  Aligned_cols=88  Identities=19%  Similarity=0.207  Sum_probs=71.9

Q ss_pred             EEEEEeeehhhhhh--ccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEE--cCCCcEEEEcC----------
Q 011287          398 VLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV--SSPSHFKIVTP----------  463 (489)
Q Consensus       398 i~~~g~~~k~~g~~--~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~--~~~~~f~i~~p----------  463 (489)
                      ++++|||.|++|..  ||+|||||++.-..||.++.....+|.|+|..+.  +....  +.+..|.|.+|          
T Consensus       213 ~~k~G~L~K~g~~~k~WkkRwFVL~~~~L~Yyk~~~~~~p~G~I~L~~~~--v~~~~~~~~~~~F~I~~~~~~~~~~~~~  290 (347)
T 2r09_A          213 PDREGWLLKLGGRVKTWKRRWFILTDNCLYYFEYTTDKEPRGIIPLENLS--IREVEDPRKPNCFELYNPSHKGQVIKAC  290 (347)
T ss_dssp             CCEEEEEEEECSSSCCEEEEEEEEETTEEEEESSTTCSSCSEEEECTTCE--EEEECCSSCSSEEEEECSSSTTCCCCCE
T ss_pred             cccCCeeEecCCCcccceeEEEEEcCCEEEEEcCCCccCCcEEEEcCCeE--EEEccCCCCCCEEEEEeCCccccccccc
Confidence            57999999999865  9999999999877788888778899999999752  22211  34678999987          


Q ss_pred             ------------CceEEEEc-CCccHHHHHHHHHHhc
Q 011287          464 ------------KKVLSFED-AKQRASQWKKAIEALQ  487 (489)
Q Consensus       464 ------------~r~y~~~d-~~~~~~~W~~~i~~~~  487 (489)
                                  .|+|+|.. .+.++++|+++|+.++
T Consensus       291 k~~~~g~~v~~~~r~y~l~A~s~ee~~~Wi~aI~~ai  327 (347)
T 2r09_A          291 KTEADGRVVEGNHVVYRISAPSPEEKEEWMKSIKASI  327 (347)
T ss_dssp             EECTTSCEEECCCSCEEEECSSHHHHHHHHHHHHHHH
T ss_pred             cccccccccccCceEEEEECCCHHHHHHHHHHHHHHH
Confidence                        49999994 5589999999999876

>1btn_A Beta-spectrin; signal transduction protein; HET: I3P; 2.00A {Mus musculus} SCOP: b.55.1.1 PDB: 1mph_A

Probab=99.10  E-value=4.4e-11  Score=98.66  Aligned_cols=86  Identities=13%  Similarity=0.206  Sum_probs=60.4

Q ss_pred             EEeeehhh--------hhh--ccceeEEEecCCeEEEECCCC----CeeeeeeeccCCCCceEEEE---cCCCcEEEEcC
Q 011287          401 ISMVKKLQ--------KLT--SKKVQLILTNKPKLIYVDPSK----LVVKGNIIWSDNSNDLSIQV---SSPSHFKIVTP  463 (489)
Q Consensus       401 ~g~~~k~~--------g~~--~k~r~~~lt~~p~l~y~d~~~----~~~kg~i~~~~~~~~~~~~~---~~~~~f~i~~p  463 (489)
                      +|||.|++        +..  ||+|||||++.-..||.|+..    ...++.++++.....+.+..   +.++.|.|.|+
T Consensus         2 eG~L~kk~~~~~~gk~~~~~~Wk~rwfvL~~~~L~yyk~~~~~~~~~~~~~~~~i~l~~~~~~~~~~~~~~~~~F~i~~~   81 (106)
T 1btn_A            2 EGFLNRKHEWEAHNKKASSRSWHNVYCVINNQEMGFYKDAKSAASGIPYHSEVPVSLKEAICEVALDYKKKKHVFKLRLS   81 (106)
T ss_dssp             EEEEEEEEEECSTTCBCSCCCCEEEEEEEETTEEEEESSHHHHHHTCCSSSCCCEECTTCEEEECSSCCSSSSEEEEECT
T ss_pred             ccEEEEEEEEeCCCccCCCCChhEEEEEEECCEEEEEeCCcccccCCCCCCcceEECCCCEEEEcccccCCccEEEEEec
Confidence            68888887        433  999999999876667777642    33345555554322223221   34679999987


Q ss_pred             C-ceEEEEc-CCccHHHHHHHHHHh
Q 011287          464 K-KVLSFED-AKQRASQWKKAIEAL  486 (489)
Q Consensus       464 ~-r~y~~~d-~~~~~~~W~~~i~~~  486 (489)
                      + |+|+|.. .+.++++|+++|+.+
T Consensus        82 ~~~~~~~~A~s~~e~~~Wi~ai~~A  106 (106)
T 1btn_A           82 DGNEYLFQAKDDEEMNTWIQAISSA  106 (106)
T ss_dssp             TSCEEEEECSSHHHHHHHHHHHHHC
T ss_pred             CCCEEEEECCCHHHHHHHHHHHhcC
Confidence            5 9999995 558999999999863

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.05  E-value=1.7e-10  Score=113.65  Aligned_cols=192  Identities=16%  Similarity=0.217  Sum_probs=122.3

Q ss_pred             eEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCC--ccEEEEEEEcCC---EEEEEE
Q 011287           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPG--VVRLFFTFQDTF---SLYMAL  124 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpn--Iv~l~~~~~~~~---~lylV~  124 (489)
                      +.++.|....||++.     ..+++|+....     .....+.+|..+|+.+ .+..  +.+++....+..   ..|+||
T Consensus        26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm   95 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF   95 (304)
T ss_dssp             CEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred             EecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence            458999999999873     56899986422     3456688899999887 3332  344554443333   348999


Q ss_pred             eccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 011287          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS-----------------------------------------  163 (489)
Q Consensus       125 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~-----------------------------------------  163 (489)
                      ++++|.+|.....  ..++..+...++.+++..|..||+                                         
T Consensus        96 ~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           96 TKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             ECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             cccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9999988875433  247888888899999999999996                                         


Q ss_pred             -----------------CCcEeeccCCCCeeeCC--CCCEEEeeccCccccCCcc-ccccCCC---CCCCCccceecCCc
Q 011287          164 -----------------MGLIHRDIKPENLLLTA--DGHIKIADFGSVKPMQDSR-ITVLPNA---ASDDKACTFVGTAA  220 (489)
Q Consensus       164 -----------------~gIiHrDLKpeNILl~~--~g~ikL~DFG~a~~~~~~~-~~~~~~~---~~~~~~~~~~gt~~  220 (489)
                                       ..++|+|++|.||++++  ++.+.|+||+.+..-.... .......   ........+...-.
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence                             13699999999999998  4567899999986532110 0000000   00000000000001


Q ss_pred             CCC-hhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCC
Q 011287          221 YVP-PEVLNSSPATFGNDLWALGCTLYQMLSGTSPFK  256 (489)
Q Consensus       221 Y~a-PE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~  256 (489)
                      ... |+.....  ....+.|++|.++|.+.+|..+|.
T Consensus       254 ~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          254 HKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             CSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             CCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHHH
Confidence            112 2222111  112589999999999999987763

>3a8p_A T-lymphoma invasion and metastasis-inducing protein 2; guanine nucleotide exchange factor, alternative splicing, cell projection, coiled coil; 2.10A {Mus musculus} PDB: 3a8q_A

Probab=99.04  E-value=4.5e-10  Score=108.40  Aligned_cols=88  Identities=18%  Similarity=0.177  Sum_probs=68.4

Q ss_pred             ceEEEEEeee--------hhhhh----h--ccceeEEEecCCeEEEECC------CCCeeeeeeeccCCCCceEEEE---
Q 011287          396 ESVLMISMVK--------KLQKL----T--SKKVQLILTNKPKLIYVDP------SKLVVKGNIIWSDNSNDLSIQV---  452 (489)
Q Consensus       396 ~~i~~~g~~~--------k~~g~----~--~k~r~~~lt~~p~l~y~d~------~~~~~kg~i~~~~~~~~~~~~~---  452 (489)
                      ..++++|||.        |.++.    .  ||+|||||++.-..||.|+      .....+|.|+|..+    .+..   
T Consensus         9 ~~v~K~G~L~~k~~~~~~K~g~~~~~~~K~WkrRWfVL~~~~L~yyK~~~~~~~~~~~~p~g~I~L~~~----~v~~~~~   84 (263)
T 3a8p_A            9 GVVRKAGWLFFKPLVTLQKERKLELVARRKWKQYWVTLKGCTLLFYETYGKNSTEQNSAPRCALFAEDS----IVQSVPE   84 (263)
T ss_dssp             -CEEEEEEEEEEEEEEEEGGGEEEECTTCCCEEEEEEEETTEEEEESSCCC------CCCSEEEECTTC----EEEECTT
T ss_pred             CCeEEEEEeeecccccccCCCCccCccCCCceEEEEEEcCCEEEEEecCcccccccccCccceEEcCCc----EEEECCc
Confidence            3589999998        66666    3  9999999999877788774      34567899999854    2322   


Q ss_pred             --cCCCcEEEEc-CCceEEEE-cCCccHHHHHHHHHHhc
Q 011287          453 --SSPSHFKIVT-PKKVLSFE-DAKQRASQWKKAIEALQ  487 (489)
Q Consensus       453 --~~~~~f~i~~-p~r~y~~~-d~~~~~~~W~~~i~~~~  487 (489)
                        +.++.|.|.| ++|+|+|. |.+.++++|+++|+.+.
T Consensus        85 ~~kk~~~F~I~t~~~r~y~f~A~s~ee~~~Wi~aI~~a~  123 (263)
T 3a8p_A           85 HPKKEHVFCLSNSCGDVYLFQATSQTDLENWVTAIHSAC  123 (263)
T ss_dssp             CSSCSSEEEEECTTSCEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             CCCCCCEEEEEcCCCcEEEEEcCCHHHHHHHHHHHHHHH
Confidence              3467999999 58999999 55689999999999865

>2q13_A DCC-interacting protein 13 alpha; APPL1, BAR domain, PH domain, BAR-PH domain, protein transpo; 2.05A {Homo sapiens} PDB: 2z0o_A 2elb_A

Probab=98.96  E-value=2.8e-10  Score=116.23  Aligned_cols=90  Identities=10%  Similarity=0.097  Sum_probs=67.8

Q ss_pred             eEEEEEeeehhhhh-----hccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEE-cCCCcEEEEcCC--ceEE
Q 011287          397 SVLMISMVKKLQKL-----TSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV-SSPSHFKIVTPK--KVLS  468 (489)
Q Consensus       397 ~i~~~g~~~k~~g~-----~~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~-~~~~~f~i~~p~--r~y~  468 (489)
                      .++++|||.|+++.     .||||||+|.++-..||.+ ......|.|++..+.+ ..++. .....|.|.||+  |||+
T Consensus       277 ~~~k~G~L~K~~~~~~~~~~WkkRwfvL~~~~L~y~k~-~~~~~~~~i~l~~~~v-~~~~~~~r~~~F~i~t~~~~~~~~  354 (385)
T 2q13_A          277 LTRKAGYLNARNKTGLVSSTWDRQFYFTQGGNLMSQAR-GDVAGGLAMDIDNCSV-MAVDCEDRRYCFQITSFDGKKSSI  354 (385)
T ss_dssp             CSCCEEEEEEC--------CCEEEEEEEETTEEEEECS-SCSSCEEEEECTTCEE-EEECCTTCSSEEEEECTTSCBCCC
T ss_pred             CccEEEEEEEecCCCCCcCCceeEEEEEECCEEEEecC-CCcCCCceEEccceEE-EeccccCCCceEEEEeCCCCeEEE
Confidence            46899999998753     3999999999886666666 4556679999987621 12221 334689999998  9999


Q ss_pred             EE-cCCccHHHHHHHHHHhcC
Q 011287          469 FE-DAKQRASQWKKAIEALQN  488 (489)
Q Consensus       469 ~~-d~~~~~~~W~~~i~~~~~  488 (489)
                      |. +.+.++++|+++|+.++.
T Consensus       355 l~A~s~~e~~~Wi~ai~~~~~  375 (385)
T 2q13_A          355 LQAESKKDHEEWICTINNISK  375 (385)
T ss_dssp             EECSSHHHHHHHHHHHHHHHT
T ss_pred             EEeCCHHHHHHHHHHHHHHHH
Confidence            99 556899999999999764

>3lju_X ARF-GAP with dual PH domain-containing protein 1; structural genomics consortium, GTPase activation, SGC, binding, nucleus, phosphoprotein; HET: IP9; 1.70A {Homo sapiens} PDB: 3feh_A* 3fm8_C 3mdb_C*

Probab=98.92  E-value=1e-09  Score=111.80  Aligned_cols=84  Identities=8%  Similarity=0.078  Sum_probs=66.4

Q ss_pred             EEEEeeehhhhhh--ccceeEEE--ecCCeEEEECCCCCeeeeeeeccCCCCceEEEE-----cCCCcEEEE----cCCc
Q 011287          399 LMISMVKKLQKLT--SKKVQLIL--TNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV-----SSPSHFKIV----TPKK  465 (489)
Q Consensus       399 ~~~g~~~k~~g~~--~k~r~~~l--t~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~-----~~~~~f~i~----~p~r  465 (489)
                      +++|||.|+++..  ||||||||  .+.-..||.++...+.+|.|++...    .+..     .++..|.|.    +++|
T Consensus       147 ~keG~L~KrG~~~k~WkrRwFVL~~~~~~L~Yy~~~~~~~p~g~I~L~~~----~~~~~~~~~~~~~~f~I~~~~~~~~R  222 (386)
T 3lju_X          147 YREGFLWKRGRDNGQFLSRKFVLTEREGALKYFNRNDAKEPKAVMKIEHL----NATFQPAKIGHPHGLQVTYLKDNSTR  222 (386)
T ss_dssp             EEEEEEEEECSSSCCEEEEEEEEETTTTEEEEEC-----CCSEEEEGGGE----EEEECHHHHTSTTCEEEEEEETTEEE
T ss_pred             ccccceeeeccccCCceEEEEEEEcCCCEEEEECCCCccCcccEEEeecc----EEEEcccccCCCceEEEEEecCCCce
Confidence            8999999999876  99999999  6676778888888999999999973    3333     466789887    8899


Q ss_pred             eEEEEcC-CccHHHHHHHHHHh
Q 011287          466 VLSFEDA-KQRASQWKKAIEAL  486 (489)
Q Consensus       466 ~y~~~d~-~~~~~~W~~~i~~~  486 (489)
                      +|+|... ..++.+|+++|..+
T Consensus       223 ~y~l~A~s~~e~~~Wi~aIr~a  244 (386)
T 3lju_X          223 NIFIYHEDGKEIVDWFNALRAA  244 (386)
T ss_dssp             EEEEECSSHHHHHHHHHHHHHH
T ss_pred             EEEEEcCCHHHHHHHHHhhhhc
Confidence            9999954 58999999999875

>4h8s_A DCC-interacting protein 13-beta; BAR domain, pleckstrin homology domain, adaptor protein, RAB signaling protein; 3.50A {Homo sapiens}

Probab=98.85  E-value=1.6e-09  Score=111.38  Aligned_cols=91  Identities=9%  Similarity=0.090  Sum_probs=67.4

Q ss_pred             CceEEEEEeeehh---hhh--hccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEE--cCCCcEEEEcCC--c
Q 011287          395 GESVLMISMVKKL---QKL--TSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV--SSPSHFKIVTPK--K  465 (489)
Q Consensus       395 ~~~i~~~g~~~k~---~g~--~~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~--~~~~~f~i~~p~--r  465 (489)
                      ...+.|+|||.|+   ||.  .|+||||+|.++-..||. .......|.|+|..+  .++...  .....|.|.||+  |
T Consensus       298 ~~~~~k~G~L~k~~~~g~~~~~W~rrwfvl~~~~l~y~~-~~~~~~~~~~~l~~~--~v~~~~~~~r~~cF~i~~~~~~~  374 (407)
T 4h8s_A          298 RNLIQKAGYLNLRNKTGLVTTTWERLYFFTQGGNLMCQP-RGAVAGGLIQDLDNC--SVMAVDCEDRRYCFQITTPNGKS  374 (407)
T ss_dssp             CSCSCCEEEEEEEEECSSSCEEEEEEEEEECSSCEECCC-TTCSSCCCCBCSSCC--EEEEECCTTCSSEEEEECTTSSC
T ss_pred             CCcceeeceeeeeccCCCCCCCceEEEEEEECCEEEEEe-CCCCCCCeEEECCce--EEEECCCCCCCceEEEEecCCCc
Confidence            3457899999987   333  399999999886554554 455667789998865  233222  234589999985  7


Q ss_pred             eEEEE-cCCccHHHHHHHHHHhcC
Q 011287          466 VLSFE-DAKQRASQWKKAIEALQN  488 (489)
Q Consensus       466 ~y~~~-d~~~~~~~W~~~i~~~~~  488 (489)
                      ||+|. +.+.++++|+++|++++.
T Consensus       375 ~~~l~A~s~~e~~~Wi~ai~~a~~  398 (407)
T 4h8s_A          375 GIILQAESRKENEEWICAINNISR  398 (407)
T ss_dssp             CEEEECSSSHHHHHHHHHHHHHHS
T ss_pred             eEEEEcCCHHHHHHHHHHHHHHHH
Confidence            99998 667899999999999864

>1dro_A Beta-spectrin; cytoskeleton; NMR {Drosophila melanogaster} SCOP: b.55.1.1

Probab=98.84  E-value=1.2e-09  Score=92.88  Aligned_cols=91  Identities=10%  Similarity=0.117  Sum_probs=66.2

Q ss_pred             EEEEEeeehhhh----------hhccceeEEEecCCeEEEECCCCCeee--------eeeeccCCCCceEEEE-cCCCcE
Q 011287          398 VLMISMVKKLQK----------LTSKKVQLILTNKPKLIYVDPSKLVVK--------GNIIWSDNSNDLSIQV-SSPSHF  458 (489)
Q Consensus       398 i~~~g~~~k~~g----------~~~k~r~~~lt~~p~l~y~d~~~~~~k--------g~i~~~~~~~~~~~~~-~~~~~f  458 (489)
                      +.++|+|.|++.          -.||+|||+|.+.-..||.|+.....+        |.|++..+.+....+. +.++.|
T Consensus         8 v~k~G~L~rK~~~~~~gkk~~~~~Wk~rw~vL~~~~L~~yk~~~~~~~~~~~~~~~~~~i~L~~~~v~~~~d~~kr~~~F   87 (122)
T 1dro_A            8 EGHEGYVTRKHEWDSTTKKASNRSWDKVYMAAKAGRISFYKDQKGYKSNPELTFRGEPSYDLQNAAIEIASDYTKKKHVL   87 (122)
T ss_dssp             SSEEEEEEEECSCCCCCCTTCCCCCEEEEEEESSSCCBEESSSSHHHHCTTCCSSCCCBCCCSSCCCEECCSSSSSTTEE
T ss_pred             eEEEEEEEEEEEEeCCCccCCCCCccEEEEEEECCEEEEEeCCcccccCCCcccCCCceEECCCCEEEeCCCCCCCCeEE
Confidence            568999976431          239999999999988899998654432        4566765422111111 446899


Q ss_pred             EEEc-CCceEEEE-cCCccHHHHHHHHHHhcC
Q 011287          459 KIVT-PKKVLSFE-DAKQRASQWKKAIEALQN  488 (489)
Q Consensus       459 ~i~~-p~r~y~~~-d~~~~~~~W~~~i~~~~~  488 (489)
                      .|.| ++|+|+|. +.+.++++|+++|+.++.
T Consensus        88 ~l~t~~~~~~lfqA~s~~e~~~Wi~ai~~~i~  119 (122)
T 1dro_A           88 RVKLANGALFLLQAHDDTEMSQWVTSLKAQSD  119 (122)
T ss_dssp             EEECSSSCEEEEECSSSHHHHHHHHHHHHHHT
T ss_pred             EEEEcCCCEEEEECCCHHHHHHHHHHHHHHHH
Confidence            9997 67999999 566899999999999864

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=98.83  E-value=2.2e-09  Score=111.54  Aligned_cols=92  Identities=14%  Similarity=0.218  Sum_probs=64.4

Q ss_pred             eEEEEEeeehhhhhh--ccceeEEEe-cCCeEEEECCCCCeeeeeeeccCCCCc---e-EEEEcCCCcEEEEcCCceEE-
Q 011287          397 SVLMISMVKKLQKLT--SKKVQLILT-NKPKLIYVDPSKLVVKGNIIWSDNSND---L-SIQVSSPSHFKIVTPKKVLS-  468 (489)
Q Consensus       397 ~i~~~g~~~k~~g~~--~k~r~~~lt-~~p~l~y~d~~~~~~kg~i~~~~~~~~---~-~~~~~~~~~f~i~~p~r~y~-  468 (489)
                      .|+|+||+.|+++.+  ||+|||+|+ |+-.+||+++.....+|.||++..+..   + ..+...++.|.|.+++.++. 
T Consensus         5 ~v~keG~L~K~g~~~k~Wk~r~fvL~~~~~l~yyk~~~~~~~~~~i~l~~~~~~~~~~~~~~~~~~~~f~I~~~~~~~~~   84 (446)
T 4ejn_A            5 AIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVI   84 (446)
T ss_dssp             CEEEEEEEEEEETTTTEEEEEEEEEETTSBEEEESSCC-------CCCGGGBCTTCEEEEECSSSTTEEEEEEEETTEEE
T ss_pred             eEEEEeeEEeeccccccccceEEEEeeCCEEEEEecCCCCCccCcccccCccccceeecCCCCCCCceeEEEcCCCceee
Confidence            489999999999877  999999998 677778999888888999999985321   1 22223367999998764443 


Q ss_pred             ---EE-cCCccHHHHHHHHHHhcC
Q 011287          469 ---FE-DAKQRASQWKKAIEALQN  488 (489)
Q Consensus       469 ---~~-d~~~~~~~W~~~i~~~~~  488 (489)
                         +. +...++++|+.+|+.++.
T Consensus        85 ~r~~~~~~~ee~e~W~~ai~~~i~  108 (446)
T 4ejn_A           85 ERTFHVETPEEREEWTTAIQTVAD  108 (446)
T ss_dssp             EEEEECSSHHHHHHHHHHHHHHCC
T ss_pred             eeEEecCCHHHHHHHHHHHHhhhh
Confidence               33 455789999999998763

>2d9w_A Docking protein 2; PH domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=98.81  E-value=1e-08  Score=85.34  Aligned_cols=90  Identities=17%  Similarity=0.199  Sum_probs=71.0

Q ss_pred             CceEEEEEeeehhhh-hh---ccceeEEEec-----CCeEEEECCCCC-----eeeeeeeccCCCCceEEEEcCC-----
Q 011287          395 GESVLMISMVKKLQK-LT---SKKVQLILTN-----KPKLIYVDPSKL-----VVKGNIIWSDNSNDLSIQVSSP-----  455 (489)
Q Consensus       395 ~~~i~~~g~~~k~~g-~~---~k~r~~~lt~-----~p~l~y~d~~~~-----~~kg~i~~~~~~~~~~~~~~~~-----  455 (489)
                      +|-++++|+|.+..- .|   ||||||+|+.     .-||-|.|-...     .-+..|.|+.+   ++|...+.     
T Consensus         9 ~e~~vk~G~L~~q~q~~fgkKWrk~w~vLy~~S~~GvaRLE~yd~~ek~~r~~~~rrVIrLsdC---isV~~~~~e~~~p   85 (127)
T 2d9w_A            9 GDGAVKQGFLYLQQQQTFGKKWRRFGASLYGGSDCALARLELQEGPEKPRRCEAARKVIRLSDC---LRVAEAGGEASSP   85 (127)
T ss_dssp             CCCSSEEEEEEECBCSSSSCBCCEEEEEEECCSSSSCCEEEEECCCSCSSSCSCCEEEECGGGE---EEEEECCSCSSSC
T ss_pred             cCccccceEEEecccchhhhhhheeEEEEecCCCCCceeeeeeeccCccccCCCCceEEEhhhC---CeEecccCccCCC
Confidence            566899999998662 33   9999999996     478855554322     34788999998   77776432     


Q ss_pred             ---CcEEEEcCCceEEEEcCCccHHHHHHHHHHhc
Q 011287          456 ---SHFKIVTPKKVLSFEDAKQRASQWKKAIEALQ  487 (489)
Q Consensus       456 ---~~f~i~~p~r~y~~~d~~~~~~~W~~~i~~~~  487 (489)
                         ..|.|.|+.|+|.|.....+..+|+.+|-++.
T Consensus        86 k~~~aF~l~T~er~~~laAe~~E~~~Wi~~ic~~a  120 (127)
T 2d9w_A           86 RDTSAFFLETKERLYLLAAPAAERGDWVQAICLLA  120 (127)
T ss_dssp             SSCEEEEEEESSCEEEEEECHHHHHHHHHHHHHHH
T ss_pred             CcceEEEEEeCCcEEEEEeCcHHHHHHHHHHHHHh
Confidence               68999999999999977778999999998863

>2rov_A RHO-associated protein kinase 2; ATP-binding, coiled coil, cytoplasm, membrane, metal-binding, nucleotide-binding, phorbol-ester binding; NMR {Rattus norvegicus}

Probab=98.79  E-value=3.1e-09  Score=89.52  Aligned_cols=85  Identities=13%  Similarity=0.112  Sum_probs=64.6

Q ss_pred             EEEeeeh--hhhh---hccceeEEEecCCeEEEECCCC---CeeeeeeeccCCCCceEEEEc------------CCCcEE
Q 011287          400 MISMVKK--LQKL---TSKKVQLILTNKPKLIYVDPSK---LVVKGNIIWSDNSNDLSIQVS------------SPSHFK  459 (489)
Q Consensus       400 ~~g~~~k--~~g~---~~k~r~~~lt~~p~l~y~d~~~---~~~kg~i~~~~~~~~~~~~~~------------~~~~f~  459 (489)
                      ++|||.+  ++|.   .|++|+|||++.-.+||.+...   ...+|.|+++..   +.|+..            .+..|.
T Consensus         3 ~eGwl~~pk~~~~~k~~Wkkr~~vL~~~kL~~y~~~~~~~~~~p~~~Idl~~~---~~V~~V~~~d~i~~~~~~~p~iF~   79 (117)
T 2rov_A            3 LEGWLSLPVRNNTKKFGWVKKYVIVSSKKILFYDSEQDKEQSNPYMVLDIDKL---FHVRPVTQTDVYRADAKEIPRIFQ   79 (117)
T ss_dssp             SEEEEECCCCSSSSCCCCCEEEEEEETTEEEEESCHHHHHTTCCSEEECGGGE---EEEEECCTTTCSSSCTTTGGGEEE
T ss_pred             eEEEEEeecCCCccCCCcEEEEEEEECCEEEEEECCCCcccCCceEEEECccc---EEEEEcccccccccccccCCcEEE
Confidence            4799985  7664   5999999999987667766542   366899999875   554442            135799


Q ss_pred             EEc------CCceEEEEc-CCccHHHHHHHHHHhc
Q 011287          460 IVT------PKKVLSFED-AKQRASQWKKAIEALQ  487 (489)
Q Consensus       460 i~~------p~r~y~~~d-~~~~~~~W~~~i~~~~  487 (489)
                      |.+      |+|+|+|.. .+.+.++|+.+|.+.+
T Consensus        80 I~~~~~~~~~~~~l~l~A~s~~e~~~WV~aL~~~i  114 (117)
T 2rov_A           80 ILYANEGISSAKNLLLLANSTEEQQKWVSRLVKKI  114 (117)
T ss_dssp             EEECSSSSTTCEEEEEECSSHHHHHHHHHHHHHHC
T ss_pred             EEeCCCCCCCCcEEEEEeCCHHHHHHHHHHHHHHh
Confidence            975      469999985 5689999999999876

>3pp2_A RHO GTPase-activating protein 27; PH domain, GTPase activator, pleckstrin homology domain, STR genomics consortium, SGC, hydrolase activator; HET: CIT; 1.42A {Homo sapiens}

Probab=98.79  E-value=5.2e-09  Score=89.18  Aligned_cols=90  Identities=12%  Similarity=0.111  Sum_probs=66.2

Q ss_pred             eEEEEEeeehhh--------h-hhccceeEEEecCCeEEEECCCCC------------eeeeeeeccCCCCceEEE---E
Q 011287          397 SVLMISMVKKLQ--------K-LTSKKVQLILTNKPKLIYVDPSKL------------VVKGNIIWSDNSNDLSIQ---V  452 (489)
Q Consensus       397 ~i~~~g~~~k~~--------g-~~~k~r~~~lt~~p~l~y~d~~~~------------~~kg~i~~~~~~~~~~~~---~  452 (489)
                      .|.++|+|.++.        + -.|++|||||++.-.+||.|+...            ...|-|+|..+  .+.+-   .
T Consensus         7 ~v~keG~L~rK~~~~~gkk~~~r~W~~~w~VL~~~~L~~yKd~~~~~~~~~~~~~~~~~~~~~i~L~~a--~v~~~~~d~   84 (124)
T 3pp2_A            7 TLDKAGVLHRTKTADKGKRLRKKHWSASWTVLEGGVLTFFKDSKTSAAGGLRQPSKFSTPEYTVELRGA--TLSWAPKDK   84 (124)
T ss_dssp             --CEEEEEEEEEEEETTEECSSCCCEEEEEEEETTEEEEESCSBCC---CBCCGGGGCSEEEEEECTTC--EEEECCGGG
T ss_pred             cEEEEEEEEEEEeccCCccCCCCCceEEEEEEECCEEEEEecCccccccCccCcccccCCcceEEcCCC--EEEeccccc
Confidence            378899997651        2 369999999999988899987654            34577777765  22221   1


Q ss_pred             -cCCCcEEEEcC-CceEEEE-cCCccHHHHHHHHHHhcC
Q 011287          453 -SSPSHFKIVTP-KKVLSFE-DAKQRASQWKKAIEALQN  488 (489)
Q Consensus       453 -~~~~~f~i~~p-~r~y~~~-d~~~~~~~W~~~i~~~~~  488 (489)
                       +.++.|.|.|+ +++|.|. +.+.++++|+++|+.++.
T Consensus        85 ~krk~vF~l~t~~~~~ylfqA~s~~e~~~Wi~aI~~aI~  123 (124)
T 3pp2_A           85 SSRKNVLELRSRDGSEYLIQHDSEAIISTWHKAIAQGIQ  123 (124)
T ss_dssp             CSSSSEEEEECTTSCEEEEECSCHHHHHHHHHHHHHHHC
T ss_pred             CCCceEEEEECCCCCEEEEECCCHHHHHHHHHHHHHHHh
Confidence             34689999986 5899998 556899999999999874

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.60  E-value=7.2e-07  Score=87.85  Aligned_cols=133  Identities=14%  Similarity=0.213  Sum_probs=95.3

Q ss_pred             eeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCC---CccEEEEEEE-cCCEEEEEEe
Q 011287           50 GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP---GVVRLFFTFQ-DTFSLYMALE  125 (489)
Q Consensus        50 ~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp---nIv~l~~~~~-~~~~lylV~E  125 (489)
                      ++.++.|....||++     |..+++|+...     ......+..|..+|+.+.+.   .+.+++.+.. ..+..|+|||
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e   93 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR   93 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence            445788999999998     57899998522     23456788899999998642   2455666654 4456789999


Q ss_pred             ccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 011287          126 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM-----------------------------------------  164 (489)
Q Consensus       126 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~-----------------------------------------  164 (489)
                      +++|..|....-  ..++......++.++...|..||+.                                         
T Consensus        94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            999988866322  2345555666666666666666643                                         


Q ss_pred             -------------------CcEeeccCCCCeeeCC---CCCE-EEeeccCccc
Q 011287          165 -------------------GLIHRDIKPENLLLTA---DGHI-KIADFGSVKP  194 (489)
Q Consensus       165 -------------------gIiHrDLKpeNILl~~---~g~i-kL~DFG~a~~  194 (489)
                                         .++|+|++|.||+++.   ++.+ .|+||+.+..
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                               3599999999999987   4665 8999998864

>3tca_A Amyloid beta A4 precursor protein-binding family 1-interacting protein; RA domain, RBD, PH domain; 2.35A {Mus musculus}

Probab=98.56  E-value=3.7e-08  Score=96.27  Aligned_cols=87  Identities=11%  Similarity=0.095  Sum_probs=67.1

Q ss_pred             EEEEeeehhhhhh--ccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEE----------cCCCcEEEEcCC--
Q 011287          399 LMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV----------SSPSHFKIVTPK--  464 (489)
Q Consensus       399 ~~~g~~~k~~g~~--~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~----------~~~~~f~i~~p~--  464 (489)
                      .++|||.|+++..  ||+|||||.+....||.++.....+|.|++.... ...+..          ..+..|.|.+|+  
T Consensus       169 ~~~G~L~k~~~~~k~WkkR~fvL~~~~L~yyk~~~~~~~~~~i~l~~l~-~~~v~~~~~~~~~~~~~~~~~F~i~~~~~~  247 (291)
T 3tca_A          169 ELEGALYLKEDGKKSWKRRYFLLRASGIYYVPKGKTKTSRDLACFIQFE-NVNIYYGIQCKMKYKAPTDHCFVLKHPQIQ  247 (291)
T ss_dssp             CCEEEEEEECTTSSCEEEEEEEECSSEEEECCTTCCSSTTTCEEEEEGG-GCEEEEECSHHHHHCCSSSCEEEEECTTCC
T ss_pred             ceEEEEEEeCCCCCCceEEEEEEeCCEEEEEecCccccccCceeeccce-eEEEEecCccccccCCCCCeEEEEEcCCCC
Confidence            4789999998755  9999999999877788888888889999886531 123322          124689998864  


Q ss_pred             ----ceEEEE-cCCccHHHHHHHHHHh
Q 011287          465 ----KVLSFE-DAKQRASQWKKAIEAL  486 (489)
Q Consensus       465 ----r~y~~~-d~~~~~~~W~~~i~~~  486 (489)
                          |+|+|. +.+.++..|+.+|.-+
T Consensus       248 ~~~~~~~~l~A~s~~e~~~Wi~air~A  274 (291)
T 3tca_A          248 KESQYIKYLCCDDARTLSQWVMGIRIA  274 (291)
T ss_dssp             SCCTTSEEEECSSHHHHHHHHHHHHHH
T ss_pred             CCCceEEEEECCCHHHHHHHHHHHHHH
Confidence                679999 5568999999999754

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.56  E-value=9e-07  Score=84.95  Aligned_cols=138  Identities=17%  Similarity=0.170  Sum_probs=98.0

Q ss_pred             CeEEeeEEeeeCc-eEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCEEEEE
Q 011287           46 DFELGKIYGVGSY-SKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        46 dy~~~~~LG~G~~-g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~lylV  123 (489)
                      .|++.. +..|.- +.||+......+..+.+|+-..      .....+.+|..+|+.+. +--+-+++.+..+.+..|+|
T Consensus        26 g~~~~~-~~~G~S~~~v~rl~~~~~~~~~~lk~~~~------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lv   98 (272)
T 4gkh_A           26 GYRWAR-DNVGQSGATIYRLYGKPNAPELFLKHGKG------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLL   98 (272)
T ss_dssp             TCEEEE-EECSSSSCEEEEEECCTTCCCEEEEEEET------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             CCeEEE-ccCCCcCCeEEEEEecCCCeEEEEEECCC------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEE
Confidence            344433 344544 4799988877788899998643      34556788999998874 32366788889999999999


Q ss_pred             EeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------
Q 011287          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM---------------------------------------  164 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~---------------------------------------  164 (489)
                      ||+++|.++.+.....    ......++.++...|..||+.                                       
T Consensus        99 me~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (272)
T 4gkh_A           99 TTAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGW  174 (272)
T ss_dssp             EECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTC
T ss_pred             EEeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccch
Confidence            9999998877655432    122334555555666666642                                       


Q ss_pred             -------------------CcEeeccCCCCeeeCCCCCEEEeeccCccc
Q 011287          165 -------------------GLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (489)
Q Consensus       165 -------------------gIiHrDLKpeNILl~~~g~ikL~DFG~a~~  194 (489)
                                         .++|+|+.|.|||++.++.+-|+||+.+..
T Consensus       175 ~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          175 PVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             CHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                               158999999999998777677999998763

>2dtc_A RAL guanine nucleotide exchange factor ralgps1A; PH domain, protein binding, structural genomics, NPPSFA; 1.70A {Mus musculus}

Probab=98.56  E-value=1.1e-07  Score=80.70  Aligned_cols=85  Identities=19%  Similarity=0.266  Sum_probs=65.1

Q ss_pred             EEEEeeehhhhh----hccceeEEEecCCeEEEECCC---------CCeeeeeeeccCCCCceEEEE----cCCCcEEEE
Q 011287          399 LMISMVKKLQKL----TSKKVQLILTNKPKLIYVDPS---------KLVVKGNIIWSDNSNDLSIQV----SSPSHFKIV  461 (489)
Q Consensus       399 ~~~g~~~k~~g~----~~k~r~~~lt~~p~l~y~d~~---------~~~~kg~i~~~~~~~~~~~~~----~~~~~f~i~  461 (489)
                      |...++.|+|+.    .||+|||+|++.-.+||..+.         +.+..|.|||...    .|+.    +.++.|.|.
T Consensus         7 L~rk~llK~G~k~~~ksWkr~W~vL~g~~L~yf~~~~~~~~~~~~~~~~P~~~i~L~g~----~V~~~e~~~~~~~F~L~   82 (126)
T 2dtc_A            7 LRRKTLLKEGRKPALSSWTRYWVVLSGATLLYYGAKSLRGTDRKHYKSTPGKKVSIVGW----MVQLPDDPEHPDIFQLN   82 (126)
T ss_dssp             EEEEEEEBTTBCCSSCCCEEEEEEEETTEEEEEEBSSSCCSSGGGBCSSCSEEEECTTC----EEECCCCTTSTTEEEEE
T ss_pred             eeeeehhhcCCcccccCcccEEEEEeCCEEEEEcccccccccccccccCCCceEEeCCC----EEEecCCCCCCCEEEEe
Confidence            444555576663    399999999998877777552         4567899999875    3333    456899999


Q ss_pred             cC--CceEEEEc-CCccHHHHHHHHHHhc
Q 011287          462 TP--KKVLSFED-AKQRASQWKKAIEALQ  487 (489)
Q Consensus       462 ~p--~r~y~~~d-~~~~~~~W~~~i~~~~  487 (489)
                      ++  +.+|.|.. ...++..|+++|..++
T Consensus        83 ~~~~G~~Y~fqA~s~~~~~~W~~ai~~a~  111 (126)
T 2dtc_A           83 NPDKGNVYKFQTGSRFHAILWHKHLDDAC  111 (126)
T ss_dssp             CTTSCSEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             eCCCCCEEEEeCCCHHHHHHHHHHHHHHH
Confidence            76  89999995 4589999999999876

>2fjl_A 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma 1; beta-barrel, hydrolase; NMR {Rattus norvegicus} SCOP: b.55.1.1

Probab=98.52  E-value=8.5e-08  Score=83.03  Aligned_cols=88  Identities=15%  Similarity=0.212  Sum_probs=63.4

Q ss_pred             EEEEeeehhhhhh--ccceeEEEecCCeEEEEC-------------------C-------C-----C-------------
Q 011287          399 LMISMVKKLQKLT--SKKVQLILTNKPKLIYVD-------------------P-------S-----K-------------  432 (489)
Q Consensus       399 ~~~g~~~k~~g~~--~k~r~~~lt~~p~l~y~d-------------------~-------~-----~-------------  432 (489)
                      +|.|+|.|+.+.-  |++|+|||++. +|||..                   |       .     .             
T Consensus         2 ~k~G~L~~~~~~~~~w~~~~fvL~~~-~L~y~~e~s~~~~~~~~e~~~~~~~~~~~~~~~n~~fh~~~~~~~e~~~~~l~   80 (150)
T 2fjl_A            2 IKNGILYLEDPVNHEWYPHYFVLTSS-KIYYSEETSSDQGNEDEEEPKEASGSTELHSSLEVLFQGPNPAILEPEREHLD   80 (150)
T ss_dssp             CEEEEEEEEETTTTEEEEEEEEEETT-EEEECCCCSCSSCCSCCCCSCCCCCSCCCCCCSSSGGGSSCSTTSCTTCSSSC
T ss_pred             CcceEEEeecCCCCCceEeEEEEECC-EEEEEeeccccccccCcccccccCCchhhcccchhccccCCccccchhHhccc
Confidence            5899999999876  99999999954 556633                   1       0     0             


Q ss_pred             ------CeeeeeeeccCCCCceEEEEc--CCCcEEEEcC---CceEEEE-cCCccHHHHHHHHHHhc
Q 011287          433 ------LVVKGNIIWSDNSNDLSIQVS--SPSHFKIVTP---KKVLSFE-DAKQRASQWKKAIEALQ  487 (489)
Q Consensus       433 ------~~~kg~i~~~~~~~~~~~~~~--~~~~f~i~~p---~r~y~~~-d~~~~~~~W~~~i~~~~  487 (489)
                            .-++|.|++..+.+++....+  ....|.|.+|   .|+|.|. |...++.+|+++|.++.
T Consensus        81 E~~~lG~l~kG~IdL~gc~V~~~~~~~~~~~~vF~I~~~~~~~~~~~laAds~Eem~dW~kaIreaa  147 (150)
T 2fjl_A           81 ENSPLGDLLRGVLDVPACQIAIRPEGKNNRLFVFSISMPSVAQWSLDVAADSQEELQDWVKKIREVA  147 (150)
T ss_dssp             TTTTTTTCCCEEECSTTCEEEEETTCSSSCSCEEEEECTTTSSCCEEEEESSHHHHHHHHHHHHHHH
T ss_pred             ccccccccccceEecCccEEEeccCCCCCCceEEEEeCCCCCCceEEEEeCCHHHHHHHHHHHHHHH
Confidence                  012799999987222211122  3469999887   4699999 56689999999999975

>2ys3_A UNC-112-related protein 2; PH domain, kindlin-3, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=98.48  E-value=1.1e-07  Score=80.67  Aligned_cols=73  Identities=8%  Similarity=0.155  Sum_probs=57.2

Q ss_pred             ccceeEEEecCCeEEEECCCCC--eeeeeeeccCCCCceEEEE---cCCCcEEEEcCC----ceEEEE-cCCccHHHHHH
Q 011287          412 SKKVQLILTNKPKLIYVDPSKL--VVKGNIIWSDNSNDLSIQV---SSPSHFKIVTPK----KVLSFE-DAKQRASQWKK  481 (489)
Q Consensus       412 ~k~r~~~lt~~p~l~y~d~~~~--~~kg~i~~~~~~~~~~~~~---~~~~~f~i~~p~----r~y~~~-d~~~~~~~W~~  481 (489)
                      ||+|||+|.+.-..||.++...  +..|.|+|..+  ++..++   ..+..|.+.+|.    |+|+|. |.+.+..+|+.
T Consensus        28 ~KrrWFvlk~~~L~YyK~kee~~~ePig~I~L~gc--eV~pd~~~~~~kf~ikl~iPs~~g~r~y~l~cdsEeqy~~WMa  105 (137)
T 2ys3_A           28 YRQHWVVFKETTLSYYKSQDEAPGDPIQQLNLKGC--EVVPDVNVSGQKFCIKLLVPSPEGMSEIYLRCQDEQQYARWMA  105 (137)
T ss_dssp             SCCCEEEECSSCEEEESSTTTTTSCCSCCBCTTTC--EEEECCBGGGTBEEEEEEEECSSSEEEEEEEESSHHHHHHHHH
T ss_pred             ceeEEEEEeCCEEEEECCchhccCCCceEEECCCC--EEeccccccCCceEEEEEccCCCCceEEEEECCCHHHHHHHHH
Confidence            8999999999977788788875  88999999986  344443   223344556675    999999 66799999999


Q ss_pred             HHHHh
Q 011287          482 AIEAL  486 (489)
Q Consensus       482 ~i~~~  486 (489)
                      ++..+
T Consensus       106 A~rlA  110 (137)
T 2ys3_A          106 GCRLA  110 (137)
T ss_dssp             HHHHH
T ss_pred             HHHHh
Confidence            98764

>2coa_A Protein kinase C, D2 type; protein kinase D2, PH domain, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.55.1.1

Probab=98.41  E-value=5.2e-07  Score=75.03  Aligned_cols=91  Identities=19%  Similarity=0.201  Sum_probs=73.3

Q ss_pred             CceEEEEEeeehhhhhh--ccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEEc----------CCCcEEEEc
Q 011287          395 GESVLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVS----------SPSHFKIVT  462 (489)
Q Consensus       395 ~~~i~~~g~~~k~~g~~--~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~----------~~~~f~i~~  462 (489)
                      +..+||+||+.+..-.-  +||+-+.|..+-..+|.+....+.=-||||+..   +.++..          ..+.|+|.|
T Consensus         5 ~s~vlkeGW~VH~t~~d~~rKRHYWrLD~K~Itlf~~e~~~~~ykeIpL~eI---l~v~~~~~~~~l~~~~~~hcFEi~T   81 (125)
T 2coa_A            5 SSGTLREGWVVHYSNKDTLRKRHYWRLDCKCITLFQNNTTNRYYKEIPLSEI---LTVESAQNFSLVPPGTNPHCFEIVT   81 (125)
T ss_dssp             CCSCSEEEEEEECCSSSCCCEEEEEEECSSEEEEESSSSCSSCSEEEETTTC---CEEEESCCCSSSCTTSCCEEEEEEC
T ss_pred             CCceeecceEEEEccCCccccceeeEecCCeEEEEecCCCCceeeeeehhHe---ecccccccccccCCCCCCceEEEEe
Confidence            44589999998766433  788888999999999998877777788999986   888874          336799999


Q ss_pred             CCceEEEEc----CCcc--------HHHHHHHHHHhcC
Q 011287          463 PKKVLSFED----AKQR--------ASQWKKAIEALQN  488 (489)
Q Consensus       463 p~r~y~~~d----~~~~--------~~~W~~~i~~~~~  488 (489)
                      .++|||+-+    +..+        |..|..+|..++-
T Consensus        82 ~~~~yyVg~~~~~~p~~~sg~g~~~a~~W~~aIrqALm  119 (125)
T 2coa_A           82 ANATYFVGEMPGGTPGGPSGQGAEAARGWETAIRQALM  119 (125)
T ss_dssp             SSCCCCEECCSCCCSSSCCCCCSHHHHHHHHHHHHHGG
T ss_pred             CCeEEEEccCCCCCCCCcCccccHHHHHHHHHHHhhcc
Confidence            999999985    2223        8999999998764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.29  E-value=1.1e-06  Score=89.68  Aligned_cols=81  Identities=16%  Similarity=0.129  Sum_probs=49.7

Q ss_pred             EeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccc-cch---hHHHHHHHHHHHHHhCCC--CCc-cEEEEEEEcCCEEE
Q 011287           49 LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFI-TKE---NKTAYVKLERIVLDQLDH--PGV-VRLFFTFQDTFSLY  121 (489)
Q Consensus        49 ~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~-~~~---~~~~~~~~E~~il~~l~h--pnI-v~l~~~~~~~~~ly  121 (489)
                      -.+.||.|..+.||+++...+++.|++|....... ..+   ........|..+|+.+..  |.. .+++.+  +....+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~  111 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  111 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence            46788999999999998766678999998653211 000   112345668888887632  333 355543  344568


Q ss_pred             EEEeccCCCC
Q 011287          122 MALESCEGGE  131 (489)
Q Consensus       122 lV~E~~~gg~  131 (489)
                      +|||+++|..
T Consensus       112 lvmE~l~g~~  121 (397)
T 2olc_A          112 TVMEDLSHLK  121 (397)
T ss_dssp             EEECCCTTSE
T ss_pred             EEEEeCCCcc
Confidence            9999998743

>2d9z_A Protein kinase C, NU type; PH domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=98.15  E-value=3e-06  Score=70.67  Aligned_cols=90  Identities=20%  Similarity=0.224  Sum_probs=71.7

Q ss_pred             CceEEEEEeeehhhhhh--ccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEEc----------CCCcEEEEc
Q 011287          395 GESVLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVS----------SPSHFKIVT  462 (489)
Q Consensus       395 ~~~i~~~g~~~k~~g~~--~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~----------~~~~f~i~~  462 (489)
                      +..+||+||+.+..-.-  +||+-+.|..+-..+|.+....+.=-||||+..   +.++..          +++.|+|.|
T Consensus         5 ~s~vlkeGWmVH~t~~d~~rKRHYWrLD~K~Itlf~~e~~~k~ykeIpLseI---L~v~~~~~~~~~~~~~~phcFEi~T   81 (129)
T 2d9z_A            5 SSGMVKEGWMVHYTSRDNLRKRHYWRLDSKCLTLFQNESGSKYYKEIPLSEI---LRISSPRDFTNISQGSNPHCFEIIT   81 (129)
T ss_dssp             CTTSEEEEEEEEEESSCCCCEEEEEEEESSCEEEESCSSCCSCCCEECTTTC---CEECCTTCCCCSSSCSCCCSEEEEC
T ss_pred             CCceeecceEEEEccCCccccceeeEecCCeEEEEecCCCCceeceeeHHHh---cccccccCccccCCCCCCceEEEEE
Confidence            55689999988655433  778888999999999998777777778999986   777773          237899999


Q ss_pred             CCceEEEEc-C-----------C----ccHHHHHHHHHHhc
Q 011287          463 PKKVLSFED-A-----------K----QRASQWKKAIEALQ  487 (489)
Q Consensus       463 p~r~y~~~d-~-----------~----~~~~~W~~~i~~~~  487 (489)
                      .++|||+-+ +           +    ..|..|..+|..++
T Consensus        82 ~~~~y~Vge~~~~~~~~~~~~~sg~g~~~a~~We~aIrqAL  122 (129)
T 2d9z_A           82 DTMVYFVGENNGDSSHNPVLAATGVGLDVAQSWEKAIRQAL  122 (129)
T ss_dssp             SSCEEEECBCCSCCSCCTTTTTTTCBHHHHHHHHHHHHHHH
T ss_pred             CCEEEEEccCCCCCCCCccccccccchHHHHHHHHHHHHhc
Confidence            999999974 2           1    35889999999875

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.09  E-value=2.4e-05  Score=77.26  Aligned_cols=136  Identities=15%  Similarity=0.147  Sum_probs=77.8

Q ss_pred             EeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-----CCCCccEEE---EEEEcCCEE
Q 011287           49 LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-----DHPGVVRLF---FTFQDTFSL  120 (489)
Q Consensus        49 ~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~l~---~~~~~~~~l  120 (489)
                      -.+.|+.|..+.||++...  +..+++|+....    .   ..+..|..+++.|     ..|.++...   .+..+.+..
T Consensus        36 ~~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~----~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~  106 (346)
T 2q83_A           36 KIDVIQGNQMALVWKVHTD--SGAVCLKRIHRP----E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFL  106 (346)
T ss_dssp             EEEECC----CEEEEEEET--TEEEEEEEECSC----H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEE
T ss_pred             EeeeccccccCcEEEEEeC--CCCEEEEecCCC----H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEE
Confidence            3456677788999999763  345999998652    1   2233344444444     234444310   012346678


Q ss_pred             EEEEeccCCCChH--------------HHHHh-CCCC--C-----------HH--------H------------------
Q 011287          121 YMALESCEGGELF--------------DQITS-KGHL--S-----------ED--------E------------------  146 (489)
Q Consensus       121 ylV~E~~~gg~L~--------------~~l~~-~~~l--~-----------e~--------~------------------  146 (489)
                      |+||+|++|..+.              ..+.. ...+  +           ..        .                  
T Consensus       107 ~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  186 (346)
T 2q83_A          107 FVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQ  186 (346)
T ss_dssp             EEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHH
T ss_pred             EEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHH
Confidence            9999999986431              11111 0101  0           00        0                  


Q ss_pred             -----HHHHHHHHHHHHHHHH-------------hCCcEeeccCCCCeeeCCCCCEEEeeccCcc
Q 011287          147 -----ARFYTAEVVDALEYIH-------------SMGLIHRDIKPENLLLTADGHIKIADFGSVK  193 (489)
Q Consensus       147 -----~~~i~~qil~aL~~LH-------------~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~  193 (489)
                           +..+..++..++.+|+             ..+++|+|++|.|||++.++.+.|+||+.+.
T Consensus       187 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          187 LYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence                 1112223344566665             3579999999999999888899999999875

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.05  E-value=3.2e-06  Score=84.69  Aligned_cols=85  Identities=9%  Similarity=-0.037  Sum_probs=54.7

Q ss_pred             EEeeEE-eeeCceEEEEEEEc--C----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-C--CCccEEEEEEEcC
Q 011287           48 ELGKIY-GVGSYSKVVRAKKI--D----TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-H--PGVVRLFFTFQDT  117 (489)
Q Consensus        48 ~~~~~L-G~G~~g~Vy~a~~~--~----tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~-h--pnIv~l~~~~~~~  117 (489)
                      ...+.| +.|....+|++...  .    ++..+++|+..............+.+|..+++.|. +  -.+.+++.+..+.
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~  102 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG  102 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence            456778 88888999988753  1    26789999865432000000133566888887773 2  3466777777655


Q ss_pred             ---CEEEEEEeccCCCCh
Q 011287          118 ---FSLYMALESCEGGEL  132 (489)
Q Consensus       118 ---~~lylV~E~~~gg~L  132 (489)
                         ...|+|||+++|..+
T Consensus       103 ~~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          103 DVLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             TTTSSCEEEEECCCCBCC
T ss_pred             CccCCceEEEEecCCCCh
Confidence               356899999998654

>3a8n_A TIAM-1, T-lymphoma invasion and metastasis-inducing protein 1; guanine nucleotide exchange factor, guanine-nucleotide releasing factor, lipoprotein; 4.50A {Mus musculus}

Probab=97.77  E-value=2.3e-06  Score=82.39  Aligned_cols=77  Identities=13%  Similarity=0.139  Sum_probs=55.1

Q ss_pred             hccceeEEEecCCeEEEECCCCC------eeeeeeeccCCCCceEEE-EcCCCcEEEEcC-CceEEEEc-CCccHHHHHH
Q 011287          411 TSKKVQLILTNKPKLIYVDPSKL------VVKGNIIWSDNSNDLSIQ-VSSPSHFKIVTP-KKVLSFED-AKQRASQWKK  481 (489)
Q Consensus       411 ~~k~r~~~lt~~p~l~y~d~~~~------~~kg~i~~~~~~~~~~~~-~~~~~~f~i~~p-~r~y~~~d-~~~~~~~W~~  481 (489)
                      .|++||+||.+.-.+||.|....      ..+|-|++..+.++...+ .+.++.|.|.|+ +++|.|.. ...+++.|++
T Consensus        38 ~Wkk~w~VLkg~~L~fYKde~~~~~~~~~~p~~~I~L~ga~v~~a~d~~kKk~vF~L~t~~g~~yLFQA~s~eEm~~WI~  117 (279)
T 3a8n_A           38 KWKHYWVSLKGCTLFFYETDGRSGIDHNSVPKHAVWVENSIVQAVPEHPKKDFVFCLSNSLGDAFLFQTTSQTELENWIT  117 (279)
T ss_dssp             CCEEEEEEEETTEECCBCCC--------CCCSSCCBCCSCEECCCTTSSSSCSCCCEEETTTEEEECCCSCHHHHHHHHH
T ss_pred             CCeEEEEEEeCCEEEEEecccccccccccCCCceEeccCcEEEeccccCCCCcEEEEEcCCCCEEEEeCCCHHHHHHHHH
Confidence            49999999999888888887532      235568888762221112 244679999875 78899884 5589999999


Q ss_pred             HHHHhc
Q 011287          482 AIEALQ  487 (489)
Q Consensus       482 ~i~~~~  487 (489)
                      +|+.+.
T Consensus       118 aI~~a~  123 (279)
T 3a8n_A          118 AIHSAC  123 (279)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.75  E-value=9.5e-05  Score=75.84  Aligned_cols=32  Identities=22%  Similarity=0.308  Sum_probs=27.9

Q ss_pred             HhCCcEeeccCCCCeeeCCCCCEEEeeccCccc
Q 011287          162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (489)
Q Consensus       162 H~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~  194 (489)
                      +...++|+|++|.|||++.++ +.|+||+.+..
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            356799999999999998876 99999998764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.71  E-value=0.00022  Score=70.23  Aligned_cols=76  Identities=12%  Similarity=0.032  Sum_probs=59.8

Q ss_pred             EeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC---CCCccEEEEEEEcCCEEEEEEe
Q 011287           49 LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD---HPGVVRLFFTFQDTFSLYMALE  125 (489)
Q Consensus        49 ~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~lylV~E  125 (489)
                      -.+.|+.|....+|++..  ++..|++|+....      ....+..|...|+.|.   ...+.+++.+..+....|+|||
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme  111 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE  111 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence            457789999999999975  4778999987532      2456778888888773   3557788888888888999999


Q ss_pred             ccCCCCh
Q 011287          126 SCEGGEL  132 (489)
Q Consensus       126 ~~~gg~L  132 (489)
                      +++|..+
T Consensus       112 ~l~G~~~  118 (312)
T 3jr1_A          112 ALNKSKN  118 (312)
T ss_dssp             CCCCCCC
T ss_pred             eccCCCC
Confidence            9998754

>3hk0_A Growth factor receptor-bound protein 10; GRB10, RA, PH, RAS-associating, pleckstrin-homology, adapter phosphoprotein, SH2 domain; 2.60A {Homo sapiens}

Probab=97.65  E-value=8e-05  Score=70.85  Aligned_cols=95  Identities=14%  Similarity=0.139  Sum_probs=60.9

Q ss_pred             ccCCCceEEEEEeeehhhh--hhccceeEEEecCCeEEEECCCCCeeeee---eeccCCCCceEEEE--cC------CCc
Q 011287          391 FLDPGESVLMISMVKKLQK--LTSKKVQLILTNKPKLIYVDPSKLVVKGN---IIWSDNSNDLSIQV--SS------PSH  457 (489)
Q Consensus       391 ~~~~~~~i~~~g~~~k~~g--~~~k~r~~~lt~~p~l~y~d~~~~~~kg~---i~~~~~~~~~~~~~--~~------~~~  457 (489)
                      |+..+..--.+|+|.++++  -.||||||+|.+....||.+......++.   ++++..  .+..-.  ++      +..
T Consensus       125 f~~~s~~P~~~G~L~~ke~~~K~WkkRyfvLr~sgLy~~~k~~sk~~r~l~~~~~L~~~--~vy~~~~~kKk~kaPt~~~  202 (256)
T 3hk0_A          125 FLNSSSSPEIQGFLHVKELGKKSWKKLYVCLRRSGLYCSTKGTSAAPRHLQLLADLEDS--NIFSLIAGRKQYNAPTDHG  202 (256)
T ss_dssp             HHCTTSCEEEEEEEEEECTTSSCEEEEEEEEETTEEEEESSTTCCCGGGEEEEECCTTE--EEEEESSTHHHHCCSSSEE
T ss_pred             hhcCCCCCcceeEEEEecCCCCcceEEEEEEeCCEEEEEecCCCCccccceEEEEcCCC--EEEEecccccccCCCCCCE
Confidence            3333444567899998763  45999999999887655554433344443   588763  222221  11      357


Q ss_pred             EEEEcCC------ceEEEE-cCCccHHHHHHHHHHhc
Q 011287          458 FKIVTPK------KVLSFE-DAKQRASQWKKAIEALQ  487 (489)
Q Consensus       458 f~i~~p~------r~y~~~-d~~~~~~~W~~~i~~~~  487 (489)
                      |.|..+.      .+|+|. |.+.++++|+.+|..+.
T Consensus       203 F~ik~~k~~~~~~~~~~lcaede~~~~~W~~aIr~ak  239 (256)
T 3hk0_A          203 LCIKPNKVRNETKELRLLCAEDEQTRTSWMTAFRLLK  239 (256)
T ss_dssp             EEEEETTCSSCCTTCEEEEESSHHHHHHHHHHHHHHH
T ss_pred             EEEEcccccCCCceEEEEEeCCHHHHHHHHHHHHHHH
Confidence            7877332      359999 55689999999998753

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.55  E-value=0.00018  Score=70.12  Aligned_cols=132  Identities=17%  Similarity=0.057  Sum_probs=73.7

Q ss_pred             eeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-cEEEEEEEcCCEEEEEEecc-
Q 011287           50 GKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV-VRLFFTFQDTFSLYMALESC-  127 (489)
Q Consensus        50 ~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~lylV~E~~-  127 (489)
                      ++.|+.|....+|++      ..+++|+.......    ......|..+++.+...++ .+++...  ...-++|+||+ 
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~   90 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA   90 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence            788999999999999      56899987643111    0112347777766632222 3555543  33346899999 


Q ss_pred             CCCChHHH---------------H---HhCC-CC----C-HHHHHHHHHH--------------HHHHHHHHH----h--
Q 011287          128 EGGELFDQ---------------I---TSKG-HL----S-EDEARFYTAE--------------VVDALEYIH----S--  163 (489)
Q Consensus       128 ~gg~L~~~---------------l---~~~~-~l----~-e~~~~~i~~q--------------il~aL~~LH----~--  163 (489)
                      +|.+|...               +   ...+ .+    + ...+..+...              +...+..+.    .  
T Consensus        91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~  170 (301)
T 3dxq_A           91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP  170 (301)
T ss_dssp             TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence            66444210               0   1111 01    1 1111111111              111111111    1  


Q ss_pred             --CCcEeeccCCCCeeeCCCCCEEEeeccCccc
Q 011287          164 --MGLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (489)
Q Consensus       164 --~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~  194 (489)
                        ..++|+|+.|.||+ ..++.+.|+||..+..
T Consensus       171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             CCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence              23899999999999 5677899999998763

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.30  E-value=0.0011  Score=61.15  Aligned_cols=123  Identities=16%  Similarity=0.115  Sum_probs=81.7

Q ss_pred             CChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHH-HhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCC
Q 011287          130 GELFDQITSK-GHLSEDEARFYTAEVVDALEYI-HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAA  207 (489)
Q Consensus       130 g~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~L-H~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~  207 (489)
                      -+|.+.|... .+++|++++.++.|.+.+|.-+ +...-..+=+.|..|++..+|.|-+.+ +.+.              
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------   97 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------   97 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------
Confidence            4788888754 6799999999999999998776 222222444567899999999888764 2211              


Q ss_pred             CCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 011287          208 SDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDLID  287 (489)
Q Consensus       208 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~Li~  287 (489)
                              .....+.|||.+. ...+.+.=|+|||++||..+--..|=                 .-+..+|+.+.+||.
T Consensus        98 --------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e-----------------~eE~eLS~~LE~LL~  151 (229)
T 2yle_A           98 --------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE-----------------NEERELSPPLEQLID  151 (229)
T ss_dssp             -----------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT-----------------TEEECCCHHHHHHHH
T ss_pred             --------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc-----------------ccchhhCHHHHHHHH
Confidence                    1233567888763 34456678999999999988532221                 123458999999999


Q ss_pred             HhhccC
Q 011287          288 RLLDVD  293 (489)
Q Consensus       288 ~~L~~d  293 (489)
                      .|..-.
T Consensus       152 ~Mt~~~  157 (229)
T 2yle_A          152 HMANTV  157 (229)
T ss_dssp             HHTTCC
T ss_pred             HHHhcc
Confidence            998663

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.30  E-value=0.00042  Score=67.88  Aligned_cols=142  Identities=15%  Similarity=0.103  Sum_probs=78.3

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-----CCCccEEE---EEEEc
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-----HPGVVRLF---FTFQD  116 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~-----hpnIv~l~---~~~~~  116 (489)
                      .+..-.+.|+.|....+|++...  +..+++|+.....     ....+..|..+++.|.     -|.++...   .+...
T Consensus        22 ~~~~~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~   94 (322)
T 2ppq_A           22 GSLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL   94 (322)
T ss_dssp             CCEEEEEEECC---EEEEEEEES--SCCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE
T ss_pred             CcceEeeccCCCcccceEEEEeC--CccEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEE
Confidence            34455677888988999999763  3378999986531     1123445666665552     23333210   01123


Q ss_pred             CCEEEEEEeccCCCChH-----------H---HHHhC-CCC--------CHHHHHH---------------HHHHHHHHH
Q 011287          117 TFSLYMALESCEGGELF-----------D---QITSK-GHL--------SEDEARF---------------YTAEVVDAL  158 (489)
Q Consensus       117 ~~~lylV~E~~~gg~L~-----------~---~l~~~-~~l--------~e~~~~~---------------i~~qil~aL  158 (489)
                      .+..+++|++++|..+.           .   .+... ..+        ....-..               +...+..++
T Consensus        95 ~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~  174 (322)
T 2ppq_A           95 SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEI  174 (322)
T ss_dssp             TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHH
T ss_pred             CCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHH
Confidence            45679999999985431           0   11110 011        1000000               011234455


Q ss_pred             HHHHh-------CCcEeeccCCCCeeeCCCCCEEEeeccCcc
Q 011287          159 EYIHS-------MGLIHRDIKPENLLLTADGHIKIADFGSVK  193 (489)
Q Consensus       159 ~~LH~-------~gIiHrDLKpeNILl~~~g~ikL~DFG~a~  193 (489)
                      +.++.       .+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus       175 ~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          175 DYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             HHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            55552       369999999999999876556899999875

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.25  E-value=0.0024  Score=61.56  Aligned_cols=79  Identities=16%  Similarity=0.084  Sum_probs=54.5

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-C--CCccEEEEEEEcCCEEEE
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-H--PGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~-h--pnIv~l~~~~~~~~~lyl  122 (489)
                      ...-++.+|.|..+.||+++. .+|+.|.+|+.....   ......+..|...|+.|. .  -.+.+++.+  +.  -++
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~---~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~l   87 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDA---PALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTL   87 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTC---CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEE
T ss_pred             CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCC---cchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceE
Confidence            456788899999999999986 568999999865332   112245677888888773 2  234455554  22  368


Q ss_pred             EEeccCCCCh
Q 011287          123 ALESCEGGEL  132 (489)
Q Consensus       123 V~E~~~gg~L  132 (489)
                      ||||+.++..
T Consensus        88 v~e~l~~~~~   97 (288)
T 3f7w_A           88 AMEWVDERPP   97 (288)
T ss_dssp             EEECCCCCCC
T ss_pred             EEEeecccCC
Confidence            9999987643

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.21  E-value=0.00084  Score=69.05  Aligned_cols=74  Identities=9%  Similarity=0.001  Sum_probs=49.5

Q ss_pred             EeeEEeeeCceEEEEEEEcC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-cEEEEEEEcCCEE
Q 011287           49 LGKIYGVGSYSKVVRAKKID-------TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV-VRLFFTFQDTFSL  120 (489)
Q Consensus        49 ~~~~LG~G~~g~Vy~a~~~~-------tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~l  120 (489)
                      -++.|+.|....||++....       ++..|++|+.....     ....+.+|..+++.|...++ .++++.+.+    
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-----TESHLVAESVIFTLLSERHLGPKLYGIFSG----  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-----cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence            45678888899999998753       35789999984321     11233468888887743333 567776643    


Q ss_pred             EEEEeccCCCC
Q 011287          121 YMALESCEGGE  131 (489)
Q Consensus       121 ylV~E~~~gg~  131 (489)
                      .+|+||++|.+
T Consensus       148 g~v~e~l~G~~  158 (429)
T 1nw1_A          148 GRLEEYIPSRP  158 (429)
T ss_dssp             EEEECCCCEEE
T ss_pred             CEEEEEeCCcc
Confidence            28999998643

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.15  E-value=0.00062  Score=68.85  Aligned_cols=140  Identities=15%  Similarity=0.166  Sum_probs=83.5

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccEEEEEEEc
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKID-------TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQD  116 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~-------tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~  116 (489)
                      ++.+ ++.|..|-...+|++....       +++.|++|+....    ......+.+|..+++.|. +.-..++++++.+
T Consensus        51 ~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~  125 (379)
T 3feg_A           51 EELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI----LQGVDSLVLESVMFAILAERSLGPQLYGVFPE  125 (379)
T ss_dssp             GGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT
T ss_pred             CceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc----cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC
Confidence            4444 3566778888899998642       3578999986332    112344567988888774 3223567776654


Q ss_pred             CCEEEEEEeccCCCChH--------------HHHH---hC----C-CCC--HHHHHHHHHHHHH----------------
Q 011287          117 TFSLYMALESCEGGELF--------------DQIT---SK----G-HLS--EDEARFYTAEVVD----------------  156 (489)
Q Consensus       117 ~~~lylV~E~~~gg~L~--------------~~l~---~~----~-~l~--e~~~~~i~~qil~----------------  156 (489)
                      .    +||||++|..|.              +.+.   ..    + ...  ...+..+..++-.                
T Consensus       126 g----~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~  201 (379)
T 3feg_A          126 G----RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYS  201 (379)
T ss_dssp             E----EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTT
T ss_pred             c----cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHH
Confidence            2    899999985542              1111   11    1 111  3455555544422                


Q ss_pred             ---HHHHHH----h----CCcEeeccCCCCeeeCCC----CCEEEeeccCcc
Q 011287          157 ---ALEYIH----S----MGLIHRDIKPENLLLTAD----GHIKIADFGSVK  193 (489)
Q Consensus       157 ---aL~~LH----~----~gIiHrDLKpeNILl~~~----g~ikL~DFG~a~  193 (489)
                         .++.|.    .    ..++|+|+.+.||+++.+    +.+.|+||..|.
T Consensus       202 l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          202 LKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence               233332    2    248999999999999876    789999999876

>4gmv_A RAS-associated and pleckstrin homology domains-CO protein 1; RA-PH, coiled-coil region, RAS-association domain, pleckstri homology domain; 2.40A {Homo sapiens} PDB: 4gn1_A

Probab=97.11  E-value=0.00058  Score=65.70  Aligned_cols=86  Identities=10%  Similarity=0.040  Sum_probs=55.3

Q ss_pred             EEEEeeehhhh--hhccceeEEEecCCeEEEECCCCCee---eeeeeccCCCCceEEEE------c--CCCcEEEEcC--
Q 011287          399 LMISMVKKLQK--LTSKKVQLILTNKPKLIYVDPSKLVV---KGNIIWSDNSNDLSIQV------S--SPSHFKIVTP--  463 (489)
Q Consensus       399 ~~~g~~~k~~g--~~~k~r~~~lt~~p~l~y~d~~~~~~---kg~i~~~~~~~~~~~~~------~--~~~~f~i~~p--  463 (489)
                      -.+|++.++++  -.||||||+|.+....||.+......   .+-++++..  +++.-.      +  .+..|.|..|  
T Consensus       159 e~~G~L~~k~~~~k~WkkRyfvLr~sgLyy~~K~~sk~~r~l~~l~~L~~~--~VY~~~~~kkk~kaPt~~~F~ik~~~~  236 (281)
T 4gmv_A          159 EIEGVLWLKDDGKKSWKKRYFLLRASGIYYVPKGKAKVSRDLVCFLQLDHV--NVYYGQDYRNKYKAPTDYCLVLKHPQI  236 (281)
T ss_dssp             CCEEEEEEECTTSSCEEEEEEEECSSCEEEC---------CCEEEECGGGC--EEEEESSHHHHTCCSCSCEEEEECTTC
T ss_pred             ccEEEEEEECCCCCCCeEEEEEEeCCEEEEEeCCCCCccccceEEEEcCCc--EEEEecccccccCCCCCcEEEEecCcc
Confidence            36899988764  45999999999988765555433334   344577763  233321      1  1458888754  


Q ss_pred             ----CceEEEE-cCCccHHHHHHHHHHh
Q 011287          464 ----KKVLSFE-DAKQRASQWKKAIEAL  486 (489)
Q Consensus       464 ----~r~y~~~-d~~~~~~~W~~~i~~~  486 (489)
                          +.+|+|. |.+..+..|+.+|.-+
T Consensus       237 ~~~~~~~~~~caede~~~~~Wv~Air~a  264 (281)
T 4gmv_A          237 QKKSQYIKYLCCDDVRTLHQWVNGIRIA  264 (281)
T ss_dssp             CSCCTTCEEEECSSHHHHHHHHHHHHHH
T ss_pred             CCCCCceEEEEeCCHHHHHHHHHHHHHH
Confidence                3689999 5558999999999754

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.08  E-value=0.0014  Score=64.21  Aligned_cols=135  Identities=16%  Similarity=0.143  Sum_probs=75.9

Q ss_pred             eEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--ccEEEEE-----EEcCCEEEEE
Q 011287           51 KIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG--VVRLFFT-----FQDTFSLYMA  123 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~-----~~~~~~lylV  123 (489)
                      ..|+ |....||++.. .+|+.+++|+......    ....+..|..+++.|...+  +.+++..     ....+..++|
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l  105 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV  105 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence            4566 88889998764 3467899999853211    1234556777776663111  3333332     1234567889


Q ss_pred             EeccCCCChH----H-------H---HHh---CC------CCCHHHH----H------------------HHHHHHHHHH
Q 011287          124 LESCEGGELF----D-------Q---ITS---KG------HLSEDEA----R------------------FYTAEVVDAL  158 (489)
Q Consensus       124 ~E~~~gg~L~----~-------~---l~~---~~------~l~e~~~----~------------------~i~~qil~aL  158 (489)
                      |++++|..+.    +       .   +..   ..      .++....    +                  ..+.+++..+
T Consensus       106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l  185 (328)
T 1zyl_A          106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV  185 (328)
T ss_dssp             EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred             EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence            9999875431    0       1   110   00      1111110    1                  1111222222


Q ss_pred             HHH----HhCCcEeeccCCCCeeeCCCCCEEEeeccCcc
Q 011287          159 EYI----HSMGLIHRDIKPENLLLTADGHIKIADFGSVK  193 (489)
Q Consensus       159 ~~L----H~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~  193 (489)
                      +-+    ....++|+|++|.|||++ + .+.|+||+.+.
T Consensus       186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence            222    124589999999999998 4 89999998875

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.07  E-value=0.0012  Score=65.14  Aligned_cols=31  Identities=32%  Similarity=0.597  Sum_probs=27.1

Q ss_pred             CCcEeeccCCCCeeeCCC----CCEEEeeccCccc
Q 011287          164 MGLIHRDIKPENLLLTAD----GHIKIADFGSVKP  194 (489)
Q Consensus       164 ~gIiHrDLKpeNILl~~~----g~ikL~DFG~a~~  194 (489)
                      ..++|||+.+.|||++.+    +.+.|+||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            469999999999999875    6899999998764

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.06  E-value=0.00077  Score=67.61  Aligned_cols=75  Identities=16%  Similarity=0.003  Sum_probs=44.3

Q ss_pred             EeeEEeeeCceEEEEEEEcC--------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC-ccEEEEEEEcCCE
Q 011287           49 LGKIYGVGSYSKVVRAKKID--------TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG-VVRLFFTFQDTFS  119 (489)
Q Consensus        49 ~~~~LG~G~~g~Vy~a~~~~--------tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~  119 (489)
                      -.+.|+.|....+|++....        .+..|++|+.....   . .......|..+++.+...+ +.+++..+  .+ 
T Consensus        37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-  109 (369)
T 3c5i_A           37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---D-ELYNTISEFEVYKTMSKYKIAPQLLNTF--NG-  109 (369)
T ss_dssp             EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---G-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT-
T ss_pred             EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---c-ceecHHHHHHHHHHHHhcCCCCceEEec--CC-
Confidence            35667888889999998643        13689999875421   1 1112356777777774333 34666654  22 


Q ss_pred             EEEEEeccCCCC
Q 011287          120 LYMALESCEGGE  131 (489)
Q Consensus       120 lylV~E~~~gg~  131 (489)
                       ++||||++|..
T Consensus       110 -~~v~e~i~G~~  120 (369)
T 3c5i_A          110 -GRIEEWLYGDP  120 (369)
T ss_dssp             -EEEEECCCSEE
T ss_pred             -cEEEEEecCCc
Confidence             68999998754

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.92  E-value=0.003  Score=62.65  Aligned_cols=31  Identities=29%  Similarity=0.366  Sum_probs=27.6

Q ss_pred             CCcEeeccCCCCeeeCCCCCEEEeeccCccc
Q 011287          164 MGLIHRDIKPENLLLTADGHIKIADFGSVKP  194 (489)
Q Consensus       164 ~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~  194 (489)
                      ..++|+|+.|.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3699999999999999888999999988764

>3mpx_A FYVE, rhogef and PH domain-containing protein 5; structural genomics consortium, DH domain, SGC, L binding protein; 2.80A {Homo sapiens}

Probab=96.90  E-value=0.0015  Score=67.09  Aligned_cols=101  Identities=17%  Similarity=0.227  Sum_probs=70.2

Q ss_pred             cccccCCCceEEEEEeeehhhhhhccceeEEEecCCeEEEEC--CCCCeeeeeeeccCCCCceEEEEcCCCcEEEEcCCc
Q 011287          388 WQQFLDPGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVD--PSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKK  465 (489)
Q Consensus       388 ~~~~~~~~~~i~~~g~~~k~~g~~~k~r~~~lt~~p~l~y~d--~~~~~~kg~i~~~~~~~~~~~~~~~~~~f~i~~p~r  465 (489)
                      |..++.+|...++.|.+.+..+.-.+.|+++|-+.-.++..-  .++-..|+.||++....+.......+..|.|.++++
T Consensus       234 ~~~l~~~~r~li~~g~l~~~~~~~~~~r~~fLF~d~Ll~~k~~~~~~y~~k~~i~L~~l~v~~~~~~~~~~~f~i~~~~~  313 (434)
T 3mpx_A          234 QGDLLQPGREFLKEGTLMKVTGKNRRPRHLFLMNDVLLYTYPQKDGKYRLKNTLAVANMKVSRPVMEKVPYALKIETSES  313 (434)
T ss_dssp             CCCCCCTTCCEEECCEEEEEETTEEEEEEEEEESSEEEEEEECTTSCEEEEEEEEC-----CCCCCTTSCSEEEEECSSC
T ss_pred             ccccccCCcceEecceEEEEeCCCceEEEEEEECCEEEEEEecCCCeEEEEEEEEcCCcEEEecCCCCCCeeEEEecCCe
Confidence            456677888899999998766655677888888875555442  235678899999974221111113368999999999


Q ss_pred             eEEEEcCC-ccHHHHHHHHHHhcC
Q 011287          466 VLSFEDAK-QRASQWKKAIEALQN  488 (489)
Q Consensus       466 ~y~~~d~~-~~~~~W~~~i~~~~~  488 (489)
                      +|.|...+ .+.++|+++|++++.
T Consensus       314 ~~~l~a~s~~ek~~W~~~i~~ai~  337 (434)
T 3mpx_A          314 CLMLSASSCAERDEWYGCLSRALP  337 (434)
T ss_dssp             EEEEECSSHHHHHHHHHHHHHC--
T ss_pred             EEEEecCCHHHHHHHHHHHHHHHH
Confidence            99999655 899999999998763

>1v5m_A SH2 and PH domain-containing adapter protein APS; adaptor protein, pleckstrin homology domain, cellular signaling, structural genomics; NMR {Mus musculus} SCOP: b.55.1.1

Probab=96.77  E-value=0.00092  Score=55.82  Aligned_cols=77  Identities=17%  Similarity=0.205  Sum_probs=57.7

Q ss_pred             hhccceeEEEecC-----CeE-EEECCCCCeeeeeeeccCCCCceEEE-----EcCCCcEEEEcCCc-eEEEEc-CCccH
Q 011287          410 LTSKKVQLILTNK-----PKL-IYVDPSKLVVKGNIIWSDNSNDLSIQ-----VSSPSHFKIVTPKK-VLSFED-AKQRA  476 (489)
Q Consensus       410 ~~~k~r~~~lt~~-----p~l-~y~d~~~~~~kg~i~~~~~~~~~~~~-----~~~~~~f~i~~p~r-~y~~~d-~~~~~  476 (489)
                      --|+|++|+|-..     -.| ||..|...+.|..|+++.. .+++..     .-+.++|.|.+.++ -|+|+. .+.++
T Consensus        40 ~~W~k~RLvL~k~g~G~~y~LEfy~PPkssKpK~~i~cs~I-~EVR~tt~LEmPD~~nTFVlK~~n~~eyi~ea~d~~q~  118 (136)
T 1v5m_A           40 AQWQKCRLLLRRAVAGERFRLEFFVPPKASRPKVSIPLSAI-IEVRTTMPLEMPEKDNTFVLKVENGAEYILETIDSLQK  118 (136)
T ss_dssp             CCCEEEEEEEEECSSSCCEEEEEESSTTSSSCSSCEETTTC-CBCCCCCCSSSCCCTTEECCBCTTSCBEEEECSSHHHH
T ss_pred             cchhheeeEEEEccCCCceEEEEecCCcccCCccccchhhh-hhhhhccccccCCccceEEEEecCCcEEEEEcCCHHHH
Confidence            4488988988752     344 8888999999999999965 122111     14678999999988 788884 45799


Q ss_pred             HHHHHHHHHhc
Q 011287          477 SQWKKAIEALQ  487 (489)
Q Consensus       477 ~~W~~~i~~~~  487 (489)
                      ..|+..|..-+
T Consensus       119 ~sWla~Ir~C~  129 (136)
T 1v5m_A          119 HSWVADIQGCV  129 (136)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHhhc
Confidence            99999997643

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.72  E-value=0.008  Score=62.22  Aligned_cols=76  Identities=14%  Similarity=0.177  Sum_probs=49.1

Q ss_pred             EeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-cEEEEEEEcCCEEEEEEecc
Q 011287           49 LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGV-VRLFFTFQDTFSLYMALESC  127 (489)
Q Consensus        49 ~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~lylV~E~~  127 (489)
                      -++.|+.|-...+|++.....+..|++|+.....   ... -...+|..+++.|...++ .+++.++.  +.  +||||+
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~---~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I  183 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT---DEI-INREREKKISCILYNKNIAKKIYVFFT--NG--RIEEFM  183 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C---CSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECC
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh---hhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEee
Confidence            4567888989999999875545889999885431   100 012468888888864444 46777763  22  499999


Q ss_pred             CCCCh
Q 011287          128 EGGEL  132 (489)
Q Consensus       128 ~gg~L  132 (489)
                      +|..|
T Consensus       184 ~G~~l  188 (458)
T 2qg7_A          184 DGYAL  188 (458)
T ss_dssp             CSEEC
T ss_pred             CCccC
Confidence            87443

>3tfm_A Myosin X; split PH domain, motor protein; 2.53A {Rattus norvegicus}

Probab=96.56  E-value=0.0019  Score=60.43  Aligned_cols=74  Identities=12%  Similarity=0.159  Sum_probs=52.1

Q ss_pred             EEEEEeeehhhhhh--ccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCce-EEEEcC-CCcEEEEcCCceEEEEcCC
Q 011287          398 VLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDL-SIQVSS-PSHFKIVTPKKVLSFEDAK  473 (489)
Q Consensus       398 i~~~g~~~k~~g~~--~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~-~~~~~~-~~~f~i~~p~r~y~~~d~~  473 (489)
                      .-+.|+|.|++|+.  ||||||||+++...||.....-.+.|-.--...  .. ..-.++ .++|+|.+++.-+|+.+..
T Consensus        21 ~~~~g~l~~~~~~~~~w~~rw~vl~~~~~~~~~~~~~~~k~G~L~K~g~--~~~~~~~k~WkkRwfvL~~~~L~Yyk~~~   98 (228)
T 3tfm_A           21 PYFHSFLYMNGGLMNSWKRRWCVLKDETFLWFRSKQEALKQGWLHNNGG--GSSTLSRRNWKKRWFVLRQSKLMYFENDS   98 (228)
T ss_dssp             CCEEEEEEECCTTTCCCEEEEEEEETTEEEEESSCCCSSEEEEEEECGG--GCSSSCGGGCEEEEEEECSSEEEEESSTT
T ss_pred             CceEEEEeecCcccccceEEEEEEeCCEEEEeccCCCcceEEEEEEECC--CcCCcccCCceEEEEEEeCCEEEEEeCCC
Confidence            35789999999987  999999999998888888777677676532211  00 000011 3678888888888887654

>1v61_A RAC/CDC42 guanine nucleotide exchange factor (GEF) 6; pleckstrin homology domain, structural genomics; NMR {Mus musculus} SCOP: b.55.1.1

Probab=96.43  E-value=0.0087  Score=50.77  Aligned_cols=89  Identities=15%  Similarity=0.275  Sum_probs=63.9

Q ss_pred             CceEEEEEeeehhhhhh--ccceeEEEecCCeEEEECCC---CCeeeeeeeccCCCCceEEEE-----cCCCcEEEEcCC
Q 011287          395 GESVLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPS---KLVVKGNIIWSDNSNDLSIQV-----SSPSHFKIVTPK  464 (489)
Q Consensus       395 ~~~i~~~g~~~k~~g~~--~k~r~~~lt~~p~l~y~d~~---~~~~kg~i~~~~~~~~~~~~~-----~~~~~f~i~~p~  464 (489)
                      |+ |++.|.|..+.|-.  .+-|.|+|-+.-.||..-..   .-.+||.+|++.    +.|..     ..++.|.|.-+.
T Consensus        26 G~-ii~~s~v~~~~~~~~~~~eR~l~LF~~~Ll~~s~~~~~~~f~~kgklPL~g----~~V~~~ed~~~~~~aFeI~g~~  100 (132)
T 1v61_A           26 GN-VIFMSQVVMQHGACEEKEERYFLLFSSVLIMLSASPRMSGFMYQGKIPIAG----MVVNRLDEIEGSDCMFEITGST  100 (132)
T ss_dssp             CC-CSCEEEEEBCCSSSSCCCEEEEEECSSCEEEEECSSSSSCCEEEEEECTTT----CBCSTTCSSSSSCCCEEEECSS
T ss_pred             CC-eEEEeeEEEEEcccCcceEEEEEEcCCeEEEEEecCCCceEEEEEEEecce----eEEEeccccccCccEEEEecCC
Confidence            54 44455555544322  35699999998887776543   348999999997    45443     245799998765


Q ss_pred             -ceEEEEcCC-ccHHHHHHHHHHhcC
Q 011287          465 -KVLSFEDAK-QRASQWKKAIEALQN  488 (489)
Q Consensus       465 -r~y~~~d~~-~~~~~W~~~i~~~~~  488 (489)
                       +++.+...+ .+.++|+++|+.+++
T Consensus       101 ~~~i~v~~~s~eE~~~Wl~~L~~~i~  126 (132)
T 1v61_A          101 VERIVVHCNNNQDFQEWMEQLNRLTK  126 (132)
T ss_dssp             SCEEEECCCCSHHHHHHHHHHHHHHT
T ss_pred             CceEEEEeCCHHHHHHHHHHHHHHHh
Confidence             888888765 789999999998764

>4f7h_A Fermitin family homolog 2; beta-barrel, membrane binding, integrin activation, cytoplas membrane, cell adhesion; HET: SRT; 1.90A {Homo sapiens} PDB: 2lko_A*

Probab=95.87  E-value=0.011  Score=51.49  Aligned_cols=71  Identities=14%  Similarity=0.207  Sum_probs=51.7

Q ss_pred             ccceeEEEecCCeEEEECCCC--CeeeeeeeccCCCCceEEEE-cCCCcEEE--EcC----CceEEEE-cCCccHHHHHH
Q 011287          412 SKKVQLILTNKPKLIYVDPSK--LVVKGNIIWSDNSNDLSIQV-SSPSHFKI--VTP----KKVLSFE-DAKQRASQWKK  481 (489)
Q Consensus       412 ~k~r~~~lt~~p~l~y~d~~~--~~~kg~i~~~~~~~~~~~~~-~~~~~f~i--~~p----~r~y~~~-d~~~~~~~W~~  481 (489)
                      ||+|||++-|.-..||..+..  .+..|.|+|.-+  ++.+++ .+...|.|  ..|    .+.|+|. |.+....+|..
T Consensus        66 yKryWFv~kd~~LsyYKskEe~~geP~~~I~LrGC--EVtpDVnva~~Kf~IkL~vP~~~gm~e~~Lrcd~E~qya~WMA  143 (173)
T 4f7h_A           66 YKQYWCTFKDTSISCYKSKEESSGTPAHQMNLRGC--EVTPDVNISGQKFNIKLLIPVAEGMNEIWLRCDNEKQYAHWMA  143 (173)
T ss_dssp             CEEEEEEEETTEEEEESCGGGCSSCCSEEEECTTC--EEEEEEETTTTEEEEEEEEEETTEEEEEEEEESSHHHHHHHHH
T ss_pred             ceeEEEEEeCCEEEEEcCHhHhcCCCceEEecCce--EEeccccccccceeEEEeccCCCCcceeeeecCCHHHHHHHHH
Confidence            899999999988778877765  778899999976  555554 22344433  233    4778888 67789999987


Q ss_pred             HHH
Q 011287          482 AIE  484 (489)
Q Consensus       482 ~i~  484 (489)
                      |..
T Consensus       144 Acr  146 (173)
T 4f7h_A          144 ACR  146 (173)
T ss_dssp             HHH
T ss_pred             Hhh
Confidence            753

>4bbk_A Kindlin-1, fermitin family homolog 1; PH domain, cell adhesion; 2.10A {Mus musculus}

Probab=95.77  E-value=0.01  Score=51.18  Aligned_cols=71  Identities=13%  Similarity=0.217  Sum_probs=52.2

Q ss_pred             ccceeEEEecCCeEEEECCCC--CeeeeeeeccCCCCceEEEEc-CCCcE--EEEcC----CceEEEE-cCCccHHHHHH
Q 011287          412 SKKVQLILTNKPKLIYVDPSK--LVVKGNIIWSDNSNDLSIQVS-SPSHF--KIVTP----KKVLSFE-DAKQRASQWKK  481 (489)
Q Consensus       412 ~k~r~~~lt~~p~l~y~d~~~--~~~kg~i~~~~~~~~~~~~~~-~~~~f--~i~~p----~r~y~~~-d~~~~~~~W~~  481 (489)
                      ||+|||++.|.-..||+++..  ....|.|+|..+  ++.+++. +.+.|  ++..|    ...++|. |.+....+|.-
T Consensus        45 fKryWfv~kDt~LsyYKSkEe~~geP~~~inLrGC--EVtPDVnva~~Kf~ikL~ip~~~gm~e~~LrcdsE~QYa~WMA  122 (165)
T 4bbk_A           45 CKQYWFVFKDTSIAYFKNKELEQGEPIEKLNLRGC--EIVPDVNVSGRKFGIKLLIPVADGMNEVYLRCDHEDQYARWMA  122 (165)
T ss_dssp             CEEEEEEEETTEEEEESSGGGTTSCCSEEEECTTC--EEEEEEETTTTEEEEEEEEEETTEEEEEEEEESSHHHHHHHHH
T ss_pred             ceeEEEEEeCCEEEEEcCHHHhcCCCceEEecCcc--EEecccccccceeeEEEecCCCCcceeeeeecCCHHHHHHHHH
Confidence            899999999998888888865  678899999975  5666653 33444  33233    3567777 67789999987


Q ss_pred             HHH
Q 011287          482 AIE  484 (489)
Q Consensus       482 ~i~  484 (489)
                      |..
T Consensus       123 Acr  125 (165)
T 4bbk_A          123 ACI  125 (165)
T ss_dssp             HHH
T ss_pred             Hhh
Confidence            754

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.73  E-value=0.025  Score=57.86  Aligned_cols=76  Identities=16%  Similarity=0.020  Sum_probs=48.0

Q ss_pred             EeeEEeeeCceEEEEEEEcCC-------CcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCEE
Q 011287           49 LGKIYGVGSYSKVVRAKKIDT-------GTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSL  120 (489)
Q Consensus        49 ~~~~LG~G~~g~Vy~a~~~~t-------g~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~l  120 (489)
                      -++.|..|-...+|++.....       +..|++++.....   +. .....+|..+++.+. +.-..++++.+.  +  
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--  145 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GK-FYDSKVELDVFRYLSNINIAPNIIADFP--E--  145 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----C-CCCHHHHHHHHHHHHHTTSSCCEEEEET--T--
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---ch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--
Confidence            455667788889999987521       6889999875421   11 112345777777774 222345665443  2  


Q ss_pred             EEEEeccCCCCh
Q 011287          121 YMALESCEGGEL  132 (489)
Q Consensus       121 ylV~E~~~gg~L  132 (489)
                      ++||||++|..|
T Consensus       146 ~~I~efI~G~~l  157 (424)
T 3mes_A          146 GRIEEFIDGEPL  157 (424)
T ss_dssp             EEEEECCCSEEC
T ss_pred             CEEEEEeCCccC
Confidence            689999998653

>3ml4_A Protein DOK-7; tyrosine phosphorylation, adapter protein, dimerization, SIG protein; HET: PTR; 2.60A {Mus musculus}

Probab=95.68  E-value=0.012  Score=53.78  Aligned_cols=87  Identities=17%  Similarity=0.278  Sum_probs=65.5

Q ss_pred             eEEEEEeeehhhhhhccceeEEEec-CC-----eE-EEECCCC----CeeeeeeeccCCCCceEEEE-----cCCCcEEE
Q 011287          397 SVLMISMVKKLQKLTSKKVQLILTN-KP-----KL-IYVDPSK----LVVKGNIIWSDNSNDLSIQV-----SSPSHFKI  460 (489)
Q Consensus       397 ~i~~~g~~~k~~g~~~k~r~~~lt~-~p-----~l-~y~d~~~----~~~kg~i~~~~~~~~~~~~~-----~~~~~f~i  460 (489)
                      ..+-+|.|+.+.|..||+||+||-- .|     +| +|.|...    ...|..|.|..-   +-+|.     +..++.-|
T Consensus         8 ~~v~eg~vk~r~~KkWk~rw~vlrk~s~~adcl~L~vYkd~~dr~k~~~~KaslsL~~~---~GlE~g~~ldk~s~TlAI   84 (224)
T 3ml4_A            8 AALVEGQVKLRDGKKWKSRWLVLRKPSPVADCLLMLVYKDKCERSKGLRERSSLTLEDI---CGLEPALPYEGLAHTLAI   84 (224)
T ss_dssp             CCSEEEEEEEC---CCEEEEEEEECSSTTSSCEEEEEESSSHHHHSCCCCSEEEEECCE---EEEEEEEEETTEEEEEEE
T ss_pred             ceeEEEeeeeecCCceeeEEEEEEcCCCchheEEEEEEcChhhhhcCCcccceeehHHh---cCccccccccCcccEEEE
Confidence            4567899999999999999999997 44     34 7878753    445777888765   55555     44578888


Q ss_pred             EcCCceEEEE-cCCccHHHHHHHHHHh
Q 011287          461 VTPKKVLSFE-DAKQRASQWKKAIEAL  486 (489)
Q Consensus       461 ~~p~r~y~~~-d~~~~~~~W~~~i~~~  486 (489)
                      .+...|+.|. |....+.+|...|...
T Consensus        85 Ic~d~~~vLAFds~e~l~~W~~~l~~s  111 (224)
T 3ml4_A           85 ICLSQAVMLGFDSHEAMCAWDTRIRYA  111 (224)
T ss_dssp             EESSCEEEEECSSHHHHHHHHHHHHHH
T ss_pred             EecCcEEEEEeCCHHHHHHHHHHHhhc
Confidence            9999999999 7778999999988754

>1zc3_B Exocyst complex protein EXO84; exocytosis, small GTPase, GTP-binding protein,, signaling protein; HET: GNP; 2.00A {Rattus norvegicus} SCOP: b.55.1.1 PDB: 1zc4_B*

Probab=95.58  E-value=0.08  Score=43.52  Aligned_cols=89  Identities=13%  Similarity=0.177  Sum_probs=62.1

Q ss_pred             CCceEEEEEeeehhhhh---hccceeEEEecCCeEEEECCC-C----CeeeeeeeccCCCCceEEEE-----cCCCcEEE
Q 011287          394 PGESVLMISMVKKLQKL---TSKKVQLILTNKPKLIYVDPS-K----LVVKGNIIWSDNSNDLSIQV-----SSPSHFKI  460 (489)
Q Consensus       394 ~~~~i~~~g~~~k~~g~---~~k~r~~~lt~~p~l~y~d~~-~----~~~kg~i~~~~~~~~~~~~~-----~~~~~f~i  460 (489)
                      +|.-++++|.+.+...-   ..++++|.|-|. .|+|..+. +    .+....+||..    +.++.     .-.+.|.|
T Consensus         4 pgR~lv~eG~l~el~~~~~k~~~~v~~FLfND-~Ll~a~~~~~~~~~~~~~~~~~L~~----~~v~d~~d~~~~~n~f~i   78 (113)
T 1zc3_B            4 PGQYLVYNGDLVEYEADHMAQLQRVHGFLMND-CLLVATWLPQRRGMYRYNALYPLDR----LAVVNVKDNPPMKDMFKL   78 (113)
T ss_dssp             -CCCEEEEEEEEEEETTTCCEEEEEEEEEESS-EEEEEEEECCTTSCEEEEEEEETTT----CEEEEECCBTTBSSEEEE
T ss_pred             CCeEEEEeCcEEEEccccCCCCccEEEEecCC-EEEEEEEeccCcccEEEEEEEEccc----CEEEECCCCcccceEEEE
Confidence            57788999998875432   234566666665 55555552 1    36677888887    45543     23689999


Q ss_pred             EcCCceEEEEcC-CccHHHHHHHHHHhc
Q 011287          461 VTPKKVLSFEDA-KQRASQWKKAIEALQ  487 (489)
Q Consensus       461 ~~p~r~y~~~d~-~~~~~~W~~~i~~~~  487 (489)
                      .++.+++.+... ..+-.+|+.+|++++
T Consensus        79 ~~~~~s~~~~aes~~eK~~Wl~~~~~a~  106 (113)
T 1zc3_B           79 LMFPESRIFQAENAKIKREWLEVLEETK  106 (113)
T ss_dssp             EETTEEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             EeCCceEEEEcCCHHHHHHHHHHHHHHH
Confidence            999999888754 478899999999875

>1dbh_A Protein (human SOS 1); guanine nucleotide exchange factor, gene regulation; 2.30A {Homo sapiens} SCOP: a.87.1.1 b.55.1.1 PDB: 1pms_A 1awe_A

Probab=95.35  E-value=0.082  Score=52.45  Aligned_cols=91  Identities=12%  Similarity=0.223  Sum_probs=66.3

Q ss_pred             ccCCCceEEEEEeeehhhhhhccceeEEEecCCeEEEECC-----------CCCeeeeeeeccCCCCceEEEEc-----C
Q 011287          391 FLDPGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDP-----------SKLVVKGNIIWSDNSNDLSIQVS-----S  454 (489)
Q Consensus       391 ~~~~~~~i~~~g~~~k~~g~~~k~r~~~lt~~p~l~y~d~-----------~~~~~kg~i~~~~~~~~~~~~~~-----~  454 (489)
                      ++.++...+++|.+.+.+  ..+.|.++|-+.-.++....           ..-..|+.||++.    +.+...     .
T Consensus       240 l~~~~r~li~eG~l~~~g--~~~~~~~fLF~d~Ll~~k~~~~~~~~~~~~~~~y~~k~~i~l~~----~~v~~~~d~~~~  313 (354)
T 1dbh_A          240 IGQCCNEFIMEGTLTRVG--AKHERHIFLFDGLMICCKSNHGQPRLPGASNAEYRLKEKFFMRK----VQINDKDDTNEY  313 (354)
T ss_dssp             GGGTCCCEEEEEEEEETT--CSSCEEEEEESSEEEEEEECTTCCCCTTSCCCSEEEEEEEESCS----CEEEECCCSSSC
T ss_pred             cccccceEEEEeeEEEEe--cCceEEEEEeCCEEEEEecCCCCCCCCCCCCcceeEEEEEeccc----eEEEeCCccccc
Confidence            445577789999998883  45678888877755444432           1335789999997    455442     1


Q ss_pred             CCcEEEEcCC-ceEEEEcCC-ccHHHHHHHHHHhc
Q 011287          455 PSHFKIVTPK-KVLSFEDAK-QRASQWKKAIEALQ  487 (489)
Q Consensus       455 ~~~f~i~~p~-r~y~~~d~~-~~~~~W~~~i~~~~  487 (489)
                      ++.|.|..++ ++|.|...+ .+.++|+++|.++.
T Consensus       314 ~~~F~i~~~~~~~~~l~a~s~~ek~~W~~~i~~~~  348 (354)
T 1dbh_A          314 KHAFEIILKDENSVIFSAKSAEEKNNWMAALISLQ  348 (354)
T ss_dssp             CSEEEECCTTSCCEEEECSSHHHHHHHHHHHHHHH
T ss_pred             CccEEEecCCCCEEEEEeCCHHHHHHHHHHHHHHH
Confidence            4789998874 899999665 78999999999875

>1xcg_A PDZ-rhogef, RHO guanine nucleotide exchange factor 11; X-RAY crystallography, regulation of RHOA GTPase, protein complex; 2.50A {Homo sapiens} SCOP: a.87.1.1 b.55.1.1 PDB: 3kz1_A*

Probab=94.23  E-value=0.15  Score=50.79  Aligned_cols=96  Identities=8%  Similarity=0.125  Sum_probs=63.4

Q ss_pred             cccccCCCceEEEEEeeehhh-hhhccceeEEEecCCeEEEECCC------------------CCeeeeeeeccCCCCce
Q 011287          388 WQQFLDPGESVLMISMVKKLQ-KLTSKKVQLILTNKPKLIYVDPS------------------KLVVKGNIIWSDNSNDL  448 (489)
Q Consensus       388 ~~~~~~~~~~i~~~g~~~k~~-g~~~k~r~~~lt~~p~l~y~d~~------------------~~~~kg~i~~~~~~~~~  448 (489)
                      |..+..++...+++|.+.+.. +-..+.|+++|-+.-.++....+                  +-..++.||++.    +
T Consensus       243 ~~~l~~~~R~li~~G~l~~~~~~~~~~~~~~fLF~d~Ll~~k~~~~k~~~~~~~~~~~~~~~~~~~~~~~i~l~~----~  318 (368)
T 1xcg_A          243 FKSLDLTTRKMIHEGPLTWRISKDKTLDLHVLLLEDLLVLLQKQDEKLLLKCHSKTAVGSSDSKQTFSPVLKLNA----V  318 (368)
T ss_dssp             GGGCCGGGSCEEEEEEEEECCSSSCCCEEEEEEESSEEEEEEECSSCEECCC-------------CCCSEEEGGG----E
T ss_pred             hhhcccccceEEeecceEeeecCCCeeEEEEEcccccHHHhhcccccceeeeccccccCCCCcccCcCCceEccc----e
Confidence            333434566788999987543 22356688877776555544321                  123478899986    4


Q ss_pred             EEEE--cCCCcEEEEcC-----CceEEEEcCC-ccHHHHHHHHHHhc
Q 011287          449 SIQV--SSPSHFKIVTP-----KKVLSFEDAK-QRASQWKKAIEALQ  487 (489)
Q Consensus       449 ~~~~--~~~~~f~i~~p-----~r~y~~~d~~-~~~~~W~~~i~~~~  487 (489)
                      .++.  ...+.|.|.+.     .++|.|...+ .+.+.|+++|++++
T Consensus       319 ~v~~~~~~~~~f~i~~~~~~g~~~~~~l~a~s~~ek~~W~~~i~~ai  365 (368)
T 1xcg_A          319 LIRSVATDKRAFFIICTSKLGPPQIYELVALTSSDKNTWMELLEEAV  365 (368)
T ss_dssp             EEEECSSCSSEEEEEECCSSSTTCEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             eeecccCCCceEEEEEecCCCCceEEEEEcCCHHHHHHHHHHHHHHH
Confidence            5554  34578887643     4899999765 78999999999876

>3t06_A PDZ-rhogef, RHO guanine nucleotide exchange factor 11; DH-PH RHOA complex, pdzrhogef, guanine nucleotide exchange F RHOA, signaling protein; 2.84A {Homo sapiens}

Probab=94.16  E-value=0.15  Score=51.74  Aligned_cols=90  Identities=8%  Similarity=0.124  Sum_probs=63.4

Q ss_pred             CCceEEEEEeeehhhh-hhccceeEEEecCCeEEEECCC------------------CCeeeeeeeccCCCCceEEEE--
Q 011287          394 PGESVLMISMVKKLQK-LTSKKVQLILTNKPKLIYVDPS------------------KLVVKGNIIWSDNSNDLSIQV--  452 (489)
Q Consensus       394 ~~~~i~~~g~~~k~~g-~~~k~r~~~lt~~p~l~y~d~~------------------~~~~kg~i~~~~~~~~~~~~~--  452 (489)
                      ++...+++|.+.+..+ --++.|+++|-+.-.++....+                  ....|+.|+++.    +.+..  
T Consensus       291 ~~r~li~eG~l~~~~~~~~~~~~~~fLF~d~Ll~~k~~~~k~~~~~~~~~~~~~~~~~~~~k~~i~l~~----~~v~~~~  366 (418)
T 3t06_A          291 TTRKMIHEGPLTWRISKDKTLDLHVLLLEDLLVLLQKQDEKLLLKCHSKTAVGSSDSKQTFSPVLKLNA----VLIRSVA  366 (418)
T ss_dssp             GGSCEEEEEEEEECCBTTBCCEEEEEEESSEEEEEEECSSCEECCC-------------CCCSEEEGGG----EEEEECS
T ss_pred             ccceeEEeceEEEEeCCCCeEEEEEEecCCEEEEEEEcCCceEEeecccccccCCCcccccCCceechh----ceecccc
Confidence            4566889999976543 2356788888887777665432                  234568899987    44443  


Q ss_pred             cCCCcEEEEcC-----CceEEEEcCC-ccHHHHHHHHHHhc
Q 011287          453 SSPSHFKIVTP-----KKVLSFEDAK-QRASQWKKAIEALQ  487 (489)
Q Consensus       453 ~~~~~f~i~~p-----~r~y~~~d~~-~~~~~W~~~i~~~~  487 (489)
                      ...+.|+|...     .++|.|...+ .+.+.|+++|++++
T Consensus       367 ~~~~~f~l~~~~~~~~~~~~~l~A~s~~ek~~W~~~I~~a~  407 (418)
T 3t06_A          367 TDKRAFFIICTSKLGPPQIYELVALTSSDKNTWMELLEEAV  407 (418)
T ss_dssp             SCSSEEEEEECCSSSTTCEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             ccCceEEEEecCCCCCceEEEEEcCCHHHHHHHHHHHHHHH
Confidence            34568888642     3899999765 78999999999986

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.15  E-value=0.13  Score=51.88  Aligned_cols=29  Identities=24%  Similarity=0.410  Sum_probs=24.9

Q ss_pred             cEeeccCCCCeee------CCCCCEEEeeccCccc
Q 011287          166 LIHRDIKPENLLL------TADGHIKIADFGSVKP  194 (489)
Q Consensus       166 IiHrDLKpeNILl------~~~g~ikL~DFG~a~~  194 (489)
                      ++|+|+.+.|||+      ++++.+.++||.+|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6899999999999      4567899999998763

>2z0q_A XPLN, RHO guanine nucleotide exchange factor 3; DH-PH domain, alternative splicing, cytoplasm, guanine- nucleotide releasing factor; 1.79A {Mus musculus} PDB: 3eo2_A

Probab=93.96  E-value=0.11  Score=51.33  Aligned_cols=90  Identities=14%  Similarity=0.222  Sum_probs=62.9

Q ss_pred             ccCCCceEEEEEeeehhhhhhccceeEEEecCCeEEEECC--CC----CeeeeeeeccCCCCceEEEEcC----------
Q 011287          391 FLDPGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDP--SK----LVVKGNIIWSDNSNDLSIQVSS----------  454 (489)
Q Consensus       391 ~~~~~~~i~~~g~~~k~~g~~~k~r~~~lt~~p~l~y~d~--~~----~~~kg~i~~~~~~~~~~~~~~~----------  454 (489)
                      .+.++...++.|.+.+.+|   +.|+++|=+.-.++....  +.    ...|+-||++.    +.++...          
T Consensus       225 l~~~~r~li~~G~l~~~~~---~~~~~fLF~d~Ll~~k~~~~~~~~~~~v~k~~i~l~~----l~v~~~~d~~~~~~~s~  297 (346)
T 2z0q_A          225 LIDSSRVLCCHGELKNNRG---VKLHVFLFQEVLVITRAVTHNEQLCYQLYRQPIPVKD----LTLEDLQDGEVRLGGSL  297 (346)
T ss_dssp             HHHTCCCEEEEEEEEETTS---CEEEEEEESSEEEEEEEEEETTEEEEEESSCCEEGGG----CEEEECCTTTSCCCSCC
T ss_pred             cccCCeEEEEeceeEECCC---cEEEEEECCCcEEEEEEeccCCceeeeeecCCcchhh----ceeeecCCCccccCccc
Confidence            4446777889999987766   677887777655444321  11    12578899987    4555432          


Q ss_pred             ----------CCcEEEEc----CCceEEEEcCC-ccHHHHHHHHHHhc
Q 011287          455 ----------PSHFKIVT----PKKVLSFEDAK-QRASQWKKAIEALQ  487 (489)
Q Consensus       455 ----------~~~f~i~~----p~r~y~~~d~~-~~~~~W~~~i~~~~  487 (489)
                                ++.|.|..    ++++|.|...+ .+.++|+++|++++
T Consensus       298 ~g~~~~~~~~~~~F~i~~~~~~~~~~~~l~a~s~~ek~~W~~~i~~ai  345 (346)
T 2z0q_A          298 RGAFSNNERVKNFFRVSFKNGSQSQTHSLQANDTFNKQQWLNCIRQAK  345 (346)
T ss_dssp             --CCSHHHHTSSEEEEEECCGGGCEEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             cccccCCcccccceEEEEecCCCCceEEEEECCHHHHHHHHHHHHHhh
Confidence                      35799963    47899999665 78999999999875

>2dfk_A Collybistin II; DH domain, PH domain, cell cycle; 2.15A {Rattus norvegicus} SCOP: a.87.1.1 b.55.1.1

Probab=93.79  E-value=0.27  Score=49.70  Aligned_cols=93  Identities=15%  Similarity=0.224  Sum_probs=65.4

Q ss_pred             ccCCCceEEEEEeeehhhhh--hccceeEEEecCCeEEEECC----CCCeeeeeeeccCCCCceEEEEcC----------
Q 011287          391 FLDPGESVLMISMVKKLQKL--TSKKVQLILTNKPKLIYVDP----SKLVVKGNIIWSDNSNDLSIQVSS----------  454 (489)
Q Consensus       391 ~~~~~~~i~~~g~~~k~~g~--~~k~r~~~lt~~p~l~y~d~----~~~~~kg~i~~~~~~~~~~~~~~~----------  454 (489)
                      ++.++...+++|.+.+..+.  -.+.|+++|-+.-.++....    ..-..|+.||++.    +.+....          
T Consensus       250 l~~~~r~Li~~G~l~~~~~~~~k~~~r~~fLF~d~Ll~~k~~~~~~~~~~~k~~i~l~~----~~v~~~~d~~~~~~~~~  325 (402)
T 2dfk_A          250 ILDRSSELIYTGEMAWIYQPYGRNQQRVFFLFDHQMVLCKKDLIRRDILYYKGRIDMDK----YEVIDIEDGRDDDFNVS  325 (402)
T ss_dssp             GGGTCCCEEEEEEEEEESSTTCCCEEEEEEEETTEEEEEEECSSCTTCEEEEEEEEGGG----EEEEECCSEECSSSCCE
T ss_pred             ccccccceEEeceEEEEeccCCceEEEEEEeeCCEEEEEEeccccCCceEEeeeeeccc----eEEEecCCCCccccccc
Confidence            34456668899998765442  24568888888766665532    2356899999986    4554421          


Q ss_pred             -CCcEEEEcC--CceEEEEcCC-ccHHHHHHHHHHhc
Q 011287          455 -PSHFKIVTP--KKVLSFEDAK-QRASQWKKAIEALQ  487 (489)
Q Consensus       455 -~~~f~i~~p--~r~y~~~d~~-~~~~~W~~~i~~~~  487 (489)
                       ++.|.|..+  .++|.|...+ .+.+.|+++|.+.+
T Consensus       326 ~~~~F~i~~~~~~~~~~l~a~s~~eK~~Wi~~i~~a~  362 (402)
T 2dfk_A          326 MKNAFKLHNKETEEVHLFFAKKLEEKIRWLRAFREER  362 (402)
T ss_dssp             ESSEEEEEESSSSCEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             cceeEEEEECCCCeEEEEEeCCHHHHHHHHHHHHHHH
Confidence             368999865  5789998655 78999999998754

>3jzy_A Intersectin 2; C2 domain, structural genomics consortium (SGC), endocytosis; 1.56A {Homo sapiens} PDB: 3qbv_B* 1ki1_B

Probab=92.32  E-value=0.025  Score=59.14  Aligned_cols=88  Identities=18%  Similarity=0.241  Sum_probs=0.0

Q ss_pred             CCceEEEEEeeehhhhhhccceeEEEecCCeEEEECCCCC--------------------eeeeeeeccCCCCceEEEE-
Q 011287          394 PGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPSKL--------------------VVKGNIIWSDNSNDLSIQV-  452 (489)
Q Consensus       394 ~~~~i~~~g~~~k~~g~~~k~r~~~lt~~p~l~y~d~~~~--------------------~~kg~i~~~~~~~~~~~~~-  452 (489)
                      ++..++++|.+.|.++  .+.|+++|-+.-.++.. +.+.                    ..|+.|+++..    .+.. 
T Consensus       249 ~~r~li~eG~l~~~~~--~~~~~~fLF~d~Ll~~k-~~~~~~~~~g~~~~f~~~~~~~~~v~k~~i~l~~~----~v~~~  321 (510)
T 3jzy_A          249 GPRKLLHSGKLYKTKS--NKELHGFLFNDFLLLTY-MVKQFAVSSGSEKLFSSKSNAQFKMYKTPIFLNEV----LVKLP  321 (510)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             ccceeEEeceEEEcCC--CcEEEEEcccceeEEee-ecccccccCCcccccCcccccceeEEcCceehhhe----EEecc
Confidence            3456788888877643  46787777766555443 2211                    24788998874    3332 


Q ss_pred             ----cCCCcEEEEcCCceEEEEcCC-ccHHHHHHHHHHhcC
Q 011287          453 ----SSPSHFKIVTPKKVLSFEDAK-QRASQWKKAIEALQN  488 (489)
Q Consensus       453 ----~~~~~f~i~~p~r~y~~~d~~-~~~~~W~~~i~~~~~  488 (489)
                          ..+..|.|..+.|+|.|..++ .+.++|+++|++++.
T Consensus       322 ~d~~~~~~~F~i~~~~~~~~l~a~s~~ek~~W~~~i~~ai~  362 (510)
T 3jzy_A          322 TDPSSDEPVFHISHIDRVYTLRTDNINERTAWVQKIKAASE  362 (510)
T ss_dssp             -----------------------------------------
T ss_pred             CCCCccccceeeeccceeEEeccCCHHHHHHHHHHHHHHHH
Confidence                235799999999999999655 789999999998753

>2pz1_A RHO guanine nucleotide exchange factor 4; helical bundle, beta barrel, beta sandwich, signaling protei; 2.25A {Homo sapiens} PDB: 2dx1_A 3nmz_D 3nmx_D

Probab=92.01  E-value=0.56  Score=48.24  Aligned_cols=91  Identities=12%  Similarity=0.173  Sum_probs=63.7

Q ss_pred             CCCceEEEEEeeehhhhh--hccceeEEEecCCeEEEECC----CCCeeeeeeeccCCCCceEEEEcC-----------C
Q 011287          393 DPGESVLMISMVKKLQKL--TSKKVQLILTNKPKLIYVDP----SKLVVKGNIIWSDNSNDLSIQVSS-----------P  455 (489)
Q Consensus       393 ~~~~~i~~~g~~~k~~g~--~~k~r~~~lt~~p~l~y~d~----~~~~~kg~i~~~~~~~~~~~~~~~-----------~  455 (489)
                      .++...+++|.+.+..+.  -.+.|+++|-+.-.++....    .....|+.||++.    +.+....           +
T Consensus       329 ~~~r~li~~G~l~~~~~~~~~~~~r~~fLF~d~Ll~~k~~~~~~~~~~~k~~i~l~~----~~v~~~~d~~~~~~~~~~~  404 (466)
T 2pz1_A          329 VRSSELIYSGELTRVTQPQAKSQQRMFFLFDHQLIYCKKDLLRRDVLYYKGRLDMDG----LEVVDLEDGKDRDLHVSIK  404 (466)
T ss_dssp             HHCSCEEEEEEEEEECTTTCCEEEEEEEEETTEEEEEEECSSCTTCEEEEEEEETTT----CEEEECCSBSCCSSCCCBC
T ss_pred             cccceeEEeeeEEEEecCCCCeeEEEEEEECCEEEEEEeccccCCceEEeeeeeccc----eEEEeCCCCcccccccccc
Confidence            345567889988765442  24568888888766665532    2456799999987    4554321           2


Q ss_pred             CcEEEEcC--CceEEEEcCC-ccHHHHHHHHHHhc
Q 011287          456 SHFKIVTP--KKVLSFEDAK-QRASQWKKAIEALQ  487 (489)
Q Consensus       456 ~~f~i~~p--~r~y~~~d~~-~~~~~W~~~i~~~~  487 (489)
                      +.|.|..+  .++|.|...+ .+.+.|+++|.+.+
T Consensus       405 ~~F~i~~~~~~~~~~l~a~s~~eK~~W~~~i~~a~  439 (466)
T 2pz1_A          405 NAFRLHRGATGDSHLLCTRKPEQKQRWLKAFARER  439 (466)
T ss_dssp             EEEEEECSSSCCEEEEEESSHHHHHHHHHHHHHHH
T ss_pred             eeEEEEeCCCCeEEEEEeCCHHHHHHHHHHHHHHH
Confidence            57999865  5789888655 78999999998864

>2lg1_A A-kinase anchor protein 13; metal binding protein; NMR {Homo sapiens}

Probab=91.69  E-value=0.34  Score=43.40  Aligned_cols=89  Identities=11%  Similarity=0.135  Sum_probs=54.6

Q ss_pred             CceEEEEEeee-hhhhhhccceeEEEecCCeEEEECCCCC-e------eeeeeeccCCCCceEEEE--cCCCcEEEEcC-
Q 011287          395 GESVLMISMVK-KLQKLTSKKVQLILTNKPKLIYVDPSKL-V------VKGNIIWSDNSNDLSIQV--SSPSHFKIVTP-  463 (489)
Q Consensus       395 ~~~i~~~g~~~-k~~g~~~k~r~~~lt~~p~l~y~d~~~~-~------~kg~i~~~~~~~~~~~~~--~~~~~f~i~~p-  463 (489)
                      +..++++|.|. |...--++.|.++|-+.-.++....+.. .      +..-|++..    +.|..  ...+.|++... 
T Consensus        68 ~R~Ll~eG~L~~k~~~~~~~d~~~fLf~D~Ll~~~~~~~ky~~~~~~~~~pvi~L~~----~~vre~a~d~~~~fli~~~  143 (185)
T 2lg1_A           68 RKKLVRDGSVFLKNAAGRLKEVQAVLLTDILVFLQEKDQKYIFASLDQKSTVISLKK----LIVREVAHEEKGLFLISMG  143 (185)
T ss_dssp             TSCEEEEEEEEEECTTCCEEEEEEEEESSEEECCEEETTEEECCCCSSSCSEEESSS----CEEECCSSCSSEEEEECCS
T ss_pred             CCceeeeceEEEeccCCCeeeEEEEeecCEEEEEEecCCEEEEEcccCCCCeEeecc----eEEeccCCCCCeEEEEEec
Confidence            45689999996 3221135667776666533333221111 1      124577776    34544  34466766642 


Q ss_pred             ---CceEEEEcCC-ccHHHHHHHHHHhc
Q 011287          464 ---KKVLSFEDAK-QRASQWKKAIEALQ  487 (489)
Q Consensus       464 ---~r~y~~~d~~-~~~~~W~~~i~~~~  487 (489)
                         .+.|-|...+ .+.+.|+++|.+++
T Consensus       144 ~~g~~~yel~a~s~~er~~W~~~I~~Ai  171 (185)
T 2lg1_A          144 MTDPEMVEVHASSKEERNSWIQIIQDTI  171 (185)
T ss_dssp             SSCCCCEEEECSSHHHHHHHHHHHHHHH
T ss_pred             CCCCeEEEEEcCCHHHHHHHHHHHHHHH
Confidence               4899999765 89999999999865

>1txd_A RHO guanine nucleotide exchange factor 12; helical bundle (DH), beta sandwich (PH), signaling protein; 2.13A {Homo sapiens} SCOP: a.87.1.1 b.55.1.1 PDB: 1x86_A

Probab=90.86  E-value=0.41  Score=47.90  Aligned_cols=90  Identities=7%  Similarity=0.082  Sum_probs=56.8

Q ss_pred             CCceEEEEEeeehhhh-hhccceeEEEecCCeEEEECCC------------------CCeeeeeeeccCCCCceEEEEc-
Q 011287          394 PGESVLMISMVKKLQK-LTSKKVQLILTNKPKLIYVDPS------------------KLVVKGNIIWSDNSNDLSIQVS-  453 (489)
Q Consensus       394 ~~~~i~~~g~~~k~~g-~~~k~r~~~lt~~p~l~y~d~~------------------~~~~kg~i~~~~~~~~~~~~~~-  453 (489)
                      ++...+++|.+.++.+ .-.+.|+++|-+.-.++....+                  ....++.|+++.    +.++.. 
T Consensus       253 ~~R~li~eG~l~~~~~~~~~~~~~~fLF~d~Ll~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~l~~----~~v~~~~  328 (385)
T 1txd_A          253 TKRKMIHEGPLVWKVNRDKTIDLYTLLLEDILVLLQKQDDRLVLRCHSKILASTADSKHTFSPVIKLST----VLVRQVA  328 (385)
T ss_dssp             GGSCEEEEEEEEEESSSSCBCCEEEEEESSEEEEEEEETTEEECCC-------------CCCSEEEGGG----EEEEECC
T ss_pred             ccceEEEECcEEEEcCCCCeEEEEEEecCCeeEEEEecCCeeEEeeccccccccCCCCcCCCCceeccc----ccccccc
Confidence            4566788999875432 2246677777766554443221                  123578899986    455442 


Q ss_pred             -CCCcEEEEc----CCceEEEEcCC-ccHHHHHHHHHHhc
Q 011287          454 -SPSHFKIVT----PKKVLSFEDAK-QRASQWKKAIEALQ  487 (489)
Q Consensus       454 -~~~~f~i~~----p~r~y~~~d~~-~~~~~W~~~i~~~~  487 (489)
                       ..+.|++.+    +.++|.|...+ .+.+.|+++|.+++
T Consensus       329 ~d~~~~f~i~~~~~~~~~~~l~a~s~~ek~~W~~~i~~~i  368 (385)
T 1txd_A          329 TDNKALFVISMSDNGAQIYELVAQTVSEKTVWQDLICRMA  368 (385)
T ss_dssp             C-CCEEEEEEECSSCEEEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             cCCceEEEEEEcCCCceEEEEEcCCHHHHHHHHHHHHHHH
Confidence             234555543    35899998665 78999999999875

>1mai_A Phospholipase C delta-1; pleckstrin, inositol trisphosphate, signal transduction protein, hydrolase; HET: I3P; 1.90A {Rattus norvegicus} SCOP: b.55.1.1

Probab=90.19  E-value=0.62  Score=39.10  Aligned_cols=74  Identities=14%  Similarity=0.199  Sum_probs=52.4

Q ss_pred             ccceeEEEecCCeEEEEC--CC-CCeeeeeeeccCCCCceEEEEcC--------------CCcEEEEcCC--ceEEEEcC
Q 011287          412 SKKVQLILTNKPKLIYVD--PS-KLVVKGNIIWSDNSNDLSIQVSS--------------PSHFKIVTPK--KVLSFEDA  472 (489)
Q Consensus       412 ~k~r~~~lt~~p~l~y~d--~~-~~~~kg~i~~~~~~~~~~~~~~~--------------~~~f~i~~p~--r~y~~~d~  472 (489)
                      .|.|.|+|++...++|..  |. ....++.|+++..   -.|....              ...|.|+-.+  ++-+|..+
T Consensus        28 ~k~r~f~l~~~~~~~w~~s~~~~~~~~~~~i~i~~I---~eIr~G~~s~~~~~~~~~~~~~~~FsIiy~~~~k~LdlvA~  104 (131)
T 1mai_A           28 RRERFYKLQEDCKTIWQESRKVMRSPESQLFSIEDI---QEVRMGHRTEGLEKFARDIPEDRCFSIVFKDQRNTLDLIAP  104 (131)
T ss_dssp             EEEEEEEECTTSSEEEECCCCTTCCTTTTEEEGGGE---EEEEESSCSHHHHHHCTTSCGGGEEEEEESSSCCCEEEECS
T ss_pred             ceeEEEEECCCCCEEEeCCcCCCCCCcCcEEEHhhh---HHHHCCCCCHHHHhhhhcCCccceEEEEECCCCceEEEEeC
Confidence            367999999977777773  32 2346799999974   4555532              1358887554  57787765


Q ss_pred             C-ccHHHHHHHHHHhcC
Q 011287          473 K-QRASQWKKAIEALQN  488 (489)
Q Consensus       473 ~-~~~~~W~~~i~~~~~  488 (489)
                      + .+|+.|+..|+.++.
T Consensus       105 s~~e~~~Wv~gL~~L~~  121 (131)
T 1mai_A          105 SPADAQHWVQGLRKIIH  121 (131)
T ss_dssp             SHHHHHHHHHHHHHHHC
T ss_pred             CHHHHHHHHHHHHHHHH
Confidence            5 899999999998763

>3qwm_A Iqsec1, IQ motif and SEC7 domain-containing protein 1; structural genomics, structural genomics consortium, SGC; 2.39A {Homo sapiens}

Probab=89.89  E-value=3.3  Score=35.06  Aligned_cols=90  Identities=11%  Similarity=0.217  Sum_probs=62.8

Q ss_pred             CCceEEEEEee------ehhhhhhccceeEEEecCCeEEEE---CC---CCCeeeeeeeccCCCCceEEEEc----CCCc
Q 011287          394 PGESVLMISMV------KKLQKLTSKKVQLILTNKPKLIYV---DP---SKLVVKGNIIWSDNSNDLSIQVS----SPSH  457 (489)
Q Consensus       394 ~~~~i~~~g~~------~k~~g~~~k~r~~~lt~~p~l~y~---d~---~~~~~kg~i~~~~~~~~~~~~~~----~~~~  457 (489)
                      +....+..+.+      .|..+.-...|+|.|=|.-.||-+   ++   ++-..++-+|+..    +++..-    -++.
T Consensus         9 phRrlvc~~~l~ev~d~~K~~~kg~qqR~~FLFND~LL~TK~~~kkk~~~~Y~vr~~~~L~g----m~V~~~e~e~~p~~   84 (140)
T 3qwm_A            9 PHRRLVCYCRLFEVPDPNKPQKLGLHQREIFLFNDLLVVTKIFQKKKNSVTYSFRQSFSLYG----MQVLLFENQYYPNG   84 (140)
T ss_dssp             -CCCEEEEEEEEECSCTTSCCCTTTTEEEEEEESSCEEEEECCC---CCCCCCCEEEECCTT----EEEEEECCSSCTTE
T ss_pred             CCceEEEEEeeeeeccCcccccccccceEEEEecchhhheeecccCCCCCceEEEEEeeecc----eEEEcccCCCCceE
Confidence            33444555555      466665568899999887776664   11   3567788999886    666653    3578


Q ss_pred             EEEEcC--C----ceEEEEcCC-ccHHHHHHHHHHhc
Q 011287          458 FKIVTP--K----KVLSFEDAK-QRASQWKKAIEALQ  487 (489)
Q Consensus       458 f~i~~p--~----r~y~~~d~~-~~~~~W~~~i~~~~  487 (489)
                      |.|..+  +    ++..|..++ .++..|+++|.+.+
T Consensus        85 ~~l~s~~~G~~~k~~i~~~A~s~~ER~rwi~dL~esI  121 (140)
T 3qwm_A           85 IRLTSSVPGADIKVLINFNAPNPQDRKKFTDDLRESI  121 (140)
T ss_dssp             EEEEECCTTSCCEEEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             EEEEecCCCCcceEEEEEECCCHHHHHHHHHHHHHHH
Confidence            888754  3    778888665 79999999998875

>3odw_A RHO guanine nucleotide exchange factor 1; regulation of RHOA GTPase, rhogef, DH, PH, signaling PR; 3.20A {Homo sapiens} PDB: 3odx_A

Probab=89.67  E-value=1.2  Score=46.72  Aligned_cols=96  Identities=6%  Similarity=0.112  Sum_probs=62.7

Q ss_pred             cccccCCCceEEEEEeeehhhhh-hccceeEEEecCCeEEEECCCC------------------CeeeeeeeccCCCCce
Q 011287          388 WQQFLDPGESVLMISMVKKLQKL-TSKKVQLILTNKPKLIYVDPSK------------------LVVKGNIIWSDNSNDL  448 (489)
Q Consensus       388 ~~~~~~~~~~i~~~g~~~k~~g~-~~k~r~~~lt~~p~l~y~d~~~------------------~~~kg~i~~~~~~~~~  448 (489)
                      |..+...+...|++|.+.++.+- -++.|+++|-+.-.|+......                  ...++.|+++.    +
T Consensus       402 ~~~ldl~~R~LI~eG~l~~~~~~~k~~~r~~fLF~D~LL~~k~k~~ky~~k~~~~~~~~~~d~k~~~~~~i~L~~----l  477 (536)
T 3odw_A          402 FKNLDITKKKLVHEGPLTWRVTKDKAVEVHVLLLDDLLLLLQRQDERLLLKSHSRTLTPTPDGKTMLRPVLRLTS----A  477 (536)
T ss_dssp             SSSCCCTTSCEEEEEEEEEESCC---CEEEEEEESSEEEEEEEETTEEECCCC------------CCCSEEEGGG----E
T ss_pred             hcccccccceeeeecceEEEecCCCeeEEEEEEcCCEEEEEEEcCCeEEEeecccccccccccccccCceeeccc----c
Confidence            54444456778999999765432 3567888887776666553211                  12345688886    4


Q ss_pred             EEEE--cCCCcEEEEc----CCceEEEEcCC-ccHHHHHHHHHHhc
Q 011287          449 SIQV--SSPSHFKIVT----PKKVLSFEDAK-QRASQWKKAIEALQ  487 (489)
Q Consensus       449 ~~~~--~~~~~f~i~~----p~r~y~~~d~~-~~~~~W~~~i~~~~  487 (489)
                      .++.  ...+.|++..    +.++|.|...+ .+.+.|++.|++++
T Consensus       478 ~v~e~~~d~~~ffli~~~~~~~~~~~L~A~S~eEK~~W~~~I~~aI  523 (536)
T 3odw_A          478 MTREVATDHKAFYVLFTWDQEAQIYELVAQTVSERKNWCALITETA  523 (536)
T ss_dssp             EEEECTTCTTEEEEEEC---CCCEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             eeecccccCCceEEEecCCCCceEEEEECCCHHHHHHHHHHHHHHH
Confidence            5554  2345666643    46899999766 78999999999876

>2vrw_B P95VAV, VAV1, proto-oncogene VAV; lipoprotein, GTP-binding, metal-binding, phosphoprotein, exchange factor, RAC, GTPase, membrane domain; 1.85A {Mus musculus} PDB: 3bji_A 1f5x_A

Probab=89.57  E-value=0.77  Score=46.26  Aligned_cols=90  Identities=11%  Similarity=0.115  Sum_probs=60.2

Q ss_pred             CCCceEEEEEeeehhh--hhhccceeEEEecCCeEEEECCC-CCeeeeeeeccCCCCceEEEEc---------CCCcEEE
Q 011287          393 DPGESVLMISMVKKLQ--KLTSKKVQLILTNKPKLIYVDPS-KLVVKGNIIWSDNSNDLSIQVS---------SPSHFKI  460 (489)
Q Consensus       393 ~~~~~i~~~g~~~k~~--g~~~k~r~~~lt~~p~l~y~d~~-~~~~kg~i~~~~~~~~~~~~~~---------~~~~f~i  460 (489)
                      ..|+ .+++|.+.+..  +...+.|.++|-+.-.++....+ .-..|+.||++.    +.+...         ..+.|.|
T Consensus       230 ~~gr-li~~G~l~~~~~~~~~~~~~~~fLF~d~Ll~~k~k~~~y~~k~~i~l~~----~~v~~~~~~~~~~~~~~~~F~i  304 (406)
T 2vrw_B          230 NYGR-PKIDGELKITSVERRSKTDRYAFLLDKALLICKRRGDSYDLKASVNLHS----FQVRDDSSGERDNKKWSHMFLL  304 (406)
T ss_dssp             GGCS-EEEEEEEEEECSSCCSCEEEEEEEESSEEEEEEEETTEEEEEEEEETTT----EEEEC--------CTTCEEEEE
T ss_pred             ccCc-ccccccEEEEecCCCccceEEEEecCCEEEEEEecCCceEEEEEecccc----eeeeecCCCCccCCccceeeEE
Confidence            3466 56788887543  22346688877776555444322 346789999986    444432         1368988


Q ss_pred             Ec--CCceEEEEcCC-ccHHHHHHHHHHhc
Q 011287          461 VT--PKKVLSFEDAK-QRASQWKKAIEALQ  487 (489)
Q Consensus       461 ~~--p~r~y~~~d~~-~~~~~W~~~i~~~~  487 (489)
                      ..  +.++|.|...+ .+.++|+++|++++
T Consensus       305 ~~~~~~~~~~l~a~s~~ek~~W~~~i~~ai  334 (406)
T 2vrw_B          305 IEDQGAQGYELFFKTRELKKKWMEQFEMAI  334 (406)
T ss_dssp             EETTCSCEEEEEESSHHHHHHHHHHHHHHH
T ss_pred             EecCCCceEEEeCCCHHHHHHHHHHHHHHH
Confidence            74  67899998655 78899999998875

>3p6a_A RHO guanine nucleotide exchange factor 1; regulation of RHOA GTPase, rhogef, DH, PH, signaling PR; 2.50A {Homo sapiens} PDB: 3odo_A

Probab=88.44  E-value=1.4  Score=43.64  Aligned_cols=96  Identities=7%  Similarity=0.114  Sum_probs=61.1

Q ss_pred             cccccCCCceEEEEEeeehhhh-hhccceeEEEecCCeEEEECCCC------------------CeeeeeeeccCCCCce
Q 011287          388 WQQFLDPGESVLMISMVKKLQK-LTSKKVQLILTNKPKLIYVDPSK------------------LVVKGNIIWSDNSNDL  448 (489)
Q Consensus       388 ~~~~~~~~~~i~~~g~~~k~~g-~~~k~r~~~lt~~p~l~y~d~~~------------------~~~kg~i~~~~~~~~~  448 (489)
                      |......+...+++|.+..+.+ --++.|+++|=+.-.++....+.                  ....+.|+++.    +
T Consensus       249 ~~~l~~~~r~li~eG~l~~~~~~~~~~~~~~fLF~d~Ll~~k~k~~k~~~k~~~~~~~~~~~~k~~~~~~i~l~~----~  324 (377)
T 3p6a_A          249 FKNLDITKKKLVHEGPLTWRVTKDKAVEVHVLLLDDLLLLLQRQDERLLLKSHSRTLTPTPDGKTMLRPVLRLTS----A  324 (377)
T ss_dssp             STTCCCTTSCEEEEEEEEEESSSSCEEEEEEEEESSEEEEEEEETTEEECCCCCCC---------CSCSEEEGGG----E
T ss_pred             hcccccccceEEEECCcEEEecCCCeEEEEEEeeCCEEEEEEEcCceeEEeecccccccCccccCCCCCeEechh----h
Confidence            5444445677899999965432 23566888777766666553221                  11234688887    4


Q ss_pred             EEEE--cCCCcEE-EEc---CCceEEEEcCC-ccHHHHHHHHHHhc
Q 011287          449 SIQV--SSPSHFK-IVT---PKKVLSFEDAK-QRASQWKKAIEALQ  487 (489)
Q Consensus       449 ~~~~--~~~~~f~-i~~---p~r~y~~~d~~-~~~~~W~~~i~~~~  487 (489)
                      .++.  ...+.|+ |.+   +.++|.|...+ .+.+.|++.|++++
T Consensus       325 ~v~e~~~~~~~~~~i~~~~~~~~~~~l~A~s~~ek~~W~~~I~~ai  370 (377)
T 3p6a_A          325 MTREVATDHKAFYVLFTWDQEAQIYELVAQTVSERKNWCALITETA  370 (377)
T ss_dssp             EEEECTTCTTEEEEEETTCTTCCEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             hccccccccceeEEEecCCCCCeeEEEecCCHHHHHHHHHHHHHHH
Confidence            4444  2234455 444   56899998765 78999999999876

>1kz7_A Guanine nucleotide exchange factor DBS; guanine nucleotide exchange factor (GEF), small G-protein, signaling protein; 2.40A {Mus musculus} SCOP: a.87.1.1 b.55.1.1 PDB: 1lb1_A 1kzg_A 1rj2_A

Probab=88.37  E-value=1.3  Score=43.73  Aligned_cols=72  Identities=17%  Similarity=0.254  Sum_probs=50.5

Q ss_pred             ccceeEEEecCCeEEEECC----------CCCeeeeeeeccCCCCceEEEE---cCCCcEEEEc--CCceEEEEcCC-cc
Q 011287          412 SKKVQLILTNKPKLIYVDP----------SKLVVKGNIIWSDNSNDLSIQV---SSPSHFKIVT--PKKVLSFEDAK-QR  475 (489)
Q Consensus       412 ~k~r~~~lt~~p~l~y~d~----------~~~~~kg~i~~~~~~~~~~~~~---~~~~~f~i~~--p~r~y~~~d~~-~~  475 (489)
                      .+.|.+.|=+.-.++....          ..-..|+-|+++.    +.+..   ..++.|.|..  +.++|.|...+ .+
T Consensus       237 ~~~r~~fLF~d~Ll~~k~~~~~~~~~~~~~~y~~k~~i~l~~----~~v~e~~~~~~~~F~i~~~~~~~~~~l~a~s~~e  312 (353)
T 1kz7_A          237 PMQRHLFLHEKAVLFCKKREENGEGYEKAPSYSYKQSLNMTA----VGITENVKGDTKKFEIWYNAREEVYIIQAPTPEI  312 (353)
T ss_dssp             CEEEEEEEESSEEEEEEEECCCCSSCCCSCEEEEEEEEEGGG----EEEECCBTTBTTEEEEEETTTTEEEEEECSSHHH
T ss_pred             cceeEEEEECCEEEEEEeccccccCCCCCCeEEEEEEeEccc----ceeeEcCCCCCceEEEEECCCCcEEEEECCCHHH
Confidence            4568887777755555432          1235689999986    45543   2467999975  56789888655 78


Q ss_pred             HHHHHHHHHHhc
Q 011287          476 ASQWKKAIEALQ  487 (489)
Q Consensus       476 ~~~W~~~i~~~~  487 (489)
                      .++|+++|++++
T Consensus       313 k~~W~~~i~~ai  324 (353)
T 1kz7_A          313 KAAWVNAIRKVL  324 (353)
T ss_dssp             HHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHH
Confidence            899999999875

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=88.20  E-value=0.54  Score=43.06  Aligned_cols=85  Identities=16%  Similarity=0.133  Sum_probs=62.3

Q ss_pred             CCCCCccEEEEEEEcCCEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCC
Q 011287          102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD  181 (489)
Q Consensus       102 l~hpnIv~l~~~~~~~~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~  181 (489)
                      ..||+++.. .+-.+++.+.+.++.-..+-=+..+.   .++......++..|+....++  ..-+|--|+|+||+++.+
T Consensus        42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik---~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~~  115 (215)
T 4ann_A           42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK---SFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTRD  115 (215)
T ss_dssp             SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG---GSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECTT
T ss_pred             ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH---hcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcCC
Confidence            368999977 56666677777666554322223333   478899999999998877544  334788899999999999


Q ss_pred             CCEEEeeccCc
Q 011287          182 GHIKIADFGSV  192 (489)
Q Consensus       182 g~ikL~DFG~a  192 (489)
                      +.+++.=.|.-
T Consensus       116 ~~p~i~~RGik  126 (215)
T 4ann_A          116 GLPIAKTRGLQ  126 (215)
T ss_dssp             SCEEESCCEET
T ss_pred             CCEEEEEccCc
Confidence            99999877764

>1nty_A Triple functional domain protein; DBL, pleckstrin, GEF, RHO, GTPase, guanine-nucleotide releas factor, phosphorylation, signaling protein; 1.70A {Homo sapiens} SCOP: a.87.1.1 b.55.1.1 PDB: 2nz8_B 2kr9_A

Probab=87.68  E-value=1.4  Score=42.50  Aligned_cols=71  Identities=17%  Similarity=0.342  Sum_probs=49.4

Q ss_pred             cceeEEEecCCeEEEECC------CCCeeeeeeeccCCCCceEEEE---cCCCcEEEEc-----CCceEEEEcCC-ccHH
Q 011287          413 KKVQLILTNKPKLIYVDP------SKLVVKGNIIWSDNSNDLSIQV---SSPSHFKIVT-----PKKVLSFEDAK-QRAS  477 (489)
Q Consensus       413 k~r~~~lt~~p~l~y~d~------~~~~~kg~i~~~~~~~~~~~~~---~~~~~f~i~~-----p~r~y~~~d~~-~~~~  477 (489)
                      +.|++.|=+.-.++....      ..-..|+.|+++.    +.+..   ..+..|.|..     +.++|.|...+ .+.+
T Consensus       222 ~~r~~fLF~d~Ll~~k~~~~~~~~~~y~~k~~i~l~~----~~v~e~~~~~~~~F~i~~~~~~~~~~~~~l~a~s~~ek~  297 (311)
T 1nty_A          222 RERHLFLFEMSLVFSKEVKDSSGRSKYLYKSKLFTSE----LGVTEHVEGDPCKFALWVGRTPTSDNKIVLKASSIENKQ  297 (311)
T ss_dssp             EEEEEEEESSEEEEEEEEECTTCCEEEEEEEEEEGGG----EEEECCCTTCTTEEEEEESSSCCTTTCEEEECSSHHHHH
T ss_pred             ceeEEEeccCeEEEEEeeccCCCCceeEEeeeeeccc----eeeEEccCCCCceEEEEeCCCCCCCceEEEECCCHHHHH
Confidence            568887777644444321      1235789999986    55553   2356899865     45788888665 7899


Q ss_pred             HHHHHHHHhc
Q 011287          478 QWKKAIEALQ  487 (489)
Q Consensus       478 ~W~~~i~~~~  487 (489)
                      +|+++|++++
T Consensus       298 ~W~~~i~~~i  307 (311)
T 1nty_A          298 DWIKHIREVI  307 (311)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHH
Confidence            9999999876

>2rgn_B RHOA/RAC/CDC42 exchange factor; heterotrimeric G-protein, small molecular weight G-protein, complex, protein-protein complex, rhogef, galphaq; HET: GDP; 3.50A {Homo sapiens}

Probab=87.13  E-value=1  Score=44.53  Aligned_cols=72  Identities=17%  Similarity=0.284  Sum_probs=50.2

Q ss_pred             ccceeEEEecCCeEEEECCC---------CCeeeeeeeccCCCCceEEEE---cCCCcEEEEc--C---CceEEEEcCC-
Q 011287          412 SKKVQLILTNKPKLIYVDPS---------KLVVKGNIIWSDNSNDLSIQV---SSPSHFKIVT--P---KKVLSFEDAK-  473 (489)
Q Consensus       412 ~k~r~~~lt~~p~l~y~d~~---------~~~~kg~i~~~~~~~~~~~~~---~~~~~f~i~~--p---~r~y~~~d~~-  473 (489)
                      .+.|.+.|=+.-.++..-..         .-..|+-||++.    +.+..   ..++.|.|..  |   ..+|.|...+ 
T Consensus       228 ~~~r~~fLF~d~Ll~~k~~~~~~~~~~~~~y~~k~~i~l~~----~~v~~~~~~~~~~F~i~~~~~~~~~~~~~l~a~s~  303 (354)
T 2rgn_B          228 GRERRVFLFEQIIIFSEALGGGVRGGTQPGYVYKNSIKVSC----LGLEGNLQGDPCRFALTSRGPEGGIQRYVLQAADP  303 (354)
T ss_dssp             CCEEEEEEESSEEEEEEECC--------CCEEEEEEEEGGG----EEEEESGGGCTTEEEEEEECSSSCEEEEEEEESSH
T ss_pred             CceEEEEEeCCcEEEEEeccCCCCCCCCCceEEcceeeccc----eeeeeccCCCCceEEEEecCCCCCceEEEEECCCH
Confidence            45677777776554443221         346789999986    56654   3457899964  3   3788888655 


Q ss_pred             ccHHHHHHHHHHhc
Q 011287          474 QRASQWKKAIEALQ  487 (489)
Q Consensus       474 ~~~~~W~~~i~~~~  487 (489)
                      .+.+.|+++|.+++
T Consensus       304 ~ek~~W~~~i~~ai  317 (354)
T 2rgn_B          304 AISQAWIKHVAQIL  317 (354)
T ss_dssp             HHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHH
Confidence            78999999999875

>3ky9_A Proto-oncogene VAV; calponin homology domain, DBL homology domain, pleckst homology domain, C1 domain, guanine-nucleotide releasing FA metal-binding; 2.73A {Homo sapiens} PDB: 2d86_A

Probab=86.76  E-value=1.2  Score=47.17  Aligned_cols=92  Identities=12%  Similarity=0.102  Sum_probs=62.4

Q ss_pred             ccCCCceEEEEEeeehhhh--hhccceeEEEecCCeEEEECC-CCCeeeeeeeccCCCCceEEEEcC---------CCcE
Q 011287          391 FLDPGESVLMISMVKKLQK--LTSKKVQLILTNKPKLIYVDP-SKLVVKGNIIWSDNSNDLSIQVSS---------PSHF  458 (489)
Q Consensus       391 ~~~~~~~i~~~g~~~k~~g--~~~k~r~~~lt~~p~l~y~d~-~~~~~kg~i~~~~~~~~~~~~~~~---------~~~f  458 (489)
                      +...|+ .++.|.+.+..+  .-.+.|+++|-+.-.++.... .+-..|+.||++.    +.++...         ++.|
T Consensus       400 l~~~gr-ll~~G~l~~~~~~~~~~~~r~~fLF~d~Ll~~k~~~~~y~~k~~i~L~~----~~v~~~~~~~~~~~~~~~~f  474 (587)
T 3ky9_A          400 LAHYGR-PKIDGELKITSVERRSKMDRYAFLLDKALLICKRRGDSYDLKDFVNLHS----FQVRDDSSGDRDNKKWSHMF  474 (587)
T ss_dssp             GGGGCC-EEEEEEEEEECSSCCSCEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG----EEEEEC-----CCCTTCEEE
T ss_pred             hhhcCc-eEEEeeEEEEeccCCCcceEEEEEECCEEEEEEecCCEEEeeeeechhh----ceeeecCCCCccccccccee
Confidence            334466 578888876432  235668888888766665543 2456889999997    5555432         2579


Q ss_pred             EEEcCC--ceEEEEcCC-ccHHHHHHHHHHhc
Q 011287          459 KIVTPK--KVLSFEDAK-QRASQWKKAIEALQ  487 (489)
Q Consensus       459 ~i~~p~--r~y~~~d~~-~~~~~W~~~i~~~~  487 (489)
                      .|....  ++|.|...+ .+.++|+++|++++
T Consensus       475 ~i~~~~~~~~~~L~A~S~eeK~~Wi~~I~~ai  506 (587)
T 3ky9_A          475 LLIEDQGAQGYELFFKTRELKKKWMEQFEMAI  506 (587)
T ss_dssp             EEEETTC---CEEEESSHHHHHHHHHHHHHHH
T ss_pred             EEEEcCCCceEEEEeCCHHHHHHHHHHHHHHh
Confidence            998754  899888655 78999999999875

>1foe_A T-lymphoma invasion and metastasis inducing protein 1; DBL homology domain, pleckstrin homology domain, GTPase, guanine nucleotide exchange factor; 2.80A {Mus musculus} SCOP: a.87.1.1 b.55.1.1

Probab=83.91  E-value=5.3  Score=39.49  Aligned_cols=50  Identities=14%  Similarity=0.236  Sum_probs=36.8

Q ss_pred             eeeeeeeccCCCCceEEEEcC------CCcEEEE--------cCCceEEEEcCC-ccHHHHHHHHHHhc
Q 011287          434 VVKGNIIWSDNSNDLSIQVSS------PSHFKIV--------TPKKVLSFEDAK-QRASQWKKAIEALQ  487 (489)
Q Consensus       434 ~~kg~i~~~~~~~~~~~~~~~------~~~f~i~--------~p~r~y~~~d~~-~~~~~W~~~i~~~~  487 (489)
                      ..|+.||++.    +.+....      ...|.|.        +|.++|.|...+ .+.+.|+++|++++
T Consensus       301 ~~k~~i~l~~----~~v~~~~~~~~~~~~~f~i~~~~~~~~~~~~~~~~l~A~s~~eK~~W~~~i~~~i  365 (377)
T 1foe_A          301 RFRHMIPTEA----LQVRALPSADAEANAVCEIVHVKSESEGRPERVFHLCCSSPESRKDFLKSVHSIL  365 (377)
T ss_dssp             CCEEEEEGGG----EEEECCCCTTTTSCCEEEEEECCBTGGGBCCEEEEEEESSHHHHHHHHHHHHHHH
T ss_pred             eEeeeccccc----eEEEecCCCccchhhHHHHHhccccccCCCcceEEEEeCCHHHHHHHHHHHHHHh
Confidence            5678899986    5665422      1236675        478999999665 78999999999875

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=83.65  E-value=2.8  Score=38.41  Aligned_cols=84  Identities=11%  Similarity=-0.039  Sum_probs=62.4

Q ss_pred             CCCCccEEEEEEEcCCEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHH-HHHhCCcEeeccCCCCeeeCCC
Q 011287          103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE-YIHSMGLIHRDIKPENLLLTAD  181 (489)
Q Consensus       103 ~hpnIv~l~~~~~~~~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~-~LH~~gIiHrDLKpeNILl~~~  181 (489)
                      .||++ . -.+-.+++.+.+.++.-+++.=+..++   .++......++..|+.... ++  ..-+|--|+|+||+++.+
T Consensus        48 ~~~~f-~-~~I~~~eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~  120 (219)
T 4ano_A           48 VDPCI-V-RDIDVSEDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRA  120 (219)
T ss_dssp             SCSSS-E-EEEEECSSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTT
T ss_pred             cCCCC-C-eEEEEeCCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCC
Confidence            68888 3 344467777777777664544445554   4788999999988888665 43  455888999999999999


Q ss_pred             CCEEEeeccCcc
Q 011287          182 GHIKIADFGSVK  193 (489)
Q Consensus       182 g~ikL~DFG~a~  193 (489)
                      +.+++.=.|.-.
T Consensus       121 ~~p~i~hRGi~~  132 (219)
T 4ano_A          121 LEPFFLHVGVKE  132 (219)
T ss_dssp             CCEEESCCEETT
T ss_pred             CcEEEEEcCCcc
Confidence            999998887643

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	489
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-96
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-86
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-85
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-81
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-80
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-78
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-76
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-74
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-74
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	9e-74
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-73
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-73
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	9e-73
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	5e-72
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-71
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-71
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	5e-71
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-69
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-69
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-68
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-67
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-67
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-66
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-63
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-62
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-60
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-59
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-58
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-58
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	6e-57
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-56
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-56
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-56
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-55
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-55
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	6e-55
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	8e-55
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-54
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	6e-54
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-54
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-53
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-53
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	5e-53
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	8e-53
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	9e-53
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-52
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-52
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-52
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-51
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	7e-51
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-50
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-49
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	6e-49
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	9e-49
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-48
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-48
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	9e-47
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-46
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-46
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	9e-46
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-44
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-38
d1w1ha_	147	b.55.1.1 (A:) 3-phosphoinositide dependent protein	1e-15
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-15

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  291 bits (745), Expect = 2e-96
 Identities = 138/288 (47%), Positives = 183/288 (63%), Gaps = 9/288 (3%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           DF+ GKI G GS+S VV A+++ T   YA+KI++K+ I KENK  YV  ER V+ +LDHP
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 165
             V+L+FTFQD   LY  L   + GEL   I   G   E   RFYTAE+V ALEY+H  G
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128

Query: 166 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 225
           +IHRD+KPEN+LL  D HI+I DFG+ K +               +A +FVGTA YV PE
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--------KQARANSFVGTAQYVSPE 180

Query: 226 VLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAARDL 285
           +L    A   +DLWALGC +YQ+++G  PF+  +E+LIFQ+II  +  FP  F   ARDL
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDL 240

Query: 286 IDRLLDVDPSGRPGAG-PGGYAVLKMHPFFKGIDWKNIRGQTPPKLAS 332
           +++LL +D + R G     GY  LK HPFF+ + W+N+  QTPPKL +
Sbjct: 241 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLTA 288

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  264 bits (675), Expect = 2e-86
 Identities = 88/276 (31%), Positives = 137/276 (49%), Gaps = 17/276 (6%)

Query: 41  HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 100
            ++++DFE+G+  G G +  V  A++  +  + ALK++ K  + K      ++ E  +  
Sbjct: 2   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 61

Query: 101 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEY 160
            L HP ++RL+  F D   +Y+ LE    G ++ ++       E     Y  E+ +AL Y
Sbjct: 62  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 121

Query: 161 IHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
            HS  +IHRDIKPENLLL + G +KIADFG                A   +  T  GT  
Sbjct: 122 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSV------------HAPSSRRTTLCGTLD 169

Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSD 280
           Y+PPE++         DLW+LG   Y+ L G  PF+  +    ++RI   +  FP++ ++
Sbjct: 170 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 229

Query: 281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 316
            ARDLI RLL  +PS RP         +  HP+   
Sbjct: 230 GARDLISRLLKHNPSQRPML-----REVLEHPWITA 260

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  262 bits (671), Expect = 5e-85
 Identities = 107/303 (35%), Positives = 173/303 (57%), Gaps = 18/303 (5%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
           +S+QDF++ +  G GS+ +V   +    G  YA+K++ K+ + +  +  +   ER++L  
Sbjct: 1   YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 60

Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
           + HP ++R++ TFQD   ++M ++  EGGELF  +          A+FY AEV  ALEY+
Sbjct: 61  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120

Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           HS  +I+RD+KPEN+LL  +GHIKI DFG  K +              D   T  GT  Y
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV-------------PDVTYTLCGTPDY 167

Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDA 281
           + PEV+++ P     D W+ G  +Y+ML+G +PF D++    +++I+  ++RFP +F++ 
Sbjct: 168 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNED 227

Query: 282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPPKLASEPMVQSG 339
            +DL+ RL+  D S R G    G   +K HP+FK + W+ +  R    P    EP +Q G
Sbjct: 228 VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETP---YEPPIQQG 284

Query: 340 EGD 342
           +GD
Sbjct: 285 QGD 287

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  252 bits (645), Expect = 4e-81
 Identities = 96/288 (33%), Positives = 145/288 (50%), Gaps = 17/288 (5%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL-DQL 102
           I+DF L K+ G GS+ KV  A+   T   +A+K + K  +  ++      +E+ VL    
Sbjct: 1   IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60

Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           +HP +  +F TFQ   +L+  +E   GG+L   I S        A FY AE++  L+++H
Sbjct: 61  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S G+++RD+K +N+LL  DGHIKIADFG  K               D K  TF GT  Y+
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML----------GDAKTNTFCGTPDYI 170

Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAA 282
            PE+L         D W+ G  LY+ML G SPF    E  +F  I   +  +P +    A
Sbjct: 171 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEA 230

Query: 283 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ--TPP 328
           +DL+ +L   +P  R G        ++ HP F+ I+W+ +  +   PP
Sbjct: 231 KDLLVKLFVREPEKRLGV----RGDIRQHPLFREINWEELERKEIDPP 274

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  250 bits (639), Expect = 5e-80
 Identities = 105/288 (36%), Positives = 153/288 (53%), Gaps = 12/288 (4%)

Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           ++ DF+  K+ G G++ KV+  ++  TG  YA+KI+ K+ I  +++ A+   E  VL   
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62

Query: 103 DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
            HP +  L + FQ    L   +E   GGELF  ++ +   +E+ ARFY AE+V ALEY+H
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S  +++RDIK ENL+L  DGHIKI DFG  K                    TF GT  Y+
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS----------DGATMKTFCGTPEYL 172

Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAA 282
            PEVL  +      D W LG  +Y+M+ G  PF +     +F+ I+  +IRFP   S  A
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA 232

Query: 283 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ--TPP 328
           + L+  LL  DP  R G GP     +  H FF  I+W+++  +   PP
Sbjct: 233 KSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPP 280

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  247 bits (632), Expect = 1e-78
 Identities = 97/315 (30%), Positives = 151/315 (47%), Gaps = 24/315 (7%)

Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV---L 99
           ++ DF + +I G G + +V   +K DTG +YA+K +DKK I  +        ERI+   +
Sbjct: 2   TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61

Query: 100 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 159
              D P +V + + F     L   L+   GG+L   ++  G  SE + RFY AE++  LE
Sbjct: 62  STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121

Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           ++H+  +++RD+KP N+LL   GH++I+D G            L    S  K    VGT 
Sbjct: 122 HMHNRFVVYRDLKPANILLDEHGHVRISDLG------------LACDFSKKKPHASVGTH 169

Query: 220 AYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE---WLIFQRIIARDIRFP 275
            Y+ PEVL          D ++LGC L+++L G SPF+         I +  +   +  P
Sbjct: 170 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP 229

Query: 276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ--TPPKLASE 333
           + FS   R L++ LL  D + R G    G   +K  PFF+ +DW+ +  Q   PP +   
Sbjct: 230 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLI--- 286

Query: 334 PMVQSGEGDDVHDSS 348
           P        D  D  
Sbjct: 287 PPRGEVNAADAFDIG 301

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  240 bits (614), Expect = 4e-76
 Identities = 81/297 (27%), Positives = 136/297 (45%), Gaps = 27/297 (9%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
            +++ +  G G++  V R  +  TG V+  K ++  +   +     VK E  +++QL HP
Sbjct: 30  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT---VKNEISIMNQLHHP 86

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 164
            ++ L   F+D + + + LE   GGELFD+I ++ + +SE E   Y  +  + L+++H  
Sbjct: 87  KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 146

Query: 165 GLIHRDIKPENLLLTA--DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
            ++H DIKPEN++        +KI DFG    +             D+       TA + 
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP-----------DEIVKVTTATAEFA 195

Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----NYF 278
            PE+++  P  F  D+WA+G   Y +LSG SPF    +    Q +   D  F     +  
Sbjct: 196 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV 255

Query: 279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPM 335
           S  A+D I  LL  +P  R             HP+ KG D  N+  + P    ++  
Sbjct: 256 SPEAKDFIKNLLQKEPRKRLTV-----HDALEHPWLKG-DHSNLTSRIPSSRYNKIR 306

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  234 bits (599), Expect = 1e-74
 Identities = 76/287 (26%), Positives = 132/287 (45%), Gaps = 27/287 (9%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
            +E+    G G++ KV +A+  +T  + A K++D K    E +     +E  +L   DHP
Sbjct: 13  FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCDHP 69

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHSM 164
            +V+L   F    +L++ +E C GG +   +      L+E + +    + +DAL Y+H  
Sbjct: 70  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
            +IHRD+K  N+L T DG IK+ADFG                 +  +  +F+GT  ++ P
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR----------TIQRRDSFIGTPYWMAP 179

Query: 225 EVL-----NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD---IRFPN 276
           EV+        P  +  D+W+LG TL +M     P  + +   +  +I   +   +  P+
Sbjct: 180 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPS 239

Query: 277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR 323
            +S   +D + + L+ +   R        + L  HPF      K IR
Sbjct: 240 RWSSNFKDFLKKCLEKNVDARWTT-----SQLLQHPFVTVDSNKPIR 281

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  235 bits (601), Expect = 4e-74
 Identities = 75/293 (25%), Positives = 124/293 (42%), Gaps = 26/293 (8%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  +++ +  G G++  V R  +  TG  +A K +       E+    V+ E   +  L 
Sbjct: 25  LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLR 81

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIH 162
           HP +V L   F+D   + M  E   GGELF+++  +   +SEDEA  Y  +V   L ++H
Sbjct: 82  HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 141

Query: 163 SMGLIHRDIKPENLLLTAD--GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
               +H D+KPEN++ T      +K+ DFG    +                     GTA 
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP-----------KQSVKVTTGTAE 190

Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN---- 276
           +  PEV    P  +  D+W++G   Y +LSG SPF   ++    + + + D    +    
Sbjct: 191 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFS 250

Query: 277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPK 329
             S+  +D I +LL  DP+ R             HP+    +      Q P  
Sbjct: 251 GISEDGKDFIRKLLLADPNTRMTI-----HQALEHPWLTPGNAPGRDSQIPSS 298

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  234 bits (598), Expect = 9e-74
 Identities = 101/293 (34%), Positives = 157/293 (53%), Gaps = 15/293 (5%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERI 97
            Q    +  F+  K  G GS+ +V+  K  ++G  YA+KI+DK+ + K  +  +   E+ 
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93

Query: 98  VLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           +L  ++ P +V+L F+F+D  +LYM +E   GGE+F  +   G  SE  ARFY A++V  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
            EY+HS+ LI+RD+KPENLL+   G+I++ DFG  K ++                 T  G
Sbjct: 154 FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------------WTLCG 200

Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
           T   + PE++ S       D WALG  +Y+M +G  PF       I+++I++  +RFP++
Sbjct: 201 TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH 260

Query: 278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQTPP 328
           FS   +DL+  LL VD + R G    G   +K H +F   DW  I  R    P
Sbjct: 261 FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAP 313

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  232 bits (592), Expect = 1e-73
 Identities = 80/288 (27%), Positives = 137/288 (47%), Gaps = 33/288 (11%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL------ERIV 98
           +++E  +I G G  S V R     T   YA+KI+D       +     +L      E  +
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 99  LDQL-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           L ++  HP +++L  T++     ++  +  + GELFD +T K  LSE E R     +++ 
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           +  +H + ++HRD+KPEN+LL  D +IK+ DFG    +              +K     G
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-----------GEKLREVCG 171

Query: 218 TAAYVPPEVL------NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 271
           T +Y+ PE++      N        D+W+ G  +Y +L+G+ PF    + L+ + I++ +
Sbjct: 172 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 231

Query: 272 IRFP----NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
            +F     + +SD  +DL+ R L V P  R  A          HPFF+
Sbjct: 232 YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTA-----EEALAHPFFQ 274

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  230 bits (587), Expect = 4e-73
 Identities = 76/276 (27%), Positives = 125/276 (45%), Gaps = 19/276 (6%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           ++D++L +  G G+Y +V  A    T    A+KI+D K      +   +K E  +   L+
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLN 61

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           H  VV+ +   ++    Y+ LE C GGELFD+I     + E +A+ +  +++  + Y+H 
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
           +G+ HRDIKPENLLL    ++KI+DFG           V      +       GT  YV 
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLAT--------VFRYNNRERLLNKMCGTLPYVA 173

Query: 224 PEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYF---S 279
           PE+L          D+W+ G  L  ML+G  P+   S+             + N +    
Sbjct: 174 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 233

Query: 280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
            A   L+ ++L  +PS R          +K   ++ 
Sbjct: 234 SAPLALLHKILVENPSARITI-----PDIKKDRWYN 264

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  230 bits (588), Expect = 9e-73
 Identities = 91/295 (30%), Positives = 145/295 (49%), Gaps = 27/295 (9%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
             ++   + G G++S+V+ A+   T  + A+K + KK +  E K   ++ E  VL ++ H
Sbjct: 9   DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKH 66

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P +V L   ++    LY+ ++   GGELFD+I  KG  +E +A     +V+DA++Y+H +
Sbjct: 67  PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 126

Query: 165 GLIHRDIKPENLLLT---ADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           G++HRD+KPENLL      D  I I+DFG  K                    T  GT  Y
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP-----------GSVLSTACGTPGY 175

Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----NY 277
           V PEVL   P +   D W++G   Y +L G  PF D ++  +F++I+  +  F     + 
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDD 235

Query: 278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW--KNIRGQTPPKL 330
            SD+A+D I  L++ DP  R             HP+  G     KNI      ++
Sbjct: 236 ISDSAKDFIRHLMEKDPEKRFTC-----EQALQHPWIAGDTALDKNIHQSVSEQI 285

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  228 bits (583), Expect = 5e-72
 Identities = 71/285 (24%), Positives = 112/285 (39%), Gaps = 28/285 (9%)

Query: 40  EHFSIQD----FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE 95
           E F   D    F   +  G GS+  V  A+ +    V A+K M         K   +  E
Sbjct: 6   ELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKE 65

Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
              L +L HP  ++    +    + ++ +E C G         K  L E E    T   +
Sbjct: 66  VRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGAL 125

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
             L Y+HS  +IHRD+K  N+LL+  G +K+ DFGS   M  +               +F
Sbjct: 126 QGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN--------------SF 171

Query: 216 VGTAAYVPPEVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI 272
           VGT  ++ PEV+   +        D+W+LG T  ++     P  + +       I   + 
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES 231

Query: 273 RF--PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
                 ++S+  R+ +D  L   P  RP +      VL  H F  
Sbjct: 232 PALQSGHWSEYFRNFVDSCLQKIPQDRPTS-----EVLLKHRFVL 271

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  228 bits (581), Expect = 2e-71
 Identities = 70/322 (21%), Positives = 120/322 (37%), Gaps = 64/322 (19%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           DFE     G G+   V +     +G V A K++  +   K      +  E  VL + + P
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSP 64

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM- 164
            +V  +  F     + + +E  +GG L   +   G + E      +  V+  L Y+    
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
            ++HRD+KP N+L+ + G IK+ DFG    + DS               +FVGT +Y+ P
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN------------SFVGTRSYMSP 172

Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE---WLIFQRIIARDIRF------- 274
           E L  +  +  +D+W++G +L +M  G  P          L+F   +  D          
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232

Query: 275 ----------------------------------PNYFSDAARDLIDRLLDVDPSGRPGA 300
                                                FS   +D +++ L  +P+ R   
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292

Query: 301 GPGGYAVLKMHPFFKGIDWKNI 322
                  L +H F K  D + +
Sbjct: 293 -----KQLMVHAFIKRSDAEEV 309

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (577), Expect = 2e-71
 Identities = 72/274 (26%), Positives = 121/274 (44%), Gaps = 22/274 (8%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           + +   +  G G+   V  A  + TG   A++ M+ +   ++ K   +  E +V+ +  +
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ---QQPKKELIINEILVMRENKN 76

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
           P +V    ++     L++ +E   GG L D +T      E +      E + ALE++HS 
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSN 135

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
            +IHRDIK +N+LL  DG +K+ DFG    +               K  T VGT  ++ P
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP----------EQSKRSTMVGTPYWMAP 185

Query: 225 EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFSDA 281
           EV+         D+W+LG    +M+ G  P+ + +       I      +++ P   S  
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245

Query: 282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
            RD ++R LD+D   R  A       L  H F K
Sbjct: 246 FRDFLNRCLDMDVEKRGSA-----KELLQHQFLK 274

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (577), Expect = 5e-71
 Identities = 106/312 (33%), Positives = 166/312 (53%), Gaps = 20/312 (6%)

Query: 28  QRSKSFAFRAPQEHFSIQDFELGKIYGVGSYSKVVRAKKI---DTGTVYALKIMDKKFIT 84
              ++       E   I++FEL K+ G G+Y KV   +KI   DTG +YA+K++ K  I 
Sbjct: 7   HELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIV 66

Query: 85  KENK-TAYVKLERIVLDQLDH-PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHL 142
           ++ K T + + ER VL+ +   P +V L + FQ    L++ L+   GGELF  ++ +   
Sbjct: 67  QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERF 126

Query: 143 SEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV 202
           +E E + Y  E+V ALE++H +G+I+RDIK EN+LL ++GH+ + DFG  K         
Sbjct: 127 TEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE- 185

Query: 203 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFG--NDLWALGCTLYQMLSGTSPFKDTSE 260
                   +A  F GT  Y+ P+++    +      D W+LG  +Y++L+G SPF    E
Sbjct: 186 --------RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE 237

Query: 261 ----WLIFQRIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG 316
                 I +RI+  +  +P   S  A+DLI RLL  DP  R G GP     +K H FF+ 
Sbjct: 238 KNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297

Query: 317 IDWKNIRGQTPP 328
           I+W ++  +  P
Sbjct: 298 INWDDLAAKKVP 309

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (565), Expect = 1e-69
 Identities = 81/305 (26%), Positives = 138/305 (45%), Gaps = 30/305 (9%)

Query: 39  QEHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL---E 95
           QE+     ++ G+  G G ++ V + ++  TG  YA K + K+      +    +    E
Sbjct: 5   QENVD-DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 63

Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
             +L ++ HP V+ L   +++   + + LE   GGELFD +  K  L+E+EA  +  +++
Sbjct: 64  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 123

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQDSRITVLPNAASDDK 211
           + + Y+HS+ + H D+KPEN++L         IKI DFG    +              ++
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----------FGNE 172

Query: 212 ACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD 271
                GT  +V PE++N  P     D+W++G   Y +LSG SPF   ++      + A +
Sbjct: 173 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN 232

Query: 272 IRFPN----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNI--RGQ 325
             F +      S  A+D I RLL  DP  R             HP+ K  D +       
Sbjct: 233 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI-----QDSLQHPWIKPKDTQQALSSAW 287

Query: 326 TPPKL 330
           + P+ 
Sbjct: 288 SHPQF 292

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  220 bits (562), Expect = 2e-69
 Identities = 76/280 (27%), Positives = 128/280 (45%), Gaps = 28/280 (10%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           D+E+    G GSY +  + ++   G +   K +D   +T+  K   V  E  +L +L HP
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVS-EVNLLRELKHP 63

Query: 106 GVVRLFFTFQDTFS--LYMALESCEGGELFDQIT----SKGHLSEDEARFYTAEVVDALE 159
            +VR +    D  +  LY+ +E CEGG+L   IT     + +L E+       ++  AL+
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 160 YIHSMG-----LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
             H        ++HRD+KP N+ L    ++K+ DFG  + +                A  
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD----------TSFAKA 173

Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-R 273
           FVGT  Y+ PE +N       +D+W+LGC LY++ +   PF   S+  +  +I      R
Sbjct: 174 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR 233

Query: 274 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 313
            P  +SD   ++I R+L++    RP         +  +P 
Sbjct: 234 IPYRYSDELNEIITRMLNLKDYHRPSV-----EEILENPL 268

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (555), Expect = 2e-68
 Identities = 52/279 (18%), Positives = 108/279 (38%), Gaps = 29/279 (10%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG 106
            +     G GS+  V +    +T    A   +  + +TK  +  + + E  +L  L HP 
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKE-EAEMLKGLQHPN 69

Query: 107 VVRLFFTFQDTF----SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           +VR + +++ T      + +  E    G L   +     +     R +  +++  L+++H
Sbjct: 70  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129

Query: 163 SMG--LIHRDIKPENLLLTA-DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           +    +IHRD+K +N+ +T   G +KI D G     + S                 +GT 
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK------------AVIGTP 177

Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR---FPN 276
            ++ PE+          D++A G  + +M +   P+ +        R +   ++   F  
Sbjct: 178 EFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDK 236

Query: 277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
                 +++I+  +  +   R          L  H FF+
Sbjct: 237 VAIPEVKEIIEGCIRQNKDERYSI-----KDLLNHAFFQ 270

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (554), Expect = 1e-67
 Identities = 73/289 (25%), Positives = 121/289 (41%), Gaps = 31/289 (10%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
            + + +  G G +  V R  +  +   Y  K +  K   +      VK E  +L+   H 
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV----LVKKEISILNIARHR 61

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSM 164
            ++ L  +F+    L M  E   G ++F++I +    L+E E   Y  +V +AL+++HS 
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121

Query: 165 GLIHRDIKPENLLLTAD--GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
            + H DI+PEN++        IKI +FG  + ++             D          Y 
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-----------GDNFRLLFTAPEYY 170

Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----NYF 278
            PEV      +   D+W+LG  +Y +LSG +PF   +   I + I+  +  F        
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEI 230

Query: 279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG----IDWKNIR 323
           S  A D +DRLL  +   R  A     +    HP+ K     +  K IR
Sbjct: 231 SIEAMDFVDRLLVKERKSRMTA-----SEALQHPWLKQKIERVSTKVIR 274

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  215 bits (548), Expect = 3e-67
 Identities = 67/263 (25%), Positives = 120/263 (45%), Gaps = 15/263 (5%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
            +ELG+I G G  S+V  A+ +      A+K++        +     + E      L+HP
Sbjct: 8   RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67

Query: 106 GVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
            +V ++ T +         Y+ +E  +G  L D + ++G ++   A    A+   AL + 
Sbjct: 68  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 127

Query: 162 HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAY 221
           H  G+IHRD+KP N++++A   +K+ DFG  + + DS         S  +    +GTA Y
Sbjct: 128 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS-------GNSVTQTAAVIGTAQY 180

Query: 222 VPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY---- 277
           + PE          +D+++LGC LY++L+G  PF   S   +  + +  D   P+     
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 240

Query: 278 FSDAARDLIDRLLDVDPSGRPGA 300
            S     ++ + L  +P  R   
Sbjct: 241 LSADLDAVVLKALAKNPENRYQT 263

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (544), Expect = 1e-66
 Identities = 80/280 (28%), Positives = 133/280 (47%), Gaps = 31/280 (11%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---VKLERIVLDQL 102
            +++G + G G +  V    ++      A+K ++K  I+   +      V +E ++L ++
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 103 D--HPGVVRLFFTFQDTFSLYMALESCEGG-ELFDQITSKGHLSEDEARFYTAEVVDALE 159
                GV+RL   F+   S  + LE  E   +LFD IT +G L E+ AR +  +V++A+ 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124

Query: 160 YIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           + H+ G++HRDIK EN+L+  + G +K+ DFGS   ++D+  T             F GT
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT------------DFDGT 172

Query: 219 AAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
             Y PPE +           +W+LG  LY M+ G  PF+   E      II   + F   
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR 226

Query: 278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI 317
            S   + LI   L + PS RP         ++ HP+ + +
Sbjct: 227 VSSECQHLIRWCLALRPSDRPTF-----EEIQNHPWMQDV 261

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (526), Expect = 3e-63
 Identities = 76/290 (26%), Positives = 124/290 (42%), Gaps = 41/290 (14%)

Query: 44  IQDFE-LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           I D++   ++ G+G   KV++     T   +ALK++      +           +     
Sbjct: 10  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREV-------ELHWRAS 62

Query: 103 DHPGVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVD 156
             P +VR+   +++ ++    L + +E  +GGELF +I  +G    +E EA      + +
Sbjct: 63  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 122

Query: 157 ALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           A++Y+HS+ + HRD+KPENLL T+   +  +K+ DFG  K              S +   
Sbjct: 123 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-----------SHNSLT 171

Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE----WLIFQRIIA 269
           T   T  YV PEVL         D+W+LG  +Y +L G  PF           +  RI  
Sbjct: 172 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 231

Query: 270 RDIRFPN----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
               FPN      S+  + LI  LL  +P+ R             HP+  
Sbjct: 232 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI-----TEFMNHPWIM 276

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 1e-62
 Identities = 56/263 (21%), Positives = 109/263 (41%), Gaps = 23/263 (8%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
              +G+  G GS+  V + K        A+K+++    T +   A+   E  VL +  H 
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHV 64

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQI-TSKGHLSEDEARFYTAEVVDALEYIHSM 164
            ++  F  +     L +  + CEG  L+  +   +      +      +    ++Y+H+ 
Sbjct: 65  NILL-FMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
            +IHRD+K  N+ L  D  +KI DFG           V    +   +     G+  ++ P
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLAT--------VKSRWSGSHQFEQLSGSILWMAP 175

Query: 225 EVL---NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY---- 277
           EV+   + +P +F +D++A G  LY++++G  P+ + +       ++ R    P+     
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 235

Query: 278 --FSDAARDLIDRLLDVDPSGRP 298
                A + L+   L      RP
Sbjct: 236 SNCPKAMKRLMAECLKKKRDERP 258

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 5e-60
 Identities = 56/288 (19%), Positives = 112/288 (38%), Gaps = 23/288 (7%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRA--KKIDTGTVYALKIMDKKFITKENKTAYVKLE 95
            ++  +++D ELG     G++  V +   +        A+KI+  +      K   +  E
Sbjct: 4   DRKLLTLEDKELGS----GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA-E 58

Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVV 155
             V+ QLD+P +VR+    +   S  + +E  E G L   +    H+ +        +V 
Sbjct: 59  ANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVS 117

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
             ++Y+     +HRD+   N+LL    + KI+DFG  K ++                   
Sbjct: 118 MGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-------KAQTHG 170

Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IR 273
                +  PE +N    +  +D+W+ G  +++  S G  P++      +   +   + + 
Sbjct: 171 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG 230

Query: 274 FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM--HPFFKGIDW 319
            P        DL++     D   RPG      AV     + ++  ++ 
Sbjct: 231 CPAGCPREMYDLMNLCWTYDVENRPGFA----AVELRLRNYYYDVVNE 274

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (495), Expect = 1e-59
 Identities = 56/264 (21%), Positives = 108/264 (40%), Gaps = 25/264 (9%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
            ++++ +L +  G G +  V+       G   A+K +      +         E  V+ Q
Sbjct: 4   LNMKELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQA-----FLAEASVMTQ 56

Query: 102 LDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDAL 158
           L H  +V+L     ++   LY+  E    G L D + S+G   L  D    ++ +V +A+
Sbjct: 57  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116

Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           EY+     +HRD+   N+L++ D   K++DFG  K    ++              T    
Sbjct: 117 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-------------DTGKLP 163

Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIA-RDIRFPN 276
             +  PE L     +  +D+W+ G  L+++ S G  P+       +  R+     +  P+
Sbjct: 164 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD 223

Query: 277 YFSDAARDLIDRLLDVDPSGRPGA 300
               A  +++     +D + RP  
Sbjct: 224 GCPPAVYEVMKNCWHLDAAMRPSF 247

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 2e-58
 Identities = 67/314 (21%), Positives = 128/314 (40%), Gaps = 52/314 (16%)

Query: 43  SIQDFELGKIYGVGSYSKVVRAKKI-DTGTVYALKIMDKKFITKENKTAYVKLERIV--L 99
           + Q +E     G G+Y KV +A+ + + G   ALK +  +   +    + ++   ++  L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 100 DQLDHPGVVRLFFTFQDTFS-----LYMALESCEGGEL-FDQITSKGHLSEDEARFYTAE 153
           +  +HP VVRLF     + +     L +  E  +     +     +  +  +  +    +
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           ++  L+++HS  ++HRD+KP+N+L+T+ G IK+ADFG  +                    
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF-----------QMALT 173

Query: 214 TFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA---- 269
           + V T  Y  PEVL  S      DLW++GC   +M      F+ +S+     +I+     
Sbjct: 174 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233

Query: 270 -----------------------RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYA 306
                                     +F     +  +DL+ + L  +P+ R  A      
Sbjct: 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA-----Y 288

Query: 307 VLKMHPFFKGIDWK 320
               HP+F+ ++  
Sbjct: 289 SALSHPYFQDLERC 302

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 2e-58
 Identities = 58/285 (20%), Positives = 110/285 (38%), Gaps = 25/285 (8%)

Query: 38  PQEHFSIQDFELGKIYGVGSYSKVVRA--KKIDTGTVYALKIMDKKFITKENKTAYVKLE 95
            +++  I D ELG     G++  V +   +        A+K++ +   T++  T  +  E
Sbjct: 6   KRDNLLIADIELGC----GNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMRE 59

Query: 96  RIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEV 154
             ++ QLD+P +VRL    Q   +L + +E   GG L   +  K   +          +V
Sbjct: 60  AQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 118

Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
              ++Y+     +HRD+   N+LL    + KI+DFG  K +         + +       
Sbjct: 119 SMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG-------ADDSYYTARSA 171

Query: 215 FVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIA-RDI 272
                 +  PE +N    +  +D+W+ G T+++ LS G  P+K      +   I   + +
Sbjct: 172 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM 231

Query: 273 RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM--HPFFK 315
             P         L+          RP        V +     ++ 
Sbjct: 232 ECPPECPPELYALMSDCWIYKWEDRPDFL----TVEQRMRACYYS 272

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 6e-57
 Identities = 59/263 (22%), Positives = 98/263 (37%), Gaps = 15/263 (5%)

Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDT---GTVYALKIMDKKFITKENKTAYVKLERIVL 99
             +D  L +  G GS+  V R +           A+K +    +++         E   +
Sbjct: 6   GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65

Query: 100 DQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDAL 158
             LDH  ++RL+        + M  E    G L D++    GH        Y  +V + +
Sbjct: 66  HSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124

Query: 159 EYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
            Y+ S   IHRD+   NLLL     +KI DFG ++ +         N             
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ-------NDDHYVMQEHRKVP 177

Query: 219 AAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDIRF--P 275
            A+  PE L +   +  +D W  G TL++M + G  P+   +   I  +I     R   P
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP 237

Query: 276 NYFSDAARDLIDRLLDVDPSGRP 298
                   +++ +     P  RP
Sbjct: 238 EDCPQDIYNVMVQCWAHKPEDRP 260

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 2e-56
 Identities = 71/314 (22%), Positives = 115/314 (36%), Gaps = 53/314 (16%)

Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
            +  +E     G G++ +V +A+   TG   ALK +  +   KE        E  +L  L
Sbjct: 8   EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLL 66

Query: 103 DHPGVVRLFFTFQDTFS--------LYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 154
            H  VV L    +   S        +Y+  + CE              +  E +     +
Sbjct: 67  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 126

Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           ++ L YIH   ++HRD+K  N+L+T DG +K+ADFG  +    ++ +        ++   
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ------PNRYTN 180

Query: 215 FVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA---- 269
            V T  Y PPE+L          DLW  GC + +M + +   +  +E      I      
Sbjct: 181 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240

Query: 270 ----------------------------RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAG 301
                                       +D          A DLID+LL +DP+ R  + 
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS- 299

Query: 302 PGGYAVLKMHPFFK 315
                    H FF 
Sbjct: 300 ----DDALNHDFFW 309

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (477), Expect = 4e-56
 Identities = 60/289 (20%), Positives = 115/289 (39%), Gaps = 42/289 (14%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           F  ++ E GK+ G G++ KV+ A      K       A+K++ +K  + E +   +  E 
Sbjct: 34  FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA--LMSEL 91

Query: 97  IVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-------------- 141
            ++ QL  H  +V L      +  +Y+  E C  G+L + + SK                
Sbjct: 92  KMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 151

Query: 142 ---------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV 192
                    L+ ++   +  +V   +E++     +HRD+   N+L+T    +KI DFG  
Sbjct: 152 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 211

Query: 193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-G 251
           + +      V+                 ++ PE L     T  +D+W+ G  L+++ S G
Sbjct: 212 RDIMSDSNYVVR--------GNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 263

Query: 252 TSPFKDTSEWLIFQRIIARDIRF--PNYFSDAARDLIDRLLDVDPSGRP 298
            +P+        F ++I    +   P Y ++    ++      D   RP
Sbjct: 264 VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRP 312

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (477), Expect = 6e-56
 Identities = 76/327 (23%), Positives = 123/327 (37%), Gaps = 63/327 (19%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
            +   K+ G GS+  V +AK  D+G + A+K + +    K         E  ++ +LDH 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 73

Query: 106 GVVRLFFTF------QDTFSLYMALESCEGG---ELFDQITSKGHLSEDEARFYTAEVVD 156
            +VRL + F      +D   L + L+               +K  L     + Y  ++  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133

Query: 157 ALEYIHSMGLIHRDIKPENLLLTADG-HIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
           +L YIHS G+ HRDIKP+NLLL  D   +K+ DFGS K +              +   ++
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-----------GEPNVSY 182

Query: 216 VGTAAYVPP-EVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII------ 268
           + +  Y  P  +  ++  T   D+W+ GC L ++L G   F   S       II      
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242

Query: 269 -----------ARDIRFPNY------------FSDAARDLIDRLLDVDPSGRPGAGPGGY 305
                        + +FP                  A  L  RLL+  P+ R        
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP----- 297

Query: 306 AVLKMHPFFKGIDWKNIRGQTPPKLAS 332
                H FF  +   N++        +
Sbjct: 298 LEACAHSFFDELRDPNVKLPNGRDTPA 324

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (469), Expect = 2e-55
 Identities = 64/299 (21%), Positives = 102/299 (34%), Gaps = 46/299 (15%)

Query: 48  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKL--ERIVLDQLDHP 105
           E     G G ++ V +A+  +T  + A+K +     ++           E  +L +L HP
Sbjct: 1   EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 165
            ++ L   F    ++ +  +  E         +   L+    + Y    +  LEY+H   
Sbjct: 61  NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120

Query: 166 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 225
           ++HRD+KP NLLL  +G +K+ADFG  K                      V T  Y  PE
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN----------RAYTHQVVTRWYRAPE 170

Query: 226 VLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP--------- 275
           +L        G D+WA+GC L ++L         S+     RI                 
Sbjct: 171 LLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230

Query: 276 -------------------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
                              +   D   DLI  L   +P  R  A            +F 
Sbjct: 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA-----TQALKMKYFS 284

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (464), Expect = 4e-55
 Identities = 52/257 (20%), Positives = 103/257 (40%), Gaps = 17/257 (6%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           +D    K  G G +  V   K        A+K++ +  ++++        E  V+  L H
Sbjct: 4   KDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDE----FIEEAKVMMNLSH 58

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQIT-SKGHLSEDEARFYTAEVVDALEYIHS 163
             +V+L+        +++  E    G L + +   +      +      +V +A+EY+ S
Sbjct: 59  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
              +HRD+   N L+   G +K++DFG  + + D   T          +        + P
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT---------SSVGSKFPVRWSP 169

Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNYFSDA 281
           PEVL  S  +  +D+WA G  ++++ S G  P++  +     + I     +  P+  S+ 
Sbjct: 170 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK 229

Query: 282 ARDLIDRLLDVDPSGRP 298
              ++          RP
Sbjct: 230 VYTIMYSCWHEKADERP 246

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  183 bits (465), Expect = 6e-55
 Identities = 52/263 (19%), Positives = 94/263 (35%), Gaps = 17/263 (6%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
               D  +    G G Y +V            A+K + +  +  E        E  V+ +
Sbjct: 14  MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKE 69

Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH--LSEDEARFYTAEVVDALE 159
           + HP +V+L          Y+  E    G L D +       +S     +   ++  A+E
Sbjct: 70  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 129

Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           Y+     IHRD+   N L+  +  +K+ADFG  + M     T                  
Sbjct: 130 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH---------AGAKFPI 180

Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR--FPNY 277
            +  PE L  +  +  +D+WA G  L+++ +         +      ++ +D R   P  
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 240

Query: 278 FSDAARDLIDRLLDVDPSGRPGA 300
             +   +L+      +PS RP  
Sbjct: 241 CPEKVYELMRACWQWNPSDRPSF 263

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 8e-55
 Identities = 51/258 (19%), Positives = 109/258 (42%), Gaps = 17/258 (6%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
           +    +  G G +  V     ++     A+K + +  +++E+       E  V+ +L HP
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEED----FIEEAEVMMKLSHP 60

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHL-SEDEARFYTAEVVDALEYIHSM 164
            +V+L+    +   + +  E  E G L D + ++  L + +       +V + + Y+   
Sbjct: 61  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
            +IHRD+   N L+  +  IK++DFG  + + D + T          +        +  P
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT---------SSTGTKFPVKWASP 171

Query: 225 EVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNYFSDAA 282
           EV + S  +  +D+W+ G  ++++ S G  P+++ S   + + I     +  P   S   
Sbjct: 172 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHV 231

Query: 283 RDLIDRLLDVDPSGRPGA 300
             +++      P  RP  
Sbjct: 232 YQIMNHCWKERPEDRPAF 249

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  182 bits (462), Expect = 2e-54
 Identities = 67/300 (22%), Positives = 120/300 (40%), Gaps = 47/300 (15%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
            +   +  G G+Y  V +A+  + G  +ALK +  +   +   +  ++ E  +L +L H 
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHS 60

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 165
            +V+L+        L +  E  +          +G L    A+ +  ++++ + Y H   
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120

Query: 166 LIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPE 225
           ++HRD+KP+NLL+  +G +KIADFG  +                 K    + T  Y  P+
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGI----------PVRKYTHEIVTLWYRAPD 170

Query: 226 VL-NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA--------------- 269
           VL  S   +   D+W++GC   +M++GT  F   SE     RI                 
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230

Query: 270 --------------RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK 315
                             F     ++  DL+ ++L +DP+ R  A          H +FK
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA-----KQALEHAYFK 285

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 6e-54
 Identities = 54/278 (19%), Positives = 110/278 (39%), Gaps = 24/278 (8%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
              +  +L +  G G + +V      +  T  A+K + +  ++ +        E  ++ Q
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDA----FLAEANLMKQ 64

Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALE 159
           L H  +VRL+        +Y+  E  E G L D + +     L+ ++     A++ + + 
Sbjct: 65  LQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123

Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           +I     IHRD++  N+L++     KIADFG  + ++D+                     
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN---------EYTAREGAKFPI 174

Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 277
            +  PE +N    T  +D+W+ G  L ++++ G  P+   +   + Q +     +  P+ 
Sbjct: 175 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 234

Query: 278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM-HPFF 314
             +    L+       P  RP        +  +   FF
Sbjct: 235 CPEELYQLMRLCWKERPEDRPTFD----YLRSVLEDFF 268

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  181 bits (459), Expect = 6e-54
 Identities = 51/288 (17%), Positives = 106/288 (36%), Gaps = 41/288 (14%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           +   + E  +  G G++ +V +A+       +  T+ A+K++ ++           + E 
Sbjct: 10  YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD--FQREA 67

Query: 97  IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH--------------- 141
            ++ + D+P +V+L         + +  E    G+L + + S                  
Sbjct: 68  ALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 127

Query: 142 ---------LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSV 192
                    LS  E      +V   + Y+     +HRD+   N L+  +  +KIADFG  
Sbjct: 128 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 187

Query: 193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-G 251
           + +  +                      ++PPE +  +  T  +D+WA G  L+++ S G
Sbjct: 188 RNIYSADYY--------KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239

Query: 252 TSPFKDTSEWLIFQRIIARDIR-FPNYFSDAARDLIDRLLDVDPSGRP 298
             P+   +   +   +   +I   P        +L+       P+ RP
Sbjct: 240 LQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRP 287

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (456), Expect = 2e-53
 Identities = 73/305 (23%), Positives = 125/305 (40%), Gaps = 47/305 (15%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +++F+  +  G G+Y  V +A+   TG V ALK +     T+   +  ++ E  +L +L+
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 59

Query: 104 HPGVVRLFFTFQDTFSLYMALESCE-GGELFDQITSKGHLSEDEARFYTAEVVDALEYIH 162
           HP +V+L         LY+  E      + F   ++   +     + Y  +++  L + H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S  ++HRD+KP+NLL+  +G IK+ADFG  +                      V T  Y 
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV----------PVRTYTHEVVTLWYR 169

Query: 223 PPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRII-----------AR 270
            PE+L      +   D+W+LGC   +M++  + F   SE     RI              
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229

Query: 271 DIRFPNY------------------FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHP 312
               P+Y                    +  R L+ ++L  DP+ R  A          HP
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA-----KAALAHP 284

Query: 313 FFKGI 317
           FF+ +
Sbjct: 285 FFQDV 289

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 4e-53
 Identities = 59/275 (21%), Positives = 110/275 (40%), Gaps = 30/275 (10%)

Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
              D +   + G G++ +V++A+    G      I   K    ++       E  VL +L
Sbjct: 8   DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 67

Query: 103 -DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI----------------TSKGHLSED 145
             HP ++ L    +    LY+A+E    G L D +                ++   LS  
Sbjct: 68  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127

Query: 146 EARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN 205
           +   + A+V   ++Y+     IHRD+   N+L+  +   KIADFG  +  +         
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV-------- 179

Query: 206 AASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIF 264
                K         ++  E LN S  T  +D+W+ G  L++++S G +P+   +   ++
Sbjct: 180 ---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 236

Query: 265 QRII-ARDIRFPNYFSDAARDLIDRLLDVDPSGRP 298
           +++     +  P    D   DL+ +     P  RP
Sbjct: 237 EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERP 271

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 5e-53
 Identities = 52/282 (18%), Positives = 106/282 (37%), Gaps = 24/282 (8%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQ 101
              +   L    G G + +V       T  V A+K +    ++ E        E  V+ +
Sbjct: 14  IPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEA----FLQEAQVMKK 68

Query: 102 LDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALE 159
           L H  +V+L+    +   +Y+  E    G L D +  +   +L   +     A++   + 
Sbjct: 69  LRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 127

Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           Y+  M  +HRD++  N+L+  +   K+ADFG  + ++D+  T                  
Sbjct: 128 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT---------ARQGAKFPI 178

Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNY 277
            +  PE       T  +D+W+ G  L ++ + G  P+       +  ++     +  P  
Sbjct: 179 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE 238

Query: 278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM-HPFFKGID 318
             ++  DL+ +    +P  RP        +      +F   +
Sbjct: 239 CPESLHDLMCQCWRKEPEERPTFE----YLQAFLEDYFTSTE 276

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 8e-53
 Identities = 50/307 (16%), Positives = 108/307 (35%), Gaps = 16/307 (5%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKF--ITKENKTAYVKLERIVLDQLD 103
           +F+  K+ G G++  V +   I  G    + +  K+    T       +  E  V+  +D
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS 163
           +P V RL      +    +      G  L      K ++       +  ++   + Y+  
Sbjct: 70  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
             L+HRD+   N+L+    H+KI DFG  K +             +  A        ++ 
Sbjct: 130 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--------KEYHAEGGKVPIKWMA 181

Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRFPNYFSDA 281
            E +     T  +D+W+ G T++++++ G+ P+       I   +   + +  P   +  
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 241

Query: 282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQSGEG 341
              ++ +   +D   RP        ++           + +  Q   ++       S   
Sbjct: 242 VYMIMVKCWMIDADSRPKFR----ELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFY 297

Query: 342 DDVHDSS 348
             + D  
Sbjct: 298 RALMDEE 304

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 9e-53
 Identities = 63/260 (24%), Positives = 109/260 (41%), Gaps = 14/260 (5%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           +  ELG+  G G +  V +   +       A+ I   K  T ++       E + + Q D
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 104 HPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIH 162
           HP +V+L     +   +++ +E C  GEL   +  +   L       Y  ++  AL Y+ 
Sbjct: 67  HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125

Query: 163 SMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
           S   +HRDI   N+L++++  +K+ DFG  + M+DS            KA        ++
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY---------KASKGKLPIKWM 176

Query: 223 PPEVLNSSPATFGNDLWALGCTLYQML-SGTSPFKDTSEWLIFQRII-ARDIRFPNYFSD 280
            PE +N    T  +D+W  G  ++++L  G  PF+      +  RI     +  P     
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 236

Query: 281 AARDLIDRLLDVDPSGRPGA 300
               L+ +    DPS RP  
Sbjct: 237 TLYSLMTKCWAYDPSRRPRF 256

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 2e-52
 Identities = 65/314 (20%), Positives = 108/314 (34%), Gaps = 54/314 (17%)

Query: 40  EHFSIQD-FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIV 98
           + F +   +      G G+Y  V  A         A+K +       +        E  +
Sbjct: 2   QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF--EHQTYCQRTLREIKI 59

Query: 99  LDQLDHPGVVRLF-----FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAE 153
           L +  H  ++ +       T +    +Y+            ++    HLS D   ++  +
Sbjct: 60  LLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGAD--LYKLLKTQHLSNDHICYFLYQ 117

Query: 154 VVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           ++  L+YIHS  ++HRD+KP NLLL     +KI DFG  +          P+        
Sbjct: 118 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD-------PDHDHTGFLT 170

Query: 214 TFVGTAAYVPPEVL-NSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI 272
            +V T  Y  PE++ NS   T   D+W++GC L +MLS    F           I+    
Sbjct: 171 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 230

Query: 273 -------------------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAG 301
                                          R        A DL+D++L  +P  R    
Sbjct: 231 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV- 289

Query: 302 PGGYAVLKMHPFFK 315
                    HP+ +
Sbjct: 290 ----EQALAHPYLE 299

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  177 bits (449), Expect = 2e-52
 Identities = 51/268 (19%), Positives = 105/268 (39%), Gaps = 13/268 (4%)

Query: 40  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKLER 96
           +   I   ++ ++ G G + +V        G      A+K +   +  K+ +      E 
Sbjct: 21  KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRD--FLSEA 78

Query: 97  IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFD-QITSKGHLSEDEARFYTAEVV 155
            ++ Q DHP V+ L      +  + +  E  E G L      + G  +  +       + 
Sbjct: 79  SIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIA 138

Query: 156 DALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTF 215
             ++Y+  M  +HRD+   N+L+ ++   K++DFG  + ++D       +  +   A   
Sbjct: 139 AGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT-----SDPTYTSALGG 193

Query: 216 VGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIR 273
                +  PE +     T  +D+W+ G  +++++S G  P+ D +   +   I     + 
Sbjct: 194 KIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP 253

Query: 274 FPNYFSDAARDLIDRLLDVDPSGRPGAG 301
            P     A   L+      D + RP  G
Sbjct: 254 PPMDCPSALHQLMLDCWQKDRNHRPKFG 281

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 4e-52
 Identities = 74/326 (22%), Positives = 125/326 (38%), Gaps = 60/326 (18%)

Query: 42  FSIQD-FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 100
           + ++  +   +  G G+Y  V  A    TG   A+K + + F ++       + E  +L 
Sbjct: 14  WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLK 72

Query: 101 QLDHPGVVRLFFTFQ------DTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEV 154
            + H  V+ L   F       D    Y+ +     G    ++     L ED  +F   ++
Sbjct: 73  HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQM 130

Query: 155 VDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACT 214
           +  L YIH+ G+IHRD+KP NL +  D  +KI DFG  +               D +   
Sbjct: 131 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA-------------DSEMTG 177

Query: 215 FVGTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR 273
           +V T  Y  PEV LN    T   D+W++GC + +M++G + FK +      + I+     
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237

Query: 274 FPNYF-------------------------------SDAARDLIDRLLDVDPSGRPGAGP 302
            P  F                               S  A +L++++L +D   R  A  
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA-- 295

Query: 303 GGYAVLKMHPFFKGIDWKNIRGQTPP 328
                   HP+F+ +       Q   
Sbjct: 296 ---GEALAHPYFESLHDTEDEPQVQK 318

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  174 bits (441), Expect = 2e-51
 Identities = 51/298 (17%), Positives = 98/298 (32%), Gaps = 33/298 (11%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP- 105
           + LG+  G GS+  +     I  G   A+K+   K    +     + +E  +   +    
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ-----LHIESKIYKMMQGGV 63

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 165
           G+  + +   +     M +E                 S         +++  +EYIHS  
Sbjct: 64  GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 123

Query: 166 LIHRDIKPENLLLTADGH---IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYV 222
            IHRD+KP+N L+        + I DFG  K  +D+R           +     GTA Y 
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP---YRENKNLTGTARYA 180

Query: 223 PPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR--------F 274
                     +  +DL +LG  L     G+ P++        Q+      +         
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240

Query: 275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM--HPFFK-------GIDWKNIR 323
              +       ++    +    +P        + ++  + F +         DW  ++
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYS----YLRQLFRNLFHRQGFSYDYVFDWNMLK 294

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 7e-51
 Identities = 66/302 (21%), Positives = 114/302 (37%), Gaps = 47/302 (15%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH 104
           Q +E  +  G G+Y  V +AK  +T  + ALK +      +   ++ ++ E  +L +L H
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKH 60

Query: 105 PGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM 164
             +VRL         L +  E C+        +  G L  +  + +  +++  L + HS 
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120

Query: 165 GLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPP 224
            ++HRD+KP+NLL+  +G +K+A+FG  +                      V T  Y PP
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGI----------PVRCYSAEVVTLWYRPP 170

Query: 225 EVLNSSPA-TFGNDLWALGCTLYQMLSGTSP-FKDTSEWLIFQRIIARDIRFPNY----- 277
           +VL  +   +   D+W+ GC   ++ +   P F         +RI               
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230

Query: 278 ------------------------FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPF 313
                                    +   RDL+  LL  +P  R  A          HP+
Sbjct: 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA-----EEALQHPY 285

Query: 314 FK 315
           F 
Sbjct: 286 FS 287

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 2e-50
 Identities = 63/286 (22%), Positives = 107/286 (37%), Gaps = 37/286 (12%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           F       GK  G G++ KVV A      K D     A+K++       E +   +  E 
Sbjct: 20  FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA--LMSEL 77

Query: 97  IVLDQL-DHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH-------------- 141
            VL  L +H  +V L           +  E C  G+L + +  K                
Sbjct: 78  KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137

Query: 142 ----LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD 197
               L  ++   ++ +V   + ++ S   IHRD+   N+LLT     KI DFG  + +++
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197

Query: 198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSP-FK 256
               V+                 ++ PE + +   TF +D+W+ G  L+++ S  S  + 
Sbjct: 198 DSNYVVKG--------NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249

Query: 257 DTSEWLIFQRIIARDIR--FPNYFSDAARDLIDRLLDVDPSGRPGA 300
                  F ++I    R   P +      D++    D DP  RP  
Sbjct: 250 GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTF 295

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  170 bits (431), Expect = 2e-49
 Identities = 67/320 (20%), Positives = 119/320 (37%), Gaps = 68/320 (21%)

Query: 43  SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL 102
           +  D++L +  G G YS+V  A  I       +KI+      K      +K E  +L+ L
Sbjct: 33  NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK------IKREIKILENL 86

Query: 103 -DHPGVVRLFFTFQDTFS--LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALE 159
              P ++ L    +D  S    +  E     +          L++ + RFY  E++ AL+
Sbjct: 87  RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALD 143

Query: 160 YIHSMGLIHRDIKPENLLLTADG-HIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGT 218
           Y HSMG++HRD+KP N+++  +   +++ D+G  +                 +    V +
Sbjct: 144 YCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP-----------GQEYNVRVAS 192

Query: 219 AAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNY 277
             +  PE+ ++     +  D+W+LGC L  M+    PF    +       IA+ +   + 
Sbjct: 193 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 252

Query: 278 F--------------------------------------SDAARDLIDRLLDVDPSGRPG 299
           +                                      S  A D +D+LL  D   R  
Sbjct: 253 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT 312

Query: 300 AGPGGYAVLKMHPFFKGIDW 319
           A          HP+F  +  
Sbjct: 313 A-----REAMEHPYFYTVVK 327

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 6e-49
 Identities = 52/299 (17%), Positives = 110/299 (36%), Gaps = 36/299 (12%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLER 96
            + +   + +  G GS+  V         K +  T  A+K +++    +E        E 
Sbjct: 17  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FLNEA 74

Query: 97  IVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGH----------LSEDE 146
            V+ + +   VVRL           + +E    G+L   + S              S  +
Sbjct: 75  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134

Query: 147 ARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNA 206
                 E+ D + Y+++   +HRD+   N ++  D  +KI DFG  + + ++        
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----- 189

Query: 207 ASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGT-SPFKDTSEWLIFQ 265
               K    +    ++ PE L     T  +D+W+ G  L+++ +    P++  S   + +
Sbjct: 190 ---RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 246

Query: 266 RIIARDIR-FPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM-----HPFFKGID 318
            ++   +   P+   D   +L+      +P  RP        ++        P F+ + 
Sbjct: 247 FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFL----EIISSIKEEMEPGFREVS 301

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  167 bits (423), Expect = 9e-49
 Identities = 45/266 (16%), Positives = 91/266 (34%), Gaps = 22/266 (8%)

Query: 47  FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH-P 105
           +++G+  G GS+  +     +      A+K   ++    +     ++ E      L    
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ-----LRDEYRTYKLLAGCT 61

Query: 106 GVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG 165
           G+  +++  Q+     + ++                 S         +++  ++ IH   
Sbjct: 62  GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121

Query: 166 LIHRDIKPENLLLTA-----DGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAA 220
           L++RDIKP+N L+          I + DFG VK  +D             +     GTA 
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK---QHIPYREKKNLSGTAR 178

Query: 221 YVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE---WLIFQRIIARDIRFP-- 275
           Y+          +  +DL ALG      L G+ P++          ++RI  +    P  
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238

Query: 276 ---NYFSDAARDLIDRLLDVDPSGRP 298
                F +     +    ++     P
Sbjct: 239 ELCAGFPEEFYKYMHYARNLAFDATP 264

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 2e-48
 Identities = 62/284 (21%), Positives = 112/284 (39%), Gaps = 34/284 (11%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAK-----KIDTGTVYALKIMDKKFITKENKTAYVKLER 96
           F     +LGK  G G++ +V+ A      K  T    A+K++ +     E++ A +   +
Sbjct: 10  FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR-ALMSELK 68

Query: 97  IVLDQLDHPGVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-------------- 141
           I++    H  VV L     +    L + +E C+ G L   + SK +              
Sbjct: 69  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128

Query: 142 --LSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR 199
             L+ +    Y+ +V   +E++ S   IHRD+   N+LL+    +KI DFG  + +    
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD- 187

Query: 200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGT-SPFKDT 258
                      +         ++ PE +     T  +D+W+ G  L+++ S   SP+   
Sbjct: 188 -------PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240

Query: 259 SEWLIFQRIIARDIR--FPNYFSDAARDLIDRLLDVDPSGRPGA 300
                F R +    R   P+Y +      +      +PS RP  
Sbjct: 241 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF 284

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 4e-48
 Identities = 59/282 (20%), Positives = 109/282 (38%), Gaps = 34/282 (12%)

Query: 42  FSIQDFELGKIYGVGSYSKVVRAKKIDT-------GTVYALKIMDKKFITKENKTAYVKL 94
                  LGK  G G++ +VV A+ I          T  A+K++ K   T+++ +  +  
Sbjct: 10  LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISE 68

Query: 95  ERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQI----------------TS 138
             ++     H  ++ L         LY+ +E    G L + +                  
Sbjct: 69  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128

Query: 139 KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS 198
           +  LS  +      +V   +EY+ S   IHRD+   N+L+T D  +KIADFG  + +   
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188

Query: 199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKD 257
                       K         ++ PE L     T  +D+W+ G  L+++ + G SP+  
Sbjct: 189 D--------YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 240

Query: 258 TSEWLIFQRIIA-RDIRFPNYFSDAARDLIDRLLDVDPSGRP 298
                +F+ +     +  P+  ++    ++       PS RP
Sbjct: 241 VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP 282

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 9e-47
 Identities = 71/311 (22%), Positives = 121/311 (38%), Gaps = 56/311 (18%)

Query: 42  FSIQD-FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD 100
           + + + ++     G G+Y  V  A    TG   A+K + + F +  +     + E  +L 
Sbjct: 14  WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLK 72

Query: 101 QLDHPGVVRLFFTFQDTFSL----YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVD 156
            + H  V+ L   F    SL     + L +   G   + I     L++D  +F   +++ 
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 132

Query: 157 ALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFV 216
            L+YIHS  +IHRD+KP NL +  D  +KI DFG  +               DD+   +V
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT-------------DDEMTGYV 179

Query: 217 GTAAYVPPEV-LNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP 275
            T  Y  PE+ LN        D+W++GC + ++L+G + F  T      + I+       
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 239

Query: 276 NYF-------------------------------SDAARDLIDRLLDVDPSGRPGAGPGG 304
                                             +  A DL++++L +D   R  A    
Sbjct: 240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA---- 295

Query: 305 YAVLKMHPFFK 315
            A    H +F 
Sbjct: 296 -AQALAHAYFA 305

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 1e-46
 Identities = 52/257 (20%), Positives = 107/257 (41%), Gaps = 15/257 (5%)

Query: 49  LGKIYGVGSYSKVVRAKKID---TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
             ++ G G +  V     +D        A+K +++  IT   + +    E I++    HP
Sbjct: 31  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHP 88

Query: 106 GVVRLF-FTFQDTFSLYMALESCEGGELFDQITSKGH-LSEDEARFYTAEVVDALEYIHS 163
            V+ L     +   S  + L   + G+L + I ++ H  +  +   +  +V   ++++ S
Sbjct: 89  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 148

Query: 164 MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVP 223
              +HRD+   N +L     +K+ADFG  + M D          S            ++ 
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK------EFDSVHNKTGAKLPVKWMA 202

Query: 224 PEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRII-ARDIRFPNYFSDA 281
            E L +   T  +D+W+ G  L+++++ G  P+ D + + I   ++  R +  P Y  D 
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 262

Query: 282 ARDLIDRLLDVDPSGRP 298
             +++ +        RP
Sbjct: 263 LYEVMLKCWHPKAEMRP 279

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 2e-46
 Identities = 44/261 (16%), Positives = 96/261 (36%), Gaps = 16/261 (6%)

Query: 45  QDFELGKIYGVGSYSKVVRAKKIDTG----TVYALKIMDKKFITKENKTAYVKLERIVLD 100
                 K+ G G + +V +     +        A+K +   +  K+        E  ++ 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD--FLGEAGIMG 64

Query: 101 QLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALE 159
           Q  H  ++RL         + +  E  E G L   +  K G  S  +       +   ++
Sbjct: 65  QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124

Query: 160 YIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTA 219
           Y+ +M  +HRD+   N+L+ ++   K++DFG  + ++D       +  +           
Sbjct: 125 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED-------DPEATYTTSGGKIPI 177

Query: 220 AYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR--FPNY 277
            +  PE ++    T  +D+W+ G  ++++++               + I    R   P  
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD 237

Query: 278 FSDAARDLIDRLLDVDPSGRP 298
              A   L+ +    + + RP
Sbjct: 238 CPSAIYQLMMQCWQQERARRP 258

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 9e-46
 Identities = 57/320 (17%), Positives = 118/320 (36%), Gaps = 68/320 (21%)

Query: 44  IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD 103
           ++ ++  K  G G+   V  A         A+K + + F  + +     + E +++  ++
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVN 74

Query: 104 HPGVVRLFFTF------QDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDA 157
           H  ++ L   F      ++   +Y+ +E  +          +  L  +   +   +++  
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCG 131

Query: 158 LEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVG 217
           ++++HS G+IHRD+KP N+++ +D  +KI DFG  +                     +V 
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-----------SFMMTPYVV 180

Query: 218 TAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIA-------- 269
           T  Y  PEV+         D+W++GC + +M+     F        + ++I         
Sbjct: 181 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240

Query: 270 -------------------RDIRFPNYF---------------SDAARDLIDRLLDVDPS 295
                                + FP  F               +  ARDL+ ++L +DP+
Sbjct: 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 300

Query: 296 GRPGAGPGGYAVLKMHPFFK 315
            R             HP+  
Sbjct: 301 KRISV-----DDALQHPYIN 315

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 2e-44
 Identities = 53/295 (17%), Positives = 104/295 (35%), Gaps = 53/295 (17%)

Query: 46  DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHP 105
              L +  G G + +V R K    G   A+KI   +    E ++ + + E      L H 
Sbjct: 4   TIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHE 57

Query: 106 GVVRLFFTFQDTFS----LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYI 161
            ++               L++  +  E G LFD + ++  ++ +            L ++
Sbjct: 58  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHL 116

Query: 162 HS--------MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKAC 213
           H           + HRD+K +N+L+  +G   IAD G       +  T+      D    
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI------DIAPN 170

Query: 214 TFVGTAAYVPPEVLNSS------PATFGNDLWALGCTLYQMLSGTSPFKDTSEW------ 261
             VGT  Y+ PEVL+ S       +    D++A+G   +++    S      ++      
Sbjct: 171 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230

Query: 262 ---------LIFQRIIARDIR--FPNYFS-----DAARDLIDRLLDVDPSGRPGA 300
                     + + +  + +R   PN +           ++      + + R  A
Sbjct: 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 285

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  141 bits (356), Expect = 2e-38
 Identities = 59/362 (16%), Positives = 121/362 (33%), Gaps = 78/362 (21%)

Query: 40  EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLER--- 96
           E +    + L +  G G +S V  AK +   T  A+KI+    +  E     +KL +   
Sbjct: 8   EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVN 67

Query: 97  ----IVLDQLDHPGVVRLFFTFQDTFS--LYMALESCEGG---ELFDQITSKGHLSEDEA 147
                  D +    +++L   F       +++ +     G       +      +     
Sbjct: 68  DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127

Query: 148 RFYTAEVVDALEYI-HSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNA 206
           +  + +++  L+Y+    G+IH DIKPEN+L+      +      +  + ++        
Sbjct: 128 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY----- 182

Query: 207 ASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTS------- 259
             D+     + T  Y  PEVL  +P   G D+W+  C ++++++G   F+          
Sbjct: 183 --DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240

Query: 260 -----------------------------------------EWLIFQRIIARDIRFPNYF 278
                                                    ++   + ++    +F    
Sbjct: 241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 300

Query: 279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPPKLASEPMVQS 338
           +    D +  +L +DP  R  A       L  HP+      K+  G    ++    +  S
Sbjct: 301 AKEISDFLSPMLQLDPRKRADA-----GGLVNHPWL-----KDTLGMEEIRVPDRELYGS 350

Query: 339 GE 340
           G 
Sbjct: 351 GS 352

>d1w1ha_ b.55.1.1 (A:) 3-phosphoinositide dependent protein kinase-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 147

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: 3-phosphoinositide dependent protein kinase-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.1 bits (176), Expect = 1e-15
 Identities = 34/136 (25%), Positives = 59/136 (43%), Gaps = 6/136 (4%)

Query: 353 HIGDISAKINDGNGGASSSEGSITRLASIDSFDSKWQQFLDPGESVLMISMVKKLQKLTS 412
           +I D+ +   + +   S  E  +          + W QF++    +L +  V K + L +
Sbjct: 6   YIHDLDSNSFELDLQFSEDEKRLLLEKQAGG--NPWHQFVE-NNLILKMGPVDKRKGLFA 62

Query: 413 KKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFEDA 472
           ++ QL+LT  P L YVDP   V+KG I WS        +  +   F + TP +     D 
Sbjct: 63  RRRQLLLTEGPHLYYVDPVNKVLKGEIPWSQEL---RPEAKNFKTFFVHTPNRTYYLMDP 119

Query: 473 KQRASQWKKAIEALQN 488
              A +W + I+ +  
Sbjct: 120 SGNAHKWCRKIQEVWR 135

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 73.3 bits (179), Expect = 1e-15
 Identities = 21/159 (13%), Positives = 48/159 (30%), Gaps = 28/159 (17%)

Query: 48  ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAY---------------V 92
            +GK+ G G  S V      +      +K       + +                     
Sbjct: 3   AIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61

Query: 93  KLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTA 152
           + E   L +L    V +++          + +E                +  +       
Sbjct: 62  RNEFRALQKLQGLAVPKVY----AWEGNAVLME-------LIDAKELYRVRVENPDEVLD 110

Query: 153 EVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS 191
            +++ +   +  G++H D+   N+L++ +  I I DF  
Sbjct: 111 MILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQ 148

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	489
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1w1ha_	147	3-phosphoinositide dependent protein kinase-1 {Hum	99.92
d2coaa1	112	Protein kinase c, d2 type {Human (Homo sapiens) [T	99.6
d2coda1	102	Centaurin-delta 1 {Human (Homo sapiens) [TaxId: 96	99.53
d1faoa_	100	Dual adaptor of phosphotyrosine and 3-phosphoinosi	99.47
d1eaza_	103	Tapp1 {Human (Homo sapiens) [TaxId: 9606]}	99.36
d1btka_	169	Bruton's tyrosine kinase {Human (Homo sapiens) [Ta	99.27
d1qqga1	103	Insulin receptor substrate 1, IRS-1 {Human (Homo s	99.25
d1x1fa1	136	Signal-transducing adaptor protein 1, STAP-1 {Huma	99.24
d1v89a_	118	Rho-GTPase-activating protein 25 (KIAA0053) {Human	99.24
d2dyna_	111	Dynamin {Human (Homo sapiens) [TaxId: 9606]}	99.24
d1u5da1	106	Src kinase-associated phosphoprotein SKAP55 (SCAP1	99.21
d1v88a_	130	Oxysterol binding protein-related protein 8 (ORP-8	99.2
d1wg7a_	150	Dedicator of cytokinesis protein 9, DOCK9 {Human (	99.18
d1plsa_	113	Pleckstrin {Human (Homo sapiens) [TaxId: 9606]}	99.17
d2fjla1	101	Phosphoinositide phospholipase C, PLC-gamma-1 {Rat	99.16
d1v5ua_	117	SET binding factor 1, Sbf1 {Mouse (Mus musculus) [	99.15
d2elba2	101	DCC-interacting protein 13-alpha, APPL1 {Human (Ho	99.15
d1unqa_	118	Rac-alpha serine/threonine kinase {Human (Homo sap	99.15
d1omwa2	119	G-protein coupled receptor kinase 2 (beta-adrenerg	99.15
d1u5fa1	111	Src-associated adaptor protein Skap2 {Mouse (Mus m	99.14
d2i5fa1	104	Pleckstrin {Human (Homo sapiens) [TaxId: 9606]}	99.12
d2coca1	99	FYVE, RhoGEF and PH domain containing protein 3, F	99.1
d1fgya_	127	Grp1 {Mouse (Mus musculus) [TaxId: 10090]}	99.09
d1wgqa_	109	FYVE, RhoGEF and PH domain containing protein 6, F	99.07
d1upqa_	107	Phosphoinositol 3-phosphate binding protein-1, PEP	99.07
d1u5ea1	209	Src-associated adaptor protein Skap2 {Mouse (Mus m	99.06
d1wi1a_	126	Calcium-dependent activator protein for secretion,	99.06
d1x1ga1	116	Pleckstrin-2 {Human (Homo sapiens) [TaxId: 9606]}	99.01
d2j59m1	133	Rho GTPase-activating protein 21 {Human (Homo sapi	98.98
d2cofa1	95	KIAA1914 {Human (Homo sapiens) [TaxId: 9606]}	98.93
d1v5pa_	126	Tapp2 {Mouse (Mus musculus) [TaxId: 10090]}	98.91
d1v5ma_	136	SH2 and PH domain-containing adapter protein APS {	98.89
d1droa_	122	beta-spectrin {Fruit fly (Drosophila melanogaster)	98.67
d1btna_	106	beta-spectrin {Mouse (Mus musculus), brain [TaxId:	98.54
d1wjma_	123	beta-spectrin {Human (Homo sapiens), brain 2 isofo	98.48
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.45
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.97
d1v61a_	132	Rac/CDC42 GEF 6, alpha-pix {Mouse (Mus musculus) [	97.93
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.92
d1maia_	119	Phospholipase C delta-1 {Rat (Rattus norvegicus) [	97.74
d1zc3b1	109	Exocyst complex protein EXO84 {Rat (Rattus norvegi	97.4
d1dbha2	133	Son of sevenless-1 (sos-1) {Human (Homo sapiens) [	97.38
d2dfka2	162	Rho guanine nucleotide exchange factor 9, Collybis	97.37
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.03
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.79
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.36
d1ki1b2	142	GEF of intersectin {Human (Homo sapiens) [TaxId: 9	95.46
d1ntya2	121	Triple functional domain protein TRIO {Human (Homo	95.32
d1fhoa_	119	UNC-89 {Nematode (Caenorhabditis elegans) [TaxId:	94.84
d1xcga2	140	Rho guanine nucleotide exchange factor 11, PDZ-Rho	94.81
d1txda2	114	Rho guanine nucleotide exchange factor 12 {Human (	93.06
d1kz7a2	147	Dbl's big sister, Dbs {Mouse (Mus musculus) [TaxId	89.64

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-68  Score=526.43  Aligned_cols=284  Identities=49%  Similarity=0.861  Sum_probs=259.3

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCE
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  119 (489)
                      .+..++||++++.||+|+||+||+|+++.+|+.||||++.+.....+.....+.+|+.+|++++|||||+++++|.++..
T Consensus         3 ~~~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~   82 (288)
T d1uu3a_           3 RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK   82 (288)
T ss_dssp             CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSE
T ss_pred             CCCCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCE
Confidence            45678999999999999999999999999999999999988766666677889999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcc
Q 011287          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      +|+|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.+....
T Consensus        83 ~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~  162 (288)
T d1uu3a_          83 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  162 (288)
T ss_dssp             EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence            99999999999999999998999999999999999999999999999999999999999999999999999998764322


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS  279 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~  279 (489)
                              ......+.+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+...++++|....+.+|..++
T Consensus       163 --------~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s  234 (288)
T d1uu3a_         163 --------KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFF  234 (288)
T ss_dssp             ---------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCC
T ss_pred             --------cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCC
Confidence                    123344678999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCC-CCHHHHhcCCCCCCCCcccccCCCCCCCC
Q 011287          280 DAARDLIDRLLDVDPSGRPGAGP-GGYAVLKMHPFFKGIDWKNIRGQTPPKLA  331 (489)
Q Consensus       280 ~~~~~Li~~~L~~dP~~R~t~~~-~~~~~l~~hpff~~i~~~~~~~~~~p~~~  331 (489)
                      +++++||.+||+.||++|||+.+ .....+++||||++++|+.+..++||+++
T Consensus       235 ~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~~~pP~l~  287 (288)
T d1uu3a_         235 PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT  287 (288)
T ss_dssp             HHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCCC
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhcCCCCCCC
Confidence            99999999999999999999976 46677899999999999999999888753

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-66  Score=518.64  Aligned_cols=281  Identities=37%  Similarity=0.646  Sum_probs=259.7

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~l  120 (489)
                      +++++||++++.||+|+||.||+|+++.+|+.||||++.+...........+.+|+.+|+.++||||++++++|++...+
T Consensus         1 ~i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   80 (337)
T d1o6la_           1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL   80 (337)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred             CCchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccc
Confidence            46789999999999999999999999999999999999887666666677888999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      |+|||||+||+|.+++.+.+.+++..++.+++||+.||+|||++||+||||||+|||++.+|++||+|||+|+.....  
T Consensus        81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~--  158 (337)
T d1o6la_          81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--  158 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT--
T ss_pred             ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC--
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999865332  


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCH
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSD  280 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~  280 (489)
                              .....+++||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..++++++....+.+|..+|+
T Consensus       159 --------~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~  230 (337)
T d1o6la_         159 --------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSP  230 (337)
T ss_dssp             --------TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCH
T ss_pred             --------CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCH
Confidence                    234457899999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC-CCCCCC
Q 011287          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLA  331 (489)
Q Consensus       281 ~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~-~~p~~~  331 (489)
                      ++++||.+||++||++|++....+++++++||||++++|+.+..+ .+|++.
T Consensus       231 ~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~~~p~~  282 (337)
T d1o6la_         231 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFK  282 (337)
T ss_dssp             HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCC
T ss_pred             HHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHHHHHhCCCCCCCC
Confidence            999999999999999999876667899999999999999998654 344443

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.8e-64  Score=500.22  Aligned_cols=271  Identities=37%  Similarity=0.712  Sum_probs=252.9

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ly  121 (489)
                      ++++||++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++|||||+++++|.+...+|
T Consensus         1 ~sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   80 (316)
T d1fota_           1 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF   80 (316)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred             CchhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeee
Confidence            46899999999999999999999999999999999998776656666778889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccc
Q 011287          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~  201 (489)
                      +|||||+||+|..++...+.+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+|+....    
T Consensus        81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~----  156 (316)
T d1fota_          81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----  156 (316)
T ss_dssp             EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----
T ss_pred             eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc----
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999986532    


Q ss_pred             ccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHH
Q 011287          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDA  281 (489)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~  281 (489)
                               ...+.+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+++++|......+|..++++
T Consensus       157 ---------~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~  227 (316)
T d1fota_         157 ---------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNED  227 (316)
T ss_dssp             ---------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred             ---------ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHH
Confidence                     23357899999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC
Q 011287          282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ  325 (489)
Q Consensus       282 ~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~  325 (489)
                      +++||.+||+.||.+|++....+++++++||||++++|+.+..+
T Consensus       228 ~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~  271 (316)
T d1fota_         228 VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSR  271 (316)
T ss_dssp             HHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTT
T ss_pred             HHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHHHHHhC
Confidence            99999999999999998665556699999999999999998643

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-64  Score=489.49  Aligned_cols=258  Identities=34%  Similarity=0.616  Sum_probs=242.9

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEE
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~l  120 (489)
                      +++++||++++.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+.+++.++|||||+++++|.++..+
T Consensus         2 ~~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~   81 (263)
T d2j4za1           2 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV   81 (263)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             CcchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEE
Confidence            57899999999999999999999999999999999999877666666677788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      |+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....   
T Consensus        82 ~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~---  158 (263)
T d2j4za1          82 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---  158 (263)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC---
T ss_pred             EEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC---
Confidence            99999999999999999988999999999999999999999999999999999999999999999999999986532   


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCH
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSD  280 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~  280 (489)
                               ......+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..++++++....+.+|+.+|+
T Consensus       159 ---------~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~  229 (263)
T d2j4za1         159 ---------SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE  229 (263)
T ss_dssp             ---------CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCH
T ss_pred             ---------CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCH
Confidence                     22345689999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 011287          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (489)
Q Consensus       281 ~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~  315 (489)
                      ++++||.+||+.||++|||+     +++++||||+
T Consensus       230 ~~~~li~~~L~~dp~~R~t~-----~eil~hp~~~  259 (263)
T d2j4za1         230 GARDLISRLLKHNPSQRPML-----REVLEHPWIT  259 (263)
T ss_dssp             HHHHHHHHHTCSSGGGSCCH-----HHHHTCHHHH
T ss_pred             HHHHHHHHHccCCHhHCcCH-----HHHHcCcCcC
Confidence            99999999999999999998     8999999996

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.7e-62  Score=494.80  Aligned_cols=280  Identities=35%  Similarity=0.629  Sum_probs=254.7

Q ss_pred             CCCCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCE
Q 011287           40 EHFSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (489)
Q Consensus        40 ~~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  119 (489)
                      ....+++|++++.||+|+||.||+|+++.+|+.||||++.+...........+.+|+.+|+.++|||||+++++|.+...
T Consensus        36 ~~~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  115 (350)
T d1rdqe_          36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN  115 (350)
T ss_dssp             CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CCCCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccc
Confidence            44567999999999999999999999999999999999987765555666778899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcc
Q 011287          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      +|+||||+.||+|..++.+.+.+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+..  
T Consensus       116 ~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~--  193 (350)
T d1rdqe_         116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--  193 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred             cccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc--
Confidence            999999999999999999989999999999999999999999999999999999999999999999999999986542  


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFS  279 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~  279 (489)
                                 ...+.+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+...++.+|....+.+|..++
T Consensus       194 -----------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s  262 (350)
T d1rdqe_         194 -----------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFS  262 (350)
T ss_dssp             -----------CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCC
T ss_pred             -----------ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCC
Confidence                       233678999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC-CCCCCCC
Q 011287          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLAS  332 (489)
Q Consensus       280 ~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~-~~p~~~~  332 (489)
                      +++.+||++||+.||.+|+.....+++++++||||++++|+.+..+ .+|++.|
T Consensus       263 ~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p  316 (350)
T d1rdqe_         263 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP  316 (350)
T ss_dssp             HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred             HHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHHHhcCCCcCccC
Confidence            9999999999999999997433334599999999999999998654 3444333

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-62  Score=486.96  Aligned_cols=273  Identities=35%  Similarity=0.634  Sum_probs=245.4

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHH-HhCCCCCccEEEEEEEcCCEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVL-DQLDHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il-~~l~hpnIv~l~~~~~~~~~lyl  122 (489)
                      ++||++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|..++ +.++|||||+++++|.+...+|+
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence            58999999999999999999999999999999999876555445555556666665 47899999999999999999999


Q ss_pred             EEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccc
Q 011287          123 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITV  202 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~  202 (489)
                      |||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.....    
T Consensus        81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~----  156 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG----  156 (320)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT----
T ss_pred             EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc----
Confidence            9999999999999999899999999999999999999999999999999999999999999999999999865432    


Q ss_pred             cCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHH
Q 011287          203 LPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPNYFSDAA  282 (489)
Q Consensus       203 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~~~~~~~  282 (489)
                            .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...++.+|....+.+|..+|+++
T Consensus       157 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~  230 (320)
T d1xjda_         157 ------DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEA  230 (320)
T ss_dssp             ------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred             ------cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHH
Confidence                  22334568999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC-CCCCC
Q 011287          283 RDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKL  330 (489)
Q Consensus       283 ~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~-~~p~~  330 (489)
                      ++||++||+.||++||++.    .++++||||++++|+.+..+ .+|+.
T Consensus       231 ~dli~~~L~~dP~~R~s~~----~~l~~hpff~~~~~~~l~~~~~~pp~  275 (320)
T d1xjda_         231 KDLLVKLFVREPEKRLGVR----GDIRQHPLFREINWEELERKEIDPPF  275 (320)
T ss_dssp             HHHHHHHSCSSGGGSBTTB----SCGGGSGGGTTCCHHHHHTTCSCC--
T ss_pred             HHHHHHhcccCCCCCcCHH----HHHHhCchhccCCHHHHHhcCCCCCC
Confidence            9999999999999999983    36999999999999988654 34433

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.4e-61  Score=492.08  Aligned_cols=279  Identities=33%  Similarity=0.580  Sum_probs=243.1

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHH---HHHHHhCCCCCccEEEEEEEcCC
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLE---RIVLDQLDHPGVVRLFFTFQDTF  118 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E---~~il~~l~hpnIv~l~~~~~~~~  118 (489)
                      +++++|+++++||+|+||.||+|+++.+|+.||||++.+...........+.+|   +.+++.++|||||+++++|.+..
T Consensus         1 lslddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~   80 (364)
T d1omwa3           1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD   80 (364)
T ss_dssp             CCSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred             CCHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC
Confidence            478999999999999999999999999999999999987655444433444444   56677778999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      .+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.+...
T Consensus        81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~  160 (364)
T d1omwa3          81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  160 (364)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred             EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence            99999999999999999999899999999999999999999999999999999999999999999999999999865432


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCC---HHHHHHHHHhcCCCC
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTS---EWLIFQRIIARDIRF  274 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~---~~~~~~~i~~~~~~~  274 (489)
                                  .....+||+.|+|||++.. ..++.++|||||||++|+|++|+.||.+.+   ...+...+......+
T Consensus       161 ------------~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  228 (364)
T d1omwa3         161 ------------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL  228 (364)
T ss_dssp             ------------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCC
T ss_pred             ------------cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCC
Confidence                        2345689999999999964 568999999999999999999999998654   344555666777888


Q ss_pred             CCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCC-CCCCCCC
Q 011287          275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQ-TPPKLAS  332 (489)
Q Consensus       275 p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~-~~p~~~~  332 (489)
                      |..+++++++||.+||+.||++|||..+.+++++++||||++++|+.+..+ .+|++.|
T Consensus       229 ~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~~~p~~p  287 (364)
T d1omwa3         229 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIP  287 (364)
T ss_dssp             CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred             CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHHhcCCCCcCcCC
Confidence            999999999999999999999999976667899999999999999988654 3444433

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-61  Score=473.01  Aligned_cols=257  Identities=29%  Similarity=0.455  Sum_probs=221.4

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      .+||++++.||+|+||+||+|+++.+|+.||||++.+....  ...+.+.+|+.+|++++|||||++++++.+...+|+|
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv   81 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   81 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence            58999999999999999999999999999999999765322  2335678899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      ||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.+....    
T Consensus        82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~----  157 (271)
T d1nvra_          82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN----  157 (271)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT----
T ss_pred             EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC----
Confidence            9999999999999888899999999999999999999999999999999999999999999999999998764322    


Q ss_pred             CCCCCCCCccceecCCcCCChhhhcCCCC-CCCCcchhhhHHHHHHhhCCCCCCCCCHHHHH-HHHHhcCCC--CCCCCC
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIF-QRIIARDIR--FPNYFS  279 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~-~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~-~~i~~~~~~--~p~~~~  279 (489)
                          ......+.+||+.|+|||++.+..+ +.++|||||||++|+|++|++||.+.+..... ..+......  .+..++
T Consensus       158 ----~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s  233 (271)
T d1nvra_         158 ----RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID  233 (271)
T ss_dssp             ----EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSC
T ss_pred             ----ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCC
Confidence                1123446789999999999988775 67899999999999999999999876554333 333332222  224689


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 011287          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (489)
Q Consensus       280 ~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~  315 (489)
                      +++++||.+||+.||++|||+     +++++||||+
T Consensus       234 ~~~~~li~~~L~~dP~~R~t~-----~eil~hpwf~  264 (271)
T d1nvra_         234 SAPLALLHKILVENPSARITI-----PDIKKDRWYN  264 (271)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCH-----HHHTTCTTTT
T ss_pred             HHHHHHHHHHcCCChhHCcCH-----HHHhcCHhhC
Confidence            999999999999999999998     8999999996

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-61  Score=473.06  Aligned_cols=253  Identities=28%  Similarity=0.459  Sum_probs=228.8

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+...   ...+.+.+|+.+|+.++|||||+++++|.+...+|+||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   96 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC---hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence            479999999999999999999999999999999976532   23466889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccC
Q 011287          125 ESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLP  204 (489)
Q Consensus       125 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~  204 (489)
                      |||+||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.+...      
T Consensus        97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~------  169 (293)
T d1yhwa1          97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE------  169 (293)
T ss_dssp             ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST------
T ss_pred             EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccc------
Confidence            99999999998876 46999999999999999999999999999999999999999999999999999876432      


Q ss_pred             CCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc---CCCCCCCCCHH
Q 011287          205 NAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---DIRFPNYFSDA  281 (489)
Q Consensus       205 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~---~~~~p~~~~~~  281 (489)
                          .......+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+.......+...   .+..|..++++
T Consensus       170 ----~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  245 (293)
T d1yhwa1         170 ----QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI  245 (293)
T ss_dssp             ----TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHH
T ss_pred             ----cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHH
Confidence                22344678999999999999999999999999999999999999999999988877776654   34556789999


Q ss_pred             HHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          282 ARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       282 ~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      +++||.+||+.||++|||+     +++++||||+.
T Consensus       246 ~~~li~~~L~~dP~~R~s~-----~eil~Hp~~~~  275 (293)
T d1yhwa1         246 FRDFLNRCLDMDVEKRGSA-----KELLQHQFLKI  275 (293)
T ss_dssp             HHHHHHHHTCSSTTTSCCH-----HHHTTCGGGGG
T ss_pred             HHHHHHHHccCChhHCcCH-----HHHhcCHhhCC
Confidence            9999999999999999998     89999999973

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-60  Score=468.79  Aligned_cols=263  Identities=30%  Similarity=0.525  Sum_probs=235.1

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE---NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ly  121 (489)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+......   ...+.+.+|+.+|++++|||||+++++|.+...+|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            569999999999999999999999999999999987654332   23567889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCC----CEEEeeccCccccCC
Q 011287          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG----HIKIADFGSVKPMQD  197 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g----~ikL~DFG~a~~~~~  197 (489)
                      +|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|    ++||+|||+|+....
T Consensus        90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~  169 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF  169 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred             EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCC
Confidence            9999999999999999888999999999999999999999999999999999999998876    599999999987543


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCC--
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP--  275 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p--  275 (489)
                      .           ....+.+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+++..|......++  
T Consensus       170 ~-----------~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  238 (293)
T d1jksa_         170 G-----------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE  238 (293)
T ss_dssp             S-----------CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHH
T ss_pred             C-----------ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCch
Confidence            2           233466899999999999999999999999999999999999999999999999999999887766  


Q ss_pred             --CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCccccc
Q 011287          276 --NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR  323 (489)
Q Consensus       276 --~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~  323 (489)
                        ..+|+++++||++||+.||++|||+     +++++||||++.+|+...
T Consensus       239 ~~~~~s~~~~~li~~~L~~dP~~R~s~-----~eil~hp~~~~~~~~~~l  283 (293)
T d1jksa_         239 YFSNTSALAKDFIRRLLVKDPKKRMTI-----QDSLQHPWIKPKDTQQAL  283 (293)
T ss_dssp             HHTTSCHHHHHHHHTTSCSSGGGSCCH-----HHHHHSTTTCC-------
T ss_pred             hcCCCCHHHHHHHHHHccCChhHCcCH-----HHHhcCcccCCCChhHhh
Confidence              5689999999999999999999998     899999999999987653

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=4.1e-60  Score=478.53  Aligned_cols=262  Identities=28%  Similarity=0.479  Sum_probs=237.3

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lyl  122 (489)
                      .+++|++++.||+|+||+||+|+++.+|+.||||++.+..   ....+.+.+|+.+|++++|||||+++++|.+...+|+
T Consensus        24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i  100 (350)
T d1koaa2          24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM  100 (350)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred             CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            3579999999999999999999999999999999997653   3345678899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCC--CCCEEEeeccCccccCCcc
Q 011287          123 ALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA--DGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~--~g~ikL~DFG~a~~~~~~~  199 (489)
                      |||||+||+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+|||++.  +|.+||+|||+|+.+... 
T Consensus       101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-  179 (350)
T d1koaa2         101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-  179 (350)
T ss_dssp             EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-
T ss_pred             EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc-
Confidence            9999999999999954 467999999999999999999999999999999999999964  589999999999876432 


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCC---
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN---  276 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~---  276 (489)
                                ....+.+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+++..|......++.   
T Consensus       180 ----------~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  249 (350)
T d1koaa2         180 ----------QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF  249 (350)
T ss_dssp             ----------SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGG
T ss_pred             ----------cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccc
Confidence                      2344678999999999999999999999999999999999999999999999999999988877663   


Q ss_pred             -CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCccccc
Q 011287          277 -YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIR  323 (489)
Q Consensus       277 -~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~  323 (489)
                       .+++++++||.+||+.||++|||+     +++++||||+..+|....
T Consensus       250 ~~~s~~~~~li~~~L~~dP~~R~t~-----~eil~hp~~~~~~~~~~~  292 (350)
T d1koaa2         250 SGISEDGKDFIRKLLLADPNTRMTI-----HQALEHPWLTPGNAPGRD  292 (350)
T ss_dssp             GGCCHHHHHHHHHHCCSSGGGSCCH-----HHHHHSTTTSCTTCCSCC
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCH-----HHHhcCcccCCCCCCCch
Confidence             589999999999999999999998     899999999988775443

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-60  Score=473.85  Aligned_cols=255  Identities=34%  Similarity=0.601  Sum_probs=216.7

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      .+.|++++.||+|+||+||+|+++.+|+.||||++.+.....  ....+.+|+.+|+.++|||||+++++|.+...+|+|
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   85 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI   85 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            356999999999999999999999999999999998765432  235677899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeC---CCCCEEEeeccCccccCCccc
Q 011287          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT---ADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~---~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      ||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+.   ++|++||+|||+|+.....  
T Consensus        86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~--  163 (307)
T d1a06a_          86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--  163 (307)
T ss_dssp             ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred             EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC--
Confidence            99999999999999988999999999999999999999999999999999999995   5789999999999865322  


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCC----C
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----N  276 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p----~  276 (489)
                               ....+.+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+...+...+......++    .
T Consensus       164 ---------~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  234 (307)
T d1a06a_         164 ---------SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWD  234 (307)
T ss_dssp             ------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTT
T ss_pred             ---------CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCcccc
Confidence                     233467899999999999999999999999999999999999999999999999999998876654    4


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      .+|+++++||.+||+.||++|||+     +++++||||++
T Consensus       235 ~~s~~~~~li~~~L~~dP~~R~s~-----~eil~hp~~~~  269 (307)
T d1a06a_         235 DISDSAKDFIRHLMEKDPEKRFTC-----EQALQHPWIAG  269 (307)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCH-----HHHHHSTTTTS
T ss_pred             CCCHHHHHHHHHHccCCHhHCcCH-----HHHhcCHhhCC
Confidence            689999999999999999999998     89999999985

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-60  Score=460.66  Aligned_cols=255  Identities=29%  Similarity=0.528  Sum_probs=219.4

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc--CCEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD--TFSLY  121 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~ly  121 (489)
                      .+||++++.||+|+||+||+|+++.+|+.||+|++.+..... ...+.+.+|+.+|++++|||||++++++.+  ...+|
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~   81 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   81 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCH-HHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCH-HHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence            589999999999999999999999999999999998765543 345668889999999999999999999965  45689


Q ss_pred             EEEeccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC-----cEeeccCCCCeeeCCCCCEEEeeccCc
Q 011287          122 MALESCEGGELFDQITS----KGHLSEDEARFYTAEVVDALEYIHSMG-----LIHRDIKPENLLLTADGHIKIADFGSV  192 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~aL~~LH~~g-----IiHrDLKpeNILl~~~g~ikL~DFG~a  192 (489)
                      +|||||+||+|.+++.+    .+.+++..++.++.||+.||.|||+.|     |+||||||+||||+.+|++||+|||+|
T Consensus        82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a  161 (269)
T d2java1          82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  161 (269)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred             EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence            99999999999998864    357999999999999999999999976     999999999999999999999999999


Q ss_pred             cccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC
Q 011287          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI  272 (489)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~  272 (489)
                      +.+...          .....+.+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..++..+|....+
T Consensus       162 ~~~~~~----------~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~  231 (269)
T d2java1         162 RILNHD----------TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF  231 (269)
T ss_dssp             HHC---------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC
T ss_pred             eecccC----------CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC
Confidence            876432          1233467899999999999999999999999999999999999999999999999999988765


Q ss_pred             -CCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          273 -RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       273 -~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                       .+|..+|+++++||.+||+.||++|||+     +++++|||.
T Consensus       232 ~~~~~~~s~~l~~li~~~L~~dp~~Rps~-----~ell~hp~i  269 (269)
T d2java1         232 RRIPYRYSDELNEIITRMLNLKDYHRPSV-----EEILENPLI  269 (269)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHHTSTTC
T ss_pred             CCCCcccCHHHHHHHHHHcCCChhHCcCH-----HHHHhCCcC
Confidence             4778899999999999999999999998     899999994

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-60  Score=466.49  Aligned_cols=254  Identities=29%  Similarity=0.496  Sum_probs=226.8

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMAL  124 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~  124 (489)
                      +.|++++.||+|+||+||+|+++.+|+.||||++.+..   ....+.+.+|+.+|+.++|||||+++++|.+...+|+||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm   88 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI   88 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence            46999999999999999999999999999999997652   233456778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          125 ESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       125 E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      |||+||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+......    
T Consensus        89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~----  164 (288)
T d2jfla1          89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI----  164 (288)
T ss_dssp             ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH----
T ss_pred             ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc----
Confidence            99999999998765 4579999999999999999999999999999999999999999999999999997653221    


Q ss_pred             CCCCCCCCccceecCCcCCChhhhc-----CCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC---CCC
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLN-----SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI---RFP  275 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~-----~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~---~~p  275 (489)
                            ....+.+||+.|+|||++.     +..|+.++|||||||++|+|++|++||.+.+..+++.++.....   ..|
T Consensus       165 ------~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~  238 (288)
T d2jfla1         165 ------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP  238 (288)
T ss_dssp             ------HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSG
T ss_pred             ------ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence                  1233678999999999984     45688999999999999999999999999999888888887653   445


Q ss_pred             CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       276 ~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      ..+++++++||.+||+.||++|||+     +++++||||+.
T Consensus       239 ~~~s~~~~~li~~~L~~dp~~R~t~-----~ell~hp~~~~  274 (288)
T d2jfla1         239 SRWSSNFKDFLKKCLEKNVDARWTT-----SQLLQHPFVTV  274 (288)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCH-----HHHTTSGGGCC
T ss_pred             ccCCHHHHHHHHHHccCChhHCcCH-----HHHhcCcccCC
Confidence            6899999999999999999999998     89999999974

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.8e-59  Score=472.82  Aligned_cols=255  Identities=30%  Similarity=0.536  Sum_probs=232.8

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+..   ......+.+|+.+|++++|||||+++++|.++..+|+|
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv  104 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  104 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            467999999999999999999999999999999997653   23345678899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeC--CCCCEEEeeccCccccCCccc
Q 011287          124 LESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT--ADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~--~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      ||||+||+|.+++.+.+ ++++..++.++.||+.||.|||++||+||||||+||||+  .+|++||+|||+|+.+...  
T Consensus       105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~--  182 (352)
T d1koba_         105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--  182 (352)
T ss_dssp             EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred             EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC--
Confidence            99999999999877654 699999999999999999999999999999999999998  5789999999999876432  


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCC----C
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----N  276 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p----~  276 (489)
                               ....+.+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+...++..|....+.+|    .
T Consensus       183 ---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  253 (352)
T d1koba_         183 ---------EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS  253 (352)
T ss_dssp             ---------SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTT
T ss_pred             ---------CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccc
Confidence                     234567899999999999999999999999999999999999999999999999999999887766    4


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                      .+++++++||.+||+.||.+|||+     +++++||||++.
T Consensus       254 ~~s~~~~~li~~~L~~dp~~R~s~-----~eil~Hp~~~~~  289 (352)
T d1koba_         254 SVSPEAKDFIKNLLQKEPRKRLTV-----HDALEHPWLKGD  289 (352)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCH-----HHHHTSTTTSSC
T ss_pred             CCCHHHHHHHHHHccCChhHCcCH-----HHHhcCHhhCCC
Confidence            689999999999999999999998     899999999873

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-60  Score=476.19  Aligned_cols=261  Identities=26%  Similarity=0.449  Sum_probs=224.2

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ly  121 (489)
                      +..++|++++.||+|+||+||+|+++.+|+.||+|++.+..  .......+.+|+.+|+.++|||||+++++|.+...+|
T Consensus         3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   80 (322)
T d1s9ja_           3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   80 (322)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred             CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            45689999999999999999999999999999999997653  3344567889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          122 MALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~-~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      +|||||+||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+||||+.+|++||+|||+|+.+..   
T Consensus        81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~---  157 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---  157 (322)
T ss_dssp             EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH---
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC---
Confidence            999999999999999998899999999999999999999997 5999999999999999999999999999986532   


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHH----------------
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIF----------------  264 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~----------------  264 (489)
                               ....+++||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+.....                
T Consensus       158 ---------~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  228 (322)
T d1s9ja_         158 ---------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP  228 (322)
T ss_dssp             ---------HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------
T ss_pred             ---------CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCc
Confidence                     2234679999999999999999999999999999999999999999876532210                


Q ss_pred             --------------------------HHHHhc-CCCCCC-CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          265 --------------------------QRIIAR-DIRFPN-YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       265 --------------------------~~i~~~-~~~~p~-~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                                                ..+... ...+|. .++.+++|||.+||+.||++|||+     +++++||||+.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta-----~e~L~Hpf~~~  303 (322)
T d1s9ja_         229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL-----KQLMVHAFIKR  303 (322)
T ss_dssp             -----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSHHHHH
T ss_pred             ccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCH-----HHHhhCHhhCc
Confidence                                      111111 111222 368999999999999999999999     89999999987


Q ss_pred             CCccc
Q 011287          317 IDWKN  321 (489)
Q Consensus       317 i~~~~  321 (489)
                      .+|+.
T Consensus       304 ~~~~~  308 (322)
T d1s9ja_         304 SDAEE  308 (322)
T ss_dssp             HHHSC
T ss_pred             CCccc
Confidence            66643

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7e-59  Score=461.81  Aligned_cols=252  Identities=27%  Similarity=0.384  Sum_probs=229.8

Q ss_pred             CeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEe
Q 011287           46 DFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (489)
Q Consensus        46 dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E  125 (489)
                      .|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+|+.++|||||+++++|.+...+|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            49999999999999999999999999999999988766666677788899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCC
Q 011287          126 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  205 (489)
Q Consensus       126 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~  205 (489)
                      ||.+|+|..++...+.+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+|+....        
T Consensus        96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~--------  167 (309)
T d1u5ra_          96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--------  167 (309)
T ss_dssp             CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--------
T ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC--------
Confidence            999999988888888899999999999999999999999999999999999999999999999999985432        


Q ss_pred             CCCCCCccceecCCcCCChhhhcC---CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCH
Q 011287          206 AASDDKACTFVGTAAYVPPEVLNS---SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF--PNYFSD  280 (489)
Q Consensus       206 ~~~~~~~~~~~gt~~Y~aPE~l~~---~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~--p~~~~~  280 (489)
                            ....+||+.|+|||++.+   ..|+.++|||||||++|+|++|..||.+.+....+.++.......  +..+|+
T Consensus       168 ------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~  241 (309)
T d1u5ra_         168 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSE  241 (309)
T ss_dssp             ------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCH
T ss_pred             ------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCH
Confidence                  235689999999999864   458899999999999999999999999999988888887765432  346899


Q ss_pred             HHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          281 AARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       281 ~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      ++++||.+||+.||++|||+     +++++||||..
T Consensus       242 ~~~~li~~~L~~dP~~Rpt~-----~ell~Hp~~~~  272 (309)
T d1u5ra_         242 YFRNFVDSCLQKIPQDRPTS-----EVLLKHRFVLR  272 (309)
T ss_dssp             HHHHHHHHHTCSSGGGSCCH-----HHHTTCHHHHS
T ss_pred             HHHHHHHHHCcCChhHCcCH-----HHHHhCHHhcC
Confidence            99999999999999999999     89999999963

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-58  Score=449.37  Aligned_cols=250  Identities=21%  Similarity=0.383  Sum_probs=219.9

Q ss_pred             eEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc----CCEEEE
Q 011287           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD----TFSLYM  122 (489)
Q Consensus        47 y~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~lyl  122 (489)
                      |++.+.||+|+||+||+|+++.+++.||+|++....... ...+.+.+|+.+|++++|||||+++++|.+    ...+|+
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence            478889999999999999999999999999998765443 345668889999999999999999999875    456899


Q ss_pred             EEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeeccCCCCeeeC-CCCCEEEeeccCccccCCcc
Q 011287          123 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMG--LIHRDIKPENLLLT-ADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~g--IiHrDLKpeNILl~-~~g~ikL~DFG~a~~~~~~~  199 (489)
                      |||||++|+|.+++.+.+.+++..++.++.||+.||+|||++|  |+||||||+||||+ +++++||+|||+|+....  
T Consensus        90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~--  167 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--  167 (270)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT--
T ss_pred             EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC--
Confidence            9999999999999999889999999999999999999999999  99999999999997 579999999999975322  


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCC-CHHHHHHHHHhcC--CCCCC
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT-SEWLIFQRIIARD--IRFPN  276 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~-~~~~~~~~i~~~~--~~~p~  276 (489)
                                ....+.+||+.|+|||++.+ .++.++|||||||++|+|++|++||.+. +...+++.+....  ..++.
T Consensus       168 ----------~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~  236 (270)
T d1t4ha_         168 ----------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDK  236 (270)
T ss_dssp             ----------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGG
T ss_pred             ----------CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCc
Confidence                      23346789999999999876 5899999999999999999999999765 4555666666543  34566


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~  315 (489)
                      ..++++++||.+||+.||++|||+     +++++||||+
T Consensus       237 ~~~~~~~~li~~~l~~dp~~R~s~-----~ell~Hp~fk  270 (270)
T d1t4ha_         237 VAIPEVKEIIEGCIRQNKDERYSI-----KDLLNHAFFQ  270 (270)
T ss_dssp             CCCHHHHHHHHHHSCSSGGGSCCH-----HHHHTSGGGC
T ss_pred             cCCHHHHHHHHHHccCCHhHCcCH-----HHHhCCcccC
Confidence            789999999999999999999998     9999999995

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.7e-58  Score=449.03  Aligned_cols=257  Identities=30%  Similarity=0.525  Sum_probs=231.9

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccc------hhHHHHHHHHHHHHHhCC-CCCccEEEEEEEc
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITK------ENKTAYVKLERIVLDQLD-HPGVVRLFFTFQD  116 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~------~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~  116 (489)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+.....      ......+.+|+.++++++ ||||++++++|.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            479999999999999999999999999999999998765432      223446778999999996 9999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccC
Q 011287          117 TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (489)
Q Consensus       117 ~~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~  196 (489)
                      +..+|+|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++.+.
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  161 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD  161 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence            99999999999999999999998999999999999999999999999999999999999999999999999999998754


Q ss_pred             CccccccCCCCCCCCccceecCCcCCChhhhcC------CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc
Q 011287          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNS------SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR  270 (489)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~------~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~  270 (489)
                      ..           ......+||+.|+|||++.+      ..++.++||||+||++|+|++|+.||.+.+.....+.+...
T Consensus       162 ~~-----------~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~  230 (277)
T d1phka_         162 PG-----------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG  230 (277)
T ss_dssp             TT-----------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred             CC-----------CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC
Confidence            32           22345689999999999853      34688999999999999999999999999999999999988


Q ss_pred             CCCCCC----CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          271 DIRFPN----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       271 ~~~~p~----~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      ...++.    .+|+++++||.+||+.||++||++     +++++||||+.
T Consensus       231 ~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~-----~eil~h~~~~~  275 (277)
T d1phka_         231 NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTA-----EEALAHPFFQQ  275 (277)
T ss_dssp             CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCH-----HHHTTSGGGCT
T ss_pred             CCCCCCcccccCCHHHHHHHHHHccCChhHCcCH-----HHHHcCHHHHH
Confidence            776553    689999999999999999999998     89999999985

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-58  Score=458.04  Aligned_cols=253  Identities=28%  Similarity=0.474  Sum_probs=231.7

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+..    .....+.+|+.+|+.++|||||+++++|++...+|+|
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   79 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            578999999999999999999999999999999997652    2334577899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCC--CCEEEeeccCccccCCccc
Q 011287          124 LESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD--GHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~--g~ikL~DFG~a~~~~~~~~  200 (489)
                      ||||+||+|.+++.+.+ .+++.+++.++.||+.||+|||++||+||||||+|||++.+  +.+||+|||+++.....  
T Consensus        80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~--  157 (321)
T d1tkia_          80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--  157 (321)
T ss_dssp             ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred             EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC--
Confidence            99999999999998765 79999999999999999999999999999999999999854  48999999999865432  


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCC----
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFPN----  276 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p~----  276 (489)
                               ....+.+||+.|+|||.+.+..++.++|||||||++|+|++|.+||.+.+...++.+|....+.+|.    
T Consensus       158 ---------~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  228 (321)
T d1tkia_         158 ---------DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFK  228 (321)
T ss_dssp             ---------CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred             ---------CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhcc
Confidence                     2344678999999999999999999999999999999999999999999999999999999888875    


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      .+++++++||.+||+.||++|||+     +++++||||+.
T Consensus       229 ~~s~~~~~li~~~L~~dp~~R~s~-----~eil~hp~~~~  263 (321)
T d1tkia_         229 EISIEAMDFVDRLLVKERKSRMTA-----SEALQHPWLKQ  263 (321)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCH-----HHHHHSHHHHS
T ss_pred             CCCHHHHHHHHHHccCChhHCcCH-----HHHhcCHhhcc
Confidence            689999999999999999999998     89999999964

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-57  Score=447.32  Aligned_cols=255  Identities=25%  Similarity=0.358  Sum_probs=216.9

Q ss_pred             EEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccch--hHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEe
Q 011287           48 ELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKE--NKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALE  125 (489)
Q Consensus        48 ~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E  125 (489)
                      +.+++||+|+||+||+|+++.+|+.||||++.+......  .....+.+|+.+|+.++|||||+++++|.++..+|+|||
T Consensus         1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE   80 (299)
T d1ua2a_           1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD   80 (299)
T ss_dssp             CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred             CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence            357899999999999999999999999999976543322  223467889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCC
Q 011287          126 SCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPN  205 (489)
Q Consensus       126 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~  205 (489)
                      ||.++++..+....+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+......      
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~------  154 (299)
T d1ua2a_          81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN------  154 (299)
T ss_dssp             CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC------
T ss_pred             hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCc------
Confidence            99998887777767789999999999999999999999999999999999999999999999999998654321      


Q ss_pred             CCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCC-----------
Q 011287          206 AASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR-----------  273 (489)
Q Consensus       206 ~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~-----------  273 (489)
                          ....+.+||+.|+|||++.. ..++.++|||||||++|+|++|.+||.+.++.+++.+|......           
T Consensus       155 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~  230 (299)
T d1ua2a_         155 ----RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS  230 (299)
T ss_dssp             ----CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred             ----ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhc
Confidence                23345689999999999865 45899999999999999999999999999999988887642100           


Q ss_pred             ---------C--------CCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          274 ---------F--------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       274 ---------~--------p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                               +        ...+++++++||.+||+.||++||||     +++++||||++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa-----~e~L~Hp~f~~~  286 (299)
T d1ua2a_         231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA-----TQALKMKYFSNR  286 (299)
T ss_dssp             STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCH-----HHHHTSGGGTSS
T ss_pred             cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCH-----HHHhCCHhhCCC
Confidence                     0        12468899999999999999999999     899999999854

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-56  Score=446.69  Aligned_cols=283  Identities=37%  Similarity=0.676  Sum_probs=243.0

Q ss_pred             CCCCCCCCCCeEEeeEEeeeCceEEEEEEE---cCCCcEEEEEEeecccccc-hhHHHHHHHHHHHHHhCCC-CCccEEE
Q 011287           37 APQEHFSIQDFELGKIYGVGSYSKVVRAKK---IDTGTVYALKIMDKKFITK-ENKTAYVKLERIVLDQLDH-PGVVRLF  111 (489)
Q Consensus        37 ~~~~~~~~~dy~~~~~LG~G~~g~Vy~a~~---~~tg~~vAiK~~~k~~~~~-~~~~~~~~~E~~il~~l~h-pnIv~l~  111 (489)
                      ...++..++||++++.||+|+||+||+|++   +.+|+.||||++.+..... ......+.+|+.+|++++| |||++++
T Consensus        16 ~~~~~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~   95 (322)
T d1vzoa_          16 GHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH   95 (322)
T ss_dssp             SCCCCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEE
T ss_pred             CCCcccchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEee
Confidence            344556789999999999999999999998   4479999999997764432 2334557789999999966 8999999


Q ss_pred             EEEEcCCEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccC
Q 011287          112 FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS  191 (489)
Q Consensus       112 ~~~~~~~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~  191 (489)
                      +++.+...+|+||||+.+|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+
T Consensus        96 ~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~  175 (322)
T d1vzoa_          96 YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL  175 (322)
T ss_dssp             EEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             eeeccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccccCCCCCCCCccceecCCcCCChhhhcCC--CCCCCCcchhhhHHHHHHhhCCCCCCCCCHH----HHHH
Q 011287          192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS--PATFGNDLWALGCTLYQMLSGTSPFKDTSEW----LIFQ  265 (489)
Q Consensus       192 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~--~~~~~sDiwSLG~ilyelltG~~PF~~~~~~----~~~~  265 (489)
                      |+.+....         .....+..|++.|+|||.+.+.  .++.++|||||||++|+|++|+.||.+.+..    .+.+
T Consensus       176 a~~~~~~~---------~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~  246 (322)
T d1vzoa_         176 SKEFVADE---------TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR  246 (322)
T ss_dssp             EEECCGGG---------GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH
T ss_pred             hhhhcccc---------cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            98764332         2233466899999999999764  3678999999999999999999999876543    3444


Q ss_pred             HHHhcCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCcccccCCCCC
Q 011287          266 RIIARDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDWKNIRGQTPP  328 (489)
Q Consensus       266 ~i~~~~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~~~~~~~~~p  328 (489)
                      ........+|..+++++.+||.+||++||.+|||+...+++++++||||++++|+.+..+..|
T Consensus       247 ~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~  309 (322)
T d1vzoa_         247 RILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVP  309 (322)
T ss_dssp             HHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred             hcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCC
Confidence            455667788899999999999999999999999876556799999999999999999875543

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-57  Score=441.39  Aligned_cols=252  Identities=31%  Similarity=0.538  Sum_probs=221.9

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhH---HHHHHHHHHHHHhCC--CCCccEEEEEEEcCC
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENK---TAYVKLERIVLDQLD--HPGVVRLFFTFQDTF  118 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~---~~~~~~E~~il~~l~--hpnIv~l~~~~~~~~  118 (489)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+........   ...+.+|+.+|++++  |||||+++++|.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            368999999999999999999999999999999998765443211   123557999999986  899999999999999


Q ss_pred             EEEEEEeccCC-CChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCC-CCEEEeeccCccccC
Q 011287          119 SLYMALESCEG-GELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD-GHIKIADFGSVKPMQ  196 (489)
Q Consensus       119 ~lylV~E~~~g-g~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~-g~ikL~DFG~a~~~~  196 (489)
                      .+|+||||+.+ +++.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~  162 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK  162 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence            99999999976 6888899888899999999999999999999999999999999999999854 799999999998643


Q ss_pred             CccccccCCCCCCCCccceecCCcCCChhhhcCCCC-CCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCC
Q 011287          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPA-TFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP  275 (489)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~-~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p  275 (489)
                      .            ....+++||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.      ..+......+|
T Consensus       163 ~------------~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~  224 (273)
T d1xwsa_         163 D------------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFR  224 (273)
T ss_dssp             S------------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCS
T ss_pred             c------------ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCC
Confidence            2            23346789999999999987664 67789999999999999999999864      34677888999


Q ss_pred             CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 011287          276 NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (489)
Q Consensus       276 ~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~  318 (489)
                      ..+|+++++||.+||+.||++|||+     +++++||||+++-
T Consensus       225 ~~~s~~~~~li~~~L~~dp~~R~s~-----~eil~hp~~~~~~  262 (273)
T d1xwsa_         225 QRVSSECQHLIRWCLALRPSDRPTF-----EEIQNHPWMQDVL  262 (273)
T ss_dssp             SCCCHHHHHHHHHHTCSSGGGSCCH-----HHHHTSGGGSSCC
T ss_pred             CCCCHHHHHHHHHHccCCHhHCcCH-----HHHhcCHhhCCCC
Confidence            9999999999999999999999998     8999999998754

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-56  Score=438.58  Aligned_cols=258  Identities=29%  Similarity=0.452  Sum_probs=218.3

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      +++|++++.||+|+||+||+|++..+|+.||||++.+.... +.....+.+|+.+|++++|||||+++++|.+...+|+|
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv   79 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV   79 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence            58999999999999999999999999999999999765322 23345678899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHH-h-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccc
Q 011287          124 LESCEGGELFDQIT-S-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (489)
Q Consensus       124 ~E~~~gg~L~~~l~-~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~  201 (489)
                      ||||.++ +..++. . .+.+++..++.++.||+.||.|||++|||||||||+|||++.++++||+|||+|+.....   
T Consensus        80 ~e~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~---  155 (298)
T d1gz8a_          80 FEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---  155 (298)
T ss_dssp             EECCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC---
T ss_pred             EeecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCC---
Confidence            9999764 444443 3 356999999999999999999999999999999999999999999999999999865432   


Q ss_pred             ccCCCCCCCCccceecCCcCCChhhhcCCC-CCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC--------
Q 011287          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI--------  272 (489)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~-~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~--------  272 (489)
                             .......+||+.|+|||++.... ++.++|+|||||++|+|++|+.||.+.+....+.++.....        
T Consensus       156 -------~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  228 (298)
T d1gz8a_         156 -------VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP  228 (298)
T ss_dssp             -------SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             -------cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcc
Confidence                   23344568999999999987766 57899999999999999999999999998887777654210        


Q ss_pred             ----------CCC-----------CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 011287          273 ----------RFP-----------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (489)
Q Consensus       273 ----------~~p-----------~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~  318 (489)
                                .++           ..+++++++||++||+.||++|||+     +++++||||+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~-----~ell~H~ff~~~~  290 (298)
T d1gz8a_         229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA-----KAALAHPFFQDVT  290 (298)
T ss_dssp             TGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSGGGTTCC
T ss_pred             ccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCH-----HHHhCCHhhccCC
Confidence                      011           2467899999999999999999999     8999999998763

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=6.7e-56  Score=433.79  Aligned_cols=250  Identities=27%  Similarity=0.458  Sum_probs=216.4

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC----E
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF----S  119 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----~  119 (489)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+|+.++||||+++++++.+..    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            367999999999999999999999999999999998876666666778899999999999999999999997643    4


Q ss_pred             EEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcc
Q 011287          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      +|+|||||+||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.++|+|||.++......
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~  165 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG  165 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred             EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence            89999999999999999998999999999999999999999999999999999999999999999999999987654322


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCC----
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRFP----  275 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~p----  275 (489)
                             .......+.+||+.|+|||++.+..++.++|||||||++|+|+||++||.+.+..+.+.++.......|    
T Consensus       166 -------~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (277)
T d1o6ya_         166 -------NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH  238 (277)
T ss_dssp             --------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTS
T ss_pred             -------ccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhc
Confidence                   112344567899999999999999999999999999999999999999999999998888887765543    


Q ss_pred             CCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          276 NYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       276 ~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      +.+|+++.+||.+||+.||++||++
T Consensus       239 ~~~s~~l~~li~~~L~~dp~~R~~s  263 (277)
T d1o6ya_         239 EGLSADLDAVVLKALAKNPENRYQT  263 (277)
T ss_dssp             SSCCHHHHHHHHHHTCSSGGGSCSS
T ss_pred             cCCCHHHHHHHHHHccCCHhHCHhH
Confidence            5689999999999999999999965

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-56  Score=447.73  Aligned_cols=250  Identities=31%  Similarity=0.518  Sum_probs=214.7

Q ss_pred             CCCCeEEee-EEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHH-hCCCCCccEEEEEEEc----
Q 011287           43 SIQDFELGK-IYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLD-QLDHPGVVRLFFTFQD----  116 (489)
Q Consensus        43 ~~~dy~~~~-~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~-~l~hpnIv~l~~~~~~----  116 (489)
                      .+++|++.. +||+|+||+||+|+++.+|+.||||++.+.        ..+.+|+.++. .++|||||+++++|++    
T Consensus         9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~   80 (335)
T d2ozaa1           9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG   80 (335)
T ss_dssp             GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence            468999875 699999999999999999999999998643        34567888765 5589999999999976    


Q ss_pred             CCEEEEEEeccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCC---CCCEEEeeccC
Q 011287          117 TFSLYMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGS  191 (489)
Q Consensus       117 ~~~lylV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~---~g~ikL~DFG~  191 (489)
                      ...+|+|||||+||+|.+++.+.+  .|++.+++.++.||+.||+|||++||+||||||+|||++.   ++++||+|||+
T Consensus        81 ~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          81 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             CCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccce
Confidence            467999999999999999998753  6999999999999999999999999999999999999985   56799999999


Q ss_pred             ccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHH----HHHH
Q 011287          192 VKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLI----FQRI  267 (489)
Q Consensus       192 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~----~~~i  267 (489)
                      |+.....           ....+.+||+.|+|||++.+..|+.++||||||||+|+|++|++||.+.+....    ...+
T Consensus       161 a~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i  229 (335)
T d2ozaa1         161 AKETTSH-----------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI  229 (335)
T ss_dssp             CEECCCC-----------CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CC
T ss_pred             eeeccCC-----------CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHH
Confidence            9865432           233466899999999999999999999999999999999999999987665443    3344


Q ss_pred             HhcCCCCCC----CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          268 IARDIRFPN----YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       268 ~~~~~~~p~----~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      ....+.+|.    .+|+++++||.+||+.||++|||+     .++++||||..
T Consensus       230 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~-----~eil~hp~~~~  277 (335)
T d2ozaa1         230 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI-----TEFMNHPWIMQ  277 (335)
T ss_dssp             CSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCH-----HHHHHSHHHHT
T ss_pred             hcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCH-----HHHHcCHHhhC
Confidence            555666764    589999999999999999999998     89999999964

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-55  Score=434.99  Aligned_cols=259  Identities=27%  Similarity=0.406  Sum_probs=218.0

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCC-CcEEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCccEEEEEEEc---
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDT-GTVYALKIMDKKFITKENKTAYVKLERIVLDQL---DHPGVVRLFFTFQD---  116 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~t-g~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~---  116 (489)
                      .++|++++.||+|+||+||+|++..+ ++.||||++.+....... ...+.+|+.+|+.|   +||||++++++|..   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC-BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchH-HHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            47999999999999999999999765 677999999765433222 22344577776655   89999999999853   


Q ss_pred             --CCEEEEEEeccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCcc
Q 011287          117 --TFSLYMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVK  193 (489)
Q Consensus       117 --~~~lylV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~  193 (489)
                        ...+|++||||.++.+...... ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~  164 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  164 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence              3578999999998776544443 3569999999999999999999999999999999999999999999999999988


Q ss_pred             ccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC--
Q 011287          194 PMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD--  271 (489)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~--  271 (489)
                      .....           ......+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+++.+|....  
T Consensus       165 ~~~~~-----------~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  233 (305)
T d1blxa_         165 IYSFQ-----------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL  233 (305)
T ss_dssp             CCCGG-----------GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             hhccc-----------ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCC
Confidence            64322           23346789999999999999999999999999999999999999999999988888775420  


Q ss_pred             -------------------------CCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 011287          272 -------------------------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (489)
Q Consensus       272 -------------------------~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~  319 (489)
                                               ..++..+++++++||.+||+.||++|||+     +++++||||+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa-----~e~L~Hpff~~i~~  301 (305)
T d1blxa_         234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA-----YSALSHPYFQDLER  301 (305)
T ss_dssp             CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCH-----HHHHTSGGGTTCCC
T ss_pred             CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCH-----HHHhcChhhcCchh
Confidence                                     12345678999999999999999999999     89999999998864

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.5e-55  Score=429.70  Aligned_cols=256  Identities=27%  Similarity=0.408  Sum_probs=220.2

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      +++|++++.||+|+||+||+|+++ +|+.||||++...... +.....+.+|+.+|++++||||++++++|.+....|++
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~   78 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence            479999999999999999999995 7899999999766432 33456688899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      |||+.++.+..+....+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||.|......     
T Consensus        79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~-----  153 (286)
T d1ob3a_          79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP-----  153 (286)
T ss_dssp             EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccC-----
Confidence            999998877777777788999999999999999999999999999999999999999999999999999865432     


Q ss_pred             CCCCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcC-----------
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARD-----------  271 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~-----------  271 (489)
                           .......+|++.|+|||.+.+. .++.++|||||||++|+|++|++||.+.++.+++.++....           
T Consensus       154 -----~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  228 (286)
T d1ob3a_         154 -----VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV  228 (286)
T ss_dssp             -------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             -----ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccch
Confidence                 1233456799999999998754 57899999999999999999999999999888877765311           


Q ss_pred             ------------------CCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          272 ------------------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       272 ------------------~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                                        ..++..++++++|||++||+.||++|||+     +++++||||+.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~-----~ell~Hp~f~~  286 (286)
T d1ob3a_         229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA-----KQALEHAYFKE  286 (286)
T ss_dssp             GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCH-----HHHHTSGGGGC
T ss_pred             hhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCH-----HHHhcCcccCc
Confidence                              12235578999999999999999999999     89999999973

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.4e-54  Score=427.32  Aligned_cols=254  Identities=20%  Similarity=0.337  Sum_probs=208.1

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGT---VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~---~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  117 (489)
                      .+..++|++.+.||+|+||+||+|+++.+|+   .||||.+....  .......+.+|+.+|++++|||||++++++.+.
T Consensus        22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~   99 (299)
T d1jpaa_          22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS   99 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence            3557899999999999999999999987765   58888876542  233455688999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccC
Q 011287          118 FSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~  196 (489)
                      ..+|+|||||++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||||+.++++||+|||+|+.+.
T Consensus       100 ~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         100 TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  179 (299)
T ss_dssp             SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEcc
Confidence            9999999999999999988874 579999999999999999999999999999999999999999999999999998765


Q ss_pred             CccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCC
Q 011287          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRF  274 (489)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~  274 (489)
                      .....     ..........||+.|+|||++.+..++.++|||||||++|||+| |++||.+.+..++...+... .+..
T Consensus       180 ~~~~~-----~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~  254 (299)
T d1jpaa_         180 DDTSD-----PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP  254 (299)
T ss_dssp             ---------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC
T ss_pred             CCCCc-----ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            43211     01112223568999999999999999999999999999999998 89999999998888888764 3567


Q ss_pred             CCCCCHHHHHHHHHhhccCCCCCCCCC
Q 011287          275 PNYFSDAARDLIDRLLDVDPSGRPGAG  301 (489)
Q Consensus       275 p~~~~~~~~~Li~~~L~~dP~~R~t~~  301 (489)
                      |..+++++.+||.+||+.||++|||+.
T Consensus       255 ~~~~~~~l~~li~~cl~~~P~~RPs~~  281 (299)
T d1jpaa_         255 PMDCPSALHQLMLDCWQKDRNHRPKFG  281 (299)
T ss_dssp             CTTCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             CccchHHHHHHHHHHcCCCHhHCcCHH
Confidence            788999999999999999999999983

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-54  Score=432.90  Aligned_cols=255  Identities=23%  Similarity=0.394  Sum_probs=216.6

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCc-----EEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGT-----VYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQ  115 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~-----~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~  115 (489)
                      +..++|++++.||+|+||+||+|++..+++     .||+|.+.....  ......+.+|+.+|+++ +|||||++++++.
T Consensus        34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~  111 (325)
T d1rjba_          34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGACT  111 (325)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC--HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence            345799999999999999999999876554     699999865432  22345577899999887 8999999999999


Q ss_pred             cCCEEEEEEeccCCCChHHHHHhC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccC
Q 011287          116 DTFSLYMALESCEGGELFDQITSK-----------------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIK  172 (489)
Q Consensus       116 ~~~~lylV~E~~~gg~L~~~l~~~-----------------------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLK  172 (489)
                      +...+|+|||||++|+|.++|...                       +.+++..++.++.||+.||.|||++||+|||||
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlK  191 (325)
T d1rjba_         112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA  191 (325)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred             eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCc
Confidence            999999999999999999999764                       248999999999999999999999999999999


Q ss_pred             CCCeeeCCCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-C
Q 011287          173 PENLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-G  251 (489)
Q Consensus       173 peNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G  251 (489)
                      |+|||++.++++||+|||+|+......        ......+..||+.|+|||++.+..++.++|||||||++|||+| |
T Consensus       192 p~Nill~~~~~~Kl~DFGla~~~~~~~--------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g  263 (325)
T d1rjba_         192 ARNVLVTHGKVVKICDFGLARDIMSDS--------NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG  263 (325)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCT--------TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred             hhccccccCCeEEEeeccccccccCCC--------ceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCC
Confidence            999999999999999999998654322        1122346689999999999999999999999999999999997 8


Q ss_pred             CCCCCCCCHHHHHHHHHhcC--CCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 011287          252 TSPFKDTSEWLIFQRIIARD--IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (489)
Q Consensus       252 ~~PF~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~h  311 (489)
                      ++||.+.+....+.++....  +.+|..+|+++++||.+||+.||++|||+     ++|++|
T Consensus       264 ~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~-----~ei~~~  320 (325)
T d1rjba_         264 VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSF-----PNLTSF  320 (325)
T ss_dssp             CCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCH-----HHHHHH
Confidence            99999877666666666654  45678899999999999999999999998     777754

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.3e-54  Score=424.95  Aligned_cols=250  Identities=20%  Similarity=0.337  Sum_probs=217.7

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lyl  122 (489)
                      ..++|++++.||+|+||+||+|+++.+|+.||||++.+...    ..+.+.+|+.+|++++|||||++++++.+...+|+
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   90 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence            45799999999999999999999999999999999976532    23457889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          123 ALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      |||||++|+|.+++.+.  ..+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.......
T Consensus        91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~  170 (287)
T d1opja_          91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  170 (287)
T ss_dssp             EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred             EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence            99999999999999764  5689999999999999999999999999999999999999999999999999987644321


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCC-CCCCCCCHHHHHHHHHhc-CCCCCCCC
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGT-SPFKDTSEWLIFQRIIAR-DIRFPNYF  278 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~-~PF~~~~~~~~~~~i~~~-~~~~p~~~  278 (489)
                               .......||+.|+|||++.+..++.++|||||||++|+|++|. +||.+.+...+++.+... .+.+|..+
T Consensus       171 ---------~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~  241 (287)
T d1opja_         171 ---------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGC  241 (287)
T ss_dssp             ---------EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred             ---------eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccc
Confidence                     1223456899999999999999999999999999999999955 455666666666655443 45678899


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       279 ~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      ++++++||.+||+.||++|||+     +++++
T Consensus       242 ~~~l~~li~~cl~~dP~~Rps~-----~ei~~  268 (287)
T d1opja_         242 PEKVYELMRACWQWNPSDRPSF-----AEIHQ  268 (287)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             hHHHHHHHHHHcCCCHhHCcCH-----HHHHH
Confidence            9999999999999999999998     66753

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-54  Score=415.62  Aligned_cols=250  Identities=20%  Similarity=0.335  Sum_probs=211.0

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lyl  122 (489)
                      .+++|++++.||+|+||+||+|+++ +++.||||++.+....    .+.+.+|+.++++++|||||++++++.+...+|+
T Consensus         3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~l   77 (263)
T d1sm2a_           3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL   77 (263)
T ss_dssp             CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEE
Confidence            4679999999999999999999986 5788999999764322    3457789999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccc
Q 011287          123 ALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~  201 (489)
                      |||||++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.+....  
T Consensus        78 v~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~--  155 (263)
T d1sm2a_          78 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--  155 (263)
T ss_dssp             EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred             EEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCC--
Confidence            99999999999998765 568999999999999999999999999999999999999999999999999998664332  


Q ss_pred             ccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCCCCC
Q 011287          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFS  279 (489)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~~  279 (489)
                             ........||+.|+|||++.+..++.++|||||||++|||+| |.+||...+..++.+.+..+ ....|..++
T Consensus       156 -------~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~  228 (263)
T d1sm2a_         156 -------YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAS  228 (263)
T ss_dssp             ----------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSC
T ss_pred             -------ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccC
Confidence                   122234579999999999999999999999999999999999 68888888888888888765 455678899


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 011287          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (489)
Q Consensus       280 ~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~h  311 (489)
                      +++.+||.+||+.||++|||+     +++++|
T Consensus       229 ~~l~~li~~cl~~~p~~Rps~-----~~il~~  255 (263)
T d1sm2a_         229 THVYQIMNHCWKERPEDRPAF-----SRLLRQ  255 (263)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             HHHHHHHHHHccCCHhHCcCH-----HHHHHH
Confidence            999999999999999999998     777754

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=413.32  Aligned_cols=250  Identities=21%  Similarity=0.323  Sum_probs=223.0

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lyl  122 (489)
                      .+++|++++.||+|+||+||+|+++ +++.||||++.+....    ...+.+|+.++++++||||+++++++.+...+|+
T Consensus         2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i   76 (258)
T d1k2pa_           2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI   76 (258)
T ss_dssp             CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred             ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Confidence            4689999999999999999999985 7889999999875433    2457789999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccc
Q 011287          123 ALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~  201 (489)
                      ||||+++|+|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+|+.+....  
T Consensus        77 v~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~--  154 (258)
T d1k2pa_          77 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--  154 (258)
T ss_dssp             EEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS--
T ss_pred             EEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCC--
Confidence            99999999999987654 679999999999999999999999999999999999999999999999999998664432  


Q ss_pred             ccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCCCCC
Q 011287          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFS  279 (489)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~~  279 (489)
                             ........||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..++.+++..+ ....|...+
T Consensus       155 -------~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~  227 (258)
T d1k2pa_         155 -------YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS  227 (258)
T ss_dssp             -------CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCC
T ss_pred             -------ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCccccc
Confidence                   112234579999999999999999999999999999999998 89999999999998888775 456788899


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 011287          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (489)
Q Consensus       280 ~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~h  311 (489)
                      +++++||.+||+.||++|||+     +++++|
T Consensus       228 ~~l~~li~~cl~~dP~~RPt~-----~eil~~  254 (258)
T d1k2pa_         228 EKVYTIMYSCWHEKADERPTF-----KILLSN  254 (258)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCH-----HHHHHH
T ss_pred             HHHHHHHHHHccCCHhHCcCH-----HHHHHH
Confidence            999999999999999999998     778765

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-53  Score=424.54  Aligned_cols=261  Identities=26%  Similarity=0.333  Sum_probs=217.4

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc-------
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD-------  116 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-------  116 (489)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+.... +.....+.+|+.+|+.++||||+++++++..       
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~   87 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   87 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence            68999999999999999999999999999999998765433 3334556789999999999999999999865       


Q ss_pred             -CCEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCcccc
Q 011287          117 -TFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPM  195 (489)
Q Consensus       117 -~~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~  195 (489)
                       ...+|+|||||.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus        88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~  167 (318)
T d3blha1          88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF  167 (318)
T ss_dssp             ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence             3468999999998777666666678999999999999999999999999999999999999999999999999999866


Q ss_pred             CCccccccCCCCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCC
Q 011287          196 QDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF  274 (489)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~  274 (489)
                      ......      ......+.+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.++......+......+
T Consensus       168 ~~~~~~------~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~  241 (318)
T d3blha1         168 SLAKNS------QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI  241 (318)
T ss_dssp             CC-----------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             cccccc------ccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            543211      12334467899999999998765 68999999999999999999999999999888877765532222


Q ss_pred             CC--------------------------------CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCC
Q 011287          275 PN--------------------------------YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKG  316 (489)
Q Consensus       275 p~--------------------------------~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~  316 (489)
                      +.                                ..++++.|||.+||+.||++|||+     +++++||||+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa-----~elL~Hpff~~  310 (318)
T d3blha1         242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS-----DDALNHDFFWS  310 (318)
T ss_dssp             CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCH-----HHHHHSGGGSS
T ss_pred             ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCH-----HHHHcChhhcc
Confidence            11                                137788999999999999999999     89999999974

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-54  Score=421.18  Aligned_cols=254  Identities=20%  Similarity=0.311  Sum_probs=214.3

Q ss_pred             eEEeeeCceEEEEEEEc--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEEEeccC
Q 011287           51 KIYGVGSYSKVVRAKKI--DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMALESCE  128 (489)
Q Consensus        51 ~~LG~G~~g~Vy~a~~~--~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV~E~~~  128 (489)
                      +.||+|+||+||+|.++  .+++.||||++..... .......+.+|+.+|++++|||||++++++.++ ..|+|||||+
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence            57999999999999864  4568999999976533 333456788899999999999999999999765 5789999999


Q ss_pred             CCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccccccCCCCC
Q 011287          129 GGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVLPNAAS  208 (489)
Q Consensus       129 gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~  208 (489)
                      +|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.+......       
T Consensus        91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~-------  163 (277)
T d1xbba_          91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-------  163 (277)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE-------
T ss_pred             CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccc-------
Confidence            9999999999889999999999999999999999999999999999999999999999999999876443211       


Q ss_pred             CCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCCCCCHHHHHHH
Q 011287          209 DDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYFSDAARDLI  286 (489)
Q Consensus       209 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~Li  286 (489)
                      ........||+.|+|||++.+..++.++|||||||++|||++ |++||.+.+..++...+..+ .+.+|..+|+++.+||
T Consensus       164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li  243 (277)
T d1xbba_         164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLM  243 (277)
T ss_dssp             EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHH
Confidence            112234578999999999999999999999999999999998 99999999998888888765 4678899999999999


Q ss_pred             HHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 011287          287 DRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (489)
Q Consensus       287 ~~~L~~dP~~R~t~~~~~~~~l~~hpff~  315 (489)
                      .+||+.||++|||+.+  +.+.++|+||.
T Consensus       244 ~~cl~~dp~~RPs~~~--i~~~L~~~~~~  270 (277)
T d1xbba_         244 NLCWTYDVENRPGFAA--VELRLRNYYYD  270 (277)
T ss_dssp             HHHTCSSTTTSCCHHH--HHHHHHHHHHH
T ss_pred             HHHcCCCHhHCcCHHH--HHHHhhCHHhh
Confidence            9999999999999822  22235676664

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-53  Score=414.01  Aligned_cols=258  Identities=26%  Similarity=0.408  Sum_probs=224.8

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lylV  123 (489)
                      +++|++++.||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+.+|+.++||||++++++|.+....++|
T Consensus         1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv   79 (292)
T d1unla_           1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence            479999999999999999999999999999999997654 3445567788899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccccc
Q 011287          124 LESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRITVL  203 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~~~  203 (489)
                      ++++.+++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++++||+|||.|+......    
T Consensus        80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~----  155 (292)
T d1unla_          80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV----  155 (292)
T ss_dssp             EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC----
T ss_pred             eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC----
Confidence            9999999999998888899999999999999999999999999999999999999999999999999998764322    


Q ss_pred             CCCCCCCCccceecCCcCCChhhhcCCC-CCCCCcchhhhHHHHHHhhCCCCC-CCCCHHHHHHHHHhcC----------
Q 011287          204 PNAASDDKACTFVGTAAYVPPEVLNSSP-ATFGNDLWALGCTLYQMLSGTSPF-KDTSEWLIFQRIIARD----------  271 (489)
Q Consensus       204 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~-~~~~sDiwSLG~ilyelltG~~PF-~~~~~~~~~~~i~~~~----------  271 (489)
                            .......+++.|+|||++.... ++.++|||||||++|+|++|+.|| .+.+..+.++++....          
T Consensus       156 ------~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (292)
T d1unla_         156 ------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS  229 (292)
T ss_dssp             ------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred             ------ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhh
Confidence                  2223446788999999987665 689999999999999999999885 5666677666654311          


Q ss_pred             -------------------CCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          272 -------------------IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       272 -------------------~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                                         ...+..+++++.+||++||+.||++||||     +++++||||+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa-----~e~L~Hp~f~~~  289 (292)
T d1unla_         230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA-----EEALQHPYFSDF  289 (292)
T ss_dssp             GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCH-----HHHTTSGGGSSC
T ss_pred             hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCH-----HHHhcChhhcCC
Confidence                               11234568999999999999999999999     899999999864

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-53  Score=429.71  Aligned_cols=255  Identities=27%  Similarity=0.426  Sum_probs=214.1

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-----
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF-----  118 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----  118 (489)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+... .+.....+.+|+.+|+.++|||||+++++|.+..     
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            5789999999999999999999999999999999976533 3445667888999999999999999999998654     


Q ss_pred             -EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCC
Q 011287          119 -SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (489)
Q Consensus       119 -~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~  197 (489)
                       .+|+||||| +++|..++. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+....
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~  173 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS  173 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC
Confidence             579999999 557766665 46799999999999999999999999999999999999999999999999999986532


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC----
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI----  272 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~----  272 (489)
                                   .....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+.....    
T Consensus       174 -------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (346)
T d1cm8a_         174 -------------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA  240 (346)
T ss_dssp             -------------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             -------------ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcH
Confidence                         2345689999999999876 4578999999999999999999999999988776655543111    


Q ss_pred             ---------------------------CCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 011287          273 ---------------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (489)
Q Consensus       273 ---------------------------~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~  319 (489)
                                                 ..+..+++++++||.+||+.||++|||+     +++++||||+++.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta-----~eiL~Hp~f~~~~~  309 (346)
T d1cm8a_         241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA-----GEALAHPYFESLHD  309 (346)
T ss_dssp             HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCH-----HHHHHSGGGTTTC-
T ss_pred             HHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCH-----HHHhcChhhCcCCC
Confidence                                       1234578999999999999999999999     89999999998764

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=419.45  Aligned_cols=261  Identities=20%  Similarity=0.292  Sum_probs=222.9

Q ss_pred             CCCCeEEeeE-EeeeCceEEEEEEEcC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCE
Q 011287           43 SIQDFELGKI-YGVGSYSKVVRAKKID--TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFS  119 (489)
Q Consensus        43 ~~~dy~~~~~-LG~G~~g~Vy~a~~~~--tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  119 (489)
                      ..++|.+.+. ||+|+||+||+|.++.  ++..||||++.+..  .......+.+|+.+|++++|||||++++++.++ .
T Consensus         6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~   82 (285)
T d1u59a_           6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-A   82 (285)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred             cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-e
Confidence            4578999985 9999999999998764  45589999997542  334456688899999999999999999999764 5


Q ss_pred             EEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          120 LYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      +|+|||||++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||||+.++++||+|||+|+.+...
T Consensus        83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence            89999999999999988654 67999999999999999999999999999999999999999999999999999876543


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCC
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPN  276 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~  276 (489)
                      ...       ........||+.|+|||++.+..++.++|||||||++|||+| |++||.+.+..++...+..+ .+.+|+
T Consensus       163 ~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~  235 (285)
T d1u59a_         163 DSY-------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP  235 (285)
T ss_dssp             SCE-------ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCT
T ss_pred             ccc-------cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            211       122334578999999999999999999999999999999998 99999998888888888765 467889


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~  315 (489)
                      .+|+++.+||.+||+.||++||++.+  +.+.++|+|+.
T Consensus       236 ~~~~~l~~li~~cl~~~p~~RPs~~~--i~~~L~~~~~~  272 (285)
T d1u59a_         236 ECPPELYALMSDCWIYKWEDRPDFLT--VEQRMRACYYS  272 (285)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHH--HHHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCCHhHCcCHHH--HHHHHHHHHHH
Confidence            99999999999999999999999832  34446778763

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-54  Score=418.07  Aligned_cols=253  Identities=22%  Similarity=0.354  Sum_probs=219.7

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~lyl  122 (489)
                      ..++|++++.||+|+||+||+|+++ ++..||||++.+....    .+.+.+|+.+|++++|||||++++++.+ ..+|+
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i   84 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI   84 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence            3479999999999999999999985 5789999999765322    3457889999999999999999998765 56799


Q ss_pred             EEeccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          123 ALESCEGGELFDQITSK--GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      |||||++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||||+.++++||+|||+|+.+.....
T Consensus        85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~  164 (272)
T d1qpca_          85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (272)
T ss_dssp             EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcc
Confidence            99999999999977543  3599999999999999999999999999999999999999999999999999987654321


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCCCC
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNYF  278 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~  278 (489)
                               .......||+.|+|||++.+..++.++|||||||++|||+| |.+||...+..+..+.+..+ .+..|..+
T Consensus       165 ---------~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~  235 (272)
T d1qpca_         165 ---------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC  235 (272)
T ss_dssp             ---------ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred             ---------ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccC
Confidence                     12234578999999999998899999999999999999999 57778888888888888764 45678899


Q ss_pred             CHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc--CCCCC
Q 011287          279 SDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM--HPFFK  315 (489)
Q Consensus       279 ~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~--hpff~  315 (489)
                      ++++.+||.+||+.||++|||+     +++++  |+||.
T Consensus       236 ~~~l~~li~~cl~~~P~~Rpt~-----~ei~~~L~~~ft  269 (272)
T d1qpca_         236 PEELYQLMRLCWKERPEDRPTF-----DYLRSVLEDFFT  269 (272)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCH-----HHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHcCCCHhHCcCH-----HHHHHHhhhhhh
Confidence            9999999999999999999998     77876  77775

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-53  Score=426.42  Aligned_cols=251  Identities=29%  Similarity=0.442  Sum_probs=212.4

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc------CC
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD------TF  118 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~  118 (489)
                      -+|..+++||+|+||+||+|+++.+|+.||||++.+....       ..+|+.+|+.++||||++++++|..      ..
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~   92 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV   92 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence            4799999999999999999999999999999999765322       2369999999999999999999853      34


Q ss_pred             EEEEEEeccCCCChHH---HHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCC-CEEEeeccCccc
Q 011287          119 SLYMALESCEGGELFD---QITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-HIKIADFGSVKP  194 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~---~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g-~ikL~DFG~a~~  194 (489)
                      ++|+|||||+++.+..   +......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus        93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhh
Confidence            6899999998764332   233456799999999999999999999999999999999999999875 899999999986


Q ss_pred             cCCccccccCCCCCCCCccceecCCcCCChhhhcC-CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhc---
Q 011287          195 MQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNS-SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIAR---  270 (489)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~---  270 (489)
                      +...           ....+.+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+...++..+...   
T Consensus       173 ~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~  241 (350)
T d1q5ka_         173 LVRG-----------EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT  241 (350)
T ss_dssp             CCTT-----------SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             ccCC-----------cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            5432           23345689999999999865 56899999999999999999999999999988887776531   


Q ss_pred             --------------CCCC------------CCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCC
Q 011287          271 --------------DIRF------------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGID  318 (489)
Q Consensus       271 --------------~~~~------------p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~  318 (489)
                                    ...+            ...+++++.+||.+||+.||++|||+     .++++||||+.+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta-----~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP-----LEACAHSFFDELR  310 (350)
T ss_dssp             CCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCH-----HHHHTSGGGGGGG
T ss_pred             ChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCH-----HHHhcCHhhcccc
Confidence                          1111            23478999999999999999999999     8999999998653

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-53  Score=417.16  Aligned_cols=252  Identities=21%  Similarity=0.348  Sum_probs=207.3

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ly  121 (489)
                      +..++|++++.||+|+||+||+|+.   +..||||++...... ......+.+|+.+|++++|||||++++++.+ ..+|
T Consensus         5 i~~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~   79 (276)
T d1uwha_           5 IPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLA   79 (276)
T ss_dssp             CCTTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCC-TTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred             cccccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEE
Confidence            3467899999999999999999975   346999999765433 3455678889999999999999999997654 5689


Q ss_pred             EEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          122 MALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      +|||||+||+|.+++... +.+++..+..++.||+.||+|||++||+||||||+||||+.++++||+|||+|+...... 
T Consensus        80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~-  158 (276)
T d1uwha_          80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS-  158 (276)
T ss_dssp             EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccC-
Confidence            999999999999999764 569999999999999999999999999999999999999999999999999998654321 


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhcC---CCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC-----
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLNS---SPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-----  272 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~---~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~-----  272 (489)
                             ......+..||+.|+|||++.+   ..++.++|||||||++|||+||+.||.+.+.......+.....     
T Consensus       159 -------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~  231 (276)
T d1uwha_         159 -------GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL  231 (276)
T ss_dssp             --------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCG
T ss_pred             -------CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcc
Confidence                   1123346789999999999964   3478899999999999999999999998766554444443322     


Q ss_pred             -CCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 011287          273 -RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (489)
Q Consensus       273 -~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~h  311 (489)
                       .++..+|+++.+||.+||+.||++|||+     ++++++
T Consensus       232 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~-----~~il~~  266 (276)
T d1uwha_         232 SKVRSNCPKAMKRLMAECLKKKRDERPLF-----PQILAS  266 (276)
T ss_dssp             GGSCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             hhccccchHHHHHHHHHHcCCCHhHCcCH-----HHHHHH
Confidence             2456789999999999999999999998     677654

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=6.3e-53  Score=422.37  Aligned_cols=253  Identities=27%  Similarity=0.463  Sum_probs=212.6

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccEEEEEEEc--CCE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQD--TFS  119 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~--~~~  119 (489)
                      ..++|++++.||+|+||+||+|+++.+|+.||||++.+.      ....+.+|+.+|+.++ ||||++++++|..  ...
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~  106 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT  106 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence            457899999999999999999999999999999998653      2345778999999985 9999999999984  456


Q ss_pred             EEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCC-CEEEeeccCccccCCc
Q 011287          120 LYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADG-HIKIADFGSVKPMQDS  198 (489)
Q Consensus       120 lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g-~ikL~DFG~a~~~~~~  198 (489)
                      +|+|||||.+++|..+.   +.+++..++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||+|+.....
T Consensus       107 ~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         107 PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             EEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             eeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence            99999999999997653   4699999999999999999999999999999999999998765 5999999999865432


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCCCH-HHHHHHHHh-------
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSE-WLIFQRIIA-------  269 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~~~-~~~~~~i~~-------  269 (489)
                                 ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ......+..       
T Consensus       184 -----------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~  252 (328)
T d3bqca1         184 -----------QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL  252 (328)
T ss_dssp             -----------CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH
T ss_pred             -----------CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchh
Confidence                       233466899999999998765 479999999999999999999999976543 222222211       


Q ss_pred             ------cCC------------------------CCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCCCc
Q 011287          270 ------RDI------------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGIDW  319 (489)
Q Consensus       270 ------~~~------------------------~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i~~  319 (489)
                            ...                        .....++++++|||++||+.||++|||+     +++++||||+++.|
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta-----~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         253 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA-----REAMEHPYFYTVVK  327 (328)
T ss_dssp             HHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCH-----HHHHTSGGGTTSCC
T ss_pred             hhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCH-----HHHhcCcccCCCCC
Confidence                  000                        0112478999999999999999999999     99999999999988


Q ss_pred             c
Q 011287          320 K  320 (489)
Q Consensus       320 ~  320 (489)
                      +
T Consensus       328 ~  328 (328)
T d3bqca1         328 D  328 (328)
T ss_dssp             C
T ss_pred             C
Confidence            5

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-52  Score=419.88  Aligned_cols=258  Identities=24%  Similarity=0.359  Sum_probs=213.7

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC----EE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF----SL  120 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----~l  120 (489)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+..  .......+.+|+.+|+.++||||+++++++....    ..
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            46999999999999999999999999999999997643  3444566788999999999999999999997543    23


Q ss_pred             EEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCccc
Q 011287          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRI  200 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~  200 (489)
                      +++++|+.+|+|.+++... .+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.......
T Consensus        86 ~~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~  164 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD  164 (345)
T ss_dssp             EEEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred             EEEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence            4445566789999999764 699999999999999999999999999999999999999999999999999987644321


Q ss_pred             cccCCCCCCCCccceecCCcCCChhhhc-CCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCC-------
Q 011287          201 TVLPNAASDDKACTFVGTAAYVPPEVLN-SSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDI-------  272 (489)
Q Consensus       201 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~-~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~-------  272 (489)
                             ........+||+.|+|||++. ...++.++||||+||++|+|++|++||.+.+...+...+.....       
T Consensus       165 -------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (345)
T d1pmea_         165 -------HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  237 (345)
T ss_dssp             -------BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             -------cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence                   122345678999999999984 45678999999999999999999999999887766655432100       


Q ss_pred             ------------------------CCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          273 ------------------------RFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       273 ------------------------~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                                              .....+++++++||.+||+.||.+|||+     .++++||||+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta-----~e~L~hpf~~~~  301 (345)
T d1pmea_         238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV-----EQALAHPYLEQY  301 (345)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCH-----HHHHTSGGGTTT
T ss_pred             hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCH-----HHHhcCHhhccC
Confidence                                    0123578899999999999999999999     899999999854

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-53  Score=410.84  Aligned_cols=251  Identities=26%  Similarity=0.430  Sum_probs=208.8

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDT---GTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSL  120 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~t---g~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~l  120 (489)
                      .++|++++.||+|+||+||+|++..+   +..||||.+...  ........+.+|+.+|++++|||||++++++.+ ..+
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~   82 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPV   82 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSC
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeE
Confidence            57999999999999999999998654   356888887543  234455678889999999999999999999964 578


Q ss_pred             EEEEeccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcc
Q 011287          121 YMALESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      |+|||||++|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+|+.+....
T Consensus        83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~  162 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST  162 (273)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred             EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence            999999999999998765 4579999999999999999999999999999999999999999999999999998754322


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhcC-CCCCCC
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRFPNY  277 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~~-~~~p~~  277 (489)
                               ........||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+++.++..+. ..+|+.
T Consensus       163 ---------~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~  233 (273)
T d1mp8a_         163 ---------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN  233 (273)
T ss_dssp             -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTT
T ss_pred             ---------ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence                     122335578999999999999999999999999999999998 999999999988888887764 578899


Q ss_pred             CCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 011287          278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (489)
Q Consensus       278 ~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~h  311 (489)
                      +|+++.+||.+||+.||++|||+     .++++|
T Consensus       234 ~~~~~~~li~~cl~~dp~~Rps~-----~ei~~~  262 (273)
T d1mp8a_         234 CPPTLYSLMTKCWAYDPSRRPRF-----TELKAQ  262 (273)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             CCHHHHHHHHHHcCCCHhHCcCH-----HHHHHH
Confidence            99999999999999999999998     677654

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-52  Score=409.03  Aligned_cols=255  Identities=20%  Similarity=0.340  Sum_probs=215.5

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCEEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTFSLY  121 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ly  121 (489)
                      +..++|++++.||+|+||+||+|+++.+ ..||||++......    .+.+.+|+.++++++|||||++++++.+ +.+|
T Consensus        14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~   87 (285)
T d1fmka3          14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY   87 (285)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeE
Confidence            3458999999999999999999999765 67999999765332    3457789999999999999999999865 4689


Q ss_pred             EEEeccCCCChHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcc
Q 011287          122 MALESCEGGELFDQITS--KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       122 lV~E~~~gg~L~~~l~~--~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~  199 (489)
                      +|||||++|+|..++..  .+.+++.++..++.||+.||.|||++||+||||||+||||+.+|++||+|||+|+......
T Consensus        88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~  167 (285)
T d1fmka3          88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  167 (285)
T ss_dssp             EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence            99999999999988864  3569999999999999999999999999999999999999999999999999998654322


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCCCCC
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRFPNY  277 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~  277 (489)
                               ........||+.|+|||++....++.++|||||||++|||++ |.+||.+.+..+++..+... ...+|..
T Consensus       168 ---------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~  238 (285)
T d1fmka3         168 ---------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE  238 (285)
T ss_dssp             -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred             ---------ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcc
Confidence                     122234579999999999999999999999999999999999 57777888888888887654 4568889


Q ss_pred             CCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc--CCCCCC
Q 011287          278 FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM--HPFFKG  316 (489)
Q Consensus       278 ~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~--hpff~~  316 (489)
                      +++++++||.+||+.||++||++     +++++  |+||..
T Consensus       239 ~~~~l~~li~~cl~~dP~~Rps~-----~~i~~~L~~~~~~  274 (285)
T d1fmka3         239 CPESLHDLMCQCWRKEPEERPTF-----EYLQAFLEDYFTS  274 (285)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCH-----HHHHHHHHTTTSC
T ss_pred             cCHHHHHHHHHHcccCHhHCcCH-----HHHHHHHhhhhcC
Confidence            99999999999999999999998     77776  888875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-51  Score=404.19  Aligned_cols=250  Identities=18%  Similarity=0.300  Sum_probs=207.7

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCC----cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTG----TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg----~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  117 (489)
                      +.++.|++.++||+|+||+||+|.++.++    ..||||++.....  +.....+.+|+.+|++++|||||++++++.+.
T Consensus         4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~   81 (283)
T d1mqba_           4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY   81 (283)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC--hHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence            45678999999999999999999987654    4799999965432  23345578899999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccC
Q 011287          118 FSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~  196 (489)
                      ..+|+|||||.+|+|.+++... +.+++..+..++.||+.||+|||++||+||||||+||||+.++++||+|||+|+.+.
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence            9999999999999999988765 679999999999999999999999999999999999999999999999999998764


Q ss_pred             CccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhc-CCCC
Q 011287          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIAR-DIRF  274 (489)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~-~~~~  274 (489)
                      ....       .........||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..++++.+..+ .+..
T Consensus       162 ~~~~-------~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~  234 (283)
T d1mqba_         162 DDPE-------ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT  234 (283)
T ss_dssp             -------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC
T ss_pred             CCCc-------cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCC
Confidence            4321       1112234578999999999999999999999999999999998 56667777887777777654 4567


Q ss_pred             CCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          275 PNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       275 p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      |..+++++.+||.+||+.||++||++
T Consensus       235 ~~~~~~~l~~li~~cl~~~p~~RPt~  260 (283)
T d1mqba_         235 PMDCPSAIYQLMMQCWQQERARRPKF  260 (283)
T ss_dssp             CTTCBHHHHHHHHHHTCSSTTTSCCH
T ss_pred             chhhHHHHHHHHHHHCcCCHhHCcCH
Confidence            78899999999999999999999998

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-52  Score=421.81  Aligned_cols=255  Identities=22%  Similarity=0.387  Sum_probs=208.8

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc------C
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD------T  117 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~  117 (489)
                      +++|+++++||+|+||+||+|+++.+|+.||||++.+.... ......+.+|+.+|++++|||||+++++|..      .
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~   94 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF   94 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcC-HHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence            47899999999999999999999999999999999876543 4445668889999999999999999999963      4


Q ss_pred             CEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCC
Q 011287          118 FSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~  197 (489)
                      ..+|+|||||.+ ++.+.+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++++|||+++....
T Consensus        95 ~~~~iv~Ey~~~-~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~  171 (355)
T d2b1pa1          95 QDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  171 (355)
T ss_dssp             CEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             ceeEEEEeccch-HHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc
Confidence            789999999976 5555554  4699999999999999999999999999999999999999999999999999875432


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCC----
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIR----  273 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~----  273 (489)
                                 .......+||+.|+|||++.+..++.++||||+||++|+|++|++||.+.+......++......    
T Consensus       172 -----------~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~  240 (355)
T d2b1pa1         172 -----------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE  240 (355)
T ss_dssp             --------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             -----------ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHH
Confidence                       22334668999999999999999999999999999999999999999999888777666431110    


Q ss_pred             ------------------C---------C-----------CCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCC
Q 011287          274 ------------------F---------P-----------NYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFK  315 (489)
Q Consensus       274 ------------------~---------p-----------~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~  315 (489)
                                        .         +           ...++++.+||++||+.||++||||     +++++||||+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta-----~elL~Hpw~~  315 (355)
T d2b1pa1         241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV-----DDALQHPYIN  315 (355)
T ss_dssp             HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCH-----HHHHTSTTTG
T ss_pred             HHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCH-----HHHhcCcccC
Confidence                              0         0           1136789999999999999999999     9999999998


Q ss_pred             CCC
Q 011287          316 GID  318 (489)
Q Consensus       316 ~i~  318 (489)
                      ...
T Consensus       316 ~~~  318 (355)
T d2b1pa1         316 VWY  318 (355)
T ss_dssp             GGC
T ss_pred             CCC
Confidence            643

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-52  Score=421.20  Aligned_cols=254  Identities=26%  Similarity=0.398  Sum_probs=215.8

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC-----C
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT-----F  118 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~  118 (489)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+.... ......+.+|+.+|+.++|||||+++++|...     .
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~   95 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   95 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcC-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence            47899999999999999999999999999999999866433 33445677899999999999999999999633     3


Q ss_pred             EEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          119 SLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      ..+++|+|+.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||++..... 
T Consensus        96 ~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-  173 (348)
T d2gfsa1          96 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-  173 (348)
T ss_dssp             CCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG-
T ss_pred             ceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc-
Confidence            45667778889999998865 5799999999999999999999999999999999999999999999999999875432 


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCC-CCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCC---
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSS-PATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRIIARDIRF---  274 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i~~~~~~~---  274 (489)
                                  ...+..||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+.......+.......   
T Consensus       174 ------------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~  241 (348)
T d2gfsa1         174 ------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE  241 (348)
T ss_dssp             ------------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             ------------ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence                        23456899999999987665 46889999999999999999999999999988887776532221   


Q ss_pred             ----------------------------CCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCCCCC
Q 011287          275 ----------------------------PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFFKGI  317 (489)
Q Consensus       275 ----------------------------p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff~~i  317 (489)
                                                  ...++++++|||.+||+.||++|||+     +++++||||+.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta-----~elL~Hp~f~~~  307 (348)
T d2gfsa1         242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA-----AQALAHAYFAQY  307 (348)
T ss_dssp             HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCH-----HHHHTSGGGTTT
T ss_pred             HhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCH-----HHHhcCHhhCCC
Confidence                                        12478999999999999999999999     899999999864

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-52  Score=413.18  Aligned_cols=254  Identities=19%  Similarity=0.314  Sum_probs=212.8

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGT----VYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDT  117 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~----~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  117 (489)
                      ++..||+++++||+|+||+||+|++..+|+    +||+|.+....  .......+.+|+.++++++|||||++++++.++
T Consensus         6 ~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~   83 (317)
T d1xkka_           6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   83 (317)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             CCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            445789999999999999999999988887    47777765432  233456688899999999999999999999875


Q ss_pred             CEEEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccC
Q 011287          118 FSLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQ  196 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~  196 (489)
                       ..+++|||+.+|+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+||||+.++++||+|||+|+.+.
T Consensus        84 -~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          84 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             -SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             -CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence             567888999999999888765 579999999999999999999999999999999999999999999999999998764


Q ss_pred             CccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhcC-CCC
Q 011287          197 DSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARD-IRF  274 (489)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~~-~~~  274 (489)
                      ...        .........||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+..++...+..+. +..
T Consensus       163 ~~~--------~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~  234 (317)
T d1xkka_         163 AEE--------KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ  234 (317)
T ss_dssp             TTC--------C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCC
T ss_pred             ccc--------ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            432        1122334578999999999999999999999999999999998 899999988887777776654 567


Q ss_pred             CCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 011287          275 PNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (489)
Q Consensus       275 p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~h  311 (489)
                      |..+++++.+||.+||+.||++|||+     .+++.|
T Consensus       235 p~~~~~~~~~li~~cl~~dP~~RPs~-----~eil~~  266 (317)
T d1xkka_         235 PPICTIDVYMIMVKCWMIDADSRPKF-----RELIIE  266 (317)
T ss_dssp             CTTBCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             CcccCHHHHHHHHHhCCCChhhCcCH-----HHHHHH
Confidence            88999999999999999999999998     778776

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-52  Score=406.36  Aligned_cols=251  Identities=23%  Similarity=0.369  Sum_probs=207.4

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcC-CC--cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKID-TG--TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~-tg--~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  118 (489)
                      +..+||++.+.||+|+||+||+|+... ++  ..||||++.+.........+.+.+|+.+|+.++||||+++++++.+. 
T Consensus         5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-   83 (273)
T d1u46a_           5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-   83 (273)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-
Confidence            456899999999999999999998643 33  47899999877666666677788999999999999999999999764 


Q ss_pred             EEEEEEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCC
Q 011287          119 SLYMALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQD  197 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~  197 (489)
                      .+|+|||||++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus        84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            678999999999999877654 5799999999999999999999999999999999999999999999999999987654


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHhcCC--CC
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIARDI--RF  274 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~~~~--~~  274 (489)
                      ....       ........|+..|+|||++.+..++.++|||||||++|||+| |.+||.+.+..++..++.....  ..
T Consensus       164 ~~~~-------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~  236 (273)
T d1u46a_         164 NDDH-------YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR  236 (273)
T ss_dssp             -CCE-------EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC
T ss_pred             CCCc-------ceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCC
Confidence            3211       122334568889999999999999999999999999999998 8999999999999999887654  45


Q ss_pred             CCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          275 PNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       275 p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      |..+|+++.+||.+||+.||++|||+
T Consensus       237 ~~~~~~~l~~li~~cl~~dp~~RPt~  262 (273)
T d1u46a_         237 PEDCPQDIYNVMVQCWAHKPEDRPTF  262 (273)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             cccccHHHHHHHHHHcCCChhHCcCH
Confidence            67899999999999999999999998

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=400.51  Aligned_cols=239  Identities=23%  Similarity=0.403  Sum_probs=205.9

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc-CCEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD-TFSL  120 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~l  120 (489)
                      +.+++|++++.||+|+||.||+|++  +|..||||++++.     ...+.+.+|+.++++++||||+++++++.+ ...+
T Consensus         4 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (262)
T d1byga_           4 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   76 (262)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC-----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             cCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH-----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence            4678999999999999999999998  4789999999654     233567889999999999999999998854 4668


Q ss_pred             EEEEeccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCc
Q 011287          121 YMALESCEGGELFDQITSKG--HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDS  198 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~  198 (489)
                      |+||||+++|+|.+++.+.+  .+++..++.++.||+.||.|||+++|+||||||+|||++.+|++||+|||+++.... 
T Consensus        77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~-  155 (262)
T d1byga_          77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-  155 (262)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC-
Confidence            99999999999999997643  499999999999999999999999999999999999999999999999999985432 


Q ss_pred             cccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCCCCHHHHHHHHHh-cCCCCCC
Q 011287          199 RITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKDTSEWLIFQRIIA-RDIRFPN  276 (489)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~~~~~~~~~~i~~-~~~~~p~  276 (489)
                                  ......+|..|+|||++.+..++.++|||||||++|||+| |++||...+..++...+.. ..+++|.
T Consensus       156 ------------~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~  223 (262)
T d1byga_         156 ------------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD  223 (262)
T ss_dssp             ------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCT
T ss_pred             ------------CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence                        2234578999999999999999999999999999999998 8999999888888888875 4567889


Q ss_pred             CCCHHHHHHHHHhhccCCCCCCCC
Q 011287          277 YFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       277 ~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      .+++++++||.+||+.||++|||+
T Consensus       224 ~~~~~~~~li~~cl~~dP~~Rps~  247 (262)
T d1byga_         224 GCPPAVYEVMKNCWHLDAAMRPSF  247 (262)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             cCCHHHHHHHHHHcccCHhHCcCH
Confidence            999999999999999999999998

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-51  Score=407.97  Aligned_cols=253  Identities=24%  Similarity=0.369  Sum_probs=217.4

Q ss_pred             CCCCCCeEEeeEEeeeCceEEEEEEEcCCCcE--EEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEcC
Q 011287           41 HFSIQDFELGKIYGVGSYSKVVRAKKIDTGTV--YALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQDT  117 (489)
Q Consensus        41 ~~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~--vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  117 (489)
                      .+..++|+++++||+|+||+||+|+++.+|..  ||||.+...  ......+.+.+|+.+|+++ +|||||++++++.++
T Consensus         6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~   83 (309)
T d1fvra_           6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   83 (309)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred             ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc--cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC
Confidence            35678999999999999999999999988875  566766433  2223345688899999998 799999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCC
Q 011287          118 FSLYMALESCEGGELFDQITSK----------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTAD  181 (489)
Q Consensus       118 ~~lylV~E~~~gg~L~~~l~~~----------------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~  181 (489)
                      ..+|+|||||++|+|.+++.+.                ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus        84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~  163 (309)
T d1fvra_          84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN  163 (309)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred             CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC
Confidence            9999999999999999999754                569999999999999999999999999999999999999999


Q ss_pred             CCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhC-CCCCCCCCH
Q 011287          182 GHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSG-TSPFKDTSE  260 (489)
Q Consensus       182 g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG-~~PF~~~~~  260 (489)
                      +.+||+|||+|+.....           .......||..|+|||.+.+..++.++|||||||++|||++| .+||.+.+.
T Consensus       164 ~~~kl~DfG~a~~~~~~-----------~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~  232 (309)
T d1fvra_         164 YVAKIADFGLSRGQEVY-----------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC  232 (309)
T ss_dssp             GCEEECCTTCEESSCEE-----------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             CceEEcccccccccccc-----------ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH
Confidence            99999999999754322           222355799999999999999999999999999999999996 578999999


Q ss_pred             HHHHHHHHhc-CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 011287          261 WLIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (489)
Q Consensus       261 ~~~~~~i~~~-~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~h  311 (489)
                      .+++..+..+ .+.+|..+++++++||.+||+.||++|||+     .++++|
T Consensus       233 ~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~-----~eil~~  279 (309)
T d1fvra_         233 AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSF-----AQILVS  279 (309)
T ss_dssp             HHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             HHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCH-----HHHHHH
Confidence            9988887764 567788899999999999999999999998     778765

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-51  Score=404.61  Aligned_cols=254  Identities=24%  Similarity=0.365  Sum_probs=202.2

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEEc
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKID-----TGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQD  116 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~-----tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~  116 (489)
                      ..++|++++.||+|+||.||+|++..     +++.||||++.....  ......+.+|..++.++ +|+||+.+++++.+
T Consensus        11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~   88 (299)
T d1ywna1          11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTK   88 (299)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--cHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence            35789999999999999999999754     457899999865432  22334455566666555 78999999998765


Q ss_pred             -CCEEEEEEeccCCCChHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeC
Q 011287          117 -TFSLYMALESCEGGELFDQITSK----------------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLT  179 (489)
Q Consensus       117 -~~~lylV~E~~~gg~L~~~l~~~----------------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~  179 (489)
                       ...+|+|||||++|+|.+++...                ..+++..+..++.||+.||.|||++||+||||||+||||+
T Consensus        89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~  168 (299)
T d1ywna1          89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS  168 (299)
T ss_dssp             TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred             CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeEC
Confidence             45689999999999999999753                2489999999999999999999999999999999999999


Q ss_pred             CCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhC-CCCCCCC
Q 011287          180 ADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSG-TSPFKDT  258 (489)
Q Consensus       180 ~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG-~~PF~~~  258 (489)
                      .++++||+|||+|+......        ......+.+||+.|+|||++.+..++.++|||||||++|||++| .+||.+.
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~--------~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~  240 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDP--------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  240 (299)
T ss_dssp             GGGCEEECC------CCSCT--------TSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             CCCcEEEccCcchhhccccc--------cccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence            99999999999998654322        12234467899999999999999999999999999999999986 6789876


Q ss_pred             CHHHHHHHHHh--cCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 011287          259 SEWLIFQRIIA--RDIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (489)
Q Consensus       259 ~~~~~~~~i~~--~~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~h  311 (489)
                      +....+..++.  ..+.+|+.+++++++||.+||+.||++|||+     +++++|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~-----~eil~~  290 (299)
T d1ywna1         241 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF-----SELVEH  290 (299)
T ss_dssp             CCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             CHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCH-----HHHHHH
Confidence            65554444433  3456788899999999999999999999998     777765

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.2e-51  Score=403.18  Aligned_cols=247  Identities=21%  Similarity=0.314  Sum_probs=217.0

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEc-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF  118 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~-----~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  118 (489)
                      .++|++++.||+|+||+||+|+.+     .+++.||||++....  .......+.+|+.+|+.++||||+++++++.+..
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~   89 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK   89 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence            478999999999999999999975     357899999987542  3344567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCC
Q 011287          119 SLYMALESCEGGELFDQITSKG------------------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPE  174 (489)
Q Consensus       119 ~lylV~E~~~gg~L~~~l~~~~------------------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpe  174 (489)
                      .+++||||+++|+|.+++....                        .+++..+..++.||+.||+|||++||+||||||+
T Consensus        90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~  169 (301)
T d1lufa_          90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR  169 (301)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence            9999999999999999997532                        3889999999999999999999999999999999


Q ss_pred             CeeeCCCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhC-CC
Q 011287          175 NLLLTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSG-TS  253 (489)
Q Consensus       175 NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG-~~  253 (489)
                      ||||+.++++||+|||+|+.+....        ......+..||+.|+|||++.+..++.++|||||||++|||++| .+
T Consensus       170 NILld~~~~~Kl~DFGls~~~~~~~--------~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~  241 (301)
T d1lufa_         170 NCLVGENMVVKIADFGLSRNIYSAD--------YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  241 (301)
T ss_dssp             GEEECGGGCEEECCCSCHHHHTGGG--------CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ceEECCCCcEEEccchhheeccCCc--------cccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence            9999999999999999998654332        12233467899999999999999999999999999999999998 57


Q ss_pred             CCCCCCHHHHHHHHHhcCC-CCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          254 PFKDTSEWLIFQRIIARDI-RFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       254 PF~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                      ||.+.+..++...+..+.. .+|..+++++.+||.+||+.||++|||+
T Consensus       242 p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~  289 (301)
T d1lufa_         242 PYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSF  289 (301)
T ss_dssp             TTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCH
Confidence            8999999999888887654 4688899999999999999999999998

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=401.06  Aligned_cols=253  Identities=24%  Similarity=0.369  Sum_probs=215.0

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcCCC-------cEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKIDTG-------TVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTF  114 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~tg-------~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~  114 (489)
                      ..++|++++.||+|+||.||+|++..++       ..||||++.+..  .......+.+|...+.++ +|||||++++++
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~   88 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGAC   88 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence            4689999999999999999999986654       479999997653  233345567788877777 899999999999


Q ss_pred             EcCCEEEEEEeccCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeee
Q 011287          115 QDTFSLYMALESCEGGELFDQITSKG----------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLL  178 (489)
Q Consensus       115 ~~~~~lylV~E~~~gg~L~~~l~~~~----------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl  178 (489)
                      .++..+|+|||||++|+|.++|....                .+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus        89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl  168 (299)
T d1fgka_          89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV  168 (299)
T ss_dssp             CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee
Confidence            99999999999999999999997553                48999999999999999999999999999999999999


Q ss_pred             CCCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCCC
Q 011287          179 TADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFKD  257 (489)
Q Consensus       179 ~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~~  257 (489)
                      +.+|.+||+|||+++......        ........+||+.|+|||.+.+..++.++|||||||++|||++ |.+||.+
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~--------~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~  240 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHID--------YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG  240 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCC--------TTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             cCCCCeEeccchhhccccccc--------cccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC
Confidence            999999999999998764432        1223446689999999999999999999999999999999998 7999999


Q ss_pred             CCHHHHHHHHHhc-CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          258 TSEWLIFQRIIAR-DIRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       258 ~~~~~~~~~i~~~-~~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                      .+...+++.+..+ .+.+|..+++++++||.+||+.||++|||+     .++++
T Consensus       241 ~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~-----~eil~  289 (299)
T d1fgka_         241 VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF-----KQLVE  289 (299)
T ss_dssp             CCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCH-----HHHHH
T ss_pred             CCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCH-----HHHHH
Confidence            9998888877664 467788999999999999999999999998     66653

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-50  Score=399.02  Aligned_cols=260  Identities=19%  Similarity=0.304  Sum_probs=225.2

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKID-----TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD  116 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~-----tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  116 (489)
                      +..++|++++.||+|+||+||+|.++.     ++..||||++.+..  .......+.+|+.++++++|||||++++++..
T Consensus        17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~   94 (308)
T d1p4oa_          17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   94 (308)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence            345899999999999999999998852     46789999997543  33345567889999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEE
Q 011287          117 TFSLYMALESCEGGELFDQITSK----------GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKI  186 (489)
Q Consensus       117 ~~~lylV~E~~~gg~L~~~l~~~----------~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL  186 (489)
                      +..+++|||||++|+|.+++...          ..+++..+..++.|++.||.|||+++|+||||||+||||+.++++||
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl  174 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI  174 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEE
Confidence            99999999999999999988643          24789999999999999999999999999999999999999999999


Q ss_pred             eeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhC-CCCCCCCCHHHHHH
Q 011287          187 ADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSG-TSPFKDTSEWLIFQ  265 (489)
Q Consensus       187 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG-~~PF~~~~~~~~~~  265 (489)
                      +|||+|+.+.....        .......+||+.|+|||.+.+..++.++|||||||++|||+|| .+||.+.+..++++
T Consensus       175 ~DFGla~~~~~~~~--------~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~  246 (308)
T d1p4oa_         175 GDFGMTRDIYETDY--------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR  246 (308)
T ss_dssp             CCTTCCCGGGGGGC--------EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred             eecccceeccCCcc--------eeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            99999987644321        1233456899999999999999999999999999999999998 68999999999998


Q ss_pred             HHHhcC-CCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc------CCCCCC
Q 011287          266 RIIARD-IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM------HPFFKG  316 (489)
Q Consensus       266 ~i~~~~-~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~------hpff~~  316 (489)
                      .+..+. +..|+.+++.+.+||.+||+.||++|||+     .++++      +|+|+.
T Consensus       247 ~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~-----~~il~~L~~~~~~~~~~  299 (308)
T d1p4oa_         247 FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF-----LEIISSIKEEMEPGFRE  299 (308)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-----HHHHHHHGGGSCTTHHH
T ss_pred             HHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCH-----HHHHHHHHHhcCCCCcC
Confidence            887754 45678899999999999999999999998     66664      666654

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-49  Score=395.07  Aligned_cols=253  Identities=24%  Similarity=0.375  Sum_probs=217.4

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEc-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccEEEEEEE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKI-----DTGTVYALKIMDKKFITKENKTAYVKLERIVLDQL-DHPGVVRLFFTFQ  115 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~-----~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~  115 (489)
                      +..++|++++.||+|+||.||+|+..     .+++.||||++.+..  .......+.+|..+++.+ +|||||++++++.
T Consensus        20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~   97 (311)
T d1t46a_          20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (311)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence            34589999999999999999999863     467899999997653  233445677899999998 6999999999999


Q ss_pred             cCCEEEEEEeccCCCChHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCee
Q 011287          116 DTFSLYMALESCEGGELFDQITSKG------------------HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLL  177 (489)
Q Consensus       116 ~~~~lylV~E~~~gg~L~~~l~~~~------------------~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNIL  177 (489)
                      +...+|+|||||++|+|.+++.+..                  .+++..+..++.||+.||.|||++||+||||||+|||
T Consensus        98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl  177 (311)
T d1t46a_          98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL  177 (311)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccc
Confidence            9999999999999999999997643                  5899999999999999999999999999999999999


Q ss_pred             eCCCCCEEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhh-CCCCCC
Q 011287          178 LTADGHIKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLS-GTSPFK  256 (489)
Q Consensus       178 l~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyellt-G~~PF~  256 (489)
                      ++.++.++++|||.++.......        .......+||+.|+|||++.+..++.++|||||||++|+|+| |.+||.
T Consensus       178 ~~~~~~~ki~DfG~~~~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~  249 (311)
T d1t46a_         178 LTHGRITKICDFGLARDIKNDSN--------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP  249 (311)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTT--------SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             ccccCcccccccchheeccCCCc--------ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCC
Confidence            99999999999999987654321        122235689999999999999999999999999999999998 778888


Q ss_pred             CCCHHHHHHHHHhcC--CCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHh
Q 011287          257 DTSEWLIFQRIIARD--IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLK  309 (489)
Q Consensus       257 ~~~~~~~~~~i~~~~--~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~  309 (489)
                      +.+....+.++....  ...|..+++++.+||.+||+.||++|||+     ++++
T Consensus       250 ~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~-----~~il  299 (311)
T d1t46a_         250 GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTF-----KQIV  299 (311)
T ss_dssp             TCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCH-----HHHH
T ss_pred             CCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCH-----HHHH
Confidence            877766666665543  44567899999999999999999999998     6665

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-48  Score=382.50  Aligned_cols=252  Identities=19%  Similarity=0.311  Sum_probs=207.1

Q ss_pred             eEEeeEEeeeCceEEEEEEEcCCC---cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEc-CCEEEE
Q 011287           47 FELGKIYGVGSYSKVVRAKKIDTG---TVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQD-TFSLYM  122 (489)
Q Consensus        47 y~~~~~LG~G~~g~Vy~a~~~~tg---~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~lyl  122 (489)
                      +.+.++||+|+||+||+|++..++   ..||||++.+.  ........+.+|+.+|++++||||+++++++.+ +..+++
T Consensus        29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l  106 (311)
T d1r0pa_          29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  106 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEE
T ss_pred             eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEE
Confidence            345789999999999999987653   36899998643  345556778899999999999999999998764 578999


Q ss_pred             EEeccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccCccccCCcccc
Q 011287          123 ALESCEGGELFDQITSK-GHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGSVKPMQDSRIT  201 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~a~~~~~~~~~  201 (489)
                      |||||++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||||++++.+||+|||+++........
T Consensus       107 v~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             EEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            99999999999988865 45788899999999999999999999999999999999999999999999999876543211


Q ss_pred             ccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCC-CCHHHHHHHHHhc-CCCCCCCCC
Q 011287          202 VLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKD-TSEWLIFQRIIAR-DIRFPNYFS  279 (489)
Q Consensus       202 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~-~~~~~~~~~i~~~-~~~~p~~~~  279 (489)
                            .........||+.|+|||.+....++.++|||||||++|||++|..||.. .+..+....+..+ .+..|..++
T Consensus       187 ------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~  260 (311)
T d1r0pa_         187 ------SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP  260 (311)
T ss_dssp             ------CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCC
T ss_pred             ------cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCc
Confidence                  11222345789999999999999999999999999999999997666654 4444555555544 455778899


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCCCCHHHHhcC
Q 011287          280 DAARDLIDRLLDVDPSGRPGAGPGGYAVLKMH  311 (489)
Q Consensus       280 ~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~h  311 (489)
                      +++.+||.+||+.||++||++     .++++|
T Consensus       261 ~~l~~li~~cl~~dP~~RPs~-----~ei~~~  287 (311)
T d1r0pa_         261 DPLYEVMLKCWHPKAEMRPSF-----SELVSR  287 (311)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCH-----HHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCH-----HHHHHH
Confidence            999999999999999999998     677765

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-47  Score=378.89  Aligned_cols=259  Identities=20%  Similarity=0.252  Sum_probs=204.6

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC-ccEEEEEEEcCCEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPG-VVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~lylV  123 (489)
                      ++|++++.||+|+||+||+|++..+|+.||||++......     ..+.+|..+++.++|++ |+.++.++.+....++|
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv   81 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   81 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence            4699999999999999999999999999999998765322     23667999999997665 55666777888999999


Q ss_pred             EeccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCC---CCCEEEeeccCccccCCcc
Q 011287          124 LESCEGGELFDQITS-KGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA---DGHIKIADFGSVKPMQDSR  199 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~---~g~ikL~DFG~a~~~~~~~  199 (489)
                      ||||.+ +|...+.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.   +..++|+|||+|+.+....
T Consensus        82 me~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~  160 (299)
T d1ckia_          82 MELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  160 (299)
T ss_dssp             EECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred             EEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence            999955 66665544 567999999999999999999999999999999999999764   4579999999999875543


Q ss_pred             ccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCHHHHHHHH---HhcC-----
Q 011287          200 ITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSEWLIFQRI---IARD-----  271 (489)
Q Consensus       200 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~~~~~~~i---~~~~-----  271 (489)
                      ....   .......+.+||+.|+|||++.+..++.++|||||||++|+|++|.+||...........+   ....     
T Consensus       161 ~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ckia_         161 THQH---IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  237 (299)
T ss_dssp             TCCB---CCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred             cccc---eeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence            2111   1122345678999999999999999999999999999999999999999876554433222   1111     


Q ss_pred             CCCCCCCCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhcCCCC
Q 011287          272 IRFPNYFSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKMHPFF  314 (489)
Q Consensus       272 ~~~p~~~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~hpff  314 (489)
                      ..++..+|+++.+||.+||+.||++||++.+  +.++++|+|.
T Consensus       238 ~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~--i~~~l~~~~~  278 (299)
T d1ckia_         238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSY--LRQLFRNLFH  278 (299)
T ss_dssp             HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHH--HHHHHHHHHH
T ss_pred             hHhccCCCHHHHHHHHHHccCChhHCcCHHH--HHHHHHHHHH
Confidence            1234678999999999999999999998732  3455666654

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.2e-47  Score=376.10  Aligned_cols=247  Identities=19%  Similarity=0.293  Sum_probs=206.6

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC-CCccEEEEEEEcCCEEEEE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH-PGVVRLFFTFQDTFSLYMA  123 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~lylV  123 (489)
                      ++|++++.||+|+||+||+|++..+|+.||||++.+....     ..+.+|..+++.+.| +||+.+++++.+....|+|
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v   79 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   79 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence            5799999999999999999999999999999998654322     235668888998865 8999999999999999999


Q ss_pred             EeccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCC-----CCCEEEeeccCccccCC
Q 011287          124 LESCEGGELFDQITSKG-HLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTA-----DGHIKIADFGSVKPMQD  197 (489)
Q Consensus       124 ~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~-----~g~ikL~DFG~a~~~~~  197 (489)
                      |||| +++|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++.     ++.+||+|||+|+.+..
T Consensus        80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~  158 (293)
T d1csna_          80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  158 (293)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence            9999 679999887754 6999999999999999999999999999999999999974     57899999999998754


Q ss_pred             ccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCC---CHHHHHHHHHhcCC--
Q 011287          198 SRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDT---SEWLIFQRIIARDI--  272 (489)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~---~~~~~~~~i~~~~~--  272 (489)
                      ......   .......+++||+.|+|||++.+..++.++|||||||++|+|++|..||.+.   +....+.++.....  
T Consensus       159 ~~~~~~---~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (293)
T d1csna_         159 PVTKQH---IPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  235 (293)
T ss_dssp             TTTCCB---CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             Cccccc---eeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence            321110   1123345679999999999999999999999999999999999999999754   34444444433221  


Q ss_pred             ---CCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 011287          273 ---RFPNYFSDAARDLIDRLLDVDPSGRPGA  300 (489)
Q Consensus       273 ---~~p~~~~~~~~~Li~~~L~~dP~~R~t~  300 (489)
                         .++..+|+++.+++..|+..+|++||+.
T Consensus       236 ~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y  266 (293)
T d1csna_         236 PLRELCAGFPEEFYKYMHYARNLAFDATPDY  266 (293)
T ss_dssp             CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCH
T ss_pred             ChHHhcCCCCHHHHHHHHHHhcCCcccCcCH
Confidence               2346789999999999999999999976

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-46  Score=370.25  Aligned_cols=248  Identities=22%  Similarity=0.277  Sum_probs=192.9

Q ss_pred             CCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC----EE
Q 011287           45 QDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDHPGVVRLFFTFQDTF----SL  120 (489)
Q Consensus        45 ~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----~l  120 (489)
                      .+|.+.+.||+|+||+||+|+.  +|+.||||++...    .......+.|+..+..++|||||++++++.+..    .+
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~   76 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence            6899999999999999999986  6899999998643    222222334555556789999999999997643    68


Q ss_pred             EEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh--------CCcEeeccCCCCeeeCCCCCEEEeeccCc
Q 011287          121 YMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHS--------MGLIHRDIKPENLLLTADGHIKIADFGSV  192 (489)
Q Consensus       121 ylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~--------~gIiHrDLKpeNILl~~~g~ikL~DFG~a  192 (489)
                      |+|||||++|+|.+++++. .+++.....++.|++.||.|||+        +||+||||||+||||+.+|++||+|||++
T Consensus        77 ~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            9999999999999999875 69999999999999999999996        59999999999999999999999999999


Q ss_pred             cccCCccccccCCCCCCCCccceecCCcCCChhhhcCCC------CCCCCcchhhhHHHHHHhhCCCCCCCC--------
Q 011287          193 KPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSP------ATFGNDLWALGCTLYQMLSGTSPFKDT--------  258 (489)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~------~~~~sDiwSLG~ilyelltG~~PF~~~--------  258 (489)
                      +........      ........+||+.|+|||++.+..      ++.++|||||||++|||+||.+||...        
T Consensus       156 ~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~  229 (303)
T d1vjya_         156 VRHDSATDT------IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY  229 (303)
T ss_dssp             EEEETTTTE------ECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred             ccccCCCcc------eeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchh
Confidence            876443211      112334578999999999997653      567899999999999999999887431        


Q ss_pred             -------CHHHHHHHHHhcC--CCCCCC-----CCHHHHHHHHHhhccCCCCCCCCCCCCHHHHhc
Q 011287          259 -------SEWLIFQRIIARD--IRFPNY-----FSDAARDLIDRLLDVDPSGRPGAGPGGYAVLKM  310 (489)
Q Consensus       259 -------~~~~~~~~i~~~~--~~~p~~-----~~~~~~~Li~~~L~~dP~~R~t~~~~~~~~l~~  310 (489)
                             +.....+.+....  +.+|..     .+..+.+|+.+||+.||++|||+     .++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~-----~ei~~  290 (303)
T d1vjya_         230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA-----LRIKK  290 (303)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCH-----HHHHH
T ss_pred             hcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCH-----HHHHH
Confidence                   2222333333322  233332     23458999999999999999998     56653

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.8e-46  Score=374.64  Aligned_cols=253  Identities=25%  Similarity=0.375  Sum_probs=198.5

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-----------CCCccEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-----------HPGVVRLFF  112 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~-----------hpnIv~l~~  112 (489)
                      -.+|+++++||+|+||+||+|+++.+|+.||||++++..    .......+|+.+++.++           |+||+++++
T Consensus        12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~   87 (362)
T d1q8ya_          12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   87 (362)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEE
Confidence            356999999999999999999999999999999997652    23345667888877764           588999988


Q ss_pred             EEE--cCCEEEEEEeccCCCChHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeeccCCCCeeeCCCCC---
Q 011287          113 TFQ--DTFSLYMALESCEGGELFDQI---TSKGHLSEDEARFYTAEVVDALEYIHS-MGLIHRDIKPENLLLTADGH---  183 (489)
Q Consensus       113 ~~~--~~~~lylV~E~~~gg~L~~~l---~~~~~l~e~~~~~i~~qil~aL~~LH~-~gIiHrDLKpeNILl~~~g~---  183 (489)
                      ++.  .....+++|+++..+......   .....+++..++.++.||+.||+|||+ .||+||||||+||||+.++.   
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~  167 (362)
T d1q8ya_          88 HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN  167 (362)
T ss_dssp             EEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred             EeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccc
Confidence            875  445677777776655433322   233579999999999999999999998 89999999999999987664   


Q ss_pred             ---EEEeeccCccccCCccccccCCCCCCCCccceecCCcCCChhhhcCCCCCCCCcchhhhHHHHHHhhCCCCCCCCCH
Q 011287          184 ---IKIADFGSVKPMQDSRITVLPNAASDDKACTFVGTAAYVPPEVLNSSPATFGNDLWALGCTLYQMLSGTSPFKDTSE  260 (489)
Q Consensus       184 ---ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDiwSLG~ilyelltG~~PF~~~~~  260 (489)
                         ++++|||.|.....             .....+||+.|+|||++....++.++|+|||||++++|++|+.||.....
T Consensus       168 ~~~~kl~dfg~s~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~  234 (362)
T d1q8ya_         168 LIQIKIADLGNACWYDE-------------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG  234 (362)
T ss_dssp             EEEEEECCCTTCEETTB-------------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             cceeeEeeccccccccc-------------ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcc
Confidence               99999999875432             23456899999999999999999999999999999999999999975432


Q ss_pred             H------HHHHHHH------------------------------------------hcCCCCCCCCCHHHHHHHHHhhcc
Q 011287          261 W------LIFQRII------------------------------------------ARDIRFPNYFSDAARDLIDRLLDV  292 (489)
Q Consensus       261 ~------~~~~~i~------------------------------------------~~~~~~p~~~~~~~~~Li~~~L~~  292 (489)
                      .      .....+.                                          .....++...+++++|||.+||+.
T Consensus       235 ~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~  314 (362)
T d1q8ya_         235 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL  314 (362)
T ss_dssp             ----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS
T ss_pred             ccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCC
Confidence            1      1111111                                          011222334578899999999999


Q ss_pred             CCCCCCCCCCCCHHHHhcCCCCCCCC
Q 011287          293 DPSGRPGAGPGGYAVLKMHPFFKGID  318 (489)
Q Consensus       293 dP~~R~t~~~~~~~~l~~hpff~~i~  318 (489)
                      ||.+|||+     +++++||||++..
T Consensus       315 dP~~Rpta-----~e~L~Hp~f~~~~  335 (362)
T d1q8ya_         315 DPRKRADA-----GGLVNHPWLKDTL  335 (362)
T ss_dssp             STTTCBCH-----HHHHTCGGGTTCT
T ss_pred             ChhHCcCH-----HHHhcCcccCCCC
Confidence            99999999     8999999999654

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=5.7e-26  Score=208.09  Aligned_cols=137  Identities=17%  Similarity=0.182  Sum_probs=109.1

Q ss_pred             eEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeeccccc---------------chhHHHHHHHHHHHHHhCCCCCccEEE
Q 011287           47 FELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFIT---------------KENKTAYVKLERIVLDQLDHPGVVRLF  111 (489)
Q Consensus        47 y~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~---------------~~~~~~~~~~E~~il~~l~hpnIv~l~  111 (489)
                      +.+++.||+|+||+||+|++. +|+.||||++......               ..........|...+.++.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            468999999999999999984 6999999987532111               011123345688889999999999988


Q ss_pred             EEEEcCCEEEEEEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeeccCCCCeeeCCCCCEEEeeccC
Q 011287          112 FTFQDTFSLYMALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSMGLIHRDIKPENLLLTADGHIKIADFGS  191 (489)
Q Consensus       112 ~~~~~~~~lylV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~gIiHrDLKpeNILl~~~g~ikL~DFG~  191 (489)
                      ++..    .+++|||+++..+.       .+++..+..++.|++.||.|||++||+||||||+|||++++ .++|+|||+
T Consensus        81 ~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~  148 (191)
T d1zara2          81 AWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ  148 (191)
T ss_dssp             EEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred             EecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence            6532    26999999986653       25667778899999999999999999999999999999865 599999999


Q ss_pred             ccccC
Q 011287          192 VKPMQ  196 (489)
Q Consensus       192 a~~~~  196 (489)
                      |....
T Consensus       149 a~~~~  153 (191)
T d1zara2         149 SVEVG  153 (191)
T ss_dssp             CEETT
T ss_pred             cccCC
Confidence            97654

>d1w1ha_ b.55.1.1 (A:) 3-phosphoinositide dependent protein kinase-1 {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: 3-phosphoinositide dependent protein kinase-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=1.4e-25  Score=195.60  Aligned_cols=103  Identities=30%  Similarity=0.555  Sum_probs=96.3

Q ss_pred             cccCcccccccCCCceEEEEEeeehhhhhhccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEEcCCCcEEEE
Q 011287          382 DSFDSKWQQFLDPGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIV  461 (489)
Q Consensus       382 ~~~~~~~~~~~~~~~~i~~~g~~~k~~g~~~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~~~~~f~i~  461 (489)
                      |...++||.|+. |+.|+|+||+.|++|++|||||||||+++++||+|+.++..||+|+|+.+   +.++.++++.|.|+
T Consensus        33 q~~~~~~~~~~~-g~~ilK~G~L~Kr~~~~wkkR~FvL~~~~L~YYkd~~~~~~kG~I~L~~~---~~v~~~~~~~F~I~  108 (147)
T d1w1ha_          33 QAGGNPWHQFVE-NNLILKMGPVDKRKGLFARRRQLLLTEGPHLYYVDPVNKVLKGEIPWSQE---LRPEAKNFKTFFVH  108 (147)
T ss_dssp             HHHHCTTGGGTT-TCCEEEEEEEEECCTTSCEEEEEEEETTTEEEEEETTTTEEEEEECCCTT---CEEEEEETTEEEEE
T ss_pred             ccCCCccccccC-CCeEEEEEEEEeecCCcceEEEEEEcCCeeEEEeCCCcccccceEEeccc---cccccccCceEEEe
Confidence            445678999995 89999999999999999999999999999999999999999999999987   88999999999999


Q ss_pred             cCCceEEEEcCCccHHHHHHHHHHhcC
Q 011287          462 TPKKVLSFEDAKQRASQWKKAIEALQN  488 (489)
Q Consensus       462 ~p~r~y~~~d~~~~~~~W~~~i~~~~~  488 (489)
                      ||+|||+|.+++++|++|+++|++|++
T Consensus       109 t~~Rty~l~a~~~d~~~Wv~aI~~v~~  135 (147)
T d1w1ha_         109 TPNRTYYLMDPSGNAHKWCRKIQEVWR  135 (147)
T ss_dssp             CSSCEEEEECTTSCHHHHHHHHHHHHH
T ss_pred             cCceEEEEEcChHHHHHHHHHHHHHHH
Confidence            999999999988999999999999863

>d2coaa1 b.55.1.1 (A:8-119) Protein kinase c, d2 type {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Protein kinase c, d2 type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.60  E-value=3.3e-16  Score=129.75  Aligned_cols=86  Identities=20%  Similarity=0.225  Sum_probs=72.0

Q ss_pred             EEEEeeehhhhhh--ccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEEc----------CCCcEEEEcCCce
Q 011287          399 LMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVS----------SPSHFKIVTPKKV  466 (489)
Q Consensus       399 ~~~g~~~k~~g~~--~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~----------~~~~f~i~~p~r~  466 (489)
                      ||+|||.|+++..  ||||||||++.-..||.|+.....+|+|||+..   +.++..          ++..|.|.||+||
T Consensus         2 lk~GwL~k~~~~~~~wkkRwFvL~~~~L~YYk~~~~~~p~g~I~L~~~---~~v~~~~~~~~~~~~~~~~~F~I~T~~rt   78 (112)
T d2coaa1           2 LREGWVVHYSNKDTLRKRHYWRLDCKCITLFQNNTTNRYYKEIPLSEI---LTVESAQNFSLVPPGTNPHCFEIVTANAT   78 (112)
T ss_dssp             SEEEEEEECCSSSCCCEEEEEEECSSEEEEESSSSCSSCSEEEETTTC---CEEEESCCCSSSCTTSCCEEEEEECSSCC
T ss_pred             ceEEEEEEECCCCCCeeEEEEEEEcceEEEEeccCCCccceEEeeecc---ccccccccccccccCCCccEEEEEeCCeE
Confidence            6999999999866  999999999988889999999999999999986   455541          3356999999999


Q ss_pred             EEEEcC------------CccHHHHHHHHHHhc
Q 011287          467 LSFEDA------------KQRASQWKKAIEALQ  487 (489)
Q Consensus       467 y~~~d~------------~~~~~~W~~~i~~~~  487 (489)
                      |||...            +.++++|+++|++++
T Consensus        79 yy~~~~~~~~~~~~s~~~~~~~~~W~~aI~~A~  111 (112)
T d2coaa1          79 YFVGEMPGGTPGGPSGQGAEAARGWETAIRQAL  111 (112)
T ss_dssp             CCEECCSCCCSSSCCCCCSHHHHHHHHHHHHHG
T ss_pred             EEEecCCccccccccccChHHHHHHHHHHHHhh
Confidence            999642            235889999999864

>d2coda1 b.55.1.1 (A:8-109) Centaurin-delta 1 {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Centaurin-delta 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.53  E-value=5.6e-15  Score=119.95  Aligned_cols=86  Identities=16%  Similarity=0.261  Sum_probs=77.4

Q ss_pred             EEEEeeehhhhhh---ccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEEcCCCcEEEEcCCceEEEE-cCCc
Q 011287          399 LMISMVKKLQKLT---SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPKKVLSFE-DAKQ  474 (489)
Q Consensus       399 ~~~g~~~k~~g~~---~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~~~~~f~i~~p~r~y~~~-d~~~  474 (489)
                      ||+|||.|+++.+   |++|||+|+++...||.++......|.|+|..+   ..+.....+.|.|+||+|+|+|. +.+.
T Consensus         2 ik~G~L~K~~~~~~~~W~kr~fvL~~~~L~~~~~~~~~~~~~~i~L~~~---~~~~~~~~~~f~i~~~~~~~~l~a~s~~   78 (102)
T d2coda1           2 VKSGWLDKLSPQGKRMFQKRWVKFDGLSISYYNNEKEMYSKGIIPLSAI---STVRVQGDNKFEVVTTQRTFVFRVEKEE   78 (102)
T ss_dssp             CEEEEEEECCSSSSSCCEEEEEEECSSEEEEEESSCCSSCCCEEETTTE---EEEEEETTTEEEEEESSCCEEEECSSHH
T ss_pred             cEEEEEEEECCCCCCCceEEEEEEECCEEEEEeccCcceeEEEEEchhc---eeeccccceeEEEEcCCcEEEEEeCCHH
Confidence            7899999998643   899999999999999999999999999999975   67777788999999999999999 4568


Q ss_pred             cHHHHHHHHHHhc
Q 011287          475 RASQWKKAIEALQ  487 (489)
Q Consensus       475 ~~~~W~~~i~~~~  487 (489)
                      ++++|+++|+.++
T Consensus        79 e~~~Wi~ai~~~i   91 (102)
T d2coda1          79 ERNDWISILLNAL   91 (102)
T ss_dssp             HHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHH
Confidence            9999999999876

>d1faoa_ b.55.1.1 (A:) Dual adaptor of phosphotyrosine and 3-phosphoinositides DAPP1/PHISH {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Dual adaptor of phosphotyrosine and 3-phosphoinositides DAPP1/PHISH
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.47  E-value=3.3e-14  Score=114.90  Aligned_cols=90  Identities=13%  Similarity=0.076  Sum_probs=74.2

Q ss_pred             EEEEEeeehhhhhh--ccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEE--cCCCcEEEEcCCceEEEE-cC
Q 011287          398 VLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV--SSPSHFKIVTPKKVLSFE-DA  472 (489)
Q Consensus       398 i~~~g~~~k~~g~~--~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~--~~~~~f~i~~p~r~y~~~-d~  472 (489)
                      ..|+|||.|+++..  ||+|||+|+++-..||.++.....+|.|+|+.+.+ +....  +..+.|.|.||+|+|+|. +.
T Consensus         4 ~~KeG~L~K~~~~~k~Wk~R~fvL~~~~L~yy~~~~~~~~~g~i~L~~~~~-v~~~~~~~~~~~F~i~~~~r~~~l~a~s   82 (100)
T d1faoa_           4 GTKEGYLTKQGGLVKTWKTRWFTLHRNELKYFKDQMSPEPIRILDLTECSA-VQFDYSQERVNCFCLVFPFRTFYLCAKT   82 (100)
T ss_dssp             TCEEEEEEEECSSSCCEEEEEEEEETTEEEEESSTTCSSCSEEEEGGGCCE-EEEECSSSSSSEEEEEETTEEEEEECSS
T ss_pred             ccEEEEEEEeCCCCCCceEEEEEEECCEEEEEeccCCccCceEEechheEE-EEeccccccccccccccCCeEEEEEeCC
Confidence            36899999999876  99999999998887888888888999999998622 22222  335689999999999999 55


Q ss_pred             CccHHHHHHHHHHhcC
Q 011287          473 KQRASQWKKAIEALQN  488 (489)
Q Consensus       473 ~~~~~~W~~~i~~~~~  488 (489)
                      +.++++|+++|+..++
T Consensus        83 ~~~~~~Wi~ai~~~i~   98 (100)
T d1faoa_          83 GVEADEWIKILRWKLS   98 (100)
T ss_dssp             HHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHh
Confidence            6899999999998763

>d1eaza_ b.55.1.1 (A:) Tapp1 {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Tapp1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.36  E-value=4.2e-13  Score=108.34  Aligned_cols=88  Identities=16%  Similarity=0.161  Sum_probs=74.7

Q ss_pred             eEEEEEeeehhhhhh--ccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEE-------cCCCcEEEEcCCceE
Q 011287          397 SVLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV-------SSPSHFKIVTPKKVL  467 (489)
Q Consensus       397 ~i~~~g~~~k~~g~~--~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~-------~~~~~f~i~~p~r~y  467 (489)
                      .|+|+|||.|+++..  |++|||+|++...+||.++.....+|.|++...   ..+..       +....|.|.+++|+|
T Consensus         2 ~vik~G~L~K~~~~~~~Wkkr~fvL~~~~l~yy~~~~~~~~~~~i~l~~~---~~~~~~~~~~~~~~~~~f~i~~~~~~~   78 (103)
T d1eaza_           2 AVIKAGYCVKQGAVMKNWKRRYFQLDENTIGYFKSELEKEPLRVIPLKEV---HKVQECKQSDIMMRDNLFEIVTTSRTF   78 (103)
T ss_dssp             CCSEEEEEEEECTTTCCEEEEEEEECSSEEEEESSTTCSSCSEEEEGGGC---CEEEECTTHHHHTCSSEEEEECSSCEE
T ss_pred             ceEEEEEEEEECCCCCCeeEEEEEEECCEEEEEecccCcccceEEEccce---EEeeccccccccccceEEEEEeCCEEE
Confidence            378999999988755  999999999999889999888899999999986   23322       335689999999999


Q ss_pred             EEE-cCCccHHHHHHHHHHhc
Q 011287          468 SFE-DAKQRASQWKKAIEALQ  487 (489)
Q Consensus       468 ~~~-d~~~~~~~W~~~i~~~~  487 (489)
                      +|. +.+.++++|+++|+.++
T Consensus        79 ~~~a~s~~e~~~W~~aI~~ai   99 (103)
T d1eaza_          79 YVQADSPEEMHSWIKAVSGAI   99 (103)
T ss_dssp             EEECSSHHHHHHHHHHHHHHH
T ss_pred             EEEeCCHHHHHHHHHHHHHHH
Confidence            998 56689999999999876

>d1btka_ b.55.1.1 (A:) Bruton's tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Bruton's tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.27  E-value=2e-12  Score=114.61  Aligned_cols=89  Identities=18%  Similarity=0.192  Sum_probs=70.3

Q ss_pred             eEEEEEeeehhhh---h----hccceeEEEecCCeEEEECCCC----CeeeeeeeccCCCCceEEEE-------------
Q 011287          397 SVLMISMVKKLQK---L----TSKKVQLILTNKPKLIYVDPSK----LVVKGNIIWSDNSNDLSIQV-------------  452 (489)
Q Consensus       397 ~i~~~g~~~k~~g---~----~~k~r~~~lt~~p~l~y~d~~~----~~~kg~i~~~~~~~~~~~~~-------------  452 (489)
                      .||++|+|.|++.   .    -||+|||||++....||.++..    ...+|.|++...   ..++.             
T Consensus         2 ~vi~eG~L~Kr~~~k~k~~~~~WkrRwFVL~~~~L~Yyk~~~~~~~~~~~kG~I~L~~~---~~v~~~~~~~~~~~~~~~   78 (169)
T d1btka_           2 AVILESIFLKRSQQKKKTSPLNFKKCLFLLTVHKLSYYEYDFERGRRGSKKGSIDVEKI---TCVETVVPEKNPPPERQI   78 (169)
T ss_dssp             CCCEEEEEEEECCCSSTTCCCCEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEEGGGE---EEEEECCCCSSCCGGGCC
T ss_pred             cEEEEEEEEEecCCCCCcCcCCceEEEEEEECCEEeeeccccccccccCccceEeccce---EEEEeecccCCCCccccc
Confidence            3799999999873   2    2999999999987778877643    468899999974   33332             


Q ss_pred             -----------------cCCCcEEEEcCCceEEEEc-CCccHHHHHHHHHHhcC
Q 011287          453 -----------------SSPSHFKIVTPKKVLSFED-AKQRASQWKKAIEALQN  488 (489)
Q Consensus       453 -----------------~~~~~f~i~~p~r~y~~~d-~~~~~~~W~~~i~~~~~  488 (489)
                                       +....|.|+|+.|||+|.. .+.++++|+++|++++.
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~F~I~t~~rt~~l~A~s~eE~~~WI~aL~~~i~  132 (169)
T d1btka_          79 PRRGEESSEMEQISIIERFPYPFQVVYDEGPLYVFSPTEELRKRWIHQLKNVIR  132 (169)
T ss_dssp             ---------CCTTHHHHCCCEEEEEEETTCCEEEEESCHHHHHHHHHHHHHHHT
T ss_pred             cccccccccccccccccccCcceEEEeCCcEEEEECCCHHHHHHHHHHHHHHHH
Confidence                             1235899999999999994 55899999999999875

>d1qqga1 b.55.1.2 (A:12-114) Insulin receptor substrate 1, IRS-1 {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Phosphotyrosine-binding domain (PTB)
domain: Insulin receptor substrate 1, IRS-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.25  E-value=6.4e-12  Score=101.43  Aligned_cols=84  Identities=17%  Similarity=0.273  Sum_probs=65.3

Q ss_pred             EEEEEeeehhhhhhccceeEEEecC------CeEEEEC-C-----CCCeeeeeeeccCCCCceEEEE----cCCCcEEEE
Q 011287          398 VLMISMVKKLQKLTSKKVQLILTNK------PKLIYVD-P-----SKLVVKGNIIWSDNSNDLSIQV----SSPSHFKIV  461 (489)
Q Consensus       398 i~~~g~~~k~~g~~~k~r~~~lt~~------p~l~y~d-~-----~~~~~kg~i~~~~~~~~~~~~~----~~~~~f~i~  461 (489)
                      |+|+|+|.|++  .||+|||+|.+.      ++|+|.+ +     .....+|.|++..+   ..+..    +....|.|.
T Consensus         2 v~k~GyL~K~k--~WkkR~fvL~~~~~~~~~~~L~yy~~~~~~~~~~~~~~~~i~l~~~---~~~~~~~~~~~~~~f~i~   76 (103)
T d1qqga1           2 VRKVGYLRKPK--SMHKRFFVLRAASEAGGPARLEYYENEKKWRHKSSAPKRSIPLESC---FNINKRADSKNKHLVALY   76 (103)
T ss_dssp             EEEEEEEECTT--TCCEEEEEEECCBTTTBSSEEEEESSHHHHHTTCSCCSEEEEGGGE---EEEEEECCSSCSSEEEEE
T ss_pred             cceeEEEEEcC--CCCEEEEEEecccccCCccEEEEEcchhhhhcccccccceEeccee---eEEeecccCCCceEEEEE
Confidence            78999999986  499999999874      4565554 2     34556799999875   33333    335689999


Q ss_pred             cCCceEEEE-cCCccHHHHHHHHHHh
Q 011287          462 TPKKVLSFE-DAKQRASQWKKAIEAL  486 (489)
Q Consensus       462 ~p~r~y~~~-d~~~~~~~W~~~i~~~  486 (489)
                      |++|+|+|. +.+.++++|+++|.++
T Consensus        77 t~~r~~~l~A~s~~e~~~Wi~al~~l  102 (103)
T d1qqga1          77 TRDEHFAIAADSEAEQDSWYQALLQL  102 (103)
T ss_dssp             ESSCEEEEECSSHHHHHHHHHHHHHH
T ss_pred             eCCeEEEEEcCCHHHHHHHHHHHHhh
Confidence            999999999 4558999999999986

>d1x1fa1 b.55.1.1 (A:8-143) Signal-transducing adaptor protein 1, STAP-1 {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Signal-transducing adaptor protein 1, STAP-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.24  E-value=6.6e-12  Score=107.01  Aligned_cols=88  Identities=11%  Similarity=0.201  Sum_probs=73.7

Q ss_pred             eEEEEEeeehhhhhh--ccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEE-----cCCCcEEEEcCCceEEE
Q 011287          397 SVLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV-----SSPSHFKIVTPKKVLSF  469 (489)
Q Consensus       397 ~i~~~g~~~k~~g~~--~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~-----~~~~~f~i~~p~r~y~~  469 (489)
                      -+-++|+|.|+++..  ||+|||+|++.-..||.++.....+|.|+++..   +.+..     +....|.|.|++|+|+|
T Consensus        10 ~~~~eG~L~k~~~~~k~WkkrwfvL~~~~L~yY~~~~d~~~~~~i~L~~~---~~~~~~~~~~~~~~~F~i~~~~~~~~f   86 (136)
T d1x1fa1          10 PLYFEGFLLIKRSGYREYEHYWTELRGTTLFFYTDKKSIIYVDKLDIVDL---TCLTEQNSTEKNCAKFTLVLPKEEVQL   86 (136)
T ss_dssp             CEEEEEEEEEECTTCCSCEEEEEEEETTEEEEESCSSCSSCSEECCCSSC---CEEEECCCTTSCCCEEEEECSSCCEEE
T ss_pred             CccEEEEEEEECCCCCCeEEEEEEEcCCEeEEEeecccccccccccccce---eeeeeecccccccceeeecCCCceEEE
Confidence            367899999998765  999999999987778888988899999999986   33332     23478999999999999


Q ss_pred             Ec-CCccHHHHHHHHHHhc
Q 011287          470 ED-AKQRASQWKKAIEALQ  487 (489)
Q Consensus       470 ~d-~~~~~~~W~~~i~~~~  487 (489)
                      .. .+.++.+|+++|+.|+
T Consensus        87 ~Aes~~e~~~Wi~~I~~v~  105 (136)
T d1x1fa1          87 KTENTESGEEWRGFILTVT  105 (136)
T ss_dssp             ECSSHHHHHHHHHHHHHHH
T ss_pred             EeCCHHHHHHHHHHHHHHH
Confidence            95 4589999999999876

>d1v89a_ b.55.1.1 (A:) Rho-GTPase-activating protein 25 (KIAA0053) {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Rho-GTPase-activating protein 25 (KIAA0053)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.24  E-value=6e-12  Score=104.05  Aligned_cols=90  Identities=11%  Similarity=0.228  Sum_probs=72.6

Q ss_pred             CceEEEEEeeehhhhhh--ccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEE------cCCCcEEEEcCC--
Q 011287          395 GESVLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV------SSPSHFKIVTPK--  464 (489)
Q Consensus       395 ~~~i~~~g~~~k~~g~~--~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~------~~~~~f~i~~p~--  464 (489)
                      ++.++++|||.|+++..  ||+|||+|++....||.++.....+|.|+|..+   .-.+.      +....|.|.+++  
T Consensus         5 ~s~~~k~G~L~K~~~~~k~WkkR~fvL~~~~l~y~~~~~~~~~~~~~~l~~~---~~~~~~~~~~~~~~~~f~l~~~~~~   81 (118)
T d1v89a_           5 SSGPIKMGWLKKQRSIVKNWQQRYFVLRAQQLYYYKDEEDTKPQGCMYLPGC---TIKEIATNPEEAGKFVFEIIPASWD   81 (118)
T ss_dssp             SSCEEEEEEEEEECSSSSCEEEEEEEEETTEEEEESSSSCCSCSEEECSTTE---EEEEECCCSSCCCCCEEEEEESCCS
T ss_pred             CCCCeEEEEEEEECCCCCCcEEEEEEEECCEEEEecccCcccccceeccCce---EEEEeccccccCCCcEEEEecCCCc
Confidence            34589999999988766  899999999987778888888999999999975   22222      223578887654  


Q ss_pred             ------ceEEEE-cCCccHHHHHHHHHHhc
Q 011287          465 ------KVLSFE-DAKQRASQWKKAIEALQ  487 (489)
Q Consensus       465 ------r~y~~~-d~~~~~~~W~~~i~~~~  487 (489)
                            |+|+|. |.+.++++|+++|+++.
T Consensus        82 ~~~~~~~~~~~~a~s~ee~~~Wi~aI~~a~  111 (118)
T d1v89a_          82 QNRMGQDSYVLMASSQAEMEEWVKFLRRVA  111 (118)
T ss_dssp             SCCSSCCCEEEECSSHHHHHHHHHHHHHHH
T ss_pred             ceecCCcEEEEEcCCHHHHHHHHHHHHHHH
Confidence                  789998 66799999999999976

>d2dyna_ b.55.1.1 (A:) Dynamin {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Dynamin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.24  E-value=9.6e-12  Score=102.04  Aligned_cols=90  Identities=16%  Similarity=0.134  Sum_probs=68.7

Q ss_pred             eEEEEEeeehhhh-h---hccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEE---cCCCcEEEEcC------
Q 011287          397 SVLMISMVKKLQK-L---TSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV---SSPSHFKIVTP------  463 (489)
Q Consensus       397 ~i~~~g~~~k~~g-~---~~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~---~~~~~f~i~~p------  463 (489)
                      .|+|+|||.|+++ +   .||+|||+|+++-..||.|+.....+|.|++.... +..++.   .....|.|.+|      
T Consensus         2 ~vik~GwL~k~~~~~~~~~WkkRwFvL~~~~L~yyk~~~~~~~~~~i~l~~~~-v~~~~~~~~~~~~~F~l~~~~~~~~~   80 (111)
T d2dyna_           2 LVIRKGWLTINNIGIMKGGSKEYWFVLTAENLSWYKDDEEKEKKYMLSVDNLK-LRDVEKGFMSSKHIFALFNTEQRNVY   80 (111)
T ss_dssp             CEEEEEEEEETTCCTTTTSSEEEEEEEESSEEEEESSTTCCCEEEEEECTTEE-EEEECCCSTTCSEEEEEEESSCSCSB
T ss_pred             eEEEEeeEEEECCCCCcCCceEEEEEEECCEEEEEcchhhcccccccccccce-eEeeccccccccccEEeeeccccccc
Confidence            4899999999864 2   29999999999866678888888999999998631 112222   23457998765      


Q ss_pred             --CceEEEEc-CCccHHHHHHHHHHhc
Q 011287          464 --KKVLSFED-AKQRASQWKKAIEALQ  487 (489)
Q Consensus       464 --~r~y~~~d-~~~~~~~W~~~i~~~~  487 (489)
                        .|||+|.. .+.++.+|+++|.++.
T Consensus        81 ~~~r~~~l~a~s~ed~~~W~~al~~A~  107 (111)
T d2dyna_          81 KDYRQLELACETQEEVDSWKASFLRAG  107 (111)
T ss_dssp             TTBSSEEEEESSHHHHHHHHHHHHHTT
T ss_pred             cCceeEEEECCCHHHHHHHHHHHHHhc
Confidence              48999995 5589999999999864

>d1u5da1 b.55.1.1 (A:108-213) Src kinase-associated phosphoprotein SKAP55 (SCAP1) {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Src kinase-associated phosphoprotein SKAP55 (SCAP1)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.21  E-value=1.1e-11  Score=100.49  Aligned_cols=89  Identities=16%  Similarity=0.269  Sum_probs=70.0

Q ss_pred             EEEEEeeehhhh---h---hccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEE------cCCCcEEEEcC-C
Q 011287          398 VLMISMVKKLQK---L---TSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV------SSPSHFKIVTP-K  464 (489)
Q Consensus       398 i~~~g~~~k~~g---~---~~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~------~~~~~f~i~~p-~  464 (489)
                      |+|+|+|.|+++   .   -|++|||+|++.-.+||.++.....+|.|++...  ......      +....|.|.|+ +
T Consensus         1 vik~G~L~k~~~~~~~~~~~Wkkr~~vL~~~~L~y~~~~~~~~~~~~i~l~~~--~~~~~~~~~~~~~~~~~f~i~~~~~   78 (106)
T d1u5da1           1 VIKQGYLEKKSKDHSFFGSEWQKRWCVVSRGLFYYYANEKSKQPKGTFLIKGY--SVRMAPHLRRDSKKESCFELTSQDR   78 (106)
T ss_dssp             EEEEEEEEEEEECSSSSCEEEEEEEEEEETTEEEEESSTTCSSCSEEEECTTC--EEEECGGGCSSGGGGGEEEEECSSS
T ss_pred             CeEEEEEEEECCCCCCCcCCcEEEEEEEECCEEEEEecccccccccccccCCc--eEeeccccccccCCceeEEEEcCCC
Confidence            799999998664   2   2899999999988878888888889999999875  111111      23368999886 5


Q ss_pred             ceEEEEcC-CccHHHHHHHHHHhcC
Q 011287          465 KVLSFEDA-KQRASQWKKAIEALQN  488 (489)
Q Consensus       465 r~y~~~d~-~~~~~~W~~~i~~~~~  488 (489)
                      |+|+|... +.++++|+++|+.|+.
T Consensus        79 ~~~~f~a~s~~e~~~W~~ai~~~i~  103 (106)
T d1u5da1          79 RTYEFTATSPAEARDWVDQISFLLK  103 (106)
T ss_dssp             CCEEEECSSHHHHHHHHHHHHHHHH
T ss_pred             cEEEEEeCCHHHHHHHHHHHHHHHH
Confidence            89999954 5899999999999863

>d1v88a_ b.55.1.1 (A:) Oxysterol binding protein-related protein 8 (ORP-8, KIAA1451) {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Oxysterol binding protein-related protein 8 (ORP-8, KIAA1451)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.20  E-value=3.4e-12  Score=107.52  Aligned_cols=92  Identities=17%  Similarity=0.176  Sum_probs=67.1

Q ss_pred             eEEEEEeeehhhhhh-ccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEEcCCCcEEEEcCC-----------
Q 011287          397 SVLMISMVKKLQKLT-SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPK-----------  464 (489)
Q Consensus       397 ~i~~~g~~~k~~g~~-~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~~~~~f~i~~p~-----------  464 (489)
                      -|+++|||+|++.+- ||+|||||++.-..||.++.....+|.|+|..+.++.....+....|.|.+|.           
T Consensus         7 ~~~~~GwLkk~~~~k~WkkRwfvL~~~~L~yyk~~~~~~~~g~i~L~~~~v~~~~~~~~~~~f~i~~~~~~~~~~~~~~~   86 (130)
T d1v88a_           7 GIVMADWLKIRGTLKSWTKLWCVLKPGVLLIYKTQKNGQWVGTVLLNACEIIERPSKKDGFCFKLFHPLEQSIWAVKGPK   86 (130)
T ss_dssp             SCCEEEEEEECCSSSSCEEEEEEEETTEEEEESCSSSCCCCEEEECSSCEECCCCTTTSSCEEEEECTTCCCCSCSSCTT
T ss_pred             CCeEeCeEEeCCCCCCceEEEEEEeCCEEEEEcCCCCCcceeEEECCCeEEEEccccCCCceEEEEcCCCcceecccCcc
Confidence            389999997765433 99999999988777888998889999999997521111112334567765532           


Q ss_pred             -------------ceEEEE-cCCccHHHHHHHHHHhcC
Q 011287          465 -------------KVLSFE-DAKQRASQWKKAIEALQN  488 (489)
Q Consensus       465 -------------r~y~~~-d~~~~~~~W~~~i~~~~~  488 (489)
                                   +.|+|. +.+.++++|+++|+.++.
T Consensus        87 ~~~~~~~~~~~~~~~~~l~A~s~~e~~~Wi~al~~~i~  124 (130)
T d1v88a_          87 GEAVGSITQPLPSSYLIIRATSESDGRCWMDALELALK  124 (130)
T ss_dssp             SCSCSCCCSCCCSSCCEEECSSHHHHHHHHHHHHHHHT
T ss_pred             cccceeEEecCCcEEEEEECCCHHHHHHHHHHHHHHhh
Confidence                         335666 556899999999999874

>d1wg7a_ b.55.1.1 (A:) Dedicator of cytokinesis protein 9, DOCK9 {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Dedicator of cytokinesis protein 9, DOCK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.18  E-value=6.6e-12  Score=108.74  Aligned_cols=91  Identities=13%  Similarity=0.119  Sum_probs=69.0

Q ss_pred             eEEEEEeeehhhh------h--hccceeEEEecCC-----eEEEECCC-CCeeeeeeeccCCCCceEEEEcCCCcEEEEc
Q 011287          397 SVLMISMVKKLQK------L--TSKKVQLILTNKP-----KLIYVDPS-KLVVKGNIIWSDNSNDLSIQVSSPSHFKIVT  462 (489)
Q Consensus       397 ~i~~~g~~~k~~g------~--~~k~r~~~lt~~p-----~l~y~d~~-~~~~kg~i~~~~~~~~~~~~~~~~~~f~i~~  462 (489)
                      .|+|+|||.|++.      .  .||+|||||++..     .+||.|.. ....+|.|++..+..+..........|.|.+
T Consensus        17 ~v~k~G~L~K~~~~~~~~~~~k~WkkR~fvL~~~~~~~~~L~yy~~~~~~~~~~g~i~l~~~~~~~~~~~~~~~~F~i~~   96 (150)
T d1wg7a_          17 GITKHGWLYKGNMNSAISVTMRSFKRRFFHLIQLGDGSYNLNFYKDEKISKEPKGSIFLDSCMGVVQNNKVRRFAFELKM   96 (150)
T ss_dssp             CCCCEEEEEECCCCSSHHHHHSSCEEEEEEEEECSSSCEEEEEESSSCCSSCCSEEECTTTCCEECCCCSSCTTEEEEEC
T ss_pred             CEeEEEEEEEecCCCCcccccccceEEEEEEEcCcCCceeEEEEeccccccccccccccccccccccCccccceEEEEEc
Confidence            4899999998752      1  2999999999753     45777654 4678999999987332233334457899988


Q ss_pred             C-CceEEEE-cCCccHHHHHHHHHHhc
Q 011287          463 P-KKVLSFE-DAKQRASQWKKAIEALQ  487 (489)
Q Consensus       463 p-~r~y~~~-d~~~~~~~W~~~i~~~~  487 (489)
                      + +|+|+|. +.+.++++|+++|+.++
T Consensus        97 ~~~~~~~l~A~s~~e~~~Wi~aL~~~i  123 (150)
T d1wg7a_          97 QDKSSYLLAADSEVEMEEWITILNKIL  123 (150)
T ss_dssp             SSSCEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             CCCeEEEEEeCCHHHHHHHHHHHHHHH
Confidence            7 5899999 55689999999999875

>d1plsa_ b.55.1.1 (A:) Pleckstrin {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Pleckstrin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.17  E-value=1.2e-11  Score=101.50  Aligned_cols=90  Identities=19%  Similarity=0.138  Sum_probs=72.0

Q ss_pred             EEEEEeeehhhhhh--ccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEE--EcCCCcEEEEc-CCceEEEEcC
Q 011287          398 VLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQ--VSSPSHFKIVT-PKKVLSFEDA  472 (489)
Q Consensus       398 i~~~g~~~k~~g~~--~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~--~~~~~~f~i~~-p~r~y~~~d~  472 (489)
                      +||+|||.|+++..  |++|||+|++.-.+||.++.....+|.|++..+.....+.  ......|.|.+ ++|+|+|...
T Consensus         5 ~ikeG~L~k~~~~~k~WkkryfvL~~~~L~~y~~~~~~~p~~~i~l~~~~~~~~~~~~~~~~~~f~l~~~~~~~~~~~a~   84 (113)
T d1plsa_           5 RIREGYLVKKGSVFNTWKPMWVVLLEDGIEFYKKKSDNSPKGMIPLKGSTLTSPCQDFGKRMFVFKITTTKQQDHFFQAA   84 (113)
T ss_dssp             CSEEEEEEEESSSSSCCEEEEEEEETTEEEEESSTTCSSCSEEEESSSCCEESSCCSSCCSSSEEEEEETTTEEEEEECS
T ss_pred             ceEEEEEEEeCCCCCCceEEEEEEECCEEEEEecCCccccceEEECccCeEEeeecccCCcceEEEEecCCCeEEEEECC
Confidence            68999999987655  9999999999988899899888999999999862211111  13346788876 6799999954


Q ss_pred             -CccHHHHHHHHHHhc
Q 011287          473 -KQRASQWKKAIEALQ  487 (489)
Q Consensus       473 -~~~~~~W~~~i~~~~  487 (489)
                       +.++++|+++|+.++
T Consensus        85 s~~e~~~Wi~ai~~ai  100 (113)
T d1plsa_          85 FLEERDAWVRDINKAI  100 (113)
T ss_dssp             SHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHH
Confidence             589999999999875

>d2fjla1 b.55.1.1 (A:1-37,A:87-150) Phosphoinositide phospholipase C, PLC-gamma-1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Phosphoinositide phospholipase C, PLC-gamma-1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.16  E-value=3e-11  Score=97.07  Aligned_cols=87  Identities=15%  Similarity=0.197  Sum_probs=70.1

Q ss_pred             EEEEeeehhhhhh--ccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEE--c--CCCcEEEEcC---CceEEE
Q 011287          399 LMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV--S--SPSHFKIVTP---KKVLSF  469 (489)
Q Consensus       399 ~~~g~~~k~~g~~--~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~--~--~~~~f~i~~p---~r~y~~  469 (489)
                      +|+|+|.|++...  |++|||+|++....||.++.....+|.|++..+.  +....  .  ....|.|.++   .|+|+|
T Consensus         2 iK~G~L~k~~~~~k~W~kR~fvL~~~~L~yy~~~~~~~~~~~i~l~~~~--v~~~~~~~~~~~~~f~i~~~~~~~~~~~~   79 (101)
T d2fjla1           2 IKNGILYLEDPVNHEWYPHYFVLTSSKIYYSEETSSDLLRGVLDVPACQ--IAIRPEGKNNRLFVFSISMPSVAQWSLDV   79 (101)
T ss_dssp             CEEEEEEEEETTTTEEEEEEEEEETTEEEECCCCSCTCCCEEECSTTCE--EEEETTCSSSCSCEEEEECTTTSSCCEEE
T ss_pred             ceEEEEEEEcCCCCCCeEEEEEEECCEEEEEeccccceecceEEcCCce--eEeeeeecccccceeEEeccccccEEEEE
Confidence            6899999998866  9999999999888788888888999999998751  22111  2  2357898876   489999


Q ss_pred             E-cCCccHHHHHHHHHHhc
Q 011287          470 E-DAKQRASQWKKAIEALQ  487 (489)
Q Consensus       470 ~-d~~~~~~~W~~~i~~~~  487 (489)
                      . +.+.++.+|+++|+++.
T Consensus        80 ~a~s~~e~~~Wi~ai~~~~   98 (101)
T d2fjla1          80 AADSQEELQDWVKKIREVA   98 (101)
T ss_dssp             EESSHHHHHHHHHHHHHHH
T ss_pred             EeCCHHHHHHHHHHHHHHH
Confidence            8 56689999999999975

>d1v5ua_ b.55.1.1 (A:) SET binding factor 1, Sbf1 {Mouse (Mus musculus) [TaxId: 10090]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: SET binding factor 1, Sbf1
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.15  E-value=2.2e-11  Score=100.32  Aligned_cols=89  Identities=19%  Similarity=0.242  Sum_probs=69.2

Q ss_pred             eEEEEEeeehhhhhh--ccceeEEEec-CCeE-EEECCCCCeeeeeeeccCCCCceEEEEc-----------CCCcEEEE
Q 011287          397 SVLMISMVKKLQKLT--SKKVQLILTN-KPKL-IYVDPSKLVVKGNIIWSDNSNDLSIQVS-----------SPSHFKIV  461 (489)
Q Consensus       397 ~i~~~g~~~k~~g~~--~k~r~~~lt~-~p~l-~y~d~~~~~~kg~i~~~~~~~~~~~~~~-----------~~~~f~i~  461 (489)
                      .++++|||.|+++..  ||+|||+|.. ...| ||.++.....+|.|+++..   ..+...           ....|.++
T Consensus         7 ~~~~eG~L~k~~~~~k~WkkR~fvL~~~~~~L~~~~~~~~~~p~g~i~l~~~---~~v~~~~~~~~~~~~~~~~~~~~~~   83 (117)
T d1v5ua_           7 GRSYEGILYKKGAFMKPWKARWFVLDKTKHQLRYYDHRMDTECKGVIDLAEV---EAVAPGTPTIGAPKTVDEKAFFDVK   83 (117)
T ss_dssp             SSSEEEEEEECCCSSSCCEEEEEEEETTTTEEEEESSSSCSSCCCEEEGGGE---EEEECCCCCTTSCSSSCTTTCEEEE
T ss_pred             CCeEEEEEEEECCCCCCceEEEEEEeCCCCEEEecccccccCcceEEEecce---EEEeecccccccccccccceEEEee
Confidence            468999999998754  9999999985 4555 5566667888999999864   333331           12468888


Q ss_pred             cCCceEEEE-cCCccHHHHHHHHHHhcC
Q 011287          462 TPKKVLSFE-DAKQRASQWKKAIEALQN  488 (489)
Q Consensus       462 ~p~r~y~~~-d~~~~~~~W~~~i~~~~~  488 (489)
                      +++|+|+|. |.+.++++|+++|+.++.
T Consensus        84 ~~~~~~~~~a~s~~e~~~Wv~~l~~ai~  111 (117)
T d1v5ua_          84 TTRRVYNFCAQDVPSAQQWVDRIQSCLS  111 (117)
T ss_dssp             ESSCEEEEECSSHHHHHHHHHHHHTTCC
T ss_pred             CCCcEEEEEeCCHHHHHHHHHHHHHHHh
Confidence            999999999 566899999999999873

>d2elba2 b.55.1.1 (A:274-374) DCC-interacting protein 13-alpha, APPL1 {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: DCC-interacting protein 13-alpha, APPL1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.15  E-value=7e-12  Score=101.04  Aligned_cols=89  Identities=11%  Similarity=0.044  Sum_probs=62.8

Q ss_pred             eEEEEEeeehhh--hhh---ccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEEcCCCcEEEEcC--CceEEE
Q 011287          397 SVLMISMVKKLQ--KLT---SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTP--KKVLSF  469 (489)
Q Consensus       397 ~i~~~g~~~k~~--g~~---~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~~~~~f~i~~p--~r~y~~  469 (489)
                      .+.|+|+|.|+.  |..   |+||||+|+++ .|+|........+|.|++..+.+....+......|.|.++  +|+|+|
T Consensus         4 ~~~k~G~L~k~~~~g~~~k~W~kRwfvL~~~-~L~y~~~~~~~~~~~i~l~~~~v~~~~~~~~~~~f~i~~~~~~~~~~l   82 (101)
T d2elba2           4 LTRKAGYLNARNKTGLVSSTWDRQFYFTQGG-NLMSQARGDVAGGLAMDIDNCSVMAVDCEDRRYCFQITSFDGKKSSIL   82 (101)
T ss_dssp             CSCCEEEEEECSCCC----CCCEEEEEEETT-EEEEECTTCCCE----EEEECCCCCCCCCCSSSSSEECCCSSSCCCCE
T ss_pred             CccEeEEEEEeccCCCCccccEEEEEEEeCC-EEEEEccCCcccceEEEecccccccccccCCcceEEEEeecccceEEE
Confidence            467899998873  432   99999999986 6666666667888999997653322323344568999875  599999


Q ss_pred             E-cCCccHHHHHHHHHHh
Q 011287          470 E-DAKQRASQWKKAIEAL  486 (489)
Q Consensus       470 ~-d~~~~~~~W~~~i~~~  486 (489)
                      . +.+.++++|++||++|
T Consensus        83 ~A~s~~e~~~Wi~al~~v  100 (101)
T d2elba2          83 QAESKKDHEEWICTINNI  100 (101)
T ss_dssp             ECSSHHHHHHHHHHHHHT
T ss_pred             ECCCHHHHHHHHHHHHhc
Confidence            9 5558999999999985

>d1unqa_ b.55.1.1 (A:) Rac-alpha serine/threonine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Rac-alpha serine/threonine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.15  E-value=7.9e-12  Score=103.16  Aligned_cols=93  Identities=14%  Similarity=0.191  Sum_probs=69.4

Q ss_pred             CceEEEEEeeehhhhhh--ccceeEEEecCCeE-EEECCCCCeeeeeeeccCCCCc--eEEE--EcCCCcEEEEcC----
Q 011287          395 GESVLMISMVKKLQKLT--SKKVQLILTNKPKL-IYVDPSKLVVKGNIIWSDNSND--LSIQ--VSSPSHFKIVTP----  463 (489)
Q Consensus       395 ~~~i~~~g~~~k~~g~~--~k~r~~~lt~~p~l-~y~d~~~~~~kg~i~~~~~~~~--~~~~--~~~~~~f~i~~p----  463 (489)
                      +..|+++|||.|+++..  ||+|||||++...| ||.+......+|.||+......  ..+.  .+..+.|.|.++    
T Consensus         4 ~~~v~k~G~L~K~~~~~k~Wk~RwfvL~~~~~l~~~~~~~~~~~~~~i~l~~~~~~~~~~~~~~~~~~~~f~i~~~~~~~   83 (118)
T d1unqa_           4 DVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTT   83 (118)
T ss_dssp             GGCEEEEEEEEEECSSSCCEEEEEEEEETTSEEEEESSCCCSHHHHTSCSEEEECTTCEEEEECSSSTTEEEEEEEETTE
T ss_pred             cCCEEEEEEEEEECCCCCCcEEEEEEEeccceeEEEeeccCccccccccccceEEeecccccccccCCceEEEEeccccc
Confidence            45699999999998876  99999999986655 6777777788899998643111  1222  234578998753    


Q ss_pred             CceEEEE-cCCccHHHHHHHHHHhc
Q 011287          464 KKVLSFE-DAKQRASQWKKAIEALQ  487 (489)
Q Consensus       464 ~r~y~~~-d~~~~~~~W~~~i~~~~  487 (489)
                      .++|+|. +.+.++++|+++|+.++
T Consensus        84 ~~~~~f~a~s~~e~~~Wi~ai~~~~  108 (118)
T d1unqa_          84 VIERTFHVETPEEREEWTTAIQTVA  108 (118)
T ss_dssp             EEEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             eeEEEEEeCCHHHHHHHHHHHHHHH
Confidence            4668887 55689999999999875

>d1omwa2 b.55.1.1 (A:550-668) G-protein coupled receptor kinase 2 (beta-adrenergic receptor kinase 1) {Cow (Bos taurus) [TaxId: 9913]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: G-protein coupled receptor kinase 2 (beta-adrenergic receptor kinase 1)
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.15  E-value=1.7e-11  Score=101.75  Aligned_cols=92  Identities=11%  Similarity=0.079  Sum_probs=66.6

Q ss_pred             CCceEEEEEeeehhhhhh---ccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEEcCCCcEEEEc-CCceEEE
Q 011287          394 PGESVLMISMVKKLQKLT---SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQVSSPSHFKIVT-PKKVLSF  469 (489)
Q Consensus       394 ~~~~i~~~g~~~k~~g~~---~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~~~~~~f~i~~-p~r~y~~  469 (489)
                      .|.-++++|+|.|++|.+   ||+|||||+++-..||.++  ...+|.|++.....+-.........|+|.+ ++|+|+|
T Consensus         6 ~~~~~i~eG~L~K~g~~~~~~WkkR~fvL~~~~L~yy~~~--~~~~~~i~l~~~~~v~~~~~~~~~~f~i~~~~~~~~~f   83 (119)
T d1omwa2           6 LGKDCIMHGYMSKMGNPFLTQWQRRYFYLFPNRLEWRGEG--EAPQSLLTMEEIQSVEETQIKERKCLLLKIRGGKQFVL   83 (119)
T ss_dssp             TTSCCCEEEEEEECC------CEEEEEEEETTEEEEECTT--SCCCEEEEGGGEEEEEEEESSSCEEEEEEETTSCEEEE
T ss_pred             cCCCeEEEEEEEEECCCCCCCeEEEEEEEEcCeEEEEecc--cccCccceeccccccccccccccceEEEEcCCCcEEEE
Confidence            466789999999998643   9999999998765566544  456789999865221122224456788876 5799999


Q ss_pred             Ec-CCccHHHHHHHHHHhc
Q 011287          470 ED-AKQRASQWKKAIEALQ  487 (489)
Q Consensus       470 ~d-~~~~~~~W~~~i~~~~  487 (489)
                      .. .+.++++|+++|.+++
T Consensus        84 ~a~s~~e~~~W~~al~~a~  102 (119)
T d1omwa2          84 QCDSDPELVQWKKELRDAY  102 (119)
T ss_dssp             ECSSHHHHHHHHHHHHHHH
T ss_pred             ECCCHHHHHHHHHHHHHHH
Confidence            94 5589999999998864

>d1u5fa1 b.55.1.1 (A:109-219) Src-associated adaptor protein Skap2 {Mouse (Mus musculus) [TaxId: 10090]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Src-associated adaptor protein Skap2
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.14  E-value=4.5e-11  Score=97.58  Aligned_cols=89  Identities=17%  Similarity=0.235  Sum_probs=72.0

Q ss_pred             eEEEEEeeehhhh---h---hccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEE-------cCCCcEEEEcC
Q 011287          397 SVLMISMVKKLQK---L---TSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV-------SSPSHFKIVTP  463 (489)
Q Consensus       397 ~i~~~g~~~k~~g---~---~~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~-------~~~~~f~i~~p  463 (489)
                      .|+++|||.|++.   +   .|++|||+|++.-..||.++.....+|.|++...   ..+..       .....|.|.++
T Consensus         8 ~v~k~G~L~k~~~~~~~~~~~W~~r~~vL~~~~L~~y~~~~~~~p~g~i~L~~~---~~~~~~~~~~~~~~~~~f~i~~~   84 (111)
T d1u5fa1           8 FVIKAGYLEKRRKDHSFLGFEWQKRWCALSKTVFYYYGSDKDKQQKGEFAIDGY---DVRMNNTLRKDGKKDCCFEICAP   84 (111)
T ss_dssp             SEEEEEEEEEECCCSSCSSCSEEEEEEEEETTEEEEESSTTCSSCSEEEECTTC---EEEECTTSCSSTTGGGEEEEECT
T ss_pred             CeeEEEEEEEECCCCCCCcCCceEEEEEEECCEEEeeccccccCcceEEEeccc---EEEeeccccccccccceEEEEcc
Confidence            4899999998753   2   2999999999998888989888888999999975   22222       23478999886


Q ss_pred             -CceEEEE-cCCccHHHHHHHHHHhcC
Q 011287          464 -KKVLSFE-DAKQRASQWKKAIEALQN  488 (489)
Q Consensus       464 -~r~y~~~-d~~~~~~~W~~~i~~~~~  488 (489)
                       +|+|+|. +.+.++++|+++|+.+++
T Consensus        85 ~~~~~~~~a~s~~e~~~W~~ai~~~i~  111 (111)
T d1u5fa1          85 DKRIYQFTAASPKDAEEWVQQLKFILQ  111 (111)
T ss_dssp             TSCEEEEECSSHHHHHHHHHHHHHHCC
T ss_pred             CCcEEEEEcCCHHHHHHHHHHHHHHhC
Confidence             6899998 566899999999999864

>d2i5fa1 b.55.1.1 (A:244-347) Pleckstrin {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Pleckstrin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.12  E-value=1.2e-10  Score=93.46  Aligned_cols=88  Identities=19%  Similarity=0.257  Sum_probs=66.3

Q ss_pred             EEEEEeeehhhhhh--ccceeEEEecCCeE-EEEC-CCCCeeeeeeeccCCCCceEEEE---------cCCCcEEEEcC-
Q 011287          398 VLMISMVKKLQKLT--SKKVQLILTNKPKL-IYVD-PSKLVVKGNIIWSDNSNDLSIQV---------SSPSHFKIVTP-  463 (489)
Q Consensus       398 i~~~g~~~k~~g~~--~k~r~~~lt~~p~l-~y~d-~~~~~~kg~i~~~~~~~~~~~~~---------~~~~~f~i~~p-  463 (489)
                      |+|+|+|.|+++..  ||+|||+|.+...+ ||.+ +.....+|.|++...   ..++.         .....|.|.++ 
T Consensus         2 v~k~G~L~k~~~~~k~WkkR~fvL~~~~~~l~~~~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~   78 (104)
T d2i5fa1           2 IIKQGCLLKQGHRRKNWKVRKFILREDPAYLHYYDPAGAEDPLGAIHLRGC---VVTSVESNSNGRKSEEENLFEIITAD   78 (104)
T ss_dssp             EEEEEEEEEECTTTCCEEEEEEEEETTTTEEEEECTTSCSSCSEEEECTTC---EEEEECC--------CCSEEEEECTT
T ss_pred             EEEEEEEEEECCCCCCcEEEEEEEECCeeEEEEEcCccccCccceEeecce---EEEEeccCcccccccCccEEEEECCC
Confidence            79999999998765  99999999986544 4444 456778899999875   22221         23458888876 


Q ss_pred             CceEEEE-cCCccHHHHHHHHHHhcC
Q 011287          464 KKVLSFE-DAKQRASQWKKAIEALQN  488 (489)
Q Consensus       464 ~r~y~~~-d~~~~~~~W~~~i~~~~~  488 (489)
                      .|+|+|. +.+.++++|+++|+.+++
T Consensus        79 ~~~~~~~a~s~~e~~~W~~ai~~a~r  104 (104)
T d2i5fa1          79 EVHYFLQAATPKERTEWIKAIQMASR  104 (104)
T ss_dssp             CCEEEEECSSHHHHHHHHHHHHHHHC
T ss_pred             CeEEEEEcCCHHHHHHHHHHHHHHhC
Confidence            5889988 556899999999998753

>d2coca1 b.55.1.1 (A:8-106) FYVE, RhoGEF and PH domain containing protein 3, FGD3 {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: FYVE, RhoGEF and PH domain containing protein 3, FGD3
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.10  E-value=2.8e-11  Score=96.58  Aligned_cols=87  Identities=11%  Similarity=0.050  Sum_probs=64.7

Q ss_pred             EEEeeehhhhh-hccceeEEEecC-C-eEE-EECCCCCeeeeeeeccCCCCceEEEE----cCCCcEEEEcCCceEEEE-
Q 011287          400 MISMVKKLQKL-TSKKVQLILTNK-P-KLI-YVDPSKLVVKGNIIWSDNSNDLSIQV----SSPSHFKIVTPKKVLSFE-  470 (489)
Q Consensus       400 ~~g~~~k~~g~-~~k~r~~~lt~~-p-~l~-y~d~~~~~~kg~i~~~~~~~~~~~~~----~~~~~f~i~~p~r~y~~~-  470 (489)
                      ..|+|.|+.+. .||||||||+++ + .|| |.++.....+|.|++....+ ..+..    +....|.|.+++|+|+|. 
T Consensus         3 ~~G~L~~~~~~k~W~krwfvL~~~~~~~ly~~~~~~~~~~~~~i~l~~~~~-~~~~~~~~~~~~~~F~i~~~~r~~~l~A   81 (99)
T d2coca1           3 LCGPLRLSESGETWSEVWAAIPMSDPQVLHLQGGSQDGRLPRTIPLPSCKL-SVPDPEERLDSGHVWKLQWAKQSWYLSA   81 (99)
T ss_dssp             SEEEEEEESSSSCEEEEEEECCTTCTTCEEEECCTTCSSSCSEECGGGCEE-ECCCSSSCCSSSEEEEEEETTEEEEEEE
T ss_pred             eEEEEEccCCCCCccEEEEEEecCCccEEEEECcCccccccccccccceee-eecccccccCCceEEEEEcCCcEEEEEC
Confidence            46999877654 599999999985 3 354 45567788899999997511 11111    223479999999999999 


Q ss_pred             cCCccHHHHHHHHHHhc
Q 011287          471 DAKQRASQWKKAIEALQ  487 (489)
Q Consensus       471 d~~~~~~~W~~~i~~~~  487 (489)
                      +.+.++++|+++|+.+.
T Consensus        82 ~s~~e~~~Wi~aL~~Aa   98 (99)
T d2coca1          82 SSAELQQQWLETLSTAA   98 (99)
T ss_dssp             SSHHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHHHhc
Confidence            55689999999999863

>d1fgya_ b.55.1.1 (A:) Grp1 {Mouse (Mus musculus) [TaxId: 10090]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Grp1
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.09  E-value=4.9e-11  Score=99.60  Aligned_cols=88  Identities=17%  Similarity=0.109  Sum_probs=67.9

Q ss_pred             EEEEeeehhhhhh--ccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEE-cCC--------------------
Q 011287          399 LMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV-SSP--------------------  455 (489)
Q Consensus       399 ~~~g~~~k~~g~~--~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~-~~~--------------------  455 (489)
                      .|+|||.|+++..  ||+|||||++.-..||.++.....+|.|++....+ ..+.. ...                    
T Consensus         6 ~keG~L~K~~~~~k~WkrR~fvL~~~~L~yy~~~~~~~~~g~i~L~~~~v-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (127)
T d1fgya_           6 DREGWLLKLGGRVKTWKRRWFILTDNCLYYFEYTTDKEPRGIIPLENLSI-REVLDPRKPNCFELYNPSHKGQVIKACKT   84 (127)
T ss_dssp             SEEEEEEEECSSSCCEEEEEEEEETTEEEEESSTTCSSCSEEEECTTCEE-EEECCSSCSSEEEEECSSSTTCCCCCEEE
T ss_pred             ceEEEEEEECCCCCCcEEEEEEEECCEEEEEccCCCccccceEeCCCeEE-EEccCCCCCceEEEecccccccccccccc
Confidence            5899999998766  99999999988777888988889999999987511 11110 111                    


Q ss_pred             --CcEEEEcCCceEEEEcC-CccHHHHHHHHHHhc
Q 011287          456 --SHFKIVTPKKVLSFEDA-KQRASQWKKAIEALQ  487 (489)
Q Consensus       456 --~~f~i~~p~r~y~~~d~-~~~~~~W~~~i~~~~  487 (489)
                        ..|.+.++.|+|+|... +.++++|+.+|++++
T Consensus        85 ~~~~~~~~~~~~~~~f~a~s~~e~~~Wi~aL~~~i  119 (127)
T d1fgya_          85 EADGRVVEGNHVVYRISAPSPEEKEEWMKSIKASI  119 (127)
T ss_dssp             CTTSCEEECCCSEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             ccceeEeeCCCeEEEEECCCHHHHHHHHHHHHHHH
Confidence              23455678899999954 589999999999986

>d1wgqa_ b.55.1.1 (A:) FYVE, RhoGEF and PH domain containing protein 6, Fgd6 (KIAA1362) {Mouse (Mus musculus) [TaxId: 10090]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: FYVE, RhoGEF and PH domain containing protein 6, Fgd6 (KIAA1362)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.07  E-value=7.7e-11  Score=95.90  Aligned_cols=92  Identities=12%  Similarity=0.162  Sum_probs=72.0

Q ss_pred             CceEEEEEeeehhhhhh--ccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEE--cCCCcEEEEcC-CceEEE
Q 011287          395 GESVLMISMVKKLQKLT--SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV--SSPSHFKIVTP-KKVLSF  469 (489)
Q Consensus       395 ~~~i~~~g~~~k~~g~~--~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~--~~~~~f~i~~p-~r~y~~  469 (489)
                      .+..+++|||.|+++..  |++|||+|++.-.+||.++.....++.|++..... ..+..  +.++.|.|.++ +++|+|
T Consensus         5 ~~~~~~~G~L~k~~~~~~~W~kr~~vL~~~~L~~~k~~~~~~~~~~i~l~~~~~-~~~~~~~~~~~~F~i~~~~~~~~~f   83 (109)
T d1wgqa_           5 SSGSTMSGYLYRSKGSKKPWKHLWFVIKNKVLYTYAASEDVAALESQPLLGFTV-TLVKDENSESKVFQLLHKGMVFYVF   83 (109)
T ss_dssp             CCSCSCEEEEEEESSTTSCCEEEEEEEETTEEEEESCTTCSSCSEEEECSSEEE-EECCCSSCSSSEEEEEETTEEEEEE
T ss_pred             CCCCcEEEEEEEECCCCCCceEEEEEEeCCEEEEeccccccccccccccceeee-eecccccccceeeeeecccceEEEE
Confidence            34468999999887754  99999999998888888988888999999987511 11111  23578999876 578888


Q ss_pred             E-cCCccHHHHHHHHHHhc
Q 011287          470 E-DAKQRASQWKKAIEALQ  487 (489)
Q Consensus       470 ~-d~~~~~~~W~~~i~~~~  487 (489)
                      . +.+.++++|+++|+.+.
T Consensus        84 ~a~s~~~~~~Wi~ai~~a~  102 (109)
T d1wgqa_          84 KADDAHSTQRWIDAFQEGT  102 (109)
T ss_dssp             ECSSHHHHHHHHHHHHHHH
T ss_pred             ECCCHHHHHHHHHHHHHHh
Confidence            7 56689999999999976

>d1upqa_ b.55.1.1 (A:) Phosphoinositol 3-phosphate binding protein-1, PEPP1 {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Phosphoinositol 3-phosphate binding protein-1, PEPP1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.07  E-value=1.8e-10  Score=92.94  Aligned_cols=91  Identities=15%  Similarity=0.240  Sum_probs=70.4

Q ss_pred             CCceEEEEEeeehhhhh--h-ccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEE-----cCCCcEEEEcC-C
Q 011287          394 PGESVLMISMVKKLQKL--T-SKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV-----SSPSHFKIVTP-K  464 (489)
Q Consensus       394 ~~~~i~~~g~~~k~~g~--~-~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~-----~~~~~f~i~~p-~  464 (489)
                      ++-.++++|||.|+++.  . |++|||+|.+...+||.++.....++.|++....  +....     +....|.|.++ +
T Consensus         5 p~~~~~~~G~L~k~~~~~~k~W~kr~~vL~~~~L~~y~~~~~~~~~~~i~l~~~~--v~~~~~~~~~~~~~~~~i~~~~~   82 (107)
T d1upqa_           5 PNLPVHIRGWLHKQDSSGLRLWKRRWFVLSGHCLFYYKDSREESVLGSVLLPSYN--IRPDGPGAPRGRRFTFTAEHPGM   82 (107)
T ss_dssp             TTSCEEEEEEEEEECSSSSCCEEEEEEEEETTEEEEESSTTCCSCCEEEEGGGCE--EEECCSSCTTSSSSEEEEECTTS
T ss_pred             cCCceeEEEEEEEeCCCCCCCeeEEEEEEECCEEEEecCcccccccceecccceE--EEEeccCcccCcceEEEEEcCCC
Confidence            34458999999987642  2 9999999999888889999888899999998751  21111     22347788776 6


Q ss_pred             ceEEEE-cCCccHHHHHHHHHHh
Q 011287          465 KVLSFE-DAKQRASQWKKAIEAL  486 (489)
Q Consensus       465 r~y~~~-d~~~~~~~W~~~i~~~  486 (489)
                      |+|+|. +.+.++++|+++|+.+
T Consensus        83 ~~~~~~a~s~~e~~~Wi~al~~A  105 (107)
T d1upqa_          83 RTYVLAADTLEDLRGWLRALGRA  105 (107)
T ss_dssp             CCEEEECSSHHHHHHHHHHHHHH
T ss_pred             eEEEEEcCCHHHHHHHHHHHHHH
Confidence            899999 4558999999999986

>d1u5ea1 b.55.1.1 (A:14-222) Src-associated adaptor protein Skap2 {Mouse (Mus musculus) [TaxId: 10090]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Src-associated adaptor protein Skap2
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.06  E-value=1.1e-10  Score=106.44  Aligned_cols=89  Identities=17%  Similarity=0.231  Sum_probs=71.7

Q ss_pred             ceEEEEEeeehhhh---h---hccceeEEEecCCeEEEECCCCCeeeeeeeccCCCCceEEEE-------cCCCcEEEEc
Q 011287          396 ESVLMISMVKKLQK---L---TSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDNSNDLSIQV-------SSPSHFKIVT  462 (489)
Q Consensus       396 ~~i~~~g~~~k~~g---~---~~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~~~~~~~~~-------~~~~~f~i~~  462 (489)
                      ..++++|+|.|+++   .   .|++|||+|+++-.+||.+......+|.|+|..+   ..+..       +....|.|.|
T Consensus       102 ~~~~k~G~L~K~~~~~~~~~~~Wkkr~fvL~~~~L~yy~~~~~~~~~~~i~L~~~---~~~~~~~~~~~~~~~~~F~i~~  178 (209)
T d1u5ea1         102 PFVIKAGYLEKRRKDHSFLGFEWQKRWCALSKTVFYYYGSDKDKQQKGEFAIDGY---DVRMNNTLRKDGKKDCCFEICA  178 (209)
T ss_dssp             SSEEEEEEEEEEEHHHHTTTCCCEEEEEEEETTEEEEESSTTCSSCSEEEECTTC---EEEECGGGCSSTTGGGEEEEEC
T ss_pred             CCeeEEEEEEEecCCCCCccccceEEEEEEECCEEEEEecCCCCccceEEEecce---eeeeccccccccCCCcEEEEEc
Confidence            35899999998764   1   3999999999988888999888899999999975   22211       1235899999


Q ss_pred             C-CceEEEEc-CCccHHHHHHHHHHhc
Q 011287          463 P-KKVLSFED-AKQRASQWKKAIEALQ  487 (489)
Q Consensus       463 p-~r~y~~~d-~~~~~~~W~~~i~~~~  487 (489)
                      | +|+|+|.. .+.++++|+++|+.++
T Consensus       179 ~~~r~~~f~a~s~~e~~~Wi~al~~~i  205 (209)
T d1u5ea1         179 PDKRIYQFTAASPKDAEEWVQQLKFIL  205 (209)
T ss_dssp             SSSCEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             CCCCEEEEEcCCHHHHHHHHHHHHHHH
Confidence            8 59999995 5589999999999886

>d1wi1a_ b.55.1.1 (A:) Calcium-dependent activator protein for secretion, CAPS {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Calcium-dependent activator protein for secretion, CAPS
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.06  E-value=1.2e-10  Score=97.32  Aligned_cols=89  Identities=13%  Similarity=0.079  Sum_probs=64.2

Q ss_pred             eEEEEEeeehhhh-hh--ccceeEEEecC-CeEEEECCC---CCeeeeeeeccCCCCceEEEE-------cCCCcEEEEc
Q 011287          397 SVLMISMVKKLQK-LT--SKKVQLILTNK-PKLIYVDPS---KLVVKGNIIWSDNSNDLSIQV-------SSPSHFKIVT  462 (489)
Q Consensus       397 ~i~~~g~~~k~~g-~~--~k~r~~~lt~~-p~l~y~d~~---~~~~kg~i~~~~~~~~~~~~~-------~~~~~f~i~~  462 (489)
                      .+.++|||.|+++ .+  ||||||||.+. ..+||.+..   ....+|.|++...   ..+..       +....|.|.+
T Consensus         7 ~~~~~G~L~K~g~~~~k~WkkRwfvL~~~~~~~yy~~~~~~~~~~~~~~i~l~~~---~~~~~~~~~~~~~~~~~~~i~~   83 (126)
T d1wi1a_           7 GMKHSGYLWAIGKNVWKRWKKRFFVLVQVSQYTFAMCSYREKKAEPQELLQLDGY---TVDYTDPQPGLEGGRAFFNAVK   83 (126)
T ss_dssp             CEEEEEEEEEECSSSCCSCEEEEEEEEEEETTEEEEEECCSSSSCCSEEEECSSC---EEEECCCCSSCCSCSSEEEEEC
T ss_pred             CCcEEEEEEEECCCCCCCceEEEEEEeCCceEEEEEcccccccccceeeeeecee---eeeeccccccccccceeEEecc
Confidence            4789999999875 43  99999999974 555654332   3345788999875   22111       1123466788


Q ss_pred             CCceEEEE-cCCccHHHHHHHHHHhcC
Q 011287          463 PKKVLSFE-DAKQRASQWKKAIEALQN  488 (489)
Q Consensus       463 p~r~y~~~-d~~~~~~~W~~~i~~~~~  488 (489)
                      ++|+|+|. +.+.++++|+++|..++.
T Consensus        84 ~~r~~~f~A~s~~e~~~Wv~al~~a~~  110 (126)
T d1wi1a_          84 EGDTVIFASDDEQDRILWVQAMYRATG  110 (126)
T ss_dssp             SSCEEEEECSSHHHHHHHHHHHHHHHT
T ss_pred             CCeEEEEEECCHHHHHHHHHHHHHHHH
Confidence            99999999 556899999999998763

>d1x1ga1 b.55.1.1 (A:8-123) Pleckstrin-2 {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Pleckstrin-2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.01  E-value=1.8e-10  Score=94.41  Aligned_cols=90  Identities=20%  Similarity=0.300  Sum_probs=65.6

Q ss_pred             ceEEEEEeeehhhhhh--ccceeEEEecCCe-EEEECC--CCCeeeeeeeccCCCCceEEEE----------cCCCcEEE
Q 011287          396 ESVLMISMVKKLQKLT--SKKVQLILTNKPK-LIYVDP--SKLVVKGNIIWSDNSNDLSIQV----------SSPSHFKI  460 (489)
Q Consensus       396 ~~i~~~g~~~k~~g~~--~k~r~~~lt~~p~-l~y~d~--~~~~~kg~i~~~~~~~~~~~~~----------~~~~~f~i  460 (489)
                      ..|+++|+|.|+++..  ||+|||+|++... ++|.+.  .....+|.|++..+.. ..+..          .....|.|
T Consensus         9 ~~v~k~G~L~K~~~~~k~WkkR~fvL~~~~~~~~~~~~~~~~~~p~~~i~L~~~~i-~~~~~~~~~~~~~~~~~~~~f~i   87 (116)
T d1x1ga1           9 GTVVKQGYLAKQGHKRKNWKVRRFVLRKDPAFLHYYDPSKEENRPVGGFSLRGSLV-SALEDNGVPTGVKGNVQGNLFKV   87 (116)
T ss_dssp             SEEEEEEEEEEECSSSSSEEEEEEEEEESSCEEEEECSSSCCSSCSCCEESTTCCC-EECCSSSSCSSCSSCCCSSCEEE
T ss_pred             CCEEEEEEEEEEcCCCCCCceEEEEEECCCcEEEEeccccccccceeEEEcCCCEE-EEecccCcccccccccccceeEE
Confidence            3589999999987755  9999999998544 555543  3457789999987521 12221          11246889


Q ss_pred             EcCC-ceEEEE-cCCccHHHHHHHHHHh
Q 011287          461 VTPK-KVLSFE-DAKQRASQWKKAIEAL  486 (489)
Q Consensus       461 ~~p~-r~y~~~-d~~~~~~~W~~~i~~~  486 (489)
                      .+++ |+|+|. +.+.++++|+++|++|
T Consensus        88 ~~~~~~~~~f~a~s~ee~~~Wi~ai~~~  115 (116)
T d1x1ga1          88 ITKDDTHYYIQASSKAERAEWIEAIKKL  115 (116)
T ss_dssp             CCTTCCCEEECCSSHHHHHHHHHHHHHH
T ss_pred             EeCCCeEEEEECCCHHHHHHHHHHHHhh
Confidence            8875 678888 5568999999999986

>d2j59m1 b.55.1.1 (M:931-1063) Rho GTPase-activating protein 21 {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Rho GTPase-activating protein 21
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.98  E-value=6.9e-10  Score=93.61  Aligned_cols=87  Identities=16%  Similarity=0.190  Sum_probs=59.1

Q ss_pred             EEEeee---------hhh-hhh--ccceeEEEecCCeEEEECCCCC----eeeeeeeccCCCCceEEEE---cCCCcEEE
Q 011287          400 MISMVK---------KLQ-KLT--SKKVQLILTNKPKLIYVDPSKL----VVKGNIIWSDNSNDLSIQV---SSPSHFKI  460 (489)
Q Consensus       400 ~~g~~~---------k~~-g~~--~k~r~~~lt~~p~l~y~d~~~~----~~kg~i~~~~~~~~~~~~~---~~~~~f~i  460 (489)
                      |+|||.         |+. +.+  |++|||+|+++-..||.++...    ...|.|+|..+  .+.+..   +.+..|.|
T Consensus         3 KeG~L~~k~~~~~~~kk~~~~~k~Wkkr~fvL~~~~L~~y~~~~~~~~~~~~~~~i~L~~~--~v~~~~~~~~r~~~F~i   80 (133)
T d2j59m1           3 KEGWLHFRPLVTDKGKRVGGSIRPWKQMYVVLRGHSLYLYKDKREQTTPSEEEQPISVNAC--LIDISYSETKRKNVFRL   80 (133)
T ss_dssp             EEEEEEEEECC------------CCEEEEEEEETTEEEEESCTTCC--------CEECSSC--EEEECSSSCSCSSEEEE
T ss_pred             ceEEEEeeccccccccccCCCCCCceEEEEEEeCCEEEEEeccccccccccccccceecce--EEEEcccccccCceeEE
Confidence            789996         233 333  9999999998777777765432    45677888875  222222   23457999


Q ss_pred             EcCCceEEEEc-CCccHHHHHHHHHHhcC
Q 011287          461 VTPKKVLSFED-AKQRASQWKKAIEALQN  488 (489)
Q Consensus       461 ~~p~r~y~~~d-~~~~~~~W~~~i~~~~~  488 (489)
                      .|++|+|+|.. .+.++++|+++|+.+.+
T Consensus        81 ~~~~~~~~f~A~s~~e~~~Wi~ai~~a~~  109 (133)
T d2j59m1          81 TTSDCECLFQAEDRDDMLAWIKTIQESSN  109 (133)
T ss_dssp             ECSSCEEEEECSSHHHHHHHHHHHHHHCC
T ss_pred             ecCCCEEEEEeCCHHHHHHHHHHHHHHHh
Confidence            99999999994 56899999999998753

>d2cofa1 b.55.1.1 (A:8-102) KIAA1914 {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: KIAA1914
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.93  E-value=2.2e-10  Score=90.83  Aligned_cols=86  Identities=12%  Similarity=0.098  Sum_probs=65.0

Q ss_pred             EEeeehhhhhhccceeEEEecCCeEEEECCC-CCeeeeeeeccCCCCceEEEEcCCCcEEEEc-CCceEEEE-cCCccHH
Q 011287          401 ISMVKKLQKLTSKKVQLILTNKPKLIYVDPS-KLVVKGNIIWSDNSNDLSIQVSSPSHFKIVT-PKKVLSFE-DAKQRAS  477 (489)
Q Consensus       401 ~g~~~k~~g~~~k~r~~~lt~~p~l~y~d~~-~~~~kg~i~~~~~~~~~~~~~~~~~~f~i~~-p~r~y~~~-d~~~~~~  477 (489)
                      +|++.|.+.--||+|||+|.++-.+||.++. ....+|.|++..+.++.....+.+..|.|.+ .+|+|+|. +.+.+++
T Consensus         4 s~yl~~~~~~~WkkR~fvL~~~~L~yyk~~~~~~~~~~~i~l~~~~v~~~~~~~~~~~f~~~~~~~~~~~l~A~s~~e~~   83 (95)
T d2cofa1           4 SSYLNVLVNSQWKSRWCSVRDNHLHFYQDRNRSKVAQQPLSLVGCEVVPDPSPDHLYSFRILHKGEELAKLEAKSSEEMG   83 (95)
T ss_dssp             CCEEEEEETTEEEEEEEEECSSCEEEECSSTTCSEEEEEECTTTCEEECCCBTTBSCEEEEEETTEEEEEEECSSHHHHH
T ss_pred             ccchhhhcCCCceEEEEEEECCEEEEEecccccccccccccccceEEEecccccceecceeccccceeEEeeCCCHHHHH
Confidence            5788888777799999999988888888875 4467899999875221112224456788765 57999999 5568999


Q ss_pred             HHHHHHHHh
Q 011287          478 QWKKAIEAL  486 (489)
Q Consensus       478 ~W~~~i~~~  486 (489)
                      +|+++|..+
T Consensus        84 ~Wi~~L~~~   92 (95)
T d2cofa1          84 HWLGLLLSE   92 (95)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHHH
Confidence            999999875

>d1v5pa_ b.55.1.1 (A:) Tapp2 {Mouse (Mus musculus) [TaxId: 10090]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Tapp2
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=98.91  E-value=3e-10  Score=94.85  Aligned_cols=87  Identities=13%  Similarity=0.179  Sum_probs=60.5

Q ss_pred             EEEEeeehhh-hh--hccceeEEEec-CCeE-EEECCCCCeeeeeeec-----cCCCCceEEEE-------cCCCcEEEE
Q 011287          399 LMISMVKKLQ-KL--TSKKVQLILTN-KPKL-IYVDPSKLVVKGNIIW-----SDNSNDLSIQV-------SSPSHFKIV  461 (489)
Q Consensus       399 ~~~g~~~k~~-g~--~~k~r~~~lt~-~p~l-~y~d~~~~~~kg~i~~-----~~~~~~~~~~~-------~~~~~f~i~  461 (489)
                      .++|+|.|++ +-  .|+||||||.. .+.| ||.+......+|.||+     ...   ..+..       +....|.|.
T Consensus        16 ~~~GyL~k~~~~~~k~WkrRwFvL~~~~~~L~yy~~~~~~~~~g~~~l~~i~~~~~---~~~~~~~~~~~~~~~~~~~~~   92 (126)
T d1v5pa_          16 RICGFLDIEDNENSGKFLRRYFILDTQANCLLWYMDNPQNLAVGAGAVGSLQLTYI---SKVSIATPKQKPKTPFCFVIN   92 (126)
T ss_dssp             CEECCEEEECTTCSSCEEEEEEEEETTTTEEEEESSCTTTSCTTCCCSEEEETTTC---CEEEECCTTTSCSCSSEEEEE
T ss_pred             ceeeeEEEECCCCCCCeeEEEEEEEcCCCeEEEeeccccccccceeecccceeeee---eccccccccccccccceEEEc
Confidence            4589998875 32  39999999974 5666 4455544455555554     443   22322       112578888


Q ss_pred             cCCceEEEE-cCCccHHHHHHHHHHhcC
Q 011287          462 TPKKVLSFE-DAKQRASQWKKAIEALQN  488 (489)
Q Consensus       462 ~p~r~y~~~-d~~~~~~~W~~~i~~~~~  488 (489)
                      |++|+|+|. +.+.++++|+++|+++.+
T Consensus        93 ~~~r~~~l~Aes~~e~~~Wi~aL~~A~~  120 (126)
T d1v5pa_          93 ALSQRYFLQANDQKDLKDWVEALNQASK  120 (126)
T ss_dssp             CSSCEEEEECSSHHHHHHHHHHHHHTTT
T ss_pred             CCCeeEEEECCCHHHHHHHHHHHHHHhc
Confidence            999999999 556899999999999764

>d1v5ma_ b.55.1.1 (A:) SH2 and PH domain-containing adapter protein APS {Mouse (Mus musculus) [TaxId: 10090]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: SH2 and PH domain-containing adapter protein APS
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=98.89  E-value=3.8e-10  Score=95.77  Aligned_cols=90  Identities=14%  Similarity=0.142  Sum_probs=66.6

Q ss_pred             EEEEEeeehh--------h-h-hhccceeEEEecCC-----eE-EEECCCCCeeeeeeeccCCCCceEEEE----cCCCc
Q 011287          398 VLMISMVKKL--------Q-K-LTSKKVQLILTNKP-----KL-IYVDPSKLVVKGNIIWSDNSNDLSIQV----SSPSH  457 (489)
Q Consensus       398 i~~~g~~~k~--------~-g-~~~k~r~~~lt~~p-----~l-~y~d~~~~~~kg~i~~~~~~~~~~~~~----~~~~~  457 (489)
                      |.|+|+|.++        + | -.||+|||||.+..     +| ||.++.....+|.|++........+..    +.++.
T Consensus        18 v~keG~L~~~~~~~~~~~~~~~~~WkkrwfvL~~~~~~~~~~L~yy~~~~~~k~~g~i~l~~~~~~~~~~~~~~~~~~~~   97 (136)
T d1v5ma_          18 IQREGALRFMVADDAASGPGGTAQWQKCRLLLRRAVAGERFRLEFFVPPKASRPKVSIPLSAIIEVRTTMPLEMPEKDNT   97 (136)
T ss_dssp             CCEEEEEEEEECSCCCSSSCCSCCCEEEEEEEEECSSSCCEEEEEESSTTSSSCSSCEETTTCCBCCCCCCSSSCCCTTE
T ss_pred             eeEEEEEEeeccccccCCCCCCCCceEEEEEEeCCcccchhhhhhhCcccccCcCcceecccceeeeeeccccCCCCCcE
Confidence            6789999642        1 2 23999999999853     45 677788889999999986422111211    34578


Q ss_pred             EEEEcCCc-eEEEE-cCCccHHHHHHHHHHhc
Q 011287          458 FKIVTPKK-VLSFE-DAKQRASQWKKAIEALQ  487 (489)
Q Consensus       458 f~i~~p~r-~y~~~-d~~~~~~~W~~~i~~~~  487 (489)
                      |.|.|+++ +|+|. |.+.++++|+++|++++
T Consensus        98 F~l~t~~~~~y~f~A~s~~e~~~Wv~ai~~ai  129 (136)
T d1v5ma_          98 FVLKVENGAEYILETIDSLQKHSWVADIQGCV  129 (136)
T ss_dssp             ECCBCTTSCBEEEECSSHHHHHHHHHHHHHHH
T ss_pred             EEEEcCCCcEEEEECCCHHHHHHHHHHHHHHH
Confidence            99999875 68886 66799999999999987

>d1droa_ b.55.1.1 (A:) beta-spectrin {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: beta-spectrin
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=98.67  E-value=3.9e-09  Score=87.28  Aligned_cols=90  Identities=11%  Similarity=0.184  Sum_probs=63.0

Q ss_pred             EEEEeeehhhh----------hhccceeEEEecCCeEEEECCCCCeeeeeeeccCC------CCceEEEE---cCCCcEE
Q 011287          399 LMISMVKKLQK----------LTSKKVQLILTNKPKLIYVDPSKLVVKGNIIWSDN------SNDLSIQV---SSPSHFK  459 (489)
Q Consensus       399 ~~~g~~~k~~g----------~~~k~r~~~lt~~p~l~y~d~~~~~~kg~i~~~~~------~~~~~~~~---~~~~~f~  459 (489)
                      .++|+|.|++.          -.|+||||||.+.-.+||.++.....++.|.+...      ...+....   +....|.
T Consensus         9 ~~eG~L~rk~~~~~~~kk~~~~~W~kr~~vL~~~~L~yy~~~~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~   88 (122)
T d1droa_           9 GHEGYVTRKHEWDSTTKKASNRSWDKVYMAAKAGRISFYKDQKGYKSNPELTFRGEPSYDLQNAAIEIASDYTKKKHVLR   88 (122)
T ss_dssp             SEEEEEEEECSCCCCCCTTCCCCCEEEEEEESSSCCBEESSSSHHHHCTTCCSSCCCBCCCSSCCCEECCSSSSSTTEEE
T ss_pred             ceEEEEEEeecccccCcccCCCCceEEEEEEeCCEEEEEcCcccccccCcccccccceEeccceEEEeccccccccceEE
Confidence            57888876542          23999999999988889988865444454443321      11122211   3456899


Q ss_pred             EEcCC-ceEEEE-cCCccHHHHHHHHHHhcC
Q 011287          460 IVTPK-KVLSFE-DAKQRASQWKKAIEALQN  488 (489)
Q Consensus       460 i~~p~-r~y~~~-d~~~~~~~W~~~i~~~~~  488 (489)
                      |.+++ ++|+|. +.+.++++|+++|+.+.+
T Consensus        89 l~~~~~~~~~f~a~s~~d~~~Wv~al~~~~~  119 (122)
T d1droa_          89 VKLANGALFLLQAHDDTEMSQWVTSLKAQSD  119 (122)
T ss_dssp             EECSSSCEEEEECSSSHHHHHHHHHHHHHHT
T ss_pred             EECCCCcEEEEECCCHHHHHHHHHHHHHHHh
Confidence            99875 889888 667899999999999864

>d1btna_ b.55.1.1 (A:) beta-spectrin {Mouse (Mus musculus), brain [TaxId: 10090]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: beta-spectrin
species: Mouse (Mus musculus), brain [TaxId: 10090]

Probab=98.54  E-value=4.2e-08  Score=78.56  Aligned_cols=75  Identities=13%  Similarity=0.208  Sum_probs=53.6

Q ss_pred             hhccceeEEEecCCeEEEECCC------CCeeeeeeeccCCCCceEEEE---cCCCcEEEEcC-CceEEEE-cCCccHHH
Q 011287          410 LTSKKVQLILTNKPKLIYVDPS------KLVVKGNIIWSDNSNDLSIQV---SSPSHFKIVTP-KKVLSFE-DAKQRASQ  478 (489)
Q Consensus       410 ~~~k~r~~~lt~~p~l~y~d~~------~~~~kg~i~~~~~~~~~~~~~---~~~~~f~i~~p-~r~y~~~-d~~~~~~~  478 (489)
                      ..|++|||+|+++...||.++.      .....|.|++..+  .+....   +.++.|.|.++ +++|+|. +.+.++++
T Consensus        21 ~~Wk~r~~vL~~~~L~~yk~~~~~~~~~~~~~~~~i~l~~~--~~~~~~~~~~~~~~f~i~~~~~~~~~~~a~s~~e~~~   98 (106)
T d1btna_          21 RSWHNVYCVINNQEMGFYKDAKSAASGIPYHSEVPVSLKEA--ICEVALDYKKKKHVFKLRLSDGNEYLFQAKDDEEMNT   98 (106)
T ss_dssp             CCCEEEEEEEETTEEEEESSHHHHHHTCCSSSCCCEECTTC--EEEECSSCCSSSSEEEEECTTSCEEEEECSSHHHHHH
T ss_pred             CCCcEEEEEEECCEEEEEeChhhcccccccCcceeEEeccc--eeeeccccccCcceEeecccCCCEEEEECCCHHHHHH
Confidence            3499999999987776777753      2345566777754  122221   33478999987 5899988 55689999


Q ss_pred             HHHHHHHh
Q 011287          479 WKKAIEAL  486 (489)
Q Consensus       479 W~~~i~~~  486 (489)
                      |+++|+.+
T Consensus        99 W~~ai~~A  106 (106)
T d1btna_          99 WIQAISSA  106 (106)
T ss_dssp             HHHHHHHC
T ss_pred             HHHHHHhC
Confidence            99999863

>d1wjma_ b.55.1.1 (A:) beta-spectrin {Human (Homo sapiens), brain 2 isoform [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: beta-spectrin
species: Human (Homo sapiens), brain 2 isoform [TaxId: 9606]

Probab=98.48  E-value=1.3e-08  Score=83.92  Aligned_cols=87  Identities=17%  Similarity=0.166  Sum_probs=55.6

Q ss_pred             EEEEeeehhhh----------hhccceeEEEecCCeEEEECCCCCeeeeee------eccCCCCceEEEE---cCCCcEE
Q 011287          399 LMISMVKKLQK----------LTSKKVQLILTNKPKLIYVDPSKLVVKGNI------IWSDNSNDLSIQV---SSPSHFK  459 (489)
Q Consensus       399 ~~~g~~~k~~g----------~~~k~r~~~lt~~p~l~y~d~~~~~~kg~i------~~~~~~~~~~~~~---~~~~~f~  459 (489)
                      .++|+|.++.+          ..||+|||+|.+.-..||.++......+.+      .+..+  ......   +.+..|.
T Consensus         9 ~~eG~L~rk~~~~~~~kr~~~k~Wkkrw~vL~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~f~   86 (123)
T d1wjma_           9 QMEGMLCRKQEMEAFGKKAANRSWQNVYCVLRRGSLGFYKDAKAASAGVPYHGEVPVSLARA--QGSVAFDYRKRKHVFK   86 (123)
T ss_dssp             CEEEEEEEEEEEEETTEECSCCCCEEEEEEEETTEEEEESSHHHHTTTCBSSSCCCEECTTC--EEEECTTCSSCSSEEE
T ss_pred             eeEEEEEEEeeccccCcccCCCCCcEEEEEEECCEEEEEecchhccccccccccccccccce--eEEecccccccCcEEE
Confidence            45777765432          239999999998876677655332222333      23322  111111   2335688


Q ss_pred             EEcC-CceEEEEc-CCccHHHHHHHHHHhc
Q 011287          460 IVTP-KKVLSFED-AKQRASQWKKAIEALQ  487 (489)
Q Consensus       460 i~~p-~r~y~~~d-~~~~~~~W~~~i~~~~  487 (489)
                      |.++ +++|+|.. .+.++++|+++|+.++
T Consensus        87 i~~~~~~~~~l~a~s~~e~~~Wi~aI~~a~  116 (123)
T d1wjma_          87 LGLQDGKEYLFQAKDEAEMSSWLRVVNAAI  116 (123)
T ss_dssp             EECSSSCEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             EEcCCCcEEEEECCCHHHHHHHHHHHHHHH
Confidence            8875 68999994 5689999999999876

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.45  E-value=2.5e-07  Score=86.08  Aligned_cols=140  Identities=16%  Similarity=0.142  Sum_probs=92.6

Q ss_pred             CCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCEEEE
Q 011287           44 IQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTFQDTFSLYM  122 (489)
Q Consensus        44 ~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~lyl  122 (489)
                      ++.|+..+..+-++.+.||++.  ..+..+.+|+.......   ....+.+|..+++.+. +--+.+++.+..+.+..|+
T Consensus        13 ~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~---~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l   87 (263)
T d1j7la_          13 IEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             hhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc---chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence            3567777776556668999886  35677888987544211   1223566888777663 3335677888888899999


Q ss_pred             EEeccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 011287          123 ALESCEGGELFDQITSKGHLSEDEARFYTAEVVDALEYIHSM--------------------------------------  164 (489)
Q Consensus       123 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~aL~~LH~~--------------------------------------  164 (489)
                      ||++++|..+.+....     ......++.++...+..||+.                                      
T Consensus        88 v~~~l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T d1j7la_          88 LMSEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             EEECCSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTC
T ss_pred             EEEecccccccccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccc
Confidence            9999999877553321     111122233333334444421                                      


Q ss_pred             ---------------------CcEeeccCCCCeeeCCCCCEEEeeccCcc
Q 011287          165 ---------------------GLIHRDIKPENLLLTADGHIKIADFGSVK  193 (489)
Q Consensus       165 ---------------------gIiHrDLKpeNILl~~~g~ikL~DFG~a~  193 (489)
                                           .++|+|+.|.|||+++++.+-|+||+.+.
T Consensus       163 ~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                 25899999999999877666799999876

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.97  E-value=7.2e-06  Score=81.19  Aligned_cols=82  Identities=17%  Similarity=0.160  Sum_probs=48.8

Q ss_pred             EeeEEeeeCceEEEEEEEcCCCcEEEEEEeeccc-ccc---hhHHHHHHHHHHHHHhCC-C-C-CccEEEEEEEcCCEEE
Q 011287           49 LGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKF-ITK---ENKTAYVKLERIVLDQLD-H-P-GVVRLFFTFQDTFSLY  121 (489)
Q Consensus        49 ~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~-~~~---~~~~~~~~~E~~il~~l~-h-p-nIv~l~~~~~~~~~ly  121 (489)
                      -.+.||.|....||++.+..+++.|++|.-.... ...   .........|..+|+.+. + | .+.+++.+  +....+
T Consensus        30 ~~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~  107 (392)
T d2pula1          30 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  107 (392)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             eEEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCE
Confidence            3557899999999999988888999999643211 101   111233456777777652 2 3 34555544  444557


Q ss_pred             EEEeccCCCCh
Q 011287          122 MALESCEGGEL  132 (489)
Q Consensus       122 lV~E~~~gg~L  132 (489)
                      +|||++.+..+
T Consensus       108 lvmE~L~~~~~  118 (392)
T d2pula1         108 TVMEDLSHLKI  118 (392)
T ss_dssp             EEECCCTTSEE
T ss_pred             EEEeccCCccc
Confidence            89999987554

>d1v61a_ b.55.1.1 (A:) Rac/CDC42 GEF 6, alpha-pix {Mouse (Mus musculus) [TaxId: 10090]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Rac/CDC42 GEF 6, alpha-pix
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=97.93  E-value=6.8e-06  Score=68.39  Aligned_cols=92  Identities=15%  Similarity=0.237  Sum_probs=67.7

Q ss_pred             CCceEEEEEeeehhhhh--hccceeEEEecCCeEEEECC---CCCeeeeeeeccCCCCceEEEE--cCCCcEEEEcC-Cc
Q 011287          394 PGESVLMISMVKKLQKL--TSKKVQLILTNKPKLIYVDP---SKLVVKGNIIWSDNSNDLSIQV--SSPSHFKIVTP-KK  465 (489)
Q Consensus       394 ~~~~i~~~g~~~k~~g~--~~k~r~~~lt~~p~l~y~d~---~~~~~kg~i~~~~~~~~~~~~~--~~~~~f~i~~p-~r  465 (489)
                      .|+ +++.|+|.+..+.  -+|.|+|+|-+.-.+|+...   ..-..+|.||+....+. .++.  ..+..|.|.+| .+
T Consensus        25 ~G~-li~~g~~~~~~~~~~~~k~R~~fLF~~~Ll~~k~~~~~~~~~~k~~i~l~~~~v~-~~~~~~~~~~~f~i~~~~~~  102 (132)
T d1v61a_          25 LGN-VIFMSQVVMQHGACEEKEERYFLLFSSVLIMLSASPRMSGFMYQGKIPIAGMVVN-RLDEIEGSDCMFEITGSTVE  102 (132)
T ss_dssp             TCC-CSCEEEEEBCCSSSSCCCEEEEEECSSCEEEEECSSSSSCCEEEEEECTTTCBCS-TTCSSSSSCCCEEEECSSSC
T ss_pred             ccC-EEEEEEEEEEEecCCCcceEEEEEeCCEEEEEEEcCCCceeEEeeecchhhcccc-ccccccCccceEEEeCCCCC
Confidence            365 5677888876543  37889999999999888742   24667999999985221 1111  23467999987 58


Q ss_pred             eEEEEcC-CccHHHHHHHHHHhc
Q 011287          466 VLSFEDA-KQRASQWKKAIEALQ  487 (489)
Q Consensus       466 ~y~~~d~-~~~~~~W~~~i~~~~  487 (489)
                      +|.|... +.+.++|+++|++++
T Consensus       103 ~~~l~a~s~eek~~Wv~~L~~~i  125 (132)
T d1v61a_         103 RIVVHCNNNQDFQEWMEQLNRLT  125 (132)
T ss_dssp             EEEECCCCSHHHHHHHHHHHHHH
T ss_pred             EEEEEcCCHHHHHHHHHHHHHHH
Confidence            9998854 588999999999986

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.92  E-value=7e-06  Score=75.54  Aligned_cols=134  Identities=12%  Similarity=0.092  Sum_probs=80.8

Q ss_pred             EeeeC-ceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC--CCccEEEEEEEcCCEEEEEEeccCC
Q 011287           53 YGVGS-YSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH--PGVVRLFFTFQDTFSLYMALESCEG  129 (489)
Q Consensus        53 LG~G~-~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~~~lylV~E~~~g  129 (489)
                      +..|. -+.||++.. .++..+.+|......      ...+..|..+++.+..  -.+.+++.+..+....|+||++++|
T Consensus        18 ~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G   90 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG   90 (255)
T ss_dssp             CSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred             cCCcccCCeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence            34444 468998875 457778899764432      2235667777776632  2356778888888899999999988


Q ss_pred             CChHH--------------HHHhCC-------CCC--HHHH-----HHHH---------------HHHHHHHHHHHhC--
Q 011287          130 GELFD--------------QITSKG-------HLS--EDEA-----RFYT---------------AEVVDALEYIHSM--  164 (489)
Q Consensus       130 g~L~~--------------~l~~~~-------~l~--e~~~-----~~i~---------------~qil~aL~~LH~~--  164 (489)
                      .++.+              .+.+-.       .+.  ....     ..+.               ......+..+...  
T Consensus        91 ~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  170 (255)
T d1nd4a_          91 QDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMP  170 (255)
T ss_dssp             EETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCC
T ss_pred             cccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCC
Confidence            66522              111100       000  0000     0000               0012223333332  


Q ss_pred             -----CcEeeccCCCCeeeCCCCCEEEeeccCcc
Q 011287          165 -----GLIHRDIKPENLLLTADGHIKIADFGSVK  193 (489)
Q Consensus       165 -----gIiHrDLKpeNILl~~~g~ikL~DFG~a~  193 (489)
                           .++|+|+.|.|||+++++.+-|+||+.+.
T Consensus       171 ~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         171 DGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             SSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                 27999999999999877667799999875

>d1maia_ b.55.1.1 (A:) Phospholipase C delta-1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Phospholipase C delta-1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=97.74  E-value=3.2e-05  Score=62.82  Aligned_cols=82  Identities=12%  Similarity=0.156  Sum_probs=56.1

Q ss_pred             eehhhhhhc-cceeEEEecCCeE-EEECCC--CCeeeeeeeccCCCCceEEEEcC--------------CCcEEEE--cC
Q 011287          404 VKKLQKLTS-KKVQLILTNKPKL-IYVDPS--KLVVKGNIIWSDNSNDLSIQVSS--------------PSHFKIV--TP  463 (489)
Q Consensus       404 ~~k~~g~~~-k~r~~~lt~~p~l-~y~d~~--~~~~kg~i~~~~~~~~~~~~~~~--------------~~~f~i~--~p  463 (489)
                      +.|-++.-| |+|+|.|+...++ +|.++.  ....+|.||++..   ..|....              ...|.|+  ++
T Consensus        17 l~K~~~~~~~k~R~f~L~~d~~~i~~~~~~~~~~~~~~~i~i~~I---~~V~~G~~s~~~~~~~~~~~~~~~FsIv~~~~   93 (119)
T d1maia_          17 LLKVKSSSWRRERFYKLQEDCKTIWQESRKVMRSPESQLFSIEDI---QEVRMGHRTEGLEKFARDIPEDRCFSIVFKDQ   93 (119)
T ss_dssp             EEEESSSSCEEEEEEEECTTSSEEEECCCCTTCCTTTTEEEGGGE---EEEEESSCSHHHHHHCTTSCGGGEEEEEESSS
T ss_pred             EEEeCCCCCCEEEEEEEcCCCCEEEEeCCCCCCCccceEEEHHHc---eEEEcCCCCchhhhcccCCCcCceEEEEEcCC
Confidence            444443334 6699999875554 554332  3345799999974   5555521              1248887  67


Q ss_pred             CceEEEEcCC-ccHHHHHHHHHHhcC
Q 011287          464 KKVLSFEDAK-QRASQWKKAIEALQN  488 (489)
Q Consensus       464 ~r~y~~~d~~-~~~~~W~~~i~~~~~  488 (489)
                      .||++|..++ .++..|+.+|+.+++
T Consensus        94 ~r~l~l~a~s~~~~~~Wv~~L~~L~~  119 (119)
T d1maia_          94 RNTLDLIAPSPADAQHWVQGLRKIIH  119 (119)
T ss_dssp             CCCEEEECSSHHHHHHHHHHHHHHHC
T ss_pred             CcEEEEEECCHHHHHHHHHHHHHHhC
Confidence            8999999765 899999999998764

>d1zc3b1 b.55.1.1 (B:171-279) Exocyst complex protein EXO84 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Exocyst complex protein EXO84
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=97.40  E-value=0.00049  Score=54.49  Aligned_cols=89  Identities=12%  Similarity=0.139  Sum_probs=64.7

Q ss_pred             CceEEEEEeeehhhhhh---ccceeEEEecCCeEEEEC-C---CCCeeeeeeeccCCCCceEEEE-----cCCCcEEEEc
Q 011287          395 GESVLMISMVKKLQKLT---SKKVQLILTNKPKLIYVD-P---SKLVVKGNIIWSDNSNDLSIQV-----SSPSHFKIVT  462 (489)
Q Consensus       395 ~~~i~~~g~~~k~~g~~---~k~r~~~lt~~p~l~y~d-~---~~~~~kg~i~~~~~~~~~~~~~-----~~~~~f~i~~  462 (489)
                      |..+|++|.|.+...-.   .++|.+.|=+.-.|+..- +   +.-..++.||++..    .++.     .-.+.|.|.+
T Consensus         1 GR~li~eG~l~~~~~~~~k~~~~~~~fLF~d~Ll~~k~~~~~~~~~~~~~~~~l~~~----~v~~~~d~~~~~n~f~i~~   76 (109)
T d1zc3b1           1 GQYLVYNGDLVEYEADHMAQLQRVHGFLMNDCLLVATWLPQRRGMYRYNALYPLDRL----AVVNVKDNPPMKDMFKLLM   76 (109)
T ss_dssp             CCCEEEEEEEEEEETTTCCEEEEEEEEEESSEEEEEEEECCTTSCEEEEEEEETTTC----EEEEECCBTTBSSEEEEEE
T ss_pred             CCEEEEeeeEEEEccCCCCcceeEEEEEecCEEEEEEEcCCcceEEEeeeEEeccce----EEEEeecccccceEEEEcc
Confidence            56678999998754333   456677777777766642 2   24577899999874    4433     1246899999


Q ss_pred             CCceEEEEcCC-ccHHHHHHHHHHhc
Q 011287          463 PKKVLSFEDAK-QRASQWKKAIEALQ  487 (489)
Q Consensus       463 p~r~y~~~d~~-~~~~~W~~~i~~~~  487 (489)
                      +.++|.|...+ .+..+|+++|++++
T Consensus        77 ~~~~~~~~a~s~~eK~~W~~~l~~a~  102 (109)
T d1zc3b1          77 FPESRIFQAENAKIKREWLEVLEETK  102 (109)
T ss_dssp             TTEEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             CCCEEEEEECCHHHHHHHHHHHHHHH
Confidence            99999998554 89999999999876

>d1dbha2 b.55.1.1 (A:418-550) Son of sevenless-1 (sos-1) {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Son of sevenless-1 (sos-1)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.38  E-value=0.00044  Score=56.91  Aligned_cols=92  Identities=12%  Similarity=0.222  Sum_probs=69.6

Q ss_pred             cccCCCceEEEEEeeehhhhhhccceeEEEecCCeEEEECC-----------CCCeeeeeeeccCCCCceEEEEc-----
Q 011287          390 QFLDPGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDP-----------SKLVVKGNIIWSDNSNDLSIQVS-----  453 (489)
Q Consensus       390 ~~~~~~~~i~~~g~~~k~~g~~~k~r~~~lt~~p~l~y~d~-----------~~~~~kg~i~~~~~~~~~~~~~~-----  453 (489)
                      .++.+|...+++|.+.|.++  .+.|++.|-|.-.+|+.-.           ..-.+|+.||++.    +.+...     
T Consensus        19 ~l~~~gr~li~eG~l~~~~~--~k~r~~fLF~d~Li~~k~~~~~~~~~~~~~~~y~~k~~i~l~~----~~v~~~~~~~~   92 (133)
T d1dbha2          19 DIGQCCNEFIMEGTLTRVGA--KHERHIFLFDGLMICCKSNHGQPRLPGASNAEYRLKEKFFMRK----VQINDKDDTNE   92 (133)
T ss_dssp             CGGGTCCCEEEEEEEEETTC--SSCEEEEEESSEEEEEEECTTCCCCTTSCCCSEEEEEEEESCS----CEEEECCCSSS
T ss_pred             CccccCcEEEEEeEEEEecC--CCeEEEEEecCeEEEEEecccccccccCCCccEEEEeeeeccc----ccccccCCCcc
Confidence            35667888999999998764  4789999999888777632           1235789999997    455432     


Q ss_pred             CCCcEEEEcC-CceEEEEcCC-ccHHHHHHHHHHhc
Q 011287          454 SPSHFKIVTP-KKVLSFEDAK-QRASQWKKAIEALQ  487 (489)
Q Consensus       454 ~~~~f~i~~p-~r~y~~~d~~-~~~~~W~~~i~~~~  487 (489)
                      -++.|.|.++ ++.|.|...+ .+..+|+++|.++.
T Consensus        93 ~~~~f~i~~~~~~~~~l~a~s~~eK~~W~~~l~~~~  128 (133)
T d1dbha2          93 YKHAFEIILKDENSVIFSAKSAEEKNNWMAALISLQ  128 (133)
T ss_dssp             CCSEEEECCTTSCCEEEECSSHHHHHHHHHHHHHHH
T ss_pred             cccceeEEcCCCcEEEEEECCHHHHHHHHHHHHHHH
Confidence            1468998774 6789888655 89999999999865

>d2dfka2 b.55.1.1 (A:240-401) Rho guanine nucleotide exchange factor 9, Collybistin {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Rho guanine nucleotide exchange factor 9, Collybistin
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=97.37  E-value=0.00061  Score=58.09  Aligned_cols=93  Identities=15%  Similarity=0.219  Sum_probs=69.2

Q ss_pred             ccCCCceEEEEEeeehhhh--hhccceeEEEecCCeEEEEC----CCCCeeeeeeeccCCCCceEEEEcC----------
Q 011287          391 FLDPGESVLMISMVKKLQK--LTSKKVQLILTNKPKLIYVD----PSKLVVKGNIIWSDNSNDLSIQVSS----------  454 (489)
Q Consensus       391 ~~~~~~~i~~~g~~~k~~g--~~~k~r~~~lt~~p~l~y~d----~~~~~~kg~i~~~~~~~~~~~~~~~----------  454 (489)
                      ++.++...+++|.|.+..+  .-++.|+|+|-+.-.+|+.-    ...-..++.|+++.    +.++...          
T Consensus        20 L~~~~r~Li~eG~L~~~~~~~~k~~~r~~fLF~d~Ll~~k~~~~~~~~y~~k~~i~L~~----~~v~~~~~~~~~~~~~~   95 (162)
T d2dfka2          20 ILDRSSELIYTGEMAWIYQPYGRNQQRVFFLFDHQMVLCKKDLIRRDILYYKGRIDMDK----YEVIDIEDGRDDDFNVS   95 (162)
T ss_dssp             GGGTCCCEEEEEEEEEESSTTCCCEEEEEEEETTEEEEEEECSSCTTCEEEEEEEEGGG----EEEEECCSEECSSSCCE
T ss_pred             ccccCceEEEEEEEEEEEcCCCCceeEEEEEeCCeEEEEEecCCCCCceEEccccchhh----ceeeecccccccccCcc
Confidence            4555667899999988643  33678999999999988863    23568899999987    4555421          


Q ss_pred             -CCcEEEEc--CCceEEEEcCC-ccHHHHHHHHHHhc
Q 011287          455 -PSHFKIVT--PKKVLSFEDAK-QRASQWKKAIEALQ  487 (489)
Q Consensus       455 -~~~f~i~~--p~r~y~~~d~~-~~~~~W~~~i~~~~  487 (489)
                       ++.|.|+.  .+++|.|...+ .+...|+++|.+.+
T Consensus        96 ~~~~f~i~~~~~~~~~~~~A~s~~eK~~W~~~l~~~~  132 (162)
T d2dfka2          96 MKNAFKLHNKETEEVHLFFAKKLEEKIRWLRAFREER  132 (162)
T ss_dssp             ESSEEEEEESSSSCEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             ccceEEEEECCCCeEEEEEeCCHHHHHHHHHHHHHHH
Confidence             25699973  46899999554 89999999998753

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.03  E-value=0.00097  Score=65.25  Aligned_cols=80  Identities=11%  Similarity=0.088  Sum_probs=53.7

Q ss_pred             CCCCeEEeeEEeeeCceEEEEEEEcC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccEEEEEE
Q 011287           43 SIQDFELGKIYGVGSYSKVVRAKKID-------TGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-HPGVVRLFFTF  114 (489)
Q Consensus        43 ~~~dy~~~~~LG~G~~g~Vy~a~~~~-------tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~  114 (489)
                      ..+++++ +.|+.|-.-.+|++....       ..+.|.+++....    .. .....+|..+++.+. +.-..++++++
T Consensus        41 ~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~----~~-~idr~~E~~i~~~ls~~gl~Pkll~~~  114 (395)
T d1nw1a_          41 PLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ET-ESHLVAESVIFTLLSERHLGPKLYGIF  114 (395)
T ss_dssp             CGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CC-HHHHHHHHHHHHHHHHTTSSSCEEEEE
T ss_pred             CccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc----ch-hhHHHHHHHHHHHHHhCCCCCeEEEEc
Confidence            3456665 577888888999998753       3467888887532    11 234567888888874 33344778777


Q ss_pred             EcCCEEEEEEeccCCCCh
Q 011287          115 QDTFSLYMALESCEGGEL  132 (489)
Q Consensus       115 ~~~~~lylV~E~~~gg~L  132 (489)
                      .+    .+|+||++|..|
T Consensus       115 ~~----g~I~efi~g~~l  128 (395)
T d1nw1a_         115 SG----GRLEEYIPSRPL  128 (395)
T ss_dssp             TT----EEEECCCCEEEC
T ss_pred             CC----ceEEEEeccccC
Confidence            54    588999987544

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.79  E-value=0.0011  Score=63.05  Aligned_cols=69  Identities=13%  Similarity=0.119  Sum_probs=42.6

Q ss_pred             ceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC---C--CccEE--EEEEEcCCEEEEEEeccCCC
Q 011287           58 YSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLDH---P--GVVRL--FFTFQDTFSLYMALESCEGG  130 (489)
Q Consensus        58 ~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~h---p--nIv~l--~~~~~~~~~lylV~E~~~gg  130 (489)
                      --.||+++. ++|..|++|+.....-    ....+..|...+..|..   |  ..+..  -..+......+.+++++.|.
T Consensus        35 EN~vy~v~~-~dg~~~VlK~~rp~~~----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          35 ENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             cceeEEEEc-CCCCEEEEEEeCCCCC----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            368999987 5689999999864321    23446667777766631   1  11111  12234466788999999764


Q ss_pred             C
Q 011287          131 E  131 (489)
Q Consensus       131 ~  131 (489)
                      .
T Consensus       110 ~  110 (325)
T d1zyla1         110 Q  110 (325)
T ss_dssp             E
T ss_pred             C
Confidence            3

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.36  E-value=0.0086  Score=55.99  Aligned_cols=145  Identities=15%  Similarity=0.066  Sum_probs=74.6

Q ss_pred             CCCCCeEEeeEEeeeCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-----CCCccEEE---EE
Q 011287           42 FSIQDFELGKIYGVGSYSKVVRAKKIDTGTVYALKIMDKKFITKENKTAYVKLERIVLDQLD-----HPGVVRLF---FT  113 (489)
Q Consensus        42 ~~~~dy~~~~~LG~G~~g~Vy~a~~~~tg~~vAiK~~~k~~~~~~~~~~~~~~E~~il~~l~-----hpnIv~l~---~~  113 (489)
                      +.+....-.+.|..|---+.|+++..  +..|++|++.+...     ...+..|..++..|.     .|..+...   .+
T Consensus        15 Y~lg~~~~~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~~~-----~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~   87 (316)
T d2ppqa1          15 YDVGSLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRVE-----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELL   87 (316)
T ss_dssp             BCCCCEEEEEEECC---EEEEEEEES--SCCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSC
T ss_pred             CCCCCceEeecCCCCcccCeEEEEEC--CCcEEEEEcCCCCC-----HHHHHHHHHHHHhhhhccccccccceecCCCcc
Confidence            44555566666777777889999863  34599999865421     123444555555542     22222210   11


Q ss_pred             EEcCCEEEEEEeccCCCChH--------------HHHHhCC---------CC------------------CHHHHHHHHH
Q 011287          114 FQDTFSLYMALESCEGGELF--------------DQITSKG---------HL------------------SEDEARFYTA  152 (489)
Q Consensus       114 ~~~~~~lylV~E~~~gg~L~--------------~~l~~~~---------~l------------------~e~~~~~i~~  152 (489)
                      ..-......++.+..|....              ..+....         ..                  ........+.
T Consensus        88 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  167 (316)
T d2ppqa1          88 GELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIR  167 (316)
T ss_dssp             EEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHH
T ss_pred             eeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHH
Confidence            11234455566666553321              0000000         00                  1111112222


Q ss_pred             HHHHHHHHHHh----CCcEeeccCCCCeeeCCCCCEEEeeccCcc
Q 011287          153 EVVDALEYIHS----MGLIHRDIKPENLLLTADGHIKIADFGSVK  193 (489)
Q Consensus       153 qil~aL~~LH~----~gIiHrDLKpeNILl~~~g~ikL~DFG~a~  193 (489)
                      .+...+.-.+.    .|+||+|+.+.||+++.+...-|+||+.+.
T Consensus       168 ~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         168 PEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             HHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            33333333332    479999999999999988777899999875

>d1ki1b2 b.55.1.1 (B:1439-1580) GEF of intersectin {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: GEF of intersectin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.46  E-value=0.0069  Score=49.90  Aligned_cols=86  Identities=16%  Similarity=0.243  Sum_probs=57.5

Q ss_pred             ceEEEEEeeehhhhhhccceeEEEecCCeEEEECCC-----------------CCeeeeeeeccCCCCceEEEEc-----
Q 011287          396 ESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPS-----------------KLVVKGNIIWSDNSNDLSIQVS-----  453 (489)
Q Consensus       396 ~~i~~~g~~~k~~g~~~k~r~~~lt~~p~l~y~d~~-----------------~~~~kg~i~~~~~~~~~~~~~~-----  453 (489)
                      ...|++|.|.|.++  .+.|.+.|=|.-.+|..-..                 .-+.++.|+++.    +.+...     
T Consensus        23 R~li~eG~L~k~~~--~k~r~~FLFnD~Ll~tK~~~~~~~~~~~~~~~~~~~~~~~~~~~i~l~~----l~v~~~~d~~~   96 (142)
T d1ki1b2          23 RKFLHSGKLYKAKN--NKELYGFLFNDFLLLTQITKPLGSSGTDKVFSPKSNLQYMYKTPIFLNE----VLVKLPTDPSG   96 (142)
T ss_dssp             CCEEEECCCBCSSS--CCCCEEEEESSEEEEEEEECC-------CCSCSSCCEEEECSSCEEGGG----EEEECCSSSCC
T ss_pred             eEEEEeeEEEEecC--CCEEEEEEecCEEEEEEeccccceeccccccccCCceeEEEEcccchhh----heeeccCCccc
Confidence            44799999977543  36788888777665542111                 123456678875    444442     


Q ss_pred             CCCcEEEEcCCceEEEEcCC-ccHHHHHHHHHHhc
Q 011287          454 SPSHFKIVTPKKVLSFEDAK-QRASQWKKAIEALQ  487 (489)
Q Consensus       454 ~~~~f~i~~p~r~y~~~d~~-~~~~~W~~~i~~~~  487 (489)
                      ....|.+..++++|.|..++ .+...|+++|++++
T Consensus        97 ~~~~~~~~~~~~~~~l~a~s~~ek~~W~~~I~~Ai  131 (142)
T d1ki1b2          97 DEPIFHISHIDRVYTLRAESINERTAWVQKIKAAS  131 (142)
T ss_dssp             C---CEEEETTEEEECBCSSHHHHHHHHHHHHHHH
T ss_pred             ceeEEEecCCCEEEEEEeCCHHHHHHHHHHHHHHH
Confidence            23467777899999999665 89999999999875

>d1ntya2 b.55.1.1 (A:1415-1535) Triple functional domain protein TRIO {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Triple functional domain protein TRIO
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.32  E-value=0.034  Score=44.04  Aligned_cols=89  Identities=18%  Similarity=0.333  Sum_probs=62.3

Q ss_pred             CCceEEEEEeee----hhhhhhccceeEEEecCCeEEEEC--CC----CCeeeeeeeccCCCCceEEEE---cCCCcEEE
Q 011287          394 PGESVLMISMVK----KLQKLTSKKVQLILTNKPKLIYVD--PS----KLVVKGNIIWSDNSNDLSIQV---SSPSHFKI  460 (489)
Q Consensus       394 ~~~~i~~~g~~~----k~~g~~~k~r~~~lt~~p~l~y~d--~~----~~~~kg~i~~~~~~~~~~~~~---~~~~~f~i  460 (489)
                      .|+ .|++|.+.    |....-.+.|.+.|=|.-.+|..-  ..    ....+..|+++.    +.++.   .....|.|
T Consensus        10 ~G~-Ll~~g~l~v~~~~~~~~k~~~R~~FLF~d~Ll~~K~k~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~f~i   84 (121)
T d1ntya2          10 QGE-LILQESFQVWDPKTLIRKGRERHLFLFEMSLVFSKEVKDSSGRSKYLYKSKLFTSE----LGVTEHVEGDPCKFAL   84 (121)
T ss_dssp             GCC-EEEEEEEEEECSSSSSCCEEEEEEEEESSEEEEEEEEECTTCCEEEEEEEEEEGGG----EEEECCCTTCTTEEEE
T ss_pred             CCc-EEEEeEEEEEcccccCCCCcEEEEEeeCCeEEEEEEecCCCCCceeEEEeeEEecc----eEEEEcCCCCCceEEE
Confidence            477 67888876    222222467999888888777642  11    346888899987    55554   34578988


Q ss_pred             E-----cCCceEEEEcCC-ccHHHHHHHHHHhc
Q 011287          461 V-----TPKKVLSFEDAK-QRASQWKKAIEALQ  487 (489)
Q Consensus       461 ~-----~p~r~y~~~d~~-~~~~~W~~~i~~~~  487 (489)
                      .     .+.+.|.|...+ .+.++|+++|++++
T Consensus        85 ~~~~~~~~~~~~~l~a~s~~eK~~W~~~I~~~i  117 (121)
T d1ntya2          85 WVGRTPTSDNKIVLKASSIENKQDWIKHIREVI  117 (121)
T ss_dssp             EESSSCCTTTCEEEECSSHHHHHHHHHHHHHHH
T ss_pred             EEecCCCCceEEEEECCCHHHHHHHHHHHHHHH
Confidence            4     356789888655 78999999999976

>d1fhoa_ b.55.1.1 (A:) UNC-89 {Nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: UNC-89
species: Nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=94.84  E-value=0.028  Score=44.76  Aligned_cols=92  Identities=8%  Similarity=0.005  Sum_probs=61.1

Q ss_pred             CCceEEEEEeeehhhhhhccceeEEEecCCeEEEECCC-----CCeeeeeeeccCCCCceEEEEcCCCcEEEEcCC--c-
Q 011287          394 PGESVLMISMVKKLQKLTSKKVQLILTNKPKLIYVDPS-----KLVVKGNIIWSDNSNDLSIQVSSPSHFKIVTPK--K-  465 (489)
Q Consensus       394 ~~~~i~~~g~~~k~~g~~~k~r~~~lt~~p~l~y~d~~-----~~~~kg~i~~~~~~~~~~~~~~~~~~f~i~~p~--r-  465 (489)
                      .|++++.-++....+.--.|.|++.|=+.-.||+....     .-..|+.|+++..  .+.-...+...|.|...+  + 
T Consensus         7 ~G~ll~~~~f~v~~~~~k~k~R~vFLF~~~ll~~K~~~~~~~~~y~~K~~i~l~~~--~v~e~~gd~~~F~i~~~~~~~~   84 (119)
T d1fhoa_           7 LGRIIRHDAFQVWEGDEPPKLRYVFLFRNKIMFTEQDASTSPPSYTHYSSIRLDKY--NIRQHTTDEDTIVLQPQEPGLP   84 (119)
T ss_dssp             CCCSSEEEEEEECSTTCSCEEEEEEEETTEEEEEEECCSSSSCCCSSCCEEESSSC--EEEEECTTCCEEEEECCSTTCC
T ss_pred             CCceEEEeEEEEEeCCCCceEEEEEEEcCeEEEEEeccCCCCceEEEecEEECCce--EEEEcCCCCcEEEEEeCCCCCC
Confidence            48877777777765554456799999998888876432     2457999999974  222223567899997433  2 


Q ss_pred             ----eEEEEc-CCccHHHHHHHHHHhc
Q 011287          466 ----VLSFED-AKQRASQWKKAIEALQ  487 (489)
Q Consensus       466 ----~y~~~d-~~~~~~~W~~~i~~~~  487 (489)
                          ++.+.. .+...+.|+++|.+.+
T Consensus        85 ~~~~~~~~~a~s~~~K~~Wv~~I~e~~  111 (119)
T d1fhoa_          85 SFRIKPKDFETSEYVRKAWLRDIAEEQ  111 (119)
T ss_dssp             CBCCCCCSSSSCSHHHHHHHHHHHTCC
T ss_pred             cceEEEEEecCCHHHHHHHHHHHHHHH
Confidence                233333 3355789999998754

>d1xcga2 b.55.1.1 (A:942-1081) Rho guanine nucleotide exchange factor 11, PDZ-RhoGEF {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Rho guanine nucleotide exchange factor 11, PDZ-RhoGEF
species: Human (Homo sapiens) [TaxId: 9606]

Probab=94.81  E-value=0.043  Score=44.66  Aligned_cols=96  Identities=8%  Similarity=0.190  Sum_probs=59.4

Q ss_pred             cccccCCCceEEEEEeee-hhhhhhccceeEEEecCCeEEEECCCC------------------CeeeeeeeccCCCCce
Q 011287          388 WQQFLDPGESVLMISMVK-KLQKLTSKKVQLILTNKPKLIYVDPSK------------------LVVKGNIIWSDNSNDL  448 (489)
Q Consensus       388 ~~~~~~~~~~i~~~g~~~-k~~g~~~k~r~~~lt~~p~l~y~d~~~------------------~~~kg~i~~~~~~~~~  448 (489)
                      |..+..++...|++|.|. |...--.+.|++.|=+.-.+|..-...                  ....+.++++.    +
T Consensus        15 ~~~l~~~~R~Li~eG~L~~k~~~~k~k~r~~FLF~D~Ll~tk~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~----~   90 (140)
T d1xcga2          15 FKSLDLTTRKMIHEGPLTWRISKDKTLDLHVLLLEDLLVLLQKQDEKLLLKCHSKTAVGSSDSKQTFSPVLKLNA----V   90 (140)
T ss_dssp             GGGCCGGGSCEEEEEEEEECCSSSCCCEEEEEEESSEEEEEEECSSCEECCC-------------CCCSEEEGGG----E
T ss_pred             hcccCcccceEEEEeeEEEEecCCCceEEEEEEecCeEEEEEecccceeeccccccccccccceeeecceEecce----E
Confidence            444444577789999996 443333456777777765555433211                  12234455554    3


Q ss_pred             EEEE--cCCCcEEEEc-----CCceEEEEcCC-ccHHHHHHHHHHhc
Q 011287          449 SIQV--SSPSHFKIVT-----PKKVLSFEDAK-QRASQWKKAIEALQ  487 (489)
Q Consensus       449 ~~~~--~~~~~f~i~~-----p~r~y~~~d~~-~~~~~W~~~i~~~~  487 (489)
                      .++.  ...+.|.|..     +.++|.|...+ .+..+|+++|++++
T Consensus        91 ~~~~~~~~~~~f~li~~~~~~~~~~~~l~A~s~~eK~~Wi~~i~~aI  137 (140)
T d1xcga2          91 LIRSVATDKRAFFIICTSKLGPPQIYELVALTSSDKNTWMELLEEAV  137 (140)
T ss_dssp             EEEECSSCSSEEEEEECCSSSTTCEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             EEecCCCCCCeEEEEEcCCCCCceEEEEEcCCHHHHHHHHHHHHHHH
Confidence            3433  3456788753     34778888654 89999999999976

>d1txda2 b.55.1.1 (A:1020-1133) Rho guanine nucleotide exchange factor 12 {Human (Homo sapiens), gamma isoform [TaxId: 9606]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Rho guanine nucleotide exchange factor 12
species: Human (Homo sapiens), gamma isoform [TaxId: 9606]

Probab=93.06  E-value=0.19  Score=39.15  Aligned_cols=85  Identities=9%  Similarity=0.106  Sum_probs=51.2

Q ss_pred             EEEEeeehhhhhh-ccceeEEEecCCeEEEECCC------------------CCeeeeeeeccCCCCceEEEEc--C-CC
Q 011287          399 LMISMVKKLQKLT-SKKVQLILTNKPKLIYVDPS------------------KLVVKGNIIWSDNSNDLSIQVS--S-PS  456 (489)
Q Consensus       399 ~~~g~~~k~~g~~-~k~r~~~lt~~p~l~y~d~~------------------~~~~kg~i~~~~~~~~~~~~~~--~-~~  456 (489)
                      |++|.+..+.+-- .+-|.+.|=|.-.|+.....                  ....+.-|+++.    +.+...  + ..
T Consensus         2 i~eG~L~~~~~~~k~~er~vFLF~d~Ll~~k~~~~k~~~~~~~~~~~~~~~~~~~~~~~i~l~~----l~v~e~~~d~~~   77 (114)
T d1txda2           2 IHEGPLVWKVNRDKTIDLYTLLLEDILVLLQKQDDRLVLRCHSKILASTADSKHTFSPVIKLST----VLVRQVATDNKA   77 (114)
T ss_dssp             EEEEEEEEESSSSCBCCEEEEEESSEEEEEEEETTEEECCC-------------CCCSEEEGGG----EEEEECCC-CCE
T ss_pred             ceeeeEEEEecCCCceEEEEEEecCeEEEEEecccccccccccccccccccceeeecCcEEccc----EEEEEcCCCCCC
Confidence            6778776333221 24577666666555554322                  123345688886    455542  3 34


Q ss_pred             cEEEEcCC---ceEEEEcCC-ccHHHHHHHHHHhc
Q 011287          457 HFKIVTPK---KVLSFEDAK-QRASQWKKAIEALQ  487 (489)
Q Consensus       457 ~f~i~~p~---r~y~~~d~~-~~~~~W~~~i~~~~  487 (489)
                      .|.|.+.+   ..|.|...+ .+-+.|+++|.++.
T Consensus        78 ~fli~~~~~~~~~y~l~A~s~~eK~~W~~~I~~~~  112 (114)
T d1txda2          78 LFVISMSDNGAQIYELVAQTVSEKTVWQDLICRMA  112 (114)
T ss_dssp             EEEEEECSSCEEEEEEECSSHHHHHHHHHHHHHHH
T ss_pred             EEEEEecCCCceEEEEEcCCHHHHHHHHHHHHHHh
Confidence            56665533   578888665 78999999999875

>d1kz7a2 b.55.1.1 (A:819-965) Dbl's big sister, Dbs {Mouse (Mus musculus) [TaxId: 10090]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Pleckstrin-homology domain (PH domain)
domain: Dbl's big sister, Dbs
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=89.64  E-value=0.76  Score=37.21  Aligned_cols=71  Identities=17%  Similarity=0.270  Sum_probs=51.0

Q ss_pred             cceeEEEecCCeEEEECC----------CCCeeeeeeeccCCCCceEEEEc---CCCcEEEE--cCCceEEEEcCC-ccH
Q 011287          413 KKVQLILTNKPKLIYVDP----------SKLVVKGNIIWSDNSNDLSIQVS---SPSHFKIV--TPKKVLSFEDAK-QRA  476 (489)
Q Consensus       413 k~r~~~lt~~p~l~y~d~----------~~~~~kg~i~~~~~~~~~~~~~~---~~~~f~i~--~p~r~y~~~d~~-~~~  476 (489)
                      +.|.+.|=+.-.+|+...          ..-.+|+.|+++.    +.+...   +...|.+.  +|...|.|...+ ..-
T Consensus        41 ~~R~~FLF~~~Li~cK~~~~~~~~~~~~~~y~~k~~~~~~~----~~v~~~~~~~~~~f~~~~~~~~~~~~l~a~s~eeK  116 (147)
T d1kz7a2          41 MQRHLFLHEKAVLFCKKREENGEGYEKAPSYSYKQSLNMTA----VGITENVKGDTKKFEIWYNAREEVYIIQAPTPEIK  116 (147)
T ss_dssp             EEEEEEEESSEEEEEEEECCCCSSCCCSCEEEEEEEEEGGG----EEEECCBTTBTTEEEEEETTTTEEEEEECSSHHHH
T ss_pred             ceEEEEEecCcEEEEEecccCCcccccCceEEEeeEEecCC----ceeEecCCCCcceEEEEeCCCCcEEEEEeCCHHHH
Confidence            458888888777776532          1246789999996    555542   34566665  578889998665 789


Q ss_pred             HHHHHHHHHhc
Q 011287          477 SQWKKAIEALQ  487 (489)
Q Consensus       477 ~~W~~~i~~~~  487 (489)
                      +.|+++|++++
T Consensus       117 ~~W~~~I~~~l  127 (147)
T d1kz7a2         117 AAWVNAIRKVL  127 (147)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHHH
Confidence            99999999865